Citrus Sinensis ID: 042107

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230--
Protein Sequence
MSNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFLA
Secondary Structure (PSIPRED)
ccccccccEEcccccccEEEccccccccccEEEccccccccccccEEEccccccEEEccccccccccccEEEccccccccccccccccccccccEEEEccccEEEEEEEccccEEEEEEEEccccccHHHHHHHHHHHHHccccccccEEEEccccccEEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHHcccccccEEEcccccccccccccccEEEcc
Secondary Structure Prediction (SSPRO)
cccccHEEEEcccccccccccccccccccccccccccccccccccEEEccccccEEcccHHHHHcccccEEEccccEEEEEcccHHHccccHHccccccccccEEEcEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHEEEEccccEEEEEEEcccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEEccccHHHHccccccccHHcc
Coil and Loop (DISEMBL)
MSNLKVLLRIDlstnnfscvfptTIEYNRLQDSLRNsigdltslksldlsnnnfsgaipipleklldlkdlnlsfntlegkiprpfrNFLEVFNLisrggfgsIYKARIQDGMEVVVKGFnlqyggafknldVECNMMKIIRHQNLIKIISSCSKDDFKALILEymphgslgkclstsnYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHcdlkssnvllddnmvAHFLA
Flexible Loop (DISEMBL)
MSNLKVLLRIdlstnnfscVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLegkiprpfrNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFLA
Low Complexity Region (SEG)
MSNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPleklldlkdlnlSFNTLEGKIPRPFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFLA
Disordered region (IsUnstruct)
****KVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHF**
Disordered Region (DISOPRED)
MSNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYG*AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFLA
Disordered Region (DISEMBL)
MSNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFLA
Disordered Region (DISPRO)
*SNLKVLLRIDLSTNNFSCVFPTTI******************LKSLDLS*NNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA*FL*
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MSNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFLA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	232	2.2.26 [Sep-21-2011]
C0LGP4	1010	Probable LRR receptor-lik	no	no	0.581	0.133	0.44	1e-26
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.564	0.133	0.436	2e-24
C0LGT6	1031	LRR receptor-like serine/	no	no	0.581	0.130	0.426	2e-23
Q9SD62	1025	Putative receptor-like pr	no	no	0.581	0.131	0.4	7e-22
Q9FID9	880	Probable receptor-like pr	no	no	0.788	0.207	0.330	1e-21
Q9FID8	873	Putative receptor-like pr	no	no	0.724	0.192	0.327	4e-21
C0LGI2	929	Probable LRR receptor-lik	no	no	0.568	0.142	0.429	5e-20
C0LGD9	871	Probable LRR receptor-lik	no	no	0.577	0.153	0.375	1e-19
O22187	834	Probable receptor-like pr	no	no	0.620	0.172	0.350	2e-18
Q9FN92	829	Probable receptor-like pr	no	no	0.568	0.159	0.380	2e-18

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  119 bits (299), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 66/150 (44%), Positives = 93/150 (62%), Gaps = 15/150 (10%)

Query: 94  NLISRGGFGSIYKARIQDGMEVV-VKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISS 152
           N++  G FG++YKA +    +VV VK  N+Q  GA K+   EC  +K IRH+NL+K++++
Sbjct: 706 NMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTA 765

Query: 153 CSK-----DDFKALILEYMPHGSLGKCLSTS--------NYILDFFQRLHIMIDVASAVE 199
           CS      ++F+ALI E+MP+GSL   L           +  L   +RL+I IDVAS ++
Sbjct: 766 CSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLD 825

Query: 200 YLHFGHSTHVIIHCDLKSSNVLLDDNMVAH 229
           YLH  H    I HCDLK SNVLLDD++ AH
Sbjct: 826 YLHV-HCHEPIAHCDLKPSNVLLDDDLTAH 854

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  112 bits (281), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 62/142 (43%), Positives = 88/142 (61%), Gaps = 11/142 (7%)

Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFN----LQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           +LI  G FG +YK  +++  +V VK  +    L++ G+FK    EC ++K  RH+NLI+I
Sbjct: 665 SLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKR---ECQILKRTRHRNLIRI 721

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYI---LDFFQRLHIMIDVASAVEYLHFGHS 206
           I++CSK  F AL+L  MP+GSL + L    Y    LD  Q ++I  DVA  + YLH  +S
Sbjct: 722 ITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHH-YS 780

Query: 207 THVIIHCDLKSSNVLLDDNMVA 228
              ++HCDLK SN+LLDD M A
Sbjct: 781 PVKVVHCDLKPSNILLDDEMTA 802

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  109 bits (272), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 64/150 (42%), Positives = 88/150 (58%), Gaps = 15/150 (10%)

Query: 94  NLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISS 152
           NLI  G FG+++K  +  +   V VK  NL   GA K+   EC   K IRH+NL+K+I+ 
Sbjct: 716 NLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITV 775

Query: 153 CSK-----DDFKALILEYMPHGSLGKCLSTSN--------YILDFFQRLHIMIDVASAVE 199
           CS      +DF+AL+ E+MP GSL   L   +          L   ++L+I IDVASA+E
Sbjct: 776 CSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALE 835

Query: 200 YLHFGHSTHVIIHCDLKSSNVLLDDNMVAH 229
           YLH  H    + HCD+K SN+LLDD++ AH
Sbjct: 836 YLHV-HCHDPVAHCDIKPSNILLDDDLTAH 864

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  103 bits (258), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 60/150 (40%), Positives = 87/150 (58%), Gaps = 15/150 (10%)

Query: 94  NLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISS 152
           NLI  G FG+++K  +      V +K  NL   GA K+   EC  +  IRH+NL+K+++ 
Sbjct: 723 NLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTI 782

Query: 153 CSK-----DDFKALILEYMPHGSLGKCL--------STSNYILDFFQRLHIMIDVASAVE 199
           CS      +DF+AL+ E+MP+G+L   L           +  L  F RL+I IDVASA+ 
Sbjct: 783 CSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALV 842

Query: 200 YLHFGHSTHVIIHCDLKSSNVLLDDNMVAH 229
           YLH  +  + I HCD+K SN+LLD ++ AH
Sbjct: 843 YLHT-YCHNPIAHCDIKPSNILLDKDLTAH 871

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FID9|Y5389_ARATH Probable receptor-like protein kinase At5g38990 OS=Arabidopsis thaliana GN=At5g38990 PE=2 SV=1

 Score =  103 bits (256), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 103/203 (50%), Gaps = 20/203 (9%)

Query: 31  QDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFL 90
           + S  +S G L  L     +N   + ++P  L +   + ++  + N  E K+        
Sbjct: 480 KPSTNSSWGPL--LHGTGSTNTKSASSLPSDLCRRFSIYEIKSATNDFEEKL-------- 529

Query: 91  EVFNLISRGGFGSIYKARIQDGMEVV-VKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
               +I  GGFGS+YK RI  G  +V VK   +      K  D E  M+  +RH +L+ +
Sbjct: 530 ----IIGVGGFGSVYKGRIDGGATLVAVKRLEITSNQGAKEFDTELEMLSKLRHVHLVSL 585

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCL----STSNYILDFFQRLHIMIDVASAVEYLHFGH 205
           I  C  D+   L+ EYMPHG+L   L      S+  L + +RL I I  A  ++YLH G 
Sbjct: 586 IGYCDDDNEMVLVYEYMPHGTLKDHLFRRDKASDPPLSWKRRLEICIGAARGLQYLHTG- 644

Query: 206 STHVIIHCDLKSSNVLLDDNMVA 228
           + + IIH D+K++N+LLD+N VA
Sbjct: 645 AKYTIIHRDIKTTNILLDENFVA 667

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FID8|Y5900_ARATH Putative receptor-like protein kinase At5g39000 OS=Arabidopsis thaliana GN=At5g39000 PE=3 SV=1

 Score =  101 bits (252), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 61/186 (32%), Positives = 98/186 (52%), Gaps = 18/186 (9%)

Query: 48  DLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNLISRGGFGSIYKA 107
           D +N   + ++P  L +   + ++  + N  E K+            +I  GGFGS+YK 
Sbjct: 488 DSTNTKPAKSLPADLCRRFSIFEIKSATNDFEDKL------------IIGVGGFGSVYKG 535

Query: 108 RIQDGMEVV-VKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM 166
           +I  G  +V VK   +      K  + E  M+  +RH +L+ +I  C +D+   L+ EYM
Sbjct: 536 QIDGGATLVAVKRLEITSNQGAKEFETELEMLSKLRHVHLVSLIGYCDEDNEMVLVYEYM 595

Query: 167 PHGSLGKCL----STSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL 222
           PHG+L   L     TS+  L + +RL I I  A  ++YLH G + + IIH D+K++N+LL
Sbjct: 596 PHGTLKDHLFRRDKTSDPPLSWKRRLEICIGAARGLQYLHTG-AKYTIIHRDIKTTNILL 654

Query: 223 DDNMVA 228
           D+N V 
Sbjct: 655 DENFVT 660

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1

 Score = 97.8 bits (242), Expect = 5e-20,   Method: Composition-based stats.
 Identities = 58/135 (42%), Positives = 79/135 (58%), Gaps = 3/135 (2%)

Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSK 155
           + RG FGS+Y  R++DG EV VK          +    E  ++  I H+NL+ +I  C +
Sbjct: 612 VGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHRNLVPLIGYCEE 671

Query: 156 DDFKALILEYMPHGSLGKCL-STSNYI-LDFFQRLHIMIDVASAVEYLHFGHSTHVIIHC 213
            D + L+ EYM +GSLG  L  +S+Y  LD+  RL I  D A  +EYLH G +   IIH 
Sbjct: 672 ADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAAKGLEYLHTGCNPS-IIHR 730

Query: 214 DLKSSNVLLDDNMVA 228
           D+KSSN+LLD NM A
Sbjct: 731 DVKSSNILLDINMRA 745

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGD9|Y1756_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07560 OS=Arabidopsis thaliana GN=At1g07560 PE=2 SV=1

 Score = 96.7 bits (239), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 51/136 (37%), Positives = 77/136 (56%), Gaps = 2/136 (1%)

Query: 95  LISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 154
           ++ +GGFG +Y   I    EV VK  +      +K    E  ++  + H NL+ ++  C 
Sbjct: 575 VLGKGGFGMVYHGYINGTEEVAVKLLSPSSAQGYKEFKTEVELLLRVYHTNLVSLVGYCD 634

Query: 155 KDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCD 214
           + D  ALI +YM +G L K  S S+ I+ +  RL+I +D AS +EYLH G    +I+H D
Sbjct: 635 EKDHLALIYQYMVNGDLKKHFSGSS-IISWVDRLNIAVDAASGLEYLHIG-CKPLIVHRD 692

Query: 215 LKSSNVLLDDNMVAHF 230
           +KSSN+LLDD + A  
Sbjct: 693 VKSSNILLDDQLQAKL 708

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O22187|Y2232_ARATH Probable receptor-like protein kinase At2g23200 OS=Arabidopsis thaliana GN=At2g23200 PE=3 SV=1

 Score = 92.8 bits (229), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 53/151 (35%), Positives = 80/151 (52%), Gaps = 7/151 (4%)

Query: 85  PFRNFLEVFN------LISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMM 138
           PF + L   N      LI +GGFG +YKA + DG +  +K      G        E  ++
Sbjct: 477 PFTDILSATNNFDEQLLIGKGGFGYVYKAILPDGTKAAIKRGKTGSGQGILEFQTEIQVL 536

Query: 139 KIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI-LDFFQRLHIMIDVASA 197
             IRH++L+ +   C ++    L+ E+M  G+L + L  SN   L + QRL I I  A  
Sbjct: 537 SRIRHRHLVSLTGYCEENSEMILVYEFMEKGTLKEHLYGSNLPSLTWKQRLEICIGAARG 596

Query: 198 VEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
           ++YLH   S   IIH D+KS+N+LLD++ +A
Sbjct: 597 LDYLHSSGSEGAIIHRDVKSTNILLDEHNIA 627

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FN92|Y5597_ARATH Probable receptor-like protein kinase At5g59700 OS=Arabidopsis thaliana GN=At5g59700 PE=1 SV=1

 Score = 92.8 bits (229), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 51/134 (38%), Positives = 76/134 (56%), Gaps = 2/134 (1%)

Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSK 155
           I  GGFG +YK  + DG +V VK  N +          E  M+   RH++L+ +I  C +
Sbjct: 488 IGVGGFGKVYKGELHDGTKVAVKRANPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDE 547

Query: 156 DDFKALILEYMPHGSLGKCLSTSNYI-LDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCD 214
           ++   L+ EYM +G+L   L  S  + L + QRL I I  A  + YLH G +  V IH D
Sbjct: 548 NNEMILVYEYMENGTLKSHLYGSGLLSLSWKQRLEICIGSARGLHYLHTGDAKPV-IHRD 606

Query: 215 LKSSNVLLDDNMVA 228
           +KS+N+LLD+N++A
Sbjct: 607 VKSANILLDENLMA 620

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	232
296085726	932	unnamed protein product [Vitis vinifera]	0.982	0.244	0.446	4e-53
302143445	2843	unnamed protein product [Vitis vinifera]	0.943	0.077	0.512	3e-50
298204751	1979	unnamed protein product [Vitis vinifera]	0.982	0.115	0.432	7e-50
297740829	1892	unnamed protein product [Vitis vinifera]	0.818	0.100	0.522	4e-47
302143439	830	unnamed protein product [Vitis vinifera]	0.883	0.246	0.445	5e-47
297735349	2145	unnamed protein product [Vitis vinifera]	0.969	0.104	0.406	5e-46
147866276	1326	hypothetical protein VITISV_033547 [Viti	0.982	0.171	0.440	5e-45
147864989	797	hypothetical protein VITISV_033877 [Viti	0.982	0.286	0.401	8e-45
302143440	929	unnamed protein product [Vitis vinifera]	0.879	0.219	0.432	1e-44
224139658	1019	predicted protein [Populus trichocarpa]	0.581	0.132	0.617	5e-42

>gi|296085726|emb|CBI29526.3| unnamed protein product [Vitis vinifera]

 Score =  213 bits (543), Expect = 4e-53,   Method: Compositional matrix adjust.
 Identities = 125/280 (44%), Positives = 165/280 (58%), Gaps = 52/280 (18%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPT-----------TIEYNRLQDSLRNSIGDLTSLKSLDL 49
           + N+K +  +DLS N  S   P+           ++  NRLQ  +    GDL SL+SLDL
Sbjct: 471 VGNMKSITTLDLSKNLVSGYIPSKMGKLQSLITLSLSQNRLQGPIPIEFGDLVSLESLDL 530

Query: 50  SNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPR--PFRNFL-EVF------------- 93
           S NN SG IP  LE L+ LK LN+S N L+G+IP   PF NF  E F             
Sbjct: 531 SQNNLSGTIPKSLEALIYLKYLNVSLNKLQGEIPNGGPFINFTAESFIRDNMEIPTPIDS 590

Query: 94  ------------------------NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFK 129
                                   NLI +G  G +YK  + +G+ V +K FNL++ GA +
Sbjct: 591 WLPGTHEKISHQQLLYATNDFGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALR 650

Query: 130 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLH 189
           + D EC +M+ IRH+NL++II+ CS  DFKAL+LEYMP+GSL K L + NY LD  QRL+
Sbjct: 651 SFDSECEVMQGIRHRNLVRIITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLN 710

Query: 190 IMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAH 229
           IMIDVASA+EYLH   S+ +++HCDLK +NVLLDD+MVAH
Sbjct: 711 IMIDVASALEYLHHDCSS-LVVHCDLKPNNVLLDDDMVAH 749

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143445|emb|CBI22006.3| unnamed protein product [Vitis vinifera]

 Score =  204 bits (518), Expect = 3e-50,   Method: Compositional matrix adjust.
 Identities = 121/236 (51%), Positives = 153/236 (64%), Gaps = 17/236 (7%)

Query: 10   IDLSTNNFSCVFPTTI-EYNRLQDSLR-----NSIGDLTSLKSLDLSNNNFSGAIPIPLE 63
            +DLS+N      P+      RL++        N+I  L +L  L LS+N   G +P  LE
Sbjct: 2457 LDLSSNKLPGTIPSYFGNLTRLRNIYSTNYPWNTISLLQNLLQLFLSHNKLQGHMPPNLE 2516

Query: 64   KLLDLKDLNLSFNTLEGKIPR--PFRNF--------LEVFNLISRGGFGSIYKARIQDGM 113
             L  LK LN+SFN ++G+IP   PF NF        L ++NLI +G  G +YK  + DG+
Sbjct: 2517 ALKYLKYLNVSFNKVQGEIPNGGPFANFTAESFISNLALYNLIGKGSLGMVYKGVLSDGL 2576

Query: 114  EVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGK 173
             V VK FNL+  GAFK+ +VEC +M+ IRH+NL KIISSCS  DFKAL+LEYMP+GSL K
Sbjct: 2577 IVAVKVFNLELQGAFKSFEVECEVMRNIRHRNLAKIISSCSNLDFKALVLEYMPNGSLEK 2636

Query: 174  CLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAH 229
             L +  Y LDF QRL IMIDVAS +EYLH  +S  V +HCDLK SNVLLDD+MVAH
Sbjct: 2637 WLYSHKYYLDFVQRLKIMIDVASGLEYLHHDYSNPV-VHCDLKPSNVLLDDDMVAH 2691

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|298204751|emb|CBI25249.3| unnamed protein product [Vitis vinifera]

 Score =  202 bits (515), Expect = 7e-50,   Method: Compositional matrix adjust.
 Identities = 125/289 (43%), Positives = 161/289 (55%), Gaps = 61/289 (21%)

Query: 1    MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDL 49
            M NLKVL++IDLS N  S   P+ I            +NR +  + +S  +L SL+ +DL
Sbjct: 1061 MGNLKVLVKIDLSRNQLSGEIPSNIGGLQDLTSLSLAHNRFEGPILHSFSNLKSLEFMDL 1120

Query: 50   SNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPR--PFRNF------------------ 89
            S+N   G IP  LE L+ LK L++SFN L G+IP   PF NF                  
Sbjct: 1121 SDNALFGEIPKSLEGLVYLKYLDVSFNGLYGEIPPEGPFANFSAESFMMNKALCRKRNAV 1180

Query: 90   ------------------LEVF---------NLISRGGFGSIYKARIQDGMEVVVKGFNL 122
                               E+F         NL+ RG  GS+Y+  + DG    +K FNL
Sbjct: 1181 LPTQSESLLTATWRRISYQEIFQATNGFSAGNLLGRGSLGSVYRGTLSDGKNAAIKVFNL 1240

Query: 123  QYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKD--DFKALILEYMPHGSLGKCLSTSNY 180
            Q   AFK+ D EC +M  IRH+NLIKI+SSCS    DFKAL+LEY+P+GSL + L + NY
Sbjct: 1241 QEEAAFKSFDAECEVMHHIRHRNLIKIVSSCSNSYIDFKALVLEYVPNGSLERWLYSHNY 1300

Query: 181  ILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAH 229
             LD  QRL+IMIDVA A+EYLH G ST V +HCDLK SN+LLD++   H
Sbjct: 1301 CLDILQRLNIMIDVALAMEYLHHGCSTPV-VHCDLKPSNILLDEDFGGH 1348

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297740829|emb|CBI31011.3| unnamed protein product [Vitis vinifera]

 Score =  193 bits (491), Expect = 4e-47,   Method: Compositional matrix adjust.
 Identities = 103/197 (52%), Positives = 138/197 (70%), Gaps = 7/197 (3%)

Query: 39   GDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPR--PFRNFLEVFNLI 96
            GDL SL+SLDLS NN SG IP  LE L+ LK LN+SFN L+G+IP   PF  F     + 
Sbjct: 1555 GDLVSLESLDLSQNNLSGTIPKTLEALIYLKYLNVSFNKLQGEIPNGGPFVKFTAESFMF 1614

Query: 97   SRGGFGS----IYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISS 152
            +    G+    +    + +G+ V +K FNL++ GA ++ + EC +M+ IRH+NL++II+ 
Sbjct: 1615 NEALCGAPHFQVMAWVLSNGLTVAIKVFNLEFQGALRSFNSECEVMQGIRHRNLVRIITC 1674

Query: 153  CSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIH 212
            CS  DFKAL+L+YMP+GSL K L +  Y LD  QRL+IMIDVASA+EYLH   S+ +++H
Sbjct: 1675 CSNLDFKALVLKYMPNGSLEKLLYSHYYFLDLIQRLNIMIDVASALEYLHHDCSS-LVVH 1733

Query: 213  CDLKSSNVLLDDNMVAH 229
            CDLK SNVLLDD+MVAH
Sbjct: 1734 CDLKPSNVLLDDDMVAH 1750

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143439|emb|CBI22000.3| unnamed protein product [Vitis vinifera]

 Score =  193 bits (491), Expect = 5e-47,   Method: Compositional matrix adjust.
 Identities = 110/247 (44%), Positives = 146/247 (59%), Gaps = 42/247 (17%)

Query: 24  TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKI- 82
           ++  N LQ  +    GD+ SL+SLDLS NN SG IP  LE L+ LK LN+SFN  +G+I 
Sbjct: 488 SLSKNNLQGPIPLKFGDVVSLESLDLSWNNLSGTIPQSLEALIYLKHLNVSFNKRQGEIR 547

Query: 83  -----------------------------PRPFR-----------NFLEVFNLISRGGFG 102
                                        P  +R           N+    NLI +G  G
Sbjct: 548 NGGPFVNFTAKSFISNEALYIPIQVDSSLPTTYRKISHQELLHATNYFSEGNLIGKGSMG 607

Query: 103 SIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI 162
           ++YK  + DG+   +K FNL++ G+FK  + EC +M+ IRH+NLIKIISSCS   FKAL+
Sbjct: 608 TVYKGVLFDGLTAAIKVFNLEFLGSFKGFEAECEVMRNIRHRNLIKIISSCSNLGFKALV 667

Query: 163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL 222
           LE+MP+ SL + L + NY LD  QRL+IMIDVASA+EYLH  +S  V +HCDLK +NVLL
Sbjct: 668 LEFMPNRSLERWLYSHNYCLDLIQRLNIMIDVASALEYLHHDYSNPV-VHCDLKPNNVLL 726

Query: 223 DDNMVAH 229
           D++ VAH
Sbjct: 727 DEDRVAH 733

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297735349|emb|CBI17789.3| unnamed protein product [Vitis vinifera]

 Score =  190 bits (482), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 115/283 (40%), Positives = 156/283 (55%), Gaps = 58/283 (20%)

Query: 3   NLKVLLRIDLSTNNFSCVFPT-----------TIEYNRLQDSLRNSIGDLTSLKSLDLSN 51
           ++K+L  +DLS N  S   PT            +  N    S+  S+G+L +L  +DLS+
Sbjct: 213 SMKMLQTMDLSWNRISGNIPTILGAFESLSSLNLSGNLFWGSIPESLGELITLDYMDLSH 272

Query: 52  NNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPR--------------PFR---------- 87
           NN SG+IP  L  L  L+ LNLSFN L G+IPR               +R          
Sbjct: 273 NNLSGSIPKLLVALSHLRHLNLSFNKLSGEIPRDGLPILVALVLLMIKYRQSKVETLNTV 332

Query: 88  ---------------------NFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG 126
                                +F E  N++  G FGS++K  + +G  V VK  NLQ  G
Sbjct: 333 DVAPAVEHRMISYQELRHATNDFSEA-NILGVGSFGSVFKGLLSEGTLVAVKVLNLQLEG 391

Query: 127 AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQ 186
           AFK+ D EC ++  +RH+NL+K+I+SCS  + +AL+L+YMP+GSL K L + NY L  FQ
Sbjct: 392 AFKSFDAECKVLARVRHRNLVKVITSCSNPELRALVLQYMPNGSLEKWLYSFNYSLSLFQ 451

Query: 187 RLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAH 229
           R+ I++DVA A+EYLH G S  V +HCDLK SNVLLDD MVAH
Sbjct: 452 RVSILLDVALALEYLHHGQSEPV-VHCDLKPSNVLLDDEMVAH 493

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147866276|emb|CAN79935.1| hypothetical protein VITISV_033547 [Vitis vinifera]

 Score =  186 bits (473), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 115/261 (44%), Positives = 150/261 (57%), Gaps = 33/261 (12%)

Query: 1    MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDL 49
            + N+K +  +DLS N  S   P  I             N+LQ S+    GDL SL+S+DL
Sbjct: 925  VGNMKSITTLDLSKNLISGYIPRRIGELQNLVNLSLSQNKLQGSIPVEFGDLLSLESMDL 984

Query: 50   SNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPR--PFRNFLEVFNLISRGGFGSIYKA 107
            S NN SG IP  LE  + LK LN+SFN L+ +I    PF NF+    + ++   G+ +  
Sbjct: 985  SRNNLSGTIPKSLEAFIYLKYLNVSFNKLQEEISNGGPFXNFIAELFIFNKALCGARHFQ 1044

Query: 108  RIQDG-------------------MEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIK 148
             I                      + V    FNL++ GA ++ D EC +M+ I H+NLI+
Sbjct: 1045 VIACDKNNCTQSWKTKSFILKYILLPVGSTVFNLEFQGALRSFDSECEVMQGICHRNLIR 1104

Query: 149  IISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH 208
            II+ CS  DFKAL+LEYMP GSL K L + NY LD FQRL IMIDVASA+EYLH      
Sbjct: 1105 IITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLFQRLTIMIDVASALEYLHH-DCLS 1163

Query: 209  VIIHCDLKSSNVLLDDNMVAH 229
            +++HCDLK SNVLLD+NMVAH
Sbjct: 1164 LVVHCDLKPSNVLLDNNMVAH 1184

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147864989|emb|CAN79365.1| hypothetical protein VITISV_033877 [Vitis vinifera]

 Score =  186 bits (471), Expect = 8e-45,   Method: Compositional matrix adjust.
 Identities = 114/284 (40%), Positives = 151/284 (53%), Gaps = 56/284 (19%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDL 49
           M ++K+L  +DLS N  S   PT +             N    S+  S+G+L +L  +DL
Sbjct: 372 MRSIKMLQTMDLSWNRISGDIPTILGAFESLSSLDLSGNLFWGSIPESLGELITLDYMDL 431

Query: 50  SNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPR------------------------- 84
           S+NN SG+IP  L  L  L+ LNLSFN L G+IPR                         
Sbjct: 432 SHNNLSGSIPKSLVALSHLRHLNLSFNKLSGEIPRDGLPILVALVLLMIKXRQSKVETLX 491

Query: 85  ----------------PFRNFLEVF---NLISRGGFGSIYKARIQDGMEVVVKGFNLQYG 125
                             R+    F   N++  G FGS++K  + +G  V VK  NLQ  
Sbjct: 492 TVDVAPAVEHRMISYQELRHATXDFSEANILGVGSFGSVFKGLLSEGTLVAVKVLNLQLE 551

Query: 126 GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFF 185
           GAFK+ D EC ++  +RH+NL+K I+SCS  + +AL+L+YM +GSL K L + NY L  F
Sbjct: 552 GAFKSFDAECKVLARVRHRNLVKXITSCSNPELRALVLQYMXNGSLEKWLYSFNYXLSLF 611

Query: 186 QRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAH 229
           QR+ I  DVA A+EYLH G S  V +HCDLK SNVLLDD MVAH
Sbjct: 612 QRVSIXXDVALALEYLHHGQSEPV-VHCDLKPSNVLLDDEMVAH 654

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302143440|emb|CBI22001.3| unnamed protein product [Vitis vinifera]

 Score =  185 bits (470), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 116/268 (43%), Positives = 152/268 (56%), Gaps = 64/268 (23%)

Query: 25  IEYNRLQDSLRNSIGDLT-SLKSLDLSNNNFSGAIP---------------IP--LEKLL 66
           IE N L+  L NS+G+L+ SL+ L ++ N   G+IP               IP  L+ L 
Sbjct: 521 IEDNPLKGILPNSLGNLSISLEKLGIAGNRLRGSIPNDLCRLKNLGYLFLIIPKSLKALT 580

Query: 67  DLKDLNLSFNTLEGKIPR--PFRNF--------------LEVF----------------- 93
            LK LN+SFN L+G+IP   PF NF              LEV                  
Sbjct: 581 YLKYLNVSFNKLQGEIPDGGPFMNFTAESFIFNEALRKNLEVPTPIDSWLPGSHEKISHQ 640

Query: 94  ------------NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKII 141
                       NLI +G    +YK  + +G+ V VK FNL++ GAF++ D EC +M+ I
Sbjct: 641 QLLYATNYFGEDNLIGKGSLSMVYKGVLSNGLTVAVKVFNLEFQGAFRSFDSECEVMQSI 700

Query: 142 RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL 201
           RH+NL+KII+ CS  DFKAL+LEYMP GSL K L + NY LD  QRL+IMIDVASA+EYL
Sbjct: 701 RHRNLVKIITCCSNLDFKALVLEYMPKGSLDKWLYSHNYFLDLIQRLNIMIDVASALEYL 760

Query: 202 HFGHSTHVIIHCDLKSSNVLLDDNMVAH 229
           H      +++HCDLK +N+LLDD+MVAH
Sbjct: 761 HH-DCPSLVVHCDLKPNNILLDDDMVAH 787

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224139658|ref|XP_002323215.1| predicted protein [Populus trichocarpa] gi|222867845|gb|EEF04976.1| predicted protein [Populus trichocarpa]

 Score =  176 bits (447), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 84/136 (61%), Positives = 106/136 (77%), Gaps = 1/136 (0%)

Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSC 153
           NL+  G FGS+Y+ R++DG+ V VK FNLQ   AF++ D EC +M+ IRH+NL+KII SC
Sbjct: 735 NLLGIGSFGSVYQGRLRDGLNVAVKIFNLQLQRAFRSFDTECEIMRNIRHRNLVKIICSC 794

Query: 154 SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHC 213
           S  DFKAL+LEYMP GSL K L + NY LD  QR++IMIDVASA+EYLH G+ + V +HC
Sbjct: 795 SNLDFKALVLEYMPKGSLEKWLYSHNYCLDIIQRVNIMIDVASALEYLHHGYPSPV-VHC 853

Query: 214 DLKSSNVLLDDNMVAH 229
           DLK SNVLLD++MVAH
Sbjct: 854 DLKPSNVLLDEDMVAH 869

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	232
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.581	0.131	0.408	1.9e-33
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.581	0.133	0.433	3.2e-32
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.581	0.133	0.446	1.1e-31
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.564	0.133	0.436	9.2e-31
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.581	0.133	0.406	1e-30
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.577	0.130	0.417	1e-29
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.581	0.130	0.426	2.6e-29
TAIR|locus:2175703	502	AT5G39390 [Arabidopsis thalian	0.568	0.262	0.444	7.5e-28
TAIR|locus:2120412	992	BAM3 "BARELY ANY MERISTEM 3" [	0.581	0.136	0.374	1e-25
TAIR|locus:2051628	1008	PSKR1 "phytosulfokin receptor	0.607	0.139	0.351	3.6e-25

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 286 (105.7 bits), Expect = 1.9e-33, Sum P(3) = 1.9e-33
 Identities = 60/147 (40%), Positives = 93/147 (63%)

Query:    94 NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSC 153
             NL+  G FGS+YK ++     V VK   L+   A K+   EC  ++ +RH+NL+KI++ C
Sbjct:   712 NLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTIC 771

Query:   154 SK-----DDFKALILEYMPHGSLGKCL--STSNYI----LDFFQRLHIMIDVASAVEYLH 202
             S      +DFKA++ ++MP+GSL   +   T++      L+  +R+ I++DVA A++YLH
Sbjct:   772 SSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLH 831

Query:   203 FGHSTHVIIHCDLKSSNVLLDDNMVAH 229
               H    ++HCD+KSSNVLLD +MVAH
Sbjct:   832 -RHGPEPVVHCDIKSSNVLLDSDMVAH 857

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 296 (109.3 bits), Expect = 3.2e-32, Sum P(2) = 3.2e-32
 Identities = 65/150 (43%), Positives = 93/150 (62%)

Query:    94 NLISRGGFGSIYKARIQDGMEVV-VKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISS 152
             N++  G FG+++KA +Q   ++V VK  N+Q  GA K+   EC  +K IRH+NL+K++++
Sbjct:   705 NIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTA 764

Query:   153 CSKDDF-----KALILEYMPHGSLGKCLSTSNY--------ILDFFQRLHIMIDVASAVE 199
             C+  DF     +ALI E+MP+GSL K L              L   +RL+I IDVAS ++
Sbjct:   765 CASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLD 824

Query:   200 YLHFGHSTHVIIHCDLKSSNVLLDDNMVAH 229
             YLH  H    I HCDLK SN+LLDD++ AH
Sbjct:   825 YLHV-HCHEPIAHCDLKPSNILLDDDLTAH 853

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 293 (108.2 bits), Expect = 1.1e-31, Sum P(2) = 1.1e-31
 Identities = 67/150 (44%), Positives = 91/150 (60%)

Query:    94 NLISRGGFGSIYKARIQDGMEVV-VKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISS 152
             N++  G FG++YKA +    +VV VK  N+Q  GA K+   EC  +K IRH+NL+K++++
Sbjct:   706 NMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTA 765

Query:   153 CSKDDF-----KALILEYMPHGSLGKCLSTSNY--------ILDFFQRLHIMIDVASAVE 199
             CS  DF     +ALI E+MP+GSL   L              L   +RL+I IDVAS ++
Sbjct:   766 CSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLD 825

Query:   200 YLHFGHSTHVIIHCDLKSSNVLLDDNMVAH 229
             YLH  H    I HCDLK SNVLLDD++ AH
Sbjct:   826 YLHV-HCHEPIAHCDLKPSNVLLDDDLTAH 854

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 279 (103.3 bits), Expect = 9.2e-31, Sum P(2) = 9.2e-31
 Identities = 62/142 (43%), Positives = 88/142 (61%)

Query:    94 NLISRGGFGSIYKARIQDGMEVVVKGFN----LQYGGAFKNLDVECNMMKIIRHQNLIKI 149
             +LI  G FG +YK  +++  +V VK  +    L++ G+FK    EC ++K  RH+NLI+I
Sbjct:   665 SLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKR---ECQILKRTRHRNLIRI 721

Query:   150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYI---LDFFQRLHIMIDVASAVEYLHFGHS 206
             I++CSK  F AL+L  MP+GSL + L    Y    LD  Q ++I  DVA  + YLH  +S
Sbjct:   722 ITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHH-YS 780

Query:   207 THVIIHCDLKSSNVLLDDNMVA 228
                ++HCDLK SN+LLDD M A
Sbjct:   781 PVKVVHCDLKPSNILLDDEMTA 802

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 279 (103.3 bits), Expect = 1.0e-30, Sum P(2) = 1.0e-30
 Identities = 61/150 (40%), Positives = 91/150 (60%)

Query:    94 NLISRGGFGSIYKARIQDGMEVV-VKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISS 152
             N++  G FG+++KA +    ++V VK  N+Q  GA K+   EC  +K  RH+NL+K++++
Sbjct:   707 NMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVKLLTA 766

Query:   153 CSKDDF-----KALILEYMPHGSLGKCLSTSNY--------ILDFFQRLHIMIDVASAVE 199
             C+  DF     +ALI EY+P+GS+   L              L   +RL+I+IDVAS ++
Sbjct:   767 CASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPPRTLTLLERLNIVIDVASVLD 826

Query:   200 YLHFGHSTHVIIHCDLKSSNVLLDDNMVAH 229
             YLH  H    I HCDLK SNVLL+D++ AH
Sbjct:   827 YLHV-HCHEPIAHCDLKPSNVLLEDDLTAH 855

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 259 (96.2 bits), Expect = 1.0e-29, Sum P(2) = 1.0e-29
 Identities = 63/151 (41%), Positives = 89/151 (58%)

Query:    94 NLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISS 152
             NLI  G FG+++K  +      V +K  NL   GA K+   EC  +  IRH+NL+K+++ 
Sbjct:   723 NLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTI 782

Query:   153 CSK-----DDFKALILEYMPHGSLGKCL------STSN--YILDFFQRLHIMIDVASAVE 199
             CS      +DF+AL+ E+MP+G+L   L       T N    L  F RL+I IDVASA+ 
Sbjct:   783 CSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDVASALV 842

Query:   200 YLH-FGHSTHVIIHCDLKSSNVLLDDNMVAH 229
             YLH + H+   I HCD+K SN+LLD ++ AH
Sbjct:   843 YLHTYCHNP--IAHCDIKPSNILLDKDLTAH 871

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 271 (100.5 bits), Expect = 2.6e-29, Sum P(2) = 2.6e-29
 Identities = 64/150 (42%), Positives = 89/150 (59%)

Query:    94 NLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISS 152
             NLI  G FG+++K  +  +   V VK  NL   GA K+   EC   K IRH+NL+K+I+ 
Sbjct:   716 NLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITV 775

Query:   153 CSK-----DDFKALILEYMPHGSLGKCLSTSNY--ILDFF------QRLHIMIDVASAVE 199
             CS      +DF+AL+ E+MP GSL   L   +   + D        ++L+I IDVASA+E
Sbjct:   776 CSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALE 835

Query:   200 YLHFGHSTHVIIHCDLKSSNVLLDDNMVAH 229
             YLH  H    + HCD+K SN+LLDD++ AH
Sbjct:   836 YLHV-HCHDPVAHCDIKPSNILLDDDLTAH 864

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)]

 Score = 270 (100.1 bits), Expect = 7.5e-28, Sum P(2) = 7.5e-28
 Identities = 68/153 (44%), Positives = 92/153 (60%)

Query:    94 NLISRGGFGSIYKARIQDGME---VVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKII 150
             NLI  G F  ++K  +  G+E   V VK  NL   GA K+   EC   K IRH+NL K+I
Sbjct:   213 NLIGSGNFSDVFKGLL--GLEEKLVAVKVLNLLKHGATKSFIAECESFKGIRHRNLAKLI 270

Query:   151 SSCSK-----DDFKALILEYMPHGSLGKCL------STSNYI--LDFFQRLHIMIDVASA 197
             + CS      +DF+AL+ E+MP GSL   L      S +N+   L F ++++I IDVASA
Sbjct:   271 TVCSSLDSQGNDFRALVYEFMPKGSLDMWLQPEDLESANNHSRSLTFAEKVNIAIDVASA 330

Query:   198 VEYLH-FGHSTHVIIHCDLKSSNVLLDDNMVAH 229
             +EYLH + H    + HCD+K SNVLLDD++ AH
Sbjct:   331 LEYLHVYCHDP--VAHCDIKPSNVLLDDDLTAH 361

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2120412 BAM3 "BARELY ANY MERISTEM 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 224 (83.9 bits), Expect = 1.0e-25, Sum P(2) = 1.0e-25
 Identities = 52/139 (37%), Positives = 80/139 (57%)

Query:    94 NLISRGGFGSIYKARIQDGMEVVVKGF-NLQYGGAFKN-LDVECNMMKIIRHQNLIKIIS 151
             ++I +GG G +YK  + +G EV VK    +  G +  N L  E   +  IRH+N++++++
Sbjct:   714 HVIGKGGRGIVYKGVMPNGEEVAVKKLLTITKGSSHDNGLAAEIQTLGRIRHRNIVRLLA 773

Query:   152 SCSKDDFKALILEYMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVI 210
              CS  D   L+ EYMP+GSLG+ L   +   L +  RL I ++ A  + YLH   S  +I
Sbjct:   774 FCSNKDVNLLVYEYMPNGSLGEVLHGKAGVFLKWETRLQIALEAAKGLCYLHHDCSP-LI 832

Query:   211 IHCDLKSSNVLLDDNMVAH 229
             IH D+KS+N+LL     AH
Sbjct:   833 IHRDVKSNNILLGPEFEAH 851

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010075 "regulation of meristem growth" evidence=IGI;RCA

GO:0048437 "floral organ development" evidence=IGI

GO:0000271 "polysaccharide biosynthetic process" evidence=RCA

GO:0009825 "multidimensional cell growth" evidence=RCA

GO:0009855 "determination of bilateral symmetry" evidence=RCA

GO:0009932 "cell tip growth" evidence=RCA

GO:0010014 "meristem initiation" evidence=RCA

GO:0010073 "meristem maintenance" evidence=RCA

GO:0010817 "regulation of hormone levels" evidence=RCA

GO:0043481 "anthocyanin accumulation in tissues in response to UV light" evidence=RCA

GO:0048653 "anther development" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0071555 "cell wall organization" evidence=RCA

TAIR|locus:2051628 PSKR1 "phytosulfokin receptor 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 212 (79.7 bits), Expect = 3.6e-25, Sum P(2) = 3.6e-25
 Identities = 51/145 (35%), Positives = 75/145 (51%)

Query:    88 NFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLI 147
             N  +  N+I  GGFG +YKA + DG +V +K  +   G   +  + E   +   +H NL+
Sbjct:   732 NSFDQANIIGCGGFGMVYKATLPDGKKVAIKKLSGDCGQIEREFEAEVETLSRAQHPNLV 791

Query:   148 KIISSCSKDDFKALILEYMPHGSLGKCLSTSN---YILDFFQRLHIMIDVASAVEYLHFG 204
              +   C   + + LI  YM +GSL   L   N    +L +  RL I    A  + YLH G
Sbjct:   792 LLRGFCFYKNDRLLIYSYMENGSLDYWLHERNDGPALLKWKTRLRIAQGAAKGLLYLHEG 851

Query:   205 HSTHVIIHCDLKSSNVLLDDNMVAH 229
                H I+H D+KSSN+LLD+N  +H
Sbjct:   852 CDPH-ILHRDIKSSNILLDENFNSH 875

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0001653 "peptide receptor activity" evidence=IMP;IDA

GO:0009611 "response to wounding" evidence=IGI

GO:0004383 "guanylate cyclase activity" evidence=IDA

GO:0045087 "innate immune response" evidence=IMP

GO:0031347 "regulation of defense response" evidence=IGI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00014285001 SubName- Full=Chromosome chr18 scaffold_1, whole genome shotgun sequence; (1016 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	232
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-26
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-22
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-22
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	8e-20
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-19
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-19
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-17
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-16
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-15
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-15
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-14
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-12
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-12
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-12
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-12
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-12
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-11
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-11
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-10
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-10
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-10
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-10
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-10
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-10
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-10
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-10
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-10
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-09
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-09
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-09
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-09
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-09
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-09
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-09
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	8e-09
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-09
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-08
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-08
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-08
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-08
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-08
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-08
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-08
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-08
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-08
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-08
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-08
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-07
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-07
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-07
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-07
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-07
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-07
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-07
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-07
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-07
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-07
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-07
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-07
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-07
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-07
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-07
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-07
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-07
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-07
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	9e-07
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-06
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-06
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-06
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-06
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-06
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-06
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	5e-06
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-06
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-06
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-06
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-06
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	7e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-06
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	8e-06
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	8e-06
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-05
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-05
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-05
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-05
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-05
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-05
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-05
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-05
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-05
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-05
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-05
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-05
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-05
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-05
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-05
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-05
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-05
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-05
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-05
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-05
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	5e-05
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-05
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-05
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	7e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-05
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-05
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-05
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-04
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-04
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-04
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-04
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-04
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-04
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-04
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-04
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-04
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-04
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-04
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-04
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-04
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-04
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-04
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-04
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-04
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-04
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-04
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-04
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-04
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-04
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-04
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-04
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-04
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-04
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	6e-04
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	8e-04
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	8e-04
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	9e-04
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	0.001
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	0.001
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	0.001
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	0.001
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	0.001
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	0.001
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	0.002
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	0.002
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	0.002
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	0.002
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	0.003
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	0.003
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	0.003
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	0.003
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	0.003

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  101 bits (254), Expect = 1e-26
 Identities = 40/132 (30%), Positives = 68/132 (51%), Gaps = 6/132 (4%)

Query: 96  ISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKN-LDVECNMMKIIRHQNLIKIISSC 153
           +  GGFG++Y AR  + G +V +K    +   +    L  E  ++K + H N++K+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 154 SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHC 213
             ++   L++EY   GSL   L  +   L   + L I++ +   +EYLH    ++ IIH 
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH----SNGIIHR 116

Query: 214 DLKSSNVLLDDN 225
           DLK  N+LLD +
Sbjct: 117 DLKPENILLDSD 128

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 90.7 bits (226), Expect = 5e-22
 Identities = 37/139 (26%), Positives = 65/139 (46%), Gaps = 7/139 (5%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIK 148
           E+   +  G FG +Y AR  + G  V +K    +      + +  E  ++K ++H N+++
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61

Query: 149 IISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH 208
           +      +D   L++EY   G L   L      L   +    +  + SA+EYLH    + 
Sbjct: 62  LYDVFEDEDKLYLVMEYCEGGDLFDLLK-KRGRLSEDEARFYLRQILSALEYLH----SK 116

Query: 209 VIIHCDLKSSNVLLDDNMV 227
            I+H DLK  N+LLD++  
Sbjct: 117 GIVHRDLKPENILLDEDGH 135

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 90.0 bits (224), Expect = 9e-22
 Identities = 40/135 (29%), Positives = 64/135 (47%), Gaps = 8/135 (5%)

Query: 96  ISRGGFGSIYKAR-IQDGMEVVVKGFNLQ--YGGAFKNLDVECNMMKIIRHQNLIKIISS 152
           +  G FG++YKA+    G  V VK    +       +    E  +++ + H N++++I +
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66

Query: 153 CSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIH 212
               D   L++EY   G L   LS     L   +   I + +   +EYLH  +    IIH
Sbjct: 67  FEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLH-SNG---IIH 121

Query: 213 CDLKSSNVLLDDNMV 227
            DLK  N+LLD+N V
Sbjct: 122 RDLKPENILLDENGV 136

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 84.5 bits (210), Expect = 8e-20
 Identities = 35/139 (25%), Positives = 65/139 (46%), Gaps = 10/139 (7%)

Query: 96  ISRGGFGSIYKARIQD-----GMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKI 149
           +  G FG +YK +++       +EV VK           +    E  +M+ + H N++K+
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV 209
           +  C++++   +++EYM  G L   L  +   L     L   + +A  +EYL   +    
Sbjct: 67  LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKN---- 122

Query: 210 IIHCDLKSSNVLLDDNMVA 228
            IH DL + N L+ +N+V 
Sbjct: 123 FIHRDLAARNCLVGENLVV 141

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 83.7 bits (208), Expect = 2e-19
 Identities = 35/140 (25%), Positives = 61/140 (43%), Gaps = 16/140 (11%)

Query: 98  RGGFGSIYKARI-----QDGMEVVVKGFNLQYGG----AFKNLDVECNMMKIIRHQNLIK 148
            G FG +YK  +         +V VK             F     E ++MK + H N+++
Sbjct: 9   EGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLE---EASIMKKLSHPNIVR 65

Query: 149 IISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH 208
           ++  C++ +   ++ EYMP G L   L      L     L + + +A  +EYL   +   
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN--- 122

Query: 209 VIIHCDLKSSNVLLDDNMVA 228
             +H DL + N L+ +N+V 
Sbjct: 123 -FVHRDLAARNCLVTENLVV 141

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 82.6 bits (205), Expect = 5e-19
 Identities = 36/140 (25%), Positives = 64/140 (45%), Gaps = 11/140 (7%)

Query: 96  ISRGGFGSIYKARIQDG-----MEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKI 149
           +  G FG +YK  ++       +EV VK           +    E  +M+ + H N++K+
Sbjct: 7   LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYLHFGHSTH 208
           +  C++++   +++EYMP G L   L       L     L   + +A  +EYL   +   
Sbjct: 67  LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--- 123

Query: 209 VIIHCDLKSSNVLLDDNMVA 228
             IH DL + N L+ +N+V 
Sbjct: 124 -FIHRDLAARNCLVGENLVV 142

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 77.2 bits (191), Expect = 4e-17
 Identities = 43/136 (31%), Positives = 74/136 (54%), Gaps = 5/136 (3%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           E+   I +GGFG +YKAR  + G EV +K   L+     + +  E  ++K  +H N++K 
Sbjct: 3   EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKY 62

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV 209
             S  K D   +++E+   GSL   L ++N  L   Q  ++  ++   +EYLH    ++ 
Sbjct: 63  YGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH----SNG 118

Query: 210 IIHCDLKSSNVLLDDN 225
           IIH D+K++N+LL  +
Sbjct: 119 IIHRDIKAANILLTSD 134

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 74.9 bits (185), Expect = 3e-16
 Identities = 38/143 (26%), Positives = 66/143 (46%), Gaps = 22/143 (15%)

Query: 94  NLISRGGFGSIYKARIQD-GMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKII 150
            L+ RG FGS+Y A  +D G  + VK   L        + L+ E  ++  ++H N+++  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 151 SSCSKDDFKAL--ILEYMPHGSLGKCLSTSNYILDFFQRLHI------MIDVASAVEYLH 202
            S   ++   L   LEY+  GSL         +L  F +L           +   + YLH
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSS-------LLKKFGKLPEPVIRKYTRQILEGLAYLH 118

Query: 203 FGHSTHVIIHCDLKSSNVLLDDN 225
               ++ I+H D+K +N+L+D +
Sbjct: 119 ----SNGIVHRDIKGANILVDSD 137

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 73.3 bits (181), Expect = 1e-15
 Identities = 38/150 (25%), Positives = 66/150 (44%), Gaps = 21/150 (14%)

Query: 94  NLISRGGFGSIYKARIQDG----MEVVVKGFNLQYGGAFKNLDV---ECNMMKIIRHQNL 146
             +  G FG +YK +++       EV VK   L+   + +       E  +MK + H N+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVK--TLKEDASEEERKDFLKEARVMKKLGHPNV 58

Query: 147 IKIISSCSKDDFKALILEYMPHGSL--------GKCLSTSNYILDFFQRLHIMIDVASAV 198
           ++++  C++++   L+LEYM  G L            S     L     L   I +A  +
Sbjct: 59  VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118

Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
           EYL    S    +H DL + N L+ +++V 
Sbjct: 119 EYL---ASKK-FVHRDLAARNCLVGEDLVV 144

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 71.0 bits (175), Expect = 8e-15
 Identities = 38/143 (26%), Positives = 63/143 (44%), Gaps = 10/143 (6%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMKIIRHQNLI 147
           E+   I +G FG +Y  R   DG   V+K  +L      +  D   E  ++K + H N+I
Sbjct: 3   EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII 62

Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFF---QRLHIMIDVASAVEYLHFG 204
           K   S  +     +++EY   G L + +         F   Q L   + +  A++YLH  
Sbjct: 63  KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH-- 120

Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
             +  I+H D+K  N+ L  N +
Sbjct: 121 --SRKILHRDIKPQNIFLTSNGL 141

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 70.3 bits (173), Expect = 2e-14
 Identities = 39/140 (27%), Positives = 66/140 (47%), Gaps = 6/140 (4%)

Query: 87  RNFLEVFNLISRGGFGSIYKA-RIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN 145
           R   +    I  G  G +YKA     G EV +K   L+     + +  E  +MK  +H N
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLR-KQNKELIINEILIMKDCKHPN 76

Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 205
           ++    S    D   +++EYM  GSL   ++ +   ++  Q  ++  +V   +EYLH  +
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN 136

Query: 206 STHVIIHCDLKSSNVLLDDN 225
               +IH D+KS N+LL  +
Sbjct: 137 ----VIHRDIKSDNILLSKD 152

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 64.3 bits (157), Expect = 2e-12
 Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 7/140 (5%)

Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           L++   I +G FG +     + G +V VK        A   L  E ++M  +RH NL+++
Sbjct: 8   LKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLA-EASVMTTLRHPNLVQL 65

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYLHFGHSTH 208
           +    + +   ++ EYM  GSL   L S    ++   Q+L   +DV   +EYL       
Sbjct: 66  LGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE----EK 121

Query: 209 VIIHCDLKSSNVLLDDNMVA 228
             +H DL + NVL+ +++VA
Sbjct: 122 NFVHRDLAARNVLVSEDLVA 141

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 64.6 bits (158), Expect = 2e-12
 Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 19/152 (12%)

Query: 91  EVFNLISRGGFGSIYKA-RIQDGMEVVVKGFNLQYGG---AFKNLDV-ECNMMKIIRHQN 145
           EV   I +G FG++ K  R  DG  +V K  +  YG      K   V E N+++ ++H N
Sbjct: 3   EVLETIGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHPN 60

Query: 146 LIK----IISSCSKDDFKALILEYMPHGSLG----KCLSTSNYILDFFQRLHIMIDVASA 197
           +++    II   ++  +  +++EY   G L     KC     YI + F    I+  +  A
Sbjct: 61  IVRYYDRIIDRSNQTLY--IVMEYCEGGDLAQLIQKCKKERKYIEEEFI-WRILTQLLLA 117

Query: 198 VEYLHFG-HSTHVIIHCDLKSSNVLLDDNMVA 228
           +   H      + ++H DLK +N+ LD N   
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNV 149

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 64.0 bits (156), Expect = 2e-12
 Identities = 41/135 (30%), Positives = 64/135 (47%), Gaps = 7/135 (5%)

Query: 95  LISRGGFGSIYKARIQDGMEVVVKG--FNLQYGGAFKNLDVECNMMKIIRHQNLIKIISS 152
            I +G FG +YK  ++   EV VK     L      K L  E  ++K   H N++K+I  
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQ-EAEILKQYDHPNIVKLIGV 60

Query: 153 CSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIH 212
           C +     +++E +P GSL   L      L   + L + +D A+ +EYL     +   IH
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE----SKNCIH 116

Query: 213 CDLKSSNVLLDDNMV 227
            DL + N L+ +N V
Sbjct: 117 RDLAARNCLVGENNV 131

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 3e-12
 Identities = 41/134 (30%), Positives = 69/134 (51%), Gaps = 12/134 (8%)

Query: 94  NLISRGGFGSIYKA-RIQDGMEVVVKGFNLQ--YGGAFKNLDVECNMMKIIRHQNLIKII 150
           +LI RG FG +YK   ++ G  V +K  +L+     A K++  E +++K ++H N++K I
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 151 SSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHI--MIDVASAVEYLHFGHSTH 208
            S    D   +ILEY  +GSL + +        F + L    +  V   + YLH      
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLH----EQ 118

Query: 209 VIIHCDLKSSNVLL 222
            +IH D+K++N+L 
Sbjct: 119 GVIHRDIKAANILT 132

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 62.9 bits (154), Expect = 8e-12
 Identities = 37/151 (24%), Positives = 67/151 (44%), Gaps = 32/151 (21%)

Query: 91  EVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDV-------------ECNM 137
           E    I  G +G +YKAR +   E+V          A K + +             E  +
Sbjct: 2   EKIAQIGEGTYGQVYKARNKKTGELV----------ALKKIRMENEKEGFPITAIREIKL 51

Query: 138 MKIIRHQNLIK---IISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDV 194
           ++ +RH N+++   I++S  K     ++ EYM H  L   L +        Q    M  +
Sbjct: 52  LQKLRHPNIVRLKEIVTSKGKGSI-YMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQL 109

Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
              ++YLH    ++ I+H D+K SN+L++++
Sbjct: 110 LEGLQYLH----SNGILHRDIKGSNILINND 136

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 61.3 bits (149), Expect = 3e-11
 Identities = 35/149 (23%), Positives = 63/149 (42%), Gaps = 13/149 (8%)

Query: 85  PFRNFLEVFNLISRGGFGSIYKARI-----QDGMEVVVKGFNLQYGGAFKN-LDVECNMM 138
             R  L+    +  G FG +   R        G +V VK  N       ++  + E  ++
Sbjct: 2   EKR-HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEIL 60

Query: 139 KIIRHQNLIKIISSCSKDDFKA--LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVAS 196
           + + H+N++K    C K   ++  LI+EY+P GSL   L      ++  + L     +  
Sbjct: 61  RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICK 120

Query: 197 AVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++YL         IH DL + N+L++  
Sbjct: 121 GMDYLGSQR----YIHRDLAARNILVESE 145

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.0 bits (148), Expect = 6e-11
 Identities = 37/109 (33%), Positives = 53/109 (48%), Gaps = 20/109 (18%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPI 60
           +S L+ L  I+LS N+     P              S+G +TSL+ LDLS N+F+G+IP 
Sbjct: 438 ISKLRHLQSINLSGNSIRGNIPP-------------SLGSITSLEVLDLSYNSFNGSIPE 484

Query: 61  PLEKLLDLKDLNLSFNTLEGKIP-----RPFRNFLEVFNLISRGGFGSI 104
            L +L  L+ LNL+ N+L G++P     R        FN     G   I
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALGGRLLHR--ASFNFTDNAGLCGI 531

Length = 623

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 60.3 bits (147), Expect = 6e-11
 Identities = 35/135 (25%), Positives = 67/135 (49%), Gaps = 11/135 (8%)

Query: 96  ISRGGFGSIYKAR-IQDG----MEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKII 150
           IS+G +G ++ A+    G    ++V+ K  ++        +  E +++   +   ++K+ 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKA-DMIRKNQVDQVLTERDILSQAQSPYVVKLY 59

Query: 151 SSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVI 210
            S        L++EY+P G L   L     + +   R++I  ++  A+EYLH    ++ I
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-EIVLALEYLH----SNGI 114

Query: 211 IHCDLKSSNVLLDDN 225
           IH DLK  N+L+D N
Sbjct: 115 IHRDLKPDNILIDSN 129

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 59.7 bits (145), Expect = 1e-10
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 28/153 (18%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGA-FKNLDVECNMMKIIRHQN 145
           R  +++   +  G FG +++    +   V VK   L+ G    K+   E  +MK +RH  
Sbjct: 5   RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVK--TLKPGTMDPKDFLAEAQIMKKLRHPK 62

Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQR-------LHIMID----V 194
           LI++ + C+ ++   ++ E M +GSL          L++ Q        L  +ID    V
Sbjct: 63  LIQLYAVCTLEEPIYIVTELMKYGSL----------LEYLQGGAGRALKLPQLIDMAAQV 112

Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           AS + YL         IH DL + NVL+ +N +
Sbjct: 113 ASGMAYLE----AQNYIHRDLAARNVLVGENNI 141

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 1e-10
 Identities = 43/140 (30%), Positives = 68/140 (48%), Gaps = 8/140 (5%)

Query: 90  LEVFNLISR---GGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN 145
            E + LI R   G +G +YKAR I  G  V +K   L+ G  F+ +  E +M+K  RH N
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPN 61

Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 205
           ++    S  + D   +++EY   GSL      +   L   Q  ++  +    + YL   H
Sbjct: 62  IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL---H 118

Query: 206 STHVIIHCDLKSSNVLLDDN 225
            T   IH D+K +N+LL ++
Sbjct: 119 ETGK-IHRDIKGANILLTED 137

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 59.8 bits (145), Expect = 1e-10
 Identities = 39/155 (25%), Positives = 63/155 (40%), Gaps = 30/155 (19%)

Query: 96  ISRGGFGSIYKARI------QDGMEVVVKGF-NLQYGGAFKNLDVECNMMKIIRHQNLIK 148
           +  G FG ++           D   V VK         A K+ + E  ++   +H+N++K
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 149 IISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFF-------------QRLHIMIDVA 195
               C++ D   ++ EYM HG L K L +      F              Q L I + +A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 196 SAVEYL---HFGHSTHVIIHCDLKSSNVLLDDNMV 227
           S + YL   HF       +H DL + N L+  ++V
Sbjct: 133 SGMVYLASQHF-------VHRDLATRNCLVGYDLV 160

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 58.5 bits (142), Expect = 2e-10
 Identities = 47/165 (28%), Positives = 74/165 (44%), Gaps = 43/165 (26%)

Query: 82  IPRPFRNFLEVFNLISR---GGFGSIYKARIQDGMEVVVKGFNLQYG----GAFKNLDVE 134
           IPR      E   L  +   G FG ++        +V VK   L+ G     AF  L  E
Sbjct: 3   IPR------ESLKLERKLGAGQFGEVWMGTWNGTTKVAVK--TLKPGTMSPEAF--LQ-E 51

Query: 135 CNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQ-------R 187
             +MK +RH  L+++ + CS+++   ++ EYM  GSL          LDF +       R
Sbjct: 52  AQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSL----------LDFLKSGEGKKLR 101

Query: 188 LHIMID----VASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
           L  ++D    +A  + YL   +     IH DL + N+L+ +N+V 
Sbjct: 102 LPQLVDMAAQIAEGMAYLESRN----YIHRDLAARNILVGENLVC 142

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 58.1 bits (140), Expect = 4e-10
 Identities = 46/156 (29%), Positives = 71/156 (45%), Gaps = 26/156 (16%)

Query: 94  NLISRGGFGSIYKARI-QDG--MEVVVKGFNLQYGGAFKNLDVECNMMKIIR---HQNLI 147
           ++I  G FG + KARI +DG  M+  +K    +Y     + D    +  + +   H N+I
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI---------------LDFFQRLHIMI 192
            ++ +C    +  L +EY PHG+L   L  S  +               L   Q LH   
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
           DVA  ++YL    S    IH DL + N+L+ +N VA
Sbjct: 132 DVARGMDYL----SQKQFIHRDLAARNILVGENYVA 163

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 57.7 bits (139), Expect = 5e-10
 Identities = 39/155 (25%), Positives = 65/155 (41%), Gaps = 30/155 (19%)

Query: 96  ISRGGFGSIYKARI------QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           +  G FG ++ A        QD M V VK        A ++   E  ++ +++HQ++++ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSN---YILD-----------FFQRLHIMIDVA 195
              C++     ++ EYM HG L + L +      IL              Q L I   +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 196 SAVEY---LHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           S + Y   LHF       +H DL + N L+   +V
Sbjct: 133 SGMVYLASLHF-------VHRDLATRNCLVGQGLV 160

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 57.4 bits (139), Expect = 6e-10
 Identities = 36/139 (25%), Positives = 65/139 (46%), Gaps = 8/139 (5%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNL-QYGGAFKNLDVECNMMKIIRHQNLIK 148
           E+  +I  G    +Y A  + +  +V +K  +L +   +   L  E   M    H N++K
Sbjct: 4   ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63

Query: 149 IISSCSKDDFKALILEYMPHGSLGKCLSTSNY--ILDFFQRLHIMIDVASAVEYLHFGHS 206
             +S    D   L++ Y+  GSL   + +S     LD      ++ +V   +EYLH    
Sbjct: 64  YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---- 119

Query: 207 THVIIHCDLKSSNVLLDDN 225
           ++  IH D+K+ N+LL ++
Sbjct: 120 SNGQIHRDIKAGNILLGED 138

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 56.9 bits (138), Expect = 8e-10
 Identities = 35/138 (25%), Positives = 65/138 (47%), Gaps = 10/138 (7%)

Query: 91  EVFNL---ISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL 146
           EVF++   +  G +GS+YKA   + G  V +K   +      + +  E +++K      +
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYI 60

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHS 206
           +K   S  K+    +++EY   GS+   +  +N  L   +   I+      +EYLH    
Sbjct: 61  VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK- 119

Query: 207 THVIIHCDLKSSNVLLDD 224
               IH D+K+ N+LL++
Sbjct: 120 ---KIHRDIKAGNILLNE 134

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 56.8 bits (137), Expect = 8e-10
 Identities = 39/137 (28%), Positives = 72/137 (52%), Gaps = 8/137 (5%)

Query: 91  EVFNLISRGGFGSIYKA-RIQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMKIIRHQNLI 147
           E   ++ RG FG ++   R  D   V++K   ++     + L    EC ++K++ H N+I
Sbjct: 3   EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNII 62

Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHS 206
           +   +  +D    +++EY P G+L + +    N +LD    LH  + +  A+ ++H    
Sbjct: 63  EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---- 118

Query: 207 THVIIHCDLKSSNVLLD 223
           T +I+H DLK+ N+LLD
Sbjct: 119 TKLILHRDLKTQNILLD 135

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 56.3 bits (136), Expect = 2e-09
 Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 35/172 (20%)

Query: 81  KIPRPFRNFLEVFNLISRGGFGSIYKARI--QDGME----VVVKGFNLQYGGA----FKN 130
           +IP     FLE    +  G FG +YK  +   +       V +K             F+ 
Sbjct: 1   EIPLSAVRFLEE---LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ 57

Query: 131 LDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCL--------------- 175
              E  +M  ++H N++ ++  C+K+    ++ EY+ HG L + L               
Sbjct: 58  ---EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114

Query: 176 STSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
            T    LD    LHI I +A+ +EYL    S+H  +H DL + N L+ + + 
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYL----SSHHFVHRDLAARNCLVGEGLT 162

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 55.8 bits (134), Expect = 2e-09
 Identities = 40/153 (26%), Positives = 63/153 (41%), Gaps = 25/153 (16%)

Query: 96  ISRGGFGSIYKAR------IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           +  G FG ++ A        +D M V VK        A K+   E  ++  ++H++++K 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLST---------------SNYILDFFQRLHIMIDV 194
              C   D   ++ EYM HG L K L                 +   L   Q LHI   +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           AS + YL   H     +H DL + N L+  N++
Sbjct: 133 ASGMVYLASQH----FVHRDLATRNCLVGANLL 161

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 55.6 bits (134), Expect = 3e-09
 Identities = 46/157 (29%), Positives = 69/157 (43%), Gaps = 26/157 (16%)

Query: 95  LISRGGFGSIYKARI--QDG--MEVVVKGFNLQYGGAFKNLD---VECNMMKIIRHQNLI 147
           ++  G FGS+ + ++   DG  ++V VK   L     +  ++    E   MK   H N++
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD-IHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 148 KIISSC----SKDDFKA--LILEYMPHGSLGKCLSTSN-----YILDFFQRLHIMIDVAS 196
           K+I  C    S        +IL +M HG L   L  S        L     L  M+D+A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 197 AVEYLHFGHSTHVIIHCDLKSSNVLLDDNM---VAHF 230
            +EYL    S    IH DL + N +L ++M   VA F
Sbjct: 125 GMEYL----SNRNFIHRDLAARNCMLREDMTVCVADF 157

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 55.4 bits (133), Expect = 3e-09
 Identities = 43/143 (30%), Positives = 66/143 (46%), Gaps = 9/143 (6%)

Query: 87  RNFLEVFNLISR---GGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR 142
           RN  E F LI R   G +G +YKAR +  G    +K   L+ G  F  +  E  MMK  +
Sbjct: 5   RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK 64

Query: 143 HQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH 202
           H N++    S  + D   + +E+   GSL      +   L   Q  ++  +    + YLH
Sbjct: 65  HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH 123

Query: 203 FGHSTHVIIHCDLKSSNVLLDDN 225
               +   +H D+K +N+LL DN
Sbjct: 124 ----SKGKMHRDIKGANILLTDN 142

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 54.8 bits (133), Expect = 4e-09
 Identities = 36/135 (26%), Positives = 60/135 (44%), Gaps = 8/135 (5%)

Query: 96  ISRGGFGSIYKAR-IQDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISS 152
           +  G +G +YKAR  + G  V +K   L     G       E +++K ++H N++K++  
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66

Query: 153 CSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIH 212
              +    L+ EY     L K L      L       IM  +   + Y H    +H I+H
Sbjct: 67  IHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH----SHRILH 121

Query: 213 CDLKSSNVLLDDNMV 227
            DLK  N+L++ + V
Sbjct: 122 RDLKPQNILINRDGV 136

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 54.4 bits (131), Expect = 6e-09
 Identities = 38/138 (27%), Positives = 66/138 (47%), Gaps = 13/138 (9%)

Query: 95  LISRGGFGSIYKARIQD-GMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQNLIK 148
           L+ +G FG +Y     D G E+ VK         +       L+ E  ++K ++H+ +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 149 IISSCSKDDFKALI-LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
               C +DD    I +EYMP GS+   L     + +   R +    +   VEYLH    +
Sbjct: 69  YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-QILEGVEYLH----S 122

Query: 208 HVIIHCDLKSSNVLLDDN 225
           ++I+H D+K +N+L D  
Sbjct: 123 NMIVHRDIKGANILRDSA 140

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 54.4 bits (131), Expect = 7e-09
 Identities = 39/137 (28%), Positives = 68/137 (49%), Gaps = 11/137 (8%)

Query: 95  LISRGGFGSIYKA-RIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQNLIK 148
           L+  G FGS+Y+   + DG    VK  +L         A K L+ E  ++  ++H N+++
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66

Query: 149 IISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH 208
            + +  ++D   + LE +P GSL K L       +   RL+    +   +EYLH  +   
Sbjct: 67  YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLEYLHDRN--- 122

Query: 209 VIIHCDLKSSNVLLDDN 225
             +H D+K +N+L+D N
Sbjct: 123 -TVHRDIKGANILVDTN 138

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 54.5 bits (131), Expect = 7e-09
 Identities = 38/131 (29%), Positives = 66/131 (50%), Gaps = 7/131 (5%)

Query: 93  FNLISRGGFGSIYKA-RIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIIS 151
           F  I +G  G++Y A  +  G EV +K  NLQ     + +  E  +M+  +H N++  + 
Sbjct: 24  FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLD 83

Query: 152 SCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVII 211
           S    D   +++EY+  GSL   ++ +   +D  Q   +  +   A+E+LH       +I
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ----VI 137

Query: 212 HCDLKSSNVLL 222
           H D+KS N+LL
Sbjct: 138 HRDIKSDNILL 148

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 54.7 bits (130), Expect = 8e-09
 Identities = 37/141 (26%), Positives = 61/141 (43%), Gaps = 12/141 (8%)

Query: 91  EVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQ-NL 146
            +   +  G FG +Y AR  D   V +K    +        +    E  ++  + H  N+
Sbjct: 3   RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGK--CLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           +K+      +    L++EY+  GSL            L   + L I+  + SA+EYLH  
Sbjct: 61  VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH-- 118

Query: 205 HSTHVIIHCDLKSSNVLLDDN 225
             +  IIH D+K  N+LLD +
Sbjct: 119 --SKGIIHRDIKPENILLDRD 137

Length = 384

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 54.0 bits (130), Expect = 9e-09
 Identities = 35/145 (24%), Positives = 66/145 (45%), Gaps = 6/145 (4%)

Query: 84  RPFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRH 143
           RP   F  +   +  G FG +++   ++ + V +K          ++   E   +K +RH
Sbjct: 3   RPREEF-TLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61

Query: 144 QNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLH 202
           ++LI + + CS  +   +I E M  GSL   L +    +L     + +   VA  + YL 
Sbjct: 62  KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121

Query: 203 FGHSTHVIIHCDLKSSNVLLDDNMV 227
             +     IH DL + N+L+ +++V
Sbjct: 122 EQN----SIHRDLAARNILVGEDLV 142

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 53.5 bits (128), Expect = 1e-08
 Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 36/161 (22%)

Query: 94  NLISRGGFGSIYKARIQ-DGMEV-----VVKGF-----NLQYGGAFKNLDVECNMMKIIR 142
           ++I  G FG + +A I+ DG+++     ++K F     +  + G    L+V C   K+  
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAG---ELEVLC---KLGH 61

Query: 143 HQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI---------------LDFFQR 187
           H N+I ++ +C    +  + +EY P+G+L   L  S  +               L   Q 
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 188 LHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
           L    DVA+ ++YL    S    IH DL + NVL+ +N+ +
Sbjct: 122 LQFASDVATGMQYL----SEKQFIHRDLAARNVLVGENLAS 158

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 53.5 bits (128), Expect = 2e-08
 Identities = 39/150 (26%), Positives = 64/150 (42%), Gaps = 22/150 (14%)

Query: 96  ISRGGFGSIYKARI------QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           +  G FG ++ A        QD + V VK        A K+   E  ++  ++H++++K 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSN------------YILDFFQRLHIMIDVASA 197
              C + D   ++ EYM HG L K L                  L   Q LHI   +A+ 
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 198 VEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           + YL   H     +H DL + N L+ +N++
Sbjct: 133 MVYLASQH----FVHRDLATRNCLVGENLL 158

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 52.9 bits (127), Expect = 2e-08
 Identities = 27/95 (28%), Positives = 53/95 (55%), Gaps = 5/95 (5%)

Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCL-STSNYILDFFQRLHIMI 192
           E  +MK I+H NL++++  C+++    +I E+M +G+L   L   +   ++    L++  
Sbjct: 52  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 111

Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
            ++SA+EYL   +     IH DL + N L+ +N +
Sbjct: 112 QISSAMEYLEKKN----FIHRDLAARNCLVGENHL 142

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 2e-08
 Identities = 34/136 (25%), Positives = 57/136 (41%), Gaps = 10/136 (7%)

Query: 96  ISRGGFGSIYKARIQDGMEVV----VKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIIS 151
           I  G +G +YKAR +   E+V    +K      G     L  E  ++K + H N+IK++ 
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLD 65

Query: 152 SCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVII 211
                    L+ E+M    L K +      L        +  +   + + H    +H I+
Sbjct: 66  VFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH----SHGIL 120

Query: 212 HCDLKSSNVLLDDNMV 227
           H DLK  N+L++   V
Sbjct: 121 HRDLKPENLLINTEGV 136

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 53.0 bits (127), Expect = 2e-08
 Identities = 36/97 (37%), Positives = 50/97 (51%), Gaps = 9/97 (9%)

Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKA--LILEYMPHGSLGKCLSTSNYILDFFQRLHIM 191
           E N++K + H+N++K    CS+   K   LI+EY+P GSL   L      L+  Q L   
Sbjct: 56  EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFA 113

Query: 192 IDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD-DNMV 227
             +   + YLH  H     IH DL + NVLLD D +V
Sbjct: 114 QQICEGMAYLHSQH----YIHRDLAARNVLLDNDRLV 146

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 2e-08
 Identities = 34/141 (24%), Positives = 64/141 (45%), Gaps = 8/141 (5%)

Query: 91  EVFNLISRGGFGSIYKARIQD-GMEVVVKGFNLQYGG-AFKNLDV-ECNMMKIIRHQNLI 147
           EV  ++  G +G + K R +  G  V +K F         K   + E  +++ +RH+N++
Sbjct: 4   EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIV 63

Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
            +  +  +     L+ EY+   +L + L  S   L        +  +  A+ Y H    +
Sbjct: 64  NLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH----S 118

Query: 208 HVIIHCDLKSSNVLLDDNMVA 228
           H IIH D+K  N+L+ ++ V 
Sbjct: 119 HNIIHRDIKPENILVSESGVL 139

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 53.0 bits (128), Expect = 2e-08
 Identities = 34/141 (24%), Positives = 62/141 (43%), Gaps = 10/141 (7%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECN----MMKIIRHQN 145
           +   +I  G F ++  A+  +   E  +K  + +     K +         + ++  H  
Sbjct: 4   KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPG 63

Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 205
           +IK+  +   ++    +LEY P+G L + +      LD         ++  A+EYLH   
Sbjct: 64  IIKLYYTFQDEENLYFVLEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLH--- 119

Query: 206 STHVIIHCDLKSSNVLLDDNM 226
            +  IIH DLK  N+LLD +M
Sbjct: 120 -SKGIIHRDLKPENILLDKDM 139

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 52.3 bits (125), Expect = 3e-08
 Identities = 35/134 (26%), Positives = 60/134 (44%), Gaps = 5/134 (3%)

Query: 95  LISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFK-NLDVECNMMKIIRHQNLIKIISSC 153
           L+ +G FG ++K  ++D   V VK          K     E  ++K   H N++K+I  C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 154 SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHC 213
           ++     +++E +P G     L      L   Q +   +D A+ + YL   +     IH 
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC----IHR 117

Query: 214 DLKSSNVLLDDNMV 227
           DL + N L+ +N V
Sbjct: 118 DLAARNCLVGENNV 131

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 52.2 bits (125), Expect = 3e-08
 Identities = 30/140 (21%), Positives = 68/140 (48%), Gaps = 11/140 (7%)

Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGA------FKNLDVECNMMKIIRHQNLI 147
            ++ +G +G++Y      G  + VK   L           ++ L  E +++K ++H N++
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           + + +C  D+  ++ +E++P GS+   L+    + +     +    +   V YLH     
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVAYLH----N 120

Query: 208 HVIIHCDLKSSNVLLDDNMV 227
           + ++H D+K +NV+L  N +
Sbjct: 121 NCVVHRDIKGNNVMLMPNGI 140

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 52.9 bits (127), Expect = 4e-08
 Identities = 40/116 (34%), Positives = 55/116 (47%), Gaps = 13/116 (11%)

Query: 4   LKVLLRIDLSTNNFSCVFP------TTIEY-----NRLQDSLRNSIGDLTSLKSLDLSNN 52
           L  L  +DL  NN +   P        ++Y     N+L   +  SI  L  L SLDLS+N
Sbjct: 235 LTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN 294

Query: 53  NFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNLISRGGFGSIYK 106
           + SG IP  + +L +L+ L+L  N   GKIP    +   L+V  L S    G I K
Sbjct: 295 SLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350

Length = 968

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 52.0 bits (125), Expect = 5e-08
 Identities = 40/142 (28%), Positives = 65/142 (45%), Gaps = 18/142 (12%)

Query: 94  NLISRGGFGSIYKA-RIQDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKII 150
           N I  G FG +Y A  +  G  + VK   +Q       K +  E  ++++++H NL+K  
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 151 SSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVAS-----AVEYLHFGH 205
                 +   + +EY   G+L + L     ILD       +I V +      + YLH   
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEE-LLEHGRILD-----EHVIRVYTLQLLEGLAYLH--- 116

Query: 206 STHVIIHCDLKSSNVLLDDNMV 227
            +H I+H D+K +N+ LD N V
Sbjct: 117 -SHGIVHRDIKPANIFLDHNGV 137

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 51.3 bits (123), Expect = 8e-08
 Identities = 29/125 (23%), Positives = 62/125 (49%), Gaps = 5/125 (4%)

Query: 99  GGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD 157
           G FG +YKA+  + G+    K   ++     ++  VE +++   +H N++ +  +   ++
Sbjct: 16  GAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN 75

Query: 158 FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKS 217
              +++E+   G+L   +      L   Q  ++   +  A+ +LH    +H +IH DLK+
Sbjct: 76  KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH----SHKVIHRDLKA 131

Query: 218 SNVLL 222
            N+LL
Sbjct: 132 GNILL 136

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 51.0 bits (122), Expect = 1e-07
 Identities = 38/145 (26%), Positives = 60/145 (41%), Gaps = 22/145 (15%)

Query: 94  NLISRGGFGSIYKARIQD-------GMEVVVKGFNLQYGGA---FKNLDVECNMMKIIRH 143
           N +  G FG +Y+    D        + V VK   L+ G      K    E ++M    H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVK--TLRKGATDQEKKEFLKEAHLMSNFNH 58

Query: 144 QNLIKIISSCSKDDFKALILEYMPHGSL------GKCLSTSNYILDFFQRLHIMIDVASA 197
            N++K++  C  ++ + +I+E M  G L       +       +L   + L I +DVA  
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 198 VEYLHFGHSTHVIIHCDLKSSNVLL 222
             YL   H     IH DL + N L+
Sbjct: 119 CVYLEQMH----FIHRDLAARNCLV 139

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 50.6 bits (121), Expect = 1e-07
 Identities = 40/142 (28%), Positives = 68/142 (47%), Gaps = 20/142 (14%)

Query: 95  LISRGGFGSIYKA-RIQDGMEVVVKGFNL----------QYGGAFKNLDVECNMMKIIRH 143
           LI +G +G +Y A  +  G  + VK   L          +     K L  E   +K + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 144 QNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL--HIMIDVASAVEYL 201
            N+++ +   + +++ ++ LEY+P GS+G CL T      F ++L       V   + YL
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYL 124

Query: 202 HFGHSTHVIIHCDLKSSNVLLD 223
           H    +  I+H DLK+ N+L+D
Sbjct: 125 H----SKGILHRDLKADNLLVD 142

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 50.5 bits (121), Expect = 1e-07
 Identities = 36/134 (26%), Positives = 61/134 (45%), Gaps = 9/134 (6%)

Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMKIIRHQNLIKIISSC 153
           +  G FG ++  + +  ++V +K       GA    D   E  +M  + H NL+++   C
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 154 SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHC 213
           +K     ++ EYM +G L   L      L     L +  DV  A+EYL     ++  IH 
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE----SNGFIHR 124

Query: 214 DLKSSNVLLDDNMV 227
           DL + N L+ ++ V
Sbjct: 125 DLAARNCLVGEDNV 138

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 50.7 bits (122), Expect = 1e-07
 Identities = 34/136 (25%), Positives = 59/136 (43%), Gaps = 17/136 (12%)

Query: 99  GGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNM-----MKI---IRHQNLIKI 149
           G +  +YKAR  + G  V +K   L   G  K      N      +K+   ++H N+I +
Sbjct: 11  GTYAVVYKARDKETGRIVAIKKIKL---GERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV 209
           +          L+ E+M    L K +   + +L        M+     +EYLH    ++ 
Sbjct: 68  LDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH----SNW 122

Query: 210 IIHCDLKSSNVLLDDN 225
           I+H DLK +N+L+  +
Sbjct: 123 ILHRDLKPNNLLIASD 138

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 40/143 (27%), Positives = 65/143 (45%), Gaps = 9/143 (6%)

Query: 87  RNFLEVFNLISR---GGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR 142
           RN    + LI R   G +G +YKAR +  G    VK   L+ G  F  +  E  M+K  +
Sbjct: 5   RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK 64

Query: 143 HQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH 202
           H N++    S    +   + +EY   GSL      +  + +  Q  ++  +    + YLH
Sbjct: 65  HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL-QIAYVCRETLQGLAYLH 123

Query: 203 FGHSTHVIIHCDLKSSNVLLDDN 225
               +   +H D+K +N+LL DN
Sbjct: 124 ----SKGKMHRDIKGANILLTDN 142

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 49.8 bits (120), Expect = 2e-07
 Identities = 37/134 (27%), Positives = 63/134 (47%), Gaps = 11/134 (8%)

Query: 96  ISRGGFGSIYKARIQD-----GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKII 150
           + +G FG +   R +D      M+V+ K   ++     ++   E N++  I H  ++K+ 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRK-EVEHTLTERNILSRINHPFIVKLH 59

Query: 151 SSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVI 210
            +   ++   L+LEY P G L   LS      +   R     ++  A+EYLH    +  I
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-YAAEIVLALEYLH----SLGI 114

Query: 211 IHCDLKSSNVLLDD 224
           I+ DLK  N+LLD 
Sbjct: 115 IYRDLKPENILLDA 128

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 40/141 (28%), Positives = 68/141 (48%), Gaps = 9/141 (6%)

Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           L++   I +G FG +     + G +V VK   ++     +    E ++M  +RH NL+++
Sbjct: 8   LKLLQTIGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQL 64

Query: 150 ISSCSKDDFKALIL-EYMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           +    ++     I+ EYM  GSL   L S    +L     L   +DV  A+EYL      
Sbjct: 65  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----A 120

Query: 208 HVIIHCDLKSSNVLLDDNMVA 228
           +  +H DL + NVL+ ++ VA
Sbjct: 121 NNFVHRDLAARNVLVSEDNVA 141

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 50.2 bits (120), Expect = 2e-07
 Identities = 36/135 (26%), Positives = 61/135 (45%), Gaps = 10/135 (7%)

Query: 96  ISRGGFGSIYKARIQDGMEV----VVKGFNLQYGGAFKNLDVE-CNMMKIIRHQNLIKII 150
           IS+G FGS+Y A+ +   +     V+K  ++       N+  E   MM       + K+ 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 151 SSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVI 210
            S    D+  L++EY+  G     + T   + + + + +I  +V   VE LH       I
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIA-EVVLGVEDLH----QRGI 118

Query: 211 IHCDLKSSNVLLDDN 225
           IH D+K  N+L+D  
Sbjct: 119 IHRDIKPENLLIDQT 133

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 49.8 bits (119), Expect = 2e-07
 Identities = 30/137 (21%), Positives = 67/137 (48%), Gaps = 17/137 (12%)

Query: 95  LISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSC 153
           ++ +G +G +Y AR +   + + +K    +     + L  E  +   ++H+N+++ + S 
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 154 SKDDFKALILEYMPHGSLGKCLST-------SNYILDFFQRLHIMIDVASAVEYLHFGHS 206
           S++ F  + +E +P GSL   L +       +   + F+ +      +   ++YLH    
Sbjct: 75  SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-----QILEGLKYLH---- 125

Query: 207 THVIIHCDLKSSNVLLD 223
            + I+H D+K  NVL++
Sbjct: 126 DNQIVHRDIKGDNVLVN 142

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 50.0 bits (119), Expect = 2e-07
 Identities = 37/138 (26%), Positives = 64/138 (46%), Gaps = 15/138 (10%)

Query: 95  LISRGGFGSIYKARIQD-GMEVVVKGFNLQYGGA-----FKNLDVECNMMKIIRHQNLIK 148
           L+ RG FG +Y     D G E+ VK                 L+ E  ++K +RH  +++
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 149 IISSCSKDDFK---ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 205
               C +D  +   ++ +EYMP GS+   L     + +   R +    +   V YLH   
Sbjct: 69  YYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR-QILQGVSYLH--- 123

Query: 206 STHVIIHCDLKSSNVLLD 223
            +++I+H D+K +N+L D
Sbjct: 124 -SNMIVHRDIKGANILRD 140

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 49.9 bits (119), Expect = 2e-07
 Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 30/159 (18%)

Query: 95  LISRGGFGSIYKARIQ----DGMEVVVKGFNLQYGGAFKNLDVE-----CNMMKIIRHQN 145
           ++ +G FGS+ +A+++       +V VK         F + D+E        MK   H N
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD---IFSSSDIEEFLREAACMKEFDHPN 62

Query: 146 LIKIISSCSKDDFKA------LILEYMPHGSLGKCLSTSN-----YILDFFQRLHIMIDV 194
           +IK+I    +   K       +IL +M HG L   L  S      + L     +  MID+
Sbjct: 63  VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122

Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM---VAHF 230
           AS +EYL    S+   IH DL + N +L++NM   VA F
Sbjct: 123 ASGMEYL----SSKNFIHRDLAARNCMLNENMTVCVADF 157

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 50.2 bits (120), Expect = 3e-07
 Identities = 31/84 (36%), Positives = 41/84 (48%), Gaps = 17/84 (20%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPI 60
           M +L++L    L+ N F    P         DS  +       L++LDLS N FSGA+P 
Sbjct: 451 MPSLQML---SLARNKFFGGLP---------DSFGSK-----RLENLDLSRNQFSGAVPR 493

Query: 61  PLEKLLDLKDLNLSFNTLEGKIPR 84
            L  L +L  L LS N L G+IP 
Sbjct: 494 KLGSLSELMQLKLSENKLSGEIPD 517

Length = 968

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 49.7 bits (118), Expect = 3e-07
 Identities = 37/131 (28%), Positives = 68/131 (51%), Gaps = 7/131 (5%)

Query: 93  FNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIIS 151
           +  I +G  G+++ A  +  G EV +K  NLQ     + +  E  +MK +++ N++  + 
Sbjct: 24  YEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLD 83

Query: 152 SCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVII 211
           S    D   +++EY+  GSL   ++ +   +D  Q   +  +   A+E+LH     + +I
Sbjct: 84  SFLVGDELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH----ANQVI 137

Query: 212 HCDLKSSNVLL 222
           H D+KS NVLL
Sbjct: 138 HRDIKSDNVLL 148

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 49.6 bits (119), Expect = 3e-07
 Identities = 35/139 (25%), Positives = 66/139 (47%), Gaps = 9/139 (6%)

Query: 94  NLISRGGFGSIYKARIQ----DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIK 148
            +I  G FG + + R++      ++V +K            +   E ++M    H N+I+
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 149 IISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH 208
           +    +K     +I EYM +GSL K L  ++      Q + ++  +AS ++YL    S  
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL----SEM 125

Query: 209 VIIHCDLKSSNVLLDDNMV 227
             +H DL + N+L++ N+V
Sbjct: 126 NYVHRDLAARNILVNSNLV 144

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 49.6 bits (118), Expect = 3e-07
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 34/153 (22%)

Query: 100 GFGSIYKARIQ-DGME----VVVKGF----NLQYGGAFKNLDVECNMMKIIRHQNLIKII 150
            FG IYK  +   GM+    V +K      N Q  G F+    E ++M  + H N++ ++
Sbjct: 17  AFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQ---EASLMAELHHPNIVCLL 73

Query: 151 SSCSKDDFKALILEYM-------------PHGSLGKCLS----TSNYILDFFQRLHIMID 193
              +++    ++ EY+             PH  +G C S    T    LD    LHI I 
Sbjct: 74  GVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVG-CSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 194 VASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           +A+ +EYL    S+H  +H DL + N+L+ + +
Sbjct: 133 IAAGMEYL----SSHFFVHKDLAARNILIGEQL 161

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 50.2 bits (120), Expect = 4e-07
 Identities = 30/106 (28%), Positives = 47/106 (44%), Gaps = 12/106 (11%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPT-----------TIEYNRLQDSLRNSIGDLTSLKSLDL 49
           +   + L R+ L  N+FS   P+            I  N LQ  + +   D+ SL+ L L
Sbjct: 400 LGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSL 459

Query: 50  SNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNL 95
           + N F G +P        L++L+LS N   G +PR   +  E+  L
Sbjct: 460 ARNKFFGGLP-DSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQL 504

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 49.8 bits (119), Expect = 5e-07
 Identities = 30/88 (34%), Positives = 41/88 (46%), Gaps = 11/88 (12%)

Query: 7   LLRIDLSTNNFSCVFPTT-----------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFS 55
           L  +DLS N FS   P             +  N+L   + + +     L SLDLS+N  S
Sbjct: 477 LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLS 536

Query: 56  GAIPIPLEKLLDLKDLNLSFNTLEGKIP 83
           G IP    ++  L  L+LS N L G+IP
Sbjct: 537 GQIPASFSEMPVLSQLDLSQNQLSGEIP 564

Length = 968

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 49.0 bits (116), Expect = 5e-07
 Identities = 36/131 (27%), Positives = 68/131 (51%), Gaps = 7/131 (5%)

Query: 93  FNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIIS 151
           F  I +G  G++Y A  +  G EV ++  NLQ     + +  E  +M+  ++ N++  + 
Sbjct: 25  FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84

Query: 152 SCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVII 211
           S    D   +++EY+  GSL   ++ +   +D  Q   +  +   A+E+LH    ++ +I
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVI 138

Query: 212 HCDLKSSNVLL 222
           H D+KS N+LL
Sbjct: 139 HRDIKSDNILL 149

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 48.9 bits (116), Expect = 5e-07
 Identities = 37/131 (28%), Positives = 68/131 (51%), Gaps = 7/131 (5%)

Query: 93  FNLISRGGFGSIYKA-RIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIIS 151
           F  I +G  G++Y A  I  G EV +K  NLQ     + +  E  +M+  ++ N++  + 
Sbjct: 24  FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 83

Query: 152 SCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVII 211
           S    D   +++EY+  GSL   ++ +   +D  Q   +  +   A+++LH    ++ +I
Sbjct: 84  SYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH----SNQVI 137

Query: 212 HCDLKSSNVLL 222
           H D+KS N+LL
Sbjct: 138 HRDIKSDNILL 148

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 49.5 bits (118), Expect = 6e-07
 Identities = 30/71 (42%), Positives = 36/71 (50%), Gaps = 3/71 (4%)

Query: 27  YNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPF 86
           YN L   +   IG LTSL  LDL  NN +G IP  L  L +L+ L L  N L G IP   
Sbjct: 221 YNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIP--- 277

Query: 87  RNFLEVFNLIS 97
            +   +  LIS
Sbjct: 278 PSIFSLQKLIS 288

Length = 968

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 49.1 bits (118), Expect = 6e-07
 Identities = 38/148 (25%), Positives = 69/148 (46%), Gaps = 24/148 (16%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNL-DV-----ECNMMKIIRH 143
           E+   I  G +G +  A   + G +V +K  +      F +L D      E  +++ +RH
Sbjct: 3   ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN----VFDDLIDAKRILREIKLLRHLRH 58

Query: 144 QNLIK---IISSCSKDDFKALIL--EYMPHGSLGKCLSTSNYI-LDFFQRLHIMIDVASA 197
           +N+I    I+   S +DF  + +  E M    L K + +   +  D  Q  + +  +   
Sbjct: 59  ENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQ--YFLYQILRG 115

Query: 198 VEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
           ++YLH  +    +IH DLK SN+L++ N
Sbjct: 116 LKYLHSAN----VIHRDLKPSNILVNSN 139

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 48.7 bits (116), Expect = 6e-07
 Identities = 35/145 (24%), Positives = 62/145 (42%), Gaps = 30/145 (20%)

Query: 95  LISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV------ECNMMKIIRHQNLI 147
            +  G F S Y+AR ++ G  + VK        + +  +V      E  +M  + H ++I
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLS---------TSNYILDFFQRLHIMIDVASAV 198
           +++ +  +D    L +E+M  GS+   LS           NY     +           +
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR----------GL 116

Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLD 223
            YLH     + IIH D+K +N+L+D
Sbjct: 117 SYLH----ENQIIHRDVKGANLLID 137

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 48.4 bits (116), Expect = 7e-07
 Identities = 40/150 (26%), Positives = 60/150 (40%), Gaps = 28/150 (18%)

Query: 88  NFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLI 147
               +   I +G FG +YKA  +   +VV          A K +D+E    +I   Q  I
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVV----------AIKVIDLEEAEDEIEDIQQEI 50

Query: 148 KIISSCSK-----------DDFK-ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVA 195
           + +S C                K  +I+EY   GS    L      LD      I+ +V 
Sbjct: 51  QFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP--GKLDETYIAFILREVL 108

Query: 196 SAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
             +EYLH        IH D+K++N+LL + 
Sbjct: 109 LGLEYLHEEGK----IHRDIKAANILLSEE 134

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 48.3 bits (115), Expect = 7e-07
 Identities = 27/91 (29%), Positives = 41/91 (45%), Gaps = 5/91 (5%)

Query: 137 MMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVAS 196
           MMK+  H+ L+++   C+K     ++ EYM +G L   L          Q L +  DV  
Sbjct: 53  MMKL-SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCE 111

Query: 197 AVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
            + YL     +   IH DL + N L+DD   
Sbjct: 112 GMAYLE----SKQFIHRDLAARNCLVDDQGC 138

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 48.6 bits (116), Expect = 7e-07
 Identities = 38/145 (26%), Positives = 70/145 (48%), Gaps = 13/145 (8%)

Query: 90  LEVFNLISRGGFGSIYKAR---IQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQ 144
           L+    + +G FGS+   R   +QD    VV    LQ+  A   ++ + E  ++K ++H 
Sbjct: 6   LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHD 65

Query: 145 NLIK---IISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL 201
           N++K   +  S  + + + L++EY+P+GSL   L      LD  + L     +   +EYL
Sbjct: 66  NIVKYKGVCYSAGRRNLR-LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYL 124

Query: 202 HFGHSTHVIIHCDLKSSNVLLDDNM 226
                +   +H DL + N+L++   
Sbjct: 125 ----GSKRYVHRDLATRNILVESEN 145

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 48.4 bits (115), Expect = 8e-07
 Identities = 37/146 (25%), Positives = 70/146 (47%), Gaps = 12/146 (8%)

Query: 87  RNFLEVFNLISRGGFGSIYKARI-----QDGMEVVVKGFNLQYGGA-FKNLDVECNMMKI 140
           + FL+    +  G FG +   R        G +V VK    + GG    +L  E  +++ 
Sbjct: 3   KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRN 62

Query: 141 IRHQNLIKIISSCSKDDFKA--LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV 198
           + H+N++K    C++D      LI+E++P GSL + L  +   ++  Q+L   + +   +
Sbjct: 63  LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGM 122

Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDD 224
           +YL     +   +H DL + NVL++ 
Sbjct: 123 DYL----GSRQYVHRDLAARNVLVES 144

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 48.1 bits (115), Expect = 9e-07
 Identities = 34/136 (25%), Positives = 57/136 (41%), Gaps = 5/136 (3%)

Query: 90  LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGA-FKNLDVECNMMKIIRHQNLI 147
           LE    +  G  G + K   +  G  + VK   L+   A  K +  E +++       ++
Sbjct: 3   LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIV 62

Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
               +   +   ++ +EYM  GSL K L      +       I + V   + YLH     
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EK 119

Query: 208 HVIIHCDLKSSNVLLD 223
           H IIH D+K SN+L++
Sbjct: 120 HKIIHRDVKPSNILVN 135

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 47.5 bits (113), Expect = 1e-06
 Identities = 38/140 (27%), Positives = 62/140 (44%), Gaps = 15/140 (10%)

Query: 95  LISRGGFGSIYKA-RIQDGMEVVVKGFNLQYGGA---------FKNLDVECNMMKIIRHQ 144
           LI  G FGS+Y       G  + VK   L    A            L  E  ++K ++H+
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N+++ + S    D   + LEY+P GS+   L+      +   R  +   +   + YLH  
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR-QILKGLNYLH-- 123

Query: 205 HSTHVIIHCDLKSSNVLLDD 224
                IIH D+K +N+L+D+
Sbjct: 124 --NRGIIHRDIKGANILVDN 141

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 47.9 bits (114), Expect = 2e-06
 Identities = 32/87 (36%), Positives = 42/87 (48%), Gaps = 9/87 (10%)

Query: 7   LLRIDLSTNNFS---------CVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGA 57
           L  ++LS NNF+          +    +  N L   + N IG  +SLK LDL  N   G 
Sbjct: 120 LRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK 179

Query: 58  IPIPLEKLLDLKDLNLSFNTLEGKIPR 84
           IP  L  L  L+ L L+ N L G+IPR
Sbjct: 180 IPNSLTNLTSLEFLTLASNQLVGQIPR 206

Length = 968

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 47.3 bits (112), Expect = 2e-06
 Identities = 35/138 (25%), Positives = 67/138 (48%), Gaps = 9/138 (6%)

Query: 95  LISRGGFGSIYKA--RIQDGMEVVVKGFNLQYGGAFK---NLDVECNMMKIIRHQNLIKI 149
           +I  G FG +++   ++    EV V    L+ G   K   +   E ++M    H N+I++
Sbjct: 12  VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV 209
               +K     +I EYM +G+L K L   +     +Q + ++  +A+ ++YL    S   
Sbjct: 72  EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL----SDMN 127

Query: 210 IIHCDLKSSNVLLDDNMV 227
            +H DL + N+L++ N+ 
Sbjct: 128 YVHRDLAARNILVNSNLE 145

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 47.4 bits (112), Expect = 2e-06
 Identities = 47/156 (30%), Positives = 71/156 (45%), Gaps = 26/156 (16%)

Query: 94  NLISRGGFGSIYKARIQ-DG--MEVVVKGFNLQYGGAFKNLDVECNM---MKIIRHQNLI 147
           ++I  G FG + KARI+ DG  M+  +K    +Y     + D    +    K+  H N+I
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNII 59

Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI---------------LDFFQRLHIMI 192
            ++ +C    +  L +EY PHG+L   L  S  +               L   Q LH   
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
           DVA  ++YL    S    IH DL + N+L+ +N VA
Sbjct: 120 DVARGMDYL----SQKQFIHRDLAARNILVGENYVA 151

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 46.9 bits (111), Expect = 2e-06
 Identities = 34/134 (25%), Positives = 56/134 (41%), Gaps = 9/134 (6%)

Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMKIIRHQNLIKIISSC 153
           I  G FG ++     +  +V +K       GA    D   E  +M  + H  L+++   C
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR---EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68

Query: 154 SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHC 213
           ++     L+ E+M HG L   L            L + +DV   + YL     +  +IH 
Sbjct: 69  TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE----SSNVIHR 124

Query: 214 DLKSSNVLLDDNMV 227
           DL + N L+ +N V
Sbjct: 125 DLAARNCLVGENQV 138

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 46.6 bits (110), Expect = 3e-06
 Identities = 43/160 (26%), Positives = 77/160 (48%), Gaps = 34/160 (21%)

Query: 81  KIPRPFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG----AFKNLDVECN 136
           +IPR     LEV   + +G FG ++         V +K   L+ G     AF     E  
Sbjct: 2   EIPRESLR-LEV--KLGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQ---EAQ 53

Query: 137 MMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCL--STSNYILDFFQRLHIMIDV 194
           +MK +RH+ L+++ +  S++    ++ EYM  GSL   L      Y+     RL  ++D+
Sbjct: 54  VMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYL-----RLPQLVDM 107

Query: 195 ASA-------VEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           A+        VE +++       +H DL+++N+L+ +N+V
Sbjct: 108 AAQIASGMAYVERMNY-------VHRDLRAANILVGENLV 140

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 46.6 bits (111), Expect = 3e-06
 Identities = 36/140 (25%), Positives = 65/140 (46%), Gaps = 8/140 (5%)

Query: 91  EVFNLISRGGFGSIYKARIQD-GMEVVVKGF-NLQYGGAFKNLDV-ECNMMKIIRHQNLI 147
           E   L+  G +G + K + ++ G  V +K F   +     K + + E  M+K +RH+NL+
Sbjct: 4   ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLV 63

Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
            +I    +     L+ E++ H  L   L      LD  +    +  +   +E+ H    +
Sbjct: 64  NLIEVFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIEFCH----S 118

Query: 208 HVIIHCDLKSSNVLLDDNMV 227
           H IIH D+K  N+L+  + V
Sbjct: 119 HNIIHRDIKPENILVSQSGV 138

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 47.2 bits (112), Expect = 4e-06
 Identities = 32/88 (36%), Positives = 45/88 (51%), Gaps = 16/88 (18%)

Query: 10  IDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK 69
           I+LS N  S   P  I                +SL+ L+LSNNNF+G   IP   + +L+
Sbjct: 98  INLSNNQLSGPIPDDIFTTS------------SSLRYLNLSNNNFTG--SIPRGSIPNLE 143

Query: 70  DLNLSFNTLEGKIPRPFRNF--LEVFNL 95
            L+LS N L G+IP    +F  L+V +L
Sbjct: 144 TLDLSNNMLSGEIPNDIGSFSSLKVLDL 171

Length = 968

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 46.3 bits (110), Expect = 5e-06
 Identities = 21/54 (38%), Positives = 32/54 (59%)

Query: 30  LQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIP 83
           L+  + N I  L  L+S++LS N+  G IP  L  +  L+ L+LS+N+  G IP
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483

Length = 623

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 46.0 bits (109), Expect = 5e-06
 Identities = 39/140 (27%), Positives = 67/140 (47%), Gaps = 21/140 (15%)

Query: 96  ISRGGFGSIYKARIQDGMEVV-VKGFNLQYGGA-----FKNLDVECNMMKIIRHQNLIKI 149
           I  G FG++Y AR     EVV +K  +  Y G      ++++  E   ++ +RH N I+ 
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMS--YSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDF----FQRLHIMIDVASAVEYLHFGH 205
                ++    L++EY        CL +++ IL+      Q + I      A++ L + H
Sbjct: 81  KGCYLREHTAWLVMEY--------CLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132

Query: 206 STHVIIHCDLKSSNVLLDDN 225
           S H  IH D+K+ N+LL + 
Sbjct: 133 S-HERIHRDIKAGNILLTEP 151

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 45.8 bits (108), Expect = 6e-06
 Identities = 33/131 (25%), Positives = 59/131 (45%), Gaps = 6/131 (4%)

Query: 96  ISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFK-NLDVECNMMKIIRHQNLIKIISSC 153
           I RG FG ++  R++ D   V VK          K     E  ++K   H N++++I  C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 154 SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHC 213
           ++     +++E +  G     L T    L   + + ++ + A+ +EYL   H     IH 
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHC----IHR 118

Query: 214 DLKSSNVLLDD 224
           DL + N L+ +
Sbjct: 119 DLAARNCLVTE 129

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 45.8 bits (108), Expect = 6e-06
 Identities = 33/148 (22%), Positives = 63/148 (42%), Gaps = 26/148 (17%)

Query: 101 FGSIYKARI------QDGMEVVVKGFNLQYGGAFKN-LDVECNMMKIIRHQNLIKIISSC 153
           FG +YK  +      +    V +K    +  G  +     E  M   ++H N++ ++   
Sbjct: 18  FGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV 77

Query: 154 SKDDFKALILEYMPHGSLGKCL---------------STSNYILDFFQRLHIMIDVASAV 198
           +K+   ++I  Y  H  L + L                T    L+    +HI+  +A+ +
Sbjct: 78  TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGM 137

Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           E+L    S+H ++H DL + NVL+ D +
Sbjct: 138 EFL----SSHHVVHKDLATRNVLVFDKL 161

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 45.5 bits (108), Expect = 6e-06
 Identities = 35/137 (25%), Positives = 69/137 (50%), Gaps = 7/137 (5%)

Query: 87  RNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN 145
           R++L+ F  I  G  G +  A     G +V VK  +L+     + L  E  +M+  +H N
Sbjct: 18  RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN 77

Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 205
           ++++ SS    D   +++E++  G+L   ++ +   ++  Q   + + V  A+ +LH   
Sbjct: 78  IVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLH--- 132

Query: 206 STHVIIHCDLKSSNVLL 222
               +IH D+KS ++LL
Sbjct: 133 -AQGVIHRDIKSDSILL 148

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 45.7 bits (109), Expect = 7e-06
 Identities = 38/138 (27%), Positives = 68/138 (49%), Gaps = 12/138 (8%)

Query: 91  EVFNLISRGGFGSIYKARIQDGMEVV----VKGFNLQYGGAFKNLDVECNMMKIIRHQNL 146
           E  N I  G +G +Y+AR +   E+V    +K    + G    +L  E N++  ++H N+
Sbjct: 8   EKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQHPNI 66

Query: 147 IKI--ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           + +  +   S  D   +++EY+ H  L   + T        +   +M+ + S V +LH  
Sbjct: 67  VTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH-- 123

Query: 205 HSTHVIIHCDLKSSNVLL 222
              + I+H DLK+SN+LL
Sbjct: 124 --DNWILHRDLKTSNLLL 139

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 45.4 bits (107), Expect = 7e-06
 Identities = 38/153 (24%), Positives = 74/153 (48%), Gaps = 28/153 (18%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQN 145
           R  +++   +  G FG ++     +  +V VK   L+ G  + +    E N+MK ++H  
Sbjct: 5   RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDK 62

Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQR-------LHIMID----V 194
           L+++ +  +K++   +I EYM  GSL          LDF +        L  +ID    +
Sbjct: 63  LVRLYAVVTKEEPIYIITEYMAKGSL----------LDFLKSDEGGKVLLPKLIDFSAQI 112

Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           A  + Y+   +     IH DL+++NVL+ ++++
Sbjct: 113 AEGMAYIERKN----YIHRDLRAANVLVSESLM 141

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 46.0 bits (109), Expect = 8e-06
 Identities = 32/95 (33%), Positives = 45/95 (47%), Gaps = 8/95 (8%)

Query: 2   SNLKVLL--------RIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNN 53
           S+LKVL         +I  S  N + +   T+  N+L   +   +G + SLK + L  NN
Sbjct: 164 SSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNN 223

Query: 54  FSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRN 88
            SG IP  +  L  L  L+L +N L G IP    N
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGN 258

Length = 968

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 45.4 bits (107), Expect = 8e-06
 Identities = 33/133 (24%), Positives = 61/133 (45%), Gaps = 5/133 (3%)

Query: 91  EVFNLISRGGFGSIYKARIQD-GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           E+   +  G FG +YKA+ ++ G     K    +     ++  VE  ++    H  ++K+
Sbjct: 15  EIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKL 74

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV 209
           + +   D    +++E+ P G++   +   +  L       I +     +E L + HS   
Sbjct: 75  LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGL---TEPQIQVICRQMLEALQYLHSMK- 130

Query: 210 IIHCDLKSSNVLL 222
           IIH DLK+ NVLL
Sbjct: 131 IIHRDLKAGNVLL 143

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 45.4 bits (107), Expect = 8e-06
 Identities = 36/138 (26%), Positives = 69/138 (50%), Gaps = 15/138 (10%)

Query: 95  LISRGGFGSIYKARIQD-GMEVVVKG--FNLQYGGAFKN---LDVECNMMKIIRHQNLIK 148
           L+ +G FG +Y     D G E+ VK   F+ +     K    L+ E  ++K + H+ +++
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 149 IISSCSKDDFK---ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 205
               C +D  +   ++ +E+MP GS+   L +   + +   R +    +   V YLH   
Sbjct: 69  YYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR-QILEGVSYLH--- 123

Query: 206 STHVIIHCDLKSSNVLLD 223
            +++I+H D+K +N+L D
Sbjct: 124 -SNMIVHRDIKGANILRD 140

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 37/119 (31%), Positives = 61/119 (51%), Gaps = 9/119 (7%)

Query: 94  NLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISS 152
           N+ISRG  G+ YK + I++GM+ VVK  N        +   +   M  ++H N++K+I  
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD---MGKLQHPNIVKLIGL 751

Query: 153 CSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVII 211
           C  +    LI EY+   +L + L      L + +R  I I +A A+ +LH   S  V++
Sbjct: 752 CRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVV 806

Length = 968

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 44.8 bits (106), Expect = 1e-05
 Identities = 35/145 (24%), Positives = 71/145 (48%), Gaps = 15/145 (10%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG----AFKNLDVECNMMKIIR 142
           R  L++   +  G FG ++        +V +K  +L+ G     AF     E N+MK ++
Sbjct: 5   RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIK--SLKQGSMSPEAFL---AEANLMKQLQ 59

Query: 143 HQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI-LDFFQRLHIMIDVASAVEYL 201
           H  L+++ +  +++    +I EYM +GSL   L T   I L   + + +   +A  + ++
Sbjct: 60  HPRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI 118

Query: 202 HFGHSTHVIIHCDLKSSNVLLDDNM 226
              +     IH DL+++N+L+ + +
Sbjct: 119 ERKNY----IHRDLRAANILVSETL 139

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 44.7 bits (106), Expect = 1e-05
 Identities = 34/141 (24%), Positives = 67/141 (47%), Gaps = 25/141 (17%)

Query: 96  ISRGGFGSIYKARIQDGMEVV----VKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIIS 151
           I +G F  +YKA       VV    V+ F +    A ++   E +++K + H N+IK ++
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 152 SCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMID----------VASAVEYL 201
           S  +++   ++LE    G L +       ++  F++   +I           + SA+E++
Sbjct: 70  SFIENNELNIVLELADAGDLSR-------MIKHFKKQKRLIPERTIWKYFVQLCSALEHM 122

Query: 202 HFGHSTHVIIHCDLKSSNVLL 222
           H    +  I+H D+K +NV +
Sbjct: 123 H----SKRIMHRDIKPANVFI 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 44.6 bits (105), Expect = 1e-05
 Identities = 44/154 (28%), Positives = 71/154 (46%), Gaps = 23/154 (14%)

Query: 96  ISRGGFGSIYKARI-QDG--MEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKII 150
           +  G FGS+ + ++ QD   ++V VK   +        ++   E   MK   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 151 SSC----SKDDFKA--LILEYMPHGSLGKCLSTSNY-----ILDFFQRLHIMIDVASAVE 199
             C      + + +  +IL +M HG L   L  S        L     +  M D+AS +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 200 YLHFGHSTHVIIHCDLKSSNVLLDDNM---VAHF 230
           YL    S+   IH DL + N +L++NM   VA F
Sbjct: 127 YL----SSKSFIHRDLAARNCMLNENMNVCVADF 156

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 44.8 bits (106), Expect = 1e-05
 Identities = 36/156 (23%), Positives = 70/156 (44%), Gaps = 29/156 (18%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGME------VVVKGF------NLQYGGAFKNLDVE 134
           R+ L+    + RG FG ++ A+ +   E      V+VK        NLQ    F+    E
Sbjct: 4   RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQ--SEFRR---E 58

Query: 135 CNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFF--------Q 186
            +M + + H+N+++++  C + +   +ILEY   G L + L  +    +          Q
Sbjct: 59  LDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQ 118

Query: 187 RLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL 222
           ++ +   +A  +++L    S    +H DL + N L+
Sbjct: 119 KVALCTQIALGMDHL----SNARFVHRDLAARNCLV 150

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 44.7 bits (106), Expect = 1e-05
 Identities = 43/149 (28%), Positives = 65/149 (43%), Gaps = 15/149 (10%)

Query: 84  RPFRNFLEVFNLISRGGFGSIYKARIQDGMEVV----VKGFNLQYGGAFKNLDVECNMMK 139
           R    F E  N I  G +G +Y+AR     E+V    V+  N + G    +L  E  ++ 
Sbjct: 4   RSVTEF-EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLL 61

Query: 140 IIRHQN---LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVAS 196
            +RH N   L +++     D    L++EY     L   L          Q   +M+ +  
Sbjct: 62  NLRHPNIVELKEVVVGKHLDSI-FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLR 119

Query: 197 AVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++YLH     + IIH DLK SN+LL D 
Sbjct: 120 GLQYLH----ENFIIHRDLKVSNLLLTDK 144

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 44.7 bits (105), Expect = 1e-05
 Identities = 32/138 (23%), Positives = 64/138 (46%), Gaps = 15/138 (10%)

Query: 95  LISRGGFGSIYKA-RIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQNLIK 148
           L+ +G FG +Y    +  G E+  K         +       L+ E  ++K ++H+ +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 149 IISSCSKDDFK---ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 205
               C +D  +    + +EYMP GS+   L     + +   R +    +   + YLH   
Sbjct: 69  YYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR-QILEGMSYLH--- 123

Query: 206 STHVIIHCDLKSSNVLLD 223
            +++I+H D+K +N+L D
Sbjct: 124 -SNMIVHRDIKGANILRD 140

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.5 bits (103), Expect = 1e-05
 Identities = 28/139 (20%), Positives = 62/139 (44%), Gaps = 14/139 (10%)

Query: 95  LISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLI--KIISS 152
           L+  G    +Y    +D  + V+K    +  GA +  +V   +++++  + L   K+++S
Sbjct: 5   LLKGGLTNRVYLLGTKDE-DYVLKINPSREKGADREREVA--ILQLLARKGLPVPKVLAS 61

Query: 153 CSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIH 212
              D +  L++E++   +L +        +   ++  I   +A  +  LH      V+ H
Sbjct: 62  GESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLH-QLPLLVLCH 112

Query: 213 CDLKSSNVLLDDNMVAHFL 231
            DL   N+L+DD  +   +
Sbjct: 113 GDLHPGNILVDDGKILGII 131

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 44.8 bits (106), Expect = 2e-05
 Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 14/92 (15%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLS 50
           +NL VL   DLSTNN +   P  +             N L+  +  S+G   SL+ + L 
Sbjct: 356 NNLTVL---DLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQ 412

Query: 51  NNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKI 82
           +N+FSG +P    KL  +  L++S N L+G+I
Sbjct: 413 DNSFSGELPSEFTKLPLVYFLDISNNNLQGRI 444

Length = 968

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 44.6 bits (105), Expect = 2e-05
 Identities = 27/104 (25%), Positives = 53/104 (50%), Gaps = 15/104 (14%)

Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLST---------SNYI--L 182
           E  +M  +++ N+I+++  C  DD   +I EYM +G L + LS          +N I  +
Sbjct: 67  EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126

Query: 183 DFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
                L++ + +AS ++YL    ++   +H DL + N L+ ++ 
Sbjct: 127 SIANLLYMAVQIASGMKYL----ASLNFVHRDLATRNCLVGNHY 166

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 44.2 bits (104), Expect = 2e-05
 Identities = 35/134 (26%), Positives = 66/134 (49%), Gaps = 9/134 (6%)

Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSK 155
           I  G FG++ +     G +V VK  N++     +    E  +M  + H+NL++++     
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH 70

Query: 156 DDFKALILEYMPHGSLGKCLST-SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCD 214
           +    +++E M  G+L   L T    ++   Q L   +DVA  +EYL     +  ++H D
Sbjct: 71  NGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE----SKKLVHRD 125

Query: 215 LKSSNVLLDDNMVA 228
           L + N+L+ ++ VA
Sbjct: 126 LAARNILVSEDGVA 139

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 44.3 bits (105), Expect = 2e-05
 Identities = 34/133 (25%), Positives = 67/133 (50%), Gaps = 11/133 (8%)

Query: 96  ISRGGFGSIYKARIQDGMEVV-VKGFN---LQYGGAFKNLDVECNMMKIIRHQNLIKIIS 151
           + +GG+G ++ A+ +D  E+V +K      L      +++  E +++   + + L+K++ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 152 SCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-FGHSTHVI 210
           +   D++  L +EY+P G     L+    + +   R + M ++  AV+ LH  G      
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFY-MAEMFEAVDALHELG-----Y 122

Query: 211 IHCDLKSSNVLLD 223
           IH DLK  N L+D
Sbjct: 123 IHRDLKPENFLID 135

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 44.2 bits (105), Expect = 2e-05
 Identities = 35/152 (23%), Positives = 58/152 (38%), Gaps = 35/152 (23%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR------- 142
           E    I  G +G++YKAR +  G  V +K   +        L  E   +  +R       
Sbjct: 2   EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVP-------LSEEGIPLSTLREIALLKQ 54

Query: 143 -----HQNLIKIISSCSKDDFK-----ALILEYMP---HGSLGKCLSTSNYILDFFQRLH 189
                H N+++++  C            L+ E++       L KC       L       
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG---LPPETIKD 111

Query: 190 IMIDVASAVEYLHFGHSTHVIIHCDLKSSNVL 221
           +M  +   V++LH    +H I+H DLK  N+L
Sbjct: 112 LMRQLLRGVDFLH----SHRIVHRDLKPQNIL 139

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 44.0 bits (104), Expect = 2e-05
 Identities = 38/146 (26%), Positives = 62/146 (42%), Gaps = 20/146 (13%)

Query: 91  EVFNLISRGGFGSIYKA-RIQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMKIIRHQNLI 147
           +V   + +G +GS+YK  R+ D     +K  +L      +  D   E  ++  + H N+I
Sbjct: 3   KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII 62

Query: 148 KIISSCSKDDF-----KALILEYMPHGSLGKCLSTSNYILDFFQR---LHIMIDVASAVE 199
                  K+ F       +++EY P G L K +S                I I +   ++
Sbjct: 63  -----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117

Query: 200 YLHFGHSTHVIIHCDLKSSNVLLDDN 225
            LH       I+H DLKS+N+LL  N
Sbjct: 118 ALH----EQKILHRDLKSANILLVAN 139

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 43.7 bits (104), Expect = 2e-05
 Identities = 38/138 (27%), Positives = 62/138 (44%), Gaps = 12/138 (8%)

Query: 90  LEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAF-KNLDVECNMMKIIR---HQ 144
           LE   ++ +G  G +YK R    G    +K  ++     F K L  E   +K +R     
Sbjct: 3   LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRE---LKTLRSCESP 59

Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
            ++K   +  K+   +++LEYM  GSL   L     I +      I   +   ++YLH  
Sbjct: 60  YVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-IARQILKGLDYLH-- 116

Query: 205 HSTHVIIHCDLKSSNVLL 222
            +   IIH D+K SN+L+
Sbjct: 117 -TKRHIIHRDIKPSNLLI 133

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 44.5 bits (105), Expect = 3e-05
 Identities = 33/105 (31%), Positives = 49/105 (46%), Gaps = 11/105 (10%)

Query: 3   NLKVLLRIDLSTNNFSCVFPTTIEY-----------NRLQDSLRNSIGDLTSLKSLDLSN 51
           +L+ L+ +DLS N+ S   P  +             N     +  ++  L  L+ L L +
Sbjct: 282 SLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWS 341

Query: 52  NNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNLI 96
           N FSG IP  L K  +L  L+LS N L G+IP    +   +F LI
Sbjct: 342 NKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLI 386

Length = 968

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 43.9 bits (103), Expect = 3e-05
 Identities = 36/139 (25%), Positives = 69/139 (49%), Gaps = 21/139 (15%)

Query: 96  ISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGA-----FKNLDVECNMMKIIRHQNLIKI 149
           I  G FG++Y AR +++   V +K   + Y G      ++++  E   ++ +RH N I+ 
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIK--KMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDF----FQRLHIMIDVASAVEYLHFGH 205
                ++    L++EY        CL +++ +L+      Q + I      A++ L + H
Sbjct: 81  RGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132

Query: 206 STHVIIHCDLKSSNVLLDD 224
           S H +IH D+K+ N+LL +
Sbjct: 133 S-HNMIHRDVKAGNILLSE 150

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 43.7 bits (103), Expect = 3e-05
 Identities = 43/172 (25%), Positives = 69/172 (40%), Gaps = 38/172 (22%)

Query: 87  RNFLEVFNLISRGGFGSIYKARI------QDGMEVVVK----GFNLQYGGAFKNLDVECN 136
           RN +E    I +G FG +++AR       +    V VK      +      F+    E  
Sbjct: 4   RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR---EAA 60

Query: 137 MMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCL--------------------S 176
           +M    H N++K++  C+      L+ EYM +G L + L                     
Sbjct: 61  LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120

Query: 177 TSNYI-LDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
             N + L   ++L I   VA+ + YL    S    +H DL + N L+ +NMV
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYL----SERKFVHRDLATRNCLVGENMV 168

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 43.5 bits (102), Expect = 3e-05
 Identities = 36/138 (26%), Positives = 70/138 (50%), Gaps = 19/138 (13%)

Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGGA-----FKNLDVECNMMKIIRHQNLIKII 150
           I  G FG++Y AR     EVV     + Y G      ++++  E   ++ I+H N I+  
Sbjct: 33  IGHGSFGAVYFARDVRTNEVVAIK-KMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91

Query: 151 SSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVAS----AVEYLHFGHS 206
               ++    L++EY        CL +++ +L+  ++    +++A+    A++ L + HS
Sbjct: 92  GCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS 143

Query: 207 THVIIHCDLKSSNVLLDD 224
            H +IH D+K+ N+LL +
Sbjct: 144 -HNMIHRDIKAGNILLTE 160

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 43.5 bits (102), Expect = 3e-05
 Identities = 39/155 (25%), Positives = 70/155 (45%), Gaps = 33/155 (21%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL 146
           R  L++   +  G FG ++        +V VK            L+ E  +MK +RH  L
Sbjct: 5   RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLE-EAQIMKKLRHDKL 63

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQ-------RLHIMIDVASAV- 198
           +++ +  S++    ++ EYM  GSL          LDF +       +L  ++D+A+ V 
Sbjct: 64  VQLYAVVSEEPI-YIVTEYMSKGSL----------LDFLKDGEGRALKLPNLVDMAAQVA 112

Query: 199 ------EYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
                 E +++       IH DL+S+N+L+ D +V
Sbjct: 113 AGMAYIERMNY-------IHRDLRSANILVGDGLV 140

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 43.4 bits (103), Expect = 4e-05
 Identities = 34/132 (25%), Positives = 57/132 (43%), Gaps = 8/132 (6%)

Query: 96  ISRGGFGSIYKAR-IQDGMEVVVKGFNLQ--YGGAFKNLDVECNMMKIIRHQNLIKIISS 152
           I  G  G ++KA+  + G  V +K   L+   GG       E   ++  +H  ++K++  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 153 CSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIH 212
                   L++EYMP   L + L      L   Q    M  +   V Y+H     + I+H
Sbjct: 68  FPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH----ANGIMH 122

Query: 213 CDLKSSNVLLDD 224
            DLK +N+L+  
Sbjct: 123 RDLKPANLLISA 134

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 43.1 bits (102), Expect = 4e-05
 Identities = 34/151 (22%), Positives = 71/151 (47%), Gaps = 25/151 (16%)

Query: 91  EVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQY--------GGAFKNLDVECNMMKIIR 142
           E+  +I +G FG +   + +D  ++    F ++Y         G+ +N+  E  +++ + 
Sbjct: 3   ELLRVIGKGAFGKVCIVQKRDTKKM----FAMKYMNKQKCVEKGSVRNVLNERRILQELN 58

Query: 143 HQNLIKIISSCSKDDFKALILEYMPHGSL----GKCLSTSNYILDFFQRLHIMIDVASAV 198
           H  L+ +  S   ++   L+++ +  G L     + +  S   + F+     + ++  A+
Sbjct: 59  HPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFW-----ICEIVLAL 113

Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNMVAH 229
           EYLH    +  IIH D+K  N+LLD+    H
Sbjct: 114 EYLH----SKGIIHRDIKPDNILLDEQGHVH 140

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 43.5 bits (102), Expect = 4e-05
 Identities = 32/114 (28%), Positives = 55/114 (48%), Gaps = 20/114 (17%)

Query: 130 NLDVECNMMKII-RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLST----------- 177
           +L  E  MMK+I +H+N+I ++ +C++D    +I+EY   G+L + L             
Sbjct: 66  DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125

Query: 178 ----SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
                +  + F   +     VA  +EYL    ++   IH DL + NVL+ +N V
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYL----ASQKCIHRDLAARNVLVTENNV 175

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 43.5 bits (102), Expect = 4e-05
 Identities = 38/137 (27%), Positives = 70/137 (51%), Gaps = 7/137 (5%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN 145
           R+ LE +  I  G  G +  AR +  G +V VK  +L+     + L  E  +M+  +HQN
Sbjct: 20  RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQN 79

Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 205
           ++++  S    +   +++E++  G+L   +S +   L+  Q   +   V  A+ YLH   
Sbjct: 80  VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLH--- 134

Query: 206 STHVIIHCDLKSSNVLL 222
            +  +IH D+KS ++LL
Sbjct: 135 -SQGVIHRDIKSDSILL 150

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 42.8 bits (101), Expect = 5e-05
 Identities = 36/149 (24%), Positives = 65/149 (43%), Gaps = 22/149 (14%)

Query: 94  NLISRGGFGSIYKARIQDGM-----EVVVKGFNLQYGGAFKNLDV---ECNMMKIIRHQN 145
           +L+  G FG I+   + D       EV VK   ++   +   + +   E  ++  + HQN
Sbjct: 12  DLLQEGTFGRIFYGILIDEKPGKEEEVFVK--TVKDHASEIQVTLLLQESCLLYGLSHQN 69

Query: 146 LIKIISSCSKDDFKALILE-YMPHGSLGKCLSTSNYI-------LDFFQRLHIMIDVASA 197
           ++ I+  C +D     +L  YM  G+L   L             L   Q +H+ I +A  
Sbjct: 70  ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACG 129

Query: 198 VEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           + YLH       +IH D+ + N ++D+ +
Sbjct: 130 MSYLH----KRGVIHKDIAARNCVIDEEL 154

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 42.8 bits (101), Expect = 6e-05
 Identities = 31/140 (22%), Positives = 61/140 (43%), Gaps = 10/140 (7%)

Query: 87  RNFLEVFNLISRGGFGSIYKA----RIQDGMEVVVKGFNLQYGGAFKNLDV-ECNMMKII 141
           R  + +   I  G FG +Y+        + + V VK        + +   + E  +M+  
Sbjct: 5   REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF 64

Query: 142 RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL 201
            H +++K+I   + ++   +++E  P G L   L  + Y LD    +     +++A+ YL
Sbjct: 65  DHPHIVKLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL 123

Query: 202 HFGHSTHVIIHCDLKSSNVL 221
               S    +H D+ + NVL
Sbjct: 124 ---ESKR-FVHRDIAARNVL 139

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 42.7 bits (100), Expect = 6e-05
 Identities = 37/139 (26%), Positives = 71/139 (51%), Gaps = 21/139 (15%)

Query: 96  ISRGGFGSIYKARIQDGMEVV-VKGFNLQYGGA-----FKNLDVECNMMKIIRHQNLIKI 149
           I  G FG++Y A      EVV VK   + Y G      ++++  E   ++ ++H N I+ 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVK--KMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVAS----AVEYLHFGH 205
                K+    L++EY        CL +++ +L+  ++    +++A+    A++ L + H
Sbjct: 87  KGCYLKEHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 138

Query: 206 STHVIIHCDLKSSNVLLDD 224
           S H +IH D+K+ N+LL +
Sbjct: 139 S-HNMIHRDIKAGNILLTE 156

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 42.8 bits (100), Expect = 7e-05
 Identities = 38/145 (26%), Positives = 67/145 (46%), Gaps = 14/145 (9%)

Query: 90  LEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMK-IIRHQNLI 147
            E+  L+  G +G +YK R ++ G    +K  ++  G   + +  E NM+K    H+N+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIA 66

Query: 148 KIISSCSK------DDFKALILEYMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEY 200
               +  K      DD   L++E+   GS+   + +T    L      +I  ++   + +
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126

Query: 201 LHFGHSTHVIIHCDLKSSNVLLDDN 225
           LH     H +IH D+K  NVLL +N
Sbjct: 127 LH----QHKVIHRDIKGQNVLLTEN 147

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 42.9 bits (101), Expect = 8e-05
 Identities = 28/83 (33%), Positives = 38/83 (45%), Gaps = 13/83 (15%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPI 60
           +S+ K L+ +DLS N  S   P              S  ++  L  LDLS N  SG IP 
Sbjct: 519 LSSCKKLVSLDLSHNQLSGQIPA-------------SFSEMPVLSQLDLSQNQLSGEIPK 565

Query: 61  PLEKLLDLKDLNLSFNTLEGKIP 83
            L  +  L  +N+S N L G +P
Sbjct: 566 NLGNVESLVQVNISHNHLHGSLP 588

Length = 968

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 42.1 bits (99), Expect = 8e-05
 Identities = 33/143 (23%), Positives = 59/143 (41%), Gaps = 20/143 (13%)

Query: 91  EVFNLISRGGFGSIYKA-RIQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMKIIRHQNLI 147
           E+ N I +G FG ++K  R  D     +K  +L      +  +   E  ++  +    +I
Sbjct: 3   EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYII 62

Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLS-------TSNYILDFFQRLHIMIDVASAVEY 200
           +   S        +++EY  +G L K L          + +  FF      I +   + +
Sbjct: 63  RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF------IQILLGLAH 116

Query: 201 LHFGHSTHVIIHCDLKSSNVLLD 223
           LH    +  I+H D+KS N+ LD
Sbjct: 117 LH----SKKILHRDIKSLNLFLD 135

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 42.4 bits (100), Expect = 9e-05
 Identities = 39/167 (23%), Positives = 69/167 (41%), Gaps = 33/167 (19%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQD------GMEVVVKGFNLQYGGA----FKNLDVECN 136
           R+ L +   +  G FG + KA             V VK   +    A      +L  E  
Sbjct: 11  RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVK---MLKDDATEKDLSDLVSEME 67

Query: 137 MMKII-RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLST-------SNYILD----- 183
           MMK+I +H+N+I ++  C+++    +++EY  HG+L   L         ++         
Sbjct: 68  MMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEE 127

Query: 184 ---FFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
                  +     VA  +E+L    ++   IH DL + NVL+ ++ V
Sbjct: 128 TLTQKDLVSFAYQVARGMEFL----ASKKCIHRDLAARNVLVTEDHV 170

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 31/145 (21%), Positives = 67/145 (46%), Gaps = 20/145 (13%)

Query: 96  ISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV----ECNMMKIIRHQNLIKII 150
           I +G FG ++KAR  +    V +K   +      +   +    E  ++++++H+N++ +I
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 151 SSCSK-----DDFKA---LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH 202
             C       + +K    L+ E+  H  L   LS  N      +   +M  + + + Y+H
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136

Query: 203 FGHSTHVIIHCDLKSSNVLLDDNMV 227
                  I+H D+K++N+L+  + +
Sbjct: 137 RNK----ILHRDMKAANILITKDGI 157

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 42.1 bits (99), Expect = 1e-04
 Identities = 30/151 (19%), Positives = 67/151 (44%), Gaps = 19/151 (12%)

Query: 91  EVFNLISRGGFGSIYKARIQDG-------MEVVVKGFNLQYGG-----AFKNLDVECNMM 138
            V   +  G FG +YK R ++         E+ V              +  ++  E  ++
Sbjct: 3   AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTII 62

Query: 139 K-IIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFF--QRL-HIMIDV 194
           K  +RH N+++   +  ++D   ++++ +    LG+  ++       F  +R+ +I + +
Sbjct: 63  KEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122

Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
             A+ YL   H    I+H DL  +N++L ++
Sbjct: 123 VLALRYL---HKEKRIVHRDLTPNNIMLGED 150

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 41.9 bits (99), Expect = 1e-04
 Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 33/153 (21%)

Query: 99  GGFGSIYKAR-IQDGMEVVVK---------GFNLQYGGAFKNLDVECNMMKIIRHQNLIK 148
           G FG +YKAR I+ G  V +K         GF +    A +    E  ++K ++H N++ 
Sbjct: 19  GTFGEVYKARQIKTGRVVALKKILMHNEKDGFPIT---ALR----EIKILKKLKHPNVVP 71

Query: 149 II------SSCSKDDFKA--LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEY 200
           +I         SK    +  ++  YM H  L   L   +  L   Q    M+ +   + Y
Sbjct: 72  LIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINY 130

Query: 201 LHFGHSTHVIIHCDLKSSNVLLDDN---MVAHF 230
           LH  H    I+H D+K++N+L+D+     +A F
Sbjct: 131 LHENH----ILHRDIKAANILIDNQGILKIADF 159

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 41.8 bits (98), Expect = 1e-04
 Identities = 36/138 (26%), Positives = 63/138 (45%), Gaps = 9/138 (6%)

Query: 95  LISRGGFGSIYKARI--QDGMEVVVKGFNLQYGGAFK---NLDVECNMMKIIRHQNLIKI 149
           +I  G FG +   R+      E+ V    L+ G   K   +   E ++M    H N+I +
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV 209
               +K     ++ EYM +GSL   L   +      Q + ++  +AS ++YL    S   
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL----SDMG 126

Query: 210 IIHCDLKSSNVLLDDNMV 227
            +H DL + N+L++ N+V
Sbjct: 127 YVHRDLAARNILVNSNLV 144

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 41.7 bits (98), Expect = 1e-04
 Identities = 27/94 (28%), Positives = 46/94 (48%), Gaps = 13/94 (13%)

Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLST----SNYILDFFQRLH 189
           E  ++K + H  +I++  +     F  +++EY+P G L   L      SN    F+    
Sbjct: 51  EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYAS-- 108

Query: 190 IMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD 223
              ++  A+EYLH    +  I++ DLK  N+LLD
Sbjct: 109 ---EIVCALEYLH----SKEIVYRDLKPENILLD 135

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 41.8 bits (99), Expect = 1e-04
 Identities = 29/94 (30%), Positives = 43/94 (45%), Gaps = 13/94 (13%)

Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGS----LGKCLSTSNYILDFFQRLH 189
           E  +++ IRH  L+ +  S   D    L++EY+P G     L K       +  F+    
Sbjct: 51  EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYA--- 107

Query: 190 IMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD 223
               V  A+EYLH       I++ DLK  N+LLD
Sbjct: 108 --AQVVLALEYLHSLD----IVYRDLKPENLLLD 135

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 41.8 bits (98), Expect = 2e-04
 Identities = 29/92 (31%), Positives = 43/92 (46%), Gaps = 1/92 (1%)

Query: 15  NNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKL-LDLKDLNL 73
           NN S V    +    +   + ++I  L  +++++LSNN  SG IP  +      L+ LNL
Sbjct: 66  NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNL 125

Query: 74  SFNTLEGKIPRPFRNFLEVFNLISRGGFGSIY 105
           S N   G IPR     LE  +L +    G I 
Sbjct: 126 SNNNFTGSIPRGSIPNLETLDLSNNMLSGEIP 157

Length = 968

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 30/130 (23%), Positives = 55/130 (42%), Gaps = 12/130 (9%)

Query: 99  GGFGSIYKARIQDGMEVVVKGFNL--QYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKD 156
                + K +  + + V VK  NL        K L  E    + ++H N++  ++S   D
Sbjct: 13  LMIVHLAKHKPTNTL-VAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71

Query: 157 DFKALILEYMPHGSLGKCLSTSNYILDFFQRL---HIMIDVASAVEYLHFGHSTHVIIHC 213
               ++   M +GS    L    +  +    L    I+ DV +A++Y+H        IH 
Sbjct: 72  SELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYIHSKG----FIHR 125

Query: 214 DLKSSNVLLD 223
            +K+S++LL 
Sbjct: 126 SVKASHILLS 135

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 41.2 bits (96), Expect = 2e-04
 Identities = 37/140 (26%), Positives = 69/140 (49%), Gaps = 23/140 (16%)

Query: 96  ISRGGFGSIYKAR-IQDGMEVVVKG---FNLQYGGAFKNLDVECNMMKIIRHQNLIKIIS 151
           I RG F  +Y+A  + DG+ V +K    F+L    A  +   E +++K + H N+IK  +
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 152 SCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIM---------IDVASAVEYLH 202
           S  +D+   ++LE    G L      S  I  F ++  ++         + + SA+E++H
Sbjct: 70  SFIEDNELNIVLELADAGDL------SRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 203 FGHSTHVIIHCDLKSSNVLL 222
               +  ++H D+K +NV +
Sbjct: 124 ----SRRVMHRDIKPANVFI 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 41.8 bits (98), Expect = 2e-04
 Identities = 35/131 (26%), Positives = 62/131 (47%), Gaps = 9/131 (6%)

Query: 96  ISRGGFGSIYKARIQDGMEV----VVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIIS 151
           ISRG FG +Y  R ++  ++    VVK  ++        +  E + + + +   ++ +  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71

Query: 152 SCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVII 211
           S    +   L++EY+  G +   L    Y  +     +I  +VA A++YLH     H II
Sbjct: 72  SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVALALDYLH----RHGII 126

Query: 212 HCDLKSSNVLL 222
           H DLK  N+L+
Sbjct: 127 HRDLKPDNMLI 137

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 41.3 bits (97), Expect = 2e-04
 Identities = 34/132 (25%), Positives = 61/132 (46%), Gaps = 10/132 (7%)

Query: 96  ISRGGFGS--IYKARIQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMKIIRHQNLIKIIS 151
           + +G FG   +Y+ R +D   VV K  NL      +  D   E  ++ +++H N+I   +
Sbjct: 8   LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66

Query: 152 SCSKDDFKALILEYMPHGSLG-KCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVI 210
               D+   + +EY   G+L  K +     + +    L  +  + SAV Y+H       I
Sbjct: 67  HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH----KAGI 122

Query: 211 IHCDLKSSNVLL 222
           +H D+K+ N+ L
Sbjct: 123 LHRDIKTLNIFL 134

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 41.2 bits (96), Expect = 2e-04
 Identities = 32/117 (27%), Positives = 56/117 (47%), Gaps = 21/117 (17%)

Query: 128 FKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTS-------- 178
             +L  E  MMK+I +H+N+I ++ +C++D    +++EY   G+L + L           
Sbjct: 61  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYS 120

Query: 179 -------NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL-DDNMV 227
                     L F   +     VA  +EYL    ++   IH DL + NVL+ +DN++
Sbjct: 121 FDTCKLPEEQLTFKDLVSCAYQVARGMEYL----ASQKCIHRDLAARNVLVTEDNVM 173

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 40.7 bits (95), Expect = 2e-04
 Identities = 36/139 (25%), Positives = 65/139 (46%), Gaps = 23/139 (16%)

Query: 96  ISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAF--KNLDVECNMMKIIRHQNLIKIISS 152
           + +G +G +   R   DG + V+K  NL+       K  + E  ++  ++H N++    S
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 153 CSKDD-FKALILEYMPHGSL--------GKCLSTSNYILDFFQRLHIMIDVASAVEYLHF 203
              +D    +++ +   G L        GK L   N ++++F      + +A A++YLH 
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLL-PENQVVEWF------VQIAMALQYLHE 120

Query: 204 GHSTHVIIHCDLKSSNVLL 222
            H    I+H DLK+ NV L
Sbjct: 121 KH----ILHRDLKTQNVFL 135

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 41.1 bits (97), Expect = 3e-04
 Identities = 34/152 (22%), Positives = 66/152 (43%), Gaps = 43/152 (28%)

Query: 96  ISRGGFGSIYKARIQ---DGMEVVVKGF---NLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           I RG +G +YKA+ +   DG E  +K F     QY G  ++   E  +++ ++H+N++ +
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 150 ISSCSKDDFKA--LILEYMPHGSLGKCLSTSNYILDFFQRLH-----------------I 190
           +    +   K+  L+ +Y  H              D +Q +                  +
Sbjct: 68  VEVFLEHADKSVYLLFDYAEH--------------DLWQIIKFHRQAKRVSIPPSMVKSL 113

Query: 191 MIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL 222
           +  + + V YLH       ++H DLK +N+L+
Sbjct: 114 LWQILNGVHYLHSNW----VLHRDLKPANILV 141

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 40.8 bits (95), Expect = 3e-04
 Identities = 35/137 (25%), Positives = 67/137 (48%), Gaps = 7/137 (5%)

Query: 87  RNFLEVFNLISRGGFGSIYKA-RIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN 145
           R +L+ F  I  G  G +  A     G +V VK  +L+     + L  E  +M+   H+N
Sbjct: 21  REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHEN 80

Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 205
           ++ + +S    D   +++E++  G+L   ++ +   ++  Q   + + V  A+ YLH   
Sbjct: 81  VVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH--- 135

Query: 206 STHVIIHCDLKSSNVLL 222
               +IH D+KS ++LL
Sbjct: 136 -NQGVIHRDIKSDSILL 151

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 40.6 bits (95), Expect = 3e-04
 Identities = 36/139 (25%), Positives = 56/139 (40%), Gaps = 20/139 (14%)

Query: 96  ISRGGFGSIYKARIQDGM---EVVVKGFNLQYGGAFKNLDV---ECNMMKIIRHQNLIKI 149
           I  G FG +       GM    VVVK   L+         +   E    + + H N+++ 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVK--ELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYIL------DFFQRLHIMIDVASAVEYLHF 203
           +  C +     L+LE+ P G L   L ++  ++      D  QR+    +VAS + +LH 
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLHQ 118

Query: 204 GHSTHVIIHCDLKSSNVLL 222
                  IH DL   N  L
Sbjct: 119 AD----FIHSDLALRNCQL 133

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 40.3 bits (95), Expect = 4e-04
 Identities = 33/134 (24%), Positives = 59/134 (44%), Gaps = 9/134 (6%)

Query: 96  ISRGGFGSIYKARIQDGMEV----VVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIIS 151
           +  GGFG +   +++          VK  ++   G  +++  E  +++   H  ++K+  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 152 SCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVII 211
           +     +  +++EY   G L   L       ++  R +I   V  A EYLH       II
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIAC-VVLAFEYLH----NRGII 115

Query: 212 HCDLKSSNVLLDDN 225
           + DLK  N+LLD N
Sbjct: 116 YRDLKPENLLLDSN 129

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 40.5 bits (95), Expect = 4e-04
 Identities = 33/139 (23%), Positives = 61/139 (43%), Gaps = 11/139 (7%)

Query: 90  LEVFNLISRGGFGSIYKAR-IQDG----MEVVVKGFNLQYG-GAFKNLDVECNMMKIIRH 143
           LE   ++  G FG++YK   I +G    + V +K    +    A K +  E  +M  + H
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68

Query: 144 QNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHF 203
            ++++++  C       LI + MP G L   +      +     L+  + +A  + YL  
Sbjct: 69  PHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL-- 125

Query: 204 GHSTHVIIHCDLKSSNVLL 222
                 ++H DL + NVL+
Sbjct: 126 --EEKRLVHRDLAARNVLV 142

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 40.4 bits (94), Expect = 4e-04
 Identities = 36/145 (24%), Positives = 64/145 (44%), Gaps = 14/145 (9%)

Query: 90  LEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIK 148
            E+  ++  G +G +YK R ++ G    +K  ++      + + +E NM+K   H   I 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIA 76

Query: 149 II-------SSCSKDDFKALILEYMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEY 200
                    S    DD   L++E+   GS+   + +T    L      +I  ++   + +
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136

Query: 201 LHFGHSTHVIIHCDLKSSNVLLDDN 225
           LH     H +IH D+K  NVLL +N
Sbjct: 137 LH----AHKVIHRDIKGQNVLLTEN 157

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 40.4 bits (94), Expect = 4e-04
 Identities = 33/117 (28%), Positives = 56/117 (47%), Gaps = 21/117 (17%)

Query: 128 FKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTS-------- 178
             +L  E  MMK+I +H+N+I ++ +C++D    +I+EY   G+L + L           
Sbjct: 67  LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYC 126

Query: 179 -------NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL-DDNMV 227
                     L F   +     VA  +EYL    ++   IH DL + NVL+ +DN++
Sbjct: 127 YNPTQVPEEQLSFKDLVSCAYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVM 179

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 40.2 bits (95), Expect = 4e-04
 Identities = 37/149 (24%), Positives = 63/149 (42%), Gaps = 36/149 (24%)

Query: 93  FNLISR---GGFGSIYKARIQDGMEVV-VKGFNLQYGGAFKNLDVECN-------MMKII 141
           + +I +   G FGS+Y AR ++  E+V +K         F + + EC        + K+ 
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWE-ECMNLREVKSLRKLN 55

Query: 142 RHQNLIKIISSCSKDDFKALILEYMPHGSL--------GKCLSTSNYILDFFQRLHIMID 193
            H N++K+     ++D    + EYM  G+L        GK  S S           I+  
Sbjct: 56  EHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSES-------VIRSIIYQ 107

Query: 194 VASAVEYLHFGHSTHVIIHCDLKSSNVLL 222
           +   + ++H     H   H DLK  N+L+
Sbjct: 108 ILQGLAHIH----KHGFFHRDLKPENLLV 132

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 40.4 bits (94), Expect = 4e-04
 Identities = 47/194 (24%), Positives = 81/194 (41%), Gaps = 25/194 (12%)

Query: 50  SNNNFSGAIPIPLEKLLDLKDLNLSF--------NTLEGKIPRPFRNFLEVFNLISRGGF 101
           +N   SG   +  +KL + +  + +           ++  I R      ++ N+I  G F
Sbjct: 20  ANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSF 79

Query: 102 GSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI--------ISSC 153
           G +Y+A   D  E V     LQ    +KN   E  +MK + H N+I +            
Sbjct: 80  GVVYEAICIDTSEKVAIKKVLQ-DPQYKNR--ELLIMKNLNHINIIFLKDYYYTECFKKN 136

Query: 154 SKDDFKALILEYMPHG--SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVII 211
            K+ F  +++E++P       K  + +N+ L  F        +  A+ Y+H    +  I 
Sbjct: 137 EKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH----SKFIC 192

Query: 212 HCDLKSSNVLLDDN 225
           H DLK  N+L+D N
Sbjct: 193 HRDLKPQNLLIDPN 206

Length = 440

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 39.9 bits (93), Expect = 5e-04
 Identities = 33/140 (23%), Positives = 57/140 (40%), Gaps = 14/140 (10%)

Query: 96  ISRGGFGSIYKARIQDGM---EVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKII 150
           I  G FG +    +  G    +VVVK   +        K L+ E    + ++H NL++ +
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLE-EAQPYRSLQHSNLLQCL 61

Query: 151 SSCSKDDFKALILEYMPHGSLGK----CLSTSNYILDFFQRLHIMIDVASAVEYLHFGHS 206
             C++     L++E+ P G L      C        D      +  ++A  + +LH    
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---- 117

Query: 207 THVIIHCDLKSSNVLLDDNM 226
            +  IH DL   N LL  ++
Sbjct: 118 KNNFIHSDLALRNCLLTADL 137

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 40.0 bits (93), Expect = 5e-04
 Identities = 36/140 (25%), Positives = 67/140 (47%), Gaps = 23/140 (16%)

Query: 96  ISRGGFGSIYKAR-IQDGMEVVVKG---FNLQYGGAFKNLDVECNMMKIIRHQNLIKIIS 151
           I RG F  +Y+A  + D   V +K    F +    A ++   E +++K + H N+IK + 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 152 SCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIM---------IDVASAVEYLH 202
           S  +D+   ++LE    G L      S  I  F ++  ++         + + SAVE++H
Sbjct: 70  SFIEDNELNIVLELADAGDL------SQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123

Query: 203 FGHSTHVIIHCDLKSSNVLL 222
               +  ++H D+K +NV +
Sbjct: 124 ----SRRVMHRDIKPANVFI 139

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 40.0 bits (93), Expect = 5e-04
 Identities = 37/150 (24%), Positives = 70/150 (46%), Gaps = 41/150 (27%)

Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGG----AFKNLDVECNMMKIIRHQNLIKIIS 151
           + +G FG ++        +V +K   L+ G     AF     E  +MK +RH  L+ + +
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIK--TLKPGTMMPEAFLQ---EAQIMKKLRHDKLVPLYA 68

Query: 152 SCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQ-------RLHIMIDVASAV------ 198
             S++    ++ E+M  GSL          LDF +       +L  ++D+A+ +      
Sbjct: 69  VVSEEPI-YIVTEFMGKGSL----------LDFLKEGDGKYLKLPQLVDMAAQIADGMAY 117

Query: 199 -EYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
            E +++       IH DL+++N+L+ DN+V
Sbjct: 118 IERMNY-------IHRDLRAANILVGDNLV 140

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 39.7 bits (93), Expect = 5e-04
 Identities = 25/94 (26%), Positives = 39/94 (41%), Gaps = 12/94 (12%)

Query: 133 VECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMI 192
            E  +M  + H+NLI++           ++ E  P GSL   L      L  F  +  + 
Sbjct: 45  KEAAIMHSLDHENLIRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDA--LGHFL-ISTLC 100

Query: 193 D----VASAVEYLHFGHSTHVIIHCDLKSSNVLL 222
           D    +A+ + YL         IH DL + N+LL
Sbjct: 101 DYAVQIANGMRYLESKR----FIHRDLAARNILL 130

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 40.0 bits (94), Expect = 5e-04
 Identities = 24/102 (23%), Positives = 45/102 (44%), Gaps = 14/102 (13%)

Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLST--------SNYI--LD 183
           E  ++  +   N+ +++  C+ D    +I+EYM +G L + L          +     L 
Sbjct: 69  EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128

Query: 184 FFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
           F   L++   +AS + YL     +   +H DL + N L+  N
Sbjct: 129 FSTLLYMATQIASGMRYL----ESLNFVHRDLATRNCLVGKN 166

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 40.2 bits (94), Expect = 5e-04
 Identities = 49/191 (25%), Positives = 80/191 (41%), Gaps = 24/191 (12%)

Query: 40  DLTSLKSLDLSNNNFSGAIPIPL--EKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNLIS 97
           DLT    L L   + S A+P+PL           + S +       +     LE  N I 
Sbjct: 29  DLT----LPLPQRDPSLAVPLPLPPPSSSSSSSSSSSASGSAPSAAKSLSE-LERVNRIG 83

Query: 98  RGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVE-CNMMKIIR---HQNLIKIISS 152
            G  G++YK   +  G    +K   + YG     +  + C  ++I+R   H N++K    
Sbjct: 84  SGAGGTVYKVIHRPTGRLYALK---VIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDM 140

Query: 153 CSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIH 212
              +    ++LE+M  GSL        +I D      +   + S + YLH  H    I+H
Sbjct: 141 FDHNGEIQVLLEFMDGGSL-----EGTHIADEQFLADVARQILSGIAYLHRRH----IVH 191

Query: 213 CDLKSSNVLLD 223
            D+K SN+L++
Sbjct: 192 RDIKPSNLLIN 202

Length = 353

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 39.8 bits (93), Expect = 6e-04
 Identities = 40/154 (25%), Positives = 74/154 (48%), Gaps = 32/154 (20%)

Query: 91  EVFNLISRGGFGSIYKARIQDGMEVV----VKGFNLQYGGAFKNLDV-ECNMMKIIRHQN 145
           ++   I  G +G +YKAR +D  E+V    V+  N + G  F    + E  +++ + H+N
Sbjct: 10  DIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG--FPITAIREIKILRQLNHRN 67

Query: 146 LIKIISSCSKD----DFKA------LILEYMPHGSLGKCLS-----TSNYILDFFQRLHI 190
           ++ +    +      DFK       L+ EYM H  +G   S     + ++I  F ++L  
Sbjct: 68  IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL-- 125

Query: 191 MIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD 224
                  +E L++ H  +  +H D+K SN+LL++
Sbjct: 126 -------LEGLNYCHKKN-FLHRDIKCSNILLNN 151

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 39.6 bits (92), Expect = 6e-04
 Identities = 19/54 (35%), Positives = 32/54 (59%)

Query: 128 FKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI 181
            ++L  E N++K + H ++IK+  +CS+D    LI+EY  +GSL   L  S  +
Sbjct: 47  LRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKV 100

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 39.6 bits (93), Expect = 6e-04
 Identities = 38/146 (26%), Positives = 62/146 (42%), Gaps = 16/146 (10%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMM-KIIRHQNLIK 148
           E+  +I  G +G +YKAR  + G  V +K  ++      + +  E N++ K   H N+  
Sbjct: 9   ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIAT 67

Query: 149 II------SSCSKDDFKALILEYMPHGS---LGKCLSTSNYILDFFQRLHIMIDVASAVE 199
                   +    DD   L++E    GS   L K L      L      +I+ +    + 
Sbjct: 68  FYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLA 127

Query: 200 YLHFGHSTHVIIHCDLKSSNVLLDDN 225
           YLH     + +IH D+K  N+LL  N
Sbjct: 128 YLH----ENKVIHRDIKGQNILLTKN 149

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 39.6 bits (92), Expect = 6e-04
 Identities = 39/152 (25%), Positives = 67/152 (44%), Gaps = 27/152 (17%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL 146
           R  L++   +  G FG ++ A      +V VK            L  E N+MK ++H  L
Sbjct: 5   RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA-EANVMKTLQHDKL 63

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFF-------QRLHIMID----VA 195
           +K+ +  +K+    +I E+M  GSL          LDF        Q L  +ID    +A
Sbjct: 64  VKLHAVVTKEPI-YIITEFMAKGSL----------LDFLKSDEGSKQPLPKLIDFSAQIA 112

Query: 196 SAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
             + ++         IH DL+++N+L+  ++V
Sbjct: 113 EGMAFIE----QRNYIHRDLRAANILVSASLV 140

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 39.5 bits (92), Expect = 8e-04
 Identities = 34/145 (23%), Positives = 70/145 (48%), Gaps = 9/145 (6%)

Query: 88  NFLEVFNLISRGGFGSIYKARIQ--DGMEVVVKGFNLQYGGAFK---NLDVECNMMKIIR 142
           + +++  +I  G FG + + R++     E+ V    L+ G   K   +   E ++M    
Sbjct: 4   SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 63

Query: 143 HQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH 202
           H N+I +    +K     +I E+M +G+L   L  ++      Q + ++  +A+ ++YL 
Sbjct: 64  HPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL- 122

Query: 203 FGHSTHVIIHCDLKSSNVLLDDNMV 227
              S    +H DL + N+L++ N+V
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLV 144

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 39.6 bits (92), Expect = 8e-04
 Identities = 31/114 (27%), Positives = 54/114 (47%), Gaps = 20/114 (17%)

Query: 130 NLDVECNMMKII-RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLS-----TSNYILD 183
           +L  E  +MK+I +H+N+I ++  C+++    +I+EY   G+L + L        +Y  D
Sbjct: 63  DLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFD 122

Query: 184 ----------FFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
                     F   +     VA  +EYL     +   IH DL + NVL+ ++ V
Sbjct: 123 ITKVPEEQLSFKDLVSCAYQVARGMEYL----ESRRCIHRDLAARNVLVTEDNV 172

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 39.3 bits (92), Expect = 9e-04
 Identities = 39/153 (25%), Positives = 63/153 (41%), Gaps = 25/153 (16%)

Query: 87  RNFLEVFNLISRGGFGSIYKA--RIQDG----MEVVVKGFNLQYGGAFKNLD--VECNMM 138
           R+ + +   +  G FG +Y+   R +DG    ++V VK             D  +E  +M
Sbjct: 5   RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ-DESDFLMEALIM 63

Query: 139 KIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCL---------STSNYILDFFQRLH 189
               HQN++++I    +   + ++LE M  G L   L          +S  + D    L 
Sbjct: 64  SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL---LF 120

Query: 190 IMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL 222
              DVA   +YL   H     IH D+ + N LL
Sbjct: 121 CARDVAKGCKYLEENH----FIHRDIAARNCLL 149

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 38.8 bits (90), Expect = 0.001
 Identities = 31/136 (22%), Positives = 64/136 (47%), Gaps = 5/136 (3%)

Query: 88  NFLEVFNLISRGGFGSIYKARIQD-GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL 146
            F E+   +  G FG +YKA+ ++ G+    K  + +     ++  VE +++    H N+
Sbjct: 5   EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHS 206
           +K++ +   ++   +++E+   G++   +      L   Q   +      A+ YLH    
Sbjct: 65  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---- 120

Query: 207 THVIIHCDLKSSNVLL 222
            + IIH DLK+ N+L 
Sbjct: 121 ENKIIHRDLKAGNILF 136

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 39.0 bits (91), Expect = 0.001
 Identities = 38/138 (27%), Positives = 69/138 (50%), Gaps = 21/138 (15%)

Query: 95  LISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV-----ECNMMKIIRH---QN 145
           LI RG +G++Y+ + +  G  V +K  NL       + DV     E  ++  +R     N
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPN 63

Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 205
           + K   S  K     +I+EY   GS+ + L  +  I + +  + I+ +V  A++Y+H   
Sbjct: 64  ITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISV-IIREVLVALKYIH--- 118

Query: 206 STHV-IIHCDLKSSNVLL 222
              V +IH D+K++N+L+
Sbjct: 119 --KVGVIHRDIKAANILV 134

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 38.8 bits (90), Expect = 0.001
 Identities = 38/148 (25%), Positives = 70/148 (47%), Gaps = 19/148 (12%)

Query: 91  EVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQ 144
           E+   I  G FG IY A+ + D    V+K  +L     +   A K    E  ++  ++H 
Sbjct: 3   EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHP 59

Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIM---IDVASAVEYL 201
           N++   +S  ++    +++EY   G L K ++    +L  F    I+   + ++  ++++
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVL--FSEDQILSWFVQISLGLKHI 117

Query: 202 HFGHSTHVIIHCDLKSSNVLLDDN-MVA 228
           H       I+H D+KS N+ L  N MVA
Sbjct: 118 H----DRKILHRDIKSQNIFLSKNGMVA 141

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 38.8 bits (90), Expect = 0.001
 Identities = 28/112 (25%), Positives = 55/112 (49%), Gaps = 24/112 (21%)

Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILD---------- 183
           E  ++  ++  N+I+++  C  +D   +I EYM +G L + LS S+++ D          
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLS-SHHLDDKEENGNDAVP 127

Query: 184 ---------FFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
                    +   LH+ + +AS ++YL    S+   +H DL + N L+ +N+
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYL----SSLNFVHRDLATRNCLVGENL 175

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 38.5 bits (89), Expect = 0.001
 Identities = 40/142 (28%), Positives = 64/142 (45%), Gaps = 28/142 (19%)

Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS- 154
           I +G FG ++K  I +  + VV         A K +D+E    +I   Q  I ++S C  
Sbjct: 12  IGKGSFGEVFKG-IDNRTQKVV---------AIKIIDLEEAEDEIEDIQQEITVLSQCDS 61

Query: 155 -----------KDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHF 203
                      KD    +I+EY+  GS    L      LD  Q   I+ ++   ++YLH 
Sbjct: 62  PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH- 118

Query: 204 GHSTHVIIHCDLKSSNVLLDDN 225
              +   IH D+K++NVLL ++
Sbjct: 119 ---SEKKIHRDIKAANVLLSEH 137

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 38.5 bits (89), Expect = 0.001
 Identities = 38/142 (26%), Positives = 63/142 (44%), Gaps = 28/142 (19%)

Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS- 154
           I +G FG ++K  I +  + VV         A K +D+E    +I   Q  I ++S C  
Sbjct: 12  IGKGSFGEVFKG-IDNRTQQVV---------AIKIIDLEEAEDEIEDIQQEITVLSQCDS 61

Query: 155 -----------KDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHF 203
                      K     +I+EY+  GS    L    +  D FQ   ++ ++   ++YLH 
Sbjct: 62  PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH- 118

Query: 204 GHSTHVIIHCDLKSSNVLLDDN 225
              +   IH D+K++NVLL + 
Sbjct: 119 ---SEKKIHRDIKAANVLLSEQ 137

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 38.6 bits (90), Expect = 0.002
 Identities = 36/151 (23%), Positives = 59/151 (39%), Gaps = 13/151 (8%)

Query: 87  RNFLEVFNLISRGGFGSIYKA------RIQDGMEVVVKGFNLQYGGAFKN-LDVECNMMK 139
           RN L     +  G FG + +A      +    M+V VK        + +  L  E  +M 
Sbjct: 34  RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93

Query: 140 II-RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCL-STSNYILDFFQRLHIMIDVASA 197
            +  H+N++ ++ +C+      +I EY  +G L   L       L     L     VA  
Sbjct: 94  HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153

Query: 198 VEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
           + +L   +     IH DL + NVLL    + 
Sbjct: 154 MAFLASKNC----IHRDLAARNVLLTHGKIV 180

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 38.3 bits (89), Expect = 0.002
 Identities = 27/102 (26%), Positives = 49/102 (48%), Gaps = 14/102 (13%)

Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLS---------TSNYILDF 184
           E  +M  ++  N+I++++ C   D   +I EYM +G L + LS          ++ +   
Sbjct: 69  EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128

Query: 185 FQRLHIM-IDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
           +  L  M   +AS ++YL    S+   +H DL + N L+  N
Sbjct: 129 YSTLIFMATQIASGMKYL----SSLNFVHRDLATRNCLVGKN 166

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 38.0 bits (89), Expect = 0.002
 Identities = 34/138 (24%), Positives = 66/138 (47%), Gaps = 11/138 (7%)

Query: 91  EVFNLISRGGFGSIYKARIQDGMEV----VVKGFNLQYGGAFKNLDVECNMMKIIRHQNL 146
           EV  +I RG FG ++  R +D  +V    V++  ++       ++  E +++       +
Sbjct: 4   EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWI 63

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-FGH 205
           +K+  S   ++   L++EYMP G L   L   +   +   R +I  ++  A++ +H  G 
Sbjct: 64  VKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA-ELVLALDSVHKLGF 122

Query: 206 STHVIIHCDLKSSNVLLD 223
                IH D+K  N+L+D
Sbjct: 123 -----IHRDIKPDNILID 135

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 38.2 bits (89), Expect = 0.002
 Identities = 28/155 (18%), Positives = 59/155 (38%), Gaps = 21/155 (13%)

Query: 89  FLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV-------------- 133
           +++    +  G +G + KA     G  V +K   +         D               
Sbjct: 10  YIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLR 69

Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMID 193
           E  +M  I+H+N++ ++    + DF  L+++ M    L K +      L   Q   I++ 
Sbjct: 70  ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVD-RKIRLTESQVKCILLQ 127

Query: 194 VASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
           + + +  LH        +H DL  +N+ ++   + 
Sbjct: 128 ILNGLNVLH----KWYFMHRDLSPANIFINSKGIC 158

Length = 335

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 37.7 bits (88), Expect = 0.003
 Identities = 33/164 (20%), Positives = 61/164 (37%), Gaps = 31/164 (18%)

Query: 87  RNFLEVFNLISRGGFGSIYK---ARIQDG---MEVVVKGFN----LQYGGAFKNLDVECN 136
           R  + +   + +G FG +Y+     +  G     V +K  N    ++    F N   E +
Sbjct: 5   REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN---EAS 61

Query: 137 MMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCL--------STSNYILDFFQRL 188
           +MK     ++++++   S      +++E M  G L   L        +         Q+ 
Sbjct: 62  VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121

Query: 189 HIM-IDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL 231
             M  ++A  + YL         +H DL + N      MVA  L
Sbjct: 122 IQMAAEIADGMAYLAAKK----FVHRDLAARNC-----MVAEDL 156

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 37.9 bits (88), Expect = 0.003
 Identities = 33/137 (24%), Positives = 66/137 (48%), Gaps = 13/137 (9%)

Query: 95  LISRGGFGSIYKARIQDG--------MEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL 146
           ++ +GG+G +++ R   G        M+V+ K   ++      +   E N+++ ++H  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHS 206
           + +I +        LILEY+  G L   L      ++     ++  +++ A+E+LH    
Sbjct: 63  VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-EISLALEHLH---- 117

Query: 207 THVIIHCDLKSSNVLLD 223
              II+ DLK  N+LLD
Sbjct: 118 QQGIIYRDLKPENILLD 134

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 37.7 bits (87), Expect = 0.003
 Identities = 34/137 (24%), Positives = 69/137 (50%), Gaps = 7/137 (5%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQD-GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN 145
           R +L+ F  I  G  G +  A ++  G  V VK  +L+     + L  E  +M+  +H+N
Sbjct: 19  RTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN 78

Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 205
           ++++ +S    D   +++E++  G+L   ++ +   ++  Q   + + V  A+  LH   
Sbjct: 79  VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLH--- 133

Query: 206 STHVIIHCDLKSSNVLL 222
               +IH D+KS ++LL
Sbjct: 134 -AQGVIHRDIKSDSILL 149

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 37.5 bits (87), Expect = 0.003
 Identities = 32/131 (24%), Positives = 56/131 (42%), Gaps = 9/131 (6%)

Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMKIIRHQNLIKIISSC 153
           +  G FG ++  + +  ++V +K  N    GA    D   E  +M  + H  L+++   C
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 154 SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHC 213
           ++     ++ E+M +G L   L      L     L +  DV   +EYL      +  IH 
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE----RNSFIHR 124

Query: 214 DLKSSNVLLDD 224
           DL + N L+  
Sbjct: 125 DLAARNCLVSS 135

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 37.5 bits (87), Expect = 0.003
 Identities = 33/135 (24%), Positives = 63/135 (46%), Gaps = 15/135 (11%)

Query: 96  ISRGGFGSIYKARIQDGMEVV-VKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISS 152
           I  G +G +YKAR +   E + +K   L+    G       E +++K ++H N++++   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 153 CSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHI----MIDVASAVEYLHFGHSTH 208
              +    L+ EY+    L K + +S    DF +   +    +  +   + Y H    +H
Sbjct: 70  VHSEKRLYLVFEYLDL-DLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCH----SH 121

Query: 209 VIIHCDLKSSNVLLD 223
            ++H DLK  N+L+D
Sbjct: 122 RVLHRDLKPQNLLID 136

Length = 294

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	232
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.97
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.97
KOG0575	592	consensus Polo-like serine/threonine protein kinas	99.97
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.97
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.97
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.97
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.96
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.96
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.96
KOG0605	550	consensus NDR and related serine/threonine kinases	99.96
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.96
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.96
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.96
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.96
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.96
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.95
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.95
KOG0610	459	consensus Putative serine/threonine protein kinase	99.95
KOG0198	313	consensus MEKK and related serine/threonine protei	99.95
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.95
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.95
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.95
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.95
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.95
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.95
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.95
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.95
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.94
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.94
KOG0578	550	consensus p21-activated serine/threonine protein k	99.94
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.94
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.94
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.94
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.94
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.94
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.94
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.94
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.94
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.94
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.94
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.94
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.94
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.94
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.94
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.94
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.94
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.94
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.94
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.94
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.94
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.94
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.94
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.94
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.94
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.93
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.93
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.93
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.93
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.93
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.93
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.93
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.93
KOG0586	596	consensus Serine/threonine protein kinase [General	99.93
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.93
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.93
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.93
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.93
PTZ00267	478	NIMA-related protein kinase; Provisional	99.93
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.93
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.93
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.93
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.93
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.93
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.93
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.93
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.93
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.93
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.93
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.93
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.93
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.93
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.93
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.93
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.93
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.93
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.93
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.93
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.93
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.93
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.93
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.93
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.93
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.92
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.92
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.92
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.92
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.92
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.92
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.92
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.92
KOG0589	426	consensus Serine/threonine protein kinase [General	99.92
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.92
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.92
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.92
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.92
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.92
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.92
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.92
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.92
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.92
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.92
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.92
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.92
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.92
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.92
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.92
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.92
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.92
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.92
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.92
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.92
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.92
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.92
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.92
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.92
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.92
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.92
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.92
PHA02988	283	hypothetical protein; Provisional	99.92
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.92
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.92
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.92
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.92
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.92
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.92
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.92
PHA03212	391	serine/threonine kinase US3; Provisional	99.92
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.92
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.92
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.92
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.92
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.92
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.92
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.92
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.92
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.92
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.92
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.91
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.91
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.91
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.91
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.91
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.91
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.91
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.91
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.91
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.91
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.91
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.91
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.91
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.91
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.91
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.91
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.91
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.91
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.91
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.91
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.91
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.91
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.91
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.91
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.91
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.91
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.91
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.91
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.91
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.91
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.91
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.91
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.91
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.91
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.91
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.91
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.91
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.91
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.91
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.91
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.91
PHA03211	461	serine/threonine kinase US3; Provisional	99.91
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.91
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.91
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.91
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.91
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.91
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.91
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.91
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.91
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.91
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.91
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.91
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.91
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.91
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.91
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.91
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.91
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.91
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.91
PHA03209	357	serine/threonine kinase US3; Provisional	99.91
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.91
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.91
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.91
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.91
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.91
PTZ00283	496	serine/threonine protein kinase; Provisional	99.91
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.91
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.9
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.9
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.9
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.9
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.9
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.9
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.9
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.9
KOG3653	534	consensus Transforming growth factor beta/activin	99.9
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.9
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.9
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.9
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.9
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.9
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.9
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.9
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.9
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.9
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.9
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.9
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.9
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.9
PTZ00036	440	glycogen synthase kinase; Provisional	99.9
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.9
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.9
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.9
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.9
PHA03207	392	serine/threonine kinase US3; Provisional	99.9
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.9
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.9
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.9
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.9
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.9
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.9
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.9
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.9
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.9
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.9
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.9
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.9
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.9
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.9
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.9
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.9
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.9
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.9
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.9
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.9
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.9
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.9
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.9
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.9
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.9
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.9
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.9
KOG0584	632	consensus Serine/threonine protein kinase [General	99.9
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.9
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.9
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.89
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.89
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.89
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.89
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.89
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.89
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.89
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.89
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.89
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.89
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.89
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.89
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.89
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.89
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.89
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.89
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.89
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.89
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.89
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.89
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.89
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.89
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.89
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.89
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.89
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.89
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.89
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.89
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.89
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.89
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.89
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.89
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.89
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.88
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.88
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.88
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.88
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.88
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.88
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.88
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.88
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.88
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.88
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.88
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.88
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.88
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.88
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.88
PLN00009	294	cyclin-dependent kinase A; Provisional	99.88
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.88
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.88
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.88
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.88
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.88
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.88
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.88
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.88
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.88
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.88
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.87
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.87
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.87
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.87
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.87
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.87
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.87
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.87
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.87
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.87
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.87
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.87
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.87
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.87
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.87
PRK10345	210	hypothetical protein; Provisional	99.87
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.87
PHA03210	501	serine/threonine kinase US3; Provisional	99.87
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.87
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.87
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.86
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.86
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.86
PTZ00284	467	protein kinase; Provisional	99.86
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.86
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.86
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.86
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.86
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.86
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.86
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.86
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.85
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.85
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.85
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.85
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.85
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.85
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.85
KOG1152	772	consensus Signal transduction serine/threonine kin	99.85
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.84
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.84
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.84
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.84
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.83
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.83
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.82
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.82
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.82
PHA02882	294	putative serine/threonine kinase; Provisional	99.82
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.81
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.81
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.8
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.8
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.79
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.79
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
smart00090	237	RIO RIO-like kinase.	99.79
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.79
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.78
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.78
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.78
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.78
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.76
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.76
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
PRK12274	218	serine/threonine protein kinase; Provisional	99.74
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.73
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.73
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.72
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.71
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.7
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.67
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.66
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.63
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.62
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.59
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.57
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.51
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.5
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.49
PLN00181	793	protein SPA1-RELATED; Provisional	99.39
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.35
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.32
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.3
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.23
PLN03150	623	hypothetical protein; Provisional	99.18
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.17
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.15
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.11
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.07
KOG3087	229	consensus Serine/threonine protein kinase [General	99.03
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.02
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.0
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	98.98
PLN03150	623	hypothetical protein; Provisional	98.97
KOG1243	690	consensus Protein kinase [General function predict	98.96
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.93
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.83
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.83
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.81
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.78
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.69
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.69
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.67
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.53
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.47
PRK09902	216	hypothetical protein; Provisional	98.47
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.46
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.4
KOG0617	264	consensus Ras suppressor protein (contains leucine	98.39
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.34
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.33
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	98.32
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.28
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.28
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.19
KOG0617	264	consensus Ras suppressor protein (contains leucine	98.17
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.16
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.15
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	98.11
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.06
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.04
KOG0472	565	consensus Leucine-rich repeat protein [Function un	98.03
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	97.97
PF12799	44	LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_	97.94
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	97.9
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	97.88
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	97.86
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	97.86
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	97.83
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.76
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.75
KOG4237	498	consensus Extracellular matrix protein slit, conta	97.67
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	97.63
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	97.6
PLN02876	822	acyl-CoA dehydrogenase	97.6
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.58
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	97.52
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.51
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	97.49
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.48
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	97.48
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	97.47
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.42
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.4
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	97.37
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	97.36
PRK10593	297	hypothetical protein; Provisional	97.35
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	97.35
PF01636	239	APH: Phosphotransferase enzyme family This family	97.21
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.18
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	97.14
PF00560	22	LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le	97.11
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	97.09
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	97.07
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	97.04

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=9.8e-36  Score=273.75  Aligned_cols=221  Identities=31%  Similarity=0.501  Sum_probs=186.4

Q ss_pred             CCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKD   70 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~   70 (232)
                      .++++|+.|+|++|+++|.+|..+           ++|+++|.+|..++.+++|+.|+|++|+++|.+|..+..+..|+.
T Consensus       496 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~  575 (968)
T PLN00113        496 GSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQ  575 (968)
T ss_pred             hhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCE
Confidence            456788889999999998888754           689999999999999999999999999999999999999999999


Q ss_pred             cccccccccCCCCCc--cc----------------c----------------c---------------------------
Q 042107           71 LNLSFNTLEGKIPRP--FR----------------N----------------F---------------------------   89 (232)
Q Consensus        71 l~l~~n~l~g~~p~~--~~----------------~----------------~---------------------------   89 (232)
                      +++++|+++|.+|..  +.                .                .                           
T Consensus       576 l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  655 (968)
T PLN00113        576 VNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGR  655 (968)
T ss_pred             EeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhh
Confidence            999999998877641  00                0                0                           


Q ss_pred             ------------------------------------ceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHH
Q 042107           90 ------------------------------------LEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLD  132 (232)
Q Consensus        90 ------------------------------------~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~  132 (232)
                                                          +...+.||+|+||.||+|+. .++..||+|.+......    ..
T Consensus       656 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~  731 (968)
T PLN00113        656 NNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PS  731 (968)
T ss_pred             hcccccccccccccccccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cH
Confidence                                                00123689999999999976 57899999988643321    23


Q ss_pred             HHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeee
Q 042107          133 VECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIH  212 (232)
Q Consensus       133 ~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiH  212 (232)
                      .|++.+++++|||||++++++..++..++||||+++|+|.++++.    ++|..+..++.|+++|++|+|+.+ ..+|+|
T Consensus       732 ~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~-~~~iiH  806 (968)
T PLN00113        732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRC-SPAVVV  806 (968)
T ss_pred             HHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCC-CCCeec
Confidence            468889999999999999999999999999999999999999963    788999999999999999999654 458999


Q ss_pred             CCCCCCceeeCCCCceeec
Q 042107          213 CDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       213 rdlk~~Nill~~~~~~~l~  231 (232)
                      ||+||+||+++.++.++++
T Consensus       807 ~dlkp~Nil~~~~~~~~~~  825 (968)
T PLN00113        807 GNLSPEKIIIDGKDEPHLR  825 (968)
T ss_pred             CCCCHHhEEECCCCceEEE
Confidence            9999999999998887753

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-34  Score=226.29  Aligned_cols=133  Identities=31%  Similarity=0.488  Sum_probs=120.4

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecc--cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQ--YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      ..|.+.+.||+|+||+||+|+++ ++..||||.+...  .....+.+..|+++++.++|||||.+++++..++++|+|||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            34667788999999999999865 6899999999766  34456778889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN  225 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~  225 (232)
                      ||.||||.++++..+ .+++..++.++.|++.|+++||    .++||||||||+|||++..
T Consensus        90 yC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~----~~~IiHRDLKPQNiLLs~~  145 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLH----ENNIIHRDLKPQNILLSTT  145 (429)
T ss_pred             eCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCcceEEeccC
Confidence            999999999998865 5899999999999999999999    8899999999999999875

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-33  Score=227.73  Aligned_cols=141  Identities=38%  Similarity=0.622  Sum_probs=126.0

Q ss_pred             ceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCC-eeEEEEeccCC
Q 042107           90 LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD-FKALILEYMPH  168 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~  168 (232)
                      +.....||+|+||.||+|...++..||||++........++|..|+.++..++|||+|+++|+|.+.+ ...||+|||++
T Consensus        77 Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~n  156 (361)
T KOG1187|consen   77 FSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPN  156 (361)
T ss_pred             CchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCC
Confidence            34557899999999999999999999999886654331455999999999999999999999999888 59999999999


Q ss_pred             CChhhhhccCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNY-ILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+|.+++..... .++|..+.+|+.++|+||+|||+.+. .+|+||||||+|||+|+++++||+
T Consensus       157 GsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~-~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  157 GSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCP-PPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             CCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCC-CCEecCCCCHHHeeECCCCCEEcc
Confidence            999999988755 78999999999999999999997763 379999999999999999999986

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.1e-31  Score=213.77  Aligned_cols=146  Identities=24%  Similarity=0.389  Sum_probs=126.6

Q ss_pred             CCCCcccccceeeecccCCCcceeeeEE-eCCCcEEEEEEeecccCc-------hHHHHHHHHHHhcCCCCCCccceeEE
Q 042107           81 KIPRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGG-------AFKNLDVECNMMKIIRHQNLIKIISS  152 (232)
Q Consensus        81 ~~p~~~~~~~~~~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~  152 (232)
                      ..|..+.+.|.+.+.+|+|+||.|.+|. .++|+.||||++..+...       ......+|+++|++++|||||+++++
T Consensus       165 ~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~  244 (475)
T KOG0615|consen  165 VPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF  244 (475)
T ss_pred             CccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee
Confidence            4566888999999999999999999994 668999999999765311       12335689999999999999999999


Q ss_pred             EecCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC---Ccee
Q 042107          153 CSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN---MVAH  229 (232)
Q Consensus       153 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~---~~~~  229 (232)
                      +..++..|+||||++||+|.+.+-.++ .+.+.....+++|++.|+.|||    +.||+||||||+|||+..+   ..+|
T Consensus       245 f~~~ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH----~~GI~HRDiKPeNILl~~~~e~~llK  319 (475)
T KOG0615|consen  245 FEVPDSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLH----SQGIIHRDIKPENILLSNDAEDCLLK  319 (475)
T ss_pred             eecCCceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHH----HcCcccccCCcceEEeccCCcceEEE
Confidence            999999999999999999999987654 4777778899999999999999    8999999999999999876   5556


Q ss_pred             ec
Q 042107          230 FL  231 (232)
Q Consensus       230 l~  231 (232)
                      |+
T Consensus       320 It  321 (475)
T KOG0615|consen  320 IT  321 (475)
T ss_pred             ec
Confidence            54

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=4.3e-31  Score=215.01  Aligned_cols=139  Identities=28%  Similarity=0.419  Sum_probs=125.5

Q ss_pred             ccceeeecccCCCcceeeeEE-eCCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecC--CeeEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKD--DFKALI  162 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  162 (232)
                      +.|+.+++||+|+||.||+|+ ..+|+.||+|++....  .+......+||.++++++||||+++.+.....  ..+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            446778999999999999996 4689999999997664  55667788999999999999999999987765  689999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|||++ ||.-++...+..+++.++..++.|++.||.|||    .++|+|||||.+|||||.+|++|||
T Consensus       197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH----~~gvlHRDIK~SNiLidn~G~LKia  260 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH----SRGVLHRDIKGSNILIDNNGVLKIA  260 (560)
T ss_pred             Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh----hcCeeeccccccceEEcCCCCEEec
Confidence            999987 999998887777999999999999999999999    8899999999999999999999997

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.2e-30  Score=215.06  Aligned_cols=139  Identities=24%  Similarity=0.312  Sum_probs=128.8

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecc---cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQ---YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      ..|...+.||+|+|+.||+++. .+|+.||+|++.+.   .....+.+.+|+++.+.++|||||+++++|++.+.+|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4588899999999999999986 78999999999764   3456688999999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+|+.++|.++++. ...+++..++.+++||+.||.|||    +.+|+|||||..|+++++++++|||
T Consensus        98 ELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH----~~~IiHRDLKLGNlfL~~~~~VKIg  160 (592)
T KOG0575|consen   98 ELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLH----SLGIIHRDLKLGNLFLNENMNVKIG  160 (592)
T ss_pred             EecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHH----hcCceecccchhheeecCcCcEEec
Confidence            99999999999984 457999999999999999999999    8899999999999999999999997

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-30  Score=211.19  Aligned_cols=137  Identities=31%  Similarity=0.476  Sum_probs=121.7

Q ss_pred             eeeecccCCCcceeeeEEeCCCcEEEEEEeecccCch--HHHHHHHHHHhcCCCCCCccceeEEEecCC-eeEEEEeccC
Q 042107           91 EVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKIISSCSKDD-FKALILEYMP  167 (232)
Q Consensus        91 ~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~  167 (232)
                      ...+.+|+|+||.||+|.++....||+|.+.......  .+.|.+|+.++.+++|||||+++|+|..+. ..++||||++
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            4556799999999999999855559999997654322  468999999999999999999999999887 7899999999


Q ss_pred             CCChhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCC-eeeCCCCCCceeeCCCC-ceeec
Q 042107          168 HGSLGKCLST-SNYILDFFQRLHIMIDVASAVEYLHFGHSTHV-IIHCDLKSSNVLLDDNM-VAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~-iiHrdlk~~Nill~~~~-~~~l~  231 (232)
                      +|+|.+++.. ....+++..++.++.|||+||.|||    ..+ ||||||||+|||++.++ ++|||
T Consensus       124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH----~~~~iIHrDLK~~NiLv~~~~~~~KI~  186 (362)
T KOG0192|consen  124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH----SEGPIIHRDLKSDNILVDLKGKTLKIA  186 (362)
T ss_pred             CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh----cCCCeeecccChhhEEEcCCCCEEEEC
Confidence            9999999987 3567999999999999999999999    667 99999999999999998 99987

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.97  E-value=2e-30  Score=204.34  Aligned_cols=139  Identities=23%  Similarity=0.273  Sum_probs=123.3

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCC-eeEEEEec
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD-FKALILEY  165 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~  165 (232)
                      -.+....||+|..|+||+++++ +++.+|+|.+.... ....+++.+|+++++.++||+||++|++|..+. .+.++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            3456788999999999999865 78999999995543 344678899999999999999999999999988 59999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |++|+|.+++... +.+++...-+++.++++||.|||.   .++||||||||+|||++..|++|||
T Consensus       160 MDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~---~~~IIHRDIKPsNlLvNskGeVKic  221 (364)
T KOG0581|consen  160 MDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE---ERKIIHRDIKPSNLLVNSKGEVKIC  221 (364)
T ss_pred             cCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh---ccCeeeccCCHHHeeeccCCCEEec
Confidence            9999999999865 358889999999999999999992   2689999999999999999999997

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.97  E-value=4.2e-30  Score=202.45  Aligned_cols=139  Identities=24%  Similarity=0.401  Sum_probs=125.5

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      +.+++.++||+|+||+|+.++.+ +++.+|+|+++++.   ....+....|..++..++||.||+++..|++.+.+|+|+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            44678999999999999999754 68999999997653   334677888999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+.||+|...|+..+ .+++..+..++.+|+.||.|||    ..+|||||+||+|||+|.+|.++|+
T Consensus       105 d~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH----~~gIiyRDlKPENILLd~~GHi~Lt  167 (357)
T KOG0598|consen  105 DYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLH----SKGIIYRDLKPENILLDEQGHIKLT  167 (357)
T ss_pred             eccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHH----hCCeeeccCCHHHeeecCCCcEEEe
Confidence            9999999999998754 5888888999999999999999    9999999999999999999999885

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.96  E-value=2.7e-30  Score=198.85  Aligned_cols=138  Identities=23%  Similarity=0.309  Sum_probs=120.6

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      .|+.+.++|+|+||+||+|+.+ +|+.||||++.....  .-.+-..+|+.+++.++|||+|.++++|.....+++|+||
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~   82 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY   82 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence            4667788999999999999865 699999999965533  2234567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+. ++.+-+......++.....++++|++.|+.|+|    ++++|||||||+|||++..|.+|+|
T Consensus        83 ~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH----k~n~IHRDIKPENILit~~gvvKLC  143 (396)
T KOG0593|consen   83 CDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH----KNNCIHRDIKPENILITQNGVVKLC  143 (396)
T ss_pred             cch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh----hcCeecccCChhheEEecCCcEEec
Confidence            987 555556655556888999999999999999999    8899999999999999999999987

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.96  E-value=1.7e-29  Score=191.08  Aligned_cols=138  Identities=25%  Similarity=0.433  Sum_probs=124.7

Q ss_pred             cceeeecccCCCcceeeeEE-eCCCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           89 FLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      .|...+++|+|.||.||+|+ ..+|+.||||++.....  +.-....+|+..++.++|+||+.++++|...+.+.+|+||
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf   82 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF   82 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence            35567899999999999996 45899999999976532  2235567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+. ||...++.....++......++.++++|++|||    .+.|+|||+||.|+|++.+|.+|||
T Consensus        83 m~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H----~~~IlHRDlKPnNLLis~~g~lKiA  143 (318)
T KOG0659|consen   83 MPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH----SKWILHRDLKPNNLLISSDGQLKIA  143 (318)
T ss_pred             ccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH----hhhhhcccCCccceEEcCCCcEEee
Confidence            987 999999998888999999999999999999999    8899999999999999999999986

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=6.5e-30  Score=203.85  Aligned_cols=141  Identities=25%  Similarity=0.401  Sum_probs=129.2

Q ss_pred             ccccceeeecccCCCcceeeeEE-eCCCcEEEEEEeecc---cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQ---YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      +...|++.+.||+|+||.|-+|. ...|+.||||.+.+.   +.++.-.+.+|+++|..++||||+.++++|+..+.+.+
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            44568899999999999999995 467999999998654   45566778999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||..+|+|++|+...+ .+++..+..+++||..|+.|+|    .++++|||||.+|||+|.++++||+
T Consensus       131 vMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCH----knrVvHRDLKLENILLD~N~NiKIA  195 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCH----KNRVVHRDLKLENILLDQNNNIKIA  195 (668)
T ss_pred             EEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHh----hccceecccchhheeecCCCCeeee
Confidence            999999999999999865 5899999999999999999999    9999999999999999999999997

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.96  E-value=7.2e-29  Score=203.38  Aligned_cols=139  Identities=22%  Similarity=0.332  Sum_probs=126.2

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      +-++++..||+|+||.||+|+. .+|..+|+|++.+..   ....+.+..|-.+|...++|+||+++..|.+.+++||||
T Consensus       141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM  220 (550)
T KOG0605|consen  141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM  220 (550)
T ss_pred             ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence            3467889999999999999975 479999999998763   345677888999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+||||+..+|...+ .+++..++.++.+++.|+..+|    ..|+|||||||+|+|||..|..|++
T Consensus       221 EylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH----~~gyIHRDIKPdNlLiD~~GHiKLS  283 (550)
T KOG0605|consen  221 EYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIH----QLGYIHRDIKPDNLLIDAKGHIKLS  283 (550)
T ss_pred             EecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHH----HcCcccccCChhheeecCCCCEeec
Confidence            9999999999998765 5888889999999999999999    8899999999999999999999986

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=6.9e-29  Score=203.65  Aligned_cols=137  Identities=28%  Similarity=0.489  Sum_probs=124.9

Q ss_pred             ceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCC
Q 042107           90 LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHG  169 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  169 (232)
                      +.+.+.||+|.||.||.|++.....||+|.+.... ...+.|.+|+++|++++|++||+++++|..++.+|||||||+.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            45678999999999999999988899999987653 23477889999999999999999999999988999999999999


Q ss_pred             Chhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          170 SLGKCLST-SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       170 ~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|.++++. .+..+...+.+.++.|||+|++||+    ++++|||||.++|||++++..+|||
T Consensus       287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe----s~~~IHRDLAARNiLV~~~~~vKIs  345 (468)
T KOG0197|consen  287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE----SKNYIHRDLAARNILVDEDLVVKIS  345 (468)
T ss_pred             cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH----hCCccchhhhhhheeeccCceEEEc
Confidence            99999997 4566888889999999999999999    8899999999999999999999997

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.8e-30  Score=196.97  Aligned_cols=146  Identities=21%  Similarity=0.337  Sum_probs=123.8

Q ss_pred             ccccceeeecccCCCcceeeeEE-eCCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeE-EEecCCe-eE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIIS-SCSKDDF-KA  160 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~-~~  160 (232)
                      -...|++.++||+|.||.||++. ..+|..+|.|.+.-..  ....+.+..|+.+++.++|||||++++ .+..++. ++
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            34557899999999999999995 6789999999886432  334567888999999999999999998 5555555 89


Q ss_pred             EEEeccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLST---SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|||||.+|||.+.++.   ....+++..+++++.|++.||..+|....+..|+||||||+||+++..|++|++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG  170 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG  170 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence            99999999999999874   345689999999999999999999953333459999999999999999999986

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.2e-28  Score=201.14  Aligned_cols=142  Identities=23%  Similarity=0.298  Sum_probs=125.8

Q ss_pred             cccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecc----cC-chHHHHHHHHHHhcCCC-CCCccceeEEEecCC
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQ----YG-GAFKNLDVECNMMKIIR-HQNLIKIISSCSKDD  157 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  157 (232)
                      .....|.+.+.||+|+||.|+.|+. .++..||+|.+...    .. ...+.+.+|+.+++.++ ||||+++++++.+..
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3445688999999999999999964 57899999976553    12 23456778999999999 999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC-Cceeec
Q 042107          158 FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN-MVAHFL  231 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~-~~~~l~  231 (232)
                      ..++||||+.||+|.+++.. ...+.+..+..++.|++.|++|||    +++|+||||||+|+|++.+ +++||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H----~~gi~HRDLK~ENilld~~~~~~Kl~  163 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH----SRGIVHRDLKPENILLDGNEGNLKLS  163 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH----hCCEeeCCCCHHHEEecCCCCCEEEe
Confidence            99999999999999999998 456888999999999999999999    8899999999999999999 999985

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.96  E-value=7.3e-29  Score=203.59  Aligned_cols=139  Identities=24%  Similarity=0.385  Sum_probs=123.8

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc---CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY---GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .-|.+.+.||+|+|+.|++|+. .++++||||++.+..   ....+.+.+|-.+|..| .||.|++++-.|.++..+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            3456889999999999999964 579999999997652   33345677788889999 899999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +||+++|+|.++|+..+ .+++..++.++.+|+.||+|||    .+|||||||||+|||+|+||..+|+
T Consensus       153 Le~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH----~~GIIHRDlKPENILLd~dmhikIT  216 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLH----SNGIIHRDLKPENILLDKDGHIKIT  216 (604)
T ss_pred             EEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHH----hcCceeccCChhheeEcCCCcEEEe
Confidence            99999999999998764 5888889999999999999999    9999999999999999999999885

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=3.2e-28  Score=197.11  Aligned_cols=142  Identities=28%  Similarity=0.356  Sum_probs=120.9

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC--------------chHHHHHHHHHHhcCCCCCCccce
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG--------------GAFKNLDVECNMMKIIRHQNLIKI  149 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~niv~~  149 (232)
                      ...+.|++.+.||+|.||.|.+|+.. +++.||||++.+...              ...+...+|+.+|++++|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            34567889999999999999999754 789999999965321              123578899999999999999999


Q ss_pred             eEEEecC--CeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCc
Q 042107          150 ISSCSKD--DFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV  227 (232)
Q Consensus       150 ~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~  227 (232)
                      +++..++  +.+|||+|||..|.+...=.. ...+.+.+++++++++..||+|||    .++||||||||+|+|++++|+
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d-~~els~~~Ar~ylrDvv~GLEYLH----~QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPD-KPELSEQQARKYLRDVVLGLEYLH----YQGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCC-cccccHHHHHHHHHHHHHHHHHHH----hcCeeccccchhheEEcCCCc
Confidence            9999775  589999999999987654322 222888899999999999999999    889999999999999999999


Q ss_pred             eeec
Q 042107          228 AHFL  231 (232)
Q Consensus       228 ~~l~  231 (232)
                      +||+
T Consensus       249 VKIs  252 (576)
T KOG0585|consen  249 VKIS  252 (576)
T ss_pred             EEee
Confidence            9997

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-29  Score=204.24  Aligned_cols=140  Identities=24%  Similarity=0.398  Sum_probs=124.9

Q ss_pred             ccccceeeecccCCCcceeeeEE-eCCCcEEEEEEeecccCchHHHH--HHHHHHhcCCC-CCCccceeEEEecCC-eeE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNL--DVECNMMKIIR-HQNLIKIISSCSKDD-FKA  160 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~--~~e~~~l~~l~-h~niv~~~~~~~~~~-~~~  160 (232)
                      +.+.|.+.++||.|+||.||+|+ ..+++.||||+++..... ++++  .+|+..++++. ||||+++.+++.+.+ .+|
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            45668889999999999999996 457999999999766432 3333  46999999998 999999999998877 999


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|||||+. +|+++++.++..+++..+..|+.||++||+|+|    .+|+.|||+||+|||+.....+|||
T Consensus        87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH----k~GfFHRDlKPENiLi~~~~~iKia  152 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH----KHGFFHRDLKPENILISGNDVIKIA  152 (538)
T ss_pred             eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH----hcCcccccCChhheEecccceeEec
Confidence            99999966 999999999888999999999999999999999    9999999999999999998888886

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.95  E-value=5.3e-28  Score=190.10  Aligned_cols=139  Identities=24%  Similarity=0.362  Sum_probs=122.2

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCC-ccceeEEEecCC------
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQN-LIKIISSCSKDD------  157 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~------  157 (232)
                      ..|+..+++|+|+||+||+|+. .+|+.||+|++.....  +......+|+.+++.++|+| |+++++++.+.+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            3456678899999999999975 5789999999977643  45566788999999999999 999999998877      


Q ss_pred             eeEEEEeccCCCChhhhhccCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          158 FKALILEYMPHGSLGKCLSTSN---YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ..++|+||+.. +|.+++....   ..++...++.+++|++.||+|||    +++|+||||||.|||++++|..|||
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H----~~~IlHRDLKPQNlLi~~~G~lKla  162 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH----SHGILHRDLKPQNLLISSSGVLKLA  162 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH----hCCeecccCCcceEEECCCCcEeee
Confidence            88999999966 9999998754   35777789999999999999999    8999999999999999999999986

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=4.9e-28  Score=193.10  Aligned_cols=140  Identities=20%  Similarity=0.322  Sum_probs=124.0

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC---chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG---GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      +.+++++.||+|.-|.||+++.+ ++..+|+|++.+...   ....+...|.+|++.++||.++++|..++++.+.|++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            44678899999999999999876 468999999977642   33455677999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+||+|..+.+.+ ...+++..++.++.+++.||+|||    ..|||+|||||+|||+.++|.+-++
T Consensus       157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH----mlGivYRDLKPENILvredGHIMLs  221 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH----MLGIVYRDLKPENILVREDGHIMLS  221 (459)
T ss_pred             ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH----hhceeeccCCcceeEEecCCcEEee
Confidence            999999999988865 456899999999999999999999    9999999999999999999987654

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=9.1e-28  Score=191.08  Aligned_cols=138  Identities=28%  Similarity=0.424  Sum_probs=122.3

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCC--eeEEEEecc
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD--FKALILEYM  166 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~  166 (232)
                      +...+.||+|+||.||++... +|...|||.+...+....+.+.+|+.+++.++|||||+++|.....+  ..++.|||+
T Consensus        19 ~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~   98 (313)
T KOG0198|consen   19 WSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA   98 (313)
T ss_pred             hhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence            456788999999999999754 58999999997764444677899999999999999999999755544  688999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC-CCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD-NMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~-~~~~~l~  231 (232)
                      ++|+|.+++...+..+++..++.+.+|+++||.|||    +++|+||||||+|||++. ++.+|||
T Consensus        99 ~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH----s~g~vH~DiK~~NiLl~~~~~~~Kla  160 (313)
T KOG0198|consen   99 PGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH----SKGIVHCDIKPANILLDPSNGDVKLA  160 (313)
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeccCcccceEEEeCCCCeEEec
Confidence            999999999987546899999999999999999999    889999999999999999 6999986

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.95  E-value=1.5e-28  Score=202.77  Aligned_cols=137  Identities=27%  Similarity=0.403  Sum_probs=124.7

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      .|.+.+.||+|.||.||+|+.+ +.+.||+|.+.+..  ....+.+.+|+++++.++||||+.++++|++...+|+|+||
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~   82 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY   82 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence            4678899999999999999765 68889999997653  34567889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +.| +|..++.... .++++.+..++.+++.||.|||    +.+|+|||+||.|||++..|++|+|
T Consensus        83 a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLh----s~rilhrd~kPqniLl~~~~~~Klc  142 (808)
T KOG0597|consen   83 AVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLH----SNRILHRDMKPQNILLEKGGTLKLC  142 (808)
T ss_pred             hhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH----hcCcccccCCcceeeecCCCceeec
Confidence            977 9999998654 5999999999999999999999    8899999999999999999999987

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-27  Score=192.23  Aligned_cols=141  Identities=27%  Similarity=0.349  Sum_probs=127.8

Q ss_pred             cccceeeecccCCCcceeeeEE-eCCCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           87 RNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .+.|++.+.||.|..+.||+|+ ...++.||||++.... ....+.+.+|+..|.-++||||++++..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            3568899999999999999996 4568999999997664 3346889999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||.+|++.++++.. ...+++..+..|.+++++||.|||    .+|.||||+|+.|||++.+|.+|||
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH----~~G~IHRdvKAgnILi~~dG~VkLa  168 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH----QNGHIHRDVKAGNILIDSDGTVKLA  168 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH----hcCceecccccccEEEcCCCcEEEc
Confidence            99999999999864 334888999999999999999999    8899999999999999999999986

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.95  E-value=7.3e-28  Score=187.59  Aligned_cols=139  Identities=24%  Similarity=0.339  Sum_probs=121.0

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecC--CeeEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKD--DFKALI  162 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  162 (232)
                      +.|+.++.|++|+||.||+|+. ++++.||+|+++-..  .+..-.-.+|+.++.+++|||||.+.++....  +.+|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            3467889999999999999975 578999999986543  33334457899999999999999999887654  579999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||++ ||..++......+...++..++.|+++|+.|||    .+.|+||||||+|+|+.+.|..|||
T Consensus       156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH----~~wilHRDLK~SNLLm~~~G~lKia  219 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH----DNWILHRDLKTSNLLLSHKGILKIA  219 (419)
T ss_pred             HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh----hceeEecccchhheeeccCCcEEec
Confidence            999987 999999887777888999999999999999999    8899999999999999999999987

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=3.6e-28  Score=181.36  Aligned_cols=142  Identities=25%  Similarity=0.315  Sum_probs=125.3

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.+++.+.||+|.||.||.|+.+ ++-.||+|++.+..   .+....+.+|+++-..++||||.++++++.++...|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            345678999999999999999754 67889999996653   23346788999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeecC
Q 042107          163 LEYMPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFLA  232 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~~  232 (232)
                      +||.+.|++...+... ...+++.....++.|+|.|+.|+|    .++++|||+||+|+|++.++..|||.
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h----~k~VIhRdiKpenlLlg~~~~lkiAd  167 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH----LKRVIHRDIKPENLLLGSAGELKIAD  167 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc----cCCcccCCCCHHHhccCCCCCeeccC
Confidence            9999999999999854 334788888899999999999999    88999999999999999999999874

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-27  Score=197.95  Aligned_cols=137  Identities=25%  Similarity=0.402  Sum_probs=122.7

Q ss_pred             eeeecccCCCcceeeeEEeCC--C--cE-EEEEEeecc---cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           91 EVFNLISRGGFGSIYKARIQD--G--ME-VVVKGFNLQ---YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        91 ~~~~~lg~g~~g~V~~~~~~~--~--~~-vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.++||+|+||.||+|++..  +  .. ||+|.....   ......++..|+++|+.++|||||+++|++..+..+++|
T Consensus       160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv  239 (474)
T KOG0194|consen  160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV  239 (474)
T ss_pred             cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence            456899999999999997542  2  23 899988753   245567889999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+|+||+|.++++.....++..++..++.++|.||+|||    .+.++||||-++|+|++.++.+|||
T Consensus       240 mEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh----~k~~IHRDIAARNcL~~~~~~vKIS  304 (474)
T KOG0194|consen  240 MELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH----SKNCIHRDIAARNCLYSKKGVVKIS  304 (474)
T ss_pred             EEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH----HCCCcchhHhHHHheecCCCeEEeC
Confidence            9999999999999987767899999999999999999999    8899999999999999999999986

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.95  E-value=2.7e-27  Score=181.65  Aligned_cols=140  Identities=25%  Similarity=0.324  Sum_probs=125.3

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC---chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG---GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.++..+.||.|+||.|.+++.+ +|.-+|+|++..+..   ...+....|..+++.+.||+++++++.+.+.+.+|+|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            344677889999999999999865 588899999977643   3346677899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||++||.|..+++..+ .+++..++.++.||+.|++|||    ..+|++||+||+|||+|.+|..||.
T Consensus       123 meyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH----~~~iiYRDLKPENiLlD~~G~iKit  186 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLH----SLDIIYRDLKPENLLLDQNGHIKIT  186 (355)
T ss_pred             EeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHH----hcCeeeccCChHHeeeccCCcEEEE
Confidence            99999999999998765 5899999999999999999999    8899999999999999999999884

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=7.2e-27  Score=193.53  Aligned_cols=138  Identities=20%  Similarity=0.320  Sum_probs=122.8

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME   81 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence            3678899999999999999764 68999999997542   2334567789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.++|+
T Consensus        82 ~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~  143 (364)
T cd05599          82 YLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH----KLGYIHRDIKPDNLLLDAKGHIKLS  143 (364)
T ss_pred             CCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEECCCCCEEEe
Confidence            999999999987643 5888899999999999999999    8899999999999999999999875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.95  E-value=8.6e-27  Score=194.25  Aligned_cols=138  Identities=17%  Similarity=0.266  Sum_probs=122.2

Q ss_pred             cceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .|++.+.||+|+||.||+|+. .+++.||+|++....   ....+.+..|+.+++.++||||+++++++.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            467889999999999999975 468899999997542   2334668889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.++|+
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH----~~givHrDlKp~Nili~~~~~~kL~  143 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH----KMGFIHRDIKPDNILIDLDGHIKLT  143 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCcHHHEEECCCCCEEEe
Confidence            999999999987643 4788888899999999999999    8899999999999999999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.2e-26  Score=193.07  Aligned_cols=138  Identities=19%  Similarity=0.274  Sum_probs=121.8

Q ss_pred             cceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .|.+.+.||+|+||.||+++. .+++.||+|++....   ....+.+..|+++++.++||||+++++++.+.+..|+|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            366789999999999999975 478999999986532   2334667889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.++|+
T Consensus        82 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH----~~givHrDlkp~NIll~~~~~~kl~  143 (377)
T cd05629          82 FLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH----KLGFIHRDIKPDNILIDRGGHIKLS  143 (377)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEECCCCCEEEe
Confidence            999999999987543 5788888899999999999999    8899999999999999999999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.94  E-value=1.2e-26  Score=192.10  Aligned_cols=138  Identities=20%  Similarity=0.279  Sum_probs=122.2

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .|++.+.||+|+||.||+|+.. +++.||+|++....   ......+..|+.++..++||+|+++++.+.+....|+|||
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E   81 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME   81 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence            3677899999999999999754 68899999997542   2234567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        82 ~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH----~~givHrDlKp~NILi~~~~~vkL~  143 (363)
T cd05628          82 FLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH----QLGFIHRDIKPDNLLLDSKGHVKLS  143 (363)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEecCCCHHHeEECCCCCEEEe
Confidence            999999999987643 5888999999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3e-27  Score=195.03  Aligned_cols=137  Identities=28%  Similarity=0.373  Sum_probs=126.4

Q ss_pred             cceeeecccCCCcceeeeEE-eCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccC
Q 042107           89 FLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      .|...++||+|+.|.||.++ ..+++.||||++........+-+..|+.+|+..+|+|||.+++.|...+.+|+|||||+
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~  353 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME  353 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence            45667899999999999995 55789999999998877777888999999999999999999999998999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+|.+.+...  .+++.+...|++++++||+|||    ..+|+|||||.+|||++.+|.+||+
T Consensus       354 ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH----~~gIiHrDIKSDnILL~~~g~vKlt  411 (550)
T KOG0578|consen  354 GGSLTDVVTKT--RMTEGQIAAICREILQGLKFLH----ARGIIHRDIKSDNILLTMDGSVKLT  411 (550)
T ss_pred             CCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHH----hcceeeeccccceeEeccCCcEEEe
Confidence            99999998765  4899999999999999999999    8999999999999999999999985

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.94  E-value=2.7e-26  Score=187.73  Aligned_cols=140  Identities=21%  Similarity=0.269  Sum_probs=123.9

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.|++.+.||+|+||.||+|+.. +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++..++..+++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            355788899999999999999765 68899999987542   23346688899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        97 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~NIll~~~~~~kl~  160 (329)
T PTZ00263         97 LEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH----SKDIIYRDLKPENLLLDNKGHVKVT  160 (329)
T ss_pred             EcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHEEECCCCCEEEe
Confidence            99999999999987643 4788888899999999999999    8899999999999999999999885

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.94  E-value=2.1e-26  Score=191.53  Aligned_cols=138  Identities=18%  Similarity=0.279  Sum_probs=121.8

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .|++.+.||+|+||.||+++.. +++.||+|.+....   ....+.+.+|+.+++.++||||+++++.+..++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            4678899999999999999754 68899999986432   2234667889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++|+|.+++.... .+++..+..++.|++.||+|||    ..+|+||||||+|||++.++.++|+
T Consensus        82 ~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nill~~~~~ikL~  143 (376)
T cd05598          82 YIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH----KMGFIHRDIKPDNILIDRDGHIKLT  143 (376)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHEEECCCCCEEEE
Confidence            999999999987653 4788888889999999999999    8899999999999999999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.94  E-value=1.7e-26  Score=192.60  Aligned_cols=138  Identities=18%  Similarity=0.287  Sum_probs=121.9

Q ss_pred             cceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .|++.+.||+|+||.||+|+. .+++.||+|.+....   ....+.+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            366889999999999999975 468899999987542   2334567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH----~~~ivHrDlKp~NILl~~~g~~kL~  143 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH----KMGFIHRDIKPDNILIDRDGHIKLT  143 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEEe
Confidence            999999999987643 4788888899999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.94  E-value=2.9e-26  Score=182.00  Aligned_cols=139  Identities=17%  Similarity=0.327  Sum_probs=121.8

Q ss_pred             cceeeecccCCCcceeeeEEeC----CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      .+++.+.||+|+||.||+|.+.    .+..||+|.+..... .....+.+|+..++.++||||+++++++...+..++||
T Consensus         6 ~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   85 (266)
T cd05064           6 SIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVT   85 (266)
T ss_pred             HeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEE
Confidence            3668899999999999999643    356899998865432 23456788999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+++|+|.+++......+++..++.++.|++.||+|+|    ..+++||||||+||+++.++.++++
T Consensus        86 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH----~~~iiH~dikp~nili~~~~~~~l~  149 (266)
T cd05064          86 EYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS----EMGYVHKGLAAHKVLVNSDLVCKIS  149 (266)
T ss_pred             EeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeeccccHhhEEEcCCCcEEEC
Confidence            999999999999765556889999999999999999999    8899999999999999999998875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=4.1e-26  Score=186.78  Aligned_cols=139  Identities=20%  Similarity=0.243  Sum_probs=122.6

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .|++.+.||+|+||.||+++.. +++.||+|.+....   ....+.+..|..++..++|+||+++++++..++..|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD   81 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence            4678899999999999999754 68899999986532   2234567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++|+|.+++......+++..+..++.|++.||.|||    .++|+||||||+|||++.++.++|+
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~~kl~  144 (331)
T cd05597          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH----QLGYVHRDIKPDNVLLDKNGHIRLA  144 (331)
T ss_pred             cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----hCCeEECCCCHHHEEECCCCCEEEE
Confidence            99999999999765556888899999999999999999    8899999999999999999998875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=2e-26  Score=185.32  Aligned_cols=138  Identities=24%  Similarity=0.330  Sum_probs=121.8

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .|++.+.||+|+||.||+|+.. +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            3667899999999999999765 68899999986542   1234567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++|+|.+++.... .+++..+..++.|++.||.|||    .++++||||||+||+++.++.+||+
T Consensus        82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~NIli~~~~~~kl~  143 (291)
T cd05612          82 YVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH----SKEIVYRDLKPENILLDKEGHIKLT  143 (291)
T ss_pred             CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEECCCCCEEEE
Confidence            999999999987654 4788888999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.94  E-value=4.4e-26  Score=185.98  Aligned_cols=133  Identities=23%  Similarity=0.288  Sum_probs=117.5

Q ss_pred             ecccCCCcceeeeEEe-CCCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCC
Q 042107           94 NLISRGGFGSIYKARI-QDGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHG  169 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  169 (232)
                      +.||+|+||.||+++. .+++.||+|++....   ......+..|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999975 478999999987542   233456778999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          170 SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       170 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH----~~~ivHrDlkp~NIll~~~~~~kl~  137 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH----SCDVVYRDLKLENLMLDKDGHIKIT  137 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHEEECCCCCEEEe
Confidence            9999887643 5788899999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.94  E-value=4.7e-26  Score=189.03  Aligned_cols=139  Identities=21%  Similarity=0.276  Sum_probs=122.3

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.|++.+.||+|+||.||+++.. +++.+|+|.+....   ....+.+.+|+.+++.++||||+++++++..++..|+|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            345788899999999999999765 68899999986532   22345577899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+++|+|.+++...  .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       122 ~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH----~~~IvHrDLKp~NILl~~~~~~kL~  184 (370)
T cd05621         122 MEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIH----SMGLIHRDVKPDNMLLDKHGHLKLA  184 (370)
T ss_pred             EcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEECCCCCEEEE
Confidence            9999999999998754  3788888999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.94  E-value=5.2e-26  Score=186.75  Aligned_cols=139  Identities=19%  Similarity=0.274  Sum_probs=121.9

Q ss_pred             ccceeeecccCCCcceeeeEEeC-C-CcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-D-GMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      +.|++.+.||+|+||.||+|... + +..||+|.+....   ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            45778899999999999999754 3 3689999986542   23456678899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.++|+
T Consensus       110 ~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NILl~~~~~ikL~  173 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ----SLNIVYRDLKPENLLLDKDGFIKMT  173 (340)
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEccCCCHHHEEECCCCCEEEe
Confidence            99999999999997643 5788889999999999999999    8899999999999999999999885

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=5.1e-26  Score=186.34  Aligned_cols=138  Identities=22%  Similarity=0.395  Sum_probs=122.6

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+..|+.++..++||||+++++++...+..++|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            3678899999999999999865 58899999997542   2334567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus        82 ~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kL~  143 (333)
T cd05600          82 YVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH----ELGYIHRDLKPENFLIDASGHIKLT  143 (333)
T ss_pred             CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEECCCCCEEEE
Confidence            999999999997543 4788889999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.94  E-value=5.6e-26  Score=182.46  Aligned_cols=138  Identities=20%  Similarity=0.365  Sum_probs=120.7

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      .|++.+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   85 (288)
T cd07871           6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL   85 (288)
T ss_pred             cceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence            3678899999999999999754 68899999986543 223456778999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++ +|.+++......+++..+..++.|++.||+|||    ..+|+||||||+|||++.++.+||+
T Consensus        86 ~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~Nil~~~~~~~kl~  145 (288)
T cd07871          86 DS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH----KRKILHRDLKPQNLLINEKGELKLA  145 (288)
T ss_pred             Cc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEC
Confidence            75 899988765556788889999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.94  E-value=5e-27  Score=201.78  Aligned_cols=139  Identities=28%  Similarity=0.500  Sum_probs=123.2

Q ss_pred             ceeeecccCCCcceeeeEEe------CCCcEEEEEEeecccCc-hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           90 LEVFNLISRGGFGSIYKARI------QDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~------~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      ....+.||+|+||+||+|+.      .+...||||.++..... ..++|++|+++++.++|||||+++|+|..++..++|
T Consensus       488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv  567 (774)
T KOG1026|consen  488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV  567 (774)
T ss_pred             eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence            45678999999999999973      24568999999766554 678899999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccC---------C----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCcee
Q 042107          163 LEYMPHGSLGKCLSTS---------N----YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAH  229 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~---------~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~  229 (232)
                      +|||..|||.++|...         +    ..++..+.+.|+.|||.|++||-    ++.+|||||.++|+||.++..+|
T Consensus       568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs----~~~FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS----SHHFVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH----hCcccccchhhhhceeccceEEE
Confidence            9999999999998743         1    12777889999999999999998    88899999999999999999999


Q ss_pred             ecC
Q 042107          230 FLA  232 (232)
Q Consensus       230 l~~  232 (232)
                      ||.
T Consensus       644 IsD  646 (774)
T KOG1026|consen  644 ISD  646 (774)
T ss_pred             ecc
Confidence            973

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.94  E-value=5.2e-26  Score=185.58  Aligned_cols=133  Identities=22%  Similarity=0.299  Sum_probs=117.3

Q ss_pred             ecccCCCcceeeeEEe-CCCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCC
Q 042107           94 NLISRGGFGSIYKARI-QDGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHG  169 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  169 (232)
                      +.||+|+||.||+++. .++..||+|.+....   ......+..|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3689999999999975 468999999997542   233456678999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          170 SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       170 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|..++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~  137 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKIT  137 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEEcCCCCEEec
Confidence            9998887543 5788899999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.94  E-value=5.8e-26  Score=183.67  Aligned_cols=140  Identities=24%  Similarity=0.441  Sum_probs=118.7

Q ss_pred             ccceeeecccCCCcceeeeEEeCC-----------------CcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccce
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQD-----------------GMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKI  149 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~  149 (232)
                      +.|.+.+.||+|+||.||+|.+.+                 +..||+|.+..... .....+.+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            346788899999999999997432                 34699998865432 234568899999999999999999


Q ss_pred             eEEEecCCeeEEEEeccCCCChhhhhccCC------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCee
Q 042107          150 ISSCSKDDFKALILEYMPHGSLGKCLSTSN------------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVII  211 (232)
Q Consensus       150 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~ii  211 (232)
                      ++++...+..+++|||+++|+|.+++....                  ..+++.....++.|++.||.|||    ..+|+
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~iv  160 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS----SLNFV  160 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH----HCCcc
Confidence            999999999999999999999999885421                  23567788899999999999999    88999


Q ss_pred             eCCCCCCceeeCCCCceeec
Q 042107          212 HCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       212 Hrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||||+|||++.++.+||+
T Consensus       161 H~dlkp~Nill~~~~~~kl~  180 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIA  180 (304)
T ss_pred             ccCcchhheEEcCCccEEEC
Confidence            99999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.94  E-value=6.7e-26  Score=185.50  Aligned_cols=139  Identities=21%  Similarity=0.230  Sum_probs=122.1

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .|++.+.||+|+||.||+++.. +++.||+|.+....   ......+..|..++..++|++|+++++++..++..|+|||
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E   81 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD   81 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            4678899999999999999765 67889999986532   2234557789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++|+|.+++......+++..+..++.|++.||.|+|    .++|+||||||+|||++.++.+||+
T Consensus        82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH----~~~iiHrDlkp~Nill~~~~~~kl~  144 (331)
T cd05624          82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH----QLHYVHRDIKPDNVLLDMNGHIRLA  144 (331)
T ss_pred             CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCchHHEEEcCCCCEEEE
Confidence            99999999999765456888889999999999999999    8899999999999999999998874

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.94  E-value=6.6e-26  Score=185.42  Aligned_cols=139  Identities=21%  Similarity=0.267  Sum_probs=123.6

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .|++.+.||+|+||.||+++.. +++.||+|.+....   ....+.+..|+.+++.++||||+++++++...+..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            3678899999999999999754 68899999997543   2234567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++|+|.+++......+++..+..++.|++.||.|+|    ..+|+||||||+||+++.++.+||+
T Consensus        82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~~i~H~Dlkp~NIll~~~~~~kL~  144 (330)
T cd05601          82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH----QMGYVHRDIKPENVLIDRTGHIKLA  144 (330)
T ss_pred             CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeEcccCchHheEECCCCCEEec
Confidence            99999999999876556889999999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=1.9e-26  Score=198.73  Aligned_cols=143  Identities=29%  Similarity=0.390  Sum_probs=123.6

Q ss_pred             cccceeeecccCCCcceeeeEEeCCC-cEEEEEEeecccCchHHHHHHHHHHhcCCC-CCCccceeEEE-ec---C---C
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQDG-MEVVVKGFNLQYGGAFKNLDVECNMMKIIR-HQNLIKIISSC-SK---D---D  157 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~-~~---~---~  157 (232)
                      ....++.+.|.+|+|+.||.|+...+ ..||+|++-..+....+.+.+|+++|+.|+ |+|||.+++.. ..   .   -
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            34567889999999999999987654 999999998888888999999999999997 99999999932 21   1   2


Q ss_pred             eeEEEEeccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          158 FKALILEYMPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .+.|.||||+||.|-+++..+ ...+++.++++|+.++++|+++||..  ..+|||||||.+|||++.++..|||
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~--~pPiIHRDLKiENvLls~~g~~KLC  188 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL--KPPIIHRDLKIENVLLSADGNYKLC  188 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC--CCccchhhhhhhheEEcCCCCEEeC
Confidence            457899999999999999854 33499999999999999999999955  5579999999999999999999987

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.94  E-value=9.4e-26  Score=184.42  Aligned_cols=133  Identities=24%  Similarity=0.315  Sum_probs=117.6

Q ss_pred             ecccCCCcceeeeEEe-CCCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCC
Q 042107           94 NLISRGGFGSIYKARI-QDGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHG  169 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  169 (232)
                      +.||+|+||.||+++. .+++.||+|.+....   ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999975 468999999997542   234466778999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          170 SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       170 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|..++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDikp~NIll~~~~~~kL~  137 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH----SGKIVYRDLKLENLMLDKDGHIKIT  137 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEecccCHHHeEECCCCcEEEe
Confidence            9998886543 5888899999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.94  E-value=9.3e-26  Score=187.29  Aligned_cols=138  Identities=21%  Similarity=0.271  Sum_probs=121.2

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      +.|++.+.||+|+||.||+++.. +++.||+|.+....   ....+.+..|+.+++.++||||+++++++.+++..++||
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM  122 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence            45678899999999999999764 68899999986532   223355778999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+++|+|.+++...  .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       123 Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NILl~~~~~~kL~  184 (370)
T cd05596         123 EYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLA  184 (370)
T ss_pred             cCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEEcCCCCEEEE
Confidence            999999999998754  3777888889999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.94  E-value=5.1e-27  Score=184.84  Aligned_cols=134  Identities=27%  Similarity=0.461  Sum_probs=110.4

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecC--C---eeEEE
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKD--D---FKALI  162 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~---~~~lv  162 (232)
                      .++..+++|.|+||.||+|... +++.||||++-....    .-.+|.++|+.++|||||++.-+|...  .   +..+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            3566789999999999999754 579999999854432    234689999999999999998877542  2   34589


Q ss_pred             EeccCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC-Cceeec
Q 042107          163 LEYMPHGSLGKCLSTS---NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN-MVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~-~~~~l~  231 (232)
                      |||||. +|.+.++..   +..++...++-++.|+.+||.|||    ..+|+||||||.|+|+|.+ |.+|||
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh----~~~IcHRDIKPqNlLvD~~tg~LKic  168 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH----SHGICHRDIKPQNLLVDPDTGVLKIC  168 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH----hcCcccCCCChheEEEcCCCCeEEec
Confidence            999987 999988742   334677778889999999999999    8899999999999999986 888886

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.94  E-value=9.6e-26  Score=186.61  Aligned_cols=138  Identities=20%  Similarity=0.282  Sum_probs=122.1

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .|+..+.||+|+||.||+++.. +++.||+|.+....   ......+..|+.++..++||+|+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            3567899999999999999764 68899999986532   2345667889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.++|+
T Consensus        82 ~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH----~~givHrDLkp~NIli~~~~~vkL~  143 (360)
T cd05627          82 FLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH----QLGFIHRDIKPDNLLLDAKGHVKLS  143 (360)
T ss_pred             CCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEccCCCHHHEEECCCCCEEEe
Confidence            999999999987643 4788889999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.94  E-value=4.6e-26  Score=186.89  Aligned_cols=140  Identities=25%  Similarity=0.380  Sum_probs=116.5

Q ss_pred             ccceeeecccCCCcceeeeEEe------CCCcEEEEEEeeccc-CchHHHHHHHHHHhcCC-CCCCccceeEEEecC-Ce
Q 042107           88 NFLEVFNLISRGGFGSIYKARI------QDGMEVVVKGFNLQY-GGAFKNLDVECNMMKII-RHQNLIKIISSCSKD-DF  158 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~~  158 (232)
                      +.|++.+.||+|+||.||+|..      .++..||+|.+.... ....+.+..|+.++..+ +||||+++++++... +.
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (338)
T cd05102           7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP   86 (338)
T ss_pred             hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence            4567889999999999999963      235679999986432 22346688899999999 899999999988764 45


Q ss_pred             eEEEEeccCCCChhhhhccCC-----------------------------------------------------------
Q 042107          159 KALILEYMPHGSLGKCLSTSN-----------------------------------------------------------  179 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  179 (232)
                      .+++|||+++|+|.+++....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (338)
T cd05102          87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL  166 (338)
T ss_pred             eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence            789999999999998886421                                                           


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          180 --YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       180 --~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                        ..+++.....++.|+++||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       167 ~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDiKp~Nil~~~~~~~kl~  216 (338)
T cd05102         167 WKSPLTMEDLICYSFQVARGMEFLA----SRKCIHRDLAARNILLSENNVVKIC  216 (338)
T ss_pred             ccCCCCHHHHHHHHHHHHHHHHHHH----HCCEECCCCccceEEEcCCCcEEEe
Confidence              23667778889999999999999    8899999999999999999998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.94  E-value=1.6e-25  Score=176.64  Aligned_cols=137  Identities=23%  Similarity=0.343  Sum_probs=121.8

Q ss_pred             ceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCC
Q 042107           90 LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHG  169 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  169 (232)
                      +++.+.||+|+||.||++++.++..+|+|.+.... ...+.+..|+.+++.++||||+++++++...+..+++|||+++|
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~   84 (256)
T cd05114           6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENG   84 (256)
T ss_pred             cEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCC
Confidence            45678899999999999998888889999876432 23467888999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          170 SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       170 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|.+++......+++..+..++.|++.||.|+|    ..+++||||||+||+++.++.++++
T Consensus        85 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~i~~~~~~kl~  142 (256)
T cd05114          85 CLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE----RNSFIHRDLAARNCLVSSTGVVKVS  142 (256)
T ss_pred             cHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH----HCCccccccCcceEEEcCCCeEEEC
Confidence            999998765445888999999999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.94  E-value=1.4e-25  Score=181.41  Aligned_cols=139  Identities=21%  Similarity=0.337  Sum_probs=120.9

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      +.|++.+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (303)
T cd07869           5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY   84 (303)
T ss_pred             ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence            45788899999999999999765 688999999865432 2234567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++ +++.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~Nill~~~~~~kl~  145 (303)
T cd07869          85 VH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH----QRYILHRDLKPQNLLISDTGELKLA  145 (303)
T ss_pred             CC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEC
Confidence            96 5888877765556888889999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.1e-25  Score=182.69  Aligned_cols=131  Identities=20%  Similarity=0.251  Sum_probs=116.2

Q ss_pred             ccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCCh
Q 042107           96 ISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSL  171 (232)
Q Consensus        96 lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  171 (232)
                      ||+|+||.||+|+.. +++.||+|.+....   ......+.+|+.+++.++||||+++++++..++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999765 68899999986532   23446677899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          172 GKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       172 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.++|+
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~HrDlkp~Nili~~~~~~kl~  135 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENLH----KFNVIYRDLKPENILLDYQGHIALC  135 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHeEECCCCcEEEE
Confidence            99987643 4788899999999999999999    8899999999999999999998875

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=8.2e-26  Score=186.18  Aligned_cols=138  Identities=22%  Similarity=0.341  Sum_probs=123.4

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .|.+.+.||+|+||.||+|+.. +++.||+|++....   ......+..|+.+++.++||||+++++++..++..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            3678899999999999999765 78999999997542   2345678889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++++|.+++... ..+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.++|+
T Consensus        82 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH----~~giiH~Dlkp~NIll~~~~~~kL~  143 (350)
T cd05573          82 YMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVH----KLGFIHRDIKPDNILIDADGHIKLA  143 (350)
T ss_pred             CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEee
Confidence            99999999998765 45888899999999999999999    8899999999999999999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.93  E-value=2.3e-25  Score=181.89  Aligned_cols=133  Identities=22%  Similarity=0.290  Sum_probs=116.5

Q ss_pred             ecccCCCcceeeeEEe-CCCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCC
Q 042107           94 NLISRGGFGSIYKARI-QDGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHG  169 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  169 (232)
                      +.||+|+||.||+++. .+++.||+|.+....   ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999999975 478999999997542   223456677999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeeCCCCCCceeeCCCCceeec
Q 042107          170 SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST-HVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       170 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|..++.... .+++..+..++.|++.||.|||    . .+|+||||||+|||++.++.+||+
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH----~~~~ivHrDikp~NIll~~~~~~kL~  138 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH----SEKNVVYRDLKLENLMLDKDGHIKIT  138 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hcCCEEecCCCCCeEEECCCCCEEEe
Confidence            9998886543 5888899999999999999999    6 689999999999999999999885

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.93  E-value=1.7e-25  Score=179.42  Aligned_cols=138  Identities=19%  Similarity=0.271  Sum_probs=119.4

Q ss_pred             ceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           90 LEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      |+..+.||+|+||.||+|.. .+++.||+|.+....   ......+.+|+.+++.++|++|+++++++...+..+++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            45778999999999999975 578999999986542   12234567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|+|.+++... ...+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.++|+
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~iiH~dikp~Nill~~~~~~kl~  144 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ----RERIVYRDLKPENILLDDRGHIRIS  144 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHEEECCCCCEEEe
Confidence            9999998877543 235788899999999999999999    8899999999999999999988875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.93  E-value=2.6e-26  Score=190.17  Aligned_cols=143  Identities=24%  Similarity=0.399  Sum_probs=126.5

Q ss_pred             cccccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      ..++.+.+.++||+|.||.|.+|....+..||+|.++.... .....|.+|+++|..++||||++++++|..++.+++++
T Consensus       535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            44556678899999999999999988789999999976643 34588999999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYI-LDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||++|+|.+++..+..+ ..-....+|+.||+.|++||.    +..++|||+.+.|+|+|.++++|||
T Consensus       615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe----s~nfVHrd~a~rNcLv~~e~~iKia  679 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE----SLNFVHRDLATRNCLVDGEFTIKIA  679 (807)
T ss_pred             HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH----hhchhhccccccceeecCcccEEec
Confidence            999999999999876322 244456789999999999999    8889999999999999999999997

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.93  E-value=2.2e-25  Score=185.06  Aligned_cols=138  Identities=22%  Similarity=0.269  Sum_probs=121.3

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      +.|++.+.||+|+||.||+++.. +++.+|+|.+....   ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus        43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~  122 (371)
T cd05622          43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM  122 (371)
T ss_pred             hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            45778899999999999999765 68899999986432   223455778999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+++|+|.+++...  .+++..+..++.|++.||.|||    .++|+||||||+|||++.++.+||+
T Consensus       123 Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDLkp~NIll~~~~~ikL~  184 (371)
T cd05622         123 EYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLA  184 (371)
T ss_pred             cCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCEEeCCCCHHHEEECCCCCEEEE
Confidence            999999999998754  3778888899999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=4e-26  Score=191.43  Aligned_cols=137  Identities=24%  Similarity=0.344  Sum_probs=123.7

Q ss_pred             ceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           90 LEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      +++.+.||.|+-|.|..|+. .+|+.+|||++....   ......+.+|+.+|+-+.||||++++++|....++|+|.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            46788999999999999975 589999999997662   22346688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|.|.+++-.++ .+++..+.++++||+.|+.|||    ..+|+|||+||+|+|+|.+.+.|||
T Consensus        94 v~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH----~~~icHRDLKpENlLLd~~~nIKIA  154 (786)
T KOG0588|consen   94 VPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCH----AFNICHRDLKPENLLLDVKNNIKIA  154 (786)
T ss_pred             cCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHh----hhcceeccCCchhhhhhcccCEeee
Confidence            99999999998765 5788888999999999999999    8899999999999999999999986

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.93  E-value=2.1e-26  Score=191.34  Aligned_cols=134  Identities=27%  Similarity=0.467  Sum_probs=122.1

Q ss_pred             eeeecccCCCcceeeeEEeCCCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           91 EVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        91 ~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      .+.+.||+|.||+||+|+|.  ..||||.+.....  ...+.|..|+.++++-+|.||+-+.|+|..++. .+|+.||+|
T Consensus       395 ~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeG  471 (678)
T KOG0193|consen  395 LLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEG  471 (678)
T ss_pred             hccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccC
Confidence            46789999999999999985  3699999976643  357889999999999999999999999998877 899999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      -+|+.+++.....++..+.+.|+.|+++|+.|||    .++|||||||..||++.+++.+||+
T Consensus       472 sSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH----AK~IIHrDLKSnNIFl~~~~kVkIg  530 (678)
T KOG0193|consen  472 SSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH----AKNIIHRDLKSNNIFLHEDLKVKIG  530 (678)
T ss_pred             chhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh----hhhhhhhhccccceEEccCCcEEEe
Confidence            9999999887777888899999999999999999    8999999999999999999999986

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=9.2e-26  Score=187.88  Aligned_cols=139  Identities=29%  Similarity=0.415  Sum_probs=124.5

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .+|.+...||+|.|+.|.+++.. ++..||+|.+++...  ...+.+.+|+++|+.+.|||||+++++..++..+|+|||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e  135 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME  135 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence            45788999999999999999754 699999999976643  334568899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+.+|.+++++...+. ..+..+..++.|+..|++|||    .+.|+|||||++|+|++.++++|||
T Consensus       136 ya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH----~k~ivHrdLk~eNilL~~~mnikIa  197 (596)
T KOG0586|consen  136 YASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCH----SKNIVHRDLKAENILLDENMNIKIA  197 (596)
T ss_pred             eccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHh----hcceeccccchhhcccccccceeee
Confidence            9999999999987654 455778889999999999999    8899999999999999999999997

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.93  E-value=4.1e-25  Score=174.49  Aligned_cols=137  Identities=23%  Similarity=0.354  Sum_probs=121.9

Q ss_pred             ceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCC
Q 042107           90 LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHG  169 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  169 (232)
                      +.+.+.||+|+||.||.+++.++..+|+|.+..... ..+.+..|+.+++.++||||+++++++...+..+++|||+++|
T Consensus         6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd05113           6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG   84 (256)
T ss_pred             eEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence            567789999999999999887777899998864432 3466888999999999999999999999888899999999999


Q ss_pred             ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          170 SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       170 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|.+++......+++..+..++.|++.|+.|||    ..+++|+||||+||+++.++.+||+
T Consensus        85 ~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~nili~~~~~~kl~  142 (256)
T cd05113          85 CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE----SKQFIHRDLAARNCLVDDQGCVKVS  142 (256)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccCcceEEEcCCCCEEEC
Confidence            999998765446889999999999999999999    8899999999999999999998885

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.93  E-value=2.6e-25  Score=182.11  Aligned_cols=139  Identities=19%  Similarity=0.224  Sum_probs=121.6

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .|++.+.||+|+||.||+++.. +++.+|+|.+....   ......+..|+.++..++|++|+++++++..++..++|||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            3678899999999999999765 57889999986432   2233457789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++|+|.+++......+++..+..++.|++.||.|+|    ..+|+||||||+|||++.++.++|+
T Consensus        82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH----~~~iiHrDlkp~Nili~~~~~~kL~  144 (332)
T cd05623          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH----QLHYVHRDIKPDNILMDMNGHIRLA  144 (332)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHEEECCCCCEEEe
Confidence            99999999999765456888889999999999999999    8899999999999999999998875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.93  E-value=2.1e-25  Score=181.99  Aligned_cols=133  Identities=24%  Similarity=0.364  Sum_probs=116.1

Q ss_pred             ecccCCCcceeeeEEe----CCCcEEEEEEeeccc----CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           94 NLISRGGFGSIYKARI----QDGMEVVVKGFNLQY----GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      +.||+|+||.||+++.    .+++.||+|.+....    ......+..|+.+++.++||||+++++.+..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999974    357899999986532    22345567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++++|.+++.... .+.+..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~  142 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH----QQGIIYRDLKPENILLDAQGHVKLT  142 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCCEEEe
Confidence            99999999987643 4677888889999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.93  E-value=3.5e-25  Score=177.28  Aligned_cols=139  Identities=25%  Similarity=0.437  Sum_probs=121.3

Q ss_pred             cceeeecccCCCcceeeeEEe-----CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEec--CCeeEE
Q 042107           89 FLEVFNLISRGGFGSIYKARI-----QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSK--DDFKAL  161 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l  161 (232)
                      .+++.+.||+|+||.||++..     .++..||+|.+........+.+.+|+++++.++||||+++++++..  ....++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   84 (284)
T cd05081           5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL   84 (284)
T ss_pred             cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence            466788999999999999964     2578899999876655556788899999999999999999998754  346889


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||+++++|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        85 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH----~~~i~H~dlkp~nili~~~~~~~l~  150 (284)
T cd05081          85 VMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG----SKRYVHRDLATRNILVESENRVKIG  150 (284)
T ss_pred             EEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCCHhhEEECCCCeEEEC
Confidence            99999999999999765556889999999999999999999    8899999999999999999998875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.93  E-value=2.3e-25  Score=190.64  Aligned_cols=141  Identities=21%  Similarity=0.251  Sum_probs=122.0

Q ss_pred             cccceeeecccCCCcceeeeEEeC-C-CcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-D-GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      ...|.+.+.||+|+||.||+|... + +..||+|.+..........+..|+.+++.++||||+++++++..++..++|||
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E  145 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME  145 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence            344788999999999999999643 4 67888887765554455667889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTS---NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++|+|.+++...   ...+++..+..++.|++.||.|+|    ..+|+||||||+|||++.++.+||+
T Consensus       146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH----~~~ivHrDlkp~NIll~~~~~~kL~  211 (478)
T PTZ00267        146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH----SRKMMHRDLKSANIFLMPTGIIKLG  211 (478)
T ss_pred             CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCEEECCcCHHhEEECCCCcEEEE
Confidence            99999999877532   335788888999999999999999    8899999999999999999999875

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.93  E-value=3.4e-25  Score=180.79  Aligned_cols=136  Identities=22%  Similarity=0.360  Sum_probs=116.8

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHh---cCCCCCCccceeEEEecCCeeEEE
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMM---KIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      |++.+.||+|+||.||+|+.. +++.||+|.+....   ....+.+.+|+.++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            456789999999999999754 68999999997542   22345566666554   567899999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+++++|..++...  .+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+
T Consensus        81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH----~~~ivHrdlkp~Nill~~~~~~kL~  143 (324)
T cd05589          81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH----ENKIVYRDLKLDNLLLDTEGFVKIA  143 (324)
T ss_pred             EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCeEecCCCHHHeEECCCCcEEeC
Confidence            9999999999888653  4889999999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.93  E-value=3e-25  Score=181.49  Aligned_cols=133  Identities=19%  Similarity=0.251  Sum_probs=116.8

Q ss_pred             ecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEEEeccCC
Q 042107           94 NLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      +.||+|+||.||+++.. +++.||+|.+....   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            36899999999999764 68899999997542   23345677899999888 699999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+|.+++... ..+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+
T Consensus        81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nili~~~~~~kL~  138 (329)
T cd05588          81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLH----ERGIIYRDLKLDNVLLDAEGHIKLT  138 (329)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEECCCCCEEEC
Confidence            9999888654 35889999999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.93  E-value=2.7e-26  Score=165.17  Aligned_cols=137  Identities=23%  Similarity=0.368  Sum_probs=122.2

Q ss_pred             ceeeecccCCCcceeeeEE-eCCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           90 LEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      |.-.++||+|.||+||+|+ +.+++.||+|.++..+  .+......+|+.+++.++|.|||+++++...+....+|+|||
T Consensus         4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c   83 (292)
T KOG0662|consen    4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC   83 (292)
T ss_pred             hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence            4456899999999999997 4578999999997653  444567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .. +|..+.......++...+..++.|+++|+.|+|    ++.++|||+||.|.|++.+|+.|++
T Consensus        84 dq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch----shnvlhrdlkpqnllin~ngelkla  143 (292)
T KOG0662|consen   84 DQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH----SHNVLHRDLKPQNLLINRNGELKLA  143 (292)
T ss_pred             hH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh----hhhhhhccCCcceEEeccCCcEEec
Confidence            65 898888877777888999999999999999999    8889999999999999999999986

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.93  E-value=3e-25  Score=180.63  Aligned_cols=133  Identities=22%  Similarity=0.298  Sum_probs=116.7

Q ss_pred             ecccCCCcceeeeEEe----CCCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccC
Q 042107           94 NLISRGGFGSIYKARI----QDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      +.||+|+||.||+++.    .+++.+|+|++.....  .....+..|+++++.++||||+++++++..++..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999864    3578999999975432  233456779999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.++|+
T Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kL~  140 (318)
T cd05582          82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH----SLGIIYRDLKPENILLDEEGHIKLT  140 (318)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHeEECCCCcEEEe
Confidence            999999986543 5889999999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.93  E-value=1.5e-25  Score=186.37  Aligned_cols=139  Identities=24%  Similarity=0.334  Sum_probs=118.1

Q ss_pred             cceeeecccCCCcceeeeEEe------CCCcEEEEEEeeccc-CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeE
Q 042107           89 FLEVFNLISRGGFGSIYKARI------QDGMEVVVKGFNLQY-GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  160 (232)
                      .+++.+.||+|+||.||+|++      .++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...+..+
T Consensus        36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~  115 (375)
T cd05104          36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL  115 (375)
T ss_pred             HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence            466789999999999999963      235689999986442 23346688899999999 8999999999999999999


Q ss_pred             EEEeccCCCChhhhhccCC-------------------------------------------------------------
Q 042107          161 LILEYMPHGSLGKCLSTSN-------------------------------------------------------------  179 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~-------------------------------------------------------------  179 (232)
                      +||||+++|+|.+++....                                                             
T Consensus       116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (375)
T cd05104         116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI  195 (375)
T ss_pred             eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence            9999999999998885421                                                             


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          180 -------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       180 -------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                                   ..+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nill~~~~~~kl~  256 (375)
T cd05104         196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA----SKNCIHRDLAARNILLTHGRITKIC  256 (375)
T ss_pred             ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCchhhEEEECCCcEEEe
Confidence                         13677788899999999999999    8899999999999999999888875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.93  E-value=3e-25  Score=177.05  Aligned_cols=128  Identities=20%  Similarity=0.343  Sum_probs=110.1

Q ss_pred             cccCCCcceeeeEEeCC-------------------------CcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccce
Q 042107           95 LISRGGFGSIYKARIQD-------------------------GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI  149 (232)
Q Consensus        95 ~lg~g~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~  149 (232)
                      .||+|+||.||+|.+..                         ...|++|.+..........+..|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999996421                         13588888865544445677889999999999999999


Q ss_pred             eEEEecCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC
Q 042107          150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM  226 (232)
Q Consensus       150 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~  226 (232)
                      ++++......++||||+++|+|..++......+++..+..++.|+++||.|+|    ..+|+||||||+||+++..+
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~iiH~dlkp~Nill~~~~  154 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE----DKNLVHGNVCAKNILLARLG  154 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----cCCccCCCCCcccEEEeccC
Confidence            99999999999999999999999998765556888999999999999999999    88999999999999998654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.93  E-value=5.4e-25  Score=180.19  Aligned_cols=137  Identities=19%  Similarity=0.268  Sum_probs=119.2

Q ss_pred             ceeeecccCCCcceeeeEEe----CCCcEEEEEEeeccc----CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeE
Q 042107           90 LEVFNLISRGGFGSIYKARI----QDGMEVVVKGFNLQY----GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  160 (232)
                      |++.+.||+|+||.||+++.    .+++.||+|.+....    ....+.+..|+.+++.+ +||+|+++++++..++..+
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            56789999999999999864    357899999986432    22345677899999999 4999999999999999999


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +||||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        82 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivHrDlkp~Nili~~~~~~kl~  147 (332)
T cd05614          82 LILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH----KLGIVYRDIKLENILLDSEGHVVLT  147 (332)
T ss_pred             EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcEecCCCHHHeEECCCCCEEEe
Confidence            9999999999999887543 4788889999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.93  E-value=5.1e-25  Score=173.83  Aligned_cols=137  Identities=25%  Similarity=0.361  Sum_probs=121.5

Q ss_pred             ceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCC
Q 042107           90 LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHG  169 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  169 (232)
                      +++.+.||+|+||.||++++.++..+|+|.+..... ....+..|+++++.++||||+++++++...+..+++|||++++
T Consensus         6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd05059           6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG   84 (256)
T ss_pred             cchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence            457789999999999999887777899998864432 2356778999999999999999999999989999999999999


Q ss_pred             ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          170 SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       170 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|.+++......+++..+..++.|++.|+.|+|    ..+++|||+||+||+++.++.++|+
T Consensus        85 ~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~ni~i~~~~~~kl~  142 (256)
T cd05059          85 CLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE----SNGFIHRDLAARNCLVGEDNVVKVS  142 (256)
T ss_pred             CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCcccccccHhhEEECCCCcEEEC
Confidence            999998765556889999999999999999999    8899999999999999999998886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.93  E-value=4.8e-25  Score=179.73  Aligned_cols=133  Identities=21%  Similarity=0.297  Sum_probs=114.9

Q ss_pred             ecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEEEeccCC
Q 042107           94 NLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      +.||+|+||.||+|+.. +++.||+|.+....   ....+.+..|.+++..+ +||+|+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36899999999999765 57899999987542   23345566788888765 799999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+|..++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.++|+
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDikp~Nill~~~~~~kL~  138 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH----RHGVIYRDLKLDNILLDAEGHCKLA  138 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEEe
Confidence            99998887543 4788888999999999999999    8899999999999999999999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.93  E-value=5.2e-25  Score=180.12  Aligned_cols=133  Identities=21%  Similarity=0.275  Sum_probs=115.6

Q ss_pred             ecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEEEeccCC
Q 042107           94 NLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      +.||+|+||.||+++.. +++.||+|.+....   ....+.+..|+.++..+ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            36899999999999764 68899999997542   23345677788888766 799999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+|..++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dikp~Nili~~~~~~kL~  138 (329)
T cd05618          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLT  138 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEECCCCCEEEe
Confidence            99998886543 5888899999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.93  E-value=8.6e-25  Score=178.97  Aligned_cols=139  Identities=19%  Similarity=0.231  Sum_probs=122.0

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      +.|++.+.||+|+||.||+++.. ++..+|+|.+..... ...+.+.+|+++++.++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            45778899999999999999765 688899998875432 2346788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-CeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH-VIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++++|.+++.... .+++..+..++.|++.||.|||    .. +|+||||||+||+++.++.++|+
T Consensus        85 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~~ivH~dlkp~Nil~~~~~~~kl~  146 (331)
T cd06649          85 MDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR----EKHQIMHRDVKPSNILVNSRGEIKLC  146 (331)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh----hcCCEEcCCCChhhEEEcCCCcEEEc
Confidence            99999999987643 4788888999999999999999    53 69999999999999999999885

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.93  E-value=6.9e-25  Score=172.58  Aligned_cols=134  Identities=24%  Similarity=0.417  Sum_probs=118.4

Q ss_pred             ecccCCCcceeeeEEeC-CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCCh
Q 042107           94 NLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSL  171 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  171 (232)
                      +.||+|+||.||+|+.. +++.+|+|.+.... ......+.+|+++++.++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46899999999999764 78899999875443 23346688899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          172 GKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       172 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .+++......+++..+..++.|++.||.|+|    ..+++||||||+||+++.++.++++
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dl~p~nil~~~~~~~kl~  136 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE----SKHCIHRDLAARNCLVTEKNVLKIS  136 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccchheEEEcCCCcEEEC
Confidence            9999765556889999999999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.93  E-value=6.1e-25  Score=173.67  Aligned_cols=139  Identities=23%  Similarity=0.369  Sum_probs=125.4

Q ss_pred             cceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           89 FLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      .|++.+.||+|+||.||+|...+++.+++|.+..........+..|+.+++.++||||+++++++...+..+++|||+++
T Consensus         7 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   86 (261)
T cd05148           7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEK   86 (261)
T ss_pred             HHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeeccc
Confidence            46678899999999999998877899999998766555567788999999999999999999999999999999999999


Q ss_pred             CChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|.+++... ...+++..+..++.|++.|+.|||    ..+++||||||+||+++.++.++|+
T Consensus        87 ~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~h~dl~~~nilv~~~~~~kl~  146 (261)
T cd05148          87 GSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE----EQNSIHRDLAARNILVGEDLVCKVA  146 (261)
T ss_pred             CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccCcceEEEcCCceEEEc
Confidence            9999999763 345788899999999999999999    8899999999999999999998885

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.93  E-value=7.3e-25  Score=178.85  Aligned_cols=137  Identities=19%  Similarity=0.236  Sum_probs=118.2

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCC-CccceeEEEecCCeeEEEEe
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQ-NLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e  164 (232)
                      |++.+.||+|+||.||+|+.. +++.||+|.+....   ....+.+..|..++..++|+ +|+++++++...+..|+|||
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME   81 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence            567889999999999999765 57899999987542   23456677899999988765 58889999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.++|+
T Consensus        82 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~Nill~~~~~~kL~  143 (324)
T cd05587          82 YVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVMLDAEGHIKIA  143 (324)
T ss_pred             CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEEcCCCCEEEe
Confidence            999999999887543 4788889999999999999999    8899999999999999999998875

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.93  E-value=5.2e-25  Score=181.36  Aligned_cols=137  Identities=23%  Similarity=0.341  Sum_probs=123.1

Q ss_pred             CCcccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCc---hHHHHHHHHHHhcCCC-CCCccceeEEEecCC
Q 042107           83 PRPFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGG---AFKNLDVECNMMKIIR-HQNLIKIISSCSKDD  157 (232)
Q Consensus        83 p~~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  157 (232)
                      +..+...|++.+.||+|.||.||+|+.+ +|+.+|+|.+.+....   ..+.+.+|+.+|+.+. |||||.+++++++..
T Consensus        30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~  109 (382)
T KOG0032|consen   30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD  109 (382)
T ss_pred             cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence            4466778999999999999999999765 5999999999766432   3468899999999998 999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC
Q 042107          158 FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN  225 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~  225 (232)
                      ..++|||+|.||+|.+.+...  .+++..+..++.|++.|+.|+|    ..+++|||+||+|+|+...
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH----~~gvvHrDlKpEN~L~~~~  171 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLH----SLGVVHRDLKPENLLLASK  171 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHH----hCCceeccCCHHHeeeccc
Confidence            999999999999999998776  2899999999999999999999    8899999999999999754

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.93  E-value=6.4e-25  Score=178.94  Aligned_cols=133  Identities=23%  Similarity=0.326  Sum_probs=115.2

Q ss_pred             ecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEEEeccCC
Q 042107           94 NLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      +.||+|+||.||+|+.. +++.||+|.+....   ....+.+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999765 68899999987542   23445566788888766 699999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+|||++.++.++|+
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH----~~~ivH~dlkp~NIli~~~~~~kL~  138 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH----DKGIIYRDLKLDNVLLDHEGHCKLA  138 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHeEECCCCcEEEe
Confidence            99999887643 4888899999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.93  E-value=1e-24  Score=178.72  Aligned_cols=139  Identities=19%  Similarity=0.261  Sum_probs=121.5

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      +.|++.+.||+|+||.||++... ++..+|+|.+..... .....+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            45778899999999999999765 688899998865432 2346688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST-HVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++++|.+++.... .+++.....++.+++.|+.|||    . .+++||||||+||+++.++.+||+
T Consensus        85 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH----~~~~ivH~dlkp~Nili~~~~~~kL~  146 (333)
T cd06650          85 MDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLC  146 (333)
T ss_pred             CCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hcCCEEecCCChhhEEEcCCCCEEEe
Confidence            99999999987643 4788888899999999999999    4 369999999999999999998875

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.93  E-value=7e-25  Score=175.66  Aligned_cols=140  Identities=26%  Similarity=0.497  Sum_probs=121.1

Q ss_pred             ccceeeecccCCCcceeeeEEe-----CCCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecC--Cee
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-----QDGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKD--DFK  159 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~  159 (232)
                      .+|++.+.||+|+||.||+++.     .++..||+|.+.... ....+.+.+|+++++.++|||++++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3567889999999999999973     357889999986543 33346788999999999999999999988775  568


Q ss_pred             EEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          160 ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|||+++++|.+++......+++..+..++.|++.||.|+|    .++++||||||+||+++.++.++|+
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH----~~gi~H~dlkp~Nil~~~~~~~~l~  151 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG----SRQYVHRDLAARNVLVESEHQVKIG  151 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccchheEEEcCCCCEEEC
Confidence            9999999999999998765445889999999999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.93  E-value=9.5e-25  Score=176.98  Aligned_cols=139  Identities=19%  Similarity=0.354  Sum_probs=120.5

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      +.|.+.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+++++.++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            34678899999999999999764 67889999986543 22334567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++ ++.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.++|+
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~ivH~dlkp~Nill~~~~~~kl~  146 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH----RRKVLHRDLKPQNLLINERGELKLA  146 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEC
Confidence            975 888888765556788889999999999999999    8899999999999999999998875

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.93  E-value=3.1e-25  Score=184.42  Aligned_cols=140  Identities=25%  Similarity=0.380  Sum_probs=118.2

Q ss_pred             ccceeeecccCCCcceeeeEEeC------CCcEEEEEEeeccc-CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCee
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ------DGMEVVVKGFNLQY-GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFK  159 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  159 (232)
                      +.|++.+.||+|+||.||+|+..      ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...+..
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            34678899999999999998632      24579999986543 22345678899999999 899999999999999999


Q ss_pred             EEEEeccCCCChhhhhccCC------------------------------------------------------------
Q 042107          160 ALILEYMPHGSLGKCLSTSN------------------------------------------------------------  179 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~~------------------------------------------------------------  179 (232)
                      ++||||+++|+|.+++....                                                            
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            99999999999998875321                                                            


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          180 ---------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       180 ---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                               ..+++..+.+++.|++.||.|||    .++|+||||||+|||+++++.++|+
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH----~~giiHrDLkp~Nil~~~~~~~kL~  254 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA----SKNCIHRDVAARNVLLTDGRVAKIC  254 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHH----HCCEEeccCchheEEEeCCCeEEEe
Confidence                     13667788899999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.93  E-value=8.4e-25  Score=178.58  Aligned_cols=133  Identities=26%  Similarity=0.332  Sum_probs=113.3

Q ss_pred             ecccCCCcceeeeEEe-CCCcEEEEEEeeccc---CchHHHHHHHHH-HhcCCCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           94 NLISRGGFGSIYKARI-QDGMEVVVKGFNLQY---GGAFKNLDVECN-MMKIIRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      +.||+|+||.||+|+. .+++.+|+|++....   ......+..|.. +++.++||||+++++.+..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            3689999999999975 468999999986542   223344455554 57789999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+|..++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH----~~givH~Dlkp~NIll~~~~~~kL~  138 (325)
T cd05604          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH----SINIVYRDLKPENILLDSQGHVVLT  138 (325)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEECCCCCEEEe
Confidence            99998886543 5888899999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.93  E-value=8.3e-25  Score=177.96  Aligned_cols=133  Identities=19%  Similarity=0.355  Sum_probs=114.4

Q ss_pred             ecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcC-CCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           94 NLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKI-IRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      +.||+|+||.||+|+.. +++.||+|.+....   ....+....|..++.. .+||+|+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            36899999999999765 68899999997542   2334556667777765 4899999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+|..++.... .+++..+..++.|++.||+|||    ..+|+||||||+||+++.++.++|+
T Consensus        81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivHrDlkp~Nil~~~~~~~kl~  138 (316)
T cd05620          81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH----SKGIIYRDLKLDNVMLDRDGHIKIA  138 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEECCCCCEEeC
Confidence            99999887643 4788889999999999999999    8899999999999999999998885

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.93  E-value=3.5e-25  Score=175.27  Aligned_cols=136  Identities=32%  Similarity=0.517  Sum_probs=117.4

Q ss_pred             eeecccCCCcceeeeEEeC-----CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           92 VFNLISRGGFGSIYKARIQ-----DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        92 ~~~~lg~g~~g~V~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      +.+.||.|.||.||+|.+.     .+..|+||.+..... ...+.+..|++.++.++||||+++++++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            5678999999999999766     356899999955432 2367889999999999999999999999987889999999


Q ss_pred             cCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|+|.+++... ...+++..+..++.|++.||.|||    ..+++|+||+++||+++.++.+||+
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh----~~~iiH~~l~~~nill~~~~~~Kl~  145 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH----SNNIIHGNLSPSNILLDSNGQVKLS  145 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH----HTTEEEST-SGGGEEEETTTEEEEE
T ss_pred             cccccccccccccccccccccccccccccccccccccc----ccccccccccccccccccccccccc
Confidence            9999999999876 556899999999999999999999    7889999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.93  E-value=1.3e-24  Score=172.38  Aligned_cols=139  Identities=24%  Similarity=0.425  Sum_probs=121.6

Q ss_pred             cceeeecccCCCcceeeeEEeC----CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      .+++.+.||+|+||.||+|++.    +...||+|.+.... ......+..|+.+++.++||||+++++.+...+..+++|
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   84 (266)
T cd05033           5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT   84 (266)
T ss_pred             HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence            3567889999999999999764    24578999886543 233456888999999999999999999999989999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+++++|.+++......+++..+..++.|++.|+.|||    .++|+|||+||+||++++++.++++
T Consensus        85 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh----~~~i~H~di~p~nili~~~~~~~l~  148 (266)
T cd05033          85 EYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS----EMNYVHRDLAARNILVNSNLVCKVS  148 (266)
T ss_pred             EcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEEcCCCCEEEC
Confidence            999999999999776556889999999999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.92  E-value=8.9e-25  Score=177.71  Aligned_cols=137  Identities=21%  Similarity=0.354  Sum_probs=117.9

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCc----EEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGM----EVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      |+..+.||+|+||.||+|++. ++.    .||+|.+.... ....+.+..|+.+++.++||||+++++++... ..++++
T Consensus         9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~   87 (316)
T cd05108           9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   87 (316)
T ss_pred             ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeee
Confidence            567889999999999999753 333    48999886443 23456788899999999999999999998764 567999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+++|+|.+++......+++.....++.|++.||+|||    ..+|+||||||+||+++.++.+||+
T Consensus        88 e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~iiH~dlkp~Nill~~~~~~kl~  151 (316)
T cd05108          88 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----ERRLVHRDLAARNVLVKTPQHVKIT  151 (316)
T ss_pred             ecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH----hcCeeccccchhheEecCCCcEEEc
Confidence            999999999999876556888889999999999999999    8899999999999999999999885

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=6.6e-25  Score=175.34  Aligned_cols=140  Identities=21%  Similarity=0.361  Sum_probs=126.3

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      +.|++.+.||+|+||.||++... ++..+|+|.+........+.+..|+++++.++||||+++++.+..++..++||||+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC   84 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence            44778899999999999999764 68899999987665555677888999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++......+++..+..++.|++.|+.|+|    ..+++|+|+||+||+++.++.++|+
T Consensus        85 ~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~nili~~~~~~~l~  145 (280)
T cd06611          85 DGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH----SHKVIHRDLKAGNILLTLDGDVKLA  145 (280)
T ss_pred             CCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEECCCCCEEEc
Confidence            999999998775556899999999999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.92  E-value=1.1e-24  Score=177.75  Aligned_cols=133  Identities=28%  Similarity=0.348  Sum_probs=113.0

Q ss_pred             ecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHH-HhcCCCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           94 NLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECN-MMKIIRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      +.||+|+||.||+|+.. +++.||+|.+....   ......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36899999999999764 68999999987542   122334444544 56789999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+|..++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~givH~dikp~NIll~~~~~~kl~  138 (323)
T cd05575          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH----SLNIIYRDLKPENILLDSQGHVVLT  138 (323)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCCHHHeEECCCCcEEEe
Confidence            99999887643 5788888999999999999999    8899999999999999999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.92  E-value=1e-24  Score=177.81  Aligned_cols=133  Identities=26%  Similarity=0.313  Sum_probs=112.6

Q ss_pred             ecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHH-HHhcCCCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           94 NLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVEC-NMMKIIRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      +.||+|+||.||+|+.. +++.||+|.+....   ......+..|. .+++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999764 68899999986542   12233444454 467889999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|...+... ..+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus        81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH----~~~ivH~Dlkp~NIll~~~~~~kl~  138 (321)
T cd05603          81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLH----SLNIIYRDLKPENILLDSQGHVVLT  138 (321)
T ss_pred             CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEECCCCCEEEc
Confidence            9999888654 34778888899999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.92  E-value=1e-24  Score=177.47  Aligned_cols=133  Identities=20%  Similarity=0.331  Sum_probs=112.8

Q ss_pred             ecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcC-CCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           94 NLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKI-IRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      +.||+|+||.||+|+.. +++.||+|.+....   ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999764 58899999987542   2233445556666654 4899999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+|..++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH----~~~ivH~dlkp~Nill~~~~~~kL~  138 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH----KKGIIYRDLKLDNVLLDKDGHIKIA  138 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEEeCCCCHHHeEECCCCCEEEc
Confidence            99999887643 4788889999999999999999    8899999999999999999998885

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.92  E-value=8.7e-25  Score=178.62  Aligned_cols=136  Identities=21%  Similarity=0.285  Sum_probs=117.5

Q ss_pred             eeecccCC--CcceeeeEEe-CCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           92 VFNLISRG--GFGSIYKARI-QDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        92 ~~~~lg~g--~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      +.++||+|  +|+.||+++. .+++.||+|.+....  ....+.+..|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  6789999965 478999999986543  223456778999999999999999999999999999999999


Q ss_pred             CCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|+|.+++... ...+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.++++
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~iiH~dlkp~Nil~~~~~~~~l~  143 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH----HMGYVHRSVKASHILISVDGKVYLS  143 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCChhhEEEecCCcEEEc
Confidence            999999998653 334788899999999999999999    8899999999999999998887763

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.92  E-value=9.7e-25  Score=174.60  Aligned_cols=132  Identities=21%  Similarity=0.286  Sum_probs=114.2

Q ss_pred             ccCCCcceeeeEEeC-CCcEEEEEEeecccC---chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCCh
Q 042107           96 ISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG---GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSL  171 (232)
Q Consensus        96 lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  171 (232)
                      ||+|+||.||++... +++.||+|.+.....   ...+.+..|+.+++.++||||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999754 788999999865422   2235567899999999999999999999999999999999999999


Q ss_pred             hhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          172 GKCLST---SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       172 ~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ..++..   ....+++..+..++.|++.||.|+|    ..+|+||||||+||+++.++.++|+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~l~  139 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH----QRRIIYRDLKPENVLLDNDGNVRIS  139 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEe
Confidence            887743   2345888999999999999999999    8899999999999999999988874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=1.7e-24  Score=171.22  Aligned_cols=139  Identities=26%  Similarity=0.403  Sum_probs=123.2

Q ss_pred             ccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccC
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      +.+++.+.||+|++|.||+|...+++.||+|.+..... ..+.+.+|+.+++.++||||+++++++...+..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK   84 (261)
T ss_pred             hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence            34678899999999999999877778899999865432 34678889999999999999999999999999999999999


Q ss_pred             CCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|.+++.... ..+++..+..++.|++.|+.|+|    ..+++||||||+||++++++.++|+
T Consensus        85 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~l~  145 (261)
T cd05068          85 YGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE----AQNYIHRDLAARNVLVGENNICKVA  145 (261)
T ss_pred             CCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCCcceEEEcCCCCEEEC
Confidence            999999987643 45789999999999999999999    8899999999999999999998875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.92  E-value=1.4e-25  Score=183.45  Aligned_cols=140  Identities=24%  Similarity=0.394  Sum_probs=124.4

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCe-eEEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF-KALIL  163 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~lv~  163 (232)
                      +.|...+.+|+|+||.++.++++ ++..+++|.+....  ....+....|+.++++++|||||.+.+.|..++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            46788999999999999999765 67899999997654  2334567889999999999999999999998887 99999


Q ss_pred             eccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +||+||++.+.+.... ..+++.....++.|++.|+.|||    ...|+|||||++||+++.+..++|+
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH----~~~iLHRDlK~~Nifltk~~~VkLg  148 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH----ENRVLHRDLKCANIFLTKDKKVKLG  148 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH----hhhhhcccchhhhhhccccCceeec
Confidence            9999999999998764 56899999999999999999999    8899999999999999999988875

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.92  E-value=1.3e-24  Score=176.74  Aligned_cols=133  Identities=18%  Similarity=0.339  Sum_probs=114.2

Q ss_pred             ecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcC-CCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           94 NLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKI-IRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      +.||+|+||.||+|+.. +++.||+|.+....   ....+....|..++.. .+||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            36899999999999765 57899999997642   2334455667777765 5899999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+|.+++... ..+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH----~~~ivHrdikp~Nil~~~~~~~kl~  138 (316)
T cd05619          81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLH----SKGIVYRDLKLDNILLDTDGHIKIA  138 (316)
T ss_pred             CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH----hCCeEeCCCCHHHEEECCCCCEEEc
Confidence            9999998754 34788889999999999999999    8899999999999999999998875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.92  E-value=1.2e-24  Score=172.47  Aligned_cols=130  Identities=18%  Similarity=0.339  Sum_probs=112.1

Q ss_pred             ecccCCCcceeeeEEeCC-------------CcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeE
Q 042107           94 NLISRGGFGSIYKARIQD-------------GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  160 (232)
                      +.||+|+||.||+|.+.+             ...|++|.+..........+..|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999997532             2358888876655555567888999999999999999999999888899


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCc
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV  227 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~  227 (232)
                      ++|||+++|+|..++......+++..+..++.|+++|++|+|    ..+|+||||||+|||++.++.
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~  143 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE----DKDLVHGNVCTKNILLAREGI  143 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh----hCCeECCCCCcccEEEecCCc
Confidence            999999999999988765556888999999999999999999    889999999999999987654

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.92  E-value=1.9e-24  Score=169.74  Aligned_cols=134  Identities=25%  Similarity=0.424  Sum_probs=118.7

Q ss_pred             ecccCCCcceeeeEEeCCCcEEEEEEeecccCc-hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCChh
Q 042107           94 NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLG  172 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  172 (232)
                      +.||+|+||.||+|...++..+|+|.+...... ....+.+|+++++.++||||+++++.+...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            368999999999998878889999988654322 2346788999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          173 KCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       173 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++......+++..+..++.+++.|+.|+|    .++++|||+||+||+++.++.++++
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~~~H~dl~p~nili~~~~~~~l~  135 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE----SKNCIHRDLAARNCLVGENNVLKIS  135 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccChheEEEcCCCeEEEC
Confidence            998765555788999999999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.92  E-value=1e-24  Score=174.82  Aligned_cols=138  Identities=19%  Similarity=0.292  Sum_probs=119.1

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      .|++.+.||+|+||.||+|+.. +++.||+|++....  ....+.+.+|+++++.++||||+++++++..++..++||||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY   81 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence            3678899999999999999865 68889999986542  23346678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++.+..+... ...+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+
T Consensus        82 ~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dlkp~Nill~~~~~~kl~  142 (287)
T cd07848          82 VEKNMLELLEEM-PNGVPPEKVRSYIYQLIKAIHWCH----KNDIVHRDIKPENLLISHNDVLKLC  142 (287)
T ss_pred             CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCcEEEe
Confidence            998777655433 345888889999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.92  E-value=1.7e-24  Score=174.06  Aligned_cols=140  Identities=24%  Similarity=0.351  Sum_probs=125.8

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      +.|++.+.||+|+||.||+|+.. ++..+++|.+........+.+..|+.+++.++||||+++++.+..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56788899999999999999765 58899999987666556677888999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++++..++......+++..+..++.|++.|+.|+|    ..+++|||+||+||+++.++.++|+
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~kl~  152 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH----SMKIIHRDLKAGNVLLTLDGDIKLA  152 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh----cCCeeecCCCcceEEEcCCCCEEEc
Confidence            999998887655456889999999999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.92  E-value=9.7e-25  Score=180.16  Aligned_cols=135  Identities=24%  Similarity=0.315  Sum_probs=116.4

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      +.++..+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+++++.++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            34567789999999999999754 689999999865432 2346688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|+|....     ..++.....++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~kL~  210 (353)
T PLN00034        154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLH----RRHIVHRDIKPSNLLINSAKNVKIA  210 (353)
T ss_pred             CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCCCCEEEc
Confidence            9999986532     2456677889999999999999    8899999999999999999999885

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.92  E-value=1.9e-24  Score=171.60  Aligned_cols=139  Identities=24%  Similarity=0.428  Sum_probs=120.3

Q ss_pred             cceeeecccCCCcceeeeEEeC-C---CcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-D---GMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      .|++.+.||+|+||.||+|+.. +   +..+|+|.+.... ....+.+..|+.+++.++||||+++++++..++..+++|
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (267)
T cd05066           5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT   84 (267)
T ss_pred             HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence            3567889999999999999753 2   3378999886443 223467888999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+++++|.+++......+++..+..++.|++.|+.|+|    ..+++|||+||+||+++.++.++++
T Consensus        85 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~h~dlkp~nili~~~~~~~l~  148 (267)
T cd05066          85 EYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS----DMGYVHRDLAARNILVNSNLVCKVS  148 (267)
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeehhhchhcEEECCCCeEEeC
Confidence            999999999999876556888899999999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=6.3e-25  Score=184.94  Aligned_cols=138  Identities=21%  Similarity=0.338  Sum_probs=120.9

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  162 (232)
                      +.+.+.++||+|.||+|+++..+ +++.+|||.+++..   .++.+....|..++.-. +||.++.++.+|.+.+++|.|
T Consensus       368 ~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fv  447 (694)
T KOG0694|consen  368 DDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFV  447 (694)
T ss_pred             cceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEE
Confidence            45678899999999999999765 68899999997763   45567777788877766 599999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+.|||+..+.+.  ..+++..+..++..++.||.|||    .++||+||||.+|||+|.+|.+|||
T Consensus       448 mey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH----~~~IIYRDlKLdNiLLD~eGh~kiA  510 (694)
T KOG0694|consen  448 MEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLH----ENGIIYRDLKLDNLLLDTEGHVKIA  510 (694)
T ss_pred             EEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHH----hcCceeeecchhheEEcccCcEEec
Confidence            999999996555543  35899999999999999999999    8999999999999999999999996

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.92  E-value=1.7e-24  Score=171.13  Aligned_cols=139  Identities=22%  Similarity=0.400  Sum_probs=122.5

Q ss_pred             ccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccC
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      +.+++.++||+|+||.||+|...++..||+|.+.... ...+.+..|+.+++.++||||+++++.+...+..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   84 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA   84 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence            4567889999999999999988788889999876433 235678889999999999999999999999999999999999


Q ss_pred             CCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|.+++... ...+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH----~~~i~H~dl~p~nili~~~~~~~l~  145 (261)
T cd05072          85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE----RKNYIHRDLRAANVLVSESLMCKIA  145 (261)
T ss_pred             CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhhEEecCCCcEEEC
Confidence            99999998653 345788888999999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=1.5e-24  Score=173.99  Aligned_cols=138  Identities=20%  Similarity=0.274  Sum_probs=119.3

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC---chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG---GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      |++.+.||+|+||.||++... +++.||+|.+.....   .....+.+|+.+++.++||||+++++.+..++..++||||
T Consensus         2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05605           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence            567889999999999999754 688999999865421   2224466799999999999999999999999999999999


Q ss_pred             cCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|+|.+++... ...+++..+..++.|++.|+.|+|    ..+++||||||+||++++++.++|+
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~~l~  144 (285)
T cd05605          82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH----RERIVYRDLKPENILLDDYGHIRIS  144 (285)
T ss_pred             cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH----HCCcEecCCCHHHEEECCCCCEEEe
Confidence            9999999887543 235888899999999999999999    8899999999999999999988874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.92  E-value=1.9e-24  Score=176.45  Aligned_cols=133  Identities=26%  Similarity=0.300  Sum_probs=111.4

Q ss_pred             ecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHH-HHhcCCCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           94 NLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVEC-NMMKIIRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      +.||+|+||.||+|+.. +++.||+|.+....   ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36899999999999765 67889999987542   12223334443 456788999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.++|+
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH----~~giiHrDlkp~Nili~~~~~~kl~  138 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH----SLNIVYRDLKPENILLDSQGHIVLT  138 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCHHHeEECCCCCEEEc
Confidence            99999987643 4677788889999999999999    8899999999999999999998875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.92  E-value=1.2e-24  Score=182.05  Aligned_cols=140  Identities=24%  Similarity=0.342  Sum_probs=117.5

Q ss_pred             ccceeeecccCCCcceeeeEEeC------CCcEEEEEEeecccC-chHHHHHHHHHHhcCCC-CCCccceeEEEecCCee
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ------DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIR-HQNLIKIISSCSKDDFK  159 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~  159 (232)
                      +.+.+.+.||+|+||.||+|...      .+..||+|.+..... ...+.+.+|+++++.+. ||||+++++++...+..
T Consensus        37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~  116 (400)
T cd05105          37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI  116 (400)
T ss_pred             cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence            44668899999999999999642      234799999865432 23467888999999996 99999999999999999


Q ss_pred             EEEEeccCCCChhhhhccCC------------------------------------------------------------
Q 042107          160 ALILEYMPHGSLGKCLSTSN------------------------------------------------------------  179 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~~------------------------------------------------------------  179 (232)
                      ++|||||++|+|.+++....                                                            
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (400)
T cd05105         117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE  196 (400)
T ss_pred             EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence            99999999999998875321                                                            


Q ss_pred             -----------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC
Q 042107          180 -----------------------------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD  224 (232)
Q Consensus       180 -----------------------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~  224 (232)
                                                         ..+++..+..++.|++.||.|||    ..+++||||||+||+++.
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivH~dikp~Nill~~  272 (400)
T cd05105         197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA----SKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChHhEEEeC
Confidence                                               13567777889999999999999    889999999999999999


Q ss_pred             CCceeec
Q 042107          225 NMVAHFL  231 (232)
Q Consensus       225 ~~~~~l~  231 (232)
                      ++.+||+
T Consensus       273 ~~~~kL~  279 (400)
T cd05105         273 GKIVKIC  279 (400)
T ss_pred             CCEEEEE
Confidence            9988875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.92  E-value=1.6e-24  Score=177.16  Aligned_cols=133  Identities=20%  Similarity=0.265  Sum_probs=116.2

Q ss_pred             ecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEEEeccCC
Q 042107           94 NLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      +.||+|+||.||+|+.. +++.||+|.+....   ....+.+..|+.++..+ +||+|+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            36899999999999764 67899999997542   23445677899888887 699999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+|..++.... .+++..+..++.|++.||.|||    ..+++||||||+|||++.++.+||+
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nili~~~~~~kl~  138 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH----ERGIIYRDLKLDNVLLDADGHIKLT  138 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEEeCCCCEEEe
Confidence            99998886543 5889999999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.92  E-value=1.8e-24  Score=173.06  Aligned_cols=140  Identities=22%  Similarity=0.364  Sum_probs=123.8

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      ++|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++|||++++++.+..++..++||||+
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            34677889999999999999765 57788999886655455677888999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|..++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH----~~~i~H~dlkp~nili~~~~~~kl~  145 (282)
T cd06643          85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH----ENKIIHRDLKAGNILFTLDGDIKLA  145 (282)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCcccEEEccCCCEEEc
Confidence            999999887654456889999999999999999999    8899999999999999999998876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.92  E-value=1.9e-24  Score=175.94  Aligned_cols=133  Identities=22%  Similarity=0.295  Sum_probs=116.0

Q ss_pred             ecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEEEeccCC
Q 042107           94 NLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      +.||+|+||.||+++.. +++.||+|.+....   ......+..|..+++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36899999999999765 57899999997542   23345567788888877 699999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+|..++.... .+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nill~~~~~~kl~  138 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH----ERGIIYRDLKLDNVLLDSEGHIKIA  138 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEccCCCHHHeEECCCCcEEec
Confidence            99998887643 5889999999999999999999    8899999999999999999998885

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.92  E-value=2.6e-24  Score=170.68  Aligned_cols=140  Identities=26%  Similarity=0.373  Sum_probs=124.0

Q ss_pred             cccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      .+.|++.+.||+|+||.||+|+. .+++.||+|.+..........+.+|+.+++.++||||+++++.+..++..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            34577889999999999999975 46889999998765555556788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++++|.+++.... .+++..+..++.|++.|+.|+|    ..+|+|||+||+||+++.++.++|+
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nill~~~~~~~l~  148 (267)
T cd06646          88 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH----SKGKMHRDIKGANILLTDNGDVKLA  148 (267)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEECCCCCEEEC
Confidence            99999999886543 5788889999999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.92  E-value=1.9e-24  Score=176.32  Aligned_cols=137  Identities=19%  Similarity=0.235  Sum_probs=117.4

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCC-CCCccceeEEEecCCeeEEEEe
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIR-HQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      ++..+.||+|+||.||+|+.. +++.||+|.+....   ....+.+..|..+++.+. |++|+++++++...+..|+|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            356788999999999999754 68899999987542   233455677888888876 5778889999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.++|+
T Consensus        82 y~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH----~~~ivHrDikp~Nill~~~~~ikL~  143 (323)
T cd05615          82 YVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH----RRGIIYRDLKLDNVMLDSEGHIKIA  143 (323)
T ss_pred             CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEEe
Confidence            999999999887643 4888999999999999999999    8899999999999999999998875

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.92  E-value=2.7e-24  Score=170.86  Aligned_cols=138  Identities=23%  Similarity=0.439  Sum_probs=120.7

Q ss_pred             ceeeecccCCCcceeeeEEeC-CC---cEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DG---MEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      +++.+.||+|+||.||+|... ++   ..||+|.+.... ....+.+..|+.+++.++||||+++++++..++..+++||
T Consensus         6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   85 (269)
T cd05065           6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE   85 (269)
T ss_pred             eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence            567899999999999999754 33   369999886542 3345678899999999999999999999999899999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++++|.+++......+++..+..++.|++.|+.|+|    ..+++||||||+||+++.++.++++
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH----~~g~~H~dl~p~nili~~~~~~kl~  148 (269)
T cd05065          86 FMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS----EMNYVHRDLAARNILVNSNLVCKVS  148 (269)
T ss_pred             cCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccChheEEEcCCCcEEEC
Confidence            99999999999765556888999999999999999999    8899999999999999999888874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.92  E-value=2.7e-24  Score=175.42  Aligned_cols=137  Identities=19%  Similarity=0.241  Sum_probs=116.9

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEEEe
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      |++.+.||+|+||.||+|+.. +++.||+|.+....   ....+.+..|..++..+ +|++|+++++++...+..++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME   81 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence            467789999999999999765 57899999987542   22334456677777766 58999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        82 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~kL~  143 (323)
T cd05616          82 YVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVMLDSEGHIKIA  143 (323)
T ss_pred             CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEEecCCCHHHeEECCCCcEEEc
Confidence            999999998886543 4788899999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.92  E-value=1.9e-24  Score=177.17  Aligned_cols=136  Identities=19%  Similarity=0.342  Sum_probs=116.2

Q ss_pred             ceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecC-----CeeEE
Q 042107           90 LEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKD-----DFKAL  161 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~l  161 (232)
                      |++.+.||+|+||.||+|+. .+++.||+|.+....  ......+.+|+.+++.++||||+++++++...     ...|+
T Consensus         2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l   81 (338)
T cd07859           2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV   81 (338)
T ss_pred             eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence            56789999999999999975 468999999986432  23345678899999999999999999987543     24799


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||++ ++|.+++.... .+++..+..++.|+++||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        82 v~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIll~~~~~~kL~  145 (338)
T cd07859          82 VFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH----TANVFHRDLKPKNILANADCKLKIC  145 (338)
T ss_pred             EEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCcEEEc
Confidence            999995 68998887543 4888999999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.92  E-value=2.3e-24  Score=173.02  Aligned_cols=140  Identities=27%  Similarity=0.460  Sum_probs=121.3

Q ss_pred             ccceeeecccCCCcceeeeEEe------CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARI------QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      +.+.+.+.||+|+||.||++..      .++..+|+|.+........+.+.+|+++++.++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            3456788999999999999963      2345689998876554556778899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCC------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCcee
Q 042107          162 ILEYMPHGSLGKCLSTSN------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAH  229 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~  229 (232)
                      +|||+++++|.+++....            ..+++..+..++.|++.||.|+|    ..+++||||||+||++++++.++
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH----~~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA----SQHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccCcceEEEccCCcEE
Confidence            999999999999886432            24788999999999999999999    88999999999999999999988


Q ss_pred             ec
Q 042107          230 FL  231 (232)
Q Consensus       230 l~  231 (232)
                      |+
T Consensus       161 l~  162 (288)
T cd05093         161 IG  162 (288)
T ss_pred             ec
Confidence            75

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.92  E-value=2.5e-24  Score=171.51  Aligned_cols=139  Identities=22%  Similarity=0.381  Sum_probs=120.7

Q ss_pred             cceeeecccCCCcceeeeEEeC------CCcEEEEEEeecccCc-hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ------DGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      .++..+.||+|+||.||+|+..      +.+.+++|.+...... ..+.+.+|+++++.++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   85 (275)
T cd05046           6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYM   85 (275)
T ss_pred             hceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceE
Confidence            3567788999999999999753      2467899988655433 45778999999999999999999999998889999


Q ss_pred             EEeccCCCChhhhhccCC--------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSN--------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||+++|+|.+++....        ..+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++++
T Consensus        86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH----~~~i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          86 ILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS----NARFVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             EEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh----hcCcccCcCccceEEEeCCCcEEEc
Confidence            999999999999987543        14789999999999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.92  E-value=3.9e-24  Score=172.71  Aligned_cols=138  Identities=19%  Similarity=0.351  Sum_probs=120.8

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      .|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~   86 (301)
T cd07873           7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL   86 (301)
T ss_pred             ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence            4678899999999999999764 68899999986543 223355678999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      + ++|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        87 ~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~  146 (301)
T cd07873          87 D-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH----RRKVLHRDLKPQNLLINERGELKLA  146 (301)
T ss_pred             c-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHHHEEECCCCcEEEC
Confidence            7 5898888765556888889999999999999999    8899999999999999999998885

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.92  E-value=3.8e-24  Score=171.25  Aligned_cols=138  Identities=23%  Similarity=0.456  Sum_probs=118.2

Q ss_pred             ceeeecccCCCcceeeeEEe-----CCCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           90 LEVFNLISRGGFGSIYKARI-----QDGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      +++.+.||+|+||.||+|..     .++..+++|.+.... ......+.+|+++++.++||||+++++++..++..|++|
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   86 (283)
T cd05090           7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF   86 (283)
T ss_pred             ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence            56778999999999999963     246789999986433 233467888999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccC----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCc
Q 042107          164 EYMPHGSLGKCLSTS----------------NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV  227 (232)
Q Consensus       164 e~~~~g~L~~~l~~~----------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~  227 (232)
                      ||+++++|.+++...                ...+++.....++.|++.||.|+|    .++++||||||+||++++++.
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~nili~~~~~  162 (283)
T cd05090          87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS----SHFFVHKDLAARNILIGEQLH  162 (283)
T ss_pred             EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hcCeehhccccceEEEcCCCc
Confidence            999999999988522                123677888899999999999999    889999999999999999999


Q ss_pred             eeec
Q 042107          228 AHFL  231 (232)
Q Consensus       228 ~~l~  231 (232)
                      +|++
T Consensus       163 ~kl~  166 (283)
T cd05090         163 VKIS  166 (283)
T ss_pred             EEec
Confidence            8885

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.92  E-value=2.4e-24  Score=169.91  Aligned_cols=127  Identities=22%  Similarity=0.392  Sum_probs=109.5

Q ss_pred             ecccCCCcceeeeEEeCC-C----------cEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           94 NLISRGGFGSIYKARIQD-G----------MEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      +.||+|+||.||+|...+ +          ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            468999999999997653 3          25777776544332 5778889999999999999999999887 778999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM  226 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~  226 (232)
                      |||+++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dlkp~Nill~~~~  138 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE----DKKLVHGNVCGKNILVARYG  138 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh----hCCeecccCccceEEEecCc
Confidence            9999999999999865546888899999999999999999    88999999999999999887

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.92  E-value=3.8e-26  Score=176.31  Aligned_cols=136  Identities=21%  Similarity=0.359  Sum_probs=124.6

Q ss_pred             ceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           90 LEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      +.++++||+|+||.||++-+ .+|..+|+|.+...  .+.+++..|+.+|+.++.|++|++||.|.....+|+|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            45788999999999999954 57999999998764  4678899999999999999999999998888889999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+..++++.+...+.+.....+++..++||+|||    ...-+|||||+.|||++.+|.+|++
T Consensus       113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH----~~~KIHRDIKAGNILLNT~G~AKLA  171 (502)
T KOG0574|consen  113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH----DLKKIHRDIKAGNILLNTDGIAKLA  171 (502)
T ss_pred             CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH----HHHHHHhhcccccEEEcccchhhhh
Confidence            9999999988888999999999999999999999    7678999999999999999999986

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.92  E-value=4.5e-24  Score=172.99  Aligned_cols=138  Identities=20%  Similarity=0.226  Sum_probs=120.2

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      .|++.+.||+|+||.||+++.. ++..+|+|.+..... .....+.+|+++++.++||||+++++++..++..+++|||+
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~   81 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM   81 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence            3678899999999999999754 678889998865422 23456788999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST-HVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++... ..+++..+..++.|++.||.|||    . .+++|||+||+||+++.++.++|+
T Consensus        82 ~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH----~~~~i~H~dl~p~nil~~~~~~~~l~  142 (308)
T cd06615          82 DGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLC  142 (308)
T ss_pred             CCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----hhCCEEECCCChHHEEEecCCcEEEc
Confidence            999999999765 34788889999999999999999    5 479999999999999999988875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>PHA02988 hypothetical protein; Provisional

Probab=99.92  E-value=3e-24  Score=172.12  Aligned_cols=132  Identities=25%  Similarity=0.308  Sum_probs=114.9

Q ss_pred             ecccCCCcceeeeEEeCCCcEEEEEEeecccCch---HHHHHHHHHHhcCCCCCCccceeEEEec----CCeeEEEEecc
Q 042107           94 NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGA---FKNLDVECNMMKIIRHQNLIKIISSCSK----DDFKALILEYM  166 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~  166 (232)
                      ..+|+|++|.||+|.+ +|+.||+|.+.......   .+.+.+|+.++++++||||+++++++.+    ....+++|||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            4689999999999987 58899999986543322   4677899999999999999999999866    34788999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST-HVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|+|.+++.... .+++.....++.+++.|+.|+|    . .+++||||||+||+++.++.+||+
T Consensus       105 ~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH----~~~~~~Hrdlkp~nill~~~~~~kl~  165 (283)
T PHA02988        105 TRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY----KYTNKPYKNLTSVSFLVTENYKLKII  165 (283)
T ss_pred             CCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHH----hcCCCCCCcCChhhEEECCCCcEEEc
Confidence            9999999997653 5788889999999999999999    5 378899999999999999999985

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=5.6e-25  Score=173.06  Aligned_cols=136  Identities=22%  Similarity=0.333  Sum_probs=118.3

Q ss_pred             ceeeecccCCCcceeeeEEe-CCCcEEEEEEee--cccCchHHHHHHHHHHhcCCCCCCccceeEEEec-----CCeeEE
Q 042107           90 LEVFNLISRGGFGSIYKARI-QDGMEVVVKGFN--LQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSK-----DDFKAL  161 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~~~l  161 (232)
                      |...+.||+|+||.|..+.. .+|+.||+|++.  -...-..++..+|+.+++.++|+||+.+.+.+..     -+.+|+
T Consensus        24 y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYi  103 (359)
T KOG0660|consen   24 YVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYL  103 (359)
T ss_pred             ecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEE
Confidence            33468899999999999964 579999999997  3344556888999999999999999999998876     247899


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+|+|+ .||.+.++..+ .++...+..++.|+++||.|+|    +.+|+|||+||+|++++.+...|||
T Consensus       104 V~elMe-tDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiH----SAnViHRDLKPsNll~n~~c~lKI~  167 (359)
T KOG0660|consen  104 VFELME-TDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIH----SANVIHRDLKPSNLLLNADCDLKIC  167 (359)
T ss_pred             ehhHHh-hHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhh----cccccccccchhheeeccCCCEEec
Confidence            999994 49999998754 4888899999999999999999    8899999999999999999999986

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.92  E-value=5.5e-24  Score=170.00  Aligned_cols=132  Identities=19%  Similarity=0.309  Sum_probs=113.3

Q ss_pred             ccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCCh
Q 042107           96 ISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSL  171 (232)
Q Consensus        96 lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  171 (232)
                      ||+|+||.||+++.. +++.||+|.+....   ....+.+..|+++++.++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999754 68999999986432   11234456699999999999999999999999999999999999999


Q ss_pred             hhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          172 GKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       172 ~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .+++... ...+++..+..++.|++.||.|+|    ..+++||||||+||+++.++.++|+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dikp~Nili~~~~~~~l~  137 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH----SMDIVYRDMKPENVLLDDQGNCRLS  137 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----HCCEEEccCChHhEEEcCCCCEEEe
Confidence            8887543 234788888899999999999999    8899999999999999999988875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=9.1e-24  Score=166.89  Aligned_cols=140  Identities=28%  Similarity=0.397  Sum_probs=126.3

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      +.|++.+.+|+|+||.||+|... +++.+++|.+........+.+.+|+++++.++||||+++++.+...+..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            45778899999999999999764 57889999998766556788899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++......+++..+..++.|++.|+.|||    ..+++|+||||+||+++.++.++|+
T Consensus        83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~ni~i~~~~~~~l~  143 (262)
T cd06613          83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH----ETGKIHRDIKGANILLTEDGDVKLA  143 (262)
T ss_pred             CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH----hCCceecCCChhhEEECCCCCEEEC
Confidence            999999998765456888999999999999999999    8899999999999999999988876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.92  E-value=1.3e-26  Score=174.02  Aligned_cols=136  Identities=22%  Similarity=0.410  Sum_probs=118.3

Q ss_pred             cccccceeeecccCCCcceeeeEE-eCCCcEEEEEEeecc--cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQ--YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      .|.+.|++.+.||+|.|+.||++. ..+|+.+|+|.+...  .....+.+.+|+.+.+.++|||||++.+.+....+.|+
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            467788899999999999999994 567999999988654  23467889999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN  225 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~  225 (232)
                      |+|+|.|++|..-+-.+ ...++..+-..++||++||.|+|    .++|+|||+||+|+++...
T Consensus        88 vFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH----~n~IvHRDvkP~nllLASK  146 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH----SNGIVHRDLKPENLLLASK  146 (355)
T ss_pred             EEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH----hcCceeccCChhheeeeec
Confidence            99999999997655433 34677788899999999999999    8899999999999999654

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.92  E-value=7.5e-25  Score=173.10  Aligned_cols=131  Identities=21%  Similarity=0.330  Sum_probs=113.6

Q ss_pred             ecccCCCcceeeeEEeCC--------CcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           94 NLISRGGFGSIYKARIQD--------GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      +.||+|+||.||+|....        ...+++|.+........+.+..|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            468999999999996532        234888887655545556788899999999999999999999998899999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCce
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA  228 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~  228 (232)
                      +++|+|.+++......+++..+..++.|++.|+.|||    ..+|+||||||+||+++.++..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~iiH~dlkp~nili~~~~~~  139 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE----DKGLTHGNVCAKNVLLIREEDR  139 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCccceEEEeccccc
Confidence            9999999999876556888999999999999999999    8899999999999999887654

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.92  E-value=3.6e-25  Score=186.96  Aligned_cols=130  Identities=30%  Similarity=0.459  Sum_probs=112.4

Q ss_pred             ceeeecccCCCcceeeeEE-eCCCcEEEEEEeecc-cCchHHHHHHHHHHhcCCCCCCccceeEEEecCC------eeEE
Q 042107           90 LEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQ-YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD------FKAL  161 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~l  161 (232)
                      ....+.||+|+||.||+|+ ..+|+.||||.+... .....+...+|++++++++|||||+++++-++..      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            3456889999999999998 557999999998653 3445677889999999999999999998765543      4579


Q ss_pred             EEeccCCCChhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeC
Q 042107          162 ILEYMPHGSLGKCLSTS--NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD  223 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~  223 (232)
                      +||||++|||...+...  ...+++.+.+.+..+++.||.|||    .++|+||||||.||++-
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr----En~IvHRDlKP~NIvl~  154 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR----ENGIVHRDLKPGNIVLQ  154 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH----HcCceeccCCCCcEEEe
Confidence            99999999999999864  345999999999999999999999    88999999999999974

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.92  E-value=4.9e-24  Score=168.46  Aligned_cols=132  Identities=22%  Similarity=0.374  Sum_probs=114.0

Q ss_pred             cccCCCcceeeeEEeC---CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCC
Q 042107           95 LISRGGFGSIYKARIQ---DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGS  170 (232)
Q Consensus        95 ~lg~g~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  170 (232)
                      .||+|+||.||+|.++   ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.. +..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999653   355799998865532 234668899999999999999999998754 56789999999999


Q ss_pred             hhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          171 LGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       171 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |.+++......+++..+..++.|++.|+.|+|    ..+++||||||+||+++.++.+|++
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nil~~~~~~~kl~  137 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE----GKNFVHRDLAARNVLLVNQHYAKIS  137 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hcCeeecccchheEEEcCCCcEEec
Confidence            99999765556899999999999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.92  E-value=3.5e-24  Score=178.95  Aligned_cols=132  Identities=21%  Similarity=0.302  Sum_probs=116.3

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      ..|++.+.||+|+||.||+|.. .+++.||+|...      .+.+.+|+++++.++||||+++++++......+++||++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            4588999999999999999975 468899999643      234678999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      . ++|..++.... .+++..++.++.|++.||.|+|    ..+|+||||||+|||++.++.+||+
T Consensus       166 ~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH----~~~IvHrDiKP~NIll~~~~~vkL~  224 (391)
T PHA03212        166 K-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH----ENRIIHRDIKAENIFINHPGDVCLG  224 (391)
T ss_pred             C-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHhEEEcCCCCEEEE
Confidence            5 68888876543 4788889999999999999999    8899999999999999999998875

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.92  E-value=2.7e-24  Score=173.23  Aligned_cols=140  Identities=24%  Similarity=0.392  Sum_probs=118.2

Q ss_pred             ccceeeecccCCCcceeeeEEeCC---------------CcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQD---------------GMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIIS  151 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~  151 (232)
                      +.|++.+.||+|+||.||+|+...               ...||+|.+.... ......+.+|+++++.++|||++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            346788999999999999986432               2358999886542 223456888999999999999999999


Q ss_pred             EEecCCeeEEEEeccCCCChhhhhccCC-----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCce
Q 042107          152 SCSKDDFKALILEYMPHGSLGKCLSTSN-----------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNV  220 (232)
Q Consensus       152 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Ni  220 (232)
                      ++...+..++||||+++++|.+++....           ..+++..+..++.|++.|+.|||    ..+++||||||+||
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~Ni  160 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA----SLNFVHRDLATRNC  160 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH----hcCeeccccChhhE
Confidence            9999999999999999999999885431           13577888999999999999999    88999999999999


Q ss_pred             eeCCCCceeec
Q 042107          221 LLDDNMVAHFL  231 (232)
Q Consensus       221 ll~~~~~~~l~  231 (232)
                      +++.++.+|++
T Consensus       161 ll~~~~~~kl~  171 (295)
T cd05097         161 LVGNHYTIKIA  171 (295)
T ss_pred             EEcCCCcEEec
Confidence            99999988875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.92  E-value=4.7e-24  Score=188.79  Aligned_cols=139  Identities=24%  Similarity=0.355  Sum_probs=122.2

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      +.|.+.+.||+|+||.||+|+.. +++.||+|++....   ......+..|+.+++.++||||+++++++...+..|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            45678899999999999999765 68899999986543   223466788999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+++++|.+++.... .+++..++.++.|++.||.|||    ..+|+||||||+|||++.++.++|+
T Consensus        84 Ey~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH----~~gIiHrDLKP~NILl~~~g~vkL~  146 (669)
T cd05610          84 EYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH----RHGIIHRDLKPDNMLISNEGHIKLT  146 (669)
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCccHHHEEEcCCCCEEEE
Confidence            9999999999987543 4788889999999999999999    7899999999999999999998875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=5.2e-24  Score=167.94  Aligned_cols=137  Identities=28%  Similarity=0.458  Sum_probs=122.1

Q ss_pred             cceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           89 FLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      .+++.+.||+|+||.||+|... ++.||+|.+..... ..+.+..|+.+++.++|+||+++++++...+..+++|||+++
T Consensus         7 ~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~   84 (256)
T cd05039           7 ELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK   84 (256)
T ss_pred             hccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence            3567889999999999999765 78899999875543 457788899999999999999999999988899999999999


Q ss_pred             CChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|.+++.... ..+++..+..++.|++.|+.|+|    ..+++||||||+||+++.++.++|+
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh----~~~i~H~di~p~Nili~~~~~~~l~  144 (256)
T cd05039          85 GSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE----EKNFVHRDLAARNVLVSEDLVAKVS  144 (256)
T ss_pred             CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCccchhcccceEEEeCCCCEEEc
Confidence            99999987643 25889999999999999999999    8899999999999999999998875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.92  E-value=4.2e-24  Score=169.75  Aligned_cols=133  Identities=23%  Similarity=0.292  Sum_probs=111.9

Q ss_pred             cccCCCcceeeeEEeCC---CcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCC
Q 042107           95 LISRGGFGSIYKARIQD---GMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGS  170 (232)
Q Consensus        95 ~lg~g~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  170 (232)
                      .||+|+||.||+|...+   ...+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999996432   4467888765432 2234567789999999999999999999999999999999999999


Q ss_pred             hhhhhccCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          171 LGKCLSTSN----YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       171 L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |.+++....    ...++.....++.|++.|+.|+|    ..+|+||||||+||+++.++.+||+
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nill~~~~~~kl~  142 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH----QADFIHSDLALRNCQLTADLSVKIG  142 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH----hcCEecccccHhheEecCCCcEEEe
Confidence            999987542    12456677899999999999999    8899999999999999999999886

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.92  E-value=8.3e-24  Score=167.57  Aligned_cols=137  Identities=24%  Similarity=0.407  Sum_probs=120.7

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      +.+.+.||+|+||.||+|... +++.||+|.+... ....+.+.+|+++++.++||||+++++++..++..+++|||+++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (263)
T cd05052           8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY   86 (263)
T ss_pred             eEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence            557788999999999999754 5889999988643 33456788899999999999999999999999999999999999


Q ss_pred             CChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|.+++... ...+++..+..++.|+++||.|+|    ..+++||||||+||++++++.++|+
T Consensus        87 ~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~nil~~~~~~~kl~  146 (263)
T cd05052          87 GNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHLVKVA  146 (263)
T ss_pred             CcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccCcceEEEcCCCcEEeC
Confidence            9999998654 335788889999999999999999    8899999999999999999998875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.8e-24  Score=192.03  Aligned_cols=146  Identities=27%  Similarity=0.471  Sum_probs=127.8

Q ss_pred             CCCcccccceeeecccCCCcceeeeEEeCC--Cc----EEEEEEeecc-cCchHHHHHHHHHHhcCCCCCCccceeEEEe
Q 042107           82 IPRPFRNFLEVFNLISRGGFGSIYKARIQD--GM----EVVVKGFNLQ-YGGAFKNLDVECNMMKIIRHQNLIKIISSCS  154 (232)
Q Consensus        82 ~p~~~~~~~~~~~~lg~g~~g~V~~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  154 (232)
                      +|..-....+..+.||+|+||.||.|...+  +.    .||+|.+... +.+....|.+|..+|++++|||||+++|++.
T Consensus       686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l  765 (1025)
T KOG1095|consen  686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL  765 (1025)
T ss_pred             cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence            444445566788999999999999997543  33    4889988654 4556788999999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCce
Q 042107          155 KDDFKALILEYMPHGSLGKCLSTS------NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA  228 (232)
Q Consensus       155 ~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~  228 (232)
                      +....++++|||++|||..+|++.      ...+.....+.++.+||+|+.||+    ++++|||||.++|+|+++...|
T Consensus       766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe----~~~fvHRDLAaRNCLL~~~r~V  841 (1025)
T KOG1095|consen  766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE----SKHFVHRDLAARNCLLDERRVV  841 (1025)
T ss_pred             CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH----hCCCcCcchhhhheeecccCcE
Confidence            999999999999999999999976      556788888999999999999999    8899999999999999999999


Q ss_pred             eec
Q 042107          229 HFL  231 (232)
Q Consensus       229 ~l~  231 (232)
                      ||+
T Consensus       842 KIa  844 (1025)
T KOG1095|consen  842 KIA  844 (1025)
T ss_pred             EEc
Confidence            996

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.92  E-value=6.1e-24  Score=171.38  Aligned_cols=138  Identities=26%  Similarity=0.362  Sum_probs=124.0

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      ..|.+.+.||+|+||.||++.. .+++.||+|.+........+.+..|+.+++.++||||+++++.+..++..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            4577889999999999999975 578999999997665555677888999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++...  .+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        99 ~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH----~~~i~H~dL~p~Nili~~~~~~~l~  157 (297)
T cd06656          99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH----SNQVIHRDIKSDNILLGMDGSVKLT  157 (297)
T ss_pred             CCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEC
Confidence            999999998653  4788889999999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.92  E-value=4.8e-24  Score=189.89  Aligned_cols=139  Identities=23%  Similarity=0.298  Sum_probs=119.1

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+++++.++||||+++++++...+..+++||
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME   82 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP   82 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence            4678899999999999999754 68999999986432   2234568889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccC----------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTS----------NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~----------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |++||+|.+++...          ....++..+..++.|+++||+|+|    ..+|+||||||+||+++.++.++|+
T Consensus        83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH----s~GIIHRDLKPeNILLd~dg~vKLi  155 (932)
T PRK13184         83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH----SKGVLHRDLKPDNILLGLFGEVVIL  155 (932)
T ss_pred             cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH----HCCccccCCchheEEEcCCCCEEEE
Confidence            99999999988531          122455677889999999999999    8899999999999999999988874

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.92  E-value=6.9e-24  Score=171.02  Aligned_cols=138  Identities=26%  Similarity=0.365  Sum_probs=123.7

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      ..|++.+.||+|+||.||+|.. .+++.|++|.+........+.+.+|+.+++.++||||+++++.+..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            4567888999999999999975 468899999997766556677888999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++...  .+++.....++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus       100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH----~~gi~H~dLkp~Nill~~~~~~kl~  158 (296)
T cd06654         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLT  158 (296)
T ss_pred             CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEcCCCCEEEC
Confidence            999999998653  4788889999999999999999    8899999999999999999998885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=9.2e-24  Score=166.94  Aligned_cols=140  Identities=26%  Similarity=0.431  Sum_probs=124.0

Q ss_pred             cccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      .+.+.+.+.||+|+||.||++...++..+|+|.+..... ..+.+.+|+.+++.++||||+++++++..+...+++|||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            345678899999999999999887788899999875433 3467888999999999999999999999888999999999


Q ss_pred             CCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++.... ..+++..+..++.+++.|+.|+|    ..+++|+||||+||+++.++.++++
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh----~~~i~h~di~p~nili~~~~~~~l~  145 (261)
T cd05034          84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE----SRNYIHRDLAARNILVGENLVCKIA  145 (261)
T ss_pred             CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcchheEEEcCCCCEEEC
Confidence            9999999997643 45888999999999999999999    8899999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.91  E-value=8e-24  Score=167.33  Aligned_cols=139  Identities=22%  Similarity=0.407  Sum_probs=120.9

Q ss_pred             cccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      .+.|++.++||+|+||.||+|...+++.||+|.+..... ..+.+.+|+.+++.++||||+++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            455778899999999999999888889999999875433 3467888999999999999999998864 56689999999


Q ss_pred             CCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++... ...+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++++
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH----~~~i~H~dl~p~ni~i~~~~~~~l~  144 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE----RKNYIHRDLRAANILVSETLCCKIA  144 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh----cCCeecccccHHhEEEcCCCCEEEc
Confidence            999999988653 345788889999999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.91  E-value=8.8e-24  Score=167.43  Aligned_cols=138  Identities=23%  Similarity=0.380  Sum_probs=119.3

Q ss_pred             ccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccC
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      ..|++.+.||+|+||.||+|+..+...||+|.+..... ..+.+.+|+++++.++||||+++++.+. ++..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            34788899999999999999877667799999875432 3356888999999999999999998874 456799999999


Q ss_pred             CCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|+|.+++... ...+++..+..++.|++.||+|+|    ..+++||||||+||++++++.++|+
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~Nill~~~~~~~L~  144 (262)
T cd05071          84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVA  144 (262)
T ss_pred             CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH----HCCccccccCcccEEEcCCCcEEec
Confidence            99999999753 334788899999999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.91  E-value=4.9e-24  Score=170.18  Aligned_cols=139  Identities=27%  Similarity=0.455  Sum_probs=120.5

Q ss_pred             cceeeecccCCCcceeeeEEeC------CCcEEEEEEeecccCc-hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ------DGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      .|.+.+.||+|+||.||+|...      ++..||+|.+...... ..+.+.+|+++++.++||||+++++++......++
T Consensus         6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   85 (280)
T cd05049           6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIM   85 (280)
T ss_pred             HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEE
Confidence            3567789999999999999753      2478999998655433 45678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCC-------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCce
Q 042107          162 ILEYMPHGSLGKCLSTSN-------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA  228 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~  228 (232)
                      +|||+++++|.+++...+             ..+++..+..++.|++.|+.|+|    ..+++||||||+||+++.++.+
T Consensus        86 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH----~~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          86 VFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA----SQHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh----hCCeeccccccceEEEcCCCeE
Confidence            999999999999986432             23677888999999999999999    8899999999999999999998


Q ss_pred             eec
Q 042107          229 HFL  231 (232)
Q Consensus       229 ~l~  231 (232)
                      +|+
T Consensus       162 kl~  164 (280)
T cd05049         162 KIG  164 (280)
T ss_pred             EEC
Confidence            875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.91  E-value=5.2e-24  Score=168.95  Aligned_cols=139  Identities=27%  Similarity=0.374  Sum_probs=123.5

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      +.|++.+.||+|+||.||+|+. .+++.||+|.+..........+.+|+.+++.++||||+++++.+...+..+++|||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            3567788999999999999975 468899999987665555566788999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++...+ .+++..+..++.|++.|+.|+|    ..+++|+||||+||+++.++.++|+
T Consensus        89 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nili~~~~~~~l~  148 (267)
T cd06645          89 GGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH----SKGKMHRDIKGANILLTDNGHVKLA  148 (267)
T ss_pred             CCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEC
Confidence            9999999887543 5888999999999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.91  E-value=6.3e-24  Score=171.77  Aligned_cols=140  Identities=31%  Similarity=0.552  Sum_probs=117.8

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCc--EEEEEEeeccc-CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGM--EVVVKGFNLQY-GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  162 (232)
                      +.+++.+.||+|+||.||+|+.+ ++.  .+++|.+.... ....+.+.+|+.++..+ +||||+++++++..++..|++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            34577889999999999999764 454  45777665332 23345678899999999 899999999999999999999


Q ss_pred             EeccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCc
Q 042107          163 LEYMPHGSLGKCLSTSN---------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV  227 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~  227 (232)
                      |||+++++|.+++....               ..+++..++.++.|++.|++|||    .++++||||||+|||++.++.
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH----hCCccccccchheEEecCCCc
Confidence            99999999999986431               24678889999999999999999    889999999999999999999


Q ss_pred             eeec
Q 042107          228 AHFL  231 (232)
Q Consensus       228 ~~l~  231 (232)
                      ++|+
T Consensus       163 ~kl~  166 (303)
T cd05088         163 AKIA  166 (303)
T ss_pred             EEeC
Confidence            8875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=5.7e-24  Score=173.99  Aligned_cols=131  Identities=22%  Similarity=0.221  Sum_probs=110.5

Q ss_pred             ccCCCcceeeeEEeC-CCcEEEEEEeecccC---chHHHHHHHHHHhcCC---CCCCccceeEEEecCCeeEEEEeccCC
Q 042107           96 ISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG---GAFKNLDVECNMMKII---RHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        96 lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      ||+|+||.||+|+.. +++.||+|.+.....   ........|..++...   +||+|+++++.+...+..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999754 689999999865421   1223344466666554   699999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.++|+
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH----~~~ivHrDlkp~Nili~~~~~~kl~  138 (330)
T cd05586          81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH----KYDIVYRDLKPENILLDATGHIALC  138 (330)
T ss_pred             ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeEECCCCCEEEe
Confidence            99998887543 5788899999999999999999    8899999999999999999998875

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.91  E-value=7.2e-24  Score=169.40  Aligned_cols=139  Identities=24%  Similarity=0.447  Sum_probs=121.6

Q ss_pred             cceeeecccCCCcceeeeEEeC-----CCcEEEEEEeecccCc-hHHHHHHHHHHhcCCCCCCccceeEEEec--CCeeE
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-----DGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCSK--DDFKA  160 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~  160 (232)
                      .+++.+.||+|+||.||++++.     ++..+|+|.+...... ..+.+..|+++++.++||||+++++++..  ....+
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR   84 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence            3556788999999999999753     3678999998765443 45778999999999999999999998877  55789


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|||+++++|.+++......+++..+..++.|++.||.|||    ..+++|||+||+||+++.++.++|+
T Consensus        85 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~nil~~~~~~~~l~  151 (284)
T cd05038          85 LIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG----SQRYIHRDLAARNILVESEDLVKIS  151 (284)
T ss_pred             EEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHhEEEcCCCCEEEc
Confidence            999999999999999876556889999999999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.91  E-value=8.1e-24  Score=169.69  Aligned_cols=138  Identities=20%  Similarity=0.269  Sum_probs=119.2

Q ss_pred             ceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           90 LEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      |+..+.||+|+||.||++.. .+++.+|+|.+....   ......+.+|+++++.++|++++.+.+.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            45668899999999999975 468899999986542   12234567799999999999999999999999999999999


Q ss_pred             cCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++++|.+++... ...+++..+..++.|++.||.|+|    ..+|+||||||+||+++.++.++|+
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH----~~~iiH~dikp~Nili~~~~~~kl~  144 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH----RENTVYRDLKPENILLDDYGHIRIS  144 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCCHHHEEECCCCCEEEe
Confidence            9999999887643 235899999999999999999999    8899999999999999999988875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.91  E-value=9.3e-24  Score=169.74  Aligned_cols=138  Identities=28%  Similarity=0.464  Sum_probs=119.7

Q ss_pred             ceeeecccCCCcceeeeEEeC------CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           90 LEVFNLISRGGFGSIYKARIQ------DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      +.+.+.||+|+||.||+|+..      ++..+++|.+........+.+.+|+++++.++||||+++++++...+..++||
T Consensus         7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   86 (291)
T cd05094           7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVF   86 (291)
T ss_pred             eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEE
Confidence            556789999999999999632      34568889886555445567889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCce
Q 042107          164 EYMPHGSLGKCLSTSN---------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA  228 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~  228 (232)
                      ||+++++|.+++....               ..+++..+..++.|++.|+.|+|    .++++||||||+||+++.++.+
T Consensus        87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH----~~~i~H~dlkp~Nil~~~~~~~  162 (291)
T cd05094          87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA----SQHFVHRDLATRNCLVGANLLV  162 (291)
T ss_pred             ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccCcceEEEccCCcE
Confidence            9999999999986431               23788899999999999999999    8899999999999999999988


Q ss_pred             eec
Q 042107          229 HFL  231 (232)
Q Consensus       229 ~l~  231 (232)
                      +|+
T Consensus       163 ~l~  165 (291)
T cd05094         163 KIG  165 (291)
T ss_pred             EEC
Confidence            875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.91  E-value=1e-23  Score=169.40  Aligned_cols=139  Identities=19%  Similarity=0.357  Sum_probs=121.0

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      +.|++.+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            45678899999999999999765 688999999865432 2234466799999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++ +|.+++......+++..+..++.|++.||.|+|    ..+++||||||+||+++.++.++|+
T Consensus        85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH----~~~i~H~dl~p~nil~~~~~~~kl~  145 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH----QRRVLHRDLKPQNLLISERGELKLA  145 (291)
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecccCCHHHEEEcCCCCEEEC
Confidence            985 999988765556788899999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.91  E-value=1e-23  Score=168.51  Aligned_cols=138  Identities=22%  Similarity=0.385  Sum_probs=115.5

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCc----EEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGM----EVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+++.+.||+|+||.||+|.+. ++.    .+++|.+..... .....+..|+..++.++||||+++++++. ....+++
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i   86 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLV   86 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEE
Confidence            3567789999999999999764 344    467777653322 23456777888999999999999999875 4557899


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +||+++|+|.+++......+++..+..++.|++.||.|+|    ..+++||||||+||++++++.+||+
T Consensus        87 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~iiH~dlkp~nili~~~~~~kl~  151 (279)
T cd05111          87 TQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE----EHRMVHRNLAARNILLKSDSIVQIA  151 (279)
T ss_pred             EEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCEeccccCcceEEEcCCCcEEEc
Confidence            9999999999999766556899999999999999999999    8899999999999999999999885

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.91  E-value=1.1e-23  Score=165.56  Aligned_cols=134  Identities=28%  Similarity=0.455  Sum_probs=119.3

Q ss_pred             ecccCCCcceeeeEEeCCCcEEEEEEeecccCc-hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCChh
Q 042107           94 NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLG  172 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  172 (232)
                      ++||+|+||.||++...+++.|++|.+...... ....+..|+++++.++||||+++++++......+++|||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            468999999999998766999999988655433 4567888999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          173 KCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       173 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++......+++.....++.+++.|+.|+|    .++++|||+||+||+++.++.++|+
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH----~~~i~h~di~p~nili~~~~~~~l~  135 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE----SKNCIHRDLAARNCLVGENNVLKIS  135 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCEehhhcCcceEEEcCCCcEEEe
Confidence            998765445788888999999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.91  E-value=1.5e-23  Score=165.31  Aligned_cols=138  Identities=22%  Similarity=0.318  Sum_probs=122.4

Q ss_pred             ceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           90 LEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      |+..+.||+|+||.||.++. .+++.+++|.+....  ....+.+.+|+++++.++|+||+++++++...+..+++|||+
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~   81 (256)
T cd08221           2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA   81 (256)
T ss_pred             ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence            67889999999999999964 468899999986543  334567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++... ...+++..+..++.|++.|+.|+|    ..+++|+||||+||++++++.+||+
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~ni~~~~~~~~kl~  143 (256)
T cd08221          82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH----KAGILHRDIKTLNIFLTKAGLIKLG  143 (256)
T ss_pred             CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----hCCccccCCChHhEEEeCCCCEEEC
Confidence            999999999764 345788899999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.91  E-value=1.2e-23  Score=165.84  Aligned_cols=134  Identities=28%  Similarity=0.515  Sum_probs=119.6

Q ss_pred             ecccCCCcceeeeEEeCC----CcEEEEEEeecccCc-hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           94 NLISRGGFGSIYKARIQD----GMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      +.||+|+||.||+|....    +..+++|.+...... ..+.+..|++.+..++|+|++++++++......+++|||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            468999999999997653    788999998765433 267788899999999999999999999998999999999999


Q ss_pred             CChhhhhccC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTS--------NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|.+++...        ...+++..+..++.|++.|+.|||    ..+++||||||+||+++.++.++++
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~di~p~nili~~~~~~~l~  147 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA----SKKFVHRDLAARNCLVGEDLVVKIS  147 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH----cCCcccCccCcceEEECCCCcEEEc
Confidence            9999999875        356899999999999999999999    8899999999999999999998885

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.91  E-value=1.3e-23  Score=165.51  Aligned_cols=138  Identities=23%  Similarity=0.310  Sum_probs=121.7

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      |.+.+.||+|++|.||+|... +++.|++|.+....  ....+.+..|+.+++.++|||++++++++...+..+++|||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA   81 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence            456788999999999999764 68899999986542  334567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++... ...+++..+..++.+++.|+.|+|    ..+++|+|+||+||+++.++.++++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH----~~~i~h~dl~~~nili~~~~~~~l~  143 (256)
T cd08529          82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH----SKKILHRDIKSLNLFLDAYDNVKIG  143 (256)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEEeCCCCEEEc
Confidence            999999998764 446888889999999999999999    8899999999999999999988875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.91  E-value=2.7e-24  Score=169.64  Aligned_cols=137  Identities=29%  Similarity=0.507  Sum_probs=119.5

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchH--HHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAF--KNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      |++.+.||+|+||.||+++.. +++.+|+|.+........  ....+|+.+++.++||||+++++++......+++|||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567899999999999999765 567899999987643322  23345899999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++... ..+++..+..++.|+++||.+||    ..+++|+||||+||+++.++.++|+
T Consensus        81 ~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~Lh----~~~i~H~dikp~NIl~~~~~~~~l~  140 (260)
T PF00069_consen   81 PGGSLQDYLQKN-KPLSEEEILKIAYQILEALAYLH----SKGIVHRDIKPENILLDENGEVKLI  140 (260)
T ss_dssp             TTEBHHHHHHHH-SSBBHHHHHHHHHHHHHHHHHHH----HTTEEESSBSGGGEEESTTSEEEES
T ss_pred             cccccccccccc-ccccccccccccccccccccccc----ccccccccccccccccccccccccc
Confidence            999999999832 35788999999999999999999    7899999999999999999998875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.91  E-value=1.1e-23  Score=167.08  Aligned_cols=139  Identities=23%  Similarity=0.430  Sum_probs=120.6

Q ss_pred             cceeeecccCCCcceeeeEEeC-CC---cEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DG---MEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      .++..+.||+|+||.||+|+.. ++   ..+++|.+.... ....+.+..|+++++.++|||++++.+++...+..+++|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT   85 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence            3557789999999999999764 33   368999886542 233466888999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+++++|.+++......+++..+..++.|++.|+.|+|    ..+++|||+||+||+++.++.++++
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~dlkp~Nili~~~~~~kl~  149 (268)
T cd05063          86 EYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS----DMNYVHRDLAARNILVNSNLECKVS  149 (268)
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhhEEEcCCCcEEEC
Confidence            999999999999765556888999999999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.91  E-value=6e-24  Score=177.80  Aligned_cols=139  Identities=24%  Similarity=0.372  Sum_probs=117.1

Q ss_pred             cceeeecccCCCcceeeeEEeC------CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCC-CCCccceeEEEecCCeeE
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ------DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIR-HQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  160 (232)
                      .+.+.+.||+|+||.||+|++.      .++.||+|++.... ....+.+..|+.++..+. ||||+++++++...+..+
T Consensus        38 ~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~  117 (401)
T cd05107          38 NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIY  117 (401)
T ss_pred             HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcE
Confidence            4567789999999999999753      34689999996543 223456888999999997 999999999999989999


Q ss_pred             EEEeccCCCChhhhhccCC-------------------------------------------------------------
Q 042107          161 LILEYMPHGSLGKCLSTSN-------------------------------------------------------------  179 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~-------------------------------------------------------------  179 (232)
                      +||||+++|+|.+++....                                                             
T Consensus       118 iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (401)
T cd05107         118 IITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKG  197 (401)
T ss_pred             EEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchh
Confidence            9999999999999885421                                                             


Q ss_pred             ------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeC
Q 042107          180 ------------------------------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD  223 (232)
Q Consensus       180 ------------------------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~  223 (232)
                                                          ..+++.....++.|++.||.|||    ..+++||||||+|||++
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrdlkp~NiLl~  273 (401)
T cd05107         198 TVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA----SKNCVHRDLAARNVLIC  273 (401)
T ss_pred             hhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh----cCCcCcccCCcceEEEe
Confidence                                                13556677889999999999999    88999999999999999


Q ss_pred             CCCceeec
Q 042107          224 DNMVAHFL  231 (232)
Q Consensus       224 ~~~~~~l~  231 (232)
                      +++.++++
T Consensus       274 ~~~~~kL~  281 (401)
T cd05107         274 EGKLVKIC  281 (401)
T ss_pred             CCCEEEEE
Confidence            99988875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.91  E-value=1.3e-23  Score=169.39  Aligned_cols=137  Identities=24%  Similarity=0.360  Sum_probs=120.2

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCc-----hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGG-----AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      |++.+.||+|+||.||+|... +++.||+|.+......     ....+..|+++++.++|+||+++++++...+..++||
T Consensus         2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (298)
T cd07841           2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF   81 (298)
T ss_pred             ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence            456788999999999999764 6899999999654322     2345677999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+ +++|.+++......+++..+..++.|+++||.|||    ..+++|+||||+||+++.++.++|+
T Consensus        82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dl~p~nill~~~~~~~l~  144 (298)
T cd07841          82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH----SNWILHRDLKPNNLLIASDGVLKLA  144 (298)
T ss_pred             ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCChhhEEEcCCCCEEEc
Confidence            999 88999999765445889999999999999999999    8899999999999999999998885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.91  E-value=1.2e-23  Score=167.23  Aligned_cols=134  Identities=22%  Similarity=0.333  Sum_probs=113.2

Q ss_pred             ecccCCCcceeeeEEeC---CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCC
Q 042107           94 NLISRGGFGSIYKARIQ---DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHG  169 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  169 (232)
                      +.||+|+||.||+|...   ++..+|+|.+..... .....+.+|+.+++.++||||+++++++......++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            36899999999999754   345789998865432 23346788999999999999999999999888899999999999


Q ss_pred             ChhhhhccC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          170 SLGKCLSTS----NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       170 ~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|.+++...    ....++..+..++.|++.|+.|+|    ..+++|||+||+||+++.++.++++
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dlkp~nil~~~~~~~kL~  142 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH----KNNFIHSDLALRNCLLTADLTVKIG  142 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH----HCCEeccccCcceEEEcCCCcEEEC
Confidence            999998642    123566677889999999999999    8899999999999999999988885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.91  E-value=1.4e-23  Score=167.62  Aligned_cols=139  Identities=23%  Similarity=0.371  Sum_probs=119.7

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCc----EEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGM----EVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      ..+++.+.||+|+||.||+|... ++.    .+|+|....... .....+.+|+.+++.++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            44678899999999999999754 333    588888765432 234678889999999999999999999887 77899


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|||+++|+|.+++......+++..+..++.|++.|++|||    ..+++||||||+||+++.++.++|+
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~i~H~di~p~nil~~~~~~~kL~  151 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE----EKRLVHRDLAARNVLVKTPQHVKIT  151 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCEEecccCcceEEEcCCCeEEEC
Confidence            99999999999999876556889999999999999999999    7899999999999999999998875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.91  E-value=1.6e-23  Score=166.10  Aligned_cols=139  Identities=24%  Similarity=0.365  Sum_probs=120.0

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .|++.+.||+|+||.||+|+.. +++.||+|.+....   ......+..|+++++.++||||+++++++...+..+++||
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence            4678899999999999999754 78999999876432   2234567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLST---SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++++|.+++..   ....+++..+..++.|++.||.|+|    ..+++|+||||+||+++.++.++|+
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~~~nil~~~~~~~~l~  148 (267)
T cd08228          83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH----SRRVMHRDIKPANVFITATGVVKLG  148 (267)
T ss_pred             ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCCHHHEEEcCCCCEEEC
Confidence            9999999988753   2334788888999999999999999    8899999999999999999988875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.91  E-value=9.5e-24  Score=168.80  Aligned_cols=139  Identities=26%  Similarity=0.436  Sum_probs=120.8

Q ss_pred             cceeeecccCCCcceeeeEEe------CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           89 FLEVFNLISRGGFGSIYKARI------QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+...++||+|+||.||++..      .++..+++|.+........+.+.+|+++++.++||||+++++++...+..+++
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   85 (280)
T cd05092           6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMV   85 (280)
T ss_pred             hceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEE
Confidence            355778999999999999953      23567899988765555567889999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCC--------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCce
Q 042107          163 LEYMPHGSLGKCLSTSN--------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA  228 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~--------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~  228 (232)
                      |||+++++|.+++....              ..+++..+..++.|++.|+.|||    ..+++||||||+||++++++.+
T Consensus        86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          86 FEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA----SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH----HCCeecccccHhhEEEcCCCCE
Confidence            99999999999886532              24788889999999999999999    8899999999999999999998


Q ss_pred             eec
Q 042107          229 HFL  231 (232)
Q Consensus       229 ~l~  231 (232)
                      +|+
T Consensus       162 kL~  164 (280)
T cd05092         162 KIG  164 (280)
T ss_pred             EEC
Confidence            885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.91  E-value=5.6e-25  Score=167.69  Aligned_cols=141  Identities=28%  Similarity=0.390  Sum_probs=121.6

Q ss_pred             ccccceeeecccCCCcceeeeEE-eCCCcEEEEEEeecccCc--------hHHHHHHHHHHhcCC-CCCCccceeEEEec
Q 042107           86 FRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGG--------AFKNLDVECNMMKII-RHQNLIKIISSCSK  155 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  155 (232)
                      +-..|+..+.+|+|..+.|.+|. ..+|.++|+|++......        ..+....|+.+++++ .||+|+++.++|++
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            34456677899999999999985 457899999998654211        134456799999988 59999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          156 DDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       156 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +.+.++|+|.|+.|.|.+++...- .+++....+|++|+.+|+.|+|    .+.|+||||||+|||+|++++.+|+
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylH----a~~IVHRDLKpENILlddn~~i~is  165 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLH----ARNIVHRDLKPENILLDDNMNIKIS  165 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHH----HhhhhhcccChhheeeccccceEEe
Confidence            999999999999999999998754 4788889999999999999999    8899999999999999999999986

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.91  E-value=1.3e-23  Score=168.78  Aligned_cols=138  Identities=26%  Similarity=0.319  Sum_probs=122.1

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .|++.+.||+|+||.||++... +++.+|+|.+....   ....+.+.+|+++++.++||||+++++++..++..+++||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            4678899999999999999764 68999999986542   2334667889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++++|.+++.... .+++..+..++.|++.||.|+|    ..+++|+||+|+||+++.++.++|+
T Consensus        82 ~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH----~~~i~H~dl~p~nili~~~~~~kl~  143 (290)
T cd05580          82 YVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH----SLDIVYRDLKPENLLLDSDGYIKIT  143 (290)
T ss_pred             cCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEECCCCCEEEe
Confidence            999999999987653 5888889999999999999999    8899999999999999999998875

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.91  E-value=9.9e-24  Score=170.87  Aligned_cols=141  Identities=29%  Similarity=0.437  Sum_probs=120.1

Q ss_pred             cccceeeecccCCCcceeeeEEeC--------CCcEEEEEEeeccc-CchHHHHHHHHHHhcCC-CCCCccceeEEEecC
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ--------DGMEVVVKGFNLQY-GGAFKNLDVECNMMKII-RHQNLIKIISSCSKD  156 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  156 (232)
                      .+.|.+.+.||+|+||.||+++..        +...+|+|.+.... ......+..|+++++.+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            355788999999999999999642        23469999886542 23445678899999999 799999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCcee
Q 042107          157 DFKALILEYMPHGSLGKCLSTSN---------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVL  221 (232)
Q Consensus       157 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nil  221 (232)
                      +..++||||+++|+|.+++....               ..+++..+..++.|++.||+|+|    ..+++||||||+||+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~gi~H~dlkp~Nil  172 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVL  172 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH----HCCcccccccHHheE
Confidence            99999999999999999987531               24778889999999999999999    889999999999999


Q ss_pred             eCCCCceeec
Q 042107          222 LDDNMVAHFL  231 (232)
Q Consensus       222 l~~~~~~~l~  231 (232)
                      ++.++.++|+
T Consensus       173 l~~~~~~kL~  182 (307)
T cd05098         173 VTEDNVMKIA  182 (307)
T ss_pred             EcCCCcEEEC
Confidence            9999998885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.91  E-value=1.3e-23  Score=168.60  Aligned_cols=138  Identities=18%  Similarity=0.268  Sum_probs=118.4

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC---chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG---GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      |+..+.||+|+||.||++... +++.||+|.+.....   .....+..|+.+++.++|++++.+++.+.+.+..+++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            456788999999999999754 688999999865422   1234567799999999999999999999999999999999


Q ss_pred             cCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++++|.+++... ...+++..+..++.|++.||.|+|    ..+++||||||+||+++.++.++|+
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~iiH~dikp~Nil~~~~~~~~l~  144 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH----QERIVYRDLKPENILLDDHGHIRIS  144 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHEEECCCCCEEEe
Confidence            9999999888543 234788889999999999999999    8899999999999999999888774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.91  E-value=2.8e-23  Score=163.70  Aligned_cols=138  Identities=19%  Similarity=0.323  Sum_probs=120.6

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeecc-cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccC
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQ-YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      |++.+.||+|+||.||++... +++.+|+|.+... .....+.+..|+.+++.++||||+++++.+.+++..+++|||++
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (255)
T cd08219           2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD   81 (255)
T ss_pred             ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence            567889999999999999754 6889999998643 23345677889999999999999999999999999999999999


Q ss_pred             CCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++.+++... ...+++.....++.|++.|+.|+|    ..+++|+||||+||++++++.++++
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dl~p~nili~~~~~~~l~  142 (255)
T cd08219          82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH----EKRVLHRDIKSKNIFLTQNGKVKLG  142 (255)
T ss_pred             CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCcceEEECCCCcEEEc
Confidence            99999988643 345788888999999999999999    8899999999999999999988874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.91  E-value=2e-23  Score=164.49  Aligned_cols=137  Identities=23%  Similarity=0.384  Sum_probs=121.1

Q ss_pred             ceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCC
Q 042107           90 LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHG  169 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  169 (232)
                      +++.+.||+|+||.||++.+.++..+|+|.+..... ....+..|+++++.++||+++++++++......+++|||++++
T Consensus         6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (256)
T cd05112           6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG   84 (256)
T ss_pred             eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence            567789999999999999877788899998864432 2356888999999999999999999999888999999999999


Q ss_pred             ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          170 SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       170 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|.+++......+++..+..++.+++.|+.|+|    ..+++|||+||+||+++.++.++|+
T Consensus        85 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~h~dl~p~ni~i~~~~~~~l~  142 (256)
T cd05112          85 CLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE----SSNVIHRDLAARNCLVGENQVVKVS  142 (256)
T ss_pred             cHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH----HCCccccccccceEEEcCCCeEEEC
Confidence            999998765556788889999999999999999    8899999999999999998888875

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.91  E-value=1.2e-23  Score=167.83  Aligned_cols=140  Identities=17%  Similarity=0.303  Sum_probs=117.9

Q ss_pred             ccceeeecccCCCcceeeeEEeC------CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ------DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  160 (232)
                      +.|++.+.||+|+||.||+|...      ++..||+|.+.... ......+.+|+.+++.++||||+++++++......+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~   85 (277)
T cd05062           6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   85 (277)
T ss_pred             HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence            45778899999999999998642      35679999875432 223456788999999999999999999999888999


Q ss_pred             EEEeccCCCChhhhhccCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSN---------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +||||+++++|.+++....         ..+++..+..++.|++.|+.|+|    ..+++||||||+||++++++.++++
T Consensus        86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCcchheEEEcCCCCEEEC
Confidence            9999999999999886421         12466778889999999999999    8899999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.91  E-value=7e-24  Score=176.24  Aligned_cols=136  Identities=22%  Similarity=0.312  Sum_probs=116.8

Q ss_pred             ceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCC-----eeEE
Q 042107           90 LEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD-----FKAL  161 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~l  161 (232)
                      +++.+.||+|+||.||+++. .+++.||+|.+....  ....+.+.+|+.+++.++||||+++++++...+     ..|+
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   81 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV   81 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence            45678999999999999975 478999999886432  233467888999999999999999999998776     7899


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||+. ++|.+++... ..+++..+..++.|++.||.|||    ..+++||||||+|||++.++.+||+
T Consensus        82 v~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH----~~~ivH~dlkp~Nili~~~~~~kL~  145 (372)
T cd07853          82 VTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLH----SAGILHRDIKPGNLLVNSNCVLKIC  145 (372)
T ss_pred             Eeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChHHEEECCCCCEEec
Confidence            999996 5788877653 35888899999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.91  E-value=1.6e-23  Score=167.69  Aligned_cols=137  Identities=30%  Similarity=0.483  Sum_probs=117.3

Q ss_pred             cceeeecccCCCcceeeeEEe-----CCCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecC--CeeE
Q 042107           89 FLEVFNLISRGGFGSIYKARI-----QDGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKD--DFKA  160 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  160 (232)
                      ++++.+.||+|+||.||++..     .++..||+|.+..... .....+.+|+++++.++||||+++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (283)
T cd05080           5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ   84 (283)
T ss_pred             hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence            347889999999999988642     3577899999865432 2346678899999999999999999987653  4688


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|||+++++|.+++...  .+++..+..++.|++.|+.|||    ..+++||||||+||+++.++.++|+
T Consensus        85 lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~l~  149 (283)
T cd05080          85 LIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLH----SQHYIHRDLAARNVLLDNDRLVKIG  149 (283)
T ss_pred             EEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHH----HCCeeccccChheEEEcCCCcEEEe
Confidence            999999999999998764  4889999999999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.91  E-value=1.3e-23  Score=169.33  Aligned_cols=140  Identities=23%  Similarity=0.386  Sum_probs=118.5

Q ss_pred             ccceeeecccCCCcceeeeEEeC-----------------CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccce
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-----------------DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKI  149 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~  149 (232)
                      +.|++.+.||+|+||.||+++..                 +...+|+|.+.... ....+.+.+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            34678899999999999998532                 23468999886543 2334678899999999999999999


Q ss_pred             eEEEecCCeeEEEEeccCCCChhhhhccCC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCc
Q 042107          150 ISSCSKDDFKALILEYMPHGSLGKCLSTSN----------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSN  219 (232)
Q Consensus       150 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~N  219 (232)
                      ++++..++..+++|||+++++|.+++....          ..+++.....++.|++.|+.|+|    ..+++||||||+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dlkp~N  160 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS----SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH----HCCeecccCChhe
Confidence            999999999999999999999999886532          23667788999999999999999    8899999999999


Q ss_pred             eeeCCCCceeec
Q 042107          220 VLLDDNMVAHFL  231 (232)
Q Consensus       220 ill~~~~~~~l~  231 (232)
                      |+++.++.++++
T Consensus       161 ili~~~~~~~l~  172 (296)
T cd05095         161 CLVGKNYTIKIA  172 (296)
T ss_pred             EEEcCCCCEEec
Confidence            999999988875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.91  E-value=1.4e-23  Score=166.62  Aligned_cols=135  Identities=23%  Similarity=0.385  Sum_probs=117.5

Q ss_pred             eecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCCh
Q 042107           93 FNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSL  171 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  171 (232)
                      ...||+|+||.||+|+.. ++..|++|.+........+.+.+|+.+++.++|+||+++++++..++..++++||+++++|
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   92 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL   92 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence            357999999999999754 6788999988766555667889999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC-CCceeec
Q 042107          172 GKCLSTSNYIL--DFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD-NMVAHFL  231 (232)
Q Consensus       172 ~~~l~~~~~~~--~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~-~~~~~l~  231 (232)
                      .+++......+  ++..+..++.|++.|+.|||    ..+|+|||+||+||+++. ++.++|+
T Consensus        93 ~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~h~dl~p~nil~~~~~~~~~l~  151 (268)
T cd06624          93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH----DNQIVHRDIKGDNVLVNTYSGVVKIS  151 (268)
T ss_pred             HHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCCCCeEEEe
Confidence            99987643334  77788889999999999999    889999999999999986 5677764

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.91  E-value=2.4e-23  Score=164.93  Aligned_cols=139  Identities=24%  Similarity=0.362  Sum_probs=121.8

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .|++.+.||+|+||.||+|... +++.||+|.+....   ....+.+.+|+++++.++|++++++++.+...+..+++||
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   82 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence            4678899999999999999765 78999999886432   2335678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLST---SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++++|..++..   ....+++..+..++.+++.|+.|+|    ..+++||||||+||+++.++.++++
T Consensus        83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~nil~~~~~~~~l~  148 (267)
T cd08224          83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH----SKRIMHRDIKPANVFITATGVVKLG  148 (267)
T ss_pred             cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH----hCCEecCCcChhhEEECCCCcEEEe
Confidence            9999999998853   2344788899999999999999999    8899999999999999999988874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.91  E-value=7.6e-24  Score=174.20  Aligned_cols=140  Identities=25%  Similarity=0.400  Sum_probs=116.0

Q ss_pred             ccceeeecccCCCcceeeeEEe------CCCcEEEEEEeeccc-CchHHHHHHHHHHhcCC-CCCCccceeEEEecC-Ce
Q 042107           88 NFLEVFNLISRGGFGSIYKARI------QDGMEVVVKGFNLQY-GGAFKNLDVECNMMKII-RHQNLIKIISSCSKD-DF  158 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~~  158 (232)
                      +.|++.+.||+|+||.||+|..      .+++.||+|.+.... ......+.+|+.++..+ +||||+++++++... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            3477889999999999999963      346789999986543 22345678899999999 689999999987654 56


Q ss_pred             eEEEEeccCCCChhhhhccCC-----------------------------------------------------------
Q 042107          159 KALILEYMPHGSLGKCLSTSN-----------------------------------------------------------  179 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  179 (232)
                      .+++|||+++|+|.+++....                                                           
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            789999999999998875321                                                           


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          180 -------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       180 -------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                             ..+++.....++.|+++||.|+|    ..+|+||||||+||+++.++.++|+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dikp~Nil~~~~~~~kl~  221 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSENNVVKIC  221 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCccCeEEEcCCCcEEEE
Confidence                   12567777889999999999999    8899999999999999999998885

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=2.2e-23  Score=169.40  Aligned_cols=139  Identities=22%  Similarity=0.328  Sum_probs=122.3

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCc---hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGG---AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .|++.+.||+|++|.||+|... +++.+|+|.+......   ..+.+..|+++++.++||||+++++.+......+++||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            3667889999999999999765 5899999999765322   44668889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++++|.+++... ...+++..+..++.|++.||.|||    ..+++|+||||+||+++.++.++|+
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~~l~  145 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH----LLGIVYRDLKPENILLHESGHIMLS  145 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH----HCCeeccCCChHHeEEcCCCCEEEe
Confidence            99999999998753 345888899999999999999999    8899999999999999999988874

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.91  E-value=1.7e-23  Score=165.80  Aligned_cols=137  Identities=23%  Similarity=0.470  Sum_probs=120.2

Q ss_pred             ceeeecccCCCcceeeeEEeCCCcEEEEEEeecccC------chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           90 LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYG------GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      |.+.+.||+|+||.||+|...+++.+|+|.+.....      ...+.+.+|+++++.++|+||+++++++...+..+++|
T Consensus         2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (265)
T cd06631           2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM   81 (265)
T ss_pred             ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence            456788999999999999877889999998864421      12355788999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+++++|.+++.... .+++..+..++.|++.|++|+|    ..+++|+||+|+||+++.++.++|+
T Consensus        82 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~l~  144 (265)
T cd06631          82 EFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH----NNCVVHRDIKGNNVMLMPNGIIKLI  144 (265)
T ss_pred             ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcCHHhEEECCCCeEEec
Confidence            9999999999987643 4788888899999999999999    8899999999999999999998875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.91  E-value=1.6e-23  Score=165.63  Aligned_cols=138  Identities=25%  Similarity=0.415  Sum_probs=120.0

Q ss_pred             ccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccC
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      +.+++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.+++.++||+++++++++. ++..+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            34678889999999999999888888899999875433 3466889999999999999999999875 456889999999


Q ss_pred             CCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|.+++... ...+++..+..++.+++.||.|||    ..+++||||||+||++++++.++|+
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~di~p~Nili~~~~~~~l~  144 (260)
T cd05070          84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE----RMNYIHRDLRSANILVGDGLVCKIA  144 (260)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCccceEEEeCCceEEeC
Confidence            99999998753 334788899999999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.91  E-value=2.1e-23  Score=166.89  Aligned_cols=137  Identities=23%  Similarity=0.363  Sum_probs=118.9

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      |++.+.||+|++|.||+|+.. ++..||+|.+....  ....+.+..|+.+++.++||||+++++++..++..++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL   81 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence            567789999999999999764 68899999886542  223466788999999999999999999999999999999999


Q ss_pred             CCCChhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTS--NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      + +++.+++...  ...+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dl~p~nil~~~~~~~~l~  143 (285)
T cd07861          82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH----SRRVLHRDLKPQNLLIDNKGVIKLA  143 (285)
T ss_pred             C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH----hCCeeecCCCHHHEEEcCCCcEEEC
Confidence            7 5888887643  245888899999999999999999    8899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.91  E-value=1.4e-23  Score=165.46  Aligned_cols=133  Identities=22%  Similarity=0.317  Sum_probs=117.0

Q ss_pred             ecccCCCcceeeeEEeCC--C--cEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           94 NLISRGGFGSIYKARIQD--G--MEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      +.||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+..|+.+++.++||||+++++.+.. ...+++|||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999997643  2  3689999876654 556788899999999999999999999887 889999999999


Q ss_pred             CChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|.+++.... ..+++.....++.|++.||.|+|    ..+++||||||+||+++.++.+||+
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~di~p~nil~~~~~~~kl~  139 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE----SKRFIHRDLAARNILLASDDKVKIG  139 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH----hCCccccccCcccEEEecCCEEEec
Confidence            99999987654 45788999999999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.91  E-value=1.2e-23  Score=178.40  Aligned_cols=133  Identities=20%  Similarity=0.259  Sum_probs=116.7

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      ..|.+.+.||+|+||.||+|... +++.||+|...      ...+.+|+++++.++||||+++++++...+..+++||++
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~  242 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY  242 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence            35788899999999999999765 57889999642      133567999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      . ++|.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.++|+
T Consensus       243 ~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH----~~gIvHrDLKP~NILl~~~~~vkL~  302 (461)
T PHA03211        243 R-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH----GEGIIHRDIKTENVLVNGPEDICLG  302 (461)
T ss_pred             C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEEECcCCHHHEEECCCCCEEEc
Confidence            5 6898888765556899999999999999999999    8899999999999999999988875

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.91  E-value=1.5e-23  Score=169.57  Aligned_cols=141  Identities=29%  Similarity=0.459  Sum_probs=119.0

Q ss_pred             cccceeeecccCCCcceeeeEEeC--------CCcEEEEEEeeccc-CchHHHHHHHHHHhcCC-CCCCccceeEEEecC
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ--------DGMEVVVKGFNLQY-GGAFKNLDVECNMMKII-RHQNLIKIISSCSKD  156 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  156 (232)
                      .+.+.+.+.||+|+||.||+|+..        ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            344668899999999999999631        24578999886432 23456788899999999 899999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCcee
Q 042107          157 DFKALILEYMPHGSLGKCLSTSN---------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVL  221 (232)
Q Consensus       157 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nil  221 (232)
                      ...+++|||+++|+|.+++....               ..+++..+..++.|++.||.|||    .++++||||||+||+
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~givH~dlkp~Nil  169 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA----SQKCIHRDLAARNVL  169 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH----HCCeeecccccceEE
Confidence            99999999999999999986531               23677788899999999999999    889999999999999


Q ss_pred             eCCCCceeec
Q 042107          222 LDDNMVAHFL  231 (232)
Q Consensus       222 l~~~~~~~l~  231 (232)
                      ++.++.++|+
T Consensus       170 i~~~~~~kl~  179 (304)
T cd05101         170 VTENNVMKIA  179 (304)
T ss_pred             EcCCCcEEEC
Confidence            9999988875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.91  E-value=2.2e-23  Score=166.78  Aligned_cols=137  Identities=25%  Similarity=0.373  Sum_probs=122.1

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      |++.+.||+|+||.||+|+.. +++.||+|.+....  ....+.+.+|+.+++.++|||++++++++..+...++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   81 (286)
T cd07832           2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM   81 (286)
T ss_pred             ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence            567889999999999999764 68999999987654  333567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                       +++|.+++......+++..+..++.|++.||.|+|    ..+++|+||||+||+++.++.++++
T Consensus        82 -~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~~~~~~~~~l~  141 (286)
T cd07832          82 -PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH----ANGIMHRDLKPANLLISADGVLKIA  141 (286)
T ss_pred             -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCcCHHHEEEcCCCcEEEe
Confidence             99999998765556899999999999999999999    8899999999999999999888875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.91  E-value=1.6e-23  Score=168.97  Aligned_cols=139  Identities=27%  Similarity=0.477  Sum_probs=117.1

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCc--EEEEEEeecc-cCchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEEE
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGM--EVVVKGFNLQ-YGGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      .|++.+.||+|+||.||+|... ++.  .+++|.+... .....+.+.+|++++.++ +||||+++++++...+..+++|
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~   82 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAI   82 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEE
Confidence            4677889999999999999764 333  4688877532 223346688899999999 7999999999999989999999


Q ss_pred             eccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCce
Q 042107          164 EYMPHGSLGKCLSTSN---------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA  228 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~  228 (232)
                      ||+++++|.+++....               ..+++..+..++.|++.|++|||    .++++||||||+||++++++.+
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH----~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS----EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCcCCcceEEECCCCeE
Confidence            9999999999986431               24778888999999999999999    8899999999999999999988


Q ss_pred             eec
Q 042107          229 HFL  231 (232)
Q Consensus       229 ~l~  231 (232)
                      ||+
T Consensus       159 kl~  161 (297)
T cd05089         159 KIA  161 (297)
T ss_pred             EEC
Confidence            875

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.91  E-value=2.1e-23  Score=167.42  Aligned_cols=138  Identities=22%  Similarity=0.368  Sum_probs=112.0

Q ss_pred             cceeeecccCCCcceeeeEEe-C-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCC---CCCCccceeEEEec-----C
Q 042107           89 FLEVFNLISRGGFGSIYKARI-Q-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKII---RHQNLIKIISSCSK-----D  156 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~-~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~  156 (232)
                      .|++.+.||+|+||.||+|+. . ++..||+|.+....  ......+.+|+.+++.+   +||||+++++++..     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            367788999999999999975 3 46789999886543  22234455677766655   69999999998752     3


Q ss_pred             CeeEEEEeccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          157 DFKALILEYMPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       157 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ...++||||++ ++|.+++... ...+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.++|+
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH----~~~iiH~dlkp~Nil~~~~~~~kl~  152 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLA  152 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEEcCCCCEEEc
Confidence            46899999996 5898888653 334788899999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=4.8e-25  Score=193.98  Aligned_cols=138  Identities=22%  Similarity=0.294  Sum_probs=124.9

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeecc---cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQ---YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      -|++.++||+|+||.|..++.+ +++.||+|++.+.   ......-|+.|-.+|...+.+.|+.++-+|.++.++|+|||
T Consensus        76 DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMd  155 (1317)
T KOG0612|consen   76 DFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMD  155 (1317)
T ss_pred             hhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEe
Confidence            4678899999999999999764 6889999999764   23445668889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+||||-.++.... .+++..++.++.+++.||+-+|    ..|+|||||||+|||+|..|.+|+|
T Consensus       156 Y~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH----~mgyVHRDiKPDNvLld~~GHikLA  217 (1317)
T KOG0612|consen  156 YMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH----SMGYVHRDIKPDNVLLDKSGHIKLA  217 (1317)
T ss_pred             cccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH----hccceeccCCcceeEecccCcEeec
Confidence            999999999998876 6899999999999999999999    8999999999999999999999986

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.91  E-value=2.1e-23  Score=168.85  Aligned_cols=138  Identities=22%  Similarity=0.348  Sum_probs=121.1

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .|++.+.||+|+||.||+++.. +++.|++|.+....   ....+.+..|+++++.++||||+++++.+..++..+++||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            3667899999999999999764 57899999886553   2234567789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++++|.+++.... .+++..+..++.|++.|+.|+|    ..+++||||||+||+++.++.++++
T Consensus        82 ~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~NIll~~~~~~~l~  143 (305)
T cd05609          82 YVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH----NYGIVHRDLKPDNLLITSMGHIKLT  143 (305)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCchHHEEECCCCCEEEe
Confidence            999999999997653 4788888899999999999999    8899999999999999999988875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.91  E-value=2.4e-23  Score=167.91  Aligned_cols=138  Identities=27%  Similarity=0.378  Sum_probs=124.5

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      ..|++.+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++|||++++++.+...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4577889999999999999964 578999999997665555677888999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++...  .+++..+..++.+++.|+.|||    ..+++||||||+||+++.++.++|+
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH----~~~i~H~dL~p~Nili~~~~~~kl~  157 (296)
T cd06655          99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH----ANQVIHRDIKSDNVLLGMDGSVKLT  157 (296)
T ss_pred             CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEc
Confidence            999999988654  4788999999999999999999    8899999999999999999998875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.91  E-value=1.7e-23  Score=168.00  Aligned_cols=140  Identities=19%  Similarity=0.344  Sum_probs=116.6

Q ss_pred             ccceeeecccCCCcceeeeEEeC------CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ------DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  160 (232)
                      +.|++.+.||+|+||.||+|..+      .+..||+|.+..... .....+.+|+.+++.++||||+++++++...+..+
T Consensus         6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (288)
T cd05061           6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL   85 (288)
T ss_pred             HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            45678899999999999999643      245799998754432 22345678999999999999999999999888999


Q ss_pred             EEEeccCCCChhhhhccCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSN---------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|||+++|+|.+++....         ...++.....++.|++.||.|+|    .++++||||||+||+++.++.++++
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dikp~nili~~~~~~~L~  161 (288)
T cd05061          86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN----AKKFVHRDLAARNCMVAHDFTVKIG  161 (288)
T ss_pred             EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCCcCCCCChheEEEcCCCcEEEC
Confidence            9999999999999986421         22455677889999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.91  E-value=1.6e-23  Score=166.41  Aligned_cols=137  Identities=21%  Similarity=0.358  Sum_probs=117.6

Q ss_pred             ceeeecccCCCcceeeeEEeCC----CcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           90 LEVFNLISRGGFGSIYKARIQD----GMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      +.+.+.||+|+||.||+|...+    ...|++|...... ....+.+..|+.+++.++||||+++++++.. +..+++||
T Consensus         8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e   86 (270)
T cd05056           8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVME   86 (270)
T ss_pred             ceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEE
Confidence            5577899999999999997543    3468899886543 3345678889999999999999999998875 45789999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++++|.+++......+++..+..++.+++.|+.|+|    ..+++||||||+||+++.++.++++
T Consensus        87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~~H~dl~p~nili~~~~~~~l~  149 (270)
T cd05056          87 LAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE----SKRFVHRDIAARNVLVSSPDCVKLG  149 (270)
T ss_pred             cCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccChheEEEecCCCeEEc
Confidence            99999999999765556889999999999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.91  E-value=3.9e-23  Score=163.45  Aligned_cols=137  Identities=23%  Similarity=0.373  Sum_probs=118.1

Q ss_pred             cceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           89 FLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      .+.+.+.||+|++|.||++....+..+|+|.+..... ..+.+.+|+.+++.++|||++++++++. .+..+++|||+++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~   84 (260)
T cd05069           7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK   84 (260)
T ss_pred             HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence            4677889999999999999877777899998764432 3466788999999999999999998875 4568899999999


Q ss_pred             CChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|.+++... ...+++..+..++.|++.||.|+|    ..+++||||||+||++++++.++|+
T Consensus        85 ~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH----~~~i~H~dl~~~Nill~~~~~~~l~  144 (260)
T cd05069          85 GSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE----RMNYIHRDLRAANILVGDNLVCKIA  144 (260)
T ss_pred             CCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccCcceEEEcCCCeEEEC
Confidence            9999999754 334788889999999999999999    8899999999999999999998875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=2.7e-23  Score=164.39  Aligned_cols=138  Identities=25%  Similarity=0.406  Sum_probs=120.5

Q ss_pred             cceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC-----chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           89 FLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG-----GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .|++.+.||+|++|.||+|.. .+++.+|+|.+.....     ...+.+.+|+++++.++||||+++++++..++..+++
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   82 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF   82 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence            356788999999999999975 4689999998865421     1235678899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +||+++++|.+++.... .+++..+..++.|++.|+.|||    ..+++||||+|+||+++.++.++|+
T Consensus        83 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nilv~~~~~~~l~  146 (263)
T cd06625          83 MEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH----SNMIVHRDIKGANILRDSAGNVKLG  146 (263)
T ss_pred             EEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEe
Confidence            99999999999887643 4788888999999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=5.1e-24  Score=171.60  Aligned_cols=141  Identities=27%  Similarity=0.437  Sum_probs=118.7

Q ss_pred             cccccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcC--CCCCCccceeEEEecCC----e
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKI--IRHQNLIKIISSCSKDD----F  158 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~  158 (232)
                      .+.....+.+.||+|.||.||+|+|+ |+.||||++...++   +.+.+|.++...  ++|+||..+++.-..++    .
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            45556678899999999999999998 88999999976654   445667777764  69999999998755443    6


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcC----CCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          159 KALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG----HSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|||++|.+.|+|+++|...  .++....++++..+|.||++||..    .....|.|||||..|||+..++.+.||
T Consensus       284 LwLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             EEEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence            79999999999999999874  488888999999999999999921    235689999999999999999998876

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.91  E-value=1.9e-23  Score=166.03  Aligned_cols=133  Identities=22%  Similarity=0.351  Sum_probs=110.8

Q ss_pred             cccCCCcceeeeEEeCCC---cEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCC
Q 042107           95 LISRGGFGSIYKARIQDG---MEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGS  170 (232)
Q Consensus        95 ~lg~g~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  170 (232)
                      .||+|+||.||+++..++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......+++|||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            589999999999975433   345666665432 2345678889999999999999999999999889999999999999


Q ss_pred             hhhhhccCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          171 LGKCLSTSN---YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       171 L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |.+++....   ...++.....++.|++.||.|+|    ..+++||||||+|||++.++.++|+
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH----~~~i~H~dikp~nil~~~~~~~~l~  141 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH----KHNFLHSDLALRNCFLTSDLTVKVG  141 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH----HCCeeccCCccceEEEcCCccEEec
Confidence            999987531   23556667889999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.91  E-value=1e-23  Score=169.02  Aligned_cols=139  Identities=23%  Similarity=0.371  Sum_probs=121.1

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      .|++.+.||+|+||.||+++.. ++..||+|.+.... ......+.+|+.+++.++||||+++++.+..++..+++|||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            3567889999999999999765 78999999886542 233467888999999999999999999999999999999999


Q ss_pred             CCCChhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTS--NYILDFFQRLHIMIDVASAVEYLHFGHST-HVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++...  ...+++..+..++.+++.|+.|||    . .+++||||||+||+++.++.++|+
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~~i~H~dl~p~nil~~~~~~~~l~  145 (286)
T cd06622          82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK----EEHNIIHRDVKPTNVLVNGNGQVKLC  145 (286)
T ss_pred             CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH----hcCCEeeCCCCHHHEEECCCCCEEEe
Confidence            999999988753  235889999999999999999999    4 489999999999999999988875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.91  E-value=2.9e-23  Score=165.82  Aligned_cols=138  Identities=22%  Similarity=0.321  Sum_probs=117.4

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCc----EEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGM----EVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+++.+.||+|+||.||+|++. ++.    .||+|.+.... ....+.+..|+.+++.++||||+++++++.. ...+++
T Consensus         8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~   86 (279)
T cd05109           8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLV   86 (279)
T ss_pred             heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEE
Confidence            4567889999999999999753 444    48999886543 2334667889999999999999999998865 457799


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +||+++|+|.+++......+++..+..++.|++.||.|+|    .++++||||||+||+++.++.+||+
T Consensus        87 ~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~iiH~dlkp~Nil~~~~~~~kL~  151 (279)
T cd05109          87 TQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE----EVRLVHRDLAARNVLVKSPNHVKIT  151 (279)
T ss_pred             EEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccccccceEEEcCCCcEEEC
Confidence            9999999999999775556889999999999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.91  E-value=1.1e-23  Score=166.35  Aligned_cols=137  Identities=26%  Similarity=0.385  Sum_probs=122.5

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      |++.+.||+|+||.||+|+.. +++.||+|.+....   ....+.+.+|+++++.++||||+++++.+..++..++++||
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (258)
T cd05578           2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL   81 (258)
T ss_pred             ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence            577899999999999999765 68899999997543   23457788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++++|.+++... ..+++..+..++.|+++||.|||    ..+++|+||+|+||++++++.++|+
T Consensus        82 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh----~~~i~h~dl~~~nil~~~~~~~~l~  142 (258)
T cd05578          82 LLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH----SKGIIHRDIKPDNILLDEQGHVHIT  142 (258)
T ss_pred             CCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeEEcCCCCEEEe
Confidence            9999999998765 35888899999999999999999    8899999999999999999998875

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.91  E-value=2.6e-23  Score=163.80  Aligned_cols=137  Identities=28%  Similarity=0.395  Sum_probs=120.6

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc-----CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY-----GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      |+..+.||+|++|.||+|... ++..|++|.+....     ....+.+.+|+++++.++||||+++++++..++..+++|
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   81 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL   81 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence            345678999999999999765 78999999986543     224567888999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+++++|.+++.... .+++..+..++.|++.|+.|+|    ..+++|+||+|+||+++.++.+||+
T Consensus        82 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~~~ni~~~~~~~~kl~  144 (258)
T cd06632          82 ELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH----DRNTVHRDIKGANILVDTNGVVKLA  144 (258)
T ss_pred             EecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEc
Confidence            9999999999987643 4788888999999999999999    8899999999999999999999885

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.91  E-value=2.5e-23  Score=166.44  Aligned_cols=138  Identities=25%  Similarity=0.530  Sum_probs=118.0

Q ss_pred             ceeeecccCCCcceeeeEEeCC------CcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           90 LEVFNLISRGGFGSIYKARIQD------GMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      +++.+.||+|+||.||+|....      ...||+|.+..... .....+.+|+.+++.++||||+++++++...+..+++
T Consensus         7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   86 (283)
T cd05048           7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML   86 (283)
T ss_pred             cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence            5677899999999999997532      25789998864432 2345688899999999999999999999988899999


Q ss_pred             EeccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCc
Q 042107          163 LEYMPHGSLGKCLSTSN---------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV  227 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~  227 (232)
                      |||+++++|.+++....               ..+++.....++.|++.||.|||    ..+++||||||+||++++++.
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH----~~~i~H~dlkp~Nil~~~~~~  162 (283)
T cd05048          87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS----SHHFVHRDLAARNCLVGEGLT  162 (283)
T ss_pred             EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccccceEEEcCCCc
Confidence            99999999999986431               34677888999999999999999    889999999999999999998


Q ss_pred             eeec
Q 042107          228 AHFL  231 (232)
Q Consensus       228 ~~l~  231 (232)
                      ++|+
T Consensus       163 ~~L~  166 (283)
T cd05048         163 VKIS  166 (283)
T ss_pred             EEEC
Confidence            8875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.91  E-value=1e-23  Score=174.26  Aligned_cols=132  Identities=20%  Similarity=0.267  Sum_probs=115.7

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccC
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      .|++.+.||+|+||.||+|+.. ++..||+|.....      ....|+.+++.++||||+++++++...+..++|||++.
T Consensus        67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  140 (357)
T PHA03209         67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS  140 (357)
T ss_pred             CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence            4788999999999999999765 5778999975322      23458999999999999999999999999999999995


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                       ++|.+++......+++..+..++.|++.||.|||    .++|+||||||+|||++.++.++|+
T Consensus       141 -~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~kl~  199 (357)
T PHA03209        141 -SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH----AQRIIHRDVKTENIFINDVDQVCIG  199 (357)
T ss_pred             -CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEe
Confidence             5888888766566899999999999999999999    8899999999999999999998875

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.91  E-value=2.4e-23  Score=165.55  Aligned_cols=136  Identities=27%  Similarity=0.449  Sum_probs=112.6

Q ss_pred             eeecccCCCcceeeeEEeCC-Cc--EEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecC------CeeE
Q 042107           92 VFNLISRGGFGSIYKARIQD-GM--EVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKD------DFKA  160 (232)
Q Consensus        92 ~~~~lg~g~~g~V~~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~  160 (232)
                      +.+.||+|+||.||+|+..+ +.  .+|+|.+....  ....+.+..|+++++.++||||+++++.+...      ...+
T Consensus         3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   82 (272)
T cd05075           3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV   82 (272)
T ss_pred             cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence            56789999999999998654 32  58999876542  33456788899999999999999999977432      2468


Q ss_pred             EEEeccCCCChhhhhcc-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLST-----SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|||+++|+|.+++..     ....+++.....++.|++.||.|+|    .++|+||||||+||+++.++.++|+
T Consensus        83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~  154 (272)
T cd05075          83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS----SKSFIHRDLAARNCMLNENMNVCVA  154 (272)
T ss_pred             EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH----HCCeeccccchhheEEcCCCCEEEC
Confidence            99999999999988742     2234788889999999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.91  E-value=2.4e-23  Score=165.46  Aligned_cols=137  Identities=29%  Similarity=0.481  Sum_probs=115.3

Q ss_pred             eeeecccCCCcceeeeEEeC-C---CcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCCe------
Q 042107           91 EVFNLISRGGFGSIYKARIQ-D---GMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF------  158 (232)
Q Consensus        91 ~~~~~lg~g~~g~V~~~~~~-~---~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------  158 (232)
                      .+.+.||+|+||.||+|... +   +..||+|.+.....  .....+..|+..++.++||||+++++.+...+.      
T Consensus         2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   81 (273)
T cd05035           2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK   81 (273)
T ss_pred             ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence            46788999999999999753 2   46799999865432  234678889999999999999999998765443      


Q ss_pred             eEEEEeccCCCChhhhhccC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          159 KALILEYMPHGSLGKCLSTS-----NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .+++|||+++|+|..++...     ...+++..+..++.|++.||.|+|    ..+++|||+||+||++++++.+||+
T Consensus        82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~  155 (273)
T cd05035          82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS----NRNFIHRDLAARNCMLREDMTVCVA  155 (273)
T ss_pred             cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH----hCCeeccccchheEEECCCCeEEEC
Confidence            78999999999999887432     235788889999999999999999    8899999999999999999998875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.91  E-value=2.8e-23  Score=164.24  Aligned_cols=134  Identities=23%  Similarity=0.415  Sum_probs=112.8

Q ss_pred             ecccCCCcceeeeEEeC----CCcEEEEEEeecc-cCchHHHHHHHHHHhcCCCCCCccceeEEEe-cCCeeEEEEeccC
Q 042107           94 NLISRGGFGSIYKARIQ----DGMEVVVKGFNLQ-YGGAFKNLDVECNMMKIIRHQNLIKIISSCS-KDDFKALILEYMP  167 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~  167 (232)
                      +.||+|+||.||+|...    +...+|+|.+... .....+.+..|+.+++.++||||+++++++. .++..+++|||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999743    2457999987543 2334567888999999999999999999765 4556889999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|+|.+++.......++.....++.|++.|+.|+|    ..+++||||||+||++++++.++|+
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlk~~nili~~~~~~kl~  140 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA----SKKFVHRDLAARNCMLDESFTVKVA  140 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccCcceEEEcCCCcEEEC
Confidence            99999999765445677778889999999999999    8899999999999999999998875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.91  E-value=3.1e-23  Score=163.34  Aligned_cols=137  Identities=26%  Similarity=0.493  Sum_probs=120.4

Q ss_pred             eeeecccCCCcceeeeEEeCC-----CcEEEEEEeecccCc-hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           91 EVFNLISRGGFGSIYKARIQD-----GMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        91 ~~~~~lg~g~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      ++.+.||+|+||.||+++...     +..||+|.+...... ..+.+..|+.+++.++|+||+++++.+...+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            356789999999999997653     378999998655433 46778889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYI-LDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++++|.+++...... +++..+..++.|++.|+.|+|    ..+++|||+||+||+++.++.++++
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh----~~~~~h~dl~~~nil~~~~~~~~l~  145 (258)
T smart00219       82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE----SKNFIHRDLAARNCLVGENLVVKIS  145 (258)
T ss_pred             ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh----cCCeeecccccceEEEccCCeEEEc
Confidence            99999999998765433 889999999999999999999    8899999999999999999988875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.91  E-value=3.9e-23  Score=165.36  Aligned_cols=138  Identities=25%  Similarity=0.317  Sum_probs=120.1

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      .|++.+.||+|+||.||+|+.+ +++.||+|.+....  ....+.+..|+.+++.++|||++++++++......+++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~   81 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY   81 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence            4677889999999999999765 68899999886442  22335677899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++++..++... ..+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        82 ~~~~~l~~~~~~~-~~~~~~~~~~~~~ql~~~l~~LH----~~~i~H~dl~p~nil~~~~~~~~l~  142 (286)
T cd07847          82 CDHTVLNELEKNP-RGVPEHLIKKIIWQTLQAVNFCH----KHNCIHRDVKPENILITKQGQIKLC  142 (286)
T ss_pred             cCccHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH----HCCceecCCChhhEEEcCCCcEEEC
Confidence            9998888876543 34889999999999999999999    8899999999999999999998875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=1.8e-23  Score=179.36  Aligned_cols=142  Identities=23%  Similarity=0.284  Sum_probs=119.9

Q ss_pred             ccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCC-----
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD-----  157 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  157 (232)
                      ....|.+.+.||+|+||.||+|+. .+++.||+|.+....  ......+.+|+.++..++|+|++++++.+...+     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            345788999999999999999965 578999999986543  233456778999999999999999887764322     


Q ss_pred             ---eeEEEEeccCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          158 ---FKALILEYMPHGSLGKCLSTS---NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       158 ---~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                         ..++||||+++|+|.+++...   ...+++..+..++.|++.||.|+|    ..+|+||||||+|||++.++.+||+
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH----~~~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH----SKHMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEeCCCCEEEE
Confidence               368999999999999988643   235788889999999999999999    8899999999999999999999885

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.91  E-value=3e-23  Score=163.40  Aligned_cols=138  Identities=24%  Similarity=0.399  Sum_probs=123.9

Q ss_pred             ccceeeecccCCCcceeeeEEeCC-CcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQD-GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      +.|+..+.||+|+||.||+|.... +..+++|.+.....  .+.+.+|+++++.++||||+++++.+..+...++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            346778899999999999998764 78999999865432  578899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++......+++..+..++.|++.|+.|||    ..+++|+|++|+||+++.++.++|+
T Consensus        81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh----~~~i~H~dl~~~ni~~~~~~~~~l~  141 (256)
T cd06612          81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH----SNKKIHRDIKAGNILLNEEGQAKLA  141 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEECCCCcEEEc
Confidence            999999999765556899999999999999999999    8899999999999999999998885

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.90  E-value=2.7e-23  Score=167.10  Aligned_cols=140  Identities=27%  Similarity=0.436  Sum_probs=118.9

Q ss_pred             ccceeeecccCCCcceeeeEEeC------CCcEEEEEEeeccc-CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCee
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ------DGMEVVVKGFNLQY-GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFK  159 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  159 (232)
                      +.|++.+.||+|+||.||++...      ....+|+|.+.... ......+.+|+++++.+ +||||+++++++..++..
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   91 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL   91 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence            34567889999999999999753      23678999886532 23345678899999999 799999999999999999


Q ss_pred             EEEEeccCCCChhhhhccC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC
Q 042107          160 ALILEYMPHGSLGKCLSTS---------------NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD  224 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~  224 (232)
                      +++|||+++|+|.+++...               ...+++..+..++.|++.|+.|||    ..+|+||||||+||+++.
T Consensus        92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivH~dlkp~Nil~~~  167 (293)
T cd05053          92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA----SKKCIHRDLAARNVLVTE  167 (293)
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----HCCccccccceeeEEEcC
Confidence            9999999999999998532               235788889999999999999999    889999999999999999


Q ss_pred             CCceeec
Q 042107          225 NMVAHFL  231 (232)
Q Consensus       225 ~~~~~l~  231 (232)
                      ++.++++
T Consensus       168 ~~~~kL~  174 (293)
T cd05053         168 DHVMKIA  174 (293)
T ss_pred             CCeEEeC
Confidence            9998875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.90  E-value=2.4e-23  Score=168.28  Aligned_cols=140  Identities=25%  Similarity=0.352  Sum_probs=120.2

Q ss_pred             ccceeeecccCCCcceeeeEEe------CCCcEEEEEEeeccc-CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCee
Q 042107           88 NFLEVFNLISRGGFGSIYKARI------QDGMEVVVKGFNLQY-GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFK  159 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  159 (232)
                      +.+.+.+.||+|+||.||++..      .++..+|+|.+.... ....+.+..|+.+++.+ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            4467888999999999999963      235579999886543 23346688899999999 799999999999999999


Q ss_pred             EEEEeccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          160 ALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|||+++|+|.+++.... ..+++.+...++.|++.|+.|+|    ..+++|+||||+||+++.++.++++
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~~l~  183 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNVLLTHGKIVKIC  183 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeehhhhccceEEEcCCCeEEEC
Confidence            99999999999999987542 34789999999999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.90  E-value=3.7e-23  Score=164.50  Aligned_cols=134  Identities=32%  Similarity=0.574  Sum_probs=113.7

Q ss_pred             ecccCCCcceeeeEEeC-CCc--EEEEEEeeccc-CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEEEeccCC
Q 042107           94 NLISRGGFGSIYKARIQ-DGM--EVVVKGFNLQY-GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      +.||+|+||.||+|+.. ++.  .+++|.+.... ....+.+..|++++.++ +||||+++++++...+..+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36899999999999765 343  46888776432 23446788899999999 799999999999999999999999999


Q ss_pred             CChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSN---------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+|.+++....               ..+++..+..++.|++.|++|+|    ..+++||||||+||++++++.+|++
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH----~~~i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccccceEEEcCCCeEEEC
Confidence            99999986431               23678888999999999999999    8899999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.90  E-value=3.8e-23  Score=165.20  Aligned_cols=133  Identities=20%  Similarity=0.237  Sum_probs=116.0

Q ss_pred             ceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccC
Q 042107           90 LEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      +++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+..|+++++.++||||+++++.+..++..+++|||++
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   82 (279)
T cd06619           3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD   82 (279)
T ss_pred             chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence            46778999999999999975 578899999986542 2334568889999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++..+.     .+++..+..++.|++.|+.|+|    ..+++|+||||+||+++.++.++|+
T Consensus        83 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nill~~~~~~~l~  137 (279)
T cd06619          83 GGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW----SLKILHRDVKPSNMLVNTRGQVKLC  137 (279)
T ss_pred             CCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH----HCCEeeCCCCHHHEEECCCCCEEEe
Confidence            99987542     3677788899999999999999    8899999999999999999998875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.90  E-value=1.4e-23  Score=172.15  Aligned_cols=140  Identities=26%  Similarity=0.406  Sum_probs=116.3

Q ss_pred             ccceeeecccCCCcceeeeEEeC------CCcEEEEEEeecccC-chHHHHHHHHHHhcCC-CCCCccceeEEEecC-Ce
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ------DGMEVVVKGFNLQYG-GAFKNLDVECNMMKII-RHQNLIKIISSCSKD-DF  158 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~~  158 (232)
                      +.|++.+.||+|+||.||+|...      +++.||+|++..... ...+.+..|+.++..+ +||||+++++++... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            35778899999999999999532      357899998864322 2345677899999999 799999999987654 57


Q ss_pred             eEEEEeccCCCChhhhhccCC-----------------------------------------------------------
Q 042107          159 KALILEYMPHGSLGKCLSTSN-----------------------------------------------------------  179 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  179 (232)
                      .+++|||+++++|.+++....                                                           
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            889999999999998875321                                                           


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          180 -YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       180 -~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                       ..+++..+..++.|++.||.|+|    ..+|+||||||+||++++++.++|+
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH----~~~ivHrDikp~Nill~~~~~vkL~  215 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLA----SRKCIHRDLAARNILLSENNVVKIC  215 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCcceEEEeCCCcEEEe
Confidence             14688889999999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.90  E-value=1.1e-23  Score=169.63  Aligned_cols=141  Identities=25%  Similarity=0.354  Sum_probs=123.2

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      ...+.+.....||+|+||.||++... ++..||+|.+........+.+.+|+.+++.++||||+++++.+...+..+++|
T Consensus        19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence            34455556678999999999999754 68899999987655555667889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+++++|.+++...  .+++..+..++.|++.|+.|+|    ..+++||||||+||+++.++.++|+
T Consensus        99 e~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nill~~~~~~kL~  160 (292)
T cd06658          99 EFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLH----NQGVIHRDIKSDSILLTSDGRIKLS  160 (292)
T ss_pred             eCCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEcCCCCEEEc
Confidence            999999999988643  4788889999999999999999    8899999999999999999998875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.90  E-value=3.8e-23  Score=165.00  Aligned_cols=141  Identities=25%  Similarity=0.370  Sum_probs=118.0

Q ss_pred             cccceeeecccCCCcceeeeEEeC------CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCee
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ------DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFK  159 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  159 (232)
                      .+.+.+.+.||+|++|.||+|...      .+..|++|.+..... .....+..|+.+++.++|+||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            345678899999999999999764      356788998764432 2335688899999999999999999999888889


Q ss_pred             EEEEeccCCCChhhhhccCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC---ceee
Q 042107          160 ALILEYMPHGSLGKCLSTSN------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM---VAHF  230 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~---~~~l  230 (232)
                      +++|||+++++|.+++....      ..+++..+..++.|++.|+.|||    ..+++||||||+||+++.++   .+|+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE----ENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccchheEEEeccCCCcceEe
Confidence            99999999999999986542      24788889999999999999999    88999999999999998754   3555


Q ss_pred             c
Q 042107          231 L  231 (232)
Q Consensus       231 ~  231 (232)
                      +
T Consensus       161 ~  161 (277)
T cd05036         161 A  161 (277)
T ss_pred             c
Confidence            3

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=3.6e-24  Score=175.68  Aligned_cols=143  Identities=22%  Similarity=0.256  Sum_probs=125.9

Q ss_pred             cccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCc--hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGG--AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      .+...|.+.+.||+|.|++|-+|++ -+|..||||++.+....  ....+..|+.+|+-++|||||++|++..++..+||
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL   94 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL   94 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence            4566788999999999999999974 47999999999776433  34567889999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC-CCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD-NMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~-~~~~~l~  231 (232)
                      |+|.=.+|+|++++-.+...+.+..+.+++.||+.|+.|+|    ...+|||||||+||.+-+ -|-+|+.
T Consensus        95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH----qLHVVHRDLKPENVVFFEKlGlVKLT  161 (864)
T KOG4717|consen   95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH----QLHVVHRDLKPENVVFFEKLGLVKLT  161 (864)
T ss_pred             EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh----hhhhhcccCCcceeEEeeecCceEee
Confidence            99999999999999887777999999999999999999999    778999999999998755 4666663

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.90  E-value=3.8e-24  Score=173.42  Aligned_cols=136  Identities=29%  Similarity=0.444  Sum_probs=116.0

Q ss_pred             ceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhc--CCCCCCccceeEEEecCC----eeEEEE
Q 042107           90 LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMK--IIRHQNLIKIISSCSKDD----FKALIL  163 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~--~l~h~niv~~~~~~~~~~----~~~lv~  163 (232)
                      .++.+++|+|+||.||+|.+. ++.||||++....   .+.+..|-++.+  .++|+||++++++-....    ..+||+
T Consensus       212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc-CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            456789999999999999886 5899999997653   345666666665  468999999998865544    789999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcC-----CCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG-----HSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-----~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||.+.|+|.++++.+  .++|....+++..+++||+|||+.     +.+.+|+|||+|..|||+..|+++.||
T Consensus       288 ~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa  358 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA  358 (534)
T ss_pred             eeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence            999999999999876  489999999999999999999953     446789999999999999999999886

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.90  E-value=3.9e-23  Score=163.42  Aligned_cols=139  Identities=23%  Similarity=0.385  Sum_probs=120.5

Q ss_pred             cccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      .+.+++.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|+++++.++|+||+++++.+.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            34567889999999999999987777889999876432 234678889999999999999999998877 7789999999


Q ss_pred             CCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++... ....++..+..++.|++.||.|+|    ..+++||||||+||+++.++.++|+
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH----~~~i~H~dl~p~ni~i~~~~~~~l~  144 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE----QRNYIHRDLRAANILVSASLVCKIA  144 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH----hCCccccccCcceEEEcCCCcEEEC
Confidence            999999998753 344778888999999999999999    7899999999999999999998885

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.90  E-value=3.5e-23  Score=166.59  Aligned_cols=140  Identities=23%  Similarity=0.375  Sum_probs=119.8

Q ss_pred             ccceeeecccCCCcceeeeEEeCC-----------------CcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccce
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQD-----------------GMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKI  149 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~  149 (232)
                      ..|++.+.||+|+||.||++....                 +..||+|.+..... ...+.+.+|+++++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            346788999999999999986432                 24589998865432 345678889999999999999999


Q ss_pred             eEEEecCCeeEEEEeccCCCChhhhhccCC----------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCc
Q 042107          150 ISSCSKDDFKALILEYMPHGSLGKCLSTSN----------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSN  219 (232)
Q Consensus       150 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~N  219 (232)
                      ++++..++..+++|||+++++|.+++....          ..+++..+..++.|++.||.|||    ..+++||||||+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH----~~~i~H~dlkp~N  160 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE----SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH----HcCccccccchhc
Confidence            999999899999999999999999986542          24788899999999999999999    8899999999999


Q ss_pred             eeeCCCCceeec
Q 042107          220 VLLDDNMVAHFL  231 (232)
Q Consensus       220 ill~~~~~~~l~  231 (232)
                      |+++.++.++++
T Consensus       161 ili~~~~~~~l~  172 (296)
T cd05051         161 CLVGKNYTIKIA  172 (296)
T ss_pred             eeecCCCceEEc
Confidence            999999988875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.90  E-value=3.6e-23  Score=166.27  Aligned_cols=139  Identities=19%  Similarity=0.290  Sum_probs=118.3

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      +.|.+.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++|+||+++++++..++..++||||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY   84 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence            4577889999999999999975 4688999999865432 2234567899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++ +++.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        85 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~  145 (291)
T cd07870          85 MH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH----GQHILHRDLKPQNLLISYLGELKLA  145 (291)
T ss_pred             cc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHHEEEcCCCcEEEe
Confidence            96 6777776554445777888899999999999999    8899999999999999999998875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.90  E-value=4.7e-23  Score=164.24  Aligned_cols=140  Identities=16%  Similarity=0.313  Sum_probs=119.2

Q ss_pred             ccceeeecccCCCcceeeeEEeC------CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ------DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  160 (232)
                      +.+.+.+.||+|+||.||+|...      ++..||+|.+.... ......+.+|+.+++.++||||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            44668899999999999999653      24689999986443 233456788999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhccCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSN---------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|||+++|+|.+++....         ..+++..+..++.|++.||.|+|    ..+++||||||+||+++.++.++|+
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA----AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccChheEEEcCCCCEEEC
Confidence            9999999999999986421         23677888999999999999999    8899999999999999999999885

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.90  E-value=2.1e-23  Score=165.44  Aligned_cols=139  Identities=24%  Similarity=0.376  Sum_probs=120.6

Q ss_pred             cceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .|++.+.||+|+||.||+++. .++..+++|.+....   ....+.+..|+.+++.++||||+++++++..++..+++||
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE   82 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence            356778999999999999975 578999999886532   2234567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLST---SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++++|.+++..   ....+++..+..++.|++.|+.|||    ..+++|+||||+||+++.++.++++
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~p~nili~~~~~~~l~  148 (267)
T cd08229          83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH----SRRVMHRDIKPANVFITATGVVKLG  148 (267)
T ss_pred             ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCCEEEC
Confidence            9999999998863   2345788899999999999999999    8899999999999999999988875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.90  E-value=6.7e-23  Score=161.67  Aligned_cols=136  Identities=28%  Similarity=0.431  Sum_probs=117.3

Q ss_pred             cceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEe-cCCeeEEEEeccC
Q 042107           89 FLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS-KDDFKALILEYMP  167 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~  167 (232)
                      .+++.+.||+|+||.||++... +..+|+|.....  ...+.+..|+.+++.++|++++++++++. ..+..+++|||++
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~   83 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   83 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence            3567889999999999999765 778999987543  23467888999999999999999999754 4567899999999


Q ss_pred             CCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|.+++.... ..+++..+..++.|++.||.|+|    ..+++||||||+||++++++.++++
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nil~~~~~~~kl~  144 (256)
T cd05082          84 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----ANNFVHRDLAARNVLVSEDNVAKVS  144 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeccccchheEEEcCCCcEEec
Confidence            999999987643 34788889999999999999999    8899999999999999999999885

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.90  E-value=1.7e-24  Score=168.28  Aligned_cols=135  Identities=27%  Similarity=0.386  Sum_probs=120.7

Q ss_pred             ccccccee-eecccCCCcceeeeEE-eCCCcEEEEEEeecccCchHHHHHHHHHHhcCCC-CCCccceeEEEecCCeeEE
Q 042107           85 PFRNFLEV-FNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-HQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        85 ~~~~~~~~-~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~l  161 (232)
                      .|.+.|++ .+.||+|+|+.|-.|. ..+|.++|||++.++......++.+|++++..++ |+||++++++|+++...||
T Consensus        74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL  153 (463)
T KOG0607|consen   74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL  153 (463)
T ss_pred             hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence            35555654 4679999999999994 6789999999999887778888999999999885 9999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD  224 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~  224 (232)
                      |||-|.||+|...+..+. .+++..+.++..+|+.||.|||    .+||.|||+||+|||-..
T Consensus       154 VfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH----~kgIAHRDlKPENiLC~~  211 (463)
T KOG0607|consen  154 VFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLH----TKGIAHRDLKPENILCES  211 (463)
T ss_pred             EEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHh----hcCcccccCCccceeecC
Confidence            999999999999888754 5888999999999999999999    899999999999999754

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.90  E-value=4e-23  Score=164.28  Aligned_cols=137  Identities=28%  Similarity=0.454  Sum_probs=118.7

Q ss_pred             ceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC----------chHHHHHHHHHHhcCCCCCCccceeEEEecCCe
Q 042107           90 LEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG----------GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF  158 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  158 (232)
                      |...+.||+|+||.||+|.. .+++.+|+|.+.....          ...+.+..|+.+++.++|||++++++++...+.
T Consensus         3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   82 (272)
T cd06629           3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY   82 (272)
T ss_pred             eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence            45678899999999999965 4688999998854211          113457789999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          159 KALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .++||||+++++|.+++.... .+++..+..++.|++.||.|+|    ..+++||||+|+||+++.++.++++
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~~~nil~~~~~~~~l~  150 (272)
T cd06629          83 LSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH----SKGILHRDLKADNLLVDADGICKIS  150 (272)
T ss_pred             eEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh----hCCeeecCCChhhEEEcCCCeEEEe
Confidence            999999999999999987653 5788888999999999999999    7899999999999999999988875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.90  E-value=3.3e-23  Score=166.40  Aligned_cols=138  Identities=27%  Similarity=0.392  Sum_probs=116.5

Q ss_pred             ceeeecccCCCcceeeeEEeC------CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           90 LEVFNLISRGGFGSIYKARIQ------DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      +++.+.||+|+||.||+|...      ....+++|.+..... ...+.+..|+.+++.++||||+++++.+..++..+++
T Consensus         2 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (290)
T cd05045           2 LVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLI   81 (290)
T ss_pred             ccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEE
Confidence            456789999999999999642      235688888754432 2346688899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccC-----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCc
Q 042107          163 LEYMPHGSLGKCLSTS-----------------------NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSN  219 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~-----------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~N  219 (232)
                      |||+++++|.+++...                       ...+++..+..++.|++.||.|||    ..+++||||||+|
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH----~~~ivH~dikp~n  157 (290)
T cd05045          82 VEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA----EMKLVHRDLAARN  157 (290)
T ss_pred             EEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH----HCCeehhhhhhhe
Confidence            9999999999987532                       123678888999999999999999    8899999999999


Q ss_pred             eeeCCCCceeec
Q 042107          220 VLLDDNMVAHFL  231 (232)
Q Consensus       220 ill~~~~~~~l~  231 (232)
                      |++++++.++|+
T Consensus       158 ill~~~~~~kl~  169 (290)
T cd05045         158 VLVAEGRKMKIS  169 (290)
T ss_pred             EEEcCCCcEEec
Confidence            999999998875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.90  E-value=3e-23  Score=166.00  Aligned_cols=138  Identities=22%  Similarity=0.411  Sum_probs=117.5

Q ss_pred             ceeeecccCCCcceeeeEEeC------CCcEEEEEEeecccCc-hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           90 LEVFNLISRGGFGSIYKARIQ------DGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      +++.+.||+|+||.||+|...      ++..||+|.+...... ..+.+..|+.++..++||||+++++++...+..+++
T Consensus         7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~   86 (283)
T cd05091           7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI   86 (283)
T ss_pred             HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence            456788999999999999753      2578999998754332 245678899999999999999999999998999999


Q ss_pred             EeccCCCChhhhhccC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCc
Q 042107          163 LEYMPHGSLGKCLSTS---------------NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV  227 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~  227 (232)
                      +||+++++|.+++...               ...+++..+..++.|++.||.|+|    .++++||||||+||++++++.
T Consensus        87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH----~~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS----SHHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH----HcCccccccchhheEecCCCc
Confidence            9999999999987521               123677788899999999999999    889999999999999999998


Q ss_pred             eeec
Q 042107          228 AHFL  231 (232)
Q Consensus       228 ~~l~  231 (232)
                      +||+
T Consensus       163 ~kl~  166 (283)
T cd05091         163 VKIS  166 (283)
T ss_pred             eEec
Confidence            8875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.90  E-value=5.8e-23  Score=162.17  Aligned_cols=131  Identities=23%  Similarity=0.332  Sum_probs=112.8

Q ss_pred             cccCCCcceeeeEEe---CCCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCC
Q 042107           95 LISRGGFGSIYKARI---QDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHG  169 (232)
Q Consensus        95 ~lg~g~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  169 (232)
                      .||+|+||.||+|.+   .++..+|+|.+.....  ...+.+..|+.+++.++||||+++++++.. +..+++|||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999964   3578899998864432  235678889999999999999999998754 5678999999999


Q ss_pred             ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          170 SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       170 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|.+++.... .+++..+..++.|++.|+.|+|    .++++||||||+||+++.++.++|+
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dlkp~nill~~~~~~kl~  137 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE----ETNFVHRDLAARNVLLVTQHYAKIS  137 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEeecccchhhEEEcCCCeEEEC
Confidence            9999987543 5788899999999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.90  E-value=3e-23  Score=171.61  Aligned_cols=139  Identities=22%  Similarity=0.290  Sum_probs=116.2

Q ss_pred             cccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecc--cCchHHHHHHHHHHhcCCCCCCccceeEEEecCC----
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQ--YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD----  157 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  157 (232)
                      .+.+.|++.+.||+|+||.||+++. .++..||+|.+...  .......+.+|+.+++.++||||+++++++....    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            3456688999999999999999975 46899999998643  2233466778999999999999999999886543    


Q ss_pred             --eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          158 --FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       158 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                        ..++||||+++ ++.+.+..   .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.++|+
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH----~~~ivHrDlkp~NIl~~~~~~~kl~  165 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKIL  165 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEe
Confidence              46999999976 56665543   3677888899999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.1e-24  Score=181.00  Aligned_cols=137  Identities=23%  Similarity=0.362  Sum_probs=121.7

Q ss_pred             ceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           90 LEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      |..++.||.|+||.||-++. ++.+.||||++.-..   ...++.+..|+..+..++|||++.+.|+|..+...||||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            44568899999999999964 578899999996543   34567788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |-| +-.+++.....++.+..+..|+.+.+.||+|||    +.+.||||||+.|||+++.|.+|++
T Consensus       108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH----S~~~IHRDiKAGNILLse~g~VKLa  168 (948)
T KOG0577|consen  108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNRIHRDIKAGNILLSEPGLVKLA  168 (948)
T ss_pred             Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH----HhhHHhhhccccceEecCCCeeeec
Confidence            955 888888877777888889999999999999999    8899999999999999999999986

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.90  E-value=4.1e-23  Score=174.98  Aligned_cols=136  Identities=25%  Similarity=0.394  Sum_probs=111.2

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecC--------C
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKD--------D  157 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------~  157 (232)
                      ...|++.+.||+|+||.||+|... +++.||+|++....    ....+|+.+++.++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            456889999999999999999764 68899999885432    2345699999999999999998876432        2


Q ss_pred             eeEEEEeccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC-ceeec
Q 042107          158 FKALILEYMPHGSLGKCLST---SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM-VAHFL  231 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~-~~~l~  231 (232)
                      ..++||||+++ ++.+++..   ....+++..+..++.|++.||.|||    ..+|+||||||+|||++.++ .+||+
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH----~~~IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH----SKFICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCcCHHHEEEcCCCCceeee
Confidence            46799999975 67666642   2345888899999999999999999    88999999999999999664 68875

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.90  E-value=4.1e-23  Score=166.27  Aligned_cols=139  Identities=27%  Similarity=0.380  Sum_probs=123.4

Q ss_pred             cccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      .+.|.+.+.||+|+||.||++.. .++..|++|.+........+.+..|+.+++.++|||++++++.+..++..|+|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            34567889999999999999964 46889999998765555567788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++++|.+++...  .+++..+..++.|++.|+.|||    ..+++|||+||+||+++.++.++|+
T Consensus        98 ~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH----~~gi~H~dL~p~Nili~~~~~~kL~  157 (293)
T cd06647          98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLT  157 (293)
T ss_pred             CCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH----hCCEeeccCCHHHEEEcCCCCEEEc
Confidence            9999999998754  3778888999999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.90  E-value=5.6e-23  Score=162.90  Aligned_cols=138  Identities=22%  Similarity=0.353  Sum_probs=117.9

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc-----CchHHHHHHHHHHhcCCCCCCccceeEEEecC--CeeE
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY-----GGAFKNLDVECNMMKIIRHQNLIKIISSCSKD--DFKA  160 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  160 (232)
                      .|++.+.||+|+||.||++... ++..||+|.+....     ....+.+.+|+.+++.++||||+++++++..+  ...+
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS   82 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence            4567899999999999999754 68899999885432     12345778899999999999999999988663  4678


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|||+++++|.+++.... .+++.....++.|++.||.|+|    ..+++|+||||+||+++.++.++|+
T Consensus        83 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~l~  148 (265)
T cd06652          83 IFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH----SNMIVHRDIKGANILRDSVGNVKLG  148 (265)
T ss_pred             EEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEecCCCCEEEC
Confidence            9999999999999987543 4678888999999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.90  E-value=4e-23  Score=165.73  Aligned_cols=139  Identities=27%  Similarity=0.443  Sum_probs=119.1

Q ss_pred             cceeeecccCCCcceeeeEEeC------CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ------DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      .+++.+.||+|+||.||+++..      ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..++
T Consensus         6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~l   85 (288)
T cd05050           6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCL   85 (288)
T ss_pred             hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEE
Confidence            4667889999999999999753      467899998865432 234568889999999999999999999999889999


Q ss_pred             EEeccCCCChhhhhccCC---------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCce
Q 042107          162 ILEYMPHGSLGKCLSTSN---------------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNV  220 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~---------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Ni  220 (232)
                      +|||+++|+|.+++....                     ..+++..++.++.|++.||.|+|    ..+++||||||+||
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH----~~~i~H~dl~p~ni  161 (288)
T cd05050          86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS----ERKFVHRDLATRNC  161 (288)
T ss_pred             EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hCCeecccccHhhe
Confidence            999999999999986321                     23677788999999999999999    88999999999999


Q ss_pred             eeCCCCceeec
Q 042107          221 LLDDNMVAHFL  231 (232)
Q Consensus       221 ll~~~~~~~l~  231 (232)
                      +++.++.++++
T Consensus       162 l~~~~~~~~l~  172 (288)
T cd05050         162 LVGENMVVKIA  172 (288)
T ss_pred             EecCCCceEEC
Confidence            99999988875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.90  E-value=2.4e-23  Score=166.10  Aligned_cols=138  Identities=22%  Similarity=0.337  Sum_probs=120.5

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      ..|+..+.||+|+||.||+|.. .++..||+|.+.... ....+.+..|+.+++.++||||+++++.+..++..++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            3456678899999999999965 467889999886443 33456788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++++|.+++...  .+++..+..++.|++.|+.|+|    ..+++|+||+|+||+++.++.++++
T Consensus        84 ~~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH----~~~ivH~dl~p~ni~i~~~~~~~l~  143 (277)
T cd06642          84 LGGGSALDLLKPG--PLEETYIATILREILKGLDYLH----SERKIHRDIKAANVLLSEQGDVKLA  143 (277)
T ss_pred             cCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh----cCCeeccCCChheEEEeCCCCEEEc
Confidence            9999999988653  4788888999999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=3.1e-23  Score=173.45  Aligned_cols=134  Identities=23%  Similarity=0.314  Sum_probs=116.1

Q ss_pred             cccceeeecccCCCcceeeeEEeC---CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ---DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      ...|++.+.||+|+||.||+|...   .+..||+|.+...     +...+|+++++.++||||+++++++......+++|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            445889999999999999999643   3578999987543     23467999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |++. ++|.+++... ..+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.++|+
T Consensus       166 e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH----~~givHrDlkp~Nill~~~~~~~l~  227 (392)
T PHA03207        166 PKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLH----GRGIIHRDVKTENIFLDEPENAVLG  227 (392)
T ss_pred             hhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEcCCCCEEEc
Confidence            9995 5888888443 45889999999999999999999    8899999999999999999998875

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.90  E-value=5.9e-23  Score=166.89  Aligned_cols=140  Identities=27%  Similarity=0.434  Sum_probs=118.0

Q ss_pred             ccceeeecccCCCcceeeeEEeC--------CCcEEEEEEeeccc-CchHHHHHHHHHHhcCC-CCCCccceeEEEecCC
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ--------DGMEVVVKGFNLQY-GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDD  157 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  157 (232)
                      +.+.+.+.||+|+||.||+++..        ....+|+|.+.... ......+..|+.+++.+ +||||+++++++...+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            34567899999999999999632        24578999876432 23345678899999999 6999999999999888


Q ss_pred             eeEEEEeccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceee
Q 042107          158 FKALILEYMPHGSLGKCLSTSN---------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL  222 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill  222 (232)
                      ..+++|||+++|+|.+++....               ..+++..+..++.|++.||.|+|    .++++||||||+||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH----~~gi~H~dlkp~Nill  167 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE----SRRCIHRDLAARNVLV  167 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH----HCCeeeccccceeEEE
Confidence            9999999999999999986421               24778888999999999999999    8899999999999999


Q ss_pred             CCCCceeec
Q 042107          223 DDNMVAHFL  231 (232)
Q Consensus       223 ~~~~~~~l~  231 (232)
                      +.++.+||+
T Consensus       168 ~~~~~~kL~  176 (314)
T cd05099         168 TEDNVMKIA  176 (314)
T ss_pred             cCCCcEEEc
Confidence            999988875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.90  E-value=4.4e-23  Score=163.56  Aligned_cols=136  Identities=26%  Similarity=0.400  Sum_probs=118.1

Q ss_pred             eeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCc---------hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeE
Q 042107           91 EVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGG---------AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        91 ~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  160 (232)
                      .+...||+|++|.||+|.. .+++.+|+|.+......         ..+.+.+|+.+++.++||||+++++++...+..+
T Consensus         3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (267)
T cd06628           3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN   82 (267)
T ss_pred             cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence            4567899999999999975 46889999988654221         1256788999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|||+++++|.+++... ..+++..+..++.|++.|+.|+|    ..+++||||+|+||+++.++.++|+
T Consensus        83 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH----~~~ivH~di~p~nil~~~~~~~~l~  148 (267)
T cd06628          83 IFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLH----NRGIIHRDIKGANILVDNKGGIKIS  148 (267)
T ss_pred             EEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHH----hcCcccccCCHHHEEEcCCCCEEec
Confidence            999999999999999764 34788888899999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.90  E-value=1.7e-24  Score=167.64  Aligned_cols=140  Identities=24%  Similarity=0.332  Sum_probs=118.0

Q ss_pred             cccceeeecccCCCcceeeeEEeC---C--CcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEec-CCe
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ---D--GMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSK-DDF  158 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~---~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~  158 (232)
                      ...|+....||+|+||.||+|...   +  .+.+|+|+++...  .+.....-+|+.+++.++|||++++..++.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            345678889999999999999432   2  3478999996553  3445677889999999999999999998877 789


Q ss_pred             eEEEEeccCCCChhhhhccC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC----Cceee
Q 042107          159 KALILEYMPHGSLGKCLSTS----NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN----MVAHF  230 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~----~~~~l  230 (232)
                      +|+++||.++ ||.++++.+    ...++...+..|+.||+.|+.|||    ++=|+||||||+|||+..+    |.+||
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH----~NWvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH----SNWVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh----hhheeeccCCcceEEEeccCCccCeeEe
Confidence            9999999987 899988754    235788888999999999999999    7789999999999999988    88888


Q ss_pred             c
Q 042107          231 L  231 (232)
Q Consensus       231 ~  231 (232)
                      +
T Consensus       178 a  178 (438)
T KOG0666|consen  178 A  178 (438)
T ss_pred             e
Confidence            6

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.90  E-value=8.1e-23  Score=161.65  Aligned_cols=137  Identities=28%  Similarity=0.423  Sum_probs=122.5

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCc--hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGG--AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      |++.+.||+|+||.||+|... +++.|++|.+......  ..+.+..|+++++.++|+||+++++.+...+..++++||+
T Consensus         2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06626           2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC   81 (264)
T ss_pred             ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence            567789999999999999754 6889999998766543  5678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++.... .+++..+..++.+++.|+.|+|    ..+++|+||+|+||++++++.++|+
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh----~~~i~H~dl~~~nil~~~~~~~kl~  141 (264)
T cd06626          82 SGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH----SHGIVHRDIKPANIFLDHNGVIKLG  141 (264)
T ss_pred             CCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEc
Confidence            9999999987643 4778888999999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.90  E-value=5.2e-24  Score=176.44  Aligned_cols=126  Identities=24%  Similarity=0.430  Sum_probs=112.5

Q ss_pred             eecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCChh
Q 042107           93 FNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLG  172 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  172 (232)
                      ++-||.|+.|.||+|+++ ++.||||+++...       ..+|.-+++++||||+++.|+|......+||||||+.|-|+
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            467999999999999987 6789999885332       23678899999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          173 KCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       173 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .+++..+ .+.......+..+||.|+.|||    .+.|||||||.-||||..+..+||+
T Consensus       201 ~VLka~~-~itp~llv~Wsk~IA~GM~YLH----~hKIIHRDLKSPNiLIs~~d~VKIs  254 (904)
T KOG4721|consen  201 EVLKAGR-PITPSLLVDWSKGIAGGMNYLH----LHKIIHRDLKSPNILISYDDVVKIS  254 (904)
T ss_pred             HHHhccC-ccCHHHHHHHHHHhhhhhHHHH----HhhHhhhccCCCceEeeccceEEec
Confidence            9998765 4666677889999999999999    8899999999999999999999997

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.90  E-value=3.3e-23  Score=167.14  Aligned_cols=137  Identities=27%  Similarity=0.333  Sum_probs=120.7

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccC
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      .+.....||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|||++++++.+..++..+++|||++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            3445568999999999999754 688999999876555555678889999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|..++...  .+++..+..++.|++.||.|+|    ..+++||||||+||+++.++.++|+
T Consensus       102 ~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~dl~p~Nill~~~~~~kL~  159 (297)
T cd06659         102 GGALTDIVSQT--RLNEEQIATVCESVLQALCYLH----SQGVIHRDIKSDSILLTLDGRVKLS  159 (297)
T ss_pred             CCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHeEEccCCcEEEe
Confidence            99999987653  4788899999999999999999    8899999999999999999998885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.90  E-value=4.8e-23  Score=168.40  Aligned_cols=134  Identities=24%  Similarity=0.313  Sum_probs=115.6

Q ss_pred             ecccCC--CcceeeeEEe-CCCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           94 NLISRG--GFGSIYKARI-QDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        94 ~~lg~g--~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      ..||+|  +||.||+++. .+++.||+|.+.....  ...+.+.+|+.+++.++||||+++++++..++..+++|||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            457776  8899999976 4799999999865432  2346788899999999999999999999999999999999999


Q ss_pred             CChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++.+++... ...+++..+..++.|++.||.|+|    ..+++||||||+||+++.++.++++
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~ivHrDlkp~Nill~~~~~~~~~  143 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH----QNGYIHRNIKASHILISGDGLVSLS  143 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEeCCCcEEEe
Confidence            9999988754 234788888899999999999999    8899999999999999999888764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.90  E-value=2.5e-23  Score=166.53  Aligned_cols=137  Identities=23%  Similarity=0.378  Sum_probs=118.7

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      |++.+.||+|+||.||+|+.. +|+.+|+|.+....  ......+.+|+++++.++||||+++++++.+.+..++++||+
T Consensus         2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (284)
T cd07839           2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC   81 (284)
T ss_pred             ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence            567789999999999999764 68899999986542  222355677999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++ ++.+++......+++..+..++.|+++||.|||    ..+++||||||+||+++.++.++|+
T Consensus        82 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~~i~H~dl~~~nil~~~~~~~~l~  141 (284)
T cd07839          82 DQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH----SHNVLHRDLKPQNLLINKNGELKLA  141 (284)
T ss_pred             CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEEcCCCcEEEC
Confidence            74 888877655456899999999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.90  E-value=7e-23  Score=167.84  Aligned_cols=139  Identities=28%  Similarity=0.436  Sum_probs=117.7

Q ss_pred             cceeeecccCCCcceeeeEEeC--------CCcEEEEEEeeccc-CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCe
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ--------DGMEVVVKGFNLQY-GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDF  158 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  158 (232)
                      .|.+.+.||+|+||.||+++..        ....||+|.+.... ....+.+.+|+++++.+ +||||+++++++..++.
T Consensus        13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   92 (334)
T cd05100          13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP   92 (334)
T ss_pred             HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCc
Confidence            4678899999999999999642        12368999876432 23356788899999999 79999999999999899


Q ss_pred             eEEEEeccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeC
Q 042107          159 KALILEYMPHGSLGKCLSTSN---------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD  223 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~  223 (232)
                      .+++|||+++|+|.+++....               ..+++..+..++.|++.||.|||    .++++||||||+||+++
T Consensus        93 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH----~~givH~dlkp~Nill~  168 (334)
T cd05100          93 LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA----SQKCIHRDLAARNVLVT  168 (334)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH----HCCeeccccccceEEEc
Confidence            999999999999999986421               23677888899999999999999    88999999999999999


Q ss_pred             CCCceeec
Q 042107          224 DNMVAHFL  231 (232)
Q Consensus       224 ~~~~~~l~  231 (232)
                      .++.++|+
T Consensus       169 ~~~~~kL~  176 (334)
T cd05100         169 EDNVMKIA  176 (334)
T ss_pred             CCCcEEEC
Confidence            99988875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.90  E-value=7.1e-23  Score=163.79  Aligned_cols=137  Identities=22%  Similarity=0.384  Sum_probs=119.3

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccC
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      |++.+.||+|++|.||+|+.. ++..||+|.+..... ...+.+..|+++++.++||||+++++++...+..++||||++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   81 (284)
T cd07836           2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD   81 (284)
T ss_pred             ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence            567889999999999999865 688999999875532 234567789999999999999999999999999999999998


Q ss_pred             CCChhhhhccCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTSN--YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      + +|.+++....  ..+++..+..++.|++.||.|+|    ..+++|||+||+||++++++.++++
T Consensus        82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~h~dl~p~ni~~~~~~~~~l~  142 (284)
T cd07836          82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH----ENRVLHRDLKPQNLLINKRGELKLA  142 (284)
T ss_pred             c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEECCCCcEEEe
Confidence            5 8888876543  35789999999999999999999    7899999999999999999988875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.90  E-value=7.4e-23  Score=163.35  Aligned_cols=138  Identities=23%  Similarity=0.361  Sum_probs=121.3

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      ..|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+..|+.+++.++||||+++++.+...+..++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            34667788999999999999764 68899999887543 33456788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++++|.+++...  .+++.....++.|++.|+.|+|    ..+++|+||+|+||+++.++.++++
T Consensus        84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh----~~~ivH~dl~p~Nil~~~~~~~~l~  143 (277)
T cd06640          84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH----SEKKIHRDIKAANVLLSEQGDVKLA  143 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCccCcCCChhhEEEcCCCCEEEc
Confidence            9999999998753  4788888899999999999999    8899999999999999999888875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=7.5e-25  Score=183.45  Aligned_cols=140  Identities=21%  Similarity=0.319  Sum_probs=127.4

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      +++++...||.|+||.||+|..+ ++-..|.|.+........+.+..|+++++.++||+||++++.|..++.+|+..|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            45667788999999999999755 45566789888888888899999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +||....++-.-+..+.+.++..+++|++.||.|||    +..|||||||+.|||++-+|.++++
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH----s~~iIHRDLKAGNiL~TldGdirLA  172 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH----SQNIIHRDLKAGNILLTLDGDIRLA  172 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh----hcchhhhhccccceEEEecCcEeee
Confidence            999999988877778999999999999999999999    8899999999999999999999886

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.90  E-value=1e-22  Score=163.19  Aligned_cols=141  Identities=28%  Similarity=0.370  Sum_probs=125.8

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      ..+.|+..+.+|+|++|.||++... ++..+++|.+..... ..+.+..|+++++.++|+|++++++.+..++..++++|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            3455677889999999999999765 688999999976544 45678889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++++|.+++......+++..+..++.+++.|+.|+|    ..+++|+|++|+||+++.++.++|+
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH----~~gi~H~dl~p~ni~i~~~~~~~l~  158 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH----SQNVIHRDIKSDNILLSKDGSVKLA  158 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCChhhEEEcCCCCEEEC
Confidence            99999999999876546889999999999999999999    8899999999999999999998885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.6e-24  Score=174.26  Aligned_cols=137  Identities=28%  Similarity=0.425  Sum_probs=121.7

Q ss_pred             ceeeecccCCCcceeeeEE-eCCCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccC
Q 042107           90 LEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      |...+.||+|.||.||+|. ..+++.||+|++.... ....+.+..|+.++..++++||.++|+.+..+..+|++||||.
T Consensus        15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~   94 (467)
T KOG0201|consen   15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG   94 (467)
T ss_pred             cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence            3455899999999999996 4578999999997764 3456788999999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||++.+.++... .+++....-++++++.|+.|+|    ..+.+|||||++|||+..+|.+|++
T Consensus        95 gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH----~~~kiHrDIKaanil~s~~g~vkl~  153 (467)
T KOG0201|consen   95 GGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLH----SEKKIHRDIKAANILLSESGDVKLA  153 (467)
T ss_pred             CcchhhhhccCC-CCccceeeeehHHHHHHhhhhh----hcceecccccccceeEeccCcEEEE
Confidence            999999998654 3477777788999999999999    8899999999999999999999986

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.90  E-value=8.6e-23  Score=162.98  Aligned_cols=138  Identities=25%  Similarity=0.362  Sum_probs=120.7

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      +.|+..+.||+|+||.||+|.. .+++.+|+|...... ....+.+.+|+.+++.++||||+++++.+..++..++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            3466778899999999999975 468899999876443 23346688899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++++|.+++...  .+++..+..++.+++.|+.|+|    ..+++|+|+||+||+++.++.++++
T Consensus        84 ~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~dl~p~Ni~i~~~~~~~l~  143 (277)
T cd06641          84 LGGGSALDLLEPG--PLDETQIATILREILKGLDYLH----SEKKIHRDIKAANVLLSEHGEVKLA  143 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc----cCCeecCCCCHHhEEECCCCCEEEe
Confidence            9999999998653  4788889999999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.90  E-value=5.7e-23  Score=165.25  Aligned_cols=138  Identities=26%  Similarity=0.373  Sum_probs=119.1

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecC--CeeEEEE
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKD--DFKALIL  163 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  163 (232)
                      .|++.+.||+|+||.||+|... +++.+++|.+.....  .....+.+|+.+++.++||||+++++++..+  +..+++|
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~   85 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM   85 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence            4667789999999999999765 688999999865432  2234567799999999999999999998877  8899999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+++ +|.+++......+++..+..++.|++.||.|||    ..+++|+||||+||+++.++.++|+
T Consensus        86 e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~i~H~dl~p~nili~~~~~~~l~  148 (293)
T cd07843          86 EYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH----DNWILHRDLKTSNLLLNNRGILKIC  148 (293)
T ss_pred             hhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHHHEEECCCCcEEEe
Confidence            99975 999888765556899999999999999999999    8899999999999999999998875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.90  E-value=1.2e-22  Score=160.10  Aligned_cols=138  Identities=20%  Similarity=0.330  Sum_probs=120.9

Q ss_pred             ceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           90 LEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      |++.+.||+|+||.||+++. .+++.||+|.+....  ....+.+.+|+.+++.++||||+++.+++...+..++||||+
T Consensus         2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08218           2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC   81 (256)
T ss_pred             ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence            56788999999999999965 468899999986542  234467888999999999999999999999999999999999


Q ss_pred             CCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++... ...+++..+..++.|++.|+.|+|    ..+++|+|++|+||+++.++.++++
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~~l~~~nil~~~~~~~~l~  143 (256)
T cd08218          82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH----DRKILHRDIKSQNIFLTKDGTIKLG  143 (256)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCEEEe
Confidence            999999988654 234788889999999999999999    8899999999999999999988875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=8.9e-23  Score=162.55  Aligned_cols=136  Identities=26%  Similarity=0.360  Sum_probs=121.5

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccC
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      |++.+.||.|++|.||+|+.. +++.+|+|.+.... ......+.+|+.+++.++|||++++++.+..+...++++||++
T Consensus         3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~   82 (274)
T cd06609           3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG   82 (274)
T ss_pred             hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence            567788999999999999765 68899999986543 3345678889999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|.+++...  .+++..+..++.|++.|+.|+|    ..+++|||++|+||++++++.++++
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh----~~~i~h~dl~p~ni~i~~~~~~~l~  140 (274)
T cd06609          83 GGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH----EEGKIHRDIKAANILLSEEGDVKLA  140 (274)
T ss_pred             CCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEc
Confidence            99999998764  5788999999999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.90  E-value=1.1e-22  Score=160.64  Aligned_cols=132  Identities=26%  Similarity=0.375  Sum_probs=113.6

Q ss_pred             ecccCCCcceeeeEEeC-C---CcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           94 NLISRGGFGSIYKARIQ-D---GMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      +.||+|+||.||+|.+. .   +..+|+|.+..... ...+.+..|+.+++.++||||+++++++. .+..+++|||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999643 2   26899999865543 24467888999999999999999999876 4567999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|.+++.... .+++..+..++.|++.|+.|||    ..+++||||||+||+++.++.++|+
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh----~~~i~H~di~p~nili~~~~~~kl~  137 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE----SKHFVHRDLAARNVLLVNRHQAKIS  137 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh----hcCeeccCcccceEEEcCCCcEEec
Confidence            99999997654 5788999999999999999999    8899999999999999999998885

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.90  E-value=1.2e-22  Score=163.19  Aligned_cols=137  Identities=23%  Similarity=0.287  Sum_probs=118.8

Q ss_pred             ceeeecccCCCcceeeeEEe----CCCcEEEEEEeeccc----CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeE
Q 042107           90 LEVFNLISRGGFGSIYKARI----QDGMEVVVKGFNLQY----GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  160 (232)
                      |++.+.||+|+||.||+++.    .+|..||+|.+....    ....+.+..|+.++..+ +|++|+++++++..+...+
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            56788999999999999975    368899999986532    22346678899999999 5999999999999999999


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +||||+++++|.+++.... .+++.....++.|++.||.|+|    ..+++||||||+||+++.++.++|+
T Consensus        82 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH----~~~i~H~dl~p~nil~~~~~~~kl~  147 (290)
T cd05613          82 LILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVLT  147 (290)
T ss_pred             EEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeEECCCCCEEEe
Confidence            9999999999999987643 4778888889999999999999    8899999999999999999998875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.90  E-value=4.5e-23  Score=170.31  Aligned_cols=138  Identities=22%  Similarity=0.288  Sum_probs=115.4

Q ss_pred             ccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecC------
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKD------  156 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  156 (232)
                      +.+.|++.+.||+|+||.||++.. .+++.||+|.+....  ....+.+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            345678889999999999999975 468899999986432  23346677899999999999999999987643      


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          157 DFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       157 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ...+++|||+++ ++.+.+..   .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH----~~givHrDikp~Nill~~~~~~kl~  161 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKIL  161 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChHHEEECCCCCEEEe
Confidence            356899999976 67666643   3778888899999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.90  E-value=1.3e-22  Score=160.32  Aligned_cols=138  Identities=25%  Similarity=0.321  Sum_probs=123.4

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      .+++.+.||+|++|.||++... +++.|++|.+..... ...+.+..|+..+..++|||++++++++..++..+++|||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            3567789999999999999765 589999999876543 34577889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST-HVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++... ..+++..+..++.|+++|+.|+|    . .+++|||++|+||+++.++.++++
T Consensus        82 ~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh----~~~~~~H~~l~~~ni~~~~~~~~~l~  142 (264)
T cd06623          82 DGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH----TKRHIIHRDIKPSNLLINSKGEVKIA  142 (264)
T ss_pred             CCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHh----ccCCCccCCCCHHHEEECCCCCEEEc
Confidence            999999999764 35888999999999999999999    7 899999999999999999988875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=8.7e-23  Score=166.98  Aligned_cols=132  Identities=16%  Similarity=0.137  Sum_probs=104.6

Q ss_pred             CcccccceeeecccCCCcceeeeEEeC--CCcEEEEEEeecc-----cCchHHHHHHHHHHhcCCCCCCccc-eeEEEec
Q 042107           84 RPFRNFLEVFNLISRGGFGSIYKARIQ--DGMEVVVKGFNLQ-----YGGAFKNLDVECNMMKIIRHQNLIK-IISSCSK  155 (232)
Q Consensus        84 ~~~~~~~~~~~~lg~g~~g~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~  155 (232)
                      ..+.+.|.+.+.||+|+||.||+|+..  +++.+|||+....     .....+.+.+|+++++.++|+|++. +++.   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            356777899999999999999999754  5777899986533     1123456889999999999999985 4432   


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCC-CCCceeeCCCCceeec
Q 042107          156 DDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDL-KSSNVLLDDNMVAHFL  231 (232)
Q Consensus       156 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdl-k~~Nill~~~~~~~l~  231 (232)
                       +..|+||||++|++|... ..    ..   ...++.++++||.|+|    ..+|+|||| ||+|||++.++.++|+
T Consensus        91 -~~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH----~~gIiHrDL~KP~NILv~~~~~ikLi  154 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLH----RAGITHNDLAKPQNWLMGPDGEAAVI  154 (365)
T ss_pred             -CCcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHH----HCCCeeCCCCCcceEEEcCCCCEEEE
Confidence             457999999999999732 11    11   1457889999999999    889999999 9999999988888874

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.90  E-value=9.1e-23  Score=163.40  Aligned_cols=140  Identities=21%  Similarity=0.318  Sum_probs=117.0

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCC-CCCCccceeEEEe-----cCCee
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKII-RHQNLIKIISSCS-----KDDFK  159 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~-----~~~~~  159 (232)
                      .+.|++.+.||+|+||.||++... +++.+|+|...... .....+..|+.+++.+ +||||+++++++.     .++..
T Consensus        17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~   95 (286)
T cd06638          17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL   95 (286)
T ss_pred             ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence            445678899999999999999754 68899999876432 2235677899999998 6999999999874     34578


Q ss_pred             EEEEeccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          160 ALILEYMPHGSLGKCLST---SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|||+++++|.+++..   ....+++..+..++.|++.|+.|||    ..+++|||+||+||+++.++.++++
T Consensus        96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~nili~~~~~~kl~  166 (286)
T cd06638          96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH----VNKTIHRDVKGNNILLTTEGGVKLV  166 (286)
T ss_pred             EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH----hCCccccCCCHHhEEECCCCCEEEc
Confidence            999999999999988753   2335788888999999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=1.1e-23  Score=176.35  Aligned_cols=137  Identities=18%  Similarity=0.299  Sum_probs=120.2

Q ss_pred             ceeeecccCCCcceeeeEE-eCCCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           90 LEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      +-.++.||-|+||.|.+++ ..+...+|+|.+.+.+   .........|-.|++..+.+.||++|-.|.+.+.+|+||||
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            3467889999999999995 4557789999887654   23345667799999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|||+-.+|-..+ .+++..++.++.++..|++++|    ..|+|||||||+|||||.+|..||+
T Consensus       711 IPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVH----kmGFIHRDiKPDNILIDrdGHIKLT  771 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVH----KMGFIHRDIKPDNILIDRDGHIKLT  771 (1034)
T ss_pred             cCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHH----hccceecccCccceEEccCCceeee
Confidence            99999999887654 5888888889999999999999    9999999999999999999999975

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.90  E-value=9.3e-23  Score=162.13  Aligned_cols=139  Identities=25%  Similarity=0.396  Sum_probs=118.6

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCC-CCCCccceeEEEecC------Cee
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKII-RHQNLIKIISSCSKD------DFK  159 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~------~~~  159 (232)
                      ..|++.+.||+|+||.||+|... +++.||+|.+..... ....+..|+.+++.+ +||||+++++.+...      ...
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL   84 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence            44667788999999999999754 688999999865533 345678899999988 699999999988653      467


Q ss_pred             EEEEeccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          160 ALILEYMPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|||+++++|.+++... ...+++..+..++.|++.|+.|||    ..+|+|||+||+||++++++.++|+
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH----~~~ivh~dl~~~nili~~~~~~~l~  153 (272)
T cd06637          85 WLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH----QHKVIHRDIKGQNVLLTENAEVKLV  153 (272)
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHEEECCCCCEEEc
Confidence            9999999999999998764 345788889999999999999999    7899999999999999999998875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.90  E-value=6.3e-23  Score=162.70  Aligned_cols=137  Identities=24%  Similarity=0.361  Sum_probs=118.3

Q ss_pred             ceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC------chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           90 LEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG------GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      |+..+.||+|++|.||+++. .+++.+|+|.+.....      ...+.+..|+.+++.++||||+++++++...+..++|
T Consensus         2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v   81 (268)
T cd06630           2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF   81 (268)
T ss_pred             ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence            45668899999999999974 5789999999864321      1346788899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC-ceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM-VAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~-~~~l~  231 (232)
                      |||+++++|.+++.... .+++..+..++.|++.||.|||    ..+++|+||||+||+++.++ .++|+
T Consensus        82 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH----~~~i~H~~i~~~nil~~~~~~~~~l~  146 (268)
T cd06630          82 VEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH----ENQIIHRDVKGANLLIDSTGQRLRIA  146 (268)
T ss_pred             EeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEEc
Confidence            99999999999987643 5788889999999999999999    88999999999999998775 46664

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.90  E-value=4.2e-23  Score=165.29  Aligned_cols=138  Identities=25%  Similarity=0.373  Sum_probs=120.0

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      .|++.+.||+|+||.||+|... +++.||+|.+.....  ...+.+.+|+++++.++||||+++++++..++..++||||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   81 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF   81 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence            3677899999999999999875 588999998754322  2345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++++..+.... ..+++..+..++.|++.|++|||    ..+++|+|++|+||++++++.++|+
T Consensus        82 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH----~~~i~h~~l~p~ni~~~~~~~~~l~  142 (286)
T cd07846          82 VDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCH----SHNIIHRDIKPENILVSQSGVVKLC  142 (286)
T ss_pred             CCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEECCCCcEEEE
Confidence            9999888876543 24789999999999999999999    8899999999999999999988874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.90  E-value=4.3e-23  Score=169.68  Aligned_cols=137  Identities=20%  Similarity=0.304  Sum_probs=115.6

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecC------Ce
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKD------DF  158 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  158 (232)
                      +.|++.+.||+|+||.||+|.. .+++.||+|.+.....  ...+.+.+|+.+++.++||||+++++++...      ..
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            4577889999999999999975 4688999999865322  2345577899999999999999999887543      34


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          159 KALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .++++|++ +++|.+++...  .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus        95 ~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH----~~~ivHrdikp~Nil~~~~~~~kl~  160 (343)
T cd07878          95 VYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH----SAGIIHRDLKPSNVAVNEDCELRIL  160 (343)
T ss_pred             EEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecccCChhhEEECCCCCEEEc
Confidence            68999988 77998887643  4888999999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.90  E-value=1e-23  Score=176.09  Aligned_cols=141  Identities=23%  Similarity=0.358  Sum_probs=118.1

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeec----ccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCe--eE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNL----QYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF--KA  160 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~  160 (232)
                      .+.+..++||+|+|-+||+|... +|.+||--.++.    +.....+++..|+.+++.|+||||++++.+|.+...  +-
T Consensus        40 Ry~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in  119 (632)
T KOG0584|consen   40 RYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN  119 (632)
T ss_pred             ceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence            34456788999999999999654 587887443322    234456889999999999999999999999988654  77


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC-CCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD-NMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~-~~~~~l~  231 (232)
                      +|+|.+..|+|.+|.++.+ ..+....+.+++||++||.|||+.  ..+|||||||.+||+|+. .|.+|||
T Consensus       120 ~iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~--~PPIIHRDLKCDNIFinG~~G~VKIG  188 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQ--DPPIIHRDLKCDNIFVNGNLGEVKIG  188 (632)
T ss_pred             eeeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcC--CCCccccccccceEEEcCCcCceeec
Confidence            8999999999999998765 477888999999999999999976  458999999999999986 5889986

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.90  E-value=1.8e-22  Score=159.18  Aligned_cols=138  Identities=24%  Similarity=0.405  Sum_probs=118.6

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEec-CCeeEEEEec
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSK-DDFKALILEY  165 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~  165 (232)
                      |++.+.||+|++|.||++... +++.+|+|.+....  ....+.+..|+++++.++|||++++++.+.. +...+++|||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (257)
T cd08223           2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF   81 (257)
T ss_pred             ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence            578899999999999999754 57889999986543  2334567889999999999999999988764 4468999999


Q ss_pred             cCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++++|.+++... ...+++.++..++.+++.|+.|+|    ..+++||||||+||+++.++.++|+
T Consensus        82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH----~~~i~H~di~p~nil~~~~~~~~l~  144 (257)
T cd08223          82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH----EKHILHRDLKTQNVFLTRTNIIKVG  144 (257)
T ss_pred             cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCchhEEEecCCcEEEe
Confidence            9999999998753 345889999999999999999999    8899999999999999999988875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.90  E-value=1.5e-22  Score=159.43  Aligned_cols=135  Identities=26%  Similarity=0.449  Sum_probs=116.6

Q ss_pred             cceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           89 FLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      .|++.+.||+|+||.||++.. +++.+|+|......  ..+.+.+|+.+++.++|||++++++++... ..+++|||+++
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~   82 (254)
T cd05083           7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK   82 (254)
T ss_pred             HceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence            367789999999999999974 57789999885432  346788899999999999999999988654 47899999999


Q ss_pred             CChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|.+++.... ..+++..+..++.|++.|+.|+|    ..+++|||+||+||+++.++.++|+
T Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~~~H~dl~p~nili~~~~~~kl~  142 (254)
T cd05083          83 GNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE----SKKLVHRDLAARNILVSEDGVAKVS  142 (254)
T ss_pred             CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccccCcceEEEcCCCcEEEC
Confidence            99999987543 34788888999999999999999    8899999999999999999998875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.89  E-value=1.1e-22  Score=164.57  Aligned_cols=137  Identities=24%  Similarity=0.391  Sum_probs=115.0

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCc----EEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGM----EVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      ++..+.||+|+||.||+|.+. ++.    .+|+|.+..... .....+..|+.+++.++||||+++++.+... ..++++
T Consensus         9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~   87 (303)
T cd05110           9 LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVT   87 (303)
T ss_pred             ceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeee
Confidence            456788999999999999753 444    468887754432 2234678899999999999999999988654 467999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+++|+|.+++......+++..+..++.|++.||.|||    .++++||||||+||+++.++.+||+
T Consensus        88 e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~dikp~Nill~~~~~~kL~  151 (303)
T cd05110          88 QLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE----ERRLVHRDLAARNVLVKSPNHVKIT  151 (303)
T ss_pred             hhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh----hcCeeccccccceeeecCCCceEEc
Confidence            999999999998776556788889999999999999999    8899999999999999999988875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.89  E-value=1.2e-22  Score=165.13  Aligned_cols=132  Identities=20%  Similarity=0.306  Sum_probs=107.9

Q ss_pred             eecccCCCcceeeeEEeC---CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEec--CCeeEEEEeccC
Q 042107           93 FNLISRGGFGSIYKARIQ---DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSK--DDFKALILEYMP  167 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~  167 (232)
                      .++||+|+||.||+|+..   +++.+|+|.+....  ....+.+|+.+++.++||||+++++++..  +...+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999754   46789999886442  23456789999999999999999998854  457899999986


Q ss_pred             CCChhhhhccC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceee----CCCCceeec
Q 042107          168 HGSLGKCLSTS--------NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL----DDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill----~~~~~~~l~  231 (232)
                      + ++.+++...        ...+++..+..++.|++.||.|||    ..+|+||||||+|||+    +.++.+||+
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivHrDlkp~Nil~~~~~~~~~~~kl~  154 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRVKIA  154 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH----hCCEEcCCCCHHHEEEecCCCCcCcEEEe
Confidence            5 887776522        224788889999999999999999    8899999999999999    455677774

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.89  E-value=2e-22  Score=161.59  Aligned_cols=137  Identities=25%  Similarity=0.353  Sum_probs=121.2

Q ss_pred             cceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccC
Q 042107           89 FLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      .+...+.||+|++|.||++.. .+++.+++|.+........+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            344567899999999999975 4688999999876554455668889999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|.+++...  .+++..+..++.|++.|+.|+|    ..+++||||+|+||+++.++.++++
T Consensus       100 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~l~  157 (285)
T cd06648         100 GGALTDIVTHT--RMNEEQIATVCLAVLKALSFLH----AQGVIHRDIKSDSILLTSDGRVKLS  157 (285)
T ss_pred             CCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCChhhEEEcCCCcEEEc
Confidence            99999998763  4788888999999999999999    8899999999999999999998875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.89  E-value=1e-22  Score=163.13  Aligned_cols=139  Identities=21%  Similarity=0.269  Sum_probs=120.5

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      .|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+++++.++||||+++++.+...+..++||||+
T Consensus         6 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (284)
T cd06620           6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFM   85 (284)
T ss_pred             HHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecC
Confidence            3567789999999999999754 68899999886543 234567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++...+ .+++..+..++.+++.|+.|||+   ..+++|||+||+||+++.++.++|+
T Consensus        86 ~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~---~~~i~H~dl~p~nil~~~~~~~~l~  146 (284)
T cd06620          86 DCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYN---VHRIMHRDIKPSNILVNSRGQIKLC  146 (284)
T ss_pred             CCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHH---hcCeeccCCCHHHEEECCCCcEEEc
Confidence            9999999887643 47888999999999999999992   2479999999999999999988875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.89  E-value=1.4e-22  Score=161.92  Aligned_cols=140  Identities=25%  Similarity=0.399  Sum_probs=118.8

Q ss_pred             ccceeeecccCCCcceeeeEEeCC-----CcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEec-CCeeE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQD-----GMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSK-DDFKA  160 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~  160 (232)
                      +.|++.+.||+|+||.||+|....     +..|++|.+.... ....+.+.+|+.+++.++||||+++++++.. ....+
T Consensus         6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   85 (280)
T cd05043           6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF   85 (280)
T ss_pred             hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence            346678999999999999997654     6788999876432 2335667889999999999999999998766 46788


Q ss_pred             EEEeccCCCChhhhhccCC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSN-------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++||+++++|.+++....       ..+++..+..++.|++.||.|||    ..+++||||||+||++++++.+||+
T Consensus        86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH----~~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH----KRGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccCHhhEEEcCCCcEEEC
Confidence            9999999999999986531       34788899999999999999999    8899999999999999999998875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.89  E-value=1e-22  Score=161.20  Aligned_cols=138  Identities=24%  Similarity=0.307  Sum_probs=121.7

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccC
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      ++..+.||+|++|.||++... +++.+++|.+..... ...+.+.+|+++++.++||||+++++.+..++..++++||++
T Consensus         3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (265)
T cd06605           3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD   82 (265)
T ss_pred             chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence            456788999999999999765 688999999876532 344667889999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST-HVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|.+++......+++.....++.|++.|+.|+|    . .+++|+||||+||+++.++.++|+
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~i~H~dl~~~ni~~~~~~~~~l~  143 (265)
T cd06605          83 GGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH----EKHKIIHRDVKPSNILVNSRGQIKLC  143 (265)
T ss_pred             CCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc----CCCCeecCCCCHHHEEECCCCCEEEe
Confidence            99999999765456888888999999999999999    7 899999999999999999988874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.89  E-value=6.5e-23  Score=162.00  Aligned_cols=131  Identities=26%  Similarity=0.383  Sum_probs=116.7

Q ss_pred             ccCCCcceeeeEEeC-CCcEEEEEEeecccC---chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCCh
Q 042107           96 ISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG---GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSL  171 (232)
Q Consensus        96 lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  171 (232)
                      ||+|+||.||+++.. +++.+++|.+.....   ...+.+.+|+++++.++||||+++++.+..+...+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999876 589999999865432   3456788899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          172 GKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       172 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .+++.... .+++..+..++.|++.||.|+|    ..+++|+||+|+||+++.++.++|+
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH----~~~i~H~di~~~nil~~~~~~~~l~  135 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH----SNGIIHRDLKPDNILIDSNGHLKLT  135 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HcCeecCCCCHHHeEEcCCCCEEEE
Confidence            99987644 5788999999999999999999    8899999999999999999998875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=1.3e-22  Score=161.80  Aligned_cols=137  Identities=24%  Similarity=0.391  Sum_probs=120.2

Q ss_pred             cceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc-CchHHHHHHHHHHhcCCC---CCCccceeEEEecCCeeEEEE
Q 042107           89 FLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIR---HQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~  163 (232)
                      .|+..+.||+|+||.||+|.. .+++.+|+|.+.... ....+.+.+|+.+++.++   |||++++++++......+++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            356778999999999999975 578999999886542 334567888999988886   999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+++++|.+++...  .+++..+..++.|++.|+.|+|    ..+++|+||+|+||+++.++.++++
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh----~~~i~H~dl~p~ni~i~~~~~~~l~  143 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH----KVGVIHRDIKAANILVTNTGNVKLC  143 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCcCHHHEEEcCCCCEEEc
Confidence            999999999998654  5888899999999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.89  E-value=1.9e-22  Score=160.00  Aligned_cols=137  Identities=22%  Similarity=0.383  Sum_probs=117.4

Q ss_pred             ceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC-----chHHHHHHHHHHhcCCCCCCccceeEEEec--CCeeEE
Q 042107           90 LEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG-----GAFKNLDVECNMMKIIRHQNLIKIISSCSK--DDFKAL  161 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~l  161 (232)
                      |+..+.||+|+||.||++.. .++..|++|.+.....     ...+.+.+|+.+++.++||||+++++++..  ....++
T Consensus         4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   83 (266)
T cd06651           4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI   83 (266)
T ss_pred             ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence            56778999999999999975 4688999998864321     234567889999999999999999998865  357889


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|||+++++|.+++.... .+++.....++.|++.||.|||    ..+++|||+||+||+++.++.++|+
T Consensus        84 ~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH----~~~i~H~~l~p~nil~~~~~~~~l~  148 (266)
T cd06651          84 FMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH----SNMIVHRDIKGANILRDSAGNVKLG  148 (266)
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEECCCCCEEEc
Confidence            999999999999987643 4788888899999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.89  E-value=1.2e-22  Score=168.26  Aligned_cols=138  Identities=21%  Similarity=0.283  Sum_probs=115.6

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecC------
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKD------  156 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  156 (232)
                      ..+.|++.+.||+|+||.||++... .++.||+|++....  ....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3456788899999999999999754 68899999986432  23346677899999999999999999987543      


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          157 DFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       157 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ...++||||+++ ++.+.+..   .+++..+..++.|++.||.|||    .++|+||||||+||+++.++.+||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~  168 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKIL  168 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh----hCCeecCCCCHHHEEECCCCcEEEE
Confidence            357999999975 67777653   3778888899999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.89  E-value=1.7e-22  Score=163.60  Aligned_cols=139  Identities=24%  Similarity=0.359  Sum_probs=119.5

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC---chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG---GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      ..|...+.||+|+||.||+|... +++.||+|.+.....   ...+.+.+|+++++.++||||+++.+++..++..++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            34677889999999999999764 688999998864432   23456788999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||++ |++.+++......+++..+..++.|++.||.|+|    ..+++||||+|+||+++.++.++|+
T Consensus        95 e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH----~~~i~H~dl~p~nIl~~~~~~~kL~  157 (307)
T cd06607          95 EYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH----SHERIHRDIKAGNILLTEPGTVKLA  157 (307)
T ss_pred             HhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcccEEECCCCCEEEe
Confidence            9997 5777776654446889999999999999999999    8899999999999999999998875

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.89  E-value=3.4e-22  Score=156.53  Aligned_cols=138  Identities=31%  Similarity=0.492  Sum_probs=124.1

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      |+..+.||+|++|.||++... +++.+++|.+........+.+.+|++.++.++||+++++++.+...+..++++||+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   81 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG   81 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence            456788999999999999765 6889999999766555667889999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|.+++......+++..+..++.|++.|+.|+|    ..+++|+|++|+||+++.++.++|+
T Consensus        82 ~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh----~~~i~h~dl~p~ni~i~~~~~~~l~  140 (253)
T cd05122          82 GSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH----SNGIIHRDIKAANILLTSDGEVKLI  140 (253)
T ss_pred             CcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh----cCCEecCCCCHHHEEEccCCeEEEe
Confidence            9999998776456899999999999999999999    7899999999999999999988875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.89  E-value=2e-23  Score=178.06  Aligned_cols=138  Identities=25%  Similarity=0.445  Sum_probs=125.1

Q ss_pred             ceeeecccCCCcceeeeEEeC----CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           90 LEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      ..+.++||.|.||.|++|+++    ....||||.++.... .....|..|+.+|..++||||+++-|+......+++|+|
T Consensus       631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE  710 (996)
T KOG0196|consen  631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE  710 (996)
T ss_pred             eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence            357889999999999999865    245799999976643 345679999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||++|+|..+|+.++..+.+.+...+.++|+.|+.||-    ..+.|||||.+.|||++.+..+|+|
T Consensus       711 yMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs----dm~YVHRDLAARNILVNsnLvCKVs  773 (996)
T KOG0196|consen  711 YMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS----DMNYVHRDLAARNILVNSNLVCKVS  773 (996)
T ss_pred             hhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh----hcCchhhhhhhhheeeccceEEEec
Confidence            99999999999998878999999999999999999999    8899999999999999999999986

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.89  E-value=2e-22  Score=161.07  Aligned_cols=138  Identities=25%  Similarity=0.313  Sum_probs=113.7

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC-chHHHHHHHHH-HhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG-GAFKNLDVECN-MMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      .|++.+.||+|+||.||+++.. +++.||+|.+..... .....+..|.. .++..+||||+++++++..++..+++|||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~   81 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV   81 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence            3567889999999999999764 699999999875532 22234444555 46677899999999999999999999999


Q ss_pred             cCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-CeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLST---SNYILDFFQRLHIMIDVASAVEYLHFGHSTH-VIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++ |+|.+++..   ....+++..+..++.|++.|+.|+|    .+ +++||||||+||+++.++.+||+
T Consensus        82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~~i~h~dlkp~nil~~~~~~~kl~  146 (283)
T cd06617          82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH----SKLSVIHRDVKPSNVLINRNGQVKLC  146 (283)
T ss_pred             hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh----hcCCeecCCCCHHHEEECCCCCEEEe
Confidence            97 588777653   2345889999999999999999999    65 89999999999999999999885

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.89  E-value=1.7e-22  Score=161.96  Aligned_cols=137  Identities=24%  Similarity=0.383  Sum_probs=111.9

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC--chHHHHHHHHHHhcCC---CCCCccceeEEEec-----CCe
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG--GAFKNLDVECNMMKII---RHQNLIKIISSCSK-----DDF  158 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----~~~  158 (232)
                      |++.+.||+|+||.||+|+.. +++.||+|.+.....  .....+.+|+++++.+   +||||+++++++..     ...
T Consensus         2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~   81 (288)
T cd07863           2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK   81 (288)
T ss_pred             ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence            567889999999999999764 688999998865422  2223455677766655   79999999998764     245


Q ss_pred             eEEEEeccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          159 KALILEYMPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .+++|||+++ ++.+++... ...+++..+..++.|++.||.|+|    ..+++||||||+||+++.++.+||+
T Consensus        82 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dikp~Nili~~~~~~kl~  150 (288)
T cd07863          82 VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH----ANCIVHRDLKPENILVTSGGQVKLA  150 (288)
T ss_pred             EEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEEC
Confidence            7899999975 888888653 234788999999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=2.5e-23  Score=175.90  Aligned_cols=133  Identities=24%  Similarity=0.419  Sum_probs=120.0

Q ss_pred             cccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCChhh
Q 042107           95 LISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGK  173 (232)
Q Consensus        95 ~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  173 (232)
                      ++|+|+||+||.|+.. +...+|||.+..++....+.+..|+.+.+.++|.|||+++|.+...+++-+.||-+|||+|..
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6999999999999865 567899999988888888999999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC-CCceeec
Q 042107          174 CLSTSNYIL--DFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD-NMVAHFL  231 (232)
Q Consensus       174 ~l~~~~~~~--~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~-~~~~~l~  231 (232)
                      +++..-+++  .+...-.+.+||++||.|||    .+.|||||||-+|||++. .|.+||+
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLH----en~IVHRDIKGDNVLvNTySGvlKIS  718 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLH----ENKIVHRDIKGDNVLVNTYSGVLKIS  718 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhh----hcceeeccccCCcEEEeeccceEEec
Confidence            998764455  56677788999999999999    889999999999999975 6888886

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.89  E-value=2.1e-23  Score=156.80  Aligned_cols=141  Identities=19%  Similarity=0.271  Sum_probs=122.5

Q ss_pred             ccceeeecccCCCcceeeeEE-eCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecC-----CeeEE
Q 042107           88 NFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKD-----DFKAL  161 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~l  161 (232)
                      +.|.+.+.+|+|+|+.||.++ ..++..+|+|++.....++.+...+|++..++++|||+++++++...+     ...|+
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl  100 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL  100 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence            347889999999999999996 567899999999888877888999999999999999999998765433     35899


Q ss_pred             EEeccCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceee
Q 042107          162 ILEYMPHGSLGKCLSTS---NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHF  230 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l  230 (232)
                      ++.|...|+|.+.+...   +..+++.+.+.++.++++||.++|..  ..+..||||||+|||+.+++.+++
T Consensus       101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~--~~~yAH~DiKP~NILls~~~~~vl  170 (302)
T KOG2345|consen  101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK--EPPYAHRDIKPANILLSDSGLPVL  170 (302)
T ss_pred             EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc--CCcccccCCCcceeEecCCCceEE
Confidence            99999999999988753   44689999999999999999999943  225999999999999999888776

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.89  E-value=1.6e-22  Score=162.74  Aligned_cols=135  Identities=24%  Similarity=0.324  Sum_probs=119.0

Q ss_pred             eeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCC
Q 042107           91 EVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHG  169 (232)
Q Consensus        91 ~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  169 (232)
                      +....||+|+||.||++.. .+++.||+|.+..........+.+|+.+++.++|||++++++.+...+..+++|||++++
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  102 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  102 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence            3446799999999999976 478999999986554445567888999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          170 SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       170 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|.+++...  .+++.....++.|++.|+.|+|    ..+++|+|++|+||+++.++.++|+
T Consensus       103 ~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH----~~givH~dl~p~Nilv~~~~~~~l~  158 (292)
T cd06657         103 ALTDIVTHT--RMNEEQIAAVCLAVLKALSVLH----AQGVIHRDIKSDSILLTHDGRVKLS  158 (292)
T ss_pred             cHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEc
Confidence            999987543  4788889999999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=3.1e-22  Score=158.60  Aligned_cols=138  Identities=25%  Similarity=0.402  Sum_probs=118.1

Q ss_pred             cceeeecccCCCcceeeeEEe-CCCcEEEEEEeecc-----cCchHHHHHHHHHHhcCCCCCCccceeEEEecC--CeeE
Q 042107           89 FLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQ-----YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKD--DFKA  160 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~  160 (232)
                      .|++.+.||+|+||.||+|+. .+++.||+|.+...     .......+.+|+++++.++||||+++++++.+.  ...+
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS   82 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence            367789999999999999975 46899999987532     123346788899999999999999999988664  4678


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|||+++++|.+++.... .+++.....++.|++.|+.|||    ..+++|+|+||+||+++.++.++|+
T Consensus        83 ~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH----~~~i~H~dl~p~ni~i~~~~~~~l~  148 (264)
T cd06653          83 IFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH----SNMIVHRDIKGANILRDSAGNVKLG  148 (264)
T ss_pred             EEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCEEEC
Confidence            9999999999999887543 4788888999999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.89  E-value=2.3e-22  Score=160.47  Aligned_cols=132  Identities=19%  Similarity=0.268  Sum_probs=114.7

Q ss_pred             ccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCCh
Q 042107           96 ISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSL  171 (232)
Q Consensus        96 lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  171 (232)
                      ||+|+||.||+|... +++.||+|.+....   ......+..|+++++.++||||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999654 68899999986532   22234566799999999999999999999999999999999999999


Q ss_pred             hhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          172 GKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       172 ~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .+++.... ..+++..+..++.|++.|+.|+|    ..+++||||+|+||+++.++.++|+
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH----~~~i~H~di~p~Nil~~~~~~~~l~  137 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH----QRRIVYRDLKPENVLLDDHGNVRIS  137 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEECCCCCEEEc
Confidence            99886543 35888889999999999999999    8899999999999999999988875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.89  E-value=2.5e-22  Score=160.61  Aligned_cols=137  Identities=26%  Similarity=0.416  Sum_probs=120.1

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecC--CeeEEEEe
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKD--DFKALILE  164 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  164 (232)
                      |++.+.||+|++|.||+|+.. +++.+|+|.+....  ....+.+.+|+++++.++|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            456788999999999999765 58899999997653  33446678899999999999999999999887  78999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++ +|.+++......+++..+..++.|++.|+.|||    ..+++|+||||+||++++++.++|+
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH----~~~~~h~dl~p~nil~~~~~~~~l~  142 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH----SNGILHRDIKGSNILINNDGVLKLA  142 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCcHHHeEEcCCCCEEEc
Confidence            9975 898888765456889999999999999999999    7899999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.89  E-value=3.4e-22  Score=157.35  Aligned_cols=138  Identities=28%  Similarity=0.491  Sum_probs=119.1

Q ss_pred             ceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           90 LEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      |+..+.||+|+||.||++.. .+++.+|+|.+....  ....+.+..|+++++.++|||++++++.+..++..++||||+
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08220           2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA   81 (256)
T ss_pred             ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence            56788999999999999975 468899999986542  234567888999999999999999999999889999999999


Q ss_pred             CCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC-ceeec
Q 042107          167 PHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM-VAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~-~~~l~  231 (232)
                      ++++|.+++... ...+++..+..++.+++.|+.|+|    .++++|+|+||+||+++.++ .++++
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh----~~~i~h~dl~~~nil~~~~~~~~~l~  144 (256)
T cd08220          82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH----TKLILHRDLKTQNILLDKHKMVVKIG  144 (256)
T ss_pred             CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEEc
Confidence            999999999764 334788889999999999999999    88999999999999998654 45664

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=4.3e-22  Score=156.44  Aligned_cols=137  Identities=29%  Similarity=0.414  Sum_probs=122.2

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      |++.+.||+|++|.||++... +++.|++|.+.....  ...+.+.+|++++..++|||++++++++..++..+++|||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (254)
T cd06627           2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA   81 (254)
T ss_pred             ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence            456789999999999999754 688999999976543  35577889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++... ..+++..+..++.|++.|+.|+|    ..+++|||+||+||+++.++.++|+
T Consensus        82 ~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~ni~i~~~~~~~l~  141 (254)
T cd06627          82 ENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLH----EQGVIHRDIKAANILTTKDGVVKLA  141 (254)
T ss_pred             CCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCHHHEEECCCCCEEEe
Confidence            999999998765 35889999999999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.89  E-value=4.7e-22  Score=157.44  Aligned_cols=139  Identities=26%  Similarity=0.346  Sum_probs=121.9

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      .|++.+.||.|+||.||+|... ++..+++|++.... ....+.+.+|+++++.++|+|++++++.+..++..+++||++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~   81 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL   81 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence            3677889999999999999754 68889999986543 234577889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTS--NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++...  ...+++..+..++.|++.|+.|||    ..+++|||+||+||++++++.++|+
T Consensus        82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh----~~~i~h~~l~p~ni~~~~~~~~~l~  144 (267)
T cd06610          82 SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH----SNGQIHRDIKAGNILLGEDGSVKIA  144 (267)
T ss_pred             CCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHhEEEcCCCCEEEc
Confidence            999999998753  235788889999999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.89  E-value=3.6e-22  Score=162.09  Aligned_cols=137  Identities=23%  Similarity=0.401  Sum_probs=116.0

Q ss_pred             ceeeecccCCCcceeeeEEeC---CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecC--CeeEE
Q 042107           90 LEVFNLISRGGFGSIYKARIQ---DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKD--DFKAL  161 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~l  161 (232)
                      |++.+.||+|+||.||+|...   ++..||+|.+....   ....+.+.+|+.+++.++||||+++++++...  ...++
T Consensus         2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   81 (316)
T cd07842           2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL   81 (316)
T ss_pred             ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence            567788999999999999754   47899999997632   34456678899999999999999999999887  78999


Q ss_pred             EEeccCCCChhhhhccC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC----CCceeec
Q 042107          162 ILEYMPHGSLGKCLSTS----NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD----NMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~----~~~~~l~  231 (232)
                      ||||+++ ++.+++...    ...+++..+..++.|++.|+.|||    ..+++||||||+||+++.    ++.+||+
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~h~dlkp~Nil~~~~~~~~~~~kl~  154 (316)
T cd07842          82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH----SNWVLHRDLKPANILVMGEGPERGVVKIG  154 (316)
T ss_pred             EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH----hCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence            9999975 676665432    225788888999999999999999    889999999999999999    8888875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.89  E-value=3e-22  Score=179.44  Aligned_cols=140  Identities=20%  Similarity=0.314  Sum_probs=114.9

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEec--CCee
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSK--DDFK  159 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~  159 (232)
                      .+.+.|++.+.||+|+||.||+|+.. ++..+|+|.+....  ......+..|+.+++.++||||++++++|..  ...+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            34456889999999999999999764 57788999886542  2335668889999999999999999998754  3578


Q ss_pred             EEEEeccCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHhcCC---CCCCeeeCCCCCCceeeCC
Q 042107          160 ALILEYMPHGSLGKCLSTS---NYILDFFQRLHIMIDVASAVEYLHFGH---STHVIIHCDLKSSNVLLDD  224 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---~~~~iiHrdlk~~Nill~~  224 (232)
                      |+||||+++|+|.+++...   ...+++..++.++.||+.||.|||...   ...+|+||||||+|||++.
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s  160 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST  160 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence            9999999999999988642   235889999999999999999999321   0145999999999999965

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.89  E-value=2.1e-22  Score=161.13  Aligned_cols=137  Identities=22%  Similarity=0.382  Sum_probs=118.5

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      |+..+.||.|++|.||+|+.. +++.||+|.+....  ....+.+..|+++++.++||||+++++++...+..+++|||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL   81 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence            567789999999999999764 68899999886443  223356788999999999999999999999999999999999


Q ss_pred             CCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      + ++|..++... ...+++..+..++.|++.|++|||    ..+++|||++|+||+++.++.++++
T Consensus        82 ~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh----~~~i~H~~l~p~nill~~~~~~~l~  142 (284)
T cd07860          82 H-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH----SHRVLHRDLKPQNLLINTEGAIKLA  142 (284)
T ss_pred             c-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCCEEEe
Confidence            6 5888887653 345788899999999999999999    8899999999999999999998875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.89  E-value=3.1e-22  Score=161.55  Aligned_cols=140  Identities=23%  Similarity=0.356  Sum_probs=118.8

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCC------
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD------  157 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  157 (232)
                      .+.|++.+.||+|+||.||+|... +++.||+|.+....  ......+..|+++++.++||||+++++++.+..      
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            345678899999999999999765 68899999986543  223356678999999999999999999887654      


Q ss_pred             ----eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          158 ----FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       158 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                          ..++++||+++ ++...+......+++..+..++.|++.||.|||    ..+|+|||+||+||++++++.+||+
T Consensus        86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH----KKNFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCcEEeC
Confidence                78999999986 777777655446889999999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.89  E-value=9.6e-23  Score=171.20  Aligned_cols=133  Identities=23%  Similarity=0.404  Sum_probs=114.6

Q ss_pred             cceeeecccCCCcceeeeEE-eCCCcEEEEEEeecccCchHHHHHHHHHHhcCCC-C-----CCccceeEEEecCCeeEE
Q 042107           89 FLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-H-----QNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~l  161 (232)
                      .|++.+.||+|+||.|.+|. ..+++.||||+++... ....+...|+.++..++ |     -|+|+++++|...++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            46789999999999999995 5679999999997553 34455667999999886 3     389999999999999999


Q ss_pred             EEeccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCc
Q 042107          162 ILEYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV  227 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~  227 (232)
                      |+|.+.. +|+++++... ..++....+.++.||+.||.+||    ..+|||+||||+|||+.+-..
T Consensus       266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~----~l~IIHcDLKPENILL~~~~r  327 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH----ELGIIHCDLKPENILLKDPKR  327 (586)
T ss_pred             eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCChhheeeccCCc
Confidence            9999955 9999999763 34888899999999999999999    889999999999999986543

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.89  E-value=6.1e-22  Score=155.73  Aligned_cols=138  Identities=26%  Similarity=0.421  Sum_probs=122.6

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      |++.+.||+|+||.||++... ++..+++|.+.....  ...+.+..|+++++.++|||++++.+.+...+..++++||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~   81 (258)
T cd08215           2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA   81 (258)
T ss_pred             ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence            567789999999999999764 688999999876533  45567888999999999999999999999999999999999


Q ss_pred             CCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTS---NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++...   ...+++.....++.+++.|+.|+|    ..+++|+|++|+||+++.++.++|+
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh----~~~~~H~dl~~~nil~~~~~~~~l~  145 (258)
T cd08215          82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH----SRKILHRDIKPQNIFLTSNGLVKLG  145 (258)
T ss_pred             CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH----hCCEecccCChHHeEEcCCCcEEEC
Confidence            999999998764   256889999999999999999999    8899999999999999999988875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.89  E-value=4.1e-22  Score=161.53  Aligned_cols=139  Identities=27%  Similarity=0.383  Sum_probs=117.8

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecC--CeeEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKD--DFKALI  162 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  162 (232)
                      +.|++.+.||+|+||.||+|... +++.||+|.+.....  .....+.+|+.+++.++|+||+++++++...  +..++|
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV   86 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence            44778899999999999999764 689999999865432  2223456799999999999999999998654  568999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+.+ +|.+++......+++..+..++.|++.|+.|+|    ..+++||||||+||+++.++.++|+
T Consensus        87 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~kL~  150 (309)
T cd07845          87 MEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH----ENFIIHRDLKVSNLLLTDKGCLKIA  150 (309)
T ss_pred             EecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEEC
Confidence            999975 888888765456889999999999999999999    8899999999999999999998885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.89  E-value=4.4e-22  Score=161.05  Aligned_cols=139  Identities=23%  Similarity=0.409  Sum_probs=117.2

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCC-------
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD-------  157 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------  157 (232)
                      +.|++.+.||+|+||.||+|+.. +++.||+|.+....  ......+.+|+++++.++||||+++++++...+       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            34778899999999999999764 68899999886442  222345567999999999999999999887654       


Q ss_pred             -eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          158 -FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       158 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                       ..++||||+++ ++.+++......+++..+..++.|++.||.|||    ..+++|+||||+||+++.++.++|+
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dl~p~nil~~~~~~~kl~  161 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH----RNKILHRDMKAANILITKDGILKLA  161 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEECCCCcEEEC
Confidence             34999999965 888888765556889999999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.89  E-value=4.7e-22  Score=161.84  Aligned_cols=138  Identities=23%  Similarity=0.344  Sum_probs=119.0

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC---chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG---GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .|...+.||+|+||.||+++.. ++..+|+|.+.....   .....+..|+++++.++|||++++++++..++..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3567788999999999999754 688999999864422   234567889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++ ++.+.+......+++..+..++.+++.|+.|||    ..+++||||+|+||+++.++.++|+
T Consensus       106 ~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH----~~~i~H~dL~p~Nil~~~~~~~kl~  167 (317)
T cd06635         106 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNMIHRDIKAGNILLTEPGQVKLA  167 (317)
T ss_pred             CCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcccEEECCCCCEEEe
Confidence            9975 787777655556889999999999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.88  E-value=5e-22  Score=161.41  Aligned_cols=132  Identities=21%  Similarity=0.314  Sum_probs=107.2

Q ss_pred             eecccCCCcceeeeEEeC---CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEec--CCeeEEEEeccC
Q 042107           93 FNLISRGGFGSIYKARIQ---DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSK--DDFKALILEYMP  167 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~  167 (232)
                      ..+||+|+||.||+|+..   ++..||+|.+....  ....+.+|+++++.++||||+++++++..  +...+++|||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            357999999999999754   45789999886442  23457789999999999999999998854  567899999986


Q ss_pred             CCChhhhhccC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceee----CCCCceeec
Q 042107          168 HGSLGKCLSTS--------NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL----DDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill----~~~~~~~l~  231 (232)
                      + ++.+++...        ...+++..+..++.|++.||.|||    ..+|+||||||+||++    +.++.+||+
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~  154 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRVKIA  154 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH----hCCEEcCCCCHHHEEEccCCCCCCcEEEe
Confidence            5 777766421        224778888999999999999999    8899999999999999    455677774

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.88  E-value=2.5e-22  Score=163.01  Aligned_cols=133  Identities=23%  Similarity=0.234  Sum_probs=111.2

Q ss_pred             ecccCCCcceeeeEEeCCCcEEEEEEeecc--cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCCh
Q 042107           94 NLISRGGFGSIYKARIQDGMEVVVKGFNLQ--YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSL  171 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  171 (232)
                      +.+|.|+++.|++++. +++.||+|++...  .....+.+..|+++++.++||||+++++++...+..+++|||++++++
T Consensus         8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            3344444544444433 6899999998754  234557789999999999999999999999999999999999999999


Q ss_pred             hhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          172 GKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       172 ~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .+++... ...+++.....++.|++.||.|||    ..+|+||||||+||+++.++.++++
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH----~~~ivH~dlk~~Nili~~~~~~kl~  143 (314)
T cd08216          87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIH----SKGFIHRSVKASHILLSGDGKVVLS  143 (314)
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCcceEEEecCCceEEe
Confidence            9998753 334788888999999999999999    8899999999999999999988875

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.88  E-value=4.4e-22  Score=156.83  Aligned_cols=138  Identities=24%  Similarity=0.399  Sum_probs=118.7

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      |.+.+.||+|+||.||++... ++..+|+|.+....  ....+.+.+|+++++.++|+||+++++.+...+..++++||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   81 (257)
T cd08225           2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC   81 (257)
T ss_pred             ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence            567789999999999999765 68899999986542  223456788999999999999999999999999999999999


Q ss_pred             CCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCc-eeec
Q 042107          167 PHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV-AHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~-~~l~  231 (232)
                      ++++|.+++... ...+++..+..++.|+++|+.|+|    ..+++|+|+||+||++++++. ++++
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~H~dl~~~nil~~~~~~~~~l~  144 (257)
T cd08225          82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH----DRKILHRDIKSQNIFLSKNGMVAKLG  144 (257)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEEcCCCCeEEec
Confidence            999999998654 334788899999999999999999    889999999999999998753 4664

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.88  E-value=6.8e-22  Score=158.83  Aligned_cols=140  Identities=24%  Similarity=0.339  Sum_probs=118.4

Q ss_pred             cccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCC-CCCCccceeEEEecC-----Cee
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKII-RHQNLIKIISSCSKD-----DFK  159 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-----~~~  159 (232)
                      .+.|++.+.||+|+||.||++.. .+++.+|+|.+.... .....+..|+.+++.+ +|||++++++++...     +..
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~   99 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL   99 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence            45577889999999999999976 468899999886442 2335677899999988 799999999988653     357


Q ss_pred             EEEEeccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          160 ALILEYMPHGSLGKCLST---SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++||||+++++|.++++.   ....+++..+..++.|++.||.|+|    ..+++||||||+||+++.++.++|+
T Consensus       100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~ivH~dlkp~nili~~~~~~kl~  170 (291)
T cd06639         100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH----NNRIIHRDVKGNNILLTTEGGVKLV  170 (291)
T ss_pred             EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEEcCCCCEEEe
Confidence            999999999999998753   2345788899999999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.88  E-value=5e-22  Score=158.85  Aligned_cols=132  Identities=21%  Similarity=0.268  Sum_probs=108.5

Q ss_pred             cccCCCcceeeeEEeC-CCcEEEEEEeecccC---chHHHHHHHHH---HhcCCCCCCccceeEEEecCCeeEEEEeccC
Q 042107           95 LISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG---GAFKNLDVECN---MMKIIRHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        95 ~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      .||+|+||.||+++.. +++.+|+|.+.....   ........|..   ++...+||+|+.+++.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999764 688999998865421   11122333433   3344579999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|.+++.... .+++..+..++.|++.||.|+|    ..+++||||||+||++++++.++++
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH----~~~ivH~dikp~Nil~~~~~~~~l~  139 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRIS  139 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcCCCCCCHHHEEECCCCCEEEc
Confidence            999999887543 4899999999999999999999    8899999999999999999988875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.88  E-value=7.1e-22  Score=155.30  Aligned_cols=137  Identities=26%  Similarity=0.404  Sum_probs=122.1

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecC--CeeEEEEe
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKD--DFKALILE  164 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  164 (232)
                      |...+.||+|++|.||+|... +++.|++|.+.....  ...+.+.+|+..++.++||||+++++.+...  ...++++|
T Consensus         2 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   81 (260)
T cd06606           2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE   81 (260)
T ss_pred             ceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence            456688999999999999765 688999999866542  3467788999999999999999999999888  88999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++++|.+++.... .+++..+..++.+++.|+.|||    ..+++|+|++|+||+++.++.++|+
T Consensus        82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh----~~~~~h~dl~p~ni~i~~~~~~~l~  143 (260)
T cd06606          82 YVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH----SNGIVHRDIKGANILVDSDGVVKLA  143 (260)
T ss_pred             ecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEcCCCCEEEc
Confidence            999999999987654 6889999999999999999999    7899999999999999999988875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.88  E-value=6.2e-22  Score=156.63  Aligned_cols=131  Identities=24%  Similarity=0.383  Sum_probs=116.1

Q ss_pred             ccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCCh
Q 042107           96 ISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSL  171 (232)
Q Consensus        96 lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  171 (232)
                      ||.|++|.||+++.. +++.+|+|.+....   ....+.+..|+.+++.++||||+++++.+..++..+++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999765 58899999986543   23346788899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          172 GKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       172 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .+++.... .+++..+..++.|++.||.|+|    ..+++|+||+|+||+++.++.++|+
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH----~~~~~h~dl~~~nilv~~~~~~~l~  135 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH----NRGIIYRDLKPENLLLDSNGYVKLV  135 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCHHHEEEcCCCCEEEe
Confidence            99997643 4788889999999999999999    8899999999999999999998875

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.88  E-value=8.3e-22  Score=156.73  Aligned_cols=137  Identities=30%  Similarity=0.479  Sum_probs=112.9

Q ss_pred             eeeecccCCCcceeeeEEeC----CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCC------e
Q 042107           91 EVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD------F  158 (232)
Q Consensus        91 ~~~~~lg~g~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~  158 (232)
                      .+.+.||+|+||.||+|.+.    +++.||+|.+....  ....+.+.+|+++++.++||||+++++++....      .
T Consensus         2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   81 (273)
T cd05074           2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI   81 (273)
T ss_pred             cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence            45678999999999999643    36889999886542  233566788999999999999999999875432      2


Q ss_pred             eEEEEeccCCCChhhhhccC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          159 KALILEYMPHGSLGKCLSTS-----NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .++++||+++|+|.+++...     ...+++.....++.|++.|++|+|    ..+|+||||||+||+++.++.++++
T Consensus        82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~nili~~~~~~kl~  155 (273)
T cd05074          82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS----SKNFIHRDLAARNCMLNENMTVCVA  155 (273)
T ss_pred             eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCEeecccchhhEEEcCCCCEEEC
Confidence            47889999999998876421     224678888999999999999999    8899999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.88  E-value=4.1e-22  Score=159.62  Aligned_cols=138  Identities=23%  Similarity=0.343  Sum_probs=119.4

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      .|++.+.||+|+||.||+|... +++.||+|.+....  ....+.+.+|+++++.++|+||+++++++..++..+++|||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   81 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY   81 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence            3678899999999999999765 58899999886532  33346788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++.+..+... ...+++..+..++.|++.|+.|||    ..+++|||++|+||++++++.++|+
T Consensus        82 ~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~~~ni~~~~~~~~kl~  142 (288)
T cd07833          82 VERTLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCH----SHNIIHRDIKPENILVSESGVLKLC  142 (288)
T ss_pred             CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCCEEEE
Confidence            998777665544 334788899999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.88  E-value=5.5e-22  Score=163.15  Aligned_cols=139  Identities=21%  Similarity=0.334  Sum_probs=117.8

Q ss_pred             ccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCC-----
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD-----  157 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  157 (232)
                      +.+.|++.+.||+|+||.||++.. .++..||+|.+....  ....+.+..|+.+++.++||||+++++++..+.     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            456688899999999999999964 478999999885432  223456778999999999999999999887653     


Q ss_pred             -eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          158 -FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       158 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                       ..++||||+ +++|.+++...  .+++..+..++.|++.|+.|+|    ..+|+||||||+||+++.++.++++
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH----~~gi~H~dlkp~Nill~~~~~~kl~  160 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH----AAGIIHRDLKPGNLAVNEDCELKIL  160 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEe
Confidence             358999999 77998888643  4888999999999999999999    8899999999999999999988874

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.88  E-value=2.5e-22  Score=159.45  Aligned_cols=134  Identities=28%  Similarity=0.441  Sum_probs=112.7

Q ss_pred             ecccCCCcceeeeEEeCC-------CcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           94 NLISRGGFGSIYKARIQD-------GMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      +.||+|+||.||+|+..+       ++.+|+|.+.... ......+.+|+++++.++||||+++++++...+..+++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999997542       2578999875432 23456788899999999999999999999998999999999


Q ss_pred             cCCCChhhhhccC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC-----ceeec
Q 042107          166 MPHGSLGKCLSTS------NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM-----VAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~-----~~~l~  231 (232)
                      +++++|.+++...      ...+++..+..++.|++.|+.|+|    ..+++|+|+||+||+++.++     .++++
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~~~~~~l~  153 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE----QMHFIHRDLAARNCLVSEKGYDADRVVKIG  153 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH----hCCcccCCCChheEEEecCCCCCCcceEEC
Confidence            9999999998642      223678888999999999999999    88999999999999999877     66664

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.88  E-value=5.9e-22  Score=159.36  Aligned_cols=138  Identities=22%  Similarity=0.345  Sum_probs=115.4

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCC-CCCccceeEEEecCCe-----e
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIR-HQNLIKIISSCSKDDF-----K  159 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~-----~  159 (232)
                      .|++.+.||+|+||.||+|... +++.||+|.+....  ......+.+|+.+++.++ ||||+++++++...+.     .
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            3677889999999999999764 68999999876543  223456788999999995 6999999998877655     7


Q ss_pred             EEEEeccCCCChhhhhccC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC-CCceeec
Q 042107          160 ALILEYMPHGSLGKCLSTS----NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD-NMVAHFL  231 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~-~~~~~l~  231 (232)
                      |++|||+++ ++.+++...    ...+++..+..++.|++.||.|||    ..+++||||||+||+++. ++.++|+
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~i~H~dl~~~nil~~~~~~~~kl~  153 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH----KHGVMHRDLKPQNLLVDKQKGLLKIA  153 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChHHEEEecCCCeEEEe
Confidence            999999986 888877543    234788999999999999999999    889999999999999998 7888775

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=7e-22  Score=157.00  Aligned_cols=139  Identities=24%  Similarity=0.371  Sum_probs=119.7

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCC-CCCCccceeEEEecCC------ee
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKII-RHQNLIKIISSCSKDD------FK  159 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~------~~  159 (232)
                      +.|++.+.||+|++|.||+|... +++.+++|.+..... ..+.+..|+.+++.+ +||||+++++++....      ..
T Consensus         6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (275)
T cd06608           6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL   84 (275)
T ss_pred             hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence            55778899999999999999764 578899998875543 346788999999998 6999999999986644      48


Q ss_pred             EEEEeccCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          160 ALILEYMPHGSLGKCLSTS---NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|||+++++|.+++...   ...+++..+..++.|++.||.|+|    ..+++|+||+|+||+++.++.++++
T Consensus        85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH----~~~i~H~~l~p~ni~~~~~~~~~l~  155 (275)
T cd06608          85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH----ENKVIHRDIKGQNILLTKNAEVKLV  155 (275)
T ss_pred             EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHHHEEEccCCeEEEC
Confidence            9999999999999887642   345888899999999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.88  E-value=9.3e-22  Score=157.84  Aligned_cols=138  Identities=22%  Similarity=0.277  Sum_probs=117.5

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecC--CeeEEEEec
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKD--DFKALILEY  165 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~  165 (232)
                      ++..+.||.|++|.||++... +++.+|+|.+..... .....+.+|+++++.++||||+++++++...  +..+++|||
T Consensus         3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   82 (287)
T cd06621           3 IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY   82 (287)
T ss_pred             eEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence            567789999999999999764 688999998875432 3456688899999999999999999988653  468999999


Q ss_pred             cCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLST---SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++++|.+++..   ....+++.....++.|++.||.|+|    ..+++|+|++|+||+++.++.++|+
T Consensus        83 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH----~~~i~H~dl~~~nil~~~~~~~~l~  147 (287)
T cd06621          83 CEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH----SRKIIHRDIKPSNILLTRKGQVKLC  147 (287)
T ss_pred             cCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEecCCeEEEe
Confidence            999999887653   2344788888999999999999999    8899999999999999999988875

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.88  E-value=6.5e-23  Score=181.87  Aligned_cols=139  Identities=23%  Similarity=0.407  Sum_probs=111.9

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCC---------
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD---------  157 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---------  157 (232)
                      -++.++.||+|+||.||+++-+ ||+.||||++.... ......+.+|+.++++++|||||+++..|....         
T Consensus       480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~  559 (1351)
T KOG1035|consen  480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIV  559 (1351)
T ss_pred             hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccc
Confidence            3567789999999999999865 89999999997663 233466888999999999999999987653110         


Q ss_pred             --------------------------------------------------------------------------------
Q 042107          158 --------------------------------------------------------------------------------  157 (232)
Q Consensus       158 --------------------------------------------------------------------------------  157 (232)
                                                                                                      
T Consensus       560 ~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~  639 (1351)
T KOG1035|consen  560 ASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGS  639 (1351)
T ss_pred             ccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCc
Confidence                                                                                            


Q ss_pred             ------------------------------eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 042107          158 ------------------------------FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST  207 (232)
Q Consensus       158 ------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~  207 (232)
                                                    .+|+.||||+..++.+++......-.....++++++|++||.|+|    .
T Consensus       640 ~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH----~  715 (1351)
T KOG1035|consen  640 VILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH----D  715 (1351)
T ss_pred             cccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH----h
Confidence                                          124678888887777777654322134567899999999999999    8


Q ss_pred             CCeeeCCCCCCceeeCCCCceeec
Q 042107          208 HVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       208 ~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .|||||||||.||++|++..+||+
T Consensus       716 ~giIHRDLKP~NIFLd~~~~VKIG  739 (1351)
T KOG1035|consen  716 QGIIHRDLKPRNIFLDSRNSVKIG  739 (1351)
T ss_pred             CceeeccCCcceeEEcCCCCeeec
Confidence            899999999999999999999986

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.88  E-value=1.3e-21  Score=157.40  Aligned_cols=138  Identities=22%  Similarity=0.382  Sum_probs=115.0

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      .|++.+.||+|.+|.||+|+.. +++.||+|.+.....  ...+.+..|+++++.++||||+++++++...+..++||||
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY   82 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence            4678899999999999999765 688999998865432  2345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC-CCceeec
Q 042107          166 MPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD-NMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~-~~~~~l~  231 (232)
                      +++ ++.+.+.... ...++.....++.|++.||.|||    .++++||||||+||+++. ++.+||+
T Consensus        83 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~i~H~dl~p~nill~~~~~~~kl~  145 (294)
T PLN00009         83 LDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH----SHRVLHRDLKPQNLLIDRRTNALKLA  145 (294)
T ss_pred             ccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCcceEEEECCCCEEEEc
Confidence            964 7877775432 23577778889999999999999    889999999999999985 4456764

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.88  E-value=1.1e-21  Score=155.73  Aligned_cols=139  Identities=20%  Similarity=0.407  Sum_probs=115.2

Q ss_pred             ceeeecccCCCcceeeeEEeCC--CcEEEEEEeeccc----------CchHHHHHHHHHHhcC-CCCCCccceeEEEecC
Q 042107           90 LEVFNLISRGGFGSIYKARIQD--GMEVVVKGFNLQY----------GGAFKNLDVECNMMKI-IRHQNLIKIISSCSKD  156 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~  156 (232)
                      |++.+.||+|+||.||++....  ++.+|+|.+....          ......+..|+.++.+ ++||||+++++.+...
T Consensus         2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   81 (269)
T cd08528           2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN   81 (269)
T ss_pred             chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence            4567889999999999998654  6789999875331          1223456678887765 7999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          157 DFKALILEYMPHGSLGKCLST---SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       157 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +..+++|||+++++|.+++..   ....+++..++.++.|++.|+.|+|+   ..+++|+||||+||+++.++.++|+
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~~i~H~dl~~~nil~~~~~~~~l~  156 (269)
T cd08528          82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK---EKRIVHRDLTPNNIMLGEDDKVTIT  156 (269)
T ss_pred             CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc---CCceeecCCCHHHEEECCCCcEEEe
Confidence            999999999999999988743   33458888899999999999999992   2579999999999999999988875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.88  E-value=1e-21  Score=156.85  Aligned_cols=136  Identities=20%  Similarity=0.285  Sum_probs=113.7

Q ss_pred             ceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC-chHHHHHHHHHHhcCCC-CCCccceeEEEecC--CeeEEEEe
Q 042107           90 LEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIR-HQNLIKIISSCSKD--DFKALILE  164 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e  164 (232)
                      |++.+.||+|+||.||+|.. .+++.||+|.+..... ........|+.+++.+. |||++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            45678899999999999975 4688999998865422 22233446888888885 99999999999887  88999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++ ++.+.+......+++..+..++.|++.||.|||    ..+++||||||+||+++. +.++|+
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH----~~~i~H~dl~p~ni~l~~-~~~kl~  141 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH----RNGIFHRDIKPENILIKD-DILKLA  141 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCceecccCHHHEEEcC-CCeEEE
Confidence            9974 888887765456899999999999999999999    889999999999999999 888875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.88  E-value=7.2e-22  Score=157.97  Aligned_cols=137  Identities=24%  Similarity=0.389  Sum_probs=118.7

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      |++.+.||+|++|.||+|... ++..||+|.+....  ....+.+..|+++++.++|||++++++++..++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            356788999999999999754 79999999986543  223356778999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      + ++|.+++.... ..+++..+..++.|+++||.|+|    ..+++|||++|+||+++.++.++|+
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH----~~~~~H~dl~p~nil~~~~~~~~l~  141 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH----SHRVLHRDLKPQNLLIDREGALKLA  141 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCHHHEEEcCCCcEEEe
Confidence            5 68999887543 35789999999999999999999    7899999999999999999998875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.88  E-value=1.5e-21  Score=158.58  Aligned_cols=137  Identities=24%  Similarity=0.355  Sum_probs=117.9

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC---chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG---GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      +...+.||+|+||.||+|+.. +++.|++|.+.....   ...+.+..|+++++.++|||++++++++.+.+..|++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            455678999999999999754 688999999865432   2345678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +. |++.+++......+++..+..++.|++.|+.|||    ..+++|+|+||+||+++.++.++|+
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH----~~gi~H~dl~p~nili~~~~~~kL~  163 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH----SHNMIHRDIKAGNILLTEPGQVKLA  163 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCChhhEEECCCCCEEEe
Confidence            96 5787777655556889999999999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.88  E-value=4.2e-22  Score=163.21  Aligned_cols=139  Identities=19%  Similarity=0.270  Sum_probs=118.1

Q ss_pred             cccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEec----CCee
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSK----DDFK  159 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~  159 (232)
                      .+.|++.+.||+|+||.||+|.. .++..||+|.+....  ....+.+.+|+.+++.++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            35677889999999999999975 468999999986542  2345667789999999999999999987753    3468


Q ss_pred             EEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          160 ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++||||+. ++|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~Nil~~~~~~~kl~  149 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIH----SANVIHRDLKPSNLLVNEDCELRIG  149 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCcEEec
Confidence            99999995 58998886543 4889999999999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.88  E-value=1.5e-21  Score=155.92  Aligned_cols=132  Identities=21%  Similarity=0.271  Sum_probs=109.1

Q ss_pred             cccCCCcceeeeEEe-CCCcEEEEEEeecccCc---hHHHHHHH---HHHhcCCCCCCccceeEEEecCCeeEEEEeccC
Q 042107           95 LISRGGFGSIYKARI-QDGMEVVVKGFNLQYGG---AFKNLDVE---CNMMKIIRHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        95 ~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e---~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      .||+|+||.||+++. .+++.||+|.+......   ....+..|   ...++...||+|+++++.+...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999975 46889999998654211   11122223   334555689999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|.+++... ..+++..+..++.|++.|+.|+|    ..+++|||+||+||+++.++.++|+
T Consensus        81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~di~p~nili~~~~~~kl~  139 (278)
T cd05606          81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRIS  139 (278)
T ss_pred             CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----HCCEEcCCCCHHHEEECCCCCEEEc
Confidence            99999988654 35899999999999999999999    8899999999999999999988875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.88  E-value=9e-22  Score=162.47  Aligned_cols=138  Identities=22%  Similarity=0.308  Sum_probs=116.4

Q ss_pred             ccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecc--cCchHHHHHHHHHHhcCCCCCCccceeEEEecC------
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQ--YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKD------  156 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  156 (232)
                      +.+.|+..+.||+|+||.||+|+. .+++.||+|.+...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            445678889999999999999975 47899999998543  223345677899999999999999999987643      


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          157 DFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       157 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ...++||||+++ +|.+.+...   +++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH----~~gi~H~dlkp~Nil~~~~~~~kL~  160 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKIL  160 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEECCCCCEEEc
Confidence            356999999965 888877643   788888899999999999999    8899999999999999999998885

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=1.1e-21  Score=154.91  Aligned_cols=133  Identities=26%  Similarity=0.324  Sum_probs=110.7

Q ss_pred             ecccCCCcceeeeEEeC-CCcEEEEEEeecccC---chHHHHHHHHHH-hcCCCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           94 NLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG---GAFKNLDVECNM-MKIIRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      +.||+|+||.||+|... +++.||+|.+.....   .....+..|..+ ....+|||++++++++...+..+++|||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56899999999999754 688999999865421   112233445444 4455899999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|.+++.... .+++..+..++.|++.||.|+|    ..+++||||+|+||+++.++.++|+
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH----~~~i~H~dl~p~nil~~~~~~~~l~  139 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH----QRGIIHRDIKPENLLIDQTGHLKLT  139 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCcEEEe
Confidence            99999987643 4788889999999999999999    8899999999999999999998875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.88  E-value=4.4e-22  Score=163.86  Aligned_cols=129  Identities=23%  Similarity=0.359  Sum_probs=110.1

Q ss_pred             eecccCCCcceeeeEE-eCCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCC
Q 042107           93 FNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHG  169 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  169 (232)
                      .++||.|.||+||-|. .++|+.||||++.+-.  ......++.|+.++..+.||.||.+--.|++.+.+++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            4789999999999996 4589999999996542  223367888999999999999999999999999999999999664


Q ss_pred             ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC
Q 042107          170 SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN  225 (232)
Q Consensus       170 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~  225 (232)
                      -|..++......+++.....++.||+.||.|||    -.+|+|+||||+|||+...
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH----~knIvHCDLKPENVLLas~  700 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH----FKNIVHCDLKPENVLLASA  700 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh----hcceeeccCCchheeeccC
Confidence            445555555667898888899999999999999    7799999999999999754

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.88  E-value=8.2e-23  Score=165.19  Aligned_cols=138  Identities=20%  Similarity=0.288  Sum_probs=120.2

Q ss_pred             ceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           90 LEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      +...++||+|+||.||-|+. .+|+-+|.|++.+..   ...-.....|-.++.+++.+.||.+-.+|++.+.+++|+..
T Consensus       187 F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtl  266 (591)
T KOG0986|consen  187 FRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTL  266 (591)
T ss_pred             eeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEe
Confidence            45778999999999999975 479999999886542   11223456688999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |.||||.-.|...+ ..+++..++.++.+|+.||++||    ..+||+||+||+|||+|+.|+++||
T Consensus       267 MNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH----~~~iVYRDLKPeNILLDd~GhvRIS  329 (591)
T KOG0986|consen  267 MNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH----RRRIVYRDLKPENILLDDHGHVRIS  329 (591)
T ss_pred             ecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH----hcceeeccCChhheeeccCCCeEee
Confidence            99999988887653 45899999999999999999999    8899999999999999999999987

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.87  E-value=7.2e-22  Score=162.03  Aligned_cols=139  Identities=23%  Similarity=0.365  Sum_probs=117.8

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecc--cCchHHHHHHHHHHhcCC-CCCCccceeEEEecC--Cee
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQ--YGGAFKNLDVECNMMKII-RHQNLIKIISSCSKD--DFK  159 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~--~~~  159 (232)
                      +.+.|++.+.||+|+||.||+|... +++.+|+|++...  .......+.+|+.+++.+ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4556778899999999999999765 6889999988543  223345577899999999 999999999988653  368


Q ss_pred             EEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          160 ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++||||++ ++|..++...  .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.++|+
T Consensus        85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH----~~~i~H~dl~p~nill~~~~~~kl~  149 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH----SGNVIHRDLKPSNILLNSDCRVKLA  149 (337)
T ss_pred             EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCcEEEe
Confidence            99999997 4999888764  5788888899999999999999    8899999999999999999999885

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.87  E-value=8.7e-22  Score=161.49  Aligned_cols=138  Identities=21%  Similarity=0.297  Sum_probs=116.5

Q ss_pred             cccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecC-----Cee
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKD-----DFK  159 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  159 (232)
                      .+.|++.+.||+|+||.||+|.. .+++.||+|.+.... ......+..|+.+++.++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            45678899999999999999975 468999999986432 23345677899999999999999999887654     357


Q ss_pred             EEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          160 ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++||+++ ++.+.+...  .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.++|+
T Consensus        84 ~lv~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH----~~~ivH~dlkp~Nill~~~~~~kl~  148 (336)
T cd07849          84 YIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTNCDLKIC  148 (336)
T ss_pred             EEEehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEECCCCCEEEC
Confidence            999999965 888877643  4888899999999999999999    8899999999999999999988875

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.87  E-value=5.5e-22  Score=158.10  Aligned_cols=138  Identities=25%  Similarity=0.387  Sum_probs=121.3

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCC-CCCccceeEEEecCCeeEEEE
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIR-HQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  163 (232)
                      .|.+.+.||+|+||.||++... +++.||+|.+....   ....+.+..|.++++.++ ||||+++++++...+..+++|
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            3677889999999999999764 78999999986532   223456778999999998 999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+++++|.+++.... .+++..+..++.|++.||.|||    ..+++|+|++|+||+++.++.++++
T Consensus        82 e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh----~~~~~H~dl~~~ni~i~~~~~~~l~  144 (280)
T cd05581          82 EYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH----SKGIIHRDLKPENILLDKDMHIKIT  144 (280)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHeEECCCCCEEec
Confidence            9999999999997653 5899999999999999999999    8899999999999999999988874

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.87  E-value=1.2e-21  Score=160.60  Aligned_cols=135  Identities=20%  Similarity=0.313  Sum_probs=115.5

Q ss_pred             eeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCch--------------HHHHHHHHHHhcCCCCCCccceeEEEec
Q 042107           91 EVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGA--------------FKNLDVECNMMKIIRHQNLIKIISSCSK  155 (232)
Q Consensus        91 ~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~~~~~~  155 (232)
                      .+.+.||+|+||.||+|... +++.||+|.+.......              ...+.+|+++++.++||||+++++++..
T Consensus        12 ~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   91 (335)
T PTZ00024         12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE   91 (335)
T ss_pred             hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence            35577999999999999754 68999999886442211              1246789999999999999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          156 DDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       156 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++..+++|||++ |+|.+++.... .+++.....++.|++.||.|||    ..+++|+||||+||+++.++.++++
T Consensus        92 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH----~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         92 GDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLH----KWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             CCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecccccHHHeEECCCCCEEEC
Confidence            999999999997 58999886543 4788889999999999999999    8899999999999999999988875

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.87  E-value=1.2e-21  Score=157.12  Aligned_cols=137  Identities=20%  Similarity=0.285  Sum_probs=117.3

Q ss_pred             ceeeecccCCCcceeeeEEe----CCCcEEEEEEeeccc----CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeE
Q 042107           90 LEVFNLISRGGFGSIYKARI----QDGMEVVVKGFNLQY----GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  160 (232)
                      |++.+.||+|++|.||+++.    .+++.||+|.+....    ....+.+..|+.++..+ +||+|+++++.+......+
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            56778999999999999864    257889999886432    22345677899999999 5999999999999999999


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +||||+++++|.+++.... .+++.....++.|+++||.|||    ..+++|||+||+||+++.++.++++
T Consensus        82 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH----~~~~~H~dl~p~nil~~~~~~~~l~  147 (288)
T cd05583          82 LILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH----QLGIIYRDIKLENILLDSEGHVVLT  147 (288)
T ss_pred             EEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHeEECCCCCEEEE
Confidence            9999999999999887543 4788888899999999999999    8899999999999999999888774

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.87  E-value=5.8e-22  Score=165.88  Aligned_cols=137  Identities=23%  Similarity=0.418  Sum_probs=119.7

Q ss_pred             ceeeecccCCCcceeeeEEeCC---C--cEEEEEEeecc-cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           90 LEVFNLISRGGFGSIYKARIQD---G--MEVVVKGFNLQ-YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      ....+.||.|.||.||+|.+.+   |  -.||||..+.. .....+.|..|..+|+.++||||++++|+|.. ...|+||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm  469 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM  469 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence            3456789999999999997543   3  35888987664 34557889999999999999999999999965 4589999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |.++-|.|..+++.....++......++.|++.||+|||    +.+++||||...|||+....-+|++
T Consensus       470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe----SkrfVHRDIAaRNiLVsSp~CVKLa  533 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE----SKRFVHRDIAARNILVSSPQCVKLA  533 (974)
T ss_pred             ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH----hhchhhhhhhhhheeecCcceeeec
Confidence            999999999999988888998888999999999999999    8899999999999999998888875

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.87  E-value=1.5e-21  Score=154.26  Aligned_cols=142  Identities=23%  Similarity=0.353  Sum_probs=117.8

Q ss_pred             ceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEec--CCeeEEEEe
Q 042107           90 LEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSK--DDFKALILE  164 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e  164 (232)
                      |++.+.||.|+||.||++.. .++..+|+|.+....  ....+.+..|+++++.++||||+++++.+..  ....+++||
T Consensus         2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e   81 (265)
T cd08217           2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME   81 (265)
T ss_pred             ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence            56778999999999999965 468899999886543  2334567889999999999999999997754  456899999


Q ss_pred             ccCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHhcCC-CCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTS---NYILDFFQRLHIMIDVASAVEYLHFGH-STHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~-~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++++|.+++...   ...+++..+..++.|++.|+.|+|..+ ...+++|+||||+||+++.++.++++
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~  152 (265)
T cd08217          82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLG  152 (265)
T ss_pred             hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEe
Confidence            99999999998653   345888899999999999999999331 13479999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.87  E-value=1.8e-21  Score=157.77  Aligned_cols=139  Identities=23%  Similarity=0.372  Sum_probs=118.4

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      ..|...+.||+|+||.||+|+.. ++..+|+|.+....   ....+.+..|+++++.++|+|++++.+++..+...++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            33566788999999999999764 67889999886432   223456778999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+. |++.+++......+++..+..++.|++.|+.|+|    ..+++||||||+||+++.++.++++
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH----~~~i~H~dl~p~nil~~~~~~~kl~  157 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLG  157 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHhEEECCCCcEEEC
Confidence            9996 5887777554455788899999999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.87  E-value=1.2e-21  Score=156.58  Aligned_cols=139  Identities=25%  Similarity=0.415  Sum_probs=117.3

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCC-CCCCccceeEEEec------CCee
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKII-RHQNLIKIISSCSK------DDFK  159 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~------~~~~  159 (232)
                      ..|++.+.+|+|+||.||+|+. .+++.+|+|.+.... .....+..|+.+++.+ +||||+++++++..      .+..
T Consensus        16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   94 (282)
T cd06636          16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL   94 (282)
T ss_pred             hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence            4567788999999999999976 468899999886543 2335677889888888 69999999998753      4578


Q ss_pred             EEEEeccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          160 ALILEYMPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|||+++|+|.+++... ...+++..+..++.|++.|+.|||    ..+++|||+||+||+++.++.++|+
T Consensus        95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~~ivH~dl~~~nili~~~~~~~l~  163 (282)
T cd06636          95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH----AHKVIHRDIKGQNVLLTENAEVKLV  163 (282)
T ss_pred             EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEe
Confidence            9999999999999988753 334778888899999999999999    8899999999999999999988875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.87  E-value=2.2e-21  Score=154.19  Aligned_cols=132  Identities=25%  Similarity=0.277  Sum_probs=107.8

Q ss_pred             ceeeecc--cCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcC-CCCCCccceeEEEecCCeeEEEEec
Q 042107           90 LEVFNLI--SRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKI-IRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        90 ~~~~~~l--g~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      +++.+.+  |+|+||.||+++. .++..+|+|.+........     |...... .+|||++++++.+..++..++||||
T Consensus        16 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~   90 (267)
T PHA03390         16 CEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDY   90 (267)
T ss_pred             hccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEc
Confidence            3444554  9999999999975 4688899998865432211     2222221 2699999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC-ceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM-VAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~-~~~l~  231 (232)
                      +++++|.+++.... .+++..+..++.|+++|+.|+|    ..+++||||||+||+++.++ .++|+
T Consensus        91 ~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~nil~~~~~~~~~l~  152 (267)
T PHA03390         91 IKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH----KHNIIHNDIKLENVLYDRAKDRIYLC  152 (267)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEEeCCCCeEEEe
Confidence            99999999997654 6899999999999999999999    88999999999999999988 77764

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.87  E-value=9.5e-22  Score=157.06  Aligned_cols=137  Identities=26%  Similarity=0.386  Sum_probs=119.1

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      |++.+.||+|++|.||+|... +++.+++|.+.....  .....+..|+++++.++||+|+++++.+..++..+++|||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            345678999999999999764 688999998865432  24467788999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++ ++.+++......+++..+..++.|++.||.|||    ..+++|+||||+||+++.++.++|+
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~dl~p~nili~~~~~~~l~  140 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH----SHGILHRDLKPENLLINTEGVLKLA  140 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH----HCCeeecCcCHHHEEECCCCcEEEe
Confidence            75 888888765456889999999999999999999    8899999999999999999988875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.87  E-value=5.8e-22  Score=149.43  Aligned_cols=130  Identities=16%  Similarity=0.137  Sum_probs=97.2

Q ss_pred             eecccCCCcceeeeEEeCCCcEEEEEEeecccCc--h------------------------HHHHHHHHHHhcCCCCCCc
Q 042107           93 FNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG--A------------------------FKNLDVECNMMKIIRHQNL  146 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~ni  146 (232)
                      ...||+|+||.||+|...+|+.||+|++......  .                        ......|++.+..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3579999999999998778999999999654211  0                        0122348899999988776


Q ss_pred             cceeEEEecCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCCeeeCCCCCCceeeCCC
Q 042107          147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL-HFGHSTHVIIHCDLKSSNVLLDDN  225 (232)
Q Consensus       147 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~~~~~iiHrdlk~~Nill~~~  225 (232)
                      ........  ...++||||++++++...... ...++......++.|++.+|.|+ |    ..+|+|||+||+||++++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H----~~giiHrDlkP~NIli~~-  153 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQ----DCRLVHADLSEYNLLYHD-  153 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEEC-
Confidence            44333222  223899999998877554322 23578888899999999999999 7    778999999999999984 


Q ss_pred             Cceee
Q 042107          226 MVAHF  230 (232)
Q Consensus       226 ~~~~l  230 (232)
                      +.+++
T Consensus       154 ~~v~L  158 (190)
T cd05147         154 GKLYI  158 (190)
T ss_pred             CcEEE
Confidence            55554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.87  E-value=1e-21  Score=160.57  Aligned_cols=136  Identities=23%  Similarity=0.341  Sum_probs=118.8

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCC-----eeEE
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD-----FKAL  161 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~l  161 (232)
                      |++.+.||+|++|.||+|+.. +++.||+|.+....  ....+.+.+|+.+++.++||||+++.+++...+     ..|+
T Consensus         2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l   81 (330)
T cd07834           2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI   81 (330)
T ss_pred             ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence            567889999999999999765 58899999986543  344567888999999999999999999987765     7899


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|||+++ +|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        82 v~e~~~~-~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH----~~gi~H~dlkp~nili~~~~~~~L~  145 (330)
T cd07834          82 VTELMET-DLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH----SANVIHRDLKPSNILVNSNCDLKIC  145 (330)
T ss_pred             Eecchhh-hHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEc
Confidence            9999974 8988887644 6889999999999999999999    8899999999999999999998885

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.87  E-value=1.1e-21  Score=156.64  Aligned_cols=136  Identities=27%  Similarity=0.399  Sum_probs=119.6

Q ss_pred             eeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccC
Q 042107           91 EVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        91 ~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      +..+.||+|.+|.||+|+.. +++.+|+|.+....  ....+.+..|+.+++.++|||++++++++...+..++||||++
T Consensus         2 ~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   81 (282)
T cd07829           2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD   81 (282)
T ss_pred             eeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence            45678999999999999765 58999999987653  3344667889999999999999999999999899999999997


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                       ++|.+++......+++..+..++.+++.|+.|||    ..+++|||++|+||++++++.++|+
T Consensus        82 -~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH----~~~i~H~~l~~~ni~~~~~~~~~l~  140 (282)
T cd07829          82 -MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH----SHRILHRDLKPQNILINRDGVLKLA  140 (282)
T ss_pred             -cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChheEEEcCCCCEEEe
Confidence             5899999875446889999999999999999999    8899999999999999999998885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.87  E-value=1.5e-21  Score=160.47  Aligned_cols=138  Identities=20%  Similarity=0.292  Sum_probs=116.4

Q ss_pred             cccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecC---------
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKD---------  156 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---------  156 (232)
                      ...|++.+.||.|+||.||+|.. .+++.||+|.+........+.+.+|+++++.++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            45678889999999999999975 46889999999776666667788999999999999999998776543         


Q ss_pred             -----CeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC-CCceee
Q 042107          157 -----DFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD-NMVAHF  230 (232)
Q Consensus       157 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~-~~~~~l  230 (232)
                           ...+++|||++ ++|.+++...  .+++..+..++.|++.||.|||    ..+++||||||+||+++. ++.+++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH----~~givH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH----SANVLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEcCCCceEEE
Confidence                 35789999997 5898887643  4788899999999999999999    889999999999999985 445565


Q ss_pred             c
Q 042107          231 L  231 (232)
Q Consensus       231 ~  231 (232)
                      +
T Consensus       157 ~  157 (342)
T cd07854         157 G  157 (342)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=2.4e-21  Score=147.61  Aligned_cols=122  Identities=15%  Similarity=0.205  Sum_probs=97.2

Q ss_pred             eecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCC-----CCCCccceeEEEecCC---eeE-EEE
Q 042107           93 FNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKII-----RHQNLIKIISSCSKDD---FKA-LIL  163 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~---~~~-lv~  163 (232)
                      .+.||+|+||.||. ...++.. +||++........+.+.+|+.+++.+     +||||+++++++.++.   .++ +||
T Consensus         7 ~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~   84 (210)
T PRK10345          7 QSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA   84 (210)
T ss_pred             cceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence            46899999999996 3234444 69988765444567789999999999     6799999999998863   433 789


Q ss_pred             ec--cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCCeeeCCCCCCceeeCC
Q 042107          164 EY--MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV-EYLHFGHSTHVIIHCDLKSSNVLLDD  224 (232)
Q Consensus       164 e~--~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l-~~lH~~~~~~~iiHrdlk~~Nill~~  224 (232)
                      ||  +++++|.+++...  .+++.  ..++.+++.++ .|||    ..+|+||||||+|||++.
T Consensus        85 e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh----~~~IvhrDlKp~NILl~~  140 (210)
T PRK10345         85 DFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLL----DNRIVTMELKPQNILCQR  140 (210)
T ss_pred             cCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHH----HCCEeecCCCHHHEEEec
Confidence            99  6689999999763  25544  35677888777 9999    889999999999999974

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.87  E-value=2.3e-21  Score=152.59  Aligned_cols=138  Identities=25%  Similarity=0.409  Sum_probs=119.7

Q ss_pred             ceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           90 LEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      |++.+.||+|+||.||+++. .+++.+++|.+....  ......+..|+++++.++||||+++++++......+++|||+
T Consensus         2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd08530           2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA   81 (256)
T ss_pred             ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence            56778999999999999965 468899999987543  233456778999999999999999999999889999999999


Q ss_pred             CCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTS---NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++...   ...+++..+..++.+++.|+.|+|    ..+++|+|++|+||++++++.++++
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh----~~~i~h~~l~~~ni~~~~~~~~kl~  145 (256)
T cd08530          82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH----EQKILHRDLKSANILLVANDLVKIG  145 (256)
T ss_pred             CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh----hCCcccCCCCcceEEEecCCcEEEe
Confidence            999999988652   235788888999999999999999    8899999999999999999888875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.87  E-value=6.6e-22  Score=170.12  Aligned_cols=141  Identities=22%  Similarity=0.252  Sum_probs=108.3

Q ss_pred             ccccceeeecccCCCcceeeeEEeC--CCcEEEEEEee--------------c---ccCchHHHHHHHHHHhcCCCCCCc
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ--DGMEVVVKGFN--------------L---QYGGAFKNLDVECNMMKIIRHQNL  146 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~--~~~~vavK~~~--------------~---~~~~~~~~~~~e~~~l~~l~h~ni  146 (232)
                      +.+.|++.+.||+|+||.||+|..+  ++...+.|.+.              .   ........+.+|+.+++.++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            4566889999999999999998643  22222222110              0   111234557889999999999999


Q ss_pred             cceeEEEecCCeeEEEEeccCCCChhhhhccCC----CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceee
Q 042107          147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSN----YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL  222 (232)
Q Consensus       147 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill  222 (232)
                      +++++++..++..|+++|++. +++.+++....    ..........++.|++.||.|||    .++|+||||||+|||+
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH----~~gIiHrDLKP~NILl  300 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH----DKKLIHRDIKLENIFL  300 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEE
Confidence            999999999999999999985 47777664321    11234556789999999999999    8899999999999999


Q ss_pred             CCCCceeec
Q 042107          223 DDNMVAHFL  231 (232)
Q Consensus       223 ~~~~~~~l~  231 (232)
                      +.++.+||+
T Consensus       301 ~~~~~vkL~  309 (501)
T PHA03210        301 NCDGKIVLG  309 (501)
T ss_pred             CCCCCEEEE
Confidence            999999885

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.87  E-value=3.2e-21  Score=158.74  Aligned_cols=139  Identities=21%  Similarity=0.317  Sum_probs=116.3

Q ss_pred             ccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecC------
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKD------  156 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  156 (232)
                      +.+.|++.+.||+|+||.||++.. .+++.||+|++....  ....+.+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   94 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence            345678889999999999999964 578899999886432  22245677899999999999999999987543      


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          157 DFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       157 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ...++++|++ +++|.+++...  .+++..+..++.|+++|+.|+|    ..+++||||||+||+++.++.++|+
T Consensus        95 ~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIll~~~~~~kl~  162 (345)
T cd07877          95 NDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKIL  162 (345)
T ss_pred             ccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChHHEEEcCCCCEEEe
Confidence            3467888877 77998887654  4788899999999999999999    8899999999999999999998885

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.87  E-value=2.7e-21  Score=156.54  Aligned_cols=140  Identities=24%  Similarity=0.377  Sum_probs=116.8

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCc--hHHHHHHHHHHhcCCCCCCccceeEEEecC-------
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGG--AFKNLDVECNMMKIIRHQNLIKIISSCSKD-------  156 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------  156 (232)
                      .+.|++.+.||+|+||.||+|... +++.+|+|.+......  ....+.+|+++++.++||||+++++.+...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            456788999999999999999754 6889999988654322  234567899999999999999999876543       


Q ss_pred             -CeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          157 -DFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       157 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                       ...+++|||+++ ++...+......+++..+..++.|+++||.|+|    ..+++||||||+||++++++.++|+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH----~~~i~H~dl~p~nil~~~~~~~~l~  157 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH----ENHILHRDIKAANILIDNQGILKIA  157 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEEC
Confidence             346999999965 677776655456899999999999999999999    8899999999999999999998875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.86  E-value=4.8e-21  Score=156.68  Aligned_cols=139  Identities=22%  Similarity=0.306  Sum_probs=117.7

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEec-CCeeEE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSK-DDFKAL  161 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~l  161 (232)
                      +.+.|++.+.||+|+||.||++... +++.||+|.+....  ....+.+..|+++++.++||||+++.+++.. .+..++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            4556888999999999999999754 78999999885432  2334667889999999999999999998865 567899


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|||+ +++|.+++...  .+++.....++.|+++||.|||    ..+++|||++|+||++++++.++|+
T Consensus        88 v~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH----~~~iiH~dl~p~Nili~~~~~~~l~  150 (328)
T cd07856          88 VTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH----SAGVVHRDLKPSNILINENCDLKIC  150 (328)
T ss_pred             Eeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEeECCCCCEEeC
Confidence            99998 56898888653  3677788889999999999999    8899999999999999999988875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.86  E-value=2.6e-21  Score=158.80  Aligned_cols=139  Identities=21%  Similarity=0.274  Sum_probs=117.3

Q ss_pred             cccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecc--cCchHHHHHHHHHHhcCCCCCCccceeEEEecC-----Ce
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQ--YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKD-----DF  158 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  158 (232)
                      .+.|.+.+.||+|+||.||+++. .+++.||+|.+...  .......+..|+.+++.++||||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            34577889999999999999975 46899999998653  223345677899999999999999999887654     34


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          159 KALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .+++|||+. ++|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~~i~H~dlkp~Nil~~~~~~~kL~  150 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH----SANVLHRDLKPSNLLLNANCDLKIC  150 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCEEEC
Confidence            799999996 68988887543 5888999999999999999999    8899999999999999999998875

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.86  E-value=2.4e-22  Score=168.29  Aligned_cols=135  Identities=25%  Similarity=0.406  Sum_probs=119.9

Q ss_pred             eeecccCCCcceeeeEEeCC-CcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCC
Q 042107           92 VFNLISRGGFGSIYKARIQD-GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGS  170 (232)
Q Consensus        92 ~~~~lg~g~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  170 (232)
                      +..+||-|.||.||.|.|+. .-.||||.++.. ....++|..|+.+|+.++|||+|+++|+|..+..+|||+|||..|+
T Consensus       271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGN  349 (1157)
T KOG4278|consen  271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGN  349 (1157)
T ss_pred             eeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCcc
Confidence            56789999999999998864 668999988644 3456889999999999999999999999999999999999999999


Q ss_pred             hhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          171 LGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       171 L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |.+|+++.. ..++.-..+.++.||+.|+.||.    .+.+|||||.+.|+|+.++..+||+
T Consensus       350 LLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE----kknFIHRDLAARNCLVgEnhiVKvA  407 (1157)
T KOG4278|consen  350 LLDYLRECNRSEVPAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHIVKVA  407 (1157)
T ss_pred             HHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH----HhhhhhhhhhhhhccccccceEEee
Confidence            999998763 23555566789999999999999    8899999999999999999999986

>PTZ00284 protein kinase; Provisional

Probab=99.86  E-value=3.3e-21  Score=164.76  Aligned_cols=133  Identities=19%  Similarity=0.294  Sum_probs=106.0

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCC------CCCccceeEEEecC-Ce
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR------HQNLIKIISSCSKD-DF  158 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~-~~  158 (232)
                      .+.|++.+.||+|+||.||+|... +++.||||++.... ........|+++++.++      |++++++++++..+ ..
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~  206 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH  206 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence            356888999999999999999754 68889999986432 12234555777666654      45588888888764 57


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeeCCCCCCceeeCCCC
Q 042107          159 KALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST-HVIIHCDLKSSNVLLDDNM  226 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~~iiHrdlk~~Nill~~~~  226 (232)
                      .++|||++ +++|.+++.... .+++..+..++.|++.||.|||    . .+|+||||||+|||++.++
T Consensus       207 ~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH----~~~gIiHrDlKP~NILl~~~~  269 (467)
T PTZ00284        207 MCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH----TELHLMHTDLKPENILMETSD  269 (467)
T ss_pred             EEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----hcCCeecCCCCHHHEEEecCC
Confidence            88999988 678888886543 5888899999999999999999    6 4899999999999998765

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.86  E-value=4.7e-21  Score=154.40  Aligned_cols=140  Identities=24%  Similarity=0.262  Sum_probs=115.9

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC-chHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG-GAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      .+.+++.+.||+|+||.||+|... +++.||+|.+..... .....+..|+.++... .||||+++++++.++...+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            345678899999999999999876 488999999875432 2334556677666665 4999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST-HVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+++ ++..++......+++..+..++.|++.|+.|||    . .+|+||||+|+||+++.++.++|+
T Consensus        94 e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH----~~~~i~H~dl~p~nill~~~~~~kL~  157 (296)
T cd06618          94 ELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK----EKHGVIHRDVKPSNILLDASGNVKLC  157 (296)
T ss_pred             eccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----hhCCEecCCCcHHHEEEcCCCCEEEC
Confidence            99854 777776654456888888999999999999999    5 489999999999999999988875

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.86  E-value=2.1e-21  Score=155.15  Aligned_cols=137  Identities=23%  Similarity=0.335  Sum_probs=116.9

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCc-hHHHHHHHHHHhcCCC-CCCccceeEEEecCCeeEEEEecc
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIR-HQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      |.+.+.||+|++|.||+|... +++.|++|.+...... ......+|+..++.++ |||++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            356788999999999999875 5788999988654321 2233456889999999 999999999999999999999999


Q ss_pred             CCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                       +|++.+++.... ..+++..+..++.|++.||.|||    .++++|+||+|+||++++++.++|+
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh----~~~i~H~dl~~~ni~i~~~~~~~l~  141 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH----KHGFFHRDLKPENLLVSGPEVVKIA  141 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEEcCCCCEEEe
Confidence             779998887643 45789999999999999999999    8899999999999999999998885

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.86  E-value=3.9e-21  Score=150.79  Aligned_cols=131  Identities=26%  Similarity=0.343  Sum_probs=116.1

Q ss_pred             ccCCCcceeeeEEeC-CCcEEEEEEeecccC---chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCCh
Q 042107           96 ISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG---GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSL  171 (232)
Q Consensus        96 lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  171 (232)
                      ||+|+||.||++... +++.+|+|.+.....   .....+..|+.+++.++||||+++++.+..++..+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999765 588999999865432   2445788899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          172 GKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       172 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .+++.... .+++.....++.|++.|+.|+|    ..+++|+||+|+||+++.++.++++
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh----~~~~~H~~l~p~ni~~~~~~~~~l~  135 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH----SLGIIYRDLKPENILLDADGHIKLT  135 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcceEEEcCCCcEEEe
Confidence            99987653 4788899999999999999999    7899999999999999999988875

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=4.7e-21  Score=144.75  Aligned_cols=129  Identities=20%  Similarity=0.198  Sum_probs=99.3

Q ss_pred             eecccCCCcceeeeEEeCCCcEEEEEEeecccCc---------------------h-----HHHHHHHHHHhcCCCCCCc
Q 042107           93 FNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG---------------------A-----FKNLDVECNMMKIIRHQNL  146 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~e~~~l~~l~h~ni  146 (232)
                      ...||+|++|.||+|+..+|+.||+|.+......                     .     ...+..|...+..+.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4679999999999998778999999998754211                     0     1223568899999999987


Q ss_pred             cceeEEEecCCeeEEEEeccCCCChhhh-hccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeeCCCCCCceeeCC
Q 042107          147 IKIISSCSKDDFKALILEYMPHGSLGKC-LSTSNYILDFFQRLHIMIDVASAVEYLHFGHST-HVIIHCDLKSSNVLLDD  224 (232)
Q Consensus       147 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~~iiHrdlk~~Nill~~  224 (232)
                      .....+....  .++||||++++++... +..  ..++......++.+++.++.++|    . .+|+|||+||+||+++ 
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH----~~~givHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLY----QEAGLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHH----HhCCEecCCCChhhEEEE-
Confidence            5544443332  4899999998855433 332  24667788899999999999999    7 8999999999999998 


Q ss_pred             CCceee
Q 042107          225 NMVAHF  230 (232)
Q Consensus       225 ~~~~~l  230 (232)
                      ++.++|
T Consensus       153 ~~~~~l  158 (190)
T cd05145         153 DGKPYI  158 (190)
T ss_pred             CCCEEE
Confidence            677776

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.86  E-value=7.6e-21  Score=152.11  Aligned_cols=137  Identities=26%  Similarity=0.393  Sum_probs=113.5

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC--chHHHHHHHHHHhcCC---CCCCccceeEEEecCCe-----
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG--GAFKNLDVECNMMKII---RHQNLIKIISSCSKDDF-----  158 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~-----  158 (232)
                      |++.+.||+|+||.||+|+.+ +++.||+|.+.....  .....+..|+.+++.+   +|||++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            456789999999999999876 589999999864422  2234455677766555   69999999999988766     


Q ss_pred             eEEEEeccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          159 KALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .+++|||+++ +|.+++.... ..+++..+..++.|++.||.|||    ..+++|+|++|+||+++.++.++|+
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH----~~~i~h~~l~~~nili~~~~~~~l~  149 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH----SHRIVHRDLKPQNILVTSDGQVKIA  149 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCChhhEEEccCCCEEEe
Confidence            8999999975 8888876532 35889999999999999999999    8899999999999999999998875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.4e-23  Score=158.35  Aligned_cols=139  Identities=23%  Similarity=0.432  Sum_probs=117.7

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEe--ecccCchHHHHHHHHHHhcCCCCCCccceeEEEecC--------
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGF--NLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKD--------  156 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~--~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------  156 (232)
                      +.|+-..++|+|.||.||+|+.+ +|+.||+|++  .....+......+|+.++..++|+|++.+++.|.+.        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34566778999999999999754 6788888865  223344556678899999999999999998887542        


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          157 DFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       157 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ..+|+||++|++ +|..++......++...+.+++.++..||.|+|    +..|+|||+||+|+|++.+|..|||
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH----r~kilHRDmKaaNvLIt~dgilklA  166 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH----RNKILHRDMKAANVLITKDGILKLA  166 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH----HhhHHhhcccHhhEEEcCCceEEee
Confidence            257999999987 899999877667888899999999999999999    8899999999999999999999986

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.86  E-value=6.8e-21  Score=164.43  Aligned_cols=139  Identities=24%  Similarity=0.421  Sum_probs=120.0

Q ss_pred             ccceeeecccCCCcceeeeEE-eCCCcEEEEEEeecccCchHHHHHHHHHHhcCC-CCCCccceeEEEec-----CCeeE
Q 042107           88 NFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKII-RHQNLIKIISSCSK-----DDFKA  160 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-----~~~~~  160 (232)
                      +.+++.+.||.|.+|.||+++ .++++.+|+|+.......+ ++++.|.++++.. .|||++.+++++.-     ++.+|
T Consensus        19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW   97 (953)
T KOG0587|consen   19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW   97 (953)
T ss_pred             CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence            446788999999999999996 4578889999886654333 6677888888877 59999999998754     46899


Q ss_pred             EEEeccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||||.+|+..++++.. +..+.|.....|+++++.|+.+||    .+.++|||+|-.|||++.++.+|+.
T Consensus        98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH----~nkviHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH----NNKVIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh----hcceeeecccCceEEEeccCcEEEe
Confidence            999999999999998864 456889999999999999999999    8899999999999999999999874

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=5.1e-22  Score=154.97  Aligned_cols=140  Identities=22%  Similarity=0.285  Sum_probs=121.5

Q ss_pred             cccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.+..+++||+|.||.|.+|+. .+++.+|+|++++.-   ......-..|-.+++..+||.+..+...|.+.+.++.|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            34466788999999999999975 479999999987652   23344456688999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||..||.|.-.+.... .+++...+.+..+|+.||.|||    +++|+.||+|.+|.|+|.+|..||+
T Consensus       247 MeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLH----s~~ivYRDlKLENLlLDkDGHIKit  310 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLH----SRNIVYRDLKLENLLLDKDGHIKIT  310 (516)
T ss_pred             EEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhh----hCCeeeeechhhhheeccCCceEee
Confidence            99999999998887654 5788888889999999999999    7899999999999999999999986

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.85  E-value=7.6e-21  Score=161.79  Aligned_cols=142  Identities=20%  Similarity=0.262  Sum_probs=106.8

Q ss_pred             ccccceeeecccCCCcceeeeEEe-----------------CCCcEEEEEEeecccCchHHH--------------HHHH
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-----------------QDGMEVVVKGFNLQYGGAFKN--------------LDVE  134 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~e  134 (232)
                      -.+.|++.++||+|+||.||+|..                 ..++.||||++........+.              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            355678999999999999999953                 235679999986543222222              2346


Q ss_pred             HHHhcCCCCCCc-----cceeEEEec--------CCeeEEEEeccCCCChhhhhccCC----------------------
Q 042107          135 CNMMKIIRHQNL-----IKIISSCSK--------DDFKALILEYMPHGSLGKCLSTSN----------------------  179 (232)
Q Consensus       135 ~~~l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~----------------------  179 (232)
                      +..+..++|.++     ++++++|..        ++..|+||||+++++|.+++....                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            666666766544     566666543        346799999999999999886421                      


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          180 -YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       180 -~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                       ..+++..+..++.|++.||.|+|    ..+|+||||||+||+++.++.+||+
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH----~~~ivHrDLKp~NILl~~~~~~kL~  351 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH----RIGIVHRDIKPENLLVTVDGQVKII  351 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCchHhEEECCCCcEEEE
Confidence             12345667889999999999999    8899999999999999999988875

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.85  E-value=6.1e-21  Score=149.02  Aligned_cols=123  Identities=18%  Similarity=0.138  Sum_probs=105.1

Q ss_pred             CCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCChhhhhcc
Q 042107           99 GGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLST  177 (232)
Q Consensus        99 g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  177 (232)
                      |.+|.||+++. .+++.+|+|.+....     ....|...+....||||+++++++...+..+++|||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            78999999975 478999999986542     223344455556799999999999999999999999999999998865


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          178 SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       178 ~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .. .+++.....++.|++.||.|+|    ..+++||||||+||+++.++.++++
T Consensus        79 ~~-~l~~~~~~~~~~ql~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~  127 (237)
T cd05576          79 FL-NIPEECVKRWAAEMVVALDALH----REGIVCRDLNPNNILLDDRGHIQLT  127 (237)
T ss_pred             hc-CCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHEEEcCCCCEEEe
Confidence            43 4888999999999999999999    8899999999999999999988764

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.85  E-value=2.5e-22  Score=168.88  Aligned_cols=140  Identities=27%  Similarity=0.405  Sum_probs=127.3

Q ss_pred             cccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      .+.|+....+|.|++|.||+++. +.++..|+|.++.....+..-+..|+-+++..+|||||.+++.+...+..|+.|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            45677889999999999999974 57899999999888777778888999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |.+|+|++.-... .++++.+...++++.++|+.|+|    ..+-+|||+|-.||++++.|.+|++
T Consensus        94 cgggslQdiy~~T-gplselqiayvcRetl~gl~ylh----s~gk~hRdiKGanilltd~gDvkla  154 (829)
T KOG0576|consen   94 CGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLH----SQGKIHRDIKGANILLTDEGDVKLA  154 (829)
T ss_pred             cCCCcccceeeec-ccchhHHHHHHHhhhhccchhhh----cCCcccccccccceeecccCceeec
Confidence            9999999877654 46888899999999999999999    8899999999999999999999875

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.85  E-value=1.1e-21  Score=166.03  Aligned_cols=136  Identities=23%  Similarity=0.373  Sum_probs=119.0

Q ss_pred             eeeecccCCCcceeeeEEeC--CC--cEEEEEEeecccCc-hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           91 EVFNLISRGGFGSIYKARIQ--DG--MEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        91 ~~~~~lg~g~~g~V~~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      .+.++||+|.||+|++|.|.  .|  ..||||.+...... .+..|.+|+.+|.+++|||++++||+..+ ....+|||.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            45688999999999999875  23  46899999765443 67899999999999999999999999887 667899999


Q ss_pred             cCCCChhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLST-SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++.|+|.+.+.. ....+.......++.|||.|+.||.    .+++|||||...|+|+...-.+|||
T Consensus       192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe----skrlvHRDLAARNlllasprtVKI~  254 (1039)
T KOG0199|consen  192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE----SKRLVHRDLAARNLLLASPRTVKIC  254 (1039)
T ss_pred             cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh----hhhhhhhhhhhhhheecccceeeee
Confidence            999999999987 4445667777889999999999999    8899999999999999999999986

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.85  E-value=1.8e-20  Score=153.50  Aligned_cols=136  Identities=18%  Similarity=0.236  Sum_probs=112.3

Q ss_pred             ceeeecccCCCcceeeeEEeC-C--CcEEEEEEeeccc--CchHHHHHHHHHHhcCC-CCCCccceeEEEecC----Cee
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-D--GMEVVVKGFNLQY--GGAFKNLDVECNMMKII-RHQNLIKIISSCSKD----DFK  159 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~----~~~  159 (232)
                      |++.+.||+|+||.||+++.. +  +..||+|.+....  ....+.+.+|+.+++.+ +||||+++++.+...    ...
T Consensus         2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~   81 (332)
T cd07857           2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL   81 (332)
T ss_pred             ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence            567789999999999999754 4  7789999886432  22345677899999998 599999999875432    457


Q ss_pred             EEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          160 ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++||+. ++|.+++... ..+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        82 ~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH----~~givH~dlkp~Nili~~~~~~kl~  147 (332)
T cd07857          82 YLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIH----SANVLHRDLKPGNLLVNADCELKIC  147 (332)
T ss_pred             EEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHeEEcCCCCEEeC
Confidence            88999986 5899888654 35888999999999999999999    8899999999999999999998885

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.85  E-value=7e-21  Score=156.60  Aligned_cols=140  Identities=19%  Similarity=0.305  Sum_probs=118.5

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCe---
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF---  158 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---  158 (232)
                      .+.+.|++.+.||+|++|.||+|+.. ++..||+|.+....  ....+.+.+|+.+++.++|||++++.+++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34566788999999999999999765 68899999886432  2234567789999999999999999987766544   


Q ss_pred             ---eEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          159 ---KALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       159 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                         .++|+||+ +++|.+++...  .+++..+..++.|++.|+.|+|    ..+++||||||+||+++.++.++|+
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH----~~gi~H~dlkp~Nill~~~~~~kL~  160 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH----SAGIIHRDLKPSNIAVNEDCELKIL  160 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEECCCCCEEEc
Confidence               89999998 66999988753  4888999999999999999999    8899999999999999999988875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.85  E-value=4.1e-22  Score=177.80  Aligned_cols=135  Identities=28%  Similarity=0.407  Sum_probs=117.1

Q ss_pred             eeecccCCCcceeeeEE-eCCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           92 VFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        92 ~~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      -...||.|.||.||.|. ..+|+..|+|.+..+.  ....+.+.+|..++..++|||+|+++|+-...+..+|.||||++
T Consensus      1239 rg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~ 1318 (1509)
T KOG4645|consen 1239 RGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEG 1318 (1509)
T ss_pred             cccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhcc
Confidence            45689999999999995 5679999999886553  33456788899999999999999999999888999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+|.+.+...+ ..++.....+..|++.|+.|||    ..||||||+||+||+++..|..|++
T Consensus      1319 GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH----~~gIVHRDIK~aNI~Ld~~g~iK~~ 1376 (1509)
T KOG4645|consen 1319 GSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLH----EHGIVHRDIKPANILLDFNGLIKYG 1376 (1509)
T ss_pred             CcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHH----hcCceecCCCccceeeecCCcEEee
Confidence            99999987643 3566666778899999999999    8899999999999999999988764

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.85  E-value=3.3e-21  Score=159.97  Aligned_cols=136  Identities=21%  Similarity=0.314  Sum_probs=116.5

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--------CchHHHHHHHHHHhcCCC---CCCccceeEEEecCC
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--------GGAFKNLDVECNMMKIIR---HQNLIKIISSCSKDD  157 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~  157 (232)
                      |...+.+|+|+||.|+.|.++ ...+|++|.+.+..        ......+-.|+++|+.++   |+||++++++|++++
T Consensus       563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd  642 (772)
T KOG1152|consen  563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD  642 (772)
T ss_pred             ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence            556789999999999999765 46789999885542        112233556999999997   999999999999999


Q ss_pred             eeEEEEecc-CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceee
Q 042107          158 FKALILEYM-PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHF  230 (232)
Q Consensus       158 ~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l  230 (232)
                      +.|++||-- ++.+|.+++..+. .+++..+..|++|++.|+++||    ..+|+|||||-+|+.++.+|-+|+
T Consensus       643 ~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh----~~~ivhrdikdenvivd~~g~~kl  711 (772)
T KOG1152|consen  643 YYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLH----DQGIVHRDIKDENVIVDSNGFVKL  711 (772)
T ss_pred             eeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccc----ccCceecccccccEEEecCCeEEE
Confidence            999999964 5779999998764 5888999999999999999999    889999999999999999999987

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.84  E-value=1.2e-20  Score=151.35  Aligned_cols=138  Identities=24%  Similarity=0.255  Sum_probs=112.1

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC-chHHHHHHHHHHhcCCC-CCCccceeEEEecCCeeEEEEecc
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIR-HQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      ++..+.||+|+||.||++... +++.+|+|.+..... .....+..|+.++.++. ||||+++++++..++..+++|||+
T Consensus         6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~   85 (288)
T cd06616           6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM   85 (288)
T ss_pred             hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence            345678999999999999754 689999999865432 33456788999999886 999999999999888999999998


Q ss_pred             CCCChhhhh---cc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCL---ST-SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l---~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +. ++.++.   .. ....+++..+..++.+++.||+|+|+   ..+++||||||+||+++.++.++|+
T Consensus        86 ~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~  150 (288)
T cd06616          86 DI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE---ELKIIHRDVKPSNILLDRNGNIKLC  150 (288)
T ss_pred             cC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---cCCeeccCCCHHHEEEccCCcEEEe
Confidence            64 554432   21 22458888999999999999999992   2489999999999999999988875

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.84  E-value=2e-20  Score=153.77  Aligned_cols=136  Identities=21%  Similarity=0.327  Sum_probs=113.5

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCC------e
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD------F  158 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~  158 (232)
                      +.|...+.||+|+||.||+|.. .+++.||+|.+....  ......+.+|+.+++.++||||+++++++....      .
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            4567889999999999999975 468999999886432  223456778999999999999999999886543      4


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          159 KALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .++++||+.. ++..+...   .+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++++
T Consensus        95 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH----~~~i~H~dlkp~NIll~~~~~~kL~  159 (342)
T cd07879          95 FYLVMPYMQT-DLQKIMGH---PLSEDKVQYLVYQMLCGLKYIH----SAGIIHRDLKPGNLAVNEDCELKIL  159 (342)
T ss_pred             EEEEeccccc-CHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEe
Confidence            5899999964 77766532   4788889999999999999999    8899999999999999999998875

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.84  E-value=1.7e-21  Score=145.32  Aligned_cols=128  Identities=22%  Similarity=0.417  Sum_probs=110.3

Q ss_pred             cccceeeecccCCCcceeeeEE-eCCCcEEEEEEeecccCchHHHHHHHHHHhcCCC-CCCccceeEEEecCC--eeEEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-HQNLIKIISSCSKDD--FKALI  162 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~--~~~lv  162 (232)
                      .+.|++.+++|+|.++.||.|. ..+.+.++||.+++-   ..+.+.+|+.++..+. ||||+++++...++.  ...++
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            4568899999999999999995 567889999998754   3467899999999997 999999999987753  56799


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN  225 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~  225 (232)
                      +||+.+.+..++...    ++......++.+++.||.|||    +.||+|||+||.|+++|..
T Consensus       114 FE~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyCH----S~GImHRDVKPhNvmIdh~  168 (338)
T KOG0668|consen  114 FEYVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYCH----SMGIMHRDVKPHNVMIDHE  168 (338)
T ss_pred             hhhhccccHHHHhhh----hchhhHHHHHHHHHHHHhHHH----hcCcccccCCcceeeechh
Confidence            999999888776543    566778889999999999999    8899999999999999865

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.84  E-value=2e-20  Score=147.85  Aligned_cols=137  Identities=21%  Similarity=0.285  Sum_probs=110.5

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeecc-----cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQ-----YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      |.+.+.||+|+||.||+++.. .+..+++|.+...     .......+..|+.+++.++||||+++++++......+++|
T Consensus         2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (260)
T cd08222           2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT   81 (260)
T ss_pred             ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence            567789999999999999754 3444555554321     1223345667899999999999999999998888999999


Q ss_pred             eccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLST---SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+++++|.+++..   ....+++..+..++.|++.|+.|+|    ..+++|+|+||+||+++. +.++++
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~i~h~~l~~~nili~~-~~~~l~  147 (260)
T cd08222          82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH----QRRILHRDLKAKNIFLKN-NLLKIG  147 (260)
T ss_pred             EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH----HcCccccCCChhheEeec-CCEeec
Confidence            99999999988753   2345888999999999999999999    889999999999999975 345554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.83  E-value=1.2e-19  Score=139.74  Aligned_cols=137  Identities=26%  Similarity=0.360  Sum_probs=120.9

Q ss_pred             eeeecccCCCcceeeeEEeCC-CcEEEEEEeecccCc-hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           91 EVFNLISRGGFGSIYKARIQD-GMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        91 ~~~~~lg~g~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      .+.+.||+|++|.||++.... ++.+++|.+...... ..+.+..|++.++.++|+|++++++.+......++++||+++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   81 (225)
T smart00221        2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG   81 (225)
T ss_pred             ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence            456789999999999998764 889999999766544 567888899999999999999999999988999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|.+++......+++.....++.+++.++.++|    ..+++|+|++|+||+++.++.++|+
T Consensus        82 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~i~h~di~~~ni~v~~~~~~~l~  140 (225)
T smart00221       82 GDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH----SLGIVHRDLKPENILLGMDGLVKLA  140 (225)
T ss_pred             CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEe
Confidence            9999998765432788888999999999999999    7899999999999999998888774

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.83  E-value=6.2e-21  Score=163.86  Aligned_cols=135  Identities=23%  Similarity=0.336  Sum_probs=117.1

Q ss_pred             eeecccCCCcceeeeEEe-CCC----cEEEEEEeecc-cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           92 VFNLISRGGFGSIYKARI-QDG----MEVVVKGFNLQ-YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        92 ~~~~lg~g~~g~V~~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      ..++||+|+||.||+|-| ..|    .+||+|++... .....+++..|+-+|..++|||+++++++|..+. +.||++|
T Consensus       700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~  778 (1177)
T KOG1025|consen  700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL  778 (1177)
T ss_pred             hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence            457899999999999964 344    36888888544 3445688899999999999999999999998766 7899999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|.|+|.++++.++..+.....+.+..|||+|+.|||    .++++||||.++|||+..-..+||+
T Consensus       779 mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe----~qrlVHrdLaaRNVLVksP~hvkit  840 (1177)
T KOG1025|consen  779 MPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE----EQRLVHRDLAARNVLVKSPNHVKIT  840 (1177)
T ss_pred             cccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH----hcchhhhhhhhhheeecCCCeEEEE
Confidence            9999999999988777777888999999999999999    8899999999999999988777764

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.82  E-value=9.8e-21  Score=144.61  Aligned_cols=138  Identities=20%  Similarity=0.231  Sum_probs=114.2

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeecc-cCchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEEEecc
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQ-YGGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      .+.+..+|.|+.|.|++++.+ +|...|||.+... +.+..+++...+.++... +.|+||+.+|+|.....+++-||.|
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM  173 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM  173 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence            345678999999999999865 6899999999655 344566777777766555 4899999999999999999999988


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .. -+..+++....++++.-.-++...+..||.||.+   .++|+|||+||+|||+|+.|++|+|
T Consensus       174 s~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe---KH~viHRDvKPSNILlDe~GniKlC  234 (391)
T KOG0983|consen  174 ST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGNIKLC  234 (391)
T ss_pred             HH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH---hcceeecccCccceEEccCCCEEee
Confidence            54 4566666656678888888889999999999985   4579999999999999999999987

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.82  E-value=2.2e-20  Score=137.36  Aligned_cols=138  Identities=22%  Similarity=0.270  Sum_probs=113.5

Q ss_pred             ceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc-CchHHHHHHHHHHh-cCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           90 LEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY-GGAFKNLDVECNMM-KIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      +.....||+|++|.|-+-++ .+|...|+|.+...- .+..++..+|+.+. +....|.+|.++|.+..+..+|+.||.|
T Consensus        48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M  127 (282)
T KOG0984|consen   48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM  127 (282)
T ss_pred             hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence            34567899999999998875 479999999986542 33456667777754 4567999999999999999999999999


Q ss_pred             CCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLST---SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +. +|..+-+.   .+..+++...-+|+..+..||.|||+   ...++|||+||+|||++.+|.+|+|
T Consensus       128 ~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~---kL~vIHRDvKPsNiLIn~~GqVKiC  191 (282)
T KOG0984|consen  128 DT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS---KLSVIHRDVKPSNILINYDGQVKIC  191 (282)
T ss_pred             hh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH---HhhhhhccCCcceEEEccCCcEEEc
Confidence            65 77665442   35568888889999999999999995   4569999999999999999999997

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.82  E-value=4.7e-19  Score=134.52  Aligned_cols=132  Identities=31%  Similarity=0.506  Sum_probs=116.0

Q ss_pred             ccCCCcceeeeEEeC-CCcEEEEEEeecccCc-hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCChhh
Q 042107           96 ISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGK  173 (232)
Q Consensus        96 lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  173 (232)
                      ||+|.+|.||++... +++.+++|.+...... ..+.+.+|+..++.++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999865 4889999998765432 34678899999999999999999999998889999999999999999


Q ss_pred             hhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC-CCceeec
Q 042107          174 CLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD-NMVAHFL  231 (232)
Q Consensus       174 ~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~-~~~~~l~  231 (232)
                      ++......+++..+..++.++++++.++|    ..+++|+|++|.||+++. ++.++|+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh----~~~~~H~dl~~~ni~~~~~~~~~~l~  135 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLH----SNGIIHRDLKPENILLDSDNGKVKLA  135 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHhhEEEeCCCCcEEEe
Confidence            98765335788899999999999999999    889999999999999998 7777764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.82  E-value=3.4e-19  Score=143.57  Aligned_cols=140  Identities=22%  Similarity=0.288  Sum_probs=101.8

Q ss_pred             ccccceeeecccCCCcceeeeEEeCC----CcEEEEEEeecccCchH-H----------HHHHHHHHhcCCCCCCcccee
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQD----GMEVVVKGFNLQYGGAF-K----------NLDVECNMMKIIRHQNLIKII  150 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~~----~~~vavK~~~~~~~~~~-~----------~~~~e~~~l~~l~h~niv~~~  150 (232)
                      ....|++.+.||+|+||.||+|...+    +..+|+|.......... +          ....+...+..++|+++++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            44568899999999999999997654    34566665433221110 0          112233456678999999999


Q ss_pred             EEEecCC----eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC
Q 042107          151 SSCSKDD----FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM  226 (232)
Q Consensus       151 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~  226 (232)
                      +++....    ..++++|++.. ++.+.+... ...++.....++.|++.||.|+|    ..+|+||||||+|||++.++
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH----~~~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIH----EHGISHGDIKPENIMVDGNN  163 (294)
T ss_pred             EeeeEecCCceEEEEEEehhcc-CHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCC
Confidence            8765543    44678887744 666665543 23567778899999999999999    88999999999999999999


Q ss_pred             ceeec
Q 042107          227 VAHFL  231 (232)
Q Consensus       227 ~~~l~  231 (232)
                      .++|+
T Consensus       164 ~~~l~  168 (294)
T PHA02882        164 RGYII  168 (294)
T ss_pred             cEEEE
Confidence            88875

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.81  E-value=4.2e-21  Score=145.99  Aligned_cols=140  Identities=26%  Similarity=0.257  Sum_probs=111.5

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC-chHHHHHHHHHH-hcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG-GAFKNLDVECNM-MKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      +.++-+..||.|+||.|++-.+ +.|+..|||++..... ...+++..|.+. ++.-+.||||+++|++..++..|+-||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            3455677899999999999965 4799999999976654 456778888764 455578999999999999999999999


Q ss_pred             ccCCCChhhhhcc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLST----SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .|.- ++..+.+.    ....+++.-.-.|..-...||.||..   ...|||||+||+|||+|..|.+|+|
T Consensus       144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~---~lkiIHRDvKPSNILldr~G~vKLC  210 (361)
T KOG1006|consen  144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE---ELKIIHRDVKPSNILLDRHGDVKLC  210 (361)
T ss_pred             HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH---HhhhhhccCChhheEEecCCCEeee
Confidence            9954 66654431    12346766666777778899999974   4469999999999999999999987

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.81  E-value=1.3e-20  Score=145.41  Aligned_cols=124  Identities=20%  Similarity=0.280  Sum_probs=105.2

Q ss_pred             eecccCCCcceeeeEE-eCCCcEEEEEEeecccCchHHHHHHHHHHhcCC-CCCCccceeEEEec----CCeeEEEEecc
Q 042107           93 FNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKII-RHQNLIKIISSCSK----DDFKALILEYM  166 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~----~~~~~lv~e~~  166 (232)
                      .++||-|-.|.|..|. .++++.+|+|++.     +....++|+++.-.. .|||||+++++|..    ...+.+|||+|
T Consensus        67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m  141 (400)
T KOG0604|consen   67 WQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM  141 (400)
T ss_pred             hhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence            3679999999999995 4579999999885     335667888866554 59999999998865    34677999999


Q ss_pred             CCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC
Q 042107          167 PHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN  225 (232)
Q Consensus       167 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~  225 (232)
                      +||+|...++.+ ...+++.++-.|+.||+.|+.|||    +..|.|||+||+|+|....
T Consensus       142 eGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH----~~nIAHRDlKpENLLyt~t  197 (400)
T KOG0604|consen  142 EGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH----SMNIAHRDLKPENLLYTTT  197 (400)
T ss_pred             cchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH----hcchhhccCChhheeeecC
Confidence            999999999876 345899999999999999999999    8899999999999998654

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.80  E-value=1.4e-19  Score=146.71  Aligned_cols=141  Identities=26%  Similarity=0.356  Sum_probs=114.9

Q ss_pred             cccceeeecccCCCcceeeeEE-eCCCcEEEEEEeecccC-------chHHHHHHHHHHhcCCCCCCccceeEEEec-CC
Q 042107           87 RNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYG-------GAFKNLDVECNMMKIIRHQNLIKIISSCSK-DD  157 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~  157 (232)
                      .+.|-++.+||+|+|+.||++. +...+.||+|+-.....       ...+...+|..+.+.++||.||++|+++.- .+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            3445577899999999999995 55677888997644321       124567789999999999999999999865 46


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC---Cceee
Q 042107          158 FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN---MVAHF  230 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~---~~~~l  230 (232)
                      .++-|+|||+|.+|..+++.+. .+++..+..|+-||+.||.||...  ..+|||-||||.|||+-..   |..||
T Consensus       542 sFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEi--kpPIIHYDLKPgNILLv~GtacGeIKI  614 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEI--KPPIIHYDLKPGNILLVNGTACGEIKI  614 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhcc--CCCeeeeccCCccEEEecCcccceeEe
Confidence            7889999999999999998764 588889999999999999999855  5589999999999998543   45555

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.80  E-value=4.6e-19  Score=135.76  Aligned_cols=130  Identities=12%  Similarity=0.131  Sum_probs=103.8

Q ss_pred             ccccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHH---H------HHHHHHHhcCCCCCCccceeEEEecC
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFK---N------LDVECNMMKIIRHQNLIKIISSCSKD  156 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~---~------~~~e~~~l~~l~h~niv~~~~~~~~~  156 (232)
                      +...|+..+.+|+|+||.||+... ++..+|+|.+.........   .      +.+|+..+.++.||+|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            455688999999999999999755 5778999999755433222   2      57899999999999999998875533


Q ss_pred             --------CeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCce
Q 042107          157 --------DFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA  228 (232)
Q Consensus       157 --------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~  228 (232)
                              ...+++|||++|.+|.++..     ++.    ....+++.++..+|    ..+++|||+||+||+++.++ +
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH----~~gi~H~Dikp~Nili~~~g-i  173 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH----QHGMVSGDPHKGNFIVSKNG-L  173 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH----HcCCccCCCChHHEEEeCCC-E
Confidence                    35789999999999988732     222    24568999999999    88999999999999999888 5


Q ss_pred             ee
Q 042107          229 HF  230 (232)
Q Consensus       229 ~l  230 (232)
                      ++
T Consensus       174 ~l  175 (232)
T PRK10359        174 RI  175 (232)
T ss_pred             EE
Confidence            54

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.79  E-value=1.2e-18  Score=135.44  Aligned_cols=127  Identities=28%  Similarity=0.399  Sum_probs=112.8

Q ss_pred             CcceeeeEEeC-CCcEEEEEEeecccCch-HHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCChhhhhcc
Q 042107          100 GFGSIYKARIQ-DGMEVVVKGFNLQYGGA-FKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLST  177 (232)
Q Consensus       100 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~  177 (232)
                      +||.||+|... +++.+++|.+....... .+.+.+|++.++.++|+|++++++.+......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999876 58999999997655443 67889999999999999999999999988999999999999999999876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          178 SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       178 ~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ... +++.....++.+++.++.|+|    ..+++|+|++|+||+++.++.++++
T Consensus        81 ~~~-~~~~~~~~~~~~l~~~l~~lh----~~~i~h~~i~~~ni~~~~~~~~~l~  129 (244)
T smart00220       81 RGR-LSEDEARFYARQILSALEYLH----SNGIIHRDLKPENILLDEDGHVKLA  129 (244)
T ss_pred             ccC-CCHHHHHHHHHHHHHHHHHHH----HcCeecCCcCHHHeEECCCCcEEEc
Confidence            543 788889999999999999999    8899999999999999999888775

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.79  E-value=5.4e-20  Score=147.79  Aligned_cols=137  Identities=19%  Similarity=0.245  Sum_probs=114.1

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEEEe
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      +..+.+||+|+||.|.++..+ +.+.+|||++++.-   ..+.+--..|-.+++-. +-|.+++++.++.+-+.+|.|||
T Consensus       351 FnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVME  430 (683)
T KOG0696|consen  351 FNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVME  430 (683)
T ss_pred             cceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEE
Confidence            456788999999999999654 57889999886542   22333334466666655 47899999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+.||+|--.++.-+ .+.+..+..++.+||-||-|||    .++|+.||||.+||++|.+|.+||+
T Consensus       431 yvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh----~kgIiYRDLKLDNvmLd~eGHiKi~  492 (683)
T KOG0696|consen  431 YVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLH----SKGIIYRDLKLDNVMLDSEGHIKIA  492 (683)
T ss_pred             EecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhh----cCCeeeeeccccceEeccCCceEee
Confidence            999999988777544 4777888999999999999999    8999999999999999999999986

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.79  E-value=6.2e-19  Score=153.13  Aligned_cols=139  Identities=17%  Similarity=0.207  Sum_probs=95.6

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-C----CcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEE------E
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-D----GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISS------C  153 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~------~  153 (232)
                      .-.+.|++.+.||+|+||.||+|+.. +    +..||+|++.....  .+....|  .+....+.+++.+...      .
T Consensus       129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            34456889999999999999999764 4    68999998754321  1111111  1111122222222111      2


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCC-------------------CHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCC
Q 042107          154 SKDDFKALILEYMPHGSLGKCLSTSNYIL-------------------DFFQRLHIMIDVASAVEYLHFGHSTHVIIHCD  214 (232)
Q Consensus       154 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------------~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrd  214 (232)
                      ..+...++||||+++++|.+++.......                   ....+..++.|++.||.|+|    ..+|+|||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH----~~gIiHRD  280 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH----STGIVHRD  280 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH----HCCEEeCc
Confidence            34567899999999999999886542111                   12234578999999999999    88999999


Q ss_pred             CCCCceeeCC-CCceeec
Q 042107          215 LKSSNVLLDD-NMVAHFL  231 (232)
Q Consensus       215 lk~~Nill~~-~~~~~l~  231 (232)
                      |||+|||++. ++.+||+
T Consensus       281 LKP~NILl~~~~~~~KL~  298 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKII  298 (566)
T ss_pred             CCHHHEEEeCCCCcEEEE
Confidence            9999999986 5788875

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1e-18  Score=134.05  Aligned_cols=126  Identities=21%  Similarity=0.264  Sum_probs=102.2

Q ss_pred             ecccCCCcceeeeEEeCCCcEEEEEEeecccCc--------hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           94 NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG--------AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      +.||+|++|.||+|+. ++..+++|........        ....+.+|+.++..+.|++++....++...+..+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5789999999999987 5778999976433211        123567799999999999988777777677788999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceee
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHF  230 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l  230 (232)
                      ++|++|.+++....    + .+..++.+++.++.++|    ..+++|+|++|+||+++ ++.+++
T Consensus        81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH----~~~i~H~Dl~p~Nil~~-~~~~~l  135 (211)
T PRK14879         81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLH----SAGIIHGDLTTSNMILS-GGKIYL  135 (211)
T ss_pred             eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH----hCCcccCCCCcccEEEE-CCCEEE
Confidence            99999999886532    2 67789999999999999    88999999999999998 555554

>smart00090 RIO RIO-like kinase

Probab=99.79  E-value=1.1e-18  Score=135.81  Aligned_cols=132  Identities=17%  Similarity=0.129  Sum_probs=99.3

Q ss_pred             cceeeecccCCCcceeeeEE--eCCCcEEEEEEeecccCc------------------------hHHHHHHHHHHhcCCC
Q 042107           89 FLEVFNLISRGGFGSIYKAR--IQDGMEVVVKGFNLQYGG------------------------AFKNLDVECNMMKIIR  142 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~  142 (232)
                      .|.+.+.||+|+||.||+|.  ..+|+.||+|.+......                        ....+..|+..+..+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            46788899999999999997  568999999998654210                        0123567999999887


Q ss_pred             CCC--ccceeEEEecCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCC-eeeCCCCCCc
Q 042107          143 HQN--LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV-IIHCDLKSSN  219 (232)
Q Consensus       143 h~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~-iiHrdlk~~N  219 (232)
                      +..  ++++++.    ...++||||++++++....... ..........++.|++.++.++|    ..+ ++|||+||+|
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH----~~g~iiH~Dikp~N  179 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLY----KEGELVHGDLSEYN  179 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHH----hcCCEEeCCCChhh
Confidence            533  3344432    2358999999998887654322 23455556789999999999999    888 9999999999


Q ss_pred             eeeCCCCceee
Q 042107          220 VLLDDNMVAHF  230 (232)
Q Consensus       220 ill~~~~~~~l  230 (232)
                      |+++ ++.+++
T Consensus       180 Ili~-~~~i~L  189 (237)
T smart00090      180 ILVH-DGKVVI  189 (237)
T ss_pred             EEEE-CCCEEE
Confidence            9998 666665

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.79  E-value=3.2e-19  Score=147.58  Aligned_cols=131  Identities=22%  Similarity=0.283  Sum_probs=112.6

Q ss_pred             cceeeecccCCCcceeeeEEeCCCcEEEEEEeecc--cCchHHHHHHHHHHhcCCC-CCCccceeEEEecCCeeEEEEec
Q 042107           89 FLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQ--YGGAFKNLDVECNMMKIIR-HQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      .|++.+.||+|+.+.||++...+.+.+|+|++...  +......+..|+..+.+++ |.+|++++++-..++++|+||||
T Consensus       362 ~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~  441 (677)
T KOG0596|consen  362 EYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC  441 (677)
T ss_pred             hhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence            47788999999999999999888888888877433  4455678999999999995 89999999999999999999995


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD  224 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~  224 (232)
                      = ..||.++|+......+....+.+..|++.|+.++|    ..||||.||||+|+|+-.
T Consensus       442 G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH----~~gIVHSDLKPANFLlVk  495 (677)
T KOG0596|consen  442 G-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH----QHGIVHSDLKPANFLLVK  495 (677)
T ss_pred             c-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH----HhceeecCCCcccEEEEe
Confidence            4 56999999877555554467788999999999999    889999999999999754

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=2.2e-19  Score=140.99  Aligned_cols=138  Identities=19%  Similarity=0.250  Sum_probs=119.6

Q ss_pred             cceeeecccCCCcceeeeEEe-CCCcEEEEEEeecc---cCchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEEE
Q 042107           89 FLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQ---YGGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      -+.++++||+|+|++|..+++ ++.+.+|+|++++.   +.++.+....|-.+.... +||.+|.++.+|.++..+++|.
T Consensus       251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi  330 (593)
T KOG0695|consen  251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI  330 (593)
T ss_pred             cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence            356889999999999999975 46888999988654   344556666777777665 6999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||++||+|.-.++..+ .++++.+..+..+|+.||.|||    .+|||.||+|.+|+|+|.+|..|++
T Consensus       331 eyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh----~rgiiyrdlkldnvlldaeghiklt  393 (593)
T KOG0695|consen  331 EYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLH----ERGIIYRDLKLDNVLLDAEGHIKLT  393 (593)
T ss_pred             EEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHh----hcCeeeeeccccceEEccCCceeec
Confidence            9999999988777654 4888899999999999999999    8899999999999999999999875

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=1.9e-20  Score=143.15  Aligned_cols=135  Identities=21%  Similarity=0.331  Sum_probs=113.2

Q ss_pred             eeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCC-----eeEEE
Q 042107           91 EVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD-----FKALI  162 (232)
Q Consensus        91 ~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~lv  162 (232)
                      +..+.||-|+||+||.+.. ++|+.||+|++..-.  -...+.+.+|..++..++|.|+...++......     .+|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            4567899999999999964 589999999885432  234577888999999999999999988876543     46789


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|.|.. +|..++-..+ .++...++-+..||++||.|||    ..+|+||||||.|.|++.+...|||
T Consensus       136 TELmQS-DLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLH----sA~ILHRDIKPGNLLVNSNCvLKIC  198 (449)
T KOG0664|consen  136 TELMQS-DLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLH----TANILHRDIKPGNLLVNSNCILKIC  198 (449)
T ss_pred             HHHHHh-hhhheeccCC-CCCcchhhhhHHHHHhhhHHHh----hcchhhccCCCccEEeccCceEEec
Confidence            999855 8888876543 4777778889999999999999    8899999999999999999999987

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.78  E-value=2.5e-20  Score=152.81  Aligned_cols=136  Identities=22%  Similarity=0.301  Sum_probs=118.6

Q ss_pred             ceeeecccCCCcceeeeEEeCCC-cEEEEEEeecc---cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           90 LEVFNLISRGGFGSIYKARIQDG-MEVVVKGFNLQ---YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~~~-~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      ++....||-|+||.|-+++.... ..+|+|.+++.   +....+.+..|-.+|..++.|.||++|..|.++.++|+.||-
T Consensus       422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa  501 (732)
T KOG0614|consen  422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA  501 (732)
T ss_pred             hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence            34567899999999999876543 34788887654   334456788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceee
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHF  230 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l  230 (232)
                      |-||.+...++.++ .++...+..++..+++|++|||    +++||+|||||+|.++|.+|.+|+
T Consensus       502 ClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH----~k~iIYRDLKPENllLd~~Gy~KL  561 (732)
T KOG0614|consen  502 CLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLH----RKGIIYRDLKPENLLLDNRGYLKL  561 (732)
T ss_pred             hcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHH----hcCceeccCChhheeeccCCceEE
Confidence            99999999998765 5888888889999999999999    999999999999999999999987

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.78  E-value=1.6e-18  Score=151.88  Aligned_cols=137  Identities=28%  Similarity=0.423  Sum_probs=118.9

Q ss_pred             eeeecccCCCcceeeeEEeC----C----CcEEEEEEeeccc-CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeE
Q 042107           91 EVFNLISRGGFGSIYKARIQ----D----GMEVVVKGFNLQY-GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        91 ~~~~~lg~g~~g~V~~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  160 (232)
                      .+.+.+|+|.||.|++|...    .    ...||||.+.... ..+.+.+..|+++|+.+ .||||+.+.|+|...+..+
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~  378 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY  378 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence            45669999999999999632    1    4578999886442 34567789999999998 4999999999999989999


Q ss_pred             EEEeccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC
Q 042107          161 LILEYMPHGSLGKCLSTSN---------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN  225 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~  225 (232)
                      +|+||+..|+|..+++..+               ..+.....+.++.|||.|++||+    ..+++|||+-++|||+.++
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~----~~~~vHRDLAaRNVLi~~~  454 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA----SVPCVHRDLAARNVLITKN  454 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh----hCCccchhhhhhhEEecCC
Confidence            9999999999999998765               34777888999999999999999    8899999999999999999


Q ss_pred             Cceeec
Q 042107          226 MVAHFL  231 (232)
Q Consensus       226 ~~~~l~  231 (232)
                      ..+|||
T Consensus       455 ~~~kIa  460 (609)
T KOG0200|consen  455 KVIKIA  460 (609)
T ss_pred             CEEEEc
Confidence            999986

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.77  E-value=2.1e-18  Score=140.86  Aligned_cols=138  Identities=22%  Similarity=0.258  Sum_probs=112.0

Q ss_pred             CCccc-ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCC-----C---CCccceeEE
Q 042107           83 PRPFR-NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-----H---QNLIKIISS  152 (232)
Q Consensus        83 p~~~~-~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~  152 (232)
                      .+.|. ..|.+.++||.|.|++||+|.. .+.+.||+|+.+.. ....+....||.+++.++     |   ..||++++.
T Consensus        72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~  150 (590)
T KOG1290|consen   72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH  150 (590)
T ss_pred             cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence            33555 6688999999999999999964 46778999988644 334566778999998873     3   479999998


Q ss_pred             EecC----CeeEEEEeccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC
Q 042107          153 CSKD----DFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN  225 (232)
Q Consensus       153 ~~~~----~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~  225 (232)
                      |...    .++++|+|++ |.+|..+|.... ..++...++.|++|++.||.|||.   ..+|||-||||+|||+...
T Consensus       151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~---ecgIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR---ECGIIHTDLKPENVLLCST  224 (590)
T ss_pred             ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH---hcCccccCCCcceeeeecc
Confidence            8653    4889999999 668988887653 348889999999999999999995   4589999999999998654

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.76  E-value=4.3e-18  Score=129.48  Aligned_cols=122  Identities=20%  Similarity=0.281  Sum_probs=95.4

Q ss_pred             cccCCCcceeeeEEeCCCcEEEEEEeecccC--c------hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           95 LISRGGFGSIYKARIQDGMEVVVKGFNLQYG--G------AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        95 ~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~--~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      .||+|+||.||+|.+ ++..+++|.......  .      ....+.+|++++..++|+++.....++...+..+++|||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 477899998643211  1      1255678999999999887655555555566678999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceee
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHF  230 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l  230 (232)
                      +|++|.+++....     .   .++.+++.++.++|    ..+++|+|++|+||+++ ++.+++
T Consensus        80 ~g~~l~~~~~~~~-----~---~~~~~i~~~l~~lH----~~gi~H~Dl~~~Nil~~-~~~~~l  130 (199)
T TIGR03724        80 EGKPLKDVIEEGN-----D---ELLREIGRLVGKLH----KAGIVHGDLTTSNIIVR-DDKLYL  130 (199)
T ss_pred             CCccHHHHHhhcH-----H---HHHHHHHHHHHHHH----HCCeecCCCCcceEEEE-CCcEEE
Confidence            9999998875421     1   68899999999999    88999999999999998 565554

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.76  E-value=3.5e-18  Score=128.58  Aligned_cols=133  Identities=23%  Similarity=0.329  Sum_probs=111.1

Q ss_pred             ccccceeeecccCCCcceeeeEE-eCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCC-CCccceeEEEecCCeeEEEE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRH-QNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~  163 (232)
                      ....|.+.++||.|+||.+|.|. ..+|+.||||.-.....  ...+..|..+.+.+++ ..|+.+..+.....+-.+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            34568899999999999999995 56899999997644322  2456678888888875 57777777777788889999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN  225 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~  225 (232)
                      |.. |.+|.++..-....++..+++.++-|++.-++|+|    .++++||||||+|+|..-+
T Consensus        91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH----~r~fiHRDIKPdNFLMGlg  147 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH----LRNFIHRDIKPDNFLMGLG  147 (341)
T ss_pred             ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH----hhccccccCCccceeeccc
Confidence            988 77999988876666888899999999999999999    8899999999999998643

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.76  E-value=1.6e-18  Score=132.49  Aligned_cols=139  Identities=19%  Similarity=0.343  Sum_probs=113.1

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCC-CCCccceeEE-EecCCeeEEE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-HQNLIKIISS-CSKDDFKALI  162 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~-~~~~~~~~lv  162 (232)
                      +.+.|.+.+.+|+|.||.+.+++++ +.+.+++|.+.... ...+.|.+|...--.+. |.||+.-|+. |.+.+....+
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            4566778899999999999999866 57789999886543 34577888887666664 8899988774 6777888899


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeC-CC-Cceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD-DN-MVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~-~~-~~~~l~  231 (232)
                      +||+|.|+|..-+...+  +.+....+++.|++.|+.|+|    +..+||||||.+|||+- .+ ..+|+|
T Consensus       101 qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH----sknlVHRdlK~eNiLif~~df~rvKlc  165 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH----SKNLVHRDLKAENILIFDADFYRVKLC  165 (378)
T ss_pred             eccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh----ccchhhcccccceEEEecCCccEEEee
Confidence            99999999998877643  677888999999999999999    88999999999999984 33 345654

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=5.5e-18  Score=128.88  Aligned_cols=127  Identities=22%  Similarity=0.209  Sum_probs=97.6

Q ss_pred             ceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCc----------------------hHHHHHHHHHHhcCCCCCC--
Q 042107           90 LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG----------------------AFKNLDVECNMMKIIRHQN--  145 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~n--  145 (232)
                      +.+.+.||+|+||.||++...+|+.||||++......                      .......|..++..+.|++  
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            5567889999999999998888999999987543210                      0112566888888887774  


Q ss_pred             ccceeEEEecCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC
Q 042107          146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN  225 (232)
Q Consensus       146 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~  225 (232)
                      +++.++.    ...+++|||+++++|......       .....++.+++.++.++|    ..+++|||+||+||+++++
T Consensus        97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh----~~gi~H~Dl~p~Nill~~~  161 (198)
T cd05144          97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY----KHGIIHGDLSEFNILVDDD  161 (198)
T ss_pred             CCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH----HCCCCcCCCCcccEEEcCC
Confidence            4444432    345899999999998765431       234568889999999999    7899999999999999999


Q ss_pred             Cceeec
Q 042107          226 MVAHFL  231 (232)
Q Consensus       226 ~~~~l~  231 (232)
                      +.++|+
T Consensus       162 ~~~~li  167 (198)
T cd05144         162 EKIYII  167 (198)
T ss_pred             CcEEEE
Confidence            888764

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=8.1e-18  Score=145.90  Aligned_cols=125  Identities=20%  Similarity=0.217  Sum_probs=98.3

Q ss_pred             eeeecccCCCcceeeeEEeCCCcEEEEEEeecc-cC-------chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           91 EVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQ-YG-------GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        91 ~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~-~~-------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      ...+.||+|+||.||++.+.... +++|+.... ..       ...+.+.+|+++++.++|++++....++..++..++|
T Consensus       336 ~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv  414 (535)
T PRK09605        336 IPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV  414 (535)
T ss_pred             CccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence            45688999999999999876443 444433211 11       1134578899999999999998877777777778999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceee
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHF  230 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l  230 (232)
                      |||+++++|.+++.         ....++.++++++.++|    ..+++|||+||+||++ .++.++|
T Consensus       415 ~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH----~~giiHrDlkp~NILl-~~~~~~l  468 (535)
T PRK09605        415 MEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH----KAGIVHGDLTTSNFIV-RDDRLYL  468 (535)
T ss_pred             EEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH----hCCCccCCCChHHEEE-ECCcEEE
Confidence            99999999998774         34678899999999999    8899999999999999 4556655

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=2.9e-17  Score=123.62  Aligned_cols=123  Identities=16%  Similarity=0.147  Sum_probs=95.6

Q ss_pred             eeecccCCCcceeeeEEeCCCcEEEEEEeecccCc----hHHHHHHHHHHhcCCC-CCCccceeEEEecCCeeEEEEecc
Q 042107           92 VFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG----AFKNLDVECNMMKIIR-HQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        92 ~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      +...|++|+||.||.+.. ++..++.+.+......    ....+.+|+++++.+. |+++++++++    +..+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence            557899999999997765 5777877766543221    1224788999999996 5789998886    3468999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCC-CCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDL-KSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdl-k~~Nill~~~~~~~l~  231 (232)
                      +|.+|.+....        ....++.|+++++.++|    ..||+|||| ||+|||++.++.++|.
T Consensus        81 ~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH----~~GIvHrDL~kp~NILv~~~g~i~LI  134 (218)
T PRK12274         81 AGAAMYQRPPR--------GDLAYFRAARRLLQQLH----RCGVAHNDLAKEANWLVQEDGSPAVI  134 (218)
T ss_pred             cCccHHhhhhh--------hhHHHHHHHHHHHHHHH----HCcCccCCCCCcceEEEcCCCCEEEE
Confidence            99998764321        11356789999999999    889999999 7999999999888763

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.73  E-value=5e-18  Score=142.67  Aligned_cols=136  Identities=21%  Similarity=0.250  Sum_probs=109.6

Q ss_pred             ccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcC-CCCCCccceeEEEecCCeeEEEE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKI-IRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      +.+.|++...+|.|+|+.|-.+.. .+++..++|++.....    ...+|+.++.. -+||||+++.+.+.+....|+||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            455677778899999999999964 4688899999976522    23345644444 47999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceee-CCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL-DDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill-~~~~~~~l~  231 (232)
                      |.+.++.+.+.+.....  ....+..|+.+++.|+.|||    .+|++|||+||+|||+ +..+..+|+
T Consensus       396 e~l~g~ell~ri~~~~~--~~~e~~~w~~~lv~Av~~LH----~~gvvhRDLkp~NIL~~~~~g~lrlt  458 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPE--FCSEASQWAAELVSAVDYLH----EQGVVHRDLKPGNILLDGSAGHLRLT  458 (612)
T ss_pred             hhccccHHHHHHHhcch--hHHHHHHHHHHHHHHHHHHH----hcCeeecCCChhheeecCCCCcEEEE
Confidence            99999988777765432  22456679999999999999    8899999999999999 588888774

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.73  E-value=6.1e-18  Score=145.76  Aligned_cols=126  Identities=24%  Similarity=0.367  Sum_probs=101.1

Q ss_pred             ceeeecccCCCcce-eeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEEEeccC
Q 042107           90 LEVFNLISRGGFGS-IYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        90 ~~~~~~lg~g~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      +...+.+|.|+.|. ||+|... +++||||++-..   ..+-+.+|+.+++.- +|||||++++.-.++.+.|+..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            33456788888775 7999875 789999988543   334567899999887 49999999999889999999999995


Q ss_pred             CCChhhhhccCCCCC---CHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC
Q 042107          168 HGSLGKCLSTSNYIL---DFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD  224 (232)
Q Consensus       168 ~g~L~~~l~~~~~~~---~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~  224 (232)
                      . +|.+++.......   .....+.+..|++.||++||    ..+|+||||||.||||+.
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH----sl~iVHRDLkPQNILI~~  641 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH----SLKIVHRDLKPQNILISV  641 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH----hcccccccCCCceEEEEc
Confidence            5 9999998731111   11234678899999999999    889999999999999986

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.72  E-value=1.1e-17  Score=134.41  Aligned_cols=130  Identities=25%  Similarity=0.347  Sum_probs=111.9

Q ss_pred             ccccceeeecccCCCcceeeeEEeC----CCcEEEEEEeecccCchHHHHHHHHHHhcCCC-CCCccceeEEEecCCeeE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-HQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  160 (232)
                      +...|...++||+|.|+.||++...    ....||+|.+....  ....+..|++++..+. +.||+++.+++...+...
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            3455678899999999999999532    46789999886553  3466888999999985 899999999999999999


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN  225 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~  225 (232)
                      +|+||+++.+..++...    ++...+..+++.+..||.++|    .+||||||+||+|+|.+..
T Consensus       112 ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h----~~GIvHRDiKpsNFL~n~~  168 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH----KNGIVHRDIKPSNFLYNRR  168 (418)
T ss_pred             EEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh----ccCccccCCCccccccccc
Confidence            99999999999988865    556778889999999999999    8999999999999998754

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.71  E-value=9.3e-17  Score=130.99  Aligned_cols=133  Identities=23%  Similarity=0.309  Sum_probs=109.0

Q ss_pred             cceeeecccCCCcceeeeEEeCC--CcEEEEEEeecccCchHHHHHHHHHHhcCCCC----CCccceeEEE-ecCCeeEE
Q 042107           89 FLEVFNLISRGGFGSIYKARIQD--GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRH----QNLIKIISSC-SKDDFKAL  161 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~-~~~~~~~l  161 (232)
                      .|.+.+.||+|+||.||.+....  ...+|+|............+..|+.++..+..    +++..+++.. ..+.+.++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            67899999999999999997554  34788887765433322367778888888863    6888998888 47778899


Q ss_pred             EEeccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC
Q 042107          162 ILEYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM  226 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~  226 (232)
                      ||+.+ |.+|.++..... ..++..++..++.|++.+|.++|    +.|++||||||+|+++....
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH----~~G~iHRDiKp~N~~~g~~~  159 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH----SKGFIHRDIKPENFVVGQSS  159 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH----hcCcccCCcCHHHeeecCCC
Confidence            99987 779999875543 56899999999999999999999    88999999999999998653

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.70  E-value=2.6e-17  Score=130.89  Aligned_cols=137  Identities=18%  Similarity=0.211  Sum_probs=111.7

Q ss_pred             cccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCC--C----CccceeEEEecCC
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRH--Q----NLIKIISSCSKDD  157 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~----niv~~~~~~~~~~  157 (232)
                      .+...|.+...+|+|+||.|-++.. ..+..||+|+++.-. ...+...-|++++.++.+  |    -+|.+.++|.-.+
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg  164 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG  164 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence            4566788999999999999999954 357889999885432 223555668999998842  2    3677788898899


Q ss_pred             eeEEEEeccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCc
Q 042107          158 FKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV  227 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~  227 (232)
                      +.++|+|.+ |-++.+++..+. .+++...+..++.|+++++.|||    ..+++|-||||+|||+.....
T Consensus       165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh----~~kl~HTDLKPENILfvss~~  230 (415)
T KOG0671|consen  165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH----DLKLTHTDLKPENILFVSSEY  230 (415)
T ss_pred             ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH----hcceeecCCChheEEEeccce
Confidence            999999988 669999998753 45888899999999999999999    889999999999999866543

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.70  E-value=1.5e-17  Score=129.62  Aligned_cols=131  Identities=24%  Similarity=0.289  Sum_probs=105.3

Q ss_pred             eeecccCCCcceeeeEEe-CCCcEEEEEEeecc--cCchHHHHHHHHHHhcCCCCCCccceeEEEecCC------eeEEE
Q 042107           92 VFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQ--YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD------FKALI  162 (232)
Q Consensus        92 ~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------~~~lv  162 (232)
                      -+..+|.|.- .|-.+-. -.++.||+|++...  +....++..+|..++..+.|+||++++.++....      ..|+|
T Consensus        21 nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v   99 (369)
T KOG0665|consen   21 NLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLV   99 (369)
T ss_pred             eecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHH
Confidence            3456777765 4444432 25788999987443  3344677889999999999999999999987643      56899


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+|.. +|.+.+..   .++......+..|++.|+.|+|    +.+|+||||||+||++..++.+||.
T Consensus       100 ~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lh----s~~IihRdLkPsnivv~~~~~lKi~  160 (369)
T KOG0665|consen  100 MELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLH----SAGIIHRDLKPSNIVVNSDCTLKIL  160 (369)
T ss_pred             HHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHH----hcceeecccCcccceecchhheeec
Confidence            999955 88888763   3677788899999999999999    8999999999999999999999985

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.67  E-value=3e-16  Score=118.10  Aligned_cols=126  Identities=20%  Similarity=0.178  Sum_probs=85.7

Q ss_pred             eecccCCCcceeeeEEeCCCcEEEEEEeecccCch--HHH----------------------HHHHHHHhcCCCCCC--c
Q 042107           93 FNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGA--FKN----------------------LDVECNMMKIIRHQN--L  146 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~h~n--i  146 (232)
                      .+.||+|+||.||+|...+++.||+|++.......  ...                      ...|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999987789999999886532111  011                      123444454443332  3


Q ss_pred             cceeEEEecCCeeEEEEeccCCCChhhh-hccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeeCCCCCCceeeCC
Q 042107          147 IKIISSCSKDDFKALILEYMPHGSLGKC-LSTSNYILDFFQRLHIMIDVASAVEYLHFGHST-HVIIHCDLKSSNVLLDD  224 (232)
Q Consensus       147 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~~iiHrdlk~~Nill~~  224 (232)
                      .+.++.    ...+++|||++++++... +....  .. .....++.+++.++.++|    . .+|+|||+||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh----~~~~ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY----REAGLVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh----hccCcCcCCCChhhEEEE-
Confidence            344432    235899999999544321 11111  11 456788999999999999    6 8999999999999999 


Q ss_pred             CCceee
Q 042107          225 NMVAHF  230 (232)
Q Consensus       225 ~~~~~l  230 (232)
                      ++.+++
T Consensus       150 ~~~~~l  155 (187)
T cd05119         150 DGKVYI  155 (187)
T ss_pred             CCcEEE
Confidence            777665

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=9e-16  Score=110.95  Aligned_cols=127  Identities=20%  Similarity=0.270  Sum_probs=102.1

Q ss_pred             eeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCC--CCccceeEEEecCCeeEEEEeccCCC
Q 042107           92 VFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRH--QNLIKIISSCSKDDFKALILEYMPHG  169 (232)
Q Consensus        92 ~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g  169 (232)
                      +.+.+|+|.++.||++...+ ..+++|.......  ...+..|+..++.+++  ..+++++.+...++..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            34679999999999998754 7899998765433  4567889999999976  58889888888778899999999988


Q ss_pred             ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceee
Q 042107          170 SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHF  230 (232)
Q Consensus       170 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l  230 (232)
                      ++..+        +......++.++++++.++|... ..+++|+|++|+||+++..+.+++
T Consensus        79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~-~~~i~H~Dl~~~Nil~~~~~~~~l  130 (155)
T cd05120          79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLP-LLVLCHGDLHPGNILVDDGKILGI  130 (155)
T ss_pred             ecccC--------CHHHHHHHHHHHHHHHHHHhCCC-ceEEEecCCCcceEEEECCcEEEE
Confidence            77543        44566778899999999999332 247999999999999998776665

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.66  E-value=4.4e-16  Score=122.25  Aligned_cols=133  Identities=17%  Similarity=0.240  Sum_probs=111.4

Q ss_pred             cccceeeecccCCCcceeeeEE-eCCCcEEEEEEeecccCchHHHHHHHHHHhcCCC-CCCccceeEEEecCCeeEEEEe
Q 042107           87 RNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-HQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .-.|++.++||+|+||+++.|+ +-+++.||||.-....  ....+..|....+.|. .+.|..++-+-..+-+-.||+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            4468899999999999999995 5579999999754332  2355677877777764 6899998877777777889999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM  226 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~  226 (232)
                      .+ |.+|.++..-++..++...+..++.|++.-++|+|    .+.+|.|||||+|+||..-+
T Consensus       105 LL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH----~k~LIYRDIKPdNFLIGrp~  161 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH----EKDLIYRDIKPDNFLIGRPG  161 (449)
T ss_pred             hh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH----hcceeecccCccceeecCCC
Confidence            88 77999988877777999999999999999999999    88899999999999998654

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.63  E-value=4.7e-15  Score=115.73  Aligned_cols=127  Identities=16%  Similarity=0.188  Sum_probs=94.4

Q ss_pred             eeccc-CCCcceeeeEEeCCCcEEEEEEeeccc-------------CchHHHHHHHHHHhcCCCCCCc--cceeEEEecC
Q 042107           93 FNLIS-RGGFGSIYKARIQDGMEVVVKGFNLQY-------------GGAFKNLDVECNMMKIIRHQNL--IKIISSCSKD  156 (232)
Q Consensus        93 ~~~lg-~g~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~  156 (232)
                      ...+| .|+.|.||.+... +..+++|.+....             ......+.+|++++..++|+++  ++.+++...+
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            34677 7888999988765 6788998874321             1123457789999999998875  5666654332


Q ss_pred             -C---eeEEEEeccCC-CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceee
Q 042107          157 -D---FKALILEYMPH-GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHF  230 (232)
Q Consensus       157 -~---~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l  230 (232)
                       .   ..++|||++++ .+|.+++...  .++..    .+.+++.++.++|    ..||+|||+||+|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH----~~GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFH----DAGVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHH----HCCCCCCCCCchhEEEcCCCCEEE
Confidence             2   23599999997 6898887653  24433    3578999999999    889999999999999998877665

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.62  E-value=1.3e-14  Score=117.11  Aligned_cols=136  Identities=28%  Similarity=0.444  Sum_probs=115.4

Q ss_pred             ceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCc---hHHHHHHHHHHhcCCCCC-CccceeEEEecCCeeEEEEec
Q 042107           90 LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG---AFKNLDVECNMMKIIRHQ-NLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~  165 (232)
                      |.+.+.+|.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +++++.+.+......++++|+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            456788999999999999766  78899988665432   367788999999999988 799999999777778999999


Q ss_pred             cCCCChhhhhccCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC-ceeec
Q 042107          166 MPHGSLGKCLSTSN--YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM-VAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~-~~~l~  231 (232)
                      +.++++.+++....  ..++......++.|++.++.|+|    ..+++|||+||+||+++..+ .++++
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H----~~~~~hrd~kp~nil~~~~~~~~~l~  144 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH----SKGIIHRDIKPENILLDRDGRVVKLI  144 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeeecCCCCeEEEe
Confidence            99999997776543  25788888999999999999999    88899999999999999887 46553

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.59  E-value=2.8e-15  Score=123.88  Aligned_cols=140  Identities=19%  Similarity=0.253  Sum_probs=114.0

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCC------CCCccceeEEEecCCe
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR------HQNLIKIISSCSKDDF  158 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~~~  158 (232)
                      +..-|.+....|+|-|+.|.+|+.. .|..||||++.... ...+.=..|++++++|.      --++++++..|...++
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            3445677788999999999999754 58899999997553 23355567999999985      2478999999999999


Q ss_pred             eEEEEeccCCCChhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC-ceeec
Q 042107          159 KALILEYMPHGSLGKCLSTS--NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM-VAHFL  231 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~-~~~l~  231 (232)
                      +|||+|-+. -+|.++++..  ...+....+..++.|+.-||..|.    ..+|+|.||||+|||+++.- ..|||
T Consensus       509 LClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK----~c~vlHaDIKPDNiLVNE~k~iLKLC  579 (752)
T KOG0670|consen  509 LCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK----KCGVLHADIKPDNILVNESKNILKLC  579 (752)
T ss_pred             eEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH----hcCeeecccCccceEeccCcceeeec
Confidence            999999884 4899999864  234677788899999999999999    88999999999999999864 45665

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=5e-15  Score=132.37  Aligned_cols=130  Identities=25%  Similarity=0.347  Sum_probs=100.9

Q ss_pred             ccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCC---CCCccceeEEEecCCeeEEEEe
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR---HQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      ..+.+.+.+|+|+||.||+|...+|+.||+|+-........   .--.+++.+|+   -+.|..+..++.-.+..++|+|
T Consensus       698 ~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~e  774 (974)
T KOG1166|consen  698 EKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSE  774 (974)
T ss_pred             eeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHccCCcceeeee
Confidence            34678899999999999999877799999998765543221   11112233333   2345555555566677889999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN  225 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~  225 (232)
                      |.+.|+|.+++... ..++|..+..+..|++.-++.||    ..+|||+||||+|+|+...
T Consensus       775 y~~~Gtlld~~N~~-~~m~e~lv~~~~~qml~ive~lH----~~~IIHgDiKPDNfll~~~  830 (974)
T KOG1166|consen  775 YSPYGTLLDLINTN-KVMDEYLVMFFSCQMLRIVEHLH----AMGIIHGDIKPDNFLLRRE  830 (974)
T ss_pred             ccccccHHHhhccC-CCCCchhhhHHHHHHHHHHHHHH----hcceecccCCcceeEeecc
Confidence            99999999999854 46888999999999999999999    8999999999999999653

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.51  E-value=2.6e-14  Score=114.65  Aligned_cols=138  Identities=22%  Similarity=0.303  Sum_probs=109.0

Q ss_pred             ceeeecccCCCcceeeeEEeCC------CcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEec-CCeeEE
Q 042107           90 LEVFNLISRGGFGSIYKARIQD------GMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSK-DDFKAL  161 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~l  161 (232)
                      .+....+-+|.||.||.|-|++      .+.|.+|.++... .-....+..|..++..+.|||+..+.+++.. ....++
T Consensus       286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V  365 (563)
T KOG1024|consen  286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFV  365 (563)
T ss_pred             eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceE
Confidence            3456678899999999996654      3345666654332 2234567778889999999999999998755 467788


Q ss_pred             EEeccCCCChhhhhccC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTS-------NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~-------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++.++.-|+|..++.-.       ...++-.+...++.|++.|++|+|    ++++||.||.++|+++|+...+|++
T Consensus       366 ~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh----~~~ViHkDiAaRNCvIdd~LqVklt  438 (563)
T KOG1024|consen  366 LYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH----NHGVIHKDIAARNCVIDDQLQVKLT  438 (563)
T ss_pred             EEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH----hcCcccchhhhhcceehhheeEEec
Confidence            99999999999998722       123455567789999999999999    9999999999999999999988885

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.50  E-value=4.6e-15  Score=113.87  Aligned_cols=138  Identities=23%  Similarity=0.460  Sum_probs=113.4

Q ss_pred             eeeecccCCCcceeeeEEeCCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           91 EVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        91 ~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      .+..+|.+...|..|+|+|+ |..+++|++..+.  ....+.|..|.-.++.+.||||+.+++.|..+....++..|||.
T Consensus       193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            35567888999999999998 4456667765543  23356788899999999999999999999999999999999999


Q ss_pred             CChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+|+..+.+.. ...+..++.+++.++++|++|||+.  ..-|..-.+....+++|++.+++|+
T Consensus       272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhhee
Confidence            99999998753 3466778999999999999999965  2234445688899999999999886

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.49  E-value=1e-13  Score=117.07  Aligned_cols=130  Identities=16%  Similarity=0.192  Sum_probs=86.2

Q ss_pred             ecccCCCcceeeeEEeCCCcEEEEEEeecccCchH------------------------------H----------HHHH
Q 042107           94 NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAF------------------------------K----------NLDV  133 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~~  133 (232)
                      +.||.|++|.||+|+.++|+.||||+..+......                              +          .+..
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            57999999999999999999999999854311100                              0          1233


Q ss_pred             HHHHhcCC----CCCCccceeEEEe-cCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHH-HHHHHhcCCCC
Q 042107          134 ECNMMKII----RHQNLIKIISSCS-KDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVAS-AVEYLHFGHST  207 (232)
Q Consensus       134 e~~~l~~l----~h~niv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~-~l~~lH~~~~~  207 (232)
                      |...+..+    ++..-+.+...+. .....++||||++|+++.++........   ....++..++. .+..+|    .
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~----~  275 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL----R  275 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH----h
Confidence            44444433    2333333333332 2345689999999999988764321112   23345555555 467788    7


Q ss_pred             CCeeeCCCCCCceeeCCCCceee
Q 042107          208 HVIIHCDLKSSNVLLDDNMVAHF  230 (232)
Q Consensus       208 ~~iiHrdlk~~Nill~~~~~~~l  230 (232)
                      .|++|+|++|.||+++.++.+++
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~l  298 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIA  298 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEE
Confidence            79999999999999999988765

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.39  E-value=2.2e-13  Score=123.63  Aligned_cols=86  Identities=20%  Similarity=0.289  Sum_probs=68.1

Q ss_pred             CCCC-CCccceeEEEe-------cCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCee
Q 042107          140 IIRH-QNLIKIISSCS-------KDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVII  211 (232)
Q Consensus       140 ~l~h-~niv~~~~~~~-------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~ii  211 (232)
                      .++| +||.++++++.       ....++.++||+ +++|.+++......+++..++.++.||++||.|||    .++|+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~gIv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH----SQGIV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH----hCCee
Confidence            3445 57777777662       223567788987 55999999765556899999999999999999999    88999


Q ss_pred             eCCCCCCceeeCCCCceee
Q 042107          212 HCDLKSSNVLLDDNMVAHF  230 (232)
Q Consensus       212 Hrdlk~~Nill~~~~~~~l  230 (232)
                      ||||||+|||++..+.+|+
T Consensus       103 HrDlKP~NiLl~~~~~~k~  121 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSF  121 (793)
T ss_pred             eccCCchhEEEcccCcEEE
Confidence            9999999999976555543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.35  E-value=5.9e-12  Score=93.10  Aligned_cols=122  Identities=20%  Similarity=0.156  Sum_probs=83.3

Q ss_pred             ecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCc-cceeEEEecCCeeEEEEeccCCCChh
Q 042107           94 NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL-IKIISSCSKDDFKALILEYMPHGSLG  172 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L~  172 (232)
                      +.++.|.++.||+++.. +..+++|....... ....+..|+.+++.+.+.++ ++++....  ...++||||++|.++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~   79 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL   79 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence            57889999999999865 77899998754321 12335678888888765443 45554432  3357999999998876


Q ss_pred             hhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCCeeeCCCCCCceeeCCCCcee
Q 042107          173 KCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHS-THVIIHCDLKSSNVLLDDNMVAH  229 (232)
Q Consensus       173 ~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~-~~~iiHrdlk~~Nill~~~~~~~  229 (232)
                      +. .     .   .....+.+++++++.+|.... ..+++|+|++|.||++++ +.++
T Consensus        80 ~~-~-----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~-~~~~  127 (170)
T cd05151          80 TE-D-----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDD-GRLW  127 (170)
T ss_pred             cc-c-----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEEC-CeEE
Confidence            43 0     1   112456789999999993211 123599999999999984 4443

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.32  E-value=2.2e-12  Score=110.61  Aligned_cols=122  Identities=16%  Similarity=0.151  Sum_probs=74.7

Q ss_pred             ecccCCCcceeeeEEeCC-CcEEEEEEeecccCc----------------------------------hHHH------HH
Q 042107           94 NLISRGGFGSIYKARIQD-GMEVVVKGFNLQYGG----------------------------------AFKN------LD  132 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~~------~~  132 (232)
                      +.+|.|++|.||+|+.++ |+.||||+..+.-..                                  ..+.      +.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            689999999999999877 999999998654110                                  0111      22


Q ss_pred             HHHHHhcCC----CCCCccceeEEEec-CCeeEEEEeccCCCChhhhh--ccCCC---CCCHHHHHHHHHHHHHHHHHHh
Q 042107          133 VECNMMKII----RHQNLIKIISSCSK-DDFKALILEYMPHGSLGKCL--STSNY---ILDFFQRLHIMIDVASAVEYLH  202 (232)
Q Consensus       133 ~e~~~l~~l----~h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~---~~~~~~~~~i~~~i~~~l~~lH  202 (232)
                      +|+..+..+    .+...+.+..++.+ ....++||||++|+.+.++-  ...+.   .+.......++.|+       .
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence            233333332    23333444444332 34567999999999997742  22211   01111122222232       3


Q ss_pred             cCCCCCCeeeCCCCCCceeeCCCC
Q 042107          203 FGHSTHVIIHCDLKSSNVLLDDNM  226 (232)
Q Consensus       203 ~~~~~~~iiHrdlk~~Nill~~~~  226 (232)
                          ..|++|+|++|.||+++.++
T Consensus       278 ----~~GffHaDpHPGNIlv~~~g  297 (537)
T PRK04750        278 ----RDGFFHADMHPGNIFVSYDP  297 (537)
T ss_pred             ----hCCeeeCCCChHHeEEecCC
Confidence                44899999999999999887

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.30  E-value=1.3e-12  Score=113.97  Aligned_cols=135  Identities=21%  Similarity=0.270  Sum_probs=99.9

Q ss_pred             eeeecccCCCcceeeeEEe-CCCcEEEEEEeec---ccCc---hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           91 EVFNLISRGGFGSIYKARI-QDGMEVVVKGFNL---QYGG---AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        91 ~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~---~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      .....+|.|++|.|+.... ...+.++.|.+..   ....   ....+..|..+-..+.|||++.....+.......-.|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            4667899999997777743 3344444443321   1111   1122455777777889999988766655544444559


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||++ ||...+.... .+....+..++.|++.|+.|+|    ..|+.|||+|++|+++...|.+||+
T Consensus       401 E~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h----~~GiahrdlK~enll~~~~g~lki~  462 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLH----SMGLAHRDLKLENLLVTENGILKII  462 (601)
T ss_pred             hcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHH----hcCceeccCccccEEEecCCceEEe
Confidence            99999 9999887652 3667778889999999999999    8899999999999999999999875

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.23  E-value=1.8e-10  Score=88.79  Aligned_cols=108  Identities=15%  Similarity=0.128  Sum_probs=79.9

Q ss_pred             ecccCCCcceeeeEEeCCCcEEEEEEeecccC-chHHHHHHHHHHhcCCCC--CCccceeEEEecC---CeeEEEEeccC
Q 042107           94 NLISRGGFGSIYKARIQDGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRH--QNLIKIISSCSKD---DFKALILEYMP  167 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~~~  167 (232)
                      +.++.|..+.||+++..+|+.+++|....... .....+..|.++++.+.+  ..+++++.+....   +..+++|||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999877678899998754322 134567889999998875  3457777766553   25689999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 042107          168 HGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHF  203 (232)
Q Consensus       168 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~  203 (232)
                      |.++.+.+..  ..++......++.++++++..+|.
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~  117 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHS  117 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhC
Confidence            9888776532  135666677788888888888883

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PLN03150 hypothetical protein; Provisional

Probab=99.18  E-value=1.6e-11  Score=108.34  Aligned_cols=83  Identities=34%  Similarity=0.570  Sum_probs=76.9

Q ss_pred             CCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccccc
Q 042107            6 VLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLS   74 (232)
Q Consensus         6 ~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~   74 (232)
                      .++.|+|++|.++|.+|..+           +.|+++|.+|..++.+++|+.|+|++|+++|.+|..+.++++|+.|+++
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            37789999999999999754           6899999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCcccc
Q 042107           75 FNTLEGKIPRPFRN   88 (232)
Q Consensus        75 ~n~l~g~~p~~~~~   88 (232)
                      .|+++|.+|..+..
T Consensus       499 ~N~l~g~iP~~l~~  512 (623)
T PLN03150        499 GNSLSGRVPAALGG  512 (623)
T ss_pred             CCcccccCChHHhh
Confidence            99999999986543

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.17  E-value=5.7e-12  Score=112.54  Aligned_cols=131  Identities=22%  Similarity=0.289  Sum_probs=103.4

Q ss_pred             ceeeecccCCCcceeeeEEeCCCcEEEEEEeecccC-chHHHHHH---HHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           90 LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYG-GAFKNLDV---ECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~---e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      +...+.+|++.|=+|.+|+.+.|. |+||++-.++. -..+.+.+   |++ .+-+++||++.+.-+..++...|+|=+|
T Consensus        25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            456688999999999999988776 89999976652 23333333   444 5566899999988777777777888898


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCce
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA  228 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~  228 (232)
                      ..+ +|++.+..+.. +..-+.+-|+.|++.|+.-+|    ..+|+|+|||.+|||++....+
T Consensus       103 vkh-nLyDRlSTRPF-L~~iEKkWiaFQLL~al~qcH----~~gVcHGDIKsENILiTSWNW~  159 (1431)
T KOG1240|consen  103 VKH-NLYDRLSTRPF-LVLIEKKWIAFQLLKALSQCH----KLGVCHGDIKSENILITSWNWL  159 (1431)
T ss_pred             Hhh-hhhhhhccchH-HHHHHHHHHHHHHHHHHHHHH----HcCccccccccceEEEeeechh
Confidence            855 99999987643 555667789999999999999    9999999999999999875443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.15  E-value=9.8e-12  Score=105.24  Aligned_cols=132  Identities=21%  Similarity=0.237  Sum_probs=105.1

Q ss_pred             cccCCCcceeeeEE----eCCCcEEEEEEeecccC--chHHHHHHHHHHhcCCC-CCCccceeEEEecCCeeEEEEeccC
Q 042107           95 LISRGGFGSIYKAR----IQDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIR-HQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        95 ~lg~g~~g~V~~~~----~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      .+|+|.||.|+.++    ...+..+|+|.......  ........|..++...+ ||.++++...+.++...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999874    23467788887754321  11124445777888887 9999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|++...+..... +.+.....+..+++-|++++|    ..+++|||+|++||+++.+|.+++.
T Consensus        81 gg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh----~l~iiyrd~k~enilld~~Ghi~~t  139 (612)
T KOG0603|consen   81 GGDLFTRLSKEVM-FDELDVAFYLAELALALDHLH----KLGIAYRDYKLENVLLLLEGHIKLT  139 (612)
T ss_pred             cchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcc----hhHHHHhcccccceeecccCccccC
Confidence            9999988876543 455556667778999999999    8899999999999999999987753

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.11  E-value=7.4e-10  Score=87.77  Aligned_cols=137  Identities=22%  Similarity=0.314  Sum_probs=86.7

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCC----------CCccceeEEEec
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRH----------QNLIKIISSCSK  155 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~niv~~~~~~~~  155 (232)
                      +...+.||.|+++.||.++.. +++++|+|.+....   ....+.+.+|.-....+.+          -.++--++....
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            356788999999999999765 68999999885443   2345666666654444322          112212222211


Q ss_pred             ---------C---C-----eeEEEEeccCCCChhhhhcc---CCC---CCCHHHHHHHHHHHHHHHHHHhcCCCCCCeee
Q 042107          156 ---------D---D-----FKALILEYMPHGSLGKCLST---SNY---ILDFFQRLHIMIDVASAVEYLHFGHSTHVIIH  212 (232)
Q Consensus       156 ---------~---~-----~~~lv~e~~~~g~L~~~l~~---~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiH  212 (232)
                               .   .     ..+++|+-+ .+||.+++..   ...   .+....+..+..|+++.++++|    ..|++|
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh----~~GlVH  168 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH----SYGLVH  168 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH----HTTEEE
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh----hcceEe
Confidence                     1   1     124567766 4588777542   111   1333455677789999999999    889999


Q ss_pred             CCCCCCceeeCCCCceeec
Q 042107          213 CDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       213 rdlk~~Nill~~~~~~~l~  231 (232)
                      +||||+|++++.+|.+.++
T Consensus       169 gdi~~~nfll~~~G~v~Lg  187 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLG  187 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE-
T ss_pred             cccceeeEEEcCCCCEEEc
Confidence            9999999999999999876

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.07  E-value=3.5e-09  Score=79.68  Aligned_cols=122  Identities=18%  Similarity=0.194  Sum_probs=83.8

Q ss_pred             ecccCCCcceeeeEEeCC-------CcEEEEEEeeccc------------C----------chHHH----HHHHHHHhcC
Q 042107           94 NLISRGGFGSIYKARIQD-------GMEVVVKGFNLQY------------G----------GAFKN----LDVECNMMKI  140 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~-------~~~vavK~~~~~~------------~----------~~~~~----~~~e~~~l~~  140 (232)
                      ..||.|.=+.||.|...+       +..+|+|+.....            .          ...+.    ..+|...|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468889999999996442       4789999875421            0          00111    2368888888


Q ss_pred             CCC--CCccceeEEEecCCeeEEEEeccCCCChhh-hhccCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCCeeeCCCC
Q 042107          141 IRH--QNLIKIISSCSKDDFKALILEYMPHGSLGK-CLSTSNYILDFFQRLHIMIDVASAVEYL-HFGHSTHVIIHCDLK  216 (232)
Q Consensus       141 l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~i~~~i~~~l~~l-H~~~~~~~iiHrdlk  216 (232)
                      +..  -.+++.+++    ...++||||+.+..+.. .++.  ..++......+..+++.++..+ |    ..+++|+|++
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H----~~glVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYK----ECNLVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHH----hCCeecCCCC
Confidence            753  456666654    44679999997654422 2222  1244445567788999999988 7    7799999999


Q ss_pred             CCceeeCCC
Q 042107          217 SSNVLLDDN  225 (232)
Q Consensus       217 ~~Nill~~~  225 (232)
                      +.||+++++
T Consensus       153 ~~NIL~~~~  161 (197)
T cd05146         153 EYNMLWHDG  161 (197)
T ss_pred             HHHEEEECC
Confidence            999999753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.03  E-value=2.2e-09  Score=78.64  Aligned_cols=131  Identities=16%  Similarity=0.178  Sum_probs=91.2

Q ss_pred             eecccCCCcceeeeEEeCCCcEEEEEEe-ecccCc-------hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           93 FNLISRGGFGSIYKARIQDGMEVVVKGF-NLQYGG-------AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~~~~~vavK~~-~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      ...+-+|+=+.|+++.+. |+..+||.- .+....       ..++..+|+..+.++.--.|..-.=++.+...-.++||
T Consensus        12 l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   12 LELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             ceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            467888999999999875 676677743 222211       13456778888888765455444344555566679999


Q ss_pred             ccCC-CChhhhhccCCCC-CCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCce
Q 042107          165 YMPH-GSLGKCLSTSNYI-LDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA  228 (232)
Q Consensus       165 ~~~~-g~L~~~l~~~~~~-~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~  228 (232)
                      |++| -++.+++...... ........++..+-+.+.-||    ..+++|+||..+||++..++..
T Consensus        91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH----~ndiiHGDLTTSNill~~~~~~  152 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH----DNDIIHGDLTTSNILLRSDGNQ  152 (229)
T ss_pred             eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh----hCCeecccccccceEEecCCCc
Confidence            9977 4667776543222 222233678888999999999    8899999999999999877653

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.02  E-value=6.8e-10  Score=93.55  Aligned_cols=90  Identities=34%  Similarity=0.504  Sum_probs=82.5

Q ss_pred             hcCCCCCCccceeEEEecCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCe-eeCCCC
Q 042107          138 MKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVI-IHCDLK  216 (232)
Q Consensus       138 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~i-iHrdlk  216 (232)
                      |+.+.|.|+.+++|.+..+...+.|.+||+.|+|.+.+......+++.....++++++.||.|+|    ..+| .|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh----~s~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH----NSPIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh----cCcceeeeeec
Confidence            46788999999999999999999999999999999999987777899999999999999999999    4344 999999


Q ss_pred             CCceeeCCCCceeec
Q 042107          217 SSNVLLDDNMVAHFL  231 (232)
Q Consensus       217 ~~Nill~~~~~~~l~  231 (232)
                      +.|+++|..+.+|++
T Consensus        77 s~nClvd~~w~lklt   91 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLT   91 (484)
T ss_pred             cccceeeeeEEEEec
Confidence            999999999999986

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.00  E-value=3.1e-10  Score=105.50  Aligned_cols=84  Identities=38%  Similarity=0.597  Sum_probs=67.2

Q ss_pred             CCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccc
Q 042107            5 KVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNL   73 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l   73 (232)
                      ++|+.|||++|+++|.+|..+           ++|++++.+|..++.+++|+.|+|++|+++|.+|..+..++.|+.+++
T Consensus       475 ~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  554 (968)
T PLN00113        475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDL  554 (968)
T ss_pred             ccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEEC
Confidence            456667777777777666543           578888888888888888888888888888888888888888999999


Q ss_pred             ccccccCCCCCcccc
Q 042107           74 SFNTLEGKIPRPFRN   88 (232)
Q Consensus        74 ~~n~l~g~~p~~~~~   88 (232)
                      ++|+++|.+|..+..
T Consensus       555 s~N~l~~~~p~~l~~  569 (968)
T PLN00113        555 SQNQLSGEIPKNLGN  569 (968)
T ss_pred             CCCcccccCChhHhc
Confidence            999998888875543

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=98.98  E-value=6.9e-10  Score=89.91  Aligned_cols=75  Identities=28%  Similarity=0.419  Sum_probs=61.6

Q ss_pred             CCCCccceeEEEecC---------------------------CeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHH
Q 042107          142 RHQNLIKIISSCSKD---------------------------DFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDV  194 (232)
Q Consensus       142 ~h~niv~~~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i  194 (232)
                      +|||||++.++|.++                           ..+|+||.-++. +|.+++....  .+.....-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence            699999998876431                           146799988866 8999987653  4555667788999


Q ss_pred             HHHHHHHhcCCCCCCeeeCCCCCCceeeC
Q 042107          195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLD  223 (232)
Q Consensus       195 ~~~l~~lH~~~~~~~iiHrdlk~~Nill~  223 (232)
                      ++|+.|||    .++|.|||+|.+|||+.
T Consensus       351 LEav~hL~----~hgvAhRDlKSDNiL~E  375 (598)
T KOG4158|consen  351 LEAVTHLH----KHGVAHRDLKSDNILLE  375 (598)
T ss_pred             HHHHHHHH----HccchhhcccccceEEE
Confidence            99999999    99999999999999984

>PLN03150 hypothetical protein; Provisional

Probab=98.97  E-value=5.6e-10  Score=98.57  Aligned_cols=82  Identities=35%  Similarity=0.530  Sum_probs=70.3

Q ss_pred             CCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccC-CCCC
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKL-LDLK   69 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l-~~l~   69 (232)
                      +++++|+.|+|++|.|+|.+|..+           ++|+++|.+|..++++++|+.|+|++|+++|.+|..+..+ ..+.
T Consensus       439 ~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~  518 (623)
T PLN03150        439 SKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRA  518 (623)
T ss_pred             hCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCc
Confidence            568899999999999999999754           7899999999999999999999999999999999987653 4566


Q ss_pred             ccccccccccCCCC
Q 042107           70 DLNLSFNTLEGKIP   83 (232)
Q Consensus        70 ~l~l~~n~l~g~~p   83 (232)
                      .+++.+|......|
T Consensus       519 ~l~~~~N~~lc~~p  532 (623)
T PLN03150        519 SFNFTDNAGLCGIP  532 (623)
T ss_pred             eEEecCCccccCCC
Confidence            77888887544333

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.96  E-value=4.2e-09  Score=90.36  Aligned_cols=115  Identities=16%  Similarity=0.197  Sum_probs=94.1

Q ss_pred             EeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCChhhhhccCCCCCCHHHH
Q 042107          108 RIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQR  187 (232)
Q Consensus       108 ~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~  187 (232)
                      +..++.+|.|...........+...+.+..++.++||+|+++++.+..++..|+|+|-+.  .|..+++..+    ....
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v  106 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEV  106 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHH
Confidence            455788898888877666445667778889999999999999999999999999999875  3556665532    3445


Q ss_pred             HHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          188 LHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       188 ~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ..-+.||+.||.|||+   +..++|+++--+.|++++.|.-||+
T Consensus       107 ~~Gl~qIl~AL~FL~~---d~~lvHgNv~~~SVfVn~~GeWkLg  147 (690)
T KOG1243|consen  107 CLGLFQILAALSFLND---DCNLVHGNVCKDSVFVNESGEWKLG  147 (690)
T ss_pred             HHHHHHHHHHHHHHhc---cCCeeeccEeeeeEEEcCCCcEEEe
Confidence            5667899999999985   4579999999999999999998886

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.93  E-value=1.6e-08  Score=74.29  Aligned_cols=120  Identities=25%  Similarity=0.329  Sum_probs=85.0

Q ss_pred             ecccCCCcceeeeEEeCCCcEEEEEEeecc-cCc-------hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           94 NLISRGGFGSIYKARIQDGMEVVVKGFNLQ-YGG-------AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~~~~vavK~~~~~-~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      ..+++|+=+.+|.+.+. |..+++|.-.++ ...       ......+|+.++.++.--.|..-.=+..+++...++|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            35788999999998765 334666644222 111       123456688888887654444433344455667799999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM  226 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~  226 (232)
                      ++|..|.+.+...        ...++..+-.-+.-||    ..+|+|+|+.++||++..+.
T Consensus        81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH----~~givHGDLTtsNiIl~~~~  129 (204)
T COG3642          81 IEGELLKDALEEA--------RPDLLREVGRLVGKLH----KAGIVHGDLTTSNIILSGGR  129 (204)
T ss_pred             eCChhHHHHHHhc--------chHHHHHHHHHHHHHH----hcCeecCCCccceEEEeCCc
Confidence            9998888888654        2456677777888899    88999999999999998875

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.83  E-value=5.8e-08  Score=76.94  Aligned_cols=117  Identities=16%  Similarity=0.069  Sum_probs=79.4

Q ss_pred             eeeeEEeCCCcEEEEEEeecccCc-----------hHHHHHHHHHHhcCCCCCCcc--ceeEEEec-----CCeeEEEEe
Q 042107          103 SIYKARIQDGMEVVVKGFNLQYGG-----------AFKNLDVECNMMKIIRHQNLI--KIISSCSK-----DDFKALILE  164 (232)
Q Consensus       103 ~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv--~~~~~~~~-----~~~~~lv~e  164 (232)
                      .|.+..+ +|+.+.||........           ....+.+|...+..+..-+|.  +...+...     ....++|||
T Consensus        37 rvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         37 RTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             eEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            3556655 4678999976432210           111367788877776433332  33334332     234689999


Q ss_pred             ccCCC-ChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC
Q 042107          165 YMPHG-SLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD  224 (232)
Q Consensus       165 ~~~~g-~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~  224 (232)
                      ++++. +|.+++... ....+...+..++.+++..+.-+|    ..||+|+|+++.|||++.
T Consensus       116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH----~~Gi~HgDL~~~NiLl~~  173 (268)
T PRK15123        116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH----AAGINHRDCYICHFLLHL  173 (268)
T ss_pred             eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH----HCcCccCCCChhhEEEec
Confidence            99886 788887532 122445566789999999999999    889999999999999985

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.83  E-value=4.3e-08  Score=73.48  Aligned_cols=113  Identities=22%  Similarity=0.243  Sum_probs=71.6

Q ss_pred             eeeeEEeCCCcEEEEEEeecccC-------------c-------------hHHHHHHHHHHhcCCCCC--CccceeEEEe
Q 042107          103 SIYKARIQDGMEVVVKGFNLQYG-------------G-------------AFKNLDVECNMMKIIRHQ--NLIKIISSCS  154 (232)
Q Consensus       103 ~V~~~~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~e~~~l~~l~h~--niv~~~~~~~  154 (232)
                      .||.|...+|..+|+|.......             .             ......+|.+.|..+..-  ++++.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            38899888899999998754210             0             023456799999998755  566666553 


Q ss_pred             cCCeeEEEEeccC--CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCCeeeCCCCCCceeeCCCC
Q 042107          155 KDDFKALILEYMP--HGSLGKCLSTSNYILDFFQRLHIMIDVASAVEY-LHFGHSTHVIIHCDLKSSNVLLDDNM  226 (232)
Q Consensus       155 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~-lH~~~~~~~iiHrdlk~~Nill~~~~  226 (232)
                         ...+||||++  |..+..+....   ++......++.+++..+.. +|    ..+++|+|+.+.||+++++.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~----~~givHGDLs~~NIlv~~~~  144 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH----KAGIVHGDLSEYNILVDDGK  144 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH----CTTEEESS-STTSEEEETTC
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH----hcCceecCCChhhEEeecce
Confidence               2469999998  55554433221   1123345667777775555 57    78999999999999999873

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.81  E-value=4.5e-08  Score=76.14  Aligned_cols=126  Identities=21%  Similarity=0.198  Sum_probs=87.4

Q ss_pred             eeeecccCCCcceeeeEEeCCCcEEEEEEeecccC-----------------c-----hHHHHHHHHHHhcCCCCC--Cc
Q 042107           91 EVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYG-----------------G-----AFKNLDVECNMMKIIRHQ--NL  146 (232)
Q Consensus        91 ~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~-----------------~-----~~~~~~~e~~~l~~l~h~--ni  146 (232)
                      .+.+.||-|.=+.||.|..+.|.++|+|.-.....                 .     ......+|.+.|..+...  .|
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            46788999999999999988899999996432210                 0     123456788899888654  66


Q ss_pred             cceeEEEecCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC
Q 042107          147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM  226 (232)
Q Consensus       147 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~  226 (232)
                      ++.+++    +...+||||++|-.|...-      ++......++..|++-+.-.-    ..|++|+|+.+-||+++++|
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~----~~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY----RRGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH----HcCccccCCchheEEEecCC
Confidence            665544    5578999999997765432      112223334444444444443    45899999999999999997


Q ss_pred             ceee
Q 042107          227 VAHF  230 (232)
Q Consensus       227 ~~~l  230 (232)
                      .+.+
T Consensus       240 ~~~v  243 (304)
T COG0478         240 DIVV  243 (304)
T ss_pred             CEEE
Confidence            7654

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.78  E-value=5e-09  Score=63.84  Aligned_cols=61  Identities=39%  Similarity=0.581  Sum_probs=51.8

Q ss_pred             CCCCEEEccCCcccccCCCccccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccccccccc
Q 042107            5 KVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTL   78 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g~~p~~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~l   78 (232)
                      ++|+.|+|++|+|+ .+|.            ..+..+++|+.|++++|+++.-.|..+..++.|+++++++|.+
T Consensus         1 p~L~~L~l~~n~l~-~i~~------------~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLT-EIPP------------DSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTES-EECT------------TTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCC-ccCH------------HHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            57899999999999 3332            4566789999999999999966677889999999999999974

...

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.69  E-value=1.1e-08  Score=86.72  Aligned_cols=131  Identities=24%  Similarity=0.283  Sum_probs=99.5

Q ss_pred             ceeeecccCCCcceeeeEEe--CCCcEEEEEEeecccCchHHHH--HHHHHHhcCC-CCCCccceeEEEecCCeeEEEEe
Q 042107           90 LEVFNLISRGGFGSIYKARI--QDGMEVVVKGFNLQYGGAFKNL--DVECNMMKII-RHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~--~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      +..+..||.|.|+.|+.+..  .++..+++|.+...-.....++  ..|+.+...+ .|.+++.+...|..-...|+--|
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e  346 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLE  346 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchh
Confidence            45678899999999999854  3678889887754432222221  2355555554 48888988888877777889999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN  225 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~  225 (232)
                      ||++++........ ..+++...+++..|++.++.++|    ...++|+|+||+||++..+
T Consensus       347 ~~~~~s~~l~~~~~-~~~d~~~~~~~~~q~~~~l~~i~----s~~~~~~d~~psni~i~~~  402 (524)
T KOG0601|consen  347 FCEGGSSSLRSVTS-QMLDEDPRLRLTAQILTALNVIH----SKLFVHLDVKPSNILISND  402 (524)
T ss_pred             hhcCcchhhhhHHH-HhcCcchhhhhHHHHHhcccccc----chhhhcccccccceeeccc
Confidence            99999887655322 23666778889999999999999    8899999999999999886

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.69  E-value=4.5e-09  Score=92.08  Aligned_cols=139  Identities=22%  Similarity=0.252  Sum_probs=108.0

Q ss_pred             cceeeecccCCCcceeeeEEeC--CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCC-CCCccceeEEEecCCeeEEEE
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ--DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIR-HQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  163 (232)
                      .|.+.+.||+|+|+.|-.....  ....+|.|.+....  ....+....|..+-+.+. |+|++.+++.....+..++.+
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            3556777999999999888543  34556667664432  333455566777777777 999999999999999999999


Q ss_pred             eccCCCChhhhh-ccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC-ceee
Q 042107          164 EYMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM-VAHF  230 (232)
Q Consensus       164 e~~~~g~L~~~l-~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~-~~~l  230 (232)
                      ||..++++...+ .......+...+..+..|+..++.|+|.   ..++.|||+||+|.+++..+ ..++
T Consensus       101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~---~~~~~h~~ikP~n~~l~~s~~~l~~  166 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP---ENGVTHRDIKPSNSLLDESGSALKI  166 (601)
T ss_pred             CcccccccccccccCCccCCCCcchhhhhhhhccCccccCc---ccccccCCCCCccchhccCCCcccC
Confidence            999999999988 4332245556677889999999999994   44799999999999999888 5444

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.67  E-value=1.5e-07  Score=79.01  Aligned_cols=128  Identities=16%  Similarity=0.109  Sum_probs=96.6

Q ss_pred             CcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEec----CCeeEEEEeccCC-CChhh
Q 042107          100 GFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSK----DDFKALILEYMPH-GSLGK  173 (232)
Q Consensus       100 ~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-g~L~~  173 (232)
                      .....|++.. .||..|++|++.............-++..+++.|+|+|++.+++.+    +..+.+|++|.|+ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            3456788854 5899999999944332222223334677899999999999998874    3478899999885 56665


Q ss_pred             hhcc--------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          174 CLST--------------SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       174 ~l~~--------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +--.              .+...++...+.++.|+..||.++|    ..|..-+-|.|.+|+++.++..+|+
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH----ssGLAck~L~~~kIlv~G~~RIriS  435 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH----SSGLACKTLDLKKILVTGKMRIRIS  435 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH----hcCceeecccHhHeEeeCcceEEEe
Confidence            4321              1233567888999999999999999    7788889999999999999888775

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.53  E-value=5.7e-07  Score=68.73  Aligned_cols=93  Identities=25%  Similarity=0.266  Sum_probs=68.2

Q ss_pred             HHHHHHHHHhcCCCCCC--ccceeEEEecC----CeeEEEEeccCCC-ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHH
Q 042107          129 KNLDVECNMMKIIRHQN--LIKIISSCSKD----DFKALILEYMPHG-SLGKCLSTSNYILDFFQRLHIMIDVASAVEYL  201 (232)
Q Consensus       129 ~~~~~e~~~l~~l~h~n--iv~~~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~l  201 (232)
                      ....+|...+..+..-.  +++.+++....    ...++|+|++++. +|.+++..... .+......++.++++.+.-|
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l  134 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL  134 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence            44666777666664332  33444444432    2458999999884 78888875322 45556778999999999999


Q ss_pred             hcCCCCCCeeeCCCCCCceeeCCCC
Q 042107          202 HFGHSTHVIIHCDLKSSNVLLDDNM  226 (232)
Q Consensus       202 H~~~~~~~iiHrdlk~~Nill~~~~  226 (232)
                      |    ..||+|+|+++.|||++.+.
T Consensus       135 H----~~gi~H~Dl~~~NILv~~~~  155 (206)
T PF06293_consen  135 H----DAGIYHGDLNPSNILVDPDD  155 (206)
T ss_pred             H----HCcCCCCCCCcccEEEeCCC
Confidence            9    89999999999999999875

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.47  E-value=1.5e-07  Score=79.84  Aligned_cols=133  Identities=21%  Similarity=0.183  Sum_probs=103.0

Q ss_pred             cceeeecccC--CCcceeeeEEe---CCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCC-CCCccceeEEEecCCeeE
Q 042107           89 FLEVFNLISR--GGFGSIYKARI---QDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIR-HQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        89 ~~~~~~~lg~--g~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  160 (232)
                      -+.....+|.  |.+|.||.++.   .++..+|+|.-....  ......=.+|....++++ |++.++.+..+...+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            3446678899  99999999864   468889988743221  122222234666566664 999999999999999999


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCCeeeCCCCCCceeeCCCC
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVAS----AVEYLHFGHSTHVIIHCDLKSSNVLLDDNM  226 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~----~l~~lH~~~~~~~iiHrdlk~~Nill~~~~  226 (232)
                      +-+|+|. .++.++.......++....+....+..+    |+.++|    ...++|-|+||+||+...++
T Consensus       195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h----s~~~~~~~~kp~~i~~~~~~  259 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH----SNNIVHDDLKPANIFTTSDW  259 (524)
T ss_pred             eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC----CCcccccccchhheeccccc
Confidence            9999985 6888887765555777778888888888    999999    88999999999999998883

>PRK09902 hypothetical protein; Provisional

Probab=98.47  E-value=2.3e-06  Score=64.91  Aligned_cols=126  Identities=15%  Similarity=0.080  Sum_probs=87.9

Q ss_pred             cCCCcceeeeEEeCCCcEEEEEEeeccc------CchHHHHHHHHHHhcCCCCCC--ccceeEEEec----CCeeEEEEe
Q 042107           97 SRGGFGSIYKARIQDGMEVVVKGFNLQY------GGAFKNLDVECNMMKIIRHQN--LIKIISSCSK----DDFKALILE  164 (232)
Q Consensus        97 g~g~~g~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~----~~~~~lv~e  164 (232)
                      |+|+.+.|++-... |..+-+|+-...-      +-....|.+|...+..+..-+  +++.......    .-.-+||+|
T Consensus        27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe  105 (216)
T PRK09902         27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE  105 (216)
T ss_pred             CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence            56888889887665 4468888764221      223467888998888775322  4444321111    124579999


Q ss_pred             ccCC-CChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCc
Q 042107          165 YMPH-GSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV  227 (232)
Q Consensus       165 ~~~~-g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~  227 (232)
                      -+++ -||.+++.... ...+...+..+..++++.+.-+|    ..++.|+|+-+.||+++.++.
T Consensus       106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH----~~Gv~Hgdly~khIll~~~g~  166 (216)
T PRK09902        106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH----SVNRQHGCCYVRHIYVKTEGK  166 (216)
T ss_pred             eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH----HCCCcCCCCCHhheeecCCCC
Confidence            7754 58888875532 23456667789999999999999    889999999999999986665

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.46  E-value=8.7e-07  Score=76.12  Aligned_cols=128  Identities=13%  Similarity=0.104  Sum_probs=77.2

Q ss_pred             ecccCCCcceeeeEEeCCCcEEEEEEeecccCch------------------------------HH----H------HHH
Q 042107           94 NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGA------------------------------FK----N------LDV  133 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~------------------------------~~----~------~~~  133 (232)
                      +.++.++-|.||+|++++|+.||||+..+.-...                              .+    .      +.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            5788999999999999999999999876531100                              01    1      122


Q ss_pred             HHHHhcCC----CCCCccceeEEEe-cCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCC
Q 042107          134 ECNMMKII----RHQNLIKIISSCS-KDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV-EYLHFGHST  207 (232)
Q Consensus       134 e~~~l~~l----~h~niv~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l-~~lH~~~~~  207 (232)
                      |...+..+    +..-=+++-.++. -.....++|||++|-.+.+.........+..   .++..++++. .-+-    .
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k---~ia~~~~~~f~~q~~----~  283 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRK---ELAELLVRAFLRQLL----R  283 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHH---HHHHHHHHHHHHHHH----h
Confidence            44433333    2222233333332 2455679999999988887743222234422   2332222221 1111    2


Q ss_pred             CCeeeCCCCCCceeeCCCCce
Q 042107          208 HVIIHCDLKSSNVLLDDNMVA  228 (232)
Q Consensus       208 ~~iiHrdlk~~Nill~~~~~~  228 (232)
                      .|+.|.|..|.||+++.+|..
T Consensus       284 dgffHaDpHpGNi~v~~~g~i  304 (517)
T COG0661         284 DGFFHADPHPGNILVRSDGRI  304 (517)
T ss_pred             cCccccCCCccceEEecCCcE
Confidence            389999999999999998654

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.40  E-value=1.6e-07  Score=74.72  Aligned_cols=90  Identities=26%  Similarity=0.306  Sum_probs=75.4

Q ss_pred             CCCCCCccceeEEEecCC-----eeEEEEeccCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCee
Q 042107          140 IIRHQNLIKIISSCSKDD-----FKALILEYMPHGSLGKCLSTS---NYILDFFQRLHIMIDVASAVEYLHFGHSTHVII  211 (232)
Q Consensus       140 ~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~ii  211 (232)
                      .+.|.|+|+++.+|.+..     ...++.|||..|++.++|++.   ...+......+++-||..||.|||+.  ..+|+
T Consensus       123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~--~Ppii  200 (458)
T KOG1266|consen  123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC--DPPII  200 (458)
T ss_pred             HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc--CCccc
Confidence            446999999999887643     467899999999999999753   33456666788999999999999955  56899


Q ss_pred             eCCCCCCceeeCCCCceeec
Q 042107          212 HCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       212 Hrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++..+-|++..+|-.|++
T Consensus       201 hgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  201 HGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             cCCcchhheeecCCceEEec
Confidence            99999999999999988886

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=98.39  E-value=6e-08  Score=70.34  Aligned_cols=82  Identities=27%  Similarity=0.436  Sum_probs=65.9

Q ss_pred             CCCCCCCCEEEccCCcccc-cCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCC
Q 042107            1 MSNLKVLLRIDLSTNNFSC-VFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDL   68 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g-~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l   68 (232)
                      |+.++.|+.|||++|+++. .+|..+           +.|.|. .+|..++++++|+.|.+..|.+- ++|.++..+..|
T Consensus        98 fgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~l  175 (264)
T KOG0617|consen   98 FGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRL  175 (264)
T ss_pred             cCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHH
Confidence            4667788888888888885 456653           567775 68888999999999999999998 889999999999


Q ss_pred             CccccccccccCCCCC
Q 042107           69 KDLNLSFNTLEGKIPR   84 (232)
Q Consensus        69 ~~l~l~~n~l~g~~p~   84 (232)
                      ++|.+.+|.++--.|+
T Consensus       176 relhiqgnrl~vlppe  191 (264)
T KOG0617|consen  176 RELHIQGNRLTVLPPE  191 (264)
T ss_pred             HHHhcccceeeecChh
Confidence            9999998888754443

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.34  E-value=1.3e-05  Score=62.16  Aligned_cols=72  Identities=14%  Similarity=0.138  Sum_probs=53.1

Q ss_pred             ecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCC--ccceeEEEecCCeeEEEEeccCCCC
Q 042107           94 NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN--LIKIISSCSKDDFKALILEYMPHGS  170 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~  170 (232)
                      +.||+|..+.||+.   .+..+++|......  ......+|.++++.+..-.  +++.+++....+..+++||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            57899999999984   25567788875432  2355688999888875433  4677778777777889999999863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.33  E-value=3.8e-06  Score=72.15  Aligned_cols=124  Identities=15%  Similarity=0.195  Sum_probs=76.3

Q ss_pred             ecccCCCcceeeeEEeCCCcEEEEEEeecccCch---------------------------HH----H------HHHHHH
Q 042107           94 NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGA---------------------------FK----N------LDVECN  136 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~---------------------------~~----~------~~~e~~  136 (232)
                      +.||.-+.|.|++|+.++|+.||||+-++.-...                           .+    .      |..|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            6789999999999999999999999865431110                           00    1      122333


Q ss_pred             Hhc----CCCCCC------ccceeEEEecCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 042107          137 MMK----IIRHQN------LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHS  206 (232)
Q Consensus       137 ~l~----~l~h~n------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~  206 (232)
                      -..    .+.|-+      |++++..+.  ....|+||||+|..+.+.-.-....++......-+.++..-+-+.|    
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~~----  320 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFKT----  320 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHhc----
Confidence            222    223444      444444332  3467999999998776653322223555544444444433334444    


Q ss_pred             CCCeeeCCCCCCceeeCCC
Q 042107          207 THVIIHCDLKSSNVLLDDN  225 (232)
Q Consensus       207 ~~~iiHrdlk~~Nill~~~  225 (232)
                        |++|+|-.|.||++..+
T Consensus       321 --GffHaDPHPGNilv~~~  337 (538)
T KOG1235|consen  321 --GFFHADPHPGNILVRPN  337 (538)
T ss_pred             --CCccCCCCCCcEEEecC
Confidence              79999999999999953

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=98.32  E-value=5.3e-07  Score=50.78  Aligned_cols=37  Identities=41%  Similarity=0.596  Sum_probs=26.6

Q ss_pred             CCCCEEEccCCcccccCCCccccCccccccccccccCCCCCeeeCCCCcce
Q 042107            5 KVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFS   55 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g~~p~~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~   55 (232)
                      ++|++|+|++|+|+              .+|..++++++|+.|++++|+++
T Consensus         1 ~~L~~L~l~~N~i~--------------~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    1 KNLEELDLSNNQIT--------------DLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             TT-SEEEETSSS-S--------------SHGGHGTTCTTSSEEEETSSCCS
T ss_pred             CcceEEEccCCCCc--------------ccCchHhCCCCCCEEEecCCCCC
Confidence            46788888888887              34445677888888888888877

...

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.28  E-value=1.7e-05  Score=60.04  Aligned_cols=120  Identities=18%  Similarity=0.265  Sum_probs=80.5

Q ss_pred             ecccCCCcceeeeEEeCCCcEEEEEEeeccc----------------CchHHHHHHHHHHhcCC------CCCCccceeE
Q 042107           94 NLISRGGFGSIYKARIQDGMEVVVKGFNLQY----------------GGAFKNLDVECNMMKII------RHQNLIKIIS  151 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l------~h~niv~~~~  151 (232)
                      ..||+|+.-.||.-  ++....+||+.....                ....+...+|+.-...+      .+..|.+++|
T Consensus         7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            57899998888873  445556788876544                11234455565544433      4889999999


Q ss_pred             EEecCCeeEEEEeccCC------CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC
Q 042107          152 SCSKDDFKALILEYMPH------GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN  225 (232)
Q Consensus       152 ~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~  225 (232)
                      +.+++-...+|+|.+..      -+|.+++....  ++. .....+.+.   ..|+-    ...|+.+|++|+||++...
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~~~~~L~~f---~~~l~----~~~Iv~~dl~~~NIv~~~~  154 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-ELRQALDEF---KRYLL----DHHIVIRDLNPHNIVVQRR  154 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-HHHHHHHHH---HHHHH----HcCCeecCCCcccEEEEec
Confidence            99999889999997632      36777775442  444 333333333   34554    5579999999999999754

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.28  E-value=2.8e-07  Score=75.11  Aligned_cols=75  Identities=28%  Similarity=0.480  Sum_probs=59.4

Q ss_pred             CCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcc
Q 042107            3 NLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDL   71 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l   71 (232)
                      .+..|+.||+|.|+|. -+|.-+           +.|++.-.-|..+..+.+|..|||.+|.+. +||+.++++.+++.|
T Consensus       456 ~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hL  533 (565)
T KOG0472|consen  456 SLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHL  533 (565)
T ss_pred             hhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEE
Confidence            3445677777777776 344422           447775444455999999999999999998 899999999999999


Q ss_pred             cccccccc
Q 042107           72 NLSFNTLE   79 (232)
Q Consensus        72 ~l~~n~l~   79 (232)
                      ++.+|+|.
T Consensus       534 eL~gNpfr  541 (565)
T KOG0472|consen  534 ELDGNPFR  541 (565)
T ss_pred             EecCCccC
Confidence            99999998

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.19  E-value=2.1e-06  Score=77.55  Aligned_cols=102  Identities=26%  Similarity=0.392  Sum_probs=68.0

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      +-++.++.+..|++|.||..+++ +.+++|+| +.++.     -+.+.  ++.....|.+|                   
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----lilRn--ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----LILRN--ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----hhhhc--cccccCCccee-------------------
Confidence            34567789999999999999876 46778884 33321     11111  23333344443                   


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                        ||-...++..+ .++.        +++.+++|+|    ..+|+|||+||+|.+|..-|..|++
T Consensus       136 --gDc~tllk~~g-~lPv--------dmvla~Eylh----~ygivhrdlkpdnllIT~mGhiKlT  185 (1205)
T KOG0606|consen  136 --GDCATLLKNIG-PLPV--------DMVLAVEYLH----SYGIVHRDLKPDNLLITSMGHIKLT  185 (1205)
T ss_pred             --chhhhhcccCC-CCcc--------hhhHHhHhhc----cCCeecCCCCCCcceeeeccccccc
Confidence              55555555432 2332        2267899999    8899999999999999988877763

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=98.17  E-value=5.5e-07  Score=65.41  Aligned_cols=79  Identities=28%  Similarity=0.528  Sum_probs=60.8

Q ss_pred             CCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcc
Q 042107            3 NLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDL   71 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l   71 (232)
                      +|..++.|-||+|.++. +|..|           ..|++. .+|.+++.++.|+.|+++-|++. .+|..+..++.|+.|
T Consensus        31 ~~s~ITrLtLSHNKl~~-vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl  107 (264)
T KOG0617|consen   31 NMSNITRLTLSHNKLTV-VPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL  107 (264)
T ss_pred             chhhhhhhhcccCceee-cCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence            34566788889999984 44433           456665 67888888999999999988888 788888888999999


Q ss_pred             ccccccccC-CCCC
Q 042107           72 NLSFNTLEG-KIPR   84 (232)
Q Consensus        72 ~l~~n~l~g-~~p~   84 (232)
                      |+.+|+++. .+|.
T Consensus       108 dltynnl~e~~lpg  121 (264)
T KOG0617|consen  108 DLTYNNLNENSLPG  121 (264)
T ss_pred             hccccccccccCCc
Confidence            999888865 4454

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.16  E-value=1.3e-05  Score=60.34  Aligned_cols=92  Identities=23%  Similarity=0.359  Sum_probs=71.6

Q ss_pred             HHHHHhcCCCC-CCccceeEEEecCCeeEEEEeccCCCChhhh---hccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 042107          133 VECNMMKIIRH-QNLIKIISSCSKDDFKALILEYMPHGSLGKC---LSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH  208 (232)
Q Consensus       133 ~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~  208 (232)
                      .|.-+++.+++ +++++++|+|-    ..++.||.+.+++...   +.. -...+|..+.+++.++++.+.++++.... 
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~-   81 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLG-   81 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCC-
Confidence            37778888876 69999999994    3679999987755421   111 11368999999999999999999865544 


Q ss_pred             CeeeCCCCCCceeeCCCCceee
Q 042107          209 VIIHCDLKSSNVLLDDNMVAHF  230 (232)
Q Consensus       209 ~iiHrdlk~~Nill~~~~~~~l  230 (232)
                      .+.-.|++|+|+-+++++.+|+
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~  103 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKL  103 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEE
Confidence            3777999999999999998886

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.15  E-value=3.6e-05  Score=58.79  Aligned_cols=126  Identities=17%  Similarity=0.193  Sum_probs=72.7

Q ss_pred             ceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHH---------HHHHHHhcCCC---CCCccceeEEE----
Q 042107           90 LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNL---------DVECNMMKIIR---HQNLIKIISSC----  153 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~e~~~l~~l~---h~niv~~~~~~----  153 (232)
                      +...+.+-......|.+-.. +++.+++|..........+.+         .+.+..+..++   -.....++-+.    
T Consensus        33 ~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~  111 (229)
T PF06176_consen   33 YKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKI  111 (229)
T ss_pred             ceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeee
Confidence            34445555544444444443 478889998765432221111         22222222222   12222222221    


Q ss_pred             -ecCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCcee
Q 042107          154 -SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAH  229 (232)
Q Consensus       154 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~  229 (232)
                       .-....+++|||++|..|.++..     +++    .+...+.+++.-+|    ..|+.|+|..|.|++++.++..-
T Consensus       112 ~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH----~~G~~HGD~hpgNFlv~~~~i~i  175 (229)
T PF06176_consen  112 FRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLH----KHGFYHGDPHPGNFLVSNNGIRI  175 (229)
T ss_pred             ccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHH----HcCCccCCCCcCcEEEECCcEEE
Confidence             12234568999999988766532     222    23456777889999    88999999999999999877543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=98.11  E-value=5.6e-07  Score=77.42  Aligned_cols=73  Identities=41%  Similarity=0.580  Sum_probs=61.8

Q ss_pred             CCCCCCEEEccCCcccccCCCcc-----------ccCcccccccccc-ccCCCCCeeeCCCCcceecCCcccccCCCCCc
Q 042107            3 NLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSI-GDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKD   70 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~-~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~   70 (232)
                      .|..|+.||||.|++. ..|..+           ++|++. +||.++ .+++.|..||||+|++. .+|+.+..+..|+.
T Consensus       101 ~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~Lqt  177 (1255)
T KOG0444|consen  101 RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQT  177 (1255)
T ss_pred             ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhh
Confidence            4678899999999998 556653           778885 778655 68999999999999998 88999999999999


Q ss_pred             cccccccc
Q 042107           71 LNLSFNTL   78 (232)
Q Consensus        71 l~l~~n~l   78 (232)
                      |++++|.+
T Consensus       178 L~Ls~NPL  185 (1255)
T KOG0444|consen  178 LKLSNNPL  185 (1255)
T ss_pred             hhcCCChh
Confidence            99999976

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.06  E-value=7.1e-05  Score=57.96  Aligned_cols=127  Identities=20%  Similarity=0.196  Sum_probs=79.1

Q ss_pred             eeecccCCCcceeeeEEeCCCcEEEEEEeecccCch------------------------HHHHHHHHHHhcCCC--CCC
Q 042107           92 VFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGA------------------------FKNLDVECNMMKIIR--HQN  145 (232)
Q Consensus        92 ~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~------------------------~~~~~~e~~~l~~l~--h~n  145 (232)
                      +.-.|..|.-+.||+|...++..+|+|++.......                        ......|..-|+.+.  +-.
T Consensus        52 ~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          52 LVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             eEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            334677888889999988889999999986542110                        012234665555553  233


Q ss_pred             ccceeEEEecCCeeEEEEeccCCC-ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC
Q 042107          146 LIKIISSCSKDDFKALILEYMPHG-SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD  224 (232)
Q Consensus       146 iv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~  224 (232)
                      +++-+.+..    -.|||||+... .-.-.|+.-  .++......+..++++.+.-|-.   ..+++|+||..=|||+. 
T Consensus       132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv--~~e~~e~~~~~~~~v~~~~~l~~---~a~LVHgDLSEyNiL~~-  201 (268)
T COG1718         132 VPEPIAFRN----NVLVMEFIGDDGLPAPRLKDV--PLELEEAEGLYEDVVEYMRRLYK---EAGLVHGDLSEYNILVH-  201 (268)
T ss_pred             CCCceeecC----CeEEEEeccCCCCCCCCcccC--CcCchhHHHHHHHHHHHHHHHHH---hcCcccccchhhheEEE-
Confidence            334444332    46999998653 222233322  12332455666777787777651   36899999999999999 


Q ss_pred             CCce
Q 042107          225 NMVA  228 (232)
Q Consensus       225 ~~~~  228 (232)
                      ++.+
T Consensus       202 ~~~p  205 (268)
T COG1718         202 DGEP  205 (268)
T ss_pred             CCeE
Confidence            4444

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.04  E-value=8.5e-05  Score=58.18  Aligned_cols=75  Identities=13%  Similarity=0.118  Sum_probs=50.7

Q ss_pred             cccCCCc-ceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCC-CCCccceeEEEecCCeeEEEEeccCCCChh
Q 042107           95 LISRGGF-GSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-HQNLIKIISSCSKDDFKALILEYMPHGSLG  172 (232)
Q Consensus        95 ~lg~g~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  172 (232)
                      .|..|.. ..||+.... +..+++|......   ...+.+|+.+++.+. +--+++++++....+..++|||+++|.++.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3444554 678988654 4678888765432   234567888877764 334567777776666788999999998776


Q ss_pred             h
Q 042107          173 K  173 (232)
Q Consensus       173 ~  173 (232)
                      +
T Consensus        81 ~   81 (244)
T cd05150          81 A   81 (244)
T ss_pred             H
Confidence            4

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=98.03  E-value=8.8e-07  Score=72.28  Aligned_cols=56  Identities=29%  Similarity=0.307  Sum_probs=48.0

Q ss_pred             cCccccccccccc-cCCCCCeeeCCCCcceecCCcccccCCCCCccccccccccCCCCC
Q 042107           27 YNRLQDSLRNSIG-DLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPR   84 (232)
Q Consensus        27 ~n~~~~~~p~~~~-~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~   84 (232)
                      .|+++ .+|.... ++++|.+|||+.|++. +.|..++.+.+|.++|+++|.+++-.+.
T Consensus       237 ~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~s  293 (565)
T KOG0472|consen  237 ENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYS  293 (565)
T ss_pred             ccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcc
Confidence            45554 6777776 8999999999999999 8999999999999999999999886444

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=97.97  E-value=4.1e-06  Score=75.28  Aligned_cols=75  Identities=25%  Similarity=0.307  Sum_probs=51.9

Q ss_pred             CCCEEEccCCcccccCCCc--------cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccccccc
Q 042107            6 VLLRIDLSTNNFSCVFPTT--------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNT   77 (232)
Q Consensus         6 ~l~~l~ls~N~~~g~~p~~--------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~   77 (232)
                      +|+.|+|++|.|++ +|..        +++|+++. +|...   .+|+.|++++|+++ .+|..+.++..++.+++++|+
T Consensus       383 ~L~~LdLs~N~Lt~-LP~l~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~  456 (788)
T PRK15387        383 GLKELIVSGNRLTS-LPVLPSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP  456 (788)
T ss_pred             ccceEEecCCcccC-CCCcccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCC
Confidence            45566666666663 3321        25566653 55432   35677888888887 788888889999999999999


Q ss_pred             ccCCCCCcc
Q 042107           78 LEGKIPRPF   86 (232)
Q Consensus        78 l~g~~p~~~   86 (232)
                      |++..|..+
T Consensus       457 Ls~~~~~~L  465 (788)
T PRK15387        457 LSERTLQAL  465 (788)
T ss_pred             CCchHHHHH
Confidence            998877654

>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B

Probab=97.94  E-value=4.8e-06  Score=46.82  Aligned_cols=37  Identities=43%  Similarity=0.640  Sum_probs=32.4

Q ss_pred             CCCCeeeCCCCcceecCCcccccCCCCCcccccccccc
Q 042107           42 TSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLE   79 (232)
Q Consensus        42 ~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~l~   79 (232)
                      ++|+.|++++|+++ .+|..+.++++|+.+++++|.++
T Consensus         1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~   37 (44)
T PF12799_consen    1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS   37 (44)
T ss_dssp             TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred             CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence            57999999999999 78888999999999999999987

...

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=97.90  E-value=6.9e-06  Score=69.08  Aligned_cols=67  Identities=25%  Similarity=0.323  Sum_probs=56.3

Q ss_pred             eeEEEEeccCCCChhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          158 FKALILEYMPHGSLGKCLSTS--NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +.|+.|++|.-.+|.+|+...  ....++.....++.|++.|++| -      +.+|||+||.||....+..+||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-k------~~ihrdlkp~nif~~~d~q~kIg  398 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-K------GLIHRDLKPSNIFFSDDDQLKIG  398 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-c------cchhhhccccccccccchhhhhh
Confidence            578999999999999999754  3346677788999999999999 2      68999999999999888776653

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=97.88  E-value=1.7e-06  Score=74.58  Aligned_cols=51  Identities=41%  Similarity=0.589  Sum_probs=37.3

Q ss_pred             CccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccccccccc
Q 042107           28 NRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLE   79 (232)
Q Consensus        28 n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~l~   79 (232)
                      ++-...+|.++..+.+|..+|||.|++. .+|..+.++.+|..|++|+|.++
T Consensus       208 qRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it  258 (1255)
T KOG0444|consen  208 QRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT  258 (1255)
T ss_pred             cchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee
Confidence            3333567777777888888888888877 67777777777777777777654

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=97.86  E-value=2.8e-06  Score=75.82  Aligned_cols=49  Identities=41%  Similarity=0.364  Sum_probs=30.2

Q ss_pred             cCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccccccc
Q 042107           27 YNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNT   77 (232)
Q Consensus        27 ~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~   77 (232)
                      .|++. .+| .+.+++.|+.+|+|.|+++--.-......++|++||+++|.
T Consensus       439 sN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  439 SNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT  487 (1081)
T ss_pred             CCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence            35444 345 67777777778888877763221222233677777777775

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=97.86  E-value=1.5e-05  Score=58.92  Aligned_cols=74  Identities=31%  Similarity=0.383  Sum_probs=27.1

Q ss_pred             CCCCCEEEccCCcccccCCC----------ccccCcccccccccc-ccCCCCCeeeCCCCcceecCC-cccccCCCCCcc
Q 042107            4 LKVLLRIDLSTNNFSCVFPT----------TIEYNRLQDSLRNSI-GDLTSLKSLDLSNNNFSGAIP-IPLEKLLDLKDL   71 (232)
Q Consensus         4 ~~~l~~l~ls~N~~~g~~p~----------~~~~n~~~~~~p~~~-~~l~~L~~L~ls~N~l~g~ip-~~~~~l~~l~~l   71 (232)
                      +.+|+.||||+|.|+. ++.          .+++|+++.. +..+ ..+|+|+.|+|++|++..--- ..+..+++|+.|
T Consensus        41 l~~L~~L~Ls~N~I~~-l~~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L  118 (175)
T PF14580_consen   41 LDKLEVLDLSNNQITK-LEGLPGLPRLKTLDLSNNRISSI-SEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVL  118 (175)
T ss_dssp             -TT--EEE-TTS--S---TT----TT--EEE--SS---S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EE
T ss_pred             hcCCCEEECCCCCCcc-ccCccChhhhhhcccCCCCCCcc-ccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCccee
Confidence            4567777777777773 222          1256777643 2233 356777777777777753111 235566777777


Q ss_pred             cccccccc
Q 042107           72 NLSFNTLE   79 (232)
Q Consensus        72 ~l~~n~l~   79 (232)
                      ++.+|++.
T Consensus       119 ~L~~NPv~  126 (175)
T PF14580_consen  119 SLEGNPVC  126 (175)
T ss_dssp             E-TT-GGG
T ss_pred             eccCCccc
Confidence            77777664

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=97.83  E-value=3.5e-06  Score=75.16  Aligned_cols=75  Identities=33%  Similarity=0.521  Sum_probs=66.6

Q ss_pred             CCCCCCCEEEccCCcccccCCCc------------cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCC
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTT------------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK   69 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~------------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~   69 (232)
                      -+++.|+.|+|++|+++ .+|++            +++|++. .+|..++.+..|+.|...+|++. ..| ++.+++.|+
T Consensus       380 ~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~  455 (1081)
T KOG0618|consen  380 VNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLK  455 (1081)
T ss_pred             ccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcce
Confidence            46789999999999999 77775            2789987 78999999999999999999999 677 889999999


Q ss_pred             ccccccccccC
Q 042107           70 DLNLSFNTLEG   80 (232)
Q Consensus        70 ~l~l~~n~l~g   80 (232)
                      .+|++.|+++-
T Consensus       456 ~lDlS~N~L~~  466 (1081)
T KOG0618|consen  456 VLDLSCNNLSE  466 (1081)
T ss_pred             EEecccchhhh
Confidence            99999999864

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.76  E-value=0.00074  Score=51.03  Aligned_cols=115  Identities=18%  Similarity=0.343  Sum_probs=79.4

Q ss_pred             ccceeeecccCCCc-ceeeeEEeCCCcEEEEEEeec---ccC------------------chHHHHHHHHHHhcCCC---
Q 042107           88 NFLEVFNLISRGGF-GSIYKARIQDGMEVVVKGFNL---QYG------------------GAFKNLDVECNMMKIIR---  142 (232)
Q Consensus        88 ~~~~~~~~lg~g~~-g~V~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~e~~~l~~l~---  142 (232)
                      ...+..+.||.|.. |.||+++.. |..+|+|.+..   ...                  .....|..|+.....++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            34567899999999 999999876 77999999422   100                  11245777888777664   


Q ss_pred             CCCc--cceeEEEecC------------------CeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHh
Q 042107          143 HQNL--IKIISSCSKD------------------DFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH  202 (232)
Q Consensus       143 h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH  202 (232)
                      +.++  |+.+|+..-.                  ....||.||.+...          .+.    .+-+.++.+-+..+|
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~----~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ----IRDIPQMLRDLKILH  181 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc----hhHHHHHHHHHHHHH
Confidence            4556  8888886322                  12356777776533          112    223456777888899


Q ss_pred             cCCCCCCeeeCCCCCCcee
Q 042107          203 FGHSTHVIIHCDLKSSNVL  221 (232)
Q Consensus       203 ~~~~~~~iiHrdlk~~Nil  221 (232)
                          ..+|+-+|+++.|..
T Consensus       182 ----k~gI~~~Dv~~~ny~  196 (207)
T PF13095_consen  182 ----KLGIVPRDVKPRNYR  196 (207)
T ss_pred             ----HCCeeeccCcccccc
Confidence                889999999999965

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.75  E-value=0.00031  Score=51.71  Aligned_cols=79  Identities=20%  Similarity=0.298  Sum_probs=57.2

Q ss_pred             eeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCcc-ceeEEEecCCeeEEEEeccCCC
Q 042107           91 EVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLI-KIISSCSKDDFKALILEYMPHG  169 (232)
Q Consensus        91 ~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g  169 (232)
                      ++.+.|++|.+|.||+|.++ +..+|+|+-...  .....+..|++++..+.-.++. +++.+-.    .++.|||+.|-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence            46678999999999999987 557888876443  3347788899999988766554 3333322    34559999998


Q ss_pred             Chhhhhc
Q 042107          170 SLGKCLS  176 (232)
Q Consensus       170 ~L~~~l~  176 (232)
                      .|.++-.
T Consensus        98 ~L~~~~~  104 (201)
T COG2112          98 PLGKLEI  104 (201)
T ss_pred             chhhhhh
Confidence            8876644

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=97.67  E-value=2.1e-05  Score=64.25  Aligned_cols=79  Identities=25%  Similarity=0.362  Sum_probs=62.9

Q ss_pred             CCCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK   69 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~   69 (232)
                      |+++++|+.|+|++|.+++.-+.++           ..|++.-.--.-+..+..|+.|+|.+|+++-.-|..+..+..|.
T Consensus       270 f~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~  349 (498)
T KOG4237|consen  270 FKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLS  349 (498)
T ss_pred             HhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceee
Confidence            5689999999999999997766654           45777644445556778888899999999887888888888888


Q ss_pred             cccccccccc
Q 042107           70 DLNLSFNTLE   79 (232)
Q Consensus        70 ~l~l~~n~l~   79 (232)
                      .+++-.|.|.
T Consensus       350 ~l~l~~Np~~  359 (498)
T KOG4237|consen  350 TLNLLSNPFN  359 (498)
T ss_pred             eeehccCccc
Confidence            8888888763

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=97.63  E-value=3.7e-06  Score=71.81  Aligned_cols=54  Identities=28%  Similarity=0.270  Sum_probs=20.7

Q ss_pred             cCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccccccccccC
Q 042107           27 YNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEG   80 (232)
Q Consensus        27 ~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~l~g   80 (232)
                      +|+++.--+.++.-+..|+.|+|+.|+++.---..+.-+++|+.||++.|.+++
T Consensus       326 ~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~  379 (873)
T KOG4194|consen  326 SNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSW  379 (873)
T ss_pred             ccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEE
Confidence            344443333334333444444444443331111122334444444444444443

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=97.60  E-value=7.6e-06  Score=57.33  Aligned_cols=72  Identities=28%  Similarity=0.403  Sum_probs=53.5

Q ss_pred             CCCCCEEEccCCcccccCCCcc------------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcc
Q 042107            4 LKVLLRIDLSTNNFSCVFPTTI------------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDL   71 (232)
Q Consensus         4 ~~~l~~l~ls~N~~~g~~p~~~------------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l   71 (232)
                      ...|+..+||+|.|. .+|..+            ++|+++ .+|..++.++.|+.|+++.|.|+ ..|..+..+.++..|
T Consensus        52 ~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~L  128 (177)
T KOG4579|consen   52 GYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDML  128 (177)
T ss_pred             CceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHh
Confidence            346677899999998 444432            567776 46777888888888888888888 566667778888888


Q ss_pred             ccccccc
Q 042107           72 NLSFNTL   78 (232)
Q Consensus        72 ~l~~n~l   78 (232)
                      +...|..
T Consensus       129 ds~~na~  135 (177)
T KOG4579|consen  129 DSPENAR  135 (177)
T ss_pred             cCCCCcc
Confidence            7777654

>PLN02876 acyl-CoA dehydrogenase

Probab=97.60  E-value=0.0007  Score=62.33  Aligned_cols=108  Identities=14%  Similarity=0.155  Sum_probs=72.2

Q ss_pred             eecccCCCcceeeeEEeCCC---cEEEEEEeeccc-CchHHHHHHHHHHhcCCC-CCCc--cceeEEEecC---CeeEEE
Q 042107           93 FNLISRGGFGSIYKARIQDG---MEVVVKGFNLQY-GGAFKNLDVECNMMKIIR-HQNL--IKIISSCSKD---DFKALI  162 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv  162 (232)
                      .+.++.|.+..+|+....++   ..+++|+..... ......+.+|..+++.+. |+++  ++++.++.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            46789999999999876543   467777764332 122356788999999985 6665  7777777654   467899


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHF  203 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~  203 (232)
                      |||++|..+.+.   ....++...+..+..+++++|..||.
T Consensus       123 ME~v~G~~~~~~---~~~~~~~~~r~~l~~~l~~~La~LH~  160 (822)
T PLN02876        123 MEYLEGRIFVDP---KLPGVAPERRRAIYRATAKVLAALHS  160 (822)
T ss_pred             EEecCCcccCCc---cCCCCCHHHHHHHHHHHHHHHHHHhC
Confidence            999998544321   11123445556677777777777763

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.58  E-value=0.0018  Score=54.33  Aligned_cols=76  Identities=14%  Similarity=0.217  Sum_probs=53.5

Q ss_pred             eecccCCCcceeeeEEeCCC-cEEEEEEeeccc-------CchHHHHHHHHHHhcCCC---CCCccceeEEEecCCeeEE
Q 042107           93 FNLISRGGFGSIYKARIQDG-MEVVVKGFNLQY-------GGAFKNLDVECNMMKIIR---HQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~~~-~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l  161 (232)
                      .+.+|.|.+..||++...+| +.++||......       ....+....|.+.++.+.   -..+++++.+  +++..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            36789999999999988776 489999854211       123456677888777753   3457777766  3355789


Q ss_pred             EEeccCCCC
Q 042107          162 ILEYMPHGS  170 (232)
Q Consensus       162 v~e~~~~g~  170 (232)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=97.52  E-value=0.00013  Score=66.00  Aligned_cols=68  Identities=26%  Similarity=0.435  Sum_probs=35.1

Q ss_pred             CCCEEEccCCcccccCCCc---------cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccccccc
Q 042107            6 VLLRIDLSTNNFSCVFPTT---------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFN   76 (232)
Q Consensus         6 ~l~~l~ls~N~~~g~~p~~---------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n   76 (232)
                      +|+.|+|++|+|+ .+|..         +++|++. .+|..+.  .+|+.|+|++|+++ .+|..+.  .+|+.|++++|
T Consensus       221 nL~~L~Ls~N~Lt-sLP~~l~~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N  293 (754)
T PRK15370        221 NIKTLYANSNQLT-SIPATLPDTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDN  293 (754)
T ss_pred             CCCEEECCCCccc-cCChhhhccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCC
Confidence            4555555555555 23322         1345554 4444443  35666666666666 4555432  35666666666


Q ss_pred             cccC
Q 042107           77 TLEG   80 (232)
Q Consensus        77 ~l~g   80 (232)
                      +|++
T Consensus       294 ~Lt~  297 (754)
T PRK15370        294 SIRT  297 (754)
T ss_pred             cccc
Confidence            6653

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.51  E-value=0.0013  Score=51.33  Aligned_cols=73  Identities=8%  Similarity=0.139  Sum_probs=44.2

Q ss_pred             ecccCCCcc-eeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCC---CccceeEEEecC---CeeEEEEecc
Q 042107           94 NLISRGGFG-SIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQ---NLIKIISSCSKD---DFKALILEYM  166 (232)
Q Consensus        94 ~~lg~g~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~~  166 (232)
                      +.++.|+.. .||+.    +..+++|.....  .....+.+|.+++..+...   -+.++++.....   ...+++||++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            456666665 48875    235777765432  2235678899888777532   234444443332   2358899999


Q ss_pred             CCCChh
Q 042107          167 PHGSLG  172 (232)
Q Consensus       167 ~~g~L~  172 (232)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=97.49  E-value=2.2e-05  Score=62.13  Aligned_cols=70  Identities=30%  Similarity=0.373  Sum_probs=51.9

Q ss_pred             CCCEEEccCCccccc------CCC----ccccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccccc
Q 042107            6 VLLRIDLSTNNFSCV------FPT----TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSF   75 (232)
Q Consensus         6 ~l~~l~ls~N~~~g~------~p~----~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~   75 (232)
                      .|+.||||+|.|++.      +|.    .+++|++.-.  .+++.+++|+.||||+|.++ .+-.+..++-+++.|.++.
T Consensus       285 ~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~  361 (490)
T KOG1259|consen  285 ELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQ  361 (490)
T ss_pred             hhhhccccccchhhhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhh
Confidence            478899999999963      333    1377777532  44788888888888888887 6666777788888888888


Q ss_pred             ccc
Q 042107           76 NTL   78 (232)
Q Consensus        76 n~l   78 (232)
                      |.+
T Consensus       362 N~i  364 (490)
T KOG1259|consen  362 NKI  364 (490)
T ss_pred             hhH
Confidence            754

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.48  E-value=0.0025  Score=49.50  Aligned_cols=73  Identities=16%  Similarity=0.233  Sum_probs=46.3

Q ss_pred             ecccCCCcceeeeEEeCC--CcEEEEEEeecccCchHHHHHHHHHHhcCCCC-CCccceeEEEecCCeeEEEEeccCCCC
Q 042107           94 NLISRGGFGSIYKARIQD--GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRH-QNLIKIISSCSKDDFKALILEYMPHGS  170 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~  170 (232)
                      +.+..|-...+|+....+  ++.|++|........ .-...+|..+++.+.. .-.++++....    -.++|||++|.+
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            457778888999987654  678888976543221 1223457777777743 33445544332    248999999876


Q ss_pred             h
Q 042107          171 L  171 (232)
Q Consensus       171 L  171 (232)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            5

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=97.48  E-value=6.6e-05  Score=45.40  Aligned_cols=51  Identities=37%  Similarity=0.531  Sum_probs=41.1

Q ss_pred             CCCCeeeCCCCcceecCCcccccCCCCCccccccccccCCCCCccccccee
Q 042107           42 TSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEV   92 (232)
Q Consensus        42 ~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~~~~~   92 (232)
                      |+|+.|++++|+++.-.+..+..+++|+.++++.|.++...|..|.....+
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L   51 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNL   51 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTE
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCC
Confidence            578999999999994444578899999999999999987766666655443

...

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=97.47  E-value=4.8e-05  Score=56.33  Aligned_cols=75  Identities=32%  Similarity=0.448  Sum_probs=20.7

Q ss_pred             CCCCCCEEEccCCccccc--CCC--------ccccCccccccccccccCCCCCeeeCCCCcceecCCccc-ccCCCCCcc
Q 042107            3 NLKVLLRIDLSTNNFSCV--FPT--------TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPL-EKLLDLKDL   71 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~--~p~--------~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~-~~l~~l~~l   71 (232)
                      ++..++.|+|++|.|+-.  +..        +++.|+++..  ..+..+++|+.|++++|+++ .++..+ ..+++|+.|
T Consensus        17 n~~~~~~L~L~~n~I~~Ie~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L   93 (175)
T PF14580_consen   17 NPVKLRELNLRGNQISTIENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL   93 (175)
T ss_dssp             -------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred             cccccccccccccccccccchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence            445688999999999931  111        1367777743  24666888888888888888 555444 357888888


Q ss_pred             ccccccccC
Q 042107           72 NLSFNTLEG   80 (232)
Q Consensus        72 ~l~~n~l~g   80 (232)
                      ++++|.+..
T Consensus        94 ~L~~N~I~~  102 (175)
T PF14580_consen   94 YLSNNKISD  102 (175)
T ss_dssp             E-TTS---S
T ss_pred             ECcCCcCCC
Confidence            888887753

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.42  E-value=0.0013  Score=51.96  Aligned_cols=72  Identities=14%  Similarity=0.144  Sum_probs=44.1

Q ss_pred             ccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCc-cceeEEEecCCeeEEEEeccCCCChh
Q 042107           96 ISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL-IKIISSCSKDDFKALILEYMPHGSLG  172 (232)
Q Consensus        96 lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L~  172 (232)
                      +..|-.+.+|+.. .+++.+++|..........-....|..+++.+....+ ++++....    -++||||++|..+.
T Consensus         4 ~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~   76 (256)
T TIGR02721         4 LSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT   76 (256)
T ss_pred             CCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence            4567778899886 3466788887543322110124668888887754333 34444332    36899999987654

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.40  E-value=4.3e-05  Score=66.29  Aligned_cols=151  Identities=17%  Similarity=0.223  Sum_probs=97.2

Q ss_pred             CcccccCCCCCccccccccccCCCCCcc---cccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHH
Q 042107           59 PIPLEKLLDLKDLNLSFNTLEGKIPRPF---RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVEC  135 (232)
Q Consensus        59 p~~~~~l~~l~~l~l~~n~l~g~~p~~~---~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~  135 (232)
                      ..+++.+-.++.|-+..-.  |--|..+   ..++....-.++++++.+++.+-...+....+.+...     .....++
T Consensus       212 qpplfdlhpmr~l~LmTkS--~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~  284 (829)
T KOG0576|consen  212 QPPLFDLHPMRALFLMTKS--GFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAI  284 (829)
T ss_pred             CCcccccchHHHHHHhhcc--CCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHH
Confidence            3444555555555444332  2223222   3355566778899999999987544444445555433     4455688


Q ss_pred             HHhcCCCCCC-ccceeEEEecCCeeEEEEeccCCC-ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeC
Q 042107          136 NMMKIIRHQN-LIKIISSCSKDDFKALILEYMPHG-SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHC  213 (232)
Q Consensus       136 ~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHr  213 (232)
                      +++.+++||| .+..++.+..++..+++|+++.++ +-..........+...+...+.+.-+++++++|    +-.-+||
T Consensus       285 eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~----~~~~~~~  360 (829)
T KOG0576|consen  285 ELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELH----SSYKVHR  360 (829)
T ss_pred             HHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccc----cccccCc
Confidence            9999999999 777788888888999999999887 333322222223444455566777888999999    4334888


Q ss_pred             CCCCCceeeCC
Q 042107          214 DLKSSNVLLDD  224 (232)
Q Consensus       214 dlk~~Nill~~  224 (232)
                      |    ||+..+
T Consensus       361 d----~~l~s~  367 (829)
T KOG0576|consen  361 D----NILGSE  367 (829)
T ss_pred             c----cccccc
Confidence            8    666554

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=97.37  E-value=0.00011  Score=66.37  Aligned_cols=58  Identities=24%  Similarity=0.307  Sum_probs=49.6

Q ss_pred             CCCCEEEccCCcccccCCCc--------cccCccccccccccccCCCCCeeeCCCCcceecCCccccc
Q 042107            5 KVLLRIDLSTNNFSCVFPTT--------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEK   64 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g~~p~~--------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~   64 (232)
                      ++|+.||+|+|+|+. +|..        +++|+++ .+|.++.++++|+.|+|++|.|+|.+|..+..
T Consensus       402 s~L~~LdLS~N~Lss-IP~l~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~  467 (788)
T PRK15387        402 SELKELMVSGNRLTS-LPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE  467 (788)
T ss_pred             cCCCEEEccCCcCCC-CCcchhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHH
Confidence            578999999999995 6753        3689997 79999999999999999999999988876533

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=97.36  E-value=0.00031  Score=63.54  Aligned_cols=72  Identities=22%  Similarity=0.423  Sum_probs=48.2

Q ss_pred             CCCEEEccCCcccccCCCc---------cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccccccc
Q 042107            6 VLLRIDLSTNNFSCVFPTT---------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFN   76 (232)
Q Consensus         6 ~l~~l~ls~N~~~g~~p~~---------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n   76 (232)
                      .|+.|+|++|.|+ .+|..         +++|+|+ .+|..+.  ++|+.|+|++|++. .+|..+.  ..|+.|+++.|
T Consensus       200 ~L~~L~Ls~N~Lt-sLP~~l~~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N  272 (754)
T PRK15370        200 QITTLILDNNELK-SLPENLQGNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHN  272 (754)
T ss_pred             CCcEEEecCCCCC-cCChhhccCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCC
Confidence            5677777777777 45543         2566666 4565543  36778888888877 6676553  46888888888


Q ss_pred             cccCCCCCc
Q 042107           77 TLEGKIPRP   85 (232)
Q Consensus        77 ~l~g~~p~~   85 (232)
                      +++. +|..
T Consensus       273 ~L~~-LP~~  280 (754)
T PRK15370        273 KISC-LPEN  280 (754)
T ss_pred             ccCc-cccc
Confidence            8873 5553

>PRK10593 hypothetical protein; Provisional

Probab=97.35  E-value=0.0028  Score=51.28  Aligned_cols=79  Identities=10%  Similarity=0.055  Sum_probs=56.2

Q ss_pred             eeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCC---CCccceeEEEec---CCeeEEEEec
Q 042107           92 VFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRH---QNLIKIISSCSK---DDFKALILEY  165 (232)
Q Consensus        92 ~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~---~~~~~lv~e~  165 (232)
                      -.+.||.|..+.||+....++ .+++|..+..  .....+..|.+.++.+.-   -.++++++++..   .+..++|||+
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            346799999999999876555 4666764321  123567889988887753   357788877754   3568999999


Q ss_pred             cCCCChhh
Q 042107          166 MPHGSLGK  173 (232)
Q Consensus       166 ~~~g~L~~  173 (232)
                      ++++++.+
T Consensus        95 i~G~~~~~  102 (297)
T PRK10593         95 LRGVSVEA  102 (297)
T ss_pred             cCCEecCC
Confidence            99987654

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=97.35  E-value=6.2e-05  Score=64.59  Aligned_cols=77  Identities=30%  Similarity=0.365  Sum_probs=54.2

Q ss_pred             CCCCCCEEEccCCcccccCCCc-----------cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcc
Q 042107            3 NLKVLLRIDLSTNNFSCVFPTT-----------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDL   71 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p~~-----------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l   71 (232)
                      .|..+..|+|+.|+++..--++           +++|.++..-++.-...++|+.|||++|+++---|..+.-+..|+.|
T Consensus       267 ~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~L  346 (873)
T KOG4194|consen  267 GLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEEL  346 (873)
T ss_pred             eecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhh
Confidence            3456677777777777432222           26777777777777777888888888888884444567778888888


Q ss_pred             cccccccc
Q 042107           72 NLSFNTLE   79 (232)
Q Consensus        72 ~l~~n~l~   79 (232)
                      +++.|.++
T Consensus       347 nLs~Nsi~  354 (873)
T KOG4194|consen  347 NLSHNSID  354 (873)
T ss_pred             cccccchH
Confidence            88888764

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.21  E-value=0.0024  Score=49.17  Aligned_cols=78  Identities=19%  Similarity=0.353  Sum_probs=55.1

Q ss_pred             eecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCC--CccceeEEEec---CCeeEEEEeccC
Q 042107           93 FNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQ--NLIKIISSCSK---DDFKALILEYMP  167 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~---~~~~~lv~e~~~  167 (232)
                      .+.++.|..+.||+....+ ..+++|.....  .....+..|..+++.+...  -+++++.....   ....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3578899999999998776 58999987544  3446677888888777533  35566654322   335689999999


Q ss_pred             CCChhh
Q 042107          168 HGSLGK  173 (232)
Q Consensus       168 ~g~L~~  173 (232)
                      |..+..
T Consensus        79 g~~~~~   84 (239)
T PF01636_consen   79 GRPLDD   84 (239)
T ss_dssp             SEEHHH
T ss_pred             cccccc
Confidence            987776

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.18  E-value=0.0026  Score=51.29  Aligned_cols=75  Identities=16%  Similarity=0.162  Sum_probs=47.3

Q ss_pred             eecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCC--ccceeEE------EecCCeeEEEEe
Q 042107           93 FNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN--LIKIISS------CSKDDFKALILE  164 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e  164 (232)
                      .+.+..|....+|+.... +..+++|....   .....+..|+.++..+.+..  +++.+..      ....+..+.+++
T Consensus        19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            356777777889988654 34688888754   22345666777777664322  3444332      122345689999


Q ss_pred             ccCCCCh
Q 042107          165 YMPHGSL  171 (232)
Q Consensus       165 ~~~~g~L  171 (232)
                      |++|..+
T Consensus        95 ~i~G~~~  101 (296)
T cd05153          95 FLAGEHL  101 (296)
T ss_pred             eCCCCCC
Confidence            9998765

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=97.14  E-value=0.00012  Score=59.54  Aligned_cols=76  Identities=26%  Similarity=0.381  Sum_probs=44.7

Q ss_pred             CCCCEEEccCCcccc----c----CC---Cc-----cccCccccc----cccccccCCCCCeeeCCCCcceec----CCc
Q 042107            5 KVLLRIDLSTNNFSC----V----FP---TT-----IEYNRLQDS----LRNSIGDLTSLKSLDLSNNNFSGA----IPI   60 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g----~----~p---~~-----~~~n~~~~~----~p~~~~~l~~L~~L~ls~N~l~g~----ip~   60 (232)
                      ++|+.|++++|.+++    .    ++   ..     +++|.+++.    ++..+..+++|+.|++++|.+++.    ++.
T Consensus       108 ~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~  187 (319)
T cd00116         108 SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAE  187 (319)
T ss_pred             CcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHH
Confidence            347777777777762    1    11   11     256666632    334455566777777777777642    233


Q ss_pred             ccccCCCCCccccccccccC
Q 042107           61 PLEKLLDLKDLNLSFNTLEG   80 (232)
Q Consensus        61 ~~~~l~~l~~l~l~~n~l~g   80 (232)
                      .+..++.|+.++++.|.+++
T Consensus       188 ~l~~~~~L~~L~L~~n~i~~  207 (319)
T cd00116         188 GLKANCNLEVLDLNNNGLTD  207 (319)
T ss_pred             HHHhCCCCCEEeccCCccCh
Confidence            34445677777777777653

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=97.11  E-value=0.00021  Score=33.60  Aligned_cols=18  Identities=39%  Similarity=0.584  Sum_probs=11.9

Q ss_pred             CCCEEEccCCcccccCCCc
Q 042107            6 VLLRIDLSTNNFSCVFPTT   24 (232)
Q Consensus         6 ~l~~l~ls~N~~~g~~p~~   24 (232)
                      +|++||||+|+|+ .+|.+
T Consensus         1 ~L~~Ldls~n~l~-~ip~~   18 (22)
T PF00560_consen    1 NLEYLDLSGNNLT-SIPSS   18 (22)
T ss_dssp             TESEEEETSSEES-EEGTT
T ss_pred             CccEEECCCCcCE-eCChh
Confidence            4667777777777 66654

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. ; GO: 0005515 protein binding; PDB: 4ECO_B 2A0Z_A 3ULU_A 1ZIW_A 3ULV_A 1DCE_C 1LTX_A 3J0A_B 3A79_B 4FCG_A ....

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=97.09  E-value=2.8e-05  Score=66.30  Aligned_cols=67  Identities=40%  Similarity=0.606  Sum_probs=37.5

Q ss_pred             CCCCCCCEEEccCCcccccCCCcc----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTTI----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDL   71 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~~----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l   71 (232)
                      +++..|++||||.|+++ .+|..+          +.|++ ..+|..++-++.|..||.+.|++. ++|..+..+.+|..+
T Consensus       118 ~~L~~lt~l~ls~NqlS-~lp~~lC~lpLkvli~sNNkl-~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l  194 (722)
T KOG0532|consen  118 CNLEALTFLDLSSNQLS-HLPDGLCDLPLKVLIVSNNKL-TSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDL  194 (722)
T ss_pred             hhhhHHHHhhhccchhh-cCChhhhcCcceeEEEecCcc-ccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHH
Confidence            45677888999999998 445442          34444 345555554455555555555554 444444444444333

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=97.07  E-value=0.00013  Score=62.32  Aligned_cols=73  Identities=30%  Similarity=0.494  Sum_probs=53.8

Q ss_pred             CCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccc
Q 042107            5 KVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNL   73 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l   73 (232)
                      ..|..||.|.|.+. .+|+.+           ..|++. .+|..+++| .|..||+|.|+++ .||..+.++..|+++-+
T Consensus       166 ~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~L  241 (722)
T KOG0532|consen  166 PTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQL  241 (722)
T ss_pred             hhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeee
Confidence            34455555555555 444433           356665 467777744 6788999999999 99999999999999999


Q ss_pred             ccccccCC
Q 042107           74 SFNTLEGK   81 (232)
Q Consensus        74 ~~n~l~g~   81 (232)
                      .+|.+...
T Consensus       242 enNPLqSP  249 (722)
T KOG0532|consen  242 ENNPLQSP  249 (722)
T ss_pred             ccCCCCCC
Confidence            99998653

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=97.04  E-value=0.00013  Score=59.26  Aligned_cols=76  Identities=33%  Similarity=0.348  Sum_probs=36.2

Q ss_pred             CCCCCEEEccCCcccccCCCc--------------cccCcccc----ccccccccC-CCCCeeeCCCCcceec----CCc
Q 042107            4 LKVLLRIDLSTNNFSCVFPTT--------------IEYNRLQD----SLRNSIGDL-TSLKSLDLSNNNFSGA----IPI   60 (232)
Q Consensus         4 ~~~l~~l~ls~N~~~g~~p~~--------------~~~n~~~~----~~p~~~~~l-~~L~~L~ls~N~l~g~----ip~   60 (232)
                      +++|+.|+|++|.+++..+..              ++.|++++    .+...+..+ ++|+.|++++|.+++.    ++.
T Consensus        80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~  159 (319)
T cd00116          80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK  159 (319)
T ss_pred             cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence            456666666666665322211              13344442    222334444 5556666666655532    122


Q ss_pred             ccccCCCCCcccccccccc
Q 042107           61 PLEKLLDLKDLNLSFNTLE   79 (232)
Q Consensus        61 ~~~~l~~l~~l~l~~n~l~   79 (232)
                      .+..+..++.++++.|.++
T Consensus       160 ~~~~~~~L~~L~l~~n~l~  178 (319)
T cd00116         160 ALRANRDLKELNLANNGIG  178 (319)
T ss_pred             HHHhCCCcCEEECcCCCCc
Confidence            2334445555566555554

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	232
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-17
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-17
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-13
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-13
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		6e-10
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-10
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		8e-10
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-10
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-09
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		8e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-08
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-08
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-08
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-08
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-07
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-07
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-07
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-07
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-07
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-07
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-07
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-07
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-07
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-07
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-07
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-07
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-07
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-07
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-07
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		6e-07
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-07
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-07
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-07
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-07
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		7e-07
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-07
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-07
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-07
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-07
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-07
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-07
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-07
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-07
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		8e-07
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-07
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-07
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-07
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		9e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		9e-07
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-07
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-06
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-06
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-06
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-06
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-06
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-06
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-06
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-06
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-06
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-06
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-06
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-06
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-06
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-06
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-06
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-06
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-06
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-06
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-06
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-06
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-06
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-06
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-06
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-06
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		7e-06
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-05
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-05
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-05
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-05
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-05
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-05
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-05
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-05
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-05
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-05
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-05
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-05
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-05
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-05
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-05
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-05
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-05
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-05
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-05
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-05
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-05
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-05
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-05
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-05
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-05
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-05
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-05
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-05
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-05
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-05
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-05
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		4e-05
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-05
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-05
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-05
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-05
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-05
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-05
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-05
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-05
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-05
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-05
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-05
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-05
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-05
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		5e-05
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-05
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-05
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-05
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-05
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-05
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-05
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-05
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-05
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		6e-05
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-05
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-05
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-05
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		7e-05
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-05
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-05
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		7e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-05
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-05
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-05
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-05
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		7e-05
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-05
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-05
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		7e-05
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-05
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-05
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-05
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-05
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		8e-05
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		9e-05
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		9e-05
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		9e-05
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		9e-05
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-05
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-04
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-04
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-04
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-04
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-04
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-04
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-04
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-04
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-04
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-04
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-04
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-04
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-04
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-04
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-04
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-04
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-04
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-04
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-04
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-04
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-04
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-04
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-04
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-04
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-04
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-04
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-04
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-04
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-04
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-04
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-04
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-04
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-04
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-04
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-04
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-04
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-04
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-04
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-04
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-04
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		3e-04
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-04
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-04
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-04
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-04
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-04
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-04
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-04
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-04
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-04
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-04
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-04
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-04
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-04
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-04
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-04
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-04
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-04
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-04
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-04
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-04
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-04
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-04
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		6e-04
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-04
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-04
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		6e-04
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-04
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-04
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-04
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-04
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		8e-04
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-04
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-04
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-04
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-04
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-04
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		8e-04
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		8e-04
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 84.7 bits (208), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 49/140 (35%), Positives = 74/140 (52%), Gaps = 7/140 (5%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQ--YGGAFKNLDVECNMMKIIRHQNLIKIIS 151
           N++ RGGFG +YK R+ DG  V VK    +   GG  +    E  M+ +  H+NL+++  
Sbjct: 44  NILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQ-FQTEVEMISMAVHRNLLRLRG 102
Query: 152 SCSKDDFKALILEYMPHGSLGKCL---STSNYILDFFQRLHIMIDVASAVEYLHFGHSTH 208
            C     + L+  YM +GS+  CL     S   LD+ +R  I +  A  + YLH  H   
Sbjct: 103 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH-DHCDP 161
Query: 209 VIIHCDLKSSNVLLDDNMVA 228
            IIH D+K++N+LLD+   A
Sbjct: 162 KIIHRDVKAANILLDEEFEA 181

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 84.3 bits (207), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 49/140 (35%), Positives = 74/140 (52%), Gaps = 7/140 (5%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQ--YGGAFKNLDVECNMMKIIRHQNLIKIIS 151
           N++ RGGFG +YK R+ DG  V VK    +   GG  +    E  M+ +  H+NL+++  
Sbjct: 36  NILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQ-FQTEVEMISMAVHRNLLRLRG 94
Query: 152 SCSKDDFKALILEYMPHGSLGKCL---STSNYILDFFQRLHIMIDVASAVEYLHFGHSTH 208
            C     + L+  YM +GS+  CL     S   LD+ +R  I +  A  + YLH  H   
Sbjct: 95  FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH-DHCDP 153
Query: 209 VIIHCDLKSSNVLLDDNMVA 228
            IIH D+K++N+LLD+   A
Sbjct: 154 KIIHRDVKAANILLDEEFEA 173

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/136 (34%), Positives = 72/136 (52%), Gaps = 7/136 (5%)
Query: 95  LISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 154
           LI  G FG +YK  ++DG +V +K    +     +  + E   +   RH +L+ +I  C 
Sbjct: 46  LIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105
Query: 155 KDDFKALILEYMPHGSLGKCLSTSNYI---LDFFQRLHIMIDVASAVEYLHFGHSTHVII 211
           + +   LI +YM +G+L + L  S+     + + QRL I I  A  + YLH    T  II
Sbjct: 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH----TRAII 161
Query: 212 HCDLKSSNVLLDDNMV 227
           H D+KS N+LLD+N V
Sbjct: 162 HRDVKSINILLDENFV 177

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/136 (34%), Positives = 72/136 (52%), Gaps = 7/136 (5%)
Query: 95  LISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 154
           LI  G FG +YK  ++DG +V +K    +     +  + E   +   RH +L+ +I  C 
Sbjct: 46  LIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105
Query: 155 KDDFKALILEYMPHGSLGKCLSTSNYI---LDFFQRLHIMIDVASAVEYLHFGHSTHVII 211
           + +   LI +YM +G+L + L  S+     + + QRL I I  A  + YLH    T  II
Sbjct: 106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH----TRAII 161
Query: 212 HCDLKSSNVLLDDNMV 227
           H D+KS N+LLD+N V
Sbjct: 162 HRDVKSINILLDENFV 177

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 71/138 (51%), Gaps = 7/138 (5%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQ--YGGAFKNLDVECNMMKIIRHQNLI 147
           L +   I  G FG++++A    G +V VK    Q  +         E  +MK +RH N++
Sbjct: 39  LNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCL--STSNYILDFFQRLHIMIDVASAVEYLHFGH 205
             + + ++    +++ EY+  GSL + L  S +   LD  +RL +  DVA  + YLH  +
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH--N 155
Query: 206 STHVIIHCDLKSSNVLLD 223
               I+H DLKS N+L+D
Sbjct: 156 RNPPIVHRDLKSPNLLVD 173

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 69/132 (52%), Gaps = 8/132 (6%)
Query: 102 GSIYKARIQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMKIIRHQNLIKIISSCSKD--D 157
           G ++K R Q G ++VVK   ++     K+ D   EC  ++I  H N++ ++ +C      
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 158 FKALILEYMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLK 216
              LI  +MP+GSL   L   +N+++D  Q +   +D+A  + +LH      +I    L 
Sbjct: 83  HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEP--LIPRHALN 140
Query: 217 SSNVLLDDNMVA 228
           S +V++D++M A
Sbjct: 141 SRSVMIDEDMTA 152

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 67/140 (47%), Gaps = 9/140 (6%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVK---GFNLQYGGAFKNLDVECNMMKIIRHQNLIKII 150
           N +  GGFG +YK  + +    V K     ++      +  D E  +M   +H+NL++++
Sbjct: 37  NKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 151 SSCSKDDFKALILEYMPHGSLGKCLS--TSNYILDFFQRLHIMIDVASAVEYLHFGHSTH 208
              S  D   L+  YMP+GSL   LS       L +  R  I    A+ + +LH  H   
Sbjct: 97  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH-- 154
Query: 209 VIIHCDLKSSNVLLDDNMVA 228
             IH D+KS+N+LLD+   A
Sbjct: 155 --IHRDIKSANILLDEAFTA 172

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 67/140 (47%), Gaps = 9/140 (6%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVK---GFNLQYGGAFKNLDVECNMMKIIRHQNLIKII 150
           N +  GGFG +YK  + +    V K     ++      +  D E  +M   +H+NL++++
Sbjct: 31  NKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 90
Query: 151 SSCSKDDFKALILEYMPHGSLGKCLS--TSNYILDFFQRLHIMIDVASAVEYLHFGHSTH 208
              S  D   L+  YMP+GSL   LS       L +  R  I    A+ + +LH  H   
Sbjct: 91  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH-- 148
Query: 209 VIIHCDLKSSNVLLDDNMVA 228
             IH D+KS+N+LLD+   A
Sbjct: 149 --IHRDIKSANILLDEAFTA 166

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 67/140 (47%), Gaps = 9/140 (6%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVK---GFNLQYGGAFKNLDVECNMMKIIRHQNLIKII 150
           N +  GGFG +YK  + +    V K     ++      +  D E  +M   +H+NL++++
Sbjct: 37  NKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 151 SSCSKDDFKALILEYMPHGSLGKCLS--TSNYILDFFQRLHIMIDVASAVEYLHFGHSTH 208
              S  D   L+  YMP+GSL   LS       L +  R  I    A+ + +LH  H   
Sbjct: 97  GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH-- 154
Query: 209 VIIHCDLKSSNVLLDDNMVA 228
             IH D+KS+N+LLD+   A
Sbjct: 155 --IHRDIKSANILLDEAFTA 172

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/138 (30%), Positives = 71/138 (51%), Gaps = 7/138 (5%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQ--YGGAFKNLDVECNMMKIIRHQNLI 147
           L +   I  G FG++++A    G +V VK    Q  +         E  +MK +RH N++
Sbjct: 39  LNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCL--STSNYILDFFQRLHIMIDVASAVEYLHFGH 205
             + + ++    +++ EY+  GSL + L  S +   LD  +RL +  DVA  + YLH  +
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH--N 155
Query: 206 STHVIIHCDLKSSNVLLD 223
               I+H +LKS N+L+D
Sbjct: 156 RNPPIVHRNLKSPNLLVD 173

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 67/137 (48%), Gaps = 8/137 (5%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGF----NLQYGGAFKNLDVECNMMKIIRHQN 145
           L +  +I  GGFG +Y+A    G EV VK      +       +N+  E  +  +++H N
Sbjct: 9   LTLEEIIGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 205
           +I +   C K+    L++E+   G L + LS      D    ++  + +A  + YLH   
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLH-DE 124
Query: 206 STHVIIHCDLKSSNVLL 222
           +   IIH DLKSSN+L+
Sbjct: 125 AIVPIIHRDLKSSNILI 141

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 74/162 (45%), Gaps = 26/162 (16%)
Query: 88  NFLEVFNLISRGGFGSIYKARIQ-DG--MEVVVKGFNLQYGGAFKNLDVECNM---MKII 141
           N ++  ++I  G FG + KARI+ DG  M+  +K    +Y     + D    +    K+ 
Sbjct: 25  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLG 83
Query: 142 RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI---------------LDFFQ 186
            H N+I ++ +C    +  L +EY PHG+L   L  S  +               L   Q
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 187 RLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
            LH   DVA  ++YL    S    IH DL + N+L+ +N VA
Sbjct: 144 LLHFAADVARGMDYL----SQKQFIHRDLAARNILVGENYVA 181

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 74/162 (45%), Gaps = 26/162 (16%)
Query: 88  NFLEVFNLISRGGFGSIYKARIQ-DG--MEVVVKGFNLQYGGAFKNLDVECNM---MKII 141
           N ++  ++I  G FG + KARI+ DG  M+  +K    +Y     + D    +    K+ 
Sbjct: 15  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLG 73
Query: 142 RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI---------------LDFFQ 186
            H N+I ++ +C    +  L +EY PHG+L   L  S  +               L   Q
Sbjct: 74  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 133
Query: 187 RLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
            LH   DVA  ++YL    S    IH DL + N+L+ +N VA
Sbjct: 134 LLHFAADVARGMDYL----SQKQFIHRDLAARNILVGENYVA 171

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 12/160 (7%)
Query: 74  SFNTLEGKIPRPFRN-FLEVFNLISRGGFGSIYKAR---IQDGMEVVVKGFNLQYGGA-- 127
           S    E + P  F    L+    + +G FGS+   R   +QD    VV    LQ+     
Sbjct: 2   SSGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH 61
Query: 128 FKNLDVECNMMKIIRHQNLIKIISSCSKDDFK--ALILEYMPHGSLGKCLSTSNYILDFF 185
            ++ + E  ++K ++H N++K    C     +   LI+EY+P+GSL   L      +D  
Sbjct: 62  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 121
Query: 186 QRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
           + L     +   +EYL     T   IH DL + N+L+++ 
Sbjct: 122 KLLQYTSQICKGMEYL----GTKRYIHRDLATRNILVENE 157

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 12/158 (7%)
Query: 76  NTLEGKIPRPFRN-FLEVFNLISRGGFGSIYKAR---IQDGMEVVVKGFNLQYGGA--FK 129
           +  E + P  F    L+    + +G FGS+   R   +QD    VV    LQ+      +
Sbjct: 28  SAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLR 87
Query: 130 NLDVECNMMKIIRHQNLIKIISSCSKDDFK--ALILEYMPHGSLGKCLSTSNYILDFFQR 187
           + + E  ++K ++H N++K    C     +   LI+EY+P+GSL   L      +D  + 
Sbjct: 88  DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL 147
Query: 188 LHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
           L     +   +EYL     T   IH DL + N+L+++ 
Sbjct: 148 LQYTSQICKGMEYL----GTKRYIHRDLATRNILVENE 181

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 12/157 (7%)
Query: 77  TLEGKIPRPFRN-FLEVFNLISRGGFGSIYKAR---IQDGMEVVVKGFNLQYGGA--FKN 130
             E + P  F    L+    + +G FGS+   R   +QD    VV    LQ+      ++
Sbjct: 2   AFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 61
Query: 131 LDVECNMMKIIRHQNLIKIISSCSKDDFK--ALILEYMPHGSLGKCLSTSNYILDFFQRL 188
            + E  ++K ++H N++K    C     +   LI+EY+P+GSL   L      +D  + L
Sbjct: 62  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 121
Query: 189 HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
                +   +EYL     T   IH DL + N+L+++ 
Sbjct: 122 QYTSQICKGMEYL----GTKRYIHRDLATRNILVENE 154

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 12/157 (7%)
Query: 77  TLEGKIPRPFRN-FLEVFNLISRGGFGSIYKAR---IQDGMEVVVKGFNLQYGGA--FKN 130
             E + P  F    L+    + +G FGS+   R   +QD    VV    LQ+      ++
Sbjct: 3   AFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 62
Query: 131 LDVECNMMKIIRHQNLIKIISSCSKDDFK--ALILEYMPHGSLGKCLSTSNYILDFFQRL 188
            + E  ++K ++H N++K    C     +   LI+EY+P+GSL   L      +D  + L
Sbjct: 63  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 122
Query: 189 HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
                +   +EYL     T   IH DL + N+L+++ 
Sbjct: 123 QYTSQICKGMEYL----GTKRYIHRDLATRNILVENE 155

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 12/157 (7%)
Query: 77  TLEGKIPRPFRN-FLEVFNLISRGGFGSIYKAR---IQDGMEVVVKGFNLQYGGA--FKN 130
             E + P  F    L+    + +G FGS+   R   +QD    VV    LQ+      ++
Sbjct: 4   AFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 63
Query: 131 LDVECNMMKIIRHQNLIKIISSCSKDDFK--ALILEYMPHGSLGKCLSTSNYILDFFQRL 188
            + E  ++K ++H N++K    C     +   LI+EY+P+GSL   L      +D  + L
Sbjct: 64  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 123
Query: 189 HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
                +   +EYL     T   IH DL + N+L+++ 
Sbjct: 124 QYTSQICKGMEYL----GTKRYIHRDLATRNILVENE 156

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 79  EGKIPRPFRN-FLEVFNLISRGGFGSIYKAR---IQDGMEVVVKGFNLQYGGA--FKNLD 132
           E + P  F    L+    + +G FGS+   R   +QD    VV    LQ+      ++ +
Sbjct: 3   EDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFE 62
Query: 133 VECNMMKIIRHQNLIKIISSCSKDDFK--ALILEYMPHGSLGKCLSTSNYILDFFQRLHI 190
            E  ++K ++H N++K    C     +   LI+EY+P+GSL   L      +D  + L  
Sbjct: 63  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 122
Query: 191 MIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
              +   +EYL     T   IH DL + N+L+++ 
Sbjct: 123 TSQICKGMEYL----GTKRYIHRDLATRNILVENE 153

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 18/160 (11%)
Query: 80  GKIPRPFRNF-------LEVFNLISRGGFGSIYKAR---IQDGMEVVVKGFNLQYGGA-- 127
           G +PR   N        L+    + +G FGS+   R   +QD    VV    LQ+     
Sbjct: 13  GLVPRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH 72
Query: 128 FKNLDVECNMMKIIRHQNLIKIISSCSKDDFK--ALILEYMPHGSLGKCLSTSNYILDFF 185
            ++ + E  ++K ++H N++K    C     +   LI+EY+P+GSL   L      +D  
Sbjct: 73  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 132
Query: 186 QRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
           + L     +   +EYL     T   IH DL + N+L+++ 
Sbjct: 133 KLLQYTSQICKGMEYL----GTKRYIHRDLATRNILVENE 168

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 18/160 (11%)
Query: 80  GKIPRPFRNF-------LEVFNLISRGGFGSIYKAR---IQDGMEVVVKGFNLQYGGA-- 127
           G +PR   N        L+    + +G FGS+   R   +QD    VV    LQ+     
Sbjct: 13  GLVPRGSHNMTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH 72
Query: 128 FKNLDVECNMMKIIRHQNLIKIISSCSKDDFK--ALILEYMPHGSLGKCLSTSNYILDFF 185
            ++ + E  ++K ++H N++K    C     +   LI+EY+P+GSL   L      +D  
Sbjct: 73  LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 132
Query: 186 QRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
           + L     +   +EYL     T   IH DL + N+L+++ 
Sbjct: 133 KLLQYTSQICKGMEYL----GTKRYIHRDLATRNILVENE 168

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 71/157 (45%), Gaps = 12/157 (7%)
Query: 77  TLEGKIPRPFRN-FLEVFNLISRGGFGSIYKAR---IQDGMEVVVKGFNLQYGGA--FKN 130
             E + P  F    L+    + +G FGS+   R   +QD    VV    LQ+      ++
Sbjct: 1   AFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 60
Query: 131 LDVECNMMKIIRHQNLIKIISSCSKDDFK--ALILEYMPHGSLGKCLSTSNYILDFFQRL 188
            + E  ++K ++H N++K    C     +   LI+EY+P+GSL   L      +D  + L
Sbjct: 61  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLL 120
Query: 189 HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
                +   +EYL     T   IH DL + N+L+++ 
Sbjct: 121 QYTSQICKGMEYL----GTKRYIHRDLATRNILVENE 153

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 80  GKIPRPFRN-FLEVFNLISRGGFGSIYKAR---IQDGMEVVVKGFNLQYGGA--FKNLDV 133
           G  P  F    L+    + +G FGS+   R   +QD    VV    LQ+      ++ + 
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFK--ALILEYMPHGSLGKCLSTSNYILDFFQRLHIM 191
           E  ++K ++H N++K    C     +   LI+EY+P+GSL   L      +D  + L   
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 192 IDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
             +   +EYL     T   IH DL + N+L+++ 
Sbjct: 121 SQICKGMEYL----GTKRYIHRDLATRNILVENE 150

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 11/143 (7%)
Query: 90  LEVFNLISRGGFGSIYKAR---IQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQ 144
           L+    + +G FGS+   R   +QD    VV    LQ+      ++ + E  ++K ++H 
Sbjct: 11  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 70
Query: 145 NLIKIISSCSKDDFK--ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH 202
           N++K    C     +   LI+EY+P+GSL   L      +D  + L     +   +EYL 
Sbjct: 71  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL- 129
Query: 203 FGHSTHVIIHCDLKSSNVLLDDN 225
               T   IH DL + N+L+++ 
Sbjct: 130 ---GTKRYIHRDLATRNILVENE 149

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 11/143 (7%)
Query: 90  LEVFNLISRGGFGSIYKAR---IQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQ 144
           L+    + +G FGS+   R   +QD    VV    LQ+      ++ + E  ++K ++H 
Sbjct: 12  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 71
Query: 145 NLIKIISSCSKDDFK--ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH 202
           N++K    C     +   LI+EY+P+GSL   L      +D  + L     +   +EYL 
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL- 130
Query: 203 FGHSTHVIIHCDLKSSNVLLDDN 225
               T   IH DL + N+L+++ 
Sbjct: 131 ---GTKRYIHRDLATRNILVENE 150

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 80  GKIPRPFRN-FLEVFNLISRGGFGSIYKAR---IQDGMEVVVKGFNLQYGGA--FKNLDV 133
           G  P  F    L+    + +G FGS+   R   +QD    VV    LQ+      ++ + 
Sbjct: 1   GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFK--ALILEYMPHGSLGKCLSTSNYILDFFQRLHIM 191
           E  ++K ++H N++K    C     +   LI+EY+P+GSL   L      +D  + L   
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 192 IDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
             +   +EYL     T   IH DL + N+L+++ 
Sbjct: 121 SQICKGMEYL----GTKRYIHRDLATRNILVENE 150

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 75/167 (44%), Gaps = 36/167 (21%)
Query: 88  NFLEVFNLISRGGFGSIYKARIQ-DGM----------EVVVKGFNLQYGGAFKNLDVECN 136
           N ++  ++I  G FG + KARI+ DG+          E   K  +  + G    L+V C 
Sbjct: 22  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG---ELEVLC- 77
Query: 137 MMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI--------------- 181
             K+  H N+I ++ +C    +  L +EY PHG+L   L  S  +               
Sbjct: 78  --KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 135
Query: 182 LDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
           L   Q LH   DVA  ++YL    S    IH +L + N+L+ +N VA
Sbjct: 136 LSSQQLLHFAADVARGMDYL----SQKQFIHRNLAARNILVGENYVA 178

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 11/143 (7%)
Query: 90  LEVFNLISRGGFGSIYKAR---IQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQ 144
           L+    + +G FGS+   R   +QD    VV    LQ+      ++ + E  ++K ++H 
Sbjct: 10  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 69
Query: 145 NLIKIISSCSKDDFK--ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH 202
           N++K    C     +   LI+EY+P+GSL   L      +D  + L     +   +EYL 
Sbjct: 70  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL- 128
Query: 203 FGHSTHVIIHCDLKSSNVLLDDN 225
               T   IH DL + N+L+++ 
Sbjct: 129 ---GTKRYIHRDLATRNILVENE 148

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/145 (25%), Positives = 70/145 (48%), Gaps = 12/145 (8%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQD-----GMEVVVKGFNLQYGG-AFKNLDVECNMMKI 140
           + FL+    +  G FG +   R        G +V VK    + GG    +L  E  +++ 
Sbjct: 20  KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRN 79
Query: 141 IRHQNLIKIISSCSKDDFKA--LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV 198
           + H+N++K    C++D      LI+E++P GSL + L  +   ++  Q+L   + +   +
Sbjct: 80  LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139
Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLD 223
           +YL     +   +H DL + NVL++
Sbjct: 140 DYL----GSRQYVHRDLAARNVLVE 160

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/145 (25%), Positives = 70/145 (48%), Gaps = 12/145 (8%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQD-----GMEVVVKGFNLQYGG-AFKNLDVECNMMKI 140
           + FL+    +  G FG +   R        G +V VK    + GG    +L  E  +++ 
Sbjct: 8   KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRN 67
Query: 141 IRHQNLIKIISSCSKDDFKA--LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV 198
           + H+N++K    C++D      LI+E++P GSL + L  +   ++  Q+L   + +   +
Sbjct: 68  LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGM 127
Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLD 223
           +YL     +   +H DL + NVL++
Sbjct: 128 DYL----GSRQYVHRDLAARNVLVE 148

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 72/157 (45%), Gaps = 12/157 (7%)
Query: 77  TLEGKIPRPFRN-FLEVFNLISRGGFGSIYKAR---IQDGMEVVVKGFNLQYGGA--FKN 130
             E + P  F    L+    + +G FGS+   R   +QD    VV    LQ+      ++
Sbjct: 1   AFEDRDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD 60
Query: 131 LDVECNMMKIIRHQNLIKIISSCSKDDFK--ALILEYMPHGSLGKCLSTSNYILDFFQRL 188
            + E  ++K ++H N++K    C     +   LI+E++P+GSL + L      +D  + L
Sbjct: 61  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLL 120
Query: 189 HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
                +   +EYL     T   IH DL + N+L+++ 
Sbjct: 121 QYTSQICKGMEYL----GTKRYIHRDLATRNILVENE 153

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 64/140 (45%), Gaps = 9/140 (6%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVK---GFNLQYGGAFKNLDVECNMMKIIRHQNLIKII 150
           N    GGFG +YK  + +    V K     ++      +  D E  +    +H+NL++++
Sbjct: 28  NKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELL 87
Query: 151 SSCSKDDFKALILEYMPHGSLGKCLS--TSNYILDFFQRLHIMIDVASAVEYLHFGHSTH 208
              S  D   L+  Y P+GSL   LS       L +  R  I    A+ + +LH  H   
Sbjct: 88  GFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH-- 145
Query: 209 VIIHCDLKSSNVLLDDNMVA 228
             IH D+KS+N+LLD+   A
Sbjct: 146 --IHRDIKSANILLDEAFTA 163

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 8/132 (6%)
Query: 102 GSIYKARIQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMKIIRHQNLIKIISSCSKD--D 157
           G ++K R Q G ++VVK   ++     K+ D   EC  ++I  H N++ ++ +C      
Sbjct: 24  GELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82
Query: 158 FKALILEYMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLK 216
              LI  + P+GSL   L   +N+++D  Q +   +D A    +LH      +I    L 
Sbjct: 83  HPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHTLEP--LIPRHALN 140
Query: 217 SSNVLLDDNMVA 228
           S +V +D++  A
Sbjct: 141 SRSVXIDEDXTA 152

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 67/143 (46%), Gaps = 11/143 (7%)
Query: 90  LEVFNLISRGGFGSIYKAR---IQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQ 144
           L+    + +G FGS+   R   +QD    VV    LQ+      ++ + E  ++K ++H 
Sbjct: 13  LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD 72
Query: 145 NLIKIISSCSKDDFK--ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH 202
           N++K    C     +   LI+EY+P+GSL   L      +D  + L     +   +EYL 
Sbjct: 73  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL- 131
Query: 203 FGHSTHVIIHCDLKSSNVLLDDN 225
               T   IH +L + N+L+++ 
Sbjct: 132 ---GTKRYIHRNLATRNILVENE 151

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 72/150 (48%), Gaps = 12/150 (8%)
Query: 81  KIPRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNL-------QYGGAFKNLD 132
           ++P    N +E    I +GGFG ++K R ++D   V +K   L       +    F+   
Sbjct: 12  RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71
Query: 133 VECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMI 192
            E  +M  + H N++K+           +++E++P G L   L    + + +  +L +M+
Sbjct: 72  REVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLML 129
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLL 222
           D+A  +EY+   +    I+H DL+S N+ L
Sbjct: 130 DIALGIEYMQ--NQNPPIVHRDLRSPNIFL 157

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 72/150 (48%), Gaps = 12/150 (8%)
Query: 81  KIPRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNL-------QYGGAFKNLD 132
           ++P    N +E    I +GGFG ++K R ++D   V +K   L       +    F+   
Sbjct: 12  RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71
Query: 133 VECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMI 192
            E  +M  + H N++K+           +++E++P G L   L    + + +  +L +M+
Sbjct: 72  REVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLML 129
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLL 222
           D+A  +EY+   +    I+H DL+S N+ L
Sbjct: 130 DIALGIEYMQ--NQNPPIVHRDLRSPNIFL 157

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/150 (25%), Positives = 72/150 (48%), Gaps = 12/150 (8%)
Query: 81  KIPRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNL-------QYGGAFKNLD 132
           ++P    N +E    I +GGFG ++K R ++D   V +K   L       +    F+   
Sbjct: 12  RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71
Query: 133 VECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMI 192
            E  +M  + H N++K+           +++E++P G L   L    + + +  +L +M+
Sbjct: 72  REVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLML 129
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLL 222
           D+A  +EY+   +    I+H DL+S N+ L
Sbjct: 130 DIALGIEYMQ--NQNPPIVHRDLRSPNIFL 157

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 8/134 (5%)
Query: 96  ISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISS 152
           I +G F  +  AR I  G EV VK  +       + + L  E  +MK++ H N++K+   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 153 CSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIH 212
              +    L++EY   G +   L    ++ +   R      + SAV+Y H       I+H
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCH----QKFIVH 129
Query: 213 CDLKSSNVLLDDNM 226
            DLK+ N+LLD +M
Sbjct: 130 RDLKAENLLLDADM 143

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 63/153 (41%), Gaps = 25/153 (16%)
Query: 96  ISRGGFGSIYKAR------IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           +  G FG ++ A        +D M V VK        A K+   E  ++  ++H++++K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLST---------------SNYILDFFQRLHIMIDV 194
              C   D   ++ EYM HG L K L                 +   L   Q LHI   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           AS + YL   H     +H DL + N L+  N++
Sbjct: 143 ASGMVYLASQH----FVHRDLATRNCLVGANLL 171

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 63/145 (43%), Gaps = 9/145 (6%)
Query: 85  PFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIR 142
           PF   LE+  LI +G FG +Y  R     EV ++  +++       K    E    +  R
Sbjct: 31  PFEQ-LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTR 87
Query: 143 HQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH 202
           H+N++  + +C      A+I       +L   +  +  +LD  +   I  ++   + YLH
Sbjct: 88  HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH 147
Query: 203 FGHSTHVIIHCDLKSSNVLLDDNMV 227
                  I+H DLKS NV  D+  V
Sbjct: 148 ----AKGILHKDLKSKNVFYDNGKV 168

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 69/141 (48%), Gaps = 8/141 (5%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDV-ECNMMKIIRHQNLIKIISS 152
            ++ +G FG   K   ++  EV+V    +++    +   + E  +M+ + H N++K I  
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 153 CSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIH 212
             KD     I EY+  G+L   + + +    + QR+    D+AS + YLH    +  IIH
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH----SMNIIH 131
Query: 213 CDLKSSNVLLDDN---MVAHF 230
            DL S N L+ +N   +VA F
Sbjct: 132 RDLNSHNCLVRENKNVVVADF 152

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/140 (25%), Positives = 69/140 (49%), Gaps = 8/140 (5%)
Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFN---LQYGGAFKNLDVECNMMKIIRHQNL 146
           +V NL+ +G F  +Y+A  I  G+EV +K  +   +   G  + +  E  +   ++H ++
Sbjct: 14  KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSI 73
Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHS 206
           +++ +     ++  L+LE   +G + + L          +  H M  + + + YLH    
Sbjct: 74  LELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---- 129
Query: 207 THVIIHCDLKSSNVLLDDNM 226
           +H I+H DL  SN+LL  NM
Sbjct: 130 SHGILHRDLTLSNLLLTRNM 149

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/150 (26%), Positives = 64/150 (42%), Gaps = 22/150 (14%)
Query: 96  ISRGGFGSIYKARI------QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           +  G FG ++ A        QD + V VK        A K+   E  ++  ++H++++K 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSN------------YILDFFQRLHIMIDVASA 197
              C + D   ++ EYM HG L K L                  L   Q LHI   +A+ 
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 198 VEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           + YL   H     +H DL + N L+ +N++
Sbjct: 141 MVYLASQH----FVHRDLATRNCLVGENLL 166

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 66/136 (48%), Gaps = 13/136 (9%)
Query: 96  ISRGGFGSIYKARIQDGMEV----VVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIIS 151
           I  G FG++YK +    + V    VV     Q+  AF+N   E  +++  RH N++  + 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQ-AFRN---EVAVLRKTRHVNILLFMG 99
Query: 152 SCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVII 211
             +KD+  A++ ++    SL K L         FQ + I    A  ++YLH  +    II
Sbjct: 100 YMTKDNL-AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN----II 154
Query: 212 HCDLKSSNVLLDDNMV 227
           H D+KS+N+ L + + 
Sbjct: 155 HRDMKSNNIFLHEGLT 170

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 51.2 bits (121), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 77/150 (51%), Gaps = 16/150 (10%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           L++  + +RG FG ++KA++ +   V VK F +Q   +++N + E   +  ++H+N+++ 
Sbjct: 26  LQLLEVKARGRFGCVWKAQLLNEY-VAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQF 83
Query: 150 ISS----CSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHF-- 203
           I +     S D    LI  +   GSL   L  +  ++ + +  HI   +A  + YLH   
Sbjct: 84  IGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDI 141
Query: 204 -----GHSTHVIIHCDLKSSNVLLDDNMVA 228
                GH    I H D+KS NVLL +N+ A
Sbjct: 142 PGLKDGHKP-AISHRDIKSKNVLLKNNLTA 170

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 10/136 (7%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           +EV  ++ RG FG + KA+ +   +V +K   ++     K   VE   +  + H N++K+
Sbjct: 11  IEVEEVVGRGAFGVVCKAKWR-AKDVAIK--QIESESERKAFIVELRQLSRVNHPNIVKL 67
Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIM---IDVASAVEYLHFGHS 206
             +C       L++EY   GSL   L  +   L ++   H M   +  +  V YLH    
Sbjct: 68  YGACLNP--VCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLH-SMQ 123
Query: 207 THVIIHCDLKSSNVLL 222
              +IH DLK  N+LL
Sbjct: 124 PKALIHRDLKPPNLLL 139

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/136 (28%), Positives = 64/136 (47%), Gaps = 10/136 (7%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           +EV  ++ RG FG + KA+ +   +V +K   ++     K   VE   +  + H N++K+
Sbjct: 10  IEVEEVVGRGAFGVVCKAKWR-AKDVAIK--QIESESERKAFIVELRQLSRVNHPNIVKL 66
Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIM---IDVASAVEYLHFGHS 206
             +C       L++EY   GSL   L  +   L ++   H M   +  +  V YLH    
Sbjct: 67  YGACLNP--VCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLH-SMQ 122
Query: 207 THVIIHCDLKSSNVLL 222
              +IH DLK  N+LL
Sbjct: 123 PKALIHRDLKPPNLLL 138

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 62/134 (46%), Gaps = 8/134 (5%)
Query: 96  ISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISS 152
           I +G F  +  AR I  G EV VK  +       + + L  E  +MK++ H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 153 CSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIH 212
              +    L++EY   G +   L     + +   R      + SAV+Y H       I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH----QKFIVH 136
Query: 213 CDLKSSNVLLDDNM 226
            DLK+ N+LLD +M
Sbjct: 137 RDLKAENLLLDADM 150

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 68/148 (45%), Gaps = 18/148 (12%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKI--IRHQNLI 147
           L++  LI RG +G++YK  + D   V VK F+      F N   E N+ ++  + H N+ 
Sbjct: 15  LKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFIN---EKNIYRVPLMEHDNIA 70
Query: 148 KIISSCSKDDFKA-----LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH 202
           + I    +          L++EY P+GSL K LS   +  D+     +   V   + YLH
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLH 128
Query: 203 F-----GHSTHVIIHCDLKSSNVLLDDN 225
                  H    I H DL S NVL+ ++
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKND 156

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 62/134 (46%), Gaps = 8/134 (5%)
Query: 96  ISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISS 152
           I +G F  +  AR I  G EV VK  +       + + L  E  +MK++ H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 153 CSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIH 212
              +    L++EY   G +   L     + +   R      + SAV+Y H       I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH----QKFIVH 136
Query: 213 CDLKSSNVLLDDNM 226
            DLK+ N+LLD +M
Sbjct: 137 RDLKAENLLLDADM 150

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 62/134 (46%), Gaps = 8/134 (5%)
Query: 96  ISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISS 152
           I +G F  +  AR I  G EV VK  +       + + L  E  +MK++ H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 153 CSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIH 212
              +    L++EY   G +   L     + +   R      + SAV+Y H       I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH----QKFIVH 136
Query: 213 CDLKSSNVLLDDNM 226
            DLK+ N+LLD +M
Sbjct: 137 RDLKAENLLLDADM 150

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 16/152 (10%)
Query: 79  EGKIPRPFRNFLEVFNLISR---GGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVEC 135
           E ++PR      E   L+ R   G FG ++        +V VK    Q   +      E 
Sbjct: 16  EWEVPR------ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEA 68
Query: 136 NMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI-LDFFQRLHIMIDV 194
           N+MK ++HQ L+++ +  +++    +I EYM +GSL   L T + I L   + L +   +
Sbjct: 69  NLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 127
Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           A  + ++         IH DL+++N+L+ D +
Sbjct: 128 AEGMAFIE----ERNYIHRDLRAANILVSDTL 155

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 16/152 (10%)
Query: 79  EGKIPRPFRNFLEVFNLISR---GGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVEC 135
           E ++PR      E   L+ R   G FG ++        +V VK    Q   +      E 
Sbjct: 7   EWEVPR------ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEA 59
Query: 136 NMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI-LDFFQRLHIMIDV 194
           N+MK ++HQ L+++ +  +++    +I EYM +GSL   L T + I L   + L +   +
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           A  + ++         IH DL+++N+L+ D +
Sbjct: 119 AEGMAFIE----ERNYIHRDLRAANILVSDTL 146

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 16/152 (10%)
Query: 79  EGKIPRPFRNFLEVFNLISR---GGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVEC 135
           E ++PR      E   L+ R   G FG ++        +V VK    Q   +      E 
Sbjct: 12  EWEVPR------ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEA 64
Query: 136 NMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI-LDFFQRLHIMIDV 194
           N+MK ++HQ L+++ +  +++    +I EYM +GSL   L T + I L   + L +   +
Sbjct: 65  NLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 123
Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           A  + ++         IH DL+++N+L+ D +
Sbjct: 124 AEGMAFIE----ERNYIHRDLRAANILVSDTL 151

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 16/152 (10%)
Query: 79  EGKIPRPFRNFLEVFNLISR---GGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVEC 135
           E ++PR      E   L+ R   G FG ++        +V VK    Q   +      E 
Sbjct: 13  EWEVPR------ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEA 65
Query: 136 NMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI-LDFFQRLHIMIDV 194
           N+MK ++HQ L+++ +  +++    +I EYM +GSL   L T + I L   + L +   +
Sbjct: 66  NLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 124
Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           A  + ++         IH DL+++N+L+ D +
Sbjct: 125 AEGMAFIE----ERNYIHRDLRAANILVSDTL 152

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 16/152 (10%)
Query: 79  EGKIPRPFRNFLEVFNLISR---GGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVEC 135
           E ++PR      E   L+ R   G FG ++        +V VK    Q   +      E 
Sbjct: 2   EWEVPR------ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEA 54
Query: 136 NMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI-LDFFQRLHIMIDV 194
           N+MK ++HQ L+++ +  +++    +I EYM +GSL   L T + I L   + L +   +
Sbjct: 55  NLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 113
Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           A  + ++         IH DL+++N+L+ D +
Sbjct: 114 AEGMAFIE----ERNYIHRDLRAANILVSDTL 141

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 16/152 (10%)
Query: 79  EGKIPRPFRNFLEVFNLISR---GGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVEC 135
           E ++PR      E   L+ R   G FG ++        +V VK    Q   +      E 
Sbjct: 7   EWEVPR------ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEA 59
Query: 136 NMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI-LDFFQRLHIMIDV 194
           N+MK ++HQ L+++ +  +++    +I EYM +GSL   L T + I L   + L +   +
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           A  + ++         IH DL+++N+L+ D +
Sbjct: 119 AEGMAFIE----ERNYIHRDLRAANILVSDTL 146

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 16/152 (10%)
Query: 79  EGKIPRPFRNFLEVFNLISR---GGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVEC 135
           E ++PR      E   L+ R   G FG ++        +V VK    Q   +      E 
Sbjct: 9   EWEVPR------ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEA 61
Query: 136 NMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI-LDFFQRLHIMIDV 194
           N+MK ++HQ L+++ +  +++    +I EYM +GSL   L T + I L   + L +   +
Sbjct: 62  NLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 120
Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           A  + ++         IH DL+++N+L+ D +
Sbjct: 121 AEGMAFIE----ERNYIHRDLRAANILVSDTL 148

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 16/152 (10%)
Query: 79  EGKIPRPFRNFLEVFNLISR---GGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVEC 135
           E ++PR      E   L+ R   G FG ++        +V VK    Q   +      E 
Sbjct: 13  EWEVPR------ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEA 65
Query: 136 NMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI-LDFFQRLHIMIDV 194
           N+MK ++HQ L+++ +  +++    +I EYM +GSL   L T + I L   + L +   +
Sbjct: 66  NLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 124
Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           A  + ++         IH DL+++N+L+ D +
Sbjct: 125 AEGMAFIE----ERNYIHRDLRAANILVSDTL 152

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 16/152 (10%)
Query: 79  EGKIPRPFRNFLEVFNLISR---GGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVEC 135
           E ++PR      E   L+ R   G FG ++        +V VK    Q   +      E 
Sbjct: 8   EWEVPR------ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEA 60
Query: 136 NMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI-LDFFQRLHIMIDV 194
           N+MK ++HQ L+++ +  +++    +I EYM +GSL   L T + I L   + L +   +
Sbjct: 61  NLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 119
Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           A  + ++         IH DL+++N+L+ D +
Sbjct: 120 AEGMAFIE----ERNYIHRDLRAANILVSDTL 147

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 68/131 (51%), Gaps = 7/131 (5%)
Query: 93  FNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIIS 151
           F  I +G  G++Y A  +  G EV ++  NLQ     + +  E  +M+  ++ N++  + 
Sbjct: 25  FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 152 SCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVII 211
           S    D   +++EY+  GSL   ++ +   +D  Q   +  +   A+E+LH    ++ +I
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVI 138
Query: 212 HCDLKSSNVLL 222
           H D+KS N+LL
Sbjct: 139 HRDIKSDNILL 149

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 68/131 (51%), Gaps = 7/131 (5%)
Query: 93  FNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIIS 151
           F  I +G  G++Y A  +  G EV ++  NLQ     + +  E  +M+  ++ N++  + 
Sbjct: 25  FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 152 SCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVII 211
           S    D   +++EY+  GSL   ++ +   +D  Q   +  +   A+E+LH    ++ +I
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVI 138
Query: 212 HCDLKSSNVLL 222
           H D+KS N+LL
Sbjct: 139 HRDIKSDNILL 149

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 68/131 (51%), Gaps = 7/131 (5%)
Query: 93  FNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIIS 151
           F  I +G  G++Y A  +  G EV ++  NLQ     + +  E  +M+  ++ N++  + 
Sbjct: 25  FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 152 SCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVII 211
           S    D   +++EY+  GSL   ++ +   +D  Q   +  +   A+E+LH    ++ +I
Sbjct: 85  SYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVI 138
Query: 212 HCDLKSSNVLL 222
           H D+KS N+LL
Sbjct: 139 HRDIKSDNILL 149

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 16/152 (10%)
Query: 79  EGKIPRPFRNFLEVFNLISR---GGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVEC 135
           E ++PR      E   L+ R   G FG ++        +V VK    Q   +      E 
Sbjct: 7   EWEVPR------ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEA 59
Query: 136 NMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI-LDFFQRLHIMIDV 194
           N+MK ++HQ L+++ +  +++    +I EYM +GSL   L T + I L   + L +   +
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118
Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           A  + ++         IH DL+++N+L+ D +
Sbjct: 119 AEGMAFIE----ERNYIHRDLRAANILVSDTL 146

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 16/152 (10%)
Query: 79  EGKIPRPFRNFLEVFNLISR---GGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVEC 135
           E ++PR      E   L+ R   G FG ++        +V VK    Q   +      E 
Sbjct: 15  EWEVPR------ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEA 67
Query: 136 NMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI-LDFFQRLHIMIDV 194
           N+MK ++HQ L+++ +  +++    +I EYM +GSL   L T + I L   + L +   +
Sbjct: 68  NLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 126
Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           A  + ++         IH DL+++N+L+ D +
Sbjct: 127 AEGMAFIE----ERNYIHRDLRAANILVSDTL 154

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 70/139 (50%), Gaps = 14/139 (10%)
Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 154
           I +G FG +++ + + G EV VK F+  +    F+  ++   +M  +RH+N++  I++ +
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADN 106
Query: 155 KDDFKA----LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHF----GHS 206
           KD+       L+ +Y  HGSL   L+   Y +     + + +  AS + +LH        
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 164
Query: 207 THVIIHCDLKSSNVLLDDN 225
              I H DLKS N+L+  N
Sbjct: 165 KPAIAHRDLKSKNILVKKN 183

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 36/131 (27%), Positives = 68/131 (51%), Gaps = 7/131 (5%)
Query: 93  FNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIIS 151
           F  I +G  G++Y A  +  G EV ++  NLQ     + +  E  +M+  ++ N++  + 
Sbjct: 26  FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 85
Query: 152 SCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVII 211
           S    D   +++EY+  GSL   ++ +   +D  Q   +  +   A+E+LH    ++ +I
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVI 139
Query: 212 HCDLKSSNVLL 222
           H D+KS N+LL
Sbjct: 140 HRDIKSDNILL 150

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 16/152 (10%)
Query: 79  EGKIPRPFRNFLEVFNLISR---GGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVEC 135
           E ++PR      E   L+ R   G FG ++        +V VK    Q   +      E 
Sbjct: 17  EWEVPR------ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEA 69
Query: 136 NMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI-LDFFQRLHIMIDV 194
           N+MK ++HQ L+++ +  +++    +I EYM +GSL   L T + I L   + L +   +
Sbjct: 70  NLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 128
Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           A  + ++         IH DL+++N+L+ D +
Sbjct: 129 AEGMAFIE----ERNYIHRDLRAANILVSDTL 156

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 70/139 (50%), Gaps = 14/139 (10%)
Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 154
           I +G FG +++ + + G EV VK F+  +    F+  ++   +M  +RH+N++  I++ +
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADN 93
Query: 155 KDDFKA----LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHF----GHS 206
           KD+       L+ +Y  HGSL   L+   Y +     + + +  AS + +LH        
Sbjct: 94  KDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 151
Query: 207 THVIIHCDLKSSNVLLDDN 225
              I H DLKS N+L+  N
Sbjct: 152 KPAIAHRDLKSKNILVKKN 170

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 68/144 (47%), Gaps = 16/144 (11%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQ 144
           + V   I  G FG++YK +     +V VK  N+     Q   AFKN   E  +++  RH 
Sbjct: 14  ITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHV 68
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N++  +   +K    A++ ++    SL   L  S    +  + + I    A  ++YLH  
Sbjct: 69  NILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH-- 125
Query: 205 HSTHVIIHCDLKSSNVLL-DDNMV 227
                IIH DLKS+N+ L +DN V
Sbjct: 126 --AKSIIHRDLKSNNIFLHEDNTV 147

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 68/144 (47%), Gaps = 16/144 (11%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQ 144
           + V   I  G FG++YK +     +V VK  N+     Q   AFKN   E  +++  RH 
Sbjct: 26  ITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHV 80
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N++  +   +K    A++ ++    SL   L  S    +  + + I    A  ++YLH  
Sbjct: 81  NILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH-- 137
Query: 205 HSTHVIIHCDLKSSNVLL-DDNMV 227
                IIH DLKS+N+ L +DN V
Sbjct: 138 --AKSIIHRDLKSNNIFLHEDNTV 159

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 67/139 (48%), Gaps = 18/139 (12%)
Query: 100 GFGSIYKARIQD----GMEVVVKGFNLQYGGAFKNLDV------ECNMMKIIRHQNLIKI 149
           G G+  K +I +    G +V VK  N Q     ++LDV      E   +K+ RH ++IK+
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV 209
               S      +++EY+  G L   +     + +   R  +   + SAV+Y H     H+
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH----RHM 131
Query: 210 IIHCDLKSSNVLLDDNMVA 228
           ++H DLK  NVLLD +M A
Sbjct: 132 VVHRDLKPENVLLDAHMNA 150

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 62/134 (46%), Gaps = 8/134 (5%)
Query: 96  ISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISS 152
           I +G F  +  AR +  G EV VK  +       + + L  E  +MKI+ H N++K+   
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 153 CSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIH 212
              +    L++EY   G +   L     + +   R      + SAV+Y H       I+H
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH----QKYIVH 137
Query: 213 CDLKSSNVLLDDNM 226
            DLK+ N+LLD +M
Sbjct: 138 RDLKAENLLLDGDM 151

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 62/134 (46%), Gaps = 8/134 (5%)
Query: 96  ISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISS 152
           I +G F  +  AR I  G EV V+  +       + + L  E  +MK++ H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 153 CSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIH 212
              +    L++EY   G +   L     + +   R      + SAV+Y H       I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH----QKFIVH 136
Query: 213 CDLKSSNVLLDDNM 226
            DLK+ N+LLD +M
Sbjct: 137 RDLKAENLLLDADM 150

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 67/139 (48%), Gaps = 18/139 (12%)
Query: 100 GFGSIYKARIQD----GMEVVVKGFNLQYGGAFKNLDV------ECNMMKIIRHQNLIKI 149
           G G+  K +I +    G +V VK  N Q     ++LDV      E   +K+ RH ++IK+
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV 209
               S      +++EY+  G L   +     + +   R  +   + SAV+Y H     H+
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCH----RHM 131
Query: 210 IIHCDLKSSNVLLDDNMVA 228
           ++H DLK  NVLLD +M A
Sbjct: 132 VVHRDLKPENVLLDAHMNA 150

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 70/139 (50%), Gaps = 14/139 (10%)
Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 154
           I +G FG +++ + + G EV VK F+  +    F+  ++   +M  +RH+N++  I++ +
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADN 70
Query: 155 KDDFKA----LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHF----GHS 206
           KD+       L+ +Y  HGSL   L+   Y +     + + +  AS + +LH        
Sbjct: 71  KDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 128
Query: 207 THVIIHCDLKSSNVLLDDN 225
              I H DLKS N+L+  N
Sbjct: 129 KPAIAHRDLKSKNILVKKN 147

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 62/134 (46%), Gaps = 8/134 (5%)
Query: 96  ISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISS 152
           I +G F  +  AR I  G EV V+  +       + + L  E  +MK++ H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 153 CSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIH 212
              +    L++EY   G +   L     + +   R      + SAV+Y H       I+H
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCH----QKFIVH 136
Query: 213 CDLKSSNVLLDDNM 226
            DLK+ N+LLD +M
Sbjct: 137 RDLKAENLLLDADM 150

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 70/139 (50%), Gaps = 14/139 (10%)
Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 154
           I +G FG +++ + + G EV VK F+  +    F+  ++   +M  +RH+N++  I++ +
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADN 68
Query: 155 KDDFKA----LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHF----GHS 206
           KD+       L+ +Y  HGSL   L+   Y +     + + +  AS + +LH        
Sbjct: 69  KDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 126
Query: 207 THVIIHCDLKSSNVLLDDN 225
              I H DLKS N+L+  N
Sbjct: 127 KPAIAHRDLKSKNILVKKN 145

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 70/139 (50%), Gaps = 14/139 (10%)
Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 154
           I +G FG +++ + + G EV VK F+  +    F+  ++   +M  +RH+N++  I++ +
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADN 67
Query: 155 KDDFKA----LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHF----GHS 206
           KD+       L+ +Y  HGSL   L+   Y +     + + +  AS + +LH        
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125
Query: 207 THVIIHCDLKSSNVLLDDN 225
              I H DLKS N+L+  N
Sbjct: 126 KPAIAHRDLKSKNILVKKN 144

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 70/139 (50%), Gaps = 14/139 (10%)
Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS 154
           I +G FG +++ + + G EV VK F+  +    F+  ++   +M  +RH+N++  I++ +
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADN 73
Query: 155 KDDFKA----LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHF----GHS 206
           KD+       L+ +Y  HGSL   L+   Y +     + + +  AS + +LH        
Sbjct: 74  KDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGTQG 131
Query: 207 THVIIHCDLKSSNVLLDDN 225
              I H DLKS N+L+  N
Sbjct: 132 KPAIAHRDLKSKNILVKKN 150

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 63/138 (45%), Gaps = 8/138 (5%)
Query: 92  VFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIK 148
           +   I +G F  +  AR I  G EV +K  +       + + L  E  +MKI+ H N++K
Sbjct: 16  LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 75
Query: 149 IISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH 208
           +      +    LI+EY   G +   L     + +   R      + SAV+Y H      
Sbjct: 76  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH----QK 130
Query: 209 VIIHCDLKSSNVLLDDNM 226
            I+H DLK+ N+LLD +M
Sbjct: 131 RIVHRDLKAENLLLDADM 148

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 72/141 (51%), Gaps = 17/141 (12%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI---- 149
            +I  G FG +Y+A++ D  E+V     LQ G AFKN +++  +M+ + H N++++    
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-GKAFKNRELQ--IMRKLDHCNIVRLRYFF 82
Query: 150 ISSCSKDD--FKALILEYMPHG--SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-FG 204
            SS  K D  +  L+L+Y+P     + +  S +   L        M  +  ++ Y+H FG
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 205 HSTHVIIHCDLKSSNVLLDDN 225
                I H D+K  N+LLD +
Sbjct: 143 -----ICHRDIKPQNLLLDPD 158

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 72/141 (51%), Gaps = 17/141 (12%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI---- 149
            +I  G FG +Y+A++ D  E+V     LQ G AFKN +++  +M+ + H N++++    
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-GKAFKNRELQ--IMRKLDHCNIVRLRYFF 82
Query: 150 ISSCSKDD--FKALILEYMPHG--SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-FG 204
            SS  K D  +  L+L+Y+P     + +  S +   L        M  +  ++ Y+H FG
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 205 HSTHVIIHCDLKSSNVLLDDN 225
                I H D+K  N+LLD +
Sbjct: 143 -----ICHRDIKPQNLLLDPD 158

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 63/138 (45%), Gaps = 8/138 (5%)
Query: 92  VFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIK 148
           +   I +G F  +  AR I  G EV +K  +       + + L  E  +MKI+ H N++K
Sbjct: 19  LLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK 78
Query: 149 IISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH 208
           +      +    LI+EY   G +   L     + +   R      + SAV+Y H      
Sbjct: 79  LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVSAVQYCH----QK 133
Query: 209 VIIHCDLKSSNVLLDDNM 226
            I+H DLK+ N+LLD +M
Sbjct: 134 RIVHRDLKAENLLLDADM 151

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 66/137 (48%), Gaps = 15/137 (10%)
Query: 99  GGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDV------ECNMMKIIRHQNLIKIIS 151
           G FG +   + +  G +V VK  N Q     ++LDV      E   +K+ RH ++IK+  
Sbjct: 27  GTFGKVKVGKHELTGHKVAVKILNRQ---KIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 152 SCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVII 211
             S      +++EY+  G L   +   N  LD  +   +   + S V+Y H     H+++
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCH----RHMVV 138
Query: 212 HCDLKSSNVLLDDNMVA 228
           H DLK  NVLLD +M A
Sbjct: 139 HRDLKPENVLLDAHMNA 155

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/141 (29%), Positives = 72/141 (51%), Gaps = 17/141 (12%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI---- 149
            +I  G FG +Y+A++ D  E+V     LQ G AFKN +++  +M+ + H N++++    
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-GKAFKNRELQ--IMRKLDHCNIVRLRYFF 82
Query: 150 ISSCSKDD--FKALILEYMPHG--SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-FG 204
            SS  K D  +  L+L+Y+P     + +  S +   L        M  +  ++ Y+H FG
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 205 HSTHVIIHCDLKSSNVLLDDN 225
                I H D+K  N+LLD +
Sbjct: 143 -----ICHRDIKPQNLLLDPD 158

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/152 (23%), Positives = 64/152 (42%), Gaps = 24/152 (15%)
Query: 96  ISRGGFGSIYKARI------QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           +  G FG ++ A        QD M V VK        A ++   E  ++ +++HQ++++ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLST--------------SNYILDFFQRLHIMIDVA 195
              C++     ++ EYM HG L + L +              +   L   Q L +   VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 196 SAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           + + YL   H     +H DL + N L+   +V
Sbjct: 140 AGMVYLAGLH----FVHRDLATRNCLVGQGLV 167

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/152 (23%), Positives = 64/152 (42%), Gaps = 24/152 (15%)
Query: 96  ISRGGFGSIYKARI------QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           +  G FG ++ A        QD M V VK        A ++   E  ++ +++HQ++++ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLST--------------SNYILDFFQRLHIMIDVA 195
              C++     ++ EYM HG L + L +              +   L   Q L +   VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 196 SAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           + + YL   H     +H DL + N L+   +V
Sbjct: 146 AGMVYLAGLH----FVHRDLATRNCLVGQGLV 173

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/152 (23%), Positives = 64/152 (42%), Gaps = 24/152 (15%)
Query: 96  ISRGGFGSIYKARI------QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           +  G FG ++ A        QD M V VK        A ++   E  ++ +++HQ++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLST--------------SNYILDFFQRLHIMIDVA 195
              C++     ++ EYM HG L + L +              +   L   Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 196 SAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           + + YL   H     +H DL + N L+   +V
Sbjct: 169 AGMVYLAGLH----FVHRDLATRNCLVGQGLV 196

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 72/152 (47%), Gaps = 16/152 (10%)
Query: 79  EGKIPRPFRNFLEVFNLISR---GGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVEC 135
           E ++PR      E   L+ R   G FG ++        +V VK    Q   +      E 
Sbjct: 3   EWEVPR------ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEA 55
Query: 136 NMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI-LDFFQRLHIMIDV 194
           N+MK ++HQ L+++ +  +++    +I EYM +GSL   L T + I L   + L +   +
Sbjct: 56  NLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 114
Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           A  + ++         IH +L+++N+L+ D +
Sbjct: 115 AEGMAFIE----ERNYIHRNLRAANILVSDTL 142

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/131 (26%), Positives = 68/131 (51%), Gaps = 7/131 (5%)
Query: 93  FNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIIS 151
           F  I +G  G++Y A  +  G EV ++  NLQ     + +  E  +M+  ++ N++  + 
Sbjct: 26  FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 85
Query: 152 SCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVII 211
           S    D   +++EY+  GSL   ++ +   +D  Q   +  +   A+E+LH    ++ +I
Sbjct: 86  SYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVI 139
Query: 212 HCDLKSSNVLL 222
           H ++KS N+LL
Sbjct: 140 HRNIKSDNILL 150

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/144 (29%), Positives = 67/144 (46%), Gaps = 16/144 (11%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQ 144
           + V   I  G FG++YK +     +V VK  N+     Q   AFKN   E  +++  RH 
Sbjct: 26  ITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHV 80
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N++  +   +     A++ ++    SL   L  S    +  + + I    A  ++YLH  
Sbjct: 81  NILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH-- 137
Query: 205 HSTHVIIHCDLKSSNVLL-DDNMV 227
                IIH DLKS+N+ L +DN V
Sbjct: 138 --AKSIIHRDLKSNNIFLHEDNTV 159

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 67/140 (47%), Gaps = 10/140 (7%)
Query: 94  NLISRGGFGSIYKARIQDG---MEVVVKGFNLQYGGAFKN-LDV--ECNMMKIIRHQNLI 147
            +I  G FG +YK  ++      EV V    L+ G   K  +D   E  +M    H N+I
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           ++    SK     +I EYM +G+L K L   +      Q + ++  +A+ ++YL    + 
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL----AN 165
Query: 208 HVIIHCDLKSSNVLLDDNMV 227
              +H DL + N+L++ N+V
Sbjct: 166 MNYVHRDLAARNILVNSNLV 185

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 66/143 (46%), Gaps = 15/143 (10%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQ 144
           + V   I  G FG++YK +     +V VK  N+     Q   AFKN   E  +++  RH 
Sbjct: 38  ITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHV 92
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N++  +   +K    A++ ++    SL   L       +  + + I    A  ++YLH  
Sbjct: 93  NILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-- 149
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
                IIH DLKS+N+ L +++ 
Sbjct: 150 --AKSIIHRDLKSNNIFLHEDLT 170

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 69/145 (47%), Gaps = 26/145 (17%)
Query: 91  EVFNLISR---GGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRH---- 143
           EVF+++ +   G +GS+YKA  ++  ++V          A K + VE ++ +II+     
Sbjct: 29  EVFDVLEKLGEGSYGSVYKAIHKETGQIV----------AIKQVPVESDLQEIIKEISIM 78
Query: 144 -----QNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV 198
                 +++K   S  K+    +++EY   GS+   +   N  L   +   I+      +
Sbjct: 79  QQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGL 138
Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLD 223
           EYLHF       IH D+K+ N+LL+
Sbjct: 139 EYLHFMRK----IHRDIKAGNILLN 159

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 66/143 (46%), Gaps = 15/143 (10%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQ 144
           + V   I  G FG++YK +     +V VK  N+     Q   AFKN   E  +++  RH 
Sbjct: 37  ITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHV 91
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N++  +   +K    A++ ++    SL   L       +  + + I    A  ++YLH  
Sbjct: 92  NILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-- 148
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
                IIH DLKS+N+ L +++ 
Sbjct: 149 --AKSIIHRDLKSNNIFLHEDLT 169

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 66/143 (46%), Gaps = 15/143 (10%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQ 144
           + V   I  G FG++YK +     +V VK  N+     Q   AFKN   E  +++  RH 
Sbjct: 15  ITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHV 69
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N++  +   +K    A++ ++    SL   L       +  + + I    A  ++YLH  
Sbjct: 70  NILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-- 126
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
                IIH DLKS+N+ L +++ 
Sbjct: 127 --AKSIIHRDLKSNNIFLHEDLT 147

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 66/143 (46%), Gaps = 15/143 (10%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQ 144
           + V   I  G FG++YK +     +V VK  N+     Q   AFKN   E  +++  RH 
Sbjct: 15  ITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHV 69
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N++  +   +K    A++ ++    SL   L       +  + + I    A  ++YLH  
Sbjct: 70  NILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-- 126
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
                IIH DLKS+N+ L +++ 
Sbjct: 127 --AKSIIHRDLKSNNIFLHEDLT 147

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 66/143 (46%), Gaps = 15/143 (10%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQ 144
           + V   I  G FG++YK +     +V VK  N+     Q   AFKN   E  +++  RH 
Sbjct: 12  ITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHV 66
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N++  +   +K    A++ ++    SL   L       +  + + I    A  ++YLH  
Sbjct: 67  NILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-- 123
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
                IIH DLKS+N+ L +++ 
Sbjct: 124 --AKSIIHRDLKSNNIFLHEDLT 144

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 66/143 (46%), Gaps = 15/143 (10%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQ 144
           + V   I  G FG++YK +     +V VK  N+     Q   AFKN   E  +++  RH 
Sbjct: 38  ITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHV 92
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N++  +   +K    A++ ++    SL   L       +  + + I    A  ++YLH  
Sbjct: 93  NILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-- 149
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
                IIH DLKS+N+ L +++ 
Sbjct: 150 --AKSIIHRDLKSNNIFLHEDLT 170

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 66/143 (46%), Gaps = 15/143 (10%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQ 144
           + V   I  G FG++YK +     +V VK  N+     Q   AFKN   E  +++  RH 
Sbjct: 30  ITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHV 84
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N++  +   +K    A++ ++    SL   L       +  + + I    A  ++YLH  
Sbjct: 85  NILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-- 141
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
                IIH DLKS+N+ L +++ 
Sbjct: 142 --AKSIIHRDLKSNNIFLHEDLT 162

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 66/143 (46%), Gaps = 15/143 (10%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQ 144
           + V   I  G FG++YK +     +V VK  N+     Q   AFKN   E  +++  RH 
Sbjct: 10  ITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHV 64
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N++  +   +K    A++ ++    SL   L       +  + + I    A  ++YLH  
Sbjct: 65  NILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-- 121
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
                IIH DLKS+N+ L +++ 
Sbjct: 122 --AKSIIHRDLKSNNIFLHEDLT 142

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 66/143 (46%), Gaps = 15/143 (10%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQ 144
           + V   I  G FG++YK +     +V VK  N+     Q   AFKN   E  +++  RH 
Sbjct: 10  ITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHV 64
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N++  +   +K    A++ ++    SL   L       +  + + I    A  ++YLH  
Sbjct: 65  NILLFMGYSTKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-- 121
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
                IIH DLKS+N+ L +++ 
Sbjct: 122 --AKSIIHRDLKSNNIFLHEDLT 142

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 16/145 (11%)
Query: 90  LEVFNL---ISRGGFGSIYKARIQD-----GMEVVVKGFNLQYGGAFKNLDVECNMMKII 141
           LE F++   + +G FG++Y AR +       ++V+ K   L+  G    L  E  +   +
Sbjct: 11  LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKT-QLEKAGVEHQLRREVEIQSHL 69
Query: 142 RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMI-DVASAVEY 200
           RH N++++           LILEY P G++ + L   +   +  QR    I ++A+A+ Y
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE--QRTATYITELANALSY 127
Query: 201 LHFGHSTHVIIHCDLKSSNVLLDDN 225
            H    +  +IH D+K  N+LL  N
Sbjct: 128 CH----SKRVIHRDIKPENLLLGSN 148

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNY-ILDFFQRLHIMI 192
           E  +MK I+H NL++++  C+ +    ++ EYMP+G+L   L   N   +     L++  
Sbjct: 78  EAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMAT 137
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
            ++SA+EYL   +     IH DL + N L+ +N V
Sbjct: 138 QISSAMEYLEKKN----FIHRDLAARNCLVGENHV 168

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 16/145 (11%)
Query: 90  LEVFNL---ISRGGFGSIYKARIQD-----GMEVVVKGFNLQYGGAFKNLDVECNMMKII 141
           LE F++   + +G FG++Y AR +       ++V+ K   L+  G    L  E  +   +
Sbjct: 11  LEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKT-QLEKAGVEHQLRREVEIQSHL 69
Query: 142 RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMI-DVASAVEY 200
           RH N++++           LILEY P G++ + L   +   +  QR    I ++A+A+ Y
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE--QRTATYITELANALSY 127
Query: 201 LHFGHSTHVIIHCDLKSSNVLLDDN 225
            H    +  +IH D+K  N+LL  N
Sbjct: 128 CH----SKRVIHRDIKPENLLLGSN 148

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 70/138 (50%), Gaps = 19/138 (13%)
Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGGA-----FKNLDVECNMMKIIRHQNLIKII 150
           I  G FG++Y AR     EVV     + Y G      ++++  E   ++ +RH N I+  
Sbjct: 62  IGHGSFGAVYFARDVRNSEVVAIK-KMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 151 SSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVAS----AVEYLHFGHS 206
               ++    L++EY        CL +++ +L+  ++    +++A+    A++ L + HS
Sbjct: 121 GCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 207 THVIIHCDLKSSNVLLDD 224
            H +IH D+K+ N+LL +
Sbjct: 173 -HNMIHRDVKAGNILLSE 189

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 69/158 (43%), Gaps = 14/158 (8%)
Query: 80  GKIPRPFRNFLE-----VFNLISRGGFGSIYKARI----QDGMEVVVKGFNLQYGG-AFK 129
           G+  R F   +E     +  +I  G  G +   R+    Q  + V +K     Y     +
Sbjct: 36  GRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR 95
Query: 130 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLH 189
           +   E ++M    H N+I++    ++     ++ EYM +GSL   L T +      Q + 
Sbjct: 96  DFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVG 155
Query: 190 IMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           ++  V + + YL    S    +H DL + NVL+D N+V
Sbjct: 156 MLRGVGAGMRYL----SDLGYVHRDLAARNVLVDSNLV 189

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/158 (24%), Positives = 69/158 (43%), Gaps = 14/158 (8%)
Query: 80  GKIPRPFRNFLE-----VFNLISRGGFGSIYKARI----QDGMEVVVKGFNLQYGG-AFK 129
           G+  R F   +E     +  +I  G  G +   R+    Q  + V +K     Y     +
Sbjct: 36  GRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR 95
Query: 130 NLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLH 189
           +   E ++M    H N+I++    ++     ++ EYM +GSL   L T +      Q + 
Sbjct: 96  DFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVG 155
Query: 190 IMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           ++  V + + YL    S    +H DL + NVL+D N+V
Sbjct: 156 MLRGVGAGMRYL----SDLGYVHRDLAARNVLVDSNLV 189

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/183 (23%), Positives = 80/183 (43%), Gaps = 21/183 (11%)
Query: 47  LDLSNNNFSGAIPIPXXXXXXXXXXXXSFNTLEGKIPRPFRNFLEVFNLISRGGFGSIYK 106
           +D  +    G  P+P             +NTL         NF  +   I RG F  +Y+
Sbjct: 1   MDEQSQGMQGP-PVPQFQPQKALRPDMGYNTLA--------NF-RIEKKIGRGQFSEVYR 50
Query: 107 AR-IQDGMEVVVKG---FNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI 162
           A  + DG+ V +K    F+L    A  +   E +++K + H N+IK  +S  +D+   ++
Sbjct: 51  AACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110
Query: 163 LEYMPHGSLGKCL---STSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSN 219
           LE    G L + +        ++         + + SA+E++H    +  ++H D+K +N
Sbjct: 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH----SRRVMHRDIKPAN 166
Query: 220 VLL 222
           V +
Sbjct: 167 VFI 169

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 69/143 (48%), Gaps = 11/143 (7%)
Query: 91  EVFNLISRGGFGSIYKARIQDGMEVV-VKGFNLQY-----GGAFKNLDVECNMMKIIRHQ 144
           E  + +  G F ++YKAR ++  ++V +K   L +      G  +    E  +++ + H 
Sbjct: 13  EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 72
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N+I ++ +       +L+ ++M    L   +  ++ +L        M+     +EYLH  
Sbjct: 73  NIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH-- 129
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
              H I+H DLK +N+LLD+N V
Sbjct: 130 --QHWILHRDLKPNNLLLDENGV 150

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 70/138 (50%), Gaps = 19/138 (13%)
Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGGA-----FKNLDVECNMMKIIRHQNLIKII 150
           I  G FG++Y AR     EVV     + Y G      ++++  E   ++ +RH N I+  
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIK-KMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 151 SSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVAS----AVEYLHFGHS 206
               ++    L++EY        CL +++ +L+  ++    +++A+    A++ L + HS
Sbjct: 82  GCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 207 THVIIHCDLKSSNVLLDD 224
            H +IH D+K+ N+LL +
Sbjct: 134 -HNMIHRDVKAGNILLSE 150

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 59/134 (44%), Gaps = 6/134 (4%)
Query: 96  ISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFK-NLDVECNMMKIIRHQNLIKIISSC 153
           I RG FG ++  R++ D   V VK          K     E  ++K   H N++++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 154 SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHC 213
           ++     +++E +  G     L T    L     L ++ D A+ +EYL     +   IH 
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE----SKCCIHR 237
Query: 214 DLKSSNVLLDDNMV 227
           DL + N L+ +  V
Sbjct: 238 DLAARNCLVTEKNV 251

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 59/134 (44%), Gaps = 6/134 (4%)
Query: 96  ISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFK-NLDVECNMMKIIRHQNLIKIISSC 153
           I RG FG ++  R++ D   V VK          K     E  ++K   H N++++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 154 SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHC 213
           ++     +++E +  G     L T    L     L ++ D A+ +EYL     +   IH 
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE----SKCCIHR 237
Query: 214 DLKSSNVLLDDNMV 227
           DL + N L+ +  V
Sbjct: 238 DLAARNCLVTEKNV 251

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 67/141 (47%), Gaps = 7/141 (4%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL 146
           R  L++   +  G  G ++        +V VK    Q   +      E N+MK ++HQ L
Sbjct: 12  RETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRL 70
Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI-LDFFQRLHIMIDVASAVEYLHFGH 205
           +++ +  +++    +I EYM +GSL   L T + I L   + L +   +A  + ++    
Sbjct: 71  VRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--- 126
Query: 206 STHVIIHCDLKSSNVLLDDNM 226
                IH DL+++N+L+ D +
Sbjct: 127 -ERNYIHRDLRAANILVSDTL 146

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 76/154 (49%), Gaps = 17/154 (11%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL 146
           R  L++  + +RG FG ++KA++ +   V VK F LQ   ++++ + E      ++H+NL
Sbjct: 14  RGSLQLLEIKARGRFGCVWKAQLMNDF-VAVKIFPLQDKQSWQS-EREIFSTPGMKHENL 71
Query: 147 IKIISSCSK----DDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH 202
           ++ I++  +    +    LI  +   GSL   L  +  I+ + +  H+   ++  + YLH
Sbjct: 72  LQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGN--IITWNELCHVAETMSRGLSYLH 129
Query: 203 --------FGHSTHVIIHCDLKSSNVLLDDNMVA 228
                    GH    I H D KS NVLL  ++ A
Sbjct: 130 EDVPWCRGEGHKPS-IAHRDFKSKNVLLKSDLTA 162

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 37/162 (22%)
Query: 81  KIPRPFRNFLEVFNLISR---GGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECN 136
           +IPR      E   L+ R   G FG ++     +  +V VK   L+ G  + +    E N
Sbjct: 9   EIPR------ESIKLVKRLGAGQFGEVWMGYYNNSTKVAVK--TLKPGTMSVQAFLEEAN 60
Query: 137 MMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQR-------LH 189
           +MK ++H  L+++ +  ++++   +I EYM  GSL          LDF +        L 
Sbjct: 61  LMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSL----------LDFLKSDEGGKVLLP 110
Query: 190 IMID----VASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
            +ID    +A  + Y+   +     IH DL+++NVL+ ++++
Sbjct: 111 KLIDFSAQIAEGMAYIERKN----YIHRDLRAANVLVSESLM 148

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMI 192
           E  +MK I+H NL++++  C+++    +I+E+M +G+L   L   N   ++    L++  
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++SA+EYL   +     IH DL + N L+ +N
Sbjct: 124 QISSAMEYLEKKN----FIHRDLAARNCLVGEN 152

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 14/153 (9%)
Query: 82  IPRPFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQ-YGGAFKNLDVECNMMKI 140
           + R     + +   + +G +G +++   Q G  V VK F+ +     F+  ++   +M  
Sbjct: 31  VQRTVARQITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM-- 87
Query: 141 IRHQNLIKIISSCSKDDFKA----LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVAS 196
           +RH+N++  I+S       +    LI  Y   GSL   L  +   LD    L I++ +AS
Sbjct: 88  LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIAS 145
Query: 197 AVEYLH---FG-HSTHVIIHCDLKSSNVLLDDN 225
            + +LH   FG      I H DLKS N+L+  N
Sbjct: 146 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN 178

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 53/93 (56%), Gaps = 5/93 (5%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMI 192
           E  +MK I+H NL++++  C+++    +I+E+M +G+L   L   N   ++    L++  
Sbjct: 60  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 119
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++SA+EYL   +     IH DL + N L+ +N
Sbjct: 120 QISSAMEYLEKKN----FIHRDLAARNCLVGEN 148

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 65/143 (45%), Gaps = 15/143 (10%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNL-----QYGGAFKNLDVECNMMKIIRHQ 144
           + V   I  G FG++YK +     +V VK  N+     Q   AFKN   E  +++  RH 
Sbjct: 10  ITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHV 64
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N++  +   +     A++ ++    SL   L       +  + + I    A  ++YLH  
Sbjct: 65  NILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-- 121
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
                IIH DLKS+N+ L +++ 
Sbjct: 122 --AKSIIHRDLKSNNIFLHEDLT 142

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/136 (25%), Positives = 63/136 (46%), Gaps = 5/136 (3%)
Query: 88  NFLEVFNLISRGGFGSIYKARIQD-GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL 146
              E+   +  G FG +YKA+ ++ G     K    +     ++  VE  ++    H  +
Sbjct: 11  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI 70
Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHS 206
           +K++ +   D    +++E+ P G++   +   +  L   Q   I +     +E L+F HS
Sbjct: 71  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHS 127
Query: 207 THVIIHCDLKSSNVLL 222
              IIH DLK+ NVL+
Sbjct: 128 KR-IIHRDLKAGNVLM 142

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 67/143 (46%), Gaps = 9/143 (6%)
Query: 90  LEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQ 144
           + +  ++  G FG +   R++      + V +K   + Y     ++   E ++M    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N+I++    +K     ++ EYM +GSL   L   +      Q + ++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 163
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
            S    +H DL + N+L++ N+V
Sbjct: 164 -SDMGFVHRDLAARNILINSNLV 185

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 71/144 (49%), Gaps = 11/144 (7%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQN 145
           R  L +   + +G FG ++         V +K   L+ G  + +    E  +MK +RH+ 
Sbjct: 7   RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEK 64
Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCL--STSNYILDFFQRLHIMIDVASAVEYLHF 203
           L+++ +  S++    ++ EYM  GSL   L   T  Y L   Q + +   +AS + Y+  
Sbjct: 65  LVQLYAVVSEEPI-XIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVER 122
Query: 204 GHSTHVIIHCDLKSSNVLLDDNMV 227
            +     +H DL+++N+L+ +N+V
Sbjct: 123 MN----YVHRDLRAANILVGENLV 142

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 34/136 (25%), Positives = 63/136 (46%), Gaps = 5/136 (3%)
Query: 88  NFLEVFNLISRGGFGSIYKARIQD-GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL 146
              E+   +  G FG +YKA+ ++ G     K    +     ++  VE  ++    H  +
Sbjct: 19  EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI 78
Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHS 206
           +K++ +   D    +++E+ P G++   +   +  L   Q   I +     +E L+F HS
Sbjct: 79  VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ---IQVVCRQMLEALNFLHS 135
Query: 207 THVIIHCDLKSSNVLL 222
              IIH DLK+ NVL+
Sbjct: 136 KR-IIHRDLKAGNVLM 150

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMI 192
           E  +MK I+H NL++++  C+++    +I+E+M +G+L   L   N   +     L++  
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++SA+EYL   +     IH DL + N L+ +N
Sbjct: 119 QISSAMEYLEKKN----FIHRDLAARNCLVGEN 147

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 14/151 (9%)
Query: 84  RPFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQ-YGGAFKNLDVECNMMKIIR 142
           R   + + +   + +G +G +++   Q G  V VK F+ +     F+  ++   +M  +R
Sbjct: 4   RTVAHQITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM--LR 60
Query: 143 HQNLIKIISSCSKDDFKA----LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV 198
           H+N++  I+S       +    LI  Y   GSL   L  +   LD    L I++ +AS +
Sbjct: 61  HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGL 118
Query: 199 EYLH---FG-HSTHVIIHCDLKSSNVLLDDN 225
            +LH   FG      I H DLKS N+L+  N
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKN 149

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMI 192
           E  +MK I+H NL++++  C+++    +I+E+M +G+L   L   N   +     L++  
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++SA+EYL   +     IH DL + N L+ +N
Sbjct: 119 QISSAMEYLEKKN----FIHRDLAARNCLVGEN 147

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 67/143 (46%), Gaps = 9/143 (6%)
Query: 90  LEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQ 144
           + +  ++  G FG +   R++      + V +K   + Y     ++   E ++M    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N+I++    +K     ++ EYM +GSL   L   +      Q + ++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 163
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
            S    +H DL + N+L++ N+V
Sbjct: 164 -SDMGYVHRDLAARNILINSNLV 185

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMI 192
           E  +MK I+H NL++++  C+++    +I+E+M +G+L   L   N   +     L++  
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 116
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++SA+EYL   +     IH DL + N L+ +N
Sbjct: 117 QISSAMEYLEKKN----FIHRDLAARNCLVGEN 145

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 67/143 (46%), Gaps = 9/143 (6%)
Query: 90  LEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQ 144
           + +  ++  G FG +   R++      + V +K   + Y     ++   E ++M    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N+I++    +K     ++ EYM +GSL   L   +      Q + ++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 163
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
            S    +H DL + N+L++ N+V
Sbjct: 164 -SDMGYVHRDLAARNILINSNLV 185

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 67/143 (46%), Gaps = 9/143 (6%)
Query: 90  LEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQ 144
           + +  ++  G FG +   R++      + V +K   + Y     ++   E ++M    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N+I++    +K     ++ EYM +GSL   L   +      Q + ++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 163
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
            S    +H DL + N+L++ N+V
Sbjct: 164 -SDMGYVHRDLAARNILINSNLV 185

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 67/143 (46%), Gaps = 9/143 (6%)
Query: 90  LEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQ 144
           + +  ++  G FG +   R++      + V +K   + Y     ++   E ++M    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N+I++    +K     ++ EYM +GSL   L   +      Q + ++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 163
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
            S    +H DL + N+L++ N+V
Sbjct: 164 -SDMGYVHRDLAARNILINSNLV 185

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 67/143 (46%), Gaps = 9/143 (6%)
Query: 90  LEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQ 144
           + +  ++  G FG +   R++      + V +K   + Y     ++   E ++M    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N+I++    +K     ++ EYM +GSL   L   +      Q + ++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 163
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
            S    +H DL + N+L++ N+V
Sbjct: 164 -SDMGYVHRDLAARNILINSNLV 185

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 14/145 (9%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQ-YGGAFKNLDVECNMMKIIRHQNLIK 148
           + +   + +G +G +++   Q G  V VK F+ +     F+  ++   +M  +RH+N++ 
Sbjct: 10  ITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM--LRHENILG 66
Query: 149 IISSCSKDDFKA----LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-- 202
            I+S       +    LI  Y   GSL   L  +   LD    L I++ +AS + +LH  
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIE 124
Query: 203 -FG-HSTHVIIHCDLKSSNVLLDDN 225
            FG      I H DLKS N+L+  N
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKN 149

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 71/144 (49%), Gaps = 11/144 (7%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQN 145
           R  L +   + +G FG ++         V +K   L+ G  + +    E  +MK +RH+ 
Sbjct: 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEK 323
Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCL--STSNYILDFFQRLHIMIDVASAVEYLHF 203
           L+++ +  S++    ++ EYM  GSL   L   T  Y L   Q + +   +AS + Y+  
Sbjct: 324 LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVER 381
Query: 204 GHSTHVIIHCDLKSSNVLLDDNMV 227
            +     +H DL+++N+L+ +N+V
Sbjct: 382 MN----YVHRDLRAANILVGENLV 401

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 67/143 (46%), Gaps = 9/143 (6%)
Query: 90  LEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQ 144
           + +  ++  G FG +   R++      + V +K   + Y     ++   E ++M    H 
Sbjct: 45  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 104
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N+I++    +K     ++ EYM +GSL   L   +      Q + ++  +AS ++YL   
Sbjct: 105 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 161
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
            S    +H DL + N+L++ N+V
Sbjct: 162 -SDMGYVHRDLAARNILINSNLV 183

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 67/143 (46%), Gaps = 9/143 (6%)
Query: 90  LEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQ 144
           + +  ++  G FG +   R++      + V +K   + Y     ++   E ++M    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N+I++    +K     ++ EYM +GSL   L   +      Q + ++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 163
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
            S    +H DL + N+L++ N+V
Sbjct: 164 -SDMGYVHRDLAARNILINSNLV 185

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/129 (27%), Positives = 64/129 (49%), Gaps = 7/129 (5%)
Query: 99  GGFGSIYKARIQD-GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD 157
           G FG +Y+   +   + V VK          + L  E  +MK I+H NL++++  C+++ 
Sbjct: 22  GQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPNLVQLLGVCTREP 80
Query: 158 FKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLK 216
              +I E+M +G+L   L   N   +     L++   ++SA+EYL   +     IH DL 
Sbjct: 81  PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN----FIHRDLA 136
Query: 217 SSNVLLDDN 225
           + N L+ +N
Sbjct: 137 ARNCLVGEN 145

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 74/153 (48%), Gaps = 28/153 (18%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQN 145
           R  +++   +  G FG ++     +  +V VK   L+ G  + +    E N+MK ++H  
Sbjct: 11  RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDK 68
Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQR-------LHIMID----V 194
           L+++ +  +K++   +I E+M  GSL          LDF +        L  +ID    +
Sbjct: 69  LVRLYAVVTKEEPIYIITEFMAKGSL----------LDFLKSDEGGKVLLPKLIDFSAQI 118
Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           A  + Y+   +     IH DL+++NVL+ ++++
Sbjct: 119 AEGMAYIERKN----YIHRDLRAANVLVSESLM 147

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMI 192
           E  +MK I+H NL++++  C+++    +I E+M +G+L   L   N   ++    L++  
Sbjct: 60  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 119
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++SA+EYL   +     IH DL + N L+ +N
Sbjct: 120 QISSAMEYLEKKN----FIHRDLAARNCLVGEN 148

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 56/134 (41%), Gaps = 9/134 (6%)
Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMKIIRHQNLIKIISSC 153
           I  G FG ++     +  +V +K       GA    D   E  +M  + H  L+++   C
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 154 SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHC 213
            +     L+ E+M HG L   L T   +      L + +DV   + YL        +IH 
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHR 125
Query: 214 DLKSSNVLLDDNMV 227
           DL + N L+ +N V
Sbjct: 126 DLAARNCLVGENQV 139

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 57/131 (43%), Gaps = 8/131 (6%)
Query: 96  ISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISS 152
           I +G F  +  AR I  G EV VK  +       + + L  E  + K++ H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 153 CSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIH 212
              +    L+ EY   G +   L       +   R      + SAV+Y H       I+H
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCH----QKFIVH 136
Query: 213 CDLKSSNVLLD 223
            DLK+ N+LLD
Sbjct: 137 RDLKAENLLLD 147

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 71/144 (49%), Gaps = 11/144 (7%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQN 145
           R  L +   + +G FG ++         V +K   L+ G  + +    E  +MK +RH+ 
Sbjct: 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEK 240
Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCL--STSNYILDFFQRLHIMIDVASAVEYLHF 203
           L+++ +  S++    ++ EYM  GSL   L   T  Y L   Q + +   +AS + Y+  
Sbjct: 241 LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVER 298
Query: 204 GHSTHVIIHCDLKSSNVLLDDNMV 227
            +     +H DL+++N+L+ +N+V
Sbjct: 299 MN----YVHRDLRAANILVGENLV 318

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 71/144 (49%), Gaps = 11/144 (7%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQN 145
           R  L +   + +G FG ++         V +K   L+ G  + +    E  +MK +RH+ 
Sbjct: 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEK 240
Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCL--STSNYILDFFQRLHIMIDVASAVEYLHF 203
           L+++ +  S++    ++ EYM  GSL   L   T  Y L   Q + +   +AS + Y+  
Sbjct: 241 LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVER 298
Query: 204 GHSTHVIIHCDLKSSNVLLDDNMV 227
            +     +H DL+++N+L+ +N+V
Sbjct: 299 MN----YVHRDLRAANILVGENLV 318

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMI 192
           E  +MK I+H NL++++  C+++    +I E+M +G+L   L   N   ++    L++  
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 118
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++SA+EYL   +     IH DL + N L+ +N
Sbjct: 119 QISSAMEYLEKKN----FIHRDLAARNCLVGEN 147

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMI 192
           E  +MK I+H NL++++  C+++    +I E+M +G+L   L   N   ++    L++  
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 118
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++SA+EYL   +     IH DL + N L+ +N
Sbjct: 119 QISSAMEYLEKKN----FIHRDLAARNCLVGEN 147

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 71/144 (49%), Gaps = 11/144 (7%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQN 145
           R  L +   + +G FG ++         V +K   L+ G  + +    E  +MK +RH+ 
Sbjct: 10  RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEK 67
Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCL--STSNYILDFFQRLHIMIDVASAVEYLHF 203
           L+++ +  S++    ++ EYM  GSL   L   T  Y L   Q + +   +AS + Y+  
Sbjct: 68  LVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVER 125
Query: 204 GHSTHVIIHCDLKSSNVLLDDNMV 227
            +     +H DL+++N+L+ +N+V
Sbjct: 126 MN----YVHRDLRAANILVGENLV 145

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 67/143 (46%), Gaps = 9/143 (6%)
Query: 90  LEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQ 144
           + +  ++  G FG +   R++      + V +K   + Y     ++   E ++M    H 
Sbjct: 35  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 94
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N+I++    +K     ++ EYM +GSL   L   +      Q + ++  +AS ++YL   
Sbjct: 95  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 151
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
            S    +H DL + N+L++ N+V
Sbjct: 152 -SDMGYVHRDLAARNILINSNLV 173

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMI 192
           E  +MK I+H NL++++  C+++    +I E+M +G+L   L   N   ++    L++  
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++SA+EYL   +     IH DL + N L+ +N
Sbjct: 124 QISSAMEYLEKKN----FIHRDLAARNCLVGEN 152

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMI 192
           E  +MK I+H NL++++  C+++    +I E+M +G+L   L   N   ++    L++  
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 122
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++SA+EYL   +     IH DL + N L+ +N
Sbjct: 123 QISSAMEYLEKKN----FIHRDLAARNCLVGEN 151

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMI 192
           E  +MK I+H NL++++  C+++    +I E+M +G+L   L   N   ++    L++  
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++SA+EYL   +     IH DL + N L+ +N
Sbjct: 124 QISSAMEYLEKKN----FIHRDLAARNCLVGEN 152

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 56/134 (41%), Gaps = 9/134 (6%)
Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMKIIRHQNLIKIISSC 153
           I  G FG ++     +  +V +K       GA    D   E  +M  + H  L+++   C
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 154 SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHC 213
            +     L+ E+M HG L   L T   +      L + +DV   + YL        +IH 
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHR 130
Query: 214 DLKSSNVLLDDNMV 227
           DL + N L+ +N V
Sbjct: 131 DLAARNCLVGENQV 144

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 56/134 (41%), Gaps = 9/134 (6%)
Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMKIIRHQNLIKIISSC 153
           I  G FG ++     +  +V +K       GA    D   E  +M  + H  L+++   C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 154 SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHC 213
            +     L+ E+M HG L   L T   +      L + +DV   + YL        +IH 
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHR 127
Query: 214 DLKSSNVLLDDNMV 227
           DL + N L+ +N V
Sbjct: 128 DLAARNCLVGENQV 141

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 71/149 (47%), Gaps = 21/149 (14%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQN 145
           R  L +   + +G FG ++         V +K   L+ G  + +    E  +MK +RH+ 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEK 74
Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQ-------RLHIMIDVASAV 198
           L+++ +  S++    +++EYM  GSL          LDF +       RL  ++D+A+ +
Sbjct: 75  LVQLYAVVSEEPI-YIVIEYMSKGSL----------LDFLKGEMGKYLRLPQLVDMAAQI 123
Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
                       +H DL+++N+L+ +N+V
Sbjct: 124 ASGMAYVERMNYVHRDLRAANILVGENLV 152

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMI 192
           E  +MK I+H NL++++  C+++    +I E+M +G+L   L   N   ++    L++  
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++SA+EYL   +     IH DL + N L+ +N
Sbjct: 121 QISSAMEYLEKKN----FIHRDLAARNCLVGEN 149

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMI 192
           E  +MK I+H NL++++  C+++    +I E+M +G+L   L   N   ++    L++  
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++SA+EYL   +     IH DL + N L+ +N
Sbjct: 124 QISSAMEYLEKKN----FIHRDLAARNCLVGEN 152

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 33/143 (23%), Positives = 67/143 (46%), Gaps = 9/143 (6%)
Query: 90  LEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQ 144
           + +  ++  G FG +   R++      + V +K   + Y     ++   E ++M    H 
Sbjct: 18  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N+I++    +K     ++ EYM +GSL   L   +      Q + ++  +AS ++YL   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 134
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
            S    +H DL + N+L++ N+V
Sbjct: 135 -SDMGYVHRDLAARNILINSNLV 156

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMI 192
           E  +MK I+H NL++++  C+++    +I E+M +G+L   L   N   ++    L++  
Sbjct: 72  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 131
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++SA+EYL   +     IH DL + N L+ +N
Sbjct: 132 QISSAMEYLEKKN----FIHRDLAARNCLVGEN 160

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI---- 149
            +I  G FG +Y+A++ D  E+V     LQ    FKN +++  +M+ + H N++++    
Sbjct: 27  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRLRYFF 83
Query: 150 ISSCSKDD--FKALILEYMPHG--SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-FG 204
            SS  K D  +  L+L+Y+P     + +  S +   L        M  +  ++ Y+H FG
Sbjct: 84  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 143
Query: 205 HSTHVIIHCDLKSSNVLLDDN 225
                I H D+K  N+LLD +
Sbjct: 144 -----ICHRDIKPQNLLLDPD 159

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 70/149 (46%), Gaps = 21/149 (14%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQN 145
           R  L +   + +G FG ++         V +K   L+ G  + +    E  +MK IRH+ 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKIRHEK 74
Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQ-------RLHIMIDVASAV 198
           L+++ +  S++    ++ EYM  GSL          LDF +       RL  ++D+A+ +
Sbjct: 75  LVQLYAVVSEEPI-YIVTEYMSKGSL----------LDFLKGEMGKYLRLPQLVDMAAQI 123
Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
                       +H DL+++N+L+ +N+V
Sbjct: 124 ASGMAYVERMNYVHRDLRAANILVGENLV 152

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI---- 149
            +I  G FG +Y+A++ D  E+V     LQ    FKN +++  +M+ + H N++++    
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRLRYFF 82
Query: 150 ISSCSKDD--FKALILEYMPHG--SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-FG 204
            SS  K D  +  L+L+Y+P     + +  S +   L        M  +  ++ Y+H FG
Sbjct: 83  YSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 205 HSTHVIIHCDLKSSNVLLDDN 225
                I H D+K  N+LLD +
Sbjct: 143 -----ICHRDIKPQNLLLDPD 158

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMI 192
           E  +MK I+H NL++++  C+++    +I E+M +G+L   L   N   ++    L++  
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++SA+EYL   +     IH DL + N L+ +N
Sbjct: 121 QISSAMEYLEKKN----FIHRDLAARNCLVGEN 149

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI---- 149
            +I  G FG +Y+A++ D  E+V     LQ    FKN +++  +M+ + H N++++    
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRLRYFF 82
Query: 150 ISSCSKDD--FKALILEYMPHG--SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-FG 204
            SS  K D  +  L+L+Y+P     + +  S +   L        M  +  ++ Y+H FG
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 205 HSTHVIIHCDLKSSNVLLDDN 225
                I H D+K  N+LLD +
Sbjct: 143 -----ICHRDIKPQNLLLDPD 158

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 17/143 (11%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI---- 149
            +I  G FG +Y+A++ D  E+V     LQ    FKN +++  +M+ + H N++++    
Sbjct: 34  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRLRYFF 90
Query: 150 ISSCSKDD--FKALILEYMPHG--SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-FG 204
            SS  K D  +  L+L+Y+P     + +  S +   L        M  +  ++ Y+H FG
Sbjct: 91  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 150
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
                I H D+K  N+LLD +  
Sbjct: 151 -----ICHRDIKPQNLLLDPDTA 168

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 44.3 bits (103), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI---- 149
            +I  G FG +Y+A++ D  E+V     LQ    FKN +++  +M+ + H N++++    
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRLRYFF 82
Query: 150 ISSCSKDD--FKALILEYMPHG--SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-FG 204
            SS  K D  +  L+L+Y+P     + +  S +   L        M  +  ++ Y+H FG
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 205 HSTHVIIHCDLKSSNVLLDDN 225
                I H D+K  N+LLD +
Sbjct: 143 -----ICHRDIKPQNLLLDPD 158

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 17/143 (11%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI---- 149
            +I  G FG +Y+A++ D  E+V     LQ    FKN +++  +M+ + H N++++    
Sbjct: 45  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRLRYFF 101
Query: 150 ISSCSKDD--FKALILEYMPHG--SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-FG 204
            SS  K D  +  L+L+Y+P     + +  S +   L        M  +  ++ Y+H FG
Sbjct: 102 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 161
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
                I H D+K  N+LLD +  
Sbjct: 162 -----ICHRDIKPQNLLLDPDTA 179

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 71/149 (47%), Gaps = 21/149 (14%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQN 145
           R  L +   + +G FG ++         V +K   L+ G  + +    E  +MK +RH+ 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEK 74
Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQ-------RLHIMIDVASAV 198
           L+++ +  S++    +++EYM  GSL          LDF +       RL  ++D+A+ +
Sbjct: 75  LVQLYAVVSEEPI-YIVIEYMSKGSL----------LDFLKGEMGKYLRLPQLVDMAAQI 123
Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
                       +H DL+++N+L+ +N+V
Sbjct: 124 ASGMAYVERMNYVHRDLRAANILVGENLV 152

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 17/143 (11%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI---- 149
            +I  G FG +Y+A++ D  E+V     LQ    FKN +++  +M+ + H N++++    
Sbjct: 39  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRLRYFF 95
Query: 150 ISSCSKDD--FKALILEYMPHG--SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-FG 204
            SS  K D  +  L+L+Y+P     + +  S +   L        M  +  ++ Y+H FG
Sbjct: 96  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 155
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
                I H D+K  N+LLD +  
Sbjct: 156 -----ICHRDIKPQNLLLDPDTA 173

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI---- 149
            +I  G FG +Y+A++ D  E+V     LQ    FKN +++  +M+ + H N++++    
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRLRYFF 82
Query: 150 ISSCSKDD--FKALILEYMPHG--SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-FG 204
            SS  K D  +  L+L+Y+P     + +  S +   L        M  +  ++ Y+H FG
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 142
Query: 205 HSTHVIIHCDLKSSNVLLDDN 225
                I H D+K  N+LLD +
Sbjct: 143 -----ICHRDIKPQNLLLDPD 158

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 17/143 (11%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI---- 149
            +I  G FG +Y+A++ D  E+V     LQ    FKN +++  +M+ + H N++++    
Sbjct: 31  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRLRYFF 87
Query: 150 ISSCSKDD--FKALILEYMPHG--SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-FG 204
            SS  K D  +  L+L+Y+P     + +  S +   L        M  +  ++ Y+H FG
Sbjct: 88  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 147
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
                I H D+K  N+LLD +  
Sbjct: 148 -----ICHRDIKPQNLLLDPDTA 165

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMI 192
           E  +MK I+H NL++++  C+++    +I E+M +G+L   L   N   ++    L++  
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++SA+EYL   +     IH DL + N L+ +N
Sbjct: 121 QISSAMEYLEKKN----FIHRDLAARNCLVGEN 149

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 70/141 (49%), Gaps = 17/141 (12%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI---- 149
            +I  G FG +Y+A++ D  E+V     LQ    FKN +++  +M+ + H N++++    
Sbjct: 30  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRLRYFF 86
Query: 150 ISSCSKDD--FKALILEYMPHG--SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-FG 204
            SS  K D  +  L+L+Y+P     + +  S +   L        M  +  ++ Y+H FG
Sbjct: 87  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 146
Query: 205 HSTHVIIHCDLKSSNVLLDDN 225
                I H D+K  N+LLD +
Sbjct: 147 -----ICHRDIKPQNLLLDPD 162

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 17/143 (11%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI---- 149
            +I  G FG +Y+A++ D  E+V     LQ    FKN +++  +M+ + H N++++    
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRLRYFF 94
Query: 150 ISSCSKDD--FKALILEYMPHG--SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-FG 204
            SS  K D  +  L+L+Y+P     + +  S +   L        M  +  ++ Y+H FG
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 154
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
                I H D+K  N+LLD +  
Sbjct: 155 -----ICHRDIKPQNLLLDPDTA 172

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 44.3 bits (103), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 73/150 (48%), Gaps = 23/150 (15%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQN 145
           R  L++   +  G FG ++ A      +V VK   ++ G  + +    E N+MK ++H  
Sbjct: 14  RESLKLEKKLGAGQFGEVWMATYNKHTKVAVK--TMKPGSMSVEAFLAEANVMKTLQHDK 71
Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFF-------QRLHIMIDVASAV 198
           L+K+ +  +K+    +I E+M  GSL          LDF        Q L  +ID ++ +
Sbjct: 72  LVKLHAVVTKEPI-YIITEFMAKGSL----------LDFLKSDEGSKQPLPKLIDFSAQI 120
Query: 199 -EYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
            E + F    +  IH DL+++N+L+  ++V
Sbjct: 121 AEGMAFIEQRNY-IHRDLRAANILVSASLV 149

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 17/143 (11%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI---- 149
            +I  G FG +Y+A++ D  E+V     LQ    FKN +++  +M+ + H N++++    
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRLRYFF 116
Query: 150 ISSCSKDD--FKALILEYMPHG--SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-FG 204
            SS  K D  +  L+L+Y+P     + +  S +   L        M  +  ++ Y+H FG
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
                I H D+K  N+LLD +  
Sbjct: 177 -----ICHRDIKPQNLLLDPDTA 194

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMI 192
           E  +MK I+H NL++++  C+++    +I E+M +G+L   L   N   +     L++  
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++SA+EYL   +     IH DL + N L+ +N
Sbjct: 119 QISSAMEYLEKKN----FIHRDLAARNCLVGEN 147

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 17/143 (11%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI---- 149
            +I  G FG +Y+A++ D  E+V     LQ    FKN +++  +M+ + H N++++    
Sbjct: 54  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRLRYFF 110
Query: 150 ISSCSKDD--FKALILEYMPHG--SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-FG 204
            SS  K D  +  L+L+Y+P     + +  S +   L        M  +  ++ Y+H FG
Sbjct: 111 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 170
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
                I H D+K  N+LLD +  
Sbjct: 171 -----ICHRDIKPQNLLLDPDTA 188

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 17/143 (11%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI---- 149
            +I  G FG +Y+A++ D  E+V     LQ    FKN +++  +M+ + H N++++    
Sbjct: 62  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRLRYFF 118
Query: 150 ISSCSKDD--FKALILEYMPHG--SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-FG 204
            SS  K D  +  L+L+Y+P     + +  S +   L        M  +  ++ Y+H FG
Sbjct: 119 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 178
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
                I H D+K  N+LLD +  
Sbjct: 179 -----ICHRDIKPQNLLLDPDTA 196

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 17/143 (11%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI---- 149
            +I  G FG +Y+A++ D  E+V     LQ    FKN +++  +M+ + H N++++    
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRLRYFF 94
Query: 150 ISSCSKDD--FKALILEYMPHG--SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-FG 204
            SS  K D  +  L+L+Y+P     + +  S +   L        M  +  ++ Y+H FG
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 154
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
                I H D+K  N+LLD +  
Sbjct: 155 -----ICHRDIKPQNLLLDPDTA 172

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMI 192
           E  +MK I+H NL++++  C+++    +I E+M +G+L   L   N   +     L++  
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 123
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++SA+EYL   +     IH DL + N L+ +N
Sbjct: 124 QISSAMEYLEKKN----FIHRDLAARNCLVGEN 152

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 17/143 (11%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI---- 149
            +I  G FG +Y+A++ D  E+V     LQ    FKN +++  +M+ + H N++++    
Sbjct: 64  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRLRYFF 120
Query: 150 ISSCSKDD--FKALILEYMPHG--SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-FG 204
            SS  K D  +  L+L+Y+P     + +  S +   L        M  +  ++ Y+H FG
Sbjct: 121 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 180
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
                I H D+K  N+LLD +  
Sbjct: 181 -----ICHRDIKPQNLLLDPDTA 198

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 70/149 (46%), Gaps = 21/149 (14%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQN 145
           R  L +   + +G FG ++         V +K   L+ G  + +    E  +MK +RH+ 
Sbjct: 184 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK--TLKPGNMSPEAFLQEAQVMKKLRHEK 241
Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQ-------RLHIMIDVASAV 198
           L+++ +  S++    ++ EYM  GSL          LDF +       RL  ++D+A+ +
Sbjct: 242 LVQLYAVVSEEPI-YIVTEYMSKGSL----------LDFLKGEMGKYLRLPQLVDMAAQI 290
Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
                       +H DL+++N+L+ +N+V
Sbjct: 291 ASGMAYVERMNYVHRDLRAANILVGENLV 319

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMI 192
           E  +MK I+H NL++++  C+++    +I E+M +G+L   L   N   +     L++  
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 116
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++SA+EYL   +     IH DL + N L+ +N
Sbjct: 117 QISSAMEYLEKKN----FIHRDLAARNCLVGEN 145

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 17/143 (11%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI---- 149
            +I  G FG +Y+A++ D  E+V     LQ    FKN +++  +M+ + H N++++    
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRLRYFF 116
Query: 150 ISSCSKDD--FKALILEYMPHG--SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-FG 204
            SS  K D  +  L+L+Y+P     + +  S +   L        M  +  ++ Y+H FG
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
                I H D+K  N+LLD +  
Sbjct: 177 -----ICHRDIKPQNLLLDPDTA 194

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 65/141 (46%), Gaps = 8/141 (5%)
Query: 91  EVFNLISRGGFGSIYKARIQD-GMEVVVKGF-NLQYGGAFKNLDV-ECNMMKIIRHQNLI 147
           E   L+  G +G + K R +D G  V +K F         K + + E  ++K +RH+NL+
Sbjct: 28  ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLV 87
Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
            ++  C K     L+ E++ H  L       N  LD+      +  + + + + H    +
Sbjct: 88  NLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG-LDYQVVQKYLFQIINGIGFCH----S 142
Query: 208 HVIIHCDLKSSNVLLDDNMVA 228
           H IIH D+K  N+L+  + V 
Sbjct: 143 HNIIHRDIKPENILVSQSGVV 163

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 66/141 (46%), Gaps = 22/141 (15%)
Query: 96  ISRGGFGSI-----YKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKII 150
           +  G FG +     YK + +  ++ + +   L+       ++ E + +K++RH ++IK+ 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQL-LKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 151 SSCSKDDFKALILEYMPHGSL-----GKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 205
              +      +++EY   G L      K   T +    FFQ+      +  A+EY H   
Sbjct: 76  DVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQ------IICAIEYCH--- 125
Query: 206 STHVIIHCDLKSSNVLLDDNM 226
             H I+H DLK  N+LLDDN+
Sbjct: 126 -RHKIVHRDLKPENLLLDDNL 145

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 56/134 (41%), Gaps = 9/134 (6%)
Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMKIIRHQNLIKIISSC 153
           I  G FG ++     +  +V +K       GA    D   E  +M  + H  L+++   C
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 154 SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHC 213
            +     L+ E+M HG L   L T   +      L + +DV   + YL        +IH 
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHR 128
Query: 214 DLKSSNVLLDDNMV 227
           DL + N L+ +N V
Sbjct: 129 DLAARNCLVGENQV 142

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 35/134 (26%), Positives = 56/134 (41%), Gaps = 9/134 (6%)
Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMKIIRHQNLIKIISSC 153
           I  G FG ++     +  +V +K       GA    D   E  +M  + H  L+++   C
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 154 SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHC 213
            +     L+ E+M HG L   L T   +      L + +DV   + YL        +IH 
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EASVIHR 127
Query: 214 DLKSSNVLLDDNMV 227
           DL + N L+ +N V
Sbjct: 128 DLAARNCLVGENQV 141

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMI 192
           E  +MK I+H NL++++  C+++    +I E+M +G+L   L   N   +     L++  
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++SA+EYL   +     IH DL + N L+ +N
Sbjct: 119 QISSAMEYLEKKN----FIHRDLAARNCLVGEN 147

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 43.9 bits (102), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 17/143 (11%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI---- 149
            +I  G FG +Y+A++ D  E+V     LQ    FKN +++  +M+ + H N++++    
Sbjct: 105 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQ--IMRKLDHCNIVRLRYFF 161
Query: 150 ISSCSKDD--FKALILEYMPHG--SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH-FG 204
            SS  K D  +  L+L+Y+P     + +  S +   L        M  +  ++ Y+H FG
Sbjct: 162 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG 221
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
                I H D+K  N+LLD +  
Sbjct: 222 -----ICHRDIKPQNLLLDPDTA 239

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/171 (25%), Positives = 70/171 (40%), Gaps = 34/171 (19%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGME------VVVKGFNLQYGGAFK-NLDVECNMMK 139
           RN +E    I  G FG +++AR    +       V VK    +     + +   E  +M 
Sbjct: 46  RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 105
Query: 140 IIRHQNLIKIISSCSKDDFKALILEYMPHGSLGK----------C------LSTSNYI-- 181
              + N++K++  C+      L+ EYM +G L +          C      LST   +  
Sbjct: 106 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 182 -----LDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
                L   ++L I   VA+ + YL    S    +H DL + N L+ +NMV
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYL----SERKFVHRDLATRNCLVGENMV 212

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/132 (24%), Positives = 67/132 (50%), Gaps = 7/132 (5%)
Query: 95  LISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSC 153
           ++ +G +G +Y  R + + + + +K    +     + L  E  + K ++H+N+++ + S 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 154 SKDDFKALILEYMPHGSLGKCL-STSNYILDFFQRLHIMI-DVASAVEYLHFGHSTHVII 211
           S++ F  + +E +P GSL   L S    + D  Q +      +   ++YLH     + I+
Sbjct: 75  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH----DNQIV 130
Query: 212 HCDLKSSNVLLD 223
           H D+K  NVL++
Sbjct: 131 HRDIKGDNVLIN 142

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 72/163 (44%), Gaps = 23/163 (14%)
Query: 87  RNFLEVFNLISRGGFGSIYKARI--QDG--MEVVVKGFNLQYGG--AFKNLDVECNMMKI 140
           RN L +  ++  G FGS+ +  +  +DG  ++V VK   L        +    E   MK 
Sbjct: 33  RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKD 92
Query: 141 IRHQNLIKIISSCSKDDFKAL-----ILEYMPHGSLGKC-----LSTSNYILDFFQRLHI 190
             H N+I+++  C +   + +     IL +M +G L        L T    +     L  
Sbjct: 93  FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152
Query: 191 MIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM---VAHF 230
           M+D+A  +EYL    S    +H DL + N +L D+M   VA F
Sbjct: 153 MVDIALGMEYL----SNRNFLHRDLAARNCMLRDDMTVCVADF 191

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 73/150 (48%), Gaps = 23/150 (15%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQN 145
           R  L++   +  G FG ++ A      +V VK   ++ G  + +    E N+MK ++H  
Sbjct: 181 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVK--TMKPGSMSVEAFLAEANVMKTLQHDK 238
Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFF-------QRLHIMIDVASAV 198
           L+K+ +  +K+    +I E+M  GSL          LDF        Q L  +ID ++ +
Sbjct: 239 LVKLHAVVTKEPI-YIITEFMAKGSL----------LDFLKSDEGSKQPLPKLIDFSAQI 287
Query: 199 -EYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
            E + F    +  IH DL+++N+L+  ++V
Sbjct: 288 AEGMAFIEQRNY-IHRDLRAANILVSASLV 316

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 73/150 (48%), Gaps = 23/150 (15%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQN 145
           R  L++   +  G FG ++ A      +V VK   ++ G  + +    E N+MK ++H  
Sbjct: 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVK--TMKPGSMSVEAFLAEANVMKTLQHDK 244
Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFF-------QRLHIMIDVASAV 198
           L+K+ +  +K+    +I E+M  GSL          LDF        Q L  +ID ++ +
Sbjct: 245 LVKLHAVVTKEPI-YIITEFMAKGSL----------LDFLKSDEGSKQPLPKLIDFSAQI 293
Query: 199 -EYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
            E + F    +  IH DL+++N+L+  ++V
Sbjct: 294 AEGMAFIEQRNY-IHRDLRAANILVSASLV 322

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 65/144 (45%), Gaps = 18/144 (12%)
Query: 91  EVFNLISRGGFGSIYKA-RIQDGMEVVVKGFN---LQYGGAFKNLDVECNMMKIIRHQNL 146
           ++   +  G FG +  A     G +V +K  N   L        ++ E + ++++RH ++
Sbjct: 7   QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHI 66
Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLS----TSNYILDFFQRLHIMIDVASAVEYLH 202
           IK+       D   +++EY  +      +     +      FFQ+      + SAVEY H
Sbjct: 67  IKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------IISAVEYCH 120
Query: 203 FGHSTHVIIHCDLKSSNVLLDDNM 226
                H I+H DLK  N+LLD+++
Sbjct: 121 ----RHKIVHRDLKPENLLLDEHL 140

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 37/144 (25%), Positives = 71/144 (49%), Gaps = 11/144 (7%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQN 145
           R  L +   + +G FG ++         V +K   L+ G  + +    E  +MK +RH+ 
Sbjct: 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEK 240
Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCL--STSNYILDFFQRLHIMIDVASAVEYLHF 203
           L+++ +  S++    ++ EYM  GSL   L   T  Y L   Q + +   +AS + Y+  
Sbjct: 241 LVQLYAVVSEEPI-YIVGEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVER 298
Query: 204 GHSTHVIIHCDLKSSNVLLDDNMV 227
            +     +H DL+++N+L+ +N+V
Sbjct: 299 MN----YVHRDLRAANILVGENLV 318

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/140 (24%), Positives = 67/140 (47%), Gaps = 21/140 (15%)
Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCS 154
           + +G FG ++         V +K   L+ G  + +    E  +MK +RH+ L+++ +  S
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 155 KDDFKALILEYMPHGSLGKCLSTSNYILDFFQ-------RLHIMIDVASAVEYLHFGHST 207
           ++    ++ EYM  GSL          LDF +       RL  ++D+A+ +         
Sbjct: 73  EEPI-YIVTEYMSKGSL----------LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 121
Query: 208 HVIIHCDLKSSNVLLDDNMV 227
              +H DL+++N+L+ +N+V
Sbjct: 122 MNYVHRDLRAANILVGENLV 141

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 43.5 bits (101), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/132 (24%), Positives = 67/132 (50%), Gaps = 7/132 (5%)
Query: 95  LISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSC 153
           ++ +G +G +Y  R + + + + +K    +     + L  E  + K ++H+N+++ + S 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 154 SKDDFKALILEYMPHGSLGKCL-STSNYILDFFQRLHIMI-DVASAVEYLHFGHSTHVII 211
           S++ F  + +E +P GSL   L S    + D  Q +      +   ++YLH     + I+
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH----DNQIV 144
Query: 212 HCDLKSSNVLLD 223
           H D+K  NVL++
Sbjct: 145 HRDIKGDNVLIN 156

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/140 (24%), Positives = 67/140 (47%), Gaps = 21/140 (15%)
Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCS 154
           + +G FG ++         V +K   L+ G  + +    E  +MK +RH+ L+++ +  S
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 155 KDDFKALILEYMPHGSLGKCLSTSNYILDFFQ-------RLHIMIDVASAVEYLHFGHST 207
           ++    ++ EYM  GSL          LDF +       RL  ++D+A+ +         
Sbjct: 75  EEPI-YIVTEYMSKGSL----------LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 123
Query: 208 HVIIHCDLKSSNVLLDDNMV 227
              +H DL+++N+L+ +N+V
Sbjct: 124 MNYVHRDLRAANILVGENLV 143

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 65/144 (45%), Gaps = 18/144 (12%)
Query: 91  EVFNLISRGGFGSIYKA-RIQDGMEVVVKGFN---LQYGGAFKNLDVECNMMKIIRHQNL 146
           ++   +  G FG +  A     G +V +K  N   L        ++ E + ++++RH ++
Sbjct: 11  QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHI 70
Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLS----TSNYILDFFQRLHIMIDVASAVEYLH 202
           IK+       D   +++EY  +      +     +      FFQ+      + SAVEY H
Sbjct: 71  IKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------IISAVEYCH 124
Query: 203 FGHSTHVIIHCDLKSSNVLLDDNM 226
                H I+H DLK  N+LLD+++
Sbjct: 125 ----RHKIVHRDLKPENLLLDEHL 144

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 65/144 (45%), Gaps = 18/144 (12%)
Query: 91  EVFNLISRGGFGSIYKA-RIQDGMEVVVKGFN---LQYGGAFKNLDVECNMMKIIRHQNL 146
           ++   +  G FG +  A     G +V +K  N   L        ++ E + ++++RH ++
Sbjct: 17  QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHI 76
Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLS----TSNYILDFFQRLHIMIDVASAVEYLH 202
           IK+       D   +++EY  +      +     +      FFQ+      + SAVEY H
Sbjct: 77  IKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------IISAVEYCH 130
Query: 203 FGHSTHVIIHCDLKSSNVLLDDNM 226
                H I+H DLK  N+LLD+++
Sbjct: 131 ----RHKIVHRDLKPENLLLDEHL 150

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 70/149 (46%), Gaps = 21/149 (14%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQN 145
           R  L +   + +G FG ++         V +K   L+ G  + +    E  +MK +RH+ 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEK 74
Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQ-------RLHIMIDVASAV 198
           L+++ +  S++    ++ EYM  GSL          LDF +       RL  ++D+A+ +
Sbjct: 75  LVQLYAVVSEEPI-YIVTEYMSKGSL----------LDFLKGEMGKYLRLPQLVDMAAQI 123
Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
                       +H DL+++N+L+ +N+V
Sbjct: 124 ASGMAYVERMNYVHRDLRAANILVGENLV 152

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 68/135 (50%), Gaps = 11/135 (8%)
Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCS 154
           + +G FG ++         V +K   L+ G  + +    E  +MK +RH+ L+++ +  S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 155 KDDFKALILEYMPHGSLGKCL--STSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIH 212
           ++    ++ EYM  GSL   L   T  Y L   Q + +   +AS + Y+   +     +H
Sbjct: 81  EEPI-YIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVERMN----YVH 134
Query: 213 CDLKSSNVLLDDNMV 227
            DL+++N+L+ +N+V
Sbjct: 135 RDLRAANILVGENLV 149

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 4/94 (4%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMID 193
           E  +M  + H+ L+++   C+K     +I EYM +G L   L    +     Q L +  D
Sbjct: 69  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 128
Query: 194 VASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           V  A+EYL     +   +H DL + N L++D  V
Sbjct: 129 VCEAMEYLE----SKQFLHRDLAARNCLVNDQGV 158

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 65/144 (45%), Gaps = 18/144 (12%)
Query: 91  EVFNLISRGGFGSIYKA-RIQDGMEVVVKGFN---LQYGGAFKNLDVECNMMKIIRHQNL 146
           ++   +  G FG +  A     G +V +K  N   L        ++ E + ++++RH ++
Sbjct: 16  QIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHI 75
Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLS----TSNYILDFFQRLHIMIDVASAVEYLH 202
           IK+       D   +++EY  +      +     +      FFQ+      + SAVEY H
Sbjct: 76  IKLYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQ------IISAVEYCH 129
Query: 203 FGHSTHVIIHCDLKSSNVLLDDNM 226
                H I+H DLK  N+LLD+++
Sbjct: 130 ----RHKIVHRDLKPENLLLDEHL 149

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 61/134 (45%), Gaps = 11/134 (8%)
Query: 91  EVFNLISRGGFGSIYKARIQD-----GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN 145
           E+   + +G FG++Y AR +       ++V+ K   ++  G    L  E  +   + H N
Sbjct: 26  EIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKS-QIEKEGVEHQLRREIEIQAHLHHPN 84
Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 205
           ++++ +         LILEY P G L K L  S    D  +   IM ++A A+ Y H   
Sbjct: 85  ILRLYNYFYDRRRIYLILEYAPRGELYKELQKSC-TFDEQRTATIMEELADALMYCH--- 140
Query: 206 STHVIIHCDLKSSN 219
               +IH D+K  N
Sbjct: 141 -GKKVIHRDIKPEN 153

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 4/94 (4%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMID 193
           E  +M  + H+ L+++   C+K     +I EYM +G L   L    +     Q L +  D
Sbjct: 69  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 128
Query: 194 VASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           V  A+EYL     +   +H DL + N L++D  V
Sbjct: 129 VCEAMEYLE----SKQFLHRDLAARNCLVNDQGV 158

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 68/135 (50%), Gaps = 11/135 (8%)
Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCS 154
           + +G FG ++         V +K   L+ G  + +    E  +MK +RH+ L+++ +  S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 155 KDDFKALILEYMPHGSLGKCL--STSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIH 212
           ++    ++ EYM  GSL   L   T  Y L   Q + +   +AS + Y+   +     +H
Sbjct: 81  EEPI-YIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVERMN----YVH 134
Query: 213 CDLKSSNVLLDDNMV 227
            DL+++N+L+ +N+V
Sbjct: 135 RDLRAANILVGENLV 149

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 42/94 (44%), Gaps = 4/94 (4%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMID 193
           E  +M  + H  L+++   C +     L+ E+M HG L   L T   +      L + +D
Sbjct: 72  EAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 131
Query: 194 VASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           V   + YL        +IH DL + N L+ +N V
Sbjct: 132 VCEGMAYLE----EACVIHRDLAARNCLVGENQV 161

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 70/149 (46%), Gaps = 21/149 (14%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQN 145
           R  L +   + +G FG ++         V +K   L+ G  + +    E  +MK +RH+ 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEK 74
Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQ-------RLHIMIDVASAV 198
           L+++ +  S++    ++ EYM  GSL          LDF +       RL  ++D+A+ +
Sbjct: 75  LVQLYAVVSEEPI-YIVCEYMSKGSL----------LDFLKGEMGKYLRLPQLVDMAAQI 123
Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
                       +H DL+++N+L+ +N+V
Sbjct: 124 ASGMAYVERMNYVHRDLRAANILVGENLV 152

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/146 (26%), Positives = 66/146 (45%), Gaps = 14/146 (9%)
Query: 89  FLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKII-RHQNL 146
             E+  L+  G +G +YK R ++ G    +K  ++  G   + +  E NM+K    H+N+
Sbjct: 25  IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNI 83
Query: 147 IKIISSCSK------DDFKALILEYMPHGSLGKCLS-TSNYILDFFQRLHIMIDVASAVE 199
                +  K      DD   L++E+   GS+   +  T    L      +I  ++   + 
Sbjct: 84  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 143
Query: 200 YLHFGHSTHVIIHCDLKSSNVLLDDN 225
           +LH     H +IH D+K  NVLL +N
Sbjct: 144 HLH----QHKVIHRDIKGQNVLLTEN 165

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 44/90 (48%), Gaps = 5/90 (5%)
Query: 137 MMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVAS 196
           + ++  H ++I +I S     F  L+ + M  G L   L T    L   +   IM  +  
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLE 211
Query: 197 AVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           AV +LH  +    I+H DLK  N+LLDDNM
Sbjct: 212 AVSFLHANN----IVHRDLKPENILLDDNM 237

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 4/94 (4%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMID 193
           E  +M  + H+ L+++   C+K     +I EYM +G L   L    +     Q L +  D
Sbjct: 60  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKD 119
Query: 194 VASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           V  A+EYL     +   +H DL + N L++D  V
Sbjct: 120 VCEAMEYLE----SKQFLHRDLAARNCLVNDQGV 149

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 62/133 (46%), Gaps = 7/133 (5%)
Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVE-CNMMKIIRHQNLIKIISSCS 154
           +  G FG +   + +   +V +K   ++ G   ++  +E   +M  + H+ L+++   C+
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIK--MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 155 KDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCD 214
           K     +I EYM +G L   L    +     Q L +  DV  A+EYL     +   +H D
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRD 130
Query: 215 LKSSNVLLDDNMV 227
           L + N L++D  V
Sbjct: 131 LAARNCLVNDQGV 143

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 61/130 (46%), Gaps = 7/130 (5%)
Query: 99  GGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVE-CNMMKIIRHQNLIKIISSCSKDD 157
           G FG +   + +   +V +K   ++ G   ++  +E   +M  + H+ L+++   C+K  
Sbjct: 20  GQFGVVKYGKWRGQYDVAIK--MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 77
Query: 158 FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKS 217
              +I EYM +G L   L    +     Q L +  DV  A+EYL     +   +H DL +
Sbjct: 78  PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAA 133
Query: 218 SNVLLDDNMV 227
            N L++D  V
Sbjct: 134 RNCLVNDQGV 143

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/148 (22%), Positives = 64/148 (43%), Gaps = 26/148 (17%)
Query: 101 FGSIYKARI------QDGMEVVVKGFNLQYGGAFKN-LDVECNMMKIIRHQNLIKIISSC 153
           FG +YK  +      +    V +K    +  G  +     E  +   ++H N++ ++   
Sbjct: 39  FGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV 98
Query: 154 SKDDFKALILEYMPHGSLGKCL---------------STSNYILDFFQRLHIMIDVASAV 198
           +KD   ++I  Y  HG L + L                T    L+    +H++  +A+ +
Sbjct: 99  TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGM 158
Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           EYL    S+H ++H DL + NVL+ D +
Sbjct: 159 EYL----SSHHVVHKDLATRNVLVYDKL 182

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 61/130 (46%), Gaps = 7/130 (5%)
Query: 99  GGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVE-CNMMKIIRHQNLIKIISSCSKDD 157
           G FG +   + +   +V +K   ++ G   ++  +E   +M  + H+ L+++   C+K  
Sbjct: 19  GQFGVVKYGKWRGQYDVAIK--MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 76
Query: 158 FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKS 217
              +I EYM +G L   L    +     Q L +  DV  A+EYL     +   +H DL +
Sbjct: 77  PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAA 132
Query: 218 SNVLLDDNMV 227
            N L++D  V
Sbjct: 133 RNCLVNDQGV 142

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/130 (26%), Positives = 61/130 (46%), Gaps = 7/130 (5%)
Query: 99  GGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVE-CNMMKIIRHQNLIKIISSCSKDD 157
           G FG +   + +   +V +K   ++ G   ++  +E   +M  + H+ L+++   C+K  
Sbjct: 15  GQFGVVKYGKWRGQYDVAIK--MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 72
Query: 158 FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKS 217
              +I EYM +G L   L    +     Q L +  DV  A+EYL     +   +H DL +
Sbjct: 73  PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAA 128
Query: 218 SNVLLDDNMV 227
            N L++D  V
Sbjct: 129 RNCLVNDQGV 138

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 16/148 (10%)
Query: 87  RNFLEVFNLISRGGFG--SIY---KARIQDGMEVVVKGFNLQYGGAFKN-LDVECNMMKI 140
           + +L+    +  G FG  S+Y         G  V VK      G   ++    E ++++ 
Sbjct: 30  KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRT 89
Query: 141 IRHQNLIKIISSCSKDDFKA---LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASA 197
           + H+++IK    C +D   A   L++EY+P GSL   L   +  +   Q L     +   
Sbjct: 90  LYHEHIIKY-KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEG 146
Query: 198 VEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
           + YLH  H     IH DL + NVLLD++
Sbjct: 147 MAYLHAQH----YIHRDLAARNVLLDND 170

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/93 (29%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMI 192
           E  +MK I+H NL++++  C+++    +I E+M +G+L   L   N   ++    L++  
Sbjct: 305 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 364
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++SA+EYL         IH +L + N L+ +N
Sbjct: 365 QISSAMEYL----EKKNFIHRNLAARNCLVGEN 393

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 68/136 (50%), Gaps = 12/136 (8%)
Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI---- 149
            +I  G FG +++A++ +  EV +K   LQ    FKN   E  +M+I++H N++ +    
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKV-LQ-DKRFKNR--ELQIMRIVKHPNVVDLKAFF 101
Query: 150 ISSCSKDD--FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
            S+  K D  F  L+LEY+P  ++ +       +      L I + +   +  L + HS 
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI 160
Query: 208 HVIIHCDLKSSNVLLD 223
             I H D+K  N+LLD
Sbjct: 161 G-ICHRDIKPQNLLLD 175

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/148 (22%), Positives = 64/148 (43%), Gaps = 26/148 (17%)
Query: 101 FGSIYKARI------QDGMEVVVKGFNLQYGGAFKN-LDVECNMMKIIRHQNLIKIISSC 153
           FG +YK  +      +    V +K    +  G  +     E  +   ++H N++ ++   
Sbjct: 22  FGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVV 81
Query: 154 SKDDFKALILEYMPHGSLGKCL---------------STSNYILDFFQRLHIMIDVASAV 198
           +KD   ++I  Y  HG L + L                T    L+    +H++  +A+ +
Sbjct: 82  TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGM 141
Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           EYL    S+H ++H DL + NVL+ D +
Sbjct: 142 EYL----SSHHVVHKDLATRNVLVYDKL 165

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/149 (23%), Positives = 70/149 (46%), Gaps = 21/149 (14%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQN 145
           R  L +   + +G FG ++         V +K   L+ G  + +    E  +MK +RH+ 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEK 74
Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQ-------RLHIMIDVASAV 198
           L+++ +  S++    +++EYM  G L          LDF +       RL  ++D+A+ +
Sbjct: 75  LVQLYAVVSEEPI-YIVMEYMSKGCL----------LDFLKGEMGKYLRLPQLVDMAAQI 123
Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
                       +H DL+++N+L+ +N+V
Sbjct: 124 ASGMAYVERMNYVHRDLRAANILVGENLV 152

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/135 (22%), Positives = 65/135 (48%), Gaps = 8/135 (5%)
Query: 91  EVFNLISRGGFGSIYKA-RIQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLI 147
           ++F  + +G F  + +  +I  G E   K  N +   A   + L+ E  + ++++H N++
Sbjct: 7   QLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIV 66
Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           ++  S S++ F  L+ + +  G L + +    Y  +     H +  +  +V + H     
Sbjct: 67  RLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE-ADASHCIQQILESVNHCHL---- 121
Query: 208 HVIIHCDLKSSNVLL 222
           + I+H DLK  N+LL
Sbjct: 122 NGIVHRDLKPENLLL 136

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/93 (29%), Positives = 51/93 (54%), Gaps = 5/93 (5%)
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMI 192
           E  +MK I+H NL++++  C+++    +I E+M +G+L   L   N   +     L++  
Sbjct: 266 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325
Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++SA+EYL   +     IH +L + N L+ +N
Sbjct: 326 QISSAMEYLEKKN----FIHRNLAARNCLVGEN 354

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/138 (23%), Positives = 65/138 (47%), Gaps = 19/138 (13%)
Query: 96  ISRGGFGSIYK-ARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKII-------RHQNLI 147
           I  G FGS++K  +  DG    +K       G+      E N ++ +       +H +++
Sbjct: 15  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHAVLGQHSHVV 70
Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLH---IMIDVASAVEYLHFG 204
           +  S+ ++DD   +  EY   GSL   +S +  I+ +F+      +++ V   + Y+H  
Sbjct: 71  RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH-- 128
Query: 205 HSTHVIIHCDLKSSNVLL 222
             +  ++H D+K SN+ +
Sbjct: 129 --SMSLVHMDIKPSNIFI 144

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 75/168 (44%), Gaps = 33/168 (19%)
Query: 87  RNFLEVFNLISRGGFGSIY--------KARIQDGMEVVVKGFNLQYGGAFKNLD---VEC 135
           R+ L +   +  G FG +         K + ++ + V VK   L+     K+L     E 
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEM 91
Query: 136 NMMKII-RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTS-----NYILD------ 183
            MMK+I +H+N+I ++ +C++D    +I+EY   G+L + L         Y  D      
Sbjct: 92  EMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 184 ----FFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
               F   +     +A  +EYL    ++   IH DL + NVL+ +N V
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL----ASQKCIHRDLAARNVLVTENNV 195

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 66/147 (44%), Gaps = 14/147 (9%)
Query: 87  RNFLEVFNLISRGGFG--SIY---KARIQDGMEVVVKGFNLQYGGAFKN-LDVECNMMKI 140
           + +L+    +  G FG  S+Y         G  V VK      G   ++    E ++++ 
Sbjct: 13  KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRT 72
Query: 141 IRHQNLIKIISSCSKDDFKA--LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV 198
           + H+++IK    C     K+  L++EY+P GSL   L   +  +   Q L     +   +
Sbjct: 73  LYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGM 130
Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            YLH  H     IH +L + NVLLD++
Sbjct: 131 AYLHAQH----YIHRNLAARNVLLDND 153

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 75/168 (44%), Gaps = 33/168 (19%)
Query: 87  RNFLEVFNLISRGGFGSIY--------KARIQDGMEVVVKGFNLQYGGAFKNLD---VEC 135
           R+ L +   +  G FG +         K + ++ + V VK   L+     K+L     E 
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEM 91
Query: 136 NMMKII-RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTS-----NYILD------ 183
            MMK+I +H+N+I ++ +C++D    +I+EY   G+L + L         Y  D      
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 184 ----FFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
               F   +     +A  +EYL    ++   IH DL + NVL+ +N V
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL----ASQKCIHRDLAARNVLVTENNV 195

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 75/168 (44%), Gaps = 33/168 (19%)
Query: 87  RNFLEVFNLISRGGFGSIY--------KARIQDGMEVVVKGFNLQYGGAFKNLD---VEC 135
           R+ L +   +  G FG +         K + ++ + V VK   L+     K+L     E 
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEM 91
Query: 136 NMMKII-RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTS-----NYILD------ 183
            MMK+I +H+N+I ++ +C++D    +I+EY   G+L + L         Y  D      
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 184 ----FFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
               F   +     +A  +EYL    ++   IH DL + NVL+ +N V
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL----ASQKCIHRDLAARNVLVTENNV 195

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/135 (22%), Positives = 65/135 (48%), Gaps = 8/135 (5%)
Query: 91  EVFNLISRGGFGSIYKA-RIQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLI 147
           ++F  + +G F  + +  +I  G E   K  N +   A   + L+ E  + ++++H N++
Sbjct: 7   QLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIV 66
Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           ++  S S++ F  L+ + +  G L + +    Y  +     H +  +  +V + H     
Sbjct: 67  RLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE-ADASHCIQQILESVNHCHL---- 121
Query: 208 HVIIHCDLKSSNVLL 222
           + I+H DLK  N+LL
Sbjct: 122 NGIVHRDLKPENLLL 136

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/138 (23%), Positives = 65/138 (47%), Gaps = 19/138 (13%)
Query: 96  ISRGGFGSIYK-ARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKII-------RHQNLI 147
           I  G FGS++K  +  DG    +K       G+      E N ++ +       +H +++
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHAVLGQHSHVV 72
Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLH---IMIDVASAVEYLHFG 204
           +  S+ ++DD   +  EY   GSL   +S +  I+ +F+      +++ V   + Y+H  
Sbjct: 73  RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH-- 130
Query: 205 HSTHVIIHCDLKSSNVLL 222
             +  ++H D+K SN+ +
Sbjct: 131 --SMSLVHMDIKPSNIFI 146

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/149 (24%), Positives = 69/149 (46%), Gaps = 21/149 (14%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQN 145
           R  L +   + +G FG ++         V +K   L+ G  + +    E  +MK +RH+ 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEK 74
Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQ-------RLHIMIDVASAV 198
           L+++ +  S++    ++ EYM  GSL          LDF +       RL  ++D+A+ +
Sbjct: 75  LVQLYAVVSEEPI-YIVTEYMSKGSL----------LDFLKGEMGKYLRLPQLVDMAAQI 123
Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
                       +H DL ++N+L+ +N+V
Sbjct: 124 ASGMAYVERMNYVHRDLAAANILVGENLV 152

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 75/168 (44%), Gaps = 33/168 (19%)
Query: 87  RNFLEVFNLISRGGFGSIY--------KARIQDGMEVVVKGFNLQYGGAFKNLD---VEC 135
           R+ L +   +  G FG +         K + ++ + V VK   L+     K+L     E 
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEM 91
Query: 136 NMMKII-RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTS-----NYILD------ 183
            MMK+I +H+N+I ++ +C++D    +I+EY   G+L + L         Y  D      
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 184 ----FFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
               F   +     +A  +EYL    ++   IH DL + NVL+ +N V
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL----ASQKCIHRDLAARNVLVTENNV 195

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/138 (23%), Positives = 65/138 (47%), Gaps = 19/138 (13%)
Query: 96  ISRGGFGSIYK-ARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKII-------RHQNLI 147
           I  G FGS++K  +  DG    +K       G+      E N ++ +       +H +++
Sbjct: 17  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHAVLGQHSHVV 72
Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLH---IMIDVASAVEYLHFG 204
           +  S+ ++DD   +  EY   GSL   +S +  I+ +F+      +++ V   + Y+H  
Sbjct: 73  RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH-- 130
Query: 205 HSTHVIIHCDLKSSNVLL 222
             +  ++H D+K SN+ +
Sbjct: 131 --SMSLVHMDIKPSNIFI 146

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 17/146 (11%)
Query: 91  EVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGG---AFKNLDV-ECNMMKIIRHQN 145
           EV   I  G +G   K R + DG  +V K   L YG    A K + V E N+++ ++H N
Sbjct: 9   EVLYTIGTGSYGRCQKIRRKSDGKILVWK--ELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 146 LIK----IISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQR---LHIMIDVASAV 198
           +++    II   +   +  +++EY   G L   ++       +      L +M  +  A+
Sbjct: 67  IVRYYDRIIDRTNTTLY--IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 199 EYLHF-GHSTHVIIHCDLKSSNVLLD 223
           +  H      H ++H DLK +NV LD
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLD 150

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 10/138 (7%)
Query: 94  NLISRGGFGSIYKARI--QDGMEV--VVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIK 148
            +I RG FG +Y   +   DG ++   VK  N +   G       E  +MK   H N++ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 149 IISSCSKDDFKAL-ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           ++  C + +   L +L YM HG L   +    +       +   + VA  ++YL    ++
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----AS 150
Query: 208 HVIIHCDLKSSNVLLDDN 225
              +H DL + N +LD+ 
Sbjct: 151 KKFVHRDLAARNCMLDEK 168

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 68/141 (48%), Gaps = 9/141 (6%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           L++   I +G FG +     + G +V VK   ++     +    E ++M  +RH NL+++
Sbjct: 14  LKLLQTIGKGEFGDVMLGDYR-GNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQL 70
Query: 150 ISSCSKDDFKALIL-EYMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           +    ++     I+ EYM  GSL   L S    +L     L   +DV  A+EYL   +  
Sbjct: 71  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-- 128
Query: 208 HVIIHCDLKSSNVLLDDNMVA 228
              +H DL + NVL+ ++ VA
Sbjct: 129 --FVHRDLAARNVLVSEDNVA 147

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 10/138 (7%)
Query: 94  NLISRGGFGSIYKARI--QDGMEV--VVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIK 148
            +I RG FG +Y   +   DG ++   VK  N +   G       E  +MK   H N++ 
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 149 IISSCSKDDFKAL-ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           ++  C + +   L +L YM HG L   +    +       +   + VA  ++YL    ++
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----AS 170
Query: 208 HVIIHCDLKSSNVLLDDN 225
              +H DL + N +LD+ 
Sbjct: 171 KKFVHRDLAARNCMLDEK 188

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 10/138 (7%)
Query: 94  NLISRGGFGSIYKARI--QDGMEV--VVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIK 148
            +I RG FG +Y   +   DG ++   VK  N +   G       E  +MK   H N++ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 149 IISSCSKDDFKAL-ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           ++  C + +   L +L YM HG L   +    +       +   + VA  ++YL    ++
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----AS 149
Query: 208 HVIIHCDLKSSNVLLDDN 225
              +H DL + N +LD+ 
Sbjct: 150 KKFVHRDLAARNCMLDEK 167

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 17/146 (11%)
Query: 91  EVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGG---AFKNLDV-ECNMMKIIRHQN 145
           EV   I  G +G   K R + DG  +V K   L YG    A K + V E N+++ ++H N
Sbjct: 9   EVLYTIGTGSYGRCQKIRRKSDGKILVWK--ELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 146 LIK----IISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQR---LHIMIDVASAV 198
           +++    II   +   +  +++EY   G L   ++       +      L +M  +  A+
Sbjct: 67  IVRYYDRIIDRTNTTLY--IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 199 EYLHF-GHSTHVIIHCDLKSSNVLLD 223
           +  H      H ++H DLK +NV LD
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLD 150

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 10/138 (7%)
Query: 94  NLISRGGFGSIYKARI--QDGMEV--VVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIK 148
            +I RG FG +Y   +   DG ++   VK  N +   G       E  +MK   H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 149 IISSCSKDDFKAL-ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           ++  C + +   L +L YM HG L   +    +       +   + VA  ++YL    ++
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----AS 151
Query: 208 HVIIHCDLKSSNVLLDDN 225
              +H DL + N +LD+ 
Sbjct: 152 KKFVHRDLAARNCMLDEK 169

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 10/138 (7%)
Query: 94  NLISRGGFGSIYKARI--QDGMEV--VVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIK 148
            +I RG FG +Y   +   DG ++   VK  N +   G       E  +MK   H N++ 
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 149 IISSCSKDDFKAL-ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           ++  C + +   L +L YM HG L   +    +       +   + VA  ++YL    ++
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----AS 143
Query: 208 HVIIHCDLKSSNVLLDDN 225
              +H DL + N +LD+ 
Sbjct: 144 KKFVHRDLAARNCMLDEK 161

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 10/138 (7%)
Query: 94  NLISRGGFGSIYKARI--QDGMEV--VVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIK 148
            +I RG FG +Y   +   DG ++   VK  N +   G       E  +MK   H N++ 
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 149 IISSCSKDDFKAL-ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           ++  C + +   L +L YM HG L   +    +       +   + VA  ++YL    ++
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----AS 169
Query: 208 HVIIHCDLKSSNVLLDDN 225
              +H DL + N +LD+ 
Sbjct: 170 KKFVHRDLAARNCMLDEK 187

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/138 (23%), Positives = 65/138 (47%), Gaps = 19/138 (13%)
Query: 96  ISRGGFGSIYK-ARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKII-------RHQNLI 147
           I  G FGS++K  +  DG    +K       G+      E N ++ +       +H +++
Sbjct: 19  IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHAVLGQHSHVV 74
Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLH---IMIDVASAVEYLHFG 204
           +  S+ ++DD   +  EY   GSL   +S +  I+ +F+      +++ V   + Y+H  
Sbjct: 75  RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH-- 132
Query: 205 HSTHVIIHCDLKSSNVLL 222
             +  ++H D+K SN+ +
Sbjct: 133 --SMSLVHMDIKPSNIFI 148

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 10/138 (7%)
Query: 94  NLISRGGFGSIYKARI--QDGMEV--VVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIK 148
            +I RG FG +Y   +   DG ++   VK  N +   G       E  +MK   H N++ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 149 IISSCSKDDFKAL-ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           ++  C + +   L +L YM HG L   +    +       +   + VA  ++YL    ++
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----AS 150
Query: 208 HVIIHCDLKSSNVLLDDN 225
              +H DL + N +LD+ 
Sbjct: 151 KKFVHRDLAARNCMLDEK 168

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 68/141 (48%), Gaps = 9/141 (6%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           L++   I +G FG +     + G +V VK   ++     +    E ++M  +RH NL+++
Sbjct: 23  LKLLQTIGKGEFGDVMLGDYR-GNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQL 79
Query: 150 ISSCSKDDFKALIL-EYMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           +    ++     I+ EYM  GSL   L S    +L     L   +DV  A+EYL   +  
Sbjct: 80  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-- 137
Query: 208 HVIIHCDLKSSNVLLDDNMVA 228
              +H DL + NVL+ ++ VA
Sbjct: 138 --FVHRDLAARNVLVSEDNVA 156

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 75/168 (44%), Gaps = 33/168 (19%)
Query: 87  RNFLEVFNLISRGGFGSIY--------KARIQDGMEVVVKGFNLQYGGAFKNLD---VEC 135
           R+ L +   +  G FG +         K + ++ + V VK   L+     K+L     E 
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEM 91
Query: 136 NMMKII-RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTS-----NYILD------ 183
            MMK+I +H+N+I ++ +C++D    +I+EY   G+L + L         Y  D      
Sbjct: 92  EMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 184 ----FFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
               F   +     +A  +EYL    ++   IH DL + NVL+ +N V
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL----ASQKCIHRDLAARNVLVTENNV 195

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 17/146 (11%)
Query: 91  EVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGG---AFKNLDV-ECNMMKIIRHQN 145
           EV   I  G +G   K R + DG  +V K   L YG    A K + V E N+++ ++H N
Sbjct: 9   EVLYTIGTGSYGRCQKIRRKSDGKILVWK--ELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 146 LIK----IISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQR---LHIMIDVASAV 198
           +++    II   +   +  +++EY   G L   ++       +      L +M  +  A+
Sbjct: 67  IVRYYDRIIDRTNTTLY--IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 199 EYLHF-GHSTHVIIHCDLKSSNVLLD 223
           +  H      H ++H DLK +NV LD
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLD 150

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 10/138 (7%)
Query: 94  NLISRGGFGSIYKARI--QDGMEV--VVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIK 148
            +I RG FG +Y   +   DG ++   VK  N +   G       E  +MK   H N++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 149 IISSCSKDDFKAL-ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           ++  C + +   L +L YM HG L   +    +       +   + VA  ++YL    ++
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----AS 148
Query: 208 HVIIHCDLKSSNVLLDDN 225
              +H DL + N +LD+ 
Sbjct: 149 KKFVHRDLAARNCMLDEK 166

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/142 (24%), Positives = 61/142 (42%), Gaps = 9/142 (6%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMKIIRHQ 144
           R  + +   +  G FG +   + +   +V VK       G+    +   E   M  + H 
Sbjct: 7   REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHP 63
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
            L+K    CSK+    ++ EY+ +G L   L +    L+  Q L +  DV   + +L   
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL--- 120
Query: 205 HSTHVIIHCDLKSSNVLLDDNM 226
             +H  IH DL + N L+D ++
Sbjct: 121 -ESHQFIHRDLAARNCLVDRDL 141

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 10/138 (7%)
Query: 94  NLISRGGFGSIYKARI--QDGMEV--VVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIK 148
            +I RG FG +Y   +   DG ++   VK  N +   G       E  +MK   H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 149 IISSCSKDDFKAL-ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           ++  C + +   L +L YM HG L   +    +       +   + VA  ++YL    ++
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----AS 146
Query: 208 HVIIHCDLKSSNVLLDDN 225
              +H DL + N +LD+ 
Sbjct: 147 KKFVHRDLAARNCMLDEK 164

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 10/138 (7%)
Query: 94  NLISRGGFGSIYKARI--QDGMEV--VVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIK 148
            +I RG FG +Y   +   DG ++   VK  N +   G       E  +MK   H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 149 IISSCSKDDFKAL-ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           ++  C + +   L +L YM HG L   +    +       +   + VA  ++YL    ++
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL----AS 151
Query: 208 HVIIHCDLKSSNVLLDDN 225
              +H DL + N +LD+ 
Sbjct: 152 KKFVHRDLAARNCMLDEK 169

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 68/141 (48%), Gaps = 9/141 (6%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           L++   I +G FG +     + G +V VK   ++     +    E ++M  +RH NL+++
Sbjct: 8   LKLLQTIGKGEFGDVMLGDYR-GNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQL 64
Query: 150 ISSCSKDDFKALIL-EYMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           +    ++     I+ EYM  GSL   L S    +L     L   +DV  A+EYL   +  
Sbjct: 65  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-- 122
Query: 208 HVIIHCDLKSSNVLLDDNMVA 228
              +H DL + NVL+ ++ VA
Sbjct: 123 --FVHRDLAARNVLVSEDNVA 141

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 66/147 (44%), Gaps = 14/147 (9%)
Query: 87  RNFLEVFNLISRGGFG--SIY---KARIQDGMEVVVKGFNLQYGGAFKN-LDVECNMMKI 140
           + +L+    +  G FG  S+Y         G  V VK      G   ++    E ++++ 
Sbjct: 13  KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRT 72
Query: 141 IRHQNLIKIISSCSKDDFKA--LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV 198
           + H+++IK    C     K+  L++EY+P GSL   L   +  +   Q L     +   +
Sbjct: 73  LYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGM 130
Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            YLH  H     IH +L + NVLLD++
Sbjct: 131 AYLHSQH----YIHRNLAARNVLLDND 153

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 68/141 (48%), Gaps = 9/141 (6%)
Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           L++   I +G FG +     + G +V VK   ++     +    E ++M  +RH NL+++
Sbjct: 195 LKLLQTIGKGEFGDVMLGDYR-GNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNLVQL 251
Query: 150 ISSCSKDDFKALIL-EYMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           +    ++     I+ EYM  GSL   L S    +L     L   +DV  A+EYL   +  
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN-- 309
Query: 208 HVIIHCDLKSSNVLLDDNMVA 228
              +H DL + NVL+ ++ VA
Sbjct: 310 --FVHRDLAARNVLVSEDNVA 328

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 74/168 (44%), Gaps = 33/168 (19%)
Query: 87  RNFLEVFNLISRGGFGSIY--------KARIQDGMEVVVKGFNLQYGGAFKNLD---VEC 135
           R+ L +   +  G FG +         K + ++ + V VK   L+     K+L     E 
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEM 91
Query: 136 NMMKII-RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLST---------------SN 179
            MMK+I +H+N+I ++ +C++D    +I+EY   G+L + L                   
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPE 151
Query: 180 YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
             + F   +     +A  +EYL    ++   IH DL + NVL+ +N V
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYL----ASQKCIHRDLAARNVLVTENNV 195

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/136 (22%), Positives = 64/136 (47%), Gaps = 5/136 (3%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQD-GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN 145
            +F E+   +  G FG +YKA+ ++  +    K  + +     ++  VE +++    H N
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 95
Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 205
           ++K++ +   ++   +++E+   G++   +      L   Q   +      A+ YLH   
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH--- 152
Query: 206 STHVIIHCDLKSSNVL 221
             + IIH DLK+ N+L
Sbjct: 153 -DNKIIHRDLKAGNIL 167

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/136 (22%), Positives = 64/136 (47%), Gaps = 5/136 (3%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQD-GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN 145
            +F E+   +  G FG +YKA+ ++  +    K  + +     ++  VE +++    H N
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 95
Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 205
           ++K++ +   ++   +++E+   G++   +      L   Q   +      A+ YLH   
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH--- 152
Query: 206 STHVIIHCDLKSSNVL 221
             + IIH DLK+ N+L
Sbjct: 153 -DNKIIHRDLKAGNIL 167

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/143 (22%), Positives = 66/143 (46%), Gaps = 9/143 (6%)
Query: 90  LEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQ 144
           + +  ++  G FG +   R++      + V +K   + Y     ++   E ++M    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N+I++    +K     ++ E M +GSL   L   +      Q + ++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 163
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
            S    +H DL + N+L++ N+V
Sbjct: 164 -SDMGAVHRDLAARNILINSNLV 185

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/136 (22%), Positives = 64/136 (47%), Gaps = 5/136 (3%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQD-GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN 145
            +F E+   +  G FG +YKA+ ++  +    K  + +     ++  VE +++    H N
Sbjct: 36  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 95
Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 205
           ++K++ +   ++   +++E+   G++   +      L   Q   +      A+ YLH   
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH--- 152
Query: 206 STHVIIHCDLKSSNVL 221
             + IIH DLK+ N+L
Sbjct: 153 -DNKIIHRDLKAGNIL 167

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 72/166 (43%), Gaps = 29/166 (17%)
Query: 87  RNFLEVFNLISRGGFGSIY--------KARIQDGMEVVVKGFNLQYGGA-FKNLDVECNM 137
           R+ L +   +  G FG +         K + ++ + V VK            +L  E  M
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEM 93
Query: 138 MKII-RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTS-----NYILD-------- 183
           MK+I +H+N+I ++ +C++D    +I+EY   G+L + L         Y  D        
Sbjct: 94  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 184 --FFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
             F   +     +A  +EYL    ++   IH DL + NVL+ +N V
Sbjct: 154 MTFKDLVSCTYQLARGMEYL----ASQKCIHRDLAARNVLVTENNV 195

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 41.6 bits (96), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 66/144 (45%), Gaps = 18/144 (12%)
Query: 91  EVFNLISRGGFGSIYKARIQD-GMEVVVKGFNLQYGGAFKNLDVEC---NMMKIIRHQNL 146
           E+   +  GGFG + +   QD G +V +K    +   + KN +  C    +MK + H N+
Sbjct: 18  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNV 75
Query: 147 IKI------ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQR--LHIMIDVASAV 198
           +        +   + +D   L +EY   G L K L+         +     ++ D++SA+
Sbjct: 76  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 135
Query: 199 EYLHFGHSTHVIIHCDLKSSNVLL 222
            YLH     + IIH DLK  N++L
Sbjct: 136 RYLH----ENRIIHRDLKPENIVL 155

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/144 (27%), Positives = 66/144 (45%), Gaps = 18/144 (12%)
Query: 91  EVFNLISRGGFGSIYKARIQD-GMEVVVKGFNLQYGGAFKNLDVEC---NMMKIIRHQNL 146
           E+   +  GGFG + +   QD G +V +K    +   + KN +  C    +MK + H N+
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNV 74
Query: 147 IKI------ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQR--LHIMIDVASAV 198
           +        +   + +D   L +EY   G L K L+         +     ++ D++SA+
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134
Query: 199 EYLHFGHSTHVIIHCDLKSSNVLL 222
            YLH     + IIH DLK  N++L
Sbjct: 135 RYLH----ENRIIHRDLKPENIVL 154

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/143 (22%), Positives = 66/143 (46%), Gaps = 9/143 (6%)
Query: 90  LEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQ 144
           + +  ++  G FG +   R++      + V +K   + Y     ++   E ++M    H 
Sbjct: 47  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N+I++    +K     ++ E M +GSL   L   +      Q + ++  +AS ++YL   
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 163
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
            S    +H DL + N+L++ N+V
Sbjct: 164 -SDMGYVHRDLAARNILINSNLV 185

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/149 (23%), Positives = 69/149 (46%), Gaps = 21/149 (14%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQN 145
           R  L +   + +G FG ++         V +K   L+ G  + +    E  +MK +RH+ 
Sbjct: 17  RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEK 74
Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQ-------RLHIMIDVASAV 198
           L+++ +  S++    ++ EYM  G L          LDF +       RL  ++D+A+ +
Sbjct: 75  LVQLYAVVSEEPI-YIVTEYMSKGCL----------LDFLKGEMGKYLRLPQLVDMAAQI 123
Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
                       +H DL+++N+L+ +N+V
Sbjct: 124 ASGMAYVERMNYVHRDLRAANILVGENLV 152

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 41.2 bits (95), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 75/168 (44%), Gaps = 33/168 (19%)
Query: 87  RNFLEVFNLISRGGFGSIY--------KARIQDGMEVVVKGFNLQYGGAFKNLD---VEC 135
           R+ L +   +  G FG +         K + ++ + V VK   L+     K+L     E 
Sbjct: 80  RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEM 137
Query: 136 NMMKII-RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTS-----NYILD------ 183
            MMK+I +H+N+I ++ +C++D    +I+EY   G+L + L         Y  D      
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 184 ----FFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
               F   +     +A  +EYL    ++   IH DL + NVL+ +N V
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYL----ASQKCIHRDLAARNVLVTENNV 241

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/143 (22%), Positives = 67/143 (46%), Gaps = 9/143 (6%)
Query: 90  LEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQ 144
           + +  +I  G FG +   R++      + V +K   + Y     ++   E ++M    H 
Sbjct: 24  ITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 83
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N+I +    +K     ++ EYM +GSL   L  ++      Q + ++  +++ ++YL   
Sbjct: 84  NIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYL--- 140
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
            S    +H DL + N+L++ N+V
Sbjct: 141 -SDMGYVHRDLAARNILINSNLV 162

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 32/143 (22%), Positives = 66/143 (46%), Gaps = 9/143 (6%)
Query: 90  LEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQ 144
           + +  ++  G FG +   R++      + V +K   + Y     ++   E ++M    H 
Sbjct: 18  ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP 77
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N+I++    +K     ++ E M +GSL   L   +      Q + ++  +AS ++YL   
Sbjct: 78  NIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL--- 134
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
            S    +H DL + N+L++ N+V
Sbjct: 135 -SDMGYVHRDLAARNILINSNLV 156

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/140 (22%), Positives = 66/140 (47%), Gaps = 8/140 (5%)
Query: 86  FRNFLEVFNLISRGGFGSIYK-ARIQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIR 142
           F +  ++F  + +G F  + +  +     E   K  N +   A   + L+ E  + ++++
Sbjct: 29  FTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLK 88
Query: 143 HQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH 202
           H N++++  S S++ F  L+ + +  G L + +    Y  +     H +  +  +V ++H
Sbjct: 89  HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE-ADASHCIHQILESVNHIH 147
Query: 203 FGHSTHVIIHCDLKSSNVLL 222
                H I+H DLK  N+LL
Sbjct: 148 ----QHDIVHRDLKPENLLL 163

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 75/168 (44%), Gaps = 33/168 (19%)
Query: 87  RNFLEVFNLISRGGFGSIY--------KARIQDGMEVVVKGFNLQYGGAFKNLD---VEC 135
           R+ L +   +  G FG +         K + ++ + V VK   L+     K+L     E 
Sbjct: 26  RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEM 83
Query: 136 NMMKII-RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTS-----NYILD------ 183
            MMK+I +H+N+I ++ +C++D    +I+EY   G+L + L         Y  D      
Sbjct: 84  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 143
Query: 184 ----FFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
               F   +     +A  +EYL    ++   IH DL + NVL+ +N V
Sbjct: 144 EQMTFKDLVSCTYQLARGMEYL----ASQKCIHRDLAARNVLVTENNV 187

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 34/150 (22%), Positives = 70/150 (46%), Gaps = 23/150 (15%)
Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQN 145
           R  L++   +  G FG ++        +V +K   L+ G  + ++   E  +MK ++H  
Sbjct: 8   RESLQLIKRLGNGQFGEVWMGTWNGNTKVAIK--TLKPGTMSPESFLEEAQIMKKLKHDK 65
Query: 146 LIKIISSCSKDDFKALILEYMPHGSL--------GKCLSTSNYILDFFQRLHIMIDVASA 197
           L+++ +  S++    ++ EYM  GSL        G+ L   N +        +   VA+ 
Sbjct: 66  LVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLV-------DMAAQVAAG 117
Query: 198 VEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           + Y+   +     IH DL+S+N+L+ + ++
Sbjct: 118 MAYIERMN----YIHRDLRSANILVGNGLI 143

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 75/168 (44%), Gaps = 33/168 (19%)
Query: 87  RNFLEVFNLISRGGFGSIY--------KARIQDGMEVVVKGFNLQYGGAFKNLD---VEC 135
           R+ L +   +  G FG +         K + ++ + V VK   L+     K+L     E 
Sbjct: 23  RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEM 80
Query: 136 NMMKII-RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTS-----NYILD------ 183
            MMK+I +H+N+I ++ +C++D    +I+EY   G+L + L         Y  D      
Sbjct: 81  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 140
Query: 184 ----FFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
               F   +     +A  +EYL    ++   IH DL + NVL+ +N V
Sbjct: 141 EQMTFKDLVSCTYQLARGMEYL----ASQKCIHRDLAARNVLVTENNV 184

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 66/143 (46%), Gaps = 9/143 (6%)
Query: 90  LEVFNLISRGGFGSIYKARIQ--DGMEVVVKGFNLQYGGAFKNLD---VECNMMKIIRHQ 144
           +++  +I  G FG +   R++     E+ V    L+ G   K       E ++M    H 
Sbjct: 31  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 90
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N+I +    +K     +I EYM +GSL   L  ++      Q + ++  + S ++YL   
Sbjct: 91  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYL--- 147
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
            S    +H DL + N+L++ N+V
Sbjct: 148 -SDMSAVHRDLAARNILVNSNLV 169

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 75/168 (44%), Gaps = 33/168 (19%)
Query: 87  RNFLEVFNLISRGGFGSIY--------KARIQDGMEVVVKGFNLQYGGAFKNLD---VEC 135
           R+ L +   +  G FG +         K + ++ + V VK   L+     K+L     E 
Sbjct: 21  RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK--MLKDDATEKDLSDLVSEM 78
Query: 136 NMMKII-RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTS-----NYILD------ 183
            MMK+I +H+N+I ++ +C++D    +I+EY   G+L + L         Y  D      
Sbjct: 79  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 138
Query: 184 ----FFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
               F   +     +A  +EYL    ++   IH DL + NVL+ +N V
Sbjct: 139 EQMTFKDLVSCTYQLARGMEYL----ASQKCIHRDLTARNVLVTENNV 182

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/150 (20%), Positives = 64/150 (42%), Gaps = 12/150 (8%)
Query: 82  IPRPFR-------NFLEVFNLISRGGFGSIYK-ARIQDGMEVVVKGFNLQYGGAFKNLDV 133
           +P+P         ++ ++   +  G FG +++      G   V K  N  Y      +  
Sbjct: 38  VPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN 97
Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMID 193
           E ++M  + H  LI +  +        LILE++  G L   ++  +Y +   + ++ M  
Sbjct: 98  EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ 157
Query: 194 VASAVEYLHFGHSTHVIIHCDLKSSNVLLD 223
               ++++H     H I+H D+K  N++ +
Sbjct: 158 ACEGLKHMH----EHSIVHLDIKPENIMCE 183

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/138 (24%), Positives = 61/138 (44%), Gaps = 10/138 (7%)
Query: 94  NLISRGGFGSIYKARI--QDGMEV--VVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIK 148
            +I RG FG +Y   +   DG ++   VK  N +   G       E  +MK   H N++ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 149 IISSCSKDDFKAL-ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           ++  C + +   L +L YM HG L   +    +       +   + VA  +++L    ++
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----AS 152
Query: 208 HVIIHCDLKSSNVLLDDN 225
              +H DL + N +LD+ 
Sbjct: 153 KKFVHRDLAARNCMLDEK 170

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 40.4 bits (93), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 34/138 (24%), Positives = 61/138 (44%), Gaps = 10/138 (7%)
Query: 94  NLISRGGFGSIYKARI--QDGMEV--VVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIK 148
            +I RG FG +Y   +   DG ++   VK  N +   G       E  +MK   H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 149 IISSCSKDDFKAL-ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           ++  C + +   L +L YM HG L   +    +       +   + VA  +++L    ++
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----AS 210
Query: 208 HVIIHCDLKSSNVLLDDN 225
              +H DL + N +LD+ 
Sbjct: 211 KKFVHRDLAARNCMLDEK 228

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 34/138 (24%), Positives = 61/138 (44%), Gaps = 10/138 (7%)
Query: 94  NLISRGGFGSIYKARI--QDGMEV--VVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIK 148
            +I RG FG +Y   +   DG ++   VK  N +   G       E  +MK   H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 149 IISSCSKDDFKAL-ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           ++  C + +   L +L YM HG L   +    +       +   + VA  +++L    ++
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----AS 151
Query: 208 HVIIHCDLKSSNVLLDDN 225
              +H DL + N +LD+ 
Sbjct: 152 KKFVHRDLAARNCMLDEK 169

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 34/138 (24%), Positives = 61/138 (44%), Gaps = 10/138 (7%)
Query: 94  NLISRGGFGSIYKARI--QDGMEV--VVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIK 148
            +I RG FG +Y   +   DG ++   VK  N +   G       E  +MK   H N++ 
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 100
Query: 149 IISSCSKDDFKAL-ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           ++  C + +   L +L YM HG L   +    +       +   + VA  +++L    ++
Sbjct: 101 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----AS 156
Query: 208 HVIIHCDLKSSNVLLDDN 225
              +H DL + N +LD+ 
Sbjct: 157 KKFVHRDLAARNCMLDEK 174

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 16/144 (11%)
Query: 91  EVFNLISRGGFGSIYKARIQD-GMEVVVKGF-NLQYGGAFKNLDV-ECNMMKIIRHQNLI 147
           E    I  G +G ++K R +D G  V +K F   +     K + + E  M+K ++H NL+
Sbjct: 6   EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLV 65
Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQR---LHIMIDVA-SAVEYLHF 203
            ++    +     L+ EY  H  L +        LD +QR    H++  +    ++ ++F
Sbjct: 66  NLLEVFRRKRRLHLVFEYCDHTVLHE--------LDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 204 GHSTHVIIHCDLKSSNVLLDDNMV 227
            H  H  IH D+K  N+L+  + V
Sbjct: 118 CHK-HNCIHRDVKPENILITKHSV 140

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 32/117 (27%), Positives = 53/117 (45%), Gaps = 9/117 (7%)
Query: 112 GMEVVVKGFNLQYGGAFKN-LDVECNMMKIIRHQNLIKIISSCSKDDFKA--LILEYMPH 168
           G  V VK      G   ++    E  +++ + H++++K    C     K+  L++EY+P 
Sbjct: 38  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 97
Query: 169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
           GSL   L    + +   Q L     +   + YLH  H     IH  L + NVLLD++
Sbjct: 98  GSLRDYL--PRHCVGLAQLLLFAQQICEGMAYLHAQH----YIHRALAARNVLLDND 148

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 34/138 (24%), Positives = 61/138 (44%), Gaps = 10/138 (7%)
Query: 94  NLISRGGFGSIYKARI--QDGMEV--VVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIK 148
            +I RG FG +Y   +   DG ++   VK  N +   G       E  +MK   H N++ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 149 IISSCSKDDFKAL-ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           ++  C + +   L +L YM HG L   +    +       +   + VA  +++L    ++
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----AS 149
Query: 208 HVIIHCDLKSSNVLLDDN 225
              +H DL + N +LD+ 
Sbjct: 150 KKFVHRDLAARNCMLDEK 167

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 34/138 (24%), Positives = 61/138 (44%), Gaps = 10/138 (7%)
Query: 94  NLISRGGFGSIYKARI--QDGMEV--VVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIK 148
            +I RG FG +Y   +   DG ++   VK  N +   G       E  +MK   H N++ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 149 IISSCSKDDFKAL-ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           ++  C + +   L +L YM HG L   +    +       +   + VA  +++L    ++
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----AS 152
Query: 208 HVIIHCDLKSSNVLLDDN 225
              +H DL + N +LD+ 
Sbjct: 153 KKFVHRDLAARNCMLDEK 170

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 32/117 (27%), Positives = 53/117 (45%), Gaps = 9/117 (7%)
Query: 112 GMEVVVKGFNLQYGGAFKN-LDVECNMMKIIRHQNLIKIISSCSKDDFKA--LILEYMPH 168
           G  V VK      G   ++    E  +++ + H++++K    C     K+  L++EY+P 
Sbjct: 37  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 96
Query: 169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
           GSL   L    + +   Q L     +   + YLH  H     IH  L + NVLLD++
Sbjct: 97  GSLRDYL--PRHCVGLAQLLLFAQQICEGMAYLHAQH----YIHRALAARNVLLDND 147

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 34/138 (24%), Positives = 61/138 (44%), Gaps = 10/138 (7%)
Query: 94  NLISRGGFGSIYKARI--QDGMEV--VVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIK 148
            +I RG FG +Y   +   DG ++   VK  N +   G       E  +MK   H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 149 IISSCSKDDFKAL-ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           ++  C + +   L +L YM HG L   +    +       +   + VA  +++L    ++
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL----AS 151
Query: 208 HVIIHCDLKSSNVLLDDN 225
              +H DL + N +LD+ 
Sbjct: 152 KKFVHRDLAARNCMLDEK 169

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 66/143 (46%), Gaps = 9/143 (6%)
Query: 90  LEVFNLISRGGFGSIYKARIQ--DGMEVVVKGFNLQYGGAFKNLD---VECNMMKIIRHQ 144
           +++  +I  G FG +   R++     E+ V    L+ G   K       E ++M    H 
Sbjct: 16  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 75
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N+I +    +K     +I EYM +GSL   L  ++      Q + ++  + S ++YL   
Sbjct: 76  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYL--- 132
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
            S    +H DL + N+L++ N+V
Sbjct: 133 -SDMSYVHRDLAARNILVNSNLV 154

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 36/143 (25%), Positives = 66/143 (46%), Gaps = 9/143 (6%)
Query: 90  LEVFNLISRGGFGSIYKARIQ--DGMEVVVKGFNLQYGGAFKNLD---VECNMMKIIRHQ 144
           +++  +I  G FG +   R++     E+ V    L+ G   K       E ++M    H 
Sbjct: 10  IKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHP 69
Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N+I +    +K     +I EYM +GSL   L  ++      Q + ++  + S ++YL   
Sbjct: 70  NIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYL--- 126
Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
            S    +H DL + N+L++ N+V
Sbjct: 127 -SDMSYVHRDLAARNILVNSNLV 148

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 40.4 bits (93), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 35/145 (24%), Positives = 64/145 (44%), Gaps = 10/145 (6%)
Query: 86  FRNFLEVFNLISR---GGFGSIYKARIQDGMEVVVKGFNL--QYGGAFKNLDVECNMMKI 140
           F+  +E +  + +   G +G +YKA+   G  V +K   L  +  G       E +++K 
Sbjct: 16  FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKE 75
Query: 141 IRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEY 200
           + H N++ +I     +    L+ E+M    L K L  +   L   Q    +  +   V +
Sbjct: 76  LHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 201 LHFGHSTHVIIHCDLKSSNVLLDDN 225
            H     H I+H DLK  N+L++ +
Sbjct: 135 CH----QHRILHRDLKPQNLLINSD 155

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	232
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-34
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-33
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-32
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-32
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-32
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-31
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-31
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-31
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-30
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-30
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-30
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	7e-30
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	8e-30
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-29
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-29
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-28
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-28
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-28
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-22
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-21
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-20
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-20
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-19
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-19
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-19
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-19
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-19
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-19
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-19
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-16
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-15
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-14
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	8e-13
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-10
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-09
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-05
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-18
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-18
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-18
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-18
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-18
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-18
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-18
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-18
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-14
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-14
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-13
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	4e-06
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-18
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-18
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-18
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-18
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-18
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-18
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-18
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-17
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-17
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-17
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-17
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-17
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-17
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-17
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-17
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	8e-17
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	8e-17
2a19_B	284	Interferon-induced, double-stranded RNA-activated	8e-17
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-17
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-16
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-16
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-16
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-16
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-16
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-16
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-16
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-16
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-16
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-16
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-16
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-16
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-16
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-16
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-16
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-16
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-16
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-16
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	9e-16
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	9e-16
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-15
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-15
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-15
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-15
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-15
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-15
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-15
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-15
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-15
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-15
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-15
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-15
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-15
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-15
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-15
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-15
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-14
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-14
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-14
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-14
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-14
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-14
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-14
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-14
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-14
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-13
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-13
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-13
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-10
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-08
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-07
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-05
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-04
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	9e-12
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-11
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-11
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-11
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-11
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-11
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-11
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-10
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-09
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	9e-08
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-07
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-06
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-11
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-11
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	8e-11
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-10
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-09
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-08
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-07
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	5e-06
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-05
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-10
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-10
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-10
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	8e-09
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-08
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-08
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	5e-08
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-07
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-07
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-07
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-06
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-05
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-05
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-10
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-10
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-10
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-10
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-10
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-10
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-10
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-10
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-10
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-10
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-10
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-10
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-10
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-10
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-07
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-06
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-04
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-04
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	6e-10
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-10
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-08
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	6e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-06
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-04
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-04
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-04
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-10
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-09
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-09
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-09
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-09
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-09
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-09
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-09
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-09
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-09
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-09
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	8e-09
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	8e-09
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-09
3niz_A	311	Rhodanese family protein; structural genomics, str	9e-09
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-08
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-08
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-08
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-08
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-08
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-08
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-08
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-08
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-08
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-08
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-08
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-07
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-07
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-06
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-04
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-08
2dyl_A	318	Dual specificity mitogen-activated protein kinase	4e-08
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-08
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-08
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-08
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-08
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	6e-08
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-08
3fme_A	290	Dual specificity mitogen-activated protein kinase;	9e-08
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-07
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-07
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	3e-07
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-04
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-04
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-04
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-04
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-04
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-07
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-07
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-07
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-07
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-07
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-07
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-07
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-04
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-07
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-05
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-04
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-04
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-07
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	6e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-07
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-06
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-06
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-06
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-06
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-06
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-06
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-05
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	2e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-06
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-04
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-04
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-04
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-06
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-06
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-06
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-06
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-05
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-04
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-04
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-04
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	6e-04
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-06
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-05
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-04
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-04
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-04
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-06
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	9e-06
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-05
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-05
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-05
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-05
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-04
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-05
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-05
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-05
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-05
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-04
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	7e-04
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-05
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-05
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-05
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-04
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	5e-04
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	9e-05
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-04
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-04
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-05
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-05
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	5e-04
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	7e-05
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	9e-05
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-04
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-04
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-04
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-04
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-04
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-04
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	3e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-04
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-04
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-04
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	3e-04
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-04
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-04
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	9e-04
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-04
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-04
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-04
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-04
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-04
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-04
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-04
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	7e-04
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	7e-04
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-04
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-04
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	9e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  123 bits (311), Expect = 4e-34
 Identities = 49/145 (33%), Positives = 74/145 (51%), Gaps = 8/145 (5%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL 146
            NF     LI  G FG +YK  ++DG +V +K    +     +  + E   +   RH +L
Sbjct: 39  NNFDHK-FLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHL 97

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSN---YILDFFQRLHIMIDVASAVEYLHF 203
           + +I  C + +   LI +YM +G+L + L  S+     + + QRL I I  A  + YLH 
Sbjct: 98  VSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH- 156

Query: 204 GHSTHVIIHCDLKSSNVLLDDNMVA 228
              T  IIH D+KS N+LLD+N V 
Sbjct: 157 ---TRAIIHRDVKSINILLDENFVP 178

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  119 bits (301), Expect = 5e-33
 Identities = 37/144 (25%), Positives = 72/144 (50%), Gaps = 8/144 (5%)

Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLI 147
           L     ++    G ++K R Q G ++VVK   ++       ++ + EC  ++I  H N++
Sbjct: 12  LNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70

Query: 148 KIISSCSK--DDFKALILEYMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYLHFG 204
            ++ +C         LI  +MP+GSL   L   +N+++D  Q +   +D+A  + +LH  
Sbjct: 71  PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-- 128

Query: 205 HSTHVIIHCDLKSSNVLLDDNMVA 228
               +I    L S +V++D++M A
Sbjct: 129 TLEPLIPRHALNSRSVMIDEDMTA 152

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  119 bits (300), Expect = 1e-32
 Identities = 40/149 (26%), Positives = 72/149 (48%), Gaps = 14/149 (9%)

Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           L++  + +RG FG ++KA++     V VK F +Q   +++N + E   +  ++H+N+++ 
Sbjct: 26  LQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQF 83

Query: 150 ISSCSKDDFKA----LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH--- 202
           I +  +         LI  +   GSL   L     ++ + +  HI   +A  + YLH   
Sbjct: 84  IGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--ANVVSWNELCHIAETMARGLAYLHEDI 141

Query: 203 ---FGHSTHVIIHCDLKSSNVLLDDNMVA 228
                     I H D+KS NVLL +N+ A
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTA 170

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  118 bits (298), Expect = 2e-32
 Identities = 42/143 (29%), Positives = 70/143 (48%), Gaps = 7/143 (4%)

Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLI 147
           L +   I  G FG++++A    G +V VK    Q            E  +MK +RH N++
Sbjct: 39  LNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97

Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCL--STSNYILDFFQRLHIMIDVASAVEYLHFGH 205
             + + ++    +++ EY+  GSL + L  S +   LD  +RL +  DVA  + YLH  +
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH--N 155

Query: 206 STHVIIHCDLKSSNVLLDDNMVA 228
               I+H +LKS N+L+D     
Sbjct: 156 RNPPIVHRNLKSPNLLVDKKYTV 178

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  117 bits (294), Expect = 6e-32
 Identities = 36/144 (25%), Positives = 67/144 (46%), Gaps = 12/144 (8%)

Query: 90  LEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQ-------YGGAFKNLDVECNMMKII 141
           +E    I +GGFG ++K R ++D   V +K   L            F+    E  +M  +
Sbjct: 21  IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80

Query: 142 RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL 201
            H N++K+           +++E++P G L   L    + + +  +L +M+D+A  +EY+
Sbjct: 81  NHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138

Query: 202 HFGHSTHVIIHCDLKSSNVLLDDN 225
              +    I+H DL+S N+ L   
Sbjct: 139 Q--NQNPPIVHRDLRSPNIFLQSL 160

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  116 bits (291), Expect = 3e-31
 Identities = 44/151 (29%), Positives = 68/151 (45%), Gaps = 18/151 (11%)

Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKI--IRHQNLI 147
           L++  LI RG +G++YK  + D   V VK F+      F N   E N+ ++  + H N+ 
Sbjct: 15  LKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFIN---EKNIYRVPLMEHDNIA 70

Query: 148 KIISSCSKDDFKA-----LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH 202
           + I    +          L++EY P+GSL K LS   +  D+     +   V   + YLH
Sbjct: 71  RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSDWVSSCRLAHSVTRGLAYLH 128

Query: 203 -----FGHSTHVIIHCDLKSSNVLLDDNMVA 228
                  H    I H DL S NVL+ ++   
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  115 bits (290), Expect = 4e-31
 Identities = 38/143 (26%), Positives = 63/143 (44%), Gaps = 14/143 (9%)

Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-----AFKNLDVECNMMKIIRHQ 144
           LE+  LI +G FG +Y  R     EV ++  +++        AFK    E    +  RH+
Sbjct: 35  LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKR---EVMAYRQTRHE 89

Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N++  + +C      A+I       +L   +  +  +LD  +   I  ++   + YLH  
Sbjct: 90  NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH-- 147

Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
                I+H DLKS NV  D+  V
Sbjct: 148 --AKGILHKDLKSKNVFYDNGKV 168

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  114 bits (288), Expect = 6e-31
 Identities = 38/147 (25%), Positives = 65/147 (44%), Gaps = 12/147 (8%)

Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           + +   + +G +G +++   Q G  V VK F+ +   ++   + E     ++RH+N++  
Sbjct: 10  ITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGF 67

Query: 150 ISSCSKDDFKA----LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH--- 202
           I+S       +    LI  Y   GSL   L      LD    L I++ +AS + +LH   
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 203 -FGHSTHVIIHCDLKSSNVLLDDNMVA 228
                   I H DLKS N+L+  N   
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQC 152

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  113 bits (286), Expect = 2e-30
 Identities = 47/140 (33%), Positives = 71/140 (50%), Gaps = 5/140 (3%)

Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISS 152
           N++ RGGFG +YK R+ DG  V VK    +   G       E  M+ +  H+NL+++   
Sbjct: 36  NILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95

Query: 153 CSKDDFKALILEYMPHGSLGKCL---STSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV 209
           C     + L+  YM +GS+  CL     S   LD+ +R  I +  A  + YLH       
Sbjct: 96  CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK- 154

Query: 210 IIHCDLKSSNVLLDDNMVAH 229
           IIH D+K++N+LLD+   A 
Sbjct: 155 IIHRDVKAANILLDEEFEAV 174

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  112 bits (283), Expect = 6e-30
 Identities = 36/147 (24%), Positives = 64/147 (43%), Gaps = 12/147 (8%)

Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           +++   I +G +G ++  + + G +V VK F      ++   + E     ++RH+N++  
Sbjct: 39  IQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFR-ETEIYQTVLMRHENILGF 96

Query: 150 ISSCSKDDFK----ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH--- 202
           I++  K         LI +Y  +GSL   L   +  LD    L +     S + +LH   
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYLK--STTLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 203 -FGHSTHVIIHCDLKSSNVLLDDNMVA 228
                   I H DLKS N+L+  N   
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTC 181

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  111 bits (279), Expect = 6e-30
 Identities = 40/141 (28%), Positives = 67/141 (47%), Gaps = 8/141 (5%)

Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQ----YGGAFKNLDVECNMMKIIRHQN 145
           L +  +I  GGFG +Y+A    G EV VK              +N+  E  +  +++H N
Sbjct: 9   LTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67

Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 205
           +I +   C K+    L++E+   G L + LS     +     ++  + +A  + YLH   
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLH-DE 124

Query: 206 STHVIIHCDLKSSNVLLDDNM 226
           +   IIH DLKSSN+L+   +
Sbjct: 125 AIVPIIHRDLKSSNILILQKV 145

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  112 bits (281), Expect = 7e-30
 Identities = 37/147 (25%), Positives = 59/147 (40%), Gaps = 12/147 (8%)

Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           +EV  ++ RG FG + KA      +V +K    +     K   VE   +  + H N++K+
Sbjct: 10  IEVEEVVGRGAFGVVCKA-KWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKL 66

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSN--YILDFFQRLHIMIDVASAVEYLHFGHST 207
             +C       L++EY   GSL   L  +           +   +  +  V YLH     
Sbjct: 67  YGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH-SMQP 123

Query: 208 HVIIHCDLKSSNVLLDDNM----VAHF 230
             +IH DLK  N+LL        +  F
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDF 150

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  111 bits (278), Expect = 3e-29
 Identities = 38/147 (25%), Positives = 71/147 (48%), Gaps = 12/147 (8%)

Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           + +   I +G FG +++ + + G EV VK F+ +   ++   + E     ++RH+N++  
Sbjct: 44  IVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGF 101

Query: 150 ISSCSKDDFKA----LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH--- 202
           I++ +KD+       L+ +Y  HGSL   L+   Y +     + + +  AS + +LH   
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEI 159

Query: 203 -FGHSTHVIIHCDLKSSNVLLDDNMVA 228
                   I H DLKS N+L+  N   
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTC 186

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  109 bits (275), Expect = 4e-29
 Identities = 38/143 (26%), Positives = 64/143 (44%), Gaps = 15/143 (10%)

Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-----AFKNLDVECNMMKIIRHQ 144
           + V   I  G FG++YK +     +V VK  N+         AFKN   E  +++  RH 
Sbjct: 26  ITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKN---EVGVLRKTRHV 80

Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N++  +   +     A++ ++    SL   L  S    +  + + I    A  ++YLH  
Sbjct: 81  NILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH-- 137

Query: 205 HSTHVIIHCDLKSSNVLLDDNMV 227
                IIH DLKS+N+ L ++  
Sbjct: 138 --AKSIIHRDLKSNNIFLHEDNT 158

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  108 bits (272), Expect = 2e-28
 Identities = 38/143 (26%), Positives = 63/143 (44%), Gaps = 5/143 (3%)

Query: 87  RNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN 145
            + L    ++ +G FG   K    + G  +V+K          +    E  +M+ + H N
Sbjct: 9   PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPN 68

Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 205
           ++K I    KD     I EY+  G+L   + + +    + QR+    D+AS + YLH   
Sbjct: 69  VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH--- 125

Query: 206 STHVIIHCDLKSSNVLLDDNMVA 228
            +  IIH DL S N L+ +N   
Sbjct: 126 -SMNIIHRDLNSHNCLVRENKNV 147

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  108 bits (271), Expect = 2e-28
 Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 16/153 (10%)

Query: 87  RNF-----LEVFNLISRGGFGSIYKARIQDGMEVVVK----GFNLQYGGAFKNLDVECNM 137
            NF         N +  GGFG +YK  + +   V VK      ++      +  D E  +
Sbjct: 25  NNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKV 83

Query: 138 MKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNY--ILDFFQRLHIMIDVA 195
           M   +H+NL++++   S  D   L+  YMP+GSL   LS  +    L +  R  I    A
Sbjct: 84  MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAA 143

Query: 196 SAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
           + + +LH     +  IH D+KS+N+LLD+   A
Sbjct: 144 NGINFLH----ENHHIHRDIKSANILLDEAFTA 172

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 92.4 bits (230), Expect = 2e-22
 Identities = 28/145 (19%), Positives = 57/145 (39%), Gaps = 12/145 (8%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
                +  GGF  +     + DG    +K          +    E +M ++  H N++++
Sbjct: 32  LFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRL 91

Query: 150 ISSCSKDDFKA----LILEYMPHGSLGKCLSTSNYILDFF---QRLHIMIDVASAVEYLH 202
           ++ C ++        L+L +   G+L   +       +F    Q L +++ +   +E +H
Sbjct: 92  VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH 151

Query: 203 FGHSTHVIIHCDLKSSNVLLDDNMV 227
                    H DLK +N+LL D   
Sbjct: 152 ----AKGYAHRDLKPTNILLGDEGQ 172

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 88.9 bits (221), Expect = 3e-21
 Identities = 38/170 (22%), Positives = 69/170 (40%), Gaps = 19/170 (11%)

Query: 69  KDLN--LSFNTLEGKIPRPFRNFLEVFNLISRGGFGSIYKARIQDG----MEVVVK---- 118
           +DL+  L     +  IP   R       +I +G FG +Y     D     ++  +K    
Sbjct: 1   RDLDSALLAEVKDVLIPHE-RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR 59

Query: 119 GFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD-FKALILEYMPHGSLGKCLST 177
              +Q   AF     E  +M+ + H N++ +I      +    ++L YM HG L + + +
Sbjct: 60  ITEMQQVEAFLR---EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS 116

Query: 178 SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
                     +   + VA  +EYL    +    +H DL + N +LD++  
Sbjct: 117 PQRNPTVKDLISFGLQVARGMEYL----AEQKFVHRDLAARNCMLDESFT 162

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 86.9 bits (216), Expect = 2e-20
 Identities = 40/170 (23%), Positives = 66/170 (38%), Gaps = 13/170 (7%)

Query: 66  LDLKDLN--LSFNTLEGKIPRPFRNFLEVFNLISRGGFGSIYKARIQDG----MEVVVKG 119
           +DL  LN  L        I       +    +I RG FG +Y   + D     +   VK 
Sbjct: 2   IDLSALNPELVQAVQHVVIGPS-SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS 60

Query: 120 FNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL-ILEYMPHGSLGKCLST 177
            N     G       E  +MK   H N++ ++  C + +   L +L YM HG L   +  
Sbjct: 61  LNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN 120

Query: 178 SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
             +       +   + VA  ++YL    ++   +H DL + N +LD+   
Sbjct: 121 ETHNPTVKDLIGFGLQVAKGMKYL----ASKKFVHRDLAARNCMLDEKFT 166

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 85.4 bits (212), Expect = 5e-20
 Identities = 39/159 (24%), Positives = 69/159 (43%), Gaps = 24/159 (15%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDG----MEVVVKGFNLQYGGA----FKNLDVECNMM 138
           RN L +  ++  G FGS+ +  ++      ++V VK   ++   +     +    E   M
Sbjct: 33  RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVK--TMKLDNSSQREIEEFLSEAACM 90

Query: 139 KIIRHQNLIKIISSCSKDDFKA-----LILEYMPHGSL-----GKCLSTSNYILDFFQRL 188
           K   H N+I+++  C +   +      +IL +M +G L        L T    +     L
Sbjct: 91  KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150

Query: 189 HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
             M+D+A  +EYL    S    +H DL + N +L D+M 
Sbjct: 151 KFMVDIALGMEYL----SNRNFLHRDLAARNCMLRDDMT 185

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 85.9 bits (213), Expect = 1e-19
 Identities = 38/144 (26%), Positives = 68/144 (47%), Gaps = 9/144 (6%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL 146
              L++   I +G FG +     + G +V VK   ++     +    E ++M  +RH NL
Sbjct: 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNL 248

Query: 147 IKIISSCSKDDFKA-LILEYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFG 204
           ++++    ++     ++ EYM  GSL   L +    +L     L   +DV  A+EYL   
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--- 305

Query: 205 HSTHVIIHCDLKSSNVLLDDNMVA 228
              +  +H DL + NVL+ ++ VA
Sbjct: 306 -EGNNFVHRDLAARNVLVSEDNVA 328

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 84.8 bits (210), Expect = 2e-19
 Identities = 33/162 (20%), Positives = 64/162 (39%), Gaps = 16/162 (9%)

Query: 75  FNTLEGKIPRPFRNFLEVFNLISRGGFGSIYKARIQDG----MEVVVK----GFNLQYGG 126
              ++  +  P    +    +I RG FG +Y   + D     +   VK      ++    
Sbjct: 76  VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS 135

Query: 127 AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL-ILEYMPHGSLGKCLSTSNYILDFF 185
            F     E  +MK   H N++ ++  C + +   L +L YM HG L   +    +     
Sbjct: 136 QFLT---EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK 192

Query: 186 QRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
             +   + VA  +++L    ++   +H DL + N +LD+   
Sbjct: 193 DLIGFGLQVAKGMKFL----ASKKFVHRDLAARNCMLDEKFT 230

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 85.1 bits (211), Expect = 2e-19
 Identities = 34/143 (23%), Positives = 63/143 (44%), Gaps = 7/143 (4%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL 146
           R  L++   +  G FG ++ A      +V VK            L  E N+MK ++H  L
Sbjct: 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLA-EANVMKTLQHDKL 245

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYLHFGH 205
           +K+ +  +K+    +I E+M  GSL   L S         + +     +A  + ++    
Sbjct: 246 VKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI---- 300

Query: 206 STHVIIHCDLKSSNVLLDDNMVA 228
                IH DL+++N+L+  ++V 
Sbjct: 301 EQRNYIHRDLRAANILVSASLVC 323

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 83.1 bits (206), Expect = 4e-19
 Identities = 37/150 (24%), Positives = 70/150 (46%), Gaps = 12/150 (8%)

Query: 87  RNFLEVFNLISRGGFGSIYKAR-----IQDGMEVVVKGFNLQYGG-AFKNLDVECNMMKI 140
           + FL+    +  G FG +   R        G +V VK    + GG    +L  E  +++ 
Sbjct: 20  KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRN 79

Query: 141 IRHQNLIKIISSCSKDDFKA--LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV 198
           + H+N++K    C++D      LI+E++P GSL + L  +   ++  Q+L   + +   +
Sbjct: 80  LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139

Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
           +YL     +   +H DL + NVL++     
Sbjct: 140 DYL----GSRQYVHRDLAARNVLVESEHQV 165

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 82.8 bits (205), Expect = 5e-19
 Identities = 37/161 (22%), Positives = 68/161 (42%), Gaps = 27/161 (16%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDG----MEVVVKGFNLQYGGAFKNLDV-----ECNM 137
                +  ++ +G FGS+ +A+++      ++V VK           + D+     E   
Sbjct: 22  EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLK---ADIIASSDIEEFLREAAC 78

Query: 138 MKIIRHQNLIKIISSCSKDDFKA------LILEYMPHGSLGKCL-----STSNYILDFFQ 186
           MK   H ++ K++    +   K       +IL +M HG L   L       + + L    
Sbjct: 79  MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138

Query: 187 RLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
            +  M+D+A  +EYL    S+   IH DL + N +L ++M 
Sbjct: 139 LVRFMVDIACGMEYL----SSRNFIHRDLAARNCMLAEDMT 175

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 82.0 bits (203), Expect = 8e-19
 Identities = 30/132 (22%), Positives = 66/132 (50%), Gaps = 7/132 (5%)

Query: 95  LISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSC 153
           ++ +G +G +Y  R + + + + +K    +     + L  E  + K ++H+N+++ + S 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88

Query: 154 SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL--HIMIDVASAVEYLHFGHSTHVII 211
           S++ F  + +E +P GSL   L +    L   ++        +   ++YLH     + I+
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH----DNQIV 144

Query: 212 HCDLKSSNVLLD 223
           H D+K  NVL++
Sbjct: 145 HRDIKGDNVLIN 156

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 83.8 bits (208), Expect = 8e-19
 Identities = 32/102 (31%), Positives = 46/102 (45%), Gaps = 13/102 (12%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDL 49
             N   ++ +D+S N  S   P  I            +N +  S+ + +GDL  L  LDL
Sbjct: 628 FDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDL 687

Query: 50  SNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPR--PFRNF 89
           S+N   G IP  +  L  L +++LS N L G IP    F  F
Sbjct: 688 SSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETF 729

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 77.3 bits (191), Expect = 2e-16
 Identities = 27/108 (25%), Positives = 47/108 (43%), Gaps = 13/108 (12%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTIE-----------YNRLQDSLRNSIGDLTSLKSLDL 49
           ++ L      ++++  +      T +           YN L   +   IG +  L  L+L
Sbjct: 604 LNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNL 663

Query: 50  SNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRN--FLEVFNL 95
            +N+ SG+IP  +  L  L  L+LS N L+G+IP+       L   +L
Sbjct: 664 GHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDL 711

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 73.0 bits (180), Expect = 3e-15
 Identities = 35/104 (33%), Positives = 47/104 (45%), Gaps = 15/104 (14%)

Query: 7   LLRIDLSTNNFSCVFPTTI-------------EYNRLQDSLRNSIGDLTSLKSLDLSNNN 53
           LL +DLS+NNFS      +             + N     +  ++ + + L SL LS N 
Sbjct: 370 LLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNY 429

Query: 54  FSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRN--FLEVFNL 95
            SG IP  L  L  L+DL L  N LEG+IP+       LE   L
Sbjct: 430 LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLIL 473

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 71.1 bits (175), Expect = 2e-14
 Identities = 30/99 (30%), Positives = 42/99 (42%), Gaps = 11/99 (11%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDL 49
           +  +K L  + L  N+ +   P+ +             NRL   +   IG L +L  L L
Sbjct: 462 LMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKL 521

Query: 50  SNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRN 88
           SNN+FSG IP  L     L  L+L+ N   G IP     
Sbjct: 522 SNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 70.7 bits (174), Expect = 2e-14
 Identities = 27/108 (25%), Positives = 46/108 (42%), Gaps = 13/108 (12%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDL 49
           + +L  L  + L  N      P  +           ++N L   + + + + T+L  + L
Sbjct: 438 LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISL 497

Query: 50  SNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
           SNN  +G IP  + +L +L  L LS N+  G IP    +   L   +L
Sbjct: 498 SNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDL 545

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 69.9 bits (172), Expect = 4e-14
 Identities = 32/100 (32%), Positives = 45/100 (45%), Gaps = 12/100 (12%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPT----------TIEYNRLQDSLRNSIGDLTSLKSLDLS 50
           +S    L  +D+S+NNFS   P            I  N+L      +I   T LK L++S
Sbjct: 196 VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNIS 255

Query: 51  NNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFL 90
           +N F G  PIP   L  L+ L+L+ N   G+IP       
Sbjct: 256 SNQFVG--PIPPLPLKSLQYLSLAENKFTGEIPDFLSGAC 293

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 69.6 bits (171), Expect = 6e-14
 Identities = 31/97 (31%), Positives = 42/97 (43%), Gaps = 15/97 (15%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPI 60
           +SN   L+ + LS N  S   P             +S+G L+ L+ L L  N   G IP 
Sbjct: 414 LSNCSELVSLHLSFNYLSGTIP-------------SSLGSLSKLRDLKLWLNMLEGEIPQ 460

Query: 61  PLEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
            L  +  L+ L L FN L G+IP    N   L   +L
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISL 497

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 69.2 bits (170), Expect = 8e-14
 Identities = 28/110 (25%), Positives = 44/110 (40%), Gaps = 19/110 (17%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE--------------YNRLQDSLRNSIGDLTSLKSL 47
             L  L  +DLS N+ S                       N++   +   +    +L+ L
Sbjct: 148 LKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDV--DVSRCVNLEFL 205

Query: 48  DLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
           D+S+NNFS  IP  L     L+ L++S N L G   R       L++ N+
Sbjct: 206 DVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNI 254

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 68.0 bits (167), Expect = 2e-13
 Identities = 22/112 (19%), Positives = 41/112 (36%), Gaps = 18/112 (16%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE----------YNRLQDSL--RNSIGDLTSLKSLDL 49
            +L  L  + LS ++ +                   N L   +    S+G  + LK L++
Sbjct: 74  LSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNV 133

Query: 50  SNNNFSGAIPIPLE-KLLDLKDLNLSFNTLEGKIPRPFRNF-----LEVFNL 95
           S+N       +    KL  L+ L+LS N++ G     +        L+   +
Sbjct: 134 SSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAI 185

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 67.6 bits (166), Expect = 3e-13
 Identities = 31/111 (27%), Positives = 40/111 (36%), Gaps = 17/111 (15%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSL-RNSIGDLTSLKSLDL 49
                L  +DLS N+F    P                N     L  +++  +  LK LDL
Sbjct: 291 GACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDL 350

Query: 50  SNNNFSGAIPIPLEKLL-DLKDLNLSFNTLEGKIPRPFRNF----LEVFNL 95
           S N FSG +P  L  L   L  L+LS N   G I           L+   L
Sbjct: 351 SFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYL 401

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 66.5 bits (163), Expect = 7e-13
 Identities = 25/93 (26%), Positives = 41/93 (44%), Gaps = 10/93 (10%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTT---------IEYNRLQDSLRNSI-GDLTSLKSLDLS 50
           +S    L  +++S+N F    P           +  N+    + + + G   +L  LDLS
Sbjct: 243 ISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLS 302

Query: 51  NNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIP 83
            N+F GA+P        L+ L LS N   G++P
Sbjct: 303 GNHFYGAVPPFFGSCSLLESLALSSNNFSGELP 335

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 66.1 bits (162), Expect = 8e-13
 Identities = 28/99 (28%), Positives = 38/99 (38%), Gaps = 17/99 (17%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE-------------YNRLQDSLRNSIG-DLTSLKSL 47
                L  +DLS N+ S    T                 N L    + S G  L SL+ L
Sbjct: 97  KCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVL 156

Query: 48  DLSNNNFSGAIPIPLE---KLLDLKDLNLSFNTLEGKIP 83
           DLS N+ SGA  +         +LK L +S N + G + 
Sbjct: 157 DLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD 195

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 58.4 bits (142), Expect = 4e-10
 Identities = 20/129 (15%), Positives = 43/129 (33%), Gaps = 35/129 (27%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTI---------------------------------EYN 28
            + + L+ +DL+TN F+   P  +                                    
Sbjct: 535 GDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLL 594

Query: 29  RLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRN 88
             Q      +  L++    ++++  + G      +    +  L++S+N L G IP+   +
Sbjct: 595 EFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGS 654

Query: 89  F--LEVFNL 95
              L + NL
Sbjct: 655 MPYLFILNL 663

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 55.3 bits (134), Expect = 3e-09
 Identities = 22/74 (29%), Positives = 38/74 (51%), Gaps = 11/74 (14%)

Query: 10  IDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK 69
           IDLS+   +  F           ++ +S+  LT L+SL LSN++ +G++    +    L 
Sbjct: 55  IDLSSKPLNVGF----------SAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLT 103

Query: 70  DLNLSFNTLEGKIP 83
            L+LS N+L G + 
Sbjct: 104 SLDLSRNSLSGPVT 117

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 43.4 bits (103), Expect = 3e-05
 Identities = 20/119 (16%), Positives = 40/119 (33%), Gaps = 19/119 (15%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDL 49
           +  L+ L  + LS N+FS   P  +             N    ++  ++   +      +
Sbjct: 510 IGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKI 565

Query: 50  SNNNFSGAIPIPLEKLLDLKDLNLSFNTLE--GKIPRPFRNF--LEVFNLISRGGFGSI 104
           + N  +G   + ++     K+ + + N LE  G               N+ SR   G  
Sbjct: 566 AANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 81.3 bits (201), Expect = 2e-18
 Identities = 39/150 (26%), Positives = 66/150 (44%), Gaps = 15/150 (10%)

Query: 87  RNFLEVFNLISRGGFGSIYKARI-----QDGMEVVVKGFNLQYGG--AFKNLDVECNMMK 139
              L+    + +G FGS+   R        G  V VK   LQ+      ++ + E  ++K
Sbjct: 40  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEILK 97

Query: 140 IIRHQNLIKIISSCSKDDFKA--LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASA 197
            ++H N++K    C     +   LI+EY+P+GSL   L      +D  + L     +   
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 157

Query: 198 VEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           +EYL     T   IH DL + N+L+++   
Sbjct: 158 MEYL----GTKRYIHRDLATRNILVENENR 183

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 82.1 bits (203), Expect = 2e-18
 Identities = 35/144 (24%), Positives = 69/144 (47%), Gaps = 7/144 (4%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQD-GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN 145
           R  + + + +  G +G +Y+   +   + V VK          + L  E  +MK I+H N
Sbjct: 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPN 277

Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFG 204
           L++++  C+++    +I E+M +G+L   L   N   +     L++   ++SA+EYL   
Sbjct: 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--- 334

Query: 205 HSTHVIIHCDLKSSNVLLDDNMVA 228
                 IH +L + N L+ +N + 
Sbjct: 335 -EKKNFIHRNLAARNCLVGENHLV 357

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 80.8 bits (200), Expect = 2e-18
 Identities = 39/150 (26%), Positives = 66/150 (44%), Gaps = 15/150 (10%)

Query: 87  RNFLEVFNLISRGGFGSIYKARI-----QDGMEVVVKGFNLQYGG--AFKNLDVECNMMK 139
              L+    + +G FGS+   R        G  V VK   LQ+      ++ + E  ++K
Sbjct: 9   ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVK--KLQHSTEEHLRDFEREIEILK 66

Query: 140 IIRHQNLIKIISSCSKDDFKA--LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASA 197
            ++H N++K    C     +   LI+EY+P+GSL   L      +D  + L     +   
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126

Query: 198 VEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           +EYL     T   IH DL + N+L+++   
Sbjct: 127 MEYL----GTKRYIHRDLATRNILVENENR 152

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 82.2 bits (203), Expect = 2e-18
 Identities = 34/143 (23%), Positives = 64/143 (44%), Gaps = 7/143 (4%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL 146
           R  L +   + +G FG ++         V +K            L  E  +MK +RH+ L
Sbjct: 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKL 324

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGH 205
           +++ +  S++    ++ EYM  GSL   L       L   Q + +   +AS + Y+    
Sbjct: 325 VQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---- 379

Query: 206 STHVIIHCDLKSSNVLLDDNMVA 228
                +H DL+++N+L+ +N+V 
Sbjct: 380 ERMNYVHRDLRAANILVGENLVC 402

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 81.2 bits (201), Expect = 3e-18
 Identities = 35/151 (23%), Positives = 61/151 (40%), Gaps = 15/151 (9%)

Query: 87  RNFLEVFNLISRGGFGSIYKARI-----QDGMEVVVKGFNLQYGGAFKNLDV--ECNMMK 139
              L+  + + +G FGS+   R        G  V VK   LQ+ G  +  D   E  ++K
Sbjct: 22  ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVK--QLQHSGPDQQRDFQREIQILK 79

Query: 140 IIRHQNLIKIISSCSKDDFKA--LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASA 197
            +    ++K          ++  L++EY+P G L   L      LD  + L     +   
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139

Query: 198 VEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
           +EYL     +   +H DL + N+L++     
Sbjct: 140 MEYL----GSRRCVHRDLAARNILVESEAHV 166

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 79.9 bits (198), Expect = 4e-18
 Identities = 35/146 (23%), Positives = 59/146 (40%), Gaps = 13/146 (8%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG----AFKNLDVECNMMKIIR 142
            + L     I  G FG ++     +  +V +K   ++ G      F     E  +M  + 
Sbjct: 7   PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIK--TIREGAMSEEDFIE---EAEVMMKLS 61

Query: 143 HQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH 202
           H  L+++   C +     L+ E+M HG L   L T   +      L + +DV   + YL 
Sbjct: 62  HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL- 120

Query: 203 FGHSTHVIIHCDLKSSNVLLDDNMVA 228
                  +IH DL + N L+ +N V 
Sbjct: 121 ---EEACVIHRDLAARNCLVGENQVI 143

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 81.3 bits (201), Expect = 4e-18
 Identities = 34/143 (23%), Positives = 64/143 (44%), Gaps = 7/143 (4%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL 146
           R  L +   + +G FG ++         V +K            L  E  +MK +RH+ L
Sbjct: 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKL 241

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGH 205
           +++ +  S++    ++ EYM  GSL   L       L   Q + +   +AS + Y+    
Sbjct: 242 VQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV---- 296

Query: 206 STHVIIHCDLKSSNVLLDDNMVA 228
                +H DL+++N+L+ +N+V 
Sbjct: 297 ERMNYVHRDLRAANILVGENLVC 319

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 80.3 bits (199), Expect = 4e-18
 Identities = 32/102 (31%), Positives = 42/102 (41%), Gaps = 15/102 (14%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDL 49
            +NL  L  +DLS N                       N L   L   +G   +L  LDL
Sbjct: 194 FANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDL 251

Query: 50  SNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPR--PFRNF 89
            NN   G +P  L +L  L  LN+SFN L G+IP+    + F
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRF 293

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 70.3 bits (173), Expect = 1e-14
 Identities = 31/107 (28%), Positives = 42/107 (39%), Gaps = 13/107 (12%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLS 50
           + L  L  + ++  N S   P  +            YN L  +L  SI  L +L  +   
Sbjct: 98  AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157

Query: 51  NNNFSGAIPIPLEKLLDL-KDLNLSFNTLEGKIPRPFRNF-LEVFNL 95
            N  SGAIP        L   + +S N L GKIP  F N  L   +L
Sbjct: 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL 204

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 69.1 bits (170), Expect = 5e-14
 Identities = 22/100 (22%), Positives = 41/100 (41%), Gaps = 12/100 (12%)

Query: 2   SNLKVLLRIDLS-TNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDL 49
           +NL  L  + +   NN     P  I            +  +  ++ + +  + +L +LD 
Sbjct: 73  ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132

Query: 50  SNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF 89
           S N  SG +P  +  L +L  +    N + G IP  + +F
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSF 172

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 66.4 bits (163), Expect = 3e-13
 Identities = 20/94 (21%), Positives = 36/94 (38%), Gaps = 13/94 (13%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTI------------EYNRLQDSLRNSIGDLTSLKSLDL 49
           S+L  L+ I    N  S   P +               NRL   +  +  +L +L  +DL
Sbjct: 146 SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDL 204

Query: 50  SNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIP 83
           S N   G   +      + + ++L+ N+L   + 
Sbjct: 205 SRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score = 45.6 bits (109), Expect = 4e-06
 Identities = 19/91 (20%), Positives = 26/91 (28%), Gaps = 18/91 (19%)

Query: 10  IDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLE--KLLD 67
            D     +  V               ++      + +LDLS  N     PIP     L  
Sbjct: 31  TDCCNRTWLGVLC-------------DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPY 77

Query: 68  LKDLNLS-FNTLEGKIPRPFRNF--LEVFNL 95
           L  L +   N L G IP        L    +
Sbjct: 78  LNFLYIGGINNLVGPIPPAIAKLTQLHYLYI 108

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 80.6 bits (199), Expect = 4e-18
 Identities = 39/192 (20%), Positives = 77/192 (40%), Gaps = 14/192 (7%)

Query: 37  SIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLS--FNTLEGKIPRPFRNFLEVFN 94
           S G   SL SL  + ++ S  +     +  D + + L+     ++ +             
Sbjct: 6   SSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTH-QP 64

Query: 95  LISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSC 153
            + RG FG +++ +  Q G +  VK   L+          E      +    ++ +  + 
Sbjct: 65  RVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-----VFRVEELVACAGLSSPRIVPLYGAV 119

Query: 154 SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHC 213
            +  +  + +E +  GSLG+ +      L   + L+ +      +EYLH    T  I+H 
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH----TRRILHG 174

Query: 214 DLKSSNVLLDDN 225
           D+K+ NVLL  +
Sbjct: 175 DVKADNVLLSSD 186

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 79.6 bits (197), Expect = 5e-18
 Identities = 40/144 (27%), Positives = 67/144 (46%), Gaps = 9/144 (6%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL 146
              L++   I +G FG +     + G +V VK   ++     +    E ++M  +RH NL
Sbjct: 20  MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVK--CIKNDATAQAFLAEASVMTQLRHSNL 76

Query: 147 IKIISSCSKDDFKALI-LEYMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYLHFG 204
           ++++    ++     I  EYM  GSL   L S    +L     L   +DV  A+EYL   
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--- 133

Query: 205 HSTHVIIHCDLKSSNVLLDDNMVA 228
              +  +H DL + NVL+ ++ VA
Sbjct: 134 -EGNNFVHRDLAARNVLVSEDNVA 156

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 80.0 bits (198), Expect = 6e-18
 Identities = 43/165 (26%), Positives = 71/165 (43%), Gaps = 30/165 (18%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDG---MEVVVK----GFNLQYGGAFKNLDVECNMMK 139
            N ++  ++I  G FG + KARI+     M+  +K      +      F     E  ++ 
Sbjct: 24  WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG---ELEVLC 80

Query: 140 -IIRHQNLIKIISSCSKDDFKALILEYMPHGSL---------------GKCLSTSNYILD 183
            +  H N+I ++ +C    +  L +EY PHG+L                   +++   L 
Sbjct: 81  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140

Query: 184 FFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
             Q LH   DVA  ++YL    S    IH DL + N+L+ +N VA
Sbjct: 141 SQQLLHFAADVARGMDYL----SQKQFIHRDLAARNILVGENYVA 181

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 79.6 bits (197), Expect = 6e-18
 Identities = 36/146 (24%), Positives = 61/146 (41%), Gaps = 13/146 (8%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG----AFKNLDVECNMMKIIR 142
              L     +  G FG +   + +   +V +K   ++ G      F     E  +M  + 
Sbjct: 23  PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIK--MIKEGSMSEDEFIE---EAKVMMNLS 77

Query: 143 HQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH 202
           H+ L+++   C+K     +I EYM +G L   L    +     Q L +  DV  A+EYL 
Sbjct: 78  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL- 136

Query: 203 FGHSTHVIIHCDLKSSNVLLDDNMVA 228
               +   +H DL + N L++D  V 
Sbjct: 137 ---ESKQFLHRDLAARNCLVNDQGVV 159

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 80.2 bits (198), Expect = 6e-18
 Identities = 39/163 (23%), Positives = 65/163 (39%), Gaps = 13/163 (7%)

Query: 76  NTLEGKIPRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVE 134
           +   G+        L V  +++ GGF  +Y+A+ +  G E  +K          + +  E
Sbjct: 16  SDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQE 75

Query: 135 CNMMKIIR-HQNLIKIISSCSKD-------DFKALILEYMPHGSLGKCL--STSNYILDF 184
              MK +  H N+++  S+ S           + L+L  +  G L + L    S   L  
Sbjct: 76  VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC 135

Query: 185 FQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
              L I      AV+++H       IIH DLK  N+LL +   
Sbjct: 136 DTVLKIFYQTCRAVQHMH--RQKPPIIHRDLKVENLLLSNQGT 176

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 78.8 bits (195), Expect = 8e-18
 Identities = 34/142 (23%), Positives = 59/142 (41%), Gaps = 5/142 (3%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL 146
           R  + +   +  G FG +   + +   +V VK          +    E   M  + H  L
Sbjct: 7   REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ-EAQTMMKLSHPKL 65

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHS 206
           +K    CSK+    ++ EY+ +G L   L +    L+  Q L +  DV   + +L     
Sbjct: 66  VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL----E 121

Query: 207 THVIIHCDLKSSNVLLDDNMVA 228
           +H  IH DL + N L+D ++  
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCV 143

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 79.3 bits (196), Expect = 9e-18
 Identities = 32/142 (22%), Positives = 63/142 (44%), Gaps = 11/142 (7%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFK---NLDVECNMMKIIRHQNL 146
            +   I RG F  +Y+A  + DG+ V +K   +      K   +   E +++K + H N+
Sbjct: 35  RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV 94

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFF---QRLHIMIDVASAVEYLHF 203
           IK  +S  +D+   ++LE    G L + +                   + + SA+E++H 
Sbjct: 95  IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH- 153

Query: 204 GHSTHVIIHCDLKSSNVLLDDN 225
              +  ++H D+K +NV +   
Sbjct: 154 ---SRRVMHRDIKPANVFITAT 172

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 78.8 bits (195), Expect = 1e-17
 Identities = 36/144 (25%), Positives = 69/144 (47%), Gaps = 7/144 (4%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDG-MEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN 145
           R  + + + +  G +G +Y+   +   + V VK          + L  E  +MK I+H N
Sbjct: 12  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKHPN 70

Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFG 204
           L++++  C+++    +I E+M +G+L   L   N   +     L++   ++SA+EYL   
Sbjct: 71  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--- 127

Query: 205 HSTHVIIHCDLKSSNVLLDDNMVA 228
                 IH DL + N L+ +N + 
Sbjct: 128 -EKKNFIHRDLAARNCLVGENHLV 150

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 78.5 bits (194), Expect = 2e-17
 Identities = 36/150 (24%), Positives = 61/150 (40%), Gaps = 14/150 (9%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQD-----GMEVVVKGFNLQYGG-AFKNLDVECNMMKI 140
           + +L+    +  G FG +            G  V VK      G         E ++++ 
Sbjct: 30  KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRT 89

Query: 141 IRHQNLIKIISSCSKDDFKA--LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV 198
           + H+++IK    C      +  L++EY+P GSL   L   +  +   Q L     +   +
Sbjct: 90  LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGM 147

Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
            YLH        IH DL + NVLLD++ + 
Sbjct: 148 AYLH----AQHYIHRDLAARNVLLDNDRLV 173

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 78.1 bits (193), Expect = 2e-17
 Identities = 34/146 (23%), Positives = 58/146 (39%), Gaps = 9/146 (6%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLI 147
           EV   I  G +G   K R   DG  +V K  +         + L  E N+++ ++H N++
Sbjct: 9   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 68

Query: 148 KIISSCSKDDFKAL--ILEYMPHGSLGKCLSTSNYILDFF---QRLHIMIDVASAVEYLH 202
           +            L  ++EY   G L   ++       +      L +M  +  A++  H
Sbjct: 69  RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128

Query: 203 FGH-STHVIIHCDLKSSNVLLDDNMV 227
                 H ++H DLK +NV LD    
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQN 154

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 77.6 bits (192), Expect = 2e-17
 Identities = 35/143 (24%), Positives = 66/143 (46%), Gaps = 7/143 (4%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL 146
           R  L++   +  G FG ++        +V VK            L  E N+MK ++HQ L
Sbjct: 12  RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLA-EANLMKQLQHQRL 70

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYLHFGH 205
           +++ +  +++    +I EYM +GSL   L + S   L   + L +   +A  + ++    
Sbjct: 71  VRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI---- 125

Query: 206 STHVIIHCDLKSSNVLLDDNMVA 228
                IH DL+++N+L+ D +  
Sbjct: 126 EERNYIHRDLRAANILVSDTLSC 148

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 77.8 bits (192), Expect = 4e-17
 Identities = 36/168 (21%), Positives = 72/168 (42%), Gaps = 21/168 (12%)

Query: 66  LDLKDLNLSFNTLEGKIPRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQY 124
           +DL   NL F ++E         +      I  G FG     +  +DG + V+K  N+  
Sbjct: 11  VDLGTENLYFQSME--------KY-VRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR 61

Query: 125 --GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYIL 182
                 +    E  ++  ++H N+++   S  ++    ++++Y   G L K ++    +L
Sbjct: 62  MSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL 121

Query: 183 DFF---QRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
             F   Q L   + +  A++++H       I+H D+KS N+ L  +  
Sbjct: 122 --FQEDQILDWFVQICLALKHVH----DRKILHRDIKSQNIFLTKDGT 163

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 77.0 bits (190), Expect = 4e-17
 Identities = 33/149 (22%), Positives = 64/149 (42%), Gaps = 12/149 (8%)

Query: 84  RPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV---ECNMMK 139
           R    F E+   I  G FGS++K     DG    +K       G+    +          
Sbjct: 8   RYTTEFHEL-EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66

Query: 140 IIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFF---QRLHIMIDVAS 196
           + +H ++++  S+ ++DD   +  EY   GSL   +S +  I+ +F   +   +++ V  
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 197 AVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            + Y+H       ++H D+K SN+ +   
Sbjct: 127 GLRYIHSMS----LVHMDIKPSNIFISRT 151

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 77.3 bits (191), Expect = 5e-17
 Identities = 25/160 (15%), Positives = 62/160 (38%), Gaps = 26/160 (16%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDG------MEVVVK----GFNLQYGGAFKNLDVECN 136
           R  + +   + +G FG +Y+   +          V +K      +++    F N   E +
Sbjct: 24  REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN---EAS 80

Query: 137 MMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSL---------GKCLSTSNYILDFFQR 187
           +MK     ++++++   S+     +I+E M  G L             +         + 
Sbjct: 81  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140

Query: 188 LHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           + +  ++A  + YL    + +  +H DL + N ++ ++  
Sbjct: 141 IQMAGEIADGMAYL----NANKFVHRDLAARNCMVAEDFT 176

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 77.4 bits (191), Expect = 6e-17
 Identities = 30/148 (20%), Positives = 61/148 (41%), Gaps = 11/148 (7%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGME-----VVVKGFNLQYGG-AFKNLDVECNMMKI 140
              L    ++  G FG+++K       E     V +K    + G  +F+ +      +  
Sbjct: 12  ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGS 71

Query: 141 IRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEY 200
           + H ++++++  C     + L+ +Y+P GSL   +      L     L+  + +A  + Y
Sbjct: 72  LDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 130

Query: 201 LHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
           L      H ++H +L + NVLL      
Sbjct: 131 L----EEHGMVHRNLAARNVLLKSPSQV 154

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 77.3 bits (191), Expect = 8e-17
 Identities = 36/147 (24%), Positives = 61/147 (41%), Gaps = 12/147 (8%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVK----GFNLQYGGAFKNLDVECNMMKII 141
              L +   I RG FG ++  R++ D   V VK             F     E  ++K  
Sbjct: 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQ---EARILKQY 169

Query: 142 RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL 201
            H N++++I  C++     +++E +  G     L T    L     L ++ D A+ +EYL
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229

Query: 202 HFGHSTHVIIHCDLKSSNVLLDDNMVA 228
                +   IH DL + N L+ +  V 
Sbjct: 230 E----SKCCIHRDLAARNCLVTEKNVL 252

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 76.6 bits (189), Expect = 8e-17
 Identities = 29/138 (21%), Positives = 51/138 (36%), Gaps = 10/138 (7%)

Query: 95  LISRGGFGSIYKAR-IQDGMEVVVKGFNL--QYGGAFKNLDVECNMMKIIRHQNLIKIIS 151
            I RG F ++YK    +  +EV               +    E  M+K ++H N+++   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 152 SCSKDDFKA----LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           S            L+ E M  G+L   L     ++           +   +++LH   + 
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL-KRFKVMKIKVLRSWCRQILKGLQFLH-TRTP 150

Query: 208 HVIIHCDLKSSNVLLDDN 225
             IIH DLK  N+ +   
Sbjct: 151 -PIIHRDLKCDNIFITGP 167

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 76.2 bits (188), Expect = 8e-17
 Identities = 35/163 (21%), Positives = 62/163 (38%), Gaps = 27/163 (16%)

Query: 83  PRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKII 141
            R   +F +   LI  GGFG ++KA+   DG   V+K          +  + E   +  +
Sbjct: 7   KRFGMDF-KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKL 61

Query: 142 RHQNLIKIISSCSKDDFKA----------------LILEYMPHGSLGKCLSTSN-YILDF 184
            H N++         D+                  + +E+   G+L + +       LD 
Sbjct: 62  DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121

Query: 185 FQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
              L +   +   V+Y+H    +  +I+ DLK SN+ L D   
Sbjct: 122 VLALELFEQITKGVDYIH----SKKLINRDLKPSNIFLVDTKQ 160

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 76.6 bits (189), Expect = 8e-17
 Identities = 31/136 (22%), Positives = 60/136 (44%), Gaps = 5/136 (3%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           E+   +  G FG +YKA+  + G     K    +     ++  VE  ++    H  ++K+
Sbjct: 22  EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKL 81

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV 209
           + +   D    +++E+ P G++   +   +  L   Q   +   +  A+ +LH       
Sbjct: 82  LGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---- 137

Query: 210 IIHCDLKSSNVLLDDN 225
           IIH DLK+ NVL+   
Sbjct: 138 IIHRDLKAGNVLMTLE 153

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 76.1 bits (188), Expect = 1e-16
 Identities = 33/166 (19%), Positives = 64/166 (38%), Gaps = 32/166 (19%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDG------MEVVVK----GFNLQYGGAFKNLDVECN 136
            + +     +    FG +YK  +           V +K             F++   E  
Sbjct: 8   LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH---EAM 64

Query: 137 MMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSL---------------GKCLSTSNYI 181
           +   ++H N++ ++   +KD   ++I  Y  HG L                    T    
Sbjct: 65  LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124

Query: 182 LDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           L+    +H++  +A+ +EYL    S+H ++H DL + NVL+ D + 
Sbjct: 125 LEPPDFVHLVAQIAAGMEYL----SSHHVVHKDLATRNVLVYDKLN 166

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 76.5 bits (189), Expect = 1e-16
 Identities = 29/148 (19%), Positives = 56/148 (37%), Gaps = 11/148 (7%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGME-----VVVKGFNLQYG-GAFKNLDVECNMMKI 140
               +   ++  G FG++YK       E     V +K         A K +  E  +M  
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 73

Query: 141 IRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEY 200
           + + ++ +++  C     + LI + MP G L   +      +     L+  + +A  + Y
Sbjct: 74  VDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132

Query: 201 LHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
           L        ++H DL + NVL+      
Sbjct: 133 L----EDRRLVHRDLAARNVLVKTPQHV 156

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 76.6 bits (189), Expect = 1e-16
 Identities = 35/150 (23%), Positives = 67/150 (44%), Gaps = 15/150 (10%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDG----MEVVVK----GFNLQYGGAFKNLDVECNMM 138
            + + +  +I  G  G +   R++      + V +K    G+  +    F +   E ++M
Sbjct: 48  ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLS---EASIM 104

Query: 139 KIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV 198
               H N+I++    ++     ++ EYM +GSL   L T +      Q + ++  V + +
Sbjct: 105 GQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164

Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
            YL    S    +H DL + NVL+D N+V 
Sbjct: 165 RYL----SDLGYVHRDLAARNVLVDSNLVC 190

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 76.1 bits (188), Expect = 1e-16
 Identities = 38/162 (23%), Positives = 65/162 (40%), Gaps = 25/162 (15%)

Query: 87  RNFLEVFNLISRGGFGSIYKARI------QDGMEVVVKGFNLQYGGAFKNLDVECNMMKI 140
           R  + +   +  G FG ++ A        +D M V VK        A K+   E  ++  
Sbjct: 14  RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTN 73

Query: 141 IRHQNLIKIISSCSKDDFKALILEYMPHGSL---------------GKCLSTSNYILDFF 185
           ++H++++K    C   D   ++ EYM HG L                     +   L   
Sbjct: 74  LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133

Query: 186 QRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           Q LHI   +AS + YL    ++   +H DL + N L+  N++
Sbjct: 134 QMLHIASQIASGMVYL----ASQHFVHRDLATRNCLVGANLL 171

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 76.2 bits (188), Expect = 2e-16
 Identities = 41/174 (23%), Positives = 65/174 (37%), Gaps = 40/174 (22%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDG------MEVVVK----GFNLQYGGAFKNLDVECN 136
           RN +E    I  G FG +++AR            V VK      +      F+    E  
Sbjct: 46  RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR---EAA 102

Query: 137 MMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSL-----------------------GK 173
           +M    + N++K++  C+      L+ EYM +G L                        +
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162

Query: 174 CLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
             S     L   ++L I   VA+ + YL    S    +H DL + N L+ +NMV
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYL----SERKFVHRDLATRNCLVGENMV 212

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 75.9 bits (187), Expect = 2e-16
 Identities = 34/149 (22%), Positives = 67/149 (44%), Gaps = 15/149 (10%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQ----DGMEVVVK----GFNLQYGGAFKNLDVECNMM 138
              + +  ++  G FG +   R++      + V +K    G+  +    F     E ++M
Sbjct: 44  ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EASIM 100

Query: 139 KIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV 198
               H N+I++    +K     ++ EYM +GSL   L   +      Q + ++  +AS +
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160

Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           +YL    S    +H DL + N+L++ N+V
Sbjct: 161 KYL----SDMGYVHRDLAARNILINSNLV 185

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 75.4 bits (186), Expect = 2e-16
 Identities = 34/175 (19%), Positives = 61/175 (34%), Gaps = 40/175 (22%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDG------MEVVVK----GFNLQYGGAFKNLDVECN 136
           R  L +   +  G FG + KA             V VK      +        +   E N
Sbjct: 22  RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLS---EFN 78

Query: 137 MMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSL-----------------------GK 173
           ++K + H ++IK+  +CS+D    LI+EY  +GSL                         
Sbjct: 79  VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138

Query: 174 CLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
                   L     +     ++  ++YL    +   ++H DL + N+L+ +    
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYL----AEMKLVHRDLAARNILVAEGRKM 189

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 75.1 bits (185), Expect = 2e-16
 Identities = 30/153 (19%), Positives = 63/153 (41%), Gaps = 20/153 (13%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFK-NLDVECNMMKIIRHQNLIK 148
           E    + RGGFG +++A+   D     +K   L      +  +  E   +  + H  +++
Sbjct: 8   EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR 67

Query: 149 IISSCSKDDFKA------------LILEYMPHGSLGKCLSTSNYILDFFQR--LHIMIDV 194
             ++  + +               + ++     +L   ++    I +  +   LHI + +
Sbjct: 68  YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI 127

Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           A AVE+LH    +  ++H DLK SN+    + V
Sbjct: 128 AEAVEFLH----SKGLMHRDLKPSNIFFTMDDV 156

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 75.5 bits (186), Expect = 3e-16
 Identities = 36/140 (25%), Positives = 66/140 (47%), Gaps = 7/140 (5%)

Query: 87  RNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN 145
           R  L+ +  I  G  G +  AR    G +V VK  +L+     + L  E  +M+  +H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 205
           ++++  S    +   +++E++  G+L   +  S   L+  Q   +   V  A+ YLH   
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEAVLQALAYLHAQG 161

Query: 206 STHVIIHCDLKSSNVLLDDN 225
               +IH D+KS ++LL  +
Sbjct: 162 ----VIHRDIKSDSILLTLD 177

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 75.0 bits (185), Expect = 3e-16
 Identities = 33/161 (20%), Positives = 63/161 (39%), Gaps = 24/161 (14%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDG------MEVVVKGFNLQYGGAFKNLDVECNMMKI 140
           R  + +   +  G FG ++ A   +       M V VK        A ++   E  ++ +
Sbjct: 40  RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTM 99

Query: 141 IRHQNLIKIISSCSKDDFKALILEYMPHGSL--------------GKCLSTSNYILDFFQ 186
           ++HQ++++    C++     ++ EYM HG L                    +   L   Q
Sbjct: 100 LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159

Query: 187 RLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
            L +   VA+ + YL    +    +H DL + N L+   +V
Sbjct: 160 LLAVASQVAAGMVYL----AGLHFVHRDLATRNCLVGQGLV 196

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 74.7 bits (184), Expect = 4e-16
 Identities = 28/149 (18%), Positives = 59/149 (39%), Gaps = 19/149 (12%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           E   ++ +G FG + KAR   D     +K            +  E  ++  + HQ +++ 
Sbjct: 9   EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRY 67

Query: 150 ISSCSKDDFKA-------------LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVAS 196
            ++  +                  + +EY  +G+L   + + N      +   +   +  
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE 127

Query: 197 AVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
           A+ Y+H    +  IIH DLK  N+ +D++
Sbjct: 128 ALSYIH----SQGIIHRDLKPMNIFIDES 152

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 74.7 bits (184), Expect = 4e-16
 Identities = 36/140 (25%), Positives = 67/140 (47%), Gaps = 7/140 (5%)

Query: 87  RNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN 145
           +     F  I +G  G++Y A  +  G EV ++  NLQ     + +  E  +M+  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 205
           ++  + S    D   +++EY+  GSL   +  +   +D  Q   +  +   A+E+LH   
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 206 STHVIIHCDLKSSNVLLDDN 225
               +IH D+KS N+LL  +
Sbjct: 137 ----VIHRDIKSDNILLGMD 152

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 74.6 bits (184), Expect = 4e-16
 Identities = 29/139 (20%), Positives = 58/139 (41%), Gaps = 13/139 (9%)

Query: 96  ISRGGFGSIYKARIQDG---MEVVVKGFNLQYGGAFKNLDV---ECNMMKIIRHQNLIKI 149
           +  G FGS+ +   +     ++V +K   L+ G    + +    E  +M  + +  ++++
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIK--VLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV 209
           I  C  +    L++E    G L K L      +       ++  V+  ++YL        
Sbjct: 76  IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL----EEKN 130

Query: 210 IIHCDLKSSNVLLDDNMVA 228
            +H DL + NVLL +   A
Sbjct: 131 FVHRDLAARNVLLVNRHYA 149

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 74.3 bits (183), Expect = 5e-16
 Identities = 34/136 (25%), Positives = 63/136 (46%), Gaps = 7/136 (5%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           +V   +  G +GS+YKA   + G  V +K   ++     + +  E ++M+     +++K 
Sbjct: 32  DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKY 89

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV 209
             S  K+    +++EY   GS+   +   N  L   +   I+      +EYLHF      
Sbjct: 90  YGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---- 145

Query: 210 IIHCDLKSSNVLLDDN 225
            IH D+K+ N+LL+  
Sbjct: 146 KIHRDIKAGNILLNTE 161

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 75.5 bits (185), Expect = 5e-16
 Identities = 36/145 (24%), Positives = 62/145 (42%), Gaps = 14/145 (9%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQ-YGGAFKNLDVECNMMKIIRHQNLIK 148
           E+   +  GGFG + +      G +V +K    +      +   +E  +MK + H N++ 
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76

Query: 149 II------SSCSKDDFKALILEYMPHGSLGKCLST--SNYILDFFQRLHIMIDVASAVEY 200
                      + +D   L +EY   G L K L+   +   L       ++ D++SA+ Y
Sbjct: 77  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 136

Query: 201 LHFGHSTHVIIHCDLKSSNVLLDDN 225
           LH     + IIH DLK  N++L   
Sbjct: 137 LH----ENRIIHRDLKPENIVLQPG 157

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 74.7 bits (184), Expect = 6e-16
 Identities = 29/148 (19%), Positives = 56/148 (37%), Gaps = 11/148 (7%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGME-----VVVKGFNLQYG-GAFKNLDVECNMMKI 140
               +   ++  G FG++YK       E     V +K         A K +  E  +M  
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 73

Query: 141 IRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEY 200
           + + ++ +++  C     + LI + MP G L   +      +     L+  + +A  + Y
Sbjct: 74  VDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 132

Query: 201 LHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
           L        ++H DL + NVL+      
Sbjct: 133 L----EDRRLVHRDLAARNVLVKTPQHV 156

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 74.2 bits (183), Expect = 6e-16
 Identities = 35/149 (23%), Positives = 52/149 (34%), Gaps = 12/149 (8%)

Query: 87  RNFLEVFNLISRGGFGSIYKA--RIQDGMEVVV-----KGFNLQYGGAFKNLDVECNMMK 139
              L +   +  G FG + +       G  V V     K   L    A  +   E N M 
Sbjct: 17  EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 76

Query: 140 IIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVE 199
            + H+NLI++         K ++ E  P GSL   L                + VA  + 
Sbjct: 77  SLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135

Query: 200 YLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
           YL     +   IH DL + N+LL    + 
Sbjct: 136 YL----ESKRFIHRDLAARNLLLATRDLV 160

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 74.3 bits (183), Expect = 8e-16
 Identities = 38/170 (22%), Positives = 65/170 (38%), Gaps = 35/170 (20%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQD--------GMEVVVK----GFNLQYGGAFKNLDVE 134
           R+ L +   +  G FG +  A             + V VK        +      +   E
Sbjct: 80  RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS---E 136

Query: 135 CNMMK-IIRHQNLIKIISSCSKDDFKALILEYMPHGSL---------------GKCLSTS 178
             MMK I +H+N+I ++ +C++D    +I+EY   G+L                      
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196

Query: 179 NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
              + F   +     +A  +EYL    ++   IH DL + NVL+ +N V 
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVM 242

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 73.5 bits (181), Expect = 9e-16
 Identities = 29/147 (19%), Positives = 63/147 (42%), Gaps = 12/147 (8%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQD--------GMEVVVKGFNLQYGGAFKNLDVECNMM 138
              L     + +G F  I+K   ++          EV++K  +  +    ++     +MM
Sbjct: 7   NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMM 66

Query: 139 KIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV 198
             + H++L+     C   D   L+ E++  GSL   L  +   ++   +L +   +A+A+
Sbjct: 67  SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAM 126

Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            +L      + +IH ++ + N+LL   
Sbjct: 127 HFL----EENTLIHGNVCAKNILLIRE 149

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 73.4 bits (181), Expect = 9e-16
 Identities = 31/149 (20%), Positives = 59/149 (39%), Gaps = 16/149 (10%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDG----MEVVVK----GFNLQYGGAFKNLDVECNMM 138
           R  +E+   I  G FG +++          + V +K      +      F     E   M
Sbjct: 14  RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ---EALTM 70

Query: 139 KIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV 198
           +   H +++K+I   +++    +I+E    G L   L    Y LD    +     +++A+
Sbjct: 71  RQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 129

Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
            YL     +   +H D+ + NVL+  N  
Sbjct: 130 AYL----ESKRFVHRDIAARNVLVSSNDC 154

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 73.9 bits (182), Expect = 1e-15
 Identities = 38/170 (22%), Positives = 65/170 (38%), Gaps = 35/170 (20%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQD--------GMEVVVK----GFNLQYGGAFKNLDVE 134
           R+ L +   +  G FG +  A             + V VK        +      +   E
Sbjct: 34  RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS---E 90

Query: 135 CNMMK-IIRHQNLIKIISSCSKDDFKALILEYMPHGSL---------------GKCLSTS 178
             MMK I +H+N+I ++ +C++D    +I+EY   G+L                      
Sbjct: 91  MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150

Query: 179 NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
              + F   +     +A  +EYL    ++   IH DL + NVL+ +N V 
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYL----ASQKCIHRDLAARNVLVTENNVM 196

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 73.9 bits (182), Expect = 1e-15
 Identities = 36/150 (24%), Positives = 68/150 (45%), Gaps = 16/150 (10%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDG-----MEVVVK----GFNLQYGGAFKNLDVECNM 137
            + +    +I  G FG +YK  ++       + V +K    G+  +    F     E  +
Sbjct: 43  PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG---EAGI 99

Query: 138 MKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASA 197
           M    H N+I++    SK     +I EYM +G+L K L   +      Q + ++  +A+ 
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 159

Query: 198 VEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           ++YL    +    +H DL + N+L++ N+V
Sbjct: 160 MKYL----ANMNYVHRDLAARNILVNSNLV 185

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 73.9 bits (182), Expect = 1e-15
 Identities = 34/161 (21%), Positives = 63/161 (39%), Gaps = 26/161 (16%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDG------MEVVVK----GFNLQYGGAFKNLDVECN 136
           R  + +   +  G FG +Y+ ++         ++V VK      + Q      +  +E  
Sbjct: 29  RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ---DELDFLMEAL 85

Query: 137 MMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCL------STSNYILDFFQRLHI 190
           ++    HQN+++ I    +   + +++E M  G L   L       +    L     LH+
Sbjct: 86  IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145

Query: 191 MIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD---DNMVA 228
             D+A   +YL      +  IH D+ + N LL       VA
Sbjct: 146 ARDIACGCQYL----EENHFIHRDIAARNCLLTCPGPGRVA 182

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 73.5 bits (181), Expect = 1e-15
 Identities = 35/169 (20%), Positives = 62/169 (36%), Gaps = 34/169 (20%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQD------GMEVVVK----GFNLQYGGAFKNLDVECN 136
           R+ L++   + RG FG + +A             V VK    G       A  +   E  
Sbjct: 26  RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS---ELK 82

Query: 137 MMKII-RHQNLIKIISSCSKDDFKA-LILEYMPHGSL---------------GKCLSTSN 179
           ++  I  H N++ ++ +C+K      +I+E+   G+L                       
Sbjct: 83  ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142

Query: 180 YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
             L     +     VA  +E+L    ++   IH DL + N+LL +  V 
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFL----ASRKCIHRDLAARNILLSEKNVV 187

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 73.1 bits (180), Expect = 2e-15
 Identities = 35/170 (20%), Positives = 59/170 (34%), Gaps = 35/170 (20%)

Query: 87  RNFLEVFNLISRGGFGSIYKARI------QDGMEVVVK----GFNLQYGGAFKNLDVECN 136
           RN L     +  G FG + +A           M V VK      +L    A  +   E  
Sbjct: 22  RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS---ELK 78

Query: 137 MMKII-RHQNLIKIISSCSKDDFKALILEYMPHGSL-----------------GKCLSTS 178
           ++  +  H N++ ++ +C+      +I EY  +G L                    +   
Sbjct: 79  VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 179 NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
              LD    L     VA  + +L    ++   IH DL + N+LL    + 
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFL----ASKNCIHRDLAARNILLTHGRIT 184

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 73.2 bits (180), Expect = 2e-15
 Identities = 36/161 (22%), Positives = 62/161 (38%), Gaps = 26/161 (16%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDG------MEVVVK----GFNLQYGGAFKNLDVECN 136
           R  + +   +  G FG +Y+ ++         ++V VK      + Q    F     E  
Sbjct: 70  RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM---EAL 126

Query: 137 MMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCL------STSNYILDFFQRLHI 190
           ++    HQN+++ I    +   + ++LE M  G L   L       +    L     LH+
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186

Query: 191 MIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD---DNMVA 228
             D+A   +YL      +  IH D+ + N LL       VA
Sbjct: 187 ARDIACGCQYL----EENHFIHRDIAARNCLLTCPGPGRVA 223

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 73.8 bits (181), Expect = 2e-15
 Identities = 28/139 (20%), Positives = 58/139 (41%), Gaps = 13/139 (9%)

Query: 96  ISRGGFGSIYKARIQDG---MEVVVKGFNLQYGGAFKNLDV---ECNMMKIIRHQNLIKI 149
           +  G FGS+ +   +     ++V +K   L+ G    + +    E  +M  + +  ++++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIK--VLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV 209
           I  C  +    L++E    G L K L      +       ++  V+  ++YL        
Sbjct: 402 IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL----EEKN 456

Query: 210 IIHCDLKSSNVLLDDNMVA 228
            +H +L + NVLL +   A
Sbjct: 457 FVHRNLAARNVLLVNRHYA 475

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 72.7 bits (179), Expect = 2e-15
 Identities = 32/140 (22%), Positives = 59/140 (42%), Gaps = 15/140 (10%)

Query: 96  ISRGGFGSIYKARIQDG---MEVVVKGFNLQYGGAFKNLDV----ECNMMKIIRHQNLIK 148
           +  G FG++ K   Q       V VK   L+       L      E N+M+ + +  +++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVK--ILKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 149 IISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH 208
           +I  C  + +  L++E    G L K L  + + +     + ++  V+  ++YL       
Sbjct: 83  MIGICEAESWM-LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYL----EES 136

Query: 209 VIIHCDLKSSNVLLDDNMVA 228
             +H DL + NVLL     A
Sbjct: 137 NFVHRDLAARNVLLVTQHYA 156

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 72.2 bits (178), Expect = 2e-15
 Identities = 31/150 (20%), Positives = 61/150 (40%), Gaps = 16/150 (10%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDG----MEVVVK----GFNLQYGGAFKNLDVECNMM 138
           R  + +  ++  G FG +Y+    +     + V VK       L     F +   E  +M
Sbjct: 11  REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS---EAVIM 67

Query: 139 KIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV 198
           K + H +++K+I    ++    +I+E  P+G LG  L  +   L     +   + +  A+
Sbjct: 68  KNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 126

Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
            YL     +   +H D+   N+L+      
Sbjct: 127 AYL----ESINCVHRDIAVRNILVASPECV 152

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 72.7 bits (179), Expect = 2e-15
 Identities = 32/152 (21%), Positives = 56/152 (36%), Gaps = 12/152 (7%)

Query: 83  PRPFRNFLEVFNLIS---RGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAF--KNLDVECN 136
            RP   F + F  +S    G +G ++K R  +DG    VK     + G         E  
Sbjct: 49  SRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVG 108

Query: 137 -MMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVA 195
              K+ +H   +++  +  +     L  E     SL +        L   Q    + D  
Sbjct: 109 SHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTL 167

Query: 196 SAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
            A+ +LH    +  ++H D+K +N+ L     
Sbjct: 168 LALAHLH----SQGLVHLDVKPANIFLGPRGR 195

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 72.7 bits (179), Expect = 3e-15
 Identities = 36/166 (21%), Positives = 65/166 (39%), Gaps = 31/166 (18%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQD------GMEVVVK----GFNLQYGGAFKNLDVECN 136
           RN L+    +  G FG + +A           ++V VK      +     A  +   E  
Sbjct: 45  RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS---ELK 101

Query: 137 MMKII-RHQNLIKIISSCSKDDFKALILEYMPHGSL-------------GKCLSTSNYIL 182
           +M  + +H+N++ ++ +C+      +I EY  +G L                 + +N   
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161

Query: 183 DFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
                LH    VA  + +L    ++   IH D+ + NVLL +  VA
Sbjct: 162 STRDLLHFSSQVAQGMAFL----ASKNCIHRDVAARNVLLTNGHVA 203

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 73.3 bits (180), Expect = 3e-15
 Identities = 41/229 (17%), Positives = 85/229 (37%), Gaps = 24/229 (10%)

Query: 7   LLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLL 66
             R+              I   +  +    SI  L + +   + ++  S +      +++
Sbjct: 317 YCRLVNGATQSFI-----IRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEII 371

Query: 67  DLKDLNLSFNTLEGKIPRPFRNFLEVFNLISRGGFGSIYKARIQDG----MEVVVK---- 118
           D +D     +T + +I R     +E+   I  G FG +++          M V +K    
Sbjct: 372 DEEDTYTMPSTRDYEIQR---ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN 428

Query: 119 GFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTS 178
             +      F     E   M+   H +++K+I   +++    +I+E    G L   L   
Sbjct: 429 CTSDSVREKFLQ---EALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVR 484

Query: 179 NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
            + LD    +     +++A+ YL     +   +H D+ + NVL+  N  
Sbjct: 485 KFSLDLASLILYAYQLSTALAYL----ESKRFVHRDIAARNVLVSSNDC 529

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 72.5 bits (178), Expect = 3e-15
 Identities = 27/141 (19%), Positives = 56/141 (39%), Gaps = 10/141 (7%)

Query: 91  EVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG--AFKNLDVECNMMKIIRHQNL-- 146
            +   I  GG   +++   +      +K  NL+        +   E   +  ++  +   
Sbjct: 59  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 118

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHS 206
           I++      D +  +++E   +  L   L      +D ++R     ++  AV  +H    
Sbjct: 119 IRLYDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIH---- 172

Query: 207 THVIIHCDLKSSNVLLDDNMV 227
            H I+H DLK +N L+ D M+
Sbjct: 173 QHGIVHSDLKPANFLIVDGML 193

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 72.9 bits (179), Expect = 4e-15
 Identities = 26/129 (20%), Positives = 54/129 (41%), Gaps = 9/129 (6%)

Query: 98  RGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMK-IIRHQNLIKIISSCSKD 156
            G  G+I    + D  +V VK    +    F   D E  +++    H N+I+   +    
Sbjct: 34  HGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDR 90

Query: 157 DFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLK 216
            F+ + +E     +L + +   ++     + + ++    S + +LH    +  I+H DLK
Sbjct: 91  QFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH----SLNIVHRDLK 145

Query: 217 SSNVLLDDN 225
             N+L+   
Sbjct: 146 PHNILISMP 154

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 72.3 bits (177), Expect = 4e-15
 Identities = 28/182 (15%), Positives = 63/182 (34%), Gaps = 15/182 (8%)

Query: 58  IPIPLEKLLDLKDLNLSFNTLEGKIPRPFRN-FLEVFNLISRGGFGSIYKAR------IQ 110
           +  P+    +  +       ++ K      +  + V +L+  G F  +Y+A        +
Sbjct: 34  LSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAK 93

Query: 111 DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGS 170
           +  + V+K         F         +K       +K  S+    +   L+ E   +G+
Sbjct: 94  NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153

Query: 171 LG----KCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           L        +T   ++     +   + +   +E +H       IIH D+K  N +L +  
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH----DCEIIHGDIKPDNFILGNGF 209

Query: 227 VA 228
           + 
Sbjct: 210 LE 211

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 71.9 bits (177), Expect = 4e-15
 Identities = 38/175 (21%), Positives = 60/175 (34%), Gaps = 40/175 (22%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDG------MEVVVK----GFNLQYGGAFKNLDVECN 136
           R  LE   ++  G FG +  A           ++V VK      +     A  +   E  
Sbjct: 44  RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS---ELK 100

Query: 137 MMKII-RHQNLIKIISSCSKDDFKALILEYMPHGSL----------------------GK 173
           MM  +  H+N++ ++ +C+      LI EY  +G L                        
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160

Query: 174 CLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
                  +L F   L     VA  +E+L F       +H DL + NVL+    V 
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS----CVHRDLAARNVLVTHGKVV 211

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 71.6 bits (176), Expect = 5e-15
 Identities = 27/141 (19%), Positives = 56/141 (39%), Gaps = 10/141 (7%)

Query: 91  EVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNL-- 146
            +   I  GG   +++   +      +K  NL+        +   E   +  ++  +   
Sbjct: 31  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 90

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHS 206
           I++      D +  +++E   +  L   L      +D ++R     ++  AV  +H    
Sbjct: 91  IRLYDYEITDQYIYMVMECG-NIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIH---- 144

Query: 207 THVIIHCDLKSSNVLLDDNMV 227
            H I+H DLK +N L+ D M+
Sbjct: 145 QHGIVHSDLKPANFLIVDGML 165

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 71.7 bits (176), Expect = 9e-15
 Identities = 30/150 (20%), Positives = 58/150 (38%), Gaps = 15/150 (10%)

Query: 82  IPRPFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECN-MMKI 140
             +  +N +    ++  G  G++       G  V VK   + +        +E   + + 
Sbjct: 9   FEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTES 65

Query: 141 IRHQNLIKIISSCSKDDFKALILEYMPHGSL------GKCLSTSNYILDFFQRLHIMIDV 194
             H N+I+   S + D F  + LE     +L            +  +   +  + ++  +
Sbjct: 66  DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124

Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDD 224
           AS V +LH    +  IIH DLK  N+L+  
Sbjct: 125 ASGVAHLH----SLKIIHRDLKPQNILVST 150

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 70.9 bits (174), Expect = 1e-14
 Identities = 27/141 (19%), Positives = 56/141 (39%), Gaps = 10/141 (7%)

Query: 91  EVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNL-- 146
            +   I  GG   +++   +      +K  NL+        +   E   +  ++  +   
Sbjct: 12  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHS 206
           I++      D +  +++E   +  L   L      +D ++R     ++  AV  +H    
Sbjct: 72  IRLYDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDPWERKSYWKNMLEAVHTIH---- 125

Query: 207 THVIIHCDLKSSNVLLDDNMV 227
            H I+H DLK +N L+ D M+
Sbjct: 126 QHGIVHSDLKPANFLIVDGML 146

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 71.2 bits (175), Expect = 1e-14
 Identities = 38/170 (22%), Positives = 64/170 (37%), Gaps = 35/170 (20%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQD--------GMEVVVK----GFNLQYGGAFKNLDVE 134
           R+ L +   +  G FG +  A              +V VK        +      +   E
Sbjct: 68  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLIS---E 124

Query: 135 CNMMK-IIRHQNLIKIISSCSKDDFKALILEYMPHGSL---------------GKCLSTS 178
             MMK I +H+N+I ++ +C++D    +I+EY   G+L                      
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184

Query: 179 NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
              L     +     VA  +EYL    ++   IH DL + NVL+ ++ V 
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYL----ASKKCIHRDLAARNVLVTEDNVM 230

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 70.2 bits (172), Expect = 2e-14
 Identities = 29/137 (21%), Positives = 62/137 (45%), Gaps = 10/137 (7%)

Query: 95  LISRGGFGSIYKAR-IQDGMEVVVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIKI--I 150
           ++ +G   ++++ R  + G    +K FN + +         E  ++K + H+N++K+  I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 151 SSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQR--LHIMIDVASAVEYLHFGHSTH 208
              +    K LI+E+ P GSL   L   +      +   L ++ DV   + +L      +
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR----EN 131

Query: 209 VIIHCDLKSSNVLLDDN 225
            I+H ++K  N++    
Sbjct: 132 GIVHRNIKPGNIMRVIG 148

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 69.5 bits (171), Expect = 2e-14
 Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 11/155 (7%)

Query: 77  TLEGKIPRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFN---LQYGGAFKNLD 132
           +L   I     +F +V NL+ +G F  +Y+A  I  G+EV +K  +   +   G  + + 
Sbjct: 1   SLATCIGEKIEDF-KVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQ 59

Query: 133 VECNMMKIIRHQNLIKIISSCSKDDFKA-LILEYMPHGSLGKCLSTSNYILDFFQRLHIM 191
            E  +   ++H +++++ +   +D     L+LE   +G + + L          +  H M
Sbjct: 60  NEVKIHCQLKHPSILELYN-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFM 118

Query: 192 IDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
             + + + YLH    +H I+H DL  SN+LL  NM
Sbjct: 119 HQIITGMLYLH----SHGILHRDLTLSNLLLTRNM 149

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 69.8 bits (171), Expect = 3e-14
 Identities = 31/139 (22%), Positives = 60/139 (43%), Gaps = 9/139 (6%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGA---FKNLDVECNMMKIIRHQNL 146
                I  G FG++Y AR +++   V +K  +     +   ++++  E   ++ +RH N 
Sbjct: 57  SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHS 206
           I+      ++    L++EY   GS    L      L   +   +       + YLH  + 
Sbjct: 117 IQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN- 174

Query: 207 THVIIHCDLKSSNVLLDDN 225
              +IH D+K+ N+LL + 
Sbjct: 175 ---MIHRDVKAGNILLSEP 190

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 69.9 bits (171), Expect = 4e-14
 Identities = 29/137 (21%), Positives = 62/137 (45%), Gaps = 10/137 (7%)

Query: 95  LISRGGFGSIYKAR-IQDGMEVVVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIKI--I 150
           ++ +G   ++++ R  + G    +K FN + +         E  ++K + H+N++K+  I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 151 SSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQR--LHIMIDVASAVEYLHFGHSTH 208
              +    K LI+E+ P GSL   L   +      +   L ++ DV   + +L      +
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR----EN 131

Query: 209 VIIHCDLKSSNVLLDDN 225
            I+H ++K  N++    
Sbjct: 132 GIVHRNIKPGNIMRVIG 148

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 69.3 bits (170), Expect = 4e-14
 Identities = 28/148 (18%), Positives = 60/148 (40%), Gaps = 10/148 (6%)

Query: 83  PRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFN---LQYGGAFKNLDVECNMM 138
           PR  R +      + +GGF   ++            K      L      + + +E ++ 
Sbjct: 37  PRSRRRY-VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH 95

Query: 139 KIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV 198
           + + HQ+++        +DF  ++LE     SL +       + +   R + +  +    
Sbjct: 96  RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGC 154

Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           +YLH     + +IH DLK  N+ L++++
Sbjct: 155 QYLH----RNRVIHRDLKLGNLFLNEDL 178

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 68.9 bits (169), Expect = 4e-14
 Identities = 33/144 (22%), Positives = 58/144 (40%), Gaps = 13/144 (9%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGA-FKNLDVECNMMKIIRHQNLIK 148
           E+  +I  G    +  A       +V +K  NL+        L  E   M    H N++ 
Sbjct: 18  ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS 77

Query: 149 IISSCSKDDFKALILEYMPHGSL-------GKCLSTSNYILDFFQRLHIMIDVASAVEYL 201
             +S    D   L+++ +  GS+              + +LD      I+ +V   +EYL
Sbjct: 78  YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137

Query: 202 HFGHSTHVIIHCDLKSSNVLLDDN 225
           H     +  IH D+K+ N+LL ++
Sbjct: 138 H----KNGQIHRDVKAGNILLGED 157

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 68.8 bits (169), Expect = 5e-14
 Identities = 28/148 (18%), Positives = 60/148 (40%), Gaps = 10/148 (6%)

Query: 83  PRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFN---LQYGGAFKNLDVECNMM 138
           PR  R +      + +GGF   ++            K      L      + + +E ++ 
Sbjct: 11  PRSRRRY-VRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIH 69

Query: 139 KIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV 198
           + + HQ+++        +DF  ++LE     SL +       + +   R + +  +    
Sbjct: 70  RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGC 128

Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           +YLH     + +IH DLK  N+ L++++
Sbjct: 129 QYLH----RNRVIHRDLKLGNLFLNEDL 152

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 69.2 bits (169), Expect = 6e-14
 Identities = 28/141 (19%), Positives = 62/141 (43%), Gaps = 10/141 (7%)

Query: 91  EVFNLISRG--GFGSIYKAR-IQDGMEVVVKGFNL--QYGGAFKNLDVECNMMKIIRHQN 145
           E+  +I +G     ++  AR    G  V V+  NL          L  E ++ K+  H N
Sbjct: 28  ELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPN 87

Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYLHFG 204
           ++   ++   D+   ++  +M +GS    + +     ++     +I+  V  A++Y+H  
Sbjct: 88  IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH-- 145

Query: 205 HSTHVIIHCDLKSSNVLLDDN 225
                 +H  +K+S++L+  +
Sbjct: 146 --HMGYVHRSVKASHILISVD 164

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 68.7 bits (168), Expect = 1e-13
 Identities = 34/150 (22%), Positives = 65/150 (43%), Gaps = 25/150 (16%)

Query: 91  EVFNLISRGGFGSIYKAR--IQDGMEVVVKGFNLQYGG------AFKNLDVECNMMKIIR 142
           EV   I+ GG G IY A     +G  VV+KG  L + G             E   +  + 
Sbjct: 83  EVKGCIAHGGLGWIYLALDRNVNGRPVVLKG--LVHSGDAEAQAMAMA---ERQFLAEVV 137

Query: 143 HQNLIKIISSCSKDDFKA-----LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASA 197
           H ++++I +     D        +++EY+   SL +        L   + +  ++++  A
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPA 194

Query: 198 VEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           + YLH    +  +++ DLK  N++L +  +
Sbjct: 195 LSYLH----SIGLVYNDLKPENIMLTEEQL 220

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 66.5 bits (163), Expect = 2e-13
 Identities = 35/140 (25%), Positives = 63/140 (45%), Gaps = 9/140 (6%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFN---LQYGGAFKNLDVECNMMKIIRHQNL 146
           E+   + +G FG++Y AR  Q    + +K      L+  G    L  E  +   +RH N+
Sbjct: 12  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHS 206
           +++           LILEY P G++ + L   +   +       + ++A+A+ Y H    
Sbjct: 72  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCH---- 126

Query: 207 THVIIHCDLKSSNVLLDDNM 226
           +  +IH D+K  N+LL    
Sbjct: 127 SKRVIHRDIKPENLLLGSAG 146

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 66.2 bits (162), Expect = 3e-13
 Identities = 34/137 (24%), Positives = 61/137 (44%), Gaps = 8/137 (5%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNL-QYGGAFKNLDVECNMMKIIRHQNLIK 148
                I +G FG ++K    +    V +K  +L +     +++  E  ++       + K
Sbjct: 25  TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 84

Query: 149 IISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH 208
              S  KD    +I+EY+  GS    L      LD  Q   I+ ++   ++YLH    + 
Sbjct: 85  YYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH----SE 138

Query: 209 VIIHCDLKSSNVLLDDN 225
             IH D+K++NVLL ++
Sbjct: 139 KKIHRDIKAANVLLSEH 155

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 64.8 bits (158), Expect = 2e-12
 Identities = 26/153 (16%), Positives = 51/153 (33%), Gaps = 28/153 (18%)

Query: 98  RGGFGSIYKARIQDGMEVVVK-----------------GFNLQYGGAFKNLDVECNMMKI 140
           +G F  I     +D     +K                    +     + +   E  ++  
Sbjct: 41  QGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD 99

Query: 141 IRHQNLIKIISSCSKDDFKALILEYMPHGSL-------GKCLSTSNYILDFFQRLHIMID 193
           I+++  +      +  D   +I EYM + S+                 +       I+  
Sbjct: 100 IKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKS 159

Query: 194 VASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           V ++  Y+H   +   I H D+K SN+L+D N 
Sbjct: 160 VLNSFSYIH---NEKNICHRDVKPSNILMDKNG 189

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 64.7 bits (158), Expect = 3e-12
 Identities = 25/109 (22%), Positives = 45/109 (41%), Gaps = 15/109 (13%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTI------------EYNRLQDSLRNSIGDLTSLKSLDL 49
           + L  L  + ++ N+F   F   I               +L+     +   L+SL+ L++
Sbjct: 442 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNM 501

Query: 50  SNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF---LEVFNL 95
           S+NNF      P + L  L+ L+ S N +     +  ++F   L   NL
Sbjct: 502 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 550

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 63.1 bits (154), Expect = 8e-12
 Identities = 25/108 (23%), Positives = 42/108 (38%), Gaps = 14/108 (12%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE-----------YNRLQDSLRNSIGDLTSLKSLDLS 50
            +   L  +DLS      +     +            N +Q     +   L+SL+ L   
Sbjct: 49  FSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108

Query: 51  NNNFSGAIPIPLEKLLDLKDLNLSFNTLEG-KIPRPFRNF--LEVFNL 95
             N +     P+  L  LK+LN++ N ++  K+P  F N   LE  +L
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 58.5 bits (142), Expect = 3e-10
 Identities = 19/108 (17%), Positives = 31/108 (28%), Gaps = 16/108 (14%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDL 49
             + K L   DLS N    +   +                +Q     +   L+ L +L L
Sbjct: 27  PFSTKNL---DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLIL 83

Query: 50  SNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRN--FLEVFNL 95
           + N            L  L+ L      L      P  +   L+  N+
Sbjct: 84  TGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 53.1 bits (128), Expect = 2e-08
 Identities = 17/93 (18%), Positives = 33/93 (35%), Gaps = 11/93 (11%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE----------YNRLQDSLRNSI-GDLTSLKSLDLS 50
                L  +DLS N    +    +           ++ L+     S+   L +L  LD+S
Sbjct: 370 FGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429

Query: 51  NNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIP 83
           + +   A       L  L+ L ++ N+ +    
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 52.7 bits (127), Expect = 3e-08
 Identities = 27/111 (24%), Positives = 40/111 (36%), Gaps = 17/111 (15%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE-----------YNRLQD-SLRNSIGDLTSLKSLDL 49
           S L  L ++     N + +    I            +N +Q   L     +LT+L+ LDL
Sbjct: 97  SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156

Query: 50  SNNNFSGAIPIPLEKL----LDLKDLNLSFNTLEGKIPRPFRNF-LEVFNL 95
           S+N         L  L    L    L+LS N +    P  F+   L    L
Sbjct: 157 SSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTL 207

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 48.5 bits (116), Expect = 7e-07
 Identities = 25/104 (24%), Positives = 36/104 (34%), Gaps = 11/104 (10%)

Query: 2   SNLKVLLRIDLSTNNFSCVFP------TTIEYNRLQDSLRNSIGDLTSLKSLDLSNN--N 53
           S       ++L    F             + +   +     S  DL SL+ LDLS N  +
Sbjct: 301 SYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLS 360

Query: 54  FSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
           F G           LK L+LSFN +   +   F     LE  + 
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDF 403

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 44.2 bits (105), Expect = 2e-05
 Identities = 19/101 (18%), Positives = 40/101 (39%), Gaps = 14/101 (13%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE-----------YNRLQDSLRNSIGDL-TSLKSLDL 49
           ++L  L  +++S NNF  +     +            N +  S +  +    +SL  L+L
Sbjct: 491 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 550

Query: 50  SNNNFSGAIPIP--LEKLLDLKDLNLSFNTLEGKIPRPFRN 88
           + N+F+        L+ + D + L +    +E   P   + 
Sbjct: 551 TQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQG 591

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 39.6 bits (93), Expect = 5e-04
 Identities = 10/90 (11%), Positives = 24/90 (26%), Gaps = 9/90 (10%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIP 61
           S L+ L  + +     + +       +   D + +    LT++ S  L +          
Sbjct: 249 SALEGLCNLTIEEFRLAYL-------DYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKD 299

Query: 62  LEKLLDLKDLNLSFNTLEGKIPRPFRNFLE 91
                  + L L             ++   
Sbjct: 300 FSYNFGWQHLELVNCKFGQFPTLKLKSLKR 329

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 62.4 bits (152), Expect = 9e-12
 Identities = 36/144 (25%), Positives = 66/144 (45%), Gaps = 14/144 (9%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMK-IIRHQNLIK 148
           E+  L+  G +G +YK R ++ G    +K  ++  G   + +  E NM+K    H+N+  
Sbjct: 27  ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIAT 85

Query: 149 IISSCSKDDFKA------LILEYMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYL 201
              +  K +         L++E+   GS+   + +T    L      +I  ++   + +L
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 145

Query: 202 HFGHSTHVIIHCDLKSSNVLLDDN 225
           H     H +IH D+K  NVLL +N
Sbjct: 146 H----QHKVIHRDIKGQNVLLTEN 165

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 61.9 bits (151), Expect = 1e-11
 Identities = 39/178 (21%), Positives = 64/178 (35%), Gaps = 45/178 (25%)

Query: 77  TLEGKIPRPFR--NFLEVFNL---ISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKN 130
           T +  +P       F E +     + RG    + +        E  VK  ++  GG+F  
Sbjct: 1   TRDAALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSA 60

Query: 131 LDVECN----------MMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNY 180
            +V+            + K+  H N+I++  +   + F  L+ + M  G L         
Sbjct: 61  EEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL--------- 111

Query: 181 ILDFFQRL------------HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
               F  L             IM  +   +  LH       I+H DLK  N+LLDD+M
Sbjct: 112 ----FDYLTEKVTLSEKETRKIMRALLEVICALHK----LNIVHRDLKPENILLDDDM 161

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 61.6 bits (150), Expect = 2e-11
 Identities = 43/202 (21%), Positives = 78/202 (38%), Gaps = 43/202 (21%)

Query: 45  KSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNLISRGGFGSI 104
           K   L+NN+   A+ +   K+    DL +   ++    P+  R+   +   +  G  G +
Sbjct: 96  KRRPLNNNSEI-ALSLSRNKVFVFFDLTVDDQSVY---PKALRDEYIMSKTLGSGACGEV 151

Query: 105 YKAR-IQDGMEVVVKGFN--------LQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSK 155
             A   +   +V ++  +         +      N++ E  ++K + H  +IKI +    
Sbjct: 152 KLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211

Query: 156 DDFKALILEYMPHGSLGKCLSTSNYILDFFQRL------------HIMIDVASAVEYLHF 203
           +D+  ++LE M  G L             F ++                 +  AV+YLH 
Sbjct: 212 EDY-YIVLELMEGGEL-------------FDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 257

Query: 204 GHSTHVIIHCDLKSSNVLLDDN 225
               + IIH DLK  NVLL   
Sbjct: 258 ----NGIIHRDLKPENVLLSSQ 275

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 61.0 bits (149), Expect = 3e-11
 Identities = 30/153 (19%), Positives = 56/153 (36%), Gaps = 30/153 (19%)

Query: 86  FRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQ 144
            R       ++  G F  ++  +    G    +K           +L+ E  ++K I+H+
Sbjct: 7   IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHE 66

Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL------------HIMI 192
           N++ +           L+++ +  G L             F R+             ++ 
Sbjct: 67  NIVTLEDIYESTTHYYLVMQLVSGGEL-------------FDRILERGVYTEKDASLVIQ 113

Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            V SAV+YLH     + I+H DLK  N+L    
Sbjct: 114 QVLSAVKYLHE----NGIVHRDLKPENLLYLTP 142

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 60.7 bits (148), Expect = 3e-11
 Identities = 35/146 (23%), Positives = 61/146 (41%), Gaps = 21/146 (14%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFN---LQYGGAFKNLDVECNMMKIIRHQNL 146
           ++   + +G FG++Y AR  Q+   + +K      L+  G    L  E  +   +RH N+
Sbjct: 17  DIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNI 76

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL------HIMIDVASAVEY 200
           +++ +         L+LE+ P G L K L           R         M ++A A+ Y
Sbjct: 77  LRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHY 129

Query: 201 LHFGHSTHVIIHCDLKSSNVLLDDNM 226
            H       +IH D+K  N+L+    
Sbjct: 130 CH----ERKVIHRDIKPENLLMGYKG 151

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 61.2 bits (149), Expect = 3e-11
 Identities = 31/149 (20%), Positives = 68/149 (45%), Gaps = 13/149 (8%)

Query: 85  PFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVK-----GFNLQYGGAFKNLDVECNMM 138
            F +  E+  +I +G F  + +    + G +  VK      F    G + ++L  E ++ 
Sbjct: 21  LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80

Query: 139 KIIRHQNLIKIISSCSKDDFKALILEYMPHGSL-GKCLSTSNYILDFFQRL--HIMIDVA 195
            +++H ++++++ + S D    ++ E+M    L  + +  ++    + + +  H M  + 
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140

Query: 196 SAVEYLHFGHSTHVIIHCDLKSSNVLLDD 224
            A+ Y H     + IIH D+K   VLL  
Sbjct: 141 EALRYCH----DNNIIHRDVKPHCVLLAS 165

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 60.7 bits (148), Expect = 4e-11
 Identities = 28/150 (18%), Positives = 58/150 (38%), Gaps = 33/150 (22%)

Query: 95  LISRGGFGSIYKAR-IQDGMEVVVKGFN----LQYGGAFKNLDVECNMMKIIRHQNLIK- 148
           L+  G +G + +    +      VK        +      N+  E  +++ +RH+N+I+ 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 149 --IISSCSKDDFKALILEYMPHGSLGKCLSTSNYILD----------FFQRLHIMIDVAS 196
             ++ +  K     +++EY   G         + + +          +F +L        
Sbjct: 72  VDVLYNEEKQKM-YMVMEYCVCGMQ----EMLDSVPEKRFPVCQAHGYFCQL------ID 120

Query: 197 AVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
            +EYLH    +  I+H D+K  N+LL    
Sbjct: 121 GLEYLH----SQGIVHKDIKPGNLLLTTGG 146

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 61.2 bits (149), Expect = 4e-11
 Identities = 22/107 (20%), Positives = 35/107 (32%), Gaps = 13/107 (12%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLS 50
           +    L  +D+  N  S + P              ++N L      +    T+L  L L 
Sbjct: 46  TRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLM 105

Query: 51  NNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
           +N+       P  K  +L  L+LS N L             L+   L
Sbjct: 106 SNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLL 152

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 58.5 bits (142), Expect = 3e-10
 Identities = 25/109 (22%), Positives = 40/109 (36%), Gaps = 15/109 (13%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE-----------YNRLQDSLRNSIGDLTSLKSLDLS 50
             L +L  ++L  N  S +   T              N +Q    N      +L +LDLS
Sbjct: 70  QKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLS 129

Query: 51  NNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF----LEVFNL 95
           +N  S        +L +L++L LS N ++         F    L+   L
Sbjct: 130 HNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLEL 178

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 56.9 bits (138), Expect = 1e-09
 Identities = 24/117 (20%), Positives = 39/117 (33%), Gaps = 22/117 (18%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTT-------------------IEYNRLQDSLRNSIGDL 41
           +  L+ L  +DL  NN + ++                      +E N   +       DL
Sbjct: 500 LEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDL 559

Query: 42  TSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFR---NFLEVFNL 95
             LK +DL  NN +          + LK LNL  N +     + F      L   ++
Sbjct: 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDM 616

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 52.7 bits (127), Expect = 3e-08
 Identities = 20/103 (19%), Positives = 35/103 (33%), Gaps = 14/103 (13%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE-----------YNRLQDSLRNSIGDLTSLKSLDLS 50
             L  L  ++L +N F  +     +            N L     +   +  SLKSL+L 
Sbjct: 533 KGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQ 592

Query: 51  NNNFSGAIPIPLEKLLD-LKDLNLSFNTLEGKIP--RPFRNFL 90
            N  +             L +L++ FN  +        F N++
Sbjct: 593 KNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWI 635

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 52.3 bits (126), Expect = 3e-08
 Identities = 26/94 (27%), Positives = 36/94 (38%), Gaps = 11/94 (11%)

Query: 3  NLKVLLRIDLSTNNFSCV---FPTTIEY-----NRLQDSLRNSIGDLTSLKSLDLSNNNF 54
          + +V    D S    + V    PT I       N+L+     +    + L SLD+  N  
Sbjct: 5  SHEVA---DCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 55 SGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRN 88
          S   P   +KL  LK LNL  N L     + F  
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF 95

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 52.3 bits (126), Expect = 4e-08
 Identities = 25/91 (27%), Positives = 36/91 (39%), Gaps = 13/91 (14%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE-----------YNRLQ--DSLRNSIGDLTSLKSLD 48
             L+ +  I LS N +  +   +                L+  DS  +    L +L  LD
Sbjct: 427 RGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILD 486

Query: 49  LSNNNFSGAIPIPLEKLLDLKDLNLSFNTLE 79
           LSNNN +      LE L  L+ L+L  N L 
Sbjct: 487 LSNNNIANINDDMLEGLEKLEILDLQHNNLA 517

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 52.3 bits (126), Expect = 4e-08
 Identities = 18/114 (15%), Positives = 38/114 (33%), Gaps = 20/114 (17%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE-------------YNRLQDSLRNSIGDLTSLKSLD 48
             L+ L  + LS N    +    ++              N++++        +  L  L 
Sbjct: 142 VQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLF 201

Query: 49  LSNNNFSGAIPIPL---EKLLDLKDLNLSFNTLEGKIPRPFRNF----LEVFNL 95
           L+N     ++   L        +++L+LS + L       F       L + +L
Sbjct: 202 LNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 51.9 bits (125), Expect = 5e-08
 Identities = 19/98 (19%), Positives = 30/98 (30%), Gaps = 16/98 (16%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIP 61
           S L  L  +DL  N                         L ++  + LS N +       
Sbjct: 402 SWLGHLEVLDLGLNEIGQELT------------GQEWRGLENIFEIYLSYNKYLQLTRNS 449

Query: 62  LEKLLDLKDLNLSFNTLEG--KIPRPFRNF--LEVFNL 95
              +  L+ L L    L+     P PF+    L + +L
Sbjct: 450 FALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL 487

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 51.2 bits (123), Expect = 9e-08
 Identities = 25/117 (21%), Positives = 36/117 (30%), Gaps = 24/117 (20%)

Query: 3   NLKVLLRIDLSTNNFSCVFPTTIE-------------YNRLQDSLRNSIGDLTSLKSLDL 49
               +  + LS +  S    TT               YN L     +S   L  L+   L
Sbjct: 220 ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFL 279

Query: 50  SNNNFSGAIPIPLEKLLDLKDLNL---------SFNTLEGKIPRPFRNF--LEVFNL 95
             NN        L  L +++ LNL         S  +L       F+    LE  N+
Sbjct: 280 EYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNM 336

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 50.0 bits (120), Expect = 2e-07
 Identities = 19/104 (18%), Positives = 33/104 (31%), Gaps = 20/104 (19%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTI--------------------EYNRLQDSLRNSIGDL 41
           + L  L    L  NN   +F  ++                        L      S   L
Sbjct: 269 AWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWL 328

Query: 42  TSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRP 85
             L+ L++ +N+  G        L++LK L+LS +    +    
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTN 372

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 46.1 bits (110), Expect = 4e-06
 Identities = 16/112 (14%), Positives = 34/112 (30%), Gaps = 18/112 (16%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE-----------YNRLQDSLRNSIG----DLTSLKS 46
             LK L  +++  N+   +                  +        +        + L  
Sbjct: 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHI 385

Query: 47  LDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIP-RPFRNF--LEVFNL 95
           L+L+ N  S         L  L+ L+L  N +  ++  + +R    +    L
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYL 437

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 60.5 bits (147), Expect = 5e-11
 Identities = 36/178 (20%), Positives = 58/178 (32%), Gaps = 32/178 (17%)

Query: 63  EKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFN 121
           E L    DL  +                +    +  G +G +   R     +E  +K   
Sbjct: 12  ENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR 71

Query: 122 LQYGGAFKNLDV--ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN 179
                   N  +  E  ++K++ H N++K+           L++E    G L        
Sbjct: 72  KTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL-------- 123

Query: 180 YILDFFQRL------------HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
                F  +             I+  V S V YLH     H I+H DLK  N+LL+  
Sbjct: 124 -----FDEIIHRMKFNEVDAAVIIKQVLSGVTYLH----KHNIVHRDLKPENLLLESK 172

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 60.0 bits (146), Expect = 7e-11
 Identities = 37/164 (22%), Positives = 61/164 (37%), Gaps = 39/164 (23%)

Query: 83  PRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFN---LQYGGAFKNLDV----- 133
           P+  R+   +   +  G  G +  A   +   +V +K  +      G A +         
Sbjct: 5   PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64

Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL----- 188
           E  ++K + H  +IKI +    +D+  ++LE M  G L             F ++     
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGEL-------------FDKVVGNKR 110

Query: 189 -------HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
                       +  AV+YLH     + IIH DLK  NVLL   
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHE----NGIIHRDLKPENVLLSSQ 150

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 59.5 bits (145), Expect = 8e-11
 Identities = 42/154 (27%), Positives = 68/154 (44%), Gaps = 37/154 (24%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFN---LQYGGAFKNLDVECNMMKIIRHQNL 146
            + + +  G FG +        G +V VK  N   ++       +  E   +K+ RH ++
Sbjct: 14  VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI 73

Query: 147 IK---IISSCSKDDFKALILEYMPHGSLGKCLSTSNYILD-----------FFQRLHIMI 192
           IK   +IS+   D F  +++EY+  G L       +YI              FQ++    
Sbjct: 74  IKLYQVIST-PTDFF--MVMEYVSGGEL------FDYICKHGRVEEMEARRLFQQI---- 120

Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
              SAV+Y H     H+++H DLK  NVLLD +M
Sbjct: 121 --LSAVDYCH----RHMVVHRDLKPENVLLDAHM 148

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 59.9 bits (145), Expect = 1e-10
 Identities = 17/103 (16%), Positives = 37/103 (35%), Gaps = 7/103 (6%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTI------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFS 55
             L  L  I  + + F+             +Y +  ++   S  +L  L  ++L N    
Sbjct: 445 QRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNM 504

Query: 56  GAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNLISR 98
             +P  L  L +L+ LN++ N       +   ++  + +    
Sbjct: 505 TQLPDFLYDLPELQSLNIACNRGIS-AAQLKADWTRLADDEDT 546

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 55.3 bits (133), Expect = 5e-09
 Identities = 22/108 (20%), Positives = 36/108 (33%), Gaps = 21/108 (19%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTI-----------------EYNRLQDSLRNSIGDLTS 43
            + L  L  +D+S N FS  FPT                   E NR+       I    S
Sbjct: 749 ATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPS 807

Query: 44  LKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLE 91
           L  L + +N+      +  +    L  L+++ N            ++E
Sbjct: 808 LIQLQIGSNDIRK---VDEKLTPQLYILDIADNPNISIDVTSVCPYIE 852

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 53.0 bits (127), Expect = 3e-08
 Identities = 20/98 (20%), Positives = 37/98 (37%), Gaps = 12/98 (12%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIP-- 59
           +    +  I LS N       T+I  N L+     +  +   L ++DL  N  +  +   
Sbjct: 694 ATGSPISTIILSNNLM-----TSIPENSLK-PKDGNYKNTYLLTTIDLRFNKLTS-LSDD 746

Query: 60  IPLEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
                L  L ++++S+N      P    N   L+ F +
Sbjct: 747 FRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGI 783

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 51.8 bits (124), Expect = 5e-08
 Identities = 18/100 (18%), Positives = 30/100 (30%), Gaps = 23/100 (23%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQD---------SLRNSIGDL 41
           SNLK L  ++L         P  +             NR             L +     
Sbjct: 488 SNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTG 547

Query: 42  TSLKSLDLSNNNFSGAIPIP--LEKLLDLKDLNLSFNTLE 79
             ++   +  NN     P    L+K++ L  L+   N + 
Sbjct: 548 PKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR 586

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 51.0 bits (122), Expect = 1e-07
 Identities = 18/112 (16%), Positives = 33/112 (29%), Gaps = 20/112 (17%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPT------------TIEYNRLQDSLRNSIGDLTSLKSLDL 49
            N  +L  IDL  N  + +                + YN    S      + + LK+  +
Sbjct: 725 KNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGI 783

Query: 50  ------SNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNL 95
                   N      P  +     L  L +  N +  K+       L + ++
Sbjct: 784 RHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQLYILDI 834

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.9 bits (119), Expect = 3e-07
 Identities = 15/114 (13%), Positives = 33/114 (28%), Gaps = 19/114 (16%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTT-----------IEYNRLQDSLRN-SIGDLTSLKSLD 48
                 L  + L  N    +                 +N+L+      +   +  + S+D
Sbjct: 591 FGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVD 650

Query: 49  LSNNNFSG-----AIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRN--FLEVFNL 95
            S N         +  +   K ++   + LS+N ++      F     +    L
Sbjct: 651 FSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIIL 704

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 49.5 bits (118), Expect = 3e-07
 Identities = 14/95 (14%), Positives = 33/95 (34%), Gaps = 13/95 (13%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPI 60
           + N   +  + L+        P             ++IG LT LK L    ++ + +  +
Sbjct: 319 LDNNGRVTGLSLAGFGAKGRVP-------------DAIGQLTELKVLSFGTHSETVSGRL 365

Query: 61  PLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNL 95
             ++ L         + +     + F ++ +  NL
Sbjct: 366 FGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNL 400

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 47.2 bits (112), Expect = 2e-06
 Identities = 12/73 (16%), Positives = 25/73 (34%)

Query: 18  SCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNT 77
           S  +    E +   D     + +   +  L L+     G +P  + +L +LK L+   ++
Sbjct: 299 SLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHS 358

Query: 78  LEGKIPRPFRNFL 90
                       L
Sbjct: 359 ETVSGRLFGDEEL 371

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 46.4 bits (110), Expect = 3e-06
 Identities = 19/106 (17%), Positives = 35/106 (33%), Gaps = 14/106 (13%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPI 60
           M  +K   RI L       +       NR+   +  +I  LT L+ +  +N+ F+     
Sbjct: 414 MKPIKKDSRISLKDTQIGNLT------NRIT-FISKAIQRLTKLQIIYFANSPFTYDNI- 465

Query: 61  PLEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNLISRGGFGSI 104
                +D +D N  +          + N   L    L +      +
Sbjct: 466 ----AVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQL 507

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 46.0 bits (109), Expect = 5e-06
 Identities = 11/93 (11%), Positives = 23/93 (24%), Gaps = 8/93 (8%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPI 60
             ++ V+  +D S N                 S         +  ++ LS N        
Sbjct: 640 AKSVYVMGSVDFSYNKIGSEGRNI--------SCSMDDYKGINASTVTLSYNEIQKFPTE 691

Query: 61  PLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVF 93
                  +  + LS N +        +     +
Sbjct: 692 LFATGSPISTIILSNNLMTSIPENSLKPKDGNY 724

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 43.3 bits (102), Expect = 3e-05
 Identities = 17/86 (19%), Positives = 24/86 (27%), Gaps = 18/86 (20%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIP 61
             +  L  +D   N    +                + G    L  L L  N     IP  
Sbjct: 570 QKMVKLGLLDCVHNKVRHL---------------EAFGTNVKLTDLKLDYNQIEE-IPED 613

Query: 62  LEKLL-DLKDLNLSFNTLEGKIPRPF 86
                  ++ L  S N L+  IP  F
Sbjct: 614 FCAFTDQVEGLGFSHNKLKY-IPNIF 638

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 59.3 bits (143), Expect = 1e-10
 Identities = 16/193 (8%), Positives = 50/193 (25%), Gaps = 45/193 (23%)

Query: 70  DLNLSFNTLEGKIPRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFN---LQYG 125
           +   + ++L  +  R  +    +   +  G    ++  R ++   +  +K F        
Sbjct: 48  NAETTVDSLLSQGERKLK----LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSR 103

Query: 126 GAFKNLDVECNMMKIIRHQNLIKIISSC----------------------SKDDFKA--- 160
              + L         +  ++  +                            +DD+     
Sbjct: 104 SELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANY 163

Query: 161 -LILEYMPHGSLGKCLSTSNYI------LDFFQRLHIMIDVASAVEYLHFGHSTHVIIHC 213
            L++       L    ST +++              +   +      L     +  ++H 
Sbjct: 164 LLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ----SKGLVHG 218

Query: 214 DLKSSNVLLDDNM 226
                N+ +  + 
Sbjct: 219 HFTPDNLFIMPDG 231

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 59.7 bits (145), Expect = 1e-10
 Identities = 33/173 (19%), Positives = 63/173 (36%), Gaps = 33/173 (19%)

Query: 69  KDLNLSFNTLEGKIPRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFN---LQY 124
             L+ +           F +  +   ++ +G FG +   +    G E  VK  +   ++ 
Sbjct: 7   DHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ 66

Query: 125 GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDF 184
               ++L  E  ++K + H N++K+        +  L+ E    G L             
Sbjct: 67  KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL------------- 113

Query: 185 FQRL------------HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
           F  +             I+  V S + Y+H     + I+H DLK  N+LL+  
Sbjct: 114 FDEIISRKRFSEVDAARIIRQVLSGITYMH----KNKIVHRDLKPENLLLESK 162

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 59.3 bits (144), Expect = 1e-10
 Identities = 36/156 (23%), Positives = 60/156 (38%), Gaps = 35/156 (22%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVK--------GFNLQYGGAFKNLDVECNMMKII 141
              + +  G FG ++ A   +   EVVVK                    + +E  ++  +
Sbjct: 27  STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86

Query: 142 RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILD-----------FFQRLHI 190
            H N+IK++       F  L++E   HGS G  L    +I              F++L  
Sbjct: 87  EHANIIKVLDIFENQGFFQLVMEK--HGS-GLDLF--AFIDRHPRLDEPLASYIFRQL-- 139

Query: 191 MIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
                SAV YL        IIH D+K  N+++ ++ 
Sbjct: 140 ----VSAVGYLR----LKDIIHRDIKDENIVIAEDF 167

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 59.7 bits (145), Expect = 1e-10
 Identities = 13/103 (12%), Positives = 36/103 (34%), Gaps = 8/103 (7%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTI------EYNRLQDSLRNSIGDLTSLKSLDLSNNNF 54
           +  L  L +  +  + F              EY +   +      +L  L  +++ N   
Sbjct: 202 VMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPN 261

Query: 55  SGAIPIPLEKLLDLKDLNLSFNTLEG--KIPRPFRNFLEVFNL 95
              +P  L+ L +++ +N++ N      ++   ++   +    
Sbjct: 262 LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVG 304

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 57.4 bits (139), Expect = 8e-10
 Identities = 22/108 (20%), Positives = 37/108 (34%), Gaps = 21/108 (19%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTI-----------------EYNRLQDSLRNSIGDLTS 43
            + L  L+ IDLS N+FS  FPT                   + NR        I    S
Sbjct: 509 ATTLPYLVGIDLSYNSFS-KFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPS 567

Query: 44  LKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLE 91
           L  L + +N+      +  +   ++  L++  N            ++E
Sbjct: 568 LTQLQIGSNDIRK---VNEKITPNISVLDIKDNPNISIDLSYVCPYIE 612

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 56.6 bits (137), Expect = 1e-09
 Identities = 19/93 (20%), Positives = 33/93 (35%), Gaps = 6/93 (6%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPI 60
             ++ V+  ID S N        +++       L  +     ++ S++LSNN  S     
Sbjct: 398 AKSVSVMSAIDFSYNEI-----GSVDGKNFD-PLDPTPFKGINVSSINLSNNQISKFPKE 451

Query: 61  PLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVF 93
                  L  +NL  N L        ++  E F
Sbjct: 452 LFSTGSPLSSINLMGNMLTEIPKNSLKDENENF 484

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 55.0 bits (133), Expect = 5e-09
 Identities = 16/113 (14%), Positives = 30/113 (26%), Gaps = 20/113 (17%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTIEYNRLQ------------DSLRNSIGDLTSLKSLD 48
             N  +L  IDL  N  + +         L                     + ++LK   
Sbjct: 484 FKNTYLLTSIDLRFNKLTKL-SDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFG 542

Query: 49  LSN------NNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNL 95
           + N      N      P  +     L  L +  N +   +       + V ++
Sbjct: 543 IRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITPNISVLDI 594

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 54.3 bits (131), Expect = 8e-09
 Identities = 23/97 (23%), Positives = 35/97 (36%), Gaps = 10/97 (10%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIP-I 60
           S    L  I+L  N       T I  N L+     +  +   L S+DL  N  +      
Sbjct: 454 STGSPLSSINLMGNML-----TEIPKNSLK-DENENFKNTYLLTSIDLRFNKLTKLSDDF 507

Query: 61  PLEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
               L  L  ++LS+N+     P    N   L+ F +
Sbjct: 508 RATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGI 543

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 53.9 bits (130), Expect = 1e-08
 Identities = 17/109 (15%), Positives = 38/109 (34%), Gaps = 14/109 (12%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPT----------TIEYNRLQDSLRNSIGDLTSLKSLDLSN 51
             +K L  ++   N      P            + YN++ +   N  G    +++L  ++
Sbjct: 327 QKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAH 386

Query: 52  NNFSGAIPIPLE--KLLDLKDLNLSFNTLEGKIPRPFRNF-LEVFNLIS 97
           N     IP   +   +  +  ++ S+N +     + F       F  I+
Sbjct: 387 NKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGIN 434

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 53.5 bits (129), Expect = 2e-08
 Identities = 14/84 (16%), Positives = 34/84 (40%), Gaps = 9/84 (10%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNF-SGAIP 59
           +  ++++   +++ N        + E  +              ++ + +  NN  +  + 
Sbjct: 272 LPEMQLI---NVACNRG-----ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE 323

Query: 60  IPLEKLLDLKDLNLSFNTLEGKIP 83
             L+K+  L  L   +N LEGK+P
Sbjct: 324 TSLQKMKKLGMLECLYNQLEGKLP 347

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 52.0 bits (125), Expect = 5e-08
 Identities = 12/96 (12%), Positives = 25/96 (26%), Gaps = 11/96 (11%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIP-- 59
             L  L  + L ++                      I    S +       ++       
Sbjct: 102 GQLTELEVLALGSHGEKVNERLFGP---------KGISANMSDEQKQKMRMHYQKTFVDY 152

Query: 60  IPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNL 95
            P E   DL    ++ +  +  I +  R  L+   +
Sbjct: 153 DPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQI 188

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 50.8 bits (122), Expect = 1e-07
 Identities = 19/97 (19%), Positives = 33/97 (34%), Gaps = 17/97 (17%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIP 61
              + +  I +  NN                 +  S+  +  L  L+   N   G +P  
Sbjct: 302 PVGEKIQIIYIGYNNLKTF------------PVETSLQKMKKLGMLECLYNQLEGKLP-A 348

Query: 62  LEKLLDLKDLNLSFNTLEGKIPRPFRNF---LEVFNL 95
               + L  LNL++N +   IP  F  F   +E  + 
Sbjct: 349 FGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSF 384

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 50.4 bits (121), Expect = 1e-07
 Identities = 17/115 (14%), Positives = 37/115 (32%), Gaps = 21/115 (18%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQD-SLRNSIGDLTSLKSLDL 49
            +   L  ++L+ N  + +                 +N+L+          ++ + ++D 
Sbjct: 350 GSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDF 409

Query: 50  SNNNFSG-------AIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRN--FLEVFNL 95
           S N            +     K +++  +NLS N +       F     L   NL
Sbjct: 410 SYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINL 464

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 50.4 bits (121), Expect = 2e-07
 Identities = 13/110 (11%), Positives = 30/110 (27%), Gaps = 19/110 (17%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSG---- 56
           +++   +  + L     S   P             ++IG LT L+ L L ++        
Sbjct: 77  LNSNGRVTGLSLEGFGASGRVP-------------DAIGQLTELEVLALGSHGEKVNERL 123

Query: 57  AIPIPLEKLLDLKDLNLSFNTLEGKIPR--PFRNFLEVFNLISRGGFGSI 104
             P  +   +  +         +       P  +F ++            
Sbjct: 124 FGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQK 173

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 47.7 bits (114), Expect = 1e-06
 Identities = 16/115 (13%), Positives = 34/115 (29%), Gaps = 35/115 (30%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIP-- 59
                  +I   +NN +               +  ++  LT L+   + N+ F       
Sbjct: 180 RITLKDTQIGQLSNNIT--------------FVSKAVMRLTKLRQFYMGNSPFVAENICE 225

Query: 60  ---------------IPLE--KLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
                            L+   L DL D+ +       K+P   +    +++ N+
Sbjct: 226 AWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINV 280

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 44.6 bits (106), Expect = 1e-05
 Identities = 10/44 (22%), Positives = 19/44 (43%)

Query: 37  SIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEG 80
           S+     +  L L     SG +P  + +L +L+ L L  +  + 
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKV 119

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 42.7 bits (101), Expect = 6e-05
 Identities = 7/76 (9%), Positives = 23/76 (30%), Gaps = 16/76 (21%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPI 60
           ++    L ++ + +N+   V                      ++  LD+ +N        
Sbjct: 562 ITLCPSLTQLQIGSNDIRKVNEKI----------------TPNISVLDIKDNPNISIDLS 605

Query: 61  PLEKLLDLKDLNLSFN 76
            +   ++     L ++
Sbjct: 606 YVCPYIEAGMYMLFYD 621

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 59.0 bits (143), Expect = 2e-10
 Identities = 41/150 (27%), Positives = 66/150 (44%), Gaps = 37/150 (24%)

Query: 95  LISRGGFGSIYKAR-IQDGMEVVVKGFN---LQYGGAFKNLDVECNMMKIIRHQNLIK-- 148
            +  G FG +   +    G +V VK  N   ++       +  E   +K+ RH ++IK  
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 149 -IISSCSKDDFKALILEYMPHGSLGKCLSTSNYILD-----------FFQRLHIMIDVAS 196
            +IS+   D F  +++EY+  G L       +YI              FQ++       S
Sbjct: 83  QVIST-PSDIF--MVMEYVSGGEL------FDYICKNGRLDEKESRRLFQQI------LS 127

Query: 197 AVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
            V+Y H     H+++H DLK  NVLLD +M
Sbjct: 128 GVDYCH----RHMVVHRDLKPENVLLDAHM 153

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 58.4 bits (142), Expect = 2e-10
 Identities = 34/152 (22%), Positives = 58/152 (38%), Gaps = 35/152 (23%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNL-QYGGAFKNLDVECNMMKIIRHQNLIK 148
           ++   +  G +G +  A        V VK  ++ +     +N+  E  + K++ H+N++K
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 149 ---IISSCSKDDFKALILEYMPHGSLGKCLSTSNYILD-----------FFQRLHIMIDV 194
                   +    + L LEY   G L       + I             FF +L      
Sbjct: 70  FYGHRREGNI---QYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQL------ 114

Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
            + V YLH       I H D+K  N+LLD+  
Sbjct: 115 MAGVVYLH----GIGITHRDIKPENLLLDERD 142

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 58.6 bits (142), Expect = 2e-10
 Identities = 29/154 (18%), Positives = 56/154 (36%), Gaps = 31/154 (20%)

Query: 85  PFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRH 143
              ++ ++   +  G FG +++      G   V K  N  Y      +  E ++M  + H
Sbjct: 48  SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH 107

Query: 144 QNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL-------------HI 190
             LI +  +        LILE++  G L             F R+             + 
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGEL-------------FDRIAAEDYKMSEAEVINY 154

Query: 191 MIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD 224
           M      ++++H     H I+H D+K  N++ + 
Sbjct: 155 MRQACEGLKHMHE----HSIVHLDIKPENIMCET 184

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 58.9 bits (143), Expect = 2e-10
 Identities = 28/155 (18%), Positives = 60/155 (38%), Gaps = 32/155 (20%)

Query: 86  FRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMKIIR 142
           F    ++F  + +G F  + +   +  G E      N +   A  +  +  E  + ++++
Sbjct: 9   FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK 68

Query: 143 HQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL------------HI 190
           H N++++  S S++    LI + +  G L             F+ +            H 
Sbjct: 69  HPNIVRLHDSISEEGHHYLIFDLVTGGEL-------------FEDIVAREYYSEADASHC 115

Query: 191 MIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
           +  +  AV + H       ++H +LK  N+LL   
Sbjct: 116 IQQILEAVLHCH----QMGVVHRNLKPENLLLASK 146

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 58.0 bits (141), Expect = 2e-10
 Identities = 29/155 (18%), Positives = 62/155 (40%), Gaps = 32/155 (20%)

Query: 86  FRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQ--YGGAFKNLDVECNMMKIIR 142
           F +  +V   + +G F  + +      G+E   K  N +      F+ L+ E  + + ++
Sbjct: 4   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63

Query: 143 HQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL------------HI 190
           H N++++  S  ++ F  L+ + +  G L             F+ +            H 
Sbjct: 64  HPNIVRLHDSIQEESFHYLVFDLVTGGEL-------------FEDIVAREFYSEADASHC 110

Query: 191 MIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
           +  +  ++ Y H     + I+H +LK  N+LL   
Sbjct: 111 IQQILESIAYCHS----NGIVHRNLKPENLLLASK 141

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 58.5 bits (142), Expect = 2e-10
 Identities = 28/162 (17%), Positives = 64/162 (39%), Gaps = 35/162 (21%)

Query: 82  IPRPFRNFLEVFNL---ISRGGFGSIYKAR-IQDGMEVVVKGFN--LQYGGAFKNLDVEC 135
           +      F + +++   + +G F  + +      G+E   K  N        F+ L+ E 
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79

Query: 136 NMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL------- 188
            + + ++H N++++  S  ++ F  L+ + +  G L             F+ +       
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL-------------FEDIVAREFYS 126

Query: 189 -----HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
                H +  +  ++ Y H    ++ I+H +LK  N+LL   
Sbjct: 127 EADASHCIQQILESIAYCH----SNGIVHRNLKPENLLLASK 164

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 58.6 bits (142), Expect = 2e-10
 Identities = 39/180 (21%), Positives = 63/180 (35%), Gaps = 39/180 (21%)

Query: 69  KDLNLSFNTLEGKIPRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVK--------G 119
           + +       +    + F    +  ++I RG    + +      G E  VK         
Sbjct: 75  QSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERL 134

Query: 120 FNLQYGGAFKNLDVECN-MMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTS 178
              Q     +    E + + ++  H ++I +I S     F  L+ + M  G L       
Sbjct: 135 SPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL------- 187

Query: 179 NYILDFFQRL------------HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
                 F  L             IM  +  AV +LH     + I+H DLK  N+LLDDNM
Sbjct: 188 ------FDYLTEKVALSEKETRSIMRSLLEAVSFLHA----NNIVHRDLKPENILLDDNM 237

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 58.0 bits (141), Expect = 3e-10
 Identities = 34/158 (21%), Positives = 54/158 (34%), Gaps = 33/158 (20%)

Query: 84  RPFRNFLEVFNL---ISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMK 139
               +  + + L   I RG +G +  A      +    K     +         E  +MK
Sbjct: 2   STKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMK 61

Query: 140 IIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL----------- 188
            + H N+I++  +   +    L++E    G L             F+R+           
Sbjct: 62  SLDHPNIIRLYETFEDNTDIYLVMELCTGGEL-------------FERVVHKRVFRESDA 108

Query: 189 -HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
             IM DV SAV Y H       + H DLK  N L   +
Sbjct: 109 ARIMKDVLSAVAYCHK----LNVAHRDLKPENFLFLTD 142

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 58.3 bits (141), Expect = 3e-10
 Identities = 25/156 (16%), Positives = 53/156 (33%), Gaps = 31/156 (19%)

Query: 83  PRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKII 141
                +  ++   +  G FG +++      G     K     +    + +  E   M ++
Sbjct: 152 HDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL 211

Query: 142 RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL------------- 188
           RH  L+ +  +   D+   +I E+M  G L             F+++             
Sbjct: 212 RHPTLVNLHDAFEDDNEMVMIYEFMSGGEL-------------FEKVADEHNKMSEDEAV 258

Query: 189 HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD 224
             M  V   + ++H     +  +H DLK  N++   
Sbjct: 259 EYMRQVCKGLCHMHE----NNYVHLDLKPENIMFTT 290

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 57.9 bits (140), Expect = 4e-10
 Identities = 32/154 (20%), Positives = 64/154 (41%), Gaps = 6/154 (3%)

Query: 74  SFNTLEGKIPRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGA-FKNL 131
           +F T + K+     +  E  + +  G  G ++K      G+ +  K  +L+   A    +
Sbjct: 19  AFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQI 78

Query: 132 DVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIM 191
             E  ++       ++    +   D   ++ +E+M  GSL + L  +  I +      + 
Sbjct: 79  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVS 137

Query: 192 IDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
           I V   + YL      H I+H D+K SN+L++  
Sbjct: 138 IAVIKGLTYLR---EKHKIMHRDVKPSNILVNSR 168

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 57.3 bits (139), Expect = 5e-10
 Identities = 34/152 (22%), Positives = 58/152 (38%), Gaps = 35/152 (23%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNL-QYGGAFKNLDVECNMMKIIRHQNLIK 148
           ++   +  G +G +  A        V VK  ++ +     +N+  E  + K++ H+N++K
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 69

Query: 149 ---IISSCSKDDFKALILEYMPHGSLGKCLSTSNYILD-----------FFQRLHIMIDV 194
                   +    + L LEY   G L       + I             FF +L      
Sbjct: 70  FYGHRREGNI---QYLFLEYCSGGEL------FDRIEPDIGMPEPDAQRFFHQL------ 114

Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
            + V YLH       I H D+K  N+LLD+  
Sbjct: 115 MAGVVYLH----GIGITHRDIKPENLLLDERD 142

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 57.3 bits (139), Expect = 5e-10
 Identities = 33/171 (19%), Positives = 64/171 (37%), Gaps = 45/171 (26%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVK--------------------GFNLQYGGAFK 129
            + + I +G +G +  A    D     +K                    G     GG  +
Sbjct: 16  TLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75

Query: 130 NLDV------ECNMMKIIRHQNLIK---IISSCSKDDFKALILEYMPHGSLGKCLSTSNY 180
                     E  ++K + H N++K   ++   ++D    ++ E +  G + +  +    
Sbjct: 76  PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLKPL 134

Query: 181 ILD----FFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
             D    +FQ      D+   +EYLH+      IIH D+K SN+L+ ++  
Sbjct: 135 SEDQARFYFQ------DLIKGIEYLHY----QKIIHRDIKPSNLLVGEDGH 175

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 57.8 bits (139), Expect = 5e-10
 Identities = 25/193 (12%), Positives = 56/193 (29%), Gaps = 44/193 (22%)

Query: 70  DLNLSFNTLEGKIPRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYG--- 125
                  +  G+ PR     L    ++ +    +  +A   + G    V           
Sbjct: 64  GQPFRVESELGERPR----TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPS 119

Query: 126 GAFKNLDVECNMMK----------------------IIRHQNLIKIISSCSKDD------ 157
            A K +  E   ++                      +++     K+I     +       
Sbjct: 120 NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLS 179

Query: 158 -FKALILEYMPHGSLGKCLS---TSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHC 213
            F           + G+ L    +++  L    RL + + V   +  LH     + ++H 
Sbjct: 180 RFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH----HYGLVHT 235

Query: 214 DLKSSNVLLDDNM 226
            L+  +++LD   
Sbjct: 236 YLRPVDIVLDQRG 248

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 57.7 bits (140), Expect = 6e-10
 Identities = 21/107 (19%), Positives = 32/107 (29%), Gaps = 13/107 (12%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE-----------YNRLQDSLRNSIGDLTSLKSLDLS 50
           S L  L  +DL+      +   T +            N L      ++    +LK L   
Sbjct: 54  SRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI 113

Query: 51  NNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
               S    IPL     L+ L L  N +             L+V + 
Sbjct: 114 QTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDF 160

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 50.0 bits (120), Expect = 2e-07
 Identities = 19/89 (21%), Positives = 32/89 (35%), Gaps = 12/89 (13%)

Query: 7   LLRIDLSTNNFSCVFPTT-----------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFS 55
           +  I+L  + F  +   T           +    L   L + +  L++LK L LS N F 
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFE 314

Query: 56  GAIPIPLEKLLDLKDLNLSFNTLEGKIPR 84
               I       L  L++  NT   ++  
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGT 343

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 49.6 bits (119), Expect = 3e-07
 Identities = 24/111 (21%), Positives = 40/111 (36%), Gaps = 17/111 (15%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE-----------YNRLQDSLRNSI-GDLTSLKSLDL 49
            NL  L  ++LS N    +     +           + RL+     S   +L  LK L+L
Sbjct: 373 RNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432

Query: 50  SNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF-----LEVFNL 95
           S++    +     + L  L+ LNL  N       +   +      LE+  L
Sbjct: 433 SHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 48.5 bits (116), Expect = 6e-07
 Identities = 15/96 (15%), Positives = 26/96 (27%), Gaps = 10/96 (10%)

Query: 10  IDLSTNNFSCV---FPTTIE-----YNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIP 61
            +      + +    P + E     +N L      +   L +L  LDL+           
Sbjct: 17  YNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDT 76

Query: 62  LEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
            +    L  L L+ N L             L+    
Sbjct: 77  FQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 48.5 bits (116), Expect = 7e-07
 Identities = 20/110 (18%), Positives = 36/110 (32%), Gaps = 17/110 (15%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE--------------YNRLQDSLRNSIGDLTSLKSL 47
             L  L  ++L  N+F                       +  L    +++   L  +  +
Sbjct: 446 DGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHV 505

Query: 48  DLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
           DLS+N  + +    L  L  +  LNL+ N +   +P            NL
Sbjct: 506 DLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINL 554

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 47.3 bits (113), Expect = 1e-06
 Identities = 26/111 (23%), Positives = 45/111 (40%), Gaps = 16/111 (14%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTIE-----------YNRLQDSL-RNSIGDLTSLKSLD 48
           +  L  L ++ LS N F  +   +              N  +  L    + +L +L+ LD
Sbjct: 297 LVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELD 356

Query: 49  LSNNNFSGAIPIP--LEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
           LS+++   +      L  L  L+ LNLS+N         F+    LE+ +L
Sbjct: 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDL 407

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 46.5 bits (111), Expect = 3e-06
 Identities = 26/111 (23%), Positives = 47/111 (42%), Gaps = 17/111 (15%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT------------IEYNRLQ--DSLRNSIGDLTSLKSL 47
           SN   L  + +  N       T             + ++ ++  D     + +L+ L+SL
Sbjct: 322 SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSL 381

Query: 48  DLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPR-PFRNF--LEVFNL 95
           +LS N          ++   L+ L+L+F  L+ K  + PF+N   L+V NL
Sbjct: 382 NLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 41.9 bits (99), Expect = 1e-04
 Identities = 15/110 (13%), Positives = 36/110 (32%), Gaps = 18/110 (16%)

Query: 3   NLKVLLRIDLSTNNFSCVFPTTIEYNRLQ-----DSLRNSIGDLT----------SLKSL 47
           +  V   ++        V    ++ + +Q             D++          S++S+
Sbjct: 200 DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESI 259

Query: 48  DLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
           +L  + F             L++L+L+   L  ++P        L+   L
Sbjct: 260 NLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVL 308

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 40.8 bits (96), Expect = 3e-04
 Identities = 22/101 (21%), Positives = 38/101 (37%), Gaps = 13/101 (12%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE-----------YNRLQDSLRNSIGDLTSLKSLDLS 50
             L  L  + LS  + S +                 +NRL  S   ++  L  +  L+L+
Sbjct: 473 QTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLA 531

Query: 51  NNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIP-RPFRNFL 90
           +N+ S  +P  L  L   + +NL  N L+       F  + 
Sbjct: 532 SNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWY 572

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 57.3 bits (139), Expect = 6e-10
 Identities = 34/168 (20%), Positives = 58/168 (34%), Gaps = 42/168 (25%)

Query: 76  NTLEGKIPRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV- 133
             ++G       +F EV + + RG    +Y+ +         +K          K +D  
Sbjct: 41  YWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK-------KTVDKK 93

Query: 134 ----ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL- 188
               E  ++  + H N+IK+          +L+LE +  G L             F R+ 
Sbjct: 94  IVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL-------------FDRIV 140

Query: 189 -----------HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
                        +  +  AV YLH     + I+H DLK  N+L    
Sbjct: 141 EKGYYSERDAADAVKQILEAVAYLHE----NGIVHRDLKPENLLYATP 184

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 57.3 bits (139), Expect = 6e-10
 Identities = 27/108 (25%), Positives = 41/108 (37%), Gaps = 14/108 (12%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE-----------YNRLQDSLRNSIGDLTSLKSLDLS 50
           SN   L  +DLS      +                  N +Q     S   LTSL++L   
Sbjct: 53  SNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAV 112

Query: 51  NNNFSGAIPIPLEKLLDLKDLNLSFNTLEG-KIPRPFRNF--LEVFNL 95
               +     P+ +L+ LK LN++ N +   K+P  F N   L   +L
Sbjct: 113 ETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDL 160

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 53.9 bits (130), Expect = 1e-08
 Identities = 22/108 (20%), Positives = 37/108 (34%), Gaps = 14/108 (12%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT------------IEYNRLQDSLRNSIGDLTSLKSLDL 49
             L  L  + ++ N+F     +             +   +L+         L  L+ L++
Sbjct: 445 LGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNM 504

Query: 50  SNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
           S+NN          +L  L  L+ SFN +E            L  FNL
Sbjct: 505 SHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNL 552

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 47.7 bits (114), Expect = 1e-06
 Identities = 20/98 (20%), Positives = 32/98 (32%), Gaps = 10/98 (10%)

Query: 8   LRIDLSTNNFSCV---FPTTIEY-----NRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIP 59
           +         S V    P++ +      N L+     S  + + L+ LDLS         
Sbjct: 14  ITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIED 73

Query: 60  IPLEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
                L  L +L L+ N ++   P  F     LE    
Sbjct: 74  KAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 47.3 bits (113), Expect = 2e-06
 Identities = 19/88 (21%), Positives = 30/88 (34%), Gaps = 11/88 (12%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE-----------YNRLQDSLRNSIGDLTSLKSLDLS 50
           +N   L  +DLS      +     +           +N L     +    L SL +LD S
Sbjct: 470 ANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCS 529

Query: 51  NNNFSGAIPIPLEKLLDLKDLNLSFNTL 78
            N    +  I       L   NL+ N++
Sbjct: 530 FNRIETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 45.4 bits (108), Expect = 6e-06
 Identities = 21/111 (18%), Positives = 37/111 (33%), Gaps = 17/111 (15%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE-----------YNRLQD-SLRNSIGDLTSLKSLDL 49
           S L  L  +       + +    I            +N +    L     +LT+L  +DL
Sbjct: 101 SGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDL 160

Query: 50  SNNNFSGAIPIPLEKLLDLKD----LNLSFNTLEGKIPRPFRNF-LEVFNL 95
           S N         L+ L +       L++S N ++    + F+   L    L
Sbjct: 161 SYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTL 211

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 45.0 bits (107), Expect = 9e-06
 Identities = 14/89 (15%), Positives = 24/89 (26%), Gaps = 12/89 (13%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIP 61
             L+ L  +D   +    V               ++   L  L  LD+S  N        
Sbjct: 396 MGLEELQHLDFQHSTLKRVTE------------FSAFLSLEKLLYLDISYTNTKIDFDGI 443

Query: 62  LEKLLDLKDLNLSFNTLEGKIPRPFRNFL 90
              L  L  L ++ N+ +           
Sbjct: 444 FLGLTSLNTLKMAGNSFKDNTLSNVFANT 472

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 40.8 bits (96), Expect = 2e-04
 Identities = 12/94 (12%), Positives = 30/94 (31%), Gaps = 5/94 (5%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIP 61
            NL  L    L    F       I    + + L +      ++    L+  N      + 
Sbjct: 226 QNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCD-----VTIDEFRLTYTNDFSDDIVK 280

Query: 62  LEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNL 95
              L ++  ++L+  +++     P     +  ++
Sbjct: 281 FHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSI 314

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 39.6 bits (93), Expect = 5e-04
 Identities = 19/101 (18%), Positives = 29/101 (28%), Gaps = 15/101 (14%)

Query: 7   LLRIDLSTNNFSCVFPTT--------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAI 58
              + +                    +  N+   S       L SL  LDLS N  S + 
Sbjct: 309 WQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSG 366

Query: 59  PIPLE--KLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
                      L+ L+LSFN     +   F     L+  + 
Sbjct: 367 CCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDF 406

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 38.9 bits (91), Expect = 9e-04
 Identities = 21/90 (23%), Positives = 32/90 (35%), Gaps = 10/90 (11%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPI 60
            SNL  L+ +DLS N    +           + L+    +     SLD+S N     I  
Sbjct: 149 FSNLTNLVHVDLSYNYIQTITV---------NDLQFLRENPQVNLSLDMSLNPIDF-IQD 198

Query: 61  PLEKLLDLKDLNLSFNTLEGKIPRPFRNFL 90
              + + L +L L  N     I +     L
Sbjct: 199 QAFQGIKLHELTLRGNFNSSNIMKTCLQNL 228

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 57.0 bits (138), Expect = 9e-10
 Identities = 32/157 (20%), Positives = 54/157 (34%), Gaps = 32/157 (20%)

Query: 84  RPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKI 140
             F     +  ++ +G FG + K +      E  VK  N           +  E  ++K 
Sbjct: 18  GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77

Query: 141 IRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL------------ 188
           + H N++K+           ++ E    G L             F  +            
Sbjct: 78  LDHPNIMKLFEILEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAA 124

Query: 189 HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            I+  V S + Y+H     H I+H DLK  N+LL+  
Sbjct: 125 RIIKQVFSGITYMH----KHNIVHRDLKPENILLESK 157

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 56.2 bits (136), Expect = 1e-09
 Identities = 31/183 (16%), Positives = 62/183 (33%), Gaps = 43/183 (23%)

Query: 69  KDLNLSFNTLEGKIPRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVK--------- 118
           + + ++      K              +  G +G +   +      E  +K         
Sbjct: 17  QGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDK 76

Query: 119 ----GFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKC 174
                 N       + +  E +++K + H N+IK+        +  L+ E+   G L   
Sbjct: 77  GRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL--- 133

Query: 175 LSTSNYILDFFQRL------------HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL 222
                     F+++            +IM  + S + YLH     H I+H D+K  N+LL
Sbjct: 134 ----------FEQIINRHKFDECDAANIMKQILSGICYLH----KHNIVHRDIKPENILL 179

Query: 223 DDN 225
           ++ 
Sbjct: 180 ENK 182

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 56.1 bits (136), Expect = 1e-09
 Identities = 33/172 (19%), Positives = 72/172 (41%), Gaps = 37/172 (21%)

Query: 75  FNTLEGKIPRPFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDV- 133
           ++++E         + E    I +G FG ++KAR +   + V          A K + + 
Sbjct: 5   YDSVECPFCDEVSKY-EKLAKIGQGTFGEVFKARHRKTGQKV----------ALKKVLME 53

Query: 134 ------------ECNMMKIIRHQN---LIKIISSCSKDDFKA-----LILEYMPHGSLGK 173
                       E  ++++++H+N   LI+I  + +    +      L+ ++  H  L  
Sbjct: 54  NEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAG 112

Query: 174 CLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            LS         +   +M  + + + Y+H     + I+H D+K++NVL+  +
Sbjct: 113 LLSNVLVKFTLSEIKRVMQMLLNGLYYIH----RNKILHRDMKAANVLITRD 160

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 56.2 bits (135), Expect = 1e-09
 Identities = 18/168 (10%), Positives = 48/168 (28%), Gaps = 40/168 (23%)

Query: 95  LISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLD--------------------- 132
           ++ +    +  +A   + G    V             +                      
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 133 -------VECNMMKIIRHQNLIKIISSCSKDDFKALILEYM-PHGSLGKCL------STS 178
                     +++K  + + +I++          +    Y     +L          S++
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 179 NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           +  L    RL + + V   +  LH     + ++H  L+  +++LD   
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH----HYGLVHTYLRPVDIVLDQRG 243

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 55.8 bits (135), Expect = 2e-09
 Identities = 37/140 (26%), Positives = 64/140 (45%), Gaps = 18/140 (12%)

Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIK----IIS 151
           I  G FG +++A++ +  EV +K         FKN   E  +M+I++H N++       S
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQD--KRFKNR--ELQIMRIVKHPNVVDLKAFFYS 103

Query: 152 SCSKDDFKA--LILEYMPHGSLGKCLSTSNYILDFFQRLHI---MIDVASAVEYLHFGHS 206
           +  K D     L+LEY+P  ++ +       +      L I   M  +  ++ Y+H    
Sbjct: 104 NGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---- 158

Query: 207 THVIIHCDLKSSNVLLDDNM 226
           +  I H D+K  N+LLD   
Sbjct: 159 SIGICHRDIKPQNLLLDPPS 178

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 55.8 bits (135), Expect = 2e-09
 Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 36/148 (24%)

Query: 96  ISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIK---I 149
           I +G F  +  AR I  G EV +K  +       + + L  E  +MKI+ H N++K   +
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILD-----------FFQRLHIMIDVASAV 198
           I +  K  +  LI+EY   G +       +Y++             F+++       SAV
Sbjct: 83  IET-EKTLY--LIMEYASGGEV------FDYLVAHGRMKEKEARSKFRQI------VSAV 127

Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           +Y H       I+H DLK+ N+LLD +M
Sbjct: 128 QYCH----QKRIVHRDLKAENLLLDADM 151

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 55.8 bits (135), Expect = 2e-09
 Identities = 37/147 (25%), Positives = 51/147 (34%), Gaps = 29/147 (19%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           +    I  G FG     R       V VK          +N+  E    + +RH N+++ 
Sbjct: 23  DFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-ENVQREIINHRSLRHPNIVRF 81

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILD-----------FFQRLHIMIDVASAV 198
                     A+I+EY   G L         I +           FFQ+L       S V
Sbjct: 82  KEVILTPTHLAIIMEYASGGEL------YERICNAGRFSEDEARFFFQQL------LSGV 129

Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            Y H    +  I H DLK  N LLD +
Sbjct: 130 SYCH----SMQICHRDLKLENTLLDGS 152

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 55.4 bits (134), Expect = 2e-09
 Identities = 39/162 (24%), Positives = 65/162 (40%), Gaps = 27/162 (16%)

Query: 80  GKIPRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFN---LQYGGAFKNLD--- 132
           GK   P  +  +V  L+  GGFGS+Y    + D + V +K      +   G   N     
Sbjct: 35  GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 94

Query: 133 VECNMMKIIRHQ--NLIKIISSCSKDDFKALILEY-MPHGSLGKCLSTSNYILDFFQRL- 188
           +E  ++K +      +I+++    + D   LILE   P   L       ++I +    L 
Sbjct: 95  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDL------FDFITER-GALQ 147

Query: 189 -----HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
                     V  AV + H       ++H D+K  N+L+D N
Sbjct: 148 EELARSFFWQVLEAVRHCH----NCGVLHRDIKDENILIDLN 185

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 55.3 bits (134), Expect = 2e-09
 Identities = 32/156 (20%), Positives = 54/156 (34%), Gaps = 32/156 (20%)

Query: 85  PFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKII 141
            F     +  ++ +G FG + K +      E  VK  N           +  E  ++K +
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78

Query: 142 RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL------------H 189
            H N++K+           ++ E    G L             F  +             
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGEL-------------FDEIIKRKRFSEHDAAR 125

Query: 190 IMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
           I+  V S + Y+H     H I+H DLK  N+LL+  
Sbjct: 126 IIKQVFSGITYMHK----HNIVHRDLKPENILLESK 157

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 55.0 bits (133), Expect = 4e-09
 Identities = 31/162 (19%), Positives = 53/162 (32%), Gaps = 39/162 (24%)

Query: 80  GKIPRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV--ECN 136
            +    F +  EV   I  G +    +       ME  VK  +          D   E  
Sbjct: 14  HRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRDPTEEIE 67

Query: 137 -MMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL------- 188
            +++  +H N+I +        +  ++ E M  G L               ++       
Sbjct: 68  ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL-------------LDKILRQKFFS 114

Query: 189 -----HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
                 ++  +   VEYLH       ++H DLK SN+L  D 
Sbjct: 115 EREASAVLFTITKTVEYLH----AQGVVHRDLKPSNILYVDE 152

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 54.5 bits (132), Expect = 5e-09
 Identities = 25/155 (16%), Positives = 57/155 (36%), Gaps = 32/155 (20%)

Query: 84  RPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR 142
           +       +   + RG FG +++          + K   ++ G     +  E +++ I R
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIAR 59

Query: 143 HQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL-------------H 189
           H+N++ +  S    +   +I E++    +             F+R+              
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDI-------------FERINTSAFELNEREIVS 106

Query: 190 IMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD 224
            +  V  A+++LH     H I H D++  N++   
Sbjct: 107 YVHQVCEALQFLHS----HNIGHFDIRPENIIYQT 137

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 53.7 bits (130), Expect = 8e-09
 Identities = 35/150 (23%), Positives = 69/150 (46%), Gaps = 12/150 (8%)

Query: 82  IPRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKN-LDV----EC 135
           +    + + E  + +  G F ++YKAR       V +K   L +    K+ ++     E 
Sbjct: 5   VKSRAKRY-EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 136 NMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVA 195
            +++ + H N+I ++ +       +L+ ++M    L   +  ++ +L        M+   
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL 122

Query: 196 SAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
             +EYLH     H I+H DLK +N+LLD+N
Sbjct: 123 QGLEYLH----QHWILHRDLKPNNLLLDEN 148

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 53.9 bits (130), Expect = 8e-09
 Identities = 28/128 (21%), Positives = 56/128 (43%), Gaps = 5/128 (3%)

Query: 98  RGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKD 156
            G FG ++K      G+++  K    +     + +  E ++M  + H NLI++  +    
Sbjct: 99  GGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK 158

Query: 157 DFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLK 216
           +   L++EY+  G L   +   +Y L     +  M  +   + ++H       I+H DLK
Sbjct: 159 NDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH----QMYILHLDLK 214

Query: 217 SSNVLLDD 224
             N+L  +
Sbjct: 215 PENILCVN 222

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 53.7 bits (130), Expect = 9e-09
 Identities = 36/169 (21%), Positives = 68/169 (40%), Gaps = 24/169 (14%)

Query: 71  LNLSFNTLEGKIPRPFRNFLEVF---NLISRGGFGSIYKARIQDGMEVVVK--------- 118
           ++   +   G+    F+  +E +     +  G +G +YKA+   G  V +K         
Sbjct: 1   MHHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE 60

Query: 119 GFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTS 178
           G       A +    E +++K + H N++ +I     +    L+ E+M    L K L  +
Sbjct: 61  GIPST---AIR----EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDEN 112

Query: 179 NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
              L   Q    +  +   V + H     H I+H DLK  N+L++ +  
Sbjct: 113 KTGLQDSQIKIYLYQLLRGVAHCH----QHRILHRDLKPQNLLINSDGA 157

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 53.5 bits (129), Expect = 1e-08
 Identities = 33/159 (20%), Positives = 55/159 (34%), Gaps = 36/159 (22%)

Query: 85  PFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVK------GFNLQYGGAFKNLDVECNM 137
              +F ++   +  G F  + K R    G+E   K          + G   + ++ E ++
Sbjct: 9   KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68

Query: 138 MKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL--------- 188
           ++ + H N+I +           LILE +  G L             F  L         
Sbjct: 69  LRQVLHPNIITLHDVYENRTDVVLILELVSGGEL-------------FDFLAQKESLSEE 115

Query: 189 ---HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD 224
                +  +   V YLH       I H DLK  N++L D
Sbjct: 116 EATSFIKQILDGVNYLHT----KKIAHFDLKPENIMLLD 150

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 53.4 bits (129), Expect = 1e-08
 Identities = 31/151 (20%), Positives = 56/151 (37%), Gaps = 21/151 (13%)

Query: 86  FRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFN-LQYGGAFKNLDVECNMMKIIRH 143
             +       +  G FG ++       G+E V+K  N  +     + ++ E  ++K + H
Sbjct: 20  IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH 79

Query: 144 QNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL---------HIMIDV 194
            N+IKI           +++E    G L         I+    R           +M  +
Sbjct: 80  PNIIKIFEVFEDYHNMYIVMETCEGGEL------LERIVSAQARGKALSEGYVAELMKQM 133

Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            +A+ Y H       ++H DLK  N+L  D 
Sbjct: 134 MNALAYFHS----QHVVHKDLKPENILFQDT 160

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 53.4 bits (129), Expect = 1e-08
 Identities = 33/169 (19%), Positives = 54/169 (31%), Gaps = 39/169 (23%)

Query: 79  EGKIPRPFRNFLEVFNLIS----RGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV 133
           E    +   NF   + L S    RG F  + +      G E   K    +  G     ++
Sbjct: 16  ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEI 75

Query: 134 --ECNMMKIIRHQ-NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL-- 188
             E  ++++ +    +I +           LILEY   G +             F     
Sbjct: 76  LHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI-------------FSLCLP 122

Query: 189 ------------HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
                        ++  +   V YLH     + I+H DLK  N+LL   
Sbjct: 123 ELAEMVSENDVIRLIKQILEGVYYLHQ----NNIVHLDLKPQNILLSSI 167

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 53.4 bits (129), Expect = 1e-08
 Identities = 33/160 (20%), Positives = 57/160 (35%), Gaps = 36/160 (22%)

Query: 84  RPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVK------GFNLQYGGAFKNLDVECN 136
           +   +F ++   +  G F  + K R    G+E   K          + G + + ++ E +
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67

Query: 137 MMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL-------- 188
           +++ + H N+I +           LILE +  G L             F  L        
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL-------------FDFLAQKESLSE 114

Query: 189 ----HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD 224
                 +  +   V YLH       I H DLK  N++L D
Sbjct: 115 EEATSFIKQILDGVNYLHT----KKIAHFDLKPENIMLLD 150

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 53.4 bits (129), Expect = 1e-08
 Identities = 36/148 (24%), Positives = 66/148 (44%), Gaps = 34/148 (22%)

Query: 95  LISRGGFGSIYKAR-IQDGMEVVVKGFN---LQYGGAFKNLDVECNMMKIIRHQNLIK-- 148
            +  G FG +  A   +   +V +K  +   L+       ++ E + +K++RH ++IK  
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 149 -IISSCSKDDFKALILEY---------MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV 198
            +I++   D    +++EY         +    + +          FFQ++        A+
Sbjct: 76  DVITT-PTDIV--MVIEYAGGELFDYIVEKKRMTEDEG-----RRFFQQI------ICAI 121

Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           EY H     H I+H DLK  N+LLDDN+
Sbjct: 122 EYCH----RHKIVHRDLKPENLLLDDNL 145

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 53.0 bits (128), Expect = 2e-08
 Identities = 33/138 (23%), Positives = 56/138 (40%), Gaps = 8/138 (5%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNL-QYGGAFKNLDV-ECNMMKIIRHQNLI 147
           E    I  G +G ++K R    G  V +K F   +     K + + E  M+K ++H NL+
Sbjct: 6   EKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLV 65

Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
            ++    +     L+ EY  H ++   L      +       I      AV + H     
Sbjct: 66  NLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH----K 120

Query: 208 HVIIHCDLKSSNVLLDDN 225
           H  IH D+K  N+L+  +
Sbjct: 121 HNCIHRDVKPENILITKH 138

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 52.7 bits (127), Expect = 2e-08
 Identities = 32/145 (22%), Positives = 57/145 (39%), Gaps = 15/145 (10%)

Query: 90  LEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGA-FKNLDVECN-MMKIIRHQNL 146
           L+    I RG +GS+ K      G  + VK           K L ++ + +M+      +
Sbjct: 24  LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL------HIMIDVASAVEY 200
           ++   +  ++    + +E M   S  K       +LD    +       I +    A+ +
Sbjct: 84  VQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLD--DVIPEEILGKITLATVKALNH 140

Query: 201 LHFGHSTHVIIHCDLKSSNVLLDDN 225
           L        IIH D+K SN+LLD +
Sbjct: 141 LK---ENLKIIHRDIKPSNILLDRS 162

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 52.6 bits (127), Expect = 2e-08
 Identities = 29/142 (20%), Positives = 61/142 (42%), Gaps = 15/142 (10%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGA------FKNLDVECNMMKIIRH 143
           ++ + +  GG  ++Y A      ++V +K   +           F+    E +    + H
Sbjct: 14  KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFER---EVHNSSQLSH 70

Query: 144 QNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHF 203
           QN++ +I    +DD   L++EY+   +L      S+  L     ++    +   +++ H 
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTL-SEYIESHGPLSVDTAINFTNQILDGIKHAH- 128

Query: 204 GHSTHVIIHCDLKSSNVLLDDN 225
                 I+H D+K  N+L+D N
Sbjct: 129 ---DMRIVHRDIKPQNILIDSN 147

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 52.7 bits (127), Expect = 2e-08
 Identities = 27/155 (17%), Positives = 58/155 (37%), Gaps = 39/155 (25%)

Query: 95  LISRGGFGSIYKAR-IQDGMEVVVKGFN----LQYGGAFKNLDV--ECNMMKIIR----H 143
           L+ +GGFG+++    + D ++V +K       L +     ++    E  ++  +     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 144 QNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFF------QRL------HIM 191
             +I+++      +   L+LE                  D F        L         
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQ------------DLFDYITEKGPLGEGPSRCFF 145

Query: 192 IDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
             V +A+++ H    +  ++H D+K  N+L+D   
Sbjct: 146 GQVVAAIQHCH----SRGVVHRDIKDENILIDLRR 176

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 52.2 bits (126), Expect = 3e-08
 Identities = 34/138 (24%), Positives = 63/138 (45%), Gaps = 8/138 (5%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNL-QYGGAFKNLDV-ECNMMKIIRHQNLI 147
           E   L+  G +G + K R    G  V +K F         K + + E  ++K +RH+NL+
Sbjct: 28  ENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLV 87

Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
            ++  C K     L+ E++ H ++   L      LD+      +  + + + + H    +
Sbjct: 88  NLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH----S 142

Query: 208 HVIIHCDLKSSNVLLDDN 225
           H IIH D+K  N+L+  +
Sbjct: 143 HNIIHRDIKPENILVSQS 160

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 52.1 bits (125), Expect = 3e-08
 Identities = 33/192 (17%), Positives = 57/192 (29%), Gaps = 52/192 (27%)

Query: 82  IPRPFRNFLEVFNL---ISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV---- 133
                    + ++L   I +G +G +  A   Q      +K  N          DV    
Sbjct: 17  QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIK 76

Query: 134 -ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSL-------GKCLSTSNYILDFF 185
            E  +MK + H N+ ++      + +  L++E    G L           +    +    
Sbjct: 77  TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136

Query: 186 QRL--------------------------------HIMIDVASAVEYLHFGHSTHVIIHC 213
            ++                                +IM  + SA+ YLH       I H 
Sbjct: 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN----QGICHR 192

Query: 214 DLKSSNVLLDDN 225
           D+K  N L   N
Sbjct: 193 DIKPENFLFSTN 204

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 52.0 bits (125), Expect = 4e-08
 Identities = 27/139 (19%), Positives = 54/139 (38%), Gaps = 7/139 (5%)

Query: 90  LEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGA-FKNLDVECN-MMKIIRHQNL 146
           LE    +  G  G ++K R  + G  + VK           K + ++ + ++K      +
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHS 206
           ++   +   +    + +E M      K        +       + + +  A+ YL     
Sbjct: 87  VQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---E 142

Query: 207 THVIIHCDLKSSNVLLDDN 225
            H +IH D+K SN+LLD+ 
Sbjct: 143 KHGVIHRDVKPSNILLDER 161

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 51.9 bits (125), Expect = 4e-08
 Identities = 32/142 (22%), Positives = 54/142 (38%), Gaps = 31/142 (21%)

Query: 98  RGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-HQNLIKIISSCSK 155
            G    +     +    E  VK    Q G     +  E  M+   + H+N++++I    +
Sbjct: 23  EGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE 82

Query: 156 DDFKALILEYMPHGSLGKCLSTSNYILDFFQRLH------------IMIDVASAVEYLHF 203
           +D   L+ E M  GS+                +H            ++ DVASA+++LH 
Sbjct: 83  EDRFYLVFEKMRGGSI-------------LSHIHKRRHFNELEASVVVQDVASALDFLH- 128

Query: 204 GHSTHVIIHCDLKSSNVLLDDN 225
                 I H DLK  N+L +  
Sbjct: 129 ---NKGIAHRDLKPENILCEHP 147

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 51.4 bits (124), Expect = 4e-08
 Identities = 36/158 (22%), Positives = 56/158 (35%), Gaps = 36/158 (22%)

Query: 86  FRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVK------GFNLQYGGAFKNLDVECNMM 138
             +  E+   +  G F  + K R    G E   K        + + G + + ++ E N++
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62

Query: 139 KIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL---------- 188
           + IRH N+I +           LILE +  G L             F  L          
Sbjct: 63  REIRHPNIITLHDIFENKTDVVLILELVSGGEL-------------FDFLAEKESLTEDE 109

Query: 189 --HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD 224
               +  +   V YLH       I H DLK  N++L D
Sbjct: 110 ATQFLKQILDGVHYLHS----KRIAHFDLKPENIMLLD 143

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 51.6 bits (124), Expect = 5e-08
 Identities = 36/141 (25%), Positives = 66/141 (46%), Gaps = 19/141 (13%)

Query: 96  ISRGGFGSIYKARIQDGMEVV-VKGFNLQYGGAFKNLDVECNMMKIIRHQNLIK----II 150
           I  G FG +Y+A++ D  E+V +K         FKN   E  +M+ + H N+++      
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQD--KRFKNR--ELQIMRKLDHCNIVRLRYFFY 117

Query: 151 SSCSKDDFKAL--ILEYMPHGSLGKCLSTSNYILDFFQRLHI---MIDVASAVEYLHFGH 205
           SS  K D   L  +L+Y+P  ++ +     +        +++   M  +  ++ Y+H   
Sbjct: 118 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH--- 173

Query: 206 STHVIIHCDLKSSNVLLDDNM 226
            +  I H D+K  N+LLD + 
Sbjct: 174 -SFGICHRDIKPQNLLLDPDT 193

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 51.5 bits (124), Expect = 5e-08
 Identities = 33/159 (20%), Positives = 59/159 (37%), Gaps = 36/159 (22%)

Query: 85  PFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVK------GFNLQYGGAFKNLDVECNM 137
              ++ +    +  G F  + K R    G++   K        + + G + ++++ E ++
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67

Query: 138 MKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL--------- 188
           +K I+H N+I +           LILE +  G L             F  L         
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGEL-------------FDFLAEKESLTEE 114

Query: 189 ---HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD 224
                +  + + V YLH       I H DLK  N++L D
Sbjct: 115 EATEFLKQILNGVYYLHS----LQIAHFDLKPENIMLLD 149

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 51.5 bits (124), Expect = 6e-08
 Identities = 27/151 (17%), Positives = 53/151 (35%), Gaps = 21/151 (13%)

Query: 91  EVFNLISRGGFGSIYKARIQDGMEVVVK-----GFNLQYGGAFKNLDV------ECNMMK 139
            V   IS G +G++      +G+ V +K       + +      +  +      E  ++ 
Sbjct: 25  TVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLN 84

Query: 140 IIRHQNLIK---IISSCSKDDFKA--LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDV 194
              H N++    I     +       L+ E M    L + +     ++      + M  +
Sbjct: 85  HFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHI 143

Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
              +  LH       ++H DL   N+LL DN
Sbjct: 144 LLGLHVLHEAG----VVHRDLHPGNILLADN 170

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 51.1 bits (123), Expect = 7e-08
 Identities = 30/142 (21%), Positives = 50/142 (35%), Gaps = 34/142 (23%)

Query: 98  RGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-HQNLIKIISSCSK 155
            G F    K    +      VK  + +      N   E   +K+   H N++K+      
Sbjct: 21  EGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHD 77

Query: 156 DDFKALILEYMPHGSLGKCLSTSNYILDFFQRL------------HIMIDVASAVEYLHF 203
                L++E +  G L             F+R+            +IM  + SAV ++H 
Sbjct: 78  QLHTFLVMELLNGGEL-------------FERIKKKKHFSETEASYIMRKLVSAVSHMHD 124

Query: 204 GHSTHVIIHCDLKSSNVLLDDN 225
                 ++H DLK  N+L  D 
Sbjct: 125 ----VGVVHRDLKPENLLFTDE 142

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 50.7 bits (122), Expect = 9e-08
 Identities = 34/145 (23%), Positives = 62/145 (42%), Gaps = 16/145 (11%)

Query: 90  LEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGA-FKNLDVECNM-MKIIRHQNL 146
           LE    + RG +G + K R +  G  + VK           K L ++ ++ M+ +     
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL------HIMIDVASAVEY 200
           +    +  ++    + +E M   SL K       ++D  Q +       I + +  A+E+
Sbjct: 69  VTFYGALFREGDVWICMELMD-TSLDKFYK---QVIDKGQTIPEDILGKIAVSIVKALEH 124

Query: 201 LHFGHSTHVIIHCDLKSSNVLLDDN 225
           LH   S   +IH D+K SNVL++  
Sbjct: 125 LH---SKLSVIHRDVKPSNVLINAL 146

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 50.6 bits (121), Expect = 1e-07
 Identities = 27/145 (18%), Positives = 56/145 (38%), Gaps = 28/145 (19%)

Query: 96  ISRGGFGSIYKAR---IQDGMEVVVKGFNLQYGGAFKNLDV----ECNMMKIIRHQN--- 145
           + RG +G +YKA+    +D  +  +K            + +    E  +++ ++H N   
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIE------GTGISMSACREIALLRELKHPNVIS 82

Query: 146 LIKIISSCSKDDFKALILEYMPH-------GSLGKCLSTSNYILDFFQRLHIMIDVASAV 198
           L K+  S +      L+ +Y  H              +     L       ++  +   +
Sbjct: 83  LQKVFLSHADRKV-WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141

Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLD 223
            YLH     + ++H DLK +N+L+ 
Sbjct: 142 HYLH----ANWVLHRDLKPANILVM 162

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 50.5 bits (121), Expect = 1e-07
 Identities = 25/108 (23%), Positives = 41/108 (37%), Gaps = 14/108 (12%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE-----------YNRLQDSLRNSIGDLTSLKSLDLS 50
            +   L  +DLS      +     +            N +Q     +   L+SL+ L   
Sbjct: 49  FSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108

Query: 51  NNNFSGAIPIPLEKLLDLKDLNLSFNTL-EGKIPRPFRNF--LEVFNL 95
             N +     P+  L  LK+LN++ N +   K+P  F N   LE  +L
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 49.3 bits (118), Expect = 3e-07
 Identities = 23/108 (21%), Positives = 39/108 (36%), Gaps = 14/108 (12%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE-----------YNRLQDSL-RNSIGDLTSLKSLDL 49
            +L+ L+ +D+S  +    F                 N  Q++   +   +L +L  LDL
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477

Query: 50  SNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
           S        P     L  L+ LN++ N L+      F     L+   L
Sbjct: 478 SQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWL 525

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 41.6 bits (98), Expect = 1e-04
 Identities = 26/111 (23%), Positives = 40/111 (36%), Gaps = 17/111 (15%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE-----------YNRLQD-SLRNSIGDLTSLKSLDL 49
           S L  L ++     N + +    I            +N +Q   L     +LT+L+ LDL
Sbjct: 97  SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156

Query: 50  SNNNFSGAIPIPLEKLLDLK----DLNLSFNTLEGKIPRPFRNF-LEVFNL 95
           S+N         L  L  +      L+LS N +    P  F+   L    L
Sbjct: 157 SSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTL 207

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 41.6 bits (98), Expect = 1e-04
 Identities = 17/89 (19%), Positives = 28/89 (31%), Gaps = 8/89 (8%)

Query: 8  LRIDLSTNNFSCV---FPTTIE-----YNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIP 59
          +       NF  +    P + +     +N L+     S      L+ LDLS         
Sbjct: 10 ITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69

Query: 60 IPLEKLLDLKDLNLSFNTLEGKIPRPFRN 88
             + L  L  L L+ N ++      F  
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSG 98

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 41.2 bits (97), Expect = 1e-04
 Identities = 14/83 (16%), Positives = 30/83 (36%), Gaps = 12/83 (14%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIP 61
             L+ L  +D   +N   +   ++  +            L +L  LD+S+ +   A    
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLS------------LRNLIYLDISHTHTRVAFNGI 440

Query: 62  LEKLLDLKDLNLSFNTLEGKIPR 84
              L  L+ L ++ N+ +     
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLP 463

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 41.2 bits (97), Expect = 2e-04
 Identities = 18/88 (20%), Positives = 37/88 (42%), Gaps = 15/88 (17%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTI------------EYNRLQDSLRNSIGDLTSLKSLD 48
           +S+L+VL    ++ N+F   F   I               +L+     +   L+SL+ L+
Sbjct: 444 LSSLEVL---KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500

Query: 49  LSNNNFSGAIPIPLEKLLDLKDLNLSFN 76
           +++N          ++L  L+ + L  N
Sbjct: 501 MASNQLKSVPDGIFDRLTSLQKIWLHTN 528

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 39.3 bits (92), Expect = 7e-04
 Identities = 21/102 (20%), Positives = 36/102 (35%), Gaps = 8/102 (7%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLT---SLKSLDLSNN--NFS 55
               + L  ++     F  +   +++      +   +        SL+ LDLS N  +F 
Sbjct: 303 NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFK 362

Query: 56  GAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
           G           LK L+LSFN +   +   F     LE  + 
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDF 403

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 49.9 bits (120), Expect = 1e-07
 Identities = 25/142 (17%), Positives = 56/142 (39%), Gaps = 27/142 (19%)

Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFK--NLDV----------ECNMMKIIRH 143
           +  G + ++YK + +    +V          A K   L+           E +++K ++H
Sbjct: 10  LGEGTYATVYKGKSKLTDNLV----------ALKEIRLEHEEGAPCTAIREVSLLKDLKH 59

Query: 144 QNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHF 203
            N++ +      +    L+ EY+    L + L     I++       +  +   + Y H 
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH- 117

Query: 204 GHSTHVIIHCDLKSSNVLLDDN 225
                 ++H DLK  N+L+++ 
Sbjct: 118 ---RQKVLHRDLKPQNLLINER 136

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 50.2 bits (120), Expect = 2e-07
 Identities = 30/147 (20%), Positives = 64/147 (43%), Gaps = 22/147 (14%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV------ECNMMKIIRH 143
           E+ +LI  G +G + +A    +   V +K         F++L        E  ++  + H
Sbjct: 56  EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR----VFEDLIDCKRILREIAILNRLNH 111

Query: 144 QNLIK---IISSCSKDDFKA--LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV 198
            +++K   I+     + F    ++LE        K   T  Y+ +   +  ++ ++   V
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIK-TLLYNLLVGV 169

Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDN 225
           +Y+H    +  I+H DLK +N L++ +
Sbjct: 170 KYVH----SAGILHRDLKPANCLVNQD 192

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 49.1 bits (118), Expect = 2e-07
 Identities = 20/94 (21%), Positives = 42/94 (44%), Gaps = 5/94 (5%)

Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMID 193
           E  ++K ++H+N++++      D    L+ E+     L K   + N  LD       +  
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ 109

Query: 194 VASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           +   + + H    +  ++H DLK  N+L++ N  
Sbjct: 110 LLKGLGFCH----SRNVLHRDLKPQNLLINRNGE 139

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 49.0 bits (118), Expect = 3e-07
 Identities = 28/144 (19%), Positives = 55/144 (38%), Gaps = 21/144 (14%)

Query: 91  EVFNLISRGGFGSIYKARIQDGMEVVVK---------GFNLQYGGAFKNLDVECNMMKII 141
                I  G +G +YKA+   G    +K         G         +    E +++K +
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPST---TIR----EISILKEL 57

Query: 142 RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL 201
           +H N++K+           L+ E++    L K L      L+       ++ + + + Y 
Sbjct: 58  KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116

Query: 202 HFGHSTHVIIHCDLKSSNVLLDDN 225
           H       ++H DLK  N+L++  
Sbjct: 117 H----DRRVLHRDLKPQNLLINRE 136

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 49.3 bits (118), Expect = 3e-07
 Identities = 25/150 (16%), Positives = 49/150 (32%), Gaps = 46/150 (30%)

Query: 98  RGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVE---CNMMKIIRHQNLIKII--- 150
            G  G + +    + G +  +K           +        +  +     +++ I+   
Sbjct: 39  LGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCILDVY 91

Query: 151 -SSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL--------------HIMIDVA 195
            +         +I+E M  G L             F R+               IM D+ 
Sbjct: 92  ENMHHGKRCLLIIMECMEGGEL-------------FSRIQERGDQAFTEREAAEIMRDIG 138

Query: 196 SAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
           +A+++LH    +H I H D+K  N+L    
Sbjct: 139 TAIQFLH----SHNIAHRDVKPENLLYTSK 164

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 49.1 bits (117), Expect = 3e-07
 Identities = 21/96 (21%), Positives = 41/96 (42%), Gaps = 6/96 (6%)

Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI--LDFFQRLHIM 191
           +   M     +N +  +   S   +  + ++     +L   ++    +   +    LHI 
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170

Query: 192 IDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           I +A AVE+LH    +  ++H DLK SN+    + V
Sbjct: 171 IQIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDV 202

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 39.9 bits (93), Expect = 4e-04
 Identities = 14/95 (14%), Positives = 33/95 (34%), Gaps = 2/95 (2%)

Query: 86  FRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRH 143
           +    E    + RGGFG +++A+   D     +K   L     A + +  E   +  + H
Sbjct: 4   YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH 63

Query: 144 QNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTS 178
             +++  ++  +   +    E        +     
Sbjct: 64  PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWP 98

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 48.8 bits (117), Expect = 4e-07
 Identities = 16/91 (17%), Positives = 30/91 (32%), Gaps = 13/91 (14%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTI------------EYNRLQDSLRNSIGDLTSLKSLD 48
           + +L  L  +DL        +P               + + L  +L   I  LT L+ LD
Sbjct: 225 IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLD 283

Query: 49  LSNNNFSGAIPIPLEKLLDLKDLNLSFNTLE 79
           L        +P  + +L     + +  +   
Sbjct: 284 LRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 44.2 bits (105), Expect = 1e-05
 Identities = 17/99 (17%), Positives = 32/99 (32%), Gaps = 22/99 (22%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTIE-----------YNRLQDSLRNSIGDLTSLKSLDL 49
              L  L  + +         P T++            N L+ +L  SI  L  L+ L +
Sbjct: 100 AFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157

Query: 50  SNNNFSGAIP---------IPLEKLLDLKDLNLSFNTLE 79
                   +P            + L++L+ L L +  + 
Sbjct: 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR 196

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 41.1 bits (97), Expect = 1e-04
 Identities = 22/101 (21%), Positives = 38/101 (37%), Gaps = 22/101 (21%)

Query: 3   NLKVLLRIDLSTNNFSCVFPTTI--------------------EYNRLQDSLRNSIGDLT 42
           +L  L  + +         P  +                    E+  ++ SL  SI +L 
Sbjct: 148 SLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQ 206

Query: 43  SLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIP 83
           +LKSL + N+  S A+   +  L  L++L+L   T     P
Sbjct: 207 NLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYP 246

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 40.7 bits (96), Expect = 2e-04
 Identities = 9/55 (16%), Positives = 21/55 (38%), Gaps = 2/55 (3%)

Query: 25  IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLE 79
           +    L     +    L+ L+ + +        +P  +++   L+ L L+ N L 
Sbjct: 88  LRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR 140

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 48.9 bits (117), Expect = 4e-07
 Identities = 31/143 (21%), Positives = 63/143 (44%), Gaps = 24/143 (16%)

Query: 96  ISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV------ECNMMKIIRHQNLIK 148
           +  G +GS+  A   + G+ V VK    +    F+++        E  ++K ++H+N+I 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLLKHMKHENVIG 92

Query: 149 I----ISSCSKDDFKA--LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH 202
           +      + S ++F    L+   M    L   +       D  Q   ++  +   ++Y+H
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQ--FLIYQILRGLKYIH 149

Query: 203 FGHSTHVIIHCDLKSSNVLLDDN 225
                  IIH DLK SN+ ++++
Sbjct: 150 SAD----IIHRDLKPSNLAVNED 168

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 48.1 bits (115), Expect = 6e-07
 Identities = 25/140 (17%), Positives = 49/140 (35%), Gaps = 23/140 (16%)

Query: 92  VFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLI-KI 149
           V   I  G FG I++   + +  +V +K    +       L  E    K++     I  +
Sbjct: 14  VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNV 71

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQR-------LHIMIDVASAVEYLH 202
                +     L+++      LG  L     +LD   R             + + V+ +H
Sbjct: 72  YYFGQEGLHNVLVIDL-----LGPSLE---DLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123

Query: 203 FGHSTHVIIHCDLKSSNVLL 222
                  +++ D+K  N L+
Sbjct: 124 ----EKSLVYRDIKPDNFLI 139

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 48.5 bits (115), Expect = 6e-07
 Identities = 33/145 (22%), Positives = 58/145 (40%), Gaps = 23/145 (15%)

Query: 96  ISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLI-KIISSC 153
           I  G FG IY    IQ   EV +K  N++       L  E  + +I++    I  +    
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 154 SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQR-------LHIMIDVASAVEYLHFGHS 206
            + D+  L+++      LG  L     + +F  R       L +   + + VE++H    
Sbjct: 73  VEGDYNVLVMDL-----LGPSLE---DLFNFCSRKLSLKTVLMLADQMINRVEFVHS--- 121

Query: 207 THVIIHCDLKSSNVLLDDNMVAHFL 231
               +H D+K  N L+     A+ +
Sbjct: 122 -KSFLHRDIKPDNFLMGLGRRANQV 145

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 48.1 bits (115), Expect = 6e-07
 Identities = 22/150 (14%), Positives = 46/150 (30%), Gaps = 46/150 (30%)

Query: 98  RGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV--ECN-MMKIIRHQNLIKII--- 150
            G  G + +    +   +  +K                 E     +  +  ++++I+   
Sbjct: 28  LGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDVY 80

Query: 151 -SSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL--------------HIMIDVA 195
            +  +      +++E +  G L             F R+               IM  + 
Sbjct: 81  ENLYAGRKCLLIVMECLDGGEL-------------FSRIQDRGDQAFTEREASEIMKSIG 127

Query: 196 SAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            A++YLH       I H D+K  N+L    
Sbjct: 128 EAIQYLHS----INIAHRDVKPENLLYTSK 153

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 48.4 bits (115), Expect = 6e-07
 Identities = 30/163 (18%), Positives = 58/163 (35%), Gaps = 27/163 (16%)

Query: 72  NLSFNTLEGKIPRPFRNFLEVFNLISRGGFGSIYKARI------QDGMEVVVK----GFN 121
            L ++  + + PR   + L++   + RG FG + +A             V VK    G  
Sbjct: 9   RLPYDASKWEFPR---DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT 65

Query: 122 LQYGGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKA-LILEYMPHGSLGKCLSTSN 179
                A  +   E  ++  I  H N++ ++ +C+K      +I+E+   G+L   L +  
Sbjct: 66  HSEHRALMS---ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR 122

Query: 180 YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL 222
                    +  +   +       G      I  DLK     +
Sbjct: 123 ---------NEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSI 156

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 47.7 bits (114), Expect = 7e-07
 Identities = 34/136 (25%), Positives = 57/136 (41%), Gaps = 23/136 (16%)

Query: 96  ISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLI-KIISSC 153
           I  G FG IY    I  G EV +K   ++       L +E  + K+++    I  I    
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 154 SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQR-------LHIMIDVASAVEYLHFGHS 206
           ++ D+  +++E      LG  L     + +F  R       L +   + S +EY+H    
Sbjct: 75  AEGDYNVMVMEL-----LGPSLE---DLFNFCSRKFSLKTVLLLADQMISRIEYIH---- 122

Query: 207 THVIIHCDLKSSNVLL 222
           +   IH D+K  N L+
Sbjct: 123 SKNFIHRDVKPDNFLM 138

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 47.3 bits (113), Expect = 1e-06
 Identities = 31/147 (21%), Positives = 62/147 (42%), Gaps = 24/147 (16%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV------ECNMMKIIRH 143
              + I  G +G +  A    + + V +K  +      F++         E  ++   RH
Sbjct: 30  TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-----PFEHQTYCQRTLREIKILLRFRH 84

Query: 144 QNLIK---IISSCSKDDFKA--LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV 198
           +N+I    II + + +  K   ++ + M    L K L T +   D     + +  +   +
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHIC--YFLYQILRGL 141

Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDN 225
           +Y+H  +    ++H DLK SN+LL+  
Sbjct: 142 KYIHSAN----VLHRDLKPSNLLLNTT 164

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 46.1 bits (110), Expect = 2e-06
 Identities = 17/87 (19%), Positives = 35/87 (40%), Gaps = 12/87 (13%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTT---------IEYNRLQDSLRNSIGDLTSLKSLDLSN 51
             N+K L    ++  + +   P +         I    +      ++  LTSL  LD+S+
Sbjct: 65  AHNIKDL---TINNIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121

Query: 52  NNFSGAIPIPLEKLLDLKDLNLSFNTL 78
           +    +I   +  L  +  ++LS+N  
Sbjct: 122 SAHDDSILTKINTLPKVNSIDLSYNGA 148

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 46.9 bits (112), Expect = 2e-06
 Identities = 24/146 (16%), Positives = 60/146 (41%), Gaps = 19/146 (13%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGA------FKNLDVECNMMKIIRH 143
           E+  ++  GG   ++ AR ++D  +V VK               F+    E      + H
Sbjct: 15  ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRR---EAQNAAALNH 71

Query: 144 QNLIKIISSCSKDDFKA----LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVE 199
             ++ +  +   +        +++EY+   +L + +  +   +   + + ++ D   A+ 
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL-RDIVHTEGPMTPKRAIEVIADACQALN 130

Query: 200 YLHFGHSTHVIIHCDLKSSNVLLDDN 225
           + H     + IIH D+K +N+++   
Sbjct: 131 FSH----QNGIIHRDVKPANIMISAT 152

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 46.6 bits (111), Expect = 2e-06
 Identities = 22/150 (14%), Positives = 46/150 (30%), Gaps = 46/150 (30%)

Query: 98  RGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV--ECNMMK-IIRHQNLIKII--- 150
            G  G + +    +   +  +K                 E  +     +  ++++I+   
Sbjct: 72  LGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVDVY 124

Query: 151 -SSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRL--------------HIMIDVA 195
            +  +      +++E +  G L             F R+               IM  + 
Sbjct: 125 ENLYAGRKCLLIVMECLDGGEL-------------FSRIQDRGDQAFTEREASEIMKSIG 171

Query: 196 SAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            A++YLH       I H D+K  N+L    
Sbjct: 172 EAIQYLHS----INIAHRDVKPENLLYTSK 197

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 46.9 bits (112), Expect = 2e-06
 Identities = 37/147 (25%), Positives = 62/147 (42%), Gaps = 24/147 (16%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV------ECNMMKIIRH 143
           ++ +L+  G +G +  A     G  V +K         F           E  ++K  +H
Sbjct: 14  QLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-----PFDKPLFALRTLREIKILKHFKH 68

Query: 144 QNLIK---IISSCSKDDFKA--LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV 198
           +N+I    I    S ++F    +I E M    L + +ST     D  Q  + +     AV
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQ--YFIYQTLRAV 125

Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDN 225
           + LH  +    +IH DLK SN+L++ N
Sbjct: 126 KVLHGSN----VIHRDLKPSNLLINSN 148

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 46.3 bits (110), Expect = 2e-06
 Identities = 17/144 (11%), Positives = 41/144 (28%), Gaps = 21/144 (14%)

Query: 91  EVFNLISRGGFGSIYKARIQD---GMEVVVKGFNLQYGGA------FKNLDVECNMMKII 141
            +            ++A   D     +V +   + Q            +       +  I
Sbjct: 34  RLLIFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLS---RTLRLSRI 88

Query: 142 RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL 201
               + +++          ++ E++  GSL +   TS         +  M  +A+A +  
Sbjct: 89  DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAA 145

Query: 202 HFGHSTHVIIHCDLKSSNVLLDDN 225
           H       +       S V +  +
Sbjct: 146 H----RAGVALSIDHPSRVRVSID 165

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 46.7 bits (111), Expect = 3e-06
 Identities = 19/94 (20%), Positives = 37/94 (39%), Gaps = 8/94 (8%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIP 61
           S    L ++ L  N     + T + ++  +         L+ L+ L L++N  +   P  
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEG--------LSHLQVLYLNHNYLNSLPPGV 499

Query: 62  LEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNL 95
              L  L+ L+L+ N L           LE+ ++
Sbjct: 500 FSHLTALRGLSLNSNRLTVLSHNDLPANLEILDI 533

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 44.8 bits (106), Expect = 1e-05
 Identities = 28/98 (28%), Positives = 40/98 (40%), Gaps = 14/98 (14%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIP 61
            NLK L R+DLS N    +             L  S G L SLKS+D S+N         
Sbjct: 120 RNLKALTRLDLSKNQIRSL------------YLHPSFGKLNSLKSIDFSSNQIFLVCEHE 167

Query: 62  LEKL--LDLKDLNLSFNTLEGKIPRPFRNFLEVFNLIS 97
           LE L    L   +L+ N+L  ++   +   +  F  + 
Sbjct: 168 LEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMV 205

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 44.4 bits (105), Expect = 2e-05
 Identities = 18/89 (20%), Positives = 34/89 (38%), Gaps = 11/89 (12%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT-----------IEYNRLQDSLRNSIGDLTSLKSLDLS 50
             LK L  ++L+ N  + +               + YN L +   ++   L  +  +DL 
Sbjct: 287 ETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQ 346

Query: 51  NNNFSGAIPIPLEKLLDLKDLNLSFNTLE 79
            N+ +       + L  L+ L+L  N L 
Sbjct: 347 KNHIAIIQDQTFKFLEKLQTLDLRDNALT 375

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 43.3 bits (102), Expect = 4e-05
 Identities = 19/92 (20%), Positives = 34/92 (36%), Gaps = 7/92 (7%)

Query: 11  DLSTNNFSCVFPTTIE-----YNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKL 65
           D   N F+ +  +++      +  +          L  LK L+L+ N  +         L
Sbjct: 254 DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGL 313

Query: 66  LDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
            +L+ LNLS+N L       F     +   +L
Sbjct: 314 DNLQVLNLSYNLLGELYSSNFYGLPKVAYIDL 345

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 42.9 bits (101), Expect = 5e-05
 Identities = 25/112 (22%), Positives = 39/112 (34%), Gaps = 18/112 (16%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT-----------IEYNRLQDSL--RNSIGDLTSLKSLD 48
            NL  L  +DL ++    + P             + +  L D++       +L +L  LD
Sbjct: 70  RNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLD 129

Query: 49  LSNNNFSGAIPIP-LEKLLDLKDLNLSFNTLEGKIPRPFRNF----LEVFNL 95
           LS N        P   KL  LK ++ S N +               L  F+L
Sbjct: 130 LSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSL 181

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 42.5 bits (100), Expect = 6e-05
 Identities = 23/110 (20%), Positives = 40/110 (36%), Gaps = 16/110 (14%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT-----------IEYNRLQDSL-RNSIGDLTSLKSLDL 49
             L    R+ LS N    V  ++           +       ++ + +  +L +L+ LDL
Sbjct: 21  QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDL 80

Query: 50  SNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKI--PRPFRN--FLEVFNL 95
            ++      P   + L  L +L L F  L   +     FRN   L   +L
Sbjct: 81  GSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDL 130

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 42.5 bits (100), Expect = 6e-05
 Identities = 17/102 (16%), Positives = 35/102 (34%), Gaps = 13/102 (12%)

Query: 7   LLRIDLSTNNFSCVFPTT-----------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFS 55
           +  +DLS      +               + YN++      +   L +L+ L+LS N   
Sbjct: 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327

Query: 56  GAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
                    L  +  ++L  N +     + F+    L+  +L
Sbjct: 328 ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDL 369

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 40.9 bits (96), Expect = 2e-04
 Identities = 19/89 (21%), Positives = 37/89 (41%), Gaps = 19/89 (21%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTT-----------IEYNRLQDSLRNSIGDLTSLKSLDL 49
           + NL+VL   +LS N    ++ +            ++ N +      +   L  L++LDL
Sbjct: 313 LDNLQVL---NLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDL 369

Query: 50  SNNNFSGAIPIPLEKLLDLKDLNLSFNTL 78
            +N  +      +  +  + D+ LS N L
Sbjct: 370 RDNALTT-----IHFIPSIPDIFLSGNKL 393

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 46.2 bits (110), Expect = 3e-06
 Identities = 32/142 (22%), Positives = 55/142 (38%), Gaps = 25/142 (17%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGA-FKNLDVECNMMKIIRHQNLI- 147
            V   I  G FG +   + +     V +K   L+   +    L +E    K +   + I 
Sbjct: 12  RVGKKIGCGNFGELRLGKNLYTNEYVAIK---LEPMKSRAPQLHLEYRFYKQLGSGDGIP 68

Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQR-------LHIMIDVASAVEY 200
           ++        + A++LE      LG  L     + D   R       L I I + S +EY
Sbjct: 69  QVYYFGPCGKYNAMVLEL-----LGPSLE---DLFDLCDRTFSLKTVLMIAIQLISRMEY 120

Query: 201 LHFGHSTHVIIHCDLKSSNVLL 222
           +H    +  +I+ D+K  N L+
Sbjct: 121 VH----SKNLIYRDVKPENFLI 138

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 46.5 bits (111), Expect = 3e-06
 Identities = 24/96 (25%), Positives = 37/96 (38%), Gaps = 13/96 (13%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT---------IEYNRLQDSLRNSIGDLTSLKSLDLSNN 52
           SNLK L  + L  NN S + P +            N++ D   +S+ +LT++  L   +N
Sbjct: 306 SNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHN 363

Query: 53  NFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRN 88
             S     PL  L  +  L L+             N
Sbjct: 364 QISD--LTPLANLTRITQLGLNDQAWTNAPVNYKAN 397

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 43.4 bits (103), Expect = 2e-05
 Identities = 19/89 (21%), Positives = 37/89 (41%), Gaps = 9/89 (10%)

Query: 2   SNLKVLLRIDLSTNNFSCVFP-------TTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNF 54
           + L   ++  L   N +           TT++ +RL     + +  L +L  ++ SNN  
Sbjct: 21  TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQL 80

Query: 55  SGAIPIPLEKLLDLKDLNLSFNTLEGKIP 83
           +     PL+ L  L D+ ++ N +    P
Sbjct: 81  TD--ITPLKNLTKLVDILMNNNQIADITP 107

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 43.4 bits (103), Expect = 3e-05
 Identities = 23/88 (26%), Positives = 34/88 (38%), Gaps = 13/88 (14%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT---------IEYNRLQDSLRNSIGDLTSLKSLDLSNN 52
           S L  L  + L  N  S + P           +  N+L+D   + I +L +L  L L  N
Sbjct: 262 SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFN 319

Query: 53  NFSGAIPIPLEKLLDLKDLNLSFNTLEG 80
           N S     P+  L  L+ L    N +  
Sbjct: 320 NISD--ISPVSSLTKLQRLFFYNNKVSD 345

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 43.4 bits (103), Expect = 3e-05
 Identities = 25/91 (27%), Positives = 39/91 (42%), Gaps = 13/91 (14%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPT---------TIEYNRLQDSLRNSIGDLTSLKSLDLSNN 52
           + L  L  +  + N  S + P          ++  N+L+D    ++  LT+L  LDL+NN
Sbjct: 196 AKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANN 253

Query: 53  NFSGAIPIPLEKLLDLKDLNLSFNTLEGKIP 83
             S     PL  L  L +L L  N +    P
Sbjct: 254 QISN--LAPLSGLTKLTELKLGANQISNISP 282

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 41.5 bits (98), Expect = 1e-04
 Identities = 24/88 (27%), Positives = 38/88 (43%), Gaps = 13/88 (14%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT---------IEYNRLQDSLRNSIGDLTSLKSLDLSNN 52
             L  L +I+ S N  + + P           +  N++ D     + +LT+L  L L NN
Sbjct: 65  EYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADI--TPLANLTNLTGLTLFNN 122

Query: 53  NFSGAIPIPLEKLLDLKDLNLSFNTLEG 80
             +     PL+ L +L  L LS NT+  
Sbjct: 123 QITD--IDPLKNLTNLNRLELSSNTISD 148

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 39.2 bits (92), Expect = 7e-04
 Identities = 21/88 (23%), Positives = 35/88 (39%), Gaps = 14/88 (15%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT---------IEYNRLQDSLRNSIGDLTSLKSLDLSNN 52
           +NL  L  + L  N  + + P           +  N + D   +++  LTSL+ L   N 
Sbjct: 109 ANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLSFGNQ 166

Query: 53  NFSGAIPIPLEKLLDLKDLNLSFNTLEG 80
                   PL  L  L+ L++S N +  
Sbjct: 167 VTD---LKPLANLTTLERLDISSNKVSD 191

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 38.8 bits (91), Expect = 9e-04
 Identities = 24/79 (30%), Positives = 39/79 (49%), Gaps = 17/79 (21%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIP 61
           +NL  L R+D+S+N  S +               + +  LT+L+SL  +NN  S     P
Sbjct: 174 ANLTTLERLDISSNKVSDI---------------SVLAKLTNLESLIATNNQISD--ITP 216

Query: 62  LEKLLDLKDLNLSFNTLEG 80
           L  L +L +L+L+ N L+ 
Sbjct: 217 LGILTNLDELSLNGNQLKD 235

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 46.1 bits (110), Expect = 3e-06
 Identities = 26/141 (18%), Positives = 52/141 (36%), Gaps = 13/141 (9%)

Query: 91  EVFNLISRGGFGSIYKARIQD---GMEVVVKGFNLQYGG--AFKN-LDVECNMMKIIRHQ 144
            +  L+ RGG G +Y+A   D      V +K  +        F+  +  E      ++  
Sbjct: 37  RLRRLVGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94

Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           +++ I      D    + +  +    L   L      L   + + I+  + SA++  H  
Sbjct: 95  HVVPIHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH-- 151

Query: 205 HSTHVIIHCDLKSSNVLLDDN 225
                  H D+K  N+L+  +
Sbjct: 152 --AAGATHRDVKPENILVSAD 170

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 45.7 bits (109), Expect = 5e-06
 Identities = 28/151 (18%), Positives = 61/151 (40%), Gaps = 31/151 (20%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV------ECNMMKIIRH 143
                +  G +GS+  A   + G +V +K    +    F++         E  ++K ++H
Sbjct: 27  VSPTHVGSGAYGSVCSAIDKRSGEKVAIK----KLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 144 QNLIKI----ISSCSKDDFKA--LILEYMP---HGSLGKCLSTSNYILDFFQRLHIMIDV 194
           +N+I +      + S  +F    L++ +M       +G   S        +Q L      
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLK----- 137

Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
              ++Y+H       ++H DLK  N+ ++++
Sbjct: 138 --GLKYIHSAG----VVHRDLKPGNLAVNED 162

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 45.2 bits (108), Expect = 5e-06
 Identities = 18/93 (19%), Positives = 43/93 (46%), Gaps = 6/93 (6%)

Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI-LDFFQRLHIMI 192
           E +++K + H N++K++     ++   L+ E++    L K +  S    +        + 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 110

Query: 193 DVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            +   + + H    +H ++H DLK  N+L++  
Sbjct: 111 QLLQGLAFCH----SHRVLHRDLKPQNLLINTE 139

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 45.0 bits (107), Expect = 6e-06
 Identities = 13/65 (20%), Positives = 28/65 (43%), Gaps = 2/65 (3%)

Query: 33 SLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF--L 90
          ++     +    K   +++++   A+    +   ++K+L+LS N L          F  L
Sbjct: 1  AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 91 EVFNL 95
          E+ NL
Sbjct: 61 ELLNL 65

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 43.8 bits (104), Expect = 2e-05
 Identities = 17/54 (31%), Positives = 25/54 (46%)

Query: 25 IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTL 78
          +  + L+ +L +      ++K LDLS N  S      L     L+ LNLS N L
Sbjct: 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 41.5 bits (98), Expect = 1e-04
 Identities = 16/105 (15%), Positives = 36/105 (34%), Gaps = 19/105 (18%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT---------IEYNRLQDSLRNSIGDLTSLKSLDLSNN 52
           +    L  ++LS+N                  +  N +Q      +    S+++L  +NN
Sbjct: 55  APFTKLELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANN 109

Query: 53  NFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
           N S    +   +    K++ L+ N +             ++  +L
Sbjct: 110 NISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 41.1 bits (97), Expect = 1e-04
 Identities = 19/105 (18%), Positives = 40/105 (38%), Gaps = 19/105 (18%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE-----------YNRLQDSLRNSIGDLTSLKSLDLS 50
            +   +  +DLS N  S +    +             N L ++L   +  L++L++LDL+
Sbjct: 31  QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL--DLESLSTLRTLDLN 88

Query: 51  NNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNL 95
           NN         L     ++ L+ + N +  ++        +   L
Sbjct: 89  NNYVQE-----LLVGPSIETLHAANNNIS-RVSCSRGQGKKNIYL 127

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 40.7 bits (96), Expect = 2e-04
 Identities = 17/109 (15%), Positives = 34/109 (31%), Gaps = 20/109 (18%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQD-SLRNSIGDLTSLKSLD 48
               K +    L+ N  + +                + N +   +         +L+ L+
Sbjct: 119 GQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175

Query: 49  LSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
           L  N     +         LK L+LS N L   +   F++   +   +L
Sbjct: 176 LQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 39.2 bits (92), Expect = 6e-04
 Identities = 14/90 (15%), Positives = 30/90 (33%), Gaps = 10/90 (11%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFS 55
            +L  L  +DL+ N    +             N +      S       K++ L+NN  +
Sbjct: 77  ESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRV---SCSRGQGKKNIYLANNKIT 133

Query: 56  GAIPIPLEKLLDLKDLNLSFNTLEGKIPRP 85
               +       ++ L+L  N ++  +   
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEID-TVNFA 162

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 45.2 bits (108), Expect = 6e-06
 Identities = 22/91 (24%), Positives = 38/91 (41%), Gaps = 11/91 (12%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT---------IEYNRLQDSLRNSIGDLTSLKSLDLSNN 52
           +NL  L  +++ TN  S +             +  N++ D   + + +L+ L SL L+NN
Sbjct: 240 ANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNN 297

Query: 53  NFSGAIPIPLEKLLDLKDLNLSFNTLEGKIP 83
                    +  L +L  L LS N +    P
Sbjct: 298 QLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 44.5 bits (106), Expect = 1e-05
 Identities = 20/82 (24%), Positives = 34/82 (41%), Gaps = 17/82 (20%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIP 61
           SNL  L  + + TN  + +               +++ +LT+L+ L L+ +N S     P
Sbjct: 85  SNLVKLTNLYIGTNKITDI---------------SALQNLTNLRELYLNEDNISD--ISP 127

Query: 62  LEKLLDLKDLNLSFNTLEGKIP 83
           L  L  +  LNL  N     + 
Sbjct: 128 LANLTKMYSLNLGANHNLSDLS 149

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 43.7 bits (104), Expect = 2e-05
 Identities = 18/87 (20%), Positives = 36/87 (41%), Gaps = 11/87 (12%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT---------IEYNRLQDSLRNSIGDLTSLKSLDLSNN 52
            +L  L  +++ +N  S +             +  N+L +     IG LT+L +L LS N
Sbjct: 262 KDLTKLKMLNVGSNQISDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQN 321

Query: 53  NFSGAIPIPLEKLLDLKDLNLSFNTLE 79
           + +   P  L  L  +   + +   ++
Sbjct: 322 HITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 40.6 bits (96), Expect = 2e-04
 Identities = 17/87 (19%), Positives = 34/87 (39%), Gaps = 13/87 (14%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT---------IEYNRLQDSLRNSIGDLTSLKSLDLSNN 52
           ++L   +R  L   + + V             +   ++       I  LT+L+ L+L+ N
Sbjct: 19  ADLAEGIRAVLQKASVTDVVTQEELESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGN 76

Query: 53  NFSGAIPIPLEKLLDLKDLNLSFNTLE 79
             +     PL  L+ L +L +  N + 
Sbjct: 77  QITD--ISPLSNLVKLTNLYIGTNKIT 101

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 40.6 bits (96), Expect = 2e-04
 Identities = 20/88 (22%), Positives = 33/88 (37%), Gaps = 13/88 (14%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT---------IEYNRLQDSLRNSIGDLTSLKSLDLSNN 52
           +NL  L  + L+ N    + P              N++ D     + ++T L SL + NN
Sbjct: 174 ANLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVNQITDI--TPVANMTRLNSLKIGNN 231

Query: 53  NFSGAIPIPLEKLLDLKDLNLSFNTLEG 80
             +     PL  L  L  L +  N +  
Sbjct: 232 KITD--LSPLANLSQLTWLEIGTNQISD 257

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 39.8 bits (94), Expect = 3e-04
 Identities = 16/79 (20%), Positives = 33/79 (41%), Gaps = 16/79 (20%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIP 61
           +NL  +  ++L  N+                S  + + ++T L  L ++ +        P
Sbjct: 129 ANLTKMYSLNLGANHNL--------------SDLSPLSNMTGLNYLTVTESKVKD--VTP 172

Query: 62  LEKLLDLKDLNLSFNTLEG 80
           +  L DL  L+L++N +E 
Sbjct: 173 IANLTDLYSLSLNYNQIED 191

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 45.2 bits (107), Expect = 7e-06
 Identities = 31/151 (20%), Positives = 57/151 (37%), Gaps = 31/151 (20%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV------ECNMMKIIRH 143
           +    I  G  G +  A        V +K    +    F+N         E  +MK + H
Sbjct: 65  QNLKPIGSGAQGIVCAAYDAVLDRNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNH 120

Query: 144 QNLIKII----SSCSKDDFKA--LILEYMP---HGSLGKCLSTSNYILDFFQRLHIMIDV 194
           +N+I ++       + ++F+   L++E M       +   L         +Q L      
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML------ 174

Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
              +++LH       IIH DLK SN+++  +
Sbjct: 175 -CGIKHLHSAG----IIHRDLKPSNIVVKSD 200

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 45.1 bits (107), Expect = 7e-06
 Identities = 31/147 (21%), Positives = 60/147 (40%), Gaps = 22/147 (14%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV------ECNMMKIIRH 143
            + +LI RG +G +Y A        V +K    +    F++L        E  ++  ++ 
Sbjct: 29  IIKHLIGRGSYGYVYLAYDKNTEKNVAIK----KVNRMFEDLIDCKRILREITILNRLKS 84

Query: 144 QNLIK---IISSCSKDDFKA--LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV 198
             +I+   +I       F    ++LE      L K   T  ++ +   +  I+ ++    
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIK-TILYNLLLGE 142

Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            ++H       IIH DLK +N LL+ +
Sbjct: 143 NFIHESG----IIHRDLKPANCLLNQD 165

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 44.8 bits (106), Expect = 9e-06
 Identities = 29/150 (19%), Positives = 53/150 (35%), Gaps = 26/150 (17%)

Query: 95  LISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKN--LDVECNMMKIIRHQNLIKIISS 152
            I +GGFG IY A +     V      +       N  L  E    +       I+    
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 153 CSKDDFKALILEYMPHGSLGKCLSTSNYIL---------DFFQR----------LHIMID 193
             K  +   + +Y   G   K   +  +++           ++           L + + 
Sbjct: 102 TRKLKYLG-VPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLR 160

Query: 194 VASAVEYLHFGHSTHVIIHCDLKSSNVLLD 223
           +   +EY+H     H  +H D+K+SN+LL+
Sbjct: 161 ILDILEYIH----EHEYVHGDIKASNLLLN 186

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 44.5 bits (106), Expect = 1e-05
 Identities = 19/97 (19%), Positives = 36/97 (37%), Gaps = 15/97 (15%)

Query: 137 MMKIIRHQN---LIKIISSCSKDDFKA--LILEYMPHGSLGKCLSTSNYILDFFQRLHI- 190
            ++   H N   L+ + ++   D      L+ E++    L   L  +           I 
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPP--GLPAETIK 123

Query: 191 --MIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
             M      +++LH     + I+H DLK  N+L+   
Sbjct: 124 DLMRQFLRGLDFLH----ANCIVHRDLKPENILVTSG 156

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 44.5 bits (106), Expect = 1e-05
 Identities = 22/96 (22%), Positives = 44/96 (45%), Gaps = 6/96 (6%)

Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMID 193
           E +++K ++H+N+I++ S    +    LI EY  +  L K +   N  +        +  
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMD-KNPDVSMRVIKSFLYQ 140

Query: 194 VASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAH 229
           + + V + H    +   +H DLK  N+LL  +  + 
Sbjct: 141 LINGVNFCH----SRRCLHRDLKPQNLLLSVSDASE 172

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 44.5 bits (106), Expect = 1e-05
 Identities = 19/97 (19%), Positives = 45/97 (46%), Gaps = 10/97 (10%)

Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI-----LDFFQRL 188
           E ++MK ++H+N++++      ++   L+ E+M +  L K + +         L+     
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111

Query: 189 HIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
           +    +   + + H     + I+H DLK  N+L++  
Sbjct: 112 YFQWQLLQGLAFCH----ENKILHRDLKPQNLLINKR 144

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 44.5 bits (105), Expect = 1e-05
 Identities = 24/114 (21%), Positives = 34/114 (29%), Gaps = 20/114 (17%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTI------------------EYNRLQDSLRNSIGDLT 42
           +     L  +DLS N                                             
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228

Query: 43  SLKSLDLSNNNFSGAIPIPLEKLLD-LKDLNLSFNTLEGKIPRPFRNFLEVFNL 95
            L+ LDLS+N+   A   P       L  LNLSF  L+ ++P+     L V +L
Sbjct: 229 QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLSVLDL 281

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 41.4 bits (97), Expect = 1e-04
 Identities = 16/87 (18%), Positives = 28/87 (32%), Gaps = 8/87 (9%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPT----TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSG 56
           + N+    R          + P     +I      +     +    +L +LDLS+N   G
Sbjct: 128 LRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG 187

Query: 57  AIPIP----LEKLLDLKDLNLSFNTLE 79
              +       K   L+ L L    +E
Sbjct: 188 ERGLISALCPLKFPTLQVLALRNAGME 214

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 41.0 bits (96), Expect = 1e-04
 Identities = 22/92 (23%), Positives = 32/92 (34%), Gaps = 20/92 (21%)

Query: 1   MSNLKVLLRIDLSTNNFS-------CVFPTTIEY-----NRLQDSLRNSIGDLTSLKSLD 48
              L+ L   DLS N+         C +P+ +         L   +   +     L  LD
Sbjct: 227 RVQLQGL---DLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL-KQVPKGL--PAKLSVLD 280

Query: 49  LSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEG 80
           LS N      P P E L  + +L+L  N    
Sbjct: 281 LSYNRLDR-NPSPDE-LPQVGNLSLKGNPFLD 310

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 44.5 bits (105), Expect = 1e-05
 Identities = 13/65 (20%), Positives = 28/65 (43%), Gaps = 2/65 (3%)

Query: 33 SLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF--L 90
          ++     +    K   +++++   A+    +   ++K+L+LS N L          F  L
Sbjct: 1  AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 91 EVFNL 95
          E+ NL
Sbjct: 61 ELLNL 65

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 43.3 bits (102), Expect = 3e-05
 Identities = 19/73 (26%), Positives = 29/73 (39%), Gaps = 4/73 (5%)

Query: 25 IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPR 84
          +  + L+ +L +      ++K LDLS N  S      L     L+ LNLS N L      
Sbjct: 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TL 74

Query: 85 PFRNF--LEVFNL 95
             +   L   +L
Sbjct: 75 DLESLSTLRTLDL 87

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 42.9 bits (101), Expect = 4e-05
 Identities = 16/112 (14%), Positives = 34/112 (30%), Gaps = 11/112 (9%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT---------IEYNRLQDSLRNSIGDLTSLKSLDLSNN 52
           ++   L  ++L  N    V             +  N+L   +         +  + L NN
Sbjct: 166 ASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNN 224

Query: 53  NFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNLISRGGFGSI 104
                I   L    +L+  +L  N       R F +  +    +++     +
Sbjct: 225 KLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKL 275

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 42.9 bits (101), Expect = 5e-05
 Identities = 17/98 (17%), Positives = 36/98 (36%), Gaps = 18/98 (18%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE-----------YNRLQDSLRNSIGDLTSLKSLDLS 50
            +   +  +DLS N  S +    +             N L ++    +  L++L++LDL+
Sbjct: 31  QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYET--LDLESLSTLRTLDLN 88

Query: 51  NNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRN 88
           NN         L     ++ L+ + N +        + 
Sbjct: 89  NNYVQE-----LLVGPSIETLHAANNNISRVSCSRGQG 121

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 40.2 bits (94), Expect = 3e-04
 Identities = 14/96 (14%), Positives = 30/96 (31%), Gaps = 9/96 (9%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFS 55
            +L  L  +DL+ N    +             N +      S       K++ L+NN  +
Sbjct: 77  ESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRV---SCSRGQGKKNIYLANNKIT 133

Query: 56  GAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLE 91
               +       ++ L+L  N ++           +
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 39.4 bits (92), Expect = 7e-04
 Identities = 17/109 (15%), Positives = 34/109 (31%), Gaps = 20/109 (18%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQD-SLRNSIGDLTSLKSLD 48
               K +    L+ N  + +                + N +   +         +L+ L+
Sbjct: 119 GQGKKNI---YLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175

Query: 49  LSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
           L  N     +         LK L+LS N L   +   F++   +   +L
Sbjct: 176 LQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 44.1 bits (105), Expect = 1e-05
 Identities = 30/165 (18%), Positives = 58/165 (35%), Gaps = 39/165 (23%)

Query: 84  RPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFK--NLDVECN---- 136
           R  + + E    I  G +G ++KAR +++G   V          A K   +         
Sbjct: 8   RADQQY-ECVAEIGEGAYGKVFKARDLKNGGRFV----------ALKRVRVQTGEEGMPL 56

Query: 137 ----------MMKIIRHQN---LIKIISSCSKDDFKA--LILEYMPHGSLGKCL-STSNY 180
                      ++   H N   L  + +    D      L+ E++    L   L      
Sbjct: 57  STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEP 115

Query: 181 ILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            +       +M  +   +++LH    +H ++H DLK  N+L+  +
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSS 156

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 43.9 bits (104), Expect = 2e-05
 Identities = 27/148 (18%), Positives = 52/148 (35%), Gaps = 25/148 (16%)

Query: 95  LISRGGFGSIYKA-RIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSC 153
            I  GGFG IY A       +       ++Y      L  E    + +  ++ IK     
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN-GPLFSELKFYQRVAKKDCIKKWIER 102

Query: 154 SKDDFKALILEYMPHGSLGKCLSTSNYIL---------DFFQR---------LHIMIDVA 195
            + D+   I  +   G       +  +++             +         L + I + 
Sbjct: 103 KQLDYLG-IPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRML 161

Query: 196 SAVEYLHFGHSTHVIIHCDLKSSNVLLD 223
             +EY+H     +  +H D+K++N+LL 
Sbjct: 162 DVLEYIH----ENEYVHGDIKAANLLLG 185

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 43.7 bits (102), Expect = 2e-05
 Identities = 35/196 (17%), Positives = 59/196 (30%), Gaps = 58/196 (29%)

Query: 83  PRPFRNFLEVFNL-----ISRGGFGSIYKARIQDGMEVVVK--------GFNLQYGGAFK 129
           P PF + L    L     I  G FG +++    D   V +K          N  +   F+
Sbjct: 10  PVPFSHCLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFE 68

Query: 130 NLDVECNMMKII---------RHQNLIKIISSC--------------------------- 153
            +  E  + K +         R +  I + S                             
Sbjct: 69  EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128

Query: 154 ---SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVI 210
               KDD   ++LE+   G   + + T   +        I+  + ++   L    ++   
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTK--LSSLATAKSILHQLTAS---LAVAEASLRF 183

Query: 211 IHCDLKSSNVLLDDNM 226
            H DL   NVLL    
Sbjct: 184 EHRDLHWGNVLLKKTS 199

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 43.5 bits (103), Expect = 2e-05
 Identities = 32/143 (22%), Positives = 64/143 (44%), Gaps = 24/143 (16%)

Query: 96  ISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV------ECNMMKIIRHQNLIK 148
           +  G +G++  A   + G +V +K    +    F++         E  ++K +RH+N+I 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIK----KLYRPFQSELFAKRAYRELRLLKHMRHENVIG 88

Query: 149 II----SSCSKDDFKA--LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH 202
           ++       + DDF    L++ +M    LGK +       D  Q   ++  +   + Y+H
Sbjct: 89  LLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQ--FLVYQMLKGLRYIH 145

Query: 203 FGHSTHVIIHCDLKSSNVLLDDN 225
                  IIH DLK  N+ ++++
Sbjct: 146 AAG----IIHRDLKPGNLAVNED 164

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 43.4 bits (103), Expect = 2e-05
 Identities = 26/140 (18%), Positives = 60/140 (42%), Gaps = 17/140 (12%)

Query: 96  ISRGGFGSIYKARIQD-GMEVVVKGFNLQYGGAFKNLDV-ECNMMKIIRHQNLIK---II 150
             +G FG++   + +  GM V +K         F+N ++     + ++ H N+++     
Sbjct: 31  AGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYF 88

Query: 151 SSCSKDDFK----ALILEYMPHGSLGKCLSTSNYILDFFQRLHI---MIDVASAVEYLHF 203
            +  + D +     +++EY+P  +L +C             + I   +  +  ++  LH 
Sbjct: 89  YTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH- 146

Query: 204 GHSTHVIIHCDLKSSNVLLD 223
              +  + H D+K  NVL++
Sbjct: 147 -LPSVNVCHRDIKPHNVLVN 165

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 42.8 bits (101), Expect = 4e-05
 Identities = 23/88 (26%), Positives = 36/88 (40%), Gaps = 14/88 (15%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT-----------IEYNRLQDSLRNSIGDLTSLKSLDLS 50
           + +K L   DLS N  + +               ++ +R+     ++   L SL+ LDLS
Sbjct: 26  AAMKSL---DLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82

Query: 51  NNNFSGAIPIPLEKLLDLKDLNLSFNTL 78
           +N+ S         L  LK LNL  N  
Sbjct: 83  DNHLSSLSSSWFGPLSSLKYLNLMGNPY 110

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 40.1 bits (94), Expect = 3e-04
 Identities = 20/107 (18%), Positives = 33/107 (30%), Gaps = 15/107 (14%)

Query: 3   NLKVLLRIDLSTNNFSCVFPTT-----------IEYNRLQDSLRNSIGDLTSLKSLDLSN 51
               + R+ +          T            +E +++     +    L SL+ LDLS 
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSE 343

Query: 52  NNFSGAI---PIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNL 95
           N                  L+ L LS N L   + +     L + NL
Sbjct: 344 NLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNL 389

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 39.7 bits (93), Expect = 5e-04
 Identities = 25/110 (22%), Positives = 41/110 (37%), Gaps = 18/110 (16%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT--------------IEYNRLQD--SLRNSIGDLTSLK 45
            +LK L  +DLS N     +                 +  N L+        +  L +L 
Sbjct: 331 QHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLT 390

Query: 46  SLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNL 95
           SLD+S N F   +P   +    ++ LNLS   +   +       LEV ++
Sbjct: 391 SLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDV 438

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 42.8 bits (101), Expect = 5e-05
 Identities = 15/89 (16%), Positives = 31/89 (34%), Gaps = 11/89 (12%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT-----------IEYNRLQDSLRNSIGDLTSLKSLDLS 50
           S L  L ++ L   N + +               + +  +      S   L  LK L++S
Sbjct: 149 SGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEIS 208

Query: 51  NNNFSGAIPIPLEKLLDLKDLNLSFNTLE 79
           +  +   +       L+L  L+++   L 
Sbjct: 209 HWPYLDTMTPNCLYGLNLTSLSITHCNLT 237

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 42.0 bits (99), Expect = 9e-05
 Identities = 24/107 (22%), Positives = 38/107 (35%), Gaps = 13/107 (12%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT-----------IEYNRLQDSLRNSIGDLTSLKSLDLS 50
             L  L  +++S   +                  I +  L      ++  L  L+ L+LS
Sbjct: 197 KRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLS 256

Query: 51  NNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
            N  S      L +LL L+++ L    L    P  FR    L V N+
Sbjct: 257 YNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNV 303

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 41.2 bits (97), Expect = 1e-04
 Identities = 19/105 (18%), Positives = 34/105 (32%), Gaps = 14/105 (13%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT-----------IEYNRLQDSLRNSIGDLTSLKSLDLS 50
            +L  L  +++  N+   +               +E   L      ++  L  L  L L 
Sbjct: 125 QDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLR 184

Query: 51  NNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNL 95
           + N +       ++L  LK L +S       +     N L   NL
Sbjct: 185 HLNINAIRDYSFKRLYRLKVLEISHWPY---LDTMTPNCLYGLNL 226

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 40.5 bits (95), Expect = 2e-04
 Identities = 21/88 (23%), Positives = 35/88 (39%), Gaps = 11/88 (12%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT-----------IEYNRLQDSLRNSIGDLTSLKSLDLS 50
           ++   L  ++L+ N  S V P             +  NRL+         L++L  LD+S
Sbjct: 53  ASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDIS 112

Query: 51  NNNFSGAIPIPLEKLLDLKDLNLSFNTL 78
            N     +    + L +LK L +  N L
Sbjct: 113 ENKIVILLDYMFQDLYNLKSLEVGDNDL 140

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 42.4 bits (100), Expect = 5e-05
 Identities = 31/146 (21%), Positives = 55/146 (37%), Gaps = 31/146 (21%)

Query: 96  ISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV------ECNMMKIIRHQNLIK 148
           I  G  G +  A        V +K    +    F+N         E  +MK + H+N+I 
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIK----KLSRPFQNQTHAKRAYRELVLMKCVNHKNIIG 88

Query: 149 I----ISSCSKDDFKA--LILEYMP---HGSLGKCLSTSNYILDFFQRLHIMIDVASAVE 199
           +        S ++F+   +++E M       +   L         +Q L         ++
Sbjct: 89  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-------GIK 141

Query: 200 YLHFGHSTHVIIHCDLKSSNVLLDDN 225
           +LH       IIH DLK SN+++  +
Sbjct: 142 HLHSAG----IIHRDLKPSNIVVKSD 163

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 42.3 bits (100), Expect = 6e-05
 Identities = 17/88 (19%), Positives = 31/88 (35%), Gaps = 5/88 (5%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPI 60
             N+K       + + +    P      R     R           L+L+N   S ++P 
Sbjct: 30  AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLP- 87

Query: 61  PLEKLLDLKDLNLSFNTLEGKIPRPFRN 88
             E    L+ L  S N+L  ++P   ++
Sbjct: 88  --ELPPHLESLVASCNSLT-ELPELPQS 112

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 39.6 bits (93), Expect = 5e-04
 Identities = 18/83 (21%), Positives = 35/83 (42%), Gaps = 10/83 (12%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPT----TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSG 56
             +LK LL  + +    S + P      +  N+L+      + + + LK +D+ NN+   
Sbjct: 110 PQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKL--PELQNSSFLKIIDVDNNSLK- 166

Query: 57  AIPIPLEKLLDLKDLNLSFNTLE 79
            +P   +    L+ +    N LE
Sbjct: 167 KLP---DLPPSLEFIAAGNNQLE 186

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 42.4 bits (100), Expect = 7e-05
 Identities = 24/99 (24%), Positives = 36/99 (36%), Gaps = 14/99 (14%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT------------IEYNRLQDSLRNSIGDLTSLKSLDL 49
             L  L  + L  N    +                 E  RL      +   L++L+ L+L
Sbjct: 133 VYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNL 192

Query: 50  SNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRN 88
           +  N    IP  L  L+ L +L+LS N L    P  F+ 
Sbjct: 193 AMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQG 229

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 42.2 bits (99), Expect = 9e-05
 Identities = 18/97 (18%), Positives = 31/97 (31%), Gaps = 13/97 (13%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTI--------EYNRLQDSLRNSIGDLTSLKSLDLSNN 52
            S LK L    +S N  + + P             N+L   L  S+  L+S  +++L  N
Sbjct: 240 PSELKEL---MVSGNRLTSL-PMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 294

Query: 53  NFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF 89
             S      L ++      +      +       R  
Sbjct: 295 PLSERTLQALREITSAPGYSGPIIRFDMAGASAPRET 331

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 41.7 bits (98), Expect = 1e-04
 Identities = 28/150 (18%), Positives = 62/150 (41%), Gaps = 30/150 (20%)

Query: 91  EVFNLISRGGFGSIYKARIQDG-----MEVVVKGFNLQYGGAFKNLDVEC-----NMMKI 140
           E+  +I RG FG +   ++++      M+++ K   L+        +  C     +++  
Sbjct: 77  EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRA------ETACFREERDVLVN 130

Query: 141 IRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILD-----FFQRLHIMIDVA 195
              + +  +  +   D+   L+++Y   G L   LS     L      F+     + ++ 
Sbjct: 131 GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY-----LAEMV 185

Query: 196 SAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            A++ +H        +H D+K  N+L+D N
Sbjct: 186 IAIDSVH----QLHYVHRDIKPDNILMDMN 211

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 41.8 bits (98), Expect = 1e-04
 Identities = 24/89 (26%), Positives = 40/89 (44%), Gaps = 15/89 (16%)

Query: 2   SNLKVLLRIDLSTNNFS-------CVFPTTIEY-----NRLQDSLRNSIGDLTSLKSLDL 49
            N+  L  +D+S N+ +       C +  +I       N L  S+   +     +K LDL
Sbjct: 400 KNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDL 457

Query: 50  SNNNFSGAIPIPLEKLLDLKDLNLSFNTL 78
            NN    +IP  +  L  L++LN++ N L
Sbjct: 458 HNNRIM-SIPKDVTHLQALQELNVASNQL 485

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 41.6 bits (98), Expect = 1e-04
 Identities = 26/149 (17%), Positives = 63/149 (42%), Gaps = 28/149 (18%)

Query: 91  EVFNLISRGGFGSIYKARIQDGMEV----VVKGFNLQYGGAFKNLDVEC-----NMMKII 141
           E+  +I RG F  +   +++   +V    ++  +++      K  +V C     +++   
Sbjct: 64  EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM-----LKRGEVSCFREERDVLVNG 118

Query: 142 RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILD-----FFQRLHIMIDVAS 196
             + + ++  +   +++  L++EY   G L   LS     +      F+     + ++  
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY-----LAEIVM 173

Query: 197 AVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
           A++ +H        +H D+K  N+LLD  
Sbjct: 174 AIDSVH----RLGYVHRDIKPDNILLDRC 198

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 41.1 bits (97), Expect = 1e-04
 Identities = 23/104 (22%), Positives = 44/104 (42%), Gaps = 11/104 (10%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT--------IEYNRLQDSLRNSIGDLTSLKSLDLSNNN 53
             +K L  I ++  N + +            ++ N++      S+  L +L  L LS N+
Sbjct: 168 QGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 227

Query: 54  FSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRN--FLEVFNL 95
            S      L     L++L+L+ N L  K+P    +  +++V  L
Sbjct: 228 ISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 270

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 40.0 bits (94), Expect = 3e-04
 Identities = 19/95 (20%), Positives = 34/95 (35%), Gaps = 18/95 (18%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIE-----------YNRLQDSLRNSIGDLTSLKSLDLS 50
             L  L ++ LS N+ S V   ++             N+L   +   + D   ++ + L 
Sbjct: 213 KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLH 271

Query: 51  NNNFSG------AIPIPLEKLLDLKDLNLSFNTLE 79
           NNN S         P    K      ++L  N ++
Sbjct: 272 NNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 41.3 bits (97), Expect = 1e-04
 Identities = 21/99 (21%), Positives = 33/99 (33%), Gaps = 14/99 (14%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT------------IEYNRLQDSLRNSIGDLTSLKSLDL 49
             L  L  + L  N    +                 E  +L+     +   L +LK L+L
Sbjct: 144 EYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNL 203

Query: 50  SNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRN 88
              N    +P  L  L+ L++L +S N      P  F  
Sbjct: 204 GMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHG 240

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 41.1 bits (97), Expect = 1e-04
 Identities = 27/93 (29%), Positives = 45/93 (48%), Gaps = 5/93 (5%)

Query: 134 ECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMID 193
           E ++M  + H   +K+  +   D+     L Y  +G L K +       +   R +   +
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA-E 138

Query: 194 VASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM 226
           + SA+EYLH       IIH DLK  N+LL+++M
Sbjct: 139 IVSALEYLH----GKGIIHRDLKPENILLNEDM 167

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 41.2 bits (97), Expect = 1e-04
 Identities = 26/96 (27%), Positives = 40/96 (41%), Gaps = 17/96 (17%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIP 61
            N   L+ +DLS             YN L+  + +    +  L+ L +SNN    A+ + 
Sbjct: 245 LNYPGLVEVDLS-------------YNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLY 290

Query: 62  LEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
            + +  LK L+LS N L   + R    F  LE   L
Sbjct: 291 GQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 325

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 40.0 bits (94), Expect = 3e-04
 Identities = 22/104 (21%), Positives = 42/104 (40%), Gaps = 13/104 (12%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT--------IEYNRLQDSLRNSIGDLTSLKSLDLSNNN 53
           +    +  +D S N+ + V            +++N L D+    + +   L  +DLS N 
Sbjct: 202 AIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNE 259

Query: 54  FSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
               +  P  K+  L+ L +S N L   +    +    L+V +L
Sbjct: 260 LEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDL 302

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 39.6 bits (93), Expect = 4e-04
 Identities = 17/85 (20%), Positives = 33/85 (38%), Gaps = 16/85 (18%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT--------IEYNRLQDSLRNSIGDLTSLKSLDLSNNN 53
                L  + LS+N  + V  +         + YN L      ++    +++ LD S+N+
Sbjct: 162 QATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNS 216

Query: 54  FSGAIPIPLEKLLDLKDLNLSFNTL 78
            +    +     ++L  L L  N L
Sbjct: 217 INV---VRGPVNVELTILKLQHNNL 238

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 39.3 bits (92), Expect = 6e-04
 Identities = 20/89 (22%), Positives = 37/89 (41%), Gaps = 14/89 (15%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT-----------IEYNRLQDSLRNSIGDLTSLKSLDLS 50
            N+ +L  + L  N+ S +               +  N L+    ++    TSL++L LS
Sbjct: 114 QNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLS 173

Query: 51  NNNFSGAIPIPLEKLLDLKDLNLSFNTLE 79
           +N  +    + L  +  L   N+S+N L 
Sbjct: 174 SNRLTH---VDLSLIPSLFHANVSYNLLS 199

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 40.7 bits (95), Expect = 2e-04
 Identities = 17/113 (15%), Positives = 34/113 (30%), Gaps = 20/113 (17%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTIE---------------YNRLQDSLRNSIGDLTSLK 45
             +L+ L   D+STN    + P                    NR+   +  +I  L    
Sbjct: 179 PESLEAL---DVSTNLLESL-PAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTC 233

Query: 46  SLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNLISR 98
           ++ L +N  S  I   L +     D +           +       + + ++ 
Sbjct: 234 TIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTA 286

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 40.7 bits (95), Expect = 3e-04
 Identities = 16/89 (17%), Positives = 32/89 (35%), Gaps = 3/89 (3%)

Query: 8  LRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLD 67
          + I L  NN   +      YN +  +  +        +   L   N + A+ +  E L++
Sbjct: 1  MSIMLPINNNFSL-SQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLIN 59

Query: 68 -LKDLNLSFNTLEGKIPRPFRNFLEVFNL 95
             +L L+   L   +P      + V  +
Sbjct: 60 QFSELQLNRLNLS-SLPDNLPPQITVLEI 87

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 40.0 bits (93), Expect = 4e-04
 Identities = 18/110 (16%), Positives = 31/110 (28%), Gaps = 18/110 (16%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTIE--------YNRLQDSLRNSIGDLTSLKS----LD 48
            ++L+VL    +  N  + + P   E         N L+ SL          +       
Sbjct: 159 PTSLEVL---SVRNNQLTFL-PELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFR 213

Query: 49  LSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNFLEVFNLISR 98
              N  +  IP  +  L     + L  N L  +I           +    
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGP 262

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 40.4 bits (95), Expect = 2e-04
 Identities = 27/110 (24%), Positives = 49/110 (44%), Gaps = 18/110 (16%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTT------------IEYNRLQDSLRNSIGDLTSLKSLD 48
           +S+L+VL    ++ N+F   F               +   +L+     +   L+SL+ L+
Sbjct: 149 LSSLEVL---KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 205

Query: 49  LSNNNFSGAIPIPLEKLLDLKDLNLSFN---TLEGKIPRPFRNFLEVFNL 95
           +S+NNF      P + L  L+ L+ S N   T + +  + F + L   NL
Sbjct: 206 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 255

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 40.7 bits (95), Expect = 2e-04
 Identities = 22/89 (24%), Positives = 36/89 (40%), Gaps = 13/89 (14%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT-----------IEYNRLQDSLRNSIGDLTSLKSLDLS 50
            N   L+ +DLS N    +               I  NRL  +L      + +LK LDLS
Sbjct: 251 LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLS 309

Query: 51  NNNFSGAIPIPLEKLLDLKDLNLSFNTLE 79
           +N+    +     +   L++L L  N++ 
Sbjct: 310 HNHLL-HVERNQPQFDRLENLYLDHNSIV 337

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 40.7 bits (95), Expect = 3e-04
 Identities = 22/104 (21%), Positives = 42/104 (40%), Gaps = 13/104 (12%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT--------IEYNRLQDSLRNSIGDLTSLKSLDLSNNN 53
           +    +  +D S N+ + V            +++N L D+    + +   L  +DLS N 
Sbjct: 208 AIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNE 265

Query: 54  FSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRNF--LEVFNL 95
               +  P  K+  L+ L +S N L   +    +    L+V +L
Sbjct: 266 LEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDL 308

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 39.9 bits (93), Expect = 4e-04
 Identities = 17/85 (20%), Positives = 33/85 (38%), Gaps = 16/85 (18%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT--------IEYNRLQDSLRNSIGDLTSLKSLDLSNNN 53
                L  + LS+N  + V  +         + YN L      ++    +++ LD S+N+
Sbjct: 168 QATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNS 222

Query: 54  FSGAIPIPLEKLLDLKDLNLSFNTL 78
            +    +     ++L  L L  N L
Sbjct: 223 INV---VRGPVNVELTILKLQHNNL 244

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 39.1 bits (91), Expect = 9e-04
 Identities = 20/89 (22%), Positives = 37/89 (41%), Gaps = 14/89 (15%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT-----------IEYNRLQDSLRNSIGDLTSLKSLDLS 50
            N+ +L  + L  N+ S +               +  N L+    ++    TSL++L LS
Sbjct: 120 QNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLS 179

Query: 51  NNNFSGAIPIPLEKLLDLKDLNLSFNTLE 79
           +N  +    + L  +  L   N+S+N L 
Sbjct: 180 SNRLTH---VDLSLIPSLFHANVSYNLLS 205

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 40.5 bits (95), Expect = 2e-04
 Identities = 33/159 (20%), Positives = 56/159 (35%), Gaps = 50/159 (31%)

Query: 91  EVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNL---------DVEC-----N 136
           EV  +I RG FG +   R +   +V        Y  A K L         D        +
Sbjct: 72  EVVKVIGRGAFGEVQLVRHKSTRKV--------Y--AMKLLSKFEMIKRSDSAFFWEERD 121

Query: 137 MMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFF--QRLHIMIDV 194
           +M       ++++  +   D +  +++EYMP G L                    +    
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL------------VNLMSNYDVPEKW 169

Query: 195 A--------SAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
           A         A++ +H    +   IH D+K  N+LLD +
Sbjct: 170 ARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKS 204

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 40.5 bits (94), Expect = 3e-04
 Identities = 19/79 (24%), Positives = 35/79 (44%), Gaps = 16/79 (20%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPI 60
           +  L ++  +DLS             +NRL+ +L  ++  L  L+ L  S+N     +  
Sbjct: 459 LEQLLLVTHLDLS-------------HNRLR-ALPPALAALRCLEVLQASDNALE-NVD- 502

Query: 61  PLEKLLDLKDLNLSFNTLE 79
            +  L  L++L L  N L+
Sbjct: 503 GVANLPRLQELLLCNNRLQ 521

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 40.1 bits (93), Expect = 4e-04
 Identities = 18/55 (32%), Positives = 26/55 (47%), Gaps = 3/55 (5%)

Query: 25  IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLE 79
           + +  L   L + +  L  +  LDLS+N    A+P  L  L  L+ L  S N LE
Sbjct: 448 LAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE 499

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 39.8 bits (93), Expect = 4e-04
 Identities = 22/88 (25%), Positives = 36/88 (40%), Gaps = 17/88 (19%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT-----------IEYNRLQDSLRNSIGDLTSLKSLDLS 50
               +L   ++S N  S ++ +            I +NR+Q    +       L+ LDLS
Sbjct: 21  QKTTIL---NISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLS 77

Query: 51  NNNFSGAIPIPLEKLLDLKDLNLSFNTL 78
           +N       I     ++LK L+LSFN  
Sbjct: 78  HNKLVK---ISCHPTVNLKHLDLSFNAF 102

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 39.6 bits (93), Expect = 4e-04
 Identities = 18/78 (23%), Positives = 27/78 (34%), Gaps = 14/78 (17%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIP 61
                L R+ L  N    +                S+  L +L+ L L NN  S  +P  
Sbjct: 214 LRYSKLYRLGLGHNQIRMIEN-------------GSLSFLPTLRELHLDNNKLS-RVPAG 259

Query: 62  LEKLLDLKDLNLSFNTLE 79
           L  L  L+ + L  N + 
Sbjct: 260 LPDLKLLQVVYLHTNNIT 277

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 39.4 bits (92), Expect = 6e-04
 Identities = 30/143 (20%), Positives = 60/143 (41%), Gaps = 13/143 (9%)

Query: 91  EVFNLISRGGFGSIYKARIQD-----GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN 145
             F ++ RGGFG ++  +++        + + K    +  G  +   VE  ++  +  + 
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY-QGAMVEKKILAKVHSRF 246

Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMI---DVASAVEYLH 202
           ++ +  +        L++  M  G +   +   +     FQ    +     + S +E+LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306

Query: 203 FGHSTHVIIHCDLKSSNVLLDDN 225
                  II+ DLK  NVLLDD+
Sbjct: 307 ----QRNIIYRDLKPENVLLDDD 325

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 39.3 bits (92), Expect = 6e-04
 Identities = 20/100 (20%), Positives = 36/100 (36%), Gaps = 16/100 (16%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTT------------IEYNRLQDSLRNSIGDLTSLKSLDL 49
           S L+ L  + +       V                ++YN+       +   L +L+ L L
Sbjct: 51  SRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTL 110

Query: 50  SNNNFSGAIPIP---LEKLLDLKDLNLSFNTLEGKIPRPF 86
           +  N  GA+ +     + L  L+ L L  N ++   P  F
Sbjct: 111 TQCNLDGAV-LSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 39.0 bits (90), Expect = 7e-04
 Identities = 14/86 (16%), Positives = 24/86 (27%), Gaps = 12/86 (13%)

Query: 3   NLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPL 62
             + L  + +                         +  L  L++L +  +      P   
Sbjct: 29  GAENLTELYIENQQHLQHLE------------LRDLRGLGELRNLTIVKSGLRFVAPDAF 76

Query: 63  EKLLDLKDLNLSFNTLEGKIPRPFRN 88
                L  LNLSFN LE    +  + 
Sbjct: 77  HFTPRLSRLNLSFNALESLSWKTVQG 102

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 38.8 bits (91), Expect = 7e-04
 Identities = 24/154 (15%), Positives = 54/154 (35%), Gaps = 34/154 (22%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV------ECNMMKIIRH 143
                +  GG G ++ A        V +K           +         E  +++ + H
Sbjct: 14  MDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI------VLTDPQSVKHALREIKIIRRLDH 67

Query: 144 QNLIKII------------SSCSKDDFKA--LILEYMPHGSLGKCLSTSNYILDFFQRLH 189
            N++K+                S  +  +  ++ EYM    L   L     + +  +   
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHAR--L 124

Query: 190 IMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD 223
            M  +   ++Y+H  +    ++H DLK +N+ ++
Sbjct: 125 FMYQLLRGLKYIHSAN----VLHRDLKPANLFIN 154

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 38.9 bits (91), Expect = 7e-04
 Identities = 12/83 (14%), Positives = 33/83 (39%), Gaps = 7/83 (8%)

Query: 2   SNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIP 61
                +  ++L   +       T  ++ L     NS+    + +++ +++ +    +   
Sbjct: 219 DVTSSVECLELRDTDLD-----TFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKL 272

Query: 62  LEKLLDLKDLNLSFNTLEGKIPR 84
           L ++  L +L  S N L+  +P 
Sbjct: 273 LNQISGLLELEFSRNQLKS-VPD 294

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 39.2 bits (91), Expect = 8e-04
 Identities = 32/159 (20%), Positives = 60/159 (37%), Gaps = 47/159 (29%)

Query: 90  LEVFNLIS---RGGFGSIYKARIQD-----GMEVVVKGFNLQYGGAFKNLDVECNMM--- 138
           L  FN +    +G FG +  +  +       ++++ K   +Q      + DVEC M+   
Sbjct: 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ------DDDVECTMVEKR 393

Query: 139 ---KIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFF--QRLHIMI- 192
                 +   L ++ S     D    ++EY+  G L             +  Q++     
Sbjct: 394 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL------------MYHIQQVGRFKE 441

Query: 193 --------DVASAVEYLHFGHSTHVIIHCDLKSSNVLLD 223
                   ++A  + +L     +  II+ DLK  NV+LD
Sbjct: 442 PHAVFYAAEIAIGLFFLQ----SKGIIYRDLKLDNVMLD 476

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 38.9 bits (91), Expect = 9e-04
 Identities = 32/157 (20%), Positives = 62/157 (39%), Gaps = 45/157 (28%)

Query: 88  NFLEVFNLISRGGFGSIYKARIQD-----GMEVVVKGFNLQYGGAFKNLDVEC-----NM 137
            +L++   + +G FG +   + +       M+++ K   +      K+ +V        +
Sbjct: 151 EYLKL---LGKGTFGKVILVKEKATGRYYAMKILKKEVIVA-----KD-EVAHTLTENRV 201

Query: 138 MKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFF--QRLHI----- 190
           ++  RH  L  +  S    D    ++EY   G L            FF   R  +     
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL------------FFHLSRERVFSEDR 249

Query: 191 ----MIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD 223
                 ++ SA++YLH   S   +++ DLK  N++LD
Sbjct: 250 ARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLD 283

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	232
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	99.97
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.97
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.97
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.97
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.97
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.96
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.96
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.96
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.96
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.96
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.96
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.96
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.96
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.96
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.96
3uqc_A	286	Probable conserved transmembrane protein; structur	99.96
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.96
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.96
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.96
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.96
3niz_A	311	Rhodanese family protein; structural genomics, str	99.96
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.96
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.96
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.95
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.95
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.95
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.95
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.95
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.95
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.95
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.95
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.95
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.95
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.95
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.95
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.95
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.95
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.95
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.95
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.95
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.95
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.95
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.95
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.95
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.95
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.95
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.95
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.95
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.95
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.95
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.95
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.95
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.95
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.95
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.95
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.95
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.95
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.95
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.95
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.95
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.95
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.95
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.95
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.95
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.95
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.95
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.95
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.95
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.95
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.95
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.95
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.95
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.95
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.95
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.95
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.95
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.95
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.95
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.95
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.94
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.94
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.94
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.94
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.94
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.94
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.94
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.94
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.94
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.94
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.94
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.94
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.94
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.94
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.94
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.94
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.94
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.94
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.94
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.94
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.94
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.94
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.94
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.94
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.94
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.94
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.94
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.94
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.94
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.94
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.94
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.94
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.94
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.94
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.94
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.94
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.94
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.94
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.94
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.94
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.94
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.94
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.94
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.94
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.94
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.94
3bhy_A	283	Death-associated protein kinase 3; death associate	99.94
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.94
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.94
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.94
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.94
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.94
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.94
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.94
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.94
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.94
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.94
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.94
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.94
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.94
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.94
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.94
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.94
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.94
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.94
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.94
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.94
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.94
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.94
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.94
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.94
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.94
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.94
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.94
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.94
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.94
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.94
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.94
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.94
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.93
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.93
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.93
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.93
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.93
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.93
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.93
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.93
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.93
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.93
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.93
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.93
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.93
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.93
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.93
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.93
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.93
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.93
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.93
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.93
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.93
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.93
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.93
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.93
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.93
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.93
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.93
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.93
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.93
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.93
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.93
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.93
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.93
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.93
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.93
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.93
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.93
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.93
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.93
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.93
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.93
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.93
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.92
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.92
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.92
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.92
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.92
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.92
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.92
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.92
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.92
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.92
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.92
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.92
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.92
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.92
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.92
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.92
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.92
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.92
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.92
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.91
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.91
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.91
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.91
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.91
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.91
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.91
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.91
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.91
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.91
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.91
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.91
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.9
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.9
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.9
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.9
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.89
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.88
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.85
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.8
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.53
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.42
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.39
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.29
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.27
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.27
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.27
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.24
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.21
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.18
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.17
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.15
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.13
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.13
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.08
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.08
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.08
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.06
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.06
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.06
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.04
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.04
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.03
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.02
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.01
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.01
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.01
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.0
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.0
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.99
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	98.99
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	98.99
3e6j_A	229	Variable lymphocyte receptor diversity region; var	98.99
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	98.97
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	98.97
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	98.97
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	98.96
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	98.96
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	98.95
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	98.95
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	98.95
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	98.94
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	98.94
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	98.94
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	98.94
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	98.94
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	98.92
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	98.91
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	98.9
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	98.9
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	98.89
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	98.88
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.88
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.87
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	98.87
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	98.87
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	98.87
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	98.87
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	98.87
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	98.86
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	98.85
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	98.84
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	98.84
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	98.83
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	98.82
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	98.82
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	98.81
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	98.79
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	98.79
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	98.79
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	98.79
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	98.78
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	98.77
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	98.77
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	98.77
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	98.76
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	98.76
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	98.75
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	98.75
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	98.75
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	98.73
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	98.73
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	98.73
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	98.73
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	98.71
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	98.71
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	98.71
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	98.7
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	98.7
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	98.7
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	98.69
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	98.69
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	98.68
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	98.67
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	98.67
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	98.67
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.64
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	98.63
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	98.63
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	98.61
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	98.58
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.55
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	98.55
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.53
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	98.52
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	98.51
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	98.5
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	98.49
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	98.47
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	98.46
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	98.43
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	98.43
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	98.42
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.42
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.41
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	98.41
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	98.39
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	98.39
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	98.38
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	98.38
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.38
1o6v_A	466	Internalin A; bacterial infection, extracellular r	98.37
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	98.37
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	98.36
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	98.35
1o6v_A	466	Internalin A; bacterial infection, extracellular r	98.34
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	98.34
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	98.34
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	98.33
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	98.33
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.31
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.28
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	98.27
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	98.26
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	98.25
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.24
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	98.2
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	98.13
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	98.12
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	98.04
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	97.97
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.92
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	97.92
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	97.89
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	97.88
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	97.79
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.7
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	97.41
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	97.34
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	97.29
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	97.22
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	97.21
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.19
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	97.16
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	97.03
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.82
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.72
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.71
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	96.67
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.61
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.56
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	96.53
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	96.51
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.45
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	96.38
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.36
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.3
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.27
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	96.21
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	96.19
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.96
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.39
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	93.42
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	93.25
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	91.29
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	91.05
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	90.36
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	90.34
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	90.0
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.84
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	88.71
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	88.06
3mes_A	424	Choline kinase; malaria, structural genomics, stru	86.17
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	86.07

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.1e-36  Score=242.31  Aligned_cols=140  Identities=26%  Similarity=0.447  Sum_probs=123.9

Q ss_pred             ccceeeecccCCCcceeeeEEeC------CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ------DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      +.+.+.+.||+|+||.||+|++.      ++..||||++........+.|.+|+++++.++|||||+++++|.+++..++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            45678899999999999999753      477899999976655566789999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccC------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCcee
Q 042107          162 ILEYMPHGSLGKCLSTS------------NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAH  229 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~  229 (232)
                      |||||++|+|.+++...            ...+++..+..++.|++.||.|||    .++|+||||||+|||++.++.+|
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA----SQHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCccCHhhEEECCCCcEE
Confidence            99999999999999643            245899999999999999999999    88999999999999999999999


Q ss_pred             ec
Q 042107          230 FL  231 (232)
Q Consensus       230 l~  231 (232)
                      |+
T Consensus       169 i~  170 (299)
T 4asz_A          169 IG  170 (299)
T ss_dssp             EC
T ss_pred             EC
Confidence            96

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.8e-36  Score=246.07  Aligned_cols=140  Identities=24%  Similarity=0.342  Sum_probs=128.8

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      ....|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+++.++|||||++++++.+++.+|+|||
T Consensus        72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE  151 (346)
T 4fih_A           72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  151 (346)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            3456889999999999999999764 799999999987766666778899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+||+|.+++...  .+++..+..++.|++.||.|||    .++|+||||||+|||++.+|.+||+
T Consensus       152 y~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~vKl~  212 (346)
T 4fih_A          152 FLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKSDSILLTHDGRVKLS  212 (346)
T ss_dssp             CCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEEC
T ss_pred             CCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEECCCCCEEEe
Confidence            99999999999764  4899999999999999999999    8899999999999999999999986

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5.3e-36  Score=243.73  Aligned_cols=140  Identities=20%  Similarity=0.322  Sum_probs=120.3

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      +.|++.+.||+|+||.||+|+. .+++.||||++.....  ...+.+.+|+.+++.++|||||++++++.+++..|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            4588999999999999999975 4799999999976532  345678999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+||+|.+++... ...+++..++.++.|++.||.|||    .++|+||||||+|||++.+|.+||+
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~vKl~  167 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH----DRKILHRDIKSQNIFLTKDGTVQLG  167 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTCEETTCCGGGEEECTTCCEEEC
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHHHEEECCCCCEEEc
Confidence            99999999999754 345788899999999999999999    8899999999999999999999986

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.7e-36  Score=242.40  Aligned_cols=139  Identities=24%  Similarity=0.419  Sum_probs=124.8

Q ss_pred             cceeeecccCCCcceeeeEEeC------CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ------DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.+.++||+|+||.||+|+++      +++.||||++........+.|.+|+++++.++|||||+++++|.+++..++|
T Consensus        42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV  121 (329)
T 4aoj_A           42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV  121 (329)
T ss_dssp             GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4567789999999999999764      4788999999766555667899999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccC--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCce
Q 042107          163 LEYMPHGSLGKCLSTS--------------NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA  228 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~--------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~  228 (232)
                      ||||++|+|.+++...              ...+++..++.++.|++.||.|||    .++|+||||||+|||++.++.+
T Consensus       122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA----GLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh----cCCeecccccHhhEEECCCCcE
Confidence            9999999999998653              235899999999999999999999    8899999999999999999999


Q ss_pred             eec
Q 042107          229 HFL  231 (232)
Q Consensus       229 ~l~  231 (232)
                      ||+
T Consensus       198 Ki~  200 (329)
T 4aoj_A          198 KIG  200 (329)
T ss_dssp             EEC
T ss_pred             EEc
Confidence            996

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=8.8e-36  Score=247.70  Aligned_cols=139  Identities=24%  Similarity=0.354  Sum_probs=128.4

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      ...|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+|+.++|||||++++++.+++.+|+||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            456889999999999999999764 7999999999877666667789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+||+|.+++...  .+++..+..++.|++.||.|||    .++|+||||||+|||++.+|.+||+
T Consensus       230 ~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH----~~~IiHRDiKp~NILl~~~g~vKl~  289 (423)
T 4fie_A          230 LEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH----AQGVIHRDIKSDSILLTHDGRVKLS  289 (423)
T ss_dssp             CTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSTTTEEECTTCCEEEC
T ss_pred             CCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH----HCCeecccCCHHHEEEcCCCCEEEe
Confidence            9999999999764  4899999999999999999999    8899999999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=7.8e-36  Score=239.07  Aligned_cols=139  Identities=24%  Similarity=0.322  Sum_probs=126.7

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecc---cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQ---YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      +.|++.+.||+|+||.||+|+. .+++.||+|++...   .....+.+.+|+++++.++|||||++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4588999999999999999975 47999999999754   2344677899999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+||+|.+++...+ .+++..+..++.|++.||.|||    .++|+||||||+|||++.++.+||+
T Consensus       112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH----~~~IiHRDlKPeNILl~~~g~vKl~  174 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMHIQIT  174 (311)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEEC
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHeEEcCCCCEEEE
Confidence            9999999999997643 5899999999999999999999    8899999999999999999999986

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.3e-35  Score=236.27  Aligned_cols=138  Identities=23%  Similarity=0.423  Sum_probs=121.3

Q ss_pred             ceeeecccCCCcceeeeEEeC------CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           90 LEVFNLISRGGFGSIYKARIQ------DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      +++.+.||+|+||.||+|++.      +++.||||.+.... ....+.|.+|+.+++.++|||||+++++|..++..++|
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV  107 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMI  107 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEE
Confidence            457789999999999999863      46789999996543 33457899999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCc
Q 042107          163 LEYMPHGSLGKCLSTS---------------NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV  227 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~  227 (232)
                      ||||++|+|.+++...               ...+++..+..++.|++.||.|||    .++|+||||||+|||++++++
T Consensus       108 ~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          108 FSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS----SHHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGC
T ss_pred             EEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH----hCCCCCCCccccceEECCCCC
Confidence            9999999999999542               135889999999999999999999    889999999999999999999


Q ss_pred             eeec
Q 042107          228 AHFL  231 (232)
Q Consensus       228 ~~l~  231 (232)
                      +|||
T Consensus       184 ~Ki~  187 (308)
T 4gt4_A          184 VKIS  187 (308)
T ss_dssp             EEEC
T ss_pred             EEEC
Confidence            9996

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.2e-35  Score=235.05  Aligned_cols=136  Identities=26%  Similarity=0.438  Sum_probs=120.4

Q ss_pred             cceeeecccCCCcceeeeEEeCCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           89 FLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      .+.+.+.||+|+||.||+|++++  .||||+++...  ....+.|.+|+.+++.++|||||++++++.. +..++|||||
T Consensus        37 ~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~  113 (307)
T 3omv_A           37 EVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWC  113 (307)
T ss_dssp             SCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcC
Confidence            34578899999999999998753  58999986543  2345778999999999999999999998754 5689999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|+|.+++......+++..+..++.|++.||.|||    .++|+||||||+|||+++++.+||+
T Consensus       114 ~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH----~~~IiHRDlKp~NILl~~~~~~Ki~  174 (307)
T 3omv_A          114 EGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH----AKNIIHRDMKSNNIFLHEGLTVKIG  174 (307)
T ss_dssp             SSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCCSSSEEEETTEEEEEC
T ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCccCCccCHHHEEECCCCcEEEe
Confidence            999999999876667999999999999999999999    7899999999999999999999996

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.7e-34  Score=233.78  Aligned_cols=134  Identities=22%  Similarity=0.339  Sum_probs=120.7

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      +.+++.++||+|+||.||+|+.+ +|+.||||++.....     ..+|+.+++.++|||||++++++.+++..|+|||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            45778899999999999999764 699999999976432     246999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC-ceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM-VAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~-~~~l~  231 (232)
                      +||+|.++++..+ .+++..+..++.|++.||.|||    .++|+||||||+|||++.+| .+||+
T Consensus       133 ~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~~vKl~  193 (336)
T 4g3f_A          133 EGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH----TRRILHGDVKADNVLLSSDGSRAALC  193 (336)
T ss_dssp             TTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCCGGGEEECTTSCCEEEC
T ss_pred             CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecccCHHHEEEeCCCCEEEEe
Confidence            9999999997643 5899999999999999999999    88999999999999999998 58886

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.2e-34  Score=229.23  Aligned_cols=139  Identities=23%  Similarity=0.329  Sum_probs=120.4

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEec----CCeeE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSK----DDFKA  160 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~  160 (232)
                      .++++.+.||+|+||.||+|+.. ++..||+|.+.....  ...+.+.+|+.+++.++|||||++++++.+    ++.+|
T Consensus        26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~  105 (290)
T 3fpq_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence            34567788999999999999764 688999999976532  335678999999999999999999999865    35689


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCC--eeeCCCCCCceeeCC-CCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV--IIHCDLKSSNVLLDD-NMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~--iiHrdlk~~Nill~~-~~~~~l~  231 (232)
                      +|||||++|+|.+++.... .+++..+..++.|++.||.|||    .++  |+||||||+|||++. ++.+||+
T Consensus       106 lvmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH----~~~~~IiHRDlKp~NILl~~~~g~vKl~  174 (290)
T 3fpq_A          106 LVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH----TRTPPIIHRDLKCDNIFITGPTGSVKIG  174 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TSSSCCCCCCCCGGGEEESSTTSCEEEC
T ss_pred             EEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCCEEecccChhheeEECCCCCEEEE
Confidence            9999999999999997643 5899999999999999999999    666  999999999999984 7899986

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.5e-34  Score=227.21  Aligned_cols=138  Identities=24%  Similarity=0.403  Sum_probs=119.8

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      +.|++.+.||+|+||.||+|+. .+++.||+|++....   ....+.+.+|+.+++.++|||||++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            4588999999999999999975 479999999997542   233567899999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||| +|+|.+++...+ .+++..+..++.|++.||.|||    +++|+||||||+|||++.++.+||+
T Consensus        93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH----~~~IiHRDiKP~NILl~~~~~vkl~  154 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH----RHKIVHRDLKPENLLLDEHLNVKIA  154 (275)
T ss_dssp             ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCTTTEEECTTCCEEEC
T ss_pred             eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccccCChHHeEECCCCCEEEe
Confidence            999 679999987654 5899999999999999999999    8899999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.8e-35  Score=233.77  Aligned_cols=139  Identities=20%  Similarity=0.274  Sum_probs=118.7

Q ss_pred             ccceeeecccCCCcceeeeEEeC----CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      +.|++.+.||+|+||.||+|+..    +++.||+|++....  ......+.+|+++++.++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            45889999999999999999752    47789999986542  2223467889999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||||+||+|.+++...+ .+++..+..++.|++.||.|||    +++|+||||||+|||++.+|.+||+
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH----~~~IiHRDlKp~NILl~~~g~vKl~  168 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH----SLGIIYRDLKPENILLDEEGHIKLT  168 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEECTTSCEEEE
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCHHHeEEcCCCCEEec
Confidence            999999999999997643 5899999999999999999999    8899999999999999999999986

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=6.8e-34  Score=227.91  Aligned_cols=139  Identities=22%  Similarity=0.370  Sum_probs=118.2

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCc-hHHHHHHHHHHhcCCCCCCccceeEEEecCC---------
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCSKDD---------  157 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---------  157 (232)
                      .|++.+.||+|+||.||+|+.+ +++.||||++...... ..+.+.+|+.+++.++|||||++++++...+         
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            4788999999999999999764 7999999999765432 3467889999999999999999999986543         


Q ss_pred             ---eeEEEEeccCCCChhhhhccCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          158 ---FKALILEYMPHGSLGKCLSTSNY--ILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       158 ---~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                         .+|+|||||++|+|.+++.....  ..++..++.++.|++.||.|||    +++|+||||||+|||++.++.+||+
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH----~~~IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH----HCcCccccCcHHHeEECCCCcEEEc
Confidence               47999999999999999986532  2455667889999999999999    8899999999999999999999986

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=9.7e-34  Score=227.74  Aligned_cols=139  Identities=27%  Similarity=0.368  Sum_probs=115.8

Q ss_pred             cceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCC----eeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD----FKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e  164 (232)
                      .+.+.+.||+|+||.||+|++ +|+.||||++...... ......|+..+..++|||||++++++..++    ..|+|||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            466789999999999999987 4889999998654321 122344666677899999999999987653    5799999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH----STHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~----~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||++|+|.++++..  .+++..+.+++.|++.||+|+|+..    ...+|+||||||+|||++.++++||+
T Consensus        82 y~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~  150 (303)
T 3hmm_A           82 YHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  150 (303)
T ss_dssp             CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             CCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence            99999999999865  4899999999999999999999321    12389999999999999999999996

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=99.97  E-value=5.3e-32  Score=224.70  Aligned_cols=140  Identities=23%  Similarity=0.341  Sum_probs=122.2

Q ss_pred             ccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEec------C
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSK------D  156 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------~  156 (232)
                      +.+.|++.+.||+|+||.||+|+. .+|+.||||++.....  ...+.+.+|+.+|+.++|||||++++++..      .
T Consensus        52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~  131 (398)
T 4b99_A           52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF  131 (398)
T ss_dssp             CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred             CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence            345689999999999999999976 4799999999965432  234667889999999999999999998764      3


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          157 DFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       157 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +.+|+|||||+ |+|.+++...+ .+++..+..++.|++.||.|||    .++|+||||||+|||++.++.+||+
T Consensus       132 ~~~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH----~~~iiHRDlKP~NIl~~~~~~~Ki~  200 (398)
T 4b99_A          132 KSVYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH----SAQVIHRDLKPSNLLVNENCELKIG  200 (398)
T ss_dssp             CCEEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTCCEEEC
T ss_pred             CEEEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCcCcCCCcCccccccCCCCCEEEe
Confidence            57899999996 68999987654 5899999999999999999999    8899999999999999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.97  E-value=2.7e-32  Score=223.03  Aligned_cols=141  Identities=25%  Similarity=0.386  Sum_probs=121.0

Q ss_pred             cccceeeecccCCCcceeeeEEeCC------CcEEEEEEeecccC-chHHHHHHHHHHhcCCCC-CCccceeEEEecC-C
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQD------GMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRH-QNLIKIISSCSKD-D  157 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~-~  157 (232)
                      .+.+++.+.||+|+||.||+|++..      ++.||||.+..... ...+.+.+|+.+++.++| ||||+++++|..+ +
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~  142 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  142 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence            3567899999999999999997532      36799999865433 335678899999999976 8999999998664 5


Q ss_pred             eeEEEEeccCCCChhhhhccC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceee
Q 042107          158 FKALILEYMPHGSLGKCLSTS---------------NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL  222 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill  222 (232)
                      .+++|||||++|+|.++++..               ...+++..+..++.|+++||.|||    .++||||||||+|||+
T Consensus       143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH----~~~iiHRDLK~~NILl  218 (353)
T 4ase_A          143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILL  218 (353)
T ss_dssp             CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEE
T ss_pred             EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh----hCCeecCccCccceee
Confidence            689999999999999999642               234789999999999999999999    8899999999999999


Q ss_pred             CCCCceeec
Q 042107          223 DDNMVAHFL  231 (232)
Q Consensus       223 ~~~~~~~l~  231 (232)
                      ++++++|||
T Consensus       219 ~~~~~vKi~  227 (353)
T 4ase_A          219 SEKNVVKIC  227 (353)
T ss_dssp             CGGGCEEEC
T ss_pred             CCCCCEEEC
Confidence            999999997

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.97  E-value=2.7e-31  Score=230.08  Aligned_cols=142  Identities=17%  Similarity=0.294  Sum_probs=128.0

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      ..+.|++.+.||+|+||.||+|+.+ +|+.||+|.+........+.+.+|+.+|+.++|||||++++++.+++.+|+|||
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            3456899999999999999999764 799999999977655556778899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC--Cceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN--MVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~--~~~~l~  231 (232)
                      ||+||+|.+++......+++..+..++.|++.||.|||    .++|+||||||+|||++.+  +.+||+
T Consensus       235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH----~~~iiHRDlKp~Nill~~~~~~~vKl~  299 (573)
T 3uto_A          235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH----ENNYVHLDLKPENIMFTTKRSNELKLI  299 (573)
T ss_dssp             CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSCCCEEEC
T ss_pred             ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeccCChhhccccCCCCCCEEEe
Confidence            99999999999766556899999999999999999999    8899999999999999864  778875

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.97  E-value=3.6e-31  Score=229.88  Aligned_cols=139  Identities=21%  Similarity=0.292  Sum_probs=120.9

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHH---HHHHHHhcCCCCCCccceeEEEecCCeeE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNL---DVECNMMKIIRHQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~e~~~l~~l~h~niv~~~~~~~~~~~~~  160 (232)
                      +.|++.+.||+|+||.||+|+.. +|+.||+|++.+..   ......+   ..++.+++.++|||||++++++.+++.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            34789999999999999999764 79999999997542   1222222   33467788899999999999999999999


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|||||+||+|.+++...+ .+++..+..++.||+.||.|||    .++||||||||+|||++.+|.+||+
T Consensus       269 lVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH----~~gIiHRDLKPeNILld~~G~vKL~  334 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRIS  334 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             EEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCchHHeEEeCCCCEEec
Confidence            9999999999999997653 5899999999999999999999    8899999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.97  E-value=2.5e-31  Score=218.28  Aligned_cols=136  Identities=21%  Similarity=0.341  Sum_probs=120.3

Q ss_pred             ccccceeeecccCCCcceeeeEEeC----CCcEEEEEEeecccCchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQYGGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  160 (232)
                      +.+.|++.+.||+|+||.||+|+.+    +++.||+|.+....  ....+.+|+++++.+ +||||+++++++.+.+..|
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            4567899999999999999999642    47789999886543  345678899999988 6999999999999999999


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC-Cceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN-MVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~-~~~~l~  231 (232)
                      +|||||++|+|.+++..    +++..+..++.|++.||.|||    .++|+||||||+|||++.+ +.+||+
T Consensus        97 lvmE~~~g~~L~~~~~~----l~~~~~~~~~~qll~al~ylH----~~gIiHRDiKPeNiLl~~~~~~~kl~  160 (361)
T 4f9c_A           97 IAMPYLEHESFLDILNS----LSFQEVREYMLNLFKALKRIH----QFGIVHRDVKPSNFLYNRRLKKYALV  160 (361)
T ss_dssp             EEEECCCCCCHHHHHTT----CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             EEEeCCCcccHHHHHcC----CCHHHHHHHHHHHHHHHHHHH----HCCeEeCcCCHHHeEEeCCCCeEEEC
Confidence            99999999999999853    788999999999999999999    8899999999999999876 788875

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.96  E-value=5.9e-29  Score=200.33  Aligned_cols=140  Identities=27%  Similarity=0.361  Sum_probs=128.0

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      +.|.+.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            45778899999999999999764 68999999986655556678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~  150 (310)
T 3s95_A           90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH----SMNIIHRDLNSHNCLVRENKNVVVA  150 (310)
T ss_dssp             TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEECTTSCEEEC
T ss_pred             CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCCcCeEEECCCCCEEEe
Confidence            999999999876667899999999999999999999    8899999999999999999999885

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.96  E-value=1.2e-28  Score=197.56  Aligned_cols=140  Identities=26%  Similarity=0.357  Sum_probs=127.7

Q ss_pred             ccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      ..+.|++.+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            345678899999999999999975 5789999999987766666788999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++|+|.+++...  .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        98 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~Dlkp~Nil~~~~~~~kl~  158 (297)
T 3fxz_A           98 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLT  158 (297)
T ss_dssp             CCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEEC
T ss_pred             CCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH----hCCceeCCCCHHHEEECCCCCEEEe
Confidence            99999999999765  4888999999999999999999    8899999999999999999999885

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.96  E-value=2e-28  Score=198.21  Aligned_cols=142  Identities=34%  Similarity=0.554  Sum_probs=128.8

Q ss_pred             ccccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      ..+.|++.+.||+|+||.||+|+.++++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  116 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKY  116 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEEC
T ss_pred             HHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEc
Confidence            34557788999999999999999888999999998776666778899999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSN---YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|+|.+++....   ..+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+
T Consensus       117 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~  181 (321)
T 2qkw_B          117 MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH----TRAIIHRDVKSINILLDENFVPKIT  181 (321)
T ss_dssp             CTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCSTTEEECTTCCEEEC
T ss_pred             CCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc----CCCeecCCCCHHHEEECCCCCEEEe
Confidence            99999999997542   34889999999999999999999    8899999999999999999999885

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.96  E-value=9.2e-29  Score=200.99  Aligned_cols=141  Identities=27%  Similarity=0.378  Sum_probs=126.3

Q ss_pred             ccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      ..+.|++.+.||+|+||.||+|+. .+++.||+|++.....  ...+.+.+|+.+++.++||||+++++++..++..++|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            345688999999999999999976 5799999999976532  3456788999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+++|+|.+++...+ .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        93 ~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~NIll~~~~~~kl~  156 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH----QKRIVHRDLKAENLLLDADMNIKIA  156 (328)
T ss_dssp             ECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             EECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEeccCCCHHHEEEcCCCCEEEe
Confidence            99999999999987643 4889999999999999999999    8899999999999999999999985

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=2.3e-28  Score=193.01  Aligned_cols=139  Identities=24%  Similarity=0.354  Sum_probs=126.6

Q ss_pred             ccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccC
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      +.|++.+.||+|+||.||+|+..+++.||+|.+..... ..+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            45788899999999999999988888999999975533 34678899999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~  148 (269)
T 4hcu_A           89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHRDLAARNCLVGENQVIKVS  148 (269)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECGGGCEEEC
T ss_pred             CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH----hCCeecCCcchheEEEcCCCCEEec
Confidence            99999999876667899999999999999999999    8899999999999999999999885

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.96  E-value=2.4e-28  Score=198.25  Aligned_cols=142  Identities=23%  Similarity=0.410  Sum_probs=125.9

Q ss_pred             ccccceeeecccCCCcceeeeEEeC----CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  160 (232)
                      ..+.|++.+.||+|+||.||+|+..    .+..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..+
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  126 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM  126 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence            3456889999999999999999864    34469999997543 234567889999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +||||+++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~  193 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS----DLGYVHRDLAARNVLVDSNLVCKVS  193 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCcceEEECCCCCEEEC
Confidence            999999999999999776567899999999999999999999    8899999999999999999999885

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.96  E-value=4.1e-28  Score=196.37  Aligned_cols=140  Identities=24%  Similarity=0.312  Sum_probs=125.4

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.|++.+.||+|+||.||+|+.. +++.||+|.+....   ....+.+.+|..+++.++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            455788999999999999999765 68999999997542   23456778899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~~kL~  148 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH----SKDIIYRDLKPENILLDKNGHIKIT  148 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChheEEEcCCCCEEEe
Confidence            99999999999997643 5888999999999999999999    8899999999999999999999986

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.96  E-value=1.2e-28  Score=207.23  Aligned_cols=141  Identities=19%  Similarity=0.234  Sum_probs=125.3

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.|++.+.||+|+||.||+|+.. +++.||+|++....   ......+..|..++..++||||+++++++.+++..|+|
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  152 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV  152 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence            356788999999999999999875 57899999997532   22234477899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       153 ~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH----~~giiHrDLKp~NILl~~~g~vkL~  217 (437)
T 4aw2_A          153 MDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH----QLHYVHRDIKPDNILMDMNGHIRLA  217 (437)
T ss_dssp             ECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             EecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH----hCCeEecccCHHHeeEcCCCCEEEc
Confidence            9999999999999875556899999999999999999999    8899999999999999999999986

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=3.9e-28  Score=196.73  Aligned_cols=141  Identities=18%  Similarity=0.309  Sum_probs=125.8

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      +.+.|++.+.||+|+||.||+|+.. +++.||+|.+... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            4567889999999999999999765 6889999998644 2344668889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC--CCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD--NMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~--~~~~~l~  231 (232)
                      |+++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.  ++.+||+
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~givH~Dlkp~NIl~~~~~~~~~kl~  146 (321)
T 1tki_A           82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH----SHNIGHFDIRPENIIYQTRRSSTIKII  146 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSCCCEEEC
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCCCcCCCCHHHEEEccCCCCCEEEE
Confidence            99999999999876656899999999999999999999    889999999999999997  6788875

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.96  E-value=2.3e-28  Score=195.00  Aligned_cols=139  Identities=12%  Similarity=0.011  Sum_probs=122.7

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC---chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG---GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      +.+.|++.+.||+|+||.||+|+.. +++.||+|.+.....   ...+.+.+|+..++.++||||+++++++..++..|+
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            4456899999999999999999765 589999999976533   234678889999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||+++++|.+++...   .....+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       109 v~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH----~~givH~Dikp~NIll~~~g~~kl~  171 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH----RAGVALSIDHPSRVRVSIDGDVVLA  171 (286)
T ss_dssp             EEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEEETTSCEEEC
T ss_pred             EEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH----HCCCccCCCCcccEEEcCCCCEEEE
Confidence            99999999999999653   345567889999999999999    8899999999999999999999986

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.96  E-value=2.9e-28  Score=198.73  Aligned_cols=139  Identities=22%  Similarity=0.299  Sum_probs=124.6

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecc---cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQ---YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      +.|++.+.||+|+||.||+|+.. +++.||+|.+...   .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            45778899999999999999765 6899999999754   2344567888999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        85 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~vkL~  147 (337)
T 1o6l_A           85 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKIT  147 (337)
T ss_dssp             ECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeecCcCCHHHEEECCCCCEEEe
Confidence            9999999999887543 4888999999999999999999    8899999999999999999999986

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.96  E-value=1.7e-28  Score=202.80  Aligned_cols=141  Identities=23%  Similarity=0.429  Sum_probs=125.3

Q ss_pred             cccceeeecccCCCcceeeeEEeC----CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      .+.|.+.+.||+|+||.||+|+..    ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            346778899999999999999754    57789999987543 2335678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||+++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~  189 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS----DMGYVHRDLAARNILINSNLVCKVS  189 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCcceEEEcCCCCEEEC
Confidence            99999999999999876667899999999999999999999    8899999999999999999999886

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.96  E-value=7.8e-28  Score=197.87  Aligned_cols=142  Identities=23%  Similarity=0.357  Sum_probs=126.4

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCc------hHHHHHHHHHHhcCCCCCCccceeEEEecCC
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGG------AFKNLDVECNMMKIIRHQNLIKIISSCSKDD  157 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  157 (232)
                      .+.+.|++.+.||+|+||.||+|+.. +++.||+|.+......      ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus         9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~   88 (361)
T 2yab_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT   88 (361)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC
Confidence            56677899999999999999999765 6899999999765322      3467899999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC----ceeec
Q 042107          158 FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM----VAHFL  231 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~----~~~l~  231 (232)
                      ..++||||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++    .+||+
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~givHrDlkp~NIll~~~~~~~~~vkl~  161 (361)
T 2yab_A           89 DVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLI  161 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEeCCCCCccCEEEE
Confidence            9999999999999999997643 5899999999999999999999    88999999999999998877    57775

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.96  E-value=6.6e-28  Score=200.02  Aligned_cols=143  Identities=20%  Similarity=0.365  Sum_probs=127.4

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      .+.+.|++.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++++...+..++||
T Consensus        48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  127 (387)
T 1kob_A           48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  127 (387)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence            45567899999999999999999764 68899999997665445567889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC--CCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD--NMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~--~~~~~l~  231 (232)
                      ||+++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.  ++.+||+
T Consensus       128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~givHrDlkp~NIll~~~~~~~vkL~  193 (387)
T 1kob_A          128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH----EHSIVHLDIKPENIMCETKKASSVKII  193 (387)
T ss_dssp             ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSTTCCCEEEC
T ss_pred             EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccchHHeEEecCCCCceEEE
Confidence            999999999999876656899999999999999999999    889999999999999974  4667775

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.96  E-value=4e-28  Score=195.81  Aligned_cols=142  Identities=23%  Similarity=0.349  Sum_probs=126.0

Q ss_pred             cccccceeeecccCCCcceeeeEEeCCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.+.|++.+.||+|+||.||+|+..+++.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            5677899999999999999999998889999999986442  23356788999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+++ ++.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~  161 (311)
T 3niz_A           98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH----QHRILHRDLKPQNLLINSDGALKLA  161 (311)
T ss_dssp             EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCchHhEEECCCCCEEEc
Confidence            999985 888888776666899999999999999999999    8899999999999999999999885

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.96  E-value=1e-28  Score=197.61  Aligned_cols=143  Identities=26%  Similarity=0.436  Sum_probs=126.7

Q ss_pred             cccccceeeecccCCCcceeeeEEe-----CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecC--C
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARI-----QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKD--D  157 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~  157 (232)
                      ...+.|++.+.||+|+||.||+|++     .+++.||+|++........+.+.+|+.+++.++||||+++++++...  .
T Consensus         7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   86 (295)
T 3ugc_A            7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   86 (295)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred             CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            3456788999999999999999974     36889999999766555567889999999999999999999998653  5


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          158 FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ..++||||+++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dikp~Nil~~~~~~~kl~  156 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG----TKRYIHRDLATRNILVENENRVKIG  156 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred             ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHhhEEEcCCCeEEEc
Confidence            689999999999999999876556899999999999999999999    8899999999999999999999885

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.96  E-value=5.9e-28  Score=195.77  Aligned_cols=142  Identities=22%  Similarity=0.357  Sum_probs=120.9

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCC------
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD------  157 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  157 (232)
                      +.+.|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            3456788999999999999999875 79999999997543 335677899999999999999999999885543      


Q ss_pred             ---------------------------------------------------eeEEEEeccCCCChhhhhccCCC--CCCH
Q 042107          158 ---------------------------------------------------FKALILEYMPHGSLGKCLSTSNY--ILDF  184 (232)
Q Consensus       158 ---------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~--~~~~  184 (232)
                                                                         ..++||||+++++|.+++.....  ..++
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  163 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH  163 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence                                                               37999999999999999986532  2455


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          185 FQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       185 ~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~  206 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLH----SKGLMHRDLKPSNIFFTMDDVVKVG  206 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             HHHHHHHHHHHHHHHHHH----hCCeeecCCCcccEEEeCCCCEEEe
Confidence            668899999999999999    8899999999999999999999885

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.95  E-value=1.5e-28  Score=205.30  Aligned_cols=141  Identities=19%  Similarity=0.272  Sum_probs=125.1

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+..|..++..++||||+++++++.+++..|+|
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  139 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV  139 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            456788999999999999999864 79999999997532   12234577899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+++|+|.+++...+..+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       140 mE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~giiHrDLKp~NILld~~g~vkL~  204 (412)
T 2vd5_A          140 MEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH----RLGYVHRDIKPDNILLDRCGHIRLA  204 (412)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             EcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccCHHHeeecCCCCEEEe
Confidence            9999999999999765446899999999999999999999    8899999999999999999999986

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.95  E-value=8e-28  Score=194.86  Aligned_cols=137  Identities=26%  Similarity=0.320  Sum_probs=125.4

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccC
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      .++..+.||+|+||.||+|+.. +|+.||||.+........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  125 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQ  125 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCC
Confidence            4566779999999999999865 799999999987766667788999999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|.+++...  .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus       126 ~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~  183 (321)
T 2c30_A          126 GGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH----AQGVIHRDIKSDSILLTLDGRVKLS  183 (321)
T ss_dssp             SCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEEC
T ss_pred             CCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEECCCCcEEEe
Confidence            99999998754  4899999999999999999999    8899999999999999999999885

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.95  E-value=4.2e-28  Score=194.16  Aligned_cols=144  Identities=19%  Similarity=0.362  Sum_probs=127.9

Q ss_pred             CCcccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC---chHHHHHHHHHHhcCCCCCCccceeEEEecCCe
Q 042107           83 PRPFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG---GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF  158 (232)
Q Consensus        83 p~~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  158 (232)
                      ...+.+.|++.+.||+|+||.||+|+.. +++.||+|.+.....   ...+.+.+|+.+++.++||||+++++++..++.
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~   85 (294)
T 4eqm_A            6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC   85 (294)
T ss_dssp             SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE
T ss_pred             hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe
Confidence            4456677999999999999999999754 689999999865432   234678899999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          159 KALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .++||||+++++|.+++.... .+++..+..++.|++.||.|+|    ..+|+||||||+||+++.++.+||+
T Consensus        86 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~Dlkp~Nil~~~~~~~kl~  153 (294)
T 4eqm_A           86 YYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH----DMRIVHRDIKPQNILIDSNKTLKIF  153 (294)
T ss_dssp             EEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred             EEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCCEEEE
Confidence            999999999999999997643 5889999999999999999999    8899999999999999999999885

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.95  E-value=5.8e-28  Score=192.00  Aligned_cols=140  Identities=24%  Similarity=0.348  Sum_probs=123.8

Q ss_pred             cccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      .+.|++.+.||+|+||.||+|+..++..||+|.+..... ..+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            345788999999999999999988888999999975533 3467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.++|+
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~Nili~~~~~~kl~  162 (283)
T 3gen_A          102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAARNCLVNDQGVVKVS  162 (283)
T ss_dssp             TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCSGGGEEECTTSCEEEC
T ss_pred             CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCCccceEEEcCCCCEEEc
Confidence            999999999875556899999999999999999999    8899999999999999999999885

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.95  E-value=3.7e-28  Score=191.67  Aligned_cols=140  Identities=24%  Similarity=0.361  Sum_probs=126.6

Q ss_pred             cccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      .+.|++.+.||+|+||.||+|+..++..||+|.+..... ..+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            345788999999999999999988888999999875543 3467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~~l~  146 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE----SHQFIHRDLAARNCLVDRDLCVKVS  146 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH----HTTEEESSCSGGGEEECTTCCEEEC
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCcCcceEEECCCCCEEEc
Confidence            999999999776556899999999999999999999    8899999999999999999999885

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.95  E-value=5.1e-28  Score=199.67  Aligned_cols=141  Identities=28%  Similarity=0.455  Sum_probs=123.3

Q ss_pred             cccceeeecccCCCcceeeeEEeC--------CCcEEEEEEeecccC-chHHHHHHHHHHhcCC-CCCCccceeEEEecC
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ--------DGMEVVVKGFNLQYG-GAFKNLDVECNMMKII-RHQNLIKIISSCSKD  156 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  156 (232)
                      .+.|++.+.||+|+||.||+|+..        ++..||+|.+..... ...+.+.+|+.+++.+ +||||+++++++..+
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            466889999999999999999742        356799999865432 3456788999999999 899999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCcee
Q 042107          157 DFKALILEYMPHGSLGKCLSTSN---------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVL  221 (232)
Q Consensus       157 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nil  221 (232)
                      +..|+||||+++|+|.+++....               ..+++..+..++.|++.||.|||    ..+|+||||||+|||
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIl  235 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA----SQKCIHRDLAARNVL  235 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCeeccccchhhEE
Confidence            99999999999999999987542               24788889999999999999999    889999999999999


Q ss_pred             eCCCCceeec
Q 042107          222 LDDNMVAHFL  231 (232)
Q Consensus       222 l~~~~~~~l~  231 (232)
                      ++.++.+||+
T Consensus       236 l~~~~~~kl~  245 (370)
T 2psq_A          236 VTENNVMKIA  245 (370)
T ss_dssp             ECTTCCEEEC
T ss_pred             ECCCCCEEEc
Confidence            9999999986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.95  E-value=8.6e-28  Score=198.98  Aligned_cols=140  Identities=21%  Similarity=0.322  Sum_probs=125.7

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.|++.+.||+|+||.||+|+.. +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            356789999999999999999765 68899999986542   33457788999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        94 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIll~~~g~vkL~  157 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ----NQRIIHRDMKPDNILLDEHGHVHIT  157 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceeccCcHHHeEECCCCCEEEe
Confidence            99999999999998643 5899999999999999999999    8899999999999999999999986

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.95  E-value=5.9e-28  Score=195.84  Aligned_cols=141  Identities=22%  Similarity=0.310  Sum_probs=123.8

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      +.+.|++.+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..++||
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            5567899999999999999999765 789999999865432 23456788999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        85 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~givH~Dlkp~NIll~~~~~~kl~  147 (323)
T 3tki_A           85 EYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH----GIGITHRDIKPENLLLDERDNLKIS  147 (323)
T ss_dssp             ECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccccchHHEEEeCCCCEEEE
Confidence            9999999999997643 5899999999999999999999    8899999999999999999999885

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.95  E-value=6.8e-28  Score=197.16  Aligned_cols=140  Identities=20%  Similarity=0.261  Sum_probs=123.7

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC---chHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG---GAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  161 (232)
                      .+.|++.+.||+|+||.||+|+.. +++.||+|++.....   ...+.+.+|..+++.+ +||||+++++++.+++..|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            345788999999999999999865 688999999976532   2345677899999887 89999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        88 v~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~~kL~  152 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLT  152 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEECCCCCEEEE
Confidence            999999999999987543 5889999999999999999999    8899999999999999999999986

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.95  E-value=3e-28  Score=203.37  Aligned_cols=139  Identities=22%  Similarity=0.265  Sum_probs=123.2

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV  147 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  147 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            345788999999999999999865 68899999986531   22334577899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+++|+|.+++...  .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       148 ~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH----~~givHrDLKp~NILl~~~g~ikL~  210 (410)
T 3v8s_A          148 MEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIH----SMGFIHRDVKPDNMLLDKSGHLKLA  210 (410)
T ss_dssp             ECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             EeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCCHHHeeECCCCCEEEe
Confidence            9999999999999764  4888999999999999999999    8899999999999999999999986

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.95  E-value=4.1e-28  Score=199.02  Aligned_cols=139  Identities=23%  Similarity=0.322  Sum_probs=123.3

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecc---cCchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQ---YGGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  162 (232)
                      +.|++.+.||+|+||.||+|+.. +++.||+|++...   .....+.+..|..+++.+ +||||+++++++.+.+..|+|
T Consensus        23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv  102 (353)
T 3txo_A           23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV  102 (353)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence            45788999999999999999765 6899999999754   223446677899999887 799999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       103 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NILl~~~g~ikL~  166 (353)
T 3txo_A          103 MEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH----DKGIIYRDLKLDNVLLDHEGHCKLA  166 (353)
T ss_dssp             EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCcccCCCHHHEEECCCCCEEEc
Confidence            99999999999987643 4889999999999999999999    8899999999999999999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.95  E-value=1.7e-28  Score=203.08  Aligned_cols=140  Identities=25%  Similarity=0.389  Sum_probs=124.7

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      +.+.+.+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  193 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL  193 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence            45778899999999999999875 789999999865422 2234577899999999999999999999998999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~Nil~~~~~~~kl~  255 (377)
T 3cbl_A          194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE----SKCCIHRDLAARNCLVTEKNVLKIS  255 (377)
T ss_dssp             CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcCCcccCHHHEEEcCCCcEEEC
Confidence            9999999999865556889999999999999999999    8899999999999999999999986

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.95  E-value=6.7e-28  Score=194.35  Aligned_cols=148  Identities=29%  Similarity=0.393  Sum_probs=126.3

Q ss_pred             cCCCCCcccccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecC
Q 042107           79 EGKIPRPFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKD  156 (232)
Q Consensus        79 ~g~~p~~~~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  156 (232)
                      .+.........|++.+.||+|+||.||+|+. +++.||+|.+.....  ...+.+.+|+.+++.++||||+++++++...
T Consensus        28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 3p86_A           28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP  106 (309)
T ss_dssp             ----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             CcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            3333444556788999999999999999976 588899999865532  2346788999999999999999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCC--eeeCCCCCCceeeCCCCceeec
Q 042107          157 DFKALILEYMPHGSLGKCLSTSNY--ILDFFQRLHIMIDVASAVEYLHFGHSTHV--IIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       157 ~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~--iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +..++||||+++|+|.+++.....  .+++..+..++.|++.||.|||    ..+  |+||||||+||+++.++.+||+
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~~~ivH~Dikp~NIll~~~~~~kL~  181 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH----NRNPPIVHRNLKSPNLLVDKKYTVKVC  181 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH----TSSSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred             CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH----cCCCCEECCCCChhhEEEeCCCcEEEC
Confidence            999999999999999999986532  3888899999999999999999    778  9999999999999999999885

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.95  E-value=7.3e-28  Score=192.06  Aligned_cols=138  Identities=21%  Similarity=0.336  Sum_probs=124.0

Q ss_pred             cceeeecccCCCcceeeeEEeCCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           89 FLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      .|++.+.||+|+||.||+|+..+++.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   82 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL   82 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred             cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence            477889999999999999988889999999986543  223467888999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++ +|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~  142 (288)
T 1ob3_A           83 DQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH----DRRVLHRDLKPQNLLINREGELKIA  142 (288)
T ss_dssp             SE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             CC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCCEEEe
Confidence            86 999988876556899999999999999999999    8899999999999999999999986

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.95  E-value=1.3e-27  Score=195.88  Aligned_cols=141  Identities=18%  Similarity=0.232  Sum_probs=125.9

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      ..+.|++.+.||+|+||.||+|+.. +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  118 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            3456789999999999999999765 68999999996542   2345678889999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       119 v~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~~kL~  183 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVT  183 (350)
T ss_dssp             EEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             EEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccccCccceEEECCCCCEEEc
Confidence            999999999999997643 4889999999999999999999    8899999999999999999999985

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.95  E-value=1.8e-27  Score=193.20  Aligned_cols=142  Identities=23%  Similarity=0.321  Sum_probs=126.0

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCc------hHHHHHHHHHHhcCCCCCCccceeEEEecCC
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGG------AFKNLDVECNMMKIIRHQNLIKIISSCSKDD  157 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  157 (232)
                      .+.+.|++.+.||+|+||.||+|+.. +++.||+|.+......      ..+.+.+|+.+++.++||||+++++++..++
T Consensus         8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   87 (326)
T 2y0a_A            8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT   87 (326)
T ss_dssp             CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            45677899999999999999999765 6899999999764321      3577889999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC----ceeec
Q 042107          158 FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM----VAHFL  231 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~----~~~l~  231 (232)
                      ..++||||+++++|.+++... ..+++..+..++.|++.||.|||    ..+|+||||||+||+++.++    .+||+
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  160 (326)
T 2y0a_A           88 DVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLH----SLQIAHFDLKPENIMLLDRNVPKPRIKII  160 (326)
T ss_dssp             EEEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred             EEEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH----HCCeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence            999999999999999999764 35889999999999999999999    88999999999999999887    67775

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.95  E-value=1.1e-27  Score=198.86  Aligned_cols=141  Identities=21%  Similarity=0.278  Sum_probs=126.1

Q ss_pred             cccceeeecccCC--CcceeeeEEeC-CCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           87 RNFLEVFNLISRG--GFGSIYKARIQ-DGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        87 ~~~~~~~~~lg~g--~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      .+.|++.+.||+|  +||.||+|+.. +++.||+|++.....  ...+.+.+|+.+++.++||||+++++++..++..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4568899999999  99999999865 799999999976542  334667889999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||+++|+|.+++... ...+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~NIll~~~~~~kl~  170 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH----HMGYVHRSVKASHILISVDGKVYLS  170 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEEC
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEc
Confidence            99999999999998764 245889999999999999999999    8899999999999999999999885

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.95  E-value=1.6e-27  Score=188.95  Aligned_cols=144  Identities=22%  Similarity=0.319  Sum_probs=127.9

Q ss_pred             CCcccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           83 PRPFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        83 p~~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      ...+.+.|++.+.||+|+||.||+|+.. ++..+|+|.+........+.+.+|+++++.++||||+++++++...+..++
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (277)
T 3f3z_A            4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYL   83 (277)
T ss_dssp             --CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEE
Confidence            3345677899999999999999999765 578999999987766667889999999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceee---CCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL---DDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill---~~~~~~~l~  231 (232)
                      ||||+++++|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+||++   +.++.++|+
T Consensus        84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~~~~l~  151 (277)
T 3f3z_A           84 VMELCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH----KLNVAHRDLKPENFLFLTDSPDSPLKLI  151 (277)
T ss_dssp             EEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             EEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccCCCCCHHHEEEecCCCCCcEEEE
Confidence            999999999999887643 4889999999999999999999    8899999999999999   778888875

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.95  E-value=7.7e-28  Score=191.76  Aligned_cols=137  Identities=22%  Similarity=0.340  Sum_probs=123.1

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CC-------cEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCe
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DG-------MEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF  158 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  158 (232)
                      .+.|.+.+.||+|+||.||+|+.. ++       ..||+|.+........+.+.+|+.+++.++||||+++++++..++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            456788999999999999999754 23       4799999977666667889999999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCc
Q 042107          159 KALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV  227 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~  227 (232)
                      .++||||+++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~  151 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE----ENTLIHGNVCAKNILLIREED  151 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEEECCB
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh----hCCeECCCcCcceEEEecCCc
Confidence            99999999999999999876555899999999999999999999    889999999999999998887

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.95  E-value=8.7e-28  Score=196.46  Aligned_cols=139  Identities=17%  Similarity=0.329  Sum_probs=122.9

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  162 (232)
                      +.|++.+.||+|+||.||+|+.. +++.||+|.+....   ....+.+..|..++..+ +||||+++++++.+.+..|+|
T Consensus        17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv   96 (345)
T 1xjd_A           17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   96 (345)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence            45778999999999999999865 68899999997642   33456677888888876 899999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        97 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~g~vkL~  160 (345)
T 1xjd_A           97 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH----SKGIVYRDLKLDNILLDKDGHIKIA  160 (345)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCChhhEEECCCCCEEEe
Confidence            99999999999987643 4889999999999999999999    8899999999999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.95  E-value=2.9e-27  Score=200.81  Aligned_cols=141  Identities=27%  Similarity=0.383  Sum_probs=126.6

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      ..+.|.+.+.||+|+||.||+|+.. +|+.||+|++....   ....+.+.+|+.+++.++||||+++++++..++..++
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l   93 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM   93 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3456889999999999999999765 79999999997542   2345678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        94 v~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~givHrDLkp~NIll~~~~~vkL~  158 (476)
T 2y94_A           94 VMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH----RHMVVHRDLKPENVLLDAHMNAKIA  158 (476)
T ss_dssp             EEECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCCcccccHHHEEEecCCCeEEE
Confidence            999999999999997643 5899999999999999999999    8899999999999999999999986

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.95  E-value=3e-27  Score=188.83  Aligned_cols=139  Identities=22%  Similarity=0.339  Sum_probs=122.0

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      +.|++.+.||+|+||.||+|+.. +++.||+|.+....  ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            34788999999999999999765 68999999997543  2334678889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++ ++.+.+......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH----~~~ivH~dikp~Nil~~~~~~~kl~  143 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH----SRNVLHRDLKPQNLLINRNGELKLA  143 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEcCCCCEEEe
Confidence            9976 666666554556899999999999999999999    8899999999999999999999885

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.95  E-value=7.5e-28  Score=197.36  Aligned_cols=143  Identities=21%  Similarity=0.377  Sum_probs=123.6

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc-----CchHHHHHHHHHHhcCCCCCCccceeEEEecCCe
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY-----GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF  158 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  158 (232)
                      .+.+.|++.+.||+|+||.||+|+.. +++.||+|.+....     ....+.+.+|+.+++.++||||+++++++..++.
T Consensus        21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  100 (351)
T 3c0i_A           21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM  100 (351)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            45667899999999999999999764 68999999986432     2235778999999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCc---eeec
Q 042107          159 KALILEYMPHGSLGKCLSTS---NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV---AHFL  231 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~---~~l~  231 (232)
                      .++||||+++++|.+.+...   ...+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.   +||+
T Consensus       101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivHrDlkp~NIl~~~~~~~~~vkl~  175 (351)
T 3c0i_A          101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH----DNNIIHRDVKPHCVLLASKENSAPVKLG  175 (351)
T ss_dssp             EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred             EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCChHHeEEecCCCCCcEEEe
Confidence            99999999999998877542   334788999999999999999999    889999999999999987654   7764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.95  E-value=7e-28  Score=200.20  Aligned_cols=140  Identities=19%  Similarity=0.268  Sum_probs=122.1

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  161 (232)
                      .+.|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+..|..++..+ +||||+++++++.+++..++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            345789999999999999999865 68899999997653   22334577888888776 89999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||+++|+|..++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH----~~givHrDLKp~NILl~~~g~ikL~  195 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH----ERGIIYRDLKLDNVLLDSEGHIKLT  195 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred             EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEEeccCCHHHEEECCCCCEEEe
Confidence            999999999999987643 5899999999999999999999    8899999999999999999999986

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.95  E-value=8e-28  Score=195.34  Aligned_cols=141  Identities=21%  Similarity=0.340  Sum_probs=119.3

Q ss_pred             ccccceeeecccCCCcceeeeEEe----CCCcEEEEEEeeccc----CchHHHHHHHHHHhcCCCCCCccceeEEEecCC
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI----QDGMEVVVKGFNLQY----GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD  157 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  157 (232)
                      ..+.|++.+.||+|+||.||+++.    .+++.||+|++....    ......+.+|+.+++.++||||+++++++..++
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG   94 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence            346688999999999999999976    468999999986542    223456778999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          158 FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ..++||||+++++|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH----~~~ivH~Dlkp~Nill~~~~~~kl~  163 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH----QKGIIYRDLKPENIMLNHQGHVKLT  163 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCTTTEEECTTSCEEEC
T ss_pred             EEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH----hCCEEcccCCHHHeEECCCCcEEEE
Confidence            9999999999999999987543 4788889999999999999999    8899999999999999999999985

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.95  E-value=1.6e-27  Score=196.92  Aligned_cols=135  Identities=21%  Similarity=0.365  Sum_probs=116.3

Q ss_pred             eecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCCh
Q 042107           93 FNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSL  171 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  171 (232)
                      .+.||+|+||.||+|+. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            56899999999999976 46899999999876555567889999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceee--CCCCceeec
Q 042107          172 GKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL--DDNMVAHFL  231 (232)
Q Consensus       172 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill--~~~~~~~l~  231 (232)
                      .+++......+++..+..++.|++.||.|||    ..+|+||||||+|||+  +.++.+||+
T Consensus       174 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~~~kl~  231 (373)
T 2x4f_A          174 FDRIIDESYNLTELDTILFMKQICEGIRHMH----QMYILHLDLKPENILCVNRDAKQIKII  231 (373)
T ss_dssp             HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEEETTTTEEEEC
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccccCCHHHEEEecCCCCcEEEE
Confidence            9988765556889999999999999999999    8899999999999999  567788875

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.95  E-value=2.3e-27  Score=189.99  Aligned_cols=139  Identities=22%  Similarity=0.325  Sum_probs=117.7

Q ss_pred             cccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC--------------------------chHHHHHHHHHHhc
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG--------------------------GAFKNLDVECNMMK  139 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~  139 (232)
                      .+.|++.+.||+|+||.||+|+. .+++.||+|.+.....                          ...+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            35678999999999999999975 4688999999865421                          11355788999999


Q ss_pred             CCCCCCccceeEEEec--CCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCC
Q 042107          140 IIRHQNLIKIISSCSK--DDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKS  217 (232)
Q Consensus       140 ~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~  217 (232)
                      .++||||+++++++..  .+..++||||+++++|.+++...  .+++..+..++.|++.||.|||    ..+|+||||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp  165 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLSEDQARFYFQDLIKGIEYLH----YQKIIHRDIKP  165 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCH
Confidence            9999999999999986  56889999999999998876543  5899999999999999999999    88999999999


Q ss_pred             CceeeCCCCceeec
Q 042107          218 SNVLLDDNMVAHFL  231 (232)
Q Consensus       218 ~Nill~~~~~~~l~  231 (232)
                      +||+++.++.+||+
T Consensus       166 ~Nil~~~~~~~kl~  179 (298)
T 2zv2_A          166 SNLLVGEDGHIKIA  179 (298)
T ss_dssp             GGEEECTTSCEEEC
T ss_pred             HHEEECCCCCEEEe
Confidence            99999999999885

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.95  E-value=1.6e-27  Score=193.12  Aligned_cols=136  Identities=29%  Similarity=0.426  Sum_probs=119.2

Q ss_pred             ccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCC----eeEEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD----FKALIL  163 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~  163 (232)
                      +.|++.+.||+|+||.||+|+.. ++.||+|++..... .......|+.+++.++||||+++++++....    ..++||
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~  101 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT  101 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence            45788999999999999999876 78999999865432 2344566899999999999999999988744    469999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC----------CeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH----------VIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~----------~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+++|+|.+++...  .+++..+..++.|++.||.|||    ..          +|+||||||+|||++.++.+||+
T Consensus       102 e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH----~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          102 AFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLH----EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             ECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHT----CCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             ecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH----hhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence            999999999999764  3899999999999999999999    77          99999999999999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.95  E-value=2.4e-27  Score=190.03  Aligned_cols=142  Identities=25%  Similarity=0.487  Sum_probs=122.8

Q ss_pred             ccccceeeecccCCCcceeeeEEe-----CCCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecC--C
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-----QDGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKD--D  157 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~  157 (232)
                      ....|++.+.||+|+||.||+|++     .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..+  +
T Consensus        19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            345688999999999999999983     368899999986543 33457788999999999999999999999876  6


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          158 FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ..++||||+++++|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.++|+
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~  168 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG----SRQYVHRDLAARNVLVESEHQVKIG  168 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEEC
T ss_pred             eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh----cCCcccCCCchheEEEcCCCCEEEC
Confidence            689999999999999999665556899999999999999999999    8899999999999999999998875

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.95  E-value=4.6e-27  Score=189.59  Aligned_cols=142  Identities=23%  Similarity=0.299  Sum_probs=124.3

Q ss_pred             cccccceee-ecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcC-CCCCCccceeEEEecCCeeEE
Q 042107           85 PFRNFLEVF-NLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKI-IRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        85 ~~~~~~~~~-~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~l  161 (232)
                      .+.+.|++. +.||+|+||.||+|+. .+++.||+|++........+.+.+|++++.. .+||||+++++++..++..++
T Consensus         9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A            9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            355667774 7899999999999975 4789999999977665566788999999988 479999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCc---eeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV---AHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~---~~l~  231 (232)
                      ||||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.   +||+
T Consensus        89 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~~~~kl~  156 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH----NKGIAHRDLKPENILCEHPNQVSPVKIC  156 (316)
T ss_dssp             EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEESCSSSSCSEEEC
T ss_pred             EEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----hCCceeCCCCHHHEEEccCCCcCceEEE
Confidence            999999999999997643 4888999999999999999999    889999999999999998775   7764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.95  E-value=2.1e-27  Score=187.03  Aligned_cols=139  Identities=24%  Similarity=0.346  Sum_probs=126.2

Q ss_pred             ccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccC
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      +.|++.+.||+|+||.||+|+..+++.||+|.+..... ..+.+.+|+.+++.++||||+++++++..++..+++|||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            45778899999999999999988888999999976543 33678899999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nili~~~~~~kl~  146 (267)
T 3t9t_A           87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHRDLAARNCLVGENQVIKVS  146 (267)
T ss_dssp             TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEECGGGCEEEC
T ss_pred             CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCchheEEECCCCCEEEc
Confidence            99999999876556899999999999999999999    8899999999999999999999885

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.95  E-value=2e-27  Score=193.70  Aligned_cols=141  Identities=28%  Similarity=0.436  Sum_probs=124.3

Q ss_pred             cccceeeecccCCCcceeeeEEeC------CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCee
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ------DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFK  159 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  159 (232)
                      .+.|++.+.||+|+||.||+|+..      +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..
T Consensus        46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  125 (343)
T 1luf_A           46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM  125 (343)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence            456788999999999999999764      347899999875432 2356788999999999999999999999999999


Q ss_pred             EEEEeccCCCChhhhhccCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCC
Q 042107          160 ALILEYMPHGSLGKCLSTSN-----------------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLK  216 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk  216 (232)
                      ++||||+++|+|.+++....                       ..+++..++.++.|++.||.|||    ..+|+|||||
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlk  201 (343)
T 1luf_A          126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS----ERKFVHRDLA  201 (343)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCS
T ss_pred             EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCC
Confidence            99999999999999987531                       45888999999999999999999    8899999999


Q ss_pred             CCceeeCCCCceeec
Q 042107          217 SSNVLLDDNMVAHFL  231 (232)
Q Consensus       217 ~~Nill~~~~~~~l~  231 (232)
                      |+||+++.++.+||+
T Consensus       202 p~NIl~~~~~~~kl~  216 (343)
T 1luf_A          202 TRNCLVGENMVVKIA  216 (343)
T ss_dssp             GGGEEECGGGCEEEC
T ss_pred             cceEEECCCCeEEEe
Confidence            999999999999886

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.95  E-value=3.3e-27  Score=194.25  Aligned_cols=139  Identities=23%  Similarity=0.253  Sum_probs=123.3

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      .+.|++.+.||+|+||.||+++.. +++.||+|.+..... ..+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            456889999999999999999765 789999999975433 236688999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCc--eeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV--AHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~--~~l~  231 (232)
                      +++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.  +||+
T Consensus        98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH----~~~ivH~Dlkp~Nill~~~~~~~~kl~  160 (361)
T 3uc3_A           98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH----SMQICHRDLKLENTLLDGSPAPRLKIC  160 (361)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCSCCCCGGGEEECSSSSCCEEEC
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEcCCCCceEEEe
Confidence            99999999986543 4889999999999999999999    889999999999999988775  7765

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.95  E-value=2.5e-27  Score=192.25  Aligned_cols=141  Identities=26%  Similarity=0.461  Sum_probs=125.3

Q ss_pred             cccceeeecccCCCcceeeeEEe-----CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCC--ee
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-----QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD--FK  159 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~  159 (232)
                      .+.|++.+.||+|+||.||+|++     .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            45578999999999999999973     368899999997766666778999999999999999999999987644  68


Q ss_pred             EEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          160 ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++||||+++++|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.++|+
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dikp~NIli~~~~~~kL~  187 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG----TKRYIHRDLATRNILVENENRVKIG  187 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEEEETTEEEEC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCEeccCCCcceEEEcCCCcEEEe
Confidence            9999999999999999876666899999999999999999999    8899999999999999999998885

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.95  E-value=1.4e-27  Score=193.51  Aligned_cols=141  Identities=33%  Similarity=0.578  Sum_probs=122.9

Q ss_pred             cccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      .+.|++.+.||+|+||.||+|+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  108 (326)
T 3uim_A           29 SDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY  108 (326)
T ss_dssp             TTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEEC
T ss_pred             hhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEe
Confidence            345678899999999999999888899999999865432 2223678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCC---CCCCHHHHHHHHHHHHHHHHHHhcCCCCC---CeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSN---YILDFFQRLHIMIDVASAVEYLHFGHSTH---VIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|+|.+++....   ..+++..+..++.|++.||.|||    ..   +|+||||||+||+++.++.+||+
T Consensus       109 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A          109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH----DHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH----HSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH----hCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999997642   34889999999999999999999    66   99999999999999999999885

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.95  E-value=2e-27  Score=194.85  Aligned_cols=140  Identities=18%  Similarity=0.207  Sum_probs=124.2

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecc---cCchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQ---YGGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  161 (232)
                      .+.|++.+.||+|+||.||+|+.. +++.||+|.+...   .....+.+..|..++..+ +||+|+++++++.+.+..|+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            455788999999999999999875 5889999999754   233456778899999887 79999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        99 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIll~~~g~vkL~  163 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ----SKGIIYRDLKLDNVMLDSEGHIKIA  163 (353)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCEEeccCCHHHEEEcCCCcEEEE
Confidence            999999999999987543 4889999999999999999999    8899999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.95  E-value=2.5e-27  Score=189.94  Aligned_cols=142  Identities=22%  Similarity=0.330  Sum_probs=125.3

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      ..+.|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            4566889999999999999999875 588999999977666667888999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++++|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~  159 (302)
T 2j7t_A           97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH----SKRIIHRDLKAGNVLMTLEGDIRLA  159 (302)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred             eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh----cCCcccCCCCHHHEEECCCCCEEEE
Confidence            99999999988765456899999999999999999999    8899999999999999999999885

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.95  E-value=2.7e-27  Score=186.64  Aligned_cols=140  Identities=26%  Similarity=0.477  Sum_probs=123.6

Q ss_pred             cccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecC--CeeEEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKD--DFKALI  162 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~lv  162 (232)
                      .+.|++.+.||+|+||.||+|+.. ++.||+|.+.....  ...+.+.+|+.+++.++||||+++++++..+  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            455788999999999999999875 88899999976532  3346788999999999999999999999887  788999


Q ss_pred             EeccCCCChhhhhccCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCC--eeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNY-ILDFFQRLHIMIDVASAVEYLHFGHSTHV--IIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~--iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+++|+|.+++..... .+++..+..++.|++.||.|||    ..+  ++||||||+||+++.++.++|+
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~~~i~H~dikp~Nil~~~~~~~~l~  155 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH----TLEPLIPRHALNSRSVMIDEDMTARIS  155 (271)
T ss_dssp             EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT----TSSSCCTTCCCSGGGEEECTTSCEEEE
T ss_pred             ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh----cCCCceecCCCccceEEEcCCcceeEE
Confidence            999999999999987543 4899999999999999999999    777  9999999999999999998874

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.95  E-value=2.6e-27  Score=194.90  Aligned_cols=142  Identities=20%  Similarity=0.389  Sum_probs=124.7

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      .+.+.|++.+.||+|+||.||+|... +++.||+|.+.....  ...+.+.+|+.+++.++||||+++++++..++..++
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l  105 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL  105 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            45667899999999999999999764 689999999976532  234678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC---ceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM---VAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~---~~~l~  231 (232)
                      ||||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++   .+||+
T Consensus       106 v~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH----~~~ivH~Dlkp~NIll~~~~~~~~~kl~  173 (362)
T 2bdw_A          106 VFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH----SNGIVHRNLKPENLLLASKAKGAAVKLA  173 (362)
T ss_dssp             EECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCchHHEEEecCCCCCCEEEe
Confidence            999999999999887643 5889999999999999999999    88999999999999998654   47774

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.95  E-value=6.3e-28  Score=194.50  Aligned_cols=145  Identities=17%  Similarity=0.335  Sum_probs=126.1

Q ss_pred             CCCcccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC---chHHHHHHHHHHhcCCCCCCccceeEEEecCC
Q 042107           82 IPRPFRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG---GAFKNLDVECNMMKIIRHQNLIKIISSCSKDD  157 (232)
Q Consensus        82 ~p~~~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  157 (232)
                      .|..+.+.|++.+.||+|+||.||+|+. .+++.||+|.+.....   .....+.+|+.+++.++||||+++++++....
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   85 (311)
T 3ork_A            6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET   85 (311)
T ss_dssp             CCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred             CcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence            3567778899999999999999999975 5789999999976432   23456888999999999999999999987654


Q ss_pred             ----eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          158 ----FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       158 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                          ..++||||+++++|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus        86 ~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~  158 (311)
T 3ork_A           86 PAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH----QNGIIHRDVKPANIMISATNAVKVM  158 (311)
T ss_dssp             TTEEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEETTSCEEEC
T ss_pred             CCCcccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCCcCCCCHHHEEEcCCCCEEEe
Confidence                3499999999999999997543 5889999999999999999999    8899999999999999999999885

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.95  E-value=6.1e-27  Score=185.64  Aligned_cols=140  Identities=25%  Similarity=0.445  Sum_probs=125.8

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      +.|++.+.||+|+||.||+|+. .+++.||+|.+....   ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            3478899999999999999976 478999999996542   233467889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+++++|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nili~~~~~~kl~  154 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH----SHGILHRDLTLSNLLLTRNMNIKIA  154 (278)
T ss_dssp             ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSSCCGGGEEECTTCCEEEC
T ss_pred             ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHEEEcCCCCEEEE
Confidence            999999999999876566899999999999999999999    8899999999999999999999885

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.95  E-value=4.2e-27  Score=190.27  Aligned_cols=142  Identities=23%  Similarity=0.350  Sum_probs=123.3

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCC--eeEE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD--FKAL  161 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~l  161 (232)
                      +.+.|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+  ..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            4566889999999999999999765 58999999997543 334567788999999999999999999987755  7799


Q ss_pred             EEeccCCCChhhhhccCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceee----CCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSN--YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL----DDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill----~~~~~~~l~  231 (232)
                      ||||+++++|.+++....  ..+++..+..++.|++.||.|||    ..+|+||||||+||++    +.++.+||+
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR----ENGIVHRNIKPGNIMRVIGEDGQSVYKLT  158 (319)
T ss_dssp             EEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred             EEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEEeccCCCCceEEEc
Confidence            999999999999997642  23889999999999999999999    8899999999999999    777888875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.95  E-value=2.4e-27  Score=200.66  Aligned_cols=139  Identities=22%  Similarity=0.380  Sum_probs=123.4

Q ss_pred             cccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      .+.+++.+.||+|+||.||+|++.++..||||.+.... ...+.+.+|+.+++.++||||+++++++. .+..++||||+
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~  264 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM  264 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence            34577889999999999999998888899999997543 34678999999999999999999999986 56789999999


Q ss_pred             CCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|+|.+++.... ..+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       265 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~Nill~~~~~~kl~  326 (454)
T 1qcf_A          265 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE----QRNYIHRDLRAANILVSASLVCKIA  326 (454)
T ss_dssp             TTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCSGGGEEECTTCCEEEC
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCCHHHEEECCCCcEEEe
Confidence            9999999997542 24788889999999999999999    8899999999999999999999986

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.95  E-value=2.6e-27  Score=192.98  Aligned_cols=140  Identities=24%  Similarity=0.361  Sum_probs=123.6

Q ss_pred             ccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      ..+.|.+.+.||+|+||.||+|+. .+++.||+|.+....   ......+.+|+.+++.++||||+++++++..++..++
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            345688999999999999999976 578999999986542   2334678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||+ +|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        87 v~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~givH~Dlkp~NIll~~~~~~kl~  150 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH----RHKIVHRDLKPENLLLDDNLNVKIA  150 (336)
T ss_dssp             EECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HHTCCCCCCSTTTEEECTTCCEEEC
T ss_pred             EEECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCchhhEEEcCCCCEEEE
Confidence            99999 679988886543 5889999999999999999999    8899999999999999999999985

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.95  E-value=3.4e-27  Score=194.85  Aligned_cols=142  Identities=25%  Similarity=0.285  Sum_probs=116.5

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC---chHHHHHHHHHH-hcCCCCCCccceeEEEecCCee
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG---GAFKNLDVECNM-MKIIRHQNLIKIISSCSKDDFK  159 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~  159 (232)
                      .-.+.|++.+.||+|+||.||+|+.. +++.||+|++.....   .....+..|..+ ++.++||||+++++++.+.+..
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~  114 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL  114 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence            34456889999999999999999865 688999999976532   223445566665 5778999999999999999999


Q ss_pred             EEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          160 ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+||||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       115 ~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~givHrDlkp~NIll~~~g~ikL~  181 (373)
T 2r5t_A          115 YFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH----SLNIVYRDLKPENILLDSQGHIVLT  181 (373)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred             EEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEECCCCCEEEe
Confidence            99999999999999987643 4788889999999999999999    8899999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.95  E-value=2.8e-27  Score=190.92  Aligned_cols=142  Identities=20%  Similarity=0.320  Sum_probs=123.4

Q ss_pred             ccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEec----CCeeE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSK----DDFKA  160 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~  160 (232)
                      ..+.|++.+.||+|+||.||+++. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..    ....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            345688999999999999999976 5789999999876655566788999999999999999999999863    34789


Q ss_pred             EEEeccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLST---SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +||||+++|+|.+++..   ....+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.++|+
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~dlkp~NIl~~~~~~~kl~  176 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH----AKGYAHRDLKPTNILLGDEGQPVLM  176 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEcCCCCEEEE
Confidence            99999999999998875   3456899999999999999999999    8899999999999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.95  E-value=1.5e-26  Score=184.13  Aligned_cols=144  Identities=27%  Similarity=0.471  Sum_probs=123.7

Q ss_pred             CCCcccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCch-------HHHHHHHHHHhcCCCCCCccceeEEE
Q 042107           82 IPRPFRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGA-------FKNLDVECNMMKIIRHQNLIKIISSC  153 (232)
Q Consensus        82 ~p~~~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~  153 (232)
                      +|....+.|++.+.||+|+||.||+|+. .+++.||+|.+.......       .+.+.+|+.+++.++||||+++++++
T Consensus        13 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   92 (287)
T 4f0f_A           13 LPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM   92 (287)
T ss_dssp             CCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence            4555567788999999999999999976 478999999986543211       26788999999999999999999998


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCC--eeeCCCCCCceeeCCCCc----
Q 042107          154 SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV--IIHCDLKSSNVLLDDNMV----  227 (232)
Q Consensus       154 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~--iiHrdlk~~Nill~~~~~----  227 (232)
                      ....  ++||||+++|+|.+.+......+++..+..++.|++.||.|||    ..+  |+||||||+||+++.++.    
T Consensus        93 ~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH----~~~~~ivH~dikp~Nil~~~~~~~~~~  166 (287)
T 4f0f_A           93 HNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ----NQNPPIVHRDLRSPNIFLQSLDENAPV  166 (287)
T ss_dssp             TTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH----TSSSCCBCSCCSGGGEEESCCCTTCSC
T ss_pred             cCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH----hCCCCeecCCCCcceEEEeccCCCCce
Confidence            7664  6999999999999988776667899999999999999999999    778  999999999999988776    


Q ss_pred             -eeec
Q 042107          228 -AHFL  231 (232)
Q Consensus       228 -~~l~  231 (232)
                       +||+
T Consensus       167 ~~kl~  171 (287)
T 4f0f_A          167 CAKVA  171 (287)
T ss_dssp             CEEEC
T ss_pred             eEEeC
Confidence             7775

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.95  E-value=5.5e-27  Score=192.07  Aligned_cols=143  Identities=21%  Similarity=0.281  Sum_probs=120.1

Q ss_pred             CCCcccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeE
Q 042107           82 IPRPFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        82 ~p~~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  160 (232)
                      ....+.+.|++.+.||+|+||.||+|+.. +++.||+|.+....  ..+.+.+|+.+++.++||||+++++++..++..+
T Consensus        47 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  124 (349)
T 2w4o_A           47 NRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS  124 (349)
T ss_dssp             BCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence            34456778999999999999999999875 58899999987543  3356788999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC---CCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD---NMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~---~~~~~l~  231 (232)
                      +||||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.   ++.+||+
T Consensus       125 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dikp~NIll~~~~~~~~~kl~  193 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH----ENGIVHRDLKPENLLYATPAPDAPLKIA  193 (349)
T ss_dssp             EEECCCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEESSSSTTCCEEEC
T ss_pred             EEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEecCCCcccEEEecCCCCCCEEEc
Confidence            9999999999999987653 4889999999999999999999    889999999999999975   7888875

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.95  E-value=3.4e-27  Score=198.91  Aligned_cols=142  Identities=19%  Similarity=0.315  Sum_probs=123.2

Q ss_pred             cccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      .+.+.|++.+.||+|+||.||+|.. .+++.+|+|.+.....  ...+.+.+|+.+++.++||||+++++++.+++..++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            4567789999999999999999975 4789999999976532  234668899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeC---CCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD---DNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~---~~~~~~l~  231 (232)
                      ||||+++|+|.+.+.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++   .++.+||+
T Consensus        88 v~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH----~~givHrDlKp~NIll~~~~~~~~vkL~  155 (444)
T 3soa_A           88 IFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH----QMGVVHRNLKPENLLLASKLKGAAVKLA  155 (444)
T ss_dssp             EECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSSTTEEESBSSTTCCEEEC
T ss_pred             EEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEeccCCCCcEEEc
Confidence            999999999999887654 4889999999999999999999    88999999999999998   45677775

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.95  E-value=2.6e-27  Score=192.19  Aligned_cols=141  Identities=22%  Similarity=0.354  Sum_probs=125.1

Q ss_pred             cccceeeecccCCCcceeeeEEe-----CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEe--cCCee
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-----QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS--KDDFK  159 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~  159 (232)
                      .+.|++.+.||+|+||.||+|++     .+++.||+|.+........+.+.+|+++++.++||||+++++++.  .....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            35678999999999999999983     368899999997665555677899999999999999999999886  45678


Q ss_pred             EEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          160 ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++||||+++++|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dikp~NIl~~~~~~~kl~  169 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG----SRRCVHRDLAARNILVESEAHVKIA  169 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEEC
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCChhhEEECCCCCEEEc
Confidence            9999999999999999765446899999999999999999999    8899999999999999999999885

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.95  E-value=3e-27  Score=194.90  Aligned_cols=143  Identities=24%  Similarity=0.364  Sum_probs=122.1

Q ss_pred             cccccceeeecccCCCcceeeeEEeC------CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCC
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ------DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD  157 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  157 (232)
                      ...+.|++.+.||+|+||.||+|++.      ++..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~  147 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  147 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            44567889999999999999999743      46789999986432 233456888999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC---ce
Q 042107          158 FKALILEYMPHGSLGKCLSTSN------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM---VA  228 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~---~~  228 (232)
                      ..++||||+++|+|.+++....      ..+++..++.++.|++.||.|||    ..+|+||||||+|||++.++   .+
T Consensus       148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE----ENHFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChhhEEEecCCCCceE
Confidence            9999999999999999987532      34888899999999999999999    88999999999999999555   47


Q ss_pred             eec
Q 042107          229 HFL  231 (232)
Q Consensus       229 ~l~  231 (232)
                      ||+
T Consensus       224 kL~  226 (367)
T 3l9p_A          224 KIG  226 (367)
T ss_dssp             EEC
T ss_pred             EEC
Confidence            775

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.95  E-value=3.4e-27  Score=201.67  Aligned_cols=139  Identities=23%  Similarity=0.380  Sum_probs=124.5

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      ..+++.+.||+|+||.||+|++. ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~  298 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM  298 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence            44678899999999999999876 48899999987543 34578899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|+|.+++... ...+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       299 ~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivHrDlkp~NIll~~~~~~kl~  360 (495)
T 1opk_A          299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----KKNFIHRNLAARNCLVGENHLVKVA  360 (495)
T ss_dssp             TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECGGGCEEEC
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCChhhEEECCCCcEEEe
Confidence            999999999753 345888999999999999999999    8899999999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.95  E-value=4.3e-27  Score=190.22  Aligned_cols=139  Identities=19%  Similarity=0.345  Sum_probs=109.8

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      +.|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   84 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEF   84 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEEC
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEe
Confidence            35678899999999999999754 68999999997543 23446788899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTS-----NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++ |+|.+++...     ...+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus        85 ~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~  150 (317)
T 2pmi_A           85 MD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH----ENKILHRDLKPQNLLINKRGQLKLG  150 (317)
T ss_dssp             CC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             cC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCChHHeEEcCCCCEEEC
Confidence            98 5999887642     234888899999999999999999    8899999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.95  E-value=3.2e-27  Score=194.48  Aligned_cols=138  Identities=17%  Similarity=0.274  Sum_probs=119.2

Q ss_pred             cccceeeecccCCCcceeeeEE------eCCCcEEEEEEeecccCchHHHHHHHHHHhcCCC---CCCccceeEEEecCC
Q 042107           87 RNFLEVFNLISRGGFGSIYKAR------IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR---HQNLIKIISSCSKDD  157 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~  157 (232)
                      .+.|.+.+.||+|+||.||+|.      ..+++.||+|.+...   ....+..|+++++.++   |+||+++++++..++
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~  140 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN  140 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence            4567889999999999999993      446889999998654   3455677777777776   999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhcc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC---------
Q 042107          158 FKALILEYMPHGSLGKCLST----SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD---------  224 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~---------  224 (232)
                      ..++||||+++|+|.+++..    ....+++..+..++.|++.||.|||    ..+|+||||||+|||++.         
T Consensus       141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH----~~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH----DCEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECGGGTCC----
T ss_pred             CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh----hCCeecCCCCHHHEEecccccCccccc
Confidence            99999999999999999974    2345899999999999999999999    889999999999999998         


Q ss_pred             --CCceeec
Q 042107          225 --NMVAHFL  231 (232)
Q Consensus       225 --~~~~~l~  231 (232)
                        ++.+||+
T Consensus       217 ~~~~~~kl~  225 (365)
T 3e7e_A          217 DLSAGLALI  225 (365)
T ss_dssp             --CTTEEEC
T ss_pred             cccCCEEEe
Confidence              8888885

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.95  E-value=5.6e-27  Score=198.15  Aligned_cols=137  Identities=28%  Similarity=0.425  Sum_probs=121.6

Q ss_pred             ccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCC-eeEEEEecc
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD-FKALILEYM  166 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~  166 (232)
                      +.+++.+.||+|+||.||+|++. ++.||||.+....  ..+.+.+|+.+++.++||||+++++++...+ ..++||||+
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~  269 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM  269 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred             HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence            45678899999999999999876 7799999986543  4577899999999999999999999987654 789999999


Q ss_pred             CCCChhhhhccCCC-CCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNY-ILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|+|.+++..... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivHrDlkp~Nill~~~~~~kl~  331 (450)
T 1k9a_A          270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSEDNVAKVS  331 (450)
T ss_dssp             TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTSCEEEC
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHhhEEECCCCCEEEe
Confidence            99999999986532 3688899999999999999999    8899999999999999999999986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.95  E-value=6.1e-27  Score=201.99  Aligned_cols=141  Identities=18%  Similarity=0.277  Sum_probs=125.2

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.|++.+.||+|+||.||+|+.. +++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            345788899999999999999765 79999999996542   23346678899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+++|+|.+++.... ..+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH----~~gIvHrDLKPeNILld~~g~vKL~  328 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH----RERIVYRDLKPENILLDDHGHIRIS  328 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCEeccCCchheEEEeCCCCeEEE
Confidence            99999999999887643 34899999999999999999999    8899999999999999999999986

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.94  E-value=2.1e-27  Score=200.51  Aligned_cols=140  Identities=22%  Similarity=0.284  Sum_probs=116.2

Q ss_pred             cccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecc---cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQ---YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.|++.+.||+|+||.||+|+. .+++.||+|.+...   .......+.+|+.+++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            45688999999999999999975 46899999999754   233345677899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST-HVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+++|+|.+++.... .+++..+..++.|++.||.|||    . .+|+||||||+|||++.++.+||+
T Consensus       227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~giiHrDlkp~NIll~~~~~~kl~  291 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH----SEKNVVYRDLKLENLMLDKDGHIKIT  291 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HHTCCCCCCCCGGGEEECSSSCEEEC
T ss_pred             EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh----hcCCEEECCCCHHHEEECCCCCEEEc
Confidence            99999999999887643 5889999999999999999999    6 789999999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.94  E-value=6.1e-27  Score=188.59  Aligned_cols=141  Identities=26%  Similarity=0.383  Sum_probs=123.3

Q ss_pred             cccceeeecccCCCcceeeeEEe------CCCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCee
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI------QDGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFK  159 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  159 (232)
                      .+.|.+.+.||+|+||.||+|+.      .++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            45678899999999999999974      245789999986543 23456788999999999999999999999999999


Q ss_pred             EEEEeccCCCChhhhhccCC-----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCC
Q 042107          160 ALILEYMPHGSLGKCLSTSN-----------------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLK  216 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk  216 (232)
                      ++||||+++++|.+++....                       ..+++..+..++.|++.||.|||    ..+|+|||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dik  177 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA----EMKLVHRDLA  177 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH----HTTEECCCCS
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH----HCCCcccccc
Confidence            99999999999999987542                       23788899999999999999999    8899999999


Q ss_pred             CCceeeCCCCceeec
Q 042107          217 SSNVLLDDNMVAHFL  231 (232)
Q Consensus       217 ~~Nill~~~~~~~l~  231 (232)
                      |+||+++.++.+||+
T Consensus       178 p~NIli~~~~~~kl~  192 (314)
T 2ivs_A          178 ARNILVAEGRKMKIS  192 (314)
T ss_dssp             GGGEEEETTTEEEEC
T ss_pred             hheEEEcCCCCEEEc
Confidence            999999999999885

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.94  E-value=9.4e-27  Score=198.46  Aligned_cols=145  Identities=21%  Similarity=0.323  Sum_probs=128.1

Q ss_pred             CCCcccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCC
Q 042107           82 IPRPFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD  157 (232)
Q Consensus        82 ~p~~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  157 (232)
                      .+..+.+.|++.+.||+|+||.||+|+.. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++...+
T Consensus        20 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   99 (484)
T 3nyv_A           20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG   99 (484)
T ss_dssp             CCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            34466778999999999999999999765 78999999996543   334677899999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceee---CCCCceeec
Q 042107          158 FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL---DDNMVAHFL  231 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill---~~~~~~~l~  231 (232)
                      ..++||||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||+   +.++.+||+
T Consensus       100 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~  171 (484)
T 3nyv_A          100 YFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH----KNKIVHRDLKPENLLLESKSKDANIRII  171 (484)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred             EEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHHHEEEecCCCCCcEEEE
Confidence            9999999999999999887653 5889999999999999999999    8899999999999999   466788875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.94  E-value=2e-26  Score=186.35  Aligned_cols=141  Identities=26%  Similarity=0.424  Sum_probs=122.7

Q ss_pred             cccccc-eeeecccCCCcceeeeEEeC-----CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEec--
Q 042107           85 PFRNFL-EVFNLISRGGFGSIYKARIQ-----DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSK--  155 (232)
Q Consensus        85 ~~~~~~-~~~~~lg~g~~g~V~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--  155 (232)
                      .+.+.| ++.+.||+|+||.||++.+.     +++.||+|++..... ...+.+.+|+++++.++||||+++++++..  
T Consensus        27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (318)
T 3lxp_A           27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG  106 (318)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence            344444 89999999999999888542     588999999975532 335678899999999999999999999987  


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          156 DDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       156 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ....++||||+++|+|.+++....  +++..+..++.|++.||.|||    ..+|+||||||+||+++.++.++|+
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH----~~~ivH~Dikp~Nil~~~~~~~kl~  176 (318)
T 3lxp_A          107 AASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH----AQHYIHRDLAARNVLLDNDRLVKIG  176 (318)
T ss_dssp             TTEEEEEECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             CceEEEEEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH----hCCccCCCCchheEEEcCCCCEEEC
Confidence            467899999999999999998653  889999999999999999999    8899999999999999999999885

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.94  E-value=5.5e-27  Score=194.28  Aligned_cols=142  Identities=28%  Similarity=0.407  Sum_probs=123.8

Q ss_pred             ccccceeeecccCCCcceeeeEEeC--------CCcEEEEEEeecccC-chHHHHHHHHHHhcCC-CCCCccceeEEEec
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ--------DGMEVVVKGFNLQYG-GAFKNLDVECNMMKII-RHQNLIKIISSCSK  155 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  155 (232)
                      ..+.|.+.+.||+|+||.||+|+..        .+..||+|++..... ...+.+.+|+++++.+ +||||+++++++..
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            3466889999999999999999742        235799999865432 3346788999999999 89999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCce
Q 042107          156 DDFKALILEYMPHGSLGKCLSTSN---------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNV  220 (232)
Q Consensus       156 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Ni  220 (232)
                      ++..++||||+++|+|.+++....               ..+++..+..++.|++.||.|||    ..+|+||||||+||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NI  222 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNV  222 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCcceE
Confidence            999999999999999999987542               34889999999999999999999    88999999999999


Q ss_pred             eeCCCCceeec
Q 042107          221 LLDDNMVAHFL  231 (232)
Q Consensus       221 ll~~~~~~~l~  231 (232)
                      |++.++.+||+
T Consensus       223 ll~~~~~~kL~  233 (382)
T 3tt0_A          223 LVTEDNVMKIA  233 (382)
T ss_dssp             EECTTCCEEEC
T ss_pred             EEcCCCcEEEc
Confidence            99999999985

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.94  E-value=1.1e-26  Score=199.55  Aligned_cols=141  Identities=21%  Similarity=0.342  Sum_probs=125.1

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.|.+.+.||+|+||.||+|+.. +++.||+|++....   ....+.+..|+.+++.++||||+++++++.+.+..|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            355778899999999999999865 69999999996542   23356788899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTS---NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||++||+|.+++...   ...+++..+..++.|++.||.|||    ..+|+||||||+|||++.+|.+||+
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH----~~gIvHrDLKP~NILl~~~g~vkL~  331 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH----QRNIIYRDLKPENVLLDDDGNVRIS  331 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH----HcCCcccCCChHHEEEeCCCCEEEe
Confidence            9999999999988653   235889999999999999999999    8899999999999999999999986

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.94  E-value=6.7e-27  Score=189.98  Aligned_cols=139  Identities=20%  Similarity=0.258  Sum_probs=122.5

Q ss_pred             ccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEEE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      +.+.|++.+.||+|+||.||+|+. .+++.||+|.+.....  .+.+..|+.+++.+ +||||+++++++..++..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            345688999999999999999975 5789999999865432  24577899999999 8999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCc-----eeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV-----AHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~-----~~l~  231 (232)
                      ||+ +++|.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.     +||+
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~iiHrDlkp~Nill~~~~~~~~~~~kl~  152 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH----SKNLIYRDVKPENFLIGRPGNKTQQVIHII  152 (330)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred             EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCCHHHeeeccCCCCCCceEEEE
Confidence            999 99999999865556999999999999999999999    889999999999999999887     8875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=6e-27  Score=191.14  Aligned_cols=141  Identities=27%  Similarity=0.402  Sum_probs=121.3

Q ss_pred             cccceeeecccCCCcceeeeEEe------CCCcEEEEEEeeccc-CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCe
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI------QDGMEVVVKGFNLQY-GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDF  158 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  158 (232)
                      .+.|++.+.||+|+||.||+|+.      .++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  123 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  123 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence            45678899999999999999975      245689999986542 33457788999999999 89999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCC----------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCC
Q 042107          159 KALILEYMPHGSLGKCLSTSNY----------------------ILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLK  216 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~~~----------------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk  216 (232)
                      .++||||+++|+|.+++.....                      .+++..+..++.|++.||.|||    ..+|+|||||
T Consensus       124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dik  199 (344)
T 1rjb_A          124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE----FKSCVHRDLA  199 (344)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH----HTTEEETTCS
T ss_pred             cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCC
Confidence            9999999999999999976532                      2688889999999999999999    8899999999


Q ss_pred             CCceeeCCCCceeec
Q 042107          217 SSNVLLDDNMVAHFL  231 (232)
Q Consensus       217 ~~Nill~~~~~~~l~  231 (232)
                      |+||+++.++.++|+
T Consensus       200 p~NIll~~~~~~kL~  214 (344)
T 1rjb_A          200 ARNVLVTHGKVVKIC  214 (344)
T ss_dssp             GGGEEEETTTEEEEC
T ss_pred             hhhEEEcCCCcEEeC
Confidence            999999999999886

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.94  E-value=1.3e-26  Score=187.69  Aligned_cols=142  Identities=23%  Similarity=0.360  Sum_probs=126.0

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCc------hHHHHHHHHHHhcCCCCCCccceeEEEecCC
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGG------AFKNLDVECNMMKIIRHQNLIKIISSCSKDD  157 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  157 (232)
                      .+.+.|++.+.||+|+||.||+|+.. +++.||+|.+......      ..+.+.+|+.+++.++||||+++++++...+
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   88 (321)
T 2a2a_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT   88 (321)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            45677899999999999999999765 6899999999765321      3577899999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC----ceeec
Q 042107          158 FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM----VAHFL  231 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~----~~~l~  231 (232)
                      ..++||||+++++|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++    .++|+
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH----~~~ivH~dikp~NIl~~~~~~~~~~~kl~  161 (321)
T 2a2a_A           89 DVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH----TKKIAHFDLKPENIMLLDKNIPIPHIKLI  161 (321)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred             EEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCChHHEEEecCCCCcCCEEEc
Confidence            9999999999999999997643 5888999999999999999999    88999999999999999887    67775

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.94  E-value=7.5e-27  Score=185.53  Aligned_cols=141  Identities=21%  Similarity=0.326  Sum_probs=122.0

Q ss_pred             ccccceeeecccCCCcceeeeEEeCC----CcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQD----GMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  160 (232)
                      ..+.|++.+.||+|+||.||+|+...    +..||+|.+..... ...+.+.+|+.+++.++||||+++++++. ++..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            34568899999999999999997642    45799998865432 33567889999999999999999999974 56789


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +||||+++++|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~  158 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLG  158 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecccccHHHEEECCCCCEEEC
Confidence            999999999999999876656899999999999999999999    8899999999999999999998885

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.94  E-value=2e-26  Score=197.33  Aligned_cols=143  Identities=20%  Similarity=0.319  Sum_probs=122.2

Q ss_pred             CcccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC-------------chHHHHHHHHHHhcCCCCCCccce
Q 042107           84 RPFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG-------------GAFKNLDVECNMMKIIRHQNLIKI  149 (232)
Q Consensus        84 ~~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~  149 (232)
                      ..+.+.|.+.+.||+|+||.||+|+.. +++.||+|.+.....             ...+.+.+|+.+++.++||||+++
T Consensus        32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~  111 (504)
T 3q5i_A           32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL  111 (504)
T ss_dssp             SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence            356677899999999999999999765 688999999865421             235678899999999999999999


Q ss_pred             eEEEecCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC---
Q 042107          150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM---  226 (232)
Q Consensus       150 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~---  226 (232)
                      ++++......++|||||++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++   
T Consensus       112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          112 FDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH----KHNIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESSTTCCS
T ss_pred             EEEEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeCCCcHHHEEEecCCCCc
Confidence            999999999999999999999999886543 4899999999999999999999    88999999999999999776   


Q ss_pred             ceeec
Q 042107          227 VAHFL  231 (232)
Q Consensus       227 ~~~l~  231 (232)
                      .+||+
T Consensus       187 ~~kl~  191 (504)
T 3q5i_A          187 NIKIV  191 (504)
T ss_dssp             SEEEC
T ss_pred             cEEEE
Confidence            46764

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.94  E-value=7.9e-27  Score=185.41  Aligned_cols=140  Identities=21%  Similarity=0.361  Sum_probs=119.9

Q ss_pred             CCcccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCe
Q 042107           83 PRPFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDF  158 (232)
Q Consensus        83 p~~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  158 (232)
                      +..+.+.|++.+.||+|+||.||+|+.. +++.||+|.+....  ......+.+|+..+..+ +||||+++++++..++.
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~   85 (289)
T 1x8b_A            6 KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH   85 (289)
T ss_dssp             CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE
T ss_pred             cccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence            3345667889999999999999999765 79999999987542  23456677899888888 89999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC
Q 042107          159 KALILEYMPHGSLGKCLSTS---NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM  226 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~  226 (232)
                      .++||||+++++|.+++...   ...+++..+..++.|++.||.|||    ..+|+||||||+||+++.++
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dikp~NIl~~~~~  152 (289)
T 1x8b_A           86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH----SMSLVHMDIKPSNIFISRTS  152 (289)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEC---
T ss_pred             EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH----hCCEeecCCCHHHEEEcCCC
Confidence            99999999999999998753   245889999999999999999999    88999999999999998554

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.94  E-value=1.2e-26  Score=189.57  Aligned_cols=142  Identities=20%  Similarity=0.292  Sum_probs=125.7

Q ss_pred             cccccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCch-----------------HHHHHHHHHHhcCCCCCCcc
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGA-----------------FKNLDVECNMMKIIRHQNLI  147 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv  147 (232)
                      .+.+.|++.+.||+|+||.||+|+. +++.||+|.+.......                 .+.+.+|+.+++.++||||+
T Consensus        28 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~  106 (348)
T 2pml_X           28 KYINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL  106 (348)
T ss_dssp             EEETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred             cccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence            3456788999999999999999988 89999999996542111                 17889999999999999999


Q ss_pred             ceeEEEecCCeeEEEEeccCCCChhhh------hccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeeCCCCCCc
Q 042107          148 KIISSCSKDDFKALILEYMPHGSLGKC------LSTS-NYILDFFQRLHIMIDVASAVEYLHFGHST-HVIIHCDLKSSN  219 (232)
Q Consensus       148 ~~~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~~iiHrdlk~~N  219 (232)
                      ++++++...+..++||||+++++|.++      +... ...+++..+..++.|++.||.|||    . .+++||||||+|
T Consensus       107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~~i~H~dl~p~N  182 (348)
T 2pml_X          107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH----NEKNICHRDVKPSN  182 (348)
T ss_dssp             CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH----HTSCEECCCCCGGG
T ss_pred             eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh----ccCCEeecCCChHh
Confidence            999999999999999999999999998      5542 446899999999999999999999    7 899999999999


Q ss_pred             eeeCCCCceeec
Q 042107          220 VLLDDNMVAHFL  231 (232)
Q Consensus       220 ill~~~~~~~l~  231 (232)
                      |+++.++.++|+
T Consensus       183 il~~~~~~~kl~  194 (348)
T 2pml_X          183 ILMDKNGRVKLS  194 (348)
T ss_dssp             EEECTTSCEEEC
T ss_pred             EEEcCCCcEEEe
Confidence            999999999886

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.94  E-value=1.8e-26  Score=183.79  Aligned_cols=143  Identities=20%  Similarity=0.340  Sum_probs=124.7

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.+.|.+.+.||+|+||.||+|+.. ++..+|+|.+.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus        19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   98 (285)
T 3is5_A           19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV   98 (285)
T ss_dssp             CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence            35667889999999999999999764 68899999997654 33467889999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceee---CCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTS---NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL---DDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill---~~~~~~~l~  231 (232)
                      |||+++|+|.+++...   ...+++..+..++.|++.||.|||    ..+|+||||||+||++   +.++.+||+
T Consensus        99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH----~~~ivH~dikp~NIl~~~~~~~~~~kl~  169 (285)
T 3is5_A           99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH----SQHVVHKDLKPENILFQDTSPHSPIKII  169 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEESSSSTTCCEEEC
T ss_pred             EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH----hCCEEECCCCHHHEEEecCCCCCCEEEE
Confidence            9999999999988542   345889999999999999999999    8899999999999999   445677774

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.94  E-value=2.5e-26  Score=181.78  Aligned_cols=141  Identities=22%  Similarity=0.306  Sum_probs=126.1

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      +.+.|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            3456789999999999999999765 68999999997553 344577889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+++++|.+++... ..+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        85 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~  147 (276)
T 2yex_A           85 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH----GIGITHRDIKPENLLLDERDNLKIS  147 (276)
T ss_dssp             ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH----hCCeeccCCChHHEEEccCCCEEEe
Confidence            999999999998764 35889999999999999999999    8899999999999999999998885

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.94  E-value=3e-27  Score=193.91  Aligned_cols=141  Identities=25%  Similarity=0.397  Sum_probs=121.0

Q ss_pred             cccceeeecccCCCcceeeeEEe------CCCcEEEEEEeecccC-chHHHHHHHHHHhcCC-CCCCccceeEEEecCC-
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI------QDGMEVVVKGFNLQYG-GAFKNLDVECNMMKII-RHQNLIKIISSCSKDD-  157 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~-  157 (232)
                      .+.|++.+.||+|+||.||+|++      .+++.||+|.+..... ...+.+.+|+.+++.+ +||||+++++++...+ 
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~  100 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  100 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence            45678999999999999999963      2467899999975432 2346688999999999 7899999999988754 


Q ss_pred             eeEEEEeccCCCChhhhhccCCC---------------------------------------------------------
Q 042107          158 FKALILEYMPHGSLGKCLSTSNY---------------------------------------------------------  180 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------  180 (232)
                      ..++||||+++|+|.+++.....                                                         
T Consensus       101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (359)
T 3vhe_A          101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  180 (359)
T ss_dssp             CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred             ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence            48999999999999999875421                                                         


Q ss_pred             --------CCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          181 --------ILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       181 --------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                              .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH----~~~ivH~Dikp~NIll~~~~~~kl~  235 (359)
T 3vhe_A          181 APEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSEKNVVKIC  235 (359)
T ss_dssp             ---CTTTTCBCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred             cccchhccccCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChhhEEEcCCCcEEEE
Confidence                    1788889999999999999999    8899999999999999999999885

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.94  E-value=2.2e-26  Score=186.62  Aligned_cols=149  Identities=30%  Similarity=0.498  Sum_probs=125.7

Q ss_pred             cCCCCCcccccceeeecccCCCcceeeeEEeC-CCcE--EEEEEeecc-cCchHHHHHHHHHHhcCC-CCCCccceeEEE
Q 042107           79 EGKIPRPFRNFLEVFNLISRGGFGSIYKARIQ-DGME--VVVKGFNLQ-YGGAFKNLDVECNMMKII-RHQNLIKIISSC  153 (232)
Q Consensus        79 ~g~~p~~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  153 (232)
                      +...|..-.+.|++.+.||+|+||.||+|+.. ++..  +|+|.+... .....+.+.+|+.+++.+ +||||+++++++
T Consensus        16 ~~~~p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~   95 (327)
T 1fvr_A           16 PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC   95 (327)
T ss_dssp             CCCSSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred             CcccccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence            34455555677889999999999999999754 5654  489988643 233446688899999999 899999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCC
Q 042107          154 SKDDFKALILEYMPHGSLGKCLSTSN---------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSS  218 (232)
Q Consensus       154 ~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~  218 (232)
                      ...+..++||||+++++|.+++....               ..+++..+..++.|++.||.|||    ..+|+||||||+
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~  171 (327)
T 1fvr_A           96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAAR  171 (327)
T ss_dssp             EETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGG
T ss_pred             eeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCccc
Confidence            99999999999999999999997643               35889999999999999999999    889999999999


Q ss_pred             ceeeCCCCceeec
Q 042107          219 NVLLDDNMVAHFL  231 (232)
Q Consensus       219 Nill~~~~~~~l~  231 (232)
                      ||+++.++.+||+
T Consensus       172 NIl~~~~~~~kL~  184 (327)
T 1fvr_A          172 NILVGENYVAKIA  184 (327)
T ss_dssp             GEEECGGGCEEEC
T ss_pred             eEEEcCCCeEEEc
Confidence            9999999999885

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.94  E-value=5.9e-27  Score=191.82  Aligned_cols=140  Identities=23%  Similarity=0.374  Sum_probs=123.0

Q ss_pred             cccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCc---hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGG---AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.|+..+.||+|+||.||+|+. .+++.||+|++......   ..+.+.+|+.+++.++||||+++++++..++..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            34578889999999999999975 57899999999754322   345688899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||++ |++.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~  196 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLG  196 (348)
T ss_dssp             EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEEETTTEEEEC
T ss_pred             EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEECCCCCEEEe
Confidence            99997 5888887654556899999999999999999999    8899999999999999999999986

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.94  E-value=1.7e-26  Score=185.91  Aligned_cols=139  Identities=24%  Similarity=0.322  Sum_probs=122.9

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCc--hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGG--AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      +.|++.+.||+|+||.||+|+.. +++.||+|++......  ..+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            45788999999999999999865 5899999988654322  24567789999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++++|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.++|+
T Consensus        83 ~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH----~~~ivH~dlkp~Nil~~~~~~~kl~  144 (311)
T 4agu_A           83 YCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCH----KHNCIHRDVKPENILITKHSVIKLC  144 (311)
T ss_dssp             CCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             eCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCChhhEEEcCCCCEEEe
Confidence            999999998876543 4889999999999999999999    8899999999999999999999885

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.94  E-value=5.3e-27  Score=198.40  Aligned_cols=139  Identities=24%  Similarity=0.385  Sum_probs=123.2

Q ss_pred             cccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      .+.+++.+.||+|+||.||+|++..+..||+|.+..... ..+.+.+|+.+++.++||||+++++++.. +..++||||+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            345778899999999999999988888899999875543 34778999999999999999999999866 6789999999


Q ss_pred             CCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|+|.+++... ...+++..+..++.|++.||.|||    .++|+||||||+|||++.++.+||+
T Consensus       261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~ivHrDlkp~Nill~~~~~~kl~  322 (452)
T 1fmk_A          261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVA  322 (452)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred             cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChhhEEECCCCCEEEC
Confidence            999999999753 234888999999999999999999    8899999999999999999999986

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.94  E-value=6e-27  Score=190.81  Aligned_cols=142  Identities=23%  Similarity=0.357  Sum_probs=124.4

Q ss_pred             cccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC--------chHHHHHHHHHHhcCCCCCCccceeEEEec
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG--------GAFKNLDVECNMMKIIRHQNLIKIISSCSK  155 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  155 (232)
                      .+.+.|++.+.||+|+||.||+|+. .+++.||+|.+.....        ...+.+.+|+.+++.++||||+++++++..
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            4556788999999999999999975 4788999999976531        123456779999999999999999999999


Q ss_pred             CCeeEEEEeccCCC-ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          156 DDFKALILEYMPHG-SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       156 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .+..++||||+.+| +|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kL~  172 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR----LKDIIHRDIKDENIVIAEDFTIKLI  172 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEEC
T ss_pred             CCEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEEeccCHHHEEEcCCCcEEEe
Confidence            99999999999777 9999987654 4899999999999999999999    8899999999999999999999885

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.94  E-value=5.1e-27  Score=189.29  Aligned_cols=142  Identities=19%  Similarity=0.208  Sum_probs=119.7

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCch--HHHHHHHHHHhcC-CCCCCccceeEEEecCCeeE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGA--FKNLDVECNMMKI-IRHQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~  160 (232)
                      .+.+.|++.+.||+|+||.||+|+.. +++.||||++.......  ......|+..+.. .+||||+++++++..++..+
T Consensus        54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~  133 (311)
T 3p1a_A           54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY  133 (311)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence            45567889999999999999999875 79999999886543222  2333445544444 48999999999999999999


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +||||+ +++|.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIll~~~~~~kl~  199 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH----SQGLVHLDVKPANIFLGPRGRCKLG  199 (311)
T ss_dssp             EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECGGGCEEEC
T ss_pred             EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEecCCCCHHHEEECCCCCEEEc
Confidence            999999 66999988766666999999999999999999999    7899999999999999999999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.94  E-value=2.2e-26  Score=184.26  Aligned_cols=142  Identities=27%  Similarity=0.387  Sum_probs=117.5

Q ss_pred             CcccccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcC--CCCCCccceeEEEec----CC
Q 042107           84 RPFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKI--IRHQNLIKIISSCSK----DD  157 (232)
Q Consensus        84 ~~~~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~----~~  157 (232)
                      +.+.+.|++.+.||+|+||.||+|+. +++.||+|++....   .+.+..|.+++..  ++||||+++++++..    ..
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSST   79 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence            45667789999999999999999987 58899999986542   3444555555554  899999999998654    34


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC----CCCCeeeCCCCCCceeeCCCCceeec
Q 042107          158 FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH----STHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~----~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ..++||||+++|+|.++++..  .+++..+..++.|++.||.|||...    ...+|+||||||+|||++.++.+||+
T Consensus        80 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             eeEEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence            689999999999999999654  5899999999999999999999321    14589999999999999999999985

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.94  E-value=1.3e-26  Score=192.95  Aligned_cols=142  Identities=23%  Similarity=0.350  Sum_probs=123.2

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCC--eeEE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD--FKAL  161 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~l  161 (232)
                      +.+.|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+  ..++
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            4567889999999999999999765 58999999996543 234567788999999999999999999988754  7799


Q ss_pred             EEeccCCCChhhhhccCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceee----CCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSN--YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL----DDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill----~~~~~~~l~  231 (232)
                      ||||+++|+|.+++....  ..+++..+..++.|++.||.|||    ..+|+||||||+|||+    +.++.+||+
T Consensus        87 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~kL~  158 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR----ENGIVHRNIKPGNIMRVIGEDGQSVYKLT  158 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred             EEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH----HCCEEECCcCHHHEEEeecCCCceeEEEe
Confidence            999999999999997642  23889999999999999999999    8899999999999999    777778875

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.94  E-value=8.8e-27  Score=193.37  Aligned_cols=144  Identities=20%  Similarity=0.378  Sum_probs=115.0

Q ss_pred             CCCCcccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCC-CCCccceeEEEecC
Q 042107           81 KIPRPFRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIR-HQNLIKIISSCSKD  156 (232)
Q Consensus        81 ~~p~~~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~  156 (232)
                      .+...+.+.|++.+.||+|+||.||+|.. .+++.||+|++....  ....+.+.+|+.+++.+. ||||+++++++..+
T Consensus         2 ~v~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~   81 (388)
T 3oz6_A            2 RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD   81 (388)
T ss_dssp             --CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT
T ss_pred             CccCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC
Confidence            44455667789999999999999999975 478999999985432  234566778999999997 99999999999765


Q ss_pred             C--eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          157 D--FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       157 ~--~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +  ..|+|||||+ ++|.+++...  .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        82 ~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH----~~~ivHrDlkp~NIll~~~~~~kl~  151 (388)
T 3oz6_A           82 NDRDVYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH----SGGLLHRDMKPSNILLNAECHVKVA  151 (388)
T ss_dssp             TSSCEEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             CCCEEEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH----hCCEEeCCCCHHHeEEcCCCCEEec
Confidence            4  6899999997 5899988764  4888899999999999999999    8899999999999999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.94  E-value=1.3e-26  Score=188.57  Aligned_cols=141  Identities=28%  Similarity=0.461  Sum_probs=122.1

Q ss_pred             cccceeeecccCCCcceeeeEEeC--------CCcEEEEEEeecccC-chHHHHHHHHHHhcCC-CCCCccceeEEEecC
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ--------DGMEVVVKGFNLQYG-GAFKNLDVECNMMKII-RHQNLIKIISSCSKD  156 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  156 (232)
                      .+.|++.+.||+|+||.||+|+..        ++..||+|.+..... ...+.+.+|+.+++.+ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            456788999999999999999752        467899999865432 3456788899999999 899999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCcee
Q 042107          157 DFKALILEYMPHGSLGKCLSTSN---------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVL  221 (232)
Q Consensus       157 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nil  221 (232)
                      +..++||||+++|+|.+++....               ..+++..+..++.|++.||.|||    ..+|+||||||+||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIl  189 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA----SQKCIHRDLAARNVL  189 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCccceEE
Confidence            99999999999999999997643               23788899999999999999999    889999999999999


Q ss_pred             eCCCCceeec
Q 042107          222 LDDNMVAHFL  231 (232)
Q Consensus       222 l~~~~~~~l~  231 (232)
                      ++.++.+||+
T Consensus       190 l~~~~~~kL~  199 (334)
T 2pvf_A          190 VTENNVMKIA  199 (334)
T ss_dssp             ECTTCCEEEC
T ss_pred             EcCCCCEEEc
Confidence            9999999885

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.94  E-value=7.5e-27  Score=197.76  Aligned_cols=140  Identities=20%  Similarity=0.322  Sum_probs=112.7

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecC-----C
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKD-----D  157 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~  157 (232)
                      +.+.|++.+.||+|+||.||+|+.. +++.||+|++.....  ...+.+.+|+.+++.++||||+++++++...     .
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            4467889999999999999999754 789999999865432  2456788999999999999999999998443     5


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          158 FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ..|+||||+ +++|.+++... ..+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH----~~~iiHrDlKp~NILl~~~~~~kl~  198 (458)
T 3rp9_A          131 ELYVVLEIA-DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVH----SAGILHRDLKPANCLVNQDCSVKVC  198 (458)
T ss_dssp             CEEEEECCC-SEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTCCEEEC
T ss_pred             eEEEEEecc-ccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHH----hCCcCCCCCChhhEEECCCCCEeec
Confidence            689999998 46999988764 35899999999999999999999    8899999999999999999999986

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.94  E-value=2.6e-26  Score=182.13  Aligned_cols=141  Identities=24%  Similarity=0.355  Sum_probs=124.1

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      ..+.|++.+.||+|+||.||+|+.. ++..||+|.+....   ......+.+|+.+++.++||||+++++++...+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3456789999999999999999765 57899999986542   2234668889999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||+++++|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.++|+
T Consensus        87 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH----~~~i~H~dlkp~Nili~~~~~~~l~  151 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIA  151 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TTTCEECCCCGGGEEECTTSCEEEC
T ss_pred             EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCEecccCChHhEEEcCCCCEEEE
Confidence            999999999999887543 4888999999999999999999    8899999999999999999999885

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.94  E-value=2.4e-26  Score=196.45  Aligned_cols=142  Identities=22%  Similarity=0.328  Sum_probs=119.9

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      .+.+.|++.+.||+|+||.||+|+.. ++..||+|++....  ......+.+|+.+++.++||||+++++++...+..++
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  113 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL  113 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            45567899999999999999999765 68899999987543  3345778899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC---Cceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN---MVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~---~~~~l~  231 (232)
                      |||||++|+|.+.+.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++..   +.+||+
T Consensus       114 v~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~  181 (494)
T 3lij_A          114 VMECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH----KHNIVHRDLKPENLLLESKEKDALIKIV  181 (494)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceeccCChhhEEEeCCCCCCcEEEE
Confidence            999999999998886543 4888999999999999999999    8899999999999999764   447764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=1.5e-26  Score=188.19  Aligned_cols=141  Identities=25%  Similarity=0.411  Sum_probs=123.6

Q ss_pred             cccceeeecccCCCcceeeeEEeCC-----CcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQD-----GMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  160 (232)
                      ...|.+.+.||+|+||.||+|+...     +..||+|.+..... .....+.+|+.+++.++||||+++++++...+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            4456788999999999999997542     34699999865432 23456888999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +||||+++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus       123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~  189 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA----NMNYVHRDLAARNILVNSNLVCKVS  189 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred             EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCChheEEECCCCcEEEC
Confidence            999999999999999876566899999999999999999999    8899999999999999999999885

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.94  E-value=8.3e-27  Score=188.73  Aligned_cols=141  Identities=26%  Similarity=0.444  Sum_probs=115.0

Q ss_pred             cccceeeecccCCCcceeeeEEeCC-C---cEEEEEEeecc--cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCee-
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQD-G---MEVVVKGFNLQ--YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFK-  159 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-  159 (232)
                      .+.|++.+.||+|+||.||+|+... +   ..||+|.+...  .....+.+.+|+.+++.++||||+++++++...... 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            3457889999999999999997653 3   27999998654  334567789999999999999999999999876654 


Q ss_pred             -----EEEEeccCCCChhhhhccC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCcee
Q 042107          160 -----ALILEYMPHGSLGKCLSTS-----NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAH  229 (232)
Q Consensus       160 -----~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~  229 (232)
                           ++||||+++|+|.+++...     ...+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+|
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH----~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS----SRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTSCEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH----cCCcccCCCCcceEEEcCCCCEE
Confidence                 8999999999999988542     224888999999999999999999    88999999999999999999998


Q ss_pred             ec
Q 042107          230 FL  231 (232)
Q Consensus       230 l~  231 (232)
                      |+
T Consensus       178 l~  179 (323)
T 3qup_A          178 VA  179 (323)
T ss_dssp             EC
T ss_pred             Ee
Confidence            85

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.94  E-value=8.6e-27  Score=187.63  Aligned_cols=141  Identities=25%  Similarity=0.360  Sum_probs=123.8

Q ss_pred             cccceeeecccCCCcceeeeEEe------CCCcEEEEEEeecccC-chHHHHHHHHHHhcCC-CCCCccceeEEEecCCe
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI------QDGMEVVVKGFNLQYG-GAFKNLDVECNMMKII-RHQNLIKIISSCSKDDF  158 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  158 (232)
                      .+.|++.+.||+|+||.||+|+.      .+++.||+|.+..... ...+.+.+|+.+++.+ +||||+++++++..++.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            35678899999999999999974      3467899999975533 2356788999999999 89999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCC-----------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCcee
Q 042107          159 KALILEYMPHGSLGKCLSTSNY-----------------ILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVL  221 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nil  221 (232)
                      .++||||+++|+|.+++.....                 .+++..+..++.|++.||.|||    ..+|+||||||+||+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil  177 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNIL  177 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCccceEE
Confidence            9999999999999999875432                 3788999999999999999999    889999999999999


Q ss_pred             eCCCCceeec
Q 042107          222 LDDNMVAHFL  231 (232)
Q Consensus       222 l~~~~~~~l~  231 (232)
                      ++.++.+||+
T Consensus       178 ~~~~~~~kl~  187 (313)
T 1t46_A          178 LTHGRITKIC  187 (313)
T ss_dssp             EETTTEEEEC
T ss_pred             EcCCCCEEEc
Confidence            9999999885

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.94  E-value=2.8e-26  Score=184.49  Aligned_cols=147  Identities=22%  Similarity=0.364  Sum_probs=117.5

Q ss_pred             CCCCCcccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC-----chHHHHHHHHHHhcCCC---CCCcccee
Q 042107           80 GKIPRPFRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG-----GAFKNLDVECNMMKIIR---HQNLIKII  150 (232)
Q Consensus        80 g~~p~~~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~---h~niv~~~  150 (232)
                      |.+...+.+.|++.+.||+|+||.||+|+. .+++.||+|.+.....     .....+.+|+.+++.++   ||||++++
T Consensus         1 Gp~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~   80 (308)
T 3g33_A            1 GPLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLM   80 (308)
T ss_dssp             ---------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred             CCCCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEee
Confidence            344556677899999999999999999975 5789999999865431     12345667887777664   99999999


Q ss_pred             EEEecCC-----eeEEEEeccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC
Q 042107          151 SSCSKDD-----FKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD  224 (232)
Q Consensus       151 ~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~  224 (232)
                      +++....     ..+++|||++ ++|.+++.... ..+++..+..++.|++.||.|||    ..+|+||||||+||+++.
T Consensus        81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~Nil~~~  155 (308)
T 3g33_A           81 DVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH----ANCIVHRDLKPENILVTS  155 (308)
T ss_dssp             EEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCTTTEEECT
T ss_pred             eeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEcC
Confidence            9987755     5799999997 59999987653 33899999999999999999999    889999999999999999


Q ss_pred             CCceeec
Q 042107          225 NMVAHFL  231 (232)
Q Consensus       225 ~~~~~l~  231 (232)
                      ++.+||+
T Consensus       156 ~~~~kl~  162 (308)
T 3g33_A          156 GGTVKLA  162 (308)
T ss_dssp             TSCEEEC
T ss_pred             CCCEEEe
Confidence            9999985

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.94  E-value=1.1e-26  Score=185.89  Aligned_cols=141  Identities=20%  Similarity=0.330  Sum_probs=122.9

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEec---------
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSK---------  155 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---------  155 (232)
                      +.+.|++.+.||+|+||.||+|+.. +++.||+|.+.... ...+.+.+|+.+++.++||||+++++++..         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            3456788999999999999999864 78999999986432 345678889999999999999999998754         


Q ss_pred             ----CCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          156 ----DDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       156 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                          .+..++||||+++|+|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH----SQGIIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH----hCCeecccCCHHhEEEcCCCCEEEe
Confidence                34679999999999999999866556788889999999999999999    8899999999999999999999885

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.94  E-value=1.1e-26  Score=189.59  Aligned_cols=143  Identities=22%  Similarity=0.318  Sum_probs=121.1

Q ss_pred             cccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecc-----cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCe
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQ-----YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF  158 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  158 (232)
                      .+.+.|++.+.||+|+||.||+|+. .+++.||+|.+...     .....+.+.+|+.+++.++||||+++++++...+.
T Consensus        23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  102 (345)
T 3hko_A           23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY  102 (345)
T ss_dssp             HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence            3456688999999999999999976 46889999998654     23456788999999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccC---------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 042107          159 KALILEYMPHGSLGKCLSTS---------------------------------------NYILDFFQRLHIMIDVASAVE  199 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~~~~~~~~~i~~~i~~~l~  199 (232)
                      .++||||+++|+|.+++...                                       ...+++..+..++.|++.||.
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  182 (345)
T 3hko_A          103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH  182 (345)
T ss_dssp             EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence            99999999999999988521                                       111345667889999999999


Q ss_pred             HHhcCCCCCCeeeCCCCCCceeeCCCC--ceeec
Q 042107          200 YLHFGHSTHVIIHCDLKSSNVLLDDNM--VAHFL  231 (232)
Q Consensus       200 ~lH~~~~~~~iiHrdlk~~Nill~~~~--~~~l~  231 (232)
                      |||    ..+|+||||||+||+++.++  .+||+
T Consensus       183 ~LH----~~~ivH~Dlkp~NIll~~~~~~~~kl~  212 (345)
T 3hko_A          183 YLH----NQGICHRDIKPENFLFSTNKSFEIKLV  212 (345)
T ss_dssp             HHH----HTTEECCCCCGGGEEESCSSSCCEEEC
T ss_pred             HHH----HCCccccCCChhhEEEecCCCceEEEe
Confidence            999    88999999999999998776  77775

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=1e-26  Score=192.04  Aligned_cols=139  Identities=23%  Similarity=0.427  Sum_probs=120.3

Q ss_pred             cceeeecccCCCcceeeeEEeC--C--CcEEEEEEeecc-cCchHHHHHHHHHHhcCCCCCCccceeEEEec-CCeeEEE
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ--D--GMEVVVKGFNLQ-YGGAFKNLDVECNMMKIIRHQNLIKIISSCSK-DDFKALI  162 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~--~--~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv  162 (232)
                      .|++.+.||+|+||.||+|+..  +  +..||+|.+... .....+.+.+|+.+++.++||||+++++++.. ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4667889999999999999753  2  246899988643 23456778999999999999999999998654 5678999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~~~~~kL~  234 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA----SKKFVHRDLAARNCMLDEKFTVKVA  234 (373)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred             EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH----HCCEecCccchheEEECCCCCEEEe
Confidence            9999999999999876666888899999999999999999    8899999999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.94  E-value=3.6e-26  Score=184.19  Aligned_cols=141  Identities=24%  Similarity=0.351  Sum_probs=120.5

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      ...+.|++.+.||+|+||.||+|... +++.||+|.+....  ..+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34566889999999999999999765 58999999987543  3467889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+++++|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus       104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~  167 (314)
T 3com_A          104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH----FMRKIHRDIKAGNILLNTEGHAKLA  167 (314)
T ss_dssp             ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCCcCCCcCHHHEEECCCCCEEEe
Confidence            999999999998754456899999999999999999999    8899999999999999999999885

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.94  E-value=1.7e-26  Score=183.19  Aligned_cols=139  Identities=24%  Similarity=0.419  Sum_probs=122.5

Q ss_pred             cccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      .+.|++.+.||+|+||.||+|+..++..||+|.+.... ...+.+.+|+++++.++||||+++++++. .+..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence            35678899999999999999998888899999986543 23577889999999999999999999886 45689999999


Q ss_pred             CCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++.... ..+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~  151 (279)
T 1qpc_A           90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE----ERNYIHRDLRAANILVSDTLSCKIA  151 (279)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEEC
T ss_pred             CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHhhEEEcCCCCEEEC
Confidence            9999999997542 24888999999999999999999    8899999999999999999999885

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.94  E-value=2e-26  Score=187.02  Aligned_cols=130  Identities=22%  Similarity=0.275  Sum_probs=114.7

Q ss_pred             ecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCC-CCCccceeEEEecCCeeEEEEeccCCCCh
Q 042107           94 NLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-HQNLIKIISSCSKDDFKALILEYMPHGSL  171 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L  171 (232)
                      +.||+|+||.||+|+.. +++.||+|.+...   ....+.+|+.+++.+. ||||+++++++.++...++||||+++|+|
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L   93 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL   93 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence            67999999999999764 6899999999654   3456778999999997 99999999999999999999999999999


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC---ceeec
Q 042107          172 GKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM---VAHFL  231 (232)
Q Consensus       172 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~---~~~l~  231 (232)
                      .+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++   .+||+
T Consensus        94 ~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~kl~  151 (325)
T 3kn6_A           94 FERIKKKK-HFSETEASYIMRKLVSAVSHMH----DVGVVHRDLKPENLLFTDENDNLEIKII  151 (325)
T ss_dssp             HHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEEC----CEEEEC
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCCeecCCCHHHEEEecCCCcccEEEe
Confidence            99998653 5899999999999999999999    88999999999999997765   67764

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=6e-27  Score=192.27  Aligned_cols=147  Identities=21%  Similarity=0.267  Sum_probs=125.3

Q ss_pred             CCCCCcccccceeeecccCCCcceeeeEEe----CCCcEEEEEEeeccc----CchHHHHHHHHHHhcCC-CCCCcccee
Q 042107           80 GKIPRPFRNFLEVFNLISRGGFGSIYKARI----QDGMEVVVKGFNLQY----GGAFKNLDVECNMMKII-RHQNLIKII  150 (232)
Q Consensus        80 g~~p~~~~~~~~~~~~lg~g~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~  150 (232)
                      +.....-.+.|++.+.||+|+||.||+|+.    .+++.||+|++....    ....+.+.+|+.+++.+ +||||++++
T Consensus        46 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~  125 (355)
T 1vzo_A           46 GHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH  125 (355)
T ss_dssp             SCCCCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEE
T ss_pred             cccccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEE
Confidence            333334446788999999999999999976    368999999985432    22335566789999998 699999999


Q ss_pred             EEEecCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceee
Q 042107          151 SSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHF  230 (232)
Q Consensus       151 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l  230 (232)
                      +++..++..++||||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||
T Consensus       126 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~~kl  200 (355)
T 1vzo_A          126 YAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVL  200 (355)
T ss_dssp             EEEEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred             EEEeeCceEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEECCCCcEEE
Confidence            99999999999999999999999987643 4888999999999999999999    889999999999999999999998


Q ss_pred             c
Q 042107          231 L  231 (232)
Q Consensus       231 ~  231 (232)
                      +
T Consensus       201 ~  201 (355)
T 1vzo_A          201 T  201 (355)
T ss_dssp             S
T ss_pred             e
Confidence            5

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.94  E-value=3.4e-26  Score=182.77  Aligned_cols=141  Identities=18%  Similarity=0.230  Sum_probs=124.8

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      ..+.|.+.+.||+|+||.||+++.. +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++..++..++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            3456789999999999999999765 58889999987653   2235678889999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||+++++|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        93 v~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~  157 (294)
T 2rku_A           93 VLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH----RNRVIHRDLKLGNLFLNEDLEVKIG  157 (294)
T ss_dssp             EEECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChHhEEEcCCCCEEEE
Confidence            999999999999887543 5889999999999999999999    8899999999999999999999885

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.94  E-value=2.1e-26  Score=189.15  Aligned_cols=143  Identities=18%  Similarity=0.229  Sum_probs=126.5

Q ss_pred             CcccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           84 RPFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        84 ~~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      ....+.|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++
T Consensus        29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  108 (360)
T 3eqc_A           29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI  108 (360)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence            345567889999999999999999765 68999999987653 2335678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-CeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH-VIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||+++++|.+++.... .+++..+..++.|++.||.|||    .. +|+||||||+||+++.++.++|+
T Consensus       109 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh----~~~~i~H~dlkp~Nil~~~~~~~kl~  174 (360)
T 3eqc_A          109 CMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLC  174 (360)
T ss_dssp             EECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HHHCCCCSCCSGGGEEECTTCCEEEC
T ss_pred             EEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HhCCEEcCCccHHHEEECCCCCEEEE
Confidence            999999999999997643 4888999999999999999999    64 89999999999999999999885

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.94  E-value=6.1e-27  Score=189.86  Aligned_cols=139  Identities=18%  Similarity=0.341  Sum_probs=119.7

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCc-hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      +.|.+.+.||+|+||.||+|+.. +++.||+|.+...... ....+.+|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            34788899999999999999765 7899999998644321 112345699999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++ |+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~  142 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH----RQKVLHRDLKPQNLLINERGELKLA  142 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEEESSCCGGGEEECTTCCEEEC
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCcCHHHEEECCCCCEEEc
Confidence            97 4899988876667899999999999999999999    8899999999999999999999885

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.94  E-value=1.6e-26  Score=184.89  Aligned_cols=141  Identities=23%  Similarity=0.416  Sum_probs=120.7

Q ss_pred             cccceeeecccCCCcceeeeEEeCC----CcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEe-cCCeeE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQD----GMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCS-KDDFKA  160 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~  160 (232)
                      ...|++.+.||+|+||.||+|+..+    ...+|+|.+.... ....+.+.+|+.+++.++||||+++++++. .++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3457788999999999999997542    2358899886533 234567889999999999999999999864 456789


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +||||+++|+|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~kl~  170 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA----SKKFVHRDLAARNCMLDEKFTVKVA  170 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEEC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCchheEEECCCCCEEEC
Confidence            999999999999999876666889999999999999999999    8899999999999999999999885

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.94  E-value=3.3e-26  Score=181.85  Aligned_cols=142  Identities=20%  Similarity=0.384  Sum_probs=124.2

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      .+.+.|++.+.||+|+||.||+|... +++.||+|.+.....  ...+.+.+|+.+++.++||||+++++++..++..++
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   82 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence            45677899999999999999999764 688999999976532  234678889999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCc---eeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV---AHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~---~~l~  231 (232)
                      ||||+++++|.+.+.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.   +||+
T Consensus        83 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~~~~kl~  150 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH----SNGIVHRNLKPENLLLASKAKGAAVKLA  150 (284)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred             EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcCcCCCCHHHEEEecCCCCCcEEEe
Confidence            999999999988886543 4889999999999999999999    889999999999999987655   7764

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.94  E-value=3.2e-26  Score=186.42  Aligned_cols=140  Identities=18%  Similarity=0.238  Sum_probs=124.5

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.|.+.+.||+|+||.||+++.. +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            456789999999999999999765 57899999987553   23456788899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+++++|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus       120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIl~~~~~~~kl~  183 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH----RNRVIHRDLKLGNLFLNEDLEVKIG  183 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEEC
T ss_pred             EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCCEecCCCchhEEEcCCCCEEEe
Confidence            99999999999887543 5889999999999999999999    8899999999999999999999885

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.94  E-value=3.4e-26  Score=181.65  Aligned_cols=141  Identities=25%  Similarity=0.340  Sum_probs=124.2

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC------chHHHHHHHHHHhcCCCCCCccceeEEEecCCe
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG------GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF  158 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  158 (232)
                      +.+.|++.+.||+|+||.||+|+.. +++.||+|.+.....      ...+.+.+|+.+++.++||||+++++++..++.
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD   82 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence            3456889999999999999999865 689999999865432      135778999999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC----ceeec
Q 042107          159 KALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM----VAHFL  231 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~----~~~l~  231 (232)
                      .++||||+++++|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+||+++.++    .++|+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~~~~kl~  154 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH----SKRIAHFDLKPENIMLLDKNVPNPRIKLI  154 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred             EEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCChHHEEEecCCCCCCceEEE
Confidence            999999999999999987533 5889999999999999999999    88999999999999999877    67764

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.94  E-value=2.3e-26  Score=201.05  Aligned_cols=132  Identities=20%  Similarity=0.333  Sum_probs=118.2

Q ss_pred             cccCCCcceeeeEEeC---CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCC
Q 042107           95 LISRGGFGSIYKARIQ---DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGS  170 (232)
Q Consensus        95 ~lg~g~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  170 (232)
                      .||+|+||.||+|.++   ++..||||.+.... ....+.+.+|+.+++.++||||+++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            7999999999999753   46679999997543 3456789999999999999999999999976 56899999999999


Q ss_pred             hhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          171 LGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       171 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~iiHrDlkp~NILl~~~~~vkL~  478 (613)
T 2ozo_A          422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE----EKNFVHRNLAARNVLLVNRHYAKIS  478 (613)
T ss_dssp             HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred             HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCEEcCcCCHHHEEEcCCCcEEEe
Confidence            99999876667899999999999999999999    8899999999999999999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.94  E-value=1.7e-26  Score=186.73  Aligned_cols=143  Identities=17%  Similarity=0.309  Sum_probs=123.6

Q ss_pred             cccccceeeecccCCCcceeeeEEeC------CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCC
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ------DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDD  157 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  157 (232)
                      ...+.|++.+.||+|+||.||+|+..      +++.||+|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  101 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ  101 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC
Confidence            34566889999999999999999653      367899999865432 23456888999999999999999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCC---------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCce
Q 042107          158 FKALILEYMPHGSLGKCLSTSN---------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA  228 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~  228 (232)
                      ..++||||+++|+|.+++....         ..+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+
T Consensus       102 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dikp~NIli~~~~~~  177 (322)
T 1p4o_A          102 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTV  177 (322)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCSGGGEEECTTCCE
T ss_pred             ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH----HCCCccCCCccceEEEcCCCeE
Confidence            9999999999999999986421         34688899999999999999999    8899999999999999999999


Q ss_pred             eec
Q 042107          229 HFL  231 (232)
Q Consensus       229 ~l~  231 (232)
                      ||+
T Consensus       178 kl~  180 (322)
T 1p4o_A          178 KIG  180 (322)
T ss_dssp             EEC
T ss_pred             EEC
Confidence            885

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=2.5e-26  Score=183.00  Aligned_cols=137  Identities=20%  Similarity=0.338  Sum_probs=119.7

Q ss_pred             ceeee-cccCCCcceeeeEEeC---CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           90 LEVFN-LISRGGFGSIYKARIQ---DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        90 ~~~~~-~lg~g~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      +.+.+ .||+|+||.||+|...   ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++. .+..++|||
T Consensus        11 ~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e   89 (287)
T 1u59_A           11 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVME   89 (287)
T ss_dssp             EEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEE
T ss_pred             hhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEEEE
Confidence            44555 8999999999999753   57789999997643 234577889999999999999999999994 556899999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++++|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~kl~  152 (287)
T 1u59_A           90 MAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE----EKNFVHRDLAARNVLLVNRHYAKIS  152 (287)
T ss_dssp             CCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEEETTEEEEC
T ss_pred             eCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH----HCCEeeCCCchheEEEcCCCCEEEC
Confidence            99999999999766666899999999999999999999    8899999999999999999998875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.94  E-value=8e-27  Score=201.11  Aligned_cols=139  Identities=24%  Similarity=0.385  Sum_probs=123.3

Q ss_pred             cccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      .+.+++.+.||+|+||.||+|++..+..||||.+..... ..+.+.+|+.+++.++||||+++++++.. +..++||||+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            345778899999999999999988888899999976543 34778999999999999999999999866 6789999999


Q ss_pred             CCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|+|.+++... ...+++..+..++.|++.||.|||    .++|+||||||+|||++.++.+||+
T Consensus       344 ~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~ivHrDlkp~NIll~~~~~~kl~  405 (535)
T 2h8h_A          344 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVA  405 (535)
T ss_dssp             TTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred             cCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCCCHhhEEEcCCCcEEEc
Confidence            999999999753 234888999999999999999999    8899999999999999999999986

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.94  E-value=1.8e-26  Score=187.31  Aligned_cols=140  Identities=21%  Similarity=0.349  Sum_probs=116.8

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcE----EEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGME----VVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  160 (232)
                      .+.|++.+.||+|+||.||+|+.. +++.    ||+|.+.... ....+.+.+|+.+++.++||||+++++++..+. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            345788999999999999999754 4443    5777774332 334577889999999999999999999998755 77


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++||+++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~Dikp~NIll~~~~~~kl~  159 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----DRRLVHRDLAARNVLVKTPQHVKIT  159 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEETTEEEEC
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCChheEEECCCCCEEEc
Confidence            999999999999999876667899999999999999999999    8899999999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.94  E-value=1.9e-26  Score=194.03  Aligned_cols=140  Identities=23%  Similarity=0.313  Sum_probs=122.5

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecC-----C
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKD-----D  157 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~  157 (232)
                      +.+.|++.+.||+|+||.||+|+.. +++.||+|++.....  ...+.+.+|+.+++.++||||+++++++...     +
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            4567889999999999999999764 688999999965432  2356788999999999999999999998766     5


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          158 FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ..|+||||++ ++|.+++... ..+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH----~~givHrDlkp~NILl~~~~~~kL~  171 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIH----ESGIIHRDLKPANCLLNQDCSVKVC  171 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             eEEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH----HCCCCCCCCCHHHeEECCCCCEEEc
Confidence            6899999996 5999999764 35899999999999999999999    8899999999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.94  E-value=1.5e-26  Score=193.89  Aligned_cols=143  Identities=24%  Similarity=0.278  Sum_probs=120.2

Q ss_pred             CCcccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC--------chHHHHHHHHHHhcCCCCCCccceeEEE
Q 042107           83 PRPFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG--------GAFKNLDVECNMMKIIRHQNLIKIISSC  153 (232)
Q Consensus        83 p~~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~  153 (232)
                      |..+.+.|.+.+.||+|+||.||+|... +++.||+|.+.....        .....+.+|+.+++.++||||+++++++
T Consensus       130 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~  209 (419)
T 3i6u_A          130 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF  209 (419)
T ss_dssp             CHHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred             chhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            4456778899999999999999999754 689999999975421        1123477899999999999999999998


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC---ceee
Q 042107          154 SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM---VAHF  230 (232)
Q Consensus       154 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~---~~~l  230 (232)
                      .. +..++||||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++   .+||
T Consensus       210 ~~-~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH----~~~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          210 DA-EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             ES-SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             ec-CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChHhEEEecCCCcceEEE
Confidence            64 45789999999999999887653 5899999999999999999999    88999999999999997544   4777


Q ss_pred             c
Q 042107          231 L  231 (232)
Q Consensus       231 ~  231 (232)
                      +
T Consensus       284 ~  284 (419)
T 3i6u_A          284 T  284 (419)
T ss_dssp             C
T ss_pred             e
Confidence            5

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.94  E-value=2.1e-26  Score=184.91  Aligned_cols=142  Identities=20%  Similarity=0.318  Sum_probs=122.5

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      .+.+.|.+.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            34566889999999999999999765 78999999997655444567889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceee---CCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL---DDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill---~~~~~~~l~  231 (232)
                      ||+++++|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+||++   +.++.++|+
T Consensus        86 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dikp~NIl~~~~~~~~~~kl~  151 (304)
T 2jam_A           86 QLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH----ENGIVHRDLKPENLLYLTPEENSKIMIT  151 (304)
T ss_dssp             CCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCSCCGGGCEESSSSTTCCEEBC
T ss_pred             EcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCccccCCCHHHEEEecCCCCCCEEEc
Confidence            9999999999886543 4788999999999999999999    8899999999999999   777888875

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.94  E-value=7e-26  Score=181.71  Aligned_cols=139  Identities=24%  Similarity=0.360  Sum_probs=125.0

Q ss_pred             cccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .+.|++.+.||+|+||.||+|+. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            45578899999999999999975 468999999997654 3446788999999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++++|.+++...  .+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus       101 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~  161 (303)
T 3a7i_A          101 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH----SEKKIHRDIKAANVLLSEHGEVKLA  161 (303)
T ss_dssp             CCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCChheEEECCCCCEEEe
Confidence            99999999998753  4889999999999999999999    8899999999999999999999885

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.94  E-value=1.6e-26  Score=185.08  Aligned_cols=141  Identities=24%  Similarity=0.312  Sum_probs=109.8

Q ss_pred             cccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .+.|++.+.||+|+||.||+|+. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            45678999999999999999975 468899999886543 2345667889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhcc-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLST-------SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~-------~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++++|.+++..       ....+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~  163 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH----KNGQIHRDVKAGNILLGEDGSVQIA  163 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCCCCCCCChhhEEEcCCCCEEEE
Confidence            9999999999863       2345889999999999999999999    8899999999999999999999885

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.94  E-value=3.4e-26  Score=181.09  Aligned_cols=141  Identities=27%  Similarity=0.382  Sum_probs=125.5

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      ..+.|.+.+.||+|+||.||+|+.. +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++..++..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            3456889999999999999999865 78999999996542   2345678899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||+++++|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        89 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~l~  153 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH----RHMVVHRDLKPENVLLDAHMNAKIA  153 (276)
T ss_dssp             EEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HHCSSCCCCCGGGEEECTTSCEEEC
T ss_pred             EEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCChhhEEECCCCCEEEe
Confidence            999999999999987543 4788999999999999999999    8899999999999999999999885

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.94  E-value=5.3e-26  Score=180.82  Aligned_cols=140  Identities=24%  Similarity=0.357  Sum_probs=124.4

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.|++.+.||+|+||.||+|+.. +++.||+|.+....   ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            456789999999999999999765 67889999986542   23346788999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+++++|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~  156 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH----ERKVIHRDIKPENLLMGYKGELKIA  156 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCSGGGEEECTTCCEEEC
T ss_pred             EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCHHHEEEcCCCCEEEe
Confidence            99999999999987643 4888999999999999999999    8899999999999999999999885

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.94  E-value=1.2e-26  Score=184.29  Aligned_cols=142  Identities=23%  Similarity=0.419  Sum_probs=123.0

Q ss_pred             CCCcccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEec-----
Q 042107           82 IPRPFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSK-----  155 (232)
Q Consensus        82 ~p~~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----  155 (232)
                      ++..+...|++.+.||+|+||.||+|+.. +++.||+|.+....    +.+.+|+.+++.++||||+++++++..     
T Consensus         5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (284)
T 2a19_B            5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP   80 (284)
T ss_dssp             CCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred             ccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence            34456677889999999999999999875 78999999997543    346679999999999999999998754     


Q ss_pred             -----------CCeeEEEEeccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeC
Q 042107          156 -----------DDFKALILEYMPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD  223 (232)
Q Consensus       156 -----------~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~  223 (232)
                                 ....++||||+++++|.+++... ...+++..+..++.|++.||.|||    ..+|+||||||+||+++
T Consensus        81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~  156 (284)
T 2a19_B           81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH----SKKLINRDLKPSNIFLV  156 (284)
T ss_dssp             --------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEE
T ss_pred             ccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCCHHHEEEc
Confidence                       34579999999999999999653 345889999999999999999999    88999999999999999


Q ss_pred             CCCceeec
Q 042107          224 DNMVAHFL  231 (232)
Q Consensus       224 ~~~~~~l~  231 (232)
                      .++.++|+
T Consensus       157 ~~~~~kl~  164 (284)
T 2a19_B          157 DTKQVKIG  164 (284)
T ss_dssp             ETTEEEEC
T ss_pred             CCCCEEEC
Confidence            99998885

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.94  E-value=2.2e-26  Score=183.22  Aligned_cols=140  Identities=24%  Similarity=0.396  Sum_probs=124.7

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      .+.|++.+.||+|+||.||+|+.. ++..||+|.+... ....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   90 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   90 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence            445778899999999999999865 5888999998654 34557788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++++|.+++... ...+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        91 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dikp~Nil~~~~~~~~l~  153 (288)
T 3kfa_A           91 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHLVKVA  153 (288)
T ss_dssp             CTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH----HHTCCCSCCSGGGEEECGGGCEEEC
T ss_pred             CCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH----HCCccCCCCCcceEEEcCCCCEEEc
Confidence            9999999999764 345889999999999999999999    8899999999999999999998875

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.94  E-value=2.6e-26  Score=195.84  Aligned_cols=142  Identities=22%  Similarity=0.348  Sum_probs=124.4

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecc--cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQ--YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      .+.+.|++.+.||+|+||.||+|+.. +++.||+|++...  .......+.+|+.+++.++||||+++++++...+..++
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   98 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence            35667899999999999999999765 7899999998653  23345778899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeC---CCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD---DNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~---~~~~~~l~  231 (232)
                      ||||+++|+|.+.+.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++   .++.+||+
T Consensus        99 v~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~Nil~~~~~~~~~~kl~  166 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH----KHNIVHRDLKPENILLESKEKDCDIKII  166 (486)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEESSSSTTCCEEEC
T ss_pred             EEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeEeccCchHHEEEecCCCCCCEEEE
Confidence            999999999998886543 5889999999999999999999    88999999999999995   45567775

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.94  E-value=6.9e-26  Score=184.08  Aligned_cols=142  Identities=25%  Similarity=0.400  Sum_probs=124.4

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCc--hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGG--AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      ...+.|++.+.||+|+||.||+|+.. +++.||+|.+......  ..+.+.+|+.+++.++||||+++++++...+..++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  101 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL  101 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence            34556889999999999999999765 5899999998655432  24557789999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||++++++.++..... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.++|+
T Consensus       102 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH----~~~ivH~dlkp~Nil~~~~~~~kl~  166 (331)
T 4aaa_A          102 VFEFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH----SHNIIHRDIKPENILVSQSGVVKLC  166 (331)
T ss_dssp             EEECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred             EEecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH----HCCEEccCcChheEEEcCCCcEEEE
Confidence            999999999988766443 4889999999999999999999    8899999999999999999999885

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.94  E-value=9.5e-26  Score=181.51  Aligned_cols=142  Identities=23%  Similarity=0.356  Sum_probs=123.2

Q ss_pred             ccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      ..+.|++.+.||+|+||.||+|+. .+++.||+|.+....   ....+.+.+|+.+++.++||||+++++++..++..++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            345688999999999999999975 478999999987532   2345668889999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLST---SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||+++++|.+++..   ....+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dl~p~NIl~~~~~~~kl~  178 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH----SRRVMHRDIKPANVFITATGVVKLG  178 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh----hCCeeCCCCcHHHEEEcCCCCEEEE
Confidence            9999999999998864   2345888999999999999999999    8899999999999999999999885

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.94  E-value=4.9e-26  Score=200.87  Aligned_cols=139  Identities=18%  Similarity=0.213  Sum_probs=123.3

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecc---cCchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQ---YGGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  162 (232)
                      +.|++.+.||+|+||.||+|+.. +++.||+|++...   .....+.+..|..++..+ +||+|+++++++.+.+..|+|
T Consensus       341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV  420 (674)
T 3pfq_A          341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV  420 (674)
T ss_dssp             TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred             cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence            34778899999999999999765 6889999999753   234456778899999887 799999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       421 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH----~~gIiHrDLKp~NILl~~~g~ikL~  484 (674)
T 3pfq_A          421 MEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ----SKGIIYRDLKLDNVMLDSEGHIKIA  484 (674)
T ss_dssp             EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTSEECCCCCSTTEEECSSSCEEEC
T ss_pred             EeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeEeccCChhhEEEcCCCcEEEe
Confidence            99999999999997643 5899999999999999999999    8899999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=3e-26  Score=183.23  Aligned_cols=138  Identities=20%  Similarity=0.332  Sum_probs=119.5

Q ss_pred             ceeeecccCCCcceeeeEEeC-C---CcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCee-EEEE
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-D---GMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFK-ALIL  163 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~lv~  163 (232)
                      +...+.||+|+||.||+|+.. +   +..+|+|.+..... ...+.+.+|+.+++.++||||+++++++...+.. +++|
T Consensus        23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~  102 (298)
T 3pls_A           23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL  102 (298)
T ss_dssp             EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred             EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence            456789999999999999753 2   33799999865432 3456788999999999999999999999776554 9999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+.+|+|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+
T Consensus       103 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dikp~Nili~~~~~~kl~  166 (298)
T 3pls_A          103 PYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA----EQKFVHRDLAARNCMLDESFTVKVA  166 (298)
T ss_dssp             CCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEEC
T ss_pred             ecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEEcCCCcEEeC
Confidence            999999999999876667889999999999999999999    8899999999999999999999885

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.94  E-value=3.2e-26  Score=186.03  Aligned_cols=141  Identities=22%  Similarity=0.318  Sum_probs=117.8

Q ss_pred             cccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      ...+.|++.+.||+|+||.||+|+. .+++.||+|++.....  ...+.+.+|+.+++.++||||+++++++..++..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            4556789999999999999999975 4789999999865432  224557789999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceee-----CCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL-----DDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill-----~~~~~~~l~  231 (232)
                      ||||+++ +|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||+     +.++.+||+
T Consensus       111 v~e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~  179 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCH----SRRCLHRDLKPQNLLLSVSDASETPVLKIG  179 (329)
T ss_dssp             EEECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred             EEecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCEECCCCCHHHEEEecCCCCccceEEEC
Confidence            9999985 9999987654 4889999999999999999999    8899999999999999     445557775

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=8.2e-26  Score=183.70  Aligned_cols=137  Identities=27%  Similarity=0.376  Sum_probs=117.7

Q ss_pred             cccccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcC--CCCCCccceeEEEecC----Ce
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKI--IRHQNLIKIISSCSKD----DF  158 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~----~~  158 (232)
                      .+.+.|++.+.||+|+||.||+|+.. ++.||+|++....   ......|.+++..  ++||||+++++++...    ..
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  109 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ  109 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence            45667899999999999999999876 8899999986442   2334445555554  4899999999998876    68


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC--------CeeeCCCCCCceeeCCCCceee
Q 042107          159 KALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH--------VIIHCDLKSSNVLLDDNMVAHF  230 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--------~iiHrdlk~~Nill~~~~~~~l  230 (232)
                      .++||||+++|+|.+++...  .+++..+..++.|++.||.|||    ..        +|+||||||+|||++.++.+||
T Consensus       110 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH----~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl  183 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH----TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI  183 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH----SCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             eEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH----HhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence            89999999999999999764  4889999999999999999999    66        9999999999999999999998


Q ss_pred             c
Q 042107          231 L  231 (232)
Q Consensus       231 ~  231 (232)
                      +
T Consensus       184 ~  184 (337)
T 3mdy_A          184 A  184 (337)
T ss_dssp             C
T ss_pred             E
Confidence            5

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.94  E-value=2.8e-26  Score=188.48  Aligned_cols=141  Identities=19%  Similarity=0.265  Sum_probs=122.4

Q ss_pred             ccccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCc-----------hHHHHHHHHHHhcCCCCCCccceeEEEe
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG-----------AFKNLDVECNMMKIIRHQNLIKIISSCS  154 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~~~~~~~  154 (232)
                      +.+.|.+.+.||+|+||.||+|...+++.||+|++......           ..+.+.+|+.+++.++||||+++++++.
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            45668899999999999999998888999999998543221           1367889999999999999999999984


Q ss_pred             c-----CCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCcee
Q 042107          155 K-----DDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAH  229 (232)
Q Consensus       155 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~  229 (232)
                      .     ....++||||++ |+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+|
T Consensus       100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~NIl~~~~~~~k  174 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH----EAGVVHRDLHPGNILLADNNDIT  174 (362)
T ss_dssp             ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEE
T ss_pred             eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCcCEecCCChHHEEEcCCCCEE
Confidence            3     346899999997 5888888776667899999999999999999999    88999999999999999999998


Q ss_pred             ec
Q 042107          230 FL  231 (232)
Q Consensus       230 l~  231 (232)
                      |+
T Consensus       175 l~  176 (362)
T 3pg1_A          175 IC  176 (362)
T ss_dssp             EC
T ss_pred             EE
Confidence            85

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.94  E-value=4.1e-26  Score=182.53  Aligned_cols=142  Identities=24%  Similarity=0.317  Sum_probs=124.8

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC---------chHHHHHHHHHHhcCCC-CCCccceeEEE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG---------GAFKNLDVECNMMKIIR-HQNLIKIISSC  153 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~~~~~~  153 (232)
                      .+.+.|++.+.||+|+||.||+|+.. +++.||+|.+.....         ...+.+.+|+.+++.+. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            45677899999999999999999765 689999999975431         12356778999999995 99999999999


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          154 SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       154 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~kl~  166 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALH----KLNIVHRDLKPENILLDDDMNIKLT  166 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCcceEEEcCCCcEEEe
Confidence            9999999999999999999999764 35889999999999999999999    8899999999999999999999885

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.94  E-value=5.4e-26  Score=182.62  Aligned_cols=136  Identities=32%  Similarity=0.465  Sum_probs=120.1

Q ss_pred             eeeecccCCCcceeeeEEeCCCcEEEEEEeeccc----CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           91 EVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQY----GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        91 ~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      ...+.||+|+||.||+|+. +++.||+|.+....    ....+.+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus        34 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  112 (307)
T 2nru_A           34 VGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM  112 (307)
T ss_dssp             TTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             ccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence            3457899999999999986 58899999986432    334577889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTS--NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|.+++...  ...+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus       113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~kl~  175 (307)
T 2nru_A          113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH----ENHHIHRDIKSANILLDEAFTAKIS  175 (307)
T ss_dssp             TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEEC
T ss_pred             CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh----cCCeecCCCCHHHEEEcCCCcEEEe
Confidence            999999998643  335889999999999999999999    8899999999999999999999885

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.94  E-value=1.4e-26  Score=187.86  Aligned_cols=139  Identities=21%  Similarity=0.340  Sum_probs=118.0

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcE----EEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGME----VVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      +.|++.+.||+|+||.||+|+.. +++.    ||+|.+.... ....+.+.+|+.+++.++||||+++++++. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            45788999999999999999754 4544    7777764332 233355677999999999999999999886 456889


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||+++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dikp~Nil~~~~~~~kl~  157 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE----EHGMVHRNLAARNVLLKSPSQVQVA  157 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH----HTTCCCSCCSSTTEEESSSSCEEEC
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH----hCCCCCCccchheEEECCCCeEEEC
Confidence            99999999999999876556888899999999999999999    8899999999999999999999885

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.94  E-value=2.4e-26  Score=182.49  Aligned_cols=142  Identities=20%  Similarity=0.331  Sum_probs=122.1

Q ss_pred             cccccceeeecccCCCcceeeeEEeCC----CcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCee
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQD----GMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFK  159 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  159 (232)
                      ...+.|.+.+.||+|+||.||+|+...    +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. +..
T Consensus         9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~   87 (281)
T 3cc6_A            9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPT   87 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSC
T ss_pred             ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCC
Confidence            445668899999999999999997532    3469999987543 2345678899999999999999999999865 456


Q ss_pred             EEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          160 ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++||||+++++|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~kl~  155 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE----SINCVHRDIAVRNILVASPECVKLG  155 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEEEETTEEEEC
T ss_pred             EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCccceEEECCCCcEEeC
Confidence            8999999999999999766556899999999999999999999    8899999999999999999998875

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.94  E-value=5e-26  Score=183.28  Aligned_cols=142  Identities=18%  Similarity=0.182  Sum_probs=124.4

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC---chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG---GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  160 (232)
                      ...+.|++.+.||+|+||.||+|+.. +++.||+|.+.....   ...+.+.+|+.+++.++||||+++++++..++..+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY  110 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence            34456889999999999999999865 688999999865432   22467889999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|||+++++|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.++|+
T Consensus       111 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dlkp~NIl~~~~~~~kl~  176 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH----AAGATHRDVKPENILVSADDFAYLV  176 (309)
T ss_dssp             EEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             EEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCcCCcCCCChHHEEEcCCCCEEEe
Confidence            9999999999999987643 5889999999999999999999    8899999999999999999999885

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.94  E-value=4.7e-26  Score=179.76  Aligned_cols=137  Identities=30%  Similarity=0.478  Sum_probs=115.6

Q ss_pred             ccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccC----chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYG----GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      +.|++.+.||+|+||.||+|+.. ++.||+|.+.....    ...+.+.+|+.+++.++||||+++++++..++..++||
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            45778899999999999999875 88999999865422    23467889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCC---eeeCCCCCCceeeCC--------CCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV---IIHCDLKSSNVLLDD--------NMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~---iiHrdlk~~Nill~~--------~~~~~l~  231 (232)
                      ||+++++|.+++...  .+++..+..++.|++.||.|||    ..+   ++||||||+||+++.        ++.++|+
T Consensus        86 e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH----~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           86 EFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLH----DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             ECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH----HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             EcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH----hCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            999999999998654  5889999999999999999999    666   999999999999986        5667764

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.94  E-value=7.7e-26  Score=185.19  Aligned_cols=140  Identities=24%  Similarity=0.412  Sum_probs=121.2

Q ss_pred             cccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecC-------
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKD-------  156 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------  156 (232)
                      .+.|++.+.||+|+||.||+|+. .+++.||+|++....  ......+.+|+.+++.++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            35688999999999999999976 578999999885543  22345678899999999999999999998773       


Q ss_pred             -CeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          157 -DFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       157 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                       +..++||||+++ ++.+.+......+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIl~~~~~~~kl~  166 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH----RNKILHRDMKAANVLITRDGVLKLA  166 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeeCCCCCHHHEEEcCCCCEEEc
Confidence             468999999975 787777766556899999999999999999999    8899999999999999999999885

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.94  E-value=4.9e-26  Score=181.55  Aligned_cols=140  Identities=24%  Similarity=0.369  Sum_probs=119.7

Q ss_pred             cccccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      ...+.|++.+.||+|+||.||+|+..  ..||+|.+.....  ...+.+.+|+.+++.++||||++++++. ..+..++|
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv   97 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV   97 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence            34556889999999999999999764  3599999865432  3356788999999999999999999965 45668999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+++++|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.++|+
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH----~~~i~H~Dlkp~Nil~~~~~~~kl~  162 (289)
T 3og7_A           98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH----AKSIIHRDLKSNNIFLHEDNTVKIG  162 (289)
T ss_dssp             EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEETTTEEEEC
T ss_pred             EEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----hCCcccccCccceEEECCCCCEEEc
Confidence            9999999999999776667899999999999999999999    8899999999999999999999885

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.93  E-value=3.4e-26  Score=185.18  Aligned_cols=143  Identities=25%  Similarity=0.292  Sum_probs=119.9

Q ss_pred             CCcccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC--------chHHHHHHHHHHhcCCCCCCccceeEEE
Q 042107           83 PRPFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG--------GAFKNLDVECNMMKIIRHQNLIKIISSC  153 (232)
Q Consensus        83 p~~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~  153 (232)
                      |..+.+.|.+.+.||+|+||.||+|+.. +++.||+|.+.....        .....+.+|+.+++.++||||+++++++
T Consensus         5 ~~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   84 (322)
T 2ycf_A            5 PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF   84 (322)
T ss_dssp             CHHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence            5566778899999999999999999764 688999999864321        1234578899999999999999999998


Q ss_pred             ecCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCc---eee
Q 042107          154 SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV---AHF  230 (232)
Q Consensus       154 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~---~~l  230 (232)
                      ..++ .++||||+++++|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.   +||
T Consensus        85 ~~~~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~dlkp~NIl~~~~~~~~~~kl  158 (322)
T 2ycf_A           85 DAED-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH----ENGIIHRDLKPENVLLSSQEEDCLIKI  158 (322)
T ss_dssp             ESSS-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred             cCCc-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCCHHHEEEecCCCCCeEEE
Confidence            7665 799999999999999887643 5889999999999999999999    889999999999999987654   776


Q ss_pred             c
Q 042107          231 L  231 (232)
Q Consensus       231 ~  231 (232)
                      +
T Consensus       159 ~  159 (322)
T 2ycf_A          159 T  159 (322)
T ss_dssp             C
T ss_pred             c
Confidence            4

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.93  E-value=1.2e-27  Score=194.80  Aligned_cols=133  Identities=20%  Similarity=0.233  Sum_probs=108.9

Q ss_pred             ccceeeecccCCCcceeeeEEeCCCcEEEEEEeeccc--------CchHHHHHHHHHHhcCCC---------CCCcccee
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQY--------GGAFKNLDVECNMMKIIR---------HQNLIKII  150 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~~~  150 (232)
                      +.|++.+.||+|+||.||+|+. +++.||+|++....        ....+.+.+|+.+++.++         ||||+++.
T Consensus        20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            4577889999999999999987 68999999997653        223477888999888875         77777776


Q ss_pred             EEE-----------------ec-------------CCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHH
Q 042107          151 SSC-----------------SK-------------DDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEY  200 (232)
Q Consensus       151 ~~~-----------------~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~  200 (232)
                      +++                 .+             .+..|+||||+++|++.+.+..  ..+++..+..++.|++.||.|
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHH
Confidence            653                 22             6789999999999977666644  347899999999999999999


Q ss_pred             HhcCCCCCCeeeCCCCCCceeeCCCC
Q 042107          201 LHFGHSTHVIIHCDLKSSNVLLDDNM  226 (232)
Q Consensus       201 lH~~~~~~~iiHrdlk~~Nill~~~~  226 (232)
                      ||+   ..+|+||||||+|||++.++
T Consensus       177 lH~---~~~ivHrDlKp~NILl~~~~  199 (336)
T 2vuw_A          177 AEA---SLRFEHRDLHWGNVLLKKTS  199 (336)
T ss_dssp             HHH---HHCCBCSCCCGGGEEEEECS
T ss_pred             HHH---hCCEeECCCCHHHEEEeccC
Confidence            992   24799999999999999887

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=2e-26  Score=188.50  Aligned_cols=140  Identities=25%  Similarity=0.411  Sum_probs=118.2

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCc-----hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGG-----AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  160 (232)
                      .+.|++.+.||+|+||.||+|+.. +++.||+|.+......     ..+.+.+|+.+++.++||||+++++++...+..+
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            456788999999999999999764 6899999998653221     1246778999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +||||+++ +|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus        89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~~~~~kl~  154 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH----QHWILHRDLKPNNLLLDENGVLKLA  154 (346)
T ss_dssp             EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH----HCCEECCCCCHHHEEEcCCCCEEEE
Confidence            99999986 899888876666888899999999999999999    8899999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.93  E-value=5.4e-26  Score=184.35  Aligned_cols=146  Identities=23%  Similarity=0.358  Sum_probs=121.3

Q ss_pred             CCCcccccceeeecccCCCcceeeeEEe------CCCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEe
Q 042107           82 IPRPFRNFLEVFNLISRGGFGSIYKARI------QDGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCS  154 (232)
Q Consensus        82 ~p~~~~~~~~~~~~lg~g~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  154 (232)
                      ++....+.|++.+.||+|+||.||+|+.      .++..||+|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (327)
T 2yfx_A           24 LKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL  103 (327)
T ss_dssp             SCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence            3445567788999999999999999973      247789999986442 234466888999999999999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCC------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC--
Q 042107          155 KDDFKALILEYMPHGSLGKCLSTSN------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM--  226 (232)
Q Consensus       155 ~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~--  226 (232)
                      ..+..++||||+++++|.+++....      ..+++..+..++.|++.||.|||    ..+|+||||||+||+++.++  
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH----~~~i~H~dlkp~NIli~~~~~~  179 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE----ENHFIHRDIAARNCLLTCPGPG  179 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESCSSTT
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh----hCCeecCcCCHhHEEEecCCCc
Confidence            9999999999999999999997642      34788899999999999999999    88999999999999999544  


Q ss_pred             -ceeec
Q 042107          227 -VAHFL  231 (232)
Q Consensus       227 -~~~l~  231 (232)
                       .++|+
T Consensus       180 ~~~kl~  185 (327)
T 2yfx_A          180 RVAKIG  185 (327)
T ss_dssp             CCEEEC
T ss_pred             ceEEEC
Confidence             57765

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.93  E-value=8.9e-26  Score=180.22  Aligned_cols=136  Identities=22%  Similarity=0.359  Sum_probs=118.5

Q ss_pred             eeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCCCC
Q 042107           92 VFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGS  170 (232)
Q Consensus        92 ~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  170 (232)
                      ....||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus        26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  105 (295)
T 2clq_A           26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGS  105 (295)
T ss_dssp             SBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEE
T ss_pred             CcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCC
Confidence            345899999999999975 4688999999987666666788999999999999999999999999999999999999999


Q ss_pred             hhhhhccCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC-CCceeec
Q 042107          171 LGKCLSTSN--YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD-NMVAHFL  231 (232)
Q Consensus       171 L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~-~~~~~l~  231 (232)
                      |.+++....  ..+++..+..++.|++.||.|||    ..+++||||||+||+++. ++.++|+
T Consensus       106 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dl~p~Nil~~~~~~~~kl~  165 (295)
T 2clq_A          106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH----DNQIVHRDIKGDNVLINTYSGVLKIS  165 (295)
T ss_dssp             HHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTCCEEEC
T ss_pred             HHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH----hCCEEccCCChhhEEEECCCCCEEEe
Confidence            999987642  23567888889999999999999    889999999999999987 8888875

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.93  E-value=9e-27  Score=192.63  Aligned_cols=140  Identities=16%  Similarity=0.152  Sum_probs=115.2

Q ss_pred             cccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecc---cCchHHHHHHHH---HHhcCCCCCCcccee-------EE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQ---YGGAFKNLDVEC---NMMKIIRHQNLIKII-------SS  152 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~niv~~~-------~~  152 (232)
                      .+.|++.+.||+|+||.||+|+. .+++.||||++...   .....+.+.+|+   ..++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            35678899999999999999985 56999999999743   334567788999   556666899999998       66


Q ss_pred             EecCC-----------------eeEEEEeccCCCChhhhhccCCC------CCCHHHHHHHHHHHHHHHHHHhcCCCCCC
Q 042107          153 CSKDD-----------------FKALILEYMPHGSLGKCLSTSNY------ILDFFQRLHIMIDVASAVEYLHFGHSTHV  209 (232)
Q Consensus       153 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~  209 (232)
                      +..++                 ..+++|||+ +|+|.+++.....      .+++..+..++.|++.||.|||    ..+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~  226 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH----HYG  226 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH----HTT
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH----hCC
Confidence            66553                 278999999 6799999875321      1234777889999999999999    889


Q ss_pred             eeeCCCCCCceeeCCCCceeec
Q 042107          210 IIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       210 iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+||||||+|||++.++.+||+
T Consensus       227 ivHrDikp~NIll~~~~~~kL~  248 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLT  248 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEEC
T ss_pred             eecCCCCHHHEEEcCCCCEEEE
Confidence            9999999999999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.93  E-value=9.3e-26  Score=181.79  Aligned_cols=141  Identities=27%  Similarity=0.456  Sum_probs=116.5

Q ss_pred             cccceeeecccCCCcceeeeEEeC----CCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCC---
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDD---  157 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---  157 (232)
                      .+.|.+.+.||+|+||.||+|+..    ++..||+|.+.....  ...+.+.+|+.+++.++||||+++++++...+   
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  112 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG  112 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence            345788999999999999999653    355899999865432  33467889999999999999999999987754   


Q ss_pred             --eeEEEEeccCCCChhhhhcc-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceee
Q 042107          158 --FKALILEYMPHGSLGKCLST-----SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHF  230 (232)
Q Consensus       158 --~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l  230 (232)
                        ..++||||+++|+|.+++..     ....+++..++.++.|++.||.|||    ..+|+||||||+||+++.++.+||
T Consensus       113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS----NRNFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH----TTTCCCCCCSGGGEEECTTSCEEE
T ss_pred             CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCcceEEEcCCCcEEE
Confidence              35999999999999998842     2345889999999999999999999    889999999999999999999988


Q ss_pred             c
Q 042107          231 L  231 (232)
Q Consensus       231 ~  231 (232)
                      +
T Consensus       189 ~  189 (313)
T 3brb_A          189 A  189 (313)
T ss_dssp             C
T ss_pred             e
Confidence            5

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.93  E-value=5.6e-26  Score=185.58  Aligned_cols=138  Identities=22%  Similarity=0.297  Sum_probs=118.0

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.+.|++.+.||+|+||.||+|+.. +++.||+|.+......    ..+|++++..+ +||||+++++++.+++..|+|
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            45667899999999999999999765 6889999999765432    34577777776 799999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC----Cceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN----MVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~----~~~~l~  231 (232)
                      |||+++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||+.++    +.+||+
T Consensus        95 ~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH----~~givHrDlkp~NIl~~~~~~~~~~~kl~  162 (342)
T 2qr7_A           95 TELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH----AQGVVHRDLKPSNILYVDESGNPESIRIC  162 (342)
T ss_dssp             ECCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEESSSSCSGGGEEEC
T ss_pred             EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH----HCCcEeccCCHHHEEEecCCCCcCeEEEE
Confidence            99999999999987653 5899999999999999999999    8899999999999998543    246764

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.93  E-value=9.1e-26  Score=181.96  Aligned_cols=140  Identities=19%  Similarity=0.293  Sum_probs=116.4

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEe---------
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCS---------  154 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~---------  154 (232)
                      .+.+.|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++||||+++++++.         
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A            8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            34566889999999999999999765 58999999997665556678899999999999999999999874         


Q ss_pred             -----cCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeC-CCCce
Q 042107          155 -----KDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD-DNMVA  228 (232)
Q Consensus       155 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~-~~~~~  228 (232)
                           ..+..++||||++ |+|.+++...  .+++..+..++.|++.||.|||    ..+|+||||||+||+++ .++.+
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH----SANVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEEETTTTEE
T ss_pred             cccccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEEcCCCCeE
Confidence                 3467899999997 5999998753  4888899999999999999999    88999999999999997 56688


Q ss_pred             eec
Q 042107          229 HFL  231 (232)
Q Consensus       229 ~l~  231 (232)
                      ||+
T Consensus       161 kl~  163 (320)
T 2i6l_A          161 KIG  163 (320)
T ss_dssp             EEC
T ss_pred             EEc
Confidence            875

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.93  E-value=1.1e-25  Score=184.88  Aligned_cols=136  Identities=24%  Similarity=0.298  Sum_probs=117.8

Q ss_pred             CCcccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCC-----CCCccceeEEEecC
Q 042107           83 PRPFRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-----HQNLIKIISSCSKD  156 (232)
Q Consensus        83 p~~~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~~~~~~~  156 (232)
                      ...+.+.|++.+.||+|+||.||+|+. .+++.||+|++... ....+.+..|+.+++.++     ||||+++++++...
T Consensus        30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~  108 (360)
T 3llt_A           30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY  108 (360)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred             ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence            335667789999999999999999976 46889999998643 223456677899888886     99999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC
Q 042107          157 DFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD  224 (232)
Q Consensus       157 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~  224 (232)
                      +..++||||+ +++|.+++.... ..+++..+..++.|++.||.|||    ..+|+||||||+|||++.
T Consensus       109 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~NIll~~  172 (360)
T 3llt_A          109 DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR----KMSLTHTDLKPENILLDD  172 (360)
T ss_dssp             TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESC
T ss_pred             CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCcccEEEcc
Confidence            9999999999 889999997653 34888999999999999999999    889999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.93  E-value=1.4e-25  Score=178.84  Aligned_cols=140  Identities=23%  Similarity=0.330  Sum_probs=120.5

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEec----CCee
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSK----DDFK  159 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~  159 (232)
                      ...|.+.+.||+|+||.||+|... ++..||+|.+....  ....+.+.+|+.+++.++||||+++++++..    ....
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            345778889999999999999764 68899999987553  2345678899999999999999999998865    3568


Q ss_pred             EEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCC--eeeCCCCCCceeeC-CCCceeec
Q 042107          160 ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV--IIHCDLKSSNVLLD-DNMVAHFL  231 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~--iiHrdlk~~Nill~-~~~~~~l~  231 (232)
                      ++||||+++++|.+++.... .+++..+..++.|++.||.|||    ..+  ++||||||+||+++ .++.++|+
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~~~i~H~dikp~Nil~~~~~~~~kl~  174 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH----TRTPPIIHRDLKCDNIFITGPTGSVKIG  174 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred             EEEEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHH----cCCCCEEECCCCHHHEEEECCCCCEEEe
Confidence            99999999999999997643 4888999999999999999999    767  99999999999998 78888875

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.93  E-value=6.8e-26  Score=183.92  Aligned_cols=144  Identities=20%  Similarity=0.282  Sum_probs=123.8

Q ss_pred             Ccccccceee-ecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCC-CCCccceeEEEecCCe
Q 042107           84 RPFRNFLEVF-NLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIR-HQNLIKIISSCSKDDF  158 (232)
Q Consensus        84 ~~~~~~~~~~-~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~  158 (232)
                      +.+.+.|.+. +.||+|+||.||+|+.. +++.||+|.+....  ......+.+|+.+++.+. ||||+++++++...+.
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            3556667776 88999999999999765 68999999986543  223567888999999885 6999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC---CCceeec
Q 042107          159 KALILEYMPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD---NMVAHFL  231 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~---~~~~~l~  231 (232)
                      .++||||+++|+|.+++... ...+++..+..++.|++.||.|||    ..+|+||||||+||+++.   ++.+||+
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH----~~givH~Dikp~NIl~~~~~~~~~~kL~  176 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH----QNNIVHLDLKPQNILLSSIYPLGDIKIV  176 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH----HCCeecCcCChHHEEEecCCCCCcEEEe
Confidence            99999999999999998653 345899999999999999999999    889999999999999998   6788875

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.93  E-value=6e-26  Score=186.82  Aligned_cols=141  Identities=23%  Similarity=0.297  Sum_probs=116.6

Q ss_pred             ccccceeeecccCCCcceeeeEEeCC------CcEEEEEEeecccCchH-----------HHHHHHHHHhcCCCCCCccc
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQD------GMEVVVKGFNLQYGGAF-----------KNLDVECNMMKIIRHQNLIK  148 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~  148 (232)
                      ..+.|++.+.||+|+||.||+|+...      ++.||+|.+........           .....|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34578899999999999999997654      47899999865432111           12334666778889999999


Q ss_pred             eeEEEecC----CeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeC-
Q 042107          149 IISSCSKD----DFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD-  223 (232)
Q Consensus       149 ~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~-  223 (232)
                      +++++...    ...++||||+ +++|.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++ 
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH----~~~iiHrDlkp~Nill~~  187 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH----EHEYVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEEES
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----HCCeEEecCCHHHEEEec
Confidence            99998764    4589999999 99999999876567999999999999999999999    88999999999999999 


Q ss_pred             -CCCceeec
Q 042107          224 -DNMVAHFL  231 (232)
Q Consensus       224 -~~~~~~l~  231 (232)
                       .++.+||+
T Consensus       188 ~~~~~~kl~  196 (364)
T 3op5_A          188 KNPDQVYLV  196 (364)
T ss_dssp             SCTTCEEEC
T ss_pred             CCCCeEEEE
Confidence             88888875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.93  E-value=1.3e-25  Score=179.42  Aligned_cols=140  Identities=15%  Similarity=0.159  Sum_probs=122.9

Q ss_pred             cccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.+.|++.+.||+|+||.||+|+. .+++.||+|.+....  ..+.+.+|+.+++.+ +|++++++++++......++|
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   84 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   84 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence            3456688999999999999999975 578999999986443  234577899999998 799999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCc-----eeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV-----AHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~-----~~l~  231 (232)
                      |||+ +++|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.     +||+
T Consensus        85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~  153 (298)
T 1csn_A           85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH----EKSLVYRDIKPDNFLIGRPNSKNANMIYVV  153 (298)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred             EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH----hCCEecCCCCHHHEEeccCCCCCCCeEEEE
Confidence            9999 99999999876556899999999999999999999    889999999999999988776     7775

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=3.8e-26  Score=188.33  Aligned_cols=139  Identities=22%  Similarity=0.364  Sum_probs=115.1

Q ss_pred             ccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCC-----
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDD-----  157 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  157 (232)
                      +.+.|++.+.||+|+||.||+|.. .+++.||+|++.....  ...+.+.+|+.+++.++||||+++++++...+     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            456688999999999999999976 4799999999854322  23467889999999999999999999997653     


Q ss_pred             -eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          158 -FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       158 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                       ..|+||||+ +++|.+++...  .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~kl~  170 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH----AAGIIHRDLKPGNLAVNEDCELKIL  170 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             ceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCccccCcCHHHEEEcCCCCEEEE
Confidence             459999999 78999998763  4888999999999999999999    8899999999999999999999986

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.93  E-value=4.4e-26  Score=193.26  Aligned_cols=138  Identities=22%  Similarity=0.272  Sum_probs=118.4

Q ss_pred             ccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecc--cCchHHHHHHHHHHhcCCCCCCccceeEEEecC------
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQ--YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKD------  156 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  156 (232)
                      +.+.|++.+.||+|+||.||+|+. .+++.||+|++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            346688999999999999999975 46899999999754  223456788999999999999999999999654      


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          157 DFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       157 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ...|+||||+++ ++.+.+..   .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH----~~~iiHrDlkp~NIll~~~~~~kl~  206 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKIL  206 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred             CeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCChHhEEEeCCCCEEEE
Confidence            356999999976 56666654   3788899999999999999999    8899999999999999999999986

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.93  E-value=8.3e-26  Score=184.55  Aligned_cols=138  Identities=18%  Similarity=0.322  Sum_probs=121.1

Q ss_pred             cccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccC--chHHHHHHHHHHhcCCCC--CCccceeEEEecCCeeEEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRH--QNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.|++.+.||+|+||.||++...+++.||+|++.....  ...+.+.+|+.+++.++|  |||+++++++..++..++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            456889999999999999999888899999999975532  234678899999999986  9999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      || +.+++|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++ ++.+||+
T Consensus        88 ~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH----~~~iiHrDikp~NIll~-~~~~kl~  149 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLIV-DGMLKLI  149 (343)
T ss_dssp             EC-CCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEE-TTEEEEC
T ss_pred             Ee-CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCcceEEEE-CCcEEEe
Confidence            99 56889999998653 5888999999999999999999    88999999999999997 5677775

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.93  E-value=8.3e-26  Score=188.29  Aligned_cols=135  Identities=16%  Similarity=0.243  Sum_probs=113.6

Q ss_pred             ccceee-ecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHh-cCCCCCCccceeEEEec----CCeeE
Q 042107           88 NFLEVF-NLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMM-KIIRHQNLIKIISSCSK----DDFKA  160 (232)
Q Consensus        88 ~~~~~~-~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~~~  160 (232)
                      +.|.+. +.||+|+||.||+|+.. +++.||+|++...     ..+.+|+.++ +..+||||+++++++..    ....|
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            334444 78999999999999764 6889999998632     4566788876 45689999999998865    56789


Q ss_pred             EEEeccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC---CCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD---NMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~---~~~~~l~  231 (232)
                      +||||+++|+|.+++.... ..+++..+..++.|++.||.|||    ..+|+||||||+|||++.   ++.+||+
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~~~~kl~  206 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLT  206 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCcCcceEEEecCCCCccEEEE
Confidence            9999999999999998653 35899999999999999999999    889999999999999998   7788875

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.93  E-value=9.1e-26  Score=185.89  Aligned_cols=141  Identities=27%  Similarity=0.389  Sum_probs=124.1

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCc--------hHHHHHHHHHHhcCC-CCCCccceeEEEec
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGG--------AFKNLDVECNMMKII-RHQNLIKIISSCSK  155 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  155 (232)
                      +.+.|++.+.||+|+||.||+|+.. +|+.||||++......        ..+.+.+|+.+++.+ +||||+++++++..
T Consensus        92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  171 (365)
T 2y7j_A           92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES  171 (365)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred             hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence            4456788899999999999999875 7999999998765321        135677899999998 79999999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          156 DDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       156 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ....++||||+++++|.+++... ..+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.++|+
T Consensus       172 ~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH----~~gi~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          172 SSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLH----ANNIVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             CCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEECCCCCEEEE
Confidence            99999999999999999998754 34889999999999999999999    8899999999999999999999875

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.93  E-value=1e-25  Score=183.26  Aligned_cols=137  Identities=31%  Similarity=0.473  Sum_probs=112.9

Q ss_pred             cccccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHH--HhcCCCCCCccceeEEEec-----CC
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECN--MMKIIRHQNLIKIISSCSK-----DD  157 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~--~l~~l~h~niv~~~~~~~~-----~~  157 (232)
                      .-.+.|++.+.||+|+||.||+|+. +++.||+|++....   ...+..|.+  .+..++||||+++++.+..     ..
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             cChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            3445678999999999999999976 58899999997543   233333444  4556899999999975532     23


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC---------CeeeCCCCCCceeeCCCCce
Q 042107          158 FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH---------VIIHCDLKSSNVLLDDNMVA  228 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---------~iiHrdlk~~Nill~~~~~~  228 (232)
                      ..++||||+++|+|.+++....  .++..+..++.|++.||.|||    ..         +|+||||||+|||++.++.+
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH----~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  159 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH----TELPRGDHYKPAISHRDLNSRNVLVKNDGTC  159 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH----CCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred             eEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH----hhhccccccccceeecccccceEEEcCCCcE
Confidence            6689999999999999997653  588889999999999999999    77         99999999999999999999


Q ss_pred             eec
Q 042107          229 HFL  231 (232)
Q Consensus       229 ~l~  231 (232)
                      ||+
T Consensus       160 kL~  162 (336)
T 3g2f_A          160 VIS  162 (336)
T ss_dssp             EEC
T ss_pred             EEe
Confidence            985

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.93  E-value=8.8e-26  Score=183.31  Aligned_cols=140  Identities=27%  Similarity=0.322  Sum_probs=120.4

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCC-CCCccceeEEEe--------cC
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-HQNLIKIISSCS--------KD  156 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~--------~~  156 (232)
                      ...|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.+. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            345789999999999999999864 78999999987665555677889999999996 999999999984        33


Q ss_pred             CeeEEEEeccCCCChhhhhcc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCC--eeeCCCCCCceeeCCCCceeec
Q 042107          157 DFKALILEYMPHGSLGKCLST--SNYILDFFQRLHIMIDVASAVEYLHFGHSTHV--IIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       157 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~--iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ...+++|||+. |+|.+++..  ....+++..+..++.|++.||.|||    ..+  |+||||||+|||++.++.+||+
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH----RQKPPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH----TSSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----hCCCCEEEccCCcccEEECCCCCEEEe
Confidence            45789999996 699888864  2345899999999999999999999    777  9999999999999999999885

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.93  E-value=1.3e-25  Score=182.33  Aligned_cols=139  Identities=21%  Similarity=0.350  Sum_probs=120.1

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcE----EEEEEeecc-cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGME----VVVKGFNLQ-YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      +.|++.+.||+|+||.||+|+.. +++.    ||+|.+... .....+.+.+|+.+++.++||||+++++++..+. .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            45788999999999999999754 4554    466766433 3345678899999999999999999999998765 789


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++||+++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kL~  159 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----DRRLVHRDLAARNVLVKTPQHVKIT  159 (327)
T ss_dssp             EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEETTEEEEC
T ss_pred             EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh----hCCCcCCCCCHHHEEEcCCCCEEEc
Confidence            99999999999999876667899999999999999999999    8899999999999999999999885

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.93  E-value=1.8e-25  Score=179.86  Aligned_cols=138  Identities=26%  Similarity=0.406  Sum_probs=117.0

Q ss_pred             ccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccC
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      +.|++.+.||+|+||.||+|+.. ++.||+|.+...  ...+.+.+|+.+++.++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            45778899999999999999875 788999998533  345778899999999999999999998764  4789999999


Q ss_pred             CCChhhhhccCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCc-eeec
Q 042107          168 HGSLGKCLSTSNY--ILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV-AHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~-~~l~  231 (232)
                      +|+|.+++.....  .+++..+..++.|+++||.|||..+ ..+|+||||||+||+++.++. +||+
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~-~~~ivH~dlkp~NIll~~~~~~~kl~  148 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ-PKALIHRDLKPPNLLLVAGGTVLKIC  148 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCS-SSCCCCCCCSGGGEEEETTTTEEEEC
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCC-CCCeecCCCChhHEEEeCCCCEEEEc
Confidence            9999999976532  3678888999999999999999322 168999999999999988876 6775

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.93  E-value=1.8e-25  Score=178.80  Aligned_cols=139  Identities=22%  Similarity=0.378  Sum_probs=119.6

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      +.|++.+.||+|+||.||+|+.. +++.||+|.+....  ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (299)
T 2r3i_A            3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence            34678899999999999999765 68999999986543  2234678889999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |++ ++|.+++.... ..+++..+..++.|++.||.|||    ..+++||||||+||+++.++.+||+
T Consensus        83 ~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nili~~~~~~kl~  145 (299)
T 2r3i_A           83 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH----SHRVLHRDLKPQNLLINTEGAIKLA  145 (299)
T ss_dssp             CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred             ccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCCCHHHeEEcCCCCEEEC
Confidence            997 59999887642 35788899999999999999999    8899999999999999999999886

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.93  E-value=2.1e-25  Score=178.81  Aligned_cols=137  Identities=16%  Similarity=0.236  Sum_probs=116.6

Q ss_pred             ccccceee-ecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHh-cCCCCCCccceeEEEec----CCe
Q 042107           86 FRNFLEVF-NLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMM-KIIRHQNLIKIISSCSK----DDF  158 (232)
Q Consensus        86 ~~~~~~~~-~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~----~~~  158 (232)
                      +.+.|.+. +.||+|+||.||+|.. .+++.||+|.+...     ..+.+|+.++ +..+||||+++++++..    ...
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            33445555 7899999999999976 47899999998642     4567788877 66789999999999876    667


Q ss_pred             eEEEEeccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC---CCceeec
Q 042107          159 KALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD---NMVAHFL  231 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~---~~~~~l~  231 (232)
                      .++||||+++|+|.+++.... ..+++..+..++.|++.||.|||    ..+|+||||||+||+++.   ++.++|+
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~~~kl~  162 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLT  162 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence            899999999999999997653 35899999999999999999999    889999999999999998   7778875

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.93  E-value=9.9e-26  Score=178.65  Aligned_cols=140  Identities=24%  Similarity=0.354  Sum_probs=120.6

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEe--cCCeeEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCS--KDDFKALI  162 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~~lv  162 (232)
                      +.|++.+.||+|+||.||+|+.. +++.||+|.+.....  ...+.+.+|+.+++.++||||+++++++.  .....++|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            45788999999999999999765 689999999975432  33566888999999999999999999874  35788999


Q ss_pred             EeccCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCC-----eeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTS---NYILDFFQRLHIMIDVASAVEYLHFGHSTHV-----IIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~-----iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+++++|.+++...   ...+++..+..++.|++.||.|||    ..+     ++||||||+||+++.++.+||+
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~  158 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH----RRSDGGHTVLHRDLKPANVFLDGKQNVKLG  158 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----HHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred             EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh----cccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence            9999999999998743   334889999999999999999999    666     9999999999999999999885

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.93  E-value=5.9e-26  Score=182.97  Aligned_cols=141  Identities=25%  Similarity=0.397  Sum_probs=120.9

Q ss_pred             cccceeeecccCCCcceeeeEEe------CCCcEEEEEEeecccC-chHHHHHHHHHHhcCC-CCCCccceeEEEecCC-
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI------QDGMEVVVKGFNLQYG-GAFKNLDVECNMMKII-RHQNLIKIISSCSKDD-  157 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~-  157 (232)
                      .+.|++.+.||+|+||.||+|+.      .+++.||+|.+..... ...+.+.+|+.+++.+ +||||+++++++..++ 
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  105 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  105 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence            45678999999999999999963      3568899999875433 2345688899999999 6999999999987754 


Q ss_pred             eeEEEEeccCCCChhhhhccCCC---------------CCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceee
Q 042107          158 FKALILEYMPHGSLGKCLSTSNY---------------ILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL  222 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill  222 (232)
                      ..++||||+++++|.+++.....               .+++..+..++.|++.||.|||    ..+|+||||||+||++
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH----~~~i~H~dikp~Nil~  181 (316)
T 2xir_A          106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILL  181 (316)
T ss_dssp             CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEE
T ss_pred             ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH----hCCcccccCccceEEE
Confidence            58999999999999999976532               2788899999999999999999    8899999999999999


Q ss_pred             CCCCceeec
Q 042107          223 DDNMVAHFL  231 (232)
Q Consensus       223 ~~~~~~~l~  231 (232)
                      +.++.+||+
T Consensus       182 ~~~~~~kl~  190 (316)
T 2xir_A          182 SEKNVVKIC  190 (316)
T ss_dssp             CGGGCEEEC
T ss_pred             CCCCCEEEC
Confidence            999999885

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.93  E-value=4.6e-26  Score=185.13  Aligned_cols=141  Identities=27%  Similarity=0.369  Sum_probs=121.5

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CC-----cEEEEEEeecccC-chHHHHHHHHHHhcCC-CCCCccceeEEEecCCe
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DG-----MEVVVKGFNLQYG-GAFKNLDVECNMMKII-RHQNLIKIISSCSKDDF  158 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  158 (232)
                      .+.|++.+.||+|+||.||+|+.. ++     ..||+|.+..... ...+.+.+|+.+++.+ +||||+++++++..++.
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  124 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP  124 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence            355788999999999999999754 22     4799999865432 3456788999999999 89999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccC-------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC
Q 042107          159 KALILEYMPHGSLGKCLSTS-------------NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN  225 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~-------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~  225 (232)
                      .++||||+++|+|.+++...             ...+++..+..++.|++.||.|||    ..+|+||||||+||+++.+
T Consensus       125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA----SKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGCEEEGG
T ss_pred             eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh----cCCcccCCcccceEEECCC
Confidence            99999999999999988642             234788899999999999999999    8899999999999999999


Q ss_pred             Cceeec
Q 042107          226 MVAHFL  231 (232)
Q Consensus       226 ~~~~l~  231 (232)
                      +.+||+
T Consensus       201 ~~~kl~  206 (333)
T 2i1m_A          201 HVAKIG  206 (333)
T ss_dssp             GEEEBC
T ss_pred             CeEEEC
Confidence            998875

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.93  E-value=9.3e-26  Score=179.77  Aligned_cols=140  Identities=24%  Similarity=0.321  Sum_probs=114.4

Q ss_pred             cccceeeecccCCCcceeeeEEeC--CCc--EEEEEEeecc---cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCee
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ--DGM--EVVVKGFNLQ---YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFK  159 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  159 (232)
                      .+.|++.+.||+|+||.||+|++.  +++  .||+|.+...   .....+.+.+|+.+++.++||||+++++++..++ .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            356789999999999999999753  333  6899988654   2334577889999999999999999999988765 8


Q ss_pred             EEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          160 ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++||||+++++|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dikp~Nili~~~~~~kl~  163 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE----SKRFIHRDLAARNLLLATRDLVKIG  163 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEEEETTEEEEC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH----hCCcccCCCchheEEEcCCCCEEEc
Confidence            8999999999999999765456889999999999999999999    8899999999999999999988875

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.93  E-value=2.3e-25  Score=178.72  Aligned_cols=140  Identities=19%  Similarity=0.293  Sum_probs=117.8

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc----CchHHHHHHHHHHhcCCCCCCccceeEEEe--cCCee
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY----GGAFKNLDVECNMMKIIRHQNLIKIISSCS--KDDFK  159 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~--~~~~~  159 (232)
                      .+.|++.+.||+|+||.||+|... +++.||+|.+....    ....+.+.+|+.+++.++||||+++++++.  ..+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            456788999999999999999764 68899999996542    334577889999999999999999999984  44578


Q ss_pred             EEEEeccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          160 ALILEYMPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++||||++++ +.+++... ...+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH----~~~i~H~dlkp~NIl~~~~~~~kl~  151 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH----SQGIVHKDIKPGNLLLTTGGTLKIS  151 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCcccEEEcCCCcEEee
Confidence            9999999886 66666542 345889999999999999999999    8899999999999999999999885

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.93  E-value=1.8e-25  Score=185.74  Aligned_cols=137  Identities=18%  Similarity=0.324  Sum_probs=120.3

Q ss_pred             ccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccC--chHHHHHHHHHHhcCCC--CCCccceeEEEecCCeeEEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIR--HQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv~  163 (232)
                      ..|++.+.||+|+||.||+|...+++.||||.+.....  ...+.+.+|+.+++.++  ||||+++++++..++..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            45889999999999999999887799999999975532  34567889999999996  599999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      | +.+++|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++ ++.+||+
T Consensus       136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH----~~~ivHrDlkp~NIll~-~~~~kl~  196 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLIV-DGMLKLI  196 (390)
T ss_dssp             E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH----TTTCCCCCCCGGGEEES-SSCEEEC
T ss_pred             e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCCHHHEEEE-CCeEEEE
Confidence            9 56889999998654 5788889999999999999999    88999999999999996 5778875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.93  E-value=6.5e-26  Score=179.75  Aligned_cols=138  Identities=28%  Similarity=0.424  Sum_probs=118.8

Q ss_pred             cccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecC-CeeEEEEec
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKD-DFKALILEY  165 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~  165 (232)
                      .+.|++.+.||+|+||.||+++.. ++.||+|.+...  ...+.+.+|+.+++.++||||+++++++... +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            355789999999999999999875 889999998644  2457788999999999999999999987554 478999999


Q ss_pred             cCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++++|.+++.... ..+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~l~  159 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSEDNVAKVS  159 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH----hCCccccCCCcceEEEeCCCcEEEe
Confidence            99999999987542 12678889999999999999999    8899999999999999999999885

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.93  E-value=3.2e-25  Score=183.66  Aligned_cols=136  Identities=21%  Similarity=0.341  Sum_probs=113.3

Q ss_pred             cccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEec----------
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSK----------  155 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----------  155 (232)
                      .+.|++.+.||+|+||.||+|+. .+++.||+|++......    ..+|+.+++.++||||+++++++..          
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~   81 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ   81 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence            45688999999999999999975 57999999998654322    2469999999999999999998843          


Q ss_pred             ----------------------------CCeeEEEEeccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 042107          156 ----------------------------DDFKALILEYMPHGSLGKCLST---SNYILDFFQRLHIMIDVASAVEYLHFG  204 (232)
Q Consensus       156 ----------------------------~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~  204 (232)
                                                  ....++||||+++ +|.+.+..   ....+++..+..++.|++.||.|||  
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--  158 (383)
T 3eb0_A           82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH--  158 (383)
T ss_dssp             ----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--
T ss_pred             cccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence                                        3348899999985 87776653   2446899999999999999999999  


Q ss_pred             CCCCCeeeCCCCCCceeeC-CCCceeec
Q 042107          205 HSTHVIIHCDLKSSNVLLD-DNMVAHFL  231 (232)
Q Consensus       205 ~~~~~iiHrdlk~~Nill~-~~~~~~l~  231 (232)
                        ..+|+||||||+||+++ .++.+||+
T Consensus       159 --~~gi~H~Dikp~Nil~~~~~~~~kl~  184 (383)
T 3eb0_A          159 --SLGICHRDIKPQNLLVNSKDNTLKLC  184 (383)
T ss_dssp             --TTTEECSCCCGGGEEEETTTTEEEEC
T ss_pred             --HCcCccCccCHHHEEEcCCCCcEEEE
Confidence              88999999999999997 67888875

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.93  E-value=3.9e-25  Score=179.31  Aligned_cols=136  Identities=21%  Similarity=0.340  Sum_probs=119.7

Q ss_pred             cccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCC-CCCccceeEEEec--CCeeE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-HQNLIKIISSCSK--DDFKA  160 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~--~~~~~  160 (232)
                      ...+.|++.+.||+|+||.||+|+. .+++.||+|.+...   ..+.+.+|+.+++.++ ||||+++++++..  ....+
T Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~  109 (330)
T 3nsz_A           33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  109 (330)
T ss_dssp             EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred             cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence            3456688999999999999999975 57899999998643   3467889999999997 9999999999987  56789


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC-ceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM-VAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~-~~~l~  231 (232)
                      +||||+++++|.+++..    +++..+..++.|++.||.|||    ..+|+||||||+|||++.++ .+||+
T Consensus       110 lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dikp~Nil~~~~~~~~kl~  173 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH----SMGIMHRDVKPHNVMIDHEHRKLRLI  173 (330)
T ss_dssp             EEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHEEEcCCCCEEEEE
Confidence            99999999999998864    788889999999999999999    88999999999999999776 77775

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.93  E-value=2e-25  Score=178.16  Aligned_cols=138  Identities=22%  Similarity=0.329  Sum_probs=118.1

Q ss_pred             ccceeee-cccCCCcceeeeEEe---CCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           88 NFLEVFN-LISRGGFGSIYKARI---QDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        88 ~~~~~~~-~lg~g~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      +.|.+.+ .||+|+||.||+|..   .+++.||+|.+....  ....+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l   94 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML   94 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred             hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence            3466767 999999999999954   246889999986543  23357788999999999999999999998 5567889


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||+++++|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus        95 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dikp~Nil~~~~~~~kl~  159 (291)
T 1xbb_A           95 VMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKIS  159 (291)
T ss_dssp             EEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEEC
T ss_pred             EEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH----hCCeEcCCCCcceEEEeCCCcEEEc
Confidence            999999999999998653 4888999999999999999999    8899999999999999999998885

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.93  E-value=2e-25  Score=180.71  Aligned_cols=141  Identities=26%  Similarity=0.397  Sum_probs=123.2

Q ss_pred             ccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCC-CCCCccceeEEEec------CC
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKII-RHQNLIKIISSCSK------DD  157 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~------~~  157 (232)
                      ..+.|++.+.||+|+||.||+|+. .+++.||+|.+.... ...+.+.+|+.+++.+ +||||+++++++..      .+
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~  100 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD  100 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence            345678999999999999999986 478999999987543 3346788899999998 79999999999876      46


Q ss_pred             eeEEEEeccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          158 FKALILEYMPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ..++||||+++++|.+++... ...+++..+..++.|++.||.|||    ..+++||||||+||+++.++.++|+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~NIl~~~~~~~kl~  171 (326)
T 2x7f_A          101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH----QHKVIHRDIKGQNVLLTENAEVKLV  171 (326)
T ss_dssp             EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred             eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCcHHHEEEcCCCCEEEe
Confidence            789999999999999999754 235888899999999999999999    8899999999999999999999885

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.93  E-value=1.3e-25  Score=196.99  Aligned_cols=132  Identities=23%  Similarity=0.329  Sum_probs=115.9

Q ss_pred             ecccCCCcceeeeEEeC---CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           94 NLISRGGFGSIYKARIQ---DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      +.||+|+||.||+|.+.   +++.||||++....  ....+.+.+|+.+++.++||||+++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999643   46789999997543  2335789999999999999999999999865 457899999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH----~~~iiHrDLkp~NILl~~~~~~kL~  511 (635)
T 4fl3_A          454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKIS  511 (635)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred             CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHH----HCCEeCCCCChHhEEEeCCCCEEEE
Confidence            99999997643 5889999999999999999999    8899999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.93  E-value=1.6e-25  Score=183.07  Aligned_cols=139  Identities=22%  Similarity=0.206  Sum_probs=113.3

Q ss_pred             cccceeeecccCCCcceeeeEEeC----CCcEEEEEEeecccCch-----------HHHHHHHHHHhcCCCCCCccceeE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQYGGA-----------FKNLDVECNMMKIIRHQNLIKIIS  151 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~~~  151 (232)
                      .+.|.+.+.||+|+||.||+|+..    ++..+|+|.........           ...+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            456889999999999999999764    57789999987553221           123567888999999999999999


Q ss_pred             EEec----CCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC-
Q 042107          152 SCSK----DDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM-  226 (232)
Q Consensus       152 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~-  226 (232)
                      ++..    ....++||||+ +++|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++ 
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH----ENEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEESSST
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeCCCcCHHHEEEccCCC
Confidence            9887    67899999999 999999998654 6899999999999999999999    88999999999999999887 


Q ss_pred             -ceeec
Q 042107          227 -VAHFL  231 (232)
Q Consensus       227 -~~~l~  231 (232)
                       .+||+
T Consensus       190 ~~~kL~  195 (345)
T 2v62_A          190 DQVYLA  195 (345)
T ss_dssp             TSEEEC
T ss_pred             CcEEEE
Confidence             88875

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.93  E-value=3.2e-25  Score=182.94  Aligned_cols=138  Identities=21%  Similarity=0.282  Sum_probs=119.6

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCC-----
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDD-----  157 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  157 (232)
                      +.+.|++.+.||+|+||.||+|+.. +++.||+|++.....  ...+.+.+|+.+++.++||||+++++++...+     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            4466889999999999999999754 688999999975432  23466788999999999999999999987654     


Q ss_pred             -eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          158 -FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       158 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                       ..++||||+++ +|.+.+..   .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH----~~~ivH~Dlkp~NIl~~~~~~~kl~  169 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKIL  169 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             cceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH----HCCeecccCCHHHEEEcCCCCEEEE
Confidence             78999999975 78888764   3788899999999999999999    8899999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.93  E-value=1.6e-25  Score=184.55  Aligned_cols=139  Identities=21%  Similarity=0.326  Sum_probs=112.6

Q ss_pred             ccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecC------
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKD------  156 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  156 (232)
                      +.+.|++.+.||+|+||.||+|.. .+++.||+|++.....  ...+.+.+|+.+++.++||||+++++++...      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            345688999999999999999975 5789999999865422  2356778899999999999999999998654      


Q ss_pred             CeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          157 DFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       157 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ...+++|||+ +++|.+++...  .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH----~~givH~Dlkp~NIll~~~~~~kL~  174 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKIL  174 (367)
T ss_dssp             CCCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CeEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCeeeCCCCHhhEEECCCCCEEEe
Confidence            5679999999 67999988753  5889999999999999999999    8899999999999999999999986

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.92  E-value=3.4e-25  Score=176.40  Aligned_cols=140  Identities=21%  Similarity=0.209  Sum_probs=116.1

Q ss_pred             cccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCc--hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGG--AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      .+.|++.+.||+|+||.||+|+. .+++.||+|.+......  ..+.+..+...++.++||||+++++++..++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            35578899999999999999976 47899999998654322  2233444555688899999999999999999999999


Q ss_pred             eccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-CeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLST---SNYILDFFQRLHIMIDVASAVEYLHFGHSTH-VIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+++ +|.+++..   ....+++..+..++.|++.||.|||    .. +++||||||+||+++.++.+||+
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~~i~H~dlkp~Nil~~~~~~~kl~  152 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH----SKLSVIHRDVKPSNVLINALGQVKMC  152 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----HHSCCCCCCCSGGGCEECTTCCEEBC
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh----hcCCeecCCCCHHHEEECCCCCEEEe
Confidence            99975 88777653   3446899999999999999999999    76 99999999999999999999885

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.92  E-value=4.3e-25  Score=181.72  Aligned_cols=138  Identities=20%  Similarity=0.240  Sum_probs=119.8

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecC-----Cee
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKD-----DFK  159 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  159 (232)
                      .+.|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            356889999999999999999754 688999999865432 2346788999999999999999999998664     368


Q ss_pred             EEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          160 ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++||||+++ +|.+++...  .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus       106 ~iv~e~~~~-~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIl~~~~~~~kl~  170 (364)
T 3qyz_A          106 YIVQDLMET-DLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKIC  170 (364)
T ss_dssp             EEEEECCSE-EHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEcccCc-CHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCChHhEEECCCCCEEEE
Confidence            999999974 999988764  4889999999999999999999    8899999999999999999999885

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.92  E-value=3.1e-25  Score=195.16  Aligned_cols=140  Identities=21%  Similarity=0.329  Sum_probs=121.4

Q ss_pred             cccceeeecccCCCcceeeeEEeC----CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ----DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      .+.|++.+.||+|+||.||+|++.    .+..||+|.+..... ...+.+.+|+.+++.++||||+++++++. ++..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence            455788999999999999999764    245799998865432 23467889999999999999999999984 466899


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||+++|+|.+++......+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus       468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~givHrDikp~NILl~~~~~vkL~  533 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLG  533 (656)
T ss_dssp             EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred             EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH----hCCccccccchHhEEEeCCCCEEEE
Confidence            99999999999999876656899999999999999999999    8899999999999999999999886

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.92  E-value=5.2e-25  Score=180.19  Aligned_cols=140  Identities=24%  Similarity=0.282  Sum_probs=121.3

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecC-----C
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKD-----D  157 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~  157 (232)
                      .+.+.|++.+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+.+++.++||||+++++++..+     .
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            45667889999999999999999765 689999999864432 2345677899999999999999999987654     6


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          158 FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ..++||||++ ++|.+++...  .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus        88 ~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH----~~~ivH~Dlkp~Nil~~~~~~~kl~  154 (353)
T 2b9h_A           88 EVYIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH----GSNVIHRDLKPSNLLINSNCDLKVC  154 (353)
T ss_dssp             CEEEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEEC
T ss_pred             eEEEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEEcCCCcEEEE
Confidence            7899999997 5899988764  4889999999999999999999    8899999999999999999999885

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.92  E-value=6.5e-25  Score=174.81  Aligned_cols=142  Identities=22%  Similarity=0.343  Sum_probs=123.8

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      .+.+.|++.+.||+|+||.||+|+.. +++.||+|.+....  ....+.+.+|+.+++.++||||+++++++...+..++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            45567889999999999999999765 68999999986543  3346778899999999999999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC---ceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM---VAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~---~~~l~  231 (232)
                      ||||+++++|.+++.... .+++..+..++.|++.||.|||    ..+++||||||+||+++.++   .+||+
T Consensus        99 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH----~~~i~H~dl~p~NIlv~~~~~~~~~kL~  166 (287)
T 2wei_A           99 VGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH----KHNIVHRDLKPENILLESKEKDCDIKII  166 (287)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeccCCChhhEEEecCCCcccEEEe
Confidence            999999999998886543 4889999999999999999999    88999999999999997643   57764

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.92  E-value=3.5e-25  Score=176.75  Aligned_cols=143  Identities=22%  Similarity=0.349  Sum_probs=115.1

Q ss_pred             CCCcccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEE-ecCCee
Q 042107           82 IPRPFRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSC-SKDDFK  159 (232)
Q Consensus        82 ~p~~~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~  159 (232)
                      ++..+.+.|++.+.||+|+||.||+|+. .+++.||+|.+.....  .+.+..|+.+++.++|++++..+..+ ...+..
T Consensus         3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (296)
T 4hgt_A            3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             --------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred             cccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence            4445667789999999999999999975 5789999998754432  23477899999999988877766654 667788


Q ss_pred             EEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceee---CCCCceeec
Q 042107          160 ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL---DDNMVAHFL  231 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill---~~~~~~~l~  231 (232)
                      ++||||+ +++|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||++   +.++.+||+
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH----~~~ivH~Dlkp~NIl~~~~~~~~~~kL~  150 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYII  150 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECCGGGTTCEEEC
T ss_pred             EEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeeeeccCCCCeEEEe
Confidence            9999999 99999999865556899999999999999999999    8899999999999999   788888875

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.92  E-value=1.6e-25  Score=184.78  Aligned_cols=137  Identities=10%  Similarity=0.090  Sum_probs=102.3

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC---chHHHHHHH---HHHhcCCCCCCcccee-------EEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG---GAFKNLDVE---CNMMKIIRHQNLIKII-------SSCS  154 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e---~~~l~~l~h~niv~~~-------~~~~  154 (232)
                      .|.+.+.||+|+||.||+|+.. +++.||+|++.....   ...+.+.+|   +..++. +||||++++       +++.
T Consensus        63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred             eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence            4778999999999999999864 789999999987543   234556677   455566 799988754       4444


Q ss_pred             cC-----------------CeeEEEEeccCCCChhhhhccCCCCCCHHHH------HHHHHHHHHHHHHHhcCCCCCCee
Q 042107          155 KD-----------------DFKALILEYMPHGSLGKCLSTSNYILDFFQR------LHIMIDVASAVEYLHFGHSTHVII  211 (232)
Q Consensus       155 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~------~~i~~~i~~~l~~lH~~~~~~~ii  211 (232)
                      .+                 ...++||||++ |+|.+++...+..+++..+      ..++.|++.||.|||    ..+|+
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH----~~~iv  216 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ----SKGLV  216 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH----HTTEE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH----HCCCc
Confidence            33                 33799999998 8999999864333455555      678899999999999    88999


Q ss_pred             eCCCCCCceeeCCCCceeec
Q 042107          212 HCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       212 Hrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||||+|||++.++.+||+
T Consensus       217 HrDikp~NIll~~~~~~kL~  236 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLG  236 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEEC
T ss_pred             cCcCCHHHEEECCCCCEEEE
Confidence            99999999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.92  E-value=6.8e-25  Score=178.66  Aligned_cols=140  Identities=26%  Similarity=0.408  Sum_probs=119.8

Q ss_pred             ccccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcC--CCCCCccceeEEEecCC----ee
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKI--IRHQNLIKIISSCSKDD----FK  159 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~----~~  159 (232)
                      +.+.|.+.+.||+|+||.||+|+. +++.||+|.+...   ..+.+.+|.+++..  ++||||+++++++...+    ..
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~  115 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL  115 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred             ccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence            456788999999999999999987 4889999998644   23556778887776  79999999999998775    78


Q ss_pred             EEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcC----CCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          160 ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG----HSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++||||+++|+|.+++...  .+++..+..++.|++.||.|||..    +...+|+||||||+||+++.++.+||+
T Consensus       116 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~  189 (342)
T 1b6c_B          116 WLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  189 (342)
T ss_dssp             EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred             EEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence            9999999999999999764  488999999999999999999932    113589999999999999999999886

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.92  E-value=5.9e-25  Score=175.53  Aligned_cols=143  Identities=22%  Similarity=0.348  Sum_probs=120.3

Q ss_pred             CCCcccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEE-ecCCee
Q 042107           82 IPRPFRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSC-SKDDFK  159 (232)
Q Consensus        82 ~p~~~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~-~~~~~~  159 (232)
                      +...+.+.|++.+.||+|+||.||+|+. .+++.||+|.+.....  .+.+.+|+.+++.++|++++..+..+ ...+..
T Consensus         3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (296)
T 3uzp_A            3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             --CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred             ccceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence            3445667789999999999999999975 5789999999865432  24578899999999988876666554 567788


Q ss_pred             EEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeC---CCCceeec
Q 042107          160 ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD---DNMVAHFL  231 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~---~~~~~~l~  231 (232)
                      ++||||+ +++|.+++......+++..+..++.|++.||.|||    ..+|+||||||+||+++   .++.+||+
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH----~~~ivH~dlkp~NIl~~~~~~~~~~kl~  150 (296)
T 3uzp_A           81 VMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYII  150 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred             EEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH----hCCeeeCCCCHHHeEEecCCCCCeEEEe
Confidence            9999999 89999999865556899999999999999999999    88999999999999994   77888875

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.92  E-value=3e-25  Score=196.43  Aligned_cols=139  Identities=24%  Similarity=0.361  Sum_probs=117.3

Q ss_pred             cccccceeeecccCCCcceeeeEEeC--CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCe---
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ--DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF---  158 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---  158 (232)
                      .+.+.|++.+.||+|+||.||+|+..  +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+.   
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            45577899999999999999999764  68899999886443 2334567889999999999999999999887654   


Q ss_pred             --eEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          159 --KALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       159 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                        .|+||||+++++|.+++..   .+++..+..++.|++.||.|+|    ..+|+||||||+|||++.+ .+||+
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH----~~giiHrDlkp~NIll~~~-~~kl~  223 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH----SIGLVYNDLKPENIMLTEE-QLKLI  223 (681)
T ss_dssp             EEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECSS-CEEEC
T ss_pred             ceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH----HCCCeecccChHHeEEeCC-cEEEE
Confidence              6999999999999988765   4899999999999999999999    8899999999999999985 67764

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.92  E-value=1.5e-25  Score=180.82  Aligned_cols=138  Identities=26%  Similarity=0.424  Sum_probs=118.6

Q ss_pred             cccceeeecccCCCcceeeeEEeCCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .+.|++.+.||+|+||.||+|+...  .+|+|.+....  ....+.+.+|+.+++.++||||+++++++..++..+++||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            3457788999999999999998753  48999886542  2233556779999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++++|.+++......+++..+..++.|++.||.|||    ..+++||||||+||+++ ++.++|+
T Consensus       110 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH----~~~i~H~dlkp~NIl~~-~~~~~l~  171 (319)
T 2y4i_B          110 LCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH----AKGILHKDLKSKNVFYD-NGKVVIT  171 (319)
T ss_dssp             CCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH----HTTCCCCCCCSTTEEEC---CCEEC
T ss_pred             cccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----hCCccccCCChhhEEEe-CCCEEEe
Confidence            99999999999876666899999999999999999999    88999999999999998 5677764

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.92  E-value=7.1e-25  Score=180.92  Aligned_cols=138  Identities=18%  Similarity=0.307  Sum_probs=120.0

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCc--hHHHHHHHHHHhcCCCCCCccceeEEEecCCee---
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGG--AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFK---  159 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~---  159 (232)
                      +.+.|.+.+.||+|+||.||+|+.. +++.||+|++......  ..+.+.+|+.+++.++||||+++++++...+..   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            4566888999999999999999754 6899999999654322  346788899999999999999999999877654   


Q ss_pred             ---EEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          160 ---ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       160 ---~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                         ++||||++ ++|.+++..   .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~Dikp~NIll~~~~~~kL~  186 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH----SAGVVHRDLKPGNLAVNEDCELKIL  186 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred             eeEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCcCHHHeEECCCCCEEEE
Confidence               99999997 588888754   3889999999999999999999    8899999999999999999999885

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.92  E-value=5e-25  Score=183.24  Aligned_cols=141  Identities=22%  Similarity=0.357  Sum_probs=114.1

Q ss_pred             CCcccccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCC-----
Q 042107           83 PRPFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD-----  157 (232)
Q Consensus        83 p~~~~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  157 (232)
                      .......|.+.+.||+|+||.||+|+...+..+|+|++......    ..+|+++++.++||||+++++++...+     
T Consensus        35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~  110 (394)
T 4e7w_A           35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE  110 (394)
T ss_dssp             CCEEEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred             CCcccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence            33455678999999999999999999877777999988644322    236999999999999999999985433     


Q ss_pred             -eeEEEEeccCCCChhhhhc--cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeC-CCCceeec
Q 042107          158 -FKALILEYMPHGSLGKCLS--TSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD-DNMVAHFL  231 (232)
Q Consensus       158 -~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~-~~~~~~l~  231 (232)
                       ..++||||++++.+.....  .....+++..+..++.|++.||.|||    ..+|+||||||+|||++ .++.+||+
T Consensus       111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~Nill~~~~~~~kL~  184 (394)
T 4e7w_A          111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH----SIGICHRDIKPQNLLLDPPSGVLKLI  184 (394)
T ss_dssp             EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----HCCccCCCCCHHHEEEcCCCCcEEEe
Confidence             4789999998754333221  12345888999999999999999999    88999999999999999 78888885

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.92  E-value=4.6e-25  Score=184.00  Aligned_cols=138  Identities=20%  Similarity=0.315  Sum_probs=108.9

Q ss_pred             ccccee-eecccCCCcceeeeEEeC---CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEec--CCeeE
Q 042107           87 RNFLEV-FNLISRGGFGSIYKARIQ---DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSK--DDFKA  160 (232)
Q Consensus        87 ~~~~~~-~~~lg~g~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~  160 (232)
                      .+.|++ .++||+|+||.||+|+..   +++.||+|.+....  ....+.+|+.+++.++||||+++++++..  ....+
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            344555 458999999999999865   57889999986443  23567889999999999999999999854  67899


Q ss_pred             EEEeccCCCChhhhhccC--------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceee----CCCCce
Q 042107          161 LILEYMPHGSLGKCLSTS--------NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL----DDNMVA  228 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill----~~~~~~  228 (232)
                      +||||+++ +|.+++...        ...+++..+..++.|++.||.|||    ..+|+||||||+|||+    +.++.+
T Consensus        97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH----~~~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH----ANWVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH----hCCEeCCCcCHHHeEEecCCCCCCcE
Confidence            99999975 787776521        224888999999999999999999    8899999999999999    677888


Q ss_pred             eec
Q 042107          229 HFL  231 (232)
Q Consensus       229 ~l~  231 (232)
                      ||+
T Consensus       172 kl~  174 (405)
T 3rgf_A          172 KIA  174 (405)
T ss_dssp             EEC
T ss_pred             EEE
Confidence            885

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.92  E-value=1.1e-24  Score=178.54  Aligned_cols=138  Identities=18%  Similarity=0.292  Sum_probs=119.1

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCCe----
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF----  158 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----  158 (232)
                      +.+.|.+.+.||+|+||.||+|+.. +|+.||+|.+.....  ...+.+.+|+.+++.++||||+++++++...+.    
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            3456788999999999999999764 689999999865432  234667889999999999999999999987654    


Q ss_pred             --eEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          159 --KALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       159 --~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                        .++||||++ ++|.+++..   .+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH----~~~ivH~dlkp~NIl~~~~~~~kl~  168 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH----SAGVVHRDLKPGNLAVNEDCELKIL  168 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSSCCGGGEEECTTCCEEEC
T ss_pred             eeEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEeECCCCcEEEe
Confidence              499999997 588888754   3889999999999999999999    8899999999999999999999886

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.92  E-value=5.7e-25  Score=190.45  Aligned_cols=130  Identities=18%  Similarity=0.155  Sum_probs=103.2

Q ss_pred             ecccCCCcceeeeEE-eCCCcEEEEEEeeccc----------CchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEE
Q 042107           94 NLISRGGFGSIYKAR-IQDGMEVVVKGFNLQY----------GGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~l  161 (232)
                      ...+.|++|.+..++ .-.|+.+++|.+....          ....+++.+|+++|+++ .|+||+++++++++++..||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            345667777766664 3468899999996542          12346689999999999 69999999999999999999


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||++|++|.+++...+ .++..   +|+.||+.||.|+|    .++||||||||+|||++.+|.+||+
T Consensus       320 VMEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH----~~GIIHRDIKPeNILL~~dg~vKL~  381 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALE----KQGFWHDDVRPWNVMVDARQHARLI  381 (569)
T ss_dssp             EEECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHH----HTTCEESCCCGGGEEECTTSCEEEC
T ss_pred             EEecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHH----HCCceeccCchHhEEECCCCCEEEe
Confidence            999999999999998754 35543   58899999999999    8899999999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.92  E-value=5.1e-25  Score=182.70  Aligned_cols=138  Identities=21%  Similarity=0.265  Sum_probs=114.0

Q ss_pred             CCcccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCC--------CCCccceeEEE
Q 042107           83 PRPFRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR--------HQNLIKIISSC  153 (232)
Q Consensus        83 p~~~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~  153 (232)
                      ...+.+.|++.+.||+|+||.||+|+. .+++.||+|++... ....+.+.+|+.+++.++        ||||+++++++
T Consensus        32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~  110 (397)
T 1wak_A           32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF  110 (397)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred             hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence            345567789999999999999999975 46889999998643 233466788999998885        78899999998


Q ss_pred             e----cCCeeEEEEeccCCCChhhhhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-CeeeCCCCCCceeeCCCC
Q 042107          154 S----KDDFKALILEYMPHGSLGKCLST-SNYILDFFQRLHIMIDVASAVEYLHFGHSTH-VIIHCDLKSSNVLLDDNM  226 (232)
Q Consensus       154 ~----~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-~iiHrdlk~~Nill~~~~  226 (232)
                      .    .....++||||+ ++++.+.+.. ....+++..+..++.|++.||.|||    .+ +|+||||||+|||++.++
T Consensus       111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH----~~~givHrDikp~NIll~~~~  184 (397)
T 1wak_A          111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH----TKCRIIHTDIKPENILLSVNE  184 (397)
T ss_dssp             EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH----HTTCEECCCCSGGGEEECCCH
T ss_pred             eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----HhCCEecCCCCHHHeeEeccc
Confidence            7    456789999999 5566555543 3345899999999999999999999    77 899999999999999876

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.92  E-value=1.8e-25  Score=183.10  Aligned_cols=135  Identities=18%  Similarity=0.228  Sum_probs=115.5

Q ss_pred             cccceeeecccCCCcceeeeEEeC---------CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccc---------
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ---------DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIK---------  148 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~---------  148 (232)
                      .+.|++.+.||+|+||.||+|+..         +++.||+|.+...     +.+.+|+.+++.++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            457889999999999999999765         3789999998754     35778999999999999987         


Q ss_pred             ------eeEEEec-CCeeEEEEeccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCce
Q 042107          149 ------IISSCSK-DDFKALILEYMPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNV  220 (232)
Q Consensus       149 ------~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Ni  220 (232)
                            +++++.. ++..++||||+ +++|.+++... ...+++..+..++.|++.||.|||    ..+|+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH----ENEYVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH----hCCccCCCCCHHHE
Confidence                  5667665 67889999999 99999999864 345899999999999999999999    88999999999999


Q ss_pred             eeCCCC--ceeec
Q 042107          221 LLDDNM--VAHFL  231 (232)
Q Consensus       221 ll~~~~--~~~l~  231 (232)
                      +++.++  .+||+
T Consensus       191 l~~~~~~~~~kl~  203 (352)
T 2jii_A          191 FVDPEDQSQVTLA  203 (352)
T ss_dssp             EEETTEEEEEEEC
T ss_pred             EEcCCCCceEEEe
Confidence            999998  77775

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.92  E-value=1.3e-24  Score=175.16  Aligned_cols=138  Identities=19%  Similarity=0.325  Sum_probs=120.6

Q ss_pred             cccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccC--chHHHHHHHHHHhcCCC--CCCccceeEEEecCCeeEEE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIR--HQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.|++.+.||+|+||.||+++..+++.||+|.+.....  ...+.+.+|+.+++.++  ||||+++++++..++..+++
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  106 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  106 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence            455889999999999999999888899999999975432  34567888999999997  59999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      || +.+++|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||++++ +.+||+
T Consensus       107 ~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH----~~~ivH~dlkp~NIl~~~-~~~kL~  168 (313)
T 3cek_A          107 ME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH----QHGIVHSDLKPANFLIVD-GMLKLI  168 (313)
T ss_dssp             EC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEEET-TEEEEC
T ss_pred             Ee-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCceecCCCcccEEEEC-CeEEEe
Confidence            99 56889999997653 5788899999999999999999    889999999999999965 777775

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.91  E-value=1.9e-24  Score=181.16  Aligned_cols=137  Identities=22%  Similarity=0.349  Sum_probs=112.0

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecC------Ce
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKD------DF  158 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  158 (232)
                      ....|++.+.||+|+||.||+|+.. +++.||||++.....    ...+|+++++.++||||+++++++...      ..
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence            3446889999999999999999875 689999999865422    234699999999999999999987431      24


Q ss_pred             eEEEEeccCCCChhhhhcc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC-Cceeec
Q 042107          159 KALILEYMPHGSLGKCLST---SNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN-MVAHFL  231 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~-~~~~l~  231 (232)
                      .++||||+++ ++.+.+..   ....+++..+..++.|++.||.|||    ..+|+||||||+|||++.+ +.+||+
T Consensus       128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH----~~~ivHrDlkp~NILl~~~~~~~kl~  199 (420)
T 1j1b_A          128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLC  199 (420)
T ss_dssp             EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH----HCCccccCCChhhEEEeCCCCeEEec
Confidence            6799999986 66655542   2346889999999999999999999    8899999999999999965 567875

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.91  E-value=1.3e-24  Score=175.87  Aligned_cols=141  Identities=22%  Similarity=0.377  Sum_probs=117.2

Q ss_pred             ccccceeeecccCCCcceeeeEEe--CCCcEEEEEEeecccC--chHHHHHHHHHHhcCC---CCCCccceeEEEe----
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI--QDGMEVVVKGFNLQYG--GAFKNLDVECNMMKII---RHQNLIKIISSCS----  154 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~----  154 (232)
                      ..+.|++.+.||+|+||.||+|+.  .+++.||+|.+.....  .....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            345688999999999999999986  4678999999865432  2223455677766655   8999999999987    


Q ss_pred             -cCCeeEEEEeccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          155 -KDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       155 -~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                       .....++||||++ |+|.+++.... ..+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.+||+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH----HCCceeccCCHHHeEEcCCCCEEEe
Confidence             4567899999998 59999987642 34889999999999999999999    8899999999999999999999885

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.91  E-value=2.9e-24  Score=180.54  Aligned_cols=141  Identities=19%  Similarity=0.286  Sum_probs=119.3

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCC------CCCCccceeEEEecCC
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKII------RHQNLIKIISSCSKDD  157 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~  157 (232)
                      .+...|++.+.||+|+||.||+|+.. +++.||+|++.... ...+.+.+|+.+++.+      .|+||+++++++...+
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            45567899999999999999999754 68899999986432 2335566777777665      6789999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCc--eeec
Q 042107          158 FKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV--AHFL  231 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~--~~l~  231 (232)
                      ..++||||++ ++|.+++.... ..+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.  +||+
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlKp~NILl~~~~~~~vkL~  244 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH----KNRIIHCDLKPENILLKQQGRSGIKVI  244 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HHTEECSCCSGGGEEESSTTSCCEEEC
T ss_pred             eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCeecCCCCHHHeEEccCCCcceEEe
Confidence            9999999996 58999887653 34889999999999999999999    889999999999999999887  7775

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.91  E-value=2.7e-25  Score=178.98  Aligned_cols=143  Identities=20%  Similarity=0.306  Sum_probs=113.1

Q ss_pred             CcccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCc------hHHHHHHHHHHhcCC----CCCCccceeEE
Q 042107           84 RPFRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGG------AFKNLDVECNMMKII----RHQNLIKIISS  152 (232)
Q Consensus        84 ~~~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l----~h~niv~~~~~  152 (232)
                      ..+.+.|++.+.||+|+||.||+|+. .+++.||+|.+......      ....+.+|+.+++.+    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            35667789999999999999999975 46889999998654321      122345578888777    89999999999


Q ss_pred             EecCCeeEEEEec-cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeC-CCCceee
Q 042107          153 CSKDDFKALILEY-MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD-DNMVAHF  230 (232)
Q Consensus       153 ~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~-~~~~~~l  230 (232)
                      +...+..++|||| +++++|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++ .++.++|
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH----~~~i~H~dlkp~Nil~~~~~~~~kl  181 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH----SRGVVHRDIKDENILIDLRRGCAKL  181 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HHTEECCCCSGGGEEEETTTTEEEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeecCCChhhEEEeCCCCeEEE
Confidence            9998999999999 78999999997643 4889999999999999999999    88999999999999999 7888887


Q ss_pred             c
Q 042107          231 L  231 (232)
Q Consensus       231 ~  231 (232)
                      +
T Consensus       182 ~  182 (312)
T 2iwi_A          182 I  182 (312)
T ss_dssp             C
T ss_pred             E
Confidence            5

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.91  E-value=1.2e-24  Score=176.04  Aligned_cols=143  Identities=22%  Similarity=0.314  Sum_probs=122.2

Q ss_pred             CcccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCc------hHHHHHHHHHHhcCCC--CCCccceeEEEe
Q 042107           84 RPFRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGG------AFKNLDVECNMMKIIR--HQNLIKIISSCS  154 (232)
Q Consensus        84 ~~~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~~~  154 (232)
                      ..+.+.|++.+.||+|+||.||+|+. .+++.||+|.+......      ..+.+.+|+.+++.++  ||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            35667789999999999999999975 47899999999765321      2244567888999886  599999999999


Q ss_pred             cCCeeEEEEeccCC-CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeC-CCCceeec
Q 042107          155 KDDFKALILEYMPH-GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD-DNMVAHFL  231 (232)
Q Consensus       155 ~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~-~~~~~~l~  231 (232)
                      .++..++|||++.+ ++|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+||+++ .++.+||+
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH----~~~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH----NCGVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH----HCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence            99999999999976 89999987643 5888999999999999999999    88999999999999999 77888885

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.91  E-value=3.7e-24  Score=180.15  Aligned_cols=134  Identities=23%  Similarity=0.311  Sum_probs=109.2

Q ss_pred             cccccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEEE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      .+.+.+...+.||+|+||.||.+...+|+.||||++...   ..+.+.+|+.+++.+ +||||+++++++.+++..++||
T Consensus        12 ~l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~   88 (434)
T 2rio_A           12 SLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL   88 (434)
T ss_dssp             SCSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence            455667778899999999998776667999999998654   235677899999875 8999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCC------CCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC
Q 042107          164 EYMPHGSLGKCLSTSNYI------LDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM  226 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~------~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~  226 (232)
                      |||. |+|.+++......      .++..+..++.|++.||.|||    ..+|+||||||+|||++.++
T Consensus        89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDLkp~NILl~~~~  152 (434)
T 2rio_A           89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH----SLKIIHRDLKPQNILVSTSS  152 (434)
T ss_dssp             CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEECCH
T ss_pred             ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH----HCCccccCCChHhEEEecCc
Confidence            9996 5999999765321      122234679999999999999    88999999999999997543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.91  E-value=4.3e-24  Score=181.64  Aligned_cols=139  Identities=21%  Similarity=0.301  Sum_probs=118.2

Q ss_pred             ccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCC-CCccceeEEEecCCeeEEEE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRH-QNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~  163 (232)
                      +.+.|++.+.||+|+||.||+|+. .+++.||||++......  +.+..|+++++.++| ++++.+..++...+..++||
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            456688999999999999999975 57899999988654332  347789999999987 55666666677788899999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceee---CCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL---DDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill---~~~~~~~l~  231 (232)
                      ||+ +++|.+++......+++..++.++.|++.||.|||    ..+|+||||||+|||+   +.++.+||+
T Consensus        83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH----~~gIvHrDIKP~NILl~~~~~~~~vkL~  148 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH----SKSFLHRDIKPDNFLMGLGRRANQVYII  148 (483)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECCGGGTTCEEEC
T ss_pred             ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----HCCEeecccCcceEEEecCCCCCeEEEE
Confidence            999 99999999865556999999999999999999999    8899999999999999   577888875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.91  E-value=4.4e-24  Score=173.08  Aligned_cols=139  Identities=22%  Similarity=0.247  Sum_probs=116.2

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC-chHHHHHHHHH-HhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG-GAFKNLDVECN-MMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      +.|++.+.||+|+||.||+|... +++.||+|.+..... .....+..|+. +++.++||||+++++++..++..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            45678899999999999999764 789999999976532 22344555555 7888999999999999999999999999


Q ss_pred             ccCCCChhhhhcc----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-CeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLST----SNYILDFFQRLHIMIDVASAVEYLHFGHSTH-VIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++ +|.+++..    ....+++..+..++.|++.||.|||    .. +++||||||+||+++.++.+||+
T Consensus       102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH----~~~~ivH~dlkp~NIll~~~~~~kl~  168 (327)
T 3aln_A          102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK----ENLKIIHRDIKPSNILLDRSGNIKLC  168 (327)
T ss_dssp             CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH----HHHSCCCSCCCGGGEEEETTTEEEEC
T ss_pred             ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh----ccCCEeECCCCHHHEEEcCCCCEEEc
Confidence            9986 78777652    2345889999999999999999999    77 99999999999999999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.91  E-value=5.5e-24  Score=173.36  Aligned_cols=139  Identities=18%  Similarity=0.234  Sum_probs=111.8

Q ss_pred             cccccceee-ecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEec----CCe
Q 042107           85 PFRNFLEVF-NLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSK----DDF  158 (232)
Q Consensus        85 ~~~~~~~~~-~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~  158 (232)
                      .+.+.|.+. +.||+|+||.||+|+.. +++.||+|++....    .........++.++||||+++++++..    ...
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            345667774 46999999999999765 68999999986431    122222334566789999999999876    446


Q ss_pred             eEEEEeccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC---Cceeec
Q 042107          159 KALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN---MVAHFL  231 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~---~~~~l~  231 (232)
                      .++||||+++|+|.+++.... ..+++..+..++.|++.||.|||    ..+|+||||||+||+++.+   +.+||+
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH----~~~ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH----SHNIAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCeecCCCCHHHEEEEecCCCceEEEe
Confidence            899999999999999998653 35899999999999999999999    8899999999999999864   447764

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.91  E-value=2.9e-24  Score=174.42  Aligned_cols=135  Identities=15%  Similarity=0.248  Sum_probs=115.6

Q ss_pred             CcccccceeeecccCCCcceeeeEEe--CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCC------CccceeEEEec
Q 042107           84 RPFRNFLEVFNLISRGGFGSIYKARI--QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQ------NLIKIISSCSK  155 (232)
Q Consensus        84 ~~~~~~~~~~~~lg~g~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~  155 (232)
                      ..+.+.|++.+.||+|+||.||+|..  .+++.||+|++.... ...+.+.+|+.+++.++|+      +++++++++..
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~   88 (339)
T 1z57_A           10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH   88 (339)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred             CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence            35667789999999999999999975  368899999986432 2346678889888877655      59999999999


Q ss_pred             CCeeEEEEeccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC
Q 042107          156 DDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD  224 (232)
Q Consensus       156 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~  224 (232)
                      .+..++||||+ +++|.+++.... ..+++..+..++.|++.||.|||    ..+|+||||||+||+++.
T Consensus        89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~ivH~Dlkp~Nil~~~  153 (339)
T 1z57_A           89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH----SNKLTHTDLKPENILFVQ  153 (339)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESC
T ss_pred             CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCHHHEEEec
Confidence            99999999999 889999987653 35788899999999999999999    889999999999999987

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.91  E-value=6.1e-24  Score=171.29  Aligned_cols=139  Identities=19%  Similarity=0.189  Sum_probs=109.7

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCch--HHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGA--FKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      +.|++.+.||+|+||.||+|+.. +++.||+|.+.......  .+.+..+..+++.++||||+++++++..++..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e  104 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME  104 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence            45778899999999999999865 78999999997653221  2334445567888999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-CeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH-VIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+ ++.+..+.......+++..+..++.|++.||.|||    .. +++||||||+||+++.++.+||+
T Consensus       105 ~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH----~~~~i~H~dlkp~Nil~~~~~~~kl~  167 (318)
T 2dyl_A          105 LM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK----EKHGVIHRDVKPSNILLDERGQIKLC  167 (318)
T ss_dssp             CC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH----HHHCCCCCCCCGGGEEECTTSCEEEC
T ss_pred             cc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH----hhCCEEeCCCCHHHEEECCCCCEEEE
Confidence            99 55666555543446889999999999999999999    74 89999999999999999999885

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.91  E-value=7.4e-24  Score=173.12  Aligned_cols=140  Identities=18%  Similarity=0.230  Sum_probs=115.6

Q ss_pred             ccCCCCCcccccceeeecccCCCcceeeeEEeC-CC-cEEEEEEeecccCchHHHHHHHHHHhcCCCCCC------ccce
Q 042107           78 LEGKIPRPFRNFLEVFNLISRGGFGSIYKARIQ-DG-MEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN------LIKI  149 (232)
Q Consensus        78 l~g~~p~~~~~~~~~~~~lg~g~~g~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~  149 (232)
                      +...+...+.+.|++.+.||+|+||.||+|+.. ++ +.||+|.+.... ...+.+.+|+.+++.++|++      ++.+
T Consensus         9 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~   87 (355)
T 2eu9_A            9 LVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLM   87 (355)
T ss_dssp             BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred             cccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence            344556677788999999999999999999764 44 689999986432 23466778999998887655      8999


Q ss_pred             eEEEecCCeeEEEEeccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeC
Q 042107          150 ISSCSKDDFKALILEYMPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD  223 (232)
Q Consensus       150 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~  223 (232)
                      ++++...+..++||||+ ++++.+++... ...+++..+..++.|++.||.|||    ..+|+||||||+|||++
T Consensus        88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH----~~~ivH~Dlkp~NIll~  157 (355)
T 2eu9_A           88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH----ENQLTHTDLKPENILFV  157 (355)
T ss_dssp             EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEES
T ss_pred             eeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH----HCCcccCCCCHHHEEEe
Confidence            99999999999999999 55676666544 345899999999999999999999    88999999999999993

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.90  E-value=4.5e-24  Score=179.42  Aligned_cols=128  Identities=20%  Similarity=0.296  Sum_probs=108.0

Q ss_pred             cceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEEEeccC
Q 042107           89 FLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      .|.+.+.||+|+||.|+.....+++.||||++.....   ..+.+|+.+++.+ +||||+++++++......|+|||||+
T Consensus        25 ~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~  101 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA  101 (432)
T ss_dssp             EEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             EEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence            3678899999999997655556789999999865432   2346799999988 79999999999999999999999996


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC
Q 042107          168 HGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD  224 (232)
Q Consensus       168 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~  224 (232)
                       |+|.+++........+..+..++.|++.||.|||    ..+|+||||||+|||++.
T Consensus       102 -g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH----~~~ivHrDlKp~NIll~~  153 (432)
T 3p23_A          102 -ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH----SLNIVHRDLKPHNILISM  153 (432)
T ss_dssp             -EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH----HTTCCCCCCSTTSEEECC
T ss_pred             -CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH----HCcCEeCCCCHHHEEEec
Confidence             5999999876544555566789999999999999    889999999999999953

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.90  E-value=1.3e-24  Score=189.71  Aligned_cols=144  Identities=25%  Similarity=0.334  Sum_probs=117.8

Q ss_pred             CcccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEec------
Q 042107           84 RPFRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSK------  155 (232)
Q Consensus        84 ~~~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------  155 (232)
                      ....+.|++.+.||+|+||.||+|+. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..      
T Consensus        10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~   89 (676)
T 3qa8_A           10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP   89 (676)
T ss_dssp             -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred             CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence            33446688999999999999999976 468999999986542 2335678889999999999999999998765      


Q ss_pred             CCeeEEEEeccCCCChhhhhccCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCc---eee
Q 042107          156 DDFKALILEYMPHGSLGKCLSTSN--YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV---AHF  230 (232)
Q Consensus       156 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~---~~l  230 (232)
                      .+..++||||+++|+|.+++....  ..+++..+..++.|++.||.|||    ..+|+||||||+||+++.++.   ++|
T Consensus        90 ~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH----s~gIVHrDLKP~NILl~~~g~~~~vKL  165 (676)
T 3qa8_A           90 NDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH----ENRIIHRDLKPENIVLQPGPQRLIHKI  165 (676)
T ss_dssp             TSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH----HTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred             CCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH----HCCCccCCCCHHHeEeecCCCceeEEE
Confidence            567899999999999999997643  24788889999999999999999    889999999999999997664   565


Q ss_pred             c
Q 042107          231 L  231 (232)
Q Consensus       231 ~  231 (232)
                      +
T Consensus       166 ~  166 (676)
T 3qa8_A          166 I  166 (676)
T ss_dssp             C
T ss_pred             c
Confidence            4

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.90  E-value=2.4e-23  Score=170.70  Aligned_cols=141  Identities=17%  Similarity=0.294  Sum_probs=102.6

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCC-------e
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD-------F  158 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------~  158 (232)
                      .+.|++.+.||+|+||.||+|+.. +++.||+|++..... .......|+..++.++||||+++++++...+       .
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  100 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY  100 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccccee
Confidence            345788999999999999999764 689999998865432 2344566777888889999999999986533       3


Q ss_pred             eEEEEeccCCCChhhhhc---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC-CCceeec
Q 042107          159 KALILEYMPHGSLGKCLS---TSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD-NMVAHFL  231 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~-~~~~~l~  231 (232)
                      .++||||+++ ++.+.+.   .....+++..+..++.|++.||.|+|..  ..+|+||||||+|||++. ++.+||+
T Consensus       101 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~--~~~ivH~Dlkp~NIll~~~~~~~kl~  174 (360)
T 3e3p_A          101 LNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP--SVNVCHRDIKPHNVLVNEADGTLKLC  174 (360)
T ss_dssp             EEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST--TTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred             EEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC--CCCeecCcCCHHHEEEeCCCCcEEEe
Confidence            7899999987 5544333   1234578888999999999999999933  458999999999999997 8888885

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.90  E-value=3.6e-23  Score=171.28  Aligned_cols=144  Identities=20%  Similarity=0.321  Sum_probs=118.4

Q ss_pred             CcccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCC-CC-----CccceeEEEecC
Q 042107           84 RPFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-HQ-----NLIKIISSCSKD  156 (232)
Q Consensus        84 ~~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~  156 (232)
                      ..+.+.|++.+.||+|+||.||+|+.. +++.||+|++.... .....+..|+.+++.++ |+     +|+++++++...
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            356678899999999999999999765 68899999986432 23456677888887774 44     499999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeC--CCCceeec
Q 042107          157 DFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD--DNMVAHFL  231 (232)
Q Consensus       157 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~--~~~~~~l~  231 (232)
                      +..++||||+++ +|.+++.... ..+++..+..++.|++.||.|||..  ..+|+||||||+|||++  .++.+||+
T Consensus       129 ~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~--~~~ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          129 NHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP--ELSIIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             TEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST--TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred             CceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC--CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence            999999999964 9999987653 3588999999999999999999932  35899999999999995  46778875

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=2.3e-23  Score=165.67  Aligned_cols=126  Identities=15%  Similarity=0.167  Sum_probs=101.3

Q ss_pred             cceeeecccCCCcceeeeEEeCCCcEEEEEEeecccC------------------chHHHHHHHHHHhcCCCCCCcccee
Q 042107           89 FLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYG------------------GAFKNLDVECNMMKIIRHQNLIKII  150 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~~~  150 (232)
                      .+.+.+.||+|+||.||+|+..+++.||+|.+.....                  .....+.+|+++++.++  | +++.
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            3456699999999999999887799999999854321                  12456889999999998  4 5555


Q ss_pred             EEEecCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceee
Q 042107          151 SSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHF  230 (232)
Q Consensus       151 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l  230 (232)
                      +++.. +..++||||+++++|.+ +..     +  ....++.|++.||.|+|    ..+|+||||||+|||++ ++.++|
T Consensus       168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~-----~--~~~~i~~qi~~~l~~lH----~~giiHrDlkp~NILl~-~~~vkl  233 (282)
T 1zar_A          168 KVYAW-EGNAVLMELIDAKELYR-VRV-----E--NPDEVLDMILEEVAKFY----HRGIVHGDLSQYNVLVS-EEGIWI  233 (282)
T ss_dssp             CEEEE-ETTEEEEECCCCEEGGG-CCC-----S--CHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEEE-TTEEEE
T ss_pred             eEEec-cceEEEEEecCCCcHHH-cch-----h--hHHHHHHHHHHHHHHHH----HCCCEeCCCCHHHEEEE-CCcEEE
Confidence            55433 45699999999999998 432     1  23468999999999999    88999999999999999 999988


Q ss_pred             c
Q 042107          231 L  231 (232)
Q Consensus       231 ~  231 (232)
                      +
T Consensus       234 ~  234 (282)
T 1zar_A          234 I  234 (282)
T ss_dssp             C
T ss_pred             E
Confidence            5

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.89  E-value=2.4e-23  Score=171.38  Aligned_cols=138  Identities=14%  Similarity=0.243  Sum_probs=115.2

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCC-----------CCCccceeEEEec
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-----------HQNLIKIISSCSK  155 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~  155 (232)
                      +.|++.+.||+|+||.||+|+. .+++.||+|.+.... ...+.+.+|+.+++.++           ||||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            4688999999999999999975 578999999986432 23466778998888776           8999999999876


Q ss_pred             CC----eeEEEEeccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC-CeeeCCCCCCceeeC------
Q 042107          156 DD----FKALILEYMPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTH-VIIHCDLKSSNVLLD------  223 (232)
Q Consensus       156 ~~----~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~-~iiHrdlk~~Nill~------  223 (232)
                      .+    ..+++|||+ +++|.+++... ...+++..+..++.|++.||.|||    .. +|+||||||+|||++      
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH----~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH----RRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH----HTTCEECSCCSGGGEEEEEEETTT
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH----hcCCEEecCCChHHeEEeccCCCc
Confidence            43    789999999 88999998764 334889999999999999999999    76 999999999999994      


Q ss_pred             CCCceeec
Q 042107          224 DNMVAHFL  231 (232)
Q Consensus       224 ~~~~~~l~  231 (232)
                      ..+.+||+
T Consensus       173 ~~~~~kl~  180 (373)
T 1q8y_A          173 NLIQIKIA  180 (373)
T ss_dssp             TEEEEEEC
T ss_pred             CcceEEEc
Confidence            34467765

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.88  E-value=1e-22  Score=175.44  Aligned_cols=123  Identities=18%  Similarity=0.211  Sum_probs=96.4

Q ss_pred             eecccCCCcceeeeEEeCCCcEEEEEEeecccCc--------hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           93 FNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGG--------AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .+.||+|+||.||+|++ .+..+++|........        ..+.+.+|+++++.++||||+++..++..++..++|||
T Consensus       341 ~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            56899999999999954 4778898876443211        13457899999999999999966555556777899999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+++++|.+++..         +..++.|+++||.|||    .++|+||||||+|||++.  .+||+
T Consensus       420 ~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH----~~gIiHrDiKp~NILl~~--~~kL~  471 (540)
T 3en9_A          420 YINGKLAKDVIED---------NLDIAYKIGEIVGKLH----KNDVIHNDLTTSNFIFDK--DLYII  471 (540)
T ss_dssp             CCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH----HTTEECTTCCTTSEEESS--SEEEC
T ss_pred             CCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH----HCcCccCCCCHHHEEECC--eEEEE
Confidence            9999999999875         4578999999999999    889999999999999998  77774

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.85  E-value=1.1e-21  Score=164.10  Aligned_cols=138  Identities=16%  Similarity=0.153  Sum_probs=103.1

Q ss_pred             cceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC---chHHHHHHHHHHhcCCCC-CCccc---------------
Q 042107           89 FLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG---GAFKNLDVECNMMKIIRH-QNLIK---------------  148 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~niv~---------------  148 (232)
                      .+...+.||+|+||.||+|+. .+++.||||++.....   ...+.+.+|+.+++.++| ++...               
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            356778999999999999985 5799999999874322   235778899999999987 22111               


Q ss_pred             ------eeEEEec-----CCeeEEEEeccCCCChhhhhc------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCee
Q 042107          149 ------IISSCSK-----DDFKALILEYMPHGSLGKCLS------TSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVII  211 (232)
Q Consensus       149 ------~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~ii  211 (232)
                            +...+..     ....+++|+++ +++|.+++.      .....+++..+..++.|++.||.|||    ..+|+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH----~~~ii  233 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH----HYGLV  233 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH----HTTEE
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH----hCCcc
Confidence                  1111111     12346677765 679998884      22334677788999999999999999    88999


Q ss_pred             eCCCCCCceeeCCCCceeec
Q 042107          212 HCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       212 Hrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||||+|||++.++.+||+
T Consensus       234 HrDiKp~NILl~~~~~~kL~  253 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLT  253 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEEC
T ss_pred             cCCcccceEEEecCCeEEEE
Confidence            99999999999999999986

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.80  E-value=1.8e-20  Score=147.13  Aligned_cols=130  Identities=19%  Similarity=0.223  Sum_probs=95.7

Q ss_pred             cceeeecccCCCcceeeeEEe-CCCcE--EEEEEeecccCc------------------------hHHHHHHHHHHhcCC
Q 042107           89 FLEVFNLISRGGFGSIYKARI-QDGME--VVVKGFNLQYGG------------------------AFKNLDVECNMMKII  141 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l  141 (232)
                      .+++.+.||+|+||.||+|.. .+|+.  ||||++......                        ....+.+|+..+..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            356788999999999999987 67888  999987443111                        013577899999999


Q ss_pred             CCCCc--cceeEEEecCCeeEEEEeccCC-C----ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCC
Q 042107          142 RHQNL--IKIISSCSKDDFKALILEYMPH-G----SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCD  214 (232)
Q Consensus       142 ~h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrd  214 (232)
                      .|+++  +..++.    +..++||||+.+ |    +|.++...    .++..+..++.|++.|+.|+|.   ..+|+|||
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~---~~givHrD  196 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ---EAELVHAD  196 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH---TSCEECSS
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH---HCCEEeCC
Confidence            88764  334432    346899999942 4    66655432    2234567899999999999993   34799999


Q ss_pred             CCCCceeeCCCCceeec
Q 042107          215 LKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       215 lk~~Nill~~~~~~~l~  231 (232)
                      |||+|||++.  .++|+
T Consensus       197 lkp~NILl~~--~~~li  211 (258)
T 1zth_A          197 LSEYNIMYID--KVYFI  211 (258)
T ss_dssp             CSTTSEEESS--SEEEC
T ss_pred             CCHHHEEEcC--cEEEE
Confidence            9999999988  66653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=9.8e-20  Score=149.35  Aligned_cols=125  Identities=16%  Similarity=0.139  Sum_probs=89.2

Q ss_pred             cceeeecccCCCcceeeeEEeCCCcEEEEEEeecccC--------------chHH--------HHHHHHHHhcCCCCCCc
Q 042107           89 FLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYG--------------GAFK--------NLDVECNMMKIIRHQNL  146 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~e~~~l~~l~h~ni  146 (232)
                      .|++...||+|++|.||+|...+|+.||||+++....              ....        ...+|...+..+.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            3788999999999999999988899999998753210              0011        12345666666644443


Q ss_pred             cceeEEEecCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC
Q 042107          147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM  226 (232)
Q Consensus       147 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~  226 (232)
                      ....-+..  ...++||||++|+++.++...     +  ....++.|++.++.|+|    ..+||||||||.|||+++++
T Consensus       176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~~-----~--~~~~l~~qll~~l~~lH----~~gIVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSSV-----P--DPASLYADLIALILRLA----KHGLIHGDFNEFNILIREEK  242 (397)
T ss_dssp             SCCCEEEE--ETTEEEEECCSCEEGGGCCCC-----S--CHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEEEEEE
T ss_pred             CCCeeeec--cCceEEEEecCCccHhhhccc-----H--HHHHHHHHHHHHHHHHH----HCCCcCCCCCHHHEEEeCCC
Confidence            22111111  124799999999988776432     1  23467899999999999    88999999999999998876

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.53  E-value=9.4e-15  Score=130.94  Aligned_cols=84  Identities=36%  Similarity=0.554  Sum_probs=79.7

Q ss_pred             CCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKD   70 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~   70 (232)
                      +++++|+.||||+|+|+|.+|..+           ++|+++|.+|..++++++|+.|||++|+++|.+|..+..++.|+.
T Consensus       629 ~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~  708 (768)
T 3rgz_A          629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTE  708 (768)
T ss_dssp             SSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSE
T ss_pred             hccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCE
Confidence            467889999999999999999875           789999999999999999999999999999999999999999999


Q ss_pred             cccccccccCCCCCc
Q 042107           71 LNLSFNTLEGKIPRP   85 (232)
Q Consensus        71 l~l~~n~l~g~~p~~   85 (232)
                      +++++|+++|.+|..
T Consensus       709 L~ls~N~l~g~iP~~  723 (768)
T 3rgz_A          709 IDLSNNNLSGPIPEM  723 (768)
T ss_dssp             EECCSSEEEEECCSS
T ss_pred             EECcCCcccccCCCc
Confidence            999999999999973

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.42  E-value=8.9e-13  Score=103.19  Aligned_cols=107  Identities=13%  Similarity=0.096  Sum_probs=81.7

Q ss_pred             ceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCC-CCCccceeEEEecCCeeEEEEeccCC
Q 042107           90 LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-HQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      |++....+.|+.+.||++... +..+++|............+.+|+.+++.+. +..++++++++...+..|+||||++|
T Consensus        16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   94 (263)
T 3tm0_A           16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG   94 (263)
T ss_dssp             SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred             ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence            556677888888999999754 6889999986532223345788998888774 67788999998888899999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHF  203 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~  203 (232)
                      .++.+.+..      ......++.++++++..||.
T Consensus        95 ~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~  123 (263)
T 3tm0_A           95 VLCSEEYED------EQSPEKIIELYAECIRLFHS  123 (263)
T ss_dssp             EEHHHHCCT------TTCHHHHHHHHHHHHHHHHH
T ss_pred             eehhhccCC------cccHHHHHHHHHHHHHHHhC
Confidence            999876421      11234677889999999995

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.39  E-value=3.6e-13  Score=120.74  Aligned_cols=63  Identities=37%  Similarity=0.587  Sum_probs=43.1

Q ss_pred             ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccccccccccCCCCCcccc
Q 042107           26 EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRN   88 (232)
Q Consensus        26 ~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~~~   88 (232)
                      ++|+++|.+|..++.+++|+.|+|++|+++|.+|..+.+++.|+.||+++|+++|.+|..+..
T Consensus       640 s~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~  702 (768)
T 3rgz_A          640 SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSA  702 (768)
T ss_dssp             CSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGG
T ss_pred             cCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhC
Confidence            456666677777777777777777777777777777777777777777777777777665543

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.29  E-value=3.9e-12  Score=95.09  Aligned_cols=84  Identities=20%  Similarity=0.255  Sum_probs=64.0

Q ss_pred             CCCEEEccCCcccccCCCc------------cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccc
Q 042107            6 VLLRIDLSTNNFSCVFPTT------------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNL   73 (232)
Q Consensus         6 ~l~~l~ls~N~~~g~~p~~------------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l   73 (232)
                      +|+.|+|++|.|++..|..            +++|++++..|..++.+++|+.|+|++|++++..|..+..+++|+.|++
T Consensus        30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  109 (192)
T 1w8a_A           30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence            6788888888887665542            2678888877888888888888888888888777777777888888888


Q ss_pred             ccccccCCCCCccccc
Q 042107           74 SFNTLEGKIPRPFRNF   89 (232)
Q Consensus        74 ~~n~l~g~~p~~~~~~   89 (232)
                      ++|.+++..|..+...
T Consensus       110 ~~N~l~~~~~~~~~~l  125 (192)
T 1w8a_A          110 YDNQISCVMPGSFEHL  125 (192)
T ss_dssp             CSSCCCEECTTSSTTC
T ss_pred             CCCcCCeeCHHHhhcC
Confidence            8888887777655543

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.27  E-value=3e-12  Score=102.93  Aligned_cols=88  Identities=25%  Similarity=0.462  Sum_probs=69.1

Q ss_pred             CCCCCCCEEEccC-CcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCC
Q 042107            2 SNLKVLLRIDLST-NNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK   69 (232)
Q Consensus         2 ~~~~~l~~l~ls~-N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~   69 (232)
                      +++++|++|||++ |.+.|.+|..+           ++|++++.+|..++.+++|+.|+|++|++++.+|..+..+++|+
T Consensus        73 ~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  152 (313)
T 1ogq_A           73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV  152 (313)
T ss_dssp             GGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCC
T ss_pred             hCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCC
Confidence            4577888888884 88888888754           56888888888888888888888888888888888888888888


Q ss_pred             ccccccccccCCCCCccccc
Q 042107           70 DLNLSFNTLEGKIPRPFRNF   89 (232)
Q Consensus        70 ~l~l~~n~l~g~~p~~~~~~   89 (232)
                      .++++.|.+++.+|..+...
T Consensus       153 ~L~L~~N~l~~~~p~~l~~l  172 (313)
T 1ogq_A          153 GITFDGNRISGAIPDSYGSF  172 (313)
T ss_dssp             EEECCSSCCEEECCGGGGCC
T ss_pred             eEECcCCcccCcCCHHHhhh
Confidence            88888888887777755443

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.27  E-value=2.6e-11  Score=94.44  Aligned_cols=96  Identities=17%  Similarity=0.115  Sum_probs=69.0

Q ss_pred             ccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCC--ccceeEEEecCCeeEEEEeccCCCChhh
Q 042107           96 ISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN--LIKIISSCSKDDFKALILEYMPHGSLGK  173 (232)
Q Consensus        96 lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~  173 (232)
                      .+.|..+.||++...+|..+++|.....   ....+..|+.+++.+.+.+  +++++++...++..++||||++|.++. 
T Consensus        28 ~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-  103 (264)
T 1nd4_A           28 TIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-  103 (264)
T ss_dssp             SCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred             ccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence            3456669999998777888999987543   2244677888888775434  567888887777889999999998884 


Q ss_pred             hhccCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 042107          174 CLSTSNYILDFFQRLHIMIDVASAVEYLHF  203 (232)
Q Consensus       174 ~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~  203 (232)
                       ...    .+   ...++.++++.+..+|.
T Consensus       104 -~~~----~~---~~~~~~~l~~~l~~lh~  125 (264)
T 1nd4_A          104 -SSH----LA---PAEKVSIMADAMRRLHT  125 (264)
T ss_dssp             -TSC----CC---HHHHHHHHHHHHHHHTT
T ss_pred             -cCc----CC---HhHHHHHHHHHHHHHhC
Confidence             221    11   23566778888888884

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.27  E-value=2.6e-12  Score=103.30  Aligned_cols=84  Identities=31%  Similarity=0.477  Sum_probs=59.4

Q ss_pred             CCCCEEEccCCcccc--cCCCcc-----------c-cCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCc
Q 042107            5 KVLLRIDLSTNNFSC--VFPTTI-----------E-YNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKD   70 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g--~~p~~~-----------~-~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~   70 (232)
                      .+++.|||++|.++|  .+|..+           + .|++.+.+|..++++++|+.|+|++|++++.+|..+..+++|++
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~  129 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence            456777777777777  666654           3 37777777777777777777777777777777777777777777


Q ss_pred             cccccccccCCCCCcccc
Q 042107           71 LNLSFNTLEGKIPRPFRN   88 (232)
Q Consensus        71 l~l~~n~l~g~~p~~~~~   88 (232)
                      |+++.|.+++.+|..+..
T Consensus       130 L~Ls~N~l~~~~p~~~~~  147 (313)
T 1ogq_A          130 LDFSYNALSGTLPPSISS  147 (313)
T ss_dssp             EECCSSEEESCCCGGGGG
T ss_pred             EeCCCCccCCcCChHHhc
Confidence            777777777777665543

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.24  E-value=1.5e-11  Score=93.82  Aligned_cols=59  Identities=25%  Similarity=0.235  Sum_probs=28.6

Q ss_pred             ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccccccccccCCCCC
Q 042107           26 EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPR   84 (232)
Q Consensus        26 ~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~   84 (232)
                      ++|++++..|..+..+++|+.|+|++|++++..|..+..+++|+.|++++|.+++..|.
T Consensus        89 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~  147 (220)
T 2v70_A           89 TSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPG  147 (220)
T ss_dssp             CSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTT
T ss_pred             CCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHH
Confidence            34445444444444455555555555555544444444455555555555555444443

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.21  E-value=1.8e-11  Score=99.04  Aligned_cols=60  Identities=18%  Similarity=0.197  Sum_probs=29.1

Q ss_pred             cCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccccccccccCCCCCcc
Q 042107           27 YNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPF   86 (232)
Q Consensus        27 ~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~~~   86 (232)
                      +|++.+.+|..++.+++|+.|+|++|++.+.+|..+..+++|+.+++++|++.+.+|..+
T Consensus       238 ~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l  297 (328)
T 4fcg_A          238 GCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLI  297 (328)
T ss_dssp             TCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGG
T ss_pred             CCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHH
Confidence            344444444444444444444444444444444444444444455555444444444433

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.18  E-value=4.3e-13  Score=114.21  Aligned_cols=29  Identities=10%  Similarity=0.146  Sum_probs=24.8

Q ss_pred             HHHHHHHHHHhcCCCCCCccceeEEEecC
Q 042107          128 FKNLDVECNMMKIIRHQNLIKIISSCSKD  156 (232)
Q Consensus       128 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~  156 (232)
                      .+.|..|++.+..++|+|+|++.++|.+.
T Consensus       323 ~~eF~~Eve~L~~i~HrNLV~L~gyC~s~  351 (487)
T 3oja_A          323 SETERLECERENQARQREIDALKEQYRTV  351 (487)
T ss_dssp             --CHHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred             HHHHHHHHHHHhcccccchhhHHHHhcCh
Confidence            45789999999999999999999998764

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.17  E-value=8e-11  Score=89.80  Aligned_cols=83  Identities=24%  Similarity=0.357  Sum_probs=55.7

Q ss_pred             CCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCc-ccccCCCCCccc
Q 042107            5 KVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPI-PLEKLLDLKDLN   72 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~-~~~~l~~l~~l~   72 (232)
                      ++|+.|+|++|.|++..|..+           ++|++++..|..+..+++|+.|+|++|+++ .+|. .+..+++|+.|+
T Consensus        32 ~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~  110 (220)
T 2v9t_B           32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLL  110 (220)
T ss_dssp             TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred             cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCC-ccCHhHccCCCCCCEEE
Confidence            356777777777775544332           567777777777777777777777777777 3443 346677777777


Q ss_pred             cccccccCCCCCcccc
Q 042107           73 LSFNTLEGKIPRPFRN   88 (232)
Q Consensus        73 l~~n~l~g~~p~~~~~   88 (232)
                      +++|.+++..|..+..
T Consensus       111 L~~N~l~~~~~~~~~~  126 (220)
T 2v9t_B          111 LNANKINCLRVDAFQD  126 (220)
T ss_dssp             CCSSCCCCCCTTTTTT
T ss_pred             CCCCCCCEeCHHHcCC
Confidence            7777777766655443

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.15  E-value=5.8e-11  Score=90.58  Aligned_cols=83  Identities=23%  Similarity=0.239  Sum_probs=73.8

Q ss_pred             CCCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK   69 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~   69 (232)
                      |+++++|+.|+|++|.|++..|..+           ++|++++..|..+..+++|+.|+|++|++++..|..+..+++|+
T Consensus        77 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  156 (220)
T 2v70_A           77 FEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLS  156 (220)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCC
T ss_pred             hCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCC
Confidence            4678899999999999997666543           68999999999999999999999999999988899999999999


Q ss_pred             ccccccccccCCCC
Q 042107           70 DLNLSFNTLEGKIP   83 (232)
Q Consensus        70 ~l~l~~n~l~g~~p   83 (232)
                      .+++++|.+++..+
T Consensus       157 ~L~L~~N~l~c~c~  170 (220)
T 2v70_A          157 TLNLLANPFNCNCY  170 (220)
T ss_dssp             EEECCSCCEECSGG
T ss_pred             EEEecCcCCcCCCc
Confidence            99999999987644

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.13  E-value=1.1e-10  Score=87.15  Aligned_cols=79  Identities=23%  Similarity=0.346  Sum_probs=51.9

Q ss_pred             CEEEccCCcccccCCCcc---------ccCcccccccc-ccccCCCCCeeeCCCCcceecCCcccccCCCCCcccccccc
Q 042107            8 LRIDLSTNNFSCVFPTTI---------EYNRLQDSLRN-SIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNT   77 (232)
Q Consensus         8 ~~l~ls~N~~~g~~p~~~---------~~n~~~~~~p~-~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~   77 (232)
                      +.||+++|.|+ .+|..+         ++|++++..|. .++.+++|+.|+|++|++++..|..+..++.|+.|++++|.
T Consensus        11 ~~l~~s~~~l~-~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~   89 (192)
T 1w8a_A           11 TTVDCTGRGLK-EIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK   89 (192)
T ss_dssp             TEEECTTSCCS-SCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred             CEEEcCCCCcC-cCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCc
Confidence            56777777774 555532         56666655553 36677777777777777776666667777777777777777


Q ss_pred             ccCCCCCccc
Q 042107           78 LEGKIPRPFR   87 (232)
Q Consensus        78 l~g~~p~~~~   87 (232)
                      +++..|..+.
T Consensus        90 l~~~~~~~~~   99 (192)
T 1w8a_A           90 IKEISNKMFL   99 (192)
T ss_dssp             CCEECSSSST
T ss_pred             CCccCHHHhc
Confidence            7766555443

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.13  E-value=2.6e-10  Score=93.25  Aligned_cols=130  Identities=14%  Similarity=0.168  Sum_probs=93.5

Q ss_pred             eecccCCCcceeeeEEeCCCcEEEEEEee--ccc-CchHHHHHHHHHHhcCCC--CCCccceeEEEecC---CeeEEEEe
Q 042107           93 FNLISRGGFGSIYKARIQDGMEVVVKGFN--LQY-GGAFKNLDVECNMMKIIR--HQNLIKIISSCSKD---DFKALILE  164 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~---~~~~lv~e  164 (232)
                      .+.++.|.++.||+.... +..+++|+..  ... ......+.+|..+++.+.  +..+++++.++.+.   +..++|||
T Consensus        43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            467899999999998765 4678888765  322 112345778999888886  45578888888766   45789999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---------------------------------------
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH---------------------------------------  205 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---------------------------------------  205 (232)
                      |++|..+.+...   ..++...+..++.++++.|..+|...                                       
T Consensus       122 ~v~G~~l~~~~~---~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          122 FVSGRVLWDQSL---PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             CCCCBCCCCTTC---TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             ecCCeecCCCcc---ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            999987754221   12567777888999999999999420                                       


Q ss_pred             ---------------CCCCeeeCCCCCCceeeCCCC
Q 042107          206 ---------------STHVIIHCDLKSSNVLLDDNM  226 (232)
Q Consensus       206 ---------------~~~~iiHrdlk~~Nill~~~~  226 (232)
                                     ....++|+|++|.||+++.++
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~  234 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE  234 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC
Confidence                           024699999999999999765

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.08  E-value=3.6e-10  Score=86.71  Aligned_cols=81  Identities=25%  Similarity=0.323  Sum_probs=52.3

Q ss_pred             CCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccc
Q 042107            5 KVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNL   73 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l   73 (232)
                      ++|+.|+|++|.|++..|..+           ++|+++...+..++.+++|+.|+|++|++++..+..+..+++|+.|++
T Consensus        40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L  119 (229)
T 3e6j_A           40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM  119 (229)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence            457777777777776655543           567775544455667777777777777777444444566777777777


Q ss_pred             ccccccCCCCCcc
Q 042107           74 SFNTLEGKIPRPF   86 (232)
Q Consensus        74 ~~n~l~g~~p~~~   86 (232)
                      +.|.++ .+|..+
T Consensus       120 s~N~l~-~lp~~~  131 (229)
T 3e6j_A          120 CCNKLT-ELPRGI  131 (229)
T ss_dssp             CSSCCC-SCCTTG
T ss_pred             cCCccc-ccCccc
Confidence            777766 455543

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.08  E-value=1.1e-10  Score=94.29  Aligned_cols=84  Identities=27%  Similarity=0.380  Sum_probs=48.8

Q ss_pred             CCCCCCCEEEccCCcccccCCCcc--------------------ccCccccccccccccCCCCCeeeCCCCcceecCCcc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTTI--------------------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIP   61 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~~--------------------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~   61 (232)
                      +++++|+.|+|++|++.+.+|..+                    ++|+++ .+|..++.+++|+.|+|++|+++ .+|..
T Consensus       147 ~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~  224 (328)
T 4fcg_A          147 ASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPA  224 (328)
T ss_dssp             GGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGG
T ss_pred             hcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchh
Confidence            345666666666666666665421                    455555 55655666666666666666665 34555


Q ss_pred             cccCCCCCccccccccccCCCCCccc
Q 042107           62 LEKLLDLKDLNLSFNTLEGKIPRPFR   87 (232)
Q Consensus        62 ~~~l~~l~~l~l~~n~l~g~~p~~~~   87 (232)
                      +..+++|+.|++++|++.+.+|..+.
T Consensus       225 l~~l~~L~~L~Ls~n~~~~~~p~~~~  250 (328)
T 4fcg_A          225 IHHLPKLEELDLRGCTALRNYPPIFG  250 (328)
T ss_dssp             GGGCTTCCEEECTTCTTCCBCCCCTT
T ss_pred             hccCCCCCEEECcCCcchhhhHHHhc
Confidence            55566666666666666665555443

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.08  E-value=3.4e-10  Score=87.90  Aligned_cols=80  Identities=24%  Similarity=0.280  Sum_probs=37.7

Q ss_pred             CCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcc
Q 042107            3 NLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDL   71 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l   71 (232)
                      ++++|+.|+|++|.|++..|..+           ++|++++..|..++.+++|+.|+|++|++++..|..+..++.|+.|
T Consensus        57 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  136 (251)
T 3m19_A           57 GLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKEL  136 (251)
T ss_dssp             TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             CcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEE
Confidence            34455555555555554433321           3455544444444555555555555555553333333445555555


Q ss_pred             ccccccccCCC
Q 042107           72 NLSFNTLEGKI   82 (232)
Q Consensus        72 ~l~~n~l~g~~   82 (232)
                      +++.|.+++..
T Consensus       137 ~Ls~N~l~~~~  147 (251)
T 3m19_A          137 RLNTNQLQSIP  147 (251)
T ss_dssp             ECCSSCCCCCC
T ss_pred             ECcCCcCCccC
Confidence            55555554433

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.07  E-value=1.5e-10  Score=100.25  Aligned_cols=54  Identities=28%  Similarity=0.398  Sum_probs=26.9

Q ss_pred             ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccccccccccCCC
Q 042107           26 EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKI   82 (232)
Q Consensus        26 ~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~   82 (232)
                      ++|+++ .+|..++.+++|+.|+|++|++++ +| .+..+++|+.|++++|.+++..
T Consensus       471 s~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~  524 (567)
T 1dce_A          471 SHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSA  524 (567)
T ss_dssp             CSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSS
T ss_pred             Cccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCC
Confidence            345554 445555555555555555555553 44 4445555555555555554443

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.07  E-value=2.3e-10  Score=84.10  Aligned_cols=83  Identities=24%  Similarity=0.276  Sum_probs=60.9

Q ss_pred             CCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccc
Q 042107            5 KVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNL   73 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l   73 (232)
                      ++|+.|+|++|.+++..|..+           ++|++++..+..++.+++|+.|+|++|++++..|..+..+++|+.+++
T Consensus        28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l  107 (177)
T 2o6r_A           28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL  107 (177)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEEC
Confidence            578888888888886554332           568887666666788888888888888888655555677888888888


Q ss_pred             ccccccCCCCCccc
Q 042107           74 SFNTLEGKIPRPFR   87 (232)
Q Consensus        74 ~~n~l~g~~p~~~~   87 (232)
                      ++|.+++..+..+.
T Consensus       108 ~~N~l~~~~~~~~~  121 (177)
T 2o6r_A          108 DTNQLKSVPDGIFD  121 (177)
T ss_dssp             CSSCCSCCCTTTTT
T ss_pred             cCCcceEeCHHHhc
Confidence            88888765444333

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.06  E-value=4.6e-10  Score=87.21  Aligned_cols=88  Identities=25%  Similarity=0.314  Sum_probs=73.0

Q ss_pred             CCCCCCCCEEEccCCcccccCCCc-----------cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPTT-----------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK   69 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~~-----------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~   69 (232)
                      |.++++|+.|+|++|.|++..|..           +++|++++..|..++.+++|+.|+|++|++++..|..+..+++|+
T Consensus        79 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  158 (251)
T 3m19_A           79 FDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQ  158 (251)
T ss_dssp             TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             hccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCC
Confidence            467889999999999999665554           378999977777789999999999999999966565788999999


Q ss_pred             ccccccccccCCCCCcccc
Q 042107           70 DLNLSFNTLEGKIPRPFRN   88 (232)
Q Consensus        70 ~l~l~~n~l~g~~p~~~~~   88 (232)
                      .|++++|.+++..|..+..
T Consensus       159 ~L~L~~N~l~~~~~~~~~~  177 (251)
T 3m19_A          159 TLSLSTNQLQSVPHGAFDR  177 (251)
T ss_dssp             EEECCSSCCSCCCTTTTTT
T ss_pred             EEECCCCcCCccCHHHHhC
Confidence            9999999998766655443

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.06  E-value=3e-10  Score=83.09  Aligned_cols=81  Identities=27%  Similarity=0.290  Sum_probs=51.8

Q ss_pred             CCCEEEccCCcccccCCCcc---------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccccccc
Q 042107            6 VLLRIDLSTNNFSCVFPTTI---------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFN   76 (232)
Q Consensus         6 ~l~~l~ls~N~~~g~~p~~~---------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n   76 (232)
                      +.+.||+++|.++. +|..+         ++|++++..|..++.+++|+.|+|++|++++..|..+..+++|+.|++++|
T Consensus        10 ~~~~l~~s~n~l~~-ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N   88 (170)
T 3g39_A           10 SGTTVDCSGKSLAS-VPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN   88 (170)
T ss_dssp             ETTEEECTTSCCSS-CCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CCCEEEeCCCCcCc-cCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence            34667777777763 44432         567777766777777777777777777777444444566777777777777


Q ss_pred             cccCCCCCccc
Q 042107           77 TLEGKIPRPFR   87 (232)
Q Consensus        77 ~l~g~~p~~~~   87 (232)
                      .+++..+..+.
T Consensus        89 ~l~~~~~~~~~   99 (170)
T 3g39_A           89 QLKSIPRGAFD   99 (170)
T ss_dssp             CCCCCCTTTTT
T ss_pred             ccCEeCHHHhc
Confidence            77665444443

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.06  E-value=1.3e-10  Score=102.16  Aligned_cols=61  Identities=21%  Similarity=0.277  Sum_probs=45.6

Q ss_pred             cCccccccccccccCCCCCeeeCCCCcceec-----------------CCcccc--cCCCCCccccccccccCCCCCccc
Q 042107           27 YNRLQDSLRNSIGDLTSLKSLDLSNNNFSGA-----------------IPIPLE--KLLDLKDLNLSFNTLEGKIPRPFR   87 (232)
Q Consensus        27 ~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~-----------------ip~~~~--~l~~l~~l~l~~n~l~g~~p~~~~   87 (232)
                      .|+++| ||..++++++|+.|+|++|+++|.                 +|..+.  ++++|++|++++|.+.|.+|..+.
T Consensus       192 ~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~  270 (636)
T 4eco_A          192 SNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK  270 (636)
T ss_dssp             SCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTT
T ss_pred             cCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHh
Confidence            567777 777777777777777777777775                 777777  777777777777777777776554


Q ss_pred             c
Q 042107           88 N   88 (232)
Q Consensus        88 ~   88 (232)
                      .
T Consensus       271 ~  271 (636)
T 4eco_A          271 A  271 (636)
T ss_dssp             T
T ss_pred             c
Confidence            4

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.04  E-value=5.5e-10  Score=87.83  Aligned_cols=86  Identities=26%  Similarity=0.309  Sum_probs=65.4

Q ss_pred             CCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKD   70 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~   70 (232)
                      +++++|++|+|++|.+++..|..+           ++|++++..|..++.+++|+.|+|++|++++..|..+..+++|+.
T Consensus        82 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  161 (272)
T 3rfs_A           82 KELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTE  161 (272)
T ss_dssp             TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             cCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCE
Confidence            567888888888888887655432           578888777777888888888888888888655555678888888


Q ss_pred             cccccccccCCCCCccc
Q 042107           71 LNLSFNTLEGKIPRPFR   87 (232)
Q Consensus        71 l~l~~n~l~g~~p~~~~   87 (232)
                      |+++.|.+++..|..+.
T Consensus       162 L~l~~n~l~~~~~~~~~  178 (272)
T 3rfs_A          162 LDLSYNQLQSLPEGVFD  178 (272)
T ss_dssp             EECCSSCCCCCCTTTTT
T ss_pred             EECCCCCcCccCHHHhc
Confidence            88888888876555443

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.04  E-value=7.1e-10  Score=83.57  Aligned_cols=83  Identities=29%  Similarity=0.299  Sum_probs=55.5

Q ss_pred             CCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccc
Q 042107            5 KVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNL   73 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l   73 (232)
                      ++|++|+|++|.+++..|..+           ++|++++..+..++.+++|+.|+|++|++++..+..+..+++|+.+++
T Consensus        28 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  107 (208)
T 2o6s_A           28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELAL  107 (208)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEc
Confidence            467778888887775444322           467777655556677777888888888777544444667777777888


Q ss_pred             ccccccCCCCCccc
Q 042107           74 SFNTLEGKIPRPFR   87 (232)
Q Consensus        74 ~~n~l~g~~p~~~~   87 (232)
                      ++|.+++..+..+.
T Consensus       108 ~~N~l~~~~~~~~~  121 (208)
T 2o6s_A          108 NTNQLQSLPDGVFD  121 (208)
T ss_dssp             CSSCCCCCCTTTTT
T ss_pred             CCCcCcccCHhHhc
Confidence            77777765554333

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.03  E-value=4.5e-10  Score=82.52  Aligned_cols=79  Identities=19%  Similarity=0.264  Sum_probs=53.4

Q ss_pred             CEEEccCCcccccCCCcc---------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccccccccc
Q 042107            8 LRIDLSTNNFSCVFPTTI---------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTL   78 (232)
Q Consensus         8 ~~l~ls~N~~~g~~p~~~---------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~l   78 (232)
                      +.+|+++|.++ .+|..+         ++|++++..|..++.+++|+.|+|++|++++..+..+..+++|+.|++++|.+
T Consensus        15 ~~l~~~~n~l~-~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l   93 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHL   93 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred             cEEEeCCCCCC-ccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCcc
Confidence            56777777775 555432         56777777777777777888888888877753333356777788888887777


Q ss_pred             cCCCCCccc
Q 042107           79 EGKIPRPFR   87 (232)
Q Consensus        79 ~g~~p~~~~   87 (232)
                      ++..+..+.
T Consensus        94 ~~l~~~~~~  102 (174)
T 2r9u_A           94 KSIPRGAFD  102 (174)
T ss_dssp             CCCCTTTTT
T ss_pred             ceeCHHHhc
Confidence            755444343

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.02  E-value=3.4e-10  Score=84.54  Aligned_cols=83  Identities=24%  Similarity=0.330  Sum_probs=70.4

Q ss_pred             CCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccc
Q 042107            5 KVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNL   73 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l   73 (232)
                      ++|+.|+|++|+|+ .+|..+           ++|++++..|..+..+++|+.|+|++|++++..|..+..+++|+.|++
T Consensus        31 ~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L  109 (193)
T 2wfh_A           31 RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL  109 (193)
T ss_dssp             TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence            47899999999998 677543           689999888888999999999999999999777778899999999999


Q ss_pred             ccccccCCCCCcccc
Q 042107           74 SFNTLEGKIPRPFRN   88 (232)
Q Consensus        74 ~~n~l~g~~p~~~~~   88 (232)
                      ++|.+++..+..+..
T Consensus       110 ~~N~l~~~~~~~~~~  124 (193)
T 2wfh_A          110 HGNDISVVPEGAFND  124 (193)
T ss_dssp             CSSCCCBCCTTTTTT
T ss_pred             CCCCCCeeChhhhhc
Confidence            999998755544543

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.01  E-value=7.7e-10  Score=83.39  Aligned_cols=88  Identities=27%  Similarity=0.313  Sum_probs=67.7

Q ss_pred             CCCCCCCCEEEccCCcccccCCCc-----------cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPTT-----------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK   69 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~~-----------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~   69 (232)
                      ++++++|+.|+|++|.|++..|..           +++|++++..+..++.+++|+.|+|++|++++..+..+..+++|+
T Consensus        48 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  127 (208)
T 2o6s_A           48 FDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLK  127 (208)
T ss_dssp             TTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             hcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCC
Confidence            357788999999999998554432           267888876667778899999999999999865555578889999


Q ss_pred             ccccccccccCCCCCcccc
Q 042107           70 DLNLSFNTLEGKIPRPFRN   88 (232)
Q Consensus        70 ~l~l~~n~l~g~~p~~~~~   88 (232)
                      .++++.|.+++..+..+..
T Consensus       128 ~L~l~~N~l~~~~~~~~~~  146 (208)
T 2o6s_A          128 DLRLYQNQLKSVPDGVFDR  146 (208)
T ss_dssp             EEECCSSCCSCCCTTTTTT
T ss_pred             EEECCCCccceeCHHHhcc
Confidence            9999999888755544443

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.01  E-value=8.4e-10  Score=82.41  Aligned_cols=81  Identities=26%  Similarity=0.372  Sum_probs=68.5

Q ss_pred             CCEEEccCCcccccCCCcc---------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccccccc
Q 042107            7 LLRIDLSTNNFSCVFPTTI---------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNT   77 (232)
Q Consensus         7 l~~l~ls~N~~~g~~p~~~---------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~   77 (232)
                      -+.+++++|.++ .+|..+         ++|+++ .+|..+..+++|+.|+|++|++++..|..+..++.|+.|++++|.
T Consensus        12 ~~~l~~~~~~l~-~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           12 DTVVRCSNKGLK-VLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             TTEEECTTSCCS-SCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CCEEEcCCCCCC-cCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            367999999998 566543         678887 788999999999999999999997777778999999999999999


Q ss_pred             ccCCCCCccccc
Q 042107           78 LEGKIPRPFRNF   89 (232)
Q Consensus        78 l~g~~p~~~~~~   89 (232)
                      +++..|..+...
T Consensus        90 l~~i~~~~f~~l  101 (193)
T 2wfh_A           90 LRCIPPRTFDGL  101 (193)
T ss_dssp             CCBCCTTTTTTC
T ss_pred             cCEeCHHHhCCC
Confidence            998877666543

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.01  E-value=8.2e-10  Score=86.82  Aligned_cols=86  Identities=26%  Similarity=0.276  Sum_probs=69.3

Q ss_pred             CCCCCCCEEEccCCcccccCCC----------ccccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPT----------TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDL   71 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~----------~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l   71 (232)
                      +.+++|+.|+|++|.+++. |.          .+++|++++..|..++.+++|+.|+|++|++++..|..+..+++|+.|
T Consensus        60 ~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  138 (272)
T 3rfs_A           60 QYLPNVRYLALGGNKLHDI-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYL  138 (272)
T ss_dssp             GGCTTCCEEECTTSCCCCC-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred             ccCCCCcEEECCCCCCCCc-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEE
Confidence            4578899999999999863 32          126799998877888999999999999999997666667889999999


Q ss_pred             ccccccccCCCCCcccc
Q 042107           72 NLSFNTLEGKIPRPFRN   88 (232)
Q Consensus        72 ~l~~n~l~g~~p~~~~~   88 (232)
                      +++.|.+++..|..+..
T Consensus       139 ~L~~n~l~~~~~~~~~~  155 (272)
T 3rfs_A          139 NLAHNQLQSLPKGVFDK  155 (272)
T ss_dssp             ECCSSCCCCCCTTTTTT
T ss_pred             ECCCCccCccCHHHhcc
Confidence            99999998766654443

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.00  E-value=8.9e-10  Score=80.56  Aligned_cols=79  Identities=19%  Similarity=0.191  Sum_probs=68.9

Q ss_pred             CCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccc
Q 042107            5 KVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNL   73 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l   73 (232)
                      ++|+.|+|++|.|++..|..+           ++|++++..|..+..+++|+.|+|++|++++..|..+..+++|+.+++
T Consensus        30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  109 (170)
T 3g39_A           30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWL  109 (170)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEe
Confidence            578999999999998877654           689999877777899999999999999999655556889999999999


Q ss_pred             ccccccCCCC
Q 042107           74 SFNTLEGKIP   83 (232)
Q Consensus        74 ~~n~l~g~~p   83 (232)
                      ++|.++..-+
T Consensus       110 ~~N~~~c~c~  119 (170)
T 3g39_A          110 LNNPWDCACS  119 (170)
T ss_dssp             CSSCBCTTBG
T ss_pred             CCCCCCCCch
Confidence            9999987644

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.00  E-value=9.2e-10  Score=92.54  Aligned_cols=83  Identities=24%  Similarity=0.258  Sum_probs=52.7

Q ss_pred             CCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccc
Q 042107            5 KVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNL   73 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l   73 (232)
                      ++|+.|||++|.+++.+|..+           ++|++++..|..++.+++|+.|+|++|++++..|..+..+++|+.|++
T Consensus       275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  354 (455)
T 3v47_A          275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL  354 (455)
T ss_dssp             SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred             cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence            466667777777666655533           456666666666666666666666666666555556666666666666


Q ss_pred             ccccccCCCCCccc
Q 042107           74 SFNTLEGKIPRPFR   87 (232)
Q Consensus        74 ~~n~l~g~~p~~~~   87 (232)
                      ++|.+++..|..+.
T Consensus       355 s~N~l~~~~~~~~~  368 (455)
T 3v47_A          355 SYNHIRALGDQSFL  368 (455)
T ss_dssp             CSSCCCEECTTTTT
T ss_pred             CCCcccccChhhcc
Confidence            66666665555443

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.00  E-value=7e-10  Score=84.54  Aligned_cols=89  Identities=28%  Similarity=0.278  Sum_probs=76.3

Q ss_pred             CCCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK   69 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~   69 (232)
                      |+++++|+.|+|++|.|++..|..+           ++|+++...+..+..+++|+.|+|++|++++..|..+..+++|+
T Consensus        52 ~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  131 (220)
T 2v9t_B           52 FSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLN  131 (220)
T ss_dssp             STTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             hhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCC
Confidence            4678899999999999998878754           68999966556679999999999999999988888899999999


Q ss_pred             ccccccccccCCCCCccccc
Q 042107           70 DLNLSFNTLEGKIPRPFRNF   89 (232)
Q Consensus        70 ~l~l~~n~l~g~~p~~~~~~   89 (232)
                      .|++++|.+++..+..+...
T Consensus       132 ~L~L~~N~l~~~~~~~~~~l  151 (220)
T 2v9t_B          132 LLSLYDNKLQTIAKGTFSPL  151 (220)
T ss_dssp             EEECCSSCCSCCCTTTTTTC
T ss_pred             EEECCCCcCCEECHHHHhCC
Confidence            99999999998776655543

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=98.99  E-value=3.6e-10  Score=80.61  Aligned_cols=74  Identities=26%  Similarity=0.285  Sum_probs=47.3

Q ss_pred             CCCCEEEccCCccc-ccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccc
Q 042107            5 KVLLRIDLSTNNFS-CVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLN   72 (232)
Q Consensus         5 ~~l~~l~ls~N~~~-g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~   72 (232)
                      ++|+.|++++|.++ |.+|..+           ++|++++.  ..++.+++|+.|+|++|++++.+|..+..+++|+.++
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~   94 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN   94 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred             ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence            45677777777776 5666542           45666654  5566666666777777766655665555666666666


Q ss_pred             cccccccC
Q 042107           73 LSFNTLEG   80 (232)
Q Consensus        73 l~~n~l~g   80 (232)
                      +++|.+++
T Consensus        95 ls~N~i~~  102 (149)
T 2je0_A           95 LSGNKIKD  102 (149)
T ss_dssp             CTTSCCCS
T ss_pred             CCCCcCCC
Confidence            66666655

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=98.99  E-value=8.6e-10  Score=88.00  Aligned_cols=86  Identities=26%  Similarity=0.352  Sum_probs=68.1

Q ss_pred             CCCCCCCCEEEccCCcccccCCCcc-----------ccCcccc-ccccccccCCCCCeeeCCCCcceecCCcccccCCCC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQD-SLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDL   68 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~-~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l   68 (232)
                      +.++++|+.|+|++|.+++..|..+           ++|++++ .+|..+..+++|+.|+|++|++++..|..+..+++|
T Consensus       122 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L  201 (306)
T 2z66_A          122 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL  201 (306)
T ss_dssp             TTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred             hhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCC
Confidence            3567888899999998887776543           5788877 578888888888888888888887778788888888


Q ss_pred             CccccccccccCCCCCcc
Q 042107           69 KDLNLSFNTLEGKIPRPF   86 (232)
Q Consensus        69 ~~l~l~~n~l~g~~p~~~   86 (232)
                      +.+++++|.+++..+..+
T Consensus       202 ~~L~L~~N~l~~~~~~~~  219 (306)
T 2z66_A          202 QVLNMSHNNFFSLDTFPY  219 (306)
T ss_dssp             CEEECTTSCCSBCCSGGG
T ss_pred             CEEECCCCccCccChhhc
Confidence            888888888877555443

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=98.99  E-value=1.7e-10  Score=101.34  Aligned_cols=83  Identities=29%  Similarity=0.490  Sum_probs=69.3

Q ss_pred             CCCCCCEEEccCCcccccCCCcc-----------ccCc-ccc-ccccccccC------CCCCeeeCCCCcceecCCc--c
Q 042107            3 NLKVLLRIDLSTNNFSCVFPTTI-----------EYNR-LQD-SLRNSIGDL------TSLKSLDLSNNNFSGAIPI--P   61 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~-~~~-~~p~~~~~l------~~L~~L~ls~N~l~g~ip~--~   61 (232)
                      ++++|++|+|++|.+.|.+|..+           ++|+ ++| .+|..++.+      ++|+.|+|++|+++ .+|.  .
T Consensus       247 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~  325 (636)
T 4eco_A          247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETS  325 (636)
T ss_dssp             GCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHH
T ss_pred             ccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhh
Confidence            78889999999999999888764           5787 888 888888776      88888888888888 8888  7


Q ss_pred             cccCCCCCccccccccccCCCCCccc
Q 042107           62 LEKLLDLKDLNLSFNTLEGKIPRPFR   87 (232)
Q Consensus        62 ~~~l~~l~~l~l~~n~l~g~~p~~~~   87 (232)
                      +.++++|+.++++.|.++|.+| .+.
T Consensus       326 l~~l~~L~~L~L~~N~l~g~ip-~~~  350 (636)
T 4eco_A          326 LQKMKKLGMLECLYNQLEGKLP-AFG  350 (636)
T ss_dssp             HTTCTTCCEEECCSCCCEEECC-CCE
T ss_pred             hccCCCCCEEeCcCCcCccchh-hhC
Confidence            8888888888888888888888 443

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=98.99  E-value=9.3e-10  Score=84.36  Aligned_cols=87  Identities=23%  Similarity=0.282  Sum_probs=72.6

Q ss_pred             CCCCCCCCEEEccCCcccccCCCc-----------cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPTT-----------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK   69 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~~-----------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~   69 (232)
                      |.++++|+.|+|++|+|+...|..           +++|++++..+..+..+++|+.|+|++|+++ .+|..+..+++|+
T Consensus        60 ~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~  138 (229)
T 3e6j_A           60 FDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLT  138 (229)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCS
T ss_pred             hhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCC
Confidence            457889999999999997544433           2689999877777899999999999999999 8999999999999


Q ss_pred             ccccccccccCCCCCcccc
Q 042107           70 DLNLSFNTLEGKIPRPFRN   88 (232)
Q Consensus        70 ~l~l~~n~l~g~~p~~~~~   88 (232)
                      .|++++|.+++..+..+..
T Consensus       139 ~L~L~~N~l~~~~~~~~~~  157 (229)
T 3e6j_A          139 HLALDQNQLKSIPHGAFDR  157 (229)
T ss_dssp             EEECCSSCCCCCCTTTTTT
T ss_pred             EEECCCCcCCccCHHHHhC
Confidence            9999999998765554543

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=98.97  E-value=1.6e-10  Score=102.96  Aligned_cols=78  Identities=28%  Similarity=0.404  Sum_probs=43.1

Q ss_pred             CCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccc
Q 042107            4 LKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLN   72 (232)
Q Consensus         4 ~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~   72 (232)
                      +++|+.|+|++|.|+ .+|..+           ++|+|+ .+|..++.+++|+.|+|++|.++ .+|..+..+++|+.|+
T Consensus       246 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~  322 (727)
T 4b8c_D          246 YDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLG  322 (727)
T ss_dssp             CCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEE
T ss_pred             CCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEe
Confidence            444555555555555 445432           455555 55555555556666666666554 5555555566666666


Q ss_pred             cccccccCCCCC
Q 042107           73 LSFNTLEGKIPR   84 (232)
Q Consensus        73 l~~n~l~g~~p~   84 (232)
                      +++|.+++.+|.
T Consensus       323 L~~N~l~~~~p~  334 (727)
T 4b8c_D          323 VEGNPLEKQFLK  334 (727)
T ss_dssp             CTTSCCCSHHHH
T ss_pred             CCCCccCCCChH
Confidence            666655554444

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=98.97  E-value=8.9e-10  Score=96.04  Aligned_cols=88  Identities=24%  Similarity=0.375  Sum_probs=74.9

Q ss_pred             CCCCCCCEEEccCCcccc-cCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCC
Q 042107            2 SNLKVLLRIDLSTNNFSC-VFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK   69 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g-~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~   69 (232)
                      ..++.|+.|+|++|.+.. .+|..+           ++|++++..|..++.+++|+.|+|++|++++..|..+..+++|+
T Consensus       466 ~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~  545 (635)
T 4g8a_A          466 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ  545 (635)
T ss_dssp             TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCC
T ss_pred             ccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCC
Confidence            467889999999998654 455543           68999999999999999999999999999987788889999999


Q ss_pred             ccccccccccCCCCCccccc
Q 042107           70 DLNLSFNTLEGKIPRPFRNF   89 (232)
Q Consensus        70 ~l~l~~n~l~g~~p~~~~~~   89 (232)
                      .|++++|++++..|..+...
T Consensus       546 ~L~Ls~N~l~~~~~~~l~~l  565 (635)
T 4g8a_A          546 VLDYSLNHIMTSKKQELQHF  565 (635)
T ss_dssp             EEECTTSCCCBCCSSCTTCC
T ss_pred             EEECCCCcCCCCCHHHHHhh
Confidence            99999999999888876654

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=98.97  E-value=1e-09  Score=97.75  Aligned_cols=83  Identities=28%  Similarity=0.391  Sum_probs=73.4

Q ss_pred             CCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKD   70 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~   70 (232)
                      ..++.|+.|||++|.+. .+|..+           ++|+|+ .+|..++.+++|+.|+|++|+++ .+|..+..+++|++
T Consensus       221 ~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~  297 (727)
T 4b8c_D          221 YDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKY  297 (727)
T ss_dssp             -CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSE
T ss_pred             ccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCE
Confidence            46788999999999999 777543           789999 99999999999999999999999 89999999999999


Q ss_pred             cccccccccCCCCCcccc
Q 042107           71 LNLSFNTLEGKIPRPFRN   88 (232)
Q Consensus        71 l~l~~n~l~g~~p~~~~~   88 (232)
                      |+++.|.++ .+|..+..
T Consensus       298 L~L~~N~l~-~lp~~~~~  314 (727)
T 4b8c_D          298 FYFFDNMVT-TLPWEFGN  314 (727)
T ss_dssp             EECCSSCCC-CCCSSTTS
T ss_pred             EECCCCCCC-ccChhhhc
Confidence            999999986 77876554

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=98.96  E-value=1.8e-09  Score=79.26  Aligned_cols=81  Identities=27%  Similarity=0.274  Sum_probs=56.5

Q ss_pred             CCCEEEccCCcccccCCCc---------cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccccccc
Q 042107            6 VLLRIDLSTNNFSCVFPTT---------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFN   76 (232)
Q Consensus         6 ~l~~l~ls~N~~~g~~p~~---------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n   76 (232)
                      +.+.+++++|.++ .+|..         +++|++++..+..++.+++|+.|+|++|++++..+..+..++.|+.+++++|
T Consensus         8 ~~~~l~~~~~~l~-~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   86 (177)
T 2o6r_A            8 SGTEIRCNSKGLT-SVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN   86 (177)
T ss_dssp             ETTEEECCSSCCS-SCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CCCEEEecCCCCc-cCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence            4567888888877 34432         2567777666666777888888888888887544445677888888888888


Q ss_pred             cccCCCCCccc
Q 042107           77 TLEGKIPRPFR   87 (232)
Q Consensus        77 ~l~g~~p~~~~   87 (232)
                      .+++..+..+.
T Consensus        87 ~l~~~~~~~~~   97 (177)
T 2o6r_A           87 KLQSLPNGVFD   97 (177)
T ss_dssp             CCCCCCTTTTT
T ss_pred             CccccCHHHhh
Confidence            88766555443

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=98.96  E-value=1.8e-10  Score=104.11  Aligned_cols=82  Identities=21%  Similarity=0.295  Sum_probs=53.9

Q ss_pred             CCCCCCCEEEccCCcccc-----------------cCCCcc-------------ccCccccccccccccCCCCCeeeCCC
Q 042107            2 SNLKVLLRIDLSTNNFSC-----------------VFPTTI-------------EYNRLQDSLRNSIGDLTSLKSLDLSN   51 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g-----------------~~p~~~-------------~~n~~~~~~p~~~~~l~~L~~L~ls~   51 (232)
                      +++++|+.|+|++|.|+|                 .+|..+             ++|++.+.+|..++++++|+.|+|++
T Consensus       445 ~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~  524 (876)
T 4ecn_A          445 QRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIAC  524 (876)
T ss_dssp             GGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTT
T ss_pred             hcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcC
Confidence            456777777777777777                 366553             35667777777777777777777777


Q ss_pred             Cc-cee-cCCcccccCC-------CCCccccccccccCCCCC
Q 042107           52 NN-FSG-AIPIPLEKLL-------DLKDLNLSFNTLEGKIPR   84 (232)
Q Consensus        52 N~-l~g-~ip~~~~~l~-------~l~~l~l~~n~l~g~~p~   84 (232)
                      |+ ++| .+|..+..+.       +|+.|+++.|.++ .+|.
T Consensus       525 N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~  565 (876)
T 4ecn_A          525 NRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPA  565 (876)
T ss_dssp             CTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCC
T ss_pred             CCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCC
Confidence            76 666 6665554444       6666666666666 5555

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=98.95  E-value=9.8e-10  Score=82.18  Aligned_cols=52  Identities=23%  Similarity=0.338  Sum_probs=25.5

Q ss_pred             ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccccccc
Q 042107           26 EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNT   77 (232)
Q Consensus        26 ~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~   77 (232)
                      ++|++++..|..++.+++|+.|+|++|++++..|..+..++.|+.|+++.|.
T Consensus        96 ~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~  147 (197)
T 4ezg_A           96 MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG  147 (197)
T ss_dssp             ECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred             ECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCC
Confidence            3444444444444455555555555555544444444445555555555544

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=98.95  E-value=1.1e-09  Score=92.01  Aligned_cols=88  Identities=24%  Similarity=0.238  Sum_probs=72.5

Q ss_pred             CCCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK   69 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~   69 (232)
                      ++++++|+.|+|++|.+++..|..+           ++|++++..|..++.+++|+.|+|++|++++..|..+..+++|+
T Consensus       295 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  374 (455)
T 3v47_A          295 FSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLK  374 (455)
T ss_dssp             TTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred             cccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhcccccccc
Confidence            3577899999999999998777653           67888888888889999999999999999888888888899999


Q ss_pred             ccccccccccCCCCCcccc
Q 042107           70 DLNLSFNTLEGKIPRPFRN   88 (232)
Q Consensus        70 ~l~l~~n~l~g~~p~~~~~   88 (232)
                      .+++++|.+++..+..+..
T Consensus       375 ~L~L~~N~l~~~~~~~~~~  393 (455)
T 3v47_A          375 ELALDTNQLKSVPDGIFDR  393 (455)
T ss_dssp             EEECCSSCCSCCCTTTTTT
T ss_pred             EEECCCCccccCCHhHhcc
Confidence            9999999988755544433

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=98.95  E-value=2e-09  Score=79.06  Aligned_cols=78  Identities=22%  Similarity=0.255  Sum_probs=66.9

Q ss_pred             CCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccc
Q 042107            5 KVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNL   73 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l   73 (232)
                      ++|+.|+|++|+|++..|..+           ++|+|++..+..++.+++|+.|+|++|++++..+..+..+++|+.+++
T Consensus        33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L  112 (174)
T 2r9u_A           33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYL  112 (174)
T ss_dssp             TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred             CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEEe
Confidence            578999999999998878654           689999866667799999999999999999554545889999999999


Q ss_pred             ccccccCCC
Q 042107           74 SFNTLEGKI   82 (232)
Q Consensus        74 ~~n~l~g~~   82 (232)
                      ++|.+....
T Consensus       113 ~~N~~~c~~  121 (174)
T 2r9u_A          113 YNNPWDCEC  121 (174)
T ss_dssp             CSSCBCTTB
T ss_pred             CCCCccccc
Confidence            999988653

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=98.94  E-value=1.2e-09  Score=88.86  Aligned_cols=79  Identities=18%  Similarity=0.152  Sum_probs=58.7

Q ss_pred             CCCCCCCCEEEccC-CcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCC
Q 042107            1 MSNLKVLLRIDLST-NNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDL   68 (232)
Q Consensus         1 ~~~~~~l~~l~ls~-N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l   68 (232)
                      |..+++|+.|+|++ |.|++..|..+           ++|+|++..|..++.+++|+.|+|++|+|++ +|........|
T Consensus        27 l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~~~L  105 (347)
T 2ifg_A           27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSL  105 (347)
T ss_dssp             SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSC-CCSTTTCSCCC
T ss_pred             CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCccce-eCHHHcccCCc
Confidence            34567788999986 88887666543           6788888888888888888888888888884 55444333348


Q ss_pred             CccccccccccC
Q 042107           69 KDLNLSFNTLEG   80 (232)
Q Consensus        69 ~~l~l~~n~l~g   80 (232)
                      +.|++.+|.+..
T Consensus       106 ~~l~l~~N~~~c  117 (347)
T 2ifg_A          106 QELVLSGNPLHC  117 (347)
T ss_dssp             CEEECCSSCCCC
T ss_pred             eEEEeeCCCccC
Confidence            888888887753

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=98.94  E-value=1.6e-09  Score=94.42  Aligned_cols=84  Identities=24%  Similarity=0.333  Sum_probs=50.1

Q ss_pred             CCCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK   69 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~   69 (232)
                      |+++++|++|||++|+|++..|..+           ++|++++..|..++.+++|+.|+|++|++++..|..+..+++|+
T Consensus        72 f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~  151 (635)
T 4g8a_A           72 FFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK  151 (635)
T ss_dssp             TTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCC
T ss_pred             HhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccC
Confidence            3456666666666666665444332           45666655555666666666666666666644444566666666


Q ss_pred             ccccccccccC-CCCC
Q 042107           70 DLNLSFNTLEG-KIPR   84 (232)
Q Consensus        70 ~l~l~~n~l~g-~~p~   84 (232)
                      .|+++.|.+++ .+|.
T Consensus       152 ~L~Ls~N~l~~~~~~~  167 (635)
T 4g8a_A          152 ELNVAHNLIQSFKLPE  167 (635)
T ss_dssp             EEECCSSCCCCCCCCG
T ss_pred             eeccccCccccCCCch
Confidence            66666666654 3344

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=98.94  E-value=1.8e-09  Score=86.15  Aligned_cols=87  Identities=24%  Similarity=0.339  Sum_probs=67.5

Q ss_pred             CCCCCCCEEEccCCcccccCC-Cc-----------cccCccccccccccccCCCCCeeeCCCCccee-cCCcccccCCCC
Q 042107            2 SNLKVLLRIDLSTNNFSCVFP-TT-----------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSG-AIPIPLEKLLDL   68 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p-~~-----------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g-~ip~~~~~l~~l   68 (232)
                      .++++|+.|+|++|.+++..+ ..           +++|++++..|..++.+++|+.|++++|++++ .+|..+..+++|
T Consensus        98 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L  177 (306)
T 2z66_A           98 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL  177 (306)
T ss_dssp             ETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTC
T ss_pred             CCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCC
Confidence            457888888888888886544 22           26788888888888888888888888888886 577778888888


Q ss_pred             CccccccccccCCCCCcccc
Q 042107           69 KDLNLSFNTLEGKIPRPFRN   88 (232)
Q Consensus        69 ~~l~l~~n~l~g~~p~~~~~   88 (232)
                      +.|+++.|.+++..|..+..
T Consensus       178 ~~L~Ls~n~l~~~~~~~~~~  197 (306)
T 2z66_A          178 TFLDLSQCQLEQLSPTAFNS  197 (306)
T ss_dssp             CEEECTTSCCCEECTTTTTT
T ss_pred             CEEECCCCCcCCcCHHHhcC
Confidence            88888888888776665544

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=98.94  E-value=2e-09  Score=85.00  Aligned_cols=83  Identities=27%  Similarity=0.277  Sum_probs=54.4

Q ss_pred             CCCCCCCEEEccCCc-ccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCC
Q 042107            2 SNLKVLLRIDLSTNN-FSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK   69 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~-~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~   69 (232)
                      +++++|+.|+|++|. ++...|..+           ++|++++..|..+..+++|+.|++++|++++..+..+..+++|+
T Consensus        77 ~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  156 (285)
T 1ozn_A           77 TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLT  156 (285)
T ss_dssp             TTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             CCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCcc
Confidence            456777777777776 554434432           46777766667777777777777777777754444566677777


Q ss_pred             ccccccccccCCCCC
Q 042107           70 DLNLSFNTLEGKIPR   84 (232)
Q Consensus        70 ~l~l~~n~l~g~~p~   84 (232)
                      .+++++|.+++..+.
T Consensus       157 ~L~l~~n~l~~~~~~  171 (285)
T 1ozn_A          157 HLFLHGNRISSVPER  171 (285)
T ss_dssp             EEECCSSCCCEECTT
T ss_pred             EEECCCCcccccCHH
Confidence            777777776654443

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=98.94  E-value=1.7e-09  Score=94.14  Aligned_cols=87  Identities=28%  Similarity=0.374  Sum_probs=58.0

Q ss_pred             CCCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK   69 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~   69 (232)
                      |+++++|+.|||++|.+++..|..+           ++|++++..|..++.+++|+.|+|++|++++..|..+.++++|+
T Consensus        52 ~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  131 (606)
T 3vq2_A           52 FSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLK  131 (606)
T ss_dssp             TTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCC
T ss_pred             ccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCC
Confidence            3466777777777777776656543           46777776677777777777777777777655555666777777


Q ss_pred             ccccccccccC-CCCCccc
Q 042107           70 DLNLSFNTLEG-KIPRPFR   87 (232)
Q Consensus        70 ~l~l~~n~l~g-~~p~~~~   87 (232)
                      +|+++.|.+++ .+|..+.
T Consensus       132 ~L~L~~n~l~~~~lp~~~~  150 (606)
T 3vq2_A          132 KLNVAHNFIHSCKLPAYFS  150 (606)
T ss_dssp             EEECCSSCCCCCCCCGGGG
T ss_pred             EEeCCCCcccceechHhHh
Confidence            77777777664 4565444

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=98.92  E-value=1.3e-09  Score=94.93  Aligned_cols=83  Identities=23%  Similarity=0.265  Sum_probs=40.1

Q ss_pred             CCCCCCCEEEccCCcccccCC-Cc-----------cccCccccccccccccCCCCCeeeCCCCcceec-CCcccccCCCC
Q 042107            2 SNLKVLLRIDLSTNNFSCVFP-TT-----------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGA-IPIPLEKLLDL   68 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p-~~-----------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~-ip~~~~~l~~l   68 (232)
                      +.+++|+.|+|++|.+++..| ..           +++|++.+.+|..++.+++|+.|++++|++++. +|..+..+++|
T Consensus       396 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L  475 (606)
T 3vq2_A          396 MGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNL  475 (606)
T ss_dssp             TTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTC
T ss_pred             cCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCC
Confidence            344555555555555555444 11           134455544444455555555555555555442 34444445555


Q ss_pred             CccccccccccCCCCC
Q 042107           69 KDLNLSFNTLEGKIPR   84 (232)
Q Consensus        69 ~~l~l~~n~l~g~~p~   84 (232)
                      +.+++++|.+++..|.
T Consensus       476 ~~L~Ls~n~l~~~~~~  491 (606)
T 3vq2_A          476 TFLDLSKCQLEQISWG  491 (606)
T ss_dssp             CEEECTTSCCCEECTT
T ss_pred             CEEECCCCcCCccChh
Confidence            5555555554444443

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=98.91  E-value=2.5e-09  Score=92.34  Aligned_cols=83  Identities=24%  Similarity=0.327  Sum_probs=40.9

Q ss_pred             CCCCCCEEEccCCcccccCCCc------------cccCccccccccccccCCCCCeeeCCCCcce-ecCCcccccCCCCC
Q 042107            3 NLKVLLRIDLSTNNFSCVFPTT------------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFS-GAIPIPLEKLLDLK   69 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p~~------------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~-g~ip~~~~~l~~l~   69 (232)
                      ++++|+.|+|++|.+++..|..            +++|++++..|..+..+++|+.|+|++|+++ +.+|..+..+++|+
T Consensus       394 ~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~  473 (570)
T 2z63_A          394 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT  473 (570)
T ss_dssp             TCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCC
T ss_pred             ccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCC
Confidence            3455555555555555443311            1345555555555555555555555555554 34454455555555


Q ss_pred             ccccccccccCCCCCc
Q 042107           70 DLNLSFNTLEGKIPRP   85 (232)
Q Consensus        70 ~l~l~~n~l~g~~p~~   85 (232)
                      .|++++|.+++..|..
T Consensus       474 ~L~l~~n~l~~~~~~~  489 (570)
T 2z63_A          474 FLDLSQCQLEQLSPTA  489 (570)
T ss_dssp             EEECTTSCCCEECTTT
T ss_pred             EEECCCCccccCChhh
Confidence            5555555554444443

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=98.90  E-value=2.4e-09  Score=92.68  Aligned_cols=80  Identities=28%  Similarity=0.350  Sum_probs=71.6

Q ss_pred             CCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecC-CcccccCCCCC
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAI-PIPLEKLLDLK   69 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~i-p~~~~~l~~l~   69 (232)
                      +++++|+.|||++|.|+ .+|..+           ++|++++ +| .++.+++|+.|+|++|++++.+ |..+..+++|+
T Consensus       460 ~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~  536 (567)
T 1dce_A          460 EQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLV  536 (567)
T ss_dssp             GGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCC
T ss_pred             cccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCC
Confidence            56789999999999999 888764           6899997 78 8999999999999999999876 99999999999


Q ss_pred             ccccccccccCCCCC
Q 042107           70 DLNLSFNTLEGKIPR   84 (232)
Q Consensus        70 ~l~l~~n~l~g~~p~   84 (232)
                      .|++++|.+++..|.
T Consensus       537 ~L~L~~N~l~~~~~~  551 (567)
T 1dce_A          537 LLNLQGNSLCQEEGI  551 (567)
T ss_dssp             EEECTTSGGGGSSSC
T ss_pred             EEEecCCcCCCCccH
Confidence            999999999987654

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=98.90  E-value=3.5e-09  Score=83.23  Aligned_cols=75  Identities=19%  Similarity=0.130  Sum_probs=37.4

Q ss_pred             CCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccccc
Q 042107            7 LLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSF   75 (232)
Q Consensus         7 l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~   75 (232)
                      |+.|||++|.+++..|..+           ++|++++..+..++.+++|+.|+|++|++++..|..+..+++|+.++++.
T Consensus        30 l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~  109 (276)
T 2z62_A           30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE  109 (276)
T ss_dssp             CCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred             ccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCC
Confidence            5555555555554333221           34555544444455555555555555555544444455555555555555


Q ss_pred             ccccCC
Q 042107           76 NTLEGK   81 (232)
Q Consensus        76 n~l~g~   81 (232)
                      |.+++.
T Consensus       110 n~l~~~  115 (276)
T 2z62_A          110 TNLASL  115 (276)
T ss_dssp             SCCCCS
T ss_pred             CCcccc
Confidence            555443

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=98.89  E-value=4.5e-09  Score=82.98  Aligned_cols=51  Identities=24%  Similarity=0.221  Sum_probs=24.0

Q ss_pred             cccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccccccccccC
Q 042107           30 LQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEG   80 (232)
Q Consensus        30 ~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~l~g   80 (232)
                      +....|..+..+++|+.|++++|++++..|..+..+++|+.+++++|.+++
T Consensus        93 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  143 (285)
T 1ozn_A           93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA  143 (285)
T ss_dssp             CCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             ccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccc
Confidence            333334444444555555555555444334444444555555555554443

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=98.88  E-value=2.7e-09  Score=92.13  Aligned_cols=89  Identities=25%  Similarity=0.336  Sum_probs=73.9

Q ss_pred             CCCCCCCCEEEccCCcccccCCCcc-----------ccCccc-cccccccccCCCCCeeeCCCCcceecCCcccccCCCC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQ-DSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDL   68 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~-~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l   68 (232)
                      +.++++|+.|+|++|.+++..|..+           ++|+++ +.+|..++.+++|+.|+|++|++++..|..+..+++|
T Consensus       417 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  496 (570)
T 2z63_A          417 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL  496 (570)
T ss_dssp             TTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred             hhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCC
Confidence            3567889999999999998777653           678887 6788889999999999999999998888888889999


Q ss_pred             CccccccccccCCCCCccccc
Q 042107           69 KDLNLSFNTLEGKIPRPFRNF   89 (232)
Q Consensus        69 ~~l~l~~n~l~g~~p~~~~~~   89 (232)
                      +.+++++|.+++..|..+...
T Consensus       497 ~~L~l~~n~l~~~~~~~~~~l  517 (570)
T 2z63_A          497 QVLNMASNQLKSVPDGIFDRL  517 (570)
T ss_dssp             CEEECCSSCCSCCCTTTTTTC
T ss_pred             CEEeCCCCcCCCCCHHHhhcc
Confidence            999999999988777655443

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=98.88  E-value=1.7e-09  Score=77.13  Aligned_cols=82  Identities=21%  Similarity=0.235  Sum_probs=69.6

Q ss_pred             CCCCCCCCEEEccCCcccccCCC----------ccccCccccccccccccCCCCCeeeCCCCcceec-CCcccccCCCCC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPT----------TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGA-IPIPLEKLLDLK   69 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~----------~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~-ip~~~~~l~~l~   69 (232)
                      ++.+++|+.|+|++|.+++. +.          .+++|++++.+|..++.+++|+.|++++|++++. .|..+..+++|+
T Consensus        38 ~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~  116 (149)
T 2je0_A           38 TDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLK  116 (149)
T ss_dssp             CTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCC
T ss_pred             HhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCC
Confidence            36788999999999999975 21          1378999998999999999999999999999963 457789999999


Q ss_pred             ccccccccccCCCC
Q 042107           70 DLNLSFNTLEGKIP   83 (232)
Q Consensus        70 ~l~l~~n~l~g~~p   83 (232)
                      .+++++|.+++..+
T Consensus       117 ~L~l~~N~l~~~~~  130 (149)
T 2je0_A          117 SLDLFNCEVTNLND  130 (149)
T ss_dssp             EEECTTCGGGGSTT
T ss_pred             EEeCcCCcccchHH
Confidence            99999999987654

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=98.87  E-value=1.6e-09  Score=78.75  Aligned_cols=75  Identities=27%  Similarity=0.268  Sum_probs=56.1

Q ss_pred             CCCCCEEEccCCccc-ccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcc
Q 042107            4 LKVLLRIDLSTNNFS-CVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDL   71 (232)
Q Consensus         4 ~~~l~~l~ls~N~~~-g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l   71 (232)
                      .++|+.|+|++|.++ |.+|..+           ++|++++.  ..++.+++|+.|+|++|++++.+|..+..+++|+.|
T Consensus        23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  100 (168)
T 2ell_A           23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL  100 (168)
T ss_dssp             TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred             cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence            467888888888887 7777653           56777765  667777888888888888876677666667788888


Q ss_pred             ccccccccC
Q 042107           72 NLSFNTLEG   80 (232)
Q Consensus        72 ~l~~n~l~g   80 (232)
                      ++++|.+++
T Consensus       101 ~Ls~N~l~~  109 (168)
T 2ell_A          101 NLSGNKLKD  109 (168)
T ss_dssp             ECBSSSCCS
T ss_pred             eccCCccCc
Confidence            888887766

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=98.87  E-value=5.6e-09  Score=82.89  Aligned_cols=85  Identities=27%  Similarity=0.299  Sum_probs=64.8

Q ss_pred             CCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKD   70 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~   70 (232)
                      +.+++|+.|||++|.|+ .+|..+           ++|++++..|..++.+++|+.|+|++|++++..|..+..+++|+.
T Consensus        74 ~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  152 (290)
T 1p9a_G           74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK  152 (290)
T ss_dssp             SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred             CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCE
Confidence            45778899999999888 556532           678888777788888889999999999888555555678888888


Q ss_pred             cccccccccCCCCCccc
Q 042107           71 LNLSFNTLEGKIPRPFR   87 (232)
Q Consensus        71 l~l~~n~l~g~~p~~~~   87 (232)
                      |+++.|.++...+..+.
T Consensus       153 L~L~~N~l~~l~~~~~~  169 (290)
T 1p9a_G          153 LSLANNNLTELPAGLLN  169 (290)
T ss_dssp             EECTTSCCSCCCTTTTT
T ss_pred             EECCCCcCCccCHHHhc
Confidence            99988888754444333

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=98.87  E-value=5.8e-09  Score=81.78  Aligned_cols=86  Identities=23%  Similarity=0.294  Sum_probs=60.4

Q ss_pred             CCCCCCCCEEEccCCcccccCCCc-----------cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPTT-----------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK   69 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~~-----------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~   69 (232)
                      |+++++|++|+|++|.++...+..           +++|++++..+..+..+++|+.|+|++|++++..|..+..+++|+
T Consensus        57 ~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  136 (270)
T 2o6q_A           57 FHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLT  136 (270)
T ss_dssp             SSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred             hcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCC
Confidence            356778888888888887433322           256777766666677788888888888888766555667788888


Q ss_pred             ccccccccccCCCCCcc
Q 042107           70 DLNLSFNTLEGKIPRPF   86 (232)
Q Consensus        70 ~l~l~~n~l~g~~p~~~   86 (232)
                      .|+++.|.+++..+..+
T Consensus       137 ~L~Ls~n~l~~~~~~~~  153 (270)
T 2o6q_A          137 YLSLGYNELQSLPKGVF  153 (270)
T ss_dssp             EEECCSSCCCCCCTTTT
T ss_pred             EEECCCCcCCccCHhHc
Confidence            88888887776544433

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=98.87  E-value=6.1e-09  Score=81.68  Aligned_cols=86  Identities=24%  Similarity=0.252  Sum_probs=68.6

Q ss_pred             CCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKD   70 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~   70 (232)
                      +++++|+.|+|++|.+++..|..+           ++|++++..|..++.+++|+.|+|++|++++..+..+..+++|+.
T Consensus        82 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~  161 (270)
T 2o6q_A           82 KELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKE  161 (270)
T ss_dssp             SSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             cCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccce
Confidence            568899999999999986544432           578888888888889999999999999998554555788999999


Q ss_pred             cccccccccCCCCCccc
Q 042107           71 LNLSFNTLEGKIPRPFR   87 (232)
Q Consensus        71 l~l~~n~l~g~~p~~~~   87 (232)
                      ++++.|.+++..+..+.
T Consensus       162 L~L~~n~l~~~~~~~~~  178 (270)
T 2o6q_A          162 LRLYNNQLKRVPEGAFD  178 (270)
T ss_dssp             EECCSSCCSCCCTTTTT
T ss_pred             eEecCCcCcEeChhHhc
Confidence            99999988876555444

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=98.87  E-value=3.4e-09  Score=83.32  Aligned_cols=88  Identities=25%  Similarity=0.346  Sum_probs=63.3

Q ss_pred             CCCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK   69 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~   69 (232)
                      |+++++|+.|+|++|.+++..|..+           ++|++++..|..++.+++|+.|++++|++++..+..+..+++|+
T Consensus        48 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~  127 (276)
T 2z62_A           48 FFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK  127 (276)
T ss_dssp             TTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCC
T ss_pred             hccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCC
Confidence            3567788888888888886555432           56777777777777888888888888888765555677778888


Q ss_pred             ccccccccccC-CCCCcccc
Q 042107           70 DLNLSFNTLEG-KIPRPFRN   88 (232)
Q Consensus        70 ~l~l~~n~l~g-~~p~~~~~   88 (232)
                      .|+++.|.+++ .+|..+..
T Consensus       128 ~L~l~~n~l~~~~l~~~~~~  147 (276)
T 2z62_A          128 ELNVAHNLIQSFKLPEYFSN  147 (276)
T ss_dssp             EEECCSSCCCCCCCCGGGGG
T ss_pred             EEECcCCccceecCchhhcc
Confidence            88888887766 35665443

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=98.87  E-value=8.8e-10  Score=99.63  Aligned_cols=79  Identities=23%  Similarity=0.365  Sum_probs=63.5

Q ss_pred             CCCCCCEEEccCCcccccCCCcc-----------ccCc-ccc-ccccccccCC-------CCCeeeCCCCcceecCCc--
Q 042107            3 NLKVLLRIDLSTNNFSCVFPTTI-----------EYNR-LQD-SLRNSIGDLT-------SLKSLDLSNNNFSGAIPI--   60 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~-~~~-~~p~~~~~l~-------~L~~L~ls~N~l~g~ip~--   60 (232)
                      ++++|+.|+|++|.+.|.+|..+           ++|+ ++| .+|..+++++       +|+.|+|++|+++ .+|.  
T Consensus       489 ~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~  567 (876)
T 4ecn_A          489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASA  567 (876)
T ss_dssp             GCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHH
T ss_pred             cCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChh
Confidence            78888888888888888888754           5677 888 8887777665       8888888888888 7887  


Q ss_pred             ccccCCCCCccccccccccCCCC
Q 042107           61 PLEKLLDLKDLNLSFNTLEGKIP   83 (232)
Q Consensus        61 ~~~~l~~l~~l~l~~n~l~g~~p   83 (232)
                      .+.++++|+.|+++.|.++ .+|
T Consensus       568 ~l~~L~~L~~L~Ls~N~l~-~lp  589 (876)
T 4ecn_A          568 SLQKMVKLGLLDCVHNKVR-HLE  589 (876)
T ss_dssp             HHTTCTTCCEEECTTSCCC-BCC
T ss_pred             hhhcCCCCCEEECCCCCcc-cch
Confidence            7788888888888888877 666

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=98.86  E-value=2.8e-09  Score=77.52  Aligned_cols=81  Identities=25%  Similarity=0.238  Sum_probs=67.0

Q ss_pred             CCCCCCCEEEccCCcccccCCC----------ccccCccccccccccccCCCCCeeeCCCCcceec-CCcccccCCCCCc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPT----------TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGA-IPIPLEKLLDLKD   70 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~----------~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~-ip~~~~~l~~l~~   70 (232)
                      +.+++|+.|+|++|.+++. +.          .+++|++++.+|..+..+++|+.|+|++|++++. .+..+..+++|+.
T Consensus        46 ~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~  124 (168)
T 2ell_A           46 AEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKS  124 (168)
T ss_dssp             GGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCE
T ss_pred             HhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCE
Confidence            5678899999999999865 22          1378999998898888899999999999999853 2267889999999


Q ss_pred             cccccccccCCCC
Q 042107           71 LNLSFNTLEGKIP   83 (232)
Q Consensus        71 l~l~~n~l~g~~p   83 (232)
                      +++++|.+++..+
T Consensus       125 L~l~~N~l~~~~~  137 (168)
T 2ell_A          125 LDLFNCEVTNLND  137 (168)
T ss_dssp             EECCSSGGGTSTT
T ss_pred             EEeeCCcCcchHH
Confidence            9999999987654

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=98.85  E-value=7.6e-09  Score=82.12  Aligned_cols=86  Identities=24%  Similarity=0.228  Sum_probs=66.4

Q ss_pred             CCCCCCCCEEEccCCcccccCCC---------ccccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcc
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPT---------TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDL   71 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~---------~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l   71 (232)
                      |.++++|+.|+|++|.|++..+.         .+++|+++ .+|..+..+++|+.|+|++|++++..|..+..+++|+.|
T Consensus        51 ~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L  129 (290)
T 1p9a_G           51 LMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL  129 (290)
T ss_dssp             GTTCTTCCEEECTTSCCCEEECCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEE
T ss_pred             hhcCCCCCEEECCCCccCcccCCCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEE
Confidence            35678889999999998864332         13678887 678888888899999999999986656678888899999


Q ss_pred             ccccccccCCCCCccc
Q 042107           72 NLSFNTLEGKIPRPFR   87 (232)
Q Consensus        72 ~l~~n~l~g~~p~~~~   87 (232)
                      ++++|.+++..+..+.
T Consensus       130 ~L~~N~l~~~~~~~~~  145 (290)
T 1p9a_G          130 YLKGNELKTLPPGLLT  145 (290)
T ss_dssp             ECTTSCCCCCCTTTTT
T ss_pred             ECCCCCCCccChhhcc
Confidence            9999988876555443

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.84  E-value=3.1e-09  Score=92.59  Aligned_cols=85  Identities=16%  Similarity=0.171  Sum_probs=56.8

Q ss_pred             CCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcc
Q 042107            3 NLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDL   71 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l   71 (232)
                      ++++|+.|+|++|.+++..|..+           ++|++++..|..++.+++|+.|+|++|++++..|..+..+++|+.|
T Consensus        73 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L  152 (597)
T 3oja_B           73 SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTL  152 (597)
T ss_dssp             HCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             cCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEE
Confidence            45677777777777776655443           5677777666677777777777777777773333334677777777


Q ss_pred             ccccccccCCCCCccc
Q 042107           72 NLSFNTLEGKIPRPFR   87 (232)
Q Consensus        72 ~l~~n~l~g~~p~~~~   87 (232)
                      ++++|.+++..|..+.
T Consensus       153 ~Ls~N~l~~~~~~~~~  168 (597)
T 3oja_B          153 SMSNNNLERIEDDTFQ  168 (597)
T ss_dssp             ECCSSCCCBCCTTTTT
T ss_pred             EeeCCcCCCCChhhhh
Confidence            7777777766665443

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=98.84  E-value=5.9e-09  Score=85.29  Aligned_cols=78  Identities=26%  Similarity=0.248  Sum_probs=38.6

Q ss_pred             CCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcc
Q 042107            3 NLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDL   71 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l   71 (232)
                      ++++|+.|+|++|+|++..|..+           ++|+++...+..+..+++|+.|+|++|++++..|..+..+++|+.|
T Consensus        62 ~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  141 (361)
T 2xot_A           62 RLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKL  141 (361)
T ss_dssp             CCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred             cccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEE
Confidence            44455555555555554333321           3455554444445555555555555555554444445555555555


Q ss_pred             ccccccccC
Q 042107           72 NLSFNTLEG   80 (232)
Q Consensus        72 ~l~~n~l~g   80 (232)
                      ++++|.+++
T Consensus       142 ~L~~N~l~~  150 (361)
T 2xot_A          142 YLSQNQISR  150 (361)
T ss_dssp             ECCSSCCCS
T ss_pred             ECCCCcCCe
Confidence            555555543

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=98.83  E-value=6.1e-09  Score=88.14  Aligned_cols=82  Identities=26%  Similarity=0.274  Sum_probs=42.4

Q ss_pred             CCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKD   70 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~   70 (232)
                      +++++|+.|+|++|.+++..|..+           ++|+++...+..++.+++|+.|+|++|++++..|..+..+++|+.
T Consensus        53 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~  132 (477)
T 2id5_A           53 ASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKS  132 (477)
T ss_dssp             TTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred             cCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCE
Confidence            345555555555555555444432           345555433344455555555555555555555555555555555


Q ss_pred             cccccccccCCCC
Q 042107           71 LNLSFNTLEGKIP   83 (232)
Q Consensus        71 l~l~~n~l~g~~p   83 (232)
                      |+++.|.+++..|
T Consensus       133 L~l~~n~l~~~~~  145 (477)
T 2id5_A          133 LEVGDNDLVYISH  145 (477)
T ss_dssp             EEECCTTCCEECT
T ss_pred             EECCCCccceeCh
Confidence            5555555544433

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=98.82  E-value=5.4e-09  Score=89.90  Aligned_cols=75  Identities=28%  Similarity=0.292  Sum_probs=39.9

Q ss_pred             CCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccccc
Q 042107            6 VLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLS   74 (232)
Q Consensus         6 ~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~   74 (232)
                      +|+.|||++|.+++..|..+           ++|++++..|..++.+++|+.|+|++|++++..|..+..+++|++|+++
T Consensus        27 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls  106 (549)
T 2z81_A           27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLM  106 (549)
T ss_dssp             TCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECT
T ss_pred             CccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECC
Confidence            45555555555555444432           3455555555555555555555555555554444445555555555555


Q ss_pred             cccccC
Q 042107           75 FNTLEG   80 (232)
Q Consensus        75 ~n~l~g   80 (232)
                      +|.+++
T Consensus       107 ~n~l~~  112 (549)
T 2z81_A          107 GNPYQT  112 (549)
T ss_dssp             TCCCSS
T ss_pred             CCcccc
Confidence            555543

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=98.82  E-value=6.6e-09  Score=84.99  Aligned_cols=81  Identities=31%  Similarity=0.331  Sum_probs=68.3

Q ss_pred             CCCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCccc----ccC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPL----EKL   65 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~----~~l   65 (232)
                      |.++++|+.|||++|.|++..|..+           ++|++++..|..+..+++|+.|+|++|+++ .+|...    ..+
T Consensus        84 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~~~~l  162 (361)
T 2xot_A           84 FVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKL  162 (361)
T ss_dssp             TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC----C
T ss_pred             ccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcCcccC
Confidence            4678999999999999997666433           689999988999999999999999999999 566654    579


Q ss_pred             CCCCccccccccccCCC
Q 042107           66 LDLKDLNLSFNTLEGKI   82 (232)
Q Consensus        66 ~~l~~l~l~~n~l~g~~   82 (232)
                      ++|+.|++++|.+++..
T Consensus       163 ~~L~~L~L~~N~l~~l~  179 (361)
T 2xot_A          163 PKLMLLDLSSNKLKKLP  179 (361)
T ss_dssp             TTCCEEECCSSCCCCCC
T ss_pred             CcCCEEECCCCCCCccC
Confidence            99999999999998643

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=98.81  E-value=4.9e-09  Score=89.63  Aligned_cols=85  Identities=26%  Similarity=0.285  Sum_probs=59.1

Q ss_pred             CCCCCCCEEEccCCcccccCCCcc-----------ccCcccc--ccccccccCCCCCeeeCCCCcceecCCcc-cccCCC
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQD--SLRNSIGDLTSLKSLDLSNNNFSGAIPIP-LEKLLD   67 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~--~~p~~~~~l~~L~~L~ls~N~l~g~ip~~-~~~l~~   67 (232)
                      +.+++|+.|||++|.+++.+|..+           ++|++++  .+|..++.+++|+.|+|++|++++.+|.. +..++.
T Consensus       321 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~  400 (520)
T 2z7x_B          321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS  400 (520)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred             hhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence            456777777777777777666543           5677776  56667777777777777777777656654 556777


Q ss_pred             CCccccccccccCCCCCcc
Q 042107           68 LKDLNLSFNTLEGKIPRPF   86 (232)
Q Consensus        68 l~~l~l~~n~l~g~~p~~~   86 (232)
                      |+.+++++|.+++.+|..+
T Consensus       401 L~~L~Ls~N~l~~~~~~~l  419 (520)
T 2z7x_B          401 LLSLNMSSNILTDTIFRCL  419 (520)
T ss_dssp             CCEEECCSSCCCGGGGGSC
T ss_pred             CCEEECcCCCCCcchhhhh
Confidence            7777777777776655543

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=98.79  E-value=1.2e-08  Score=82.32  Aligned_cols=83  Identities=27%  Similarity=0.356  Sum_probs=56.6

Q ss_pred             CCCCCCEEEccCCcccccCCCc---------cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccc
Q 042107            3 NLKVLLRIDLSTNNFSCVFPTT---------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNL   73 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p~~---------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l   73 (232)
                      ++++|+.|++++|.++. +|..         +++|++++..|..++.+++|+.|+|++|++++..|..+..++.|+.+++
T Consensus       169 ~l~~L~~L~l~~n~l~~-l~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L  247 (330)
T 1xku_A          169 GMKKLSYIRIADTNITT-IPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL  247 (330)
T ss_dssp             GCTTCCEEECCSSCCCS-CCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred             CCCCcCEEECCCCcccc-CCccccccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEEC
Confidence            34555666666666552 3332         2567777777777888888888888888887766667777888888888


Q ss_pred             ccccccCCCCCccc
Q 042107           74 SFNTLEGKIPRPFR   87 (232)
Q Consensus        74 ~~n~l~g~~p~~~~   87 (232)
                      ++|.++ .+|..+.
T Consensus       248 ~~N~l~-~lp~~l~  260 (330)
T 1xku_A          248 NNNKLV-KVPGGLA  260 (330)
T ss_dssp             CSSCCS-SCCTTTT
T ss_pred             CCCcCc-cCChhhc
Confidence            888776 5555443

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=98.79  E-value=2.5e-09  Score=85.67  Aligned_cols=78  Identities=17%  Similarity=0.163  Sum_probs=60.1

Q ss_pred             CCCCCCEEEccCCcccccCCCcc-------------ccCccccccccccccC-----CCCCeeeCCCCcceecCCccccc
Q 042107            3 NLKVLLRIDLSTNNFSCVFPTTI-------------EYNRLQDSLRNSIGDL-----TSLKSLDLSNNNFSGAIPIPLEK   64 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p~~~-------------~~n~~~~~~p~~~~~l-----~~L~~L~ls~N~l~g~ip~~~~~   64 (232)
                      ++++|+.|+|++|.++|.+|..+             ++|++++. |..++.+     ++|+.|+|++|++++..|..+..
T Consensus        93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~  171 (312)
T 1wwl_A           93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV  171 (312)
T ss_dssp             TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred             CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence            46788888888888888777642             56888777 7777766     78888888888888766677788


Q ss_pred             CCCCCccccccccccCC
Q 042107           65 LLDLKDLNLSFNTLEGK   81 (232)
Q Consensus        65 l~~l~~l~l~~n~l~g~   81 (232)
                      +++|+.|++++|.+.+.
T Consensus       172 l~~L~~L~Ls~N~l~~~  188 (312)
T 1wwl_A          172 FPALSTLDLSDNPELGE  188 (312)
T ss_dssp             CSSCCEEECCSCTTCHH
T ss_pred             CCCCCEEECCCCCcCcc
Confidence            88888888888877654

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=98.79  E-value=7.1e-09  Score=93.84  Aligned_cols=83  Identities=25%  Similarity=0.326  Sum_probs=42.4

Q ss_pred             CCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccc--cccCCCCCeeeCCCCcceecCC-cccccCCC
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNS--IGDLTSLKSLDLSNNNFSGAIP-IPLEKLLD   67 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~--~~~l~~L~~L~ls~N~l~g~ip-~~~~~l~~   67 (232)
                      +++++|+.|+|++|.+++..|..+           ++|++++.+|..  ++.+++|+.|+|++|++++..| ..+.++++
T Consensus        70 ~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~  149 (844)
T 3j0a_A           70 RNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNS  149 (844)
T ss_dssp             SSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSS
T ss_pred             cCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCC
Confidence            344555555555555555444432           345555544433  5555555555555555554333 23455555


Q ss_pred             CCccccccccccCCCCC
Q 042107           68 LKDLNLSFNTLEGKIPR   84 (232)
Q Consensus        68 l~~l~l~~n~l~g~~p~   84 (232)
                      |+.|+++.|.+++..|.
T Consensus       150 L~~L~Ls~N~i~~~~~~  166 (844)
T 3j0a_A          150 LKSIDFSSNQIFLVCEH  166 (844)
T ss_dssp             CCEEEEESSCCCCCCSG
T ss_pred             CCEEECCCCcCCeeCHH
Confidence            55555555555544443

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=98.79  E-value=8.8e-09  Score=89.64  Aligned_cols=79  Identities=24%  Similarity=0.216  Sum_probs=48.5

Q ss_pred             CCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKD   70 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~   70 (232)
                      +++++|++|||++|.+++..|..+           ++|++++..|..++.+++|+.|+|++|++++..|..+..+++|++
T Consensus        54 ~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~  133 (606)
T 3t6q_A           54 SRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES  133 (606)
T ss_dssp             TTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCE
T ss_pred             ccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccE
Confidence            455666666666666665555443           456666666666666666666666666666544555566666666


Q ss_pred             cccccccccC
Q 042107           71 LNLSFNTLEG   80 (232)
Q Consensus        71 l~l~~n~l~g   80 (232)
                      ++++.|.+++
T Consensus       134 L~L~~n~l~~  143 (606)
T 3t6q_A          134 LYLGSNHISS  143 (606)
T ss_dssp             EECCSSCCCC
T ss_pred             EECCCCcccc
Confidence            6666666655

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.78  E-value=1.2e-08  Score=88.85  Aligned_cols=82  Identities=22%  Similarity=0.257  Sum_probs=70.7

Q ss_pred             CCCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK   69 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~   69 (232)
                      |+++++|+.|+|++|.|++..|..+           ++|++++..|..++.+++|+.|+|++|.+++..|..+..+++|+
T Consensus        95 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  174 (597)
T 3oja_B           95 FAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQ  174 (597)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCC
T ss_pred             hcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCc
Confidence            4678999999999999998777653           67999865556679999999999999999988888899999999


Q ss_pred             ccccccccccCCC
Q 042107           70 DLNLSFNTLEGKI   82 (232)
Q Consensus        70 ~l~l~~n~l~g~~   82 (232)
                      .|++++|.+++..
T Consensus       175 ~L~L~~N~l~~~~  187 (597)
T 3oja_B          175 NLQLSSNRLTHVD  187 (597)
T ss_dssp             EEECTTSCCSBCC
T ss_pred             EEECcCCCCCCcC
Confidence            9999999988753

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=98.77  E-value=1.8e-08  Score=84.80  Aligned_cols=85  Identities=26%  Similarity=0.257  Sum_probs=66.6

Q ss_pred             CCCCCCCEEEccCCcccccCCC----------ccccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPT----------TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDL   71 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~----------~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l   71 (232)
                      .++++|+.|+|++|.+++ +|.          .+++|++++..|..+..+++|+.|+|++|++++..|..+..+++|+.|
T Consensus       193 ~~l~~L~~L~L~~n~l~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  271 (452)
T 3zyi_A          193 EGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVEL  271 (452)
T ss_dssp             TTCTTCCEEECTTSCCSS-CCCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             cCCCCCCEEECCCCcccc-cccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEE
Confidence            467778888888888874 343          136788888888888888899999999999888778888888889999


Q ss_pred             ccccccccCCCCCccc
Q 042107           72 NLSFNTLEGKIPRPFR   87 (232)
Q Consensus        72 ~l~~n~l~g~~p~~~~   87 (232)
                      ++++|.+++..+..+.
T Consensus       272 ~L~~N~l~~~~~~~~~  287 (452)
T 3zyi_A          272 NLAHNNLSSLPHDLFT  287 (452)
T ss_dssp             ECCSSCCSCCCTTSST
T ss_pred             ECCCCcCCccChHHhc
Confidence            9998888865555443

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=98.77  E-value=1.7e-08  Score=84.68  Aligned_cols=85  Identities=21%  Similarity=0.221  Sum_probs=63.9

Q ss_pred             CCCCCCCEEEccCCcccccCCCc----------cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTT----------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDL   71 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~----------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l   71 (232)
                      +++++|+.|+|++|.++ .+|..          +++|++++..|..+..+++|+.|+|++|++++..|..+..+++|+.|
T Consensus       182 ~~l~~L~~L~L~~n~l~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  260 (440)
T 3zyj_A          182 EGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEI  260 (440)
T ss_dssp             TTCSSCCEEECTTSCCS-SCCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEE
T ss_pred             hcccccCeecCCCCcCc-cccccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEE
Confidence            45677777777777777 44431          36788888778888888888888888888887777778888888888


Q ss_pred             ccccccccCCCCCccc
Q 042107           72 NLSFNTLEGKIPRPFR   87 (232)
Q Consensus        72 ~l~~n~l~g~~p~~~~   87 (232)
                      ++++|.+++..+..+.
T Consensus       261 ~L~~N~l~~~~~~~~~  276 (440)
T 3zyj_A          261 NLAHNNLTLLPHDLFT  276 (440)
T ss_dssp             ECTTSCCCCCCTTTTS
T ss_pred             ECCCCCCCccChhHhc
Confidence            8888888765555443

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=98.77  E-value=8.7e-09  Score=93.29  Aligned_cols=82  Identities=18%  Similarity=0.144  Sum_probs=49.8

Q ss_pred             CCCCCCCEEEccCCcccccC-CCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcc--cccCCC
Q 042107            2 SNLKVLLRIDLSTNNFSCVF-PTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIP--LEKLLD   67 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~-p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~--~~~l~~   67 (232)
                      +++++|++|||++|.+.+.+ |..+           ++|++++..|..++.+++|+.|+|++|++++.+|..  +.++++
T Consensus        45 ~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~  124 (844)
T 3j0a_A           45 PFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKA  124 (844)
T ss_dssp             SSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSS
T ss_pred             cccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCC
Confidence            45556666666666555555 3222           456666666666666666666666666666655544  566666


Q ss_pred             CCccccccccccCCCC
Q 042107           68 LKDLNLSFNTLEGKIP   83 (232)
Q Consensus        68 l~~l~l~~n~l~g~~p   83 (232)
                      |+.|+++.|.+++..|
T Consensus       125 L~~L~Ls~N~l~~~~~  140 (844)
T 3j0a_A          125 LTRLDLSKNQIRSLYL  140 (844)
T ss_dssp             CCEEEEESCCCCCCCC
T ss_pred             CCEEECCCCccccccc
Confidence            6666666666665443

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=98.76  E-value=9.5e-09  Score=90.67  Aligned_cols=84  Identities=24%  Similarity=0.222  Sum_probs=49.9

Q ss_pred             CCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcc
Q 042107            3 NLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDL   71 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l   71 (232)
                      ++++|+.|||++|.+++..|..+           ++|++++..+..++.+++|+.|+|++|++++..|..+..+++|+.+
T Consensus        47 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  126 (680)
T 1ziw_A           47 RYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITL  126 (680)
T ss_dssp             GGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEE
T ss_pred             CCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEE
Confidence            45566666666666665555432           4566654433456666666666666666664444556666666666


Q ss_pred             ccccccccCCCCCcc
Q 042107           72 NLSFNTLEGKIPRPF   86 (232)
Q Consensus        72 ~l~~n~l~g~~p~~~   86 (232)
                      +++.|.+++..|..+
T Consensus       127 ~Ls~n~l~~~~~~~~  141 (680)
T 1ziw_A          127 DLSHNGLSSTKLGTQ  141 (680)
T ss_dssp             ECCSSCCSCCCCCSS
T ss_pred             ECCCCcccccCchhh
Confidence            666666666555433

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=98.76  E-value=1.4e-08  Score=88.40  Aligned_cols=86  Identities=23%  Similarity=0.237  Sum_probs=52.4

Q ss_pred             CCCCCCCEEEccCCcccccCCCc------------cccCccccccccccccCCCCCeeeCCCCcceec---CCcccccCC
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTT------------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGA---IPIPLEKLL   66 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~------------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~---ip~~~~~l~   66 (232)
                      +++++|+.|+|++|.+++..|..            +++|++++..|..++.+++|+.|++++|++++.   .+..+..++
T Consensus       397 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~  476 (606)
T 3t6q_A          397 KECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLG  476 (606)
T ss_dssp             TTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCT
T ss_pred             cCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCC
Confidence            45667777777777777655432            145666666666666666666666666666552   223455666


Q ss_pred             CCCccccccccccCCCCCccc
Q 042107           67 DLKDLNLSFNTLEGKIPRPFR   87 (232)
Q Consensus        67 ~l~~l~l~~n~l~g~~p~~~~   87 (232)
                      +|+.+++++|.+++..|..+.
T Consensus       477 ~L~~L~Ls~n~l~~~~~~~~~  497 (606)
T 3t6q_A          477 RLEILVLSFCDLSSIDQHAFT  497 (606)
T ss_dssp             TCCEEECTTSCCCEECTTTTT
T ss_pred             CccEEECCCCccCccChhhhc
Confidence            666666666666665555443

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=98.75  E-value=6.9e-09  Score=88.30  Aligned_cols=55  Identities=22%  Similarity=0.175  Sum_probs=28.9

Q ss_pred             ccCccccccccccccCCCCCeeeCCCCcceecCCcccc-cCCCCCccccccccccC
Q 042107           26 EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLE-KLLDLKDLNLSFNTLEG   80 (232)
Q Consensus        26 ~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~-~l~~l~~l~l~~n~l~g   80 (232)
                      ++|++++..|..++.+++|+.|+|++|++++.+|..+. .++.|+.|++++|.+++
T Consensus       128 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~  183 (487)
T 3oja_A          128 ANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD  183 (487)
T ss_dssp             CSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred             CCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc
Confidence            34555555555555555555555555555555554443 44555555555555443

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=98.75  E-value=9.1e-09  Score=88.48  Aligned_cols=88  Identities=20%  Similarity=0.250  Sum_probs=75.6

Q ss_pred             CCCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCccee-cCCcccccCCCC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSG-AIPIPLEKLLDL   68 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g-~ip~~~~~l~~l   68 (232)
                      |+++++|++|+|++|.+++..|..+           ++|++++..|..++.+++|+.|+|++|++++ .+|..+.++++|
T Consensus        46 ~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L  125 (549)
T 2z81_A           46 LRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNL  125 (549)
T ss_dssp             TSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTC
T ss_pred             hhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCc
Confidence            4678999999999999998877654           6899999888889999999999999999986 467788999999


Q ss_pred             CccccccccccCCCCC-cccc
Q 042107           69 KDLNLSFNTLEGKIPR-PFRN   88 (232)
Q Consensus        69 ~~l~l~~n~l~g~~p~-~~~~   88 (232)
                      +.++++.|.+.+.+|. .+..
T Consensus       126 ~~L~L~~n~~~~~~~~~~~~~  146 (549)
T 2z81_A          126 QTLRIGNVETFSEIRRIDFAG  146 (549)
T ss_dssp             CEEEEEESSSCCEECTTTTTT
T ss_pred             cEEECCCCccccccCHhhhhc
Confidence            9999999997776664 4443

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=98.75  E-value=1.2e-08  Score=85.64  Aligned_cols=79  Identities=27%  Similarity=0.340  Sum_probs=70.2

Q ss_pred             CCCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK   69 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~   69 (232)
                      +..+++|+.|||++|.|++..|..+           ++|++++..|..+..+++|+.|+|++|++++..+..+..+++|+
T Consensus       203 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  282 (440)
T 3zyj_A          203 LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLE  282 (440)
T ss_dssp             CTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCC
T ss_pred             cCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCC
Confidence            3567899999999999998877654           68999999999999999999999999999966666678899999


Q ss_pred             cccccccccc
Q 042107           70 DLNLSFNTLE   79 (232)
Q Consensus        70 ~l~l~~n~l~   79 (232)
                      .+++++|.+.
T Consensus       283 ~L~L~~Np~~  292 (440)
T 3zyj_A          283 RIHLHHNPWN  292 (440)
T ss_dssp             EEECCSSCEE
T ss_pred             EEEcCCCCcc
Confidence            9999999875

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=98.73  E-value=2.2e-08  Score=86.49  Aligned_cols=51  Identities=33%  Similarity=0.462  Sum_probs=26.1

Q ss_pred             ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccccccccc
Q 042107           26 EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLE   79 (232)
Q Consensus        26 ~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~l~   79 (232)
                      ++|++++.+|..+.  ++|+.|+|++|+++ .+|..+..++.|+.+++++|.++
T Consensus       436 ~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~  486 (562)
T 3a79_B          436 SSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK  486 (562)
T ss_dssp             CSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC
T ss_pred             CCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC
Confidence            34444444444333  45555555555555 45555455555555555555555

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=98.73  E-value=1.3e-08  Score=85.75  Aligned_cols=80  Identities=26%  Similarity=0.311  Sum_probs=70.4

Q ss_pred             CCCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK   69 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~   69 (232)
                      +..+++|+.|||++|.|++..|..+           ++|++++..|..+..+++|+.|+|++|++++..+..+..+++|+
T Consensus       214 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  293 (452)
T 3zyi_A          214 LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLV  293 (452)
T ss_dssp             CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCC
T ss_pred             ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCC
Confidence            3567899999999999998877654           68999999999999999999999999999966666678899999


Q ss_pred             ccccccccccC
Q 042107           70 DLNLSFNTLEG   80 (232)
Q Consensus        70 ~l~l~~n~l~g   80 (232)
                      .+++++|.+.-
T Consensus       294 ~L~L~~Np~~C  304 (452)
T 3zyi_A          294 ELHLHHNPWNC  304 (452)
T ss_dssp             EEECCSSCEEC
T ss_pred             EEEccCCCcCC
Confidence            99999998754

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=98.73  E-value=1.8e-08  Score=87.10  Aligned_cols=85  Identities=21%  Similarity=0.200  Sum_probs=60.0

Q ss_pred             CCCCCCCEEEccCCcccccCCCcc-----------ccCcccc--ccccccccCCCCCeeeCCCCcceecCCcc-cccCCC
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQD--SLRNSIGDLTSLKSLDLSNNNFSGAIPIP-LEKLLD   67 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~--~~p~~~~~l~~L~~L~ls~N~l~g~ip~~-~~~l~~   67 (232)
                      +.+++|+.|+|++|.+++.+|..+           ++|++++  .+|..++.+++|+.|+|++|++++.+|.. +..+++
T Consensus       350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~  429 (562)
T 3a79_B          350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES  429 (562)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred             cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence            456777888888888887666543           5677776  45566777778888888888877656654 566777


Q ss_pred             CCccccccccccCCCCCcc
Q 042107           68 LKDLNLSFNTLEGKIPRPF   86 (232)
Q Consensus        68 l~~l~l~~n~l~g~~p~~~   86 (232)
                      |+.+++++|.+++.+|..+
T Consensus       430 L~~L~l~~n~l~~~~~~~l  448 (562)
T 3a79_B          430 ILVLNLSSNMLTGSVFRCL  448 (562)
T ss_dssp             CCEEECCSSCCCGGGGSSC
T ss_pred             CCEEECCCCCCCcchhhhh
Confidence            7777777777776665543

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=98.73  E-value=1.4e-08  Score=83.83  Aligned_cols=84  Identities=18%  Similarity=0.248  Sum_probs=55.3

Q ss_pred             CCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcc-cccCCCCCc
Q 042107            3 NLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIP-LEKLLDLKD   70 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~-~~~l~~l~~   70 (232)
                      ++++|+.|+|++|.+++..|..+           ++|++++..|..++.+++|+.|+|++|+++ .+|.. +..+++|+.
T Consensus        67 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~  145 (390)
T 3o6n_A           67 SFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTT  145 (390)
T ss_dssp             HCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCE
T ss_pred             ccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcE
Confidence            45677777777777776554332           567777666666777777777777777777 45544 466777777


Q ss_pred             cccccccccCCCCCccc
Q 042107           71 LNLSFNTLEGKIPRPFR   87 (232)
Q Consensus        71 l~l~~n~l~g~~p~~~~   87 (232)
                      |+++.|.+++..|..+.
T Consensus       146 L~L~~n~l~~~~~~~~~  162 (390)
T 3o6n_A          146 LSMSNNNLERIEDDTFQ  162 (390)
T ss_dssp             EECCSSCCCBCCTTTTS
T ss_pred             EECCCCccCccChhhcc
Confidence            77777777665554443

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=98.71  E-value=2.6e-08  Score=80.29  Aligned_cols=81  Identities=20%  Similarity=0.283  Sum_probs=71.6

Q ss_pred             CCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccc
Q 042107            5 KVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNL   73 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l   73 (232)
                      ++|+.|+|++|.+++..|..+           ++|++++..|..++.+++|+.|+|++|+++ .+|..+..++.|+.+++
T Consensus       192 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l  270 (330)
T 1xku_A          192 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL  270 (330)
T ss_dssp             TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEEC
T ss_pred             ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEEC
Confidence            689999999999998777654           689999988889999999999999999999 89999999999999999


Q ss_pred             ccccccCCCCCcc
Q 042107           74 SFNTLEGKIPRPF   86 (232)
Q Consensus        74 ~~n~l~g~~p~~~   86 (232)
                      ++|.+++..+..+
T Consensus       271 ~~N~i~~~~~~~f  283 (330)
T 1xku_A          271 HNNNISAIGSNDF  283 (330)
T ss_dssp             CSSCCCCCCTTSS
T ss_pred             CCCcCCccChhhc
Confidence            9999987655444

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=98.71  E-value=1e-08  Score=87.67  Aligned_cols=79  Identities=29%  Similarity=0.367  Sum_probs=48.8

Q ss_pred             CCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccc
Q 042107            5 KVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNL   73 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l   73 (232)
                      ++|+.|||++|.+++..|..+           ++|++++..|..++.+++|++|+|++|+++ .+|..  .+++|++|++
T Consensus        21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L   97 (520)
T 2z7x_B           21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDL   97 (520)
T ss_dssp             TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEEC
T ss_pred             ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEec
Confidence            456666666666665544332           456666666666666666666666666666 45554  5666666666


Q ss_pred             ccccccC-CCCCcc
Q 042107           74 SFNTLEG-KIPRPF   86 (232)
Q Consensus        74 ~~n~l~g-~~p~~~   86 (232)
                      ++|.+++ .+|..+
T Consensus        98 ~~N~l~~~~~p~~~  111 (520)
T 2z7x_B           98 SFNAFDALPICKEF  111 (520)
T ss_dssp             CSSCCSSCCCCGGG
T ss_pred             cCCccccccchhhh
Confidence            6666665 455443

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=98.71  E-value=8.7e-09  Score=82.52  Aligned_cols=78  Identities=21%  Similarity=0.135  Sum_probs=63.7

Q ss_pred             CCCCCCCEEEccCCcccccCCCc----------------cccCccccccccccccCCCCCeeeCCCCcceecC--Cccc-
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTT----------------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAI--PIPL-   62 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~----------------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~i--p~~~-   62 (232)
                      +.+++|+.|||++|.+++. |..                +++|++++..|..++.+++|+.|+|++|++.|.+  |..+ 
T Consensus       118 ~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~  196 (312)
T 1wwl_A          118 ATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALC  196 (312)
T ss_dssp             CCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSC
T ss_pred             hcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHH
Confidence            6788999999999999975 432                2679998888899999999999999999988763  3344 


Q ss_pred             -ccCCCCCccccccccccC
Q 042107           63 -EKLLDLKDLNLSFNTLEG   80 (232)
Q Consensus        63 -~~l~~l~~l~l~~n~l~g   80 (232)
                       ..+++|+.|++++|.+++
T Consensus       197 ~~~l~~L~~L~L~~N~l~~  215 (312)
T 1wwl_A          197 PLKFPTLQVLALRNAGMET  215 (312)
T ss_dssp             TTSCTTCCEEECTTSCCCC
T ss_pred             hccCCCCCEEECCCCcCcc
Confidence             778899999999998873

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=98.70  E-value=2.4e-08  Score=80.55  Aligned_cols=78  Identities=22%  Similarity=0.290  Sum_probs=44.5

Q ss_pred             CCCEEEccCCcccccCCCc---------cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccccccc
Q 042107            6 VLLRIDLSTNNFSCVFPTT---------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFN   76 (232)
Q Consensus         6 ~l~~l~ls~N~~~g~~p~~---------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n   76 (232)
                      +|+.|++++|.+++ +|..         +++|++++..|..+..+++|+.|+|++|++++..|..+..+++|+.+++++|
T Consensus       173 ~L~~L~l~~n~l~~-l~~~~~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  251 (332)
T 2ft3_A          173 KLNYLRISEAKLTG-IPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNN  251 (332)
T ss_dssp             CCSCCBCCSSBCSS-CCSSSCSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSS
T ss_pred             ccCEEECcCCCCCc-cCccccCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCC
Confidence            56666666666664 3432         2455665555555666666666666666666544445555666666666666


Q ss_pred             cccCCCCCc
Q 042107           77 TLEGKIPRP   85 (232)
Q Consensus        77 ~l~g~~p~~   85 (232)
                      .++ .+|..
T Consensus       252 ~l~-~lp~~  259 (332)
T 2ft3_A          252 KLS-RVPAG  259 (332)
T ss_dssp             CCC-BCCTT
T ss_pred             cCe-ecChh
Confidence            555 44443

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=98.70  E-value=1.1e-08  Score=76.40  Aligned_cols=47  Identities=21%  Similarity=0.285  Sum_probs=23.5

Q ss_pred             ccccCCCCCeeeCCCCcceecCCcccccCCCCCccccccccccCCCC
Q 042107           37 SIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIP   83 (232)
Q Consensus        37 ~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p   83 (232)
                      .++.+++|+.|++++|++++..|..+..+++|+.|+++.|.+++..|
T Consensus        83 ~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~  129 (197)
T 4ezg_A           83 PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL  129 (197)
T ss_dssp             GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGH
T ss_pred             hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhH
Confidence            44445555555555555554444445555555555555555544333

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=98.70  E-value=2.8e-08  Score=80.61  Aligned_cols=77  Identities=21%  Similarity=0.254  Sum_probs=66.6

Q ss_pred             CEEEccCC-cccccCCCcc-----------cc-CccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccccc
Q 042107            8 LRIDLSTN-NFSCVFPTTI-----------EY-NRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLS   74 (232)
Q Consensus         8 ~~l~ls~N-~~~g~~p~~~-----------~~-n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~   74 (232)
                      ..+++++| .|+. +|. +           ++ |+|++..|..++.+++|+.|+|++|+|++..|..+.++++|+.|+++
T Consensus        11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            46899998 8984 665 4           54 99998888999999999999999999999888889999999999999


Q ss_pred             cccccCCCCCcc
Q 042107           75 FNTLEGKIPRPF   86 (232)
Q Consensus        75 ~n~l~g~~p~~~   86 (232)
                      +|.|++..|..+
T Consensus        89 ~N~l~~~~~~~~  100 (347)
T 2ifg_A           89 FNALESLSWKTV  100 (347)
T ss_dssp             SSCCSCCCSTTT
T ss_pred             CCccceeCHHHc
Confidence            999997655444

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=98.69  E-value=1.5e-08  Score=80.99  Aligned_cols=80  Identities=14%  Similarity=0.100  Sum_probs=39.0

Q ss_pred             CCCCCEEEccCCcccccCCCcc-----------ccCccccc--cc--cccccCCCCCeeeCCCCcceecCCc---c-ccc
Q 042107            4 LKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDS--LR--NSIGDLTSLKSLDLSNNNFSGAIPI---P-LEK   64 (232)
Q Consensus         4 ~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~--~p--~~~~~l~~L~~L~ls~N~l~g~ip~---~-~~~   64 (232)
                      +++|+.|+|++|.+++..|..+           ++|++.+.  +|  ..++.+++|+.|+|++|+++ .+|.   . +..
T Consensus       144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~  222 (310)
T 4glp_A          144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAA  222 (310)
T ss_dssp             CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHH
T ss_pred             ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhc
Confidence            4556666666666655444432           44554432  21  22245555555555555554 1121   1 234


Q ss_pred             CCCCCccccccccccCCCCC
Q 042107           65 LLDLKDLNLSFNTLEGKIPR   84 (232)
Q Consensus        65 l~~l~~l~l~~n~l~g~~p~   84 (232)
                      ++.|+.|++++|.+++..|.
T Consensus       223 l~~L~~L~Ls~N~l~~~~p~  242 (310)
T 4glp_A          223 GVQPHSLDLSHNSLRATVNP  242 (310)
T ss_dssp             TCCCSSEECTTSCCCCCCCS
T ss_pred             CCCCCEEECCCCCCCccchh
Confidence            45555555555555555443

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=98.69  E-value=3.1e-08  Score=80.63  Aligned_cols=73  Identities=29%  Similarity=0.351  Sum_probs=39.4

Q ss_pred             CCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcc-cccCCCCCcccc
Q 042107            6 VLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIP-LEKLLDLKDLNL   73 (232)
Q Consensus         6 ~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~-~~~l~~l~~l~l   73 (232)
                      +|+.|||++|.+++..+..+           ++|++++..|..++.+++|+.|+|++|++++ +|.. +..+++|+.+++
T Consensus        53 ~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~L  131 (353)
T 2z80_A           53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNL  131 (353)
T ss_dssp             TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSS-CCHHHHTTCTTCSEEEC
T ss_pred             cCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCc-CCHhHhCCCccCCEEEC
Confidence            45566666666654333222           4455555555555556666666666666553 3332 455556666666


Q ss_pred             cccccc
Q 042107           74 SFNTLE   79 (232)
Q Consensus        74 ~~n~l~   79 (232)
                      ++|.++
T Consensus       132 ~~n~l~  137 (353)
T 2z80_A          132 LGNPYK  137 (353)
T ss_dssp             TTCCCS
T ss_pred             CCCCCc
Confidence            665555

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=98.68  E-value=2.6e-08  Score=80.37  Aligned_cols=84  Identities=18%  Similarity=0.206  Sum_probs=60.0

Q ss_pred             CCCCCCCEEEccCCccc--ccCCCcc----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCC
Q 042107            2 SNLKVLLRIDLSTNNFS--CVFPTTI----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK   69 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~--g~~p~~~----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~   69 (232)
                      +++++|+.|+|++|.++  |..|..+          ++|++++ +|..+.  ++|+.|++++|++++..|..+..+++|+
T Consensus       144 ~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~  220 (332)
T 2ft3_A          144 SGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLY  220 (332)
T ss_dssp             SSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCS
T ss_pred             CCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCC
Confidence            56778888888888885  3444432          5677765 565544  6888888888888876667788888888


Q ss_pred             ccccccccccCCCCCcccc
Q 042107           70 DLNLSFNTLEGKIPRPFRN   88 (232)
Q Consensus        70 ~l~l~~n~l~g~~p~~~~~   88 (232)
                      .+++++|.+++..|..+..
T Consensus       221 ~L~L~~N~l~~~~~~~~~~  239 (332)
T 2ft3_A          221 RLGLGHNQIRMIENGSLSF  239 (332)
T ss_dssp             CCBCCSSCCCCCCTTGGGG
T ss_pred             EEECCCCcCCcCChhHhhC
Confidence            8888888887766654443

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=98.67  E-value=2.9e-08  Score=83.93  Aligned_cols=84  Identities=18%  Similarity=0.174  Sum_probs=71.6

Q ss_pred             CCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccc
Q 042107            5 KVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNL   73 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l   73 (232)
                      ++|+.|||++|.+++..|..+           ++|++++..|..++++++|+.|+|++|++++..+..+..+++|+.|++
T Consensus        32 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  111 (477)
T 2id5_A           32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDI  111 (477)
T ss_dssp             TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEEC
T ss_pred             CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEEC
Confidence            478999999999998777654           679999999999999999999999999999544445789999999999


Q ss_pred             ccccccCCCCCcccc
Q 042107           74 SFNTLEGKIPRPFRN   88 (232)
Q Consensus        74 ~~n~l~g~~p~~~~~   88 (232)
                      +.|.+++..|..+..
T Consensus       112 s~n~i~~~~~~~~~~  126 (477)
T 2id5_A          112 SENKIVILLDYMFQD  126 (477)
T ss_dssp             TTSCCCEECTTTTTT
T ss_pred             CCCccccCChhHccc
Confidence            999998877765544

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=98.67  E-value=5.2e-08  Score=80.32  Aligned_cols=81  Identities=22%  Similarity=0.275  Sum_probs=68.3

Q ss_pred             CCCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK   69 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~   69 (232)
                      |+++++|+.|+|++|.+++..|..+           ++|+++...+..++.+++|+.|++++|++++..|..+..+++|+
T Consensus        89 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~  168 (390)
T 3o6n_A           89 FAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQ  168 (390)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCC
T ss_pred             ccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCC
Confidence            4678999999999999998777653           67888854444468999999999999999977777789999999


Q ss_pred             ccccccccccCC
Q 042107           70 DLNLSFNTLEGK   81 (232)
Q Consensus        70 ~l~l~~n~l~g~   81 (232)
                      .|+++.|.+++.
T Consensus       169 ~L~l~~n~l~~~  180 (390)
T 3o6n_A          169 NLQLSSNRLTHV  180 (390)
T ss_dssp             EEECCSSCCSBC
T ss_pred             EEECCCCcCCcc
Confidence            999999998764

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=98.67  E-value=2.9e-08  Score=72.71  Aligned_cols=77  Identities=23%  Similarity=0.217  Sum_probs=61.9

Q ss_pred             CCCCEEEccCCcccccCCC----------ccccCccccccccccccCCCCCeeeCCCCcceecCCc--ccccCCCCCccc
Q 042107            5 KVLLRIDLSTNNFSCVFPT----------TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPI--PLEKLLDLKDLN   72 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g~~p~----------~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~--~~~~l~~l~~l~   72 (232)
                      ++|+.|||++|.|++. +.          .+++|++++..|..++.+++|+.|+|++|+++ .+|.  .+..+++|+.++
T Consensus        42 ~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~  119 (176)
T 1a9n_A           42 DQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLC  119 (176)
T ss_dssp             TCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEE
T ss_pred             CCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEE
Confidence            3899999999999974 22          13789998654455589999999999999996 6776  788999999999


Q ss_pred             cccccccCCCCC
Q 042107           73 LSFNTLEGKIPR   84 (232)
Q Consensus        73 l~~n~l~g~~p~   84 (232)
                      +++|.++. +|.
T Consensus       120 l~~N~i~~-~~~  130 (176)
T 1a9n_A          120 ILRNPVTN-KKH  130 (176)
T ss_dssp             CCSSGGGG-STT
T ss_pred             ecCCCCCC-cHh
Confidence            99999874 344

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=98.63  E-value=2.2e-08  Score=80.12  Aligned_cols=86  Identities=26%  Similarity=0.362  Sum_probs=63.0

Q ss_pred             CCCCCCCCEEEccCCccccc-----------CCC----ccccCcccc--cccc-ccccCCCCCeeeCCCCcceecCCccc
Q 042107            1 MSNLKVLLRIDLSTNNFSCV-----------FPT----TIEYNRLQD--SLRN-SIGDLTSLKSLDLSNNNFSGAIPIPL   62 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~-----------~p~----~~~~n~~~~--~~p~-~~~~l~~L~~L~ls~N~l~g~ip~~~   62 (232)
                      ++++++|+.|||++|++.+.           +|.    .+++|+++.  .++. .++.+++|+.|+|++|++++.+|..+
T Consensus       165 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~  244 (310)
T 4glp_A          165 VRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSA  244 (310)
T ss_dssp             CCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCC
T ss_pred             hccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhH
Confidence            45788999999999998652           121    136788862  2222 24778999999999999998878777


Q ss_pred             ccC---CCCCccccccccccCCCCCccc
Q 042107           63 EKL---LDLKDLNLSFNTLEGKIPRPFR   87 (232)
Q Consensus        63 ~~l---~~l~~l~l~~n~l~g~~p~~~~   87 (232)
                      ..+   ++|+.|++++|.++ .+|..+.
T Consensus       245 ~~~~~~~~L~~L~Ls~N~l~-~lp~~~~  271 (310)
T 4glp_A          245 PRCMWSSALNSLNLSFAGLE-QVPKGLP  271 (310)
T ss_dssp             SSCCCCTTCCCEECCSSCCC-SCCSCCC
T ss_pred             HhccCcCcCCEEECCCCCCC-chhhhhc
Confidence            666   68999999999988 5666443

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=98.63  E-value=4e-08  Score=71.94  Aligned_cols=79  Identities=22%  Similarity=0.182  Sum_probs=63.6

Q ss_pred             CCCCCCCEEEccCCcccccCCCc-----------cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTT-----------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKD   70 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~-----------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~   70 (232)
                      .++++|+.|+|++|.++. +|..           +++|++++.  ..++.+++|+.|+|++|++++..|..+..+++|+.
T Consensus        16 ~~~~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~   92 (176)
T 1a9n_A           16 TNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTE   92 (176)
T ss_dssp             ECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCE
T ss_pred             CCcCCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCE
Confidence            357889999999999994 4532           268999875  68899999999999999999543344489999999


Q ss_pred             cccccccccCCCCC
Q 042107           71 LNLSFNTLEGKIPR   84 (232)
Q Consensus        71 l~l~~n~l~g~~p~   84 (232)
                      +++++|.++ .+|.
T Consensus        93 L~L~~N~i~-~~~~  105 (176)
T 1a9n_A           93 LILTNNSLV-ELGD  105 (176)
T ss_dssp             EECCSCCCC-CGGG
T ss_pred             EECCCCcCC-cchh
Confidence            999999984 3444

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=98.61  E-value=3.3e-08  Score=76.01  Aligned_cols=78  Identities=19%  Similarity=0.215  Sum_probs=55.3

Q ss_pred             CCCEEEccCCcccccCCCcc-----------ccCc-cccccccccccCCCCCeeeCCC-CcceecCCcccccCCCCCccc
Q 042107            6 VLLRIDLSTNNFSCVFPTTI-----------EYNR-LQDSLRNSIGDLTSLKSLDLSN-NNFSGAIPIPLEKLLDLKDLN   72 (232)
Q Consensus         6 ~l~~l~ls~N~~~g~~p~~~-----------~~n~-~~~~~p~~~~~l~~L~~L~ls~-N~l~g~ip~~~~~l~~l~~l~   72 (232)
                      +|+.|+|++|++++..|..+           ++|+ ++...+..+..+++|+.|++++ |++++..|..+..+++|+.++
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~  111 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG  111 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEe
Confidence            67788888888876555332           5665 6655556777788888888887 888755555677788888888


Q ss_pred             cccccccCCCCC
Q 042107           73 LSFNTLEGKIPR   84 (232)
Q Consensus        73 l~~n~l~g~~p~   84 (232)
                      ++.|.+++ +|.
T Consensus       112 l~~n~l~~-lp~  122 (239)
T 2xwt_C          112 IFNTGLKM-FPD  122 (239)
T ss_dssp             EEEECCCS-CCC
T ss_pred             CCCCCCcc-ccc
Confidence            88887776 454

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=98.58  E-value=1e-07  Score=84.06  Aligned_cols=83  Identities=28%  Similarity=0.318  Sum_probs=42.9

Q ss_pred             CCCCCCCEEEccCCcccccCCCc------------cccCccccccccccccCCCCCeeeCCCCcce--ecCCcccccCCC
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTT------------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFS--GAIPIPLEKLLD   67 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~------------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~--g~ip~~~~~l~~   67 (232)
                      +.+++|+.|||++|.+++.+|..            +++|++.+..|..+..+++|+.|++++|.++  +.+|..+..+++
T Consensus       402 ~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~  481 (680)
T 1ziw_A          402 SWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRN  481 (680)
T ss_dssp             TTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTT
T ss_pred             hCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCC
Confidence            45566677777777776665531            1445555444444444444444444444443  334444555555


Q ss_pred             CCccccccccccCCCCC
Q 042107           68 LKDLNLSFNTLEGKIPR   84 (232)
Q Consensus        68 l~~l~l~~n~l~g~~p~   84 (232)
                      |+.+++++|.+++..|.
T Consensus       482 L~~L~Ls~N~l~~i~~~  498 (680)
T 1ziw_A          482 LTILDLSNNNIANINDD  498 (680)
T ss_dssp             CCEEECCSSCCCCCCTT
T ss_pred             CCEEECCCCCCCcCChh
Confidence            55555555555544333

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.55  E-value=1.3e-07  Score=75.33  Aligned_cols=101  Identities=16%  Similarity=0.083  Sum_probs=66.6

Q ss_pred             ecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCC-CCC--ccceeEEEecCC---eeEEEEeccC
Q 042107           94 NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-HQN--LIKIISSCSKDD---FKALILEYMP  167 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~~  167 (232)
                      +.++.|....||+..    ..+++|.....  .....+.+|..+++.+. +..  +++++......+   ..|+|||+++
T Consensus        26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            458889999999864    46888875432  23466888999987763 332  445554443333   3589999999


Q ss_pred             CCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 042107          168 HGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHF  203 (232)
Q Consensus       168 ~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~  203 (232)
                      |.++.+....   .++..++..++.++++.+..+|.
T Consensus       100 G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~  132 (304)
T 3sg8_A          100 GVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHS  132 (304)
T ss_dssp             CEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CeECCccccc---cCCHHHHHHHHHHHHHHHHHHHc
Confidence            9887643221   24556666777777777777773

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=98.55  E-value=8.9e-08  Score=77.88  Aligned_cols=88  Identities=18%  Similarity=0.230  Sum_probs=70.0

Q ss_pred             CCCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCc--ccccCCC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPI--PLEKLLD   67 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~--~~~~l~~   67 (232)
                      ++++++|+.|+|++|.+++..|..+           ++|++++..+..++.+++|+.|+|++|+++ .+|.  .+..+++
T Consensus        72 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~  150 (353)
T 2z80_A           72 LQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTK  150 (353)
T ss_dssp             TTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTT
T ss_pred             hccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCC
Confidence            4678999999999999998777643           679998765566899999999999999998 5665  6788999


Q ss_pred             CCcccccccc-ccCCCCCccccc
Q 042107           68 LKDLNLSFNT-LEGKIPRPFRNF   89 (232)
Q Consensus        68 l~~l~l~~n~-l~g~~p~~~~~~   89 (232)
                      |+.++++.|+ +....|..+...
T Consensus       151 L~~L~l~~n~~~~~~~~~~~~~l  173 (353)
T 2z80_A          151 LQILRVGNMDTFTKIQRKDFAGL  173 (353)
T ss_dssp             CCEEEEEESSSCCEECTTTTTTC
T ss_pred             CcEEECCCCccccccCHHHccCC
Confidence            9999999995 444444455443

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=98.52  E-value=7.4e-08  Score=81.20  Aligned_cols=54  Identities=28%  Similarity=0.403  Sum_probs=30.8

Q ss_pred             ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccccccccccC--CCCCccc
Q 042107           26 EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEG--KIPRPFR   87 (232)
Q Consensus        26 ~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~l~g--~~p~~~~   87 (232)
                      ++|++++ +|..   +++|+.|++++|+++ .+|.   .+++|+.+++++|.+++  .+|..+.
T Consensus       325 s~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~  380 (454)
T 1jl5_A          325 SNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVE  380 (454)
T ss_dssp             CSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCC
T ss_pred             CCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHH
Confidence            4555554 4433   356666666666666 4554   35566666666666666  5555443

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=98.51  E-value=7.2e-08  Score=77.34  Aligned_cols=77  Identities=19%  Similarity=0.111  Sum_probs=55.9

Q ss_pred             CCCCCCEEEccCCcccccCCCcc-----------ccCcccccccccc-ccCCCCCeeeCCCCcceecCCcccccCCCCCc
Q 042107            3 NLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSI-GDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKD   70 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~-~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~   70 (232)
                      .+++|+.|+|++|.+++..|..+           ++|++++..|..+ ..+++|+.|+|++|++++. |. ...+++|+.
T Consensus       118 ~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~  195 (317)
T 3o53_A          118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKT  195 (317)
T ss_dssp             CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCE
T ss_pred             ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCE
Confidence            35678888888888887655432           6788888777666 4678888888888888754 32 234778888


Q ss_pred             cccccccccCC
Q 042107           71 LNLSFNTLEGK   81 (232)
Q Consensus        71 l~l~~n~l~g~   81 (232)
                      +++++|.+++.
T Consensus       196 L~Ls~N~l~~l  206 (317)
T 3o53_A          196 LDLSSNKLAFM  206 (317)
T ss_dssp             EECCSSCCCEE
T ss_pred             EECCCCcCCcc
Confidence            88888887754

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=98.50  E-value=4.1e-08  Score=84.91  Aligned_cols=78  Identities=19%  Similarity=0.230  Sum_probs=44.3

Q ss_pred             CCCCEEEccCCcccccCCC---c-----cccCccccccccccccCCCC-------CeeeCCCCcceecCCcccccCCCCC
Q 042107            5 KVLLRIDLSTNNFSCVFPT---T-----IEYNRLQDSLRNSIGDLTSL-------KSLDLSNNNFSGAIPIPLEKLLDLK   69 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g~~p~---~-----~~~n~~~~~~p~~~~~l~~L-------~~L~ls~N~l~g~ip~~~~~l~~l~   69 (232)
                      ++|+.|+|++|.|++ +|.   .     +++|+|+ .+|. +..  +|       +.|+|++|+++ .+|..+..+++|+
T Consensus       160 ~~L~~L~Ls~N~L~~-lp~l~~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~  233 (571)
T 3cvr_A          160 TSLEVLSVRNNQLTF-LPELPESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTC  233 (571)
T ss_dssp             TTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTE
T ss_pred             CCcCEEECCCCCCCC-cchhhCCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCC
Confidence            345555555555554 433   1     1445555 4554 332  45       66677777666 5666666677777


Q ss_pred             ccccccccccCCCCCcccc
Q 042107           70 DLNLSFNTLEGKIPRPFRN   88 (232)
Q Consensus        70 ~l~l~~n~l~g~~p~~~~~   88 (232)
                      .+++++|.+++.+|..+..
T Consensus       234 ~L~L~~N~l~~~~p~~l~~  252 (571)
T 3cvr_A          234 TIILEDNPLSSRIRESLSQ  252 (571)
T ss_dssp             EEECCSSSCCHHHHHHHHH
T ss_pred             EEEeeCCcCCCcCHHHHHH
Confidence            7777777777766654433

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=98.49  E-value=2.2e-07  Score=80.34  Aligned_cols=68  Identities=24%  Similarity=0.268  Sum_probs=36.4

Q ss_pred             CCCCCEEEccCCcccccCCC---c-----cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccccc
Q 042107            4 LKVLLRIDLSTNNFSCVFPT---T-----IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSF   75 (232)
Q Consensus         4 ~~~l~~l~ls~N~~~g~~p~---~-----~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~   75 (232)
                      +++|+.|+|++|.|++ +|.   .     +++|++++ +|.   .+++|+.|+|++|++++ +|.   .+++|+.|++++
T Consensus        99 l~~L~~L~Ls~N~l~~-ip~l~~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~  169 (571)
T 3cvr_A           99 PASLEYLDACDNRLST-LPELPASLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRN  169 (571)
T ss_dssp             CTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCS
T ss_pred             cCCCCEEEccCCCCCC-cchhhcCCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCC
Confidence            3455666666666654 443   0     13455554 444   35556666666666553 444   345555566666


Q ss_pred             ccccC
Q 042107           76 NTLEG   80 (232)
Q Consensus        76 n~l~g   80 (232)
                      |.+++
T Consensus       170 N~L~~  174 (571)
T 3cvr_A          170 NQLTF  174 (571)
T ss_dssp             SCCSC
T ss_pred             CCCCC
Confidence            65555

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=98.47  E-value=1.4e-07  Score=76.36  Aligned_cols=79  Identities=28%  Similarity=0.363  Sum_probs=63.9

Q ss_pred             CCCCCCCEEEccCCcccccCCC----------ccccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPT----------TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDL   71 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~----------~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l   71 (232)
                      +.+++|+.|+|++|.+++. |.          .+++|++++.  ..+..+++|+.|++++|++++..|..+..+++|+.+
T Consensus       240 ~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L  316 (347)
T 4fmz_A          240 ANLSQLTWLEIGTNQISDI-NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL  316 (347)
T ss_dssp             TTCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEE
T ss_pred             hcCCCCCEEECCCCccCCC-hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEE
Confidence            5678899999999998863 31          1267888764  457888999999999999988888888889999999


Q ss_pred             ccccccccCCCC
Q 042107           72 NLSFNTLEGKIP   83 (232)
Q Consensus        72 ~l~~n~l~g~~p   83 (232)
                      ++++|.+++..|
T Consensus       317 ~L~~n~l~~~~~  328 (347)
T 4fmz_A          317 FLSQNHITDIRP  328 (347)
T ss_dssp             ECCSSSCCCCGG
T ss_pred             EccCCccccccC
Confidence            999999888766

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=98.46  E-value=1.4e-07  Score=72.36  Aligned_cols=87  Identities=21%  Similarity=0.228  Sum_probs=67.8

Q ss_pred             CCCCCCCCEEEccCCc-ccccCCCcc-----------cc-CccccccccccccCCCCCeeeCCCCcceecCCcccccCCC
Q 042107            1 MSNLKVLLRIDLSTNN-FSCVFPTTI-----------EY-NRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLD   67 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~-~~g~~p~~~-----------~~-n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~   67 (232)
                      |+++++|+.|+|++|. ++...|..+           ++ |++++..|..+..+++|+.|++++|++++ +|. +..+.+
T Consensus        51 ~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~  128 (239)
T 2xwt_C           51 FSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYS  128 (239)
T ss_dssp             TTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCB
T ss_pred             ccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccc
Confidence            4578899999999997 875544332           56 89987777888999999999999999985 776 777778


Q ss_pred             CC---ccccccc-cccCCCCCccccc
Q 042107           68 LK---DLNLSFN-TLEGKIPRPFRNF   89 (232)
Q Consensus        68 l~---~l~l~~n-~l~g~~p~~~~~~   89 (232)
                      ++   .++++.| .+++..+..+...
T Consensus       129 L~~L~~L~l~~N~~l~~i~~~~~~~l  154 (239)
T 2xwt_C          129 TDIFFILEITDNPYMTSIPVNAFQGL  154 (239)
T ss_dssp             CCSEEEEEEESCTTCCEECTTTTTTT
T ss_pred             cccccEEECCCCcchhhcCcccccch
Confidence            87   9999999 7776555445443

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=98.43  E-value=4.2e-07  Score=70.95  Aligned_cols=75  Identities=25%  Similarity=0.356  Sum_probs=49.7

Q ss_pred             CCCCCCCEEEccCCcccccCCC---------ccccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPT---------TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLN   72 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~---------~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~   72 (232)
                      +++++|+.|+|++|.+++ +|.         .+++|++++.  ..++.+++|+.|+|++|++++ +| .+..+++|+.|+
T Consensus        82 ~~l~~L~~L~L~~N~l~~-l~~~~~~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~  156 (263)
T 1xeu_A           82 KDLTKLEELSVNRNRLKN-LNGIPSACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLD  156 (263)
T ss_dssp             TTCSSCCEEECCSSCCSC-CTTCCCSSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEE
T ss_pred             ccCCCCCEEECCCCccCC-cCccccCcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEE
Confidence            455666666666666664 221         1256666653  347777888888888888774 34 567777888888


Q ss_pred             cccccccCC
Q 042107           73 LSFNTLEGK   81 (232)
Q Consensus        73 l~~n~l~g~   81 (232)
                      +++|.+++.
T Consensus       157 L~~N~i~~~  165 (263)
T 1xeu_A          157 LHGNEITNT  165 (263)
T ss_dssp             CTTSCCCBC
T ss_pred             CCCCcCcch
Confidence            888877665

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=98.43  E-value=2e-07  Score=81.49  Aligned_cols=77  Identities=27%  Similarity=0.320  Sum_probs=59.7

Q ss_pred             CCCCEEEccCCcccccCCCc--------cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccccccc
Q 042107            5 KVLLRIDLSTNNFSCVFPTT--------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFN   76 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g~~p~~--------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n   76 (232)
                      ++|+.|+|++|.|++ +|..        +++|+++ .+|.   .+++|+.|+|++|+++ .+|..+..+++|+.+++++|
T Consensus       221 ~~L~~L~Ls~N~L~~-lp~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N  294 (622)
T 3g06_A          221 SGLKELIVSGNRLTS-LPVLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN  294 (622)
T ss_dssp             TTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSC
T ss_pred             CCCCEEEccCCccCc-CCCCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCC
Confidence            567788888888875 4432        2677777 4665   5678899999999998 88888889999999999999


Q ss_pred             cccCCCCCccc
Q 042107           77 TLEGKIPRPFR   87 (232)
Q Consensus        77 ~l~g~~p~~~~   87 (232)
                      .+++..|..+.
T Consensus       295 ~l~~~~~~~l~  305 (622)
T 3g06_A          295 PLSERTLQALR  305 (622)
T ss_dssp             CCCHHHHHHHH
T ss_pred             CCCCcCHHHHH
Confidence            99887776443

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=98.42  E-value=2.7e-08  Score=81.98  Aligned_cols=49  Identities=22%  Similarity=0.349  Sum_probs=23.8

Q ss_pred             cccccccccCCCCCeeeCCCCcceec----CCccccc--CCCCCccccccccccC
Q 042107           32 DSLRNSIGDLTSLKSLDLSNNNFSGA----IPIPLEK--LLDLKDLNLSFNTLEG   80 (232)
Q Consensus        32 ~~~p~~~~~l~~L~~L~ls~N~l~g~----ip~~~~~--l~~l~~l~l~~n~l~g   80 (232)
                      ..+|..+..+++|+.|+|++|++++.    +|..+..  +++|+.|++++|.+++
T Consensus       234 ~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~  288 (386)
T 2ca6_A          234 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL  288 (386)
T ss_dssp             HHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred             HHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCH
Confidence            44455555555555555555555443    3333322  4555555555555544

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.42  E-value=1.6e-06  Score=69.23  Aligned_cols=100  Identities=11%  Similarity=0.016  Sum_probs=62.8

Q ss_pred             ecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCC---CccceeEEEe-cCCeeEEEEeccCCC
Q 042107           94 NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQ---NLIKIISSCS-KDDFKALILEYMPHG  169 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~~g  169 (232)
                      +.++.|....||+.    +..+++|...  .......+..|..+++.+.+.   -+++.+.+.. ..+..+++|||++|.
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            45778888888887    5678888742  122346788899999988652   3556666664 345678999999998


Q ss_pred             ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHh
Q 042107          170 SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH  202 (232)
Q Consensus       170 ~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH  202 (232)
                      ++.+..-.   .++......++.++++.|..||
T Consensus        99 ~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH  128 (306)
T 3tdw_A           99 ILGEDGMA---VLPDDAKDRLALQLAEFMNELS  128 (306)
T ss_dssp             ECHHHHHT---TSCHHHHHHHHHHHHHHHHHHH
T ss_pred             ECchhhhh---hCCHHHHHHHHHHHHHHHHHHh
Confidence            87653111   1233334444444444444444

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.41  E-value=1.9e-07  Score=72.95  Aligned_cols=69  Identities=28%  Similarity=0.364  Sum_probs=52.7

Q ss_pred             CCCCCCEEEccCCcccccCCCccccCccccccccccccCCCCCeeeCCCCcceecCCcccccCC--CCCccccccccccC
Q 042107            3 NLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLL--DLKDLNLSFNTLEG   80 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p~~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~--~l~~l~l~~n~l~g   80 (232)
                      +++.|+.|+||+|+|++.-           .+|..+..+++|+.|+|++|++++.  ..+..+.  .|++|++++|.+.+
T Consensus       168 ~l~~L~~L~Ls~N~l~~l~-----------~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~  234 (267)
T 3rw6_A          168 NIPELLSLNLSNNRLYRLD-----------DMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCD  234 (267)
T ss_dssp             HCTTCCEEECTTSCCCCCG-----------GGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGG
T ss_pred             hCCCCCEEECCCCCCCCCc-----------cchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCcc
Confidence            4678888888888888521           2455667889999999999999864  2344444  89999999999988


Q ss_pred             CCCC
Q 042107           81 KIPR   84 (232)
Q Consensus        81 ~~p~   84 (232)
                      .+|.
T Consensus       235 ~~~~  238 (267)
T 3rw6_A          235 TFRD  238 (267)
T ss_dssp             GCSS
T ss_pred             ccCc
Confidence            7663

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=98.41  E-value=3.9e-07  Score=72.21  Aligned_cols=75  Identities=31%  Similarity=0.373  Sum_probs=38.9

Q ss_pred             CCCCCCCEEEccCCcccccCCC----------ccccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPT----------TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDL   71 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~----------~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l   71 (232)
                      +++++|+.|+|++|.+++ +|.          .+++|++++.  ..++.+++|+.|++++|++++.  ..+..+++|+.|
T Consensus        87 ~~l~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L  161 (291)
T 1h6t_A           87 ANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTL  161 (291)
T ss_dssp             TTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred             ccCCCCCEEECCCCcCCC-ChhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEE
Confidence            455666666666666664 221          0145555542  3455555555555555555532  334555555555


Q ss_pred             ccccccccCC
Q 042107           72 NLSFNTLEGK   81 (232)
Q Consensus        72 ~l~~n~l~g~   81 (232)
                      ++++|.+++.
T Consensus       162 ~L~~N~l~~~  171 (291)
T 1h6t_A          162 SLEDNQISDI  171 (291)
T ss_dssp             ECCSSCCCCC
T ss_pred             EccCCccccc
Confidence            5555555443

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=98.39  E-value=3.9e-07  Score=72.80  Aligned_cols=75  Identities=23%  Similarity=0.379  Sum_probs=39.4

Q ss_pred             CCCCCCCEEEccCCcccccCCC---------ccccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPT---------TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLN   72 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~---------~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~   72 (232)
                      +++++|+.|+|++|.+++..+-         .+++|++++..+  ++.+++|+.|+|++|++++ +|. +..+++|+.|+
T Consensus       104 ~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~  179 (308)
T 1h6u_A          104 AGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLK  179 (308)
T ss_dssp             TTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEE
T ss_pred             cCCCCCCEEECCCCCCCCchhhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEE
Confidence            3456666666666666642110         014555554332  5555666666666665553 222 45555555555


Q ss_pred             cccccccC
Q 042107           73 LSFNTLEG   80 (232)
Q Consensus        73 l~~n~l~g   80 (232)
                      ++.|.+++
T Consensus       180 l~~n~l~~  187 (308)
T 1h6u_A          180 ADDNKISD  187 (308)
T ss_dssp             CCSSCCCC
T ss_pred             CCCCccCc
Confidence            55555544

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=98.39  E-value=2.7e-07  Score=73.96  Aligned_cols=80  Identities=16%  Similarity=0.132  Sum_probs=46.7

Q ss_pred             CCCCCCCEEEccCCcccccCCC-c-----cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccccc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPT-T-----IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSF   75 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~-~-----~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~   75 (232)
                      +.+++|+.|||++|.+++..+. .     +++|++++..+..   +++|+.|++++|++++..|..+..+++|+.|+++.
T Consensus        77 ~~l~~L~~L~Ls~n~l~~l~~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~  153 (317)
T 3o53_A           77 ESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL  153 (317)
T ss_dssp             TTCTTCCEEECCSSEEEEEEECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTT
T ss_pred             hhcCCCCEEECcCCccccccCCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCC
Confidence            5678888888888888864321 1     2456555544332   45566666666666654444555556666666666


Q ss_pred             ccccCCCCC
Q 042107           76 NTLEGKIPR   84 (232)
Q Consensus        76 n~l~g~~p~   84 (232)
                      |.+++..|.
T Consensus       154 N~l~~~~~~  162 (317)
T 3o53_A          154 NEIDTVNFA  162 (317)
T ss_dssp             SCCCEEEGG
T ss_pred             CCCCcccHH
Confidence            665554433

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=98.38  E-value=4e-09  Score=78.90  Aligned_cols=74  Identities=19%  Similarity=0.298  Sum_probs=48.4

Q ss_pred             CCCCCEEEccCCcccccCCC------cc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCC
Q 042107            4 LKVLLRIDLSTNNFSCVFPT------TI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLL   66 (232)
Q Consensus         4 ~~~l~~l~ls~N~~~g~~p~------~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~   66 (232)
                      ...++.++++.|.++|.+|.      .+           ++|++++ +| .++.+++|+.|++++|+++ .+|..+..++
T Consensus        17 ~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~   93 (198)
T 1ds9_A           17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVAD   93 (198)
T ss_dssp             TTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHH
T ss_pred             cccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCC
Confidence            34556666666666666664      22           4566665 55 6667777777777777776 5666666667


Q ss_pred             CCCccccccccccC
Q 042107           67 DLKDLNLSFNTLEG   80 (232)
Q Consensus        67 ~l~~l~l~~n~l~g   80 (232)
                      +|+.|++++|.+++
T Consensus        94 ~L~~L~L~~N~l~~  107 (198)
T 1ds9_A           94 TLEELWISYNQIAS  107 (198)
T ss_dssp             HCSEEEEEEEECCC
T ss_pred             cCCEEECcCCcCCc
Confidence            77777777777665

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=98.38  E-value=5e-07  Score=78.80  Aligned_cols=41  Identities=32%  Similarity=0.357  Sum_probs=17.9

Q ss_pred             cccCCCCCeeeCCCCcceecCCcccccCCCCCccccccccccC
Q 042107           38 IGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEG   80 (232)
Q Consensus        38 ~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~l~g   80 (232)
                      +..+++|+.|+|++|++++ +| .+..+++|+.|+++.|.+++
T Consensus       171 l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~L~~N~l~~  211 (605)
T 1m9s_A          171 LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN  211 (605)
T ss_dssp             GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEECCSEEEEC
T ss_pred             hccCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEccCCcCcC
Confidence            4444444444444444442 21 24444444444444444443

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.38  E-value=3.6e-06  Score=65.65  Aligned_cols=100  Identities=17%  Similarity=0.070  Sum_probs=65.0

Q ss_pred             cccCCCcc-eeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCC-CCCccceeEEEecCCeeEEEEeccCCCCh
Q 042107           95 LISRGGFG-SIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-HQNLIKIISSCSKDDFKALILEYMPHGSL  171 (232)
Q Consensus        95 ~lg~g~~g-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L  171 (232)
                      .+..|..+ .||+.... ++..+++|.....   ....+.+|...++.+. +--+.+++.++.+.+..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            34445544 58887654 4667889986533   3456778888887664 22367888888888999999999999887


Q ss_pred             hhhhccCCCCCCHHHHHHHHHHHHHHHHHHh
Q 042107          172 GKCLSTSNYILDFFQRLHIMIDVASAVEYLH  202 (232)
Q Consensus       172 ~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH  202 (232)
                      .+.....     ......+..+++..+.-||
T Consensus       108 ~~~~~~~-----~~~~~~~~~~l~~~L~~Lh  133 (272)
T 4gkh_A          108 FQVLEEY-----PDSGENIVDALAVFLRRLH  133 (272)
T ss_dssp             HHHHHHC-----GGGHHHHHHHHHHHHHHHH
T ss_pred             cccccCC-----HHHHHHHHHHHHHHHHHhc
Confidence            6654321     1122334455555555555

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=98.37  E-value=9.2e-07  Score=74.62  Aligned_cols=78  Identities=26%  Similarity=0.400  Sum_probs=54.9

Q ss_pred             CCCCCCCEEEccCCcccccCCC---------ccccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPT---------TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLN   72 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~---------~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~   72 (232)
                      +.+++|+.|+|++|.+++..|-         .+++|++++..|  ++.+++|+.|++++|++++.  ..+..+++|+.++
T Consensus       284 ~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~  359 (466)
T 1o6v_A          284 AGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLS  359 (466)
T ss_dssp             TTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEE
T ss_pred             cCCCccCeEEcCCCcccCchhhcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEe
Confidence            4667788888888888765431         125777777665  66777778888887777754  3566777777777


Q ss_pred             cccccccCCCC
Q 042107           73 LSFNTLEGKIP   83 (232)
Q Consensus        73 l~~n~l~g~~p   83 (232)
                      +++|.+++..|
T Consensus       360 l~~n~l~~~~~  370 (466)
T 1o6v_A          360 AGHNQISDLTP  370 (466)
T ss_dssp             CCSSCCCBCGG
T ss_pred             CCCCccCccch
Confidence            77777777665

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=98.37  E-value=9.2e-07  Score=74.56  Aligned_cols=77  Identities=21%  Similarity=0.225  Sum_probs=55.4

Q ss_pred             CCCCCCCEEEccCCcccccCCCc---------cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTT---------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLN   72 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~---------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~   72 (232)
                      +.+++|+.|||++|.+++ +|-.         +++|++++.   .++.+++|+.|++++|++++ +|  +..++.|+.++
T Consensus       167 ~~l~~L~~L~ls~n~l~~-l~l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~  239 (457)
T 3bz5_A          167 TPQTQLTTLDCSFNKITE-LDVSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFD  239 (457)
T ss_dssp             TTCTTCCEEECCSSCCCC-CCCTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEE
T ss_pred             ccCCcCCEEECCCCccce-eccccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEE
Confidence            456777777777777776 3311         256777764   37778888888888888886 66  67788888888


Q ss_pred             cccccccCCCCCc
Q 042107           73 LSFNTLEGKIPRP   85 (232)
Q Consensus        73 l~~n~l~g~~p~~   85 (232)
                      ++.|.+++..+..
T Consensus       240 l~~N~l~~~~~~~  252 (457)
T 3bz5_A          240 CSVNPLTELDVST  252 (457)
T ss_dssp             CCSSCCSCCCCTT
T ss_pred             eeCCcCCCcCHHH
Confidence            8888888754443

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=98.36  E-value=3.2e-07  Score=77.41  Aligned_cols=19  Identities=32%  Similarity=0.370  Sum_probs=8.7

Q ss_pred             cccCCCCCeeeCCCCccee
Q 042107           38 IGDLTSLKSLDLSNNNFSG   56 (232)
Q Consensus        38 ~~~l~~L~~L~ls~N~l~g   56 (232)
                      ++.+++|+.|++++|++++
T Consensus       229 ~~~l~~L~~L~l~~N~l~~  247 (457)
T 3bz5_A          229 VTPLTQLTYFDCSVNPLTE  247 (457)
T ss_dssp             CTTCTTCSEEECCSSCCSC
T ss_pred             ccccCCCCEEEeeCCcCCC
Confidence            4444444444444444443

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=98.35  E-value=7.8e-07  Score=74.94  Aligned_cols=51  Identities=25%  Similarity=0.392  Sum_probs=27.1

Q ss_pred             CCCCCCCEEEccCCcccccCCCc--------cccCccccccccccccCCCCCeeeCCCCcce
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTT--------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFS   55 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~--------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~   55 (232)
                      +++++|++|++++|.+++ +|..        +++|++++ +| .++.+++|+.|++++|+++
T Consensus       150 ~~l~~L~~L~l~~N~l~~-lp~~~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~  208 (454)
T 1jl5_A          150 QNSSFLKIIDVDNNSLKK-LPDLPPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLK  208 (454)
T ss_dssp             TTCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCS
T ss_pred             CCCCCCCEEECCCCcCcc-cCCCcccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCC
Confidence            455666666666666664 3332        14555554 44 3555555555555555444

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=98.34  E-value=6.3e-07  Score=75.63  Aligned_cols=76  Identities=30%  Similarity=0.379  Sum_probs=56.3

Q ss_pred             CCCCCCCEEEccCCcccccCCC---------ccccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPT---------TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLN   72 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~---------~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~   72 (232)
                      +.+++|+.|+|++|.+++..|-         .+++|++++..|  ++.+++|+.|+|++|++++..|  +..+++|+.++
T Consensus       262 ~~l~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~  337 (466)
T 1o6v_A          262 SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLF  337 (466)
T ss_dssp             TTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEE
T ss_pred             hcCCCCCEEECCCCccCccccccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeE
Confidence            4677888888888888864331         125788877554  7788888888888888886655  56788888888


Q ss_pred             cccccccCC
Q 042107           73 LSFNTLEGK   81 (232)
Q Consensus        73 l~~n~l~g~   81 (232)
                      +++|.+++.
T Consensus       338 l~~n~l~~~  346 (466)
T 1o6v_A          338 FYNNKVSDV  346 (466)
T ss_dssp             CCSSCCCCC
T ss_pred             CCCCccCCc
Confidence            888887764

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=98.34  E-value=7.9e-07  Score=70.44  Aligned_cols=75  Identities=32%  Similarity=0.418  Sum_probs=44.4

Q ss_pred             CCCCCCEEEccCCcccccCCC---------ccccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccc
Q 042107            3 NLKVLLRIDLSTNNFSCVFPT---------TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNL   73 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p~---------~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l   73 (232)
                      .+++|+.|+|++|.+++..|-         .+++|++++ +| .++.+++|+.|+|++|++++ + ..+..+++|+.|++
T Consensus        66 ~l~~L~~L~L~~n~l~~~~~l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l  141 (291)
T 1h6t_A           66 YLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL  141 (291)
T ss_dssp             GCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEEC
T ss_pred             cCCCCCEEEccCCccCCCcccccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEc
Confidence            456666777777776654321         014566654 22 36666677777777776664 2 34566666777777


Q ss_pred             ccccccCC
Q 042107           74 SFNTLEGK   81 (232)
Q Consensus        74 ~~n~l~g~   81 (232)
                      +.|.+++.
T Consensus       142 ~~n~l~~~  149 (291)
T 1h6t_A          142 GNNKITDI  149 (291)
T ss_dssp             CSSCCCCC
T ss_pred             cCCcCCcc
Confidence            76666553

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=98.34  E-value=6e-07  Score=78.27  Aligned_cols=76  Identities=30%  Similarity=0.453  Sum_probs=64.9

Q ss_pred             CCCCCCCCEEEccCCcccccCCC----------ccccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCc
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPT----------TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKD   70 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~----------~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~   70 (232)
                      ++.|++|+.|+|++|.|++. |.          .+++|++++.  ..++.+++|+.|+|++|++++..|  +..++.|+.
T Consensus       105 l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~  179 (605)
T 1m9s_A          105 LKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQN  179 (605)
T ss_dssp             STTCTTCCEEECTTSCCCCC-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred             hccCCCCCEEEecCCCCCCC-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCE
Confidence            46789999999999999963 32          1378999876  678999999999999999997666  889999999


Q ss_pred             cccccccccCC
Q 042107           71 LNLSFNTLEGK   81 (232)
Q Consensus        71 l~l~~n~l~g~   81 (232)
                      |+++.|.+++.
T Consensus       180 L~Ls~N~i~~l  190 (605)
T 1m9s_A          180 LYLSKNHISDL  190 (605)
T ss_dssp             EECCSSCCCBC
T ss_pred             EECcCCCCCCC
Confidence            99999999874

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=98.33  E-value=4.7e-07  Score=73.21  Aligned_cols=83  Identities=29%  Similarity=0.390  Sum_probs=63.3

Q ss_pred             CCCCCCCEEEccCCcccccCCC---------ccccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPT---------TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLN   72 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~---------~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~   72 (232)
                      +.+++|+.|+|++|.+++..|-         .+++|++++.  ..+..+++|+.|++++|++++ +| .+..+++|+.++
T Consensus       218 ~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~  293 (347)
T 4fmz_A          218 ANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQLNSLF  293 (347)
T ss_dssp             GGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEE
T ss_pred             hcCCcCCEEEccCCccCCCcchhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCC-Ch-hhcCCCCCCEEE
Confidence            4578899999999999864331         1367888763  467889999999999999985 33 477889999999


Q ss_pred             cccccccCCCCCcccc
Q 042107           73 LSFNTLEGKIPRPFRN   88 (232)
Q Consensus        73 l~~n~l~g~~p~~~~~   88 (232)
                      +++|.+++..|..+..
T Consensus       294 L~~n~l~~~~~~~l~~  309 (347)
T 4fmz_A          294 LNNNQLGNEDMEVIGG  309 (347)
T ss_dssp             CCSSCCCGGGHHHHHT
T ss_pred             CcCCcCCCcChhHhhc
Confidence            9999988776654443

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=98.33  E-value=6.7e-07  Score=71.40  Aligned_cols=76  Identities=22%  Similarity=0.346  Sum_probs=54.9

Q ss_pred             CCCCCCCEEEccCCcccccCCC----------ccccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPT----------TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDL   71 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~----------~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l   71 (232)
                      +++++|+.|+|++|.+++. |.          .+++|++++. |. ++.+++|+.|++++|++++..+  +..+++|+.|
T Consensus        82 ~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L  156 (308)
T 1h6u_A           82 KNLTKITELELSGNPLKNV-SAIAGLQSIKTLDLTSTQITDV-TP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYL  156 (308)
T ss_dssp             TTCCSCCEEECCSCCCSCC-GGGTTCTTCCEEECTTSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred             ccCCCCCEEEccCCcCCCc-hhhcCCCCCCEEECCCCCCCCc-hh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEE
Confidence            5677888888888888853 32          1267777763 33 7788888888888888875433  6778888888


Q ss_pred             ccccccccCCC
Q 042107           72 NLSFNTLEGKI   82 (232)
Q Consensus        72 ~l~~n~l~g~~   82 (232)
                      +++.|.+++..
T Consensus       157 ~l~~n~l~~~~  167 (308)
T 1h6u_A          157 SIGNAQVSDLT  167 (308)
T ss_dssp             ECCSSCCCCCG
T ss_pred             EccCCcCCCCh
Confidence            88888877643

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.28  E-value=1.7e-06  Score=70.29  Aligned_cols=81  Identities=7%  Similarity=-0.020  Sum_probs=54.4

Q ss_pred             eecc-cCCCcceeeeEEeC-------CCcEEEEEEeeccc---CchHHHHHHHHHHhcCCCC---CCccceeEEEecC--
Q 042107           93 FNLI-SRGGFGSIYKARIQ-------DGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIRH---QNLIKIISSCSKD--  156 (232)
Q Consensus        93 ~~~l-g~g~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~--  156 (232)
                      .+.| +.|....+|+....       ++..+++|......   ......+.+|..+++.+..   -.+++++.++...  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4567 88888999988654       26678888764432   1012346678888877742   3467777776654  


Q ss_pred             -CeeEEEEeccCCCChhh
Q 042107          157 -DFKALILEYMPHGSLGK  173 (232)
Q Consensus       157 -~~~~lv~e~~~~g~L~~  173 (232)
                       +..++||||++|.++.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999999877653

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=98.27  E-value=1.3e-07  Score=76.20  Aligned_cols=72  Identities=19%  Similarity=0.192  Sum_probs=40.3

Q ss_pred             CCCCEEEccCCcccccCCCc----------cccCccccc-cccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccc
Q 042107            5 KVLLRIDLSTNNFSCVFPTT----------IEYNRLQDS-LRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNL   73 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g~~p~~----------~~~n~~~~~-~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l   73 (232)
                      +.++.|++++|.+++.+|..          +++|++++. +|..+..+++|+.|+|++|++++..|..+..+++|+.|++
T Consensus        70 ~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L  149 (336)
T 2ast_B           70 QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL  149 (336)
T ss_dssp             TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEEC
T ss_pred             ccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEEC
Confidence            45555666666665554432          144555544 5555555666666666666655555555555666666666


Q ss_pred             ccc
Q 042107           74 SFN   76 (232)
Q Consensus        74 ~~n   76 (232)
                      ++|
T Consensus       150 ~~~  152 (336)
T 2ast_B          150 SGC  152 (336)
T ss_dssp             TTC
T ss_pred             CCC
Confidence            655

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=98.26  E-value=9.8e-07  Score=68.86  Aligned_cols=37  Identities=30%  Similarity=0.356  Sum_probs=17.7

Q ss_pred             CCCCeeeCCCCcceecCCcccccCCCCCccccccccccC
Q 042107           42 TSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEG   80 (232)
Q Consensus        42 ~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~l~g   80 (232)
                      ++|+.|+|++|++++ +| .+..+++|+.|++++|.+++
T Consensus       106 ~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~  142 (263)
T 1xeu_A          106 ACLSRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKS  142 (263)
T ss_dssp             SSCCEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCB
T ss_pred             CcccEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCC
Confidence            444444444444442 22 34455555555555555544

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=98.25  E-value=5.8e-07  Score=73.07  Aligned_cols=28  Identities=25%  Similarity=0.259  Sum_probs=14.0

Q ss_pred             CccccccccccccCCCCCeeeCCCCcce
Q 042107           28 NRLQDSLRNSIGDLTSLKSLDLSNNNFS   55 (232)
Q Consensus        28 n~~~~~~p~~~~~l~~L~~L~ls~N~l~   55 (232)
                      |+++...|..+..+++|+.|++++|++.
T Consensus        90 N~l~~l~~~~f~~l~~L~~L~l~~n~l~  117 (350)
T 4ay9_X           90 NNLLYINPEAFQNLPNLQYLLISNTGIK  117 (350)
T ss_dssp             TTCCEECTTSBCCCTTCCEEEEEEECCS
T ss_pred             CcccccCchhhhhccccccccccccccc
Confidence            4444444444455555555555555554

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.24  E-value=5.2e-06  Score=65.52  Aligned_cols=76  Identities=11%  Similarity=0.082  Sum_probs=54.0

Q ss_pred             eeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCC---CccceeEEEecCCeeEEEEeccCC
Q 042107           92 VFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQ---NLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        92 ~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      -.+.+|.|..+.||+.+..+|+.|++|+...........+..|...|+.+.-.   -+++++...    ..+++|||+++
T Consensus        19 ~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~   94 (288)
T 3f7w_A           19 AVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDE   94 (288)
T ss_dssp             EEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCC
T ss_pred             EEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecc
Confidence            34678999999999999999999999987554433345577898888776421   244545432    24789999987


Q ss_pred             CCh
Q 042107          169 GSL  171 (232)
Q Consensus       169 g~L  171 (232)
                      +..
T Consensus        95 ~~~   97 (288)
T 3f7w_A           95 RPP   97 (288)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            643

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=98.20  E-value=2.3e-08  Score=74.70  Aligned_cols=71  Identities=28%  Similarity=0.370  Sum_probs=34.6

Q ss_pred             CCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccc
Q 042107            4 LKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLN   72 (232)
Q Consensus         4 ~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~   72 (232)
                      +++|+.|+|++|.+++ +| .+           ++|+++ .+|..+..+++|+.|+|++|++++ +| .+..+++|+.++
T Consensus        47 l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~  121 (198)
T 1ds9_A           47 LKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLY  121 (198)
T ss_dssp             TTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEE
T ss_pred             CCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEE
Confidence            3445555555555554 34 21           344444 344444444555555555555553 33 344455555555


Q ss_pred             ccccccc
Q 042107           73 LSFNTLE   79 (232)
Q Consensus        73 l~~n~l~   79 (232)
                      +++|.++
T Consensus       122 l~~N~i~  128 (198)
T 1ds9_A          122 MSNNKIT  128 (198)
T ss_dssp             ESEEECC
T ss_pred             CCCCcCC
Confidence            5555443

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=98.13  E-value=8.1e-07  Score=71.44  Aligned_cols=79  Identities=25%  Similarity=0.296  Sum_probs=62.8

Q ss_pred             CCCCCCCEEEccCCccccc-CCCc-----------cccCccccccccccccCCCCCeeeCCCC-cceec-CCcccccCCC
Q 042107            2 SNLKVLLRIDLSTNNFSCV-FPTT-----------IEYNRLQDSLRNSIGDLTSLKSLDLSNN-NFSGA-IPIPLEKLLD   67 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~-~p~~-----------~~~n~~~~~~p~~~~~l~~L~~L~ls~N-~l~g~-ip~~~~~l~~   67 (232)
                      .++++|+.|||++|.+++. +|..           +++|++++..|..++.+++|+.|+|++| .+++. +|..+..+++
T Consensus        90 ~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~  169 (336)
T 2ast_B           90 FSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR  169 (336)
T ss_dssp             CCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTT
T ss_pred             ccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCC
Confidence            3568889999999988865 5532           2678888888888888999999999998 67763 6666788889


Q ss_pred             CCccccccc-cccC
Q 042107           68 LKDLNLSFN-TLEG   80 (232)
Q Consensus        68 l~~l~l~~n-~l~g   80 (232)
                      |+.|++++| .+++
T Consensus       170 L~~L~l~~~~~l~~  183 (336)
T 2ast_B          170 LDELNLSWCFDFTE  183 (336)
T ss_dssp             CCEEECCCCTTCCH
T ss_pred             CCEEcCCCCCCcCh
Confidence            999999988 7765

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=98.12  E-value=5e-07  Score=74.32  Aligned_cols=76  Identities=24%  Similarity=0.217  Sum_probs=42.7

Q ss_pred             CCCCCEEEccCCcccccCCCc---------------ccc---Ccccccccccc-------ccCCCCCeeeCCCCccee--
Q 042107            4 LKVLLRIDLSTNNFSCVFPTT---------------IEY---NRLQDSLRNSI-------GDLTSLKSLDLSNNNFSG--   56 (232)
Q Consensus         4 ~~~l~~l~ls~N~~~g~~p~~---------------~~~---n~~~~~~p~~~-------~~l~~L~~L~ls~N~l~g--   56 (232)
                      +++|+.|+|++|.+++..|..               +++   |++++.+|..+       ..+++|+.|+|++|++++  
T Consensus        31 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~  110 (386)
T 2ca6_A           31 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA  110 (386)
T ss_dssp             CSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTT
T ss_pred             CCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHH
Confidence            456666666666666431111               122   44555555444       456666666666666665  


Q ss_pred             --cCCcccccCCCCCcccccccccc
Q 042107           57 --AIPIPLEKLLDLKDLNLSFNTLE   79 (232)
Q Consensus        57 --~ip~~~~~l~~l~~l~l~~n~l~   79 (232)
                        .+|..+..+++|+.|+++.|.++
T Consensus       111 ~~~l~~~l~~~~~L~~L~L~~n~l~  135 (386)
T 2ca6_A          111 QEPLIDFLSKHTPLEHLYLHNNGLG  135 (386)
T ss_dssp             HHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred             HHHHHHHHHhCCCCCEEECcCCCCC
Confidence              35555566666666666666654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.04  E-value=6.1e-05  Score=60.18  Aligned_cols=75  Identities=13%  Similarity=0.101  Sum_probs=58.5

Q ss_pred             eecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCC---CCCccceeEEEecCCeeEEEEeccCCC
Q 042107           93 FNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR---HQNLIKIISSCSKDDFKALILEYMPHG  169 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~g  169 (232)
                      .+.++.|....+|+... ++..+++|.....   ....+..|...++.+.   ..-+++++.+....+..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            46788999999999875 4678889987643   3456788888888773   356788888887778899999999987


Q ss_pred             Ch
Q 042107          170 SL  171 (232)
Q Consensus       170 ~L  171 (232)
                      .+
T Consensus       117 ~~  118 (312)
T 3jr1_A          117 KN  118 (312)
T ss_dssp             CC
T ss_pred             CC
Confidence            65

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=98.04  E-value=8.3e-07  Score=72.45  Aligned_cols=77  Identities=25%  Similarity=0.309  Sum_probs=41.0

Q ss_pred             CCCCEEEccCCcccccCC-----------Cc-----cccCccccccccccccC-----CCCCeeeCCCCcceecCCcccc
Q 042107            5 KVLLRIDLSTNNFSCVFP-----------TT-----IEYNRLQDSLRNSIGDL-----TSLKSLDLSNNNFSGAIPIPLE   63 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g~~p-----------~~-----~~~n~~~~~~p~~~~~l-----~~L~~L~ls~N~l~g~ip~~~~   63 (232)
                      ++|+.|||++|.+++..+           ..     +++|++++..+..++++     ++|+.|+|++|++++..+..+.
T Consensus        22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~  101 (362)
T 3goz_A           22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV  101 (362)
T ss_dssp             TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred             CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence            346666666666664322           11     24566665555555543     6666666666666544444322


Q ss_pred             c----C-CCCCccccccccccCC
Q 042107           64 K----L-LDLKDLNLSFNTLEGK   81 (232)
Q Consensus        64 ~----l-~~l~~l~l~~n~l~g~   81 (232)
                      .    + +.|+.|+++.|.+++.
T Consensus       102 ~~l~~~~~~L~~L~Ls~N~l~~~  124 (362)
T 3goz_A          102 KTLAAIPFTITVLDLGWNDFSSK  124 (362)
T ss_dssp             HHHHTSCTTCCEEECCSSCGGGS
T ss_pred             HHHHhCCCCccEEECcCCcCCcH
Confidence            2    2 5566666666665544

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=97.97  E-value=1.4e-05  Score=69.92  Aligned_cols=67  Identities=33%  Similarity=0.379  Sum_probs=35.2

Q ss_pred             CCCCCEEEccCCcccccCCCc--------cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccccc
Q 042107            4 LKVLLRIDLSTNNFSCVFPTT--------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSF   75 (232)
Q Consensus         4 ~~~l~~l~ls~N~~~g~~p~~--------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~   75 (232)
                      +++|+.|+|++|.|++ +|..        +++|+++ .+|..   +++|+.|+|++|++++ +|   ..+++|+.|++++
T Consensus       180 ~~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~-~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~  250 (622)
T 3g06_A          180 PSGLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSG  250 (622)
T ss_dssp             CTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCS
T ss_pred             CCCCcEEECCCCCCCC-CCCccchhhEEECcCCccc-ccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCC
Confidence            3677888888888885 3322        1345554 23322   2455555555555553 44   2234455555555


Q ss_pred             cccc
Q 042107           76 NTLE   79 (232)
Q Consensus        76 n~l~   79 (232)
                      |.++
T Consensus       251 N~L~  254 (622)
T 3g06_A          251 NRLT  254 (622)
T ss_dssp             SCCS
T ss_pred             CCCC
Confidence            5444

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.92  E-value=4.5e-05  Score=62.86  Aligned_cols=75  Identities=11%  Similarity=0.127  Sum_probs=48.2

Q ss_pred             eecccCCCcceeeeEEeC-CCcEEEEEEeecccC-------chHHHHHHHHHHhcCCCC--C-CccceeEEEecCCeeEE
Q 042107           93 FNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG-------GAFKNLDVECNMMKIIRH--Q-NLIKIISSCSKDDFKAL  161 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-niv~~~~~~~~~~~~~l  161 (232)
                      .+.+|.|..+.||+++.. +++.+++|.......       ...+.+..|.++++.+..  | .+++++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467899999999999754 467899997643211       123455678888776632  3 34455544  3445689


Q ss_pred             EEeccCCC
Q 042107          162 ILEYMPHG  169 (232)
Q Consensus       162 v~e~~~~g  169 (232)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=97.92  E-value=1.5e-05  Score=64.65  Aligned_cols=81  Identities=12%  Similarity=0.126  Sum_probs=61.2

Q ss_pred             CCCCEEEccCCcccccCCCcc-----------ccCcccccccc-ccccCCCCCe-eeCCCCcceecCCcccccCCCCCcc
Q 042107            5 KVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRN-SIGDLTSLKS-LDLSNNNFSGAIPIPLEKLLDLKDL   71 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~-~~~~l~~L~~-L~ls~N~l~g~ip~~~~~l~~l~~l   71 (232)
                      ++++.|+|++|+|+...+..+           ++|++.+.+|. .+..++++.. +.++.|+++...|..+..+++|+.+
T Consensus        30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L  109 (350)
T 4ay9_X           30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL  109 (350)
T ss_dssp             TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred             CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence            468899999999984333332           67888777774 5678888775 6677899986667778889999999


Q ss_pred             ccccccccCCCCCc
Q 042107           72 NLSFNTLEGKIPRP   85 (232)
Q Consensus        72 ~l~~n~l~g~~p~~   85 (232)
                      +++.|.++...+..
T Consensus       110 ~l~~n~l~~~~~~~  123 (350)
T 4ay9_X          110 LISNTGIKHLPDVH  123 (350)
T ss_dssp             EEEEECCSSCCCCT
T ss_pred             cccccccccCCchh
Confidence            99999987655543

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=97.89  E-value=1.9e-06  Score=72.34  Aligned_cols=78  Identities=17%  Similarity=0.091  Sum_probs=52.4

Q ss_pred             CCCCCCEEEccCCcccccCC-----------Cc-----cccCccccc----cccccccCCCCCeeeCCCCcceecCCccc
Q 042107            3 NLKVLLRIDLSTNNFSCVFP-----------TT-----IEYNRLQDS----LRNSIGDLTSLKSLDLSNNNFSGAIPIPL   62 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p-----------~~-----~~~n~~~~~----~p~~~~~l~~L~~L~ls~N~l~g~ip~~~   62 (232)
                      ++++|+.|||++|.+++.-+           ..     +++|++++.    +|..+..+++|+.|+|++|++++..+..+
T Consensus       282 ~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l  361 (461)
T 1z7x_W          282 AKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVREL  361 (461)
T ss_dssp             HCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHH
T ss_pred             hCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHH
Confidence            46778888888888764211           12     256777765    56666777888888888887776544443


Q ss_pred             cc-----CCCCCccccccccccC
Q 042107           63 EK-----LLDLKDLNLSFNTLEG   80 (232)
Q Consensus        63 ~~-----l~~l~~l~l~~n~l~g   80 (232)
                      ..     .+.|+.+++++|.+++
T Consensus       362 ~~~l~~~~~~L~~L~L~~n~i~~  384 (461)
T 1z7x_W          362 CQGLGQPGSVLRVLWLADCDVSD  384 (461)
T ss_dssp             HHHHTSTTCCCCEEECTTSCCCH
T ss_pred             HHHHcCCCCceEEEECCCCCCCh
Confidence            32     5678888888887765

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=97.88  E-value=2.4e-06  Score=69.64  Aligned_cols=76  Identities=24%  Similarity=0.183  Sum_probs=64.1

Q ss_pred             EEEccCCcccccCCCc-----------cccCccccccc----cccccCC-CCCeeeCCCCcceecCCcccccC-----CC
Q 042107            9 RIDLSTNNFSCVFPTT-----------IEYNRLQDSLR----NSIGDLT-SLKSLDLSNNNFSGAIPIPLEKL-----LD   67 (232)
Q Consensus         9 ~l~ls~N~~~g~~p~~-----------~~~n~~~~~~p----~~~~~l~-~L~~L~ls~N~l~g~ip~~~~~l-----~~   67 (232)
                      +++|+.|.++|.+|..           +++|++++..+    ..+..++ +|+.|+|++|++++..+..+..+     +.
T Consensus         2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~   81 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN   81 (362)
T ss_dssp             EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred             ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence            6799999999987653           37899988877    7778888 99999999999998777776665     99


Q ss_pred             CCccccccccccCCCCC
Q 042107           68 LKDLNLSFNTLEGKIPR   84 (232)
Q Consensus        68 l~~l~l~~n~l~g~~p~   84 (232)
                      |+.|++++|.+++..+.
T Consensus        82 L~~L~Ls~n~l~~~~~~   98 (362)
T 3goz_A           82 VTSLNLSGNFLSYKSSD   98 (362)
T ss_dssp             CCEEECCSSCGGGSCHH
T ss_pred             ccEEECcCCcCChHHHH
Confidence            99999999999876654

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=97.79  E-value=6.3e-07  Score=75.21  Aligned_cols=81  Identities=20%  Similarity=0.114  Sum_probs=63.4

Q ss_pred             CCCCCCEEEccCCccccc----CCCc-----------cccCccccccccccccC-----CCCCeeeCCCCcceec----C
Q 042107            3 NLKVLLRIDLSTNNFSCV----FPTT-----------IEYNRLQDSLRNSIGDL-----TSLKSLDLSNNNFSGA----I   58 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~----~p~~-----------~~~n~~~~~~p~~~~~l-----~~L~~L~ls~N~l~g~----i   58 (232)
                      .+++|+.|+|++|.++..    +|..           +++|++++..+..+++.     ++|+.|+|++|++++.    +
T Consensus       254 ~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l  333 (461)
T 1z7x_W          254 PSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHF  333 (461)
T ss_dssp             TTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHH
Confidence            578999999999999974    4432           36788887655555443     6999999999999865    5


Q ss_pred             CcccccCCCCCccccccccccCCCC
Q 042107           59 PIPLEKLLDLKDLNLSFNTLEGKIP   83 (232)
Q Consensus        59 p~~~~~l~~l~~l~l~~n~l~g~~p   83 (232)
                      |..+..++.|+.+++++|.+++..+
T Consensus       334 ~~~l~~~~~L~~L~Ls~n~i~~~~~  358 (461)
T 1z7x_W          334 SSVLAQNRFLLELQISNNRLEDAGV  358 (461)
T ss_dssp             HHHHHHCSSCCEEECCSSBCHHHHH
T ss_pred             HHHHhhCCCccEEEccCCccccccH
Confidence            6667788999999999998876533

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.70  E-value=0.00044  Score=55.41  Aligned_cols=73  Identities=10%  Similarity=0.180  Sum_probs=40.5

Q ss_pred             ecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCC-----CCCCcccee-E--EEecCCeeEEEEec
Q 042107           94 NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKII-----RHQNLIKII-S--SCSKDDFKALILEY  165 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~-~--~~~~~~~~~lv~e~  165 (232)
                      +.++.|..+.||+....++ .+++|.....    ...+..|..+++.+     ..|.++... +  +....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677889999876554 5889988642    13334455544433     234443310 1  11235678899999


Q ss_pred             cCCCCh
Q 042107          166 MPHGSL  171 (232)
Q Consensus       166 ~~~g~L  171 (232)
                      ++|.++
T Consensus       113 i~G~~~  118 (346)
T 2q83_A          113 IEGRPF  118 (346)
T ss_dssp             CCCBCC
T ss_pred             ecCccC
Confidence            998654

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=97.41  E-value=2.8e-05  Score=63.74  Aligned_cols=43  Identities=21%  Similarity=0.390  Sum_probs=21.4

Q ss_pred             ccccCCCCCeeeCCCCcceec----CCcccccCCCCCcccccccccc
Q 042107           37 SIGDLTSLKSLDLSNNNFSGA----IPIPLEKLLDLKDLNLSFNTLE   79 (232)
Q Consensus        37 ~~~~l~~L~~L~ls~N~l~g~----ip~~~~~l~~l~~l~l~~n~l~   79 (232)
                      .+..+++|+.|+|++|+++..    ++..+...+.|+.|++++|.++
T Consensus       178 ~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~  224 (372)
T 3un9_A          178 GLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG  224 (372)
T ss_dssp             HHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCC
T ss_pred             HHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCC
Confidence            334455555555555555431    1233344455555555555554

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=97.34  E-value=0.00017  Score=57.84  Aligned_cols=83  Identities=14%  Similarity=0.212  Sum_probs=56.7

Q ss_pred             CCCCCEEEccCCccc------ccCCC---------ccccCccccccccccccCCCCCeeeCCCCcceecCCc-ccccCCC
Q 042107            4 LKVLLRIDLSTNNFS------CVFPT---------TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPI-PLEKLLD   67 (232)
Q Consensus         4 ~~~l~~l~ls~N~~~------g~~p~---------~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~-~~~~l~~   67 (232)
                      +++|+.|||++|++.      |.+|.         .+..+-|.+.+|.....+++|+.|+|.. +++ .|+. .+..+++
T Consensus        48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~-~I~~~aF~~~~~  125 (329)
T 3sb4_A           48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIK-NIEDAAFKGCDN  125 (329)
T ss_dssp             CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCC-EECTTTTTTCTT
T ss_pred             hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-ccc-chhHHHhhcCcc
Confidence            678999999999999      23333         1233334444444444499999999999 777 4554 5788999


Q ss_pred             CCccccccccccCCCCCcccc
Q 042107           68 LKDLNLSFNTLEGKIPRPFRN   88 (232)
Q Consensus        68 l~~l~l~~n~l~g~~p~~~~~   88 (232)
                      |+.++++.|.+..-.+..|.+
T Consensus       126 L~~l~l~~n~i~~i~~~aF~~  146 (329)
T 3sb4_A          126 LKICQIRKKTAPNLLPEALAD  146 (329)
T ss_dssp             CCEEEBCCSSCCEECTTSSCT
T ss_pred             cceEEcCCCCccccchhhhcC
Confidence            999999999876433334443

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=97.29  E-value=2.9e-05  Score=67.14  Aligned_cols=50  Identities=16%  Similarity=0.050  Sum_probs=24.2

Q ss_pred             ccccccccccc-CCCCCeeeCCCCccee-cCCcccccCCCCCcccccccccc
Q 042107           30 LQDSLRNSIGD-LTSLKSLDLSNNNFSG-AIPIPLEKLLDLKDLNLSFNTLE   79 (232)
Q Consensus        30 ~~~~~p~~~~~-l~~L~~L~ls~N~l~g-~ip~~~~~l~~l~~l~l~~n~l~   79 (232)
                      +++..+..++. +++|+.|+|++|++++ .++..+..+++|+.|++++|.++
T Consensus       450 l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~  501 (592)
T 3ogk_B          450 LTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFS  501 (592)
T ss_dssp             CCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCB
T ss_pred             ccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCc
Confidence            44444444432 4555555555555544 23333344555555555555543

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=97.22  E-value=5.6e-05  Score=55.62  Aligned_cols=79  Identities=25%  Similarity=0.286  Sum_probs=52.4

Q ss_pred             CCCCCCCEEEccCC-ccccc--------CC--C-----ccccCccccc----cccccccCCCCCeeeCCCCcceec----
Q 042107            2 SNLKVLLRIDLSTN-NFSCV--------FP--T-----TIEYNRLQDS----LRNSIGDLTSLKSLDLSNNNFSGA----   57 (232)
Q Consensus         2 ~~~~~l~~l~ls~N-~~~g~--------~p--~-----~~~~n~~~~~----~p~~~~~l~~L~~L~ls~N~l~g~----   57 (232)
                      ..++.|+.|+|++| .++..        +.  .     .+++|++.+.    +...+...++|+.|+|++|++...    
T Consensus        33 ~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~  112 (185)
T 1io0_A           33 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA  112 (185)
T ss_dssp             TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred             hcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHH
Confidence            45677888888888 77631        11  1     1356777643    334555667888899998888753    


Q ss_pred             CCcccccCCCCCcccc--ccccccC
Q 042107           58 IPIPLEKLLDLKDLNL--SFNTLEG   80 (232)
Q Consensus        58 ip~~~~~l~~l~~l~l--~~n~l~g   80 (232)
                      +...+.....|+.|++  +.|.+..
T Consensus       113 l~~~L~~n~~L~~L~L~~~~N~i~~  137 (185)
T 1io0_A          113 LVEALQSNTSLIELRIDNQSQPLGN  137 (185)
T ss_dssp             HHHGGGGCSSCCEEECCCCSSCCCH
T ss_pred             HHHHHHhCCCceEEEecCCCCCCCH
Confidence            3455667778888888  7787754

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=97.21  E-value=5.2e-05  Score=62.14  Aligned_cols=77  Identities=18%  Similarity=0.199  Sum_probs=51.9

Q ss_pred             CCCCCEEEccCCcccccCCC------------ccccCccccccccccc-----cCCCCCeeeCCCCccee----cCCccc
Q 042107            4 LKVLLRIDLSTNNFSCVFPT------------TIEYNRLQDSLRNSIG-----DLTSLKSLDLSNNNFSG----AIPIPL   62 (232)
Q Consensus         4 ~~~l~~l~ls~N~~~g~~p~------------~~~~n~~~~~~p~~~~-----~l~~L~~L~ls~N~l~g----~ip~~~   62 (232)
                      +++|+.|||++|.|+..-..            .+++|++++.-...++     ..++|+.|+|++|+++.    .++..+
T Consensus       100 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L  179 (372)
T 3un9_A          100 RHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGL  179 (372)
T ss_dssp             SSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHH
T ss_pred             CCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHH
Confidence            35788888888888642111            1367777765444442     35788899999998864    234445


Q ss_pred             ccCCCCCccccccccccC
Q 042107           63 EKLLDLKDLNLSFNTLEG   80 (232)
Q Consensus        63 ~~l~~l~~l~l~~n~l~g   80 (232)
                      ...++|+.|++++|.++.
T Consensus       180 ~~~~~L~~L~Ls~N~l~~  197 (372)
T 3un9_A          180 AGNTSVTHLSLLHTGLGD  197 (372)
T ss_dssp             HTCSSCCEEECTTSSCHH
T ss_pred             hcCCCcCEEeCCCCCCCc
Confidence            677888899999888764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.19  E-value=0.0024  Score=52.93  Aligned_cols=73  Identities=7%  Similarity=0.049  Sum_probs=43.8

Q ss_pred             eecccCCCcceeeeEEeCCCcEEEEEEeecc----cC--c---hHHHHHHHHHHhc-CCCCCCccceeEEEecCCeeEEE
Q 042107           93 FNLISRGGFGSIYKARIQDGMEVVVKGFNLQ----YG--G---AFKNLDVECNMMK-IIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~----~~--~---~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.+|.|..+.||++.. ++..+++|.....    ..  .   ....+..|+..+. ......+++++.+.  ++..++|
T Consensus        39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv  115 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG  115 (420)
T ss_dssp             EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred             EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence            46789999999999964 4678999943221    00  0   2223333333222 11234566666654  4567899


Q ss_pred             Eecc-CC
Q 042107          163 LEYM-PH  168 (232)
Q Consensus       163 ~e~~-~~  168 (232)
                      |||+ ++
T Consensus       116 ~e~l~~g  122 (420)
T 2pyw_A          116 MRYLEPP  122 (420)
T ss_dssp             ECCCCTT
T ss_pred             EeecCCc
Confidence            9999 76

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=97.16  E-value=8.5e-05  Score=54.60  Aligned_cols=77  Identities=18%  Similarity=0.191  Sum_probs=50.3

Q ss_pred             CCCCCCEEEccCCccccc----CCC-----------ccccCccccc----cccccccCCCCCeeeC--CCCcceec----
Q 042107            3 NLKVLLRIDLSTNNFSCV----FPT-----------TIEYNRLQDS----LRNSIGDLTSLKSLDL--SNNNFSGA----   57 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~----~p~-----------~~~~n~~~~~----~p~~~~~l~~L~~L~l--s~N~l~g~----   57 (232)
                      ..++|+.|||++|.|+..    +..           .+++|++.+.    +...+...++|+.|+|  ++|.+...    
T Consensus        63 ~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~  142 (185)
T 1io0_A           63 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEME  142 (185)
T ss_dssp             TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHH
T ss_pred             hCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHH
Confidence            456788888888887631    111           1356777654    4566667778888888  77887643    


Q ss_pred             CCcccccCCCCCcccccccccc
Q 042107           58 IPIPLEKLLDLKDLNLSFNTLE   79 (232)
Q Consensus        58 ip~~~~~l~~l~~l~l~~n~l~   79 (232)
                      +...+...+.|+.|+++.|.+.
T Consensus       143 l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          143 IANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHHHhCCCcCEEeccCCCCC
Confidence            2333555677888888877754

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=97.03  E-value=0.00011  Score=57.17  Aligned_cols=48  Identities=38%  Similarity=0.388  Sum_probs=40.4

Q ss_pred             cccccccCCCCCeeeCCCCccee--cCCcccccCCCCCccccccccccCC
Q 042107           34 LRNSIGDLTSLKSLDLSNNNFSG--AIPIPLEKLLDLKDLNLSFNTLEGK   81 (232)
Q Consensus        34 ~p~~~~~l~~L~~L~ls~N~l~g--~ip~~~~~l~~l~~l~l~~n~l~g~   81 (232)
                      ++....++++|+.|+|++|++++  .+|..+..+++|+.|++++|.+++.
T Consensus       162 l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~  211 (267)
T 3rw6_A          162 LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE  211 (267)
T ss_dssp             HHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG
T ss_pred             HHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc
Confidence            33333578999999999999998  6777788999999999999999864

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.82  E-value=0.0021  Score=44.26  Aligned_cols=56  Identities=25%  Similarity=0.395  Sum_probs=41.1

Q ss_pred             CEEEccCCccc-ccCCCccccCccccccccccccCCCCCeeeCCCCcceecCCc-ccccCCCCCcccccccccc
Q 042107            8 LRIDLSTNNFS-CVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPI-PLEKLLDLKDLNLSFNTLE   79 (232)
Q Consensus         8 ~~l~ls~N~~~-g~~p~~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~-~~~~l~~l~~l~l~~n~l~   79 (232)
                      ..+|-+++.++ -.+|..         +|      ++|+.|+|++|+++ .+|. .+..++.|+.+++++|.+.
T Consensus        11 ~~v~Cs~~~L~~~~vP~~---------lp------~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           11 TLVDCGRRGLTWASLPTA---------FP------VDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TEEECCSSCCCTTTSCSC---------CC------TTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CEEEeCCCCCccccCCCC---------CC------cCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence            46777777776 345532         22      46899999999999 5555 4678899999999999764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.72  E-value=0.0022  Score=51.01  Aligned_cols=76  Identities=9%  Similarity=0.089  Sum_probs=42.2

Q ss_pred             eecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCC--ccceeEE------EecCCeeEEEEe
Q 042107           93 FNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN--LIKIISS------CSKDDFKALILE  164 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e  164 (232)
                      .+.++.|....+|+....++ .+++|......  ..+.+..|..+++.+....  +++++..      ....+..+++|+
T Consensus        27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            35677788888999876555 68889876521  1233455666665543111  2333221      122356789999


Q ss_pred             ccCCCCh
Q 042107          165 YMPHGSL  171 (232)
Q Consensus       165 ~~~~g~L  171 (232)
                      |++|..+
T Consensus       104 ~l~G~~~  110 (322)
T 2ppq_A          104 FLEGMWL  110 (322)
T ss_dssp             CCCCBCC
T ss_pred             eCCCcCC
Confidence            9988653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.71  E-value=0.026  Score=44.97  Aligned_cols=75  Identities=11%  Similarity=0.167  Sum_probs=36.9

Q ss_pred             ecccCCCcce-eeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCC--CCccceeEEEecCCeeEEEEeccCCCC
Q 042107           94 NLISRGGFGS-IYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRH--QNLIKIISSCSKDDFKALILEYMPHGS  170 (232)
Q Consensus        94 ~~lg~g~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~  170 (232)
                      +.++.|.... +|+....++..+++|.......   ..+..|+.+++.+..  -.+++++.+....+  +++||++.+.+
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            4455554444 5666544467777776543321   223345555555432  23556666533333  68999997766


Q ss_pred             hhh
Q 042107          171 LGK  173 (232)
Q Consensus       171 L~~  173 (232)
                      +.+
T Consensus        99 l~~  101 (333)
T 3csv_A           99 FTE  101 (333)
T ss_dssp             HHH
T ss_pred             hHH
Confidence            543

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=96.67  E-value=0.00084  Score=57.91  Aligned_cols=72  Identities=10%  Similarity=0.063  Sum_probs=49.7

Q ss_pred             CCCCCCEEEccCCcccccCCC---------------ccccCccc----cccccccccCCCCCeeeCCCCcceecCCcccc
Q 042107            3 NLKVLLRIDLSTNNFSCVFPT---------------TIEYNRLQ----DSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLE   63 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p~---------------~~~~n~~~----~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~   63 (232)
                      +|++|+.|+|++|.+++.-+.               .++.|+++    +.++..+..+++|+.|+|++|.+.+ +|..+.
T Consensus       162 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~  240 (592)
T 3ogk_B          162 HCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFK  240 (592)
T ss_dssp             HCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHH
T ss_pred             hCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHh
Confidence            467888889988887654111               12566666    4556666778888888888888774 566666


Q ss_pred             cCCCCCcccccc
Q 042107           64 KLLDLKDLNLSF   75 (232)
Q Consensus        64 ~l~~l~~l~l~~   75 (232)
                      .+++|+.++++.
T Consensus       241 ~~~~L~~L~l~~  252 (592)
T 3ogk_B          241 AAANLEEFCGGS  252 (592)
T ss_dssp             HCTTCCEEEECB
T ss_pred             hhhHHHhhcccc
Confidence            777777777764

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.61  E-value=0.0055  Score=51.03  Aligned_cols=73  Identities=16%  Similarity=0.255  Sum_probs=47.5

Q ss_pred             eecccCCCcceeeeEEeCC--------CcEEEEEEeecccCchHHHHHHHHHHhcCCCCCC-ccceeEEEecCCeeEEEE
Q 042107           93 FNLISRGGFGSIYKARIQD--------GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN-LIKIISSCSKDDFKALIL  163 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~  163 (232)
                      .+.++.|....+|++...+        +..+++|+....  .....+..|..+++.+...+ .+++++.+.  +  .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence            4567888888999997653        468888887331  11144556888887764333 356666553  2  3899


Q ss_pred             eccCCCCh
Q 042107          164 EYMPHGSL  171 (232)
Q Consensus       164 e~~~~g~L  171 (232)
                      ||++|.++
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.56  E-value=0.012  Score=48.14  Aligned_cols=73  Identities=15%  Similarity=0.234  Sum_probs=43.3

Q ss_pred             ecccCCCcceeeeEEeC--------CCcEEEEEEeecccCchHHHHHHHHHHhcCCC-CCCccceeEEEecCCeeEEEEe
Q 042107           94 NLISRGGFGSIYKARIQ--------DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-HQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      +.+..|....+|++...        +++.+++|+.... ........+|..+++.+. +.-.+++++.+..    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            45666778888998764        2468888876322 123455667888887764 2223566666543    39999


Q ss_pred             ccCCCCh
Q 042107          165 YMPHGSL  171 (232)
Q Consensus       165 ~~~~g~L  171 (232)
                      |++|.++
T Consensus       131 ~i~G~~l  137 (379)
T 3feg_A          131 YIPSRPL  137 (379)
T ss_dssp             CCSEEEC
T ss_pred             EecCccC
Confidence            9988654

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=96.53  E-value=0.0004  Score=56.62  Aligned_cols=39  Identities=26%  Similarity=0.452  Sum_probs=23.7

Q ss_pred             CCCCCeeeCCCCcceec----CCcccccCCCCCcccccccccc
Q 042107           41 LTSLKSLDLSNNNFSGA----IPIPLEKLLDLKDLNLSFNTLE   79 (232)
Q Consensus        41 l~~L~~L~ls~N~l~g~----ip~~~~~l~~l~~l~l~~n~l~   79 (232)
                      +++|+.|+|+.|++.+.    ++..+..++.|+.|+++.|.++
T Consensus       278 ~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~  320 (362)
T 2ra8_A          278 LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS  320 (362)
T ss_dssp             GGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred             CCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence            56677777777766542    3333445666777777666554

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=96.51  E-value=0.0036  Score=50.04  Aligned_cols=57  Identities=21%  Similarity=0.303  Sum_probs=33.0

Q ss_pred             CCCCCEEEccCCcccccCCCccccCccccccccccccCCCCCeeeCCCCcceecCCc-ccccCCCCC-cccccc
Q 042107            4 LKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPI-PLEKLLDLK-DLNLSF   75 (232)
Q Consensus         4 ~~~l~~l~ls~N~~~g~~p~~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~-~~~~l~~l~-~l~l~~   75 (232)
                      |++|+.|+|++|+++ .||..            .+..+.+|+.|+|..| +. .|+. .+..+.+|+ .+++..
T Consensus       225 ~~~L~~l~L~~n~i~-~I~~~------------aF~~~~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~  283 (329)
T 3sb4_A          225 MPNLVSLDISKTNAT-TIPDF------------TFAQKKYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA  283 (329)
T ss_dssp             CTTCCEEECTTBCCC-EECTT------------TTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT
T ss_pred             cCCCeEEECCCCCcc-eecHh------------hhhCCCCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc
Confidence            789999999999888 45442            2334555555555554 33 2333 344555555 555544

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.45  E-value=0.0073  Score=47.57  Aligned_cols=71  Identities=7%  Similarity=-0.016  Sum_probs=41.2

Q ss_pred             eecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCc-cceeEEEecCCeeEEEEecc-CCCC
Q 042107           93 FNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL-IKIISSCSKDDFKALILEYM-PHGS  170 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~g~  170 (232)
                      .+.++.|....+|+.     ..+++|......... .....|..+++.+....+ ++++...  .+.-++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            467888888999998     457888765431111 112446666665532222 4555443  33357899999 6544


Q ss_pred             h
Q 042107          171 L  171 (232)
Q Consensus       171 L  171 (232)
                      +
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=96.38  E-value=0.00042  Score=59.79  Aligned_cols=52  Identities=15%  Similarity=0.085  Sum_probs=33.0

Q ss_pred             cccccccccccc-CCCCCeeeCCCCcceecCCccc-ccCCCCCccccccccccC
Q 042107           29 RLQDSLRNSIGD-LTSLKSLDLSNNNFSGAIPIPL-EKLLDLKDLNLSFNTLEG   80 (232)
Q Consensus        29 ~~~~~~p~~~~~-l~~L~~L~ls~N~l~g~ip~~~-~~l~~l~~l~l~~n~l~g   80 (232)
                      ++++..+..++. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|.+++
T Consensus       442 ~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~  495 (594)
T 2p1m_B          442 LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGD  495 (594)
T ss_dssp             SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCH
T ss_pred             cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcH
Confidence            444444455554 6777777777777765444333 557777777777777643

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.36  E-value=0.022  Score=47.86  Aligned_cols=74  Identities=19%  Similarity=0.236  Sum_probs=45.7

Q ss_pred             eecccCCCcceeeeEEeCC-CcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCc-cceeEEEecCCeeEEEEeccCCCC
Q 042107           93 FNLISRGGFGSIYKARIQD-GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL-IKIISSCSKDDFKALILEYMPHGS  170 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~  170 (232)
                      .+.|+.|....+|++...+ +..+++|+......... .-..|..+++.+...++ +++++.+.  +  .+||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            3567788888999998764 47788887643221111 12467777777754444 56777663  2  35999998754


Q ss_pred             h
Q 042107          171 L  171 (232)
Q Consensus       171 L  171 (232)
                      +
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.30  E-value=0.075  Score=42.08  Aligned_cols=75  Identities=9%  Similarity=0.058  Sum_probs=46.4

Q ss_pred             cccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCC--CccceeEE-----EecCCeeEEEEeccC
Q 042107           95 LISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQ--NLIKIISS-----CSKDDFKALILEYMP  167 (232)
Q Consensus        95 ~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~-----~~~~~~~~lv~e~~~  167 (232)
                      .++ |....||+....+|+.+++|...... .....+..|..+++.+...  .+++++..     ....+..+++|||++
T Consensus        33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~  110 (328)
T 1zyl_A           33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  110 (328)
T ss_dssp             EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence            455 77788998876667789999886432 1235566677777665321  13333332     122456688999998


Q ss_pred             CCCh
Q 042107          168 HGSL  171 (232)
Q Consensus       168 ~g~L  171 (232)
                      |.++
T Consensus       111 G~~~  114 (328)
T 1zyl_A          111 GRQF  114 (328)
T ss_dssp             CEEC
T ss_pred             CCCC
Confidence            7543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.27  E-value=0.0075  Score=48.98  Aligned_cols=74  Identities=12%  Similarity=0.209  Sum_probs=42.1

Q ss_pred             eecccCCCcceeeeEEeCC---------CcEEEEEEeecccCchHHHHHHHHHHhcCCCCCC-ccceeEEEecCCeeEEE
Q 042107           93 FNLISRGGFGSIYKARIQD---------GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN-LIKIISSCSKDDFKALI  162 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~lv  162 (232)
                      .+.++.|....+|+....+         +..+++|....... .......|..+++.+...+ ++++++..  +  -+++
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            3567778888899987653         26788887643221 1112355777777664223 44666544  2  3689


Q ss_pred             EeccCCCCh
Q 042107          163 LEYMPHGSL  171 (232)
Q Consensus       163 ~e~~~~g~L  171 (232)
                      |||++|.++
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987543

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=96.21  E-value=0.0055  Score=42.11  Aligned_cols=37  Identities=22%  Similarity=0.398  Sum_probs=29.8

Q ss_pred             CCCEEEccCCcccccCCCccccCccccccccccccCCCCCeeeCCCCcce
Q 042107            6 VLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFS   55 (232)
Q Consensus         6 ~l~~l~ls~N~~~g~~p~~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~   55 (232)
                      +|+.|||++|+|+ .+|.            ..+..+++|+.|+|++|.+.
T Consensus        32 ~l~~L~Ls~N~l~-~l~~------------~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           32 DTTELVLTGNNLT-ALPP------------GLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TCSEEECTTSCCS-SCCT------------TTGGGCTTCCEEECCSSCCB
T ss_pred             CCCEEECCCCcCC-ccCh------------hhhhhccccCEEEecCCCee
Confidence            7999999999999 4443            23556789999999999775

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=96.19  E-value=0.0016  Score=56.19  Aligned_cols=74  Identities=20%  Similarity=0.118  Sum_probs=39.0

Q ss_pred             CCCCCEEEccCCcccccCCCcc------------ccC-ccccc-cccccccCCCCCeeeCCCCcceecCCcccc----cC
Q 042107            4 LKVLLRIDLSTNNFSCVFPTTI------------EYN-RLQDS-LRNSIGDLTSLKSLDLSNNNFSGAIPIPLE----KL   65 (232)
Q Consensus         4 ~~~l~~l~ls~N~~~g~~p~~~------------~~n-~~~~~-~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~----~l   65 (232)
                      +++|+.|+|++|.+++..+..+            .+| .+++. ++.....+++|+.|+|++|.+++..+..+.    .+
T Consensus       104 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~  183 (594)
T 2p1m_B          104 YTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTY  183 (594)
T ss_dssp             CTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTC
T ss_pred             CCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcC
Confidence            4567777777777665433221            223 23222 334444667777777777766553333222    34


Q ss_pred             CCCCcccccccc
Q 042107           66 LDLKDLNLSFNT   77 (232)
Q Consensus        66 ~~l~~l~l~~n~   77 (232)
                      ++|+.|+++.+.
T Consensus       184 ~~L~~L~l~~~~  195 (594)
T 2p1m_B          184 TSLVSLNISCLA  195 (594)
T ss_dssp             CCCCEEECTTCC
T ss_pred             CcCcEEEecccC
Confidence            466666666554

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.96  E-value=0.071  Score=42.75  Aligned_cols=68  Identities=10%  Similarity=0.130  Sum_probs=40.8

Q ss_pred             cCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCC---CCCccceeEE------EecCCeeEEEEeccC
Q 042107           97 SRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR---HQNLIKIISS------CSKDDFKALILEYMP  167 (232)
Q Consensus        97 g~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~------~~~~~~~~lv~e~~~  167 (232)
                      |.|....||+....+| .+++|+......      ..|...++.+.   -|.+++.+..      ....+..+++|||++
T Consensus        32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~  104 (339)
T 3i1a_A           32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH  104 (339)
T ss_dssp             TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred             cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence            4444678999976666 899998765432      23444444332   1224444322      223467789999999


Q ss_pred             CCCh
Q 042107          168 HGSL  171 (232)
Q Consensus       168 ~g~L  171 (232)
                      |..+
T Consensus       105 G~~~  108 (339)
T 3i1a_A          105 APNG  108 (339)
T ss_dssp             CCBT
T ss_pred             CCcC
Confidence            8765

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=93.42  E-value=0.027  Score=45.80  Aligned_cols=41  Identities=17%  Similarity=0.207  Sum_probs=30.1

Q ss_pred             cCCCCCeeeCCCCcceecCCcccc---cCCCCCccccccccccC
Q 042107           40 DLTSLKSLDLSNNNFSGAIPIPLE---KLLDLKDLNLSFNTLEG   80 (232)
Q Consensus        40 ~l~~L~~L~ls~N~l~g~ip~~~~---~l~~l~~l~l~~n~l~g   80 (232)
                      .+|+|+.|+|++|.+....+..+.   .++.|+.|+++.|.+..
T Consensus       250 ~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d  293 (362)
T 2ra8_A          250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD  293 (362)
T ss_dssp             TCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred             CCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence            478999999988888754433333   46788889998887765

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=93.25  E-value=0.2  Score=41.17  Aligned_cols=51  Identities=18%  Similarity=0.249  Sum_probs=30.0

Q ss_pred             CCCCCCCCEEEccCCcccccCCCc-cc---------cCccccccccccccCCCCCeeeCCCC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPTT-IE---------YNRLQDSLRNSIGDLTSLKSLDLSNN   52 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~~-~~---------~n~~~~~~p~~~~~l~~L~~L~ls~N   52 (232)
                      |.+|++|+.++|+.|.++ .+|.. +.         .+++.-.-...+..+++|+.+++..|
T Consensus       176 F~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~l~~I~~~aF~~~~~L~~l~l~~~  236 (401)
T 4fdw_A          176 FYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVTLKEIGSQAFLKTSQLKTIEIPEN  236 (401)
T ss_dssp             TTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTTCCEECTTTTTTCTTCCCEECCTT
T ss_pred             hhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCchheehhhHhhCCCCCCEEecCCC
Confidence            467889999999998887 33332 11         12232222244555666666666553

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=91.29  E-value=0.48  Score=38.87  Aligned_cols=18  Identities=11%  Similarity=0.106  Sum_probs=13.5

Q ss_pred             CCCCCCCCEEEccCCccc
Q 042107            1 MSNLKVLLRIDLSTNNFS   18 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~   18 (232)
                      |.+|++|+.++|++|.+.
T Consensus       267 F~~c~~L~~l~l~~~~~~  284 (401)
T 4fdw_A          267 FYYCPELAEVTTYGSTFN  284 (401)
T ss_dssp             TTTCTTCCEEEEESSCCC
T ss_pred             hhCCCCCCEEEeCCcccc
Confidence            456778888888877765

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=91.05  E-value=0.024  Score=47.71  Aligned_cols=60  Identities=8%  Similarity=0.071  Sum_probs=16.9

Q ss_pred             eeecccCCCcceeeeEEeCC-CcEEEE------EEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEe
Q 042107           92 VFNLISRGGFGSIYKARIQD-GMEVVV------KGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCS  154 (232)
Q Consensus        92 ~~~~lg~g~~g~V~~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  154 (232)
                      +.+.+|   ||.||+|.+.. ..+||+      |......  ......+.+|..+++..+|||+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            345565   99999998753 457888      6553321  223356777888999999999999987654

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=90.36  E-value=0.065  Score=39.51  Aligned_cols=68  Identities=19%  Similarity=0.169  Sum_probs=42.4

Q ss_pred             CCCCCCEEEccCC-cccccCCCccccCccccccccccccCCCCCeeeCCCCcceec----CCcccccCCCCCcccccccc
Q 042107            3 NLKVLLRIDLSTN-NFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGA----IPIPLEKLLDLKDLNLSFNT   77 (232)
Q Consensus         3 ~~~~l~~l~ls~N-~~~g~~p~~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~----ip~~~~~l~~l~~l~l~~n~   77 (232)
                      +-+.|+.|+|++| .|...=-.         .+-..+.....|+.|+|++|++...    +...+..-..|+.|+++.|.
T Consensus        39 ~n~~L~~L~L~~nn~igd~ga~---------~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~  109 (197)
T 1pgv_A           39 DDTDLKEVNINNMKRVSKERIR---------SLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNF  109 (197)
T ss_dssp             TCSSCCEEECTTCCSSCHHHHH---------HHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSB
T ss_pred             cCCCccEEECCCCCCCCHHHHH---------HHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCc
Confidence            4468999999985 77621000         1123334457788888888888632    22234556778888888887


Q ss_pred             cc
Q 042107           78 LE   79 (232)
Q Consensus        78 l~   79 (232)
                      +.
T Consensus       110 Ig  111 (197)
T 1pgv_A          110 LT  111 (197)
T ss_dssp             CC
T ss_pred             CC
Confidence            64

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=90.34  E-value=0.051  Score=39.32  Aligned_cols=13  Identities=15%  Similarity=0.171  Sum_probs=10.4

Q ss_pred             CCCEEEccCCccc
Q 042107            6 VLLRIDLSTNNFS   18 (232)
Q Consensus         6 ~l~~l~ls~N~~~   18 (232)
                      .|+.||||++.++
T Consensus        62 ~L~~LDLs~~~It   74 (176)
T 3e4g_A           62 KIQAIDATDSCIM   74 (176)
T ss_dssp             CEEEEEEESCCCC
T ss_pred             eEeEEeCcCCCcc
Confidence            5788999988766

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=90.00  E-value=0.095  Score=38.63  Aligned_cols=65  Identities=15%  Similarity=0.115  Sum_probs=43.3

Q ss_pred             CCCCCCEEEccCCcccccCCCccccCccccccccccccCCCCCeeeCCCCcceec----CCcccccCCCCCccccccc
Q 042107            3 NLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGA----IPIPLEKLLDLKDLNLSFN   76 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p~~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~----ip~~~~~l~~l~~l~l~~n   76 (232)
                      .-+.|+.|+|++|+|...--..         +-..+...+.|+.|+|++|++...    +-..+..-..|+.|++++|
T Consensus        68 ~N~~L~~L~L~~n~igd~ga~a---------lA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A           68 NSKHIEKFSLANTAISDSEARG---------LIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             TCSCCCEEECTTSCCBHHHHTT---------HHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCC
T ss_pred             hCCCcCEEEccCCCCChHHHHH---------HHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCC
Confidence            3468999999999998321111         223344457899999999998742    2223555567888888754

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.84  E-value=1.6  Score=32.43  Aligned_cols=78  Identities=8%  Similarity=0.080  Sum_probs=53.3

Q ss_pred             CCCCccceeEEEecCCeeEEEEeccCCC-ChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCce
Q 042107          142 RHQNLIKIISSCSKDDFKALILEYMPHG-SLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNV  220 (232)
Q Consensus       142 ~h~niv~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Ni  220 (232)
                      .||+.+.. .+-..++.+.+.++.-+.+ ++.. ++.    .+...+++++..++....+++    .  =+|--+.|+|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~----~~~~eKlr~l~ni~~l~~~~~----~--r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS----FTKNEKLRYLLNIKNLEEVNR----T--RYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG----SCHHHHHHHHHHGGGGGGGGG----S--SEECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh----cCHHHHHHHHHHHHHHHHHhc----C--ceEEEEecceE
Confidence            57877755 4555566655555544322 2222 322    567788889988888776665    2  47788999999


Q ss_pred             eeCCCCceeec
Q 042107          221 LLDDNMVAHFL  231 (232)
Q Consensus       221 ll~~~~~~~l~  231 (232)
                      +++.++.+++.
T Consensus       111 ~f~~~~~p~i~  121 (215)
T 4ann_A          111 FFTRDGLPIAK  121 (215)
T ss_dssp             EECTTSCEEES
T ss_pred             EEcCCCCEEEE
Confidence            99999999875

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=88.71  E-value=0.97  Score=36.38  Aligned_cols=35  Identities=17%  Similarity=0.290  Sum_probs=16.3

Q ss_pred             ccccCCCCCeeeCCCCcceecCCc-ccccCCCCCcccc
Q 042107           37 SIGDLTSLKSLDLSNNNFSGAIPI-PLEKLLDLKDLNL   73 (232)
Q Consensus        37 ~~~~l~~L~~L~ls~N~l~g~ip~-~~~~l~~l~~l~l   73 (232)
                      .+.++.+|+.+.|..+ +. .|+. .+.++.+|+.+.+
T Consensus       305 aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~i  340 (379)
T 4h09_A          305 VFMDCVKLSSVTLPTA-LK-TIQVYAFKNCKALSTISY  340 (379)
T ss_dssp             TTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCCCCC
T ss_pred             hhcCCCCCCEEEcCcc-cc-EEHHHHhhCCCCCCEEEE
Confidence            3444555666655433 32 3332 2444555555544

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=88.06  E-value=2.7  Score=31.32  Aligned_cols=78  Identities=10%  Similarity=0.091  Sum_probs=51.9

Q ss_pred             CCCCccceeEEEecCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCCeeeCCCCCCce
Q 042107          142 RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVE-YLHFGHSTHVIIHCDLKSSNV  220 (232)
Q Consensus       142 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~-~lH~~~~~~~iiHrdlk~~Ni  220 (232)
                      .||..  -...-.+++.+.+.++--+++.=...++.    .+...+++++..++.... +++      .-+|--+.|+|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~----~~~~eKlrll~nl~~L~~~~~~------~r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK----TTLLSRIRAAIHLVSKVKHHSA------RRLIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT----SCHHHHHHHHHHHHHHHSSCCS------SSEECCCCGGGE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh----cCHHHHHHHHHHHHHHHHHhhh------CceeEEEeCceE
Confidence            57777  23334566666666665434322223332    567788888888877666 554      357788999999


Q ss_pred             eeCCCCceeec
Q 042107          221 LLDDNMVAHFL  231 (232)
Q Consensus       221 ll~~~~~~~l~  231 (232)
                      +++.++.++|.
T Consensus       116 ~f~~~~~p~i~  126 (219)
T 4ano_A          116 MFNRALEPFFL  126 (219)
T ss_dssp             EECTTCCEEES
T ss_pred             EEeCCCcEEEE
Confidence            99999999874

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=86.17  E-value=1.6  Score=36.15  Aligned_cols=74  Identities=15%  Similarity=0.216  Sum_probs=45.5

Q ss_pred             eecccCCCcceeeeEEeCC--------CcEEEEEEeecccCchHHHHHHHHHHhcCCC-CCCccceeEEEecCCeeEEEE
Q 042107           93 FNLISRGGFGSIYKARIQD--------GMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-HQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  163 (232)
                      .+.+..|....+|+....+        +..+++|+........ -...+|..+++.+. +.-.+++++.+.    -++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            3566678888899987653        5778888864332111 12245777776664 223455665432    37899


Q ss_pred             eccCCCCh
Q 042107          164 EYMPHGSL  171 (232)
Q Consensus       164 e~~~~g~L  171 (232)
                      ||++|.++
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998654

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=86.07  E-value=0.16  Score=36.72  Aligned_cols=34  Identities=12%  Similarity=0.111  Sum_probs=18.5

Q ss_pred             CCCeeeCCCCcceecCCcccccCCCCCccccccc
Q 042107           43 SLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFN   76 (232)
Q Consensus        43 ~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n   76 (232)
                      +|+.|||+++.++..=-..+..++.|+.|+++.+
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C   95 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC   95 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence            5666666666554321122455666666666655

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	232
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-29
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-28
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-28
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-27
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-27
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-26
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-26
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-26
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-26
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-26
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-25
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-25
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-25
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-25
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-25
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-24
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-24
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-24
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-23
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-23
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-23
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-22
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-22
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-22
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	6e-22
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-22
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-22
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-21
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-21
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-21
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-21
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-21
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-20
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-20
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-20
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-20
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	7e-20
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-19
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-19
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-19
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-19
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-18
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-18
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-18
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-18
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-18
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-18
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-17
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-17
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-17
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-17
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-16
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-16
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-16
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-16
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-15
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-15
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-15
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-14
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-14
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-12
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-12
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-12
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-08
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	7e-06
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-04
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	5e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	2e-04
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	7e-04
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	0.001
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.004

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 3e-29
 Identities = 30/143 (20%), Positives = 58/143 (40%), Gaps = 5/143 (3%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL 146
              + V   I  G FG++YK +    + V +           +    E  +++  RH N+
Sbjct: 7   DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHS 206
           +  +   +     A++ ++    SL   L       +  + + I    A  ++YLH    
Sbjct: 67  LLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA--- 122

Query: 207 THVIIHCDLKSSNVLLDDNMVAH 229
              IIH DLKS+N+ L +++   
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVK 144

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (264), Expect = 3e-28
 Identities = 30/143 (20%), Positives = 64/143 (44%), Gaps = 5/143 (3%)

Query: 87  RNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN 145
            +F E+   +  G FG +YKA+  +  +    K  + +     ++  VE +++    H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 205
           ++K++ +   ++   +++E+   G++   +      L   Q   +      A+ YLH   
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH--- 127

Query: 206 STHVIIHCDLKSSNVLLDDNMVA 228
             + IIH DLK+ N+L   +   
Sbjct: 128 -DNKIIHRDLKAGNILFTLDGDI 149

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 5e-28
 Identities = 35/142 (24%), Positives = 67/142 (47%), Gaps = 7/142 (4%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL 146
           R  L++   +  G FG ++        +V VK               E N+MK ++HQ L
Sbjct: 12  RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRL 70

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI-LDFFQRLHIMIDVASAVEYLHFGH 205
           +++ +  +++    +I EYM +GSL   L T + I L   + L +   +A  + ++   +
Sbjct: 71  VRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 206 STHVIIHCDLKSSNVLLDDNMV 227
                IH DL+++N+L+ D + 
Sbjct: 130 ----YIHRDLRAANILVSDTLS 147

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  103 bits (257), Expect = 5e-27
 Identities = 30/147 (20%), Positives = 60/147 (40%), Gaps = 9/147 (6%)

Query: 86  FRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNL---QYGGAFKNLDVECNMMKII 141
                     I  G FG++Y AR +++   V +K  +    Q    ++++  E   ++ +
Sbjct: 13  PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 72

Query: 142 RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL 201
           RH N I+      ++    L++EY    +           L   +   +       + YL
Sbjct: 73  RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYL 131

Query: 202 HFGHSTHVIIHCDLKSSNVLLDDNMVA 228
           H    +H +IH D+K+ N+LL +  + 
Sbjct: 132 H----SHNMIHRDVKAGNILLSEPGLV 154

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 5e-27
 Identities = 29/140 (20%), Positives = 58/140 (41%), Gaps = 6/140 (4%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKN-LDVECNMMKIIRHQNLIK 148
           E  + +  G  G ++K      G+ +  K  +L+   A +N +  E  ++       ++ 
Sbjct: 9   EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 68

Query: 149 IISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH 208
              +   D   ++ +E+M  GSL + L  +   +       + I V   + YL      H
Sbjct: 69  FYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYL---REKH 124

Query: 209 VIIHCDLKSSNVLLDDNMVA 228
            I+H D+K SN+L++     
Sbjct: 125 KIMHRDVKPSNILVNSRGEI 144

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 1e-26
 Identities = 34/140 (24%), Positives = 56/140 (40%), Gaps = 5/140 (3%)

Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           L     +  G FG +   + +   +V +K               E  +M  + H+ L+++
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQL 64

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV 209
              C+K     +I EYM +G L   L    +     Q L +  DV  A+EYL        
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---- 120

Query: 210 IIHCDLKSSNVLLDDNMVAH 229
            +H DL + N L++D  V  
Sbjct: 121 FLHRDLAARNCLVNDQGVVK 140

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 1e-26
 Identities = 33/140 (23%), Positives = 56/140 (40%), Gaps = 5/140 (3%)

Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           L     I  G FG ++     +  +V +K          ++   E  +M  + H  L+++
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQL 65

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV 209
              C +     L+ E+M HG L   L T   +      L + +DV   + YL        
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EAC 121

Query: 210 IIHCDLKSSNVLLDDNMVAH 229
           +IH DL + N L+ +N V  
Sbjct: 122 VIHRDLAARNCLVGENQVIK 141

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  101 bits (253), Expect = 4e-26
 Identities = 24/136 (17%), Positives = 55/136 (40%), Gaps = 5/136 (3%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           ++   +  G FG +++      G     K     +    + +  E   M ++RH  L+ +
Sbjct: 29  DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 88

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV 209
             +   D+   +I E+M  G L + ++  +  +   + +  M  V   + ++H     + 
Sbjct: 89  HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH----ENN 144

Query: 210 IIHCDLKSSNVLLDDN 225
            +H DLK  N++    
Sbjct: 145 YVHLDLKPENIMFTTK 160

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  100 bits (251), Expect = 7e-26
 Identities = 28/140 (20%), Positives = 59/140 (42%), Gaps = 5/140 (3%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           ++   +  G FG +++      G   V K  N  Y      +  E ++M  + H  LI +
Sbjct: 32  DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 91

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV 209
             +        LILE++  G L   ++  +Y +   + ++ M      ++++H     H 
Sbjct: 92  HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH----EHS 147

Query: 210 IIHCDLKSSNVLLDDNMVAH 229
           I+H D+K  N++ +    + 
Sbjct: 148 IVHLDIKPENIMCETKKASS 167

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.4 bits (247), Expect = 9e-26
 Identities = 32/144 (22%), Positives = 64/144 (44%), Gaps = 7/144 (4%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL 146
           R  L +   + +G FG ++         V +K          +    E  +MK +RH+ L
Sbjct: 16  RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKL 74

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGK-CLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 205
           +++ +  S++    ++ EYM  GSL       +   L   Q + +   +AS + Y+    
Sbjct: 75  VQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-- 131

Query: 206 STHVIIHCDLKSSNVLLDDNMVAH 229
                +H DL+++N+L+ +N+V  
Sbjct: 132 --MNYVHRDLRAANILVGENLVCK 153

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.8 bits (243), Expect = 3e-25
 Identities = 39/143 (27%), Positives = 65/143 (45%), Gaps = 9/143 (6%)

Query: 90  LEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           L++   I +G FG +       G +V VK          +    E ++M  +RH NL+++
Sbjct: 9   LKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQL 65

Query: 150 ISSCSKDDFK-ALILEYMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           +    ++     ++ EYM  GSL   L S    +L     L   +DV  A+EYL      
Sbjct: 66  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----G 121

Query: 208 HVIIHCDLKSSNVLLDDNMVAHF 230
           +  +H DL + NVL+ ++ VA  
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKV 144

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 98.3 bits (244), Expect = 3e-25
 Identities = 31/148 (20%), Positives = 67/148 (45%), Gaps = 9/148 (6%)

Query: 87  RNFLEVFNLISRGGFGSIYKARI----QDGMEVVVKGFNLQYG-GAFKNLDVECNMMKII 141
            + +++  +I  G FG +    +    +  + V +K     Y     ++   E ++M   
Sbjct: 25  ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84

Query: 142 RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL 201
            H N+I +    +K     +I E+M +GSL   L  ++      Q + ++  +A+ ++YL
Sbjct: 85  DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144

Query: 202 HFGHSTHVIIHCDLKSSNVLLDDNMVAH 229
              +     +H DL + N+L++ N+V  
Sbjct: 145 ADMN----YVHRDLAARNILVNSNLVCK 168

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.8 bits (243), Expect = 3e-25
 Identities = 32/146 (21%), Positives = 59/146 (40%), Gaps = 7/146 (4%)

Query: 85  PFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIR 142
           PF    ++   +  G +G +  A        V VK  +++      +N+  E  + K++ 
Sbjct: 2   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN 61

Query: 143 HQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH 202
           H+N++K      + + + L LEY   G L   +   +  +           + + V YLH
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLH 120

Query: 203 FGHSTHVIIHCDLKSSNVLLDDNMVA 228
                  I H D+K  N+LLD+    
Sbjct: 121 ----GIGITHRDIKPENLLLDERDNL 142

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 97.1 bits (241), Expect = 7e-25
 Identities = 35/144 (24%), Positives = 68/144 (47%), Gaps = 7/144 (4%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQD-GMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQN 145
           R  + + + +  G +G +Y+   +   + V VK          +    E  +MK I+H N
Sbjct: 16  RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPN 74

Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFG 204
           L++++  C+++    +I E+M +G+L   L   N   +     L++   ++SA+EYL   
Sbjct: 75  LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-- 132

Query: 205 HSTHVIIHCDLKSSNVLLDDNMVA 228
                 IH DL + N L+ +N + 
Sbjct: 133 --KKNFIHRDLAARNCLVGENHLV 154

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.0 bits (241), Expect = 8e-25
 Identities = 36/137 (26%), Positives = 68/137 (49%), Gaps = 7/137 (5%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
             F  I +G  G++Y A  +  G EV ++  NLQ     + +  E  +M+  ++ N++  
Sbjct: 23  TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNY 82

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV 209
           + S    D   +++EY+  GSL   +  +   +D  Q   +  +   A+E+LH    ++ 
Sbjct: 83  LDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLH----SNQ 136

Query: 210 IIHCDLKSSNVLLDDNM 226
           +IH D+KS N+LL  + 
Sbjct: 137 VIHRDIKSDNILLGMDG 153

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.1 bits (238), Expect = 3e-24
 Identities = 38/141 (26%), Positives = 68/141 (48%), Gaps = 12/141 (8%)

Query: 96  ISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSK 155
           I +G FG +++ +   G EV VK F+ +   ++   + E     ++RH+N++  I++ +K
Sbjct: 11  IGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWFR-EAEIYQTVMLRHENILGFIAADNK 68

Query: 156 DDFKA----LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH----FGHST 207
           D+       L+ +Y  HGSL   L+   Y +     + + +  AS + +LH         
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126

Query: 208 HVIIHCDLKSSNVLLDDNMVA 228
             I H DLKS N+L+  N   
Sbjct: 127 PAIAHRDLKSKNILVKKNGTC 147

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.8 bits (235), Expect = 5e-24
 Identities = 27/138 (19%), Positives = 55/138 (39%), Gaps = 9/138 (6%)

Query: 96  ISRGGFGSIYKARIQ---DGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIIS 151
           +  G FGS+ +   +     ++V +K           + +  E  +M  + +  ++++I 
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76

Query: 152 SCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVII 211
            C  +    L++E    G L K L      +       ++  V+  ++YL         +
Sbjct: 77  VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE----KNFV 131

Query: 212 HCDLKSSNVLLDDNMVAH 229
           H DL + NVLL +   A 
Sbjct: 132 HRDLAARNVLLVNRHYAK 149

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.9 bits (233), Expect = 7e-24
 Identities = 36/142 (25%), Positives = 64/142 (45%), Gaps = 9/142 (6%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFN---LQYGGAFKNLDVECNMMKIIRHQNL 146
           E+   + +G FG++Y AR  Q    + +K      L+  G    L  E  +   +RH N+
Sbjct: 9   EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 68

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHS 206
           +++           LILEY P G++ + L   +   D  +    + ++A+A+ Y H    
Sbjct: 69  LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---- 123

Query: 207 THVIIHCDLKSSNVLLDDNMVA 228
           +  +IH D+K  N+LL      
Sbjct: 124 SKRVIHRDIKPENLLLGSAGEL 145

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.5 bits (232), Expect = 1e-23
 Identities = 35/147 (23%), Positives = 60/147 (40%), Gaps = 9/147 (6%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLI 147
           EV   I  G +G   K R   DG  +V K  +         + L  E N+++ ++H N++
Sbjct: 7   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66

Query: 148 KIISSC--SKDDFKALILEYMPHGSLGKCL---STSNYILDFFQRLHIMIDVASAVEYLH 202
           +         +    +++EY   G L   +   +     LD    L +M  +  A++  H
Sbjct: 67  RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126

Query: 203 -FGHSTHVIIHCDLKSSNVLLDDNMVA 228
                 H ++H DLK +NV LD     
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNV 153

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.5 bits (232), Expect = 2e-23
 Identities = 33/143 (23%), Positives = 59/143 (41%), Gaps = 9/143 (6%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYG---GAFKNLDVECNMMKIIRHQNL 146
           +   ++  G F ++  AR +    E  +K    ++         +  E ++M  + H   
Sbjct: 11  KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHS 206
           +K+  +   D+     L Y  +G L K +       D         ++ SA+EYLH    
Sbjct: 71  VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH---- 125

Query: 207 THVIIHCDLKSSNVLLDDNMVAH 229
              IIH DLK  N+LL+++M   
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQ 148

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.7 bits (232), Expect = 3e-23
 Identities = 38/174 (21%), Positives = 63/174 (36%), Gaps = 34/174 (19%)

Query: 87  RNFLEVFNLISRGGFGSIYKA------RIQDGMEVVVKGFNLQYG-GAFKNLDVECNMM- 138
           R  LE   ++  G FG +  A      +    ++V VK    +      + L  E  MM 
Sbjct: 36  RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMT 95

Query: 139 KIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSN------------------- 179
           ++  H+N++ ++ +C+      LI EY  +G L   L +                     
Sbjct: 96  QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155

Query: 180 ---YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHF 230
               +L F   L     VA  +E+L         +H DL + NVL+    V   
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLE----FKSCVHRDLAARNVLVTHGKVVKI 205

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.8 bits (225), Expect = 1e-22
 Identities = 32/145 (22%), Positives = 55/145 (37%), Gaps = 10/145 (6%)

Query: 89  FLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQN 145
           FL+    I RG F ++YK    +  +EV       +       +    E  M+K ++H N
Sbjct: 10  FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69

Query: 146 LIKIISSC----SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL 201
           +++   S            L+ E M  G+L   L     ++           +   +++L
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFL 128

Query: 202 HFGHSTHVIIHCDLKSSNVLLDDNM 226
           H    T  IIH DLK  N+ +    
Sbjct: 129 H--TRTPPIIHRDLKCDNIFITGPT 151

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 91.4 bits (226), Expect = 1e-22
 Identities = 45/188 (23%), Positives = 71/188 (37%), Gaps = 39/188 (20%)

Query: 71  LNLSFNTLEGKIPRPFRNFLEVFNLISRGGFGSIYKAR------IQDGMEVVVKGFNLQY 124
           LN    +LE   PR   N +E    I  G FG +++AR       +    V VK    + 
Sbjct: 1   LNPKLLSLE--YPR---NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA 55

Query: 125 GGAF-KNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCL-------- 175
                 +   E  +M    + N++K++  C+      L+ EYM +G L + L        
Sbjct: 56  SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTV 115

Query: 176 ---------------STSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNV 220
                          S     L   ++L I   VA+ + YL         +H DL + N 
Sbjct: 116 CSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK----FVHRDLATRNC 171

Query: 221 LLDDNMVA 228
           L+ +NMV 
Sbjct: 172 LVGENMVV 179

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.3 bits (223), Expect = 4e-22
 Identities = 35/166 (21%), Positives = 56/166 (33%), Gaps = 29/166 (17%)

Query: 87  RNFLEVFNLISRGGFGSIYKARI------QDGMEVVVKGFNLQYG-GAFKNLDVECNMM- 138
           RN L     +  G FG + +A           M V VK           + L  E  ++ 
Sbjct: 22  RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLS 81

Query: 139 KIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCL-----------------STSNYI 181
            +  H N++ ++ +C+      +I EY  +G L   L                       
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 182 LDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           LD    L     VA  + +L     +   IH DL + N+LL    +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNILLTHGRI 183

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.7 bits (222), Expect = 6e-22
 Identities = 26/140 (18%), Positives = 64/140 (45%), Gaps = 6/140 (4%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
            +   + RG FG +++          + K   ++ G     +  E +++ I RH+N++ +
Sbjct: 8   MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHL 66

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV 209
             S    +   +I E++    + + ++TS + L+  + +  +  V  A+++LH    +H 
Sbjct: 67  HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH----SHN 122

Query: 210 IIHCDLKSSNVLLDDNMVAH 229
           I H D++  N++      + 
Sbjct: 123 IGHFDIRPENIIYQTRRSST 142

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.5 bits (221), Expect = 6e-22
 Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 24/163 (14%)

Query: 87  RNFLEVFNLISRGGFGSIYKARIQDG---MEVVVKGFNLQY-GGAFKNLDVECNMM-KII 141
            N ++  ++I  G FG + KARI+     M+  +K           ++   E  ++ K+ 
Sbjct: 9   WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68

Query: 142 RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI---------------LDFFQ 186
            H N+I ++ +C    +  L +EY PHG+L   L  S  +               L   Q
Sbjct: 69  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 187 RLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAH 229
            LH   DVA  ++YL         IH DL + N+L+ +N VA 
Sbjct: 129 LLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYVAK 167

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.1 bits (220), Expect = 6e-22
 Identities = 30/149 (20%), Positives = 59/149 (39%), Gaps = 10/149 (6%)

Query: 87  RNFLEVFNLISRGGFGSIYKARI----QDGMEVVVKGFNLQYGGAF-KNLDVECNMMKII 141
           R  +E+   I  G FG +++          + V +K        +  +    E   M+  
Sbjct: 6   RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 65

Query: 142 RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL 201
            H +++K+I   + ++   +I+E    G L   L    Y LD    +     +++A+ YL
Sbjct: 66  DHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124

Query: 202 HFGHSTHVIIHCDLKSSNVLLDDNMVAHF 230
                +   +H D+ + NVL+  N     
Sbjct: 125 E----SKRFVHRDIAARNVLVSSNDCVKL 149

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.2 bits (218), Expect = 1e-21
 Identities = 32/142 (22%), Positives = 58/142 (40%), Gaps = 11/142 (7%)

Query: 94  NLISRGGFGSIYKARIQD---GMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIK 148
             +  G FG++ K   Q       V VK    +         L  E N+M+ + +  +++
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 149 IISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH 208
           +I  C  + +  L++E    G L K L   N  +     + ++  V+  ++YL   +   
Sbjct: 73  MIGICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESN--- 127

Query: 209 VIIHCDLKSSNVLLDDNMVAHF 230
             +H DL + NVLL     A  
Sbjct: 128 -FVHRDLAARNVLLVTQHYAKI 148

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 89.0 bits (220), Expect = 2e-21
 Identities = 30/145 (20%), Positives = 57/145 (39%), Gaps = 12/145 (8%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNL------QYGGAFKNLDVECNMMKIIRH 143
            V  +I RGGFG +Y  R    G    +K  +       Q      N  +  +++     
Sbjct: 7   SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66

Query: 144 QNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHF 203
             ++ +  +    D  + IL+ M  G L   LS      +         ++   +E++H 
Sbjct: 67  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE-ADMRFYAAEIILGLEHMH- 124

Query: 204 GHSTHVIIHCDLKSSNVLLDDNMVA 228
                 +++ DLK +N+LLD++   
Sbjct: 125 ---NRFVVYRDLKPANILLDEHGHV 146

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.5 bits (216), Expect = 2e-21
 Identities = 33/148 (22%), Positives = 51/148 (34%), Gaps = 12/148 (8%)

Query: 90  LEVFNLISRGGFGSIYKARI----QDGMEVVVKGFNLQY---GGAFKNLDVECNMMKIIR 142
           L +   +  G FG + +          + V VK           A  +   E N M  + 
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69

Query: 143 HQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLH 202
           H+NLI++         K ++ E  P GSL   L                + VA  + YL 
Sbjct: 70  HRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128

Query: 203 FGHSTHVIIHCDLKSSNVLLDDNMVAHF 230
               +   IH DL + N+LL    +   
Sbjct: 129 ----SKRFIHRDLAARNLLLATRDLVKI 152

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.6 bits (216), Expect = 2e-21
 Identities = 35/142 (24%), Positives = 63/142 (44%), Gaps = 10/142 (7%)

Query: 94  NLISRGGFGSIYKARIQDG-----MEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLI 147
            +I  G FG +YK  ++       + V +K     Y      +   E  +M    H N+I
Sbjct: 13  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72

Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           ++    SK     +I EYM +G+L K L   +      Q + ++  +A+ ++YL      
Sbjct: 73  RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA----N 128

Query: 208 HVIIHCDLKSSNVLLDDNMVAH 229
              +H DL + N+L++ N+V  
Sbjct: 129 MNYVHRDLAARNILVNSNLVCK 150

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.8 bits (214), Expect = 8e-21
 Identities = 28/144 (19%), Positives = 56/144 (38%), Gaps = 11/144 (7%)

Query: 91  EVFNLISRGGFGSIYKARIQD-----GMEVVVKGFNL-QYGGAFKNLDVECNMMKIIRHQ 144
           +   ++  G FG++YK           + V +K         A K +  E  +M  + + 
Sbjct: 12  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 71

Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           ++ +++  C     + LI + MP G L   +      +     L+  + +A  + YL   
Sbjct: 72  HVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED- 129

Query: 205 HSTHVIIHCDLKSSNVLLDDNMVA 228
                ++H DL + NVL+      
Sbjct: 130 ---RRLVHRDLAARNVLVKTPQHV 150

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.7 bits (211), Expect = 2e-20
 Identities = 25/158 (15%), Positives = 60/158 (37%), Gaps = 20/158 (12%)

Query: 87  RNFLEVFNLISRGGFGSIYKA------RIQDGMEVVVKGFNLQYG-GAFKNLDVECNMMK 139
           R  + +   + +G FG +Y+       + +    V +K  N             E ++MK
Sbjct: 19  REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMK 78

Query: 140 IIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYI---------LDFFQRLHI 190
                ++++++   S+     +I+E M  G L   L +                 + + +
Sbjct: 79  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138

Query: 191 MIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
             ++A  + YL+     +  +H DL + N ++ ++   
Sbjct: 139 AGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTV 172

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.6 bits (211), Expect = 2e-20
 Identities = 37/171 (21%), Positives = 66/171 (38%), Gaps = 11/171 (6%)

Query: 66  LDLKDLNLSF-NTLEGKIPRPFRNFLEVFNLISRGGFGSIYKARIQD----GMEVVVKGF 120
           +DL  LN      ++  +  P    +    +I RG FG +Y   + D     +   VK  
Sbjct: 4   IDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 63

Query: 121 NLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKA-LILEYMPHGSLGKCLSTS 178
           N     G       E  +MK   H N++ ++  C + +    ++L YM HG L   +   
Sbjct: 64  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 123

Query: 179 NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAH 229
            +       +   + VA  +++L         +H DL + N +LD+     
Sbjct: 124 THNPTVKDLIGFGLQVAKGMKFLASKK----FVHRDLAARNCMLDEKFTVK 170

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 84.4 bits (208), Expect = 3e-20
 Identities = 37/154 (24%), Positives = 62/154 (40%), Gaps = 16/154 (10%)

Query: 86  FRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECN-------- 136
           F    E   ++ RG    + +        E  VK  ++  GG+F   +V+          
Sbjct: 1   FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60

Query: 137 --MMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDV 194
             + K+  H N+I++  +   + F  L+ + M  G L   L+     L   +   IM  +
Sbjct: 61  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRAL 119

Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
              +  LH       I+H DLK  N+LLDD+M  
Sbjct: 120 LEVICALH----KLNIVHRDLKPENILLDDDMNI 149

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 84.8 bits (209), Expect = 4e-20
 Identities = 33/143 (23%), Positives = 59/143 (41%), Gaps = 9/143 (6%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLD---VECNMMKIIRHQNL 146
           ++   +  G FG ++  R   +G    +K    +     K ++    E  M+ I+ H  +
Sbjct: 7   QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 66

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHS 206
           I++  +        +I++Y+  G L   L   +             +V  A+EYLH    
Sbjct: 67  IRMWGTFQDAQQIFMIMDYIEGGEL-FSLLRKSQRFPNPVAKFYAAEVCLALEYLH---- 121

Query: 207 THVIIHCDLKSSNVLLDDNMVAH 229
           +  II+ DLK  N+LLD N    
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIK 144

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 83.6 bits (206), Expect = 7e-20
 Identities = 24/155 (15%), Positives = 59/155 (38%), Gaps = 13/155 (8%)

Query: 83  PRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYG---GAFKNLDVECNMM 138
           P    +  E+  ++  GG   ++ AR ++   +V VK            +     E    
Sbjct: 2   PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNA 61

Query: 139 KIIRHQNLIKIISSCSKDDFKA----LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDV 194
             + H  ++ +  +   +        +++EY+   +L   + T    +   + + ++ D 
Sbjct: 62  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADA 120

Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAH 229
             A+ + H     + IIH D+K +N+++       
Sbjct: 121 CQALNFSH----QNGIIHRDVKPANIMISATNAVK 151

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.2 bits (202), Expect = 3e-19
 Identities = 35/144 (24%), Positives = 64/144 (44%), Gaps = 11/144 (7%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQY-----GGAFKNLDVECNMMKIIRHQ 144
           E  + +  G F ++YKAR       V +K   L +      G  +    E  +++ + H 
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG 204
           N+I ++ +       +L+ ++M        +  ++ +L        M+     +EYLH  
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH-- 117

Query: 205 HSTHVIIHCDLKSSNVLLDDNMVA 228
              H I+H DLK +N+LLD+N V 
Sbjct: 118 --QHWILHRDLKPNNLLLDENGVL 139

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.4 bits (200), Expect = 5e-19
 Identities = 40/166 (24%), Positives = 66/166 (39%), Gaps = 29/166 (17%)

Query: 87  RNFLEVFNLISRGGFGSIYKAR--------IQDGMEVVVKGFNLQYG-GAFKNLDVECNM 137
           R+ L +   +  G FG +  A              +V VK            +L  E  M
Sbjct: 12  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71

Query: 138 MKII-RHQNLIKIISSCSKDDFKALILEYMPHGSLGKCL---------------STSNYI 181
           MK+I +H+N+I ++ +C++D    +I+EY   G+L + L                     
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 182 LDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           L     +     VA  +EYL     +   IH DL + NVL+ ++ V
Sbjct: 132 LSSKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVLVTEDNV 173

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.9 bits (199), Expect = 6e-19
 Identities = 34/150 (22%), Positives = 56/150 (37%), Gaps = 13/150 (8%)

Query: 85  PFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV------ECNM 137
           P  +  +V  L+  GGFGS+Y    + D + V +K         +  L        E  +
Sbjct: 1   PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVL 60

Query: 138 MKIIR--HQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVA 195
           +K +      +I+++    + D   LILE            T    L           V 
Sbjct: 61  LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVL 120

Query: 196 SAVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
            AV + H       ++H D+K  N+L+D N
Sbjct: 121 EAVRHCH----NCGVLHRDIKDENILIDLN 146

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 81.2 bits (200), Expect = 8e-19
 Identities = 24/144 (16%), Positives = 52/144 (36%), Gaps = 4/144 (2%)

Query: 86  FRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRH 143
            R+  +  +++  G F  +  A   +    V +K    +   G   +++ E  ++  I+H
Sbjct: 7   IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKH 66

Query: 144 QNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHF 203
            N++ +           LI++ +  G L   +    +         ++  V  AV+YLH 
Sbjct: 67  PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHD 125

Query: 204 GHSTHVIIHCDLKSSNVLLDDNMV 227
               H             LD++  
Sbjct: 126 LGIVH-RDLKPENLLYYSLDEDSK 148

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.9 bits (196), Expect = 2e-18
 Identities = 27/143 (18%), Positives = 59/143 (41%), Gaps = 7/143 (4%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNL--QYGGAFKNLDVECNMMKIIRHQNLI 147
           +    I  G +G +YKAR    G  V +K   L  +  G       E +++K + H N++
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64

Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           K++     ++   L+ E++         +++   +        +  +   + + H    +
Sbjct: 65  KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH----S 120

Query: 208 HVIIHCDLKSSNVLLDDNMVAHF 230
           H ++H DLK  N+L++       
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKL 143

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.2 bits (197), Expect = 2e-18
 Identities = 33/158 (20%), Positives = 62/158 (39%), Gaps = 17/158 (10%)

Query: 84  RPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR 142
           RP         +I  G FG +Y+A+    G  V +K          +  + E  +M+ + 
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLD 71

Query: 143 HQNLIKIISSC------SKDDFKALILEYMPHGSLG--KCLSTSNYILDFFQRLHIMIDV 194
           H N++++            + +  L+L+Y+P       +  S +   L        M  +
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131

Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFLA 232
             ++ Y+H    +  I H D+K  N+LLD +     L 
Sbjct: 132 FRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLC 165

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 79.1 bits (194), Expect = 3e-18
 Identities = 30/136 (22%), Positives = 52/136 (38%), Gaps = 7/136 (5%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
            +   I  G FG IY    I  G EV +K   ++       L +E  + K+++    I  
Sbjct: 10  RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPT 67

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV 209
           I  C  +    +++  +   SL    +  +        L +   + S +EY+H       
Sbjct: 68  IRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS----KN 123

Query: 210 IIHCDLKSSNVLLDDN 225
            IH D+K  N L+   
Sbjct: 124 FIHRDVKPDNFLMGLG 139

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.5 bits (195), Expect = 5e-18
 Identities = 26/142 (18%), Positives = 55/142 (38%), Gaps = 8/142 (5%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFN-LQYGGAFKNLDVECNMMKIIRHQNLIK 148
              + I  G +G +  A    + + V +K  +  ++    +    E  ++   RH+N+I 
Sbjct: 11  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG 70

Query: 149 IISSCSKDDFKALILEYMPHGSLGKCLST--SNYILDFFQRLHIMIDVASAVEYLHFGHS 206
           I         + +   Y+    +G  L        L      + +  +   ++Y+H    
Sbjct: 71  INDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---- 126

Query: 207 THVIIHCDLKSSNVLLDDNMVA 228
           +  ++H DLK SN+LL+     
Sbjct: 127 SANVLHRDLKPSNLLLNTTCDL 148

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 78.4 bits (192), Expect = 5e-18
 Identities = 29/141 (20%), Positives = 56/141 (39%), Gaps = 7/141 (4%)

Query: 91  EVFNLISRGGFGSIYKARIQDGMEVVVKGFNL--QYGGAFKNLDVECNMMKIIRHQNLIK 148
                I  G +G +YKA+   G    +K   L  +  G       E +++K ++H N++K
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64

Query: 149 IISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTH 208
           +           L+ E++    L K L      L+       ++ + + + Y H      
Sbjct: 65  LYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR--- 120

Query: 209 VIIHCDLKSSNVLLDDNMVAH 229
            ++H DLK  N+L++      
Sbjct: 121 -VLHRDLKPQNLLINREGELK 140

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.2 bits (192), Expect = 9e-18
 Identities = 20/138 (14%), Positives = 48/138 (34%), Gaps = 14/138 (10%)

Query: 95  LISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSC 153
           ++  G  G + +    +   +  +K          K         +  +  ++++I+   
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQ----DCPKARREVELHWRASQCPHIVRIVDVY 74

Query: 154 ----SKDDFKALILEYMPHGSLGKCL-STSNYILDFFQRLHIMIDVASAVEYLHFGHSTH 208
               +      +++E +  G L   +    +      +   IM  +  A++YLH    + 
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SI 130

Query: 209 VIIHCDLKSSNVLLDDNM 226
            I H D+K  N+L     
Sbjct: 131 NIAHRDVKPENLLYTSKR 148

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.5 bits (190), Expect = 1e-17
 Identities = 33/149 (22%), Positives = 60/149 (40%), Gaps = 12/149 (8%)

Query: 86  FRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQY------GGAFKNLDVECNMM 138
             ++ +    +  G F  + K R    G++   K    +       G + ++++ E +++
Sbjct: 8   VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67

Query: 139 KIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV 198
           K I+H N+I +           LILE +  G L          L   +    +  + + V
Sbjct: 68  KEIQHPNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGV 126

Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
            YLH    +  I H DLK  N++L D  V
Sbjct: 127 YYLH----SLQIAHFDLKPENIMLLDRNV 151

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 76.4 bits (187), Expect = 3e-17
 Identities = 21/140 (15%), Positives = 48/140 (34%), Gaps = 7/140 (5%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
           +V   I  G FG I++   + +  +V +K    +       L  E    K++     I  
Sbjct: 8   KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPN 65

Query: 150 ISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV 209
           +    ++    +++  +   SL   L                  + + V+ +H       
Sbjct: 66  VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH----EKS 121

Query: 210 IIHCDLKSSNVLLDDNMVAH 229
           +++ D+K  N L+      +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKN 141

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.7 bits (188), Expect = 4e-17
 Identities = 23/141 (16%), Positives = 54/141 (38%), Gaps = 10/141 (7%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDV----ECNMMKIIRHQN 145
            +  ++ +G FG ++ A   +      +K           +++     +  +     H  
Sbjct: 5   ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64

Query: 146 LIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGH 205
           L  +  +    +    ++EY+  G L   +  S +  D  +      ++   +++LH   
Sbjct: 65  LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFLHSKG 123

Query: 206 STHVIIHCDLKSSNVLLDDNM 226
               I++ DLK  N+LLD + 
Sbjct: 124 ----IVYRDLKLDNILLDKDG 140

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 76.0 bits (186), Expect = 6e-17
 Identities = 26/143 (18%), Positives = 53/143 (37%), Gaps = 9/143 (6%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLD---VECNMMKIIRHQNL 146
           +    +  G FG +   +  + G    +K  + Q     K ++    E  +++ +    L
Sbjct: 44  DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHS 206
           +K+  S   +    +++EY+  G +   L                  +    EYLH    
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH---- 158

Query: 207 THVIIHCDLKSSNVLLDDNMVAH 229
           +  +I+ DLK  N+L+D      
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQ 181

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.3 bits (184), Expect = 1e-16
 Identities = 34/180 (18%), Positives = 61/180 (33%), Gaps = 31/180 (17%)

Query: 73  LSFNTLEGKIPRPFRNFLEVFNLISRGGFGSIYKAR------IQDGMEVVVKGFNLQYG- 125
           L ++  + + PR   + L++   + RG FG + +A             V VK        
Sbjct: 1   LPYDASKWEFPR---DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH 57

Query: 126 GAFKNLDVECNMMKIIRHQNLIKII--SSCSKDDFKALILEYMPHGSLGKCL-------- 175
              + L  E  ++  I H   +  +  +         +I+E+   G+L   L        
Sbjct: 58  SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 117

Query: 176 -------STSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
                        L     +     VA  +E+L     +   IH DL + N+LL +  V 
Sbjct: 118 PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLSEKNVV 173

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.2 bits (184), Expect = 1e-16
 Identities = 30/140 (21%), Positives = 57/140 (40%), Gaps = 9/140 (6%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGA---FKNLDVECNMMKIIRHQNL 146
           +   L+ +G FG +   R    G    +K    +   A     +   E  +++  RH  L
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67

Query: 147 IKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHS 206
             +  +    D    ++EY   G L   LS    +    +      ++ SA+EYLH    
Sbjct: 68  TALKYAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEERARFYGAEIVSALEYLH---- 122

Query: 207 THVIIHCDLKSSNVLLDDNM 226
           +  +++ D+K  N++LD + 
Sbjct: 123 SRDVVYRDIKLENLMLDKDG 142

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.4 bits (179), Expect = 5e-16
 Identities = 29/149 (19%), Positives = 59/149 (39%), Gaps = 16/149 (10%)

Query: 91  EVFNLISRGGFGSIYKAR--IQDGMEVVVKGFNLQYG--GAFKNLDVECNMMKII---RH 143
           E    I  G +G ++KAR     G  V +K   +Q G  G   +   E  +++ +    H
Sbjct: 10  ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69

Query: 144 QNLIKIISSCSKDDFKA-----LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAV 198
            N++++   C+           L+ E++               +       +M  +   +
Sbjct: 70  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129

Query: 199 EYLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
           ++LH    +H ++H DLK  N+L+  +  
Sbjct: 130 DFLH----SHRVVHRDLKPQNILVTSSGQ 154

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.1 bits (178), Expect = 6e-16
 Identities = 26/140 (18%), Positives = 56/140 (40%), Gaps = 8/140 (5%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLI 147
           E    I  G +G+++KA+  +    V +K   L     G   +   E  ++K ++H+N++
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64

Query: 148 KIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST 207
           ++      D    L+ E+          S +  +         +  +   + + H     
Sbjct: 65  RLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP-EIVKSFLFQLLKGLGFCHS---- 119

Query: 208 HVIIHCDLKSSNVLLDDNMV 227
             ++H DLK  N+L++ N  
Sbjct: 120 RNVLHRDLKPQNLLINRNGE 139

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.2 bits (176), Expect = 1e-15
 Identities = 31/149 (20%), Positives = 65/149 (43%), Gaps = 16/149 (10%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLI 147
           E    I +G FG ++KAR  + G +V +K   ++    G       E  ++++++H+N++
Sbjct: 13  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72

Query: 148 KIISSCSKDDFKA--------LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVE 199
            +I  C               L+ ++  H   G   +         +   +M  + + + 
Sbjct: 73  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLNGLY 131

Query: 200 YLHFGHSTHVIIHCDLKSSNVLLDDNMVA 228
           Y+H       I+H D+K++NVL+  + V 
Sbjct: 132 YIHRNK----ILHRDMKAANVLITRDGVL 156

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.2 bits (176), Expect = 2e-15
 Identities = 27/158 (17%), Positives = 58/158 (36%), Gaps = 10/158 (6%)

Query: 80  GKIPRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECN 136
            K     R        +  G +G++  A   + G +V +K     +      K    E  
Sbjct: 10  TKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR 69

Query: 137 MMKIIRHQNLIKIISSCSKDDFKALILEYMPHGSLGKCLSTS---NYILDFFQRLHIMID 193
           ++K +RH+N+I ++   + D+      ++                +  L   +   ++  
Sbjct: 70  LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 129

Query: 194 VASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL 231
           +   + Y+H       IIH DLK  N+ ++++     L
Sbjct: 130 MLKGLRYIH----AAGIIHRDLKPGNLAVNEDCELKIL 163

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 71.0 bits (173), Expect = 4e-15
 Identities = 29/149 (19%), Positives = 63/149 (42%), Gaps = 15/149 (10%)

Query: 81  KIPRPFRNFLEVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMK 139
            +    ++  ++   + RG +  +++A  I +  +VVVK          K    E  +++
Sbjct: 28  VVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKILE 84

Query: 140 IIR-HQNLIKIISSCSKDDFK--ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVAS 196
            +R   N+I +         +  AL+ E++ +    +   T    L  +     M ++  
Sbjct: 85  NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILK 140

Query: 197 AVEYLHFGHSTHVIIHCDLKSSNVLLDDN 225
           A++Y H    +  I+H D+K  NV++D  
Sbjct: 141 ALDYCH----SMGIMHRDVKPHNVMIDHE 165

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.8 bits (167), Expect = 3e-14
 Identities = 29/143 (20%), Positives = 63/143 (44%), Gaps = 12/143 (8%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLI 147
           +  + +  G +GS+  A   + G+ V VK  +  +      K    E  ++K ++H+N+I
Sbjct: 21  QNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 80

Query: 148 KIISSC----SKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHF 203
            ++       S ++F  + L     G+    +      L       ++  +   ++Y+H 
Sbjct: 81  GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIH- 138

Query: 204 GHSTHVIIHCDLKSSNVLLDDNM 226
              +  IIH DLK SN+ ++++ 
Sbjct: 139 ---SADIIHRDLKPSNLAVNEDC 158

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.9 bits (165), Expect = 4e-14
 Identities = 34/148 (22%), Positives = 57/148 (38%), Gaps = 14/148 (9%)

Query: 91  EVFNLISRGGFGSIYKAR----IQDGMEVVVKGFN----LQYGGAFKNLDVECNMMKIIR 142
           E+  ++  G +G ++  R       G    +K       +Q     ++   E  +++ IR
Sbjct: 27  ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 86

Query: 143 HQ-NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL 201
               L+ +  +   +    LIL+Y+  G L   LS        F    + I V   V  L
Sbjct: 87  QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLAL 142

Query: 202 HFGHSTHVIIHCDLKSSNVLLDDNMVAH 229
              H    II+ D+K  N+LLD N    
Sbjct: 143 EHLHKLG-IIYRDIKLENILLDSNGHVV 169

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 63.5 bits (153), Expect = 2e-12
 Identities = 23/158 (14%), Positives = 52/158 (32%), Gaps = 20/158 (12%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKI 149
            +   +  G F +++ A+ + +   V +K          +  + E  +++ +   +  K 
Sbjct: 16  ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKE 74

Query: 150 ISSCSKDDFK---------------ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDV 194
            S  +    K                ++ E +    L       +  +       I   +
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 195 ASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFLA 232
              ++Y+H       IIH D+K  NVL++       L 
Sbjct: 135 LLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI 169

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.0 bits (152), Expect = 2e-12
 Identities = 29/150 (19%), Positives = 57/150 (38%), Gaps = 17/150 (11%)

Query: 91  EVFNLISRGGFGSIYKAR-IQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLI 147
           +    I  G  G +  A        V +K  +  +      K    E  +MK + H+N+I
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79

Query: 148 KIISSCSKDDFK------ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYL 201
            +++  +            L++E M               LD  +  +++  +   +++L
Sbjct: 80  SLLNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSYLLYQMLCGIKHL 135

Query: 202 HFGHSTHVIIHCDLKSSNVLLDDNMVAHFL 231
           H    +  IIH DLK SN+++  +     L
Sbjct: 136 H----SAGIIHRDLKPSNIVVKSDCTLKIL 161

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 60.2 bits (145), Expect = 7e-12
 Identities = 20/148 (13%), Positives = 44/148 (29%), Gaps = 26/148 (17%)

Query: 94  NLISRGGFGSIYKARIQDGMEVVVKGFNL----------QYGGAFKNLDVECNMMKIIRH 143
            L+  G   +++    +   E VVK   +          +      +  V          
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 144 QNLIKIISSCSKDDF----KALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVE 199
           + L K+        +     A+++E +    L +                ++  +   V 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEVA 117

Query: 200 YLHFGHSTHVIIHCDLKSSNVLLDDNMV 227
             +       I+H DL   NVL+ +  +
Sbjct: 118 KFY----HRGIVHGDLSQYNVLVSEEGI 141

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 50.5 bits (119), Expect = 4e-08
 Identities = 17/61 (27%), Positives = 24/61 (39%), Gaps = 1/61 (1%)

Query: 25  IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPR 84
           +  NR+  +L   +  L  L SL++S NN  G IP     L        + N      P 
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPL 309

Query: 85  P 85
           P
Sbjct: 310 P 310

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 44.0 bits (102), Expect = 7e-06
 Identities = 18/36 (50%), Positives = 22/36 (61%)

Query: 48  DLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIP 83
           DL NN   G +P  L +L  L  LN+SFN L G+IP
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 38.2 bits (87), Expect = 5e-04
 Identities = 13/61 (21%), Positives = 21/61 (34%), Gaps = 14/61 (22%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPI 60
           ++ LK L  +++S NN     P                G+L        +NN      P+
Sbjct: 264 LTQLKFLHSLNVSFNNLCGEIP--------------QGGNLQRFDVSAYANNKCLCGSPL 309

Query: 61  P 61
           P
Sbjct: 310 P 310

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.2 bits (103), Expect = 5e-06
 Identities = 23/85 (27%), Positives = 37/85 (43%), Gaps = 13/85 (15%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTT---------IEYNRLQDSLRNSIGDLTSLKSLDLSN 51
           +SNLK L  + L  NN S + P +            N++ D   +S+ +LT++  L   +
Sbjct: 303 ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSDV--SSLANLTNINWLSAGH 360

Query: 52  NNFSGAIPIPLEKLLDLKDLNLSFN 76
           N  S     PL  L  +  L L+  
Sbjct: 361 NQISD--LTPLANLTRITQLGLNDQ 383

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 2e-04
 Identities = 19/96 (19%), Positives = 33/96 (34%), Gaps = 14/96 (14%)

Query: 1   MSNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPI 60
                VL  + L+  + S              SL  ++    SL+ LDLSNN    A  +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSC---------SSLAATLLANHSLRELDLSNNCLGDAGIL 415

Query: 61  PLEKLLD-----LKDLNLSFNTLEGKIPRPFRNFLE 91
            L + +      L+ L L       ++    +   +
Sbjct: 416 QLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.6 bits (90), Expect = 2e-04
 Identities = 13/93 (13%), Positives = 25/93 (26%), Gaps = 16/93 (17%)

Query: 7  LLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLL 66
          +  +D+     S                   +  L   + + L +   + A    +   L
Sbjct: 4  IQSLDIQCEELS------------DARWAELLPLLQQCQVVRLDDCGLTEARCKDISSAL 51

Query: 67 ----DLKDLNLSFNTLEGKIPRPFRNFLEVFNL 95
               L +LNL  N L           L+  + 
Sbjct: 52 RVNPALAELNLRSNELGDVGVHCVLQGLQTPSC 84

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 37.7 bits (86), Expect = 7e-04
 Identities = 28/165 (16%), Positives = 57/165 (34%), Gaps = 1/165 (0%)

Query: 25  IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPR 84
           ++ N++ +       +L +L +L L NN  S   P     L+ L+ L LS N L+  +P 
Sbjct: 38  LQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPE 96

Query: 85  PFRNFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQ 144
                L+   +                   +VV+        +         M K+   +
Sbjct: 97  KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 156

Query: 145 NLIKIISSCSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLH 189
                I++  +    +L   ++    + K  + S   L+   +L 
Sbjct: 157 IADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 201

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 37.3 bits (85), Expect = 0.001
 Identities = 12/47 (25%), Positives = 16/47 (34%)

Query: 42 TSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPRPFRN 88
               LDL NN  +       + L +L  L L  N +    P  F  
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAP 77

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 36.9 bits (84), Expect = 0.001
 Identities = 12/49 (24%), Positives = 22/49 (44%), Gaps = 4/49 (8%)

Query: 26  EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLS 74
           + N++ D   + +  L +L  + L NN  S     PL    +L  + L+
Sbjct: 181 DDNKISDI--SPLASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLT 225

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 34.9 bits (78), Expect = 0.004
 Identities = 7/39 (17%), Positives = 12/39 (30%)

Query: 36  NSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLS 74
           +     +    LD+S           LE L  L+  +  
Sbjct: 195 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	232
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.98
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.98
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.98
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.97
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.97
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.97
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.97
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.97
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.97
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.97
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.97
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.97
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.97
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.97
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.97
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.97
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.97
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.97
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.97
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.97
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.96
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.96
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.96
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.96
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.96
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.96
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.96
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.96
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.96
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.96
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.96
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.96
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.96
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.95
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.95
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.94
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.86
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.18
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.16
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.04
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.03
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	98.88
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	98.79
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	98.73
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	98.71
d2ifga3	156	High affinity nerve growth factor receptor, N-term	98.69
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	98.68
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	98.65
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.61
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.58
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	98.56
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.39
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	98.28
d2ifga3	156	High affinity nerve growth factor receptor, N-term	98.27
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.26
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.21
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.06
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	98.0
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	97.98
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	97.92
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.86
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.81
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.81
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	97.81
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	97.78
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	97.73
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	97.64
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	97.63
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	97.56
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.42
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	97.38
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	96.88
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.79
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	96.78
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	96.54
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	96.52
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.15
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	95.81
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	95.8
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	95.77
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	95.26
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	93.91
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	93.79
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	91.17
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	90.05

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-36  Score=235.70  Aligned_cols=141  Identities=21%  Similarity=0.355  Sum_probs=129.6

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      .+.|++.+.||+|+||.||+|+.. +++.||+|++........+.+.+|+++++.++|||||++++++.+++..++||||
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            356889999999999999999764 6899999999877666778889999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |++|+|.+++......+++..+..++.|++.||.|||    .++|+||||||+|||++.++.+||+
T Consensus        91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH----~~~ivHrDiKp~NIll~~~~~~Kl~  152 (288)
T d2jfla1          91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH----DNKIIHRDLKAGNILFTLDGDIKLA  152 (288)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCEEEeecChhheeECCCCCEEEE
Confidence            9999999998765556899999999999999999999    8899999999999999999999986

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-35  Score=230.65  Aligned_cols=141  Identities=22%  Similarity=0.306  Sum_probs=124.7

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      |.+.|++.+.||+|+||.||+|+.+ +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm   82 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   82 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence            4567899999999999999999764 78999999997553 233456889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||++|+|.+++... ..+++..+..++.|++.||.|||    .++|+||||||+|||+++++.+||+
T Consensus        83 Ey~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH----~~~IiHrDiKp~NILl~~~~~~KL~  145 (271)
T d1nvra_          83 EYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLH----GIGITHRDIKPENLLLDERDNLKIS  145 (271)
T ss_dssp             ECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECTTCCEEEC
T ss_pred             eccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH----HcCCccCcccHHHEEECCCCCEEEc
Confidence            999999999999764 35899999999999999999999    8899999999999999999999986

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-35  Score=231.06  Aligned_cols=138  Identities=26%  Similarity=0.365  Sum_probs=127.3

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      +.|++.+.||+|+||.||+|+. .+|+.||+|++........+.+.+|+.+++.++|||||++++++.+++..|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4588899999999999999975 479999999998776666788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|+|.+++...  .+++..+..++.|++.||.|||    .++|+||||||+|||++.++.+||+
T Consensus       100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH----~~~iiHrDiKp~NILl~~~~~vkl~  158 (293)
T d1yhwa1         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH----SNQVIHRDIKSDNILLGMDGSVKLT  158 (293)
T ss_dssp             TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEEC
T ss_pred             CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH----HCCCcccCCcHHHeEECCCCcEeec
Confidence            999999988754  4899999999999999999999    8899999999999999999999986

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-35  Score=228.33  Aligned_cols=138  Identities=24%  Similarity=0.354  Sum_probs=126.8

Q ss_pred             cceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           89 FLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      .|++.+.||+|+||.||+|++.+++.||||++.... ...+.+.+|+++++.++||||+++++++..++..++|||||++
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~   84 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH   84 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence            467889999999999999999888899999987543 3347789999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+|.+++......+++..+..++.|++.||.|+|    .++|+||||||+|||++.++.+||+
T Consensus        85 g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH----~~~iiHrDlKp~Nill~~~~~~Kl~  143 (263)
T d1sm2a_          85 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE----EACVIHRDLAARNCLVGENQVIKVS  143 (263)
T ss_dssp             CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCTTCSGGGEEECGGGCEEEC
T ss_pred             CcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh----ccceeecccchhheeecCCCCeEec
Confidence            9999998877667899999999999999999999    8899999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.6e-34  Score=231.38  Aligned_cols=142  Identities=20%  Similarity=0.363  Sum_probs=128.1

Q ss_pred             ccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      +.+.|++.+.||+|+||.||+|+. .+|+.||+|++........+.+.+|+.+++.++|||||++++++.+++..|+|||
T Consensus        27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            446689999999999999999975 4799999999976654555678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeC--CCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD--DNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~--~~~~~~l~  231 (232)
                      ||++|+|.+++......+++..+..++.|++.||.|||    .++|+||||||+|||++  .++.+||+
T Consensus       107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH----~~~iiHRDiKp~NILl~~~~~~~vkL~  171 (352)
T d1koba_         107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH----EHSIVHLDIKPENIMCETKKASSVKII  171 (352)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSTTCCCEEEC
T ss_pred             cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HCCeeecccccccccccccCCCeEEEe
Confidence            99999999988776667999999999999999999999    88999999999999998  56788875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.5e-34  Score=227.55  Aligned_cols=139  Identities=24%  Similarity=0.386  Sum_probs=125.1

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEecc
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYM  166 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  166 (232)
                      +.|++.+.||+|+||.||+|++. +++.||||++.... ...+.+.+|+.+++.++|||||++++++.+++..++|||||
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~   95 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   95 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence            35678899999999999999875 58899999986543 34577999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|+|.+++... ...+++..+..++.|++.||.|||    .++|+||||||+|||++.++.+||+
T Consensus        96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH----~~~iiHrDlKp~NILl~~~~~~Kl~  157 (287)
T d1opja_          96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE----KKNFIHRDLAARNCLVGENHLVKVA  157 (287)
T ss_dssp             TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred             cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH----HCCcccCccccCeEEECCCCcEEEc
Confidence            999999998653 456899999999999999999999    8899999999999999999999986

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-34  Score=223.43  Aligned_cols=139  Identities=24%  Similarity=0.370  Sum_probs=125.3

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecc---cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQ---YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      +.|++.+.||+|+||.||+|+.+ +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            45788999999999999999765 6889999998653   2344567889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||++|+|.+++.... .+++..+..++.|++.||.|||    +++|+||||||+|||++.++.+||+
T Consensus        86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH----~~~ivHrDiKp~Nill~~~~~~kl~  148 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH----SKRVIHRDIKPENLLLGSAGELKIA  148 (263)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred             eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH----HCCeeeeeeccccceecCCCCEeec
Confidence            9999999999987643 5899999999999999999999    8899999999999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.4e-34  Score=226.88  Aligned_cols=140  Identities=23%  Similarity=0.416  Sum_probs=123.6

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CC---cEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DG---MEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      +.+++.+.||+|+||.||+|+.+ ++   ..||||.+.... ....+.+.+|+++++.++|||||++++++..++..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            45778899999999999999864 33   258888875543 33456789999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||++|+|.+++......+++..+..++.|+++||.|||    .++|+||||||+|||++.++.+||+
T Consensus       106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH----~~~iiHrDlKp~NILl~~~~~~Kl~  170 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA----DMNYVHRDLAARNILVNSNLVCKVS  170 (299)
T ss_dssp             EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred             EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh----hCCCccCccccceEEECCCCcEEEC
Confidence            9999999999998876667999999999999999999999    8899999999999999999999986

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-34  Score=229.20  Aligned_cols=140  Identities=19%  Similarity=0.255  Sum_probs=125.6

Q ss_pred             cccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .+.|++.+.||+|+||.||+|+. .+|+.||+|++.... ....+.+.+|+.+++.++|||||++++++.+++..|+|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            35578899999999999999976 478999999997653 3445678899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-CCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHST-HVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~-~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||++|+|.+++...+ .+++..+..++.|++.||.|||    . ++|+||||||+|||++.++.+||+
T Consensus        85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH----~~~~IiHRDiKP~NILl~~~~~vkl~  147 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR----EKHKIMHRDVKPSNILVNSRGEIKLC  147 (322)
T ss_dssp             CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HHHCCCCSCCSGGGEEECTTCCEEEC
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH----HhCCEEccccCHHHeeECCCCCEEEe
Confidence            999999999997643 4899999999999999999999    5 489999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.2e-33  Score=229.32  Aligned_cols=141  Identities=17%  Similarity=0.292  Sum_probs=127.1

Q ss_pred             cccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      .+.|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+++.++|||||++++++.+++..|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            35688999999999999999976 47899999999766555567789999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC--CCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD--NMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~--~~~~~l~  231 (232)
                      |++|+|.+++......+++..+..++.|++.||.|||    .++|+||||||+|||++.  ++.+||+
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH----~~~iiHrDiKp~NIll~~~~~~~vkL~  168 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH----ENNYVHLDLKPENIMFTTKRSNELKLI  168 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSTTSCCEEEC
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH----hcCCeeeeechhHeeeccCCCCeEEEe
Confidence            9999999999766556999999999999999999999    889999999999999964  5778875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-34  Score=222.62  Aligned_cols=138  Identities=24%  Similarity=0.411  Sum_probs=122.5

Q ss_pred             ccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccC
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      +.|++.+.||+|+||.||+|++++++.||||++.... ...+.+.+|+.+++.++|||||++++++.. +..++||||++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~   90 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence            4577889999999999999999888899999987543 345779999999999999999999998754 56799999999


Q ss_pred             CCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|+|.+++... ...+++..+..++.|+++||.|||    .++|+||||||+|||+++++.+||+
T Consensus        91 ~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH----~~~ivHrDiKp~NIll~~~~~~Kl~  151 (272)
T d1qpca_          91 NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE----ERNYIHRDLRAANILVSDTLSCKIA  151 (272)
T ss_dssp             TCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEEC
T ss_pred             CCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH----hCCcccCccchhheeeecccceeec
Confidence            99999987654 224899999999999999999999    8899999999999999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-33  Score=219.92  Aligned_cols=138  Identities=25%  Similarity=0.354  Sum_probs=126.0

Q ss_pred             cceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           89 FLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      .+++.+.||+|+||.||+|++++++.||||.+..... ..+.+.+|+.+++.++||||+++++++.+++..++||||+++
T Consensus         5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~   83 (258)
T d1k2pa_           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN   83 (258)
T ss_dssp             CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred             HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence            3567889999999999999998888999999976543 347789999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |++.+++......+++..+.+++.|+++||.|||    ..+|+||||||+||++++++.+||+
T Consensus        84 g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH----~~~iiH~dlk~~Nill~~~~~~kl~  142 (258)
T d1k2pa_          84 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE----SKQFLHRDLAARNCLVNDQGVVKVS  142 (258)
T ss_dssp             EEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH----HTTBCCSCCSGGGEEECTTCCEEEC
T ss_pred             CcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh----hcCcccccccceeEEEcCCCcEEEC
Confidence            9999998776666889999999999999999999    8899999999999999999999986

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-34  Score=223.04  Aligned_cols=137  Identities=24%  Similarity=0.409  Sum_probs=121.3

Q ss_pred             ccceeeecccCCCcceeeeEEeCCCcEEEEEEeecc--cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQ--YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      +.|++.+.||+|+||.||+|+++  ..||||++...  .....+.+.+|+.+++.++|||||++++++. ++..++||||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey   84 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQW   84 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEec
Confidence            34677899999999999999865  35999998654  3445678999999999999999999999875 4568999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |++|+|.+++......+++..+..++.|+++||.|||    +++|+||||||+|||++.++.+||+
T Consensus        85 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH----~~~ivHrDlKp~NiLl~~~~~~Kl~  146 (276)
T d1uwha_          85 CEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH----AKSIIHRDLKSNNIFLHEDLTVKIG  146 (276)
T ss_dssp             CCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEETTSSEEEC
T ss_pred             CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh----cCCEeccccCHHHEEEcCCCCEEEc
Confidence            9999999999776667999999999999999999999    8899999999999999999999986

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-33  Score=223.26  Aligned_cols=139  Identities=24%  Similarity=0.322  Sum_probs=125.7

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecc---cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQ---YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      +.|++.+.||+|+||.||+|+. .+++.||||++...   .....+.+.+|+++++.++||||+++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            4588999999999999999976 47899999999754   2344577899999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||++|+|.+++...+ .+++..+..++.|++.||.|+|    .++|+||||||+|||+++++.+||+
T Consensus        88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH----~~~iiHrDiKp~NIll~~~~~vkl~  150 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH----GKGIIHRDLKPENILLNEDMHIQIT  150 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTSCEEEC
T ss_pred             EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc----cccEEcCcCCccccccCCCceEEec
Confidence            9999999999887643 5899999999999999999999    8899999999999999999999986

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-33  Score=224.17  Aligned_cols=139  Identities=21%  Similarity=0.325  Sum_probs=123.7

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCc---hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGG---AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      ..|+..+.||+|+||.||+|+. .+++.||||++......   ..+.+.+|+.+++.++|||||++++++.+++..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            3578889999999999999975 47889999999765432   3456889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||++|++..++... ..+++..+..++.|++.||.|||    .++|+||||||+|||++.++.+||+
T Consensus        95 E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH----~~~iiHrDiKp~NILl~~~~~~Kl~  157 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH----SHNMIHRDVKAGNILLSEPGLVKLG  157 (309)
T ss_dssp             ECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCSGGGEEEETTTEEEEC
T ss_pred             EecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH----hCCEeccCCCcceEEECCCCCEEEe
Confidence            999999997766544 35899999999999999999999    8899999999999999999999986

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-33  Score=221.18  Aligned_cols=144  Identities=24%  Similarity=0.346  Sum_probs=115.3

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEec--CCeeEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSK--DDFKALI  162 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~lv  162 (232)
                      +.|++.+.||+|+||.||+|+. .+|+.||+|.+.....  ...+.+.+|+++++.++|||||++++++.+  .+.+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            4588999999999999999976 4789999999876532  235668899999999999999999999865  4568999


Q ss_pred             EeccCCCChhhhhccC---CCCCCHHHHHHHHHHHHHHHHHHhcCC-CCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTS---NYILDFFQRLHIMIDVASAVEYLHFGH-STHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~-~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||++|+|.+++...   ...+++..++.++.|++.||.|||+.+ ...+|+||||||+|||++.++.+||+
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~  156 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG  156 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEEC
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEe
Confidence            9999999999998642   346899999999999999999999321 12359999999999999999999986

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-33  Score=223.31  Aligned_cols=141  Identities=18%  Similarity=0.282  Sum_probs=124.7

Q ss_pred             ccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      +.+.|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+++++.++||||+++++++.+++..|+|||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            4456889999999999999999764 68899999997543 234567899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC--ceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM--VAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~--~~~l~  231 (232)
                      ||+||+|.+++...+..+++..+..++.|++.||.|||    ..+|+||||||+|||++.++  .+||+
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH----~~~iiHrDlKp~NIll~~~~~~~ikl~  146 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH----SHNIGHFDIRPENIIYQTRRSSTIKII  146 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEESSSSCCCEEEC
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH----HcCCCcccccccceeecCCCceEEEEc
Confidence            99999999999876667899999999999999999999    88999999999999998654  56664

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.9e-33  Score=221.51  Aligned_cols=142  Identities=20%  Similarity=0.297  Sum_probs=121.4

Q ss_pred             cccccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           85 PFRNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        85 ~~~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .+.+.|++.+.||+|+||.||+|+.+ +++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus         6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            35677899999999999999999764 68999999997553 22345677899999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeC---CCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD---DNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~---~~~~~~l~  231 (232)
                      ||||+||+|.+++...+ .+++..+..++.|++.||.|||    .++|+||||||+|||+.   +++.+||+
T Consensus        86 mE~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH----~~~iiHrDiKp~Nil~~~~~~~~~vkl~  152 (307)
T d1a06a_          86 MQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH----DLGIVHRDLKPENLLYYSLDEDSKIMIS  152 (307)
T ss_dssp             ECCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEESSSSTTCCEEEC
T ss_pred             EeccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh----hceeeeEEecccceeecccCCCceEEEe
Confidence            99999999999997643 5899999999999999999999    88999999999999994   57888875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-33  Score=219.94  Aligned_cols=141  Identities=23%  Similarity=0.339  Sum_probs=125.4

Q ss_pred             ccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC------chHHHHHHHHHHhcCCCCCCccceeEEEecCCe
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG------GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDF  158 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  158 (232)
                      +.+.|++.+.||+|+||.||+|+. .+|+.||||++.....      ...+.+.+|+.+++.++|||||++++++.+++.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            456789999999999999999986 4789999999965421      235778999999999999999999999999999


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCc----eeec
Q 042107          159 KALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV----AHFL  231 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~----~~l~  231 (232)
                      .|+|||||++|+|.+++.... .+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.    +|++
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH----~~~ivHrDiKp~Nill~~~~~~~~~vkl~  159 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH----SLQIAHFDLKPENIMLLDRNVPKPRIKII  159 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred             EEEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh----hcceeecccccceEEEecCCCcccceEec
Confidence            999999999999999997643 5899999999999999999999    889999999999999998774    6664

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-33  Score=224.15  Aligned_cols=139  Identities=22%  Similarity=0.295  Sum_probs=125.9

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecc---cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQ---YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      +.|++.+.||+|+||.||+|+. .+++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            4578899999999999999976 57999999999754   2344677889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||++|+|.+++.... .+++..++.++.|++.||.|+|    +++|+||||||+|||++.+|.+||+
T Consensus        85 ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH----~~~iiHRDlKP~NILl~~~g~vkl~  147 (337)
T d1o6la_          85 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH----SRDVVYRDIKLENLMLDKDGHIKIT  147 (337)
T ss_dssp             ECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred             eccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhh----hcCccccccCHHHeEecCCCCEEEe
Confidence            9999999999988654 5888899999999999999999    8899999999999999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-33  Score=219.85  Aligned_cols=138  Identities=20%  Similarity=0.327  Sum_probs=119.9

Q ss_pred             cceeee-cccCCCcceeeeEEeC---CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           89 FLEVFN-LISRGGFGSIYKARIQ---DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        89 ~~~~~~-~lg~g~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      .+.+.+ +||+|+||.||+|.++   ++..||||.+.... ....+.+.+|+++++.++|||||++++++.+ +..|+||
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvm   87 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM   87 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEE
Confidence            344556 4999999999999754   35579999986543 3345778999999999999999999999875 4578999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||++|+|.+++......+++..+..++.|++.||.|||    +++|+||||||+|||++.++.+||+
T Consensus        88 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH----~~~iiHrDlKp~Nill~~~~~~Kl~  151 (285)
T d1u59a_          88 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE----EKNFVHRDLAARNVLLVNRHYAKIS  151 (285)
T ss_dssp             ECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEEETTEEEEC
T ss_pred             EeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH----hCCeecCcCchhheeeccCCceeec
Confidence            999999999998776667999999999999999999999    8899999999999999999999986

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-33  Score=216.76  Aligned_cols=138  Identities=23%  Similarity=0.337  Sum_probs=119.3

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEec----CCeeEE
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSK----DDFKAL  161 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~l  161 (232)
                      ++++.+.||+|+||.||+|+.. +++.||+|.+....  ....+.+.+|+++++.++|||||++++++.+    +..+|+
T Consensus        10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            4567788999999999999764 68899999987653  2345678899999999999999999999865    346799


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCC--eeeCCCCCCceeeC-CCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHV--IIHCDLKSSNVLLD-DNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~--iiHrdlk~~Nill~-~~~~~~l~  231 (232)
                      |||||++|+|.+++.... .+++..+..++.|+++||.|||    .++  |+||||||+|||++ +++.+||+
T Consensus        90 vmE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH----~~~~~IiHrDiKp~NILl~~~~~~~Kl~  157 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH----TRTPPIIHRDLKCDNIFITGPTGSVKIG  157 (270)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----TSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred             EEeCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH----HCCCCEEeCCcChhhceeeCCCCCEEEe
Confidence            999999999999997643 5889999999999999999999    666  99999999999996 57899986

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-32  Score=220.53  Aligned_cols=139  Identities=24%  Similarity=0.316  Sum_probs=125.0

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecc---cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQ---YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      +.|++.+.||+|+||.||+|+. .+|+.||||++...   .....+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            3478999999999999999986 46999999999754   2344677889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+||++.+++.... .+++..+..++.|++.||.|||    .++|+||||||+|||++.+|.+||+
T Consensus        84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH----~~~iiHrDiKp~NILl~~~g~vkL~  146 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH----SKDIIYRDLKPENILLDKNGHIKIT  146 (316)
T ss_dssp             CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             eecCCccccccccccc-cccccHHHHHHHHHHHhhhhhc----cCcEEccccCchheeEcCCCCEEEe
Confidence            9999999999887654 4788888899999999999999    8899999999999999999999986

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.6e-33  Score=218.17  Aligned_cols=141  Identities=25%  Similarity=0.334  Sum_probs=125.7

Q ss_pred             ccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCc---------hHHHHHHHHHHhcCCC-CCCccceeEEEe
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGG---------AFKNLDVECNMMKIIR-HQNLIKIISSCS  154 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~-h~niv~~~~~~~  154 (232)
                      |.+.|++.+.||+|+||.||+|+. .+++.||||++......         ..+.+.+|+.+++.++ ||||+++++++.
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~   80 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   80 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence            346688999999999999999976 47899999999765321         1245778999999997 999999999999


Q ss_pred             cCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          155 KDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       155 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++..|+|||||++|+|.+++.... .+++..+..++.|+++||.|||    .++|+||||||+|||++.++.+||+
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH----~~~ivHrDlkp~Nill~~~~~~kl~  152 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH----KLNIVHRDLKPENILLDDDMNIKLT  152 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             cCcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH----HcCCcccccccceEEEcCCCCeEEc
Confidence            9999999999999999999997644 5899999999999999999999    8899999999999999999999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.98  E-value=1e-32  Score=217.35  Aligned_cols=144  Identities=17%  Similarity=0.319  Sum_probs=126.0

Q ss_pred             CCcccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC---chHHHHHHHHHHhcCCCCCCccceeEEEecCC-
Q 042107           83 PRPFRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG---GAFKNLDVECNMMKIIRHQNLIKIISSCSKDD-  157 (232)
Q Consensus        83 p~~~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-  157 (232)
                      |..+.+.|++.+.||+|+||.||+|+. .+++.||+|++.....   ...+.+.+|+++++.++||||+++++++..++ 
T Consensus         2 p~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~   81 (277)
T d1o6ya_           2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   81 (277)
T ss_dssp             CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred             CcCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence            566778899999999999999999975 5799999999975432   23456889999999999999999999987643 


Q ss_pred             ---eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          158 ---FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       158 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                         ..|+|||||+|++|.+++...+ .+++..+..++.|++.||.|||    .++|+||||||+|||++.++..+++
T Consensus        82 ~~~~~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH----~~~iiHrDiKP~NIll~~~~~~~l~  153 (277)
T d1o6ya_          82 AGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH----QNGIIHRDVKPANIMISATNAVKVM  153 (277)
T ss_dssp             SSEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTSCEEEC
T ss_pred             CCceEEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH----hCCccCccccCcccccCccccceee
Confidence               4789999999999999887643 5899999999999999999999    8899999999999999999988875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.1e-32  Score=217.76  Aligned_cols=138  Identities=23%  Similarity=0.376  Sum_probs=123.0

Q ss_pred             ccceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccC
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMP  167 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  167 (232)
                      +.+++.+.||+|+||.||+|+.++++.||||++.... ...+.+.+|+.+++.++|||||++++++.. +..++|||||+
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            4578999999999999999998888889999986543 345779999999999999999999999854 56799999999


Q ss_pred             CCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|++..++... ...+++..++.++.|++.||.|||    ..+|+||||||+|||++.++++||+
T Consensus        95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH----~~~ivH~DlKp~NIll~~~~~~kl~  155 (285)
T d1fmka3          95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE----RMNYVHRDLRAANILVGENLVCKVA  155 (285)
T ss_dssp             TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred             CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh----hhheecccccceEEEECCCCcEEEc
Confidence            99999887653 335899999999999999999999    8899999999999999999999986

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=2.1e-32  Score=216.21  Aligned_cols=139  Identities=25%  Similarity=0.420  Sum_probs=122.8

Q ss_pred             cceeeecccCCCcceeeeEEeCCC-----cEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           89 FLEVFNLISRGGFGSIYKARIQDG-----MEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      .++..++||+|+||.||+|.++..     ..||||.+..... .....+.+|+.+++.++|||||++++++...+..++|
T Consensus         8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v   87 (283)
T d1mqba_           8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMII   87 (283)
T ss_dssp             TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEE
Confidence            356788999999999999976532     4699999865432 2345688999999999999999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||.++++.+++......+++..+..++.|++.||.|||    .++|+||||||+|||++.++.+||+
T Consensus        88 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH----~~~iiHrDlKp~NILl~~~~~~Kl~  152 (283)
T d1mqba_          88 TEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA----NMNYVHRDLAARNILVNSNLVCKVS  152 (283)
T ss_dssp             EECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred             EEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc----ccccccCccccceEEECCCCeEEEc
Confidence            9999999999988776667999999999999999999999    8899999999999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5e-32  Score=215.55  Aligned_cols=140  Identities=19%  Similarity=0.315  Sum_probs=119.8

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      +.|++.+.||+|+||.||+|+. .+++.||+|++....  ....+.+.+|+++++.++|||||++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            4578899999999999999975 578999999995443  2235778899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+.++.+..........+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+||+
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH----~~~IiHrDiKpeNIl~~~~~~~kl~  144 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH----SHRVLHRDLKPQNLLINTEGAIKLA  144 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh----cCCEEccccCchheeecccCcceec
Confidence            99765444443444556899999999999999999999    8899999999999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.3e-32  Score=214.24  Aligned_cols=132  Identities=23%  Similarity=0.327  Sum_probs=114.5

Q ss_pred             ecccCCCcceeeeEEeC---CCcEEEEEEeecc--cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEeccCC
Q 042107           94 NLISRGGFGSIYKARIQ---DGMEVVVKGFNLQ--YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEYMPH  168 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  168 (232)
                      ++||+|+||.||+|.++   +++.||||++...  +....+.+.+|+.+++.++|||||++++++..+ ..++|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            46999999999999754   3568999998543  233456789999999999999999999999754 56899999999


Q ss_pred             CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          169 GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       169 g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |+|.+++.... .+++..+..++.|++.||.|||    .++|+||||||+|||++.++.+||+
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH----~~~iiHrDlKp~Nill~~~~~~kl~  149 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE----ESNFVHRDLAARNVLLVTQHYAKIS  149 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEEETTEEEEC
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH----hCCcccCCCcchhhcccccCccccc
Confidence            99999987653 5899999999999999999999    8899999999999999999999986

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=9.2e-32  Score=218.17  Aligned_cols=139  Identities=18%  Similarity=0.247  Sum_probs=126.0

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecc---cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQ---YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      +.|++.+.||+|+||.||+|+. .+|+.||||++...   .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5688999999999999999976 47999999998653   2344577889999999999999999999999999999999


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+.+|+|.+++.... .+++..+..++.|++.||.|||    .++|+||||||+|||++.++.+||+
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH----~~~iiHRDIKP~NILl~~~g~ikL~  183 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH----SLDLIYRDLKPENLLIDQQGYIQVT  183 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH----hCCEecCcCCHHHcccCCCCCEEee
Confidence            9999999999987643 5899999999999999999999    8899999999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.1e-32  Score=217.92  Aligned_cols=140  Identities=26%  Similarity=0.400  Sum_probs=118.8

Q ss_pred             ccceeeecccCCCcceeeeEEeCC-C-----cEEEEEEeecc-cCchHHHHHHHHHHhcCC-CCCCccceeEEEecCCee
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQD-G-----MEVVVKGFNLQ-YGGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFK  159 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  159 (232)
                      +.+++.+.||+|+||.||+|++.. +     ..||+|.+... .......+.+|+.++..+ +|||||++++++.+++..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            457789999999999999997542 2     36899988543 333456788899999988 899999999999999999


Q ss_pred             EEEEeccCCCChhhhhccCC----------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCC
Q 042107          160 ALILEYMPHGSLGKCLSTSN----------------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKS  217 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~  217 (232)
                      ++|||||++|+|.+++....                      ..+++..++.++.|++.||.|||    .++|+||||||
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH----~~~IiHRDlKp  192 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE----FKSCVHRDLAA  192 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH----HTTEEETTCSG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCch
Confidence            99999999999999997542                      24788899999999999999999    88999999999


Q ss_pred             CceeeCCCCceeec
Q 042107          218 SNVLLDDNMVAHFL  231 (232)
Q Consensus       218 ~Nill~~~~~~~l~  231 (232)
                      +|||++.++.+||+
T Consensus       193 ~Nill~~~~~~Kl~  206 (325)
T d1rjba_         193 RNVLVTHGKVVKIC  206 (325)
T ss_dssp             GGEEEETTTEEEEC
T ss_pred             hccccccCCeEEEe
Confidence            99999999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.97  E-value=1.9e-31  Score=217.38  Aligned_cols=139  Identities=21%  Similarity=0.292  Sum_probs=119.9

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeeccc---CchHHHH---HHHHHHhcCCCCCCccceeEEEecCCeeE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQY---GGAFKNL---DVECNMMKIIRHQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~e~~~l~~l~h~niv~~~~~~~~~~~~~  160 (232)
                      +.|++.+.||+|+||.||+|+.. +|+.||+|++....   ......+   ..|+.+++.++|||||++++++.+++..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            34788999999999999999764 69999999986532   1111222   34577888999999999999999999999


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|||||++|+|.+++.... .+++..+..++.|++.||.|||    .++|+||||||+|||++.+|.+||+
T Consensus        84 ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH----~~~iiHrDlKP~NILl~~~g~iKl~  149 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH----NRFVVYRDLKPANILLDEHGHVRIS  149 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECSSSCEEEC
T ss_pred             EEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH----HCCccceeeccceeEEcCCCcEEEe
Confidence            9999999999999997643 5788899999999999999999    8899999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.97  E-value=1.4e-31  Score=211.71  Aligned_cols=139  Identities=19%  Similarity=0.277  Sum_probs=123.9

Q ss_pred             ccceeeecccCCCcceeeeEEeCCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      +.|++.+.||+|+||.||+|+.++++.||||++....  ....+.+.+|+.+++.++||||+++++++..++..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            4578899999999999999998899999999996542  23357788999999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +.++.+..+.... ..+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+|++
T Consensus        82 ~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH----~~~IvHrDiKp~NIll~~~~~~kl~  142 (286)
T d1ob3a_          82 LDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCH----DRRVLHRDLKPQNLLINREGELKIA  142 (286)
T ss_dssp             CSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred             ehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhc----cCcEEecCCCCceeeEcCCCCEEec
Confidence            9887766665543 46899999999999999999999    8899999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2e-31  Score=213.81  Aligned_cols=139  Identities=17%  Similarity=0.320  Sum_probs=121.6

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecc---cCchHHHHHHHHHHhc-CCCCCCccceeEEEecCCeeEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQ---YGGAFKNLDVECNMMK-IIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      +.|++.+.||+|+||.||+|+.. +++.||||++...   .....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            34788999999999999999764 7999999999753   2334455666776654 68999999999999999999999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||||++|+|.+++.... .+++..+..++.|++.||.|||    .++|+||||||+|||++.++.+||+
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH----~~~iiHrDikp~NiL~~~~~~~kl~  145 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH----SKGIVYRDLKLDNILLDKDGHIKIA  145 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH----HTTCBCCCCCGGGEEECTTSCEEEC
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH----hCCeeeccCcccceeecCCCceecc
Confidence            99999999999997643 4888999999999999999999    8899999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.3e-31  Score=209.14  Aligned_cols=136  Identities=28%  Similarity=0.427  Sum_probs=118.4

Q ss_pred             cceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEec-CCeeEEEEeccC
Q 042107           89 FLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSK-DDFKALILEYMP  167 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~  167 (232)
                      .+++.+.||+|+||.||+|+++ |+.||||+++..  ...+.+.+|+++++.++||||+++++++.. .+..++||||++
T Consensus         8 ~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~   84 (262)
T d1byga_           8 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   84 (262)
T ss_dssp             GEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred             HeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence            4678899999999999999885 778999998643  345778999999999999999999998854 456899999999


Q ss_pred             CCChhhhhccCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          168 HGSLGKCLSTSN-YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       168 ~g~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +|+|.+++.... ..+++..++.++.|++.||.|||    ..+|+||||||+|||++.++.+|++
T Consensus        85 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH----~~~ivH~dlkp~Nil~~~~~~~kl~  145 (262)
T d1byga_          85 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE----GNNFVHRDLAARNVLVSEDNVAKVS  145 (262)
T ss_dssp             TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred             CCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc----cCceeccccchHhheecCCCCEeec
Confidence            999999986542 24789999999999999999999    8899999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=4.3e-31  Score=210.39  Aligned_cols=141  Identities=28%  Similarity=0.432  Sum_probs=123.5

Q ss_pred             cccceeeecccCCCcceeeeEEeC------CCcEEEEEEeecccCc-hHHHHHHHHHHhcCCCCCCccceeEEEecCCee
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ------DGMEVVVKGFNLQYGG-AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFK  159 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  159 (232)
                      .+.|++.+.||+|+||.||+|+++      +++.||||++...... ..+.+.+|+++++.++||||+++++++...+..
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~   91 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM   91 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence            345789999999999999999753      3578999998755433 356789999999999999999999999999999


Q ss_pred             EEEEeccCCCChhhhhccC-----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCC
Q 042107          160 ALILEYMPHGSLGKCLSTS-----------------------NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLK  216 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~-----------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk  216 (232)
                      +++|||+++|+|.+++...                       ...+++..+..++.|++.||+|+|    ..+|+|||||
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH----~~~ivHrDlK  167 (301)
T d1lufa_          92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS----ERKFVHRDLA  167 (301)
T ss_dssp             EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCS
T ss_pred             EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc----cCCeEeeEEc
Confidence            9999999999999988632                       123788899999999999999999    8899999999


Q ss_pred             CCceeeCCCCceeec
Q 042107          217 SSNVLLDDNMVAHFL  231 (232)
Q Consensus       217 ~~Nill~~~~~~~l~  231 (232)
                      |+|||++.++.+|||
T Consensus       168 p~NILld~~~~~Kl~  182 (301)
T d1lufa_         168 TRNCLVGENMVVKIA  182 (301)
T ss_dssp             GGGEEECGGGCEEEC
T ss_pred             ccceEECCCCcEEEc
Confidence            999999999999996

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.5e-31  Score=212.80  Aligned_cols=135  Identities=24%  Similarity=0.381  Sum_probs=115.1

Q ss_pred             eeecccCCCcceeeeEEe-CCCcEEEEEEeecccCc-----hHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEec
Q 042107           92 VFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGG-----AFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILEY  165 (232)
Q Consensus        92 ~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  165 (232)
                      .+++||+|+||.||+|+. .+|+.||||++......     ..+.+.+|+.+++.++|||||++++++..++..|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            457899999999999976 46899999998654321     234678899999999999999999999999999999999


Q ss_pred             cCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          166 MPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       166 ~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++++..+... ...+++..+..++.|++.||.|||    .++|+||||||+|||++.++.+||+
T Consensus        82 ~~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH----~~~iiHrDiKp~NIli~~~~~~KL~  142 (299)
T d1ua2a_          82 METDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLH----QHWILHRDLKPNNLLLDENGVLKLA  142 (299)
T ss_dssp             CSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             hcchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhh----ccceecccCCcceEEecCCCccccc
Confidence            998877766554 345888899999999999999999    8899999999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.7e-31  Score=208.73  Aligned_cols=139  Identities=21%  Similarity=0.326  Sum_probs=121.6

Q ss_pred             ccceeeecccCCCcceeeeEEeCC----CcEEEEEEeecccC-chHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQD----GMEVVVKGFNLQYG-GAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv  162 (232)
                      +.|++.+.||+|+||.||+|++..    +..||+|.+..... ...+.+.+|+.+++.++||||+++++++. ++..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            568899999999999999997642    35688888854432 33567889999999999999999999985 5678999


Q ss_pred             EeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          163 LEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||+++|++.+++......+++..++.++.|+++||.|+|    .++|+||||||+||+++.++.+||+
T Consensus        86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH----~~~iiHrDlKp~NIll~~~~~~Kl~  150 (273)
T d1mp8a_          86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE----SKRFVHRDIAARNVLVSSNDCVKLG  150 (273)
T ss_dssp             EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred             EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc----ccCeeccccchhheeecCCCcEEEc
Confidence            9999999999988776667899999999999999999999    8899999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.1e-31  Score=209.16  Aligned_cols=140  Identities=31%  Similarity=0.551  Sum_probs=120.0

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCc--EEEEEEeecc-cCchHHHHHHHHHHhcCC-CCCCccceeEEEecCCeeEEE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGM--EVVVKGFNLQ-YGGAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFKALI  162 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~lv  162 (232)
                      +.+++.+.||+|+||.||+|+++ ++.  .||||.+... .....+.+.+|++++..+ +|||||++++++..++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            45678899999999999999765 444  4778887543 333456789999999998 799999999999999999999


Q ss_pred             EeccCCCChhhhhccC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCc
Q 042107          163 LEYMPHGSLGKCLSTS---------------NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMV  227 (232)
Q Consensus       163 ~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~  227 (232)
                      |||+++|+|.+++...               ...+++..+..++.|++.||.|+|    .++|+||||||+|||++.++.
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH----~~~iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS----QKQFIHRDLAARNILVGENYV  165 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEECGGGC
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh----cCCccccccccceEEEcCCCc
Confidence            9999999999998643               246899999999999999999999    889999999999999999999


Q ss_pred             eeec
Q 042107          228 AHFL  231 (232)
Q Consensus       228 ~~l~  231 (232)
                      +||+
T Consensus       166 ~kl~  169 (309)
T d1fvra_         166 AKIA  169 (309)
T ss_dssp             EEEC
T ss_pred             eEEc
Confidence            9986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.3e-31  Score=208.11  Aligned_cols=138  Identities=23%  Similarity=0.304  Sum_probs=113.7

Q ss_pred             cceeeecccCCCcceeeeEEeC--C--CcEEEEEEeecc---cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEE
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ--D--GMEVVVKGFNLQ---YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~--~--~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~l  161 (232)
                      .|++.+.||+|+||.||+|++.  +  ...||||++...   .....+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus         9 d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~l   87 (273)
T d1u46a_           9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKM   87 (273)
T ss_dssp             GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             HeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhe
Confidence            4788999999999999999753  2  237899988654   23345778999999999999999999999965 46789


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      |||||++|++.+.+......+++..++.++.|++.||.|||    .++|+||||||+||+++.++.+||+
T Consensus        88 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH----~~~iiHrDikp~NIll~~~~~vkl~  153 (273)
T d1u46a_          88 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE----SKRFIHRDLAARNLLLATRDLVKIG  153 (273)
T ss_dssp             EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEEEETTEEEEC
T ss_pred             eeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh----hCCEeeeeecHHHhccccccceeec
Confidence            99999999999988766556899999999999999999999    8899999999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.5e-31  Score=209.07  Aligned_cols=135  Identities=24%  Similarity=0.431  Sum_probs=118.7

Q ss_pred             eecccCCCcceeeeEEeCC----CcEEEEEEeecc-cCchHHHHHHHHHHhcCCCCCCccceeEEEec-CCeeEEEEecc
Q 042107           93 FNLISRGGFGSIYKARIQD----GMEVVVKGFNLQ-YGGAFKNLDVECNMMKIIRHQNLIKIISSCSK-DDFKALILEYM  166 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~  166 (232)
                      .++||+|+||.||+|++..    ...||||.+... .....+.+.+|++++++++||||+++++++.. ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            5789999999999998643    236899998643 33456789999999999999999999999765 56889999999


Q ss_pred             CCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          167 PHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       167 ~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++|+|.+++.......++..+..++.|++.||.|+|    ..+|+||||||+|||+++++.+||+
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH----~~~iiHrDLK~~NILl~~~~~~kL~  172 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA----SKKFVHRDLAARNCMLDEKFTVKVA  172 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEECTTCCEEEC
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc----ccCcccCCccHHhEeECCCCCEEEe
Confidence            999999999877666888889999999999999999    8899999999999999999999986

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.7e-30  Score=206.90  Aligned_cols=139  Identities=27%  Similarity=0.378  Sum_probs=114.6

Q ss_pred             cceeeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecCC----eeEEEEe
Q 042107           89 FLEVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD----FKALILE  164 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e  164 (232)
                      -+.+.+.||+|+||.||+|++ +|+.||||++..... .......|+..+..++||||+++++++.+++    ..|+|||
T Consensus         4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E   81 (303)
T d1vjya_           4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence            356778999999999999986 488999999865422 1122334555666789999999999987653    6799999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcC----CCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFG----HSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~----~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||++|+|.++++..  .+++..+..++.|++.||.|+|..    ...++|+||||||+|||++.++.+||+
T Consensus        82 y~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~  150 (303)
T d1vjya_          82 YHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  150 (303)
T ss_dssp             CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred             cccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence            99999999999865  488999999999999999999942    113589999999999999999999996

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1e-30  Score=209.65  Aligned_cols=137  Identities=21%  Similarity=0.354  Sum_probs=118.1

Q ss_pred             ceeeecccCCCcceeeeEEeC-CCc----EEEEEEeecc-cCchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEE
Q 042107           90 LEVFNLISRGGFGSIYKARIQ-DGM----EVVVKGFNLQ-YGGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALIL  163 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~  163 (232)
                      |++.+.||+|+||.||+|++. +|+    .||+|.+... .....+.+.+|+.+++.++|||||++++++.++ ..+++|
T Consensus        11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~   89 (317)
T d1xkka_          11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT   89 (317)
T ss_dssp             EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred             CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence            788999999999999999764 444    5888887543 334567899999999999999999999999865 567889


Q ss_pred             eccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          164 EYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       164 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ||+.+|+|.+.+......+++..++.++.|++.||.|||    .++|+||||||+|||++.++.+||+
T Consensus        90 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH----~~~iiHrDlKp~NIll~~~~~~kl~  153 (317)
T d1xkka_          90 QLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE----DRRLVHRDLAARNVLVKTPQHVKIT  153 (317)
T ss_dssp             ECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEEETTEEEEC
T ss_pred             EeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH----HcCcccCcchhhcceeCCCCCeEee
Confidence            999999999988877677999999999999999999999    8899999999999999999999986

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-30  Score=210.38  Aligned_cols=137  Identities=16%  Similarity=0.226  Sum_probs=115.9

Q ss_pred             ccccceeee-cccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhc-CCCCCCccceeEEEec----CCe
Q 042107           86 FRNFLEVFN-LISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMK-IIRHQNLIKIISSCSK----DDF  158 (232)
Q Consensus        86 ~~~~~~~~~-~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~----~~~  158 (232)
                      +.+.|++.. .||+|+||.||+|+. .+++.||||++...     +.+.+|+.++. ..+|||||++++++.+    +..
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            345577764 699999999999975 57899999998643     55778998865 4589999999999865    457


Q ss_pred             eEEEEeccCCCChhhhhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC---CCceeec
Q 042107          159 KALILEYMPHGSLGKCLSTS-NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD---NMVAHFL  231 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~---~~~~~l~  231 (232)
                      .|+|||||+||+|.+++... ...+++..+..++.|++.||.|||    ..+|+||||||+|||++.   ++.+||+
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH----~~~iiHRDiKp~NIll~~~~~~~~~Kl~  156 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH----SINIAHRDVKPENLLYTSKRPNAILKLT  156 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH----HcCCcccccccccccccccccccccccc
Confidence            89999999999999999765 346899999999999999999999    889999999999999986   4567875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.6e-30  Score=206.86  Aligned_cols=141  Identities=28%  Similarity=0.419  Sum_probs=116.8

Q ss_pred             cccceeeecccCCCcceeeeEEeCC--------CcEEEEEEeecccC-chHHHHHHHHHHhcCC-CCCCccceeEEEecC
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQD--------GMEVVVKGFNLQYG-GAFKNLDVECNMMKII-RHQNLIKIISSCSKD  156 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  156 (232)
                      .+.|++.+.||+|+||.||+|+...        +..||||++..... .....+.+|...+..+ +|||||++++++.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            4567889999999999999997432        34799999866543 2346677888888777 799999999999999


Q ss_pred             CeeEEEEeccCCCChhhhhccCC---------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCcee
Q 042107          157 DFKALILEYMPHGSLGKCLSTSN---------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVL  221 (232)
Q Consensus       157 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nil  221 (232)
                      +..++|||||++|+|.+++....               ..+++..++.++.|++.||.|||    ..+|+||||||+|||
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH----~~~ivHrDiKp~NiL  167 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA----SKKCIHRDLAARNVL  167 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh----hCCEEeeeeccccee
Confidence            99999999999999999996542               34799999999999999999999    889999999999999


Q ss_pred             eCCCCceeec
Q 042107          222 LDDNMVAHFL  231 (232)
Q Consensus       222 l~~~~~~~l~  231 (232)
                      ++.++.+||+
T Consensus       168 l~~~~~~kl~  177 (299)
T d1fgka_         168 VTEDNVMKIA  177 (299)
T ss_dssp             ECTTCCEEEC
T ss_pred             ecCCCCeEec
Confidence            9999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.6e-30  Score=207.94  Aligned_cols=140  Identities=24%  Similarity=0.358  Sum_probs=122.0

Q ss_pred             ccceeeecccCCCcceeeeEEe------CCCcEEEEEEeecccC-chHHHHHHHHHHhcCC-CCCCccceeEEEecCCee
Q 042107           88 NFLEVFNLISRGGFGSIYKARI------QDGMEVVVKGFNLQYG-GAFKNLDVECNMMKII-RHQNLIKIISSCSKDDFK  159 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  159 (232)
                      +.+++.+.||+|+||.||+|++      .+++.||||++..... .....+.+|+.+++.+ +|||||++++++..++..
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            5677889999999999999974      2467899999975432 3445688899999998 699999999999999999


Q ss_pred             EEEEeccCCCChhhhhccCC-----------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceee
Q 042107          160 ALILEYMPHGSLGKCLSTSN-----------------YILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLL  222 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill  222 (232)
                      +++||||++|+|.+++....                 ..+++..+..++.|++.||.|||    .++++||||||+||++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH----~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA----SKNCIHRDLAARNILL  178 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCSGGGEEE
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH----hCCeeecccccccccc
Confidence            99999999999999986432                 24788899999999999999999    8899999999999999


Q ss_pred             CCCCceeec
Q 042107          223 DDNMVAHFL  231 (232)
Q Consensus       223 ~~~~~~~l~  231 (232)
                      +.++.++++
T Consensus       179 ~~~~~~ki~  187 (311)
T d1t46a_         179 THGRITKIC  187 (311)
T ss_dssp             ETTTEEEEC
T ss_pred             cccCccccc
Confidence            999999886

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.1e-30  Score=206.88  Aligned_cols=140  Identities=17%  Similarity=0.297  Sum_probs=121.7

Q ss_pred             ccceeeecccCCCcceeeeEEeC------CCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeE
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ------DGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKA  160 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  160 (232)
                      +.+++.+.||+|+||.||+|.+.      ++..||||++.... ......+.+|+.+++.++||||+++++++..++..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            55678899999999999999753      35789999996543 233456889999999999999999999999999999


Q ss_pred             EEEeccCCCChhhhhccC---------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTS---------NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~---------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +||||+++|+|.+++...         ...+++..+..++.|+++||.|||    .++|+||||||+|||++.++++||+
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH----~~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN----ANKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH----HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh----hCCeeeceEcCCceeecCCceEEEe
Confidence            999999999999987632         134688889999999999999999    8899999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.3e-29  Score=200.75  Aligned_cols=139  Identities=20%  Similarity=0.283  Sum_probs=124.0

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc--CchHHHHHHHHHHhcCCCCCCccceeEEEecCCeeEEEEe
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY--GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      +.|++.+.||+|+||.||+|+. .+++.||||++....  ....+.+.+|+.+++.++||||+++++++......++++|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            3578999999999999999975 578999999996543  3346788899999999999999999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++.++++..++... ..+++..+..++.|++.||+|||    .++|+||||||+|||++.++.+||+
T Consensus        82 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH----~~~IvHrDiKP~NIli~~~~~~kl~  143 (292)
T d1unla_          82 FCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH----SRNVLHRDLKPQNLLINRNGELKLA  143 (292)
T ss_dssp             CCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEECTTCCEEEC
T ss_pred             eccccccccccccc-cccchhHHHHHHHHHHHHHHHhh----cCCEeeecccCcccccccCCceeee
Confidence            99999988877654 45788899999999999999999    8899999999999999999998875

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=6.4e-30  Score=207.21  Aligned_cols=139  Identities=19%  Similarity=0.226  Sum_probs=116.0

Q ss_pred             cccceeeecccCCCcceeeeEEe-CCCcEEEEEEeeccc-CchHHHHHHHHHHhcCCCCCCccceeEEEecCC----eeE
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQY-GGAFKNLDVECNMMKIIRHQNLIKIISSCSKDD----FKA  160 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~  160 (232)
                      .+.|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+++++.++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            34588999999999999999975 579999999996543 234567889999999999999999999987643    234


Q ss_pred             EEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          161 LILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       161 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++++|+.+|+|.+++...  .+++..+..++.|++.||.|||    .++|+||||||+|||++.++.+||+
T Consensus        87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH----~~~iiHRDIKp~NILl~~~~~~kl~  151 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNTTCDLKIC  151 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHH----HCCCcCCCCCcceEEECCCCCEEEc
Confidence            555667799999999764  4899999999999999999999    8899999999999999999999985

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=8.1e-30  Score=206.73  Aligned_cols=139  Identities=22%  Similarity=0.364  Sum_probs=115.2

Q ss_pred             ccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecCC-----
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKDD-----  157 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  157 (232)
                      +.+.|++.+.||+|+||.||+|+. .+|+.||||++.....  ...+.+.+|+.+++.++|||||++++++...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            566789999999999999999975 4699999999965432  33567889999999999999999999997654     


Q ss_pred             -eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          158 -FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       158 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                       ..|+||||+ +.++..+.+..  .+++..++.++.|++.||.|||    .++|+||||||+|||++.++.+|++
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH----~~~IiHrDiKp~NIL~~~~~~~kl~  163 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH----AAGIIHRDLKPGNLAVNEDCELKIL  163 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTCCEEEC
T ss_pred             ceEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH----hCCCcccccCcchhhcccccccccc
Confidence             569999999 56888877654  4899999999999999999999    8899999999999999999999885

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.3e-30  Score=202.44  Aligned_cols=141  Identities=23%  Similarity=0.283  Sum_probs=119.3

Q ss_pred             ccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCc------hHHHHHHHHHHhcCCC--CCCccceeEEEecC
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGG------AFKNLDVECNMMKIIR--HQNLIKIISSCSKD  156 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~  156 (232)
                      +.+.|++.+.||+|+||.||+|+. .+++.||||.+......      ....+.+|+.+++.++  ||||+++++++.++
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            445689999999999999999976 47899999998754211      1233567999999886  89999999999999


Q ss_pred             CeeEEEEeccCC-CChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCC-Cceeec
Q 042107          157 DFKALILEYMPH-GSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDN-MVAHFL  231 (232)
Q Consensus       157 ~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~-~~~~l~  231 (232)
                      +..++||||+.+ +++.+++... ..+++..+..++.|++.||.|||    .++|+||||||+|||++.+ +.+||+
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH----~~~iiHrDiKp~NIll~~~~~~vkl~  153 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCH----NCGVLHRDIKDENILIDLNRGELKLI  153 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCSGGGEEEETTTTEEEEC
T ss_pred             CeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH----HCCCccccCcccceEEecCCCeEEEC
Confidence            999999999976 5777777654 35899999999999999999999    8899999999999999854 788875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.96  E-value=3.7e-29  Score=201.38  Aligned_cols=135  Identities=20%  Similarity=0.336  Sum_probs=117.0

Q ss_pred             ccccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCC-CCCccceeEEEecC--CeeEE
Q 042107           86 FRNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-HQNLIKIISSCSKD--DFKAL  161 (232)
Q Consensus        86 ~~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~--~~~~l  161 (232)
                      ..+.|++.+.||+|+||.||+|+. .+++.||+|++...   ..+.+.+|+++++.++ ||||+++++++...  ...++
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~  109 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  109 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence            346689999999999999999976 57899999998643   3467888999999985 99999999998753  56899


Q ss_pred             EEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC-ceeec
Q 042107          162 ILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM-VAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~-~~~l~  231 (232)
                      |||||++++|..+.+    .+++..+..++.|++.||.|||    +++|+||||||+|||++.++ .+||+
T Consensus       110 v~e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH----~~gIvHrDiKp~NILi~~~~~~vkl~  172 (328)
T d3bqca1         110 VFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH----SMGIMHRDVKPHNVMIDHEHRKLRLI  172 (328)
T ss_dssp             EEECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             EEeecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHh----hcccccccccccceEEcCCCCeeeec
Confidence            999999999987653    4889999999999999999999    88999999999999998655 57775

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.1e-29  Score=203.55  Aligned_cols=135  Identities=22%  Similarity=0.342  Sum_probs=111.4

Q ss_pred             cceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccceeEEEecC------CeeEE
Q 042107           89 FLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIKIISSCSKD------DFKAL  161 (232)
Q Consensus        89 ~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~~l  161 (232)
                      .|...++||+|+||.||+|+.. +++.||||++......    ..+|+++++.++||||+++++++...      .++++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            4778899999999999999864 6999999999754322    24699999999999999999988542      35789


Q ss_pred             EEeccCCCChhhhhc--cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC-ceeec
Q 042107          162 ILEYMPHGSLGKCLS--TSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM-VAHFL  231 (232)
Q Consensus       162 v~e~~~~g~L~~~l~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~-~~~l~  231 (232)
                      |||||+++.+..+..  .....+++..++.++.|++.||+|||    +++|+||||||+|||++.++ .+||+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH----~~~IiHrDiKp~NILl~~~~~~~kl~  165 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH----SFGICHRDIKPQNLLLDPDTAVLKLC  165 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECTTTCCEEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH----hcCCcccCCCcceEEEecCCCceeEe
Confidence            999998764433322  23446899999999999999999999    88999999999999999775 78875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.1e-29  Score=201.89  Aligned_cols=140  Identities=24%  Similarity=0.381  Sum_probs=114.4

Q ss_pred             ccceeeecccCCCcceeeeEEeC------CCcEEEEEEeecccC-chHHHHHHHHHHhcCC-CCCCccceeEEEecC-Ce
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ------DGMEVVVKGFNLQYG-GAFKNLDVECNMMKII-RHQNLIKIISSCSKD-DF  158 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-~~  158 (232)
                      +.|++.+.||+|+||.||+|++.      +++.||||++..... ...+.+..|...+..+ +|+||+.+++++..+ +.
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            56789999999999999999743      346899999865432 3345667777777665 689999999987664 46


Q ss_pred             eEEEEeccCCCChhhhhccC---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeC
Q 042107          159 KALILEYMPHGSLGKCLSTS---------------NYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLD  223 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~---------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~  223 (232)
                      .++|||||++|+|.+++...               ...+++..+..++.|++.||.|||    .++|+||||||+|||++
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH----~~~ivHrDlKp~NILl~  168 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA----SRKCIHRDLAARNILLS  168 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEEC
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH----hCCCcCCcCCccceeEC
Confidence            89999999999999998643               234788999999999999999999    88999999999999999


Q ss_pred             CCCceeec
Q 042107          224 DNMVAHFL  231 (232)
Q Consensus       224 ~~~~~~l~  231 (232)
                      .++.+||+
T Consensus       169 ~~~~~Kl~  176 (299)
T d1ywna1         169 EKNVVKIC  176 (299)
T ss_dssp             GGGCEEEC
T ss_pred             CCCcEEEc
Confidence            99999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.8e-29  Score=203.68  Aligned_cols=138  Identities=20%  Similarity=0.309  Sum_probs=119.3

Q ss_pred             ccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecC-----Cee
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKD-----DFK  159 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  159 (232)
                      +.|++.+.||+|+||.||+|+. .+++.||||++.....  ...+.+.+|+++++.++|||||++++++...     ...
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            4588999999999999999975 5799999999975433  2345678999999999999999999998643     234


Q ss_pred             EEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          160 ALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       160 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      +++|||+.+|+|.+++...  .+++..+..++.|++.||.|||    .++|+||||||+|||++.++.+|++
T Consensus        98 ~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH----~~giiHrDiKp~NILi~~~~~~kl~  163 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH----SADIIHRDLKPSNLAVNEDCELKIL  163 (348)
T ss_dssp             CEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             EEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH----hCCCcccccCCcccccccccccccc
Confidence            6677788899999999654  4899999999999999999999    8899999999999999999999875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.5e-29  Score=202.94  Aligned_cols=140  Identities=22%  Similarity=0.287  Sum_probs=122.3

Q ss_pred             cccceeeecccCCCcceeeeEEe----CCCcEEEEEEeecc----cCchHHHHHHHHHHhcCCCC-CCccceeEEEecCC
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI----QDGMEVVVKGFNLQ----YGGAFKNLDVECNMMKIIRH-QNLIKIISSCSKDD  157 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~----~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~  157 (232)
                      .+.|++.+.||+|+||.||+|+.    .+|+.||+|.+...    .....+.+.+|++++++++| |||+++++++.+..
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            46689999999999999999964    25889999998543    22334667889999999977 89999999999999


Q ss_pred             eeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          158 FKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       158 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ..+++|||+.+|+|.+++.... .+++..+..++.|++.||.|+|    ..+|+||||||+|||++.++.+||+
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH----~~~ivHrDiKp~Nill~~~~~vkL~  171 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH----KLGIIYRDIKLENILLDSNGHVVLT  171 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTSCEEES
T ss_pred             ceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhh----cCCEEeccCCccceeecCCCCEEEe
Confidence            9999999999999999987654 3677888899999999999999    8899999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1e-28  Score=198.00  Aligned_cols=140  Identities=22%  Similarity=0.385  Sum_probs=116.9

Q ss_pred             cccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecc--cCchHHHHHHHHHHhcCCCCCCccceeEEEec--------
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQ--YGGAFKNLDVECNMMKIIRHQNLIKIISSCSK--------  155 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  155 (232)
                      .+.|++.+.||+|+||.||+|+. .+|+.||||++...  .....+.+.+|+.+++.++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            35688999999999999999986 47999999998544  23345678899999999999999999998855        


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          156 DDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       156 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ++..|++|||++++.+..... ....+++..+..++.|++.||.|||    ..+|+||||||+|||++.++.+|++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~-~~~~~~~~~~~~i~~qil~~l~~lH----~~~ivHrDlKp~NILl~~~~~~kl~  159 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIH----RNKILHRDMKAANVLITRDGVLKLA  159 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTC-TTCCCCHHHHHHHHHHHHHHHHHHH----HTTEECCCCCGGGEEECTTSCEEEC
T ss_pred             CceEEEEEeccCCCccchhhh-cccccccHHHHHHHHHHHHHHHHhc----cCCEEecCcCchheeecCCCcEEee
Confidence            345799999998876655443 3445888899999999999999999    8899999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.1e-29  Score=199.17  Aligned_cols=140  Identities=20%  Similarity=0.331  Sum_probs=114.9

Q ss_pred             ccceeeecccCCCcceeeeEEe-CC-CcEEEEEEeeccc--CchHHHHHHHHHHhcCC---CCCCccceeEEEec-----
Q 042107           88 NFLEVFNLISRGGFGSIYKARI-QD-GMEVVVKGFNLQY--GGAFKNLDVECNMMKII---RHQNLIKIISSCSK-----  155 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~-----  155 (232)
                      +.|++.+.||+|+||.||+|+. .+ ++.||||++....  ......+.+|+.+++.+   +||||+++++++..     
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~   86 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   86 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence            5688999999999999999976 34 5679999986542  22233455677776655   89999999998853     


Q ss_pred             CCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          156 DDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       156 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      ....+++|||++++++..........+++..+..++.|++.||+|||    .++|+||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH----~~~ivHrDiKp~NILi~~~~~~kl~  158 (305)
T d1blxa_          87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH----SHRVVHRDLKPQNILVTSSGQIKLA  158 (305)
T ss_dssp             EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH----HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH----hCCEEecCCCccEEEEcCCCCeeec
Confidence            34679999999998776655555556899999999999999999999    8899999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.4e-28  Score=199.96  Aligned_cols=136  Identities=21%  Similarity=0.279  Sum_probs=114.8

Q ss_pred             ccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccC--chHHHHHHHHHHhcCCCCCCccceeEEEecC------Ce
Q 042107           88 NFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYG--GAFKNLDVECNMMKIIRHQNLIKIISSCSKD------DF  158 (232)
Q Consensus        88 ~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~  158 (232)
                      +.|++.++||+|+||+||+|+.. +|+.||||++.....  ...+.+.+|+.+++.++||||+++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            56899999999999999999765 799999999975432  2345688999999999999999999998643      67


Q ss_pred             eEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceeec
Q 042107          159 KALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHFL  231 (232)
Q Consensus       159 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l~  231 (232)
                      .|+|||||.++.+. .+..   .+++..++.++.|++.||.|||    ..+|+||||||+|||++.++..+++
T Consensus        97 ~~iv~Ey~~~~l~~-~~~~---~~~~~~i~~~~~qil~gl~~LH----~~giiHrDlKP~Nil~~~~~~~kl~  161 (355)
T d2b1pa1          97 VYLVMELMDANLCQ-VIQM---ELDHERMSYLLYQMLCGIKHLH----SAGIIHRDLKPSNIVVKSDCTLKIL  161 (355)
T ss_dssp             EEEEEECCSEEHHH-HHTS---CCCHHHHHHHHHHHHHHHHHHH----HTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred             eEEEEeccchHHHH-hhhc---CCCHHHHHHHHHHHHHHHHHhh----hcccccccCCccccccccccceeee
Confidence            89999999775544 4432   4789999999999999999999    8899999999999999999998875

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.95  E-value=1.5e-27  Score=188.95  Aligned_cols=138  Identities=15%  Similarity=0.175  Sum_probs=118.2

Q ss_pred             cccceeeecccCCCcceeeeEEeC-CCcEEEEEEeecccCchHHHHHHHHHHhcCCCC-CCccceeEEEecCCeeEEEEe
Q 042107           87 RNFLEVFNLISRGGFGSIYKARIQ-DGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRH-QNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e  164 (232)
                      .+.|++.+.||+|+||.||+|+.. +++.||||.+.....  .+.+.+|++.++.++| +|++.+++++......++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            456889999999999999999854 689999998865432  2346678888888875 899999999999999999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC-----CCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD-----NMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~-----~~~~~l~  231 (232)
                      |+ +++|.+++......+++..+..++.|++.||.|+|    +.+|+||||||+|||++.     ++.+||+
T Consensus        82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH----~~giiHrDiKp~Nili~~~~~~~~~~vkl~  148 (293)
T d1csna_          82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH----EKSLVYRDIKPDNFLIGRPNSKNANMIYVV  148 (293)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----TTTEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred             ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH----HCCceeccCCccceeecCcccccCCceEEc
Confidence            99 67999998876667899999999999999999999    889999999999999975     4566664

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.94  E-value=1e-26  Score=184.70  Aligned_cols=138  Identities=22%  Similarity=0.316  Sum_probs=112.1

Q ss_pred             cccceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCccc-eeEEEecCCeeEEEEe
Q 042107           87 RNFLEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNLIK-IISSCSKDDFKALILE  164 (232)
Q Consensus        87 ~~~~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e  164 (232)
                      .+.|++.+.||+|+||.||+|+. .+++.||||.+.....  .+.+..|+++++.++|++++. +.++....+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            35688999999999999999976 4689999998865432  245778999999998776554 4556677788999999


Q ss_pred             ccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCC---CCceeec
Q 042107          165 YMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDD---NMVAHFL  231 (232)
Q Consensus       165 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~---~~~~~l~  231 (232)
                      |+ ++++.+.+......+++..+..++.|++.||+|||    .++|+||||||+|||++.   +..++++
T Consensus        84 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH----~~~iiHrDiKp~NIl~~~~~~~~~vkl~  148 (299)
T d1ckia_          84 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH----SKNFIHRDVKPDNFLMGLGKKGNLVYII  148 (299)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH----HTTEECSCCCGGGEEECCGGGTTCEEEC
T ss_pred             Ec-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH----HCCeeeccCCHhhccccccCCCceeeee
Confidence            99 55777766655567999999999999999999999    889999999999998764   3456654

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=6.9e-23  Score=152.10  Aligned_cols=123  Identities=16%  Similarity=0.162  Sum_probs=95.5

Q ss_pred             eeeecccCCCcceeeeEEeCCCcEEEEEEeecccC------------------chHHHHHHHHHHhcCCCCCCccceeEE
Q 042107           91 EVFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYG------------------GAFKNLDVECNMMKIIRHQNLIKIISS  152 (232)
Q Consensus        91 ~~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~~~~~  152 (232)
                      .+.++||+|+||.||+|+..+|+.||||++.....                  ........|...+..+.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            46789999999999999888899999998743210                  011234568888999999999988765


Q ss_pred             EecCCeeEEEEeccCCCChhhhhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCCceee
Q 042107          153 CSKDDFKALILEYMPHGSLGKCLSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNMVAHF  230 (232)
Q Consensus       153 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~~~~l  230 (232)
                      ..    .+++|||+++..+.++        +......++.|++.|+.|||    ..+|+||||||+|||+++++ +++
T Consensus        83 ~~----~~lvme~~~~~~~~~l--------~~~~~~~i~~ql~~~l~~lH----~~giiHrDiKP~NILv~~~~-~~l  143 (191)
T d1zara2          83 EG----NAVLMELIDAKELYRV--------RVENPDEVLDMILEEVAKFY----HRGIVHGDLSQYNVLVSEEG-IWI  143 (191)
T ss_dssp             ET----TEEEEECCCCEEGGGC--------CCSCHHHHHHHHHHHHHHHH----HTTEECSCCSTTSEEEETTE-EEE
T ss_pred             cC----CEEEEEeeccccccch--------hhHHHHHHHHHHHHHHHHHh----hCCEEEccCChhheeeeCCC-EEE
Confidence            32    3799999988665442        23345678999999999999    88999999999999999765 443

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.86  E-value=1.5e-22  Score=164.48  Aligned_cols=133  Identities=14%  Similarity=0.185  Sum_probs=102.9

Q ss_pred             ceeeecccCCCcceeeeEEe-CCCcEEEEEEeecccCchHHHHHHHHHHhcCCC-----------CCCccceeEEEec--
Q 042107           90 LEVFNLISRGGFGSIYKARI-QDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-----------HQNLIKIISSCSK--  155 (232)
Q Consensus        90 ~~~~~~lg~g~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~--  155 (232)
                      |++.++||+|+||.||+|+. .+|+.||||++.... ...+.+.+|+.+++.++           |+||+++++++..  
T Consensus        15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~   93 (362)
T d1q8ya_          15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG   93 (362)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred             EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence            89999999999999999976 579999999986542 23456677888887664           5789999988754  


Q ss_pred             CCeeEEEEeccCCCChhhh--hccCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCCeeeCCCCCCceeeCCCC
Q 042107          156 DDFKALILEYMPHGSLGKC--LSTSNYILDFFQRLHIMIDVASAVEYLHFGHSTHVIIHCDLKSSNVLLDDNM  226 (232)
Q Consensus       156 ~~~~~lv~e~~~~g~L~~~--l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~iiHrdlk~~Nill~~~~  226 (232)
                      ....+++|+++..+.....  .......+++..+..++.|++.||.|||+   ..+|+||||||+|||++.++
T Consensus        94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~---~~~IvHrDlKp~NIll~~~~  163 (362)
T d1q8ya_          94 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVD  163 (362)
T ss_dssp             TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEE
T ss_pred             ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh---hcCcccccCChhHeeeeccC
Confidence            4566777777655443222  22234457888999999999999999992   26899999999999998655

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.18  E-value=5.7e-12  Score=99.21  Aligned_cols=83  Identities=31%  Similarity=0.492  Sum_probs=53.7

Q ss_pred             CCCEEEccCCcccc--cCCCcc-----------c-cCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcc
Q 042107            6 VLLRIDLSTNNFSC--VFPTTI-----------E-YNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDL   71 (232)
Q Consensus         6 ~l~~l~ls~N~~~g--~~p~~~-----------~-~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l   71 (232)
                      +++.|||++|.++|  .+|.++           + .|+++|.+|.+++++++|++|+|++|++.+..|..+..+..|+.+
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccc
Confidence            46667777777766  356554           2 266777777777777777777777777766666666666666666


Q ss_pred             ccccccccCCCCCcccc
Q 042107           72 NLSFNTLEGKIPRPFRN   88 (232)
Q Consensus        72 ~l~~n~l~g~~p~~~~~   88 (232)
                      +++.|.+.+.+|..+..
T Consensus       131 ~l~~N~~~~~~p~~l~~  147 (313)
T d1ogqa_         131 DFSYNALSGTLPPSISS  147 (313)
T ss_dssp             ECCSSEEESCCCGGGGG
T ss_pred             ccccccccccCchhhcc
Confidence            66666666666654443

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.16  E-value=1.9e-11  Score=96.15  Aligned_cols=76  Identities=37%  Similarity=0.469  Sum_probs=43.4

Q ss_pred             CEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccccccc
Q 042107            8 LRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFN   76 (232)
Q Consensus         8 ~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n   76 (232)
                      ..++++.|.+.|.+|..+           ..|++++.+| .++.+++|+.|+|++|+++|.+|..+.++++|+.|++++|
T Consensus       200 ~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N  278 (313)
T d1ogqa_         200 AFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN  278 (313)
T ss_dssp             SEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCC
Confidence            345566666665555432           3455555443 3555566666666666666666666666666666666666


Q ss_pred             cccCCCCC
Q 042107           77 TLEGKIPR   84 (232)
Q Consensus        77 ~l~g~~p~   84 (232)
                      +++|.+|.
T Consensus       279 ~l~g~iP~  286 (313)
T d1ogqa_         279 NLCGEIPQ  286 (313)
T ss_dssp             EEEEECCC
T ss_pred             cccccCCC
Confidence            66665554

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.04  E-value=2.2e-10  Score=83.72  Aligned_cols=84  Identities=20%  Similarity=0.239  Sum_probs=61.1

Q ss_pred             CCCCEEEccCCcccccCCCc------------cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccc
Q 042107            5 KVLLRIDLSTNNFSCVFPTT------------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLN   72 (232)
Q Consensus         5 ~~l~~l~ls~N~~~g~~p~~------------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~   72 (232)
                      ++++.|+|++|+|++.++..            +++|++....+..+..+++|+.|+|++|++++-.|..+..++.|+.|+
T Consensus        29 ~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~  108 (192)
T d1w8aa_          29 LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLN  108 (192)
T ss_dssp             TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEE
T ss_pred             CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccc
Confidence            36788888888887655432            257788777777788888888888888888855555677788888888


Q ss_pred             cccccccCCCCCcccc
Q 042107           73 LSFNTLEGKIPRPFRN   88 (232)
Q Consensus        73 l~~n~l~g~~p~~~~~   88 (232)
                      +++|.+++-.|..|..
T Consensus       109 L~~N~l~~i~~~~f~~  124 (192)
T d1w8aa_         109 LYDNQISCVMPGSFEH  124 (192)
T ss_dssp             CCSSCCCEECTTSSTT
T ss_pred             cCCccccccCHHHhcC
Confidence            8888887655555543

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.03  E-value=1.6e-10  Score=84.52  Aligned_cols=82  Identities=26%  Similarity=0.411  Sum_probs=71.9

Q ss_pred             CCCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK   69 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~   69 (232)
                      |+++++|+.|+|++|.+.+..|..+           ++|+++...|..|..+++|+.|+|++|++++..|..+..+++++
T Consensus        50 f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~  129 (192)
T d1w8aa_          50 FGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT  129 (192)
T ss_dssp             GGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCC
T ss_pred             cCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccc
Confidence            3568999999999999998776653           78999988888999999999999999999977777788999999


Q ss_pred             ccccccccccCCC
Q 042107           70 DLNLSFNTLEGKI   82 (232)
Q Consensus        70 ~l~l~~n~l~g~~   82 (232)
                      .+++++|.+....
T Consensus       130 ~l~L~~N~~~~~~  142 (192)
T d1w8aa_         130 SLNLASNPFNCNC  142 (192)
T ss_dssp             EEECTTCCBCCSG
T ss_pred             ccccccccccccc
Confidence            9999999987543

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.88  E-value=1.4e-09  Score=73.61  Aligned_cols=74  Identities=30%  Similarity=0.419  Sum_probs=33.9

Q ss_pred             CCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCC-cccccCCCCCc
Q 042107            3 NLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIP-IPLEKLLDLKD   70 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip-~~~~~l~~l~~   70 (232)
                      .++.|++||+++|.|+ .+|..+           ++|+++. +| .++.+++|+.|++++|+++...+ ..+..++.|+.
T Consensus        18 ~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~   94 (124)
T d1dcea3          18 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVL   94 (124)
T ss_dssp             GGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCE
T ss_pred             cCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCccCCCCCchhhcCCCCCCE
Confidence            3445555555555555 334322           3444443 22 24445555555555555542111 23444455555


Q ss_pred             ccccccccc
Q 042107           71 LNLSFNTLE   79 (232)
Q Consensus        71 l~l~~n~l~   79 (232)
                      +++++|.++
T Consensus        95 L~l~~N~i~  103 (124)
T d1dcea3          95 LNLQGNSLC  103 (124)
T ss_dssp             EECTTSGGG
T ss_pred             EECCCCcCC
Confidence            555555443

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.79  E-value=2.5e-09  Score=82.66  Aligned_cols=87  Identities=23%  Similarity=0.219  Sum_probs=67.6

Q ss_pred             CCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKD   70 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~   70 (232)
                      ..++.|+.+++++|.|++..|..+           ++|++++..|..+..+++|+.++++.|++++..|..+..++++++
T Consensus       126 ~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~  205 (284)
T d1ozna_         126 RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT  205 (284)
T ss_dssp             TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred             chhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccc
Confidence            456778888888888885544432           578888777788888888888888888888877888888888888


Q ss_pred             cccccccccCCCCCcccc
Q 042107           71 LNLSFNTLEGKIPRPFRN   88 (232)
Q Consensus        71 l~l~~n~l~g~~p~~~~~   88 (232)
                      ++++.|.+.+..|..+..
T Consensus       206 L~l~~N~i~~~~~~~~~~  223 (284)
T d1ozna_         206 LYLFANNLSALPTEALAP  223 (284)
T ss_dssp             EECCSSCCSCCCHHHHTT
T ss_pred             cccccccccccccccccc
Confidence            888888888766655544

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=98.73  E-value=1.1e-08  Score=69.08  Aligned_cols=69  Identities=25%  Similarity=0.385  Sum_probs=56.3

Q ss_pred             CEEEccCCcccccCCC----------ccccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccccccc
Q 042107            8 LRIDLSTNNFSCVFPT----------TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNT   77 (232)
Q Consensus         8 ~~l~ls~N~~~g~~p~----------~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~   77 (232)
                      +.|||++|+++ .+|.          .+++|+++ .+|..++.+++|+.|++++|+++ .+| .+..+++|+.+++++|.
T Consensus         1 R~L~Ls~n~l~-~l~~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~   76 (124)
T d1dcea3           1 RVLHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR   76 (124)
T ss_dssp             SEEECTTSCCS-SCCCGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred             CEEEcCCCCCC-CCcccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCc
Confidence            57999999999 4443          12789997 57888899999999999999998 455 47889999999999998


Q ss_pred             ccC
Q 042107           78 LEG   80 (232)
Q Consensus        78 l~g   80 (232)
                      ++.
T Consensus        77 i~~   79 (124)
T d1dcea3          77 LQQ   79 (124)
T ss_dssp             CCS
T ss_pred             cCC
Confidence            865

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.71  E-value=1.5e-08  Score=78.08  Aligned_cols=89  Identities=25%  Similarity=0.284  Sum_probs=75.5

Q ss_pred             CCCCCCCCEEEccCCcccccCCCc-----------cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPTT-----------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK   69 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~~-----------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~   69 (232)
                      |+++++|+.|+|++|.+.+..+..           +++|++++..+..+..+++|+.|++++|++++-.|..+..+++|+
T Consensus       101 ~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~  180 (284)
T d1ozna_         101 FHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD  180 (284)
T ss_dssp             TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred             hcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccc
Confidence            467899999999999998654433           267999987778899999999999999999977777888999999


Q ss_pred             ccccccccccCCCCCccccc
Q 042107           70 DLNLSFNTLEGKIPRPFRNF   89 (232)
Q Consensus        70 ~l~l~~n~l~g~~p~~~~~~   89 (232)
                      .++++.|++++..|..|...
T Consensus       181 ~l~l~~N~l~~i~~~~f~~l  200 (284)
T d1ozna_         181 RLLLHQNRVAHVHPHAFRDL  200 (284)
T ss_dssp             EEECCSSCCCEECTTTTTTC
T ss_pred             hhhhhhccccccChhHhhhh
Confidence            99999999998878776544

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.69  E-value=1.9e-08  Score=70.63  Aligned_cols=51  Identities=29%  Similarity=0.352  Sum_probs=33.4

Q ss_pred             cccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccccccccccC
Q 042107           30 LQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEG   80 (232)
Q Consensus        30 ~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~l~g   80 (232)
                      ++..-+..|..+++|+.|+|++|+++.-.|..+..+++++.+++++|.++.
T Consensus        44 l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~   94 (156)
T d2ifga3          44 LQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES   94 (156)
T ss_dssp             CCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSC
T ss_pred             ccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcc
Confidence            444334556667777777777777775445556677777777777777763

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.68  E-value=1.9e-08  Score=76.88  Aligned_cols=86  Identities=27%  Similarity=0.292  Sum_probs=64.0

Q ss_pred             CCCCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKD   70 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~   70 (232)
                      .++++|+.|++++|.+....+..+           .+|.++...+..+..+++|+.|++++|++++..|..+..+++|+.
T Consensus        97 ~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~  176 (266)
T d1p9ag_          97 QTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT  176 (266)
T ss_dssp             TTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCE
T ss_pred             ccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccce
Confidence            567888899999888886444332           567777666677777888888888888888666666777888888


Q ss_pred             cccccccccCCCCCcccc
Q 042107           71 LNLSFNTLEGKIPRPFRN   88 (232)
Q Consensus        71 l~l~~n~l~g~~p~~~~~   88 (232)
                      |++++|.++ .+|..+.+
T Consensus       177 L~Ls~N~L~-~lp~~~~~  193 (266)
T d1p9ag_         177 LLLQENSLY-TIPKGFFG  193 (266)
T ss_dssp             EECCSSCCC-CCCTTTTT
T ss_pred             eecccCCCc-ccChhHCC
Confidence            888888887 67765443

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.65  E-value=3.8e-08  Score=75.14  Aligned_cols=88  Identities=25%  Similarity=0.283  Sum_probs=68.7

Q ss_pred             CCCCCCCEEEccCCcccccCCC----------ccccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPT----------TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDL   71 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~----------~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l   71 (232)
                      +.+++|+.|||++|++++..+.          .+++|++....+..+..+.++..|+++.|.+....+.....++.++.+
T Consensus        74 ~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l  153 (266)
T d1p9ag_          74 GTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL  153 (266)
T ss_dssp             SCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhc
Confidence            5678999999999999864332          125777777777778888999999999999985555566778999999


Q ss_pred             ccccccccCCCCCccccc
Q 042107           72 NLSFNTLEGKIPRPFRNF   89 (232)
Q Consensus        72 ~l~~n~l~g~~p~~~~~~   89 (232)
                      +++.|++++..+..+...
T Consensus       154 ~l~~N~l~~~~~~~~~~l  171 (266)
T d1p9ag_         154 SLANNNLTELPAGLLNGL  171 (266)
T ss_dssp             ECTTSCCSCCCTTTTTTC
T ss_pred             ccccccccccCccccccc
Confidence            999999988776655443

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.61  E-value=4e-08  Score=76.37  Aligned_cols=76  Identities=20%  Similarity=0.289  Sum_probs=55.9

Q ss_pred             CCCCCEEEccCCcccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccc
Q 042107            4 LKVLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLN   72 (232)
Q Consensus         4 ~~~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~   72 (232)
                      +++|+.|++++|.+++..|..+           ++|++++..|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+
T Consensus       170 ~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~  248 (305)
T d1xkua_         170 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY  248 (305)
T ss_dssp             CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred             CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEE
Confidence            4567777777777776655543           567777777777777888888888888877 6777777788888888


Q ss_pred             cccccccC
Q 042107           73 LSFNTLEG   80 (232)
Q Consensus        73 l~~n~l~g   80 (232)
                      +++|+++.
T Consensus       249 Ls~N~i~~  256 (305)
T d1xkua_         249 LHNNNISA  256 (305)
T ss_dssp             CCSSCCCC
T ss_pred             CCCCccCc
Confidence            88887763

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.58  E-value=2.2e-08  Score=70.80  Aligned_cols=75  Identities=24%  Similarity=0.188  Sum_probs=55.9

Q ss_pred             CCCCCCEEEccCCcccccCCCc-----------cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcc
Q 042107            3 NLKVLLRIDLSTNNFSCVFPTT-----------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDL   71 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p~~-----------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l   71 (232)
                      ++..|+.|||++|.|+. +|..           +++|+++. ++ .+..+++|+.|++++|+++.-.+.....++.++.+
T Consensus        16 n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L   92 (162)
T d1a9na_          16 NAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL   92 (162)
T ss_dssp             CTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred             CcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccccc
Confidence            55678889999999883 4432           26788873 43 47788999999999999984333345678899999


Q ss_pred             ccccccccC
Q 042107           72 NLSFNTLEG   80 (232)
Q Consensus        72 ~l~~n~l~g   80 (232)
                      ++++|.++.
T Consensus        93 ~L~~N~i~~  101 (162)
T d1a9na_          93 ILTNNSLVE  101 (162)
T ss_dssp             ECCSCCCCC
T ss_pred             eeccccccc
Confidence            999998764

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.56  E-value=3.1e-08  Score=70.02  Aligned_cols=77  Identities=25%  Similarity=0.256  Sum_probs=59.9

Q ss_pred             CCCCCCCEEEccCCcccccCCC----------ccccCccccccccccccCCCCCeeeCCCCcceecCC--cccccCCCCC
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPT----------TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIP--IPLEKLLDLK   69 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~----------~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip--~~~~~l~~l~   69 (232)
                      ..++.|+.||||+|.|+ .++.          .+++|+++...+..+..+++|+.|++++|+++ .++  ..+..+++|+
T Consensus        38 ~~l~~L~~L~Ls~N~i~-~l~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~  115 (162)
T d1a9na_          38 ATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLT  115 (162)
T ss_dssp             GGTTCCSEEECCSSCCC-EECCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCC
T ss_pred             cccccCCEEECCCCCCC-ccCCcccCcchhhhhcccccccCCCccccccccccccceecccccc-ccccccccccccccc
Confidence            34678999999999998 3332          13789988765566678999999999999997 344  3577899999


Q ss_pred             ccccccccccC
Q 042107           70 DLNLSFNTLEG   80 (232)
Q Consensus        70 ~l~l~~n~l~g   80 (232)
                      .+++++|.++.
T Consensus       116 ~L~l~~N~i~~  126 (162)
T d1a9na_         116 YLCILRNPVTN  126 (162)
T ss_dssp             EEECCSSGGGG
T ss_pred             hhhcCCCcccc
Confidence            99999998754

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.39  E-value=1.3e-06  Score=66.03  Aligned_cols=104  Identities=13%  Similarity=0.126  Sum_probs=64.0

Q ss_pred             eeecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCC-CCCccceeEEEecCCeeEEEEeccCCCC
Q 042107           92 VFNLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-HQNLIKIISSCSKDDFKALILEYMPHGS  170 (232)
Q Consensus        92 ~~~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~  170 (232)
                      ..+..+-++.+.||+... +++.+++|............+.+|...+..+. +--+.+++.+...++..++|||+++|.+
T Consensus        18 ~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~   96 (263)
T d1j7la_          18 CVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVL   96 (263)
T ss_dssp             EEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEE
T ss_pred             EEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccc
Confidence            333333334467898754 46677888876554444445677877766553 3336677888888888999999999988


Q ss_pred             hhhhhccCCCCCCHHHHHHHHHHHHHHHHHHh
Q 042107          171 LGKCLSTSNYILDFFQRLHIMIDVASAVEYLH  202 (232)
Q Consensus       171 L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH  202 (232)
                      +.+.....   .   ....++.++++.++.+|
T Consensus        97 ~~~~~~~~---~---~~~~~~~~l~~~l~~lH  122 (263)
T d1j7la_          97 CSEEYEDE---Q---SPEKIIELYAECIRLFH  122 (263)
T ss_dssp             HHHHTTTC---S---CHHHHHHHHHHHHHHHH
T ss_pred             cccccccc---c---cHHHHHHHHHHHHHHHh
Confidence            76543221   1   11223445555555555

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=98.28  E-value=9.3e-07  Score=68.35  Aligned_cols=85  Identities=26%  Similarity=0.359  Sum_probs=71.5

Q ss_pred             CCCCCCCEEEccCCcccccCCCc---------cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTT---------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLN   72 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~---------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~   72 (232)
                      ..++.|+.+++++|.++ .+|..         +.+|+.++..|..+..++.+++|++++|.+++..|..+..+++|++|+
T Consensus       147 ~~l~~L~~l~l~~n~l~-~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~  225 (305)
T d1xkua_         147 QGMKKLSYIRIADTNIT-TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH  225 (305)
T ss_dssp             GGCTTCCEEECCSSCCC-SCCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEE
T ss_pred             ccccccCccccccCCcc-ccCcccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeee
Confidence            45788999999999987 34443         267899999999999999999999999999988888899999999999


Q ss_pred             cccccccCCCCCcccc
Q 042107           73 LSFNTLEGKIPRPFRN   88 (232)
Q Consensus        73 l~~n~l~g~~p~~~~~   88 (232)
                      +++|.++ .+|..+.+
T Consensus       226 L~~N~L~-~lp~~l~~  240 (305)
T d1xkua_         226 LNNNKLV-KVPGGLAD  240 (305)
T ss_dssp             CCSSCCS-SCCTTTTT
T ss_pred             ccccccc-cccccccc
Confidence            9999987 45655443

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.27  E-value=1.5e-06  Score=60.59  Aligned_cols=77  Identities=18%  Similarity=0.153  Sum_probs=60.5

Q ss_pred             CCCCCCCEEEccCCc-ccccCCCcc-----------ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCC
Q 042107            2 SNLKVLLRIDLSTNN-FSCVFPTTI-----------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLK   69 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~-~~g~~p~~~-----------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~   69 (232)
                      ..+++|+.|+|++|+ ++..-+..+           ++|+++..-|..+..+++|+.|+|++|+++ .+|........++
T Consensus        28 ~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~  106 (156)
T d2ifga3          28 PGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQ  106 (156)
T ss_dssp             CSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCC
T ss_pred             cCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-ccChhhhcccccc
Confidence            456788999997664 774333332           679998877888899999999999999998 7777766666899


Q ss_pred             cccccccccc
Q 042107           70 DLNLSFNTLE   79 (232)
Q Consensus        70 ~l~l~~n~l~   79 (232)
                      .+++++|.+.
T Consensus       107 ~L~L~~Np~~  116 (156)
T d2ifga3         107 ELVLSGNPLH  116 (156)
T ss_dssp             EEECCSSCCC
T ss_pred             ccccCCCccc
Confidence            9999999874

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.26  E-value=6e-07  Score=71.36  Aligned_cols=53  Identities=25%  Similarity=0.380  Sum_probs=34.1

Q ss_pred             ccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccccccccccCCC
Q 042107           26 EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKI   82 (232)
Q Consensus        26 ~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~   82 (232)
                      ++|++++..  .+..+++|+.|++++|++++ +| .+..+++|+++++++|++++-.
T Consensus       315 s~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~  367 (384)
T d2omza2         315 YFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLT  367 (384)
T ss_dssp             CSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCG
T ss_pred             CCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCCh
Confidence            346665543  25667777777777777763 43 4667777777777777776543

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.21  E-value=5.8e-07  Score=71.45  Aligned_cols=71  Identities=32%  Similarity=0.453  Sum_probs=57.6

Q ss_pred             CCCCCCCEEEccCCcccccCCC-c--------cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPT-T--------IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLN   72 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~-~--------~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~   72 (232)
                      ..+++++.|++++|++++..|- .        +++|++++ +| .++.+++|+.|++++|++++-.|  +.++++|+.|+
T Consensus       304 ~~~~~l~~L~ls~n~l~~l~~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~  379 (384)
T d2omza2         304 SNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLG  379 (384)
T ss_dssp             GGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEE
T ss_pred             chhcccCeEECCCCCCCCCcccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEee
Confidence            3467889999999999975331 1        37888875 44 68999999999999999996544  78899999999


Q ss_pred             cccc
Q 042107           73 LSFN   76 (232)
Q Consensus        73 l~~n   76 (232)
                      +++|
T Consensus       380 L~~N  383 (384)
T d2omza2         380 LNDQ  383 (384)
T ss_dssp             CCCE
T ss_pred             CCCC
Confidence            9887

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.06  E-value=2.2e-05  Score=58.65  Aligned_cols=75  Identities=13%  Similarity=0.069  Sum_probs=51.4

Q ss_pred             cccCCCc-ceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCC--CCccceeEEEecCCeeEEEEeccCCCCh
Q 042107           95 LISRGGF-GSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRH--QNLIKIISSCSKDDFKALILEYMPHGSL  171 (232)
Q Consensus        95 ~lg~g~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L  171 (232)
                      .+..|.. +.||+....++..+++|.......   ..+..|...++.+..  --+++++.+..+++..+++||+++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4445543 578998877788888897654432   235567766665532  2366778887888888999999988665


Q ss_pred             h
Q 042107          172 G  172 (232)
Q Consensus       172 ~  172 (232)
                      .
T Consensus        94 ~   94 (255)
T d1nd4a_          94 L   94 (255)
T ss_dssp             T
T ss_pred             c
Confidence            3

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=98.00  E-value=3.4e-08  Score=72.16  Aligned_cols=72  Identities=28%  Similarity=0.377  Sum_probs=34.6

Q ss_pred             CCCCCEEEccCCcccccCCC----------ccccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccc
Q 042107            4 LKVLLRIDLSTNNFSCVFPT----------TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNL   73 (232)
Q Consensus         4 ~~~l~~l~ls~N~~~g~~p~----------~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l   73 (232)
                      +++|++|+|++|+|+ .+|.          .+++|+++ .+|.....+++|+.|++++|+++. ++ .+..+++|+.+++
T Consensus        47 L~~L~~L~Ls~n~I~-~i~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~L  122 (198)
T d1m9la_          47 LKACKHLALSTNNIE-KISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYM  122 (198)
T ss_dssp             TTTCCEEECSEEEES-CCCCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEEEE
T ss_pred             ccccceeECcccCCC-CcccccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-ccccccccccccc
Confidence            455566666666665 3332          01345544 234333334455555555555542 22 2444555555555


Q ss_pred             cccccc
Q 042107           74 SFNTLE   79 (232)
Q Consensus        74 ~~n~l~   79 (232)
                      ++|.++
T Consensus       123 ~~N~i~  128 (198)
T d1m9la_         123 SNNKIT  128 (198)
T ss_dssp             SEEECC
T ss_pred             ccchhc
Confidence            555543

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.98  E-value=1.6e-06  Score=60.83  Aligned_cols=69  Identities=28%  Similarity=0.318  Sum_probs=48.7

Q ss_pred             CCCCCCEEEccCCcccccCCCccccCccccccccccccCCCCCeeeCCCCcceecCCc-ccccCCCCCccccccccccCC
Q 042107            3 NLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPI-PLEKLLDLKDLNLSFNTLEGK   81 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p~~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~-~~~~l~~l~~l~l~~n~l~g~   81 (232)
                      +++.|+.||||+|+|+.. +          .++..+..+++|+.|+|++|+++. ++. .......++.+++++|.+...
T Consensus        63 ~~~~L~~L~Ls~N~i~~l-~----------~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~  130 (162)
T d1koha1          63 NIPELLSLNLSNNRLYRL-D----------DMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSDT  130 (162)
T ss_dssp             HCTTCCCCCCCSSCCCCC-S----------GGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSS
T ss_pred             hCCCCCEeeCCCccccCC-c----------hhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCcC
Confidence            467888888888888732 1          133456678899999999999984 433 233445788899999988765


Q ss_pred             CC
Q 042107           82 IP   83 (232)
Q Consensus        82 ~p   83 (232)
                      ..
T Consensus       131 ~~  132 (162)
T d1koha1         131 FR  132 (162)
T ss_dssp             SS
T ss_pred             cc
Confidence            43

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.92  E-value=7.9e-06  Score=60.25  Aligned_cols=41  Identities=29%  Similarity=0.538  Sum_probs=28.7

Q ss_pred             cccCCCCCeeeCCCCcceecCCcccccCCCCCccccccccccC
Q 042107           38 IGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEG   80 (232)
Q Consensus        38 ~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~l~g   80 (232)
                      ++.+++|+.|+|++|++++ +| .+..+++|++|++++|+++.
T Consensus       169 l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~  209 (227)
T d1h6ua2         169 LANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISD  209 (227)
T ss_dssp             GTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCB
T ss_pred             hcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCC
Confidence            6667777777777777763 43 26677777777777777664

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.86  E-value=7.6e-06  Score=59.73  Aligned_cols=75  Identities=32%  Similarity=0.465  Sum_probs=58.6

Q ss_pred             CCCCCCCCEEEccCCcccccCCC-----c-----cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCc
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPT-----T-----IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKD   70 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~-----~-----~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~   70 (232)
                      ++++++|+.|++++|.+.. ++.     .     ++.|++++  +..++.+++|+.+++++|++++ ++ .+.++++|+.
T Consensus       108 l~~l~~L~~L~l~~~~~~~-~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~  182 (210)
T d1h6ta2         108 LKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQN  182 (210)
T ss_dssp             GTTCTTCCEEECTTSCCCC-CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCE
T ss_pred             ccccccccccccccccccc-cccccccccccccccccccccc--cccccccccccccccccccccc-cc-cccCCCCCCE
Confidence            3568899999999998873 221     1     25677765  3457789999999999999985 44 3788999999


Q ss_pred             cccccccccC
Q 042107           71 LNLSFNTLEG   80 (232)
Q Consensus        71 l~l~~n~l~g   80 (232)
                      |++++|.++.
T Consensus       183 L~Ls~N~i~~  192 (210)
T d1h6ta2         183 LYLSKNHISD  192 (210)
T ss_dssp             EECCSSCCCB
T ss_pred             EECCCCCCCC
Confidence            9999999874

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.81  E-value=1.2e-05  Score=58.03  Aligned_cols=40  Identities=33%  Similarity=0.506  Sum_probs=20.5

Q ss_pred             cccCCCCCeeeCCCCcceecCCcccccCCCCCcccccccccc
Q 042107           38 IGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLE   79 (232)
Q Consensus        38 ~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~l~   79 (232)
                      ++.+++|+.|++++|.+. .+| .+..++.|+.++++.+...
T Consensus        80 l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~~~  119 (199)
T d2omxa2          80 LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQIT  119 (199)
T ss_dssp             GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCC
T ss_pred             ccCCcccccccccccccc-ccc-ccccccccccccccccccc
Confidence            455555555555555554 232 2445555555555555443

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.81  E-value=1.7e-05  Score=57.80  Aligned_cols=75  Identities=31%  Similarity=0.356  Sum_probs=59.0

Q ss_pred             CCCCCCCEEEccCCcccccCCC-----c-----cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPT-----T-----IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDL   71 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~-----~-----~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l   71 (232)
                      +++++|+.|++++|++++ +|.     .     +.+|.+..  ...+..++.++.++++.|.+++  +.....++.|+.+
T Consensus        87 ~~l~~L~~L~l~~n~i~~-l~~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l  161 (210)
T d1h6ta2          87 ANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTL  161 (210)
T ss_dssp             TTCTTCCEEECCSSCCCC-GGGGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEE
T ss_pred             ccCccccccccccccccc-cccccccccccccccccccccc--cccccccccccccccccccccc--ccccccccccccc
Confidence            578999999999999995 332     1     14565543  3468889999999999999975  3456789999999


Q ss_pred             ccccccccCC
Q 042107           72 NLSFNTLEGK   81 (232)
Q Consensus        72 ~l~~n~l~g~   81 (232)
                      ++++|++++.
T Consensus       162 ~l~~n~l~~i  171 (210)
T d1h6ta2         162 SLEDNQISDI  171 (210)
T ss_dssp             ECCSSCCCCC
T ss_pred             cccccccccc
Confidence            9999999864

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.81  E-value=9.1e-06  Score=59.91  Aligned_cols=70  Identities=23%  Similarity=0.377  Sum_probs=53.5

Q ss_pred             CCCCCCCEEEccCCcccccCC-----C----ccccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCccc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFP-----T----TIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLN   72 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p-----~----~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~   72 (232)
                      .++++|+.|++++|.++...+     .    .+++|++++ +| .++.+++|+.|+|++|+++ .+| ++.++++|+.++
T Consensus       148 ~~~~~L~~L~l~~n~~~~~~~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt-~i~-~l~~l~~L~~L~  223 (227)
T d1h6ua2         148 AGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQIS-DVS-PLANTSNLFIVT  223 (227)
T ss_dssp             GGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCC-BCG-GGTTCTTCCEEE
T ss_pred             ccccccccccccccccccchhhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCC-CCc-ccccCCCCCEEE
Confidence            456788899999988874332     1    136788876 33 3889999999999999998 455 378999999999


Q ss_pred             ccc
Q 042107           73 LSF   75 (232)
Q Consensus        73 l~~   75 (232)
                      +++
T Consensus       224 lsn  226 (227)
T d1h6ua2         224 LTN  226 (227)
T ss_dssp             EEE
T ss_pred             eeC
Confidence            864

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=97.78  E-value=6.3e-07  Score=65.18  Aligned_cols=44  Identities=30%  Similarity=0.440  Sum_probs=32.9

Q ss_pred             cccccccCCCCCeeeCCCCcceecCCcccccCCCCCcccccccccc
Q 042107           34 LRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLE   79 (232)
Q Consensus        34 ~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~l~   79 (232)
                      +|.+++.+++|+.|+|++|+++ .++ .+..+++|+.|++++|.++
T Consensus        40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~   83 (198)
T d1m9la_          40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK   83 (198)
T ss_dssp             CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC
T ss_pred             hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc
Confidence            4566777888888888888877 555 4677788888888888775

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=97.73  E-value=2.6e-05  Score=56.21  Aligned_cols=74  Identities=31%  Similarity=0.457  Sum_probs=40.3

Q ss_pred             CCCCCCCEEEccCCcccccCCC-----c-----cccCccccccccccccCCCCCeeeCCCCcceecCCcccccCCCCCcc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPT-----T-----IEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPIPLEKLLDLKDL   71 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~-----~-----~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l   71 (232)
                      +++++|+.|++++|.+.. +|.     .     +.+|++...  ..+..+++|+.|++++|++. .+| .+..+++++.+
T Consensus        81 ~~l~~L~~L~l~~n~~~~-~~~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L  155 (199)
T d2omxa2          81 KNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQL  155 (199)
T ss_dssp             TTCTTCCEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEE
T ss_pred             cCCccccccccccccccc-ccccccccccccccccccccccc--cccchhhhhHHhhhhhhhhc-ccc-ccccccccccc
Confidence            567777888887777763 221     0     133333322  23455666666666666654 222 34555666666


Q ss_pred             ccccccccC
Q 042107           72 NLSFNTLEG   80 (232)
Q Consensus        72 ~l~~n~l~g   80 (232)
                      ++.+|.+++
T Consensus       156 ~l~~n~l~~  164 (199)
T d2omxa2         156 NFSSNQVTD  164 (199)
T ss_dssp             ECCSSCCCC
T ss_pred             ccccccccC
Confidence            666665544

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=97.64  E-value=4.9e-05  Score=58.98  Aligned_cols=36  Identities=31%  Similarity=0.389  Sum_probs=23.8

Q ss_pred             CCCeeeCCCCcceecCCcccccCCCCCccccccccccC
Q 042107           43 SLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEG   80 (232)
Q Consensus        43 ~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~l~g   80 (232)
                      .|+.|++++|.+. .+|. ...+..|+.++++.+.+..
T Consensus        99 ~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~  134 (353)
T d1jl5a_          99 LLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK  134 (353)
T ss_dssp             TCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSC
T ss_pred             ccccccccccccc-cccc-hhhhccceeeccccccccc
Confidence            4677777777766 5553 4567777777777766654

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=97.63  E-value=5.3e-05  Score=58.81  Aligned_cols=39  Identities=28%  Similarity=0.437  Sum_probs=26.7

Q ss_pred             CCCCCeeeCCCCcceecCCcccccCCCCCccccccccccCCCCC
Q 042107           41 LTSLKSLDLSNNNFSGAIPIPLEKLLDLKDLNLSFNTLEGKIPR   84 (232)
Q Consensus        41 l~~L~~L~ls~N~l~g~ip~~~~~l~~l~~l~l~~n~l~g~~p~   84 (232)
                      +++|+.|+|++|+++ .+|..   +.+|+.|++++|+++ .+|.
T Consensus       303 ~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~  341 (353)
T d1jl5a_         303 PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD  341 (353)
T ss_dssp             CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred             cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCc
Confidence            457777888888877 66643   346777888888776 4454

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.56  E-value=6.8e-05  Score=55.40  Aligned_cols=75  Identities=13%  Similarity=0.236  Sum_probs=45.9

Q ss_pred             CCCEEEccCCcccccCCCcc-----------ccCccccccc-cccccCCCCCeeeCC-CCcceecCCcccccCCCCCccc
Q 042107            6 VLLRIDLSTNNFSCVFPTTI-----------EYNRLQDSLR-NSIGDLTSLKSLDLS-NNNFSGAIPIPLEKLLDLKDLN   72 (232)
Q Consensus         6 ~l~~l~ls~N~~~g~~p~~~-----------~~n~~~~~~p-~~~~~l~~L~~L~ls-~N~l~g~ip~~~~~l~~l~~l~   72 (232)
                      ++++|||++|.|+...+..+           ++|.+...+| ..+..+++++.|++. .|++....|..+..+++|+.++
T Consensus        30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~  109 (242)
T d1xwdc1          30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL  109 (242)
T ss_dssp             CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred             CCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccc
Confidence            67788888888874333222           4566655544 345666677766654 3556555555566677777777


Q ss_pred             cccccccC
Q 042107           73 LSFNTLEG   80 (232)
Q Consensus        73 l~~n~l~g   80 (232)
                      ++.|.+..
T Consensus       110 l~~~~l~~  117 (242)
T d1xwdc1         110 ISNTGIKH  117 (242)
T ss_dssp             EESCCCCS
T ss_pred             cchhhhcc
Confidence            77776654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.42  E-value=0.00044  Score=55.04  Aligned_cols=76  Identities=11%  Similarity=0.161  Sum_probs=47.6

Q ss_pred             eecccCCCcceeeeEEeCC-CcEEEEEEeecc-------cCchHHHHHHHHHHhcCCC---CCCccceeEEEecCCeeEE
Q 042107           93 FNLISRGGFGSIYKARIQD-GMEVVVKGFNLQ-------YGGAFKNLDVECNMMKIIR---HQNLIKIISSCSKDDFKAL  161 (232)
Q Consensus        93 ~~~lg~g~~g~V~~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~l  161 (232)
                      .+.+|.|....||+....+ ++.+++|.....       ......+...|.+.++.+.   ...+++++.+  +++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            3568999999999997654 678999976431       1112344556777776542   2345666654  3445678


Q ss_pred             EEeccCCCC
Q 042107          162 ILEYMPHGS  170 (232)
Q Consensus       162 v~e~~~~g~  170 (232)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.38  E-value=0.0001  Score=54.34  Aligned_cols=78  Identities=18%  Similarity=0.143  Sum_probs=55.4

Q ss_pred             CCCCCCCCEEEccCCcccccCCCc-c------------ccCccccccccccccCCCCCeeeCCCCcceecCCc-ccccCC
Q 042107            1 MSNLKVLLRIDLSTNNFSCVFPTT-I------------EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIPI-PLEKLL   66 (232)
Q Consensus         1 ~~~~~~l~~l~ls~N~~~g~~p~~-~------------~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip~-~~~~l~   66 (232)
                      |.++++|++|||++|.+...+|.. +            ..|++....|..+..+++|+.|+++.|++....+. ....+.
T Consensus        49 f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~  128 (242)
T d1xwdc1          49 FSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ  128 (242)
T ss_dssp             TTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSS
T ss_pred             hhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccccchhhhccccccccccccc
Confidence            467899999999999998766542 1            35788888888899999999999999999743222 233444


Q ss_pred             CCCccccccccc
Q 042107           67 DLKDLNLSFNTL   78 (232)
Q Consensus        67 ~l~~l~l~~n~l   78 (232)
                      .+..+....+.+
T Consensus       129 ~l~~~~~~n~~l  140 (242)
T d1xwdc1         129 KVLLDIQDNINI  140 (242)
T ss_dssp             CEEEEEESCTTC
T ss_pred             cccccccccccc
Confidence            444444444444

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.88  E-value=0.00075  Score=51.07  Aligned_cols=48  Identities=21%  Similarity=0.168  Sum_probs=31.4

Q ss_pred             ccccccccccccCCCCCeeeCCC-CcceecCCcccccCCCCCccccccc
Q 042107           29 RLQDSLRNSIGDLTSLKSLDLSN-NNFSGAIPIPLEKLLDLKDLNLSFN   76 (232)
Q Consensus        29 ~~~~~~p~~~~~l~~L~~L~ls~-N~l~g~ip~~~~~l~~l~~l~l~~n   76 (232)
                      .+++..+..++++++|+.|+|++ ++++......+.++++|+.++++++
T Consensus       187 ~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~  235 (284)
T d2astb2         187 MLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI  235 (284)
T ss_dssp             TCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred             CCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence            45555566666777777777777 4566555555666777777777654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.79  E-value=0.0048  Score=47.42  Aligned_cols=68  Identities=10%  Similarity=0.110  Sum_probs=44.0

Q ss_pred             ceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCCCCCc-----cce--eEEEecCCeeEEEEeccCCCC
Q 042107          102 GSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIRHQNL-----IKI--ISSCSKDDFKALILEYMPHGS  170 (232)
Q Consensus       102 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----v~~--~~~~~~~~~~~lv~e~~~~g~  170 (232)
                      -.||+++..+|..+++|....... ..+.+..|...+..+....+     +..  -......+..+.++++++|..
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            479999988999999998765432 34667778877766532222     111  112234567788999987643

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.78  E-value=0.00011  Score=51.11  Aligned_cols=75  Identities=27%  Similarity=0.217  Sum_probs=50.0

Q ss_pred             CCCEEEccCCcccccCCCc--c----ccCccccccccccccCCCCCeeeCCCCcceec--CCcccccCCCCCcccccccc
Q 042107            6 VLLRIDLSTNNFSCVFPTT--I----EYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGA--IPIPLEKLLDLKDLNLSFNT   77 (232)
Q Consensus         6 ~l~~l~ls~N~~~g~~p~~--~----~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~--ip~~~~~l~~l~~l~l~~n~   77 (232)
                      ....||++++...-.+...  +    ..+.+...++.....+++|+.|+|++|+++.-  ++..+..+++|+.|++++|.
T Consensus        23 ~~~~Ldls~l~~~~~l~~~~~~~~l~~~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~  102 (162)
T d1koha1          23 SQQALDLKGLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNE  102 (162)
T ss_dssp             SSCCBCCCCCSSCTTTTTTTCCCCTTSHHHHHHHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSC
T ss_pred             hhCeeecccCCCCchhhhccchhhcchhhhHhhhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCc
Confidence            4566888876643222111  0    12333344455556799999999999999842  23446779999999999999


Q ss_pred             ccC
Q 042107           78 LEG   80 (232)
Q Consensus        78 l~g   80 (232)
                      ++.
T Consensus       103 i~~  105 (162)
T d1koha1         103 LKS  105 (162)
T ss_dssp             CCC
T ss_pred             ccc
Confidence            875

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.54  E-value=0.00023  Score=57.00  Aligned_cols=55  Identities=31%  Similarity=0.403  Sum_probs=35.1

Q ss_pred             ccCccccc----cccccc-cCCCCCeeeCCCCcceec----CCcccccCCCCCccccccccccC
Q 042107           26 EYNRLQDS----LRNSIG-DLTSLKSLDLSNNNFSGA----IPIPLEKLLDLKDLNLSFNTLEG   80 (232)
Q Consensus        26 ~~n~~~~~----~p~~~~-~l~~L~~L~ls~N~l~g~----ip~~~~~l~~l~~l~l~~n~l~g   80 (232)
                      ++|++++.    ++..+. ..+.|+.|+|++|+++..    ++..+..+++|++|++++|+++.
T Consensus       348 s~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~  411 (460)
T d1z7xw1         348 SNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD  411 (460)
T ss_dssp             CSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred             eeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence            45555442    333333 345688888888888642    34445667888888888888764

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.52  E-value=0.00053  Score=51.96  Aligned_cols=73  Identities=27%  Similarity=0.313  Sum_probs=45.4

Q ss_pred             CCCCCCEEEccCCcccccCCCc------------cccCccccccccccccCCCCCeeeCCCC-cceec-CCcccccCCCC
Q 042107            3 NLKVLLRIDLSTNNFSCVFPTT------------IEYNRLQDSLRNSIGDLTSLKSLDLSNN-NFSGA-IPIPLEKLLDL   68 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p~~------------~~~n~~~~~~p~~~~~l~~L~~L~ls~N-~l~g~-ip~~~~~l~~l   68 (232)
                      ...+|++|||+++.++......            +.++++++..+..++++++|+.|+|+++ .++.. +..-...+++|
T Consensus        44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L  123 (284)
T d2astb2          44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL  123 (284)
T ss_dssp             CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred             cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhc
Confidence            3467899999999887532111            2456666666677777777777777773 44421 22223456777


Q ss_pred             Ccccccc
Q 042107           69 KDLNLSF   75 (232)
Q Consensus        69 ~~l~l~~   75 (232)
                      +.+++++
T Consensus       124 ~~L~ls~  130 (284)
T d2astb2         124 DELNLSW  130 (284)
T ss_dssp             CEEECCC
T ss_pred             ccccccc
Confidence            7777765

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.15  E-value=0.011  Score=46.63  Aligned_cols=72  Identities=17%  Similarity=0.224  Sum_probs=46.5

Q ss_pred             ecccCCCcceeeeEEeCC--------CcEEEEEEeecccCchHHHHHHHHHHhcCCC-CCCccceeEEEecCCeeEEEEe
Q 042107           94 NLISRGGFGSIYKARIQD--------GMEVVVKGFNLQYGGAFKNLDVECNMMKIIR-HQNLIKIISSCSKDDFKALILE  164 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  164 (232)
                      +.|+-|-.-.+|++...+        ...|++++.. .... .....+|..+++.+. +.-.+++++++..    ++|||
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            567778888899987543        3456666654 2222 234567888888774 4334577777642    68999


Q ss_pred             ccCCCCh
Q 042107          165 YMPHGSL  171 (232)
Q Consensus       165 ~~~~g~L  171 (232)
                      |++|.++
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987544

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=95.81  E-value=0.0016  Score=50.46  Aligned_cols=44  Identities=20%  Similarity=0.221  Sum_probs=23.9

Q ss_pred             cccccCCCCCeeeCCCCcceec-----CCcccccCCCCCcccccccccc
Q 042107           36 NSIGDLTSLKSLDLSNNNFSGA-----IPIPLEKLLDLKDLNLSFNTLE   79 (232)
Q Consensus        36 ~~~~~l~~L~~L~ls~N~l~g~-----ip~~~~~l~~l~~l~l~~n~l~   79 (232)
                      ..+...+.|+.|+|+.|++...     +...+..++.|+.|+++.|.++
T Consensus       180 ~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~  228 (344)
T d2ca6a1         180 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT  228 (344)
T ss_dssp             HHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred             chhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccc
Confidence            3344556666666666665421     2223445566666666666553

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=95.80  E-value=0.00096  Score=51.73  Aligned_cols=69  Identities=23%  Similarity=0.337  Sum_probs=37.1

Q ss_pred             CCCCCCEEEccCCcccccCCCccccCccccccccccccCCCCCeeeCCCCcceec----CCcccccCCCCCccccccccc
Q 042107            3 NLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGA----IPIPLEKLLDLKDLNLSFNTL   78 (232)
Q Consensus         3 ~~~~l~~l~ls~N~~~g~~p~~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~----ip~~~~~l~~l~~l~l~~n~l   78 (232)
                      .++.|+.|+|++|.++..-        +...+...+..+++|+.|+|++|.++..    +...+..++.|+.|++++|.+
T Consensus       184 ~~~~L~~L~L~~n~i~~~g--------~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i  255 (344)
T d2ca6a1         184 SHRLLHTVKMVQNGIRPEG--------IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL  255 (344)
T ss_dssp             HCTTCCEEECCSSCCCHHH--------HHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCC
T ss_pred             hhhhhcccccccccccccc--------cccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCcc
Confidence            3567889999998886310        0001122334455666666666655421    223344555666666666655


Q ss_pred             c
Q 042107           79 E   79 (232)
Q Consensus        79 ~   79 (232)
                      +
T Consensus       256 ~  256 (344)
T d2ca6a1         256 S  256 (344)
T ss_dssp             C
T ss_pred             C
Confidence            4

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.77  E-value=0.0013  Score=52.38  Aligned_cols=77  Identities=17%  Similarity=0.113  Sum_probs=50.1

Q ss_pred             CCCCCEEEccCCccccc--------CC---Cc-----cccCccccccc----cccccCCCCCeeeCCCCcceec----CC
Q 042107            4 LKVLLRIDLSTNNFSCV--------FP---TT-----IEYNRLQDSLR----NSIGDLTSLKSLDLSNNNFSGA----IP   59 (232)
Q Consensus         4 ~~~l~~l~ls~N~~~g~--------~p---~~-----~~~n~~~~~~p----~~~~~l~~L~~L~ls~N~l~g~----ip   59 (232)
                      .+.+..+++++|.++..        ++   ..     ++.|.++..-.    ..+...++|+.|+|++|+++..    ++
T Consensus       282 ~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~  361 (460)
T d1z7xw1         282 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC  361 (460)
T ss_dssp             CTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhh
Confidence            46778888888888631        11   11     24555654422    3334567899999999998642    33


Q ss_pred             cccc-cCCCCCccccccccccC
Q 042107           60 IPLE-KLLDLKDLNLSFNTLEG   80 (232)
Q Consensus        60 ~~~~-~l~~l~~l~l~~n~l~g   80 (232)
                      ..+. ....|+.|++++|.++.
T Consensus       362 ~~l~~~~~~L~~L~Ls~n~i~~  383 (460)
T d1z7xw1         362 QGLGQPGSVLRVLWLADCDVSD  383 (460)
T ss_dssp             HHHTSTTCCCCEEECTTSCCCH
T ss_pred             hhhhcccCCCCEEECCCCCCCh
Confidence            3332 45679999999999864

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=95.26  E-value=0.0027  Score=43.94  Aligned_cols=69  Identities=20%  Similarity=0.201  Sum_probs=35.7

Q ss_pred             CCCCCCCEEEccC-CcccccCCCccccCccccccccccccCCCCCeeeCCCCcceecC----CcccccCCCCCccccccc
Q 042107            2 SNLKVLLRIDLST-NNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAI----PIPLEKLLDLKDLNLSFN   76 (232)
Q Consensus         2 ~~~~~l~~l~ls~-N~~~g~~p~~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~i----p~~~~~l~~l~~l~l~~n   76 (232)
                      .+.++|+.|+|++ |.++..   .+      ..+-..+...+.|+.|+|++|.+...-    ...+...+.++.++++.|
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~---~~------~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n   82 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKE---RI------RSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESN   82 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHH---HH------HHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSS
T ss_pred             hCCCCCcEEEeCCCCCCCHH---HH------HHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehh
Confidence            3568899999987 456521   00      011123334455666666666554211    112334455666666666


Q ss_pred             ccc
Q 042107           77 TLE   79 (232)
Q Consensus        77 ~l~   79 (232)
                      .++
T Consensus        83 ~i~   85 (167)
T d1pgva_          83 FLT   85 (167)
T ss_dssp             BCC
T ss_pred             hcc
Confidence            554

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=93.91  E-value=0.0081  Score=41.35  Aligned_cols=68  Identities=15%  Similarity=0.109  Sum_probs=42.9

Q ss_pred             CCCCCCCEEEccCCcccccCCCccccCccccccccccccCCCCCeeeCCCCcceec----CCcccccCCCCCcccccccc
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGA----IPIPLEKLLDLKDLNLSFNT   77 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~----ip~~~~~l~~l~~l~l~~n~   77 (232)
                      ...+.|+.|+|++|.+...-..         .+...+...+.|+.|+|++|.++..    +-..+...+.|+.|+++.|.
T Consensus        41 ~~n~~L~~L~Ls~n~l~~~~~~---------~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~  111 (167)
T d1pgva_          41 CNSKHIEKFSLANTAISDSEAR---------GLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQR  111 (167)
T ss_dssp             TTCSCCCEEECTTSCCBHHHHT---------THHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCS
T ss_pred             hhCCccceeeccccccchhHHH---------HHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCc
Confidence            3456788888888887632111         1223344567888888888888643    12235566778888887764


Q ss_pred             c
Q 042107           78 L   78 (232)
Q Consensus        78 l   78 (232)
                      .
T Consensus       112 ~  112 (167)
T d1pgva_         112 Q  112 (167)
T ss_dssp             S
T ss_pred             C
Confidence            3

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=93.79  E-value=0.055  Score=40.79  Aligned_cols=46  Identities=11%  Similarity=0.121  Sum_probs=25.4

Q ss_pred             ecccCCCcceeeeEEeCCCcEEEEEEeecccCchHHHHHHHHHHhcCCC
Q 042107           94 NLISRGGFGSIYKARIQDGMEVVVKGFNLQYGGAFKNLDVECNMMKIIR  142 (232)
Q Consensus        94 ~~lg~g~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~  142 (232)
                      +.|..|---..|+.+..+| .+++|+.....  ..+.+..|.+++..+.
T Consensus        24 ~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~   69 (316)
T d2ppqa1          24 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLA   69 (316)
T ss_dssp             EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHH
T ss_pred             ecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhh
Confidence            3455666667888876655 58999885432  2234555666666553

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=91.17  E-value=0.028  Score=38.32  Aligned_cols=69  Identities=19%  Similarity=0.200  Sum_probs=45.3

Q ss_pred             CCCCCCCEEEccC-CcccccCCCccccCccccccccccccCCCCCeeeCCCCcceecCC----cccccCCCCCccccccc
Q 042107            2 SNLKVLLRIDLST-NNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFSGAIP----IPLEKLLDLKDLNLSFN   76 (232)
Q Consensus         2 ~~~~~l~~l~ls~-N~~~g~~p~~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~g~ip----~~~~~l~~l~~l~l~~n   76 (232)
                      .+.+.|+.|+|++ |.++-.   .+      ..+-..+...+.|+.|+|++|.++..--    ..+...+.++.++++.+
T Consensus        14 ~~~~~L~~L~L~~~~~i~~~---~~------~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~   84 (166)
T d1io0a_          14 NNDPDLEEVNLNNIMNIPVP---TL------KACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESN   84 (166)
T ss_dssp             TTCTTCCEEECTTCTTCCHH---HH------HHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSS
T ss_pred             hcCCCCcEEEcCCCCCCCHH---HH------HHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccc
Confidence            4568999999997 556521   10      0122344567889999999998864321    22455778888888877


Q ss_pred             ccc
Q 042107           77 TLE   79 (232)
Q Consensus        77 ~l~   79 (232)
                      .+.
T Consensus        85 ~~~   87 (166)
T d1io0a_          85 FIS   87 (166)
T ss_dssp             CCC
T ss_pred             ccc
Confidence            654

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=90.05  E-value=0.028  Score=38.34  Aligned_cols=45  Identities=13%  Similarity=0.119  Sum_probs=26.5

Q ss_pred             CCCCCCCEEEccCCcccccCCCccccCccccccccccccCCCCCeeeCCCCcce
Q 042107            2 SNLKVLLRIDLSTNNFSCVFPTTIEYNRLQDSLRNSIGDLTSLKSLDLSNNNFS   55 (232)
Q Consensus         2 ~~~~~l~~l~ls~N~~~g~~p~~~~~n~~~~~~p~~~~~l~~L~~L~ls~N~l~   55 (232)
                      ..++.|+.|+|++|.++..--..+         -..+...+.++.++++.|.+.
T Consensus        43 ~~n~~L~~L~Ls~n~l~~~~~~~L---------~~~l~~~~~l~~l~l~~~~~~   87 (166)
T d1io0a_          43 KTNTYVKKFSIVGTRSNDPVAFAL---------AEMLKVNNTLKSLNVESNFIS   87 (166)
T ss_dssp             TTCCSCCEEECTTSCCCHHHHHHH---------HHHHHHCSSCCEEECCSSCCC
T ss_pred             hcCCccCeeeccCCcccHHHHHHH---------HHHHhhcccchhhhhcccccc
Confidence            467899999999999874211111         122233455666666665554